PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Mao, X; Miao, GZ; Tao, XG; Hao, SY; Zhang, H; Li, H; Hou, ZG; Tian, RF; Lu, T; Ma, J; Zhang, XD; Cheng, HW; Liu, BY				Mao, Xiang; Miao, Guozhuan; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Ma, Jun; Zhang, Xiaodong; Cheng, Hongwei; Liu, Baiyun			Saikosaponin a protects TBI rats after controlled cortical impact and the underlying mechanism	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Saikosaponin a; controlled cortical impact; neuroprotection; inflammation; mitogen-activated protein kinase	NERVOUS-SYSTEM INJURIES; TRAUMATIC BRAIN-INJURY; RAW 264.7 CELLS; INFLAMMATION; PATHWAY; MAPK; LPS; ACTIVATION; DEFICITS; STROKE	The inflammatory response plays a significant role in neuronal cell death and functional deficits after Traumatic brain injury (TBI). Importantly, anti-inflammatory agents have neuroprotective effects. To date, however, no studies have investigated the neuroprotective effects of Saikosaponin a (SSa) after TBI. In the present study, rats with controlled cortical impact (CCI) were used to investigate the neuroprotective effects of SSa. The results showed that SSa reduced body weight loss, improved neurological functions andcognition, and reduced brain edema and blood brain barrier permeability after CCI. Moreover, SSa inhibited aquaporin-4 (AQP-4), matrix metalloprotein-9 (MMP-9), mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (c-JNK), tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The reduction in the loss of occludin mediated by SSa may partially account for its neuroprotective effects. Together, our results suggest that SSa appears to counteract the inflammatory response and neurological function deficits after TBI and possibly via an anti-inflammatory response and inhibition of the MAPK signaling pathway.	[Mao, Xiang; Zhang, Hao; Zhang, Xiaodong; Cheng, Hongwei] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Anhui, Peoples R China; [Mao, Xiang; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China; [Miao, Guozhuan; Zhang, Hao; Liu, Baiyun] Gen Hosp Armed Police Forces, Dept Neurotrauma, Beijing, Peoples R China; [Tao, Xiaogang; Hao, Shuyu; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Mao, Xiang; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Mao, Xiang; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Ma, Jun] Capital Med Univ, Beijing Tian Tan Hosp, Imaging Ctr Neurosci, Beijing, Peoples R China		Cheng, HW (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Anhui, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China.	chenghongweiamu@126.com; liubaiyun1212@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144, 81471238, 81341059, 81371610]; Beijing Nova programBeijing Municipal Science & Technology Commission [2012033]; National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI09B03]	The authors report no conflict of interests related to this study or the findings specified in this paper. This study was supported by National Natural Science Foundation of China (No. 81171144, No. 81471238, No. 81341059, No. 81371610), Beijing Nova program (No. 2012033) and National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03).	Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JC, 2003, AM J CHINESE MED, V31, P363, DOI 10.1142/S0192415X03001065; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Fan WH, 2011, CHINESE J EXPT TRADI, V17, P181; KUMAZAWA Y, 1990, INT J IMMUNOPHARMACO, V12, P531, DOI 10.1016/0192-0561(90)90117-6; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Li Chang-zheng, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P839; Li ZY, 2014, PROG NEURO-PSYCHOPH, V53, P80, DOI 10.1016/j.pnpbp.2014.02.010; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu KH, 2005, FREE RADICAL BIO MED, V39, P71, DOI 10.1016/j.freeadbiomed.2005.03.033; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mao X, 2015, BRAIN INJURY, V29, P86, DOI 10.3109/02699052.2014.968621; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Noble LJ, 2002, J NEUROSCI, V22, P7526; QIAN L, 1995, PATHOL INT, V45, P207, DOI 10.1111/j.1440-1827.1995.tb03444.x; Shao JX, 2013, J NEUROIMMUNOL, V254, P83, DOI 10.1016/j.jneuroim.2012.09.012; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Shyu KG, 2004, LIFE SCI, V76, P813, DOI 10.1016/j.lfs.2004.10.003; Wang ZQ, 2012, J ETHNOPHARMACOL, V144, P145, DOI 10.1016/j.jep.2012.08.041; Yu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050694; Zeuthen T, 1997, BIOL CELL, V89, P307, DOI 10.1016/S0248-4900(97)83383-7; Zhu J, 2013, EXP THER MED, V5, P1345, DOI 10.3892/etm.2013.988	28	16	20	2	4	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2016	8	1					133	141					9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	DE1EN	WOS:000370369600013	27069547				2022-02-06	
J	McCarthy, CG; Webb, RC				McCarthy, Cameron G.; Webb, R. Clinton			The toll of the gridiron: damage-associated molecular patterns and hypertension in American football	FASEB JOURNAL			English	Article						musculoskeletal trauma; inflammation; blood; pressure	DISEASE RISK-FACTORS; BODY-MASS INDEX; LEAGUE PLAYERS; BLOOD-PRESSURE; RECURRENT CONCUSSION; CREATINE-KINASE; CARDIAC MARKERS; NFL PLAYERS; MARATHON; EXERCISE	American football has unequivocally been linked to elevations in blood pressure and hypertension, especially in linemen. However, the mechanisms of this increase cannot be attributed solely to increased body weight and associated cardiometabolic risk factors (e.g., dyslipidemia or hyperglycemia). Therefore, understanding the etiology of football-associated hypertension is essential for improving the quality of life in this mostly young population, as well as for lowering the potential for chronic disease in the future. We propose that inflammatogenic damage-associated molecular patterns (DAMPs) released into the circulation from football-induced musculoskeletal trauma activate pattern-recognition receptors of the innate immune system-specifically, high mobility group box 1 protein (HMGB1) and mitochondrial (mt) DNA which activate Toll-like receptor (TLR)4 and -9, respectively. Previously, we observed that circulating levels of these 2 DAMPs are increased in hypertension, and activation of TLR4 and -9 causes endothelial dysfunction and hypertension. Therefore, our novel hypothesis is that musculoskeletal injury from repeated hits in football players, particularly in linemen, leads to elevated circulating HMGB1 and mtDNA to activate TLRs on endothelial cells leading to impaired endothelium-dependent vasodilation, increased vascular tone, and hypertension.-McCarthy, C. G., Webb, R. C. The toll of the gridiron: damage-associated molecular patterns and hypertension in American football. FASEB J. 30, 34-40 (2016). www.fasebj.org	[McCarthy, Cameron G.; Webb, R. Clinton] Georgia Regents Univ, Dept Physiol, Augusta, GA 30912 USA		McCarthy, CG (corresponding author), Georgia Regents Univ, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	cmccarthy@gru.edu			American Heart AssociationAmerican Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071138]; NIH National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK083685]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK083685] Funding Source: NIH RePORTER	The authors thank Drs. T. Szasz and C. F. Wenceslau (Department of Physiology, Georgia Regents University, Augusta, GA, USA) and Drs. N. Jenkins and K. McCully (Department of Kinesiology, University of Georgia, Athens, GA, USA), for their critical evaluation of the manuscript and editorial expertise. The preparation of this report was supported in part by a predoctoral fellowship (to C.G.M.) and a grant-in-aid (to R.C.W.) from the American Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01HL071138 (to R.C.W.); and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK083685 (to R.C.W.). The authors declare no conflicts of interest.	Allen TW, 2010, PHYSICIAN SPORTSMED, V38, P21, DOI 10.3810/psm.2010.04.1758; Basra SS, 2014, AM J CARDIOL, V114, P1836, DOI 10.1016/j.amjcard.2014.09.021; Biderman D, 2010, WALL STREET J; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Croft LB, 2008, AM J CARDIOL, V102, P343, DOI 10.1016/j.amjcard.2008.03.065; D'Andrea A, 2007, INT J CARDIOL, V115, P342, DOI 10.1016/j.ijcard.2006.03.041; Doucleff M., 2013, NPR             0201; Ehlers GG, 2002, J ATHL TRAINING, V37, P151; Fisman EZ, 1997, AM J CARDIOL, V79, P355, DOI 10.1016/S0002-9149(96)00761-8; Fisman EZ, 2002, AM J CARDIOL, V89, P887, DOI 10.1016/S0002-9149(02)02210-5; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Garrido-Chamorro RP, 2009, J SPORT MED PHYS FIT, V49, P278; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Harp JB, 2005, JAMA-J AM MED ASSOC, V293, P1061, DOI 10.1001/jama.293.9.1061-b; Hoffman JR, 2008, INTJ SPORT PHYSIOL, V3, P387, DOI 10.1123/ijspp.3.3.387; Jee H, 2013, AM J PHYS MED REHAB, V92, P513, DOI 10.1097/PHM.0b013e31829232db; Kahanov L., 2012, ONLINE J MED MED SCI, V1, P96; KANNEL WB, 1967, ANN INTERN MED, V67, P48, DOI 10.7326/0003-4819-67-1-48; Kaplan NM, 2005, J AM COLL CARDIOL, V45, P1346, DOI 10.1016/j.jacc.2005.02.012; Karpinos AR, 2013, CIRC-CARDIOVASC QUAL, V6, P716, DOI 10.1161/CIRCOUTCOMES.113.000463; Kilbaugh TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130927; Kim JH, 2015, AM J CARDIOL, V115, P262, DOI 10.1016/j.amjcard.2014.10.033; Kim YJ, 2012, INT J SPORTS MED, V33, P171, DOI 10.1055/s-0031-1285930; Kim YJ, 2015, J CLIN HYPERTENS, V17, P868, DOI 10.1111/jch.12591; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kraemer WJ, 2013, J STRENGTH COND RES, V27, P434, DOI 10.1519/JSC.0b013e318281d1b0; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe9; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McCarthy CG, 2015, CARDIOVASC RES, V107, P119, DOI 10.1093/cvr/cvv137; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Meredith PA, 2006, J RENIN-ANGIO-ALDO S, V7, P64, DOI 10.3317/jraas.2006.012; NISHIZAWA T, 1976, AM J CLIN NUTR, V29, P1167, DOI 10.1093/ajcn/29.10.1167; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Owoeye O. B. A., 2013, AM J HYPERTENSION RE, V1, P26; Pincivero DM, 1997, SPORTS MED, V23, P247, DOI 10.2165/00007256-199723040-00004; Pokharel Y, 2014, SOUTH MED J, V107, P633, DOI 10.14423/SMJ.0000000000000173; Rehm K, 2015, INT J SPORTS MED, V36, P832, DOI 10.1055/s-0035-1547218; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Selden MA, 2009, AM J MED, V122, P811, DOI 10.1016/j.amjmed.2009.03.027; Selden MA, 2009, AM J CARDIOL, V103, P969, DOI 10.1016/j.amjcard.2008.12.046; Seys SF, 2015, ALLERGY, V70, P187, DOI 10.1111/all.12540; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Siegel AJ, 2012, AM J MED, V125, P630, DOI 10.1016/j.amjmed.2011.11.008; Smith LL, 2000, MED SCI SPORT EXER, V32, P317, DOI 10.1097/00005768-200002000-00011; Smith LL, 2004, J STRENGTH COND RES, V18, P185, DOI 10.1519/00124278-200402000-00028; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; Vaneckova I, 2014, J ENDOCRINOL, V223, pR63, DOI 10.1530/JOE-14-0368; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Vinereanu D, 2002, CLIN SCI, V103, P249, DOI 10.1042/cs1030249; Virani SS, 2012, ATHEROSCLEROSIS, V222, P551, DOI 10.1016/j.atherosclerosis.2012.03.031; Weiner RB, 2013, CIRCULATION, V128, P524, DOI 10.1161/CIRCULATIONAHA.113.003522	58	16	17	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2016	30	1					34	40		10.1096/fj.15-279588			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DA2JL	WOS:000367621000005	26316270	Green Published			2022-02-06	
J	Murry, JS; Hoang, DM; Barmparas, G; Harada, MY; Bukur, M; Bloom, MB; Inaba, K; Margulies, DR; Salim, A; Ley, EJ				Murry, Jason S.; Hoang, David M.; Barmparas, Galinos; Harada, Megan Y.; Bukur, Marko; Bloom, Matthew B.; Inaba, Kenji; Margulies, Daniel R.; Salim, Ali; Ley, Eric J.			Prospective evaluation of early propranolol after traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Propranolol; Beta blockers; Bradycardia	BETA-BLOCKER EXPOSURE; CEREBRAL-BLOOD-FLOW; HEART-RATE; RATS; CHILDREN; IMPACT; MOUSE; DEATH; TRIAL	Background: Although beta-adrenergic receptor blockade may improve outcomes after traumatic brain injury (TBI), its early use is not routine. We hypothesize that judicious early low-dose propranolol after TBI (EPAT) will improve outcomes without altering bradycardia or hypotensive events. Methods: We conducted a prospective, observational study on all patients who presented with moderate-to-severe TBI from March 2010-August 2013. Ten initial patients did not receive propranolol (control). Subsequent patients received propranolol at 1-mg intravenous every 6 h starting within 12 h of intensive care unit (ICU) admission (EPAT) for a minimum of 48 h. Heart rate and blood pressure were recorded hourly for the first 72 h. Bradycardia and hypotensive events, mortality, and length of stay (LOS) were compared between cohorts to determine significant differences. Results: Thirty-eight patients were enrolled; 10 control and 28 EPAT. The two cohorts were similar when compared by gender, emergency department (ED) systolic blood pressure, ED heart rate, and mortality. ED Glasgow coma scale was lower (4.2 versus 10.7, P < 0.01) and injury severity score higher in control. EPAT patients received a mean of 10 +/- 14 doses of propranolol. Hypotensive events were similar between cohorts, whereas bradycardia events were higher in control (5.8 versus 1.6, P = 0.05). ICU LOS (15.4 versus 30.4 d, P = 0.02) and hospital LOS (10 versus 19.1 d, P = 0.05) were lower in EPAT. Mortality rates were similar between groups (10% versus 10.7%, P = 0.9). The administration of propranolol led to no recorded complications. Conclusions: Although bradycardia and hypotensive events occur early after TBI, low-dose intravenous propranolol does not increase their number or severity. Early use of propranolol after TBI appears to be safe and may be associated with decreased ICU and hospital LOS. (C) 2016 Elsevier Inc. All rights reserved.	[Murry, Jason S.; Hoang, David M.; Barmparas, Galinos; Harada, Megan Y.; Bloom, Matthew B.; Margulies, Daniel R.; Ley, Eric J.] Cedars Sinai Med Ctr, Div Trauma & Crit Care, Dept Surg, Los Angeles, CA 90048 USA; [Bukur, Marko] Delray Med Ctr, Dept Trauma & Crit Care, Delray Beach, FL USA; [Bukur, Marko] Broward Gen Med Ctr, Ft Lauderdale, FL USA; [Inaba, Kenji] Univ So Calif, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA USA; [Salim, Ali] Brigham & Womens Hosp, Dept Surg, Div Trauma Burn & Surg Crit Care, Boston, MA 02115 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Div Trauma & Crit Care, Dept Surg, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	eric.ley@cshs.org	Barmparas, Galinos/L-6530-2019; INABA, KENJI/AAC-8532-2020; Bloom, Matthew/E-5660-2013	Bloom, Matthew/0000-0001-8102-4394; Bukur, Marko/0000-0002-1850-7147			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; [Anonymous], SURV BEN BET BLOCK S; [Anonymous], TBI GUID; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bible LE, 2014, J TRAUMA ACUTE CARE, V77, P54, DOI 10.1097/TA.0000000000000264; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Chi OZ, 1999, ANESTH ANALG, V89, P690, DOI 10.1097/00000539-199909000-00030; CLIFTON G L, 1989, Neurosurgical Review, V12, P465, DOI 10.1007/BF01790692; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; EDVINSSON L, 1979, ACTA PHYSIOL SCAND, V107, P289, DOI 10.1111/j.1748-1716.1979.tb06478.x; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HEMMINGSEN R, 1979, ACTA PHYSIOL SCAND, V105, P274, DOI 10.1111/j.1748-1716.1979.tb06342.x; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kato H, 2009, ANESTH ANALG, V108, P288, DOI 10.1213/ane.0b013e318187bb93; LASBENNES F, 1986, EXP BRAIN RES, V63, P169; Ley EJ, 2012, J TRAUMA ACUTE CARE, V72, P943, DOI 10.1097/TA.0b013e3182465527; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; LOWENSOHN RI, 1977, LANCET, V1, P626; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Sasaki M, 2001, J NEUROTRAUM, V18, P1241, DOI 10.1089/089771501317095278; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Sheng P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081802	32	16	16	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2016	200	1					221	226		10.1016/j.jss.2015.06.045			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CZ1BM	WOS:000366840700032	26188959				2022-02-06	
S	Rowe, RK; Griffiths, DR; Lifshitz, J		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Rowe, Rachel K.; Griffiths, Daniel R.; Lifshitz, Jonathan			Midline (Central) Fluid Percussion Model of Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury (TBI); Concussion; Diffuse; Fluid percussion; Trauma; Rodent; Rat; Mouse; Experimental model; Righting reflex; Fencing response; Postoperative care	RAT	Research models of traumatic brain injury (TBI) hold significant validity towards the human condition, with each model replicating a subset of clinical features and symptoms. After 30 years of characterization and implementation, fluid percussion injury (FPI) is firmly recognized as a clinically relevant model of TBI, encompassing concussion through severe injury. The midline variation of FPI may best represent mild and diffuse clinical brain injury, because of the acute behavioral deficits, the late onset of subtle behavioral morbidities, and the absence of gross histopathology. This chapter outlines the procedures for midline (diffuse) FPI in adult male rats and mice. With these procedures, it becomes possible to generate brain-injured laboratory animals for studies of injury-induced pathophysiology and behavioral deficits, for which rational therapeutic interventions can be implemented.	[Rowe, Rachel K.; Griffiths, Daniel R.; Lifshitz, Jonathan] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Griffiths, Daniel R.; Lifshitz, Jonathan] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85006 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA		Rowe, RK (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA.; Rowe, RK (corresponding author), Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85006 USA.; Rowe, RK (corresponding author), Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA.			Rowe, Rachel/0000-0002-9034-3159			Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Lifshitz J, 2008, ANIMAL MODELS ACUTE; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	8	16	16	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						211	230		10.1007/978-1-4939-3816-2_13	10.1007/978-1-4939-3816-2		20	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500015	27604721				2022-02-06	
J	Szczygielski, J; Mautes, AE; Muller, A; Sippl, C; Glameanu, C; Schwerdtfeger, K; Steudel, WI; Oertel, J				Szczygielski, Jacek; Mautes, Angelika E.; Mueller, Andreas; Sippl, Christoph; Glameanu, Cosmin; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim			Decompressive Craniectomy Increases Brain Lesion Volume and Exacerbates Functional Impairment in Closed Head Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; closed head injury; decompressive craniectomy; mouse; traumatic brain injury	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; CEREBRAL OXYGENATION; COGNITIVE DEFICITS; RAT MODEL; PRESSURE; REACTIVITY; EDEMA; METABOLISM	Decompressive craniectomy has been widely used in patients with head trauma. The randomized clinical trial on an early decompression (DECRA) demonstrated that craniectomy did not improve the neurological outcome, in contrast to previous animal experiments. The goal of our study was to analyze the effect of decompressive craniectomy in a murine model of head injury. Male mice were assigned into the following groups: sham, decompressive craniectomy, closed head injury (CHI), and CHI followed by craniectomy. At 24h post-trauma, animals underwent the Neurological Severity Score test (NSS) and Beam Balance Score test (BBS). At the same time point, magnetic resonance imaging was performed, and volume of edema and contusion was assessed, followed by histopathological analysis. According to NSS, animals undergoing both trauma and craniectomy presented the most severe neurological impairment. Also, balancing time was reduced in this group compared with sham animals. Both edema and contusion volume were increased in the trauma and craniectomy group compared with sham animals. Histopathological analysis showed that all animals that underwent trauma presented substantial neuronal loss. In animals treated with craniectomy after trauma, a massive increase of edema with hemorrhagic transformation of contusion was documented. Decompressive craniectomy applied after closed head injury in mice leads to additional structural and functional impairment. The surgical decompression via craniectomy promotes brain edema formation and contusional blossoming in our model. This additive effect of combined mechanical and surgical trauma may explain the results of the DECRA trial and should be explored further in experiments.	[Szczygielski, Jacek; Mautes, Angelika E.; Sippl, Christoph; Glameanu, Cosmin; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim] Univ Saarland, Med Ctr, Dept Neurosurg, D-66421 Homburg, Germany; [Mueller, Andreas] Univ Saarland, Med Ctr, Dept Radiol, D-66421 Homburg, Germany; [Mueller, Andreas] Univ Saarland, Fac Med, D-66421 Homburg, Germany		Szczygielski, J (corresponding author), Univ Saarland, Med Ctr, Dept Neurosurg, Kirrberger St,Bldg 90-5, D-66421 Homburg, Germany.	jacek.szczygielski@uks.eu	Szczygielski, Jacek/AAV-4791-2021; Oertel, Joachim/AAO-5012-2021	Szczygielski, Jacek/0000-0002-3157-2824; Muller, Andreas/0000-0003-0924-3490	voluntary association "Friends of Saarland University Medical Center"	This work has been supported by a financial award of voluntary association "Friends of Saarland University Medical Center'' for J.S.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Abdullah J, 2005, ACT NEUR S, V95, P311; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bian JY, 2006, NEUROSURG REV, V29, P168, DOI 10.1007/s10143-005-0010-8; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FORSTING M, 1995, STROKE, V26, P259, DOI 10.1161/01.STR.26.2.259; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; GAAB M, 1979, CHILD BRAIN, V5, P484; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Kocher T., 1901, HIRNERSCHUTTERUNG HI, V3, P262; Kunze E, 1998, ACT NEUR S, V71, P16; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Makino H, 1979, Acta Neurochir Suppl (Wien), V28, P193; Manville J, 2007, J MOL NEUROSCI, V31, P95, DOI 10.1385/JMN/31:02:95; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RINALDI A, 1990, ACT NEUR S, V51, P394; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Szczygielski J, 2010, ACTA NEUROCHIR SUPPL, V106, P225, DOI 10.1007/978-3-211-98811-4_42; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zhao Z, 2007, NEUROCRIT CARE, V7, P263, DOI 10.1007/s12028-007-0074-0; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	68	16	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					122	131		10.1089/neu.2014.3835			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200015	26102497				2022-02-06	
J	Theadom, A; Rowland, V; Levack, W; Starkey, N; Wilkinson-Meyers, L; McPherson, K				Theadom, Alice; Rowland, Vickie; Levack, William; Starkey, Nicola; Wilkinson-Meyers, Laura; McPherson, Kathryn		TBI Experiences Grp	Exploring the experience of sleep and fatigue in male and female adults over the 2 years following traumatic brain injury: a qualitative descriptive study	BMJ OPEN			English	Article							PREVALENCE; DISORDERS; INSOMNIA	Objectives: To explore the experience of fatigue and sleep difficulties over the first 2 years after traumatic brain injury (TBI). Design: Longitudinal qualitative descriptive analysis of interviews completed as part of a larger longitudinal study of recovery following TBI. Data relating to the experience of fatigue and/or sleep were extracted and coded by two independent researchers. Setting: Community-based study in the Hamilton and Auckland regions of New Zealand. Participants: 30 adult participants who had experienced mild, moderate or severe brain injury within the past 6 months (>16 years of age). 15 participants also nominated significant others to take part. Interviews were completed at 6, 12 and 24 months postinjury. Results: Participants described feeling unprepared for the intensity, impact and persistent nature of fatigue and sleep difficulties after injury. They struggled to learn how to manage their difficulties by themselves and to adapt strategies in response to changing circumstances over time. Four themes were identified: (1) Making sense of fatigue and sleep after TBI; (2) accepting the need for rest; (3) learning how to rest and; (4) need for rest impacts on ability to engage in life. Conclusions: Targeted support to understand, accept and manage the sleep and fatigue difficulties experienced may be crucial to improve recovery and facilitate engagement in everyday life. Advice needs to be timely and revised for relevance over the course of recovery.	[Theadom, Alice; Rowland, Vickie; McPherson, Kathryn] Auckland Univ Technol, Person Centred Res Ctr, Auckland, New Zealand; [Theadom, Alice; Rowland, Vickie] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Levack, William] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Wilkinson-Meyers, Laura] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [McPherson, Kathryn] Hlth Res Council New Zealand, Auckland, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Person Centred Res Ctr, Auckland, New Zealand.; Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.	alice.theadom@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Levack, William Mark Magnus/F-9607-2018	Starkey, Nicola/0000-0002-4370-8186; Levack, William Mark Magnus/0000-0001-6631-908X; Wilkinson-Meyers, Laura/0000-0001-9807-7361; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New ZealandHealth Research Council of New Zealand [10/471]	The parent study informing this work was supported by the Health Research Council of New Zealand, grant number 10/471.	Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Crotty M., 1998, FDN SOCIAL RES MEANI; Dhand R, 2006, CURR OPIN PULM MED, V12, P379; Eilertsen G, 2013, J ADV NURS, V69, P514, DOI 10.1111/jan.12002; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kirkevold M, 2012, DISABIL REHABIL, V34, P665, DOI 10.3109/09638288.2011.615373; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ponsford J, 2004, BRAIN INJURY, V18, P1065; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821	25	16	16	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	4							e010453	10.1136/bmjopen-2015-010453			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM5LV	WOS:000376391400072	27059468	gold, Green Published			2022-02-06	
J	Ruiz, JRL; Carrasco, LPO; Valenzuela, CLL; Rodriguez, NEF; Valdovinos, BDLT; Estrada, IJ; Jimenez, JMD; Jimenez, SHD				Lopez Ruiz, J. R.; Osuna Carrasco, L. P.; Lopez Valenzuela, C. L.; Franco Rodriguez, N. E.; De La Torre Valdovinos, B.; Jimenez Estrada, I.; Duenas Jimenez, J. M.; Duenas Jimenez, S. H.			THE HIPPOCAMPUS PARTICIPATES IN THE CONTROL OF LOCOMOTION SPEED	NEUROSCIENCE			English	Article						hippocampus; traumatic brain injury; locomotion; tamoxifen; neuroprotection	SPINAL-CORD-INJURY; ESTROGEN-RECEPTOR MODULATORS; SENSORIMOTOR INTEGRATION; BRAIN-INJURY; HYPOTHALAMIC STIMULATION; THETA ACTIVITY; IN-VITRO; RAT; TAMOXIFEN; NEURONS	The hippocampus role in sensory-motor integration remains unclear. In these experiments we study its function in the locomotor control. To establish the connection between the hippocampus and the locomotor system, electrical stimulation in the CA1 region was applied and EMG recordings were obtained. We also evaluated the hindlimbs and forelimbs kinematic patterns in rats with a penetrating injury (PI) in the hippocampus as well as in a cortex-injured group (CI), which served as control. After the PI, tamoxifen a selective estrogen receptor modulator (SERM) that has been described as a neuroprotector and antiinflammatory drug, or vehicle was administered. Electrical stimulation in the hippocampus produces muscle contractions in the contralateral triceps, when 6 Hz or 8 Hz pulse trains were applied. The penetrating injury in the hippocampus reduced the EMG amplitude after the electrical stimulation. At 7DPI (days post-injury) we observed an increase in the strides speed in all four limbs of the non-treated group, decreasing the correlation percentage of the studied joints. After 15DPI the strides speed in the non-treated returned to normal. These changes did not occur in the tamoxifen group nor in cortex-injured group. After 30 days, the nontreated group presented a reduction in the number of pyramidal cell layer neurons at the injury site, in comparison to the tam-treated group. The loss of neurons, may cause the interruption of the trisynaptic circuit and changes in the locomotion speed. Tamoxifen preserves the pyramidal neurons after the injury, probably resulting in the strides speed recovery. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Lopez Ruiz, J. R.; Osuna Carrasco, L. P.; Lopez Valenzuela, C. L.; Franco Rodriguez, N. E.; De La Torre Valdovinos, B.; Duenas Jimenez, S. H.] Univ Guadalajara, Dept Neurosci, Ctr Univ Ciencias Salud, Guadalajara 44340, Jalisco, Mexico; [Duenas Jimenez, J. M.] Univ Guadalajara, Dept Physiol, Ctr Univ Ciencias Salud, Guadalajara 44340, Jalisco, Mexico; [Jimenez Estrada, I.] IPN, CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City 07360, DF, Mexico		Jimenez, SHD (corresponding author), Univ Guadalajara, Dept Neurosci, Ctr Univ Ciencias Salud, Sierra Mojada 950,Col Independencia, Guadalajara 44340, Jalisco, Mexico.	ingb0b@hotmail.com; laupaucarrasco@hotmail.com; lucii.a@live.com.mx; lizzafranco@gmail.com; brandalff@gmail.com; ijimenez@fisio.cinvestav.mx; mduenas@cucs.udg.mx; sduenas@cucs.udg.mx	Franco Rodriguez, Nancy Elizabeth/B-5879-2014; Osuna Carrasco, Laura Paulina/H-1400-2017	Franco Rodriguez, Nancy Elizabeth/0000-0001-9195-8289; Osuna Carrasco, Laura Paulina/0000-0002-2230-1088; Lopez Ruiz, Jose Roberto/0000-0001-5305-9223			Arevalo MA, 2011, J NEUROENDOCRINOL; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; BLAND BH, 1972, BRAIN RES, V43, P67, DOI 10.1016/0006-8993(72)90275-2; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Bland BH, 2009, INFORMATION PROCESSING BY NEURONAL POPULATIONS, P283; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Colom LV, 2005, SYNAPSE, V58, P151, DOI 10.1002/syn.20184; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dypvik AT, 2004, J NEUROPHYSIOL, V92, P2040, DOI 10.1152/jn.01081.2003; Rodriguez NEF, 2013, BRAIN RES BULL, V98, P64, DOI 10.1016/j.brainresbull.2013.07.007; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; Fuhrmann F, 2015, NEURON; Guptarak J, 2014, J NEUROTRAUM, V31, P268, DOI 10.1089/neu.2013.3108; Hallworth NE, 2004, EXP NEUROL, V188, P430, DOI 10.1016/j.expneurol.2004.04.014; Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874; Lee Rodgers J, 1988, AM STAT, V42, P59, DOI DOI 10.1080/00031305.1988.10475524; Lu CB, 2010, NEUROSCIENCE, V166, P84, DOI 10.1016/j.neuroscience.2009.11.072; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Murphy DD, 1996, J NEUROSCI, V16, P4059; Natsume K, 1999, HIPPOCAMPUS, V9, P500, DOI 10.1002/(SICI)1098-1063(1999)9:5<500::AID-HIPO3>3.3.CO;2-6; Oddie SD, 1996, J NEUROSCI, V16, P1948; ROBINSON TE, 1974, J COMP PHYSIOL PSYCH, V86, P768, DOI 10.1037/h0036397; Salgado IK, 2015, NEURAL REGEN RES, V10, P385, DOI 10.4103/1673-5374.153685; Shen A Y, 1995, Chin J Physiol, V38, P111; Sinnamon HM, 2000, BEHAV BRAIN RES, V107, P93, DOI 10.1016/S0166-4328(99)00112-6; Sinnamon HM, 2000, NEUROSCIENCE, V98, P459, DOI 10.1016/S0306-4522(00)00145-7; SLAWINSKA U, 1995, BRAIN RES, V678, P117, DOI 10.1016/0006-8993(95)00174-O; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Velazquez-Zamora DA, 2012, HORM BEHAV, V61, P512, DOI 10.1016/j.yhbeh.2012.01.010; VERTES RP, 1994, NEUROSCIENCE, V60, P441, DOI 10.1016/0306-4522(94)90255-0; Young CK, 2011, NEUROSCIENCE, V192, P452, DOI 10.1016/j.neuroscience.2011.06.039; Zhang HQ, 2009, BRAIN RES, V1247, P196, DOI 10.1016/j.brainres.2008.10.015	36	16	16	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 17	2015	311						207	215		10.1016/j.neuroscience.2015.10.034			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CY1CJ	WOS:000366144000019	26597762				2022-02-06	
J	Hamilton, M; Williams, G; Bryant, A; Clark, R; Spelman, T				Hamilton, Megan; Williams, Gavin; Bryant, Adam; Clark, Ross; Spelman, Tim			Which factors influence the activity levels of individuals with traumatic brain injury when they are first discharged home from hospital?	BRAIN INJURY			English	Article							ASSESSMENT-TOOL HIMAT; OF-SPORTS-MEDICINE; PHYSICAL-ACTIVITY; POSTURAL STABILITY; PUBLIC-HEALTH; EXERCISE QUESTIONNAIRE; INTERRATER RELIABILITY; BEHAVIORAL-REGULATION; MULTIPLE-SCLEROSIS; OBJECTIVE MEASURES		[Hamilton, Megan; Williams, Gavin] Epworth Healthcare, Physiotherapy Dept, Epworth Rehabil, Melbourne, Vic, Australia; [Hamilton, Megan; Williams, Gavin; Bryant, Adam; Clark, Ross] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia; [Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Spelman, Tim] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia		Hamilton, M (corresponding author), Epworth Rehabil, Community Integrat Team, 29 Erin St, Richmond, Vic 3121, Australia.	megan.hamilton@epworth.org.au	Clark, Ross/K-7613-2019; Clark, Ross A/R-5664-2018	Clark, Ross/0000-0002-7291-8553; Clark, Ross A/0000-0002-7291-8553; Williams, Gavin/0000-0003-2758-7473	Epworth Healthcare Scholarship	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This research was partially funded by an Epworth Healthcare Scholarship.	Alzahrani MA, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/470648; Australian Food Statistics, 2012, AUSTR PHYS ACT SED B, P8; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Buchman AS, 2011, AM J GERIAT PSYCHIAT, V19, P571, DOI 10.1097/JGP.0b013e3181ef7a2e; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cerin E, 2008, MEAS PHYS EDUC EXERC, V12, P31, DOI 10.1080/10913670701715190; Chiu CY, 2012, REHABIL COUNS BULL, V56, P23, DOI 10.1177/0034355212439898; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cink R E, 1981, Br J Sports Med, V15, P182; Committee on Physical Activity Guidelines Advisory, 2008, PHYS ACT GUID ADV CO; de Mello MT, 2013, J AFFECT DISORDERS, V149, P241, DOI 10.1016/j.jad.2013.01.035; Department of Health, 2004, LEAST 5 WEEK EV IMP; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2008, ADAPT PHYS ACT Q, V25, P289, DOI 10.1123/apaq.25.4.289; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Fidell L, 2007, USING MULTIVARIATE S; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; IBM, 2013, IBM SPSS STAT WIND 2; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Keegan JP, 2012, REHABIL COUNS BULL, V56, P34, DOI 10.1177/0034355212440732; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Markland D, 2004, J SPORT EXERCISE PSY, V26, P191, DOI 10.1123/jsep.26.2.191; Mayo NE, 1999, DISABIL REHABIL, V21, P258; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mossberg KA, 2012, PHYS THER, V92, P726, DOI 10.2522/ptj.20110157; Moylan S, 2013, NEUROSCI BIOBEHAV R, V37, P573, DOI 10.1016/j.neubiorev.2013.02.003; Mudge S, 2009, ARCH PHYS MED REHAB, V90, P296, DOI 10.1016/j.apmr.2008.07.025; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Murtezani Ardiana, 2009, Med Arh, V63, P216; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Neven A, 2013, DISABIL REHABIL, V35, P1718, DOI 10.3109/09638288.2012.751137; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robinson CA, 2011, PHYS THER, V91, P1865, DOI 10.2522/ptj.20100216; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Santiago MC, 2004, DISABIL REHABIL, V26, P485, DOI 10.1080/09638280410001663139; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sohlberg MM, 2005, BRAIN INJURY, V19, P1249, DOI 10.1080/02699050500309510; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Teixeira CM, 2013, SOC INDIC RES, V113, P307, DOI 10.1007/s11205-012-0094-9; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; van de Port IG, 2008, J REHABIL MED, V40, P23, DOI 10.2340/16501977-0114; van Heuvelen MJG, 2006, GERONTOLOGY, V52, P366, DOI 10.1159/000094986; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d; Williams GP, 2011, PHYSIOTHER CAN, V63, P58, DOI 10.3138/ptc.2009-53; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson PM, 2012, PSYCHOL SPORT EXERC, V13, P614, DOI 10.1016/j.psychsport.2012.03.009; Wise EK, 2012, BENEFITS EXERCISE MA; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	83	16	16	2	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1572	1580		10.3109/02699052.2015.1075145			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800007	26399973				2022-02-06	
J	Walker, WC; Franke, LM; McDonald, SD; Sima, AP; Keyser-Marcus, L				Walker, W. C.; Franke, L. M.; McDonald, S. D.; Sima, A. P.; Keyser-Marcus, L.			Prevalence of mental health conditions after military blast exposure, their co- occurrence, and their relation to mild traumatic brain injury	BRAIN INJURY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CONCUSSION SYMPTOMS QUESTIONNAIRE; SPORTS-RELATED CONCUSSION; NATIONAL-GUARD SOLDIERS; OEF/OIF VETERANS; NEUROPSYCHOLOGICAL OUTCOMES; PSYCHIATRIC DIAGNOSES; COMBAT DUTY; US VETERANS; HEAD-INJURY		[Walker, W. C.; Franke, L. M.; McDonald, S. D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA 23298 USA; [Walker, W. C.; Franke, L. M.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Walker, W. C.; Franke, L. M.; McDonald, S. D.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [McDonald, S. D.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23298 USA; [Sima, A. P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Keyser-Marcus, L.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, MCV Stn, Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Franke, Lude/P-7036-2016	Franke, Lude/0000-0002-5159-8802; Sima, Adam/0000-0001-8426-9987	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and Rehabilitation Research and Development Career Development Award-2 [1IK2RX000703-01]	This material is in part based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and Rehabilitation Research and Development Career Development Award-2 (1IK2RX000703-01; S.M.). The views expressed are those of the authors and do not necessarily represent or reflect the policy or position of the Department of the Army, Department of Defense, the US Government, the Department of Veterans Affairs or any of the institutions with which the authors are affiliated.	Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Booth-Kewley S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-130; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Orsillo SM, 1996, J TRAUMA STRESS, V9, P235, DOI 10.1007/BF02110658; Orsillo SM, 1996, J NERV MENT DIS, V184, P307, DOI 10.1097/00005053-199605000-00007; Polusny MA, 2009, MIL MED, V174, P353, DOI 10.7205/MILMED-D-01-1608; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith TC, 2014, J ADDICT MED, V8, P271, DOI 10.1097/ADM.0000000000000050; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	35	16	17	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1581	1588		10.3109/02699052.2015.1075151			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800008	26479126				2022-02-06	
J	Harada, C; Azuchi, Y; Noro, T; Guo, XL; Kimura, A; Namekata, K; Harada, T				Harada, Chikako; Azuchi, Yuriko; Noro, Takahiko; Guo, Xiaoli; Kimura, Atsuko; Namekata, Kazuhiko; Harada, Takayuki			TrkB Signaling in Retinal Glia Stimulates Neuroprotection after Optic Nerve Injury	AMERICAN JOURNAL OF PATHOLOGY			English	Article							NORMAL-TENSION GLAUCOMA; NEURAL CELL-DEATH; GANGLION-CELLS; NEUROTROPHIC FACTOR; MOUSE MODEL; GLUTAMATE TRANSPORTERS; AXONAL OUTGROWTH; MULLER CELLS; ADULT RATS; IN-VIVO	Brain-derived neurotrophic factor (BDNF) regulates neural cell survival mainly by activating TrkB receptors. Several tines of evidence support a key role for BDNF-TrkB signaling in survival of adult retinal ganglion cells in animal models of optic nerve injury (ONI), but the neuroprotective effect of exogenous BDNF is transient. Glial cells have recently attracted considerable attention as mediators of neural cell survival, and TrkB expression in retinal glia suggests its role in neuroprotection. To elucidate this point directly, we examined the effect of ONI on TrkB(flox/flox):glial fibrillary acidic protein (GFAP)-Cre+ (TrkB(GFAP)) knockout (KO) mice, in which TrkB is deleted in retinal glial cells. ONI markedly increased mRNA expression Levels of basic fibroblast growth factor (bFGF) in wild-type (WT) mice but not in TrkB(GFAP) KO mice. Immunohistochemical analysis at 7 days after ONI (d7) revealed bFGF up-regulation mainly occurred in Muller glia. ONI-induced retinal ganglion cell Loss in WT mice was consistently mild compared with TrkB(GFAP) KO mice at d7. On the other hand, ONI severely decreased TrkB expression in both WT and TrkB(GFAP) KO mice after d7, and the severity of retinal degeneration was comparable with TrkB(GFAP) KO mice at d14. Our data provide direct evidence that glial TrkB signaling plays an important role in the early stage of neural protection after traumatic injury.	[Harada, Chikako; Azuchi, Yuriko; Noro, Takahiko; Guo, Xiaoli; Kimura, Atsuko; Namekata, Kazuhiko; Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Tokyo 1568506, Japan; [Noro, Takahiko] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan		Namekata, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	namekata-kz@igakuken.or.jp		Noro, Takahiko/0000-0001-9147-5455	Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25462766, 25430082, 26861479, 256400043, 26640048, 15H04999]; Funding Program for Next Generation World-Leading Researchers (NEXT Program)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [LS133]; Uehara Memorial FoundationUehara Memorial Foundation; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15H04999] Funding Source: KAKEN	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (25462766 to C.H., 25430082 to X.G., 26861479 to A.K., 256400043 to K.N., 26640048 and 15H04999 to T.H.), the Funding Program for Next Generation World-Leading Researchers (NEXT Program; LS133 to T.H.), and the Uehara Memorial Foundation (T.H.).	Berk BA, 2015, NEUROSCIENCE, V295, P175, DOI 10.1016/j.neuroscience.2015.03.037; Blanco RE, 2000, J COMP NEUROL, V423, P646; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Chen H, 2004, BRAIN RES, V1011, P99, DOI 10.1016/j.brainres.2004.03.024; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Clarke DB, 1998, VISION RES, V38, P1517, DOI 10.1016/S0042-6989(97)00341-6; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Fujita Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.298; Harada C, 2006, AM J PATHOL, V168, P261, DOI 10.2353/ajpath.2006.050765; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 1998, P NATL ACAD SCI USA, V95, P4663, DOI 10.1073/pnas.95.8.4663; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Katome T, 2013, CELL DEATH DIFFER, V20, P270, DOI 10.1038/cdd.2012.122; Kimura A, 2015, AM J PATHOL, V185, P756, DOI 10.1016/j.ajpath.2014.11.005; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; KOSTYK SK, 1994, J NEUROSCI, V14, P1441, DOI 10.1523/JNEUROSCI.14-03-01441.1994; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Luikart BW, 2005, J NEUROSCI, P25; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Miller G, 2005, SCIENCE, V308, P778, DOI 10.1126/science.308.5723.778; Namekata K, 2013, CELL DEATH DIFFER, V20, P1250, DOI 10.1038/cdd.2013.91; Namekata K, 2014, PROG RETIN EYE RES, V43, P1, DOI 10.1016/j.preteyeres.2014.06.005; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Noro T, 2015, INVEST OPHTH VIS SCI, V56, P5012, DOI 10.1167/iovs.15-17142; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Schuettauf F, 2004, CURR EYE RES, V29, P379, DOI 10.1080/02713680490517872; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.306; Semba K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.296; Semba K, 2014, NEUROSCI LETT, V581, P89, DOI 10.1016/j.neulet.2014.08.034; Soto I, 2003, J NEUROSCI RES, V73, P507, DOI 10.1002/jnr.10673; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Xie JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119119; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	45	16	16	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	DEC	2015	185	12					3238	3247		10.1016/j.ajpath.2015.08.005			10	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	CX8CB	WOS:000365929000010	26476348	Bronze			2022-02-06	
J	Johansson, B; Bjuhr, H; Karlsson, M; Karlsson, JO; Ronnback, L				Johansson, Birgitta; Bjuhr, Helena; Karlsson, Magdalena; Karlsson, Jan-Olof; Ronnback, Lars			Mindfulness-Based Stress Reduction (MBSR) Delivered Live on the Internet to Individuals Suffering from Mental Fatigue After an Acquired Brain Injury	MINDFULNESS			English	Article						Mindfulness; Internet; Mental fatigue; Attention; TBI; Stroke	CONTROLLED-TRIAL; DEPRESSION; SYMPTOMS; MEDITATION; DISORDERS; PROGRAM; STROKE; SCALE; MILD; MOOD	An acquired brain injury often leads to long-lasting mental fatigue, which can have a considerable effect on work and social interactions. Fortunately, the Mindfulness-Based Stress Reduction (MBSR) program has been found to alleviate mental fatigue. The purpose of this feasibility study was to evaluate the success of an interactive MBSR program delivered live online to individuals who have experienced a traumatic brain injury or stroke. We included the following three groups in our study: an Internet group, a face-to-face MBSR group, and an active control group who took weekly walks in natural environments. Thirty-four participants completed the study, and all were suffering from long-lasting mental fatigue after either a traumatic brain injury (16 participants) or a stroke (18 participants). However, seven did not accept to attend an Internet MBSR, and Internet was the only choice for others. We found that, according to the Mental Fatigue Scale (MFS), the program leads to significantly reduced mental fatigue in the Internet group compared with the face-to-face and the control group. Individuals in the MBSR groups also exhibited an improved ability to process two temporally close targets (attentional blink task), while this was not detected in the control group. In conclusion, we believe that it is possible for individuals suffering from mental fatigue after an acquired brain injury to obtain positive results through enrollment in a live, interactive, online MBSR program. This is promising, as the Internet is accessible to many individuals, irrespective of where they live. Further randomized control studies comparing are warranted.	[Johansson, Birgitta; Bjuhr, Helena; Karlsson, Magdalena; Ronnback, Lars] Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Dubbsgatan 14,1Tr, S-41345 Gothenburg, Sweden; [Karlsson, Jan-Olof] Univ West, Dept Econ & Informat, Trollhattan, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Dubbsgatan 14,1Tr, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se			Health & Medical Care Committee of the Vastra Gotaland Region; Swedish Stroke Association; Swedish Association for Survivors of Accident and Injury	This work was supported by grants from The Health & Medical Care Committee of the Vastra Gotaland Region, The Swedish Stroke Association, and The Swedish Association for Survivors of Accident and Injury.	Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Boettcher J, 2014, BEHAV THER, V45, P241, DOI 10.1016/j.beth.2013.11.003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Carlson LE, 2005, INT J BEHAV MED, V12, P278, DOI 10.1207/s15327558ijbm1204_9; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Detry MA, 2014, JAMA-J AM MED ASSOC, V312, P85, DOI 10.1001/jama.2014.7523; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Gluck TM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-175; Goldstein J., 2014, SHAMBHALA SUN, P36; Hansson E, 2004, NEUROCHEM RES, V29, P989, DOI 10.1023/B:NERE.0000021243.86287.43; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kabat-Zinn J., 2001, FULL FULL CATASTROPH; Kilpatrick LA, 2011, NEUROIMAGE, V56, P290, DOI 10.1016/j.neuroimage.2011.02.034; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Krusche A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000803; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; Ljotsson B, 2010, BEHAV RES THER, V48, P531, DOI 10.1016/j.brat.2010.03.003; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; McCown D, 2010, TEACHING MINDFULNESS: A PRACTICAL GUIDE FOR CLINICIANS AND EDUCATORS, P1, DOI 10.1007/978-0-387-09484-7; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morledge TJ, 2013, ANN BEHAV MED, V46, P137, DOI 10.1007/s12160-013-9490-x; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Raes F, 2011, CLIN PSYCHOL PSYCHOT, V18, P250, DOI 10.1002/cpp.702; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Ronnback L., 2012, INT SCHOLARLY RES NE, V2012, DOI [10.5402/2012/686425, DOI 10.5402/2012/686425]; Ronnback L, 2012, LONG LASTING MENTAL; Ronnback L, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-22; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Surawy C, 2005, BEHAV COGN PSYCHOTH, V33, P103, DOI 10.1017/S135246580400181X; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Wechsler D., 2003, WECHSLER ADULT INTEL; Winward C, 2009, STROKE, V40, P757, DOI 10.1161/STROKEAHA.108.527101	41	16	17	0	39	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1868-8527	1868-8535		MINDFULNESS	Mindfulness	DEC	2015	6	6					1356	1365		10.1007/s12671-015-0406-7			10	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	DB7IZ	WOS:000368689600014					2022-02-06	
J	Buchsbaum, MS; Simmons, AN; DeCastro, A; Farid, N; Matthews, SC				Buchsbaum, Monte S.; Simmons, Alan N.; DeCastro, Alex; Farid, Nikdokht; Matthews, Scott C.			Clusters of Low F-18-Fluorodeoxyglucose Uptake Voxels in Combat Veterans with Traumatic Brain Injury and Post-Traumatic Stress Disorder	JOURNAL OF NEUROTRAUMA			English	Article						amygdala; cerebellum; cluster shape; mild traumatic brain injury; positron emission tomography	WHITE-MATTER; FDG-PET; GLUCOSE-METABOLISM; PREFRONTAL CORTEX; IMAGE-ANALYSIS; FOCAL LESIONS; DIFFUSE; ACTIVATION; MEMORY; ROBUST	Individuals with mild traumatic brain injury (TBI) show diminished metabolic activity when studied with positron emission tomography (PET) with F-18-fluorodeoxyglucose (FDG). Since blast injury may not be localized in the same specific anatomical areas in every patient or may be diffuse, significance probability mapping may be vulnerable to false-negative detection of abnormalities. To address this problem, we used an anatomically independent measure to assess PET scans: increased numbers of contiguous voxels that are 2 standard deviations below values found in an uninjured control group. We examined this in three age-matched groups of male patients: 16 veterans with a history of mild TBI, 17 veterans with both mild TBI and post-traumatic stress disorder (PTSD), and 15 veterans without either condition. After FDG administration, subjects performed a modified version of the California Verbal Learning Task. Clusters of low uptake voxels were identified by computing the mean and standard deviation for each voxel in the healthy combat veteran group and then determining the voxel-based z-score for the patient groups. Abnormal clusters were defined as those that contained contiguous voxels with a z-score <-2. Patients with mild TBI alone and patients with TBI+PTSD had larger clusters of low uptake voxels, and cluster size significantly differentiated the mild TBI groups from combat controls. Clusters were more irregular in shape in patients, and patients also had a larger number of low-activity voxels throughout the brain. In mild TBI and TBI+PTSD patients, but not healthy subjects, cluster volume was significantly correlated with verbal learning during FDG uptake.	[Buchsbaum, Monte S.; Simmons, Alan N.; DeCastro, Alex; Matthews, Scott C.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Buchsbaum, Monte S.; Farid, Nikdokht] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Simmons, Alan N.; Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, ASPIRE Ctr, San Diego, CA USA		Buchsbaum, MS (corresponding author), 11388 Sorrento Valley Rd, San Diego, CA 92121 USA.	monte.buchsbaum@gmail.com	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112	Veterans Administration via Merit Grant [1I01CX000292, I01-CX000715]; CDA-2 from the VA CSRD; Veterans AffairsUS Department of Veterans Affairs [I01CX000715, I01CX000292] Funding Source: NIH RePORTER	This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research. This work supported by a Veterans Administration via Merit Grant ((1I01CX000292 & I01-CX000715 ANS). Salary support was by a CDA-2 from the VA CSR&D (SCM).	Asha'ari ZA, 2011, J LARYNGOL OTOL, V125, P781, DOI 10.1017/S0022215111000545; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Bakshi R, 1998, J NEUROIMAGING, V8, P8, DOI 10.1111/jon1998818; Bartels P, 1976, DIGITAL PROCESSING B, P101; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bourne C, 2013, PSYCHOL MED, V43, P1521, DOI 10.1017/S0033291712002358; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Esik O, 2004, PATHOL ONCOL RES, V10, P42, DOI 10.1007/BF02893408; Esik O, 1999, J NEUROL SCI, V163, P39, DOI 10.1016/S0022-510X(98)00324-4; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hazlett EA, 2010, NEUROBIOL AGING, V31, P826, DOI 10.1016/j.neurobiolaging.2008.10.005; Heller W, 1997, J ABNORM PSYCHOL, V106, P376, DOI 10.1037/0021-843X.106.3.376; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Honda Mitsuru, 2013, Acta Neurochir Suppl, V118, P259, DOI 10.1007/978-3-7091-1434-6_49; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Killgore WDS, 2014, DEPRESS ANXIETY, V31, P150, DOI 10.1002/da.22156; Kim JJ, 2003, AM J PSYCHIAT, V160, P919, DOI 10.1176/appi.ajp.160.5.919; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Morris A, 1995, ACCIDENT ANAL PREV, V27, P749, DOI 10.1016/0001-4575(95)00020-8; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nelson C, 2011, MIL MED, V176, P156, DOI 10.7205/MILMED-D-10-00252; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Schiepers C, 1997, MULT SCLER, V3, P8, DOI 10.1177/135245859700300102; Schwab KA, 2006, NEUROLOGY, V66, pA235; Shin SE, 2005, PSYCHIAT RES-NEUROIM, V138, P33, DOI 10.1016/j.pscychresns.2004.11.005; Simmons AN, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-6; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Wang EW, 2013, NEUROL RES, V35, P285, DOI 10.1179/1743132812Y.0000000138; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalley MG, 2012, PSYCHIAT RES-NEUROIM, V201, P98, DOI 10.1016/j.pscychresns.2011.08.008; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Yehuda R, 2009, J NEUROPSYCH CLIN N, V21, P132, DOI 10.1176/appi.neuropsych.21.2.132; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049	61	16	16	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1736	1750		10.1089/neu.2014.3660			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500004	25915799				2022-02-06	
J	Krishnamoorthy, V; Vavilala, MS; Mills, B; Rowhani-Rahbar, A				Krishnamoorthy, Vijay; Vavilala, Monica S.; Mills, Brianna; Rowhani-Rahbar, Ali			Demographic and clinical risk factors associated with hospital mortality after isolated severe traumatic brain injury: a cohort study	JOURNAL OF INTENSIVE CARE			English	Article						Trauma; Brain injury; Outcomes	GLASGOW COMA SCALE; EXTRACRANIAL COMPLICATIONS; OUTCOMES; PREVENTION; PNEUMONIA; INFECTIONS	Background: Traumatic brain injury (TBI) is a major public health problem and a leading cause of death worldwide. A paucity of literature exists on risk factors for mortality in isolated severe TBI, a condition that is distinct from severe TBI in the setting of multisystem trauma. We determined risk factors for in-hospital mortality in this patient population. Methods: We conducted a retrospective cohort study using data from the National Trauma Databank from 2008-2012 to study all patients admitted with a diagnosis of severe TBI, excluding children, patients with non-isolated TBI, transfers, and hospitalization < 48 h. We used multivariable Poisson regression to analyze the association between demographic, clinical, and facility-level characteristics and in-hospital mortality. Results: A total of 41,590 patients were included in our analysis. The cumulative incidence of in-hospital mortality was 10.2 %. In multivariable analysis, older age (RR 3.92, 95 % CI 3.54-4.34), male gender (RR 1.17, 95 % CI 1.09-1.25), admission hypotension (RR 1.83, 95 % CI 1.61-2.09), the need for mechanical ventilation (RR 4.18, 95 % CI 3.64-4.80), higher injury severity score (RR 1.86, 95 % CI 1.41-2.45), and poor initial neurologic grade (RR 3.06, 95 % CI 2.74-3.43) were associated with a higher risk for mortality. Conclusions: Admission hypotension and the need for mechanical ventilation were possible modifiable risk factors associated with increased in-hospital mortality following isolated severe TBI. Although risk factors for mortality are similar in isolated and non-isolated TBI, the underlying etiologies for hypotension and respiratory failure are likely different in both conditions and require further exploration.	[Krishnamoorthy, Vijay; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB 1469, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Mills, Brianna; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Vavilala, Monica S.; Mills, Brianna; Rowhani-Rahbar, Ali] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Krishnamoorthy, V (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St,BB 1469, Seattle, WA 98195 USA.	vkrish@u.washington.edu		Mills, Brianna/0000-0002-6632-9592; Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM086270]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD042828, T32HD007543] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health (National Research Service Award T32 GM086270)	Allareddy V, 2015, AM J SURG; Almahmoud K, 2015, CRIT CARE MED, V43, P1395, DOI 10.1097/CCM.0000000000000964; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Brown JR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000714; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Faul M, 2010, TRAUMATIC BRAIN INJU; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Kramer AH, 2013, CAN J ANESTH, V60, P966, DOI 10.1007/s12630-013-0001-0; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Lo Evelyn, 2008, Infect Control Hosp Epidemiol, V29 Suppl 1, pS41, DOI 10.1086/591066; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mills B, 2015, J NEUROTRAUM, V32, P841, DOI 10.1089/neu.2014.3733; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Roquilly A, 2015, CLIN INFECT DIS, V60, P64, DOI 10.1093/cid/ciu740; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Terre R, 2012, NEUROGASTROENT MOTIL, V24, P414, DOI 10.1111/j.1365-2982.2011.01869.x; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	27	16	16	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2052-0492			J INTENSIVE CARE	J. Intensive Care	NOV 10	2015	3								46	10.1186/s40560-015-0113-4			8	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	CW1KC	WOS:000364747600001	26561524	gold, Green Published			2022-02-06	
J	Adkins, DL; Ferguson, L; Lance, S; Pevtsov, A; McDonough, K; Stamschror, J; Jones, TA; Kozlowski, DA				Adkins, DeAnna L.; Ferguson, Lindsay; Lance, Steven; Pevtsov, Aleksandr; McDonough, Kevin; Stamschror, Justin; Jones, Theresa A.; Kozlowski, Dorothy A.			Combining Multiple Types of Motor Rehabilitation Enhances Skilled Forelimb Use Following Experimental Traumatic Brain Injury in Rats	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						exercise; motor rehabilitation; neuroplasticity; constraint-induced movement therapy; controlled cortical impact; recovery of function	CONSTRAINT-INDUCED MOVEMENT; SENSORIMOTOR CORTEX LESIONS; CONTROLLED CORTICAL IMPACT; LESS-AFFECTED FORELIMB; VOLUNTARY EXERCISE; FUNCTIONAL RECOVERY; STROKE REHABILITATION; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; UPPER EXTREMITY	Background. Neuroplasticity and neurorehabilitation have been extensively studied in animal models of stroke to guide clinical rehabilitation of stroke patients. Similar studies focused on traumatic brain injury (TBI) are lacking. Objective. The current study was designed to examine the effects of individual and combined rehabilitative approaches, previously shown to be beneficial following stroke, in an animal model of moderate/severe TBI, the controlled cortical impact (CCI). Methods. Rats received a unilateral CCI, followed by reach training, voluntary exercise, or unimpaired forelimb constraint, alone or in combination. Forelimb function was assessed at different time points post-CCI by tests of skilled reaching, motor coordination, and asymmetrical limb use. Results. Following CCI, skilled reaching and motor coordination were significantly enhanced by combinations of rehabilitation strategies, not by individual approaches. The return of symmetrical limb use benefited from forelimb constraint alone. None of the rehabilitation strategies affected the size of injury, suggesting that enhanced behavioral function was not a result of neuroprotection. Conclusions. The current study has provided evidence that individual rehabilitation strategies shown to be beneficial in animal models of stroke are not similarly sufficient to enhance behavioral outcome in a model of TBI. Motor rehabilitation strategies for TBI patients may need to be more intense and varied. Future basic science studies exploring the underlying mechanisms of combined rehabilitation approaches in TBI as well as clinical studies comparing rehabilitation approaches for stroke versus TBI would prove fruitful.	[Adkins, DeAnna L.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Ferguson, Lindsay; Lance, Steven; Pevtsov, Aleksandr; McDonough, Kevin; Stamschror, Justin; Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA; [Ferguson, Lindsay; Lance, Steven; Pevtsov, Aleksandr; McDonough, Kevin; Stamschror, Justin; Kozlowski, Dorothy A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Jones, Theresa A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA		Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, 2325 N Clifton, Chicago, IL 60614 USA.	dkozlows@depaul.edu	Jones, Theresa A/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Adkins, DeAnna L/0000-0002-3063-5731	DePaul University Research Council (DAK); Department of DefenseUnited States Department of Defense [W81XWH-08-1-0624]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065866] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study has been supported by DePaul University Research Council (DAK) and the Department of Defense #W81XWH-08-1-0624 (DAK, DLA, TAJ).	ADAMS FS, 1994, PHYSIOL BEHAV, V55, P947, DOI 10.1016/0031-9384(94)90084-1; Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Alaverdashvili M, 2008, BEHAV BRAIN RES, V192, P232, DOI 10.1016/j.bbr.2008.04.013; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Austin MW, 2014, NEUROSCI RES, V87, P8, DOI 10.1016/j.neures.2014.06.007; Belke TW, 2011, PSYCHOL REC, V61, P213, DOI 10.1007/BF03395757; Brazzelli M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub4; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; Faul M, 2010, TRAUMATIC BRAIN INJU; Fritz SL, 2012, EXPERT REV NEUROTHER, V12, P191, DOI [10.1586/ERN.11.201, 10.1586/ern.11.201]; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hotting K, 2013, NEUROSCI BIOBEHAV R, V37, P2243, DOI 10.1016/j.neubiorev.2013.04.005; Hsu JE, 2005, EUR J NEUROSCI, V22, P2069, DOI 10.1111/j.1460-9568.2005.04370.x; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jones T. A., 2010, BRAIN REPAIR STROKE; JONES TA, 1994, J NEUROSCI, V14, P2140; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Jones TA, 2009, STROKE, V40, pS136, DOI 10.1161/STROKEAHA.108.533653; Joo HW, 2012, EUR J NEUROSCI, V36, P3691, DOI 10.1111/ejn.12014; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; KRAUSS J, 2007, BRAIN INJURY MED PRI, P469; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; McIntyre A, 2012, TOP STROKE REHABIL, V19, P499, DOI 10.1310/tsr1906-499; MIKLYAEVA EI, 1994, J NEUROSCI, V14, P7148; Nishibe M, 2015, NEUROREHAB NEURAL RE, V29, P472, DOI 10.1177/1545968314543499; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Tennant KA, 2015, NEUROREHAB NEURAL RE, V29, P193, DOI 10.1177/1545968314541329; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	63	16	17	0	22	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	NOV-DEC	2015	29	10					989	1000		10.1177/1545968315576577			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CU2BP	WOS:000363326800008	25761884	Green Accepted			2022-02-06	
J	Alatas, OD; Gurger, M; Atescelik, M; Yildiz, M; Demir, CF; Ekingen, E; Kalayci, M; Ilhan, N; Acar, E				Alatas, Omer Dogan; Gurger, Mehtap; Atescelik, Metin; Yildiz, Mustafa; Demir, Caner Feyzi; Ekingen, Evren; Kalayci, Mehmet; Ilhan, Nevin; Acar, Ethem			Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage	MEDICINE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; STRESS GENE; EXPRESSION; MARKERS; HSP70; SHOCK; PATTERNS; S-100B; DAMAGE	The authors evaluated neuron-specific enolase (NSE), S100 calcium-binding protein B (S100B), and heat shock protein 70 (HSP 70) levels and their relationships with in-hospital mortality, Glasgow Coma Scale (GCS) scores, and National Institute of Health Stroke Scale (NIHSS) scores.In total, 35 patients older than 18 years were presented to our emergency department and were diagnosed with non-traumatic intracranial hemorrhage (ICH) and 32 healthy controls were included. Blood samples were drawn on days 0 and 5.S100 calcium-binding protein B and HSP levels were significantly higher in patients than in controls on days 0 and 5. Neuron-specific enolase levels were higher in patients than in controls on day 0, but there was no significant difference on day 5.S100 calcium-binding protein B was negatively correlated with GCS, whereas it was positively correlated with NIHSS and bleeding volume. There was also a negative correlation between NSE and GCS, but it was not statistically significant. In addition, no significant correlation was found in terms of bleeding volume or NIHSS. Heat shock protein 70 was negatively correlated with GCS and positively correlated with bleeding volume and NIHSS, but these results were not statistically significant. S100 calcium-binding protein B and HSP 70 levels were significantly higher in those who died compared with survivors. The areas under the curve of S100 B, NSE, and HSP 70 for mortality were 0.635, 0.477, and 0.770, respectively.Neuron-specific enolase, S100B, and HSP 70 levels are simple, inexpensive, and objective measures in cases of ICH. These tests can be used to support an assessment for screening ICH patients with clinical scoring systems, such as GCS and NIHSS.	[Alatas, Omer Dogan; Acar, Ethem] Mugla Sitki Kocman Univ, Dept Emergency Med, Mugla, Turkey; [Gurger, Mehtap; Atescelik, Metin; Yildiz, Mustafa] Firat Univ, Sch Med, Dept Emergency Med, TR-23169 Elazig, Turkey; [Demir, Caner Feyzi] Firat Univ, Sch Med, Dept Neurol, TR-23169 Elazig, Turkey; [Ekingen, Evren] Batman Reg State Hosp, Dept Emergency Med, Batman, Turkey; [Kalayci, Mehmet] Elazig Training Hosp, Dept Biochem, Elazig, Turkey; [Ilhan, Nevin] Firat Univ, Dept Biochem, Sch Med, Elazig, Turkey		Alatas, OD (corresponding author), Mugla Sitki Kocman Univ, Sch Med, Dept Emergency, Med, Mugla, Turkey.	dr.alatas@hotmail.com	Ilhan, Nevin/J-5761-2017; Demir, Caner Feyzi/AAO-2045-2021; Gurger, Mehtap/V-8219-2018; Atescelik, Metin/V-8844-2018	Ilhan, Nevin/0000-0002-0208-8929; Demir, Caner Feyzi/0000-0002-2861-2418; Gurger, Mehtap/0000-0002-5209-2088; KALAYCI, Mehmet/0000-0001-9122-9289	Firat UniversityFirat University [TF.11.75]	This study was published as a poster at the 9th National Congress of Emergency Medicine in Turkey (23-26 May 2013, Antalya, Turkey). We received support from Firat University research funding for this study (number: TF.11.75).	Brea D, 2009, CLIN CHEM LAB MED, V47, P1513, DOI 10.1515/CCLM.2009.337; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; Brunswick AS, 2012, J NEUROL SCI, V321, P1, DOI 10.1016/j.jns.2012.06.008; CAPLAN LR, 1992, LANCET, V339, P656, DOI 10.1016/0140-6736(92)90804-C; Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad; Fang HY, 2007, J CLIN NEUROSCI, V14, P435, DOI 10.1016/j.jocn.2005.12.022; Herrmann M, 1999, EUR J CARDIO-THORAC, V16, P513, DOI 10.1016/S1010-7940(99)00245-6; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; HOMMEL M, 1990, STROKE, V21, P546, DOI 10.1161/01.STR.21.4.546; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Hu YY, 2010, SHOCK, V33, P134, DOI 10.1097/SHK.0b013e3181ad5c88; Janice AR, 1983, J NEUROL NEUROSUR PS, V46, P1031; Kartz BS, 2015, STROKE, V46, P1508; KELLY S, 2002, CURR MED RES OPIN, V18, P55; Manaenko A, 2010, NEUROCHEM INT, V57, P844, DOI 10.1016/j.neuint.2010.09.001; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; Matz P, 1996, STROKE, V27, P504, DOI 10.1161/01.STR.27.3.504; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Nikfarjam M, 2005, INT J HYPERTHER, V21, P319, DOI 10.1080/02656730500133736; O'Sullivan JC, 2007, J NEUROTRAUM, V24, P532, DOI 10.1089/neu.2006.0128; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rylander MN, 2005, ANN NY ACAD SCI, V1066, P222, DOI 10.1196/annals.1363.009; Schoerkhuber W, 1999, STROKE, V30, P1598, DOI 10.1161/01.STR.30.8.1598; Yuan X, 2004, J APOPLEXY IN PRESS, V2; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zubay G, 1983, BIOCHEMISTRY-US, P323	27	16	17	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2015	94	45							e2007	10.1097/MD.0000000000002007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC9JJ	WOS:000369537400051	26559295	Green Published, gold			2022-02-06	
J	Li, WT; Zhang, SY; Zhou, YF; Zhang, BF; Liang, ZQ; Liu, YH; Wei, Y; Li, CK; Meng, XJ; Xia, M; Dan, Y; Song, JN				Li, Wen-Tao; Zhang, Su-Yuan; Zhou, Yue-Fei; Zhang, Bin-Fei; Liang, Zhen-Qiang; Liu, Yong-Hong; Wei, Yan; Li, Chuan-Kun; Meng, Xi-Jun; Xia, Ming; Dan, Yong; Song, Jin-Ning			Carvacrol attenuates traumatic neuronal injury through store-operated Ca2+ entry-independent regulation of intracellular Ca2+ homeostasis	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; TRPM7; Calcium homeostasis; nNOS	IN-VITRO MODEL; BRAIN-INJURY; DOWN-REGULATION; TRPM7 CHANNELS; ISCHEMIA; DEATH; MECHANISMS; TRPC1	Searching for effective pharmacological agents for traumatic brain injury (TBI) treatment has largely been unsuccessful. The transient receptor potential melastatin 7 (TRPM7), a TRP channel that is essential for embryonic development, has been shown to mediate ischemic neuronal injury in vivo and in vitro, but global deletion of TRPM7 in mice is lethal. Here, carvacrol was used to investigate the protective effect of TRPM7 inhibition in an in vitro traumatic neuronal injury model. Carvacrol (0.5 and 1 mM) reduced lactate dehydrogenase (LDH) release, apoptosis and caspase-3 activation after traumatic injury in cortical neurons. These neuroprotective effects were accompanied by alleviated cytoplasmic calcium levels as measured by calcium imaging. In contrast, the thapsigargin (TG) induced store-operated calcium entry (SOCE) and the expression of SOCE related proteins in neurons were not altered by carvacrol treatment. The involvement of TRPM7 sensitive calcium influx in our in vitro model was confirmed by the results that bradykinin induced calcium influx was prevented by carvacrol in neurons. Furthermore, carvacrol significantly inhibited the induction of neuronal nitric oxide synthase (nNOS) after traumatic injury, and treatment with carvacrol and the nNOS inhibitor NLPA together had no extra effect on calcium concentration and neuronal injury. Thus, inhibition of TRPM7 function by carvacrol protects against traumatic neuronal injury, and might be a potential drug development strategy for the treatment of TBI. (C) 2015 Elsevier Ltd. All rights reserved.	[Li, Wen-Tao; Zhang, Bin-Fei; Wei, Yan; Li, Chuan-Kun; Meng, Xi-Jun; Xia, Ming; Dan, Yong; Song, Jin-Ning] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China; [Zhang, Su-Yuan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Lib, Xian 710061, Shaanxi, Peoples R China; [Zhou, Yue-Fei] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Liang, Zhen-Qiang] Dingxi First Peoples Hosp, Dept Neurosurg, Dingxi 743000, Gansu, Peoples R China; [Liu, Yong-Hong] Northwest Civil Aviat Hosp, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China.	songjinning_xjtu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870844, 30471774]; Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" [2008ZDKG-66]; New Century Excellent Talents Program of Ministry of EducationProgram for New Century Excellent Talents in University (NCET) [NCET-05-0831]; Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education [20110201110060]; Natural Science Foundation of Shaanxi Province of ChinaNatural Science Foundation of Shaanxi Province [2003C1-16]	This work was financially supported by the National Natural Science Foundation of China (No. 30870844 and NO. 30471774), the Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" (Grant No. 2008ZDKG-66), the New Century Excellent Talents Program of Ministry of Education (No.NCET-05-0831), the Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education (Grant No. 20110201110060), and the Natural Science Foundation of Shaanxi Province of China (No. 2003C1-16).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts MM, 2005, NEUROSCIENTIST, V11, P116, DOI 10.1177/1073858404272966; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bae CYJ, 2011, ACTA PHARMACOL SIN, V32, P725, DOI 10.1038/aps.2011.60; Bianchetti E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.237; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; DeWitt D S, 1995, New Horiz, V3, P376; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhao L, 2007, LIFE SCI, V81, P1211, DOI 10.1016/j.lfs.2007.08.034	28	16	17	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2015	90						107	113		10.1016/j.neuint.2015.07.020			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CX0DH	WOS:000365366600013	26220904				2022-02-06	
J	Long, JA; Watts, LT; Li, W; Shen, Q; Muir, ER; Huang, SL; Boggs, RC; Suri, A; Duong, TQ				Long, Justin A.; Watts, Lora T.; Li, Wei; Shen, Qiang; Muir, Eric R.; Huang, Shiliang; Boggs, Robert C.; Suri, Abhinav; Duong, Timothy Q.			The effects of perturbed cerebral blood flow and cerebrovascular reactivity on structural MRI and behavioral readouts in mild traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						functional outcomes; hypercapnia; MRI: diffusion tensor imaging; TBI	CONTROLLED CORTICAL IMPACT; PERFUSION; DIFFUSION; HYPERPERFUSION; RAT; HYPOXIA; STEAL; MICROCIRCULATION; HYPERCAPNIA; MECHANISMS	This study investigated the effects of perturbed cerebral blood flow (CBF) and cerebrovascular reactivity (CR) on relaxation time constant (T-2), apparent diffusion coefficient (ADC), fractional anisotropy (FA), and behavioral scores at 1 and 3 hours, 2, 7, and 14 days after traumatic brain injury (TBI) in rats. Open-skull TBI was induced over the left primary forelimb somatosensory cortex (N=8 and 3 sham). We found the abnormal areas of CBF and CR on days 0 and 2 were larger than those of the T-2, ADC, and FA abnormalities. In the impact core, CBF was reduced on day 0, increased to 2.5 times of.normal on day 2, and returned toward normal by day 14, whereas in the tissue surrounding the impact, hypoperfusion was observed on days 0 and 2. CR in the impact core was negative, most severe on day 2 but gradually returned toward normal. T-2, ADC, and FA abnormalities in the impact core were detected on day 0, peaked on day 2, and pseudonormalized by day 14. Lesion volumes peaked on day 2 and were temporally correlated with forelimb asymmetry and foot-fault scores. This study quantified the effects of perturbed CBF and CR on structural magnetic resonance imaging and behavioral readouts.	[Long, Justin A.; Watts, Lora T.; Li, Wei; Shen, Qiang; Muir, Eric R.; Huang, Shiliang; Boggs, Robert C.; Suri, Abhinav; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Watts, Lora T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora T.; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Opthalmol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, San Antonio, TX USA		Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Watts, Lora Talley/A-2724-2012; Duong, Tim/AAL-8357-2021	Watts, Lora Talley/0000-0002-2337-1504; Duong, Tim/0000-0001-6403-2827; SURI, ABHINAV/0000-0002-7900-8763	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45879]; Mike Hogg Fund via the Clinical Translational Science Awards (CTSA) [UL1TR000149, TL1TR001119, KL2TR001118];  [KL2 TR001118]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000149, UL1TR001120, KL2TR001118, TL1TR001119] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	This work was supported in part by NIH/NINDS R01 NS45879 (TQD), a TL1 (JAL) and KL2 TR001118 and Mike Hogg Fund (LTW) via the Clinical Translational Science Awards (CTSA, parent grants UL1TR000149, TL1TR001119, and KL2TR001118).	Arteaga DF, 2014, J CEREBR BLOOD F MET, V34, P1453, DOI 10.1038/jcbfm.2014.106; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Berne R M, 1974, Adv Cardiol, V12, P303; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Feuerstein D, 2014, J CEREBR BLOOD F MET, V34, P1117, DOI 10.1038/jcbfm.2014.53; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; JOO F, 1986, NATURE, V321, P197, DOI 10.1038/321197a0; KONTOS HA, 1985, ANN BIOMED ENG, V13, P329, DOI 10.1007/BF02584251; LEE JG, 1994, ANESTH ANALG, V79, P58; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; MCCASLAND JS, 1988, J COMP NEUROL, V278, P555, DOI 10.1002/cne.902780407; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Paksoy Y, 2003, AM J NEURORADIOL, V24, P1364; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Poublanc J, 2013, CEREBROVASC DIS EXTR, V3, P55, DOI 10.1159/000348841; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2003, J CEREBR BLOOD F MET, V23, P1479, DOI 10.1097/01.WCB.0000100064.36077.03; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739	39	16	16	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2015	35	11					1852	1861		10.1038/jcbfm.2015.143			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CV4TR	WOS:000364259900018	26104285	Green Published, Bronze			2022-02-06	
J	Mayer, AR; Hanlon, FM; Dodd, AB; Ling, JM; Klimaj, SD; Meier, TB				Mayer, Andrew R.; Hanlon, Faith M.; Dodd, Andrew B.; Ling, Josef M.; Klimaj, Stefan D.; Meier, Timothy B.			A functional magnetic resonance imaging study of cognitive control and neurosensory deficits in mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						cognitive control; multisensory; auditory; visual; functional magnetic resonance imaging	POSTERIOR PARIETAL CORTEX; DUAL SENSORY IMPAIRMENT; CROSS-MODAL DISTRACTION; HEAD-INJURY; ACTIVATION; ATTENTION; MRI; BLAST; INTEGRATION; CONCUSSION	Mild traumatic brain injury patients (mTBI) frequently report symptoms of increased distractability and sensory disturbances during mutisensory stimulation. These common post-concussive symptoms could putatively result from dysfunction within the cognitive control network (CCN; top-down) or from unisensory cortex (bottom-up) itself. Functional magnetic resonance imaging (fMRI) and high-resolution structural data were therefore prospectively collected during a multisensory (audio-visual) cognitive control task from 46 mTBI patients within 3 weeks of injury and 46 matched healthy controls (HC), with a subset of participants returning at 4 months. Multisensory stimuli were presented at two frequencies to manipulate cognitive and perceptual load. Patients self-reported more cognitive, emotional, somatic, vestibular and visual symptoms relative to HC, which improved, but did not entirely resolve, over the 4 month follow-up period. There were no group differences in behavior or functional activation during cognitive control (incongruent - congruent trials). In contrast, patients exhibited abnormal activation within different regions of visual cortex that depended on whether attention was focused on auditory or visual information streams. Patients also exhibited increased activation within bilateral inferior parietal lobules during higher cognitive/perceptual loads, suggesting a compensatory mechanism to achieve similar levels of behavioral performance. Functional abnormalities within the visual cortex and inferior parietal lobules were only partially resolved at 4 months post-injury, suggesting that neural abnormalities may take longer to resolve than behavioral measures used in most clinical settings. In summary, current results indicate that abnormalities within unisensory cortex (particularly visual areas) following mTBI, which likely contribute to deficits commonly reported during multisensory stimulation. Hum Brain Mapp 36:4394-4406, 2015. (c) 2015 Wiley Periodicals, Inc.	[Mayer, Andrew R.; Hanlon, Faith M.; Dodd, Andrew B.; Ling, Josef M.; Klimaj, Stefan D.; Meier, Timothy B.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Klimaj, Stefan/AAV-4060-2020		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24-HD050836, R21-NS064464-01A1, R21-NS064464-01S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS064464] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health; Contract grant numbers: R24-HD050836, R21-NS064464-01A1, R21-NS064464-01S1 (to A.M.).	Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Baier B, 2006, J NEUROSCI, V26, P12260, DOI 10.1523/JNEUROSCI.1457-06.2006; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; HUBEL DH, 1959, SCIENCE, V129, P1279, DOI 10.1126/science.129.3358.1279; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; Mayer AR, 2009, CEREB CORTEX, V19, P993, DOI 10.1093/cercor/bhn148; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2012, HUM BRAIN MAPP, V33, P2843, DOI 10.1002/hbm.21405; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Nachev P, 2006, CORTEX, V42, P766, DOI 10.1016/S0010-9452(08)70415-5; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Talairach J., 1988, COPLANAR STEREOTAXIC; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zmigrod S, 2014, MULTISENS RES, V27, P161, DOI 10.1163/22134808-00002449	57	16	17	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	NOV	2015	36	11					4394	4406		10.1002/hbm.22930			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CV4EQ	WOS:000364219500013	26493161	Green Accepted, Green Published			2022-02-06	
J	Song, Q; Xie, DJ; Pan, SY; Xu, WJ				Song, Qi; Xie, Dujiang; Pan, Shiyong; Xu, Weijun			Rapamycin protects neurons from brain contusion-induced inflammatory reaction via modulation of microglial activation	MOLECULAR MEDICINE REPORTS			English	Article						rapamycin; brain contusion; inflammatory reaction; microglial activation; proinflammatory cytokines	TUMOR-NECROSIS-FACTOR; NERVE GROWTH-FACTOR; MAMMALIAN TARGET; OXIDATIVE STRESS; INJURY; MTOR; MICE; NEUROTOXICITY; IL-1-BETA; APOPTOSIS	The inflammatory reaction is important in secondary injury following traumatic brain injury (TBI). Rapamycin has been demonstrated as a neuroprotective agent in a mouse model of TBI, however, there is a lack of data regarding the effects of rapamycin on the inflammatory reaction following TBI. Therefore, the present study was designed to assess the effects of treatment with rapamycin on inflammatory reactions and examine the possible involvement of microglial activation following TBI. Male imprinting control region mice were randomly divided into four groups: Sham group (n=23), TBI group (n=23), TBI + dimethyl sulfoxide (DMSO) group (n=31) and TBI + rapamycin group (n=31). Rapamycin was dissolved in DMSO (50 mg/ml) and injected 30 min after TBI (2 mg/Kg; intraperitoneally). A weight-drop model of TBI was induced, and the brain tissues were harvested 24 h after TBI. The findings indicated that the administration of rapamycin following TBI was associated with decreased levels of activated microglia and neuron degeneration at the pen-injury site, reduced levels of proinflammatory cytokines and increased neurobehavioral function, possibly mediated by inactivation of the mammalian target of rapamycin pathway. The results of the present study offer novel insight into the mechanisms responsible for the anti-neuroinflammatory effects of rapamycin, possibly involving the modulation of microglial activation.	[Song, Qi; Pan, Shiyong; Xu, Weijun] Nanjing Gen Hosp Nanjing Command, Dept Healthcare, Nanjing 210002, Jiangsu, Peoples R China; [Xie, Dujiang] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing 210006, Jiangsu, Peoples R China		Song, Q (corresponding author), Nanjing Gen Hosp Nanjing Command, Dept Healthcare, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	pipisq@126.com			Project Planning of Nanjing General Hospital [2013067]	The present study was supported by the Project Planning of Nanjing General Hospital (grant no. 2013067).	Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P374, DOI 10.4161/oxim.3.6.14787; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dean JM, 2010, BRAIN BEHAV IMMUN, V24, P776, DOI 10.1016/j.bbi.2009.10.018; Dello Russo C, 2013, GLIA, V61, P301, DOI 10.1002/glia.22433; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Hosoi H, 1999, CANCER RES, V59, P886; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Min KJ, 2003, BIOCHEM BIOPH RES CO, V312, P969, DOI 10.1016/j.bbrc.2003.11.010; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pinteaux-Jones F, 2008, J NEUROCHEM, V106, P442, DOI 10.1111/j.1471-4159.2008.05426.x; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Smith RM, 1998, J ROY SOC MED, V91, P417, DOI 10.1177/014107689809100805; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Wong Michael, 2013, Biomed J, V36, P40, DOI 10.4103/2319-4170.110365; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	43	16	19	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2015	12	5	B				7203	7210		10.3892/mmr.2015.4407			8	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CW3JR	WOS:000364889100002	26458361	Green Submitted, Green Published, hybrid			2022-02-06	
J	Jennings, D; Sells, P; Allison, J; Boyd, K; Frommert, D; Kessler, C; Merryman, L; Muchmore, J; Odom, TJ; Salmon, R; Robinson, K				Jennings, David; Sells, Pat; Allison, Jenni; Boyd, Kasey; Frommert, Dave; Kessler, Chelsea; Merryman, Lindsey; Muchmore, Joe; Odom, T. J.; Salmon, Ryan; Robinson, Kevin			EFFECTS OF A SEASON OF SUBCONCUSSIVE CONTACT ON CHILD- SCAT3 SCORES IN 8-12 YEAR-OLD MALE ATHLETES	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Child-Scat3; football; subconcussive contact		Background: Each year, over 173,000 children and adolescents visit emergency departments due to sports and recreation related concussions, an increase of 60% over the last decade due to the rise in the number of children participating in sport. While numerous authors have sought to address the epidemiology of concussions across multiple age groups who participate in contact sports, a recent review of literature did not reveal a substantial amount of published articles that addressed the issue of subconcussive contact. Multiple tools have been developed to assess acute episodes of concussion. Among the assessment protocols many include an assessment of balance, short and long term memory recall, and balance. The Child-SCAT3 was designed specifically to evaluate concussions in children 5-12 years of age. Objective: The purpose of this study was to determine the effect of a season of subconcussive contact on Child-SCAT3 scores in 8-12 year old males compared to their age matched peers who participated in non-contact sports. A secondary purpose was to evaluate how scores of the sub-components of the Child-SCAT3 compare between contact and non-contact athletes. Design: A prospective cohort study was performed of 71 male athletes (58 football, 13 baseball) ages 8-12 (contact mean age 10.30 years, SD 1.20; non-contact mean age 10.03 years, SD 1.26) over the course of a season. Methods: Portions of The Child-SCAT3 were administered and scored in pre-adolescent athletes prior to and following a season of participation in football (contact sport group) and baseball (non-contact sport group). The outcome measures of interest included the portions related to Cognitive ability, Balance, and Coordination. Results: No statistically significant differences were found in group, time or time and group interaction for any of the utilized portions of the Child-SCAT3. Statistically significant differences were found between groups for preseason cognitive orientation and postseason immediate memory. Cognitive orientation and coordination were also found to be statistically significantly improved across both groups over the course of the season. Limitations: This study was potentially limited by the number of control subjects tested. Conclusions: A season of subconcussive contact in football was not detrimental to cognitive and balance scores on the Child-SCAT3.	[Jennings, David; Sells, Pat; Allison, Jenni; Boyd, Kasey; Frommert, Dave; Kessler, Chelsea; Merryman, Lindsey; Muchmore, Joe; Odom, T. J.; Salmon, Ryan; Robinson, Kevin] Belmont Univ, Sch Phys Therapy, 1900 Belmont Blvd, Nashville, TN 37212 USA		Jennings, D (corresponding author), Belmont Univ, Sch Phys Therapy, 1900 Belmont Blvd, Nashville, TN 37212 USA.	David.L.Jennings1@gmail.com					Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glaviano N, 2014, CLIN J SPORT MED, P1; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; IBM Corp, 2012, SPSS STAT WIND VERS; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Merkel DL, 2012, INT J SPORTS PHYS TH, V7, P242; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Stern RA, 2015, NEUROLOGY, V85, P1008; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	26	16	16	0	8	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	OCT	2015	10	5					667	675					9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VA2EZ	WOS:000409721600010	26491617				2022-02-06	
J	Maia, PD; Hemphill, MA; Zehnder, B; Zhang, CF; Parker, KK; Kutz, JN				Maia, Pedro D.; Hemphill, Matthew A.; Zehnder, Brendan; Zhang, Chenfei; Parker, Kevin K.; Kutz, J. Nathan			Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Focal Axonal Swelling; Traumatic brain injury; Concussions; Parkinson; Alzheimer; Multiple Sclerosis; Spike train propagation	ACTION-POTENTIALS; SPIKE PROPAGATION; ABNORMALITIES; TRANSMISSION; TRANSPORT; PATHOLOGY; BREAKAGE; DEMENTIA; MODELS	Background: Focal Axonal Swellings arise in several leading neurodegenerative diseases of the central nervous system and are hallmark features of concussions and traumatic brain injuries. Recent theories mapped how the shape of each swelling affects the propagation of spike trains and consequently the information encoded in them. Spikes can be selectively deleted, have their speed affected, or blocked depending upon the severity of the swelling. New method: Our computational toolbox extracts meaningful geometrical parameters from sequential images of injured axon segments. The algorithm provides a principled approach for dealing with imaging distortions caused by experimental artifacts in order to extract the cross-section of an axon by detecting local symmetries, turning points and turning regions. Results: Our characterization of the Focal Axonal Swelling allows for an assessment of its impact on spike propagation, leading to a color coding of the axon that highlights problematic regions for information propagation. Comparison with existing methods: Many theoretical works reported distortions in spike propagation related to axonal enlargements. Such estimates, however, were not incorporated to a toolbox that could classify axonal swellings directly from experimental images. Conclusions: Our MATLAB toolbox thus highlights potential trouble spots of axonal morphology, and similar to car traffic maps, identify blocked or impaired routes for information flow. This computational framework is a promising starting point for diagnosing and assessing the impact of axonal swellings implicated in concussions, Alzheimer's and Parkinson's disease, Multiple Sclerosis and other neurological pathologies. (C) 2015 Elsevier B.V. All rights reserved.	[Maia, Pedro D.; Zehnder, Brendan; Zhang, Chenfei; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Hemphill, Matthew A.; Parker, Kevin K.] Harvard Univ, Wyss Inst Biol Inspired Engn, Dis Biophys Grp, Cambridge, MA 02138 USA		Maia, PD (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	pedro.doria.maia@gmail.com; matt.hemphill@gmail.com; brendan.zehnder@gmail.com; kkparker@seas.harvard.edu; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257			Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Altenberger R, 2001, J NEUROSCI METH, V112, P101, DOI 10.1016/S0165-0270(01)00456-3; Baccus SA, 1998, P NATL ACAD SCI USA, V95, P8345, DOI 10.1073/pnas.95.14.8345; Baccus SA, 2000, J NEUROPHYSIOL, V83, P1693, DOI 10.1152/jn.2000.83.3.1693; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Ermentrout G., 2010, MATH FDN NEUROSCIENC; Fainaru-Wada M., 2013, CROWN ARCHETYPE; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kolaric KV, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.59; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Liberski PP, 1999, ACTA NEUROPATHOL, V97, P329, DOI 10.1007/s004010050995; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Marcuse D., 1974, THEORY DIELECTRIC OP; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Parnas I, 1979, PROPAGATION NONUNIFO, P499; RAMON F, 1975, FED PROC, V34, P1357; Rinzel J, 1990, ANN N Y ACAD SCI, V591; Segev I, 1999, J PHYSIOLOGY-PARIS, V93, P263, DOI 10.1016/S0928-4257(00)80055-8; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Smith D, 1999, J NEUROSCI, V19, P4263; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; ZHOU Y, 1994, MATH BIOSCI, V119, P169, DOI 10.1016/0025-5564(94)90075-2	39	16	16	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2015	253						233	243		10.1016/j.jneumeth.2015.06.022			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CQ8OJ	WOS:000360867400023	26188255				2022-02-06	
J	Montalcini, T; Moraca, M; Ferro, Y; Romeo, S; Serra, S; Raso, MG; Rossi, F; Sannita, WG; Dolce, G; Pujia, A				Montalcini, Tiziana; Moraca, Marta; Ferro, Yvelise; Romeo, Stefano; Serra, Sebastiano; Raso, Maria Girolama; Rossi, Francesco; Sannita, Walter G.; Dolce, Giuliano; Pujia, Arturo			Nutritional parameters predicting pressure ulcers and short-term mortality in patients with minimal conscious state as a result of traumatic and non-traumatic acquired brain injury	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						Malnutrition; Minimal conscious state; Pressure ulcer; Mid-arm circumference; Albumin	SERUM-ALBUMIN LEVEL; RISK-FACTORS; ADMISSION; MALNUTRITION; PREVALENCE; PREVENTION; SURVIVAL; DISEASE; PEOPLE; IMPACT	Background: The association between malnutrition and worse outcomes as pressure ulcers and mortality is well established in a variety of setting. Currently none investigation was conducted in patients with long-term consequences of the acquired brain injury in which recovery from brain injury could be influenced by secondary complications. The aim of this study was to investigate the association between various nutritional status parameters (in particular albumin) and pressure ulcers formation and short-term mortality in minimal conscious state patients. Methods: In this prospective, observational study of 5-months duration, a 30 patients sample admitted to a Neurological Institute was considered. All patients underwent a complete medical examination. Anthropometric parameters like mid-arm circumference and mid-arm muscle circumference and nutritional parameters as serum albumin and blood hemoglobin concentration were assessed. Results: At univariate and logistic regression analysis, mid-arm circumference (p = 0.04; beta = -0.89), mid-arm muscle circumference (p = 0.050; beta = -1.29), hemoglobin (p = 0.04, beta -1.1) and albumin (p = 0.04, beta -7.91) were inversely associated with pressure ulcers. The area under the ROC curve for albumin to predict sores was 0.76 (p = 0.02) and mortality was 0.83 (p = 0.03). Patient with lower albumin had significantly higher short-term mortality than those with higher serum albumin (p = 0.03; chi(2) test = 6.47). Conclusion: Albumin, haemoglobin and mid-arm circumference are inversely associated with pressure ulcers. Albumin is a prognostic index in MCS patients. Since albumin and haemoglobin could be affected by a variety of factors, this association suggests to optimize nutrition and investigate on other mechanism leading to mortality and pressure ulcers.	[Montalcini, Tiziana; Moraca, Marta; Ferro, Yvelise; Romeo, Stefano; Pujia, Arturo] Univ Magna Grecia, Dept Med & Surg Sci, Clin Nutr Unit, I-88100 Catanzaro, Italy; [Romeo, Stefano] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Gothenburg, Sweden; [Serra, Sebastiano; Raso, Maria Girolama; Rossi, Francesco; Sannita, Walter G.; Dolce, Giuliano] S Anna Neurol Inst, Crotone, Italy		Montalcini, T (corresponding author), Univ Magna Grecia, Dept Med & Surg Sci, Clin Nutr Unit, Viale S Venuta, I-88100 Catanzaro, Italy.	tmontalcini@unicz.it	Serra, Sebastiano/AAP-8391-2021; Ferro, Yvelise/T-2539-2017; Romeo, Stefano/L-6861-2015; Ferro, Yvelise/AAC-1121-2020	Romeo, Stefano/0000-0001-9168-4898; Ferro, Yvelise/0000-0001-7503-6188; MONTALCINI, Tiziana/0000-0001-7048-5830	Novo Nordisk FondenNovo Nordisk Foundation [NNF14OC0009321] Funding Source: researchfish		Allman RM, 1997, CLIN GERIATR MED, V13, P421; Anthony D, 2000, J ADV NURS, V32, P359, DOI 10.1046/j.1365-2648.2000.01484.x; Baltazar GA, 2015, AM SURGEON, V81, pE61; Baltazar GA, 2015, BRAIN INJURY, V29, P607, DOI 10.3109/02699052.2015.1004558; Banks M, 2010, NUTRITION, V26, P896, DOI 10.1016/j.nut.2009.09.024; Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Bredesen IM, 2015, INT J NURS STUD, V52, P149, DOI 10.1016/j.ijnurstu.2014.07.005; Cabrerizo S, 2015, MATURITAS, V81, P17, DOI 10.1016/j.maturitas.2015.02.009; Casiraghi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073651; CHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2; Dhandapani M, 2014, J CLIN NURS, V23, P1114, DOI 10.1111/jocn.12396; Di Lorenzo G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-161; DIRREN H, 1991, EUR J CLIN NUTR, V45, P43; European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel, 2009, TREAT PRESS ULC QUIC; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grasso S, 2013, CLINICS, V68, P1413, DOI 10.6061/clinics/2013(11)05; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Guenter P, 2000, Adv Skin Wound Care, V13, P164; HARVEY KB, 1981, AM J CLIN NUTR, V34, P2013, DOI 10.1093/ajcn/34.10.2013; Huo YR, 2015, J NUTR HEALTH AGING, V19, P474, DOI 10.1007/s12603-014-0543-z; Idicula TT, 2009, CEREBROVASC DIS, V28, P13, DOI 10.1159/000215938; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; Japur CC, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.12.007; Kurtul A, 2015, ANGIOLOGY; Kwak L, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-26; Langer G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003216; Lim SL, 2012, CLIN NUTR, V31, P345, DOI 10.1016/j.clnu.2011.11.001; Montalcini T, 2013, ENDOCRINE, V43, P59, DOI 10.1007/s12020-012-9813-x; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Oh IH, 2015, ARTIF ORGANS, V39, P965, DOI 10.1111/aor.12473; Shahin Eman S M, 2008, Nurs Crit Care, V13, P71, DOI 10.1111/j.1478-5153.2007.00249.x; Shindo Y, 2015, LANCET INFECT DIS, V15, P1055, DOI 10.1016/S1473-3099(15)00151-6; Sugino H, 2014, J MED INVESTIG, V61, P15, DOI 10.2152/jmi.61.15; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456; Talluri T, 1999, ANN NY ACAD SCI, V873, P94, DOI 10.1111/j.1749-6632.1999.tb09454.x; Thomas DR, 2014, NUTR CLIN PRACT, V29, P466, DOI 10.1177/0884533614539016; US Department of Health and Human Services National Institutes of Health Technology Assessment Conference Statement, 1994, BIOEL IMP AN BOD COM, P12; van Dijk PC, 2008, KIDNEY INT, V74, P705, DOI 10.1038/ki.2008.294; Waltman N L, 1991, Oncol Nurs Forum, V18, P867; Wissing U, 1999, SCAND J CARING SCI, V13, P123, DOI 10.1080/02839319950162679; World Health Organization, WHO CHILD GROWTH STA	45	16	17	2	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	SEP 17	2015	13								305	10.1186/s12967-015-0660-4			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CR5CD	WOS:000361356100002	26376778	gold, Green Published			2022-02-06	
J	Nogueira, ML; Moreira, JD; Baronzio, GF; Dubois, B; Steyaert, JM; Schwartz, L				Nogueira, Marcel Levy; Moreira, Jorgelindo da Veiga; Baronzio, Gian Franco; Dubois, Bruno; Steyaert, Jean-Marc; Schwartz, Laurent			Mechanical stress as the common denominator between chronic inflammation, cancer, and alzheimer's disease	FRONTIERS IN ONCOLOGY			English	Article						cancer; inflammation; fibrosis; pressure; Alzheimer's disease; mechanical stress	TRAUMATIC BRAIN-INJURY; NORMAL-PRESSURE HYDROCEPHALUS; MAGNETIC-RESONANCE ELASTOGRAPHY; PULSE-WAVE ENCEPHALOPATHY; A-BETA PEPTIDE; AMYLOID-BETA; CEREBROSPINAL-FLUID; TAU PATHOLOGY; CELL-DEATH; INTRACRANIAL-PRESSURE	The pathogenesis of common diseases, such as Alzheimer's disease (AD) and cancer, are currently poorly understood. Inflammation is a common risk factor for cancer and AD. Recent data, provided by our group and from others, demonstrate that increased pressure and inflammation are synonymous. There is a continuous increase in pressure from inflammation to fibrosis and then cancer. This is in line with the numerous papers reporting high interstitial pressure in cancer. But most authors focus on the role of pressure in the lack of delivery of chemotherapy in the center of the tumor. Pressure may also be a key factor in carcinogenesis. Increased pressure is responsible for oncogene activation and cytokine secretion. Accumulation of mechanical stress plays a key role in the development of diseases of old age, such as cardiomyopathy, atherosclerosis, and osteoarthritis. Growing evidence suggest also a possible link between mechanical stress in the pathogenesis of AD. The aim of this review is to describe environmental and endogenous mechanical factors possibly playing a pivotal role in the mechanism of chronic inflammation, AD, and cancer.	[Nogueira, Marcel Levy; Dubois, Bruno] Hop La Pitie Salpetriere, AP HP, Dept Neurol, IM2A, Paris, France; [Nogueira, Marcel Levy; Dubois, Bruno] Inst Cerveau & Moelle Epiniere ICM, Inst Neurosci Translat Paris IHU A ICM, Paris, France; [Nogueira, Marcel Levy; Moreira, Jorgelindo da Veiga; Steyaert, Jean-Marc; Schwartz, Laurent] Univ Paris Saclay, Ecole Polytech, Lab Informat LIX, UMR 7161, Palaiseau, France; [Baronzio, Gian Franco] Kines Med Ctr, Integrat Oncol, Milan, Italy; [Dubois, Bruno] Inst Cerveau & Moelle Epiniere ICM, INSERM, CNRS, UMR S975, Paris, France		Schwartz, L (corresponding author), Ecole Polytech, Lab Informat LIX, F-91128 Palaiseau, France.	laurent.schwartz@polytechnique.edu					Abolhassani M, 2008, INFLAMM RES, V57, P419, DOI 10.1007/s00011-007-7213-0; Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Aoyama Y, 2006, J NEUROSURG, V104, P332, DOI 10.3171/ped.2006.104.5.332; Barz H, 2013, MED HYPOTHESES, V81, P768, DOI 10.1016/j.mehy.2013.07.049; Bateman GA, 2004, MED HYPOTHESES, V63, P980, DOI 10.1016/j.mehy.2004.04.019; Bateman GA, 2004, MED HYPOTHESES, V62, P182, DOI 10.1016/S0306-9877(03)00330-X; Bateman GA, 2008, NEURORADIOLOGY, V50, P491, DOI 10.1007/s00234-008-0374-x; Bech RA, 1999, ACTA NEUROCHIR, V141, P633, DOI 10.1007/s007010050353; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Brinckmann P, 2013, MUSCULOSKELETAL BIOM; Cabral Danielle, 2011, Alzheimers Dement, V7, P509, DOI 10.1016/j.jalz.2010.12.008; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carnevale D, 2011, BIOCHEM SOC T, V39, P939, DOI 10.1042/BST0390939; Chakravarty A, 2004, MED HYPOTHESES, V63, P827, DOI 10.1016/j.mehy.2004.03.029; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chetelat G, 2013, NAT REV NEUROL, V9, P123, DOI [10.1038/nrneurol.2013.21, 10.1038/nrneurol.2013.21-c2]; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; DeVita VT, 2011, ROSENBERGS CANC PRIN; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; El Sankari S, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-12; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Fleury V, 2003, FRACTALS, V11, P397, DOI 10.1142/S0218348X0300204X; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Golomb J, 2000, J NEUROL NEUROSUR PS, V68, P778, DOI 10.1136/jnnp.68.6.778; Greig NH, 2004, ANN NY ACAD SCI, V1035, P290, DOI 10.1196/annals.1332.018; Grimble RF, 2003, CURR OPIN CLIN NUTR, V6, P21, DOI 10.1097/00075197-200301000-00005; Hachiya NS, 2008, MED HYPOTHESES, V70, P1034, DOI 10.1016/j.mehy.2007.06.043; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Heo KS, 2014, MOL CELLS, V37, P435, DOI [10.14348/molcells.2014.0078, 10.14348/molcells.2014.0108]; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hughes TM, 2013, NEUROLOGY, V81, P1711, DOI 10.1212/01.wnl.0000435301.64776.37; Hutchison JS, 2001, J NEUROTRAUM, V18, P1333, DOI 10.1089/08977150152725632; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jacobs CR, 2013, INTRODUCTION TO CELL MECHANICS AND MECHANOBIOLOGY, P1; Johnson FE, 2000, INT J ONCOL, V16, P617; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Klinge PM, 2006, NEUROREPORT, V17, P657, DOI 10.1097/00001756-200604240-00020; Kristen AV, 2010, CARDIOVASC PATHOL, V19, P228, DOI 10.1016/j.carpath.2009.04.005; Kucewicz JC, 2007, ULTRASOUND MED BIOL, V33, P681, DOI 10.1016/j.ultrasmedbio.2006.11.008; Kurata T, 2014, J STROKE CEREBROVASC, V23, P2580, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.023; LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Lee SJ, 2009, MED HYPOTHESES, V72, P199, DOI 10.1016/j.mehy.2008.09.044; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Locke D, 1998, J PATHOL, V186, P343; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Michael R, 2008, VISION RES, V48, P626, DOI 10.1016/j.visres.2007.12.005; Modesto K, 2014, PROG CARDIOVASC DIS, V57, P111, DOI 10.1016/j.pcad.2014.03.003; Mori F, 2002, NEUROPATHOLOGY, V22, P186, DOI 10.1046/j.1440-1789.2002.00445.x; Murphy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081668; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Nagai K, 2004, J AM GERIATR SOC, V52, P1037, DOI 10.1111/j.1532-5415.2004.52277_15.x; Niggemeyer O, 2012, RHEUMATOL INT, V32, P2645, DOI 10.1007/s00296-011-2005-9; Nogueira ML, 2016, ALZHEIMERS DEMENT, V12, P11, DOI 10.1016/j.jalz.2015.03.005; Nonaka Y, 2008, J NEUROS-PEDIATR, V1, P68, DOI 10.3171/PED-08/01/068; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Peters WS, 1996, ANN BOT-LONDON, V77, P657, DOI 10.1006/anbo.1996.0082; Pierce JES, 1996, J NEUROSCI, V16, P1083; Podolsky DIK, 1994, ALCOHOL RELATED DIS, P1483; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Robicsek F, 2002, ACTA CHIR BELG, V102, P1; Rothwell Peter M, 2013, Recent Results Cancer Res, V191, P121, DOI 10.1007/978-3-642-30331-9_7; Rubenstein E, 1998, LANCET, V351, P283, DOI 10.1016/S0140-6736(97)09234-9; Safar ME, 2012, CURR HYPERTENS REP, V14, P339, DOI 10.1007/s11906-012-0272-9; Savolainen S, 1999, ACTA NEUROCHIR, V141, P849, DOI 10.1007/s007010050386; Schreiber S, 2014, J ALZHEIMERS DIS, V42, pS205, DOI 10.3233/JAD-132618; Schwartz L, 2002, MED HYPOTHESES, V58, P340, DOI 10.1054/mehy.2001.1539; Schwartz L., 2004, CANC GLYCOLYSIS PHYS; Schwartz L, 2008, AM J PHYSIOL-GASTR L, V295, pG934, DOI 10.1152/ajpgi.90296.2008; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Silverberg Gerald, 2006, Cerebrospinal Fluid Res, V3, P7; Silverberg GD, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-2; Silverberg GD, 2010, BRAIN RES, V1317, P286, DOI 10.1016/j.brainres.2009.12.065; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Solar M, 2013, J MECH BEHAV BIOMED, V19, P43, DOI 10.1016/j.jmbbm.2012.10.007; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Thompson DW., 1917, GROWTH FORM; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Varongchayakul N, 2013, ACS NANO, V7, P7734, DOI 10.1021/nn402322k; Visser AW, 2015, ANN RHEUM DIS, V74, P1842, DOI 10.1136/annrheumdis-2013-205012; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wostyn P, 2004, MED HYPOTHESES, V62, P925, DOI 10.1016/j.mehy.2004.01.013; WOSTYN P, 1994, MED HYPOTHESES, V43, P219, DOI 10.1016/0306-9877(94)90069-8; Wostyn P, 2008, CLIN NEUROL NEUROSUR, V110, P101, DOI 10.1016/j.clineuro.2007.10.011; Wostyn P, 2010, MED HYPOTHESES, V74, P973, DOI 10.1016/j.mehy.2009.12.019; Xu ZP, 2010, BIOPHYS J, V98, P2053, DOI 10.1016/j.bpj.2009.12.4317; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zhong WJ, 2014, ALZ DIS ASSOC DIS, V28, P44, DOI 10.1097/WAD.0b013e3182949f06	112	16	16	2	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2234-943X			FRONT ONCOL	Front. Oncol.	SEP 17	2015	5								197	10.3389/fonc.2015.00197			8	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	CW6UI	WOS:000365133100001	26442209	Green Published, gold			2022-02-06	
J	Cohen, T; Molinari, A				Cohen, Tal; Molinari, Alain			Dynamic cavitation and relaxation in incompressible nonlinear viscoelastic solids	INTERNATIONAL JOURNAL OF SOLIDS AND STRUCTURES			English	Article						Dynamic cavity expansion; Nonlinear viscoelasticity; Cavitation rheology; Relaxation; Thick-walled spherical shell	SPHERICAL CAVITY-EXPANSION; MODEL; GROWTH; RHEOLOGY; FRACTURE	Closed form analytical solutions for the dynamic expansion of a spherical void in a finite, spherically symmetric, nonlinearly viscoelastic medium are presented. We account for finite strains and application of load, both internally, at the cavity wall, and at the external surface. Hence, the present solution may apply to a wide range of known physical phenomena with examples from biomechanics, as in the appearance of cavitation bubbles due to traumatic brain injury or expansion of soft tissue due to an internal growth, to fracture initiation in soft materials and softening of seismic bearings in large scale structures. Specifically it is suggested that the present closed form analytical relations can be facilitated to measure the local viscoelastic properties of the material through controlled relaxation experiments. (C) 2015 Elsevier Ltd. All rights reserved.	[Cohen, Tal] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Molinari, Alain] Univ Lorraine, UMR CNRS, LEM3, F-57045 Metz 01, France		Cohen, T (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	talco@mit.edu			MIT-Technion Post-Doctoral Fellowship Program	A sincere thanks goes to Professor R Abeyaratne for his insightful comments during the course of this research. This research was supported by the MIT-Technion Post-Doctoral Fellowship Program (T.C).	BALL JM, 1982, PHILOS T R SOC A, V306, P557, DOI 10.1098/rsta.1982.0095; BISHOP RF, 1945, P PHYS SOC LOND, V57, P147, DOI 10.1088/0959-5309/57/3/301; CHOUWANG MS, 1989, INT J ENG SCI, V27, P967, DOI 10.1016/0020-7225(89)90037-2; CHRISTENSEN R. M., 1982, THEORY VISCOELASTICI; Cohen T, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4007224; Cohen T, 2013, EUR J MECH A-SOLID, V37, P193, DOI 10.1016/j.euromechsol.2012.06.005; Cohen T, 2010, INT J PROT STRUCT, V1, P235, DOI 10.1260/2041-4196.1.2.235; Cohen T, 2010, J APPL MECH-T ASME, V77, DOI 10.1115/1.4000914; Cohen T, 2010, INT J ENG SCI, V48, P52, DOI 10.1016/j.ijengsci.2009.06.007; Cohen T, 2009, INT J SOLIDS STRUCT, V46, P3643, DOI 10.1016/j.ijsolstr.2009.06.013; Cristiano A, 2010, J POLYM SCI POL PHYS, V48, P1409, DOI 10.1002/polb.22026; Czarnota C, 2006, INT J FRACTURE, V141, P177, DOI 10.1007/s10704-006-0070-y; De Pascalis R, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2014.0058; Dorfmann A, 2000, J STRUCT ENG-ASCE, V126, P573, DOI 10.1061/(ASCE)0733-9445(2000)126:5(573); Drozdov A.D., 1996, COURSE NONLINEAR MEC, V434; Durban D, 1997, J APPL MECH-T ASME, V64, P743, DOI 10.1115/1.2788978; Durban D., 1974, International Journal of Non-Linear Mechanics, V9, P105, DOI 10.1016/0020-7462(74)90002-X; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Findley W.N., 1976, CREEP RELAXATION NON; FORRESTAL MJ, 1988, J APPL MECH-T ASME, V55, P275, DOI 10.1115/1.3173672; Fung Y. C., 1972, BIOMECHANICS ITS FDN, P181; GENT AN, 1991, J MATER SCI, V26, P3392, DOI 10.1007/BF01124691; Horgan C, 1995, APPL MECH REV, V48, P471, DOI DOI 10.1115/1.3005108; HORGAN CO, 1986, J ELASTICITY, V16, P189, DOI 10.1007/BF00043585; Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060; Jakub M.T., 1965, ARCH RATION MECH AN, V18, P367; Johnson GA, 1996, J BIOMECH ENG-T ASME, V118, P221, DOI 10.1115/1.2795963; Kollmannsberger P, 2011, ANNU REV MATER RES, V41, P75, DOI 10.1146/annurev-matsci-062910-100351; Kumar M, 2014, EARTHQ ENG STRUCT D, V43, P1955, DOI 10.1002/eqe.2431; Lakes R. S., 1998, VISCOELASTIC SOLIDS, V9; Masri R, 2005, J APPL MECH-T ASME, V72, P887, DOI 10.1115/1.1985428; McMahon J, 2010, MATH MECH SOLIDS, V15, P57, DOI 10.1177/1081286508092010; ORTIZ M, 1992, J APPL MECH-T ASME, V59, P48, DOI 10.1115/1.2899463; Oyen M, 2005, MRS P, V898; Provenzano P, 2001, ANN BIOMED ENG, V29, P908, DOI 10.1114/1.1408926; Provenzano PP, 2002, BIOMECH MODEL MECHAN, V1, P45, DOI 10.1007/s10237-002-0004-1; Rodriguez-Martinez JA, 2014, INT J IMPACT ENG, V73, P43, DOI 10.1016/j.ijimpeng.2014.06.005; Volokh K., 2015, BIOMECH MODEL MECHAN, P1; Wang H., 2015, SOFT MATTER; Wineman A, 2009, MATH MECH SOLIDS, V14, P300, DOI 10.1177/1081286509103660; Wineman A., 2015, J ELASTICITY, P1; Wright TW, 2008, J MECH PHYS SOLIDS, V56, P336, DOI 10.1016/j.jmps.2007.05.012; Xu F, 2008, MATH COMPUT SCI ENG, P14; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a	44	16	16	0	28	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7683	1879-2146		INT J SOLIDS STRUCT	Int. J. Solids Struct.	SEP	2015	69-70						544	552		10.1016/j.ijsolstr.2015.04.029			9	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	CO5AM	WOS:000359172000044		Bronze			2022-02-06	
J	Jang, SH; Seo, JP				Jang, Sung Ho; Seo, Jeong Pyo			Damage to the Optic Radiation in Patients With Mild Traumatic Brain Injury	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article							TENSOR IMAGING FINDINGS; VISUAL DYSFUNCTION; ABNORMALITIES; DTI	Background:There are known limitations of conventional computed tomography and magnetic resonance imaging in detecting neural injury in patients with mild traumatic brain injury (TBI). Diffusion tensor imaging (DTI) provides a method to further assess cerebral injury in this patient population. We report 2 patients with mild TBI who showed injury of the optic radiation (OR) as demonstrated by DTI.Method:Two patients who complained of visual field loss after mild TBI and 9 age-matched normal control subjects were recruited for this study. Peripheral field defects were detected with automated perimetry in both patients.Results:Regarding the configuration of OR, the total volume of OR was decreased in the right OR of both patients compared with controls; in contrast, the left ORs were divided into 2 parts in both patients. The voxel numbers of both ORs in both patients were more than 2 standard deviations lower than that of normal control subjects. The apparent diffusion coefficient value of the right OR in patient 2 was more than 2 standard deviations higher than that of normal controls.Conclusions:We demonstrated injury of the OR using DTI in 2 patients who showed visual field defects after mild TBI.	[Jang, Sung Ho; Seo, Jeong Pyo] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Seo, JP (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	raphael0905@hanmail.net			DGIST R&D Program of the Ministry of Science, ICT and Future Planning [15-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (15-BD-0401).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; ELISEVICH KV, 1984, SURG NEUROL, V22, P565, DOI 10.1016/0090-3019(84)90433-6; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kelts EA, 2010, NEUROREHABILITATION, V27, P223, DOI 10.3233/NRE-2010-0601; Kwon HG, 2011, NEUROREHABILITATION, V28, P383, DOI 10.3233/NRE-2011-0667; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Ripley DL, 2010, NEUROREHABILITATION, V27, P215, DOI 10.3233/NRE-2010-0599; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Seo JP, 2013, EUR NEUROL, V69, P236, DOI 10.1159/000345271; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Staempfli P, 2007, J MAGN RESON IMAGING, V26, P886, DOI 10.1002/jmri.21098; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; TEASDALE G, 1974, LANCET, V2, P81; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2012, BRAIN INJURY, V26, P891, DOI 10.3109/02699052.2012.661119; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114	31	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	SEP	2015	35	3					270	273		10.1097/WNO.0000000000000249			4	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	CQ4DC	WOS:000360553500008	25887304				2022-02-06	
J	Raji, CA; Willeumier, K; Taylor, D; Tarzwell, R; Newberg, A; Henderson, TA; Amen, DG				Raji, Cyrus A.; Willeumier, Kristen; Taylor, Derek; Tarzwell, Robert; Newberg, Andrew; Henderson, Theodore A.; Amen, Daniel G.			Functional neuroimaging with default mode network regions distinguishes PTSD from TBI in a military veteran population	BRAIN IMAGING AND BEHAVIOR			English	Article						Functional Neuroimaging; PTSD; SPECT; TBI	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; PROCEDURE GUIDELINE; RESTING-STATE; US VETERANS; SPECT; SOLDIERS; ANTIPSYCHOTICS; CONNECTIVITY	PTSD and TBI are two common conditions in veteran populations that can be difficult to distinguish clinically. The default mode network (DMN) is abnormal in a multitude of neurological and psychiatric disorders. We hypothesize that brain perfusion SPECT can be applied to diagnostically separate PTSD from TBI reliably in a veteran cohort using DMN regions. A group of 196 veterans (36 with PTSD, 115 with TBI, 45 with PTSD/TBI) were selected from a large multi-site population cohort of individuals with psychiatric disease. Inclusion criteria were peacetime or wartime veterans regardless of branch of service and included those for whom the traumatic brain injury was not service related. SPECT imaging was performed on this group both at rest and during a concentration task. These measures, as well as the baseline-concentration difference, were then inputted from DMN regions into separate binary logistic regression models controlling for age, gender, race, clinic site, co-morbid psychiatric diseases, TBI severity, whether or not the TBI was service related, and branch of armed service. Predicted probabilities were then inputted into a receiver operating characteristic analysis to compute sensitivity, specificity, and accuracy. Compared to PSTD, persons with TBI were older, male, and had higher rates of bipolar and major depressive disorder (p < 0.05). Baseline quantitative regions with SPECT separated PTSD from TBI in the veterans with 92 % sensitivity, 85 % specificity, and 94 % accuracy. With concentration scans, there was 85 % sensitivity, 83 % specificity and 89 % accuracy. Baseline-concentration (the difference metric between the two scans) scans were 85 % sensitivity, 80 % specificity, and 87 % accuracy. In separating TBI from PTSD/TBI visual readings of baseline scans had 85 % sensitivity, 81 % specificity, and 83 % accuracy. Concentration scans had 80 % sensitivity, 65 % specificity, and 79 % accuracy. Baseline-concentration scans had 82 % sensitivity, 69 % specificity, and 81 % accuracy. For separating PTSD from PTSD/TBI baseline scans had 87 % sensitivity, 83 % specificity, and 92 % accuracy. Concentration scans had 91 % sensitivity, 76 % specificity, and 88 % accuracy. Baseline-concentration scans had 84 % sensitivity, 64 % specificity, and 85 % accuracy. This study demonstrates the ability to separate PTSD and TBI from each other in a veteran population using functional neuroimaging.	[Raji, Cyrus A.] Univ Calif Los Angeles, Med Ctr, Dept Radiol, Los Angeles, CA 90095 USA; [Willeumier, Kristen; Taylor, Derek; Amen, Daniel G.] Amen Clin Inc, Dept Res, Costa Mesa, CA USA; [Tarzwell, Robert] Univ British Columbia, Fac Med, Sch Med, Dept Psychiat, Vancouver, BC, Canada; [Tarzwell, Robert] Lions Gate Hosp, Res Mental Hlth, Vancouver, BC, Canada; [Newberg, Andrew] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Henderson, Theodore A.] Synapt Space & Int Soc Appl Neuroimaging, Denver, CO USA		Raji, CA (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Radiol, 757 Westwood Blvd, Los Angeles, CA 90095 USA.	cyrusraji@gmail.com		Willeumier, Kristen/0000-0002-1229-8516			Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P139, DOI 10.1080/02791072.2008.10400623; Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P131, DOI 10.1080/02791072.2008.10400622; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bowe A, 2015, J DUAL DIAGN, V11, P22, DOI 10.1080/15504263.2014.989653; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bryan CJ, 2013, DEPRESS ANXIETY, V30, P55, DOI 10.1002/da.22002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Castel-Lacanal E, 2014, ANN FR ANESTH, V33, P83, DOI 10.1016/j.annfar.2013.11.006; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; CHANG W, 1984, J NUCL MED, V25, P788; Congressional Budget Office, 2012, VET HLTH ADM TREATM, DOI [11-2012/reports/02-09-PTSD_0.pdf, DOI 11-2012/REPORTS/02-09-PTSD_0.PDF]; Davis P C, 2000, Radiology, V215 Suppl, P507; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Erickson HJ, 2014, J NEUROPSYCH CLIN N, V26, P188, DOI 10.1176/appi.neuropsych.260301; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Henderson TA, 2012, CNS SPECTRUMS, V17, P176, DOI 10.1017/S1092852912000636; Hermes E, 2014, EPIDEMIOL PSYCH SCI, V23, P281, DOI 10.1017/S2045796013000449; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Jain S, 2012, PSYCHIAT SERV, V63, P154, DOI 10.1176/appi.ps.201100199; Juni JE, 2009, J NUCL MED TECHNOL, V37, P191, DOI 10.2967/jnmt.109.067850; Juni JE, 1998, J NUCL MED, V39, P923; Kapucu OL, 2009, EUR J NUCL MED MOL I, V36, P2093, DOI 10.1007/s00259-009-1266-y; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lew H. L., 2005, J REHABILITATION RES, V42, pxii; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; Murphy D., 2014, EUROPEAN J PSYCHOTRA, V5, P1; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; Newberg AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087009; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peterson A, 2014, CAN J PSYCHIAT, V59, P294, DOI 10.1177/070674371405900602; Phelps T. I., 2014, J NEUROTRAUMA; Philip NS, 2014, JOVE-J VIS EXP, DOI 10.3791/51651; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rauch SAM, 2012, J REHABIL RES DEV, V49, P679, DOI 10.1682/JRRD.2011.08.0152; Sandrone S, 2012, J NEUROSCI, V32, P1915, DOI 10.1523/JNEUROSCI.5637-11.2012; Schnyder U, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.26520; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Silver JM, 2011, TEXTBOOK OF TRAUMATI, P609; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Stecker T, 2014, PSYCHIAT SERV, V65, P1232, DOI 10.1176/appi.ps.201300433; Stecker T, 2013, PSYCHIAT SERV, V64, P280, DOI 10.1176/appi.ps.001372012; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thomas JT, 1964, J AM STAT ASSOC, V61, P852; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Wang HR, 2013, CLIN NEUROPHARMACOL, V36, P216, DOI 10.1097/WNF.0b013e3182aa365f; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225	58	16	17	1	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					527	534		10.1007/s11682-015-9385-5			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR8LQ	WOS:000361604300013	25917871	Green Published, hybrid			2022-02-06	
J	Sours, C; Chen, HX; Roys, S; Zhuo, JC; Varshney, A; Gullapalli, RP				Sours, Chandler; Chen, Haoxing; Roys, Steven; Zhuo, Jiachen; Varshney, Amitabh; Gullapalli, Rao P.			Investigation of Multiple Frequency Ranges Using Discrete Wavelet Decomposition of Resting-State Functional Connectivity in Mild Traumatic Brain Injury Patients	BRAIN CONNECTIVITY			English	Article						discrete wavelet; mild traumatic brain injury; postconcussive syndrome; resting state fMRI	DEFAULT-MODE NETWORK; MRI; RELIABILITY; DISRUPTION; IMPACT	The aim of this study was to investigate if discrete wavelet decomposition provides additional insight into resting-state processes through the analysis of functional connectivity within specific frequency ranges within the default mode network (DMN) that may be affected by mild traumatic brain injury (mTBI). Participants included 32 mTBI patients (15 with postconcussive syndrome [PCS +] and 17 without [PCS-]). mTBI patients received resting-state functional magnetic resonance imaging (rs-fMRI) at acute (within 10 days of injury) and chronic (6 months postinjury) time points and were compared with 31 controls (healthy control [HC]). The wavelet decomposition divides the time series into multiple frequency ranges based on four scaling factors (SF1: 0.125-0.250 Hz, SF2: 0.060-0.125 Hz, SF3: 0.030-0.060 Hz, SF4: 0.015-0.030 Hz). Within each SF, wavelet connectivity matrices for nodes of the DMN were created for each group (HC, PCS +, PCS-), and bivariate measures of strength and diversity were calculated. The results demonstrate reduced strength of connectivity in PCS + patients compared with PCS- patients within SF1 during both the acute and chronic stages of injury, as well as recovery of connectivity within SF1 across the two time points. Furthermore, the PCS- group demonstrated greater network strength compared with controls at both time points, suggesting a potential compensatory or protective mechanism in these patients. These findings stress the importance of investigating resting-state connectivity within multiple frequency ranges; however, many of our findings are within SF1, which may overlap with frequencies associated with cardiac and respiratory activities.	[Sours, Chandler; Roys, Steven; Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA; [Sours, Chandler; Roys, Steven; Zhuo, Jiachen; Gullapalli, Rao P.] MRRC, Baltimore, MD USA; [Chen, Haoxing] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Varshney, Amitabh] Univ Maryland, Dept Comp Sci, Inst Adv Comp Studies, College Pk, MD 20742 USA		Sours, C (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA.	csour001@umaryland.edu			Department of DefenseUnited States Department of Defense [W81XWH08-1-0725, W81XWH-12-1-0098]; NRSA grant from the National Institute of Neurological Disorders and Stroke [1F31NS081984]; University of Maryland/Mpowering the State through the Center for Health-related Informatics and Bioimaging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS081984] Funding Source: NIH RePORTER	The authors would like to thank Joshua Betz, Jacqueline Janowich, Teodora Stoica, and Joseph Rosenberg for their help with patient recruitment and George Makris for his help with acquiring the data. Support for this work was, in part, provided by the Department of Defense (W81XWH08-1-0725 and W81XWH-12-1-0098 to R.P.G). C.S. was supported by an NRSA grant from the National Institute of Neurological Disorders and Stroke (1F31NS081984). The authors also acknowledge support provided by The University of Maryland/Mpowering the State through the Center for Health-related Informatics and Bioimaging.	Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bullmore ET, 2004, NEUROIMAGE, V23, pS234, DOI 10.1016/j.neuroimage.2004.07.012; CDC, 2003, REP C MILD TRAUM BRA; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Cheng H, 2013, CHINESE MED J-PEKING, V126, P2459, DOI 10.3760/cma.j.issn.0366-6999.20122681; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Faul M, 2010, TRAUMATIC BRAIN INJU; Franco AR, 2013, BRAIN CONNECT, V3, P363, DOI 10.1089/brain.2012.0134; Gohel SR, 2015, BRAIN CONNECT, V5, P23, DOI 10.1089/brain.2013.0210; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Misiti M., 1996, WAVELET TOOLBOX; Percival D, 2000, CA ST PR MA, DOI 10.1017/CBO9780511841040; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reich S, 2005, VALIDATION ANAM TEST; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sours C, 2014, BRAIN IMAGING BEHAV; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; The World Health Organization, 2010, INT CLASS DIS; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wu JT, 2011, NEUROSCI LETT, V504, P62, DOI 10.1016/j.neulet.2011.08.059; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	37	16	16	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	SEP	2015	5	7			SI		442	450		10.1089/brain.2014.0333			9	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VG7GK	WOS:000448203700005	25808612	Green Published			2022-02-06	
J	Brenner, LA; Betthauser, LM; Bahraini, N; Lusk, JL; Terrio, H; Scher, AI; Schwab, KA				Brenner, Lisa A.; Betthauser, Lisa M.; Bahraini, Nazanin; Lusk, Jaimie L.; Terrio, Heidi; Scher, Ann I.; Schwab, Karen A.			Soldiers Returning From Deployment: A Qualitative Study Regarding Exposure, Coping, and Reintegration	REHABILITATION PSYCHOLOGY			English	Article						Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF); posttraumatic stress disorder (PTSD); traumatic brain injury (TBI); qualitative; military	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOMS; AFGHANISTAN; VETERANS; IRAQ; CARE; TBI; WAR	Purpose/Objective: The purpose of this study was to qualitatively explore exposure to deployment-related physical and/or emotional trauma and associated symptoms among Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) soldiers. Interviews also focused on in-theater- and reintegration-related experiences. Research Method/Design: OEF/OIF soldiers (N = 103) participated in semistructured interviews, and a qualitative descriptive methodology was used to analyze the data. Results: Themes were identified regarding (a) common experiences related to emotional and physical traumas and associated symptoms and strategies for coping and making meaning of experiences and (b) how combat and reintegration experiences affected soldiers' senses of self, relationships with others, and functioning. Conclusions/Implications: Themes identified support a rethinking of deployment-related mild traumatic brain injury and posttraumatic stress disorder as discrete conditions. Dimensional versus categorical models should be considered. The findings also highlight experiences and potentially meaningful constructs (e.g., moral injury, moral repair) that can be used to inform research and clinical efforts aimed at improving the lives of those who have served.	[Brenner, Lisa A.; Betthauser, Lisa M.; Bahraini, Nazanin; Lusk, Jaimie L.] Mental Illness Res Educ & Clin Ctr, Vet Integrated Serv Network 19, Denver, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin] Univ Colorado Denver, Dept Psychiat, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Neurol, Denver, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin] Univ Colorado Denver, Dept Phys Med & Rehabil, Denver, CO USA; [Betthauser, Lisa M.] Univ Colorado Denver, Dept Psychol, Denver, CO USA; [Lusk, Jaimie L.] Univ Denver, Grad Sch Profess Psychol, Denver, CO 80208 USA; [Terrio, Heidi] Def & Vet Brain Injury Ctr, Ft Carson, CO USA; [Terrio, Heidi] Evans Army Community Hosp, Colorado Springs, CO USA; [Scher, Ann I.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Schwab, Karen A.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Schwab, Karen A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Brenner, LA (corresponding author), Eastern Colorado Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Vet Integrated Serv Network 19, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019	Scher, Ann/0000-0003-4599-9834	U.S. Army Medical Research and Congressionally Directed Medical Research Programs Award [W81XWH-08-2-0105]; Veterans Integrated Service Network 19 Mental Illness Research Education and Clinical Center, located at the Denver VA Medical Center; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The authors have no conflicts of interest to report. This article conforms to applicable governmental regulations and discipline-appropriate ethical standards. Per governmental regulations and the ethical standards described previously, the authors confirm that "In the conduct of research where humans....". "In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Vol. 1, Pt. 46; Title 32, chap. 1, Pt. 219; and Title 21, chap. 1, Pt. 50 (Protection of Human Subjects)." Writing of this article was supported by U.S. Army Medical Research and Congressionally Directed Medical Research Programs Award W81XWH-08-2-0105 and the Veterans Integrated Service Network 19 Mental Illness Research Education and Clinical Center, located at the Denver VA Medical Center. The views, opinions, and findings contained in this article are those of the authors and should not be construed as official Department of Defense or Department of Veterans Affairs positions, policies, or decisions unless so designated by other documentation. We thank those who facilitated and conducted interviews (Denise Strasser, Maria Devore, Parri Hinton, Colleen Costello, and Joseph Huggins). We appreciate the support of the Defense and Veterans Brain Injury Center. Kathleen Chwalisz provided invaluable feedback regarding initial drafts of the manuscript. We also thank the soldiers who participated, and are grateful for their willingness to describe their lived experiences.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bahraini N, 2013, J HEAD TRAUMA REHAB, V28, P223, DOI 10.1097/HTR.0b013e318291dab7; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Brenner L.A., 2008, J MENTAL HEALTH COUN, V30, P211, DOI [10.17744/mehc.30.3.n6418tm72231j606, DOI 10.17744/MEHC.30.3.N6418TM72231J606]; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Denzin Norman K, 1978, RES ACT THEORETICAL; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Diekelmann N., 1989, NLN CRITERIA APPRAIS; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Jolly R, 1996, CHANGING STEP; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Maguen S, 2009, J TRAUMA STRESS, V22, P435, DOI 10.1002/jts.20451; Miles MB, 1994, EXPANDED SOURCEBOOK; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; Nazem S, 2014, J CLIN PSYCHIAT, V75, pE947, DOI 10.4088/JCP.14com09450; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Patton M.Q., 1990, QUALITATIVE EVALUATI; Sampson R., 1997, ADV CRIMINOLOGICAL T, V7, P133; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Weathers F.W., 1993, ANN CONV INT SOC TRA	30	16	16	2	34	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2015	60	3					277	285		10.1037/rep0000048			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CR0UB	WOS:000361037600008	26147237	Bronze			2022-02-06	
J	Fricia, M; Passanisi, M; Salamanna, F; Parrilli, A; Giavaresi, G; Fini, M				Fricia, Marco; Passanisi, Maurizio; Salamanna, Francesca; Parrilli, Annapaola; Giavaresi, Gianluca; Fini, Milena			Osteointegration in Custom-made Porous Hydroxyapatite Cranial Implants: From Reconstructive Surgery to Regenerative Medicine	WORLD NEUROSURGERY			English	Article						Cranioplasty; Hydroxyapatite; Osteointegration; Regenerative medicine; Traumatic brain injury	BONE; SCAFFOLDS	BACKGROUND: Custom-made porous hydroxyapatite (HA) implant (Fin-Ceramica Faenza S.p.A., Italy) is a biomimetic, osteoconductive material. Margin fusion at the bone-implant edge, cell proliferation within implant pores, and osteointegration in an animal model have already been described. CASE DESCRIPTION: Radiological, microtomographical, and histological analyses were performed on two patients who underwent surgical explantation of cranial implants after postoperative complication. Primary devices explanted after 2 years showed areas of newly formed bone strictly osteointegrated with pores of the prosthesis. These prostheses showed a focal zone of resorption in correspondence of the newly formed bone, and no signs of inflammation or cytotoxicity were observed. A back-up prosthesis, explanted from the same patient after 6 months because of an infection, did not show presence of newly formed bone both on the surface and in the internal part of the prosthesis. CONCLUSIONS: Custom-made porous HA implant is an osteoconductive material able to promote osteogenesis, osteointegrate with bone tissue, provide an effective cranial reconstruction, and restore functional features of the skull. However, complete bone healing is still a complex and long process.	[Fricia, Marco; Passanisi, Maurizio] Cannizzaro Univ Hosp, Dept Neurosurg, Catania, Italy; [Salamanna, Francesca; Parrilli, Annapaola; Giavaresi, Gianluca; Fini, Milena] Rizzoli Orthopaed Inst, Dept RIT Rizzoli, Lab Biocompatibil Technol Innovat & Adv Therapies, Bologna, Italy; [Giavaresi, Gianluca; Fini, Milena] Rizzoli Orthopaed Inst, Lab Preclin & Surg Studies, Bologna, Italy		Fricia, M (corresponding author), Cannizzaro Univ Hosp, Dept Neurosurg, Catania, Italy.	marco.fricia@aoec.it	Salamanna, Francesca/J-6032-2016; Giavaresi, Gianluca/J-5583-2016; Parrilli, Annapaola/C-7008-2019; Fini, Milena/J-4808-2016	Salamanna, Francesca/0000-0001-7402-4054; Giavaresi, Gianluca/0000-0001-7843-5969; Parrilli, Annapaola/0000-0003-0251-5094; Fini, Milena/0000-0002-3732-3570			Babis GC, 2005, INJURY, V36, pS38, DOI 10.1016/j.injury.2005.10.009; Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1; Fernandez-Yague MA, 2015, ADV DRUG DELIVER REV, V84, P1, DOI 10.1016/j.addr.2014.09.005; Fini M, 2011, J BONE MINER METAB, V29, P633, DOI 10.1007/s00774-011-0309-1; Frassanito P, 2013, CLIN NEUROL NEUROSUR, V115, P1496, DOI 10.1016/j.clineuro.2012.11.032; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Khojasteh A, 2013, OR SURG OR MED OR PA, V116, pE405, DOI 10.1016/j.oooo.2012.01.044; Gonzalez AL, 2015, CHILD NERV SYST, V31, P333, DOI 10.1007/s00381-014-2493-5; Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Messina G, 2011, ACTA NEUROCHIR, V153, P1717, DOI 10.1007/s00701-011-1014-5; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2; Sprio S, 2011, J BIOTECHNOL, V156, P347, DOI 10.1016/j.jbiotec.2011.07.034; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Tevlin R, 2014, J DENT RES, V93, P1187, DOI 10.1177/0022034514547271	17	16	16	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2015	84	2							591.e11	10.1016/j.wneu.2015.03.027			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CO7FL	WOS:000359324900068	25819529				2022-02-06	
J	Hammond, FM; Horn, SD; Smout, RJ; Seel, RT; Beaulieu, CL; Corrigan, JD; Barrett, RS; Cullen, N; Sommerfeld, T; Brandstater, ME				Hammond, Flora M.; Horn, Susan D.; Smout, Randall J.; Seel, Ronald T.; Beaulieu, Cynthia L.; Corrigan, John D.; Barrett, Ryan S.; Cullen, Nora; Sommerfeld, Teri; Brandstater, Murray E.			Rehospitalization During 9 Months After Inpatient Rehabilitation for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comorbidity; Hospitalization; Patient readmission; Rehabilitation	PROSPECTIVE-PAYMENT; MULTICENTER ANALYSIS; AFTER-DISCHARGE; MORTALITY; CARE	Objective: To assess the frequency of, causes for, and factors associated with acute rehospitalization during 9 months after discharge from inpatient rehabilitation for traumatic brain injury (TBI). Design: Multicenter observational cohort. Setting: Community. Participants: Individuals with TBI (N=1850) admitted for inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Occurrences of proxy or self-report of postrehabilitation acute care rehospitalization, as well as length of and causes for rehospitalizations. Results: A total of 510 participants (28%) had experienced 775 acute rehospitalizations. All experienced 1 admission (510 participants [66%]), whereas 154(20%) had 2 admissions, 60(8%) had 3,23 (3%) had 4,27 had between Sand 11, and 1 had 12. The most common rehospitalization causes were infection (15%), neurological (13%), neurosurgical (11%), injury (7%), psychiatric (7%), and orthopedic (7%). The mean time from rehabilitation discharge to first rehospitalization was 113 days. The mean rehospitalization duration was 6.5 days. Logistic regression analyses revealed that older age, history of seizures before injury or during acute care or rehabilitation, history of brain injuries, and non brain injury medical severity increased the risk of rehospitalization. Injury etiology of motor vehicle collision and high motor functioning at discharge decreased rehospitalization risk. Conclusions: Approximately 28% of patients with TBI were rehospitalized within 9 months of TBI rehabilitation discharge owing to various medical and surgical reasons. Future research should evaluate whether some of these occurrences may be preventable (such as infections, injuries, and psychiatric disorders) and should evaluate the extent to which persons at risk may benefit from additional screening, surveillance, and treatment protocols. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Horn, Susan D.; Smout, Randall J.; Barrett, Ryan S.] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA; [Cullen, Nora] Toronto Rehabil Inst, Toronto, ON, Canada; [Sommerfeld, Teri] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Brandstater, Murray E.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com		Cullen, Nora/0000-0001-6359-9418	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), the National Institute on Disability and Rehabilitation Research (grant no. H133A080023), and the Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	[Anonymous], 2012, CMAJ, V184, pE651; [Anonymous], 2013, REV DOOR REP US HOSP; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Canadian Institute for Health Information, ALL CAUS READM AC CA; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Centers for Medicare & Medicaid Services, SPEC ALL CAUS UNPL R; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sood N, 2008, J HEALTH ECON, V27, P1046, DOI 10.1016/j.jhealeco.2008.01.003; Sood N, 2013, J HEALTH ECON, V32, P965, DOI 10.1016/j.jhealeco.2013.05.003; Stineman MG, 2002, ARCH PHYS MED REHAB, V83, P1802, DOI 10.1053/apmr.2002.36067; The Moran Company, 2011, UT TRENDS INPA REH U; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	25	16	16	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S330	S339		10.1016/j.apmr.2014.09.041			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100013	26212407	Green Accepted, Bronze			2022-02-06	
J	Ioachimescu, AG; Hampstead, BM; Moore, A; Burgess, E; Phillips, LS				Ioachimescu, Adriana G.; Hampstead, Benjamin M.; Moore, Anna; Burgess, Elizabeth; Phillips, Lawrence S.			Growth hormone deficiency after mild combat-related traumatic brain injury	PITUITARY			English	Article						Growth hormone deficiency; Traumatic brain injury; Hypopituitarism	QUALITY-OF-LIFE; PITUITARY DYSFUNCTION; CONSENSUS GUIDELINES; REPLACEMENT THERAPY; GH DEFICIENCY; HYPOPITUITARISM; PREVALENCE; ADULTS; GLUCAGON; SECRETION	Traumatic brain injury (TBI) has been recognized as a cause of growth hormone deficiency (GHD) in civilians. However, comparable data are sparse in veterans who incurred TBI during combat. Our objective was to determine the prevalence of GHD in veterans with a history of combat-related TBI, and its association with cognitive and psychosocial dysfunction. Single center prospective study. Twenty male veterans with mild TBI incurred during combat 8-72 months prior to enrollment. GHD was defined by a GH peak < 3 mu g/L during glucagon stimulation test. Differences in neuropsychological, emotional, and quality of life of the GHD Veterans were described using Cohen's d. Large effect sizes were considered meaningful. Mean age was 33.7 years (SD 7.8) and all subjects had normal thyroid hormone and cortisol levels. Five (25 %) exhibited a subnormal response to glucagon. Sixteen participants (80 %) provided sufficient effort for valid neuropsychological assessment (12 GH-sufficient, 4 GHD). There were large effect size differences in self-monitoring during memory testing (d = 1.46) and inhibitory control (d = 0.92), with worse performances in the GHD group. While fatigue and post-traumatic stress disorder were comparable, the GHD group reported more depression (d = 0.80) and lower quality of life (d = 0.64). Our study found a 25 % prevalence of GHD in veterans with mild TBI as shown by glucagon stimulation. The neuropsychological findings raise the possibility that GHD has adverse effects on executive abilities and mood. Further studies are needed to determine whether GH replacement is an effective treatment in these patients.	[Ioachimescu, Adriana G.; Hampstead, Benjamin M.; Moore, Anna; Burgess, Elizabeth; Phillips, Lawrence S.] Emory Univ, Emory Clin, Atlanta Veteran Affairs Med Ctr, Atlanta, GA 30322 USA; [Ioachimescu, Adriana G.; Burgess, Elizabeth; Phillips, Lawrence S.] Emory Univ, Dept Med, Div Endocrinol, Atlanta, GA 30322 USA; [Ioachimescu, Adriana G.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Hampstead, Benjamin M.; Moore, Anna] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA		Ioachimescu, AG (corresponding author), Emory Univ, Emory Clin, Atlanta Veteran Affairs Med Ctr, 1365 B Clifton Rd, Atlanta, GA 30322 USA.	aioachi@emory.edu	Ioachimescu, Adriana/V-8070-2019		Novo Nordisk Inc.Novo Nordisk; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK066204, UL1 RR025008]; VA award [HSRD IIR 07-138]; Cystic Fibrosis FoundationItalian Cystic Fibrosis Research Foundation [PHILLI12A0]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R18DK066204, R21DK099716] Funding Source: NIH RePORTER	The study was funded by an Investigator Initiated Study grant from Novo Nordisk Inc. During this study, LSP was also supported by NIH awards DK066204 and UL1 RR025008, VA award HSR&D IIR 07-138, and a Cystic Fibrosis Foundation award PHILLI12A0. The funding sources played no role in the design and conduct of the study, analysis and interpretation of the data, and preparation of the manuscript. We thank Mari Hart, RN, MSN and Gordana Pajkovic, CRC (research staff). The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the United States Government. Portions of this work were presented at the annual meeting of the Endocrine Society that took place in Houston, TX in June 2012.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conceicao FL, 2003, GROWTH HORM IGF RES, V13, P347, DOI 10.1016/S1096-6374(03)00124-2; de Kloet CS, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.16206; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hoge CW, 2008, AM J EPIDEMIOL, V168, P1095, DOI 10.1093/aje/kwn261; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Koltowska-Haggstrom M, 2005, HORM RES, V64, P46, DOI 10.1159/000087444; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Munoz A, 2013, CURR OPIN ENDOCRINOL, V20, P354, DOI 10.1097/MED.0b013e32836318ba; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P169, DOI 10.1080/00981380802533322; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Toogood A, 2012, ENDOCR PRACT, V18, P325, DOI 10.4158/EP11146.OR; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; VA/DoD, 2009, J REHABIL RES DEV, V46, pCP1; van Liempt S, 2011, PSYCHONEUROENDOCRINO, V36, P1361, DOI 10.1016/j.psyneuen.2011.03.009; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Yuen KCJ, 2013, PITUITARY, V16, P220, DOI 10.1007/s11102-012-0407-7	35	16	16	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	AUG	2015	18	4					535	541		10.1007/s11102-014-0606-5			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	CL3BQ	WOS:000356824300014	25266761				2022-02-06	
J	Jin, YC; Lin, YY; Feng, JF; Jia, F; Gao, GY; Jiang, JY				Jin, Yichao; Lin, Yingying; Feng, Jun-Feng; Jia, Feng; Gao, Guoyi; Jiang, Ji-Yao			Attenuation of Cell Death in Injured Cortex After Post-Traumatic Brain Injury Moderate Hypothermia: Possible Involvement of Autophagy Pathway	WORLD NEUROSURGERY			English	Article						Apoptosis; Autophagy; Necrosis; Hypothermia; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION MODEL; CLOSED-HEAD INJURY; REGULATES AUTOPHAGY; MILD HYPOTHERMIA; DNA-DAMAGE; BECLIN 1; RAT; APOPTOSIS; PHOSPHORYLATION	OBJECTIVE: Multiple mechanisms participated hi the cell death after fluid percussion traumatic brain injury (TB!). In the present study, we evaluated the effect on cell death in the injured cortex after fluid percussion TBI and investigated a possible role of autophagy. METHODS: TBI model was induced by a fluid percussion TBI device. Moderate hypothermia (32 degrees C) was achieved by partial immersion in a water bath (0 degrees C) under general anesthesia for 4 hours. All rats were killed at 6 or 24 hours after TBI. RESULTS: Cleaved caspase 3 evaluated with Western blotting and terminal deoxynincleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end labeling-positive cells in injured cortex were significantly increased 6 hours after fluid percussion TBI and were further up-regulated 24 hours after TB!, dramatic up-regulation of Beclin-1 and protein light chain-3 expression levels was also observed. Further up-regulation of biomarkers of autophagy, attenuation of caspase 3 up-regulation and reduction of cell death was observed after 4 hours of hypothermia. Immunofluorescence analysis for cell localization demonstrated that protein light chain-3- and Beclin-1-positive cells included neurons and glial cells in the injured cortex after TBI and hypothermic treatment. By ultrastructural observation, autolysosomes in injured cortex were significantly increased at 6 and 24 hours after TBI and were further up-regulated after TBI hypothermic treatment. CONCLUSIONS: These data suggest that hypothermic treatment could attenuate TBI-induced cell death in this fluid percussion TBI model, possibly through activation of autophagy pathway.	[Jin, Yichao; Lin, Yingying; Feng, Jun-Feng; Jia, Feng; Gao, Guoyi; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200030, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200030, Peoples R China.	jiyaojiang@126.com			National Science and Nature Grant [81271381, 81471856, 81471855]; National Key project [2012CB518100]	This work was supported by grants from National Science and Nature Grant (No. 81271381, 81471856, 81471855), and National Key project (No. 2012CB518100).	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Besson VC, 2005, BRAIN RES, V1041, P149, DOI 10.1016/j.brainres.2005.01.096; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Huang Q, 2009, AUTOPHAGY, V5, P273, DOI 10.4161/auto.5.2.7640; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RINK A, 1995, AM J PATHOL, V147, P1575; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Ye YC, 2011, J PHARMACOL SCI, V117, P160, DOI 10.1254/jphs.11105FP; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0	46	16	16	2	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2015	84	2					420	430		10.1016/j.wneu.2015.03.039			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CO7FL	WOS:000359324900044	25839396				2022-02-06	
J	Niquet, J; Baldwin, R; Gezalian, M; Wasterlain, CG				Niquet, Jerome; Baldwin, Roger; Gezalian, Michael; Wasterlain, Claude G.			Deep hypothermia for the treatment of refractory status epilepticus	EPILEPSY & BEHAVIOR			English	Article						Status epilepticus; Hypothermia; EEG power	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; BARRIER PERMEABILITY; CIRCULATORY ARREST; MILD HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; PROFOUND HYPOTHERMIA; MODERATE HYPOTHERMIA; MEMBRANE-PROPERTIES; GENE-EXPRESSION	In a rat model of status epilepticus (SE) induced by lithium and pilocarpine and refractory to midazolam, deep hypothermia (20 "C for 30 min) reduced EEG power over 50-fold, stopped SE within 12 min, and reduced EEG spikes by 87%. Hypothermia deserves further investigation as a treatment of last resort for refractory SE. Published by Elsevier Inc.	[Niquet, Jerome; Wasterlain, Claude G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Niquet, Jerome; Baldwin, Roger; Gezalian, Michael; Wasterlain, Claude G.] Vet Affairs Greater Los Angeles Healthcare Syst, Epilepsy Res Lab 151, Los Angeles, CA USA; [Wasterlain, Claude G.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA		Niquet, J (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Epilepsy Res Lab, 11301 Wilshire Blvd,Bldg 114,Room 139, West Los Angeles, CA 90073 USA.	jniquet@ucla.edu		Wasterlain, Claude/0000-0002-2100-9114; Niquet, Jerome/0000-0002-1005-0517	VHA Research Service; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UO1 NS074926]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS074926] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000273] Funding Source: NIH RePORTER	This study was supported by VHA Research Service (CW) and NINDS (grant UO1 NS074926, CW).	Aihara H, 2001, BRAIN RES, V893, P36, DOI 10.1016/S0006-8993(00)03285-6; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Azzopardi D, 2009, ARCH DIS CHILD-FETAL, V94, pF260, DOI 10.1136/adc.2008.146977; Bellinger DC, 2009, CARDIOL YOUNG, V19, P86, DOI 10.1017/S1047951108003454; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bickler PE, 2012, ANESTHESIOLOGY, V117, P280, DOI 10.1097/ALN.0b013e318260a7b9; Brandt C, 2015, NEUROBIOL DIS, V75, P78, DOI 10.1016/j.nbd.2014.12.015; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Elmas I, 2001, FORENSIC SCI INT, V119, P212, DOI 10.1016/S0379-0738(00)00429-1; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Fleck TM, 2003, ANN THORAC SURG, V76, P1198, DOI 10.1016/S0003-4975(03)00832-4; Fuller BJ, 2003, CRYOLETTERS, V24, P95; Gega A, 2007, ANN THORAC SURG, V84, P759, DOI 10.1016/j.athoracsur.2007.04.107; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; HJORTH B, 1991, J CLIN NEUROPHYSIOL, V8, P391, DOI 10.1097/00004691-199110000-00004; Holtkamp M, 2005, J NEUROL NEUROSUR PS, V76, P534, DOI 10.1136/jnnp.2004.041947; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kamps M, 2011, CRIT CARE, V15, DOI 10.1186/cc10012; Karkar KM, 2002, EPILEPSIA, V43, P932, DOI 10.1046/j.1528-1157.2002.03902.x; Kendall GS, 2012, PEDIATRICS, V130, pE451, DOI 10.1542/peds.2011-3496; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kowski AB, 2012, BRAIN RES, V1446, P119, DOI 10.1016/j.brainres.2012.01.022; Lansman SL, 1999, ANN THORAC SURG, V67, P1975, DOI 10.1016/S0003-4975(99)00419-1; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; Maeda T, 1999, BRAIN RES, V818, P228, DOI 10.1016/S0006-8993(98)01269-4; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Mazarati AM, 1998, BRAIN RES, V814, P179, DOI 10.1016/S0006-8993(98)01080-4; Mazarati AM, 1999, NEUROSCI LETT, V265, P187, DOI 10.1016/S0304-3940(99)00238-4; McCullough JN, 1999, ANN THORAC SURG, V67, P1895, DOI 10.1016/S0003-4975(99)00441-5; MORRISETT RA, 1987, EXP NEUROL, V97, P193, DOI 10.1016/0014-4886(87)90293-7; Nagel S, 2012, NEUROSCIENCE, V208, P109, DOI 10.1016/j.neuroscience.2012.01.048; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; ORLOWSKI JP, 1984, CRIT CARE MED, V12, P367, DOI 10.1097/00003246-198404000-00006; OZTAS B, 1994, EPILEPSY RES, V19, P221, DOI 10.1016/0920-1211(94)90065-5; Parissis H, 2011, J CARDIOTHORAC SURG, V6, DOI [10.1186/1749-8090-6-153, 10.1186/1749-8090-6-152]; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Pretre R, 2003, CARDIAC SURG ADULT, P401; Rubens FD, 2007, PERFUSION-UK, V22, P153, DOI 10.1177/0267659107078142; Sartorius CJ, 1998, J NEUROSURG, V88, P349, DOI 10.3171/jns.1998.88.2.0349; SCHIFF SJ, 1985, BRAIN RES, V345, P279, DOI 10.1016/0006-8993(85)91004-2; Schmitt FC, 2006, NEUROBIOL DIS, V23, P689, DOI 10.1016/j.nbd.2006.05.008; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; SHEN KF, 1988, BRAIN RES, V475, P305, DOI 10.1016/0006-8993(88)90619-1; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Suchomelova L, 2006, PEDIATR RES, V59, P237, DOI 10.1203/01.pdr.0000196333.16608.30; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Volgushev M, 2004, J NEUROPHYSIOL, V92, P212, DOI 10.1152/jn.01166.2003; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; Wypij D, 2003, J THORAC CARDIOV SUR, V126, P1397, DOI 10.1016/S0022-5223(03)00940-1; Yang XF, 2005, J PHYSIOL-LONDON, V567, P215, DOI 10.1113/jphysiol.2005.088948; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	68	16	16	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2015	49						313	317		10.1016/j.yebeh.2015.06.028			5	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CO7CK	WOS:000359314900058	26198217	Green Accepted, Green Submitted			2022-02-06	
J	Schatz, P; Ybarra, V; Leitner, D				Schatz, Philip; Ybarra, Vincent; Leitner, Donald			Validating the Accuracy of Reaction Time Assessment on Computer-Based Tablet Devices	ASSESSMENT			English	Article						computer-based assessment; timing accuracy; reaction time	NEUROPSYCHOLOGICAL ASSESSMENT; IPAD VERSION; MILLITIMER; CONCUSSION; MACINTOSH; PAPER	Computer-based assessment has evolved to tablet-based devices. Despite the availability of tablets and apps, there is limited research validating their use. We documented timing delays between stimulus presentation and (simulated) touch response on iOS devices (3rd- and 4th-generation Apple iPads) and Android devices (Kindle Fire, Google Nexus, Samsung Galaxy) at response intervals of 100, 250, 500, and 1,000 milliseconds (ms). Results showed significantly greater timing error on Google Nexus and Samsung tablets (81-97 ms), than Kindle Fire and Apple iPads (27-33 ms). Within Apple devices, iOS 7 obtained significantly lower timing error than iOS 6. Simple reaction time (RT) trials (250 ms) on tablet devices represent 12% to 40% error (30-100 ms), depending on the device, which decreases considerably for choice RT trials (3-5% error at 1,000 ms). Results raise implications for using the same device for serial clinical assessment of RT using tablets, as well as the need for calibration of software and hardware.	[Schatz, Philip; Ybarra, Vincent; Leitner, Donald] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Schatz, P (corresponding author), St Josephs Univ, Psychol, 222 Post Hall,5600 City Ave, Philadelphia, PA 19131 USA.	schatzSJU@gmail.com					American Psychological Association (APA), 1986, GUID COMP BAS TESTS; Apple, 2014, NEW GAM PLAN CONC; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Bertucco M, 2014, J CHILD NEUROL, V29, P1460, DOI 10.1177/0883073813494265; Black JM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002730; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Clionsky M, 2014, CLIN NEUROPSYCHOL, V28, P747, DOI 10.1080/13854046.2014.913686; Cohen J., 2013, STAT POWER ANAL BEHA; De Clercq A, 2003, BEHAV RES METH INS C, V35, P109, DOI 10.3758/BF03195502; Dorr M, 2013, INVEST OPHTH VIS SCI, V54, P7266, DOI 10.1167/iovs.13-11743; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; MacInnes WJ, 2001, BEHAV RES METH INS C, V33, P174, DOI 10.3758/BF03195363; McKinney CJ, 1999, BEHAV RES METH INS C, V31, P129, DOI 10.3758/BF03207703; Onoda K, 2013, CLIN INTERV AGING, V8, P353, DOI 10.2147/CIA.S42342; Pearson, 2013, Q INT GROUNDBR MOB S; Pew, 2014, INT PROJ OMN SURV; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Seashore SH, 1941, J EXP PSYCHOL, V29, P342, DOI 10.1037/h0061571; Turpin A, 2014, J VISION, V14, DOI 10.1167/14.3.16; Van Tasell DJ, 2013, OTOL NEUROTOL, V34, P9, DOI 10.1097/MAO.0b013e318278c05d; WESTALL R, 1986, BEHAV RES METH INSTR, V18, P307, DOI 10.3758/BF03204405; WESTALL RF, 1989, BEHAV RES METH INSTR, V21, P540, DOI 10.3758/BF03202886; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	25	16	16	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	AUG	2015	22	4					405	410		10.1177/1073191114566622			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CN0DD	WOS:000358082100002	25612627				2022-02-06	
J	Seel, RT; Corrigan, JD; Dijkers, MP; Barrett, RS; Bogner, J; Smout, RJ; Garmoe, W; Horn, SD				Seel, Ronald T.; Corrigan, John D.; Dijkers, Marcel P.; Barrett, Ryan S.; Bogner, Jennifer; Smout, Randall J.; Garmoe, William; Horn, Susan D.			Patient Effort in Traumatic Brain Injury Inpatient Rehabilitation: Course and Associations With Age, Brain Injury Severity, and Time Postinjury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Amnesia; anterograde; Craniocerebral trauma; Psychomotor agitation; Rehabilitation	FUNCTIONAL INDEPENDENCE MEASURE; AGITATED BEHAVIOR SCALE; PSYCHOMETRIC PROPERTIES; GALVESTON ORIENTATION; RATING-SCALE; AMNESIA TEST; HEAD-INJURY; RELIABILITY; VALIDITY; PARTICIPATION	Objective: To describe patients' level of effort in occupational, physical, and speech therapy sessions during traumatic brain injury (TBI) inpatient rehabilitation and to evaluate how age, injury severity, cognitive impairment, and time are associated with effort. Design: Prospective, multicenter, longitudinal cohort study. Setting: Acute TBI rehabilitation programs. Participants: Patients (N=1946) receiving 138,555 therapy sessions. Interventions: Not applicable. Main Outcome Measures: Effort in rehabilitation sessions rated on the Rehabilitation Intensity of Therapy Scale, FIM, Comprehensive Severity Index brain injury severity score, posttraumatic amnesia (PTA), and Agitated Behavior Scale (ABS). Results: The Rehabilitation Intensity of Therapy Scale effort ratings in individual therapy sessions closely conformed to a normative distribution for all 3 disciplines. Mean Rehabilitation Intensity of Therapy Scale ratings for patients' therapy sessions were higher in the discharge week than in the admission week (P<.001). For patients who completed 2, 3, or 4 weeks of rehabilitation, differences in effort ratings (P<.001) were observed between 5 subgroups stratified by admission FIM cognitive scores and over time. In linear mixed-effects modeling, age and Comprehensive Severity Index brain injury severity score at admission, days from injury to rehabilitation admission, days from admission, and daily ratings of PTA and ABS score were predictors of level of effort (P<.0001). Conclusions: Patients' level of effort can be observed and reliably rated in the TBI inpatient rehabilitation setting using the Rehabilitation Intensity of Therapy Scale. Patients who sustain TBI show varying levels of effort in rehabilitation therapy sessions, with effort tending to increase over the stay. PTA and agitated behavior are primary risk factors that substantially reduce patient effort in therapies. (C) 2015 by the American Congress of Rehabilitation Medicine	[Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA 30309 USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Dijkers, Marcel P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Barrett, Ryan S.; Smout, Randall J.; Horn, Susan D.] Int Sever Informat Syst, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Garmoe, William] Medstar Natl Rehabil Hosp, Washington, DC USA		Seel, RT (corresponding author), Shepherd Ctr, Crawford Res Inst, 6th Fl,2020 Peachtree Rd, Atlanta, GA 30309 USA.	ron_seel@shepherd.org			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), and the National Institute on Disability and Rehabilitation Research (grant no. H133A080023); Publication of this article was supported by the American Congress of Rehabilitation Medicine	Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Christensen AL, 1998, J HEAD TRAUMA REHAB, V13, P79, DOI 10.1097/00001199-199810000-00009; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Department of Biostatistics Vanderbilt University, STAT PROBL DOC AV; Dijkers MP, 2012, J SPINAL CORD MED, V35, P624, DOI 10.1179/2045772312Y.0000000065; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Institute of Medicine, 2007, FUTURE DISABILITY AM; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Lequerica AH, 2006, REHABIL PSYCHOL, V51, P331, DOI 10.1037/0090-5550.51.4.331; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lu L, 2007, P N E SAS US GROUP C; Maclean N, 2000, SOC SCI MED, V50, P495; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Rothman K.J., 2008, Modern epidemiology, V3rd; Seel R, 2002, REHABILITATION INTEN; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS97, DOI 10.1016/j.apmr.2012.04.008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steyerberg, 2019, CLIN PREDICTION MODE; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; 2004, AM HERITAGE COLL DIC	36	16	16	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S235	S244		10.1016/j.apmr.2014.10.027			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100006	26212400	Green Accepted			2022-02-06	
J	Tanrikulu, L; Oez-Tanrikulu, A; Weiss, C; Scholz, T; Schiefer, J; Clusmann, H; Schubert, GA				Tanrikulu, L.; Oez-Tanrikulu, A.; Weiss, C.; Scholz, T.; Schiefer, J.; Clusmann, H.; Schubert, G. A.			The bigger, the better? About the size of decompressive hemicraniectomies	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Decompressive hemicraniectomy; Craniectomy size; Traumatic brain injury; Subarachnoid hemorrhage; Malignapt stroke	MIDDLE-CEREBRAL-ARTERY; INTRACEREBRAL HEMORRHAGE; MALIGNANT INFARCTION; ISCHEMIC-STROKE; COMPLICATIONS; CRANIECTOMY; SURGERY; INJURY	Introduction: Decompressive hemicraniectomy (DHC) is a treatment option in refractory ICP elevation and malignant infarction. A minimum diameter of 12 cm has been widely accepted as mandatory for effective decompression for ICP control. Complete hemispheric exposure is frequently advocated to further reduce the risk of parenchymal shear stress, hemorrhage and swelling. At the same time, superior efficacy and comparable risk profile of a more extensive decompression have yet to be established. Material and methods: We reviewed 74 patients with comprehensive clinical data sets undergoing DHC from 2008 to 2013 at our institution. With a minimum threshold of 12 cm in AP diameter being observed in all cases, patients were grouped according to the absolute size of maximum AP diameter (<18 cm, >= 18 cm) and surface estimate (<180 cm(2), >= 180 cm(2)). Surgical technique, efficacy of ICP control, surgical complications and early clinical course were recorded. Results: Baseline demographics were comparable in both groups. Surgery was effective in relieving or preventing intracranial hypertension in all patients, irrespective of craniectomy size. With smaller craniectomies, immediate surgical and secondary complications such as parenchymal herniation, hemorrhage, or swelling did not occur more frequently. Conclusion: Due to the heterogeneity of underlying disease, a conclusion as to effect of craniectomy size on long-term outcome cannot be made based on this study. However, if the obligatory lower threshold of 12 cm for DHC size and decompression to the temporal base are observed, a smaller craniectomy is equally effective in relieving intracranial hypertension. While not inadvertently associated with a more favorable surgical risk profile, it does not increase the risk for early secondary complications such as parenchymal shear stress, hemorrhage and swelling. (C) 2015 Published by Elsevier B.V.	[Tanrikulu, L.; Scholz, T.; Clusmann, H.; Schubert, G. A.] Rhein Westfal TH Aachen, Dept Neurosurg, D-52074 Aachen, Germany; [Oez-Tanrikulu, A.] St Martinus Hosp Dusseldorf, Dept Ophthalmol, Dusseldorf, Germany; [Weiss, C.] Heidelberg Univ, Inst Biomed Stat, Univ Med Mannheim, Heidelberg, Germany; [Schiefer, J.] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany		Schubert, GA (corresponding author), Rhein Westfal TH Aachen, Dept Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany.	gerrit.schubert@me.com	Schubert, Gerrit Alexander/Q-9192-2017	Schubert, Gerrit Alexander/0000-0001-9135-6042			Agarwalla PK, 2014, NEUROSURGERY, V74, pS151, DOI 10.1227/NEU.0000000000000226; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Heuts SG, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1326; Inamasu J, 2013, J STROKE CEREBROVASC, V22, P1350, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.008; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Neugebauer H, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-115; Park Jaechan, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P61, DOI 10.7461/jcen.2013.15.2.61; Rahme R, 2012, STROKE, V43, P550, DOI 10.1161/STROKEAHA.111.635185; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Suyama K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.07.015; Takeuchi S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12424; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	17	16	21	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2015	135						15	21		10.1016/j.clineuro.2015.04.019			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CL8LS	WOS:000357226800004	26005165				2022-02-06	
J	Divani, AA; Murphy, AJ; Meints, J; Sadeghi-Bazargani, H; Nordberg, J; Monga, M; Low, WC; Bhatia, PM; Beilman, GJ; SantaCruz, KS				Divani, Afshin A.; Murphy, Amanda J.; Meints, Joyce; Sadeghi-Bazargani, Homayoun; Nordberg, Jessica; Monga, Manoj; Low, Walter C.; Bhatia, Prerana M.; Beilman, Greg J.; SantaCruz, Karen S.			A Novel Preclinical Model of Moderate Primary Blast-Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal damage; blast traumatic brain injury; brain injury; functional outcomes; lithotripsy; vasospasm	SHOCK-WAVE LITHOTRIPSY; POSTTRAUMATIC-STRESS-DISORDER; RAT MODEL; INTRACRANIAL-PRESSURE; EXPLOSIVE BLAST; ANIMAL-MODEL; BLOOD-FLOW; IN-VITRO; EXPOSURE; NEUROTRAUMA	Blast-induced traumatic brain injury (bTBI) is the signature injury of the recent Iraq and Afghanistan wars. Here, we present a novel method to induce bTBI using shock wave (SW) lithotripsy. Using a lithotripsy machine, Wistar rats (N=70; 408.3 +/- 93g) received five SW pulses to the right side of the frontal cortex at 24kV and a frequency of 60Hz. Animals were then randomly divided into three study endpoints: 24h (n=25), 72h (n=19) and 168h (n=26). Neurological and behavioral assessments (Garcia's test, beam walking, Rotarod, and elevated plus maze) were performed at the baseline, and further assessments followed at 3, 6, 24, 72, and 168h post-injury, if applicable. We performed digital subtraction angiography (DSA) to assess presence of cerebral vasospasm due to induced bTBI. Damage to brain tissue was assessed by an overall histological severity (OHS) score based on depth of injury, area of hemorrhage, and extent of axonal injury. Except for beam walking, OHS was significantly correlated with the other three outcome measures with at least one of their assessments during the first 6h after the experiment. OHS manifested the highest absolute correlation coefficients with anxiety at the baseline and 6h post-injury (r(baseline)=-0.75, r(6hrs)=0.85; p<0.05). Median hemispheric differences for contrast peak values (obtained from DSA studies) for 24, 72, and 168h endpoints were 3.45%, 3.05% and 0.2%, respectively, with statistically significant differences at 1 versus 7d (p<0.05) and 3 versus 7d (p<0.01). In this study, we successfully established a preclinical rat model of bTBI with characteristics similar to those observed in clinical cases. This new method may be useful for future investigations aimed at understanding bTBI pathophysiology.	[Divani, Afshin A.; Murphy, Amanda J.; Nordberg, Jessica; Bhatia, Prerana M.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Divani, Afshin A.; Low, Walter C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Divani, Afshin A.; Bhatia, Prerana M.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Murphy, Amanda J.; Meints, Joyce] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Beilman, Greg J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Sadeghi-Bazargani, Homayoun] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Monga, Manoj] Cleveland Clin, Dept Urol, Cleveland, OH 44106 USA; [SantaCruz, Karen S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA		Divani, AA (corresponding author), Univ Minnesota, Dept Neurol, 420 Delaware St SE,MMC 295, Minneapolis, MN 55455 USA.	divani@umn.edu	Sadeghi-Bazargani, Homayoun/M-5522-2017	Sadeghi-Bazargani, Homayoun/0000-0002-0396-8709; Beilman, Gregory/0000-0001-5036-3027	Stroke Research Center, University of Minnesota; HealthEZ (Bloomington, MN); Lake Region Medical (Chaska, MN); Covidien (Mansfield, MA); American Heart Association's Stroke Council; University of Minnesota's Undergraduate Research Opportunities Program (UROP); Lake Region Medical	The study was supported in part by the Summer Student Fellowship program at the Stroke Research Center, University of Minnesota that has been established by a generous support from HealthEZ (Bloomington, MN), Lake Region Medical (Chaska, MN), and Covidien (Mansfield, MA). Amanda J. Murphy has received a Medical Student Scholarship in Cerebrovascular Disease and Stroke sponsored by the American Heart Association's Stroke Council. Prerana M. Bhatia was supported by the University of Minnesota's Undergraduate Research Opportunities Program (UROP). Dr. Divani has received research support from Lake Region Medical.	Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Albala DM, 2005, BJU INT, V96, P603, DOI 10.1111/j.1464-410X.2005.05692.x; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Auge Brian K, 2002, Curr Opin Urol, V12, P287, DOI 10.1097/00042307-200207000-00005; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bhatia PM, 2012, TRANSL STROKE RES, V3, P428, DOI 10.1007/s12975-012-0199-0; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cleveland RO, 2000, J ACOUST SOC AM, V107, P1745, DOI 10.1121/1.428572; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Colombel C, 2002, BRAIN RES, V950, P231, DOI 10.1016/S0006-8993(02)03043-3; Divani AA, 2006, J NEUROIMAGING, V16, P139, DOI 10.1111/j.1552-6569.2006.00024.x; Divani AA, 2009, ANN BIOMED ENG, V37, P2428, DOI 10.1007/s10439-009-9782-2; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Eriksson L, 2006, MULTI MEGAVARIATE DA; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Januszkiewicz AJ, 1997, TOXICOLOGY, V121, P51, DOI 10.1016/S0300-483X(97)03655-X; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Nakagawa Y, 2011, ENDOSCOPY, V43, pE310, DOI 10.1055/s-0030-1256642; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sadeghi-Bazargani H, 2011, Ann Burns Fire Disasters, V24, P191; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sweis BM, 2013, NEUROSCIENCE, V246, P142, DOI 10.1016/j.neuroscience.2013.04.052; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	47	16	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1109	1116		10.1089/neu.2014.3686			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000010	25585201				2022-02-06	
J	Godwin, EE; Lukow, HR; Lichiello, S				Godwin, Emilie E.; Lukow, Herman R., II; Lichiello, Stephanie			Promoting Resilience Following Traumatic Brain Injury: Application of an Interdisciplinary, Evidence-Based Model for Intervention	FAMILY RELATIONS			English	Article						resilience; resilience after traumatic brain injury; resilience and adjustment intervention; resilience promotion; therapeutic couples intervention; traumatic brain injury	FAMILY INTERVENTION; NEUROBEHAVIORAL INTERVENTION; POSITIVE EMOTIONS; MARITAL STABILITY; TBI; REHABILITATION; INDIVIDUALS; SKILLS; LONG; PERSPECTIVES	With an increasing instance of traumatic brain injury and little advancement over recent decades in the rehabilitation of brain injury survivors and their family members, focus has shifted toward the establishment of effective whole-family resilience promotion interventions. Using the Brain Injury Family Intervention as a model, clinicians constructed two curriculum-based interventions grounded in resilience theory and drawing from the interdisciplinary approaches of neuropsychology and marriage and family therapy: (a) the Resilience and Adjustment Intervention, for individual survivors of traumatic brain jury, and (b) the Therapeutic Couples Intervention, designed to increase relational satisfaction in couples following a traumatic brain injury. The present study outlines the need for the integration of resilience tenets into rehabilitation techniques, summarizes the empirical justification for the use of an interdisciplinary approach, and offers an overview with implementation specifics regarding these two newly designed interventions.	[Godwin, Emilie E.; Lukow, Herman R., II; Lichiello, Stephanie] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Godwin, EE (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, POB 980206, Richmond, VA 23298 USA.	eegodwin@vcu.edu			National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, Department of Education, Washington, DC [H133A120031, H133P090013]	This work was supported by Grants H133A120031 and H133P090013 from the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, Department of Education, Washington, DC.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Asoodeh MH, 2010, PROCD SOC BEHV, V5, P2042, DOI 10.1016/j.sbspro.2010.07.410; Benzies K, 2009, CHILD FAM SOC WORK, V14, P103, DOI 10.1111/j.1365-2206.2008.00586.x; Black K, 2008, J FAM NURS, V14, P33, DOI 10.1177/1074840707312237; Boswell JF, 2015, PSYCHOTHER RES, V25, P6, DOI 10.1080/10503307.2013.817696; Brain Injury Association of Queensland, 2010, GET FACTS ACQ BRAIN; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Butzer B, 2008, PERS RELATIONSHIP, V15, P141, DOI 10.1111/j.1475-6811.2007.00189.x; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Centers for disease control and prevention, 2014, INJ PREV CONTR TRAUM; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Creamer M, 2008, PSYCHIATRY, V71, P319, DOI 10.1521/psyc.2008.71.4.319; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Demery J, 2011, 119 ANN CONV AM PSYC, DOI [10.1037/e662792011-001, DOI 10.1037/E662792011-001]; Dowrick C, 2008, HEALTH-LONDON, V12, P439, DOI 10.1177/1363459308094419; Edward K, 2005, J AM PSYCHIAT NURSES, V11, P101; Faul M, 2010, TRAUMATIC BRAIN INJU; Gan C., 2012, ACQ BRAIN INJ NETW C; Gan C., 2008, ACQ BRAIN INJ NETW C; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Green RJ, 2004, J FAM PSYCHOL, V18, P290, DOI 10.1037/0893-3200.18.2.290; Hall P, 2001, MED EDUC, V35, P867, DOI 10.1046/j.1365-2923.2001.00919.x; HANNUM J W, 1991, Journal of Psychosocial Oncology, V9, P1, DOI 10.1300/J077v09n02_01; Hawley DR, 2000, AM J FAM THER, V28, P101, DOI 10.1080/019261800261699; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoofien D, 2001, BRAIN INJURY, V15, P189; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J, 2012, GETTING BETTER BETTE; Kreutzer J. S., 2000, SERVICE OBSTACLES SC; Kreutzer J. S., 2012, TRAUMATIC BRAIN INJU; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; Lefebvre H., 2012, RESILIENCE INDIVIDUA; Lefebvre H., 2006, ILLNESS CRISIS LOSS, V14, P337, DOI DOI 10.1177/105413730601400403; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Model Systems Knowledge Translation Center, 2013, TBI FACTSH BOOKL RES; Mohan N., 2010, THESIS FLINDERS U AD; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Niemeier J., 2004, 1 STEPS NEUROBEHAVIO; Niemeier JP, 2010, J VOCAT REHABIL, V33, P167, DOI 10.3233/JVR-2010-0525; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Rajkumar AP, 2008, SOC SCI MED, V67, P844, DOI 10.1016/j.socscimed.2008.05.014; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Silliman B., 1994, RATIONALE RESILIENT; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tedeschi RG, 2005, PROF PSYCHOL-RES PR, V36, P230, DOI 10.1037/0735-7028.36.3.230; Tegner I, 2009, J POETRY THER, V22, P121, DOI 10.1080/08893670903198383; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Vanderbilt-Adriance E, 2008, CLIN CHILD FAM PSYCH, V11, P30, DOI 10.1007/s10567-008-0031-2; Walsh F, 2003, FAM PROCESS, V42, P1, DOI 10.1111/j.1545-5300.2003.00001.x; Walsh F, 1996, FAM PROCESS, V35, P261, DOI 10.1111/j.1545-5300.1996.00261.x; Walsh F., 2011, STRENGTHENING FAMILY; Watt N F, 1995, J Prim Prev, V15, P209, DOI 10.1007/BF02197473; Wemer E. E., 1990, HDB EARLY CHILDHOOD, V2, P115; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Zasler N. D., 2012, BRAIN INJURY MED PRI	88	16	16	0	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-6664	1741-3729		FAM RELAT	Fam. Relat.	JUL	2015	64	3					347	362		10.1111/fare.12122			16	Family Studies; Social Work	Social Science Citation Index (SSCI)	Family Studies; Social Work	CJ9QP	WOS:000355837600001					2022-02-06	
J	Yuan, Q; Wu, X; Yu, J; Sun, YR; Li, ZQ; Du, ZY; Mao, Y; Zhou, LF; Hu, J				Yuan, Qiang; Wu, Xing; Yu, Jian; Sun, Yirui; Li, Zhiqi; Du, Zhuoying; Mao, Ying; Zhou, Liangfu; Hu, Jin			Effects and Clinical Characteristics of Intracranial Pressure Monitoring-Targeted Management for Subsets of Traumatic Brain Injury: An Observational Multicenter Study	CRITICAL CARE MEDICINE			English	Article						computed tomography; intracranial pressure monitoring; neuromonitoring; traumatic brain injury	SEVERE HEAD-INJURY; INTENSIVE-CARE; COMPLICATIONS; GUIDELINES; OUTCOMES; TRIAL	Objectives: To evaluate the efficacy of traumatic brain injury management guided by intracranial pressure monitoring and to explore the specific subgroups for which intracranial pressure monitoring might be significantly associated with improved outcomes based on a classification of the various traumatic brain injury pathophysiologies using the clinical features and CT scans. Design: Retrospective observational multicenter study. Setting: Twenty-two hospitals (16 level I trauma centers and six level II trauma centers) in nine provinces in China. Patients: Moderate or severe traumatic brain injury patients who were more than 14 years old. Interventions: Intracranial pressure monitoring. Measurements and Main Results: All data were collected by physicians from medical records. The 6-month mortality and favorable outcome were assessed with the Glasgow Outcome Scale Extended score. An intracranial pressure monitor was inserted into 838 patients (58.1%). The mean duration of intracranial pressure monitoring was 4.443.65 days. The significant predictors of intracranial pressure monitoring included the mechanism of injury, a Glasgow Coma Scale score of 9-12 at admission that dropped to a score of 3-8 within 24 hours after injury, a Marshall CT classification of III-IV, the presence of a major extracranial injury, subdural hematoma, intraparenchymal lesions, trauma center level, and intracranial pressure monitoring utilization of hospital. The intracranial pressure monitoring and no intracranial pressure monitoring groups did not significantly differ in terms of complications. For the total sample, the placement of intracranial pressure monitoring was not associated with either 6-month mortality (16.9% vs 20.5%; p = 0.086) or 6-month unfavorable outcome (49.4% vs 45.8%; p = 0.175). For patients with a Glasgow Coma Scale score of 3-8 at admission, intracranial pressure monitoring was also not significantly associated with 6-month mortality (20.9% vs 26.0%; p = 0.053) or an unfavorable outcome (56.9% vs 55.5%; p = 0.646). Multivariate logistic regression analyses showed that intracranial pressure monitoring resulted in a significantly lower 6-month mortality for patients who had a Glasgow Coma Scale score of 3-5 at admission (adjusted odds ratio, 0.57; 95% CI, 0.36-0.90; adjusted p = 0.016), those who had a Glasgow Coma Scale score of 9-12 at admission that dropped to 3-8 within 24 hours after injury (adjusted odds ratio, 0.28; 95% CI, 0.08-0.96; adjusted p = 0.043), and those who had a probability of death at 6 months greater than 0.6 (adjusted odds ratio, 0.55; 95% CI, 0.32-0.94; adjusted p = 0.029). Conclusions: There were multiple differences between the intracranial pressure monitoring and no intracranial pressure monitoring groups regarding patient characteristics, injury severity, characteristics of CT scan, and hospital type. Intracranial pressure monitoring in conjunction with intracranial pressure-targeted therapies is significantly associated with lower mortality in some special traumatic brain injury subgroups. The prospective randomized controlled trials specifically investigating these subgroups will be required to further characterize the effects of intracranial pressure monitoring on behavioral outcomes in patients with traumatic brain injury.	[Yuan, Qiang; Wu, Xing; Yu, Jian; Sun, Yirui; Li, Zhiqi; Du, Zhuoying; Mao, Ying; Zhou, Liangfu; Hu, Jin] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China		Hu, J (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China.	hujin_dana@126.com		Mao, Ying/0000-0001-8055-115X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30371454, 81271375, 81171133]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	Supported, in part, by the National Natural Science Foundation of China (grants 30371454, 81271375, and 81171133), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), and Shanghai Nature Science Foundation (08411952000). The authors have disclosed that they do not have any potential conflicts of interest.	Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KANTER RK, 1985, CRIT CARE MED, V13, P837, DOI 10.1097/00003246-198510000-00012; Lane PL, 2000, CAN J SURG, V43, P442; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rapenne T, 1997, PRESSE MED, V26, P1661; Ropper AH, 2012, NEW ENGL J MED, V367, P2539, DOI 10.1056/NEJMe1212289; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	30	16	18	2	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2015	43	7					1405	1414		10.1097/CCM.0000000000000965			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2XK	WOS:000358285900008	25803654				2022-02-06	
J	Baker, A; Unsworth, CA; Lannin, NA				Baker, Anne; Unsworth, Carolyn A.; Lannin, Natasha A.			Fitness-to-drive after mild traumatic brain injury: Mapping the time trajectory of recovery in the acute stages post injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Acute care; Fitness-to-drive; Mild traumatic brain injury	HOME MAZE TEST; VALIDITY	Introduction: Little is known about the trajectory of recovery in fitness-to-drive after mild traumatic brain injury (mTBI). This means that health-care professionals have limited evidence on which to base recommendations to this cohort about driving. Objective: To determine fitness-to-drive status of patients with a mTBI at 24 h and two weeks post injury, and to summarise issues reported by this cohort about return to driving. Method: Quasi-experimental case-control design. Two groups of participants were recruited: patients with a mTBI (n = 60) and a control group with orthopaedic injuries (n = 60). Both groups were assessed at 24 h post injury on assessments of fitness-to-drive. Follow-up occurred at two weeks post injury to establish driver status. Main Measures: Mini mental state examination, occupational therapy-drive home maze test (OT-DHMT), Road Law Road Craft Test, University of Queensland-Hazard Perception Test, and demographic/interview form collected at 24 h and at two weeks. Results: At the 24 h assessment, only the OT-DHMT showed a difference in scores between the two groups, with mTBI participants being significantly slower to complete the test (p = 0.01). At the two week follow-up, only 26 of the 60 mTBI participants had returned to driving. Injury severity combined with scores from the 24 h assessment predicted 31% of the variance in time taken to return to driving. Delayed return to driving was reported due to: "not feeling 100% right" (n = 14, 23%), headaches and pain (n = 12, 20%), and dizziness (n=5, 8%). Conclusion: This research supports existing guidelines which suggest that patients with a mTBI should not to drive for 24h; however, further research is required to map factors which facilitate timely return to driving. (C) 2015 Elsevier Ltd. All rights reserved.	[Baker, Anne] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Unsworth, Carolyn A.; Lannin, Natasha A.] La Trobe Univ, Fac Hlth Sci, Bundoora, Vic 3086, Australia; [Unsworth, Carolyn A.] Cent Queensland Univ, Dept Occupat Therapy, Melbourne, Vic, Australia; [Unsworth, Carolyn A.] Jonkoping Univ, Sch Hlth Sci, Dept Rehabil, Jonkoping, Sweden; [Unsworth, Carolyn A.] Curtin Univ, Dept Occupat Therapy, Perth, WA 6845, Australia; [Lannin, Natasha A.] Alfred Hlth, Dept Occupat Therapy, Melbourne, Vic, Australia; [Lannin, Natasha A.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia		Baker, A (corresponding author), Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia.	anne.baker@monash.edu	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345; Unsworth, Carolyn/0000-0001-6430-2823; Baker, Anne/0000-0002-3779-5463	La Trobe University Physical Activity and Rehabilitation Group; La Trobe University Postgraduate Research Scholarship	This study was supported by a grant from the La Trobe University Physical Activity and Rehabilitation Group. Anne Baker was supported by a La Trobe University Postgraduate Research Scholarship.	Asimakopulos J, 2012, AUST OCCUP THER J, V59, P402, DOI 10.1111/j.1440-1630.2011.00963.x; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Australian Bureau of Statistics, 2010, TRANSP ROAD SAF; Austroads, 2012, ASS FITN DRIV COMM P; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Baker A, 2015, AUST OCCUP THER J, V62, P50, DOI 10.1111/1440-1630.12172; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Department of Motor Vehicles, 2013, DRIV SAF INF LAPS CO; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Horswill MS, 2008, J GERONTOL B-PSYCHOL, V63, pP212, DOI 10.1093/geronb/63.4.P212; Krishnasamy C, 2012, ACCIDENT ANAL PREV, V49, P274, DOI 10.1016/j.aap.2012.02.019; Krishnasamy C, 2011, CLIN REHABIL, V25, P88, DOI 10.1177/0269215510382846; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moore C, 2004, NZ MED J, V117, P1; PORTARE, 2009, HDB DIS DRIV ASS; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Reid M.W., 2014, J NEUROTRAU IN PRESS; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; The Alfred Hospital, 2012, ALFR TRAUM REG; Thomas S.A., 2005, AUST OCCUP THER J, V52, P57, DOI DOI 10.1111/J.1440-1630.2005.00456.X; Unsworth CA, 2011, OT DORA BATTERY OCCU; Vrkljan BH, 2011, CAN J OCCUP THER, V78, P80, DOI 10.2182/cjot.2011.78.2.3; Wetton MA, 2010, ACCIDENT ANAL PREV, V42, P1232, DOI 10.1016/j.aap.2010.01.017	31	16	16	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUN	2015	79						50	55		10.1016/j.aap.2015.03.014			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CJ2ZF	WOS:000355352500005	25797386				2022-02-06	
J	Goverover, Y; DeLuca, J				Goverover, Yael; DeLuca, John			Actual reality: Using the Internet to assess everyday functioning after traumatic brain injury	BRAIN INJURY			English	Article						Activities of daily living; cognition; outcome; rehabilitation; traumatic brain injury	QUALITY-OF-LIFE; SELF-AWARENESS; INSTRUMENTAL ACTIVITIES; SUBJECTIVE REPORTS; PERFORMANCE; TECHNOLOGY; DEPRESSION; DEMENTIA; ASSOCIATION; VALIDITY	Objectives: The aim of this pilot study was to examine and compare the performance of everyday life activities in persons with traumatic brain injury (TBI) and healthy controls (HC) using a new assessment tool called 'actual reality' (AR). Method: A between-subjects design was utilized to compare 10 individuals with TBI and 10 healthy controls (HC) performing an AR task. Participants were asked to access the Internet to purchase a decorative arrangement of cookies and were administered a battery of neuropsychological tests and questionnaires to assess quality-of-life, functional status, affect symptomatology and prior Internet experience. Results: Participants with TBI had significantly more difficulties than HC participants in accurately and independently completing the AR task primarily due to cognitive impairment. In addition, self-reports of quality-of-life and everyday functional abilities were not correlated with AR performance. Conclusions: The results provide initial evidence supporting the use of the AR approach in assessing persons with TBI performing everyday life activities. The utilization and interpretation of the AR approach is a significant step forward in increasing the sensitivity, accessibility and relevancy of functional assessments in people with cognitive impairments. Actual reality will be discussed in terms of accessibility and directions for assessment and treatment.	[Goverover, Yael] NYU, Dept Occupat Therapy, New York, NY USA; [Goverover, Yael; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA		Goverover, Y (corresponding author), Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA.	yg243@nyu.edu					BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Blackstone K, 2012, J INT NEUROPSYCH SOC, V18, P79, DOI 10.1017/S135561771100141X; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bottari C., 2006, AUST OCCUP THER J, V53, P98, DOI DOI 10.1111/J.1440-1630.2006.00547.X; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis D, 2000, DELIS KAPLAN EXECUTI; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Desai AK, 2004, CNS DRUGS, V18, P853, DOI 10.2165/00023210-200418130-00003; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Engstrom ALL, 2010, SCAND J OCCUP THER, V17, P233, DOI [10.1080/11038120903191806, 10.3109/11038120903191806]; Goverover Y, 2005, ARCH PHYS MED REHAB, V86, P2303, DOI 10.1016/j.apmr.2005.05.016; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; Goverover Y, 2009, REHABIL PSYCHOL, V54, P60, DOI 10.1037/a0014556; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Kassberg AC, 2013, BRAIN INJURY, V27, P1583, DOI 10.3109/02699052.2013.837196; Lange ML, 2002, AM J OCCUP THER, V56, P107, DOI 10.5014/ajot.56.1.107; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lund ML, 2012, SCAND J OCCUP THER, V19, P164, DOI 10.3109/11038128.2011.582651; Malinowsky C, 2014, DISABILITY REHABILIT, V1, P1; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Nygard L, 2007, AGING MENT HEALTH, V11, P144, DOI 10.1080/13607860600844168; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Sadek JR, 2011, J INT NEUROPSYCH SOC, V17, P832, DOI 10.1017/S1355617711000841; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sikkes SAM, 2009, J NEUROL NEUROSUR PS, V80, P7, DOI 10.1136/jnnp.2008.155838; Smith A., 1982, SYMBOL DIGITS MODALI; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Tsai IH, 2014, ARCH PHYS MED REHAB, V95, P236, DOI 10.1016/j.apmr.2013.08.004; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Youngstrom MJ, 2002, AM J OCCUP THER, V56, P609	41	16	16	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					715	721		10.3109/02699052.2015.1004744			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700006	25688468				2022-02-06	
J	Park, HY; Maitra, K; Martinez, KM				Park, Hae Yean; Maitra, Kinsuk; Martinez, Kristina Marie			The Effect of Occupation-based Cognitive Rehabilitation for Traumatic Brain Injury: A Meta-analysis of Randomized Controlled Trials	OCCUPATIONAL THERAPY INTERNATIONAL			English	Article						occupation-based cognitive rehabilitation; meta-analysis; RCT; traumatic brain injury	LOW-BIRTH-WEIGHT; QUALITY-OF-LIFE; SELF-AWARENESS; IMPROVE; LONG; NEUROMUSCULOSKELETAL; INTERVENTION; IMPAIRMENT; MANAGEMENT; DIFFICULTY	Traumatic brain injury (TBI) is the leading cause of death and disability among people younger than 35 years in the United States. Cognitive difficulty is a common consequence of TBI. To address cognitive deficits of patients with TBI, various cognitive rehabilitation approaches have been used for the clinical setting. The purpose of this study was to investigate the overall effect of occupation-based cognitive rehabilitation on patients' improvement in cognitive performance components, activity of daily living (ADL) performance, and values, beliefs and spirituality functions of patients with TBI. The papers used in this study were retrieved from the Cochrane Database, EBSCO (CINAHL), PsycINFO, PubMed and Web of Science published between 1997 and 2014. The keywords for searching were cognitive, rehabilitation, occupation, memory, attention, problem-solving, executive function, ADL, values, beliefs, spirituality, randomized controlled trials and TBI. For the meta-analysis, we examined 60 effect sizes from nine studies that are related to the occupation-based cognitive rehabilitation on persons with TBI. In persons with TBI, overall mental functions, ADL, and values, beliefs and spirituality were significantly improved in the groups that received occupation-based cognitive rehabilitation compared with comparison groups (mean d=0.19, p<.05). Evidence from the present meta-analytic study suggests that occupation-based cognitive rehabilitation would be beneficial for individuals with TBI for improving daily functioning and positively be able to affect their psychosocial functions. Collecting many outcome measures in studies with relatively few participants and the final data are less reliable than the whole instrument itself. Future research should evaluate the effectiveness of specific occupation-based cognitive rehabilitations programmes in order to improve consistency among rehabilitation providers. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Park, Hae Yean; Maitra, Kinsuk] Florida Int Univ, Occupat Therapy, Miami, FL 33199 USA; [Park, Hae Yean] Yonsei Univ, Occupat Therapy, Wonju 220710, Gangwon Do, South Korea; [Martinez, Kristina Marie] James A Haley Vet Hosp, DVBIC, Tampa, FL 33637 USA		Maitra, K (corresponding author), Florida Int Univ, Occupat Therapy, 11200 SW 8th St,AHC 3,443, Miami, FL 33199 USA.	kmaitra@fiu.edu	Maitra, Kinsuk/AAE-4630-2021				American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; Baum C., 2005, OCCUPATIONAL THERAPY, P242; Baum C. M., 2010, NEUROPSYCHOLOGY EVER, P63; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Borenstein M, 2011, INTRO METAANALYSIS; Bovend'Eerdt TJ, 2010, ARCH PHYS MED REHAB, V91, P939, DOI 10.1016/j.apmr.2010.03.008; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chochinov HM, 2005, J PALLIAT MED, V8, P103, DOI DOI 10.1089/JPM.2005.8.S-103; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cohen J., 2013, STAT POWER ANAL BEHA; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cutler S.K., 2002, PSYCHOSOCIAL OCCUPAT; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Finset A, 2000, BRAIN INJURY, V14, P887; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hall JR, 2011, INT J ALZHEIMERS DIS, V2011, P189; Hemayattalab R, 2010, RES DEV DISABIL, V31, P81, DOI 10.1016/j.ridd.2009.07.022; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Kalivas PW, 1993, LIMBIC MOTOR CIRCUIT; Kaye P, 2006, NOTES SYMPTOM CONTRO; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Ketchum JM, 2012, NEUROREHABILITATION, V30, P23, DOI 10.3233/NRE-2012-0724; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Lieberman D, 2002, AM J OCCUP THER, V56, P344, DOI 10.5014/ajot.56.3.344; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Maitra K, 2014, AM J OCCUP THER, V68, P140, DOI 10.5014/ajot.2014.009985; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Page SJ, 2012, APHASIOLOGY, V26, P127, DOI 10.1080/02687038.2011.636027; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Park HY, 2014, AM J OCCUP THER, V68, P268, DOI 10.5014/ajot.2014.010371; Perneczky R, 2006, AGE AGEING, V35, P240, DOI 10.1093/ageing/afj054; Prince-Paul M, 2008, J PALLIAT MED, V11, P20, DOI 10.1089/jpm.2007.0119; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; REBEIRO KL, 1998, CANADIAN J OCCUPATIO, V65, P12, DOI DOI 10.1177/000841749806500102.; Rechetinikov RP, 2009, AM J OCCUP THER, V63, P255, DOI 10.5014/ajot.63.3.255; ROSENTHAL R, 1982, PSYCHOL BULL, V92, P500, DOI 10.1037/0033-2909.92.2.500; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Schaefer A, 2007, REV NEUROSCIENCE, V18, P355; SIMES RJ, 1987, STAT MED, V6, P11, DOI 10.1002/sim.4780060104; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson PH, 1998, J CHILD PSYCHOL PSYC, V39, P829, DOI 10.1111/1469-7610.00384; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	65	16	17	1	36	WILEY-HINDAWI	LONDON	ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND	0966-7903	1557-0703		OCCUP THER INT	Occup. Ther. Int.	JUN	2015	22	2					104	116		10.1002/oti.1389			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CP7TB	WOS:000360089900006	25808426				2022-02-06	
J	Tang, AD; Makowiecki, K; Bartlett, C; Rodger, J				Tang, Alexander D.; Makowiecki, Kalina; Bartlett, Carole; Rodger, Jennifer			Low Intensity Repetitive Transcranial Magnetic Stimulation Does Not Induce Cell Survival or Regeneration in a Mouse Optic Nerve Crush Model	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ALTERNATING-CURRENT STIMULATION; THETA-BURST STIMULATION; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; RAT MODEL; BDNF; RTMS; INJURY; TRANSECTION	Low intensity repetitive Transcranial Magnetic Stimulation (LI-rTMS), a non-invasive form of brain stimulation, has been shown to induce structural and functional brain plasticity, including short distance axonal sprouting. However, the potential for LI-rTMS to promote axonal regeneration following neurotrauma has not been investigated. This study examined the effect of LI-rTMS on retinal ganglion cell (RGC) survival, axon regeneration and levels of BDNF in an optic nerve crush neurotrauma model. Adult C57Bl/6J mice received a unilateral intraorbital optic nerve crush. Mice received 10 minutes of sham (handling control without stimulation) (n=6) or LI-rTMS (n = 8) daily stimulation for 14 days to the operated eye. Immunohistochemistry was used to assess RGC survival (beta-3 Tubulin) and axon regeneration across the injury (GAP43). Additionally, BDNF expression was quantified in a separate cohort by ELISA in the retina and optic nerve of injured (optic nerve crush) (sham n = 5, LIrTMS n = 5) and non-injured mice (sham n = 5, LI-rTMS n = 5) that received daily stimulation as above for 7 days. Following 14 days of LI-rTMS there was no significant difference in mean RGC survival between sham and treated animals (p > 0.05). Also, neither sham nor LIrTMS animals showed GAP43 positive labelling in the optic nerve, indicating that regeneration did not occur. At 1 week, there was no significant difference in BDNF levels in the retina or optic nerves between sham and LI-rTMS in injured or non-injured mice (p > 0.05). Although LI-rTMS has been shown to induce structural and molecular plasticity in the visual system and cerebellum, our results suggest LI-rTMS does not induce neuroprotection or regeneration following a complete optic nerve crush. These results help define the therapeutic capacity and limitations of LI-rTMS in the treatment of neurotrauma.	[Tang, Alexander D.; Makowiecki, Kalina; Bartlett, Carole; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Dept Expt & Regenerat Neurosci, Perth, WA 6009, Australia		Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Dept Expt & Regenerat Neurosci, Perth, WA 6009, Australia.	jennifer.rodger@uwa.edu.au	Rodger, Jennifer/H-5735-2014; Tang, Alexander D/S-5258-2018	Rodger, Jennifer/0000-0003-3413-4229; Makowiecki, Kalina/0000-0003-4550-3819; Tang, alexander/0000-0002-3832-847X	National Health and Medical Research Council Neurotrauma Research ProgramNational Health and Medical Research Council of Australia [634386, APP1002258]; State Government of Western Australia; Australian Research CouncilAustralian Research Council [LP110100201]	This work was supported by the National Health and Medical Research Council (634386, APP1002258; http://www.nhmrc.gov.au/) Neurotrauma Research Program, State Government of Western Australia (no grant number available, http://www.nrp.org.au/), and the Australian Research Council (LP110100201; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Bates KA, 2012, BRAIN RES, V1458, P76, DOI 10.1016/j.brainres.2012.04.006; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Bortolomasi M, 2007, PSYCHIAT RES, V150, P181, DOI 10.1016/j.psychres.2006.04.010; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Di Lazzaro V, 2013, BRAIN STIMUL, V6, P469, DOI 10.1016/j.brs.2013.01.004; Dixon KJ, 2006, EXP NEUROL, V202, P44, DOI 10.1016/j.expneurol.2006.05.010; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Grehl S, 2015, BRAIN STIMUL, V8, P114, DOI 10.1016/j.brs.2014.09.012; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Henrich-Noack P, 2013, BRAIN RES BULL, V95, P7, DOI 10.1016/j.brainresbull.2013.02.008; Henrich-Noack Petra, 2013, Neurosci Lett, V543, P1, DOI 10.1016/j.neulet.2013.03.013; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hou JM, 2014, J NEUROTRAUM, V31, P1088, DOI 10.1089/neu.2013.3096; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Khedr EM, 2010, ACTA NEUROL SCAND, V121, P30, DOI 10.1111/j.1600-0404.2009.01195.x; Kleinjung T, 2005, OTOLARYNG HEAD NECK, V132, P566, DOI 10.1016/j.otohns.2004.09.134; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; Lenz M, 2014, BRAIN STRUCT FUNCT, P1; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Macharadze T, 2009, NEUROREPORT, V20, P301, DOI 10.1097/WNR.0b013e32832027e6; Makowiecki K, 2014, J NEUROSCI, V34, P10780, DOI 10.1523/JNEUROSCI.0723-14.2014; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Morellini N, 2015, CEREBELLUM, V14, P23, DOI 10.1007/s12311-014-0617-9; Morimoto T, 2005, INVEST OPHTH VIS SCI, V46, P2147, DOI 10.1167/iovs.04-1339; Morimoto T, 2002, NEUROREPORT, V13, P227, DOI 10.1097/00001756-200202110-00011; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Panagis L, 2005, EUR J NEUROSCI, V21, P2305, DOI 10.1111/j.1460-9568.2005.04046.x; Coimbra JP, 2009, J COMP NEUROL, V514, P66, DOI 10.1002/cne.21992; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Prilloff S, 2012, INVEST OPHTH VIS SCI, V53, P1460, DOI 10.1167/iovs.11-8306; Rodger J, 2012, FASEB J, V26, P1593, DOI 10.1096/fj.11-194878; Sergeeva EG, 2012, J NEUROPHYSIOL, V108, P2494, DOI 10.1152/jn.00341.2012; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Templeton JP, 2012, MOL VIS, V18, P2147; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Volz LJ, 2013, BRAIN STIMUL, V6, P598, DOI 10.1016/j.brs.2013.01.008; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; WEIBEL D, 1995, BRAIN RES, V679, P249, DOI 10.1016/0006-8993(95)00238-L; WEISSMAN JD, 1992, ELECTROEN CLIN NEURO, V85, P215, DOI 10.1016/0168-5597(92)90135-X; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2; Zanardini R, 2006, J AFFECT DISORDERS, V91, P83, DOI 10.1016/j.jad.2005.12.029	52	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126949	10.1371/journal.pone.0126949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	WOS:000354921400085	25993112	Green Submitted, Green Published, gold			2022-02-06	
J	Sailors, PR				Sailors, Pamela R.			Personal Foul: an evaluation of the moral status of football	JOURNAL OF THE PHILOSOPHY OF SPORT			English	Article						objectification; violence; concussions; harm; football		The popularity and profitability of American gridiron football is beyond dispute. Recent polls put football as the overwhelming favorite of people who follow at least one sport and huge revenues are reported at both the professional and the university level. We know, however, that what is the case tells us little about what ought to be the case, and it is to the latter question that this paper is directed. I offer a three-pronged attack on the ethical acceptability of American football, both amateur and professional, based on (1) harm to the players, (2) objectification of the players, and (3) harm to others done by the players, leading to the conclusion that the sport, as currently constituted, is morally unacceptable.	Missouri State Univ, Dept Philosophy, Springfield, MO 65897 USA		Sailors, PR (corresponding author), Missouri State Univ, Dept Philosophy, 901 S Natl Ave, Springfield, MO 65897 USA.	pamela-sailors@missouristate.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Belson K., 2014, NY TIMES; Brady E., 2013, US TODAY; Branch Taylor, 2011, ATLANTIC; Breslow JM, 2014, 76 79 DECEASED NFL P; Corlett JA, 2014, SPORT ETHICS PHILOS, V8, P116, DOI 10.1080/17511321.2014.918167; DAVIS P, 1994, J PHILOS SPORT, V20-1, P48; Dixon N., 2001, SOCIAL THEORY PRACTI, V27, P323; Easterbrook G., 2013, KING SPORTS FOOTBALL; Engber D., 2013, SLATE           1015; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; FEINBERG J, 1986, HARM SELF MORAL LIMI; Herrera CD, 2002, J PHILOS SPORT, V29, P163, DOI 10.1080/00948705.2002.9714632; Irwin T. H., 1999, NICOMACHEAN ETHICS; Kant I., 1991, METAPHYSICS MORALS; Keteyian A., 2013, SYSTEM GLORY SCANDAL; Leclerc S, 1999, BRIT J SPORT MED, V33, P426, DOI 10.1136/bjsm.33.6.426; LUNDBERG GD, 1986, JAMA-J AM MED ASSOC, V255, P2483, DOI 10.1001/jama.255.18.2483; Messner M.A., 2007, OUT PLAY CRITICAL ES; Mill John Stuart., 1962, UTILITARIANISM OTHER; Mill John Stuart, 1989, LIBERTY OTHER WRITIN; Morris B., 2014, 538             0731; Parry S.J., 1998, ETHICS SPORT, P205; Paton H.J., 1964, GROUNDWORK METAPHYSI; RADFORD C, 1988, PHILOSOPHY, V63, P63, DOI 10.1017/S0031819100043138; ROSENBERG D, 2014, BLOOMSBURY COMPANION, P262; Rovell D, 2014, NFL MOST POPULAR 30; Sabo Donald F., 1990, SPORT MEN GENDER ORD; Schneider A., 2001, Ethics in sport, P357; Simon R. L., 2007, Ethics in sport, P379; Simon R. L, 2010, FAIR PLAY ETHICS SPO; Sports Legacy Institute, 2014, FREQ ASK QUEST CHRON; Tamburrini C, 2011, J PHILOS SPORT, V38, P1; Teitelbaum S.H., 2010, ATHLETES WHO INDULGE; Wertheimer A., 2007, Ethics in sport, P365	35	16	16	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0094-8705	1543-2939		J PHILOS SPORT	J. Philos. Sport	MAY 4	2015	42	2					269	286		10.1080/00948705.2014.1000338			18	Ethics; Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Social Sciences - Other Topics; Sport Sciences	CI3EX	WOS:000354631500001					2022-02-06	
J	Hughes, AJ; Beier, M; Hartoonian, N; Turner, AP; Amtmann, D; Ehde, DM				Hughes, Abbey J.; Beier, Meghan; Hartoonian, Narineh; Turner, Aaron P.; Amtmann, Dagmar; Ehde, Dawn M.			Self-Efficacy as a Longitudinal Predictor of Perceived Cognitive Impairment in Individuals With Multiple Sclerosis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Cognition; Executive function; Longitudinal studies; Multiple sclerosis; Rehabilitation; Self efficacy; Self report	QUALITY-OF-LIFE; DISABILITY STATUS SCALE; TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; HEALTH-STATUS; DEPRESSION; ADJUSTMENT; MANAGEMENT; DISORDERS; ADHERENCE	Objectives: To determine whether self-efficacy longitudinally predicts 2 types of perceived cognitive impairment (PCI) in multiple sclerosis (MS): general cognitive functioning and executive functioning; and secondarily to assess whether self-efficacy mediates the relationships between depression, fatigue, and PCI. Design: Longitudinal analysis of self-report survey data collected over 3 years. Hierarchical regression analyses examined the relationship between self-efficacy and PCI, adjusting for depression and fatigue. Additional analyses tested self-efficacy as a mediator between depression, fatigue, and PCI. Setting: Community. Participants: Community-dwelling individuals with MS (N=233; age range, 22-83y) were recruited from a larger longitudinal survey study of individuals with MS (N=562). Interventions: Not applicable. Main Outcome Measures: Primary outcome measures were the Applied Cognition General Concerns and the Applied Cognition Executive Function domains of the Quality of Life in Neurological Disorders (NeuroQoL) measures. Results: Self-efficacy was significantly correlated with PCI at baseline (r=.40.53) and 3 years later (r=.36.44). In multivariate regression analyses, self-efficacy was a significant longitudinal predictor of PCI, both for general cognitive functioning (13=20, P<.01) and executive functioning (13=.16, P<.05). Self-efficacy partially mediated the relationships between depression, fatigue, and PCI. Conclusions: Self-efficacy may influence how individuals with MS perceive their cognitive functioning over time. Interventions that target self-efficacy, particularly early in the disease course, may lead to improvements in PCI, as well as improvements in fatigue and depression. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hughes, Abbey J.; Beier, Meghan; Turner, Aaron P.; Amtmann, Dagmar; Ehde, Dawn M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Hughes, Abbey J.; Hartoonian, Narineh; Turner, Aaron P.] Vet Affairs Puget Sound Hlth Care Syst, Multiple Sclerosis Ctr Excellence West, Seattle, WA USA		Hughes, AJ (corresponding author), Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA.	ajhughes@uw.edu	Turner, Aaron/A-7902-2009; Ehde, Dawn/K-1883-2016; Hughes, Abbey/K-8861-2015	Turner, Aaron/0000-0001-6897-8003; Hughes, Abbey/0000-0002-7612-6887; Ehde, Dawn/0000-0002-9555-2347	Department of Education, National Institute on Disability and Rehabilitation Research [H133B031129, H133B080025]; National Institutes of Health (NIH) through the NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01AR052171-03]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [MB 0026]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U01AR052171] Funding Source: NIH RePORTER	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant nos. H133B031129, H133B080025); the National Institutes of Health (NIH) through the NIH Roadmap for Medical Research (grant no. 5U01AR052171-03); and the National Multiple Sclerosis Society (grant no. MB 0026). The contents of this article do not necessarily represent the policy of the Department of Education and should not assume endorsement by the Federal Government.	Aalto AM, 1997, PATIENT EDUC COUNS, V30, P215, DOI 10.1016/S0738-3991(96)00963-9; Aljasem LI, 2001, DIABETES EDUCATOR, V27, P393, DOI 10.1177/014572170102700309; Amtmann D, 2012, ARCH PHYS MED REHAB, V93, P1757, DOI 10.1016/j.apmr.2012.05.001; Bamer AM, 2008, MULT SCLER J, V14, P1127, DOI 10.1177/1352458508092807; Bamer AM, 2007, MULT SCLER J, V13, P1033, DOI 10.1177/1352458507077624; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barlow JH, 2002, PATIENT EDUC COUNS, V46, P11, DOI 10.1016/S0738-3991(01)00146-X; Barnwell AM, 1997, SOC SCI MED, V45, P411, DOI 10.1016/S0277-9536(96)00356-5; Benito-Leon J, 2003, DISABIL REHABIL, V25, P1291, DOI 10.1080/09638280310001608591; Bowen J, 2001, MULT SCLER, V7, P201, DOI 10.1191/135245801678438447; Buckelew SP, 1996, ARTHRIT CARE RES, V9, P97, DOI 10.1002/1529-0131(199604)9:2<97::AID-ANR1790090205>3.0.CO;2-F; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Denney DR, 2005, ARCH CLIN NEUROPSYCH, V20, P967, DOI 10.1016/j.acn.2005.04.012; Dilorio C, 1992, West J Nurs Res, V14, P292; Dilorio C, 1992, WESTERN J NURS RES, V14, P303; Garfield AC, 2012, DISABIL REHABIL, V34, P2047, DOI 10.3109/09638288.2012.667503; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; HOLDEN G, 1991, SOC WORK HEALTH CARE, V16, P53; JENSEN MP, 1991, PAIN, V47, P249, DOI 10.1016/0304-3959(91)90216-K; Jongen PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096444; Julian L, 2007, MULT SCLER J, V13, P81, DOI 10.1177/1352458506070255; Kasser SL, 2012, DISABIL HEALTH J, V5, P261, DOI 10.1016/j.dhjo.2012.07.001; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lackner JM, 1996, J CONSULT CLIN PSYCH, V64, P212, DOI 10.1037/0022-006X.64.1.212; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Motl RW, 2009, INT J REHABIL RES, V32, P260, DOI 10.1097/MRR.0b013e328325a5ed; Ng A, 2013, DISABIL REHABIL, V35, P1039, DOI 10.3109/09638288.2012.717586; Pakenham KI, 1999, HEALTH PSYCHOL, V18, P383, DOI 10.1037/0278-6133.18.4.383; Plow M, 2012, DISABIL HEALTH J, V5, P284, DOI 10.1016/j.dhjo.2012.05.007; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rae-Grant AD, 2011, J REHABIL RES DEV, V48, P1087, DOI 10.1682/JRRD.2010.08.0159; Saunders C, 2010, J NEUROSCI NURS, V42, pS10, DOI 10.1097/JNN.0b013e3181ee122b; Schmitt MM, 2014, REHABIL PSYCHOL, V59, P27, DOI 10.1037/a0035288; Schoenthaler A, 2009, HEALTH EDUC BEHAV, V36, P127, DOI 10.1177/1090198107309459; Senders A, 2014, MULT SCLER J, V20, P1102, DOI 10.1177/1352458513517279; Shnek ZM, 1997, ANN BEHAV MED, V19, P287, DOI 10.1007/BF02892293; Stuifbergen AK, 2000, NURS RES, V49, P122, DOI 10.1097/00006199-200005000-00002; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; Suh Y, 2011, BEHAV MED, V37, P87, DOI 10.1080/08964289.2011.603768; Trojan DA, 2007, MULT SCLER J, V13, P985, DOI 10.1177/1352458507077175; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Wegener ST, 2009, ARCH PHYS MED REHAB, V90, P373, DOI 10.1016/j.apmr.2008.08.222; Wollin Judy Ann, 2013, Int J MS Care, V15, P90, DOI 10.7224/1537-2073.2012-032; ZELDOW PB, 1984, J NERV MENT DIS, V172, P80, DOI 10.1097/00005053-198402000-00003	51	16	16	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2015	96	5					913	919		10.1016/j.apmr.2015.01.008			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CH6JL	WOS:000354142800019	25597915	Green Accepted			2022-02-06	
J	Love, S; Solomon, GS				Love, Shawn; Solomon, Gary S.			Talking With Parents of High School Football Players About Chronic Traumatic Encephalopathy A Concise Summary	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						chronic traumatic encephalopathy; concussion; traumatic brain injury; sports; football	LEAGUE PLAYERS; ALZHEIMERS-DISEASE; INJURY; DEPRESSION; SPORT; RISK; TAU; CONCUSSION; MORTALITY; SUICIDE	Over the past decade, athletic-related chronic traumatic encephalopathy (CTE) has garnered a great deal of attention in the popular press and, more recently, in the scientific press. With increasing frequency, sports medicine practitioners and providers are faced with questions from the parents of high school football players about CTE and the risk posed to children who participate in this or other contact or collision sports. The purpose of this review was to summarize the research on CTE in an attempt to provide some evidence-based answers to frequently asked questions in clinics from parents. Addressed are (1) the definitions of CTE and its symptoms, (2) the evidence for CTE in football, (3) abnormal tau protein, (4) the use of neuroimaging in CTE diagnosis, (5) risk for CTE, (6) CTE diagnosis in youth, (7) CTE and its relationship to suicide, and (8) contact and collision sports as a risk factor for permanent brain injury or death.	[Love, Shawn; Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA		Solomon, GS (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Neurosurg Clin, 1500 21st Ave South,Suite 1506, Nashville, TN 37232 USA.	gary.solomon@vanderbilt.edu	Solomon, Gary/K-9011-2019; Meijer, Anna/K-5118-2016		Nashville Predators; Tennessee Titans	One or more of the authors has declared the following potential conflict of interest or source of funding: G.S.S. receives consulting fees for clinical services from the Nashville Predators and the Tennessee Titans, receives royalties from book sales, and is a member of the Professional Advisory Board of ImPACT, for which he receives expense reimbursement for meeting attendance.	Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Braak H, 2012, ALZHEIMERS DEMENT, V8, P227, DOI 10.1016/j.jalz.2012.01.011; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Irwin Broh Research, 2013, SPORTS PART US, V2013; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Lavretsky H, 2009, AM J GERIAT PSYCHIAT, V17, P493, DOI 10.1097/JGP.0b013e3181953b82; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McKee A, 2012, BRAIN, V135, P1; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Federation of State High School Associations, PART STAT; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rockett IR, 2012, AM J PUBLIC HEALTH, V102, P84; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Small GW, 2012, ARCH NEUROL-CHICAGO, V69, P215, DOI 10.1001/archneurol.2011.559; Weir D. R., 2009, STUDY RETIRED NFL PL	32	16	16	1	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2015	43	5					1260	1264		10.1177/0363546514535187			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	CH4CV	WOS:000353980000036	24907288				2022-02-06	
J	Mrazik, M; Perra, A; Brooks, BL; Naidu, D				Mrazik, Martin; Perra, Andrea; Brooks, Brian L.; Naidu, Dhiren			Exploring Minor Hockey Players' Knowledge and Attitudes Toward Concussion: Implications for Prevention	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attitudes; concussion; knowledge; minor hockey; traumatic brain injury	SPORT-RELATED CONCUSSION; EDUCATIONAL INTERVENTION; HEAD-INJURY; POPULATION; SYMPTOMS; ATHLETE; COACHES	Objective: To evaluate minor hockey players' attitudes and knowledge about sport concussions. Participants: Male and female Pee Wee, Bantam, and Midget level players (n = 183) participating in minor hockey and a comparison group of non-hockey players (n = 57). Design: Survey. Main Measures: Player knowledge and attitudes were evaluated with a standardized questionnaire developed for the purpose of this study. Descriptive statistics including cross-tabulations and proportion comparisons were used to report the data. Results: Players had foundational knowledge about concussions; however, more than half underestimated the prevalence and more than 30% were unaware of return to play protocols. Although nearly all players knew what they "should" do when concussed, 33% did not follow recommendations. Players reported more concern and appreciation of the seriousness of concussion than non-players, but they tended to minimize their vulnerability. The most common and helpful information sources were parents, doctors, and coaches, and therefore knowledge translation efforts should target theses audiences. Conclusion: Young athletes continue to demonstrate gaps in their knowledge of concussions. In addition, attitudes toward concussion suggest a developmental trajectory with younger athletes being most likely to ignore current recommended guidelines.	[Mrazik, Martin; Perra, Andrea] Univ Alberta, Dept Educ Psychol, Edmonton, AB T6G 2G5, Canada; [Brooks, Brian L.] Univ Calgary, Fac Med, Neurosci Brain Injury & Rehabil Programs, Alberta Childrens Hosp,Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Med, Neurosci Brain Injury & Rehabil Programs, Alberta Childrens Hosp,Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB, Canada; [Naidu, Dhiren] Univ Alberta, Dept Phys Med & Rehabil, Sport Med, Edmonton, AB T6G 2M7, Canada		Mrazik, M (corresponding author), Univ Alberta, Dept Educ Psychol, 6-135 Educ North, Edmonton, AB T6G 2G5, Canada.	mrazik@ualberta.ca					Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDCP, HEADS CONC YOUTH SPO; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Echlin P. S., 2010, NEUROSURG FOCUS, V29, P1, DOI DOI 10.3171/2010.9FOCUS10187; ELKIND D, 1985, DEV REV, V5, P218, DOI 10.1016/0273-2297(85)90010-3; Emery CA, 2006, CLIN J SPORT MED, V16, P514, DOI 10.1097/01.jsm.0000251179.90840.58; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Morrongiello BA, 2008, INJURY PREV, V14, P176, DOI 10.1136/ip.2007.016782; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175	25	16	16	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					219	227		10.1097/HTR.0000000000000018			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100134	24590152				2022-02-06	
J	Vasterling, JJ; Proctor, SP; Aslan, M; Ko, J; Jakupcak, M; Harte, CB; Marx, BP; Concato, J				Vasterling, Jennifer J.; Proctor, Susan P.; Aslan, Mihaela; Ko, John; Jakupcak, Matthew; Harte, Christopher B.; Marx, Brian P.; Concato, John			Military, Demographic, and Psychosocial Predictors of Military Retention in Enlisted Army Soldiers 12 Months After Deployment to Iraq	MILITARY MEDICINE			English	Article							NATIONAL-GUARD SOLDIERS; HEALTH-CARE UTILIZATION; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; US MILITARY; PTSD SYMPTOMS; UNIT COHESION; ATTRITION; AFGHANISTAN; VETERANS	Objective: To examine military, demographic, and psychosocial predictors of military retention following operational deployment. Methods: Military status 12 months following return from Iraq deployment was assessed via service records in 740 regular active duty Army Soldiers. Potential predictors of military retention were derived from prospectively administered in-person interviews and questionnaires conducted within 3 months following return from Iraq. Results: At 12 months following return from deployment, 18.1% (n = 134) of the sample had separated from military service. Cox proportional hazards analyses, adjusting for demographic, military, and psychosocial predictors, identified several factors that were independently associated with military attrition: less than (vs. equal to or more than) 6 years military experience (hazards ratio [HR], 3.98; 95% CI, 2.12-7.45); unmarried (vs. married) status (HR, 1.51; 95% CI, 1.06-2.16); and lower (vs. higher) levels of self-reported unit support during deployment (HR, 2.22; 95% CI, 1.42-3.47). Conclusions: Service members early in their career may be especially prone to military attrition. With regard to military retention, our findings suggest that it may be particularly important to develop initiatives that target organizational cohesion and support.	[Vasterling, Jennifer J.; Harte, Christopher B.; Marx, Brian P.] VA Boston Healthcare Syst, Natl Ctr PTSD & Psychol, Boston, MA 02130 USA; [Vasterling, Jennifer J.; Harte, Christopher B.; Marx, Brian P.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Proctor, Susan P.] US Army Res Inst Environm Med, Natick, MA 01760 USA; [Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Aslan, Mihaela; Ko, John; Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; [Aslan, Mihaela] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Jakupcak, Matthew] VA Puget Sound Healthcare Syst, Seattle, WA 98108 USA; [Jakupcak, Matthew] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD & Psychol, 150 South Huntington Ave, Boston, MA 02130 USA.		Marx, Brian/AAK-5072-2020		U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD 17-03-0020]; Department of Veterans Affairs Clinical Sciences Research and DevelopmentUS Department of Veterans Affairs; Clinical Epidemiology Research Center, VA Cooperative Studies Program	We appreciate the support of the Defense Manpower Data Center in obtaining military service status data. We are also grateful to the Soldiers who comprise the Neurocognition Deployment Health Study cohort for volunteering their time to participate in the study and for their military service more generally. Funding for the collection of primary assessment data was provided by the U.S. Army Medical Research and Materiel Command (DAMD 17-03-0020) and the Department of Veterans Affairs Clinical Sciences Research and Development. Data analyses and collection of secondary data from military administrative records were supported by the Clinical Epidemiology Research Center, VA Cooperative Studies Program. The primary funding organizations had no role in the scientific aspects of the study or the preparation of the manuscript. The manuscript underwent scientific and administrative review within the U.S. Army Research Institute for Environmental Medicine.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Booth-Kewley S, 2002, MIL MED, V167, P760, DOI 10.1093/milmed/167.9.760; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Du Preez J, 2012, OCCUP MED-OXFORD, V62, P47, DOI 10.1093/occmed/kqr151; Han SC, 2014, J ANXIETY DISORD, V28, P446, DOI 10.1016/j.janxdis.2014.04.004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hoge CW, 2002, AM J PSYCHIAT, V159, P1576, DOI 10.1176/appi.ajp.159.9.1576; Horton JL, 2013, OCCUP ENVIRON MED, V70, P408, DOI 10.1136/oemed-2012-101073; Institute of Medicine, 2014, PREV PSYCH DIS SERV; Jones N, 2012, PSYCHIATRY, V75, P49, DOI 10.1521/psyc.2012.75.1.49; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lancaster SL, 2013, MIL MED, V178, P267, DOI 10.7205/MILMED-D-12-00147; Merrill LL, 2004, MIL MED, V169, P465, DOI 10.7205/MILMED.169.6.465; Patrick V, 2011, MIL MED, V176, P182, DOI 10.7205/MILMED-D-09-00276; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Reis JP, 2007, MIL MED, V172, P936, DOI 10.7205/MILMED.172.9.936; Rhoades L, 2002, J APPL PSYCHOL, V87, P698, DOI 10.1037//0021-9010.87.4.698; Santor DA, 1997, PSYCHOL ASSESSMENT, V9, P233, DOI 10.1037/1040-3590.9.3.233; Selim AJ, 2011, QUAL LIFE RES, V20, P1337, DOI 10.1007/s11136-011-9866-y; Stewart AL, 1992, MEASURING FUNCTIONIN; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2006, MIL MED, V171, P253, DOI 10.7205/MILMED.171.3.253; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilson ALG, 2009, SOC PSYCH PSYCH EPID, V44, P473, DOI 10.1007/s00127-008-0461-7; Wolfe J, 2005, MIL MED, V170, P1037, DOI 10.7205/MILMED.170.12.1037; Wright PJ, 2012, MIL MED, V177, P773, DOI 10.7205/MILMED-D-11-00403	29	16	16	0	10	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2015	180	5					524	532		10.7205/MILMED-D-14-00468			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ5WF	WOS:000355562600016	25939106				2022-02-06	
J	Cui, X; Baker, JM; Liu, N; Reiss, AL				Cui, Xu; Baker, Joseph M.; Liu, Ning; Reiss, Allan L.			Sensitivity of fNIRS measurement to head motion: An applied use of smartphones in the lab	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Near-infrared spectroscopy; fNIRS; Smartphone; Technology; Neuroimaging; Accelerometer	IPHONE; ACCELEROMETER; ENVIRONMENT; VALIDATION; CONCUSSION; VALIDITY; SYSTEM	Background: Powerful computing capabilities in small, easy to use hand-held devices have made smart technologies such as smartphones and tablets ubiquitous in today's society. The capabilities of these devices provide scientists with many tools that can be used to improve the scientific method. Method: Here, we demonstrate how smartphones may be used to quantify the sensitivity of functional near-infrared spectroscopy (fNIRS) signal to head motion. By attaching a smartphone to participants' heads during the fNIRS scan, we were able to capture data describing the degree of head motion. Results: Our results demonstrate that data recorded from an off-the-shelf smartphone accelerometer may be used to identify correlations between head-movement and fNIRS signal change. Furthermore, our results identify correlations between the magnitudes of head-movement and signal artifact, as well as a relationship between the direction of head movement and the location of the resulting signal noise. Conclusions: These data provide a valuable proof-of-concept for the use of off-the-shelf smart technologies in neuroimaging applications. (C) 2015 Elsevier B.V. All rights reserved.	[Cui, Xu; Baker, Joseph M.; Liu, Ning; Reiss, Allan L.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA; [Reiss, Allan L.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA		Cui, X (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA.	cuixu@stanford.edu			Stanford Institute for Neuro-Innovation and Translational Neurosciences (SINTN) fellowship;  [S10 RR024657]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR024657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019908] Funding Source: NIH RePORTER	We would like to thank Manish Saggar for helpful discussion. Furthermore, we would like to thank Kristen Sheau for her support in collecting accelerometer data. This work is supported by S10 RR024657 (A.L.R., P.I.) and the Stanford Institute for Neuro-Innovation and Translational Neurosciences (SINTN) fellowship (X.C. and A.L.R.). The funders had no role in the study design, data	Aslin RN, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854672; Balg F, 2014, SCOLIOSIS, V11, P12; Curaudeau GA, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11186; Demaerschalk BM, 2012, STROKE, V43, P3098, DOI 10.1161/STROKEAHA.112.669325; Dunton GF, 2011, OBESITY, V19, P1205, DOI 10.1038/oby.2010.302; Ege T, 2013, SKELETAL RADIOL, V42, P269, DOI 10.1007/s00256-012-1455-9; Fakhar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058665; Friston K., 2011, MAGN RESON MED, V35, P346; International Data Corporation (IDC) IDC Media Center, 2013, TABL SHIPM FOR TOP T; Isik AH, 2013, TELEMED E-HEALTH, V19, P24, DOI 10.1089/tmj.2012.0056; Izatt MT, 2012, SCOLIOSIS, V7, P1; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Kwon S, 2011, IEEE ENG MED BIO, P5260, DOI 10.1109/IEMBS.2011.6091301; Lee J, 2001, ROBOTICA, V19, P601, DOI 10.1017/S0263574701003319; Lee MH, 2011, HEALTHC INFORM RES, V17, P76, DOI 10.4258/hir.2011.17.1.76; LeMoyne R, 2010, IEEE ENG MED BIO, P3847, DOI 10.1109/IEMBS.2010.5627699; Maki H, 2011, IEEE ENG MED BIO, P5608, DOI 10.1109/IEMBS.2011.6091357; McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001; Mellone S, 2012, Z GERONTOL GERIATR, V45, P722, DOI 10.1007/s00391-012-0404-5; Mellone S, 2012, GAIT POSTURE, V36, P163, DOI 10.1016/j.gaitpost.2012.02.006; Mitchell JR, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1732; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Ockendon M, 2012, J KNEE SURG, V25, P341, DOI 10.1055/s-0031-1299669; Rogers M.E., 2013, INT J APPL SCI TECHN, V3, P97, DOI DOI 10.13140/2.1.1568.8324; Shaw M, 2012, EUR SPINE J, V21, P1062, DOI 10.1007/s00586-011-2059-0; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Stopczynski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086733; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Wieringen M, 2008, IEEE ENG MED BIO, P2397, DOI 10.1109/IEMBS.2008.4649682; Virtanen J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606576; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111	31	16	16	2	26	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 30	2015	245						37	43		10.1016/j.jneumeth.2015.02.006			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CG8XN	WOS:000353599100004	25687634	Green Accepted			2022-02-06	
J	Connolly, M; Vespa, P; Pouratian, N; Gonzalez, NR; Hu, X				Connolly, Mark; Vespa, Paul; Pouratian, Nader; Gonzalez, Nestor R.; Hu, Xiao			Characterization of the Relationship Between Intracranial Pressure and Electroencephalographic Monitoring in Burst-Suppressed Patients	NEUROCRITICAL CARE			English	Article						Neurovascular coupling; Intracranial pressure; Electroencephalogram; Multi-modality monitoring; Acute brain injury	CEREBRAL-BLOOD-FLOW; CORTICAL SPREADING DEPRESSION; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; DEPOLARIZATION; ISCHEMIA; SEIZURES; CORTEX; FLUCTUATIONS	The objective of this study is to characterize the relationship between ICP and EEG Simultaneous ICP and EEG data were obtained from burst-suppressed patients and segmented by EEG bursts. Segments were categorized as increasing/decreasing and peak/valley to investigate relationship between ICP changes and EEG burst duration. A generalized ICP response was obtained by averaging all segments time-aligned at burst onsets. A vasodilatation index (VDI) was derived from the ICP pulse waveform and calculated on a sliding interval to investigate cerebrovascular changes post-burst. Data from two patients contained 309 bursts. 246 ICP segments initially increased, of which 154 peaked. 63 ICP segments decreased, and zero reached a valley. The change in ICP (0.54 +/- A 0.85 mmHg) was significantly correlated with the burst duration (p < 0.001). Characterization of the ICP segments showed a peak at 8.1 s and a return to baseline at 14.7 s. The VDI for increasing segments was significantly elevated (median 0.56, IQR 0.31, p < 0.001) and correlated with burst duration (p < 0.001). Changes in the ICP and pulse waveform shape after EEG burst suggest that these signals can be related within the context of neurovascular coupling. Existence of a physiological relationship between ICP and EEG may allow the study of neurovascular coupling in acute brain injury patients.	[Connolly, Mark; Vespa, Paul; Pouratian, Nader; Gonzalez, Nestor R.; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hu, Xiao] Univ Calif San Francisco, Dept Physiol Nursing, Inst Computat Hlth Sci, San Francisco, CA 94143 USA; [Hu, Xiao] Univ Calif San Francisco, Dept Neurosurg, Inst Computat Hlth Sci, San Francisco, CA 94143 USA; [Hu, Xiao] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA		Hu, X (corresponding author), Univ Calif San Francisco, Dept Physiol Nursing, Inst Computat Hlth Sci, San Francisco, CA 94143 USA.	XHu@mednet.ucla.edu		Gonzalez, Nestor/0000-0002-8277-6317; Pouratian, Nader/0000-0002-0426-3241	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS076738]; University of California, San Francisco Institute of Computational Health Sciences; National Institute of neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS079477]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K23EB014326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS079477, R01NS076738] Funding Source: NIH RePORTER	XH support from the National Institutes of Health Award Number NS076738 and the University of California, San Francisco Institute of Computational Health Sciences. NRG support from National Institute of neurological Disorders and Stroke of the National Institutes of Health under Award Number K23NS079477.	Asgari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050795; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; Ayata C, 2013, STROKE, V44, pS87, DOI 10.1161/STROKEAHA.112.680264; Baumgartner C, 1998, J NUCL MED, V39, P978; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fuchtemeier M, 2010, NEUROIMAGE, V52, P445, DOI 10.1016/j.neuroimage.2010.04.237; GOLANOV EV, 1994, AM J PHYSIOL, V266, pR204, DOI 10.1152/ajpregu.1994.266.1.R204; HART RG, 1981, NEUROSURGERY, V8, P417, DOI 10.1227/00006123-198104000-00002; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Koide M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/819340; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Roche-Labarbe N, 2007, NEUROIMAGE, V36, P718, DOI 10.1016/j.neuroimage.2007.04.002; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Winer JW, 1991, NEUROSURGERY, V29, P741; Winkler MKL, 2012, EPILEPSIA, V53, P22, DOI 10.1111/j.1528-1167.2012.03699.x; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169	31	16	16	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2015	22	2					212	220		10.1007/s12028-014-0059-8			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CD9VK	WOS:000351447100006	25142827	Green Accepted, Green Submitted			2022-02-06	
J	Kronvall, E; Valdemarsson, S; Saveland, H; Nilsson, OG				Kronvall, Erik; Valdemarsson, Stig; Saveland, Hans; Nilsson, Ola G.			High Prevalence of Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Long-Term Prospective Study Using Dynamic Endocrine Testing	WORLD NEUROSURGERY			English	Article						Growth hormone deficiency; Hypopituitarism; Outcome; Pituitary deficiency; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; HYPOPITUITARISM; DEFICIENCY; NEUROENDOCRINE; DISORDERS; DIAGNOSIS	OBJECTIVE: Impaired systemic hormonal activity caused by hypothalamic and pituitary injury may contribute to neuropsychologic disturbances and poor quality of life after aneurysmal subarachnoid hemorrhage (SAH). This prospective study was designed to longitudinally evaluate long-term clinical outcome and pituitary function after SAH using dynamic tests for adrencorticotropic and somatotropic secretory capacity. METHODS: Endocrine function was assessed by basal hormonal concentrations at 6-12 months and 12-24 months after SAH. At the 12-24 months follow-up, dynamic provocative evaluation of adrenocorticotropic hormone (ACTH) and growth hormone (GH) was performed using the insulin tolerance test (ITT). In patients where ITT was contraindicated, an ACTH stimulation test was used to assess ACTH capacity, and a growth hormone releasing hormone (GHRH)-arginine stimulation test was used to assess GH capacity. RESULTS: Of 60 patients with SAH screened, 51 were included in the study, and 44 remained to be tested at the two follow-up visits. As assessed by basal hormone concentrations alone, the prevalence of pituitary dysfunction was 34% at 6-12 months and 41% at 12-24 months. When using dynamic tests (12-24 months), impaired pituitary function was detected in 43%. The ITT detected more cases of central hypoadrenalism and GH deficiency compared with the ACTH-and GHRH-arginine-stimulation tests, respectively. CONCLUSIONS: Application of dynamic endocrine tests revealed a high frequency of long-term hypothalamic-pituitary dysfunction after aneurysmal SAH. The role of pituitary dysfunction in the recovery after SAH merits further evaluation.	[Kronvall, Erik; Saveland, Hans; Nilsson, Ola G.] Lund Univ, Dept Clin Sci, Neurosurg, Lund, Sweden; [Valdemarsson, Stig] Lund Univ, Dept Clin Sci, Oncol, Lund, Sweden		Kronvall, E (corresponding author), Lund Univ, Dept Clin Sci, Neurosurg, Lund, Sweden.	erik.kronvall@med.lu.se					Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Finucane FM, 2008, CLIN ENDOCRINOL, V69, P603, DOI 10.1111/j.1365-2265.2008.03240.x; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Grossman AB, 2010, J CLIN ENDOCR METAB, V95, P4855, DOI 10.1210/jc.2010-0982; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V1, P480; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Nieuwkamp DJ, 2014, J NEUROL, V261, P309, DOI 10.1007/s00415-013-7192-8; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Scharbrodt W, 2009, J CLIN NEUROSCI, V16, P1409, DOI 10.1016/j.jocn.2009.01.011; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schuiling WJ, 2005, STROKE, V36, P578, DOI 10.1161/01.STR.0000154862.33213.73; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277	27	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					574	582		10.1016/j.wneu.2014.12.007			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500036	25514615				2022-02-06	
J	Lin, C; Zhao, X; Sun, HC				Lin, Chao; Zhao, Xin; Sun, Haichen			Analysis on the risk factors of intracranial infection secondary to traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Traumatic brain injury; Complication; Intracranial infection; Risky factor		Objective: To discuss the characteristics and risk factors for intracranial infection post traumatic brain injury to prevent and better the clinical care. Methods: Retrospective study of 520 patients with traumatic brain injury were included, 308 male and 212 female. The risky factors of intracranial infection were identified. Results: Thirty two cases (6.54%, 32/520) of intracranial infection were diagnosed. Intracranial infection most likely happened 4-10 days after injury. Cerebrospinal fluid leakage, drainage, multiple craniotomies were significant related to intracranial infection. Logistic regression predicted cerebrospinal fluid leakage and drainage as independent factors. Conclusion: Intracranial infection is a serious complication after traumatic brain injury. Patients with drainage or cerebrospinal fluid leakage are more risky for intracranial infection. Aggressive precaution should be taken to better outcome. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.	[Lin, Chao; Zhao, Xin; Sun, Haichen] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Sun, HC (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	sun_haichen@aliyun.com					Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Bellamy JL, 2013, PLAST RECONSTR SURG, V132, P154, DOI 10.1097/PRS.0b013e3182910b9b; Boque M C, 2000, Semin Respir Infect, V15, P280; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; Briggs S, 2004, SCAND J INFECT DIS, V36, P165, DOI 10.1080/00365540410027193; BROWN EM, 1994, LANCET, V344, P1547; GAMBARDELLA G, 1993, CHILD NERV SYST, V9, P470, DOI 10.1007/BF00393552; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; Morton R, 2012, NEUROSURGERY, V71, pE193, DOI 10.1227/NEU.0b013e318232e250; Park M, 2006, ANN ALLERG ASTHMA IM, V97, P681, DOI 10.1016/S1081-1206(10)61100-3; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Pitout JDD, 1997, AM J MED, V103, P51, DOI 10.1016/S0002-9343(97)00044-2; Prasad K, 2012, CURR INFECT DIS REP, V14, P445, DOI 10.1007/s11908-012-0271-7; Shapiro S, 1996, SURG NEUROL, V45, P278, DOI 10.1016/0090-3019(95)00359-2	25	16	25	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	APR	2015	18	2					81	83		10.1016/j.cjtee.2014.10.007			3	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1MH	WOS:000442085200004	26511298	gold			2022-02-06	
J	Newman, AJ; Hayes, SH; Rao, AS; Allman, BL; Manohar, S; Ding, DL; Stolzberg, D; Lobarinas, E; Mollendorf, JC; Salvi, R				Newman, Andrew J.; Hayes, Sarah H.; Rao, Abhiram S.; Allman, Brian L.; Manohar, Senthilvelan; Ding, Dalian; Stolzberg, Daniel; Lobarinas, Edward; Mollendorf, Joseph C.; Salvi, Richard			Low-cost blast wave generator for studies of hearing loss and brain injury: Blast wave effects in closed spaces	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Blast wave generator; Low cost; Cochlear hair cells; Hippocampal neurogenesis; Traumatic brain injury; Hearing loss	OUTER HAIR CELL; MICROTUBULE-ASSOCIATED PROTEIN; INDUCED NEUROTRAUMA; DOUBLECORTIN; OVERPRESSURE; EXPRESSION; MEMORY; INNER; RATS; NEUROGENESIS	Background: Military personnel and civilians living in areas of armed conflict have increased risk of exposure to blast overpressures that can cause significant hearing loss and/or brain injury. The equipment used to simulate comparable blast overpressures in animal models within laboratory settings is typically very large and prohibitively expensive. New method: To overcome the fiscal and space limitations introduced by previously reported blast wave generators, we developed a compact, low-cost blast wave generator to investigate the effects of blast exposures on the auditory system and brain. Results: The blast wave generator was constructed largely from off the shelf components, and reliably produced blasts with peak sound pressures of up to 198 dB SPL (159.3 kPa) that were qualitatively similar to those produced from muzzle blasts or explosions. Exposure of adult rats to 3 blasts of 188 dB peak SPL (50.4 kPa) resulted in significant loss of cochlear hair cells, reduced outer hair cell function and a decrease in neurogenesis in the hippocampus. Comparison to existing methods: Existing blast wave generators are typically large, expensive, and are not commercially available. The blast wave generator reported here provides a low-cost method of generating blast waves in a typical laboratory setting. Conclusions: This compact blast wave generator provides scientists with a low cost device for investigating the biological mechanisms involved in blast wave injury to the rodent cochlea and brain that may model many of the damaging effects sustained by military personnel and civilians exposed to intense blasts. (C) 2015 Elsevier B.V. All rights reserved.	[Newman, Andrew J.; Rao, Abhiram S.; Mollendorf, Joseph C.] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14214 USA; [Hayes, Sarah H.; Allman, Brian L.; Manohar, Senthilvelan; Ding, Dalian; Stolzberg, Daniel; Lobarinas, Edward; Salvi, Richard] SUNY Buffalo, Ctr Hearing & Deafness, Dept Communicat Disorders & Sci, Buffalo, NY 14214 USA		Hayes, SH (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, 137 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	ajnewman@ara.com; shhayes@buffalo.edu; abhirams@buffalo.edu; brian.allman@schulich.uwo.ca; smanohar@buffalo.edu; dding@buffalo.edu; dstolzbe@uwo.ca; elobarinas@ufl.edu; molendrf@buffalo.edu; salvi@buffalo.edu	Stolzberg, Daniel/H-8930-2019; mollendorf, joseph/AAR-7207-2020	Stolzberg, Daniel/0000-0001-6100-9891; 	NIH National Institute on Deafness and Other Communicative DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011808]; Office of Naval ResearchOffice of Naval Research [N000141210731]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC011808] Funding Source: NIH RePORTER	Research supported in part by part by NIH National Institute on Deafness and Other Communicative Disorders (R01DC011808, RS) and the Office of Naval Research (N000141210731, RS).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Birch RS, 2003, APPL ACOUST, V64, P269, DOI 10.1016/S0003-682X(02)00088-9; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen GD, 2010, HEARING RES, V265, P63, DOI 10.1016/j.heares.2010.02.010; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; FREIWALD DA, 1972, J APPL PHYS, V43, P2224, DOI 10.1063/1.1661479; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Gould E, 1993, Curr Opin Neurobiol, V3, P676, DOI 10.1016/0959-4388(93)90138-O; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; HAMERNIK RP, 1984, HEARING RES, V16, P143, DOI 10.1016/0378-5955(84)90004-2; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hoffer ME, 2011, NEUROREHABILITATION, V29, P125, DOI 10.3233/NRE-2011-0686; Hofstetter P, 1997, AUDIOLOGY, V36, P301; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Li YQ, 2011, NEUROTOX RES, V20, P307, DOI 10.1007/s12640-011-9244-0; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; MILLS DM, 1994, HEARING RES, V77, P183, DOI 10.1016/0378-5955(94)90266-6; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Newman AJ, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4002183; Newman AJ., 2010, PEAK OVERPRESSURE FI; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Reyes S, 2001, HEARING RES, V158, P139, DOI 10.1016/S0378-5955(01)00309-4; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Roberto M, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P23; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Van der Gucht E, 2006, ANAT REC PART A, V288A, P753, DOI 10.1002/ar.a.20350; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; WHITE C S, 1959, ORNL, VTID-5764, P1; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	68	16	18	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 15	2015	242						82	92		10.1016/j.jneumeth.2015.01.009			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CD2PQ	WOS:000350921900009	25597910	Green Accepted			2022-02-06	
J	Brown, J; Thiessen, A; Beukelman, D; Hux, K				Brown, Jessica; Thiessen, Amber; Beukelman, David; Hux, Karen			Noun Representation in AAC Grid Displays: Visual Attention Patterns of People with Traumatic Brain Injury	AUGMENTATIVE AND ALTERNATIVE COMMUNICATION			English	Article						Augmentative and alternative communication; Traumatic brain injury; Message representation; Grid-based displays; Eye tracking; Visual search	EYE TRACKING RESEARCH; POTENTIAL CONTRIBUTIONS; SCENE DISPLAYS; GUIDED SEARCH; INFORMATION; CATEGORIZATION; INTERVENTION; PERFORMANCE; MOVEMENTS; SURVIVORS	Clinicians supporting the communication of people with traumatic brain injury (TBI) must determine an efficient message representation method for augmentative and alternative communication (AAC) systems. Due to the frequency with which visual deficits occur following brain injury, some adults with TBI may have difficulty locating items on AAC displays. The purpose of this study was to identify aspects of graphic supports that increase efficiency of target-specific visual searches. Nine adults with severe TBI and nine individuals without neurological conditions located targets on static grids displaying one of three message representation methods. Data collected through eye tracking technology revealed significantly more efficient target location for icon-only grids than for text-only or icon-plus-text grids for both participant groups; no significant differences emerged between participant groups.	[Brown, Jessica; Beukelman, David; Hux, Karen] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA; [Thiessen, Amber] Univ Houston, Dept Special Educ & Commun Disorders, Houston, TX USA		Brown, J (corresponding author), Univ Nebraska, Barkley Mem Ctr 350, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA.	jessica.anne.brown@gmail.com	Hux, Karen/AAQ-2078-2020		Rehabilitation Engineering Research Center on Communication Enhancement (AAC-RERC) from the NIDRR in the U.S. Department of Education's OSERS [H133E080011]; Tobii Technologies	This project was supported in part by the Rehabilitation Engineering Research Center on Communication Enhancement (AAC-RERC) under grant H133E080011 from the National Institute on Disability and Rehabilitation Research (NIDRR) in the U.S. Department of Education's Office of Special Education and Rehabilitative Services (OSERS) and in part by Tobii Technologies.	ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Beck A. R., 1998, AUGMENTATIVE ALTERNA, V14, P184; Beharelle A. R., 2011, FRONT HUM NEUROSCI, V5, P1; Berryman A, 2010, NEUROREHABILITATION, V27, P261, DOI 10.3233/NRE-2010-0607; Beukelman DR, 2007, AUGMENT ALTERN COMM, V23, P230, DOI 10.1080/07434610701553668; Beukelman DR., 2013, AUGMENTATIVE ALTERNA, V4th ed; Blair MR, 2009, J EXP PSYCHOL LEARN, V35, P1196, DOI 10.1037/a0016272; Brown JA, 2015, DISABIL REHABIL-ASSI, V10, P378, DOI 10.3109/17483107.2014.921250; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cilo M, 2010, NEUROREHABILITATION, V27, P237, DOI 10.3233/NRE-2010-0603; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Dietz A., 2006, PERSPECTIVES AUGMENT, V15, P13, DOI 10.1044/aac15.1.13; Drager KDR, 2003, J SPEECH LANG HEAR R, V46, P298, DOI 10.1044/1092-4388(2003/024); Fabre-Thorpe M, 2001, J COGNITIVE NEUROSCI, V13, P171, DOI 10.1162/089892901564234; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Fried-Oken M., 1992, J HEAD TRAUMA REHAB, V9, DOI [DOI 10.1097/00001199-199209000-00008, 10.1097/00001199-199209000-00008]; Gastwirth JL, 2009, STAT SCI, V24, P343, DOI 10.1214/09-STS301; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hays WL, 1981, STATISTICS; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Higginbotham DJ, 2007, AUGMENT ALTERN COMM, V23, P243, DOI 10.1080/07434610701571058; Holmqvist K., 2011, EYE TRACKING COMPREH; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; Hulse P, 2010, NEUROREHABILITATION, V27, P269, DOI 10.3233/NRE-2010-0608; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; JAGAROO V, 2002, SMART ENG SYSTEM DES, V12, P81; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kertesz A., 2006, W APHASIA BATTERY RE; Kozleski E., 1991, EXCEPTIONALITY, V2, P173, DOI DOI 10.1080/09362839109524782; Light J, 2014, AUGMENT ALTERN COMM, V30, P99, DOI 10.3109/07434618.2014.906498; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAuliffe MJ, 2010, BRAIN INJURY, V24, P1408, DOI 10.3109/02699052.2010.511590; McKelvey ML, 2010, AM J SPEECH-LANG PAT, V19, P22, DOI 10.1044/1058-0360(2009/08-0021); Politzer T, 2010, NEUROREHABILITATION, V27, P247, DOI 10.3233/NRE-2010-0605; Poole A., 2006, ENCY HUMAN COMPUTER, V1, P211; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Ripley DL, 2010, NEUROREHABILITATION, V27, P231, DOI 10.3233/NRE-2010-0602; Ripley DL, 2010, NEUROREHABILITATION, V27, P215, DOI 10.3233/NRE-2010-0599; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schlosser R. W., 2002, AUGMENT ALTERN COMM, V18, P102, DOI [DOI 10.1080/07434610212331281201, 10.1080/07434610212331281201]; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; Simone R., 1995, ICONICITY LANGUAGE; Snyder C, 2000, J MED SPEECH-LANG PA, V8, P187; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Thiessen A, 2014, AUGMENT ALTERN COMM, V30, P120, DOI 10.3109/07434618.2014.905798; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wallace SE, 2010, PERSPECT AUGMENT ALT, V19, P79; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Wilkinson K.M., 2004, AUGMENT ALTERN COMM, V20, P123, DOI 10.1080/07434610410001699717; Wilkinson KM, 2014, AUGMENT ALTERN COMM, V30, P106, DOI 10.3109/07434618.2014.904435; Wilkinson KM, 2012, AUGMENT ALTERN COMM, V28, P137, DOI 10.3109/07434618.2012.704522; Wilkinson KM, 2011, J SPEECH LANG HEAR R, V54, P1644, DOI 10.1044/1092-4388(2011/10-0098); WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411	59	16	16	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0743-4618	1477-3848		AUGMENT ALTERN COMM	Augment. Altern. Commun.	MAR	2015	31	1					15	26		10.3109/07434618.2014.995224			12	Audiology & Speech-Language Pathology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Rehabilitation	CB7WH	WOS:000349838800002	25685881				2022-02-06	
J	Chen, LM; Liu, YH; Dong, LL; Chu, XX				Chen, Liming; Liu, Yinghui; Dong, Liangliang; Chu, Xiaoxia			Edaravone protects human peripheral blood lymphocytes from gamma-irradiation-induced apoptosis and DNA damage	CELL STRESS & CHAPERONES			English	Article						Immune depletion; Edaravone; gamma-irradiation; Apoptosis; Lymphocytes	FREE-RADICAL SCAVENGER; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; IONIZING-RADIATION; IN-VITRO; MELATONIN; PEROXIDATION; ANTIOXIDANT; PRODUCTS	Radiation-induced cellular injury is attributed primarily to the harmful effects of free radicals, which play a key role in irradiation-induced apoptosis. In this study, we investigated the radioprotective efficacy of edaravone, a licensed clinical drug and a powerful free radical scavenger that has been tested against gamma-irradiation-induced cellular damage in cultured human peripheral blood lymphocytes in studies of various diseases. Edaravone was pre-incubated with lymphocytes for 2 h prior to gamma-irradiation. It was found that pretreatment with edaravone increased cell viability and inhibited generation of gamma-radiation-induced reactive oxygen species (ROS) in lymphocytes exposed to 3 Gy gamma-radiation. In addition, gamma-radiation decreased antioxidant enzymatic activity, such as superoxide dismutase and glutathione peroxidase, as well as the level of reduced glutathione. Conversely, treatment with 100 mu M edaravone prior to irradiation improved antioxidant enzyme activity and increased reduced glutathione levels in irradiated lymphocytes. Importantly, we also report that edaravone reduced gamma-irradiation-induced apoptosis through downregulation of Bax, upregulation of Bcl-2, and consequent reduction of the Bax:Bcl-2 ratio. The current study shows edaravone to be an effective radioprotector against gamma-irradiation-induced cellular damage in lymphocytes in vitro. Finally, edaravone pretreatment significantly reduced DNA damage in gamma-irradiated lymphocytes, as measured by comet assay (% tail DNA, tail length, tail moment, and olive tail moment) (p < 0.05). Thus, the current study indicates that edaravone offers protection from radiation-induced cytogenetic alterations.	[Chen, Liming; Liu, Yinghui; Chu, Xiaoxia] Yantai Yuhuangding Hosp, Dept Hematol, Yantai 264000, Shandong, Peoples R China; [Dong, Liangliang] Yantai Yuhuangding Hosp, Dept Oncol, Yantai 264000, Shandong, Peoples R China		Chu, XX (corresponding author), Yantai Yuhuangding Hosp, Dept Hematol, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China.	xiaoxia055@yeah.net					Ando K, 2014, INT J RADIAT BIOL, V13, P1; Borek C, 2004, J NUTR, V134, p3207S, DOI 10.1093/jn/134.11.3207S; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GARRISON JC, 1988, RADIAT RES, V116, P356, DOI 10.2307/3577472; Ghosh D, 2012, J ENVIRON PATHOL TOX, V31, P155, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i2.70; Higashi Yukihito, 2006, Recent Pat Cardiovasc Drug Discov, V1, P85; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Karbownik M, 2000, P SOC EXP BIOL MED, V225, P9, DOI 10.1046/j.1525-1373.2000.22502.x; Khan A, 2013, INT J RADIAT BIOL, V89, P965, DOI 10.3109/09553002.2013.811310; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Li GY, 2013, RHEUMATOLOGY, V52, P438, DOI 10.1093/rheumatology/kes313; Lovell DP, 2008, MUTAGENESIS, V23, P171, DOI 10.1093/mutage/gen015; Lu GY, 2007, EUR POLYM J, V43, P3807, DOI 10.1016/j.eurpolymj.2007.06.016; Maurya Dharmendra K., 2006, Indian Journal of Experimental Biology, V44, P93; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; NATARAJAN AT, 1980, MUTAT RES, V69, P293, DOI 10.1016/0027-5107(80)90094-9; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Rezaee M, 2013, RADIAT RES, V179, P323, DOI 10.1667/RR3185.1; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Roh MI, 2011, INVEST OPHTH VIS SCI, V52, P3825, DOI 10.1167/iovs.10-6797; Satoh M, 2003, J PHARMACOL EXP THER, V305, P1183, DOI 10.1124/jpet.102.047522; Sharma S, 2006, INT J RADIAT BIOL, V82, P411, DOI 10.1080/09553000600774105; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Sheng BY, 2009, FREE RADICAL BIO MED, V46, P1362, DOI 10.1016/j.freeradbiomed.2009.02.018; Shimizu S, 2009, BJU INT, V104, P713, DOI 10.1111/j.1464-410X.2009.08471.x; Shirazi A, 2007, J RADIAT RES, V48, P263, DOI 10.1269/jrr.06070; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Spitz DR, 2011, OXIDATIVE STRESS CAN; Sueishi K, 2002, EUR J PHARMACOL, V451, P203, DOI 10.1016/S0014-2999(02)02251-3; Takizawa Y, 2009, PEDIATR RES, V65, P636, DOI 10.1203/PDR.0b013e3181a16a9f; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Yan YF, 2012, NEUROSCI LETT, V531, P160, DOI 10.1016/j.neulet.2012.10.043; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhang N, 2005, STROKE, V36, P2220, DOI 10.1161/01.STR.0000182241.07096.06	37	16	19	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1355-8145	1466-1268		CELL STRESS CHAPERON	Cell Stress Chaperones	MAR	2015	20	2					289	295		10.1007/s12192-014-0542-3			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CB8US	WOS:000349907600010	25181965	Green Published			2022-02-06	
J	Hou, PF; Liu, ZH; Li, N; Cheng, WJ; Guo, SW				Hou, Peng-Fei; Liu, Zhan-Hui; Li, Nan; Cheng, Wen-Jia; Guo, Shi-Wen			Knockdown of STIM1 Improves Neuronal Survival After Traumatic Neuronal Injury Through Regulating mGluR1-Dependent Ca2+ Signaling in Mouse Cortical Neurons	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; STIM1; mGluR1; Endoplasmic reticulum	METABOTROPIC GLUTAMATE RECEPTORS; CELL-DEATH MECHANISMS; DIFFUSE BRAIN-INJURY; IN-VITRO; CALCIUM-CHANNELS; ER STRESS; EXCITOTOXICITY; ACTIVATION; EXPRESSION; PATHWAY	Activation of glutamate receptors and followed increase of intracellular calcium concentration is a key pathological mechanism involved in secondary neuronal injury after traumatic brain injury (TBI). Stromal interaction molecule (STIM) proteins are considered to be important players in regulating neuronal Ca2+ homeostasis under normal aging and pathological conditions. Here, we investigated the role of STIM1 in regulating metabotropic glutamate receptor 1 (mGluR1)-related Ca2+ signaling and neuronal survival by using an in vitro traumatic neuronal injury (TNI) model. The expression of STIM1 was significantly increased at both mRNA and protein levels after TNI. Down-regulation of STIM1 by specific small interfere RNA significantly preserved neuronal viability, decreased lactate dehydrogenase release, and inhibited apoptotic cell death after traumatic injury. Moreover, knockdown of STIM1 significantly alleviated the mGluR1-related increase of cytoplasmic Ca2+ levels after TNI. By analyzing Ca2+ imaging in Ca2+-free conditions, we demonstrated that the mGluR1-dependent inositol trisphosphate receptor and/or ryanodine receptor-mediated Ca2+ release from the endoplasmic reticulum after TNI is strongly attenuated in the absence of STIM1. Together, our results demonstrate that in the mammalian nervous system, STIM1 is a key regulator of mGluR1-dependent Ca2+ signaling and knockdown of STIM1 might be an effective intervention target in TBI.	[Hou, Peng-Fei; Li, Nan; Guo, Shi-Wen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China; [Hou, Peng-Fei; Liu, Zhan-Hui] Ninth Hosp Xian, Dept Neurosurg, Xian 710054, Shaanxi, Peoples R China; [Li, Nan] Xian Chidrens Hosp, Dept Neurosurg, Xian 710043, Shaanxi, Peoples R China; [Cheng, Wen-Jia] Ninth Hosp Xian, Dept Pathol, Xian 710054, Shaanxi, Peoples R China		Guo, SW (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	guoshiwen_xjtu@163.com					Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Belousov AB, 2012, BRAIN RES, V1487, P123, DOI 10.1016/j.brainres.2012.05.063; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055601; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cucchiaroni ML, 2010, J NEUROSCI, V30, P5176, DOI 10.1523/JNEUROSCI.5351-09.2010; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Fei Z, 2005, NEUROSCI LETT, V380, P280, DOI 10.1016/j.neulet.2005.01.063; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Goudet C, 2009, BRAIN RES REV, V60, P43, DOI 10.1016/j.brainresrev.2008.12.007; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Harraz OF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00043; Hartmann J, 2014, NEURON, V82, P635, DOI 10.1016/j.neuron.2014.03.027; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Huang WD, 2005, NEUROSCI LETT, V389, P46, DOI 10.1016/j.neulet.2005.07.014; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Li B, 2014, FREE RADICAL RES, V48, P758, DOI 10.3109/10715762.2014.905687; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Ng AN, 2011, J NEUROSCI RES, V89, P1235, DOI 10.1002/jnr.22648; O'Shea RD, 2002, CLIN EXP PHARMACOL P, V29, P1018, DOI 10.1046/j.1440-1681.2002.03770.x; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004	44	16	16	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAR	2015	35	2					283	292		10.1007/s10571-014-0123-0			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CC3HG	WOS:000350236800014	25304289				2022-02-06	
J	Salunke, P; Garg, R; Kapoor, A; Chhabra, R; Mukherjee, KK				Salunke, Pravin; Garg, Ravi; Kapoor, Ankur; Chhabra, Rajesh; Mukherjee, Kanchan K.			Symptomatic contralateral subdural hygromas after decompressive craniectomy: plausible causes and management protocols	JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; contralateral subdural collections; cranioplasty; trauma	TRAUMATIC BRAIN-INJURY; EFFUSION SECONDARY; COMPLICATIONS	OBJECT Contra lateral subdural hygromas are occasionally observed after decompressive craniectomies (DCs). Some of these hygromas are symptomatic, and the etiology and management of these symptomatic contralateral subdural collections (CLDCs) present surgical challenges. The authors share their experience with managing symptomatic CLSDCs after a DC. METHODS During a 10-month period, 306 patients underwent a DC. Of these patients, 266 had a head injury, 25 a middle cerebral artery infarction (that is, a thrombotic stroke), and 15 an infarction due to a vasospasm (resulting from an aneurysmal subarachnoid hemorrhage [SAH]). Seventeen patients (15 with a head injury and 2 with an SAH) developed a CLSDC, and 7 of these patients showed overt symptoms of the fluid collection. These patients were treated with a trial intervention consisting of bur hole drainage followed by cranioplasty. If required, a ventriculo- or thecoperitoneal shunt was inserted at a later time. RESULTS Seven patients developed a symptomatic CLSDC after a DC, 6 of whom-had a head injury and 1 had an SAH. The average length of time between the DC and CLSDC formation was 24 days. Fluid drainage via a bur hole was attempted in the first 5 patients. However, symptoms in these patients improved only temporarily. All 7 patients (including the 5 in whom the bur hole drainage had failed and 2 directly after the DC) underwent a cranioplasty, and the CLSDC resolved in all of these patients. The average time it took for the CLSDC to resolve after the cranioplasty was 34 days. Three patients developed hydrocephalus after the cranioplasty, requiring a diversion procedure, and 1 patient contracted meningitis and died. CONCLUSIONS Arachnoid tears and blockage of arachnoid villi appear to be the underlying causes of a CLSDC. The absence of sufficient fluid pressure required for CSF absorption after a DC further aggravates such fluid collections. Un-derlying hydrocephalus may appear as subdural collections in some patients after the DC. Bur hole drainage appears to be only a temporary measure and leads to recurrence of a CLSDC. Therefore, cranioplasty is the definitive treatment for such collections and, if performed early, may even avert CLSDC formation. A temporary ventriculostomy or an external lumbar drainage may be added to aid the cranioplasty and may be removed postoperatively. Ventriculoperitoneal or thecoperitoneal shunting may be required for patients in whom a hydrocephalus manifests after cranioplasty and underlies the CLSDC.	[Salunke, Pravin; Garg, Ravi; Kapoor, Ankur; Chhabra, Rajesh; Mukherjee, Kanchan K.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India		Salunke, P (corresponding author), PGIMER, Dept Neurosurg, Sect 12, Chandigarh 160012, India.	drpravin_salunke@yahoo.co.uk					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Kilincer C, 2010, MED PRIN PRACT, V19, P499, DOI 10.1159/000320313; Paredes Igor, 2011, Surg Neurol Int, V2, P88, DOI 10.4103/2152-7806.82370; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Salunke P, 2012, NEUROL INDIA, V60, P254, DOI 10.4103/0028-3886.96433; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su FW, 2008, J CLIN NEUROSCI, V15, P305, DOI 10.1016/j.jocn.2006.08.019; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Wang HK, 2012, INJURY, V43, P594, DOI 10.1016/j.injury.2010.06.004; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	16	16	22	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2015	122	3					602	609		10.3171/2014.10.JNS14780			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CC3RJ	WOS:000350266600016	25495740				2022-02-06	
J	Williams, G; Lai, D; Schache, A; Morris, ME				Williams, Gavin; Lai, Daniel; Schache, Anthony; Morris, Meg E.			Classification of Gait Disorders Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain trauma; classification; gait disorders; rehabilitation	SPASTIC HEMIPLEGIA; CHILDREN; PATTERNS; IMPAIRMENT; MANAGEMENT; ASYMMETRY; OUTCOMES; PROFILE	Objective: To determine the extent to which gait disorders associated with traumatic brain injury (TBI) are able to be classified into clinically relevant and distinct subgroups. Design: Cross-sectional cohort study comprising people with TBI receiving physiotherapy for mobility limitations. Participants: One hundred two people with TBI. Outcome Measures: The taxonomic framework for gait disorders following TBI was devised on the basis of a framework previously developed for people with cerebral palsy. Participants with TBI who were receiving therapy for mobility problems were assessed using 3-dimensional gait analysis. Pelvis and bilateral lower limb kinematic data were recorded using a VICON motion analysis system while each participant walked at a self-selected speed. Five trials of data were collected for each participant. Multiclass support vector machine models were developed to systematically and automatically ascertain the clinical classification. Results: The statistical features derived from the major joint angles from unaffected limbs contributed to the best classification accuracy of 82.35% (84 of the 102 subjects). Features from the affected limb resulted in a classification accuracy of 76.47% (78 of 102 subjects). Conclusions: Despite considerable variability in gait disorders following TBI, we were able to generate a clinical classification system on the basis of 6 distinct subgroups of gait deviations. Statistical features related to the motion of the pelvis, hip, knee, and ankle on the less affected leg were able to accurately classify 82% of people with TBI-related gait disorders using a multiclass support vector machine framework.	[Williams, Gavin] Epworth Healthcare, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Melbourne, Vic, Australia; [Lai, Daniel] Victoria Univ, Melbourne, Vic 8001, Australia; [Schache, Anthony] Univ Melbourne, Sch Mech Engn, Melbourne, Vic 3010, Australia; [Morris, Meg E.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Lai, Daniel/0000-0003-3459-7709; Williams, Gavin/0000-0003-2758-7473; Morris, Meg/0000-0002-0114-4175			Balasubramanian CK, 2007, ARCH PHYS MED REHAB, V88, P43, DOI 10.1016/j.apmr.2006.10.004; Begg RK, 2005, IEEE T BIO-MED ENG, V52, P828, DOI 10.1109/TBME.2005.845241; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Davids JR, 1999, J PEDIATR ORTHOPED, V19, P211, DOI 10.1097/00004694-199903000-00015; Deuschl G, 2000, BRAIN, V123, P1568, DOI 10.1093/brain/123.8.1568; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Gradenigo B, 2002, EURA MEDICOPHYS, V38, P215; Graham HK, 2004, J PEDIATR ORTHOPED, V24, P514, DOI 10.1097/01241398-200409000-00011; Hallett M, 2001, ADV NEUROL, V87, P155; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Herbrich R., 2002, LEARNING KERNEL CLAS; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hudson CC, 2000, EXP BRAIN RES, V132, P103, DOI 10.1007/s002219900291; Kaczmarczyk K, 2009, GAIT POSTURE, V30, P207, DOI 10.1016/j.gaitpost.2009.04.010; KNUTSSON E, 1979, BRAIN, V102, P405, DOI 10.1093/brain/102.2.405; Lai DTH, 2009, IEEE T INF TECHNOL B, V13, P687, DOI 10.1109/TITB.2009.2022913; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; Oken O, 2008, EUR J PHYS REHAB MED, V44, P127; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Olver J, 2013, REHABILITATION IN MOVEMENT DISORDERS, P131; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Patikas D, 2005, EUR J NEUROL, V12, P691, DOI 10.1111/j.1468-1331.2005.01047.x; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; Shilton A, 2012, IEEE IJCNN; Steinwart I., 2008, SUPPORT VECTOR MACHI; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; SUTHERLAND DH, 1993, CLIN ORTHOP RELAT R, P139; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Vapnik V., 2000, NATURE STAT LEARNING; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437; Wong AM, 2004, ARCH PHYS MED REHAB, V85, P1625, DOI 10.1016/j.apmr.2003.11.039	48	16	17	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E13	E23		10.1097/HTR.0000000000000038			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300002	24695264				2022-02-06	
J	Nguyen, CT; Green, D; Barr, WB				Nguyen, Constance T.; Green, Debbie; Barr, William B.			Evaluation of the MMPI-2-RF for Detecting Over-reported Symptoms in a Civil Forensic and Disability Setting	CLINICAL NEUROPSYCHOLOGIST			English	Article						Feigning; Forensic; Civil; Validity scales.; MMPI-2-RF	ADULT INTELLIGENCE SCALE; CARD SORTING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; RESTRUCTURED FORM MMPI-2-RF; TRAUMATIC BRAIN-INJURY; VALIDITY TEST FAILURE; HEAD-INJURY; DIGIT SPAN; RESPONSE BIAS; INCOMPLETE EFFORT	Objective: This study investigated the classification accuracy of the Minnesota Multiphasic Personality Inventory-2-Restructured Form validity scales in a sample of disability claimants and civil forensic litigants. Method: A criterion-groups design was used, classifying examinees as "Failed Slick Criteria" through low performance on at least two performance validity indices (stand-alone or embedded) and "Passed Slick Criteria." The stand-alone measures included the Test of Memory Malingering and the Dot Counting Test. The embedded indices were extracted from the Wechsler Adult Intelligence Scales Digit Span and Vocabulary subtests, the California Verbal Learning Test-II, and the Wisconsin Card Sorting Test. Results: Among groups classified by primary complaints at the time of evaluation, those alleging neurological conditions were more frequently classified as Failed Slick Criteria than those alleging psychiatric or medical conditions. Among those with neurological or psychiatric complaints, the F-r, FBS-r, and RBS scales differentiated between those who Passed Slick Criteria from those who Failed Slick Criteria. The Fs scale was also significantly higher in the Failed Slick Criteria compared to Passed Slick Criteria examinees within the psychiatric complaints group. Conclusions: Results indicated that interpretation of scale scores should take into account the examinees' presenting illness. While this study has limitations, it highlights the possibility of different cutoffs depending on the presenting complaints and the need for further studies to cross-validate the results.	[Nguyen, Constance T.; Green, Debbie] Fairleigh Dickinson Univ, Sch Psychol, Teaneck, NJ 07666 USA; [Barr, William B.] NYU, Dept Neurol, Comprehens Epilepsy Ctr, Sch Med, New York, NY 10016 USA		Nguyen, CT (corresponding author), Fairleigh Dickinson Univ, Sch Psychol, T-WH1-01,Metropolitan Campus,1000 River Rd, Teaneck, NJ 07666 USA.	cnguyen@student.fdu.edu		Barr, William/0000-0001-7711-7758; Nguyen, Constance/0000-0002-0973-0750			Allen L., 1997, CARB 97 MANUAL COMPU; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BINDER LM, 1993, PORTLAND DIGIT RECOG; Bolinger E, 2014, ARCH CLIN NEUROPSYCH, V29, P7, DOI 10.1093/arclin/act082; Boone K., 2002, DOT COUNTING TEST; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Covic T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-6; Delis D.C., 2000, CALIFORNIA VERBAL LE; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Goodwin BE, 2013, PSYCHOL ASSESSMENT, V25, P671, DOI 10.1037/a0032214; Green P., 2003, GREENS WORD MEMORY T; Green P., 2004, GREEND MED SYMPTOM V; Green P, 1995, MANUAL ORAL WORD MEM; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heaton SK, 1993, WISCONSIN CARD SORTI; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Larrabee G. J., 2014, CLIN NEUROPSYCHOL PO, V3rd; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Locke DEC, 2010, EPILEPSY BEHAV, V17, P252, DOI 10.1016/j.yebeh.2009.12.004; Mason LH, 2013, J PERS ASSESS, V95, P585, DOI 10.1080/00223891.2013.819512; McBride WF, 2013, BEHAV SCI LAW, V31, P779, DOI 10.1002/bsl.2083; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROGERS R, 1992, SIRS STRUCTURED INTE; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tellegen, 2008, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tovilla-Zarate C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036887; Van Der Heijden PT, 2010, J PERS ASSESS, V92, P254, DOI 10.1080/00223891003670208; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	62	16	16	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2015	29	2					255	271		10.1080/13854046.2015.1033020			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CH4YZ	WOS:000354041900005	25905684				2022-02-06	
J	Belanger, HG; Barwick, F; Silva, MA; Kretzmer, T; Kip, KE; Vanderploeg, RD				Belanger, Heather G.; Barwick, Fiona; Silva, Marc A.; Kretzmer, Tracy; Kip, Kevin E.; Vanderploeg, Rodney D.			Web-Based Psychoeducational Intervention for Postconcussion Symptoms: A Randomized Trial	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIOR THERAPY; PSYCHOLOGICAL TREATMENTS; HEAD-INJURY; METAANALYSIS; CONCUSSION; COMPLAINTS; VETERANS; PILOT; DEPRESSION	The objective of this study was to investigate the effectiveness of a web-based educational intervention for reducing postconcussion symptoms. 158 participants with self-reported symptomatic mild traumatic brain injury were randomized to intervention versus control. There was no effect of intervention on symptom severity or attributions. Subgroup analyses suggested benefit of the web-based intervention in those receiving concurrent mental health treatment and in those participants with the greatest time since injury (>1 year after mild traumatic brain injury). Web-based educational intervention was not effective overall in this sample. However, there is some suggestion of promise in those receiving concurrent mental health treatment and with more chronic symptoms. Findings also suggest potential benefit of interventions targeting self-efficacy.	[Belanger, Heather G.; Silva, Marc A.; Kretzmer, Tracy; Vanderploeg, Rodney D.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Barwick, Fiona] VA Greater Los Angeles Healthcare Syst, Dept Mental Behav Hlth, Los Angeles, CA 90073 USA; [Kip, Kevin E.] Univ S Florida, Coll Nursing, Tampa, FL USA		Belanger, HG (corresponding author), James A Haley VA, Dept Mental Hlth & Behav Sci, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.		Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	Department of DefenseUnited States Department of Defense [W81XWH-10-1-0719]; Department of Veterans AffairsUS Department of Veterans Affairs; Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; James A. Haley Veterans' HospitalUS Department of Veterans Affairs; Veterans Health Administration (VHA)US Department of Veterans Affairs	The research reported here was supported by the Department of Defense (W81XWH-10-1-0719), Department of Veterans Affairs, Veterans Health Administration (VHA), and the Defense and Veterans Brain Injury Center (DVBIC). Further support was provided by the James A. Haley Veterans' Hospital.	Ackerman R, 2011, J EXP PSYCHOL-APPL, V17, P18, DOI 10.1037/a0022086; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; Derogatis LR, 2000, BSI 18 ADM SCORING P; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Griffiths KM, 2010, MED J AUSTRALIA, V192, pS4, DOI 10.5694/j.1326-5377.2010.tb03685.x; Hailey D, 2008, CAN J PSYCHIAT, V53, P769, DOI 10.1177/070674370805301109; Huckans M, 2010, J REHABIL RES DEV, V47, P43, DOI 10.1682/JRRD.2009.02.0019; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ern.12.63, 10.1586/ERN.12.63]; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King EG, 2013, REHABIL PSYCHOL, V58, P272, DOI 10.1037/a0033116; Knutson MB, 2013, J PSYCHIATR MENT HLT, V20, P874, DOI 10.1111/jpm.12043; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Krosnich, 1995, ATTITUDE STRENGTH AN, P413; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Noyes JM, 2008, ERGONOMICS, V51, P1352, DOI 10.1080/00140130802170387; Noyes JM, 2003, INT J IND ERGONOM, V31, P411, DOI 10.1016/S0169-8141(03)00027-1; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Stepnowsky C, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/239382; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Turvey CL, 2013, ELSEV INSIGHT, P3, DOI 10.1016/B978-0-12-416048-4.00001-4; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; Wastlund E, 2005, COMPUT HUM BEHAV, V21, P377, DOI 10.1016/j.chb.2004.02.007; Weathers FW, 1991, PCL C FOR DSM IV; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241; [No title captured]	53	16	16	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2015	180	2					192	200		10.7205/MILMED-D-14-00388			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7MR	WOS:000349101900012	25643387	Bronze			2022-02-06	
J	Choe, MC; Giza, CC				Choe, Meeryo C.; Giza, Christopher C.			Diagnosis and Management of Acute Concussion	SEMINARS IN NEUROLOGY			English	Article						mild traumatic brain injury; concussion; diagnosis; return-to-play	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; OPERATION IRAQI FREEDOM; TEST-RETEST RELIABILITY; MAGNETIC-RESONANCE SPECTROSCOPY; COLLEGIATE FOOTBALL PLAYERS; VISUAL SCREENING TOOL; BLUNT HEAD TRAUMA; BASE-LINE; NEUROPSYCHOLOGICAL ASSESSMENT	Mild traumatic brain injury (mTBI), or concussion, constitutes a significant percentage of the millions of TBIs sustained in the United States each year. Symptoms are typically short-lived, and may correlate to physiologic changes in the acute period after injury. There are many available tools that can be utilized on the sideline as well as in the clinical setting for assessment and diagnosis of concussion. It is important to use validated tests in conjunction with a thorough history and physical examination. Neurocognitive testing may be helpful in the subacute period. Management should begin with removal from risk if a concussion is suspected, and once diagnosis is made, education and reassurance should be provided. Once symptoms have resolved, a graded return-to-play protocol can be implemented with close supervision and observation for return of symptoms. Management should be tailored to the individual, and if symptoms are prolonged, further diagnostic evaluation may be necessary.	[Choe, Meeryo C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA		Choe, MC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Mattel Childrens Hosp, 22-474 MDCC,10833 LeConte Ave, Los Angeles, CA 90095 USA.	mchoe@mednet.ucla.edu					Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], NEUROSURGERY; [Anonymous], 2003, J AM COLL SURGEONS; [Anonymous], HEART LUNG; [Anonymous], NEUROSURGERY; [Anonymous], NEUROSURGERY; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Barnes GR, 2008, PROG BRAIN RES, V171, P441, DOI 10.1016/S0079-6123(08)00665-1; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Baugh CM, 2014, AM J SPORTS MED; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brenner DJ, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130629; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Broglio SP, NEUROSURGERY, P1057; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2002, ANN THORAC SURG, V73, P2005, DOI 10.1016/S0003-4975(01)03375-6; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cortesi F, 2012, J SLEEP RES, V21, P700, DOI 10.1111/j.1365-2869.2012.01021.x; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Del Rossi G, 2014, J ATHL TRAINING, V49, P356, DOI 10.4085/1062-6059-49.2.04; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horslen BC, 2011, EXP BRAIN RES, V215, P27, DOI 10.1007/s00221-011-2867-9; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; HOVDA DA, 1990, ACT NEUR S, V51, P331; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Irick E, 2013, 2013 14 NCAA SPORTS; Iverson GL, 2014, BRAIN INJURY, P1; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kerr ME, 1996, HEART LUNG, V25, P200, DOI 10.1016/S0147-9563(96)80030-6; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Klossner D, 2013, 2013 14 NCAA SPORTS, P56; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lewis MS, 2011, NEUROUROL URODYNAM, V30, P183, DOI 10.1002/nau.20963; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lingsma HF, 2014, J NEUROTRAUMA; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M, NEUROSURGERY, P882; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nassiri JD, 2002, MIL MED, V167, P873, DOI 10.1093/milmed/167.10.873; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Office of the US Army Surgeon General, 2009, 09068 OTSG MEDCOM OF; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Patel AV, 2007, J ATHL TRAINING, V42, P66; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Sher L, 2009, EXPERT REV NEUROTHER, V9, P921, DOI [10.1586/ern.09.61, 10.1586/ERN.09.61]; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Simpson TL, 2007, J TRAUMA STRESS, V20, P239, DOI 10.1002/jts.20209; Sosin DM, 1996, PEDIATRICS, V98, P868; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas Emily, 2013, Pediatr Nurs, V39, P299; Thurman DA, 1999, TRAUMATIC BRAIN INJU; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; United States Department of Defense, 2010, DTM09033 US DEP DEF; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wada M, 2001, NEUROSCI LETT, V302, P157, DOI 10.1016/S0304-3940(01)01662-7; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	193	16	16	2	15	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					29	41		10.1055/s-0035-1544243			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300006	25714865	Bronze			2022-02-06	
J	Cull, JD; Sakai, LM; Sabir, I; Johnson, B; Tully, A; Nagy, K; Dennis, A; Starr, FL; Joseph, K; Wiley, D; Moore, HR; Oliphant, UJ; Bokhari, F				Cull, John David; Sakai, Lauren M.; Sabir, Imran; Johnson, Brent; Tully, Andrew; Nagy, Kimberly; Dennis, Andrew; Starr, Frederic L.; Joseph, Kimberly; Wiley, Dorion; Moore, Henry R., III; Oliphant, Uretz J.; Bokhari, Faran			Outcomes in Traumatic Brain Injury for Patients Presenting on Antiplatelet Therapy	AMERICAN SURGEON			English	Article							ELDERLY-PATIENTS; HEAD-INJURY; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; OLDER; ANTICOAGULATION; MANAGEMENT; MORTALITY; AGENTS; IMPACT	An increasing number of patients are presenting to trauma units with head injuries on antiplatelet therapy (APT). The influence of APT on these patients is poorly defined. This study examines the outcomes of patients on APT presenting to the hospital with blunt head trauma (BHT). Registries of two Level I trauma centers were reviewed for patients older than 40 years of age from January 2008 to December 2011 with BHT. Patients on APT were compared with control subjects. Primary outcome measures were in-hospital mortality, intracranial hemorrhage (ICH), and need for neurosurgical intervention (NI). Hospital length of stay (LOS) was a secondary outcome measure. Multivariate analysis was used and adjusted models included antiplatelet status, age, Injury Severity Score (ISS), and Glasgow coma scale (GCS). Patients meeting inclusion criteria and having complete data (n = 1547) were included in the analysis; 422 (27%) patients were taking APT. Rates of ICH, NI, and in-hospital mortality of patients with BHT in our study were 45.4, 3.1, and 5.8 per cent, respectively. Controlling for age, ISS, and GCS, there was no significant difference in ICH (odds ratio [OR], 0.84; 95% confidence interval [CI], 0.61 to 1.16), NI (OR, 1.26; 95% CI, 0.60 to 2.67), or mortality (OR, 1.79; 95% CI, 0.89 to 3.59) associated with APT. Subgroup analysis revealed that patients with ISS 20 or greater on APT had increased in-hospital mortality (OR, 2.34; 95% CI, 1.03 to 5.31). LOS greater than 14 days was more likely in the APT group than those in the non-APT group (OR, 1.85; 95% CI, 1.09 to 3.12). The effects of antiplatelet therapy in patients with BHT aged 40 years and older showed no difference in ICH, NI, and in-hospital mortality.	[Cull, John David; Sabir, Imran; Johnson, Brent; Tully, Andrew; Nagy, Kimberly; Dennis, Andrew; Starr, Frederic L.; Joseph, Kimberly; Wiley, Dorion; Bokhari, Faran] John H Stroger Hosp, Surg, Chicago, IL 60612 USA; [Sakai, Lauren M.; Moore, Henry R., III; Oliphant, Uretz J.] Carle Fdn Hosp, Dept Surg, Urbana, IL USA		Cull, JD (corresponding author), John H Stroger Hosp, Surg, 1969 W Ogden Ave, Chicago, IL 60612 USA.	jcull@cookcountyhhs.org					Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Dauerman HL, 2010, AM HEART J, V159, P508, DOI 10.1016/j.ahj.2010.01.010; Faul M, 2010, TRAUMATIC BRAIN INJU; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; HUYEN T, 2004, JAMA-J AM MED ASSOC, V292, P1867; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	17	16	16	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2015	81	2					128	132					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CI6TK	WOS:000354894700023	25642873				2022-02-06	
J	Rao, VR; Parko, KL				Rao, Vikram R.; Parko, Karen L.			Clinical Approach to Posttraumatic Epilepsy	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; epilepsy; posttraumatic epilepsy; seizure; neuromodulation	TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; VAGUS NERVE-STIMULATION; HEAD-INJURY; CONCUSSIVE CONVULSIONS; AMERICAN-ACADEMY; RISK-FACTORS; 4 SCORE; MILD; ADULTS	Traumatic brain injury (TBI) is one of the most common causes of acquired epilepsy, and posttraumatic epilepsy (PTE) results in significant somatic and psychosocial morbidity. The risk of developing PTE relates directly to TBI severity, but the latency to first seizure can be decades after the inciting trauma. Given this "silent period," much work has focused on identification of molecular and radiographic biomarkers for risk stratification and on development of therapies to prevent epileptogenesis. Clinical management requires vigilant neurologic surveillance and recognition of the heterogeneous endophenotypes associated with PTE. Appropriate treatment of patients who have or are at risk for seizures varies as a function of time after TBI, and the clinician's armamentarium includes an ever-expanding diversity of pharmacological and surgical options. Most recently, neuromodulation with implantable devices has emerged as a promising therapeutic strategy for some patients with refractory PTE. Here, we review the epidemiology, diagnostic considerations, and treatment options for PTE and develop a roadmap for providers encountering this challenging clinical entity.	[Rao, Vikram R.; Parko, Karen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Parko, Karen L.] San Francisco VA Med Ctr, Dept Neurol, San Francisco, CA USA		Rao, VR (corresponding author), Univ Calif San Francisco, Epilepsy Ctr, 400 Parnassus Ave,8th Floor, San Francisco, CA 94143 USA.	vikram.rao@ucsf.edu					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Ben-Menachem E, 2014, NAT REV NEUROL, V10, P247, DOI 10.1038/nrneurol.2014.69; Benbadis SR, 2000, NEUROLOGY, V55, P1780, DOI 10.1212/WNL.55.12.1780; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Brigo F, 2011, CLIN NEUROPHYSIOL, V122, P2116, DOI 10.1016/j.clinph.2011.07.024; Brodie MJ, 2013, EPILEPSIA, V54, P5, DOI 10.1111/epi.12175; Burneo JG, 2013, EPILEPSY CURR, V13, P232, DOI 10.5698/1535-7597-13.5.232; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Camfield P, 2008, EPILEPSIA, V49, P25, DOI 10.1111/j.1528-1167.2008.01923.x; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen LLK, 2014, MIL MED, V179, P492, DOI 10.7205/MILMED-D-13-00413; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cornes Susannah Brock, 2011, Continuum (Minneap Minn), V17, P984, DOI 10.1212/01.CON.0000407056.94789.2d; Davidson J., 2014, NEUROSCIENTIST; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Elliott RE, 2013, J NEUROSURG, V119, P261, DOI 10.3171/2013.4.JNS121829; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; England MJ, 2012, EPILEPSY BEHAV, V25, P266, DOI 10.1016/j.yebeh.2012.06.016; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englot DJ, 2012, NEUROLOGY, V78, P1200, DOI 10.1212/WNL.0b013e318250d7ea; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2014, NAT REV NEUROL, V10, P261, DOI 10.1038/nrneurol.2014.59; Fountain Nathan B, 2010, Continuum (Minneap Minn), V16, P121, DOI 10.1212/01.CON.0000368235.64857.cf; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hamelin S, 2014, NEUROBIOL DIS, V69, P156, DOI 10.1016/j.nbd.2014.05.025; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Heck CN, 2014, EPILEPSIA, V55, P432, DOI 10.1111/epi.12534; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hernandez TD, 1997, NEUROLOGY, V48, P803, DOI 10.1212/WNL.48.4.803; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; Jensen RL, 1997, NEUROSURGERY, V41, P263, DOI 10.1097/00006123-199707000-00045; Kollevold T, 1978, J Oslo City Hosp, V28, P77; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; Langendorf FG, 2008, EPILEPSY COMPREHENSI, P2537; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maganti Rama K, 2013, Continuum (Minneap Minn), V19, P598, DOI 10.1212/01.CON.0000431378.51935.d8; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Medvdovsky M, 2006, EPILEPSY BEHAV, V8, P429, DOI 10.1016/j.yebeh.2005.12.010; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Morris GL, 2013, NEUROLOGY, V81, P1453, DOI 10.1212/WNL.0b013e3182a393d1; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Penfield W., 1961, EPILEPSIA, V2, P109; Perron AD, 2001, ACAD EMERG MED, V8, P296, DOI 10.1111/j.1553-2712.2001.tb01312.x; Pitkanen A, 2014, EPILEPSY BEHAV; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Pugh MJ, 2014, J HEAD TRAUMA REHABI; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sahaya K, 2011, J CLIN NEUROSCI, V18, P1602, DOI 10.1016/j.jocn.2011.05.016; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salinsky M, 2014, J HEAD TRAUMA REHABI; Scheffer IE, 2014, NEUROPEDIATRICS, V45, P70, DOI 10.1055/s-0034-1371508; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shrivastava V, 2013, NEUROL INDIA, V61, P156, DOI 10.4103/0028-3886.111122; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Smith Bret N, 2014, Epilepsy Curr, V14, P38, DOI 10.5698/1535-7597-14.1.38; Snell Frances I, 2010, J Psychosoc Nurs Ment Health Serv, P1, DOI 10.3928/02793695-20100108-02; So NK, 2014, NEUROLOGY, V83, P847, DOI 10.1212/WNL.0000000000000740; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Steinbaugh LA, 2012, EPILEPSY BEHAV, V23, P280, DOI 10.1016/j.yebeh.2011.12.005; Storti SF, 2012, MAGN RESON MATER PHY, V25, P345, DOI 10.1007/s10334-012-0316-9; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Temkin O., 1945, FALLING SICKNESS HIS; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Vale FL, 2011, SEIZURE-EUR J EPILEP, V20, P244, DOI 10.1016/j.seizure.2010.12.003; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Walker WC, 2011, PM&R, V3, P6, DOI 10.1016/j.pmrj.2010.11.001; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zarocostas J, 2007, BRIT MED J, V335, P470, DOI 10.1136/bmj.39328.617269.DB	120	16	16	0	9	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					57	63		10.1055/s-0035-1544239			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300009	25714868	Bronze			2022-02-06	
J	Stubberud, J; Langenbahn, D; Levine, B; Stanghelle, J; Schanke, AK				Stubberud, Jan; Langenbahn, Donna; Levine, Brian; Stanghelle, Johan; Schanke, Anne-Kristine			Emotional Health and Coping in Spina Bifida After Goal Management Training: A Randomized Controlled Trial	REHABILITATION PSYCHOLOGY			English	Article						executive functioning; cognitive rehabilitation; brain injury; goal management; evidence-based	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; EXECUTIVE FUNCTIONS; YOUNG-ADULTS; COGNITIVE REHABILITATION; RHEUMATOID-ARTHRITIS; ATTENTION; CHILDREN; ADOLESCENTS; DYSFUNCTION	Objective: Executive function impairments are common after spina bifida (SB) and potentially have a detrimental effect on the individual's emotional health and coping. Goal management training (GMT) is a cognitive rehabilitation method for improving executive function. The purpose of this study was to determine the efficacy of GMT on aspects of perceived emotional health and coping in individuals with SB. Method: Thirty-eight adult subjects with SB were included in this randomized controlled trial. Inclusion was based upon the presence of executive functioning complaints. Experimental subjects (n = 24) received 21 hr of GMT, with efficacy of GMT being compared with results of subjects in a wait-list condition (n = 14). Four self-report questionnaires assessing emotional health and coping were utilized as outcome measures. All subjects were assessed at baseline, postintervention, and at 6-month follow-up. Results: Findings indicated positive effects of GMT relative to the control group on measures of emotional health. Of note, the GMT group showed significant improvement, compared with control subjects, on a self-report inventory of depressive and anxiety symptoms after training, lasting at least 6 months posttreatment. Furthermore, both groups showed improvements after training on mental health components of health-related quality of life. Finally, the GMT group showed a significant increase in task-focused coping and a decrease in avoidant coping after training compared with pretreatment baseline assessment scores. Conclusions: Overall, findings indicate that by us a compensatory intervention to manage executive dysfunction, effective and lasting benefits can be achieved with regard to aspects of perceived emotional health and coping.	[Stubberud, Jan] Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Aker, Norway; [Langenbahn, Donna] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY 10003 USA; [Levine, Brian] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Stanghelle, Johan; Schanke, Anne-Kristine] Univ Oslo, Sunnaas Rehabil Hosp, N-0316 Oslo, Norway; [Stanghelle, Johan; Schanke, Anne-Kristine] Univ Oslo, Fac Med, N-0316 Oslo, Norway		Stubberud, J (corresponding author), Sunnaas Rehabil Hosp, Bjoemnemyrveien 11, N-1450 Nesoddtangen, Aker, Norway.	jan.stubberud@sunnaas.no	Levine, Brian/O-2725-2019; Stubberud, Jan/ABE-6922-2021; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Stubberud, Jan/0000-0001-9592-8589	South-Eastern Norway Regional Health Authority [2011041]	This work was supported by the South-Eastern Norway Regional Health Authority (Grant Number 2011041). We thank all patients, caregivers, and staff, especially Astri Andersen, Lisbeth Brondberg, Gunnar Riemer, Lena Haugen, Karen Grimsrud, Brede Dammann, Pal-Erik Plaum, Helene Barder, Per Frydenborg, and Solveig Skou, who helped to carry out the study. We also thank Marianne Lovstad and Jan Egil Nordvik for discussions concerning this study.	Abresch RT, 2007, J SPINAL CORD MED, V30, pS112; Ammerman R. T., 2006, NEURAL TUBE DEFECTS, P61; Ammerman RT, 1998, J CLIN PSYCHOL MED S, V5, P449, DOI 10.1023/A:1026211028595; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Appleton PL, 1997, J PEDIATR PSYCHOL, V22, P707, DOI 10.1093/jpepsy/22.5.707; Barf HA, 2010, J REHABIL MED, V42, P56, DOI 10.2340/16501977-0481; Bellin MH, 2010, J PEDIATR PSYCHOL, V35, P778, DOI 10.1093/jpepsy/jsp094; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1996, BEHAV ASSESSMENT DYS, P18; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Compas BE, 2001, J DEV BEHAV PEDIATR, V22, P323, DOI 10.1097/00004703-200110000-00007; Conners CK, 2000, CONNERS CPT 2 CONTIN; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; D'Zurilla TJ, 2001, HANDBOOK OF COGNITIVE-BEHAVIORAL THERAPIES, SECOND EDITION, P211; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Detrait ER, 2005, NEUROTOXICOL TERATOL, V27, P515, DOI 10.1016/j.ntt.2004.12.007; Diller, 2011, HDB HOLISTIC NEUROPS; Donker T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-79; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Finset A, 2000, BRAIN INJURY, V14, P887; Fletcher JM, 2010, DEV DISABIL RES REV, V16, P1, DOI 10.1002/ddrr.101; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P53, DOI 10.1080/87565649609540640; Folkman S., 1984, STRESS; Gioia GA IP, 2000, BEHAV RATING INVENTO; Heffelfinger AK, 2008, J INT NEUROPSYCH SOC, V14, P793, DOI 10.1017/S1355617708081022; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Iddon JL, 2004, J NEUROL NEUROSUR PS, V75, P1112, DOI 10.1136/jnnp.2003.029058; In de Braek D. M., 2012, J ATTENTION DISORDER; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JOSEPH S, 1992, PERS INDIV DIFFER, V13, P1249, DOI 10.1016/0191-8869(92)90262-N; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kalfoss MH, 2006, FLUIDS BARRIERS CNS, V3, pS31, DOI [10.1186/1743-8454-3-S1-S31., DOI 10.1186/1743-8454-3-S1-S31]; Kelly NC, 2012, CHILD NEUROPSYCHOL, V18, P417, DOI 10.1080/09297049.2011.613814; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kvien TK, 1998, J CLIN EPIDEMIOL, V51, P1077, DOI 10.1016/S0895-4356(98)00099-7; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lewis HA, 1996, J PEDIATR PSYCHOL, V21, P25, DOI 10.1093/jpepsy/21.1.25; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Loge JH, 1998, J CLIN EPIDEMIOL, V51, P1069, DOI 10.1016/S0895-4356(98)00098-5; Loge JH, 1998, SCAND J SOC MED, V26, P250; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Mathias JL, 2003, APPL NEUROPSYCHOL, V10, P57, DOI 10.1207/S15324826AN1002_01; Matthews G., 1996, HDB COPING THEORY RE, P573; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Perry GS, 2010, AM J PUBLIC HEALTH, V100, P2337, DOI 10.2105/AJPH.2010.205146; Ponsford J. L., 2013, J CLIN EXPT NEUROPSY; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Posner Michael I., 1995, P615; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Ravndal E, 2010, DRUG ALCOHOL DEPEN, V108, P65, DOI 10.1016/j.drugalcdep.2009.11.008; Robertson I., 1996, GOAL MANAGEMENT TRAI; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Robertson IH, 2013, PRINCIPLES FRONTAL L, P742; Rodin J., 1999, REV GEN PSYCHOL, V3, P317, DOI [10.1037/1089-2680.3.4.317, DOI 10.1037/1089-2680.3.4.317]; Roebroeck ME, 2006, DISABIL REHABIL, V28, P1237, DOI 10.1080/09638280600551716; Rose BM, 2007, J PEDIATR PSYCHOL, V32, P983, DOI 10.1093/jpepsy/jsm042; Rueda M. R., 2004, HDB SELF REGULATION, P401; Ruff H. A., 1996, ATTENTION EARLY DEV; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Shapiro S.L, 2000, HDB SELF REGULATION, P253, DOI 10.1016/B978-012109890-2/50037-8; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stubberud J, 2014, NEUROPSYCHOL REHABIL, V24, P26, DOI 10.1080/09602011.2013.847847; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Tarazi RA, 2008, CLIN NEUROPSYCHOL, V22, P585, DOI 10.1080/13854040701425940; TEASDALE JD, 1995, BEHAV RES THER, V33, P25, DOI 10.1016/0005-7967(94)E0011-7; Tuminello ER, 2012, CHILD NEUROPSYCHOL, V18, P105, DOI 10.1080/09297049.2011.590470; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Verhoef M, 2007, DEV MED CHILD NEUROL, V49, P192, DOI 10.1111/j.1469-8749.2007.00192.x; Ware J., 2000, SCORE VERSION 2 SF 3; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wechsler D., 1999, MANUAL WECHSLER ABBR; Winocur G, 2007, J INT NEUROPSYCH SOC, V13, P153, DOI 10.1017/S135561770707018X; Zukerman JM, 2011, J PEDIATR PSYCHOL, V36, P265, DOI 10.1093/jpepsy/jsq075	99	16	16	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2015	60	1					1	16		10.1037/rep0000018			16	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CC4VV	WOS:000350353600001	25496433				2022-02-06	
J	Ma, BQ; Zhang, M; Ba, L				Ma, Bu-Qing; Zhang, Mao; Ba, Li			Plasma pituitary adenylate cyclase-activating polypeptide concentrations and mortality after acute spontaneous basal ganglia hemorrhage	CLINICA CHIMICA ACTA			English	Article						Pituitary adenylate cyclase activating polypeptide; Intracerebral hemorrhage; Mortality; Severity; Biomarker	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; VASOACTIVE-INTESTINAL-PEPTIDE; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; PACAP; APOPTOSIS; LOCALIZATION; MACROPHAGES; NEURONS; GROWTH	Background: Plasma pituitary adenylate cyclase activating polypeptide (PACAP) concentrations are elevated after traumatic brain injury. We assessed the prognostic value of PACAP for short-term and long-term mortality of acute intracerebral hemorrhage (ICH) patients. Methods: A total of 150 patients and 150 age- and gender- matched healthy controls were recruited. The plasma PACAP concentrations were measured using sandwich immunoassays. ICH severity was assessed using hematoma volume and National Institutes of Health Stroke Scale (NIHSS) score. The end points included 1-week mortality and 6-month mortality. The relationships between plasma PACAP concentrations and ICH severity and the end points were analyzed statistically. Results: Plasma PACAP concentrations were statistically significantly higher in the ICH patients than in the healthy controls and were correlated positively with hematoma volumes and NIHSS scores using a multivariate linear regression. Multivariate analysis results indicated that plasma PACAP concentration was an independent predictor of 1-week mortality, 6-month mortality and 6-month overall survival. It also had high predictive value based on receiver operating characteristic curve. Conclusions: Plasma PACAP concentrations are increased and are highly associated with the severity of ICH; PACAP may be a good predictor of short-term and long-term mortality of ICH. (C) 2014 Elsevier B.V. All rights reserved.	[Ma, Bu-Qing; Zhang, Mao; Ba, Li] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency, Hangzhou 310000, Zhejiang, Peoples R China; [Ma, Bu-Qing] Third Peoples Hosp Hangzhou, Dept Emergency, Hangzhou 310000, Zhejiang, Peoples R China		Ba, L (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Emergency, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China.	hijiang123@163.com					Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; ARIMURA A, 1994, ANN NY ACAD SCI, V739, P228, DOI 10.1111/j.1749-6632.1994.tb19825.x; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brunswick AS, 2012, J NEUROL SCI, V321, P1, DOI 10.1016/j.jns.2012.06.008; Bukovics P, 2014, PEPTIDES, V60, P18, DOI 10.1016/j.peptides.2014.07.001; Cavallaro S, 1996, MOL PHARMACOL, V50, P60; Cheung C. M., 2008, Hong Kong Medical Journal, V14, P367; Delgado M, 1999, J IMMUNOL, V162, P2358; Delgado M, 2002, GLIA, V39, P148, DOI 10.1002/glia.10098; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Du Q, 2014, CLIN CHIM ACTA, V437, P141, DOI 10.1016/j.cca.2014.07.014; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lee EH, 2014, BMB REP, V47, P369, DOI 10.5483/BMBRep.2014.47.7.086; Li N, 2013, STROKE, V44, P658, DOI 10.1161/STROKEAHA.112.673590; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591, DOI 10.1002/jlb.63.5.591; Mester L, 2011, J MOL NEUROSCI, V43, P35, DOI 10.1007/s12031-010-9427-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; Naval NS, 2008, NEUROL CLIN, V26, P373, DOI 10.1016/j.ncl.2008.03.002; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Racz B, 2010, REGUL PEPTIDES, V160, P91, DOI 10.1016/j.regpep.2009.12.003; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Shioda S, 1998, ANN NY ACAD SCI, V865, P111, DOI 10.1111/j.1749-6632.1998.tb11169.x; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Szabadfi K, 2012, NEUROTOX RES, V21, P41, DOI 10.1007/s12640-011-9254-y; Szakaly P, 2010, TRANSPL P, V42, P2283, DOI 10.1016/j.transproceed.2010.05.012; Tanaka J, 1997, REGUL PEPTIDES, V72, P1, DOI 10.1016/S0167-0115(97)01038-0; Tsuchikawa D, 2012, J MOL NEUROSCI, V48, P508, DOI 10.1007/s12031-012-9817-2; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029	37	16	16	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN 15	2015	439						102	106		10.1016/j.cca.2014.10.010			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	AY3RG	WOS:000347499700018	25314937				2022-02-06	
J	McMillan, TM; Laurie, M; Oddy, M; Menzies, M; Stewart, E; Wainman-Lefley, J				McMillan, Thomas M.; Laurie, Marie; Oddy, Michael; Menzies, Mark; Stewart, Elaine; Wainman-Lefley, Jessica			Head Injury and Mortality in the Homeless	JOURNAL OF NEUROTRAUMA			English	Article						mortality; head injuries; lifestyle; craniocerebral trauma; traumatic brain injury; homeless; death; brain injuries	TRAUMATIC BRAIN-INJURY; PREVALENCE; COHORT; ADULTS; HOSTEL; PEOPLE; CITY; MEN	Risk factors for head injury are also risk factors for becoming homeless but there is little research on this vulnerable group, who can be neglected by health services that specialize in acquired brain injury. This study investigates the prevalence of admissions to hospital with a head injury in the homeless and associations with later mortality. It compares homeless people with and without a record of hospitalized head injury (HHI) and the Glasgow population. Data were obtained from a U.K. National Health Service strategy to enhance care of the homeless. This included development and production of local registers of homeless people. In Glasgow, the initiative took place over a seven-year period (2004-2010) and comprised 40 general practitioner (family practice) services in the locality of 55 homeless hostels. The register was linked to hospital admissions with head injury recorded in Scottish Medical Records and to the General Register of Scotland, which records deaths. A total of 1590 homeless people was registered in general practitioner (family doctor) returns. The prevalence of admission to hospital with head injury in the homeless over a 30-year period (13.5%) was 5.4 times higher than in the Glasgow population. In the homeless with HHI, 33.6% died in the seven-year census period, compared with 13.9% in the homeless with no hospitalized HI (NHHI). The standardized mortality ratio for HHI (4.51) was more than twice that for NHHI (2.08). The standardized mortality ratio for HHI aged 15-34 (17.54) was particularly high. These findings suggest that HHI is common in the homeless relative to the general population and is a risk factor for late mortality in the homeless population.	[McMillan, Thomas M.; Stewart, Elaine; Wainman-Lefley, Jessica] Univ Glasgow, Coll Med, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland; [Laurie, Marie] Natl Hlth Serv Greater Glasgow & Clyde, Dept Publ Hlth, Glasgow, Lanark, Scotland; [Menzies, Mark] Natl Hlth Serv Greater Glasgow & Clyde, Dept Informat Serv, Glasgow, Lanark, Scotland; [Oddy, Michael] Disabil Trust Fdn, Burgess Hill, England		McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk			Disabilities Trust; Chief Scientist Office [CZG/2/397] Funding Source: researchfish	This study was part funded by The Disabilities Trust. No competing financial conflicts exist.	American Psychological Association, 2010, HELP PEOPL HOM ROL P; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Faul M., 2010, TRAUMATIC BRAIN US E; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang S. W., 2009, BMJ-BRIT MED J, V339, P1, DOI DOI 10.1136/bmj.b2651; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Masel De Witt D. S., 2010, J NEUROTRAUM, V27, P1529; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan T. M., 2014, J NEUROL NEUROSURG P; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; Nordentoft M., 2003, BMJ-BRIT MED J, V327, P1; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Roworth M. A., 1988, COMMUNITY MED, V4, P327; Scottish Executive, 2006, SCOTT IND MULT DEPR; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; SUSSER E, 1993, EPIDEMIOL REV, V15, P546, DOI 10.1093/oxfordjournals.epirev.a036133; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631	22	16	16	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2015	32	2					116	119		10.1089/neu.2014.3387			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AY6QM	WOS:000347690700006	25010750				2022-02-06	
J	Bellon, K; Kolakowsky-Hayner, S; Wright, J; Huie, H; Toda, K; Bushnik, T; Englander, J				Bellon, Kimberly; Kolakowsky-Hayner, Stephanie; Wright, Jerry; Huie, Henry; Toda, Ketra; Bushnik, Tamara; Englander, Jeffrey			A home-based walking study to ameliorate perceived stress and depressive symptoms in people with a traumatic brain injury	BRAIN INJURY			English	Article						Coaching; depression; exercise; nutrition; physical activity; stress; traumatic brain injury; walking	MINOR DEPRESSION; MODERATE; TBI; COMPLAINTS; EXERCISE; OUTCOMES; RATES; MOOD	Objective: To determine whether a 12-week home-based walking programme can decrease perceived stress and depressive symptoms in persons with a traumatic brain injury (TBI). Setting: Community-and home-based. Participants: Sixty-nine participants with a TBI. Design: Comparative effectiveness cross-over design with random assignment to treatment sequence and blinded post-hoc assessment of outcome where participants completed a 12-week walking intervention and a nutrition education module. The walking intervention utilized pedometers to track the amount of steps each participant walked daily. With the assistance of an assigned coach, weekly goals were given with the intent of increasing the amount of walking that the participant was initially completing. The nutrition control group was created to offset the impact of the coaching calls. Main measures: Measurement of perceived stress and depressive symptoms was completed through the use of the Perceived Stress Scale (PSS) and Center for Epidemiological Studies-Depression (CES-D). These measures were collected at three time points: baseline and following each 12-week intervention. Results: Results indicated that both perceived stress and depression symptoms significantly improved following the walking intervention. Conclusions: While limitations existed with the study, it is evident that walking can be used as an efficient and cost-effective tool to manage perceived stress and depressive symptoms in persons who have sustained a TBI.	[Bellon, Kimberly; Kolakowsky-Hayner, Stephanie; Wright, Jerry; Toda, Ketra] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Huie, Henry; Englander, Jeffrey] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; [Bushnik, Tamara] Rusk Inst Rehabil, New York, NY USA		Bellon, K (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	kimberly.bellon@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of EducationUS Department of Education [H133A070038]	This research was supported by grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, TBI Model Systems grant to Santa Clara Valley Medical Center (H133A070038).	Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Balke B., 1963, SIMPLE FIELD TEST AS, P1; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2012, ARCH PSYCHIAT NURS, V26, P477, DOI 10.1016/j.apnu.2012.06.002; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; BERG K, 1989, Physiotherapy Canada, V41, P304; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Faul M, 2010, TRAUMATIC BRAIN INJU; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Williams G., HIGH LEVEL MOBILITY; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	35	16	17	0	25	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					313	319		10.3109/02699052.2014.974670			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000005	25356799				2022-02-06	
J	Chen, YH; Huang, EYK; Kuo, TT; Ma, HI; Hoffer, BJ; Tsui, PF; Tsai, JJ; Chou, YC; Chiang, YH				Chen, Yuan-Hao; Huang, Eagle Yi-Kung; Kuo, Tung-Tai; Ma, Hsin-I; Hoffer, Barry J.; Tsui, Pi-Fen; Tsai, Jing-Jr; Chou, Yu-Ching; Chiang, Yung-Hsiao			Dopamine Release Impairment in Striatum After Different Levels of Cerebral Cortical Fluid Percussion Injury	CELL TRANSPLANTATION			English	Article						Fluid percussion injury; Dopamine; Fast-scan cyclic voltammetry (FSCV); Novel object recognition (NOR) test; Dopamine reuptake	TRAUMATIC BRAIN-INJURY; RAT FRONTAL-CORTEX; TYROSINE-HYDROXYLASE; COMPENSATORY RESPONSE; EXPRESSION; IMPACT; MODEL; NEURONS; MEMORY; TRANSMISSION	To investigate the role of dopamine release in cognitive impairment and motor learning deficits after brain injury, different levels of traumatic brain injury (TBI) were made in rats by using fluid percussion at two different atmospheres (2 Psi and 6 Psi). Tonic and phasic bursting dopamine release and behavior tests followed at several time points. We used in vitro fast-scan cyclic voltammetry to survey dopamine release in the striatum and analyzed the rats' behavior using novel object recognition (NOR) and rotarod tests. Both tonic and bursting dopamine release were greatly depressed in the severely (6 Psi) injured group, which persisted up to 8 weeks later. However, in the 2 Psi-injured group, the suppression of bursting dopamine release occurred at 1 similar to 2 weeks after injury, but there were no significant differences after 4 weeks. Tonic dopamine release was also diminished significantly at 1 similar to 2 weeks after the injury; partial recovery could then be seen 4 weeks after injury. A significant deficiency in the fixed speed rotarod test and NOR test were noted in both 2 Psi and 6 Psi groups initially; however, the changes recovered in the 2 Psi group 2 weeks after injury while persisting in the 6 Psi group. In conclusion, striatal evoked dopamine release was affected by fluid percussion injury, with behavioral deficits showing differences as a function of injury severity. The severe fluid percussion injury (6 Psi) group showed more dopamine release defects, as well as cognitive and motor deficiencies. Recovery of dopamine release and improvement in behavioral impairment were better in the mild TBI group.	[Chen, Yuan-Hao; Ma, Hsin-I; Tsai, Jing-Jr] Tri Serv Gen Hosp, Dept Neurol Surg, Natl Def Med Ctr, Taipei 114, Taiwan; [Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Program Neuroregenerat, Taipei, Taiwan		Chen, YH (corresponding author), Tri Serv Gen Hosp, Dept Neurol Surg, Natl Def Med Ctr, 4F,325,2nd Sec,Cheng Kung Rd, Taipei 114, Taiwan.	chenyh178@gmail.com	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2314-B-016-008]; USPHSUnited States Department of Health & Human ServicesUnited States Public Health Service [NS070825]; Medical Research Project from the Tri-Service General Hospital of Taiwan [TSGH-C101-084, TSGH-C100-033]	This work was supported by the National Science Council of Taiwan under grant NSC 101-2314-B-016-008, USPHS grant NS070825, and by Medical Research Project grants TSGH-C101-084, and TSGH-C100-033 from the Tri-Service General Hospital of Taiwan. The authors declare no conflicts of interest.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Beeler JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00170; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BLANCHARD V, 1995, J NEUROCHEM, V64, P1669; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, J NEUROTRAUM, V14, P43, DOI 10.1089/neu.1997.14.43; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Grace AA, 2000, ADDICTION, V95, pS119; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Hauber W, 2010, PHARMACOPSYCHIATRY, V43, pS32, DOI 10.1055/s-0030-1248300; Huang EYK, 2003, N-S ARCH PHARMACOL, V368, P386, DOI 10.1007/s00210-003-0803-7; KATZMAN R, 1971, BRAIN RES, V25, P579, DOI 10.1016/0006-8993(71)90462-8; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lindgren N, 2000, J NEUROCHEM, V74, P2470, DOI 10.1046/j.1471-4159.2000.0742470.x; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; PASINETTI GM, 1991, BRAIN RES, V567, P253, DOI 10.1016/0006-8993(91)90803-4; Rachmany L., 2012, AGE DORDR, V35, P1621; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	48	16	16	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2015	24	10					2113	2128		10.3727/096368914X683584			16	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	CT5PB	WOS:000362861200015	25198499	Bronze			2022-02-06	
J	Fayaz, SM; Raj, YV; Krishnamurthy, RG				Fayaz, Shaik M.; Raj, Yanamala V.; Krishnamurthy, Rajanikant G.			CypD: The Key to the Death Door	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Apoptosis; calcium homeostasis; cyclosporin A; cyclophilin D; mitochondrial permeability transition pore; necroptosis; neurological disorders	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN-INJURY; ADENINE-NUCLEOTIDE TRANSLOCASE; HEPATITIS-C-VIRUS; INTERMEMBRANE JUNCTIONAL COMPLEXES; ALZHEIMERS-DISEASE IMPLICATIONS; CYCLOSPORINE DERIVATIVE NIM811; CULTURED HIPPOCAMPAL-NEURONS; TRANSIENT FOREBRAIN ISCHEMIA; ABNORMAL CALCIUM HOMEOSTASIS	Numerous studies have deciphered the importance of Cyclophilin D (CypD/peptidyl prolyl cis-trans isomerase F) in the formation and regulation of mitochondrial permeability transition pore (MPTP), implicated in the cell death mechanisms in various neurological diseases. Decrease in the ATP and increase in the calcium levels are the most common aftermath consequences that are observed in these diseases. Increased calcium level leads to the persistent opening of MPTP and cell death, which is mediated by CypD. However, the underlying mechanisms that contribute to the abnormal calcium homeostasis in different diseases remain elusive. In this review, we attempted to connect the disruption of mitochondrial bioenergetics with abnormal calcium levels and MPTP. Further, various proteins that interact with the CypD and the subsequent consequences have been described. All the cell death pathways in various neurological disorders merge at CypD, which acts as a key regulatory protein in cellular demise. Agents inhibiting CypD may have a therapeutic potential for treating neurological disorders such as Alzheimer's disease, Parkinson's disease and cerebral ischemia. Further, the knowledge regarding the pathophysiological processes involved in CypD-regulated MPTP and cell death would assist in battling with these diseases.	[Fayaz, Shaik M.; Raj, Yanamala V.; Krishnamurthy, Rajanikant G.] Natl Inst Technol Calicut, Sch Biotechnol, Calicut 673601, Kerala, India		Krishnamurthy, RG (corresponding author), Natl Inst Technol Calicut, DBT Ctr Bioinformat, Sch Biotechnol, Calicut 673601, Kerala, India.	rajanikant@nitc.ac.in	G.K, Rajanikant/H-3275-2019; S.M., Fayaz/P-6103-2015	S.M., Fayaz/0000-0002-1212-7952; , Rajanikant/0000-0001-9754-997X			Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Andreeva L, 1999, INT J EXP PATHOL, V80, P305, DOI 10.1046/j.1365-2613.1999.00128.x; Baines CP, 2007, AM J PHYSIOL-HEART C, V293, pH903, DOI 10.1152/ajpheart.00575.2007; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Bambrick LL, 1997, GLIA, V19, P352, DOI 10.1002/(SICI)1098-1136(199704)19:4<352::AID-GLIA8>3.0.CO;2-Z; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Barsukova AG, 2011, EUR J NEUROSCI, V34, P437, DOI 10.1111/j.1460-9568.2011.07760.x; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi Paolo, 2007, Novartis Found Symp, V287, P157; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Damiano M, 2013, HUM MOL GENET, V22, P3869, DOI 10.1093/hmg/ddt242; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DENTON RM, 1975, MOL CELL BIOCHEM, V9, P27, DOI 10.1007/BF01731731; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Favreau DJ, 2012, J VIROL, V86, P81, DOI 10.1128/JVI.06062-11; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Goto K, 2006, BIOCHEM BIOPH RES CO, V343, P879, DOI 10.1016/j.bbrc.2006.03.059; Guo HX, 2005, ACTA PHARMACOL SIN, V26, P1201, DOI 10.1111/j.1745-7254.2005.00189.x; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hazelton JL, 2009, J NEUROSCI RES, V87, P1250, DOI 10.1002/jnr.21921; Hokari M, 2010, J PHARM PHARMACOL, V62, P485, DOI 10.1211/jpp.62.04.0011; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Kim HJ, 2012, BRAIN, V135, P2865, DOI 10.1093/brain/aws208; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Komuro H, 2005, CELL CALCIUM, V37, P387, DOI 10.1016/j.ceca.2005.01.006; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kubota M, 2010, INT J NEUROPSYCHOPH, V13, P1355, DOI 10.1017/S1461145710000362; Kumarswamy R, 2009, MITOCHONDRION, V9, P1, DOI 10.1016/j.mito.2008.10.003; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2011, TOXICOL PATHOL, V39, P220, DOI 10.1177/0192623310389475; Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015; Mathy JE, 2008, ANTIMICROB AGENTS CH, V52, P3267, DOI 10.1128/AAC.00498-08; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Montero M, 2002, FASEB J, V16, P1955, DOI 10.1096/fj.02-0553fje; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Muirhead KEA, 2010, BIOCHEM J, V426, P255, DOI 10.1042/BJ20091941; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Naziroglu M, 2012, NEUROCHEM RES, V37, P2065, DOI 10.1007/s11064-012-0850-x; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; SCHAPIRA AHV, 1993, ADV NEUROL, V60, P288; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shinde S, 2006, NEUROL INDIA, V54, P390, DOI 10.4103/0028-3886.28112; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tavecchio M, 2013, J BIOL CHEM, V288, P5553, DOI 10.1074/jbc.M112.433045; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Valasani KR, 2014, J CHEM INF MODEL, V54, P902, DOI 10.1021/ci5000196; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Vyssokikh M, 2004, BBA-MOL CELL RES, V1644, P27, DOI 10.1016/j.bbamcr.2003.10.007; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	115	16	18	2	22	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	5					654	663		10.2174/1871527314666150429113239			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CI8DM	WOS:000354999100011	25921742				2022-02-06	
J	Hannon, MJ; Behan, LA; O'Brien, MM; Tormey, W; Javadpour, M; Sherlock, M; Thompson, CJ				Hannon, M. J.; Behan, L. A.; O'Brien, M. M.; Tormey, W.; Javadpour, M.; Sherlock, M.; Thompson, C. J.			Chronic hypopituitarism is uncommon in survivors of aneurysmal subarachnoid haemorrhage	CLINICAL ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY FUNCTION; DIABETES-INSIPIDUS; ACUTE-PHASE; NEUROENDOCRINE DYSFUNCTION; GLUCOCORTICOID DEFICIENCY; CLINICAL INSIGHTS; HIGH-RISK; PREVALENCE; HYPONATREMIA	ObjectiveThe incidence of hypopituitarism after aneurysmal subarachnoid haemorrhage (SAH) is unclear from the conflicting reports in the literature. As routine neuroendocrine screening for hypopituitarism for all patients would be costly and logistically difficult, there is a need for precise data on the frequency of hypopituitarism and on factors which might predict the later development of pituitary dysfunction. We aimed to: (i) Establish the incidence of long-term hypopituitarism in patients with aneurysmal SAH. (ii) Determine whether data from patients' acute admission with SAH could predict the occurrence of long-term hypopituitarism. DesignOne hundred patients were studied prospectively from the time of presentation with acute SAH. Plasma cortisol, plasma sodium and a variety of clinical and haemodynamic parameters were sequentially measured for the first 12days of their acute admission. Forty-one patients then underwent dynamic pituitary testing at median 15months following SAH (range 7-30months), with insulin tolerance test (ITT) or, if contraindicated, a glucagon stimulation test (GST) plus short synacthen test (SST). If symptoms of cranial diabetes insipidus (CDI) were present, a water deprivation test was also performed. ResultsForty-one patients attended for follow-up dynamic pituitary testing. Although 14 of 100 had acute glucocorticoid deficiency immediately following SAH, only two of 41 had long-term adrenocorticotrophic hormone (ACTH) deficiency and four of 41 had growth hormone (GH) deficiency. None were hypothyroid or gonadotrophin deficient. None had chronic CDI or hyponatraemia. There was no association between acute glucocorticoid deficiency, acute CDI or acute hyponatraemia and long-term pituitary dysfunction. ConclusionBoth anterior and posterior hypopituitarism are very uncommon following SAH and are not predicted by acute clinical, haemodynamic or endocrinological parameters. Routine neuroendocrine screening is not justified in SAH patients.	[Hannon, M. J.; Behan, L. A.; O'Brien, M. M.; Sherlock, M.; Thompson, C. J.] Beaumont Hosp, Acad Dept Endocrinol, RCSI Med Sch, Dublin 9, Ireland; [Tormey, W.] Beaumont Hosp, Acad Dept Chem Pathol, RCSI Med Sch, Dublin 9, Ireland; [Javadpour, M.] Beaumont Hosp, Natl Neurosurg Ctr, RCSI Med Sch, Dublin 9, Ireland; [Sherlock, M.] Adelaide & Meath Hosp, Trinity Coll Dublin, Dept Endocrinol, Sch Med, Dublin, Ireland		Hannon, MJ (corresponding author), Beaumont Hosp, Acad Dept Endocrinol, Beaumont Rd, Dublin 9, Ireland.	markjhannon2002@yahoo.co.uk	Javadpour, Mohsen/AAX-4657-2020	Javadpour, Mohsen/0000-0001-9836-1741	Novo NordiskNovo Nordisk	Funded by an unrestricted educational grant from Novo Nordisk.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Crowley RK, 2007, CLIN ENDOCRINOL, V66, P475, DOI 10.1111/j.1365-2265.2007.02754.x; Davies MJ, 1996, J ROY SOC MED, V89, pP159, DOI 10.1177/014107689608900313; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Finucane FM, 2008, CLIN ENDOCRINOL, V69, P603, DOI 10.1111/j.1365-2265.2008.03240.x; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; MCIVER B, 1991, BRIT MED J, V303, P1465, DOI 10.1136/bmj.303.6815.1465; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Prabhakar VKB, 2006, POSTGRAD MED J, V82, P259, DOI 10.1136/pgmj.2005.039768; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; SPIRO SG, 1971, BRIT MED J, V3, P411, DOI 10.1136/bmj.3.5771.411; TAKAKU A, 1979, SURG NEUROL, V11, P349; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476	31	16	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	JAN	2015	82	1					115	121		10.1111/cen.12533			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	AX2QC	WOS:000346788000017	24965315				2022-02-06	
J	Lin, LF; Liou, TH; Hu, CJ; Ma, HP; Ou, JC; Chiang, YH; Chiu, WT; Tsai, SH; Chu, WC				Lin, Li-Fong; Liou, Tsan-Hon; Hu, Chaur-Jong; Ma, Hon-Ping; Ou, Ju-Chi; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Tsai, Shin-Han; Chu, Woei-Chyn			Balance function and sensory integration after mild traumatic brain injury	BRAIN INJURY			English	Article						Balance function; mild traumatic brain injury; postural stability; sensory integration	POST-CONCUSSION SYMPTOMS; PHYSICAL-THERAPY; DEFICITS; REHABILITATION; ASSOCIATIONS; PERFORMANCE; INSTABILITY; DISORDERS; DIZZINESS; RECOVERY	Objective: This study examined the disparities in balance functions and sensory integration in patients with mild traumatic brain injuries (mTBIs) and healthy controls. Participants: One hundred and seven patients with mTBI and 107 age-and sex-matched controls were recruaited for this study. Primary measures: Symptoms of dizziness, balance functions and the ability to perform daily activities were assessed using the dizziness handicap inventory (DHI). This study also performed the postural-stability test and a modified clinical test of sensory integration by using the Biodex Stability System (BBS). Results: DHI scores (functional, emotional, physical and total self-reported scores) were substantially increased in patients following an mTBI compared with the scores of the controls (p<0.000). The postural-stability test indices (anterior-posterior) (p = 0.045) and the sensory-integration test index (eyes-open-firm-surface index) (p = 0.006) were substantially lower in patients with mTBI than in the controls. However, indices of two other postural-stability test indices (overall and medial-lateral) and three other sensory-integration tests indices (eyes-closed-firm-surface, eyes-open-foam-surface and eyes-closed-foam-surface) measured for the mTBI group did not differ from those of the control group. Conclusion: Activities of daily living, balance in postural stability and sensory integration were strongly impaired in patients with mTBI.	[Lin, Li-Fong; Chu, Woei-Chyn] Natl Yang Ming Univ, Grad Inst Biomed Engn, Taipei 112, Taiwan; [Lin, Li-Fong; Liou, Tsan-Hon] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lin, Li-Fong] Taipei Med Univ, Inst Gerontol & Hlth Management, Taipei, Taiwan; [Liou, Tsan-Hon; Chiu, Wen-Ta; Tsai, Shin-Han] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Ma, Hon-Ping; Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan		Chu, WC (corresponding author), Natl Yang Ming Univ, Inst Biomed Engn, 155 Li Long St,Sec 2, Taipei 112, Taiwan.	shtsai@tmu.edu.tw; wchu@ym.edu.tw	Liou, Tsan-Hon/I-8808-2019; Lin, Li-Fong/AAU-4368-2021	Liou, Tsan-Hon/0000-0002-0959-4023	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [98-2321-B-038-003-MY3, 98-2321-B-038-005-MY3]; Department of Health, Executive Yuan, Taiwan [101-TD-B-111-003]; Shuang Ho Hospital, Taipei Medical University [102 SHH-HCP-12]	The authors report no conflicts of interest. This study was supported by research grants from the National Science Council, Taiwan (98-2321-B-038-003-MY3 and 98-2321-B-038-005-MY3); Department of Health, Executive Yuan, Taiwan (101-TD-B-111-003); Shuang Ho Hospital, Taipei Medical University (102 SHH-HCP-12).	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Arnold BL, 1998, J ATHL TRAINING, V33, P323; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3	35	16	16	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					41	46		10.3109/02699052.2014.955881			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000006	25265292				2022-02-06	
J	Ma, YX; Nie, H; Chen, HY; Li, JF; Hong, YY; Wang, B; Wang, CX; Zhang, J; Cao, W; Zhang, MC; Xu, YN; Ding, XT; Yin, SK; Qu, XK; Ying, WH				Ma, Yingxin; Nie, Hui; Chen, Heyu; Li, Jiefu; Hong, Yunyi; Wang, Ban; Wang, Caixia; Zhang, Jie; Cao, Wei; Zhang, Mingchao; Xu, Yongning; Ding, Xianting; Yin, Shan Kai; Qu, Xinkai; Ying, Weihai			NAD(+)/NADH Metabolism and NAD(+)-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications	CURRENT MEDICINAL CHEMISTRY			English	Article						CD38; cell death; ischemic brain injury; NAD(+); poly(ADP-ribose) polymerase; sirtuins	CYCLIC ADP-RIBOSE; NF-KAPPA-B; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASE; INDUCED APOPTOSIS; CEREBRAL-ISCHEMIA; NEURONAL SURVIVAL; CD38; ACTIVATION; NADH	NAD(+) and NADH play crucial roles in a variety of biological processes including energy metabolism, mitochondrial functions, and gene expression. Multiple studies have indicated that NAD(+) administration can profoundly decrease oxidative cell death as well as ischemic and traumatic brain injury, suggesting NAD(+) metabolism as a promising therapeutic target for cerebral ischemia and head injury. Cumulating evidence has suggested that NAD(+) can produce its protective effects by multiple mechanisms, including preventing mitochondrial alterations, enhancing energy metabolism, preventing virtually all forms of cell death including apoptosis, necrosis and autophagy, inhibiting inflammation, directly increasing antioxidation capacity of cells and tissues, and activating SIRT1. Increasing evidence has also suggested that NADH metabolism is a potential therapeutic target for treating several neurological disorders. A number of studies have further indicated that multiple NAD(+)-dependent enzymes such as sirtuins, polymerase(ADP-ribose) polymerases (PARPs) and CD38 mediate cell death and multiple biological processes. In this article, an overview of the recent findings regarding the roles of NAD(+)/NADH and NAD(+)-dependent enzymes in cell death and ischemic brain injury is provided. These findings have collectively indicated that NAD(+)/NADH and NAD(+)-dependent enzymes play fundamental roles in oxidative stress-induced cell death and ischemic brain injury, which may become promising therapeutic targets for brain ischemia and multiple other neurological disorders.	[Ying, Weihai] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Ma, Yingxin; Nie, Hui; Chen, Heyu; Hong, Yunyi; Wang, Ban; Wang, Caixia; Zhang, Jie; Cao, Wei; Ding, Xianting; Ying, Weihai] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Ma, Yingxin; Nie, Hui; Chen, Heyu; Hong, Yunyi; Wang, Ban; Wang, Caixia; Zhang, Jie; Cao, Wei; Ding, Xianting; Ying, Weihai] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Li, Jiefu; Zhang, Mingchao; Xu, Yongning] Shanghai Jiao Tong Univ, Zhiyuan Coll, Shanghai 200030, Peoples R China; [Yin, Shan Kai] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Otorhinolaryngol, Shanghai 200030, Peoples R China; [Qu, Xinkai] Shanghai Jiao Tong Univ, Chest Hosp, Dept Cardiol, Shanghai 200030, Peoples R China		Ying, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Hua Shan Rd, Shanghai 200032, Peoples R China.	weihaiy@sjtu.edu.cn	; /M-8065-2017	Hong, Yunyi/0000-0002-2921-6417; /0000-0002-0062-4652	Chinese National Science FoundationNational Natural Science Foundation of China (NSFC) [81171098, 81271305]; Shanghai Jiao Tong University Grants for Interdisciplinary Research on Medicine and Engineering	This study was supported by Chinese National Science Foundation Grants #81171098 and #81271305 (to W. Y.), and Shanghai Jiao Tong University Grants for Interdisciplinary Research on Medicine and Engineering (to W. Y.).	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066; Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Banerjee S, 2008, J NEUROIMMUNE PHARM, V3, P154, DOI 10.1007/s11481-008-9105-7; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Boulares AH, 2002, CANCER RES, V62, P4439; Boulares AH, 2002, J BIOL CHEM, V277, P372, DOI 10.1074/jbc.M107738200; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Bruzzone S, 2004, J NEUROCHEM, V89, P264, DOI 10.1111/j.1471-4159.2003.02326.x; Bruzzone S, 2001, FASEB J, V15, P10; Cai AL, 2006, EUR J NEUROSCI, V24, P2169, DOI 10.1111/j.1460-9568.2006.05110.x; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chen HY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/213234; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; Guarente L, 2000, GENE DEV, V14, P1021; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; He X, 2012, BIOCHEM BIOPH RES CO, V417, P468, DOI 10.1016/j.bbrc.2011.11.141; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hong Y S.J., 2010, FASEB J; Hong YY, 2014, NEUROSCI LETT, V560, P46, DOI 10.1016/j.neulet.2013.11.039; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Huang J.Y., 1804, BIOCH BIOPHYS ACTA, P1645; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Li YX, 2013, NEUROSCI LETT, V544, P36, DOI 10.1016/j.neulet.2013.03.032; Love S, 1999, NEUROPATH APPL NEURO, V25, P98; Lu HF, 2007, BIOCHEM BIOPH RES CO, V362, P946, DOI 10.1016/j.bbrc.2007.08.095; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Ma YX, 2014, GLIA, V62, P943, DOI 10.1002/glia.22651; Ma YX, 2012, BIOCHEM BIOPH RES CO, V418, P714, DOI 10.1016/j.bbrc.2012.01.084; Ma Yingxin, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P21; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Matsuura S, 2011, BRAIN RES, V1410, P122, DOI 10.1016/j.brainres.2011.05.069; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; Narayan N., 2012, NATURE; Nie H, 2014, NEUROREPORT, V25, P838, DOI 10.1097/WNR.0000000000000192; Nie Hui, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P65; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pardo Beatriz, 2013, Front Endocrinol (Lausanne), V4, P149, DOI 10.3389/fendo.2013.00149; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Pellegrini L, 2012, CELL DEATH DIFFER, V19, P1815, DOI 10.1038/cdd.2012.62; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pillai JB, 2006, AM J PHYSIOL-HEART C, V291, pH1545, DOI 10.1152/ajpheart.01124.2005; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Sheng C., 2014, IEEE T PATTERN ANAL, P1; Sheng Caibin, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P1; Shimizu T, 2013, J CEREBR BLOOD F MET, V33, P1549, DOI 10.1038/jcbfm.2013.105; Siegel CS, 2013, NEUROSCIENCE, V237, P223, DOI 10.1016/j.neuroscience.2013.01.068; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Stryer L., 1995, BIOCHEMISTRY-US; Sundaresan NR, 2011, J MOL CELL CARDIOL, V51, P614, DOI 10.1016/j.yjmcc.2011.01.008; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Teng F, 2013, EXP NEUROL, V248, P416, DOI 10.1016/j.expneurol.2013.07.007; Thornburg JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2154; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Van Meter M, 2011, CELL CYCLE, V10, P3153, DOI 10.4161/cc.10.18.17435; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang B, 2014, CHEM-BIOL INTERACT, V212, P65, DOI 10.1016/j.cbi.2014.01.013; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Won SJ, 2012, J NEUROTRAUM, V29, P1401, DOI 10.1089/neu.2011.2228; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Xia WL, 2010, CLIN EXP PHARMACOL P, V37, P253, DOI 10.1111/j.1440-1681.2009.05279.x; Xia WL, 2009, CURR PHARM DESIGN, V15, P12, DOI 10.2174/138161209787185832; Xiong J, 2013, CELL PHYSIOL BIOCHEM, V31, P44, DOI 10.1159/000343348; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Ying W, 2010, CURR MED CHEM, V17, P2152, DOI 10.2174/092986710791299911; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; YUAN M, EXP NEUROL; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012; Zheng CB, 2012, NEUROSCI LETT, V512, P67, DOI 10.1016/j.neulet.2012.01.007; Zhu KQ, 2005, NEUROREPORT, V16, P1209, DOI 10.1097/00001756-200508010-00015	107	16	17	1	35	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2015	22	10					1239	1247		10.2174/0929867322666150209154420			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CD5WW	WOS:000351160400008	25666794				2022-02-06	
J	Oliver, J; Abbas, K; Lightfoot, JT; Baskin, K; Collins, B; Wier, D; Bramhall, JP; Huang, J; Puschett, JB				Oliver, Joel; Abbas, Kamran; Lightfoot, J. Timothy; Baskin, Kelly; Collins, Blaise; Wier, David; Bramhall, Joe P.; Huang, Jason; Puschett, Jules B.			Comparison of Neurocognitive Testing and the Measurement of Marinobufagenin in Mild Traumatic Brain Injury: A Preliminary Report	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						athletic brain trauma; concussion; bufodienolides; marinobufagenin; neurocognitive testing		The evaluation of concussed athletes, including testing to determine if and when they may return to play, has become an important task of athletic trainers and team physicians. Currently, concussion protocols are in place, which depend largely upon assessments based upon neurocognitive testing (NCT). The authors have evaluated the use of a biomarker of brain trauma, marinobufagenin (MBG), and compared its application in concussed athletes with the performance of NTC. We found a disparity between these two testing procedures. In this communication, the findings of these comparative data are presented. We noted that athletes whose NCT evaluations had returned to baseline and who were allowed to again participate in play then showed a recurrence of elevated urinary MBG excretion. These observations raise concern as to the processes currently in effect with regard to the decision as to returning athletes to the full activity. They suggest a need for further evaluation.	[Oliver, Joel; Abbas, Kamran; Puschett, Jules B.] Texas A&M Univ, Coll Vet Med & Biosci, Dept Pathobiol, College Stn, TX 77843 USA; [Lightfoot, J. Timothy; Baskin, Kelly; Collins, Blaise] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Wier, David; Bramhall, Joe P.] Texas A&M Univ, Dept Athlet, College Stn, TX USA; [Huang, Jason] Baylor Scott & White Healthcare, Coll Med, Dept Neurosurg, Temple, TX USA; [Huang, Jason] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA		Puschett, JB (corresponding author), Texas A&M Univ, Coll Vet Med & Biosci, Dept Pathobiol, College Stn, TX 77843 USA.	jbpuschett@aol.com	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168; Collins, Patrick/0000-0001-8711-1296	MD Research Endowment; Huffhines Institute; Texas A&M University School of Veterinary Medicine	These studies were funded (in part) by the Jules B. Puschett, MD Research Endowment, by a grant from the Huffhines Institute, and by the Texas A&M University School of Veterinary Medicine. The authors confirm that the funder had no influence over the study design, content of the article, or selection of this journal.	Abi-Ghanem D, 2011, J IMMUNOASS IMMUNOCH, V32, P31, DOI 10.1080/15321819.2010.538107; Agunanne E, 2011, AM J PERINAT, V28, P509, DOI 10.1055/s-0031-1272965; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Farjo B, 2014, J INVEST MED, V62, P544; Ferris C, 2014, ARCH CLIN NEUROPSYCH, V29; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasan KM, 2014, MAGN RESON IMAGING, V32, P405, DOI 10.1016/j.mri.2014.01.014; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Horvat D, 2010, HYPERTENS PREGNANCY, V29, P1, DOI 10.3109/10641950802629709; Ianosi-Irimie M, 2005, CLIN EXP HYPERTENS, V27, P605, DOI 10.1080/10641960500298608; Ing NH, 2014, AM J PHYSIOL-REG I, V306, pR918, DOI 10.1152/ajpregu.00499.2013; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kamali A, 2014, MAGN RESON IMAGING, V32, P796, DOI 10.1016/j.mri.2014.04.002; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mitchell BM, 2007, AM J HYPERTENS, V20, P1297, DOI 10.1016/j.amjhyper.2007.08.007; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Puschett JB, 2012, AM J PERINAT, V29, P777, DOI 10.1055/s-0032-1316447; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schoner W, 2002, EUR J BIOCHEM, V269, P2440, DOI 10.1046/j.1432-1033.2002.02911.x; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Shapiro L, 2011, ANN M BOOKL, V78, P2011; Singh R, 2004, JAMA-J AM MED ASSOC, V311, P1883; Thoma RJ, 2015, BRAIN INJURY, V19, P1; Uddin MN, 2009, AM J NEPHROL, V30, P26, DOI 10.1159/000193220; Uddin MN, 2009, AM J PHYSIOL-REG I, V296, pR1726, DOI 10.1152/ajpregu.90963.2008; Uddin MN, 2012, HYPERTENS PREGNANCY, V31, P70, DOI 10.3109/10641955.2010.525275; Vu H, 2006, EXP BIOL MED, V231, P215; Vu HV, 2005, AM J NEPHROL, V25, P520, DOI 10.1159/000088461; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507	42	16	16	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.		2015	9						67	72		10.4137/JEN.S27921			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V30WQ	WOS:000215593100009	26351409	Green Published, gold			2022-02-06	
J	Pham, N; Sawyer, TW; Wang, YS; Jazii, FR; Vair, C; Taghibiglou, C				Pham, Nam; Sawyer, Thomas W.; Wang, Yushan; Jazii, Ferdous Rastgar; Vair, Cory; Taghibiglou, Changiz			Primary Blast-Induced Traumatic Brain Injury in Rats Leads to Increased Prion Protein in Plasma: A Potential Biomarker for Blast-Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ELISA; brain injury; blood plasma; PrPC; blast exposure	SERUM S100B LEVELS; ENDOTHELIAL-CELLS; EXPRESSION; AFGHANISTAN; DEFINITION; DEATH; MICE; PRPC; ACCUMULATION; INFLAMMATION	Traumatic brain injury (TBI) is deemed the "signature injury" of recent military conflicts in Afghanistan and Iraq, largely because of increased blast exposure. Injuries to the brain can often be misdiagnosed, leading to further complications in the future. Therefore, the use of protein biomarkers for the screening and diagnosis of TBI is urgently needed. In the present study, we have investigated the plasma levels of soluble cellular prion protein (PrPC) as a novel biomarker for the diagnosis of primary blast-induced TBI (bTBI). We hypothesize that the primary blast wave can disrupt the brain and dislodge extracellular localized PrPC, leading to a rise in concentration within the systemic circulation. Adult male Sprague-Dawley rats were exposed to single pulse shockwave overpressures of varying intensities (15-30 psi or 103.4-206.8 kPa] using an advanced blast simulator. Blood plasma was collected 24 h after insult, and PrPC concentration was determined with a modified commercial enzyme-linked immunosorbent assay (ELISA) specific for PrPC. We provide the first report that mean PrPC concentration in primary blast exposed rats (3.97 ng/mL +/- 0.13 SE) is significantly increased compared with controls (2.46 ng/mL +/- 0.14 SE; two tailed test p<0.0001). Furthermore, we report a mild positive rank correlation between PrPC concentration and increasing blast intensity (psi) reflecting a plateaued response at higher pressure magnitudes, which may have implications for all military service members exposed to blast events. In conclusion, it appears that plasma levels of PrPC may be a novel biomarker for the detection of primary bTBI.	[Pham, Nam; Jazii, Ferdous Rastgar; Taghibiglou, Changiz] Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon S7N 5E5, SK, Canada; [Sawyer, Thomas W.; Wang, Yushan; Vair, Cory] Suffield Res Ctr, Def Res & Dev Canada, Ralston, AB, Canada		Taghibiglou, C (corresponding author), Univ Saskatchewan, Dept Pharmacol, Saskatoon S7N 5E5, SK, Canada.	changiz.taghibiglou@usask.ca	Taghibiglou, Changiz/H-4590-2019		DRDC [W7702-145664]	This research is supported by DRDC Contract W7702-145664. The authors thank the following individuals: Drs. Venkat Gopalakrishnan and John Mikler for their useful critical reviewing of our manuscript; Stephen Bjarnason at the DRDC for his managerial support for this project; Tracy Weiss, Peggy Nelson, Grant Hennes, and Julia Barnes for their excellent technical help during the blast exposure and blood collection processes; and Bing Yan and Dr. June Lim for their valuable assistance and consultation regarding statistical analysis.	Agoston D. V., 2012, FRONT NEUROL, V3, P1; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Carnini Anna, 2010, Prion, V4, P80; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Coulpier M, 2006, NEUROSCIENCE, V141, P1827, DOI 10.1016/j.neuroscience.2006.05.037; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Didonna A, 2013, CELL MOL BIOL LETT, V18, P209, DOI 10.2478/s11658-013-0085-0; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoshino S, 2003, ACT NEUR S, V86, P297; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Krupinski J, 2008, ACTA NEUROPATHOL, V116, P537, DOI 10.1007/s00401-008-0427-6; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martins VR, 2002, NEUROCHEM INT, V41, P353, DOI 10.1016/S0197-0186(02)00054-2; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ramasamy A, 2009, J R Army Med Corps, V155, P258; Rangel A, 2007, J NEUROSCI RES, V85, P2741, DOI 10.1002/jnr.21215; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ritzel D. V., 2011, NATO HFM, V207; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schardin H, 1950, WORLD WAR, VII; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Singh A., 2009, PLOS ONE, V4, P1; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taghibiglou C, 2011, BIOCHEM BIOPH RES CO, V413, P159, DOI 10.1016/j.bbrc.2011.08.011; Tanielian T., 2008, 720CCF MG RAND CORP; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	76	16	19	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2015	32	1					58	65		10.1089/neu.2014.3471			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AX4JX	WOS:000346900100008	25058115	Green Published			2022-02-06	
J	Shamloo, A; Heibatollahi, M; Mofrad, MRK				Shamloo, Amir; Heibatollahi, Motahare; Mofrad, Mohammad R. K.			Directional migration and differentiation of neural stem cells within three-dimensional microenvironments	INTEGRATIVE BIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EXTRACELLULAR-MATRIX; MICROFLUIDIC DEVICE; PRECURSOR CELLS; GROWTH-FACTOR; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; CHEMOTAXIS; NEURONS; REPAIR	A Harnessing neural stem cells to repair neuronal damage is a promising potential treatment for neuronal diseases. To enable future therapeutic efficacy, the survival, proliferation, migration and differentiation of neural stem/progenitor cells (NPCs) should be accurately studied and optimized in in vitro platforms before transplanting these cells into the body for treatment purposes. Such studies can determine the appropriate quantities of the biochemical and biomechanical factors needed to control and optimize NPC behavior in vivo. In this study, NPCs were cultured within a microfluidic device while being encapsulated within the collagen matrix. The migration and differentiation of NPCs were studied in response to varying concentrations of nerve growth factor (NGF) and within varying densities of collagen matrices. It was shown that the migration and differentiation of NPCs can be significantly improved by providing the appropriate range of NGF concentrations while encapsulating the cells within the collagen matrix of optimal density. In particular, it was observed that within collagen matrices of intermediate density (0.9 mg ml(-1)), NPCs have a higher ability to migrate farther and in a collective manner while their differentiation into neurons is significantly higher and the cells can form protrusions and connections with their neighboring cells. Within collagen matrices with higher densities (1.8 mg ml (-1)), the cells did not migrate significantly as compared to the ones within lower matrix densities; within the matrices with lower collagen densities (0.45 mg ml(-1)) most of the cells migrated in an individual manner. However, no significant differentiation into neurons was observed for these two cases. It was also found that depending on the collagen matrix density, a minimum concentration of NGF caused a collective migration of NPCs, and a minimum concentration gradient of this factor stimulated the directional navigation of the cells. The results of this study can be implemented in designing platforms appropriate for regeneration of damaged neuronal systems.	[Shamloo, Amir; Heibatollahi, Motahare; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Shamloo, Amir; Heibatollahi, Motahare; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Shamloo, Amir] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Mofrad, Mohammad R. K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA		Mofrad, MRK (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859; , amir/0000-0002-0131-0567	National Science Foundation CAREER awardNational Science Foundation (NSF) [CBET-0955291]; Siebel Stem Cell Institute	Financial support through a National Science Foundation CAREER award CBET-0955291 (M.R.K.M.) and a Siebel Stem Cell Institute post-doctoral fellowship (A.S.) is gratefully acknowledged. The authors would also like to thank the UC Berkeley Stem Cell Center and QB3 Shared Stem Cell Facilities for their assistance throughout this project. Fruitful discussions with Dr David Schaffer and the members of the Molecular Cell Biomechanics Laboratory are highly appreciated.	Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Gerardo-Nava J, 2009, NANOMEDICINE-UK, V4, P11, DOI 10.2217/17435889.4.1.11; Gordon RJ, 2012, EXP NEUROL, V233, P587, DOI 10.1016/j.expneurol.2011.11.029; Gordon RJ, 2009, MOL CELL NEUROSCI, V41, P219, DOI 10.1016/j.mcn.2009.03.001; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Han S, 2012, LAB CHIP, V12, P2305, DOI 10.1039/c2lc21285d; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Jahed Z, 2014, INT REV CEL MOL BIO, V310, P171, DOI 10.1016/B978-0-12-800180-6.00005-0; Jamali Y, 2013, J COMPUT PHYS, V244, P264, DOI 10.1016/j.jcp.2012.09.010; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kolahi KS, 2010, WIRES SYST BIOL MED, V2, P625, DOI 10.1002/wsbm.79; Kothapalli CR, 2013, BIOMATERIALS, V34, P5995, DOI 10.1016/j.biomaterials.2013.04.042; Kuhn HG, 2001, EUR ARCH PSY CLIN N, V251, P152, DOI 10.1007/s004060170035; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; McKeown SJ, 2013, DEV BIOL, V373, P244, DOI 10.1016/j.ydbio.2012.10.028; McLennan R, 2010, DEV BIOL, V339, P114, DOI 10.1016/j.ydbio.2009.12.022; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mofrad M.R.K., 2014, CELLULAR MECHANOTRAN; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Namba T, 2011, J NEUROCHEM, V118, P34, DOI 10.1111/j.1471-4159.2011.07282.x; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Rajan P, 2006, METHOD ENZYMOL, V419, P23, DOI 10.1016/S0076-6879(06)19002-3; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shamloo A, 2012, TISSUE ENG PT A, V18, P320, DOI [10.1089/ten.TEA.2011.0323, 10.1089/ten.tea.2011.0323]; Shamloo A, 2013, INTEGR BIOL-UK, V5, P1076, DOI 10.1039/c3ib40025e; Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Sherafat MA, 2012, J MOL NEUROSCI, V48, P144, DOI 10.1007/s12031-012-9791-8; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Theveneau Eric, 1800, Small GTPases, V1, P113, DOI 10.4161/sgtp.1.2.13673; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Xu H, 2013, SMALL, V9, P585, DOI 10.1002/smll.201202208; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9; Zhu WS, 2011, DRUG DELIV, V18, P338, DOI 10.3109/10717544.2011.557785	60	16	17	0	37	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1757-9694	1757-9708		INTEGR BIOL-UK	Integr. Biol.		2015	7	3					335	344		10.1039/c4ib00144c			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CD5OA	WOS:000351136500006	25633746				2022-02-06	
J	Steffens, S; Pacher, P				Steffens, Sabine; Pacher, Pal			The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?	CURRENT DRUG TARGETS			English	Article						Cannabinoid receptor CB1; CB2; diacylglycerol lipase; eicosanoid; fatty acid amide hydrolase; monoacylglycerol lipase	ACID AMIDE HYDROLASE; CB1 CANNABINOID RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; MUSCLE-CELL PROLIFERATION; CORONARY-ARTERY-DISEASE; TRAUMATIC BRAIN-INJURY; CARDIOVASCULAR FUNCTION; NEOINTIMA FORMATION; HYPERTENSIVE-RATS; DENDRITIC CELLS	Atherosclerosis and its major acute complications, myocardial infarction and stroke, are the leading causes of death and morbidity worldwide. Despite major advances in cardiovascular intervention and healthcare, improving preventive care and treatment remains a continuous mission for cardiovascular research. Within the last 10 to 15 years, the endocannabinoid system has emerged as an important lipid signaling system involved in many biological processes. Growing evidence suggests that an overactive endocannabinoid-CB1 receptor signaling promotes the development of cardiovascular risk factors such as obesity, insulin resistance and dyslipidemia. This prompted an increasing interest in studying the role of the endocannabinoid system in atherosclerosis. As opposed to the detrimental actions of CB1 signaling, the endocannabinoid-CB2 receptor axis exhibits an anti-inflammatory and atheroprotective role. We will review recent findings from experimental and clinical studies aimed at understanding the complex actions of endocannabinoid signaling in cardiovascular disease. This is followed by an outlook on emerging targets for possible therapeutic intervention.	[Steffens, Sabine] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Steffens, Sabine] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany; [Pacher, Pal] NIAAA, Sect Oxidat Stress Tissue Injury, Lab Physiol Studies, NIH, Bethesda, MD USA		Steffens, S (corresponding author), Inst Cardiovasc Prevent, Pettenkoferstr 9, D-80336 Munich, Germany.	sabine.steffens@med.uni-muenchen.de	Steffens, Sabine/AAV-4551-2020; Pacher, Pal/B-6378-2008	Steffens, Sabine/0000-0002-6892-9751; Pacher, Pal/0000-0001-7036-8108	Intramural Program of the NIAAA/NIH; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [STE1053/3-1, SFB1123 C01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000375] Funding Source: NIH RePORTER	The related research studies were supported by the Intramural Program of the NIAAA/NIH (to Pal Pacher) and the Deutsche Forschungsgemeinschaft (STE1053/3-1, SFB1123 C01 to Sabine Steffens).	Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 2013, BRIT J PHARMACOL, V169, P784, DOI 10.1111/bph.12013; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; Bonz A, 2003, J CARDIOVASC PHARM, V41, P657, DOI 10.1097/00005344-200304000-00020; Cao ZX, 2013, GASTROENTEROLOGY, V144, P808, DOI 10.1053/j.gastro.2012.12.028; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Costola-De-Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077706; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Daigle TL, 2008, J NEUROCHEM, V106, P70, DOI 10.1111/j.1471-4159.2008.05336.x; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Delsing DJM, 2011, OPEN CARDIOVASC MED, V5, P15, DOI 10.2174/1874192401105010015; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, NAT CLIN PRACT CARD, V5, P610, DOI 10.1038/ncpcardio1319; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Dol-Gleizes F, 2009, ARTERIOSCL THROM VAS, V29, P12, DOI 10.1161/ATVBAHA.108.168757; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gardiner SM, 2002, BRIT J PHARMACOL, V135, P1889, DOI 10.1038/sj.bjp.0704649; Ghosh S, 2013, LIFE SCI, V92, P498, DOI 10.1016/j.lfs.2012.06.020; Godlewski G, 2010, CHEM BIOL, V17, P1256, DOI 10.1016/j.chembiol.2010.08.013; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hoyer FF, 2014, J MOL CELL CARDIOL, V66, P126, DOI 10.1016/j.yjmcc.2013.11.013; Hoyer FF, 2011, J MOL CELL CARDIOL, V51, P1007, DOI 10.1016/j.yjmcc.2011.08.008; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Ishac EJN, 1996, BRIT J PHARMACOL, V118, P2023, DOI 10.1111/j.1476-5381.1996.tb15639.x; Jiang LS, 2009, CARDIOVASC RES, V81, P805, DOI 10.1093/cvr/cvn344; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Klumpers LE, 2013, BRIT J CLIN PHARMACO, V76, P846, DOI 10.1111/bcp.12141; Kruth HS, 2011, CURR OPIN LIPIDOL, V22, P386, DOI 10.1097/MOL.0b013e32834adadb; Krylatov AV, 2005, B EXP BIOL MED+, V139, P558, DOI 10.1007/s10517-005-0344-9; Lake KD, 1997, HYPERTENSION, V29, P1204, DOI 10.1161/01.HYP.29.5.1204; Lenglet S, 2013, ARTERIOSCL THROM VAS, V33, P215, DOI 10.1161/ATVBAHA.112.300275; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Lobato NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063449; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Maestroni GJM, 2004, FASEB J, V18, P1914, DOI 10.1096/fj.04-2190fje; Mallat A, 2008, AM J PHYSIOL-GASTR L, V294, pG9, DOI 10.1152/ajpgi.00467.2007; Maslov LN, 2004, B EXP BIOL MED+, V138, P550, DOI 10.1007/s10517-005-0123-7; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Matias I, 2002, EUR J BIOCHEM, V269, P3771, DOI 10.1046/j.1432-1033.2002.03078.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mauler F, 2003, CNS DRUG REV, V9, P343; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mendizabal VE, 2007, BRIT J PHARMACOL, V151, P427, DOI 10.1038/sj.bjp.0707261; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Molica F, 2012, AM J PHYSL HEART CIR; Molica F, 2014, THROMB HAEMOST; Molica F, 2013, J LIPID RES, V54, P1360, DOI 10.1194/jlr.M035147; Molica F, 2012, AM J PHYSIOL-HEART C, V302, pH1064, DOI 10.1152/ajpheart.00444.2011; Montecucco F, 2012, EUR HEART J, V33, P846, DOI 10.1093/eurheartj/ehr449; Montecucco F, 2009, ATHEROSCLEROSIS, V205, P433, DOI 10.1016/j.atherosclerosis.2008.12.040; Montecucco F, 2009, J MOL CELL CARDIOL, V46, P612, DOI 10.1016/j.yjmcc.2008.12.014; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V50, P179, DOI 10.1016/j.freeradbiomed.2010.11.002; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Netherland CD, 2010, ATHEROSCLEROSIS, V213, P102, DOI 10.1016/j.atherosclerosis.2010.07.060; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Noe SN, 2001, ADV EXP MED BIOL, V493, P215; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Nong L, 2001, ADV EXP MED BIOL, V493, P229; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2005, NEUROPHARMACOLOGY, V48, P1130, DOI 10.1016/j.neuropharm.2004.12.005; Pacher P, 2005, AM J PHYSIOL-HEART C, V289, pH533, DOI 10.1152/ajpheart.00107.2005; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Pacher P, 2008, HYPERTENSION, V52, P601, DOI 10.1161/HYPERTENSIONAHA.105.063651; Pacher P, 2008, AM J PHYSIOL-GASTR L, V294, pG850, DOI 10.1152/ajpgi.00523.2007; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Pertwee RG, 2005, HANDB EXP PHARMACOL, V168, P1; Quercioli A, 2013, EUR HEART J, V34, P2063, DOI 10.1093/eurheartj/eht085; Quercioli A, 2012, JACC-CARDIOVASC IMAG, V5, P805, DOI 10.1016/j.jcmg.2012.01.020; Quercioli A, 2011, EUR HEART J, V32, P1369, DOI 10.1093/eurheartj/ehr029; Rajesh M, 2008, BRIT J PHARMACOL, V153, P347, DOI 10.1038/sj.bjp.0707569; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rajesh M, 2008, BIOCHEM BIOPH RES CO, V377, P1248, DOI 10.1016/j.bbrc.2008.10.159; Randall MD, 2002, PHARMACOL THERAPEUT, V95, P191, DOI 10.1016/S0163-7258(02)00258-9; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Samson MT, 2003, J IMMUNOL, V170, P4953, DOI 10.4049/jimmunol.170.10.4953; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Silvestri C, 2012, EXPERT OPIN INV DRUG, V21, P1309, DOI 10.1517/13543784.2012.704019; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Steffens S, 2012, BRIT J PHARMACOL, V167, P313, DOI 10.1111/j.1476-5381.2012.02042.x; Sterin-Borda L, 2005, BIOCHEM PHARMACOL, V69, P1705, DOI 10.1016/j.bcp.2005.03.027; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Szekeres M, 2012, J BIOL CHEM, V287, P31540, DOI 10.1074/jbc.M112.346296; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wagner JA, 2001, EUR J PHARMACOL, V423, P203, DOI 10.1016/S0014-2999(01)01112-8; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wang PF, 2012, J CARDIOVASC PHARM, V59, P301, DOI 10.1097/FJC.0b013e3182418997; Weis F, 2010, J MOL CELL CARDIOL, V48, P1187, DOI 10.1016/j.yjmcc.2009.10.025; Wheal AJ, 2007, BRIT J PHARMACOL, V152, P717, DOI 10.1038/sj.bjp.0707410; Willecke F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019405	117	16	16	1	19	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-4501	1873-5592		CURR DRUG TARGETS	Curr. Drug Targets		2015	16	4					334	341		10.2174/1389450115666141202113225			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CF4IW	WOS:000352513400005	25469884				2022-02-06	
J	Strizzi, J; Landa, LO; Pappadis, M; Olivera, SL; Tangarife, ERV; Agis, IF; Perrin, PB; Arango-Lasprilla, JC				Strizzi, Jenna; Landa, Laiene Olabarrieta; Pappadis, Monique; Leonor Olivera, Silvia; Valdivia Tangarife, Edgar Ricardo; Agis, Inmaculada Fernandez; Perrin, Paul B.; Carlos Arango-Lasprilla, Juan			Sexual Functioning, Desire, and Satisfaction in Women with TBI and Healthy Controls	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; FUNCTION INDEX FSFI; QUALITY-OF-LIFE; PSYCHOMETRIC VALIDATION; VERSION; MEN; QUESTIONNAIRE; INVENTORY; DYSFUNCTION; PREVALENCE	Traumatic brain injury (TBI) can substantially alter many areas of a person's life and there has been little research published regarding sexual functioning in women with TBI. Methods. A total of 58 women (29 with TBI and 29 healthy controls) from Neiva, Colombia, participated. There were no statistically significant differences between groups in sociodemographic characteristics. All 58 women completed the Sexual Quality of Life Questionnaire (SQoL), Female Sexual Functioning Index (FSFI), Sexual Desire Inventory (SDI), and the Sexual Satisfaction Index (ISS). Results. Women with TBI scored statistically significantly lower on the SQoL (p < 0.001), FSFI subscales of desire (p < 0.05), arousal (p < 0.05), lubrication (p < 0.05), orgasm (p < 0.05), and satisfaction (p < 0.05), and the ISS (p < 0.001) than healthy controls. Multiple linear regressions revealed that age was negatively associated with some sexuality measures, while months since the TBI incident were positively associated with these variables. Conclusion. These results disclose that women with TBI do not fare as well as controls in these measures of sexual functioning and were less sexually satisfied. Future research is required to further understand the impact of TBI on sexual function and satisfaction to inform for rehabilitation programs.	[Strizzi, Jenna; Agis, Inmaculada Fernandez] Univ Almeria, Dept Psychol, Almeria, Spain; [Landa, Laiene Olabarrieta; Carlos Arango-Lasprilla, Juan] Univ Deusto, Dept Psychol, Bilbao, Spain; [Pappadis, Monique] Univ Texas Med Branch, Sch Hlth Profess, Div Rehabil Sci, Galveston, TX 77555 USA; [Pappadis, Monique] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Leonor Olivera, Silvia; Valdivia Tangarife, Edgar Ricardo] Univ Surcolombiana, Fac Salud, Grp Invest Carlos Finlay, Neiva, Colombia; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci Ikerbasque, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, Bilbao, Spain.	jcarango@deusto.es	Pappadis, Monique/Q-8639-2016; Landa, Laiene Olabarrieta/V-6207-2017; Perrin, Paul/L-5373-2015	Pappadis, Monique/0000-0003-4742-4380; Landa, Laiene Olabarrieta/0000-0002-8305-8720; Perrin, Paul/0000-0003-2070-215X; Fernandez Agis, Inmaculada/0000-0002-3160-5569			Abraham L, 2008, J SEX MED, V5, P595, DOI 10.1111/j.1743-6109.2007.00749.x; Abraham L, 2009, J SEX MED, V6, P2244, DOI 10.1111/j.1743-6109.2009.01336.x; Aloni A, 2003, SEXUAL DIFFICULTIES; Carrobles JA, 2011, AN PSICOL-SPAIN, V27, P27; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Bellamkonda E, 2014, BRAIN INJURY, V28, P1063, DOI 10.3109/02699052.2014.896473; Blümel M Juan Enrique, 2004, Rev. chil. obstet. ginecol., V69, P118; Burri A, 2010, J SEX MED, V7, P3929, DOI 10.1111/j.1743-6109.2010.01970.x; Christopher FS, 2000, J MARRIAGE FAM, V62, P999, DOI 10.1111/j.1741-3737.2000.00999.x; Crowe SF, 1999, BRAIN INJURY, V13, P347; DAVIS CM, 1998, HDB SEXUALITY RELATE; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; Gutierrez P, 2009, J SEX MED, V6, P2698, DOI 10.1111/j.1743-6109.2009.01315.x; Guzick DS, 2011, FERTIL STERIL, V95, P1568, DOI 10.1016/j.fertnstert.2011.01.027; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Iglesias P. S., 2009, INT J PSYCHOL PSYCHO, V9, P259; King BE, 2000, PSYCHOL REP, V86, P347, DOI 10.2466/pr0.2000.86.1.347; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Larson JH, 1998, J SEX MARITAL THER, V24, P193, DOI 10.1080/00926239808404933; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Masel B.S., 2015, J NEUROTRAUMA; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ortega V, 2006, PSYCHOL REP, V99, P147, DOI 10.2466/PR0.99.1.147-165; Pacagnella RD, 2009, CAD SAUDE PUBLICA, V25, P2333, DOI 10.1590/S0102-311X2009001100004; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sandel ME, 2007, BRAIN INJURY MED PRI, P637; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sidi H, 2007, J SEX MED, V4, P1642, DOI 10.1111/j.1743-6109.2007.00476.x; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Sun XG, 2011, J SEX MED, V8, P1101, DOI 10.1111/j.1743-6109.2010.02171.x; Symonds T, 2005, J SEX MARITAL THER, V31, P385, DOI 10.1080/00926230591006502; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; Wielinski CL, 2010, J SEX MED, V7, P1438, DOI 10.1111/j.1743-6109.2009.01408.x	43	16	16	1	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								247479	10.1155/2015/247479			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CW0MT	WOS:000364684300001	26556951	Green Published, Green Submitted, gold			2022-02-06	
J	Wares, JR; Hoke, KW; Walker, W; Franke, LM; Cifu, DX; Carne, W; Ford-Smith, C				Wares, Joanna R.; Hoke, Kathy W.; Walker, William; Franke, Laura Manning; Cifu, David X.; Carne, William; Ford-Smith, Cheryl			Characterizing effects of mild traumatic brain injury and posttraumatic stress disorder on balance impairments in blast-exposed servicemembers and Veterans using computerized posturography	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						balance; balance impairment; blast exposure; computerized posturography; impairment; mild traumatic brain injury; posttraumatic amnesia; posttraumatic stress disorder; servicemembers; Veterans	CONCUSSION; STABILITY; DIZZINESS; DEFICITS; INSTABILITY; RECOVERY; SPACE; HEAD; PTSD	The high rate of blast exposures experienced by U.S. servicemembers (SMs) during the recent conflicts in Iraq and Afghanistan has resulted in frequent combat-related mild traumatic brain injuries (mTBIs). Dizziness and postural instability can persist after mTBI as a component of postconcussion syndrome, but also occur among the somatic complaints of posttraumatic stress disorder (PTSD). The goals of this study were to examine the use of computerized posturography testing (CPT) to objectively characterize chronic balance deficits after mTBI and to explore the utility of CPT in distinguishing between combat and blast-exposed participants with and without mTBI and PTSD. Data were analyzed from a subject pool of 166 combat-exposed SMs and Veterans who had a blast experience within the past 2 yr while deployed. Using nonparametric tests and measures of impairment, we found that balance was deficient in participants diagnosed with mTBI with posttraumatic amnesia (PTA) or PTSD versus those with neither and that deficits were amplified for participants with both diagnoses. In addition, unique deficiencies were found using CPT for individuals having isolated mTBI with PTA and isolated PTSD. Computerized balance assessment offers an objective technique to examine the physiologic effects and provide differentiation between participants with combat-associated mTBI and PTSD.	[Wares, Joanna R.; Hoke, Kathy W.] Univ Richmond, Dept Math & Comp Sci, Richmond, VA 23173 USA; [Walker, William; Franke, Laura Manning; Cifu, David X.; Carne, William] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Walker, William; Franke, Laura Manning] US Dept Vet Affairs, Def & Vet Brain Injury Ctr, Richmond, VA USA; [Ford-Smith, Cheryl] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA USA		Wares, JR (corresponding author), Univ Richmond, Dept Math & Comp Sci, 28 Westhampton Way, Richmond, VA 23173 USA.	jwares@richmond.edu		Cifu, David/0000-0003-1600-9387	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0095]; Defense and Veterans Brain Injury Center, U.S. Army Medical Research and Materiel Command	This material was based upon work supported by the U.S. Army Medical Research and Materiel Command (award no. W81XWH-13-2-0095). The U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland, is the awarding and administering acquisition office. This material was also based upon work supported with resources and the use of facilities at the Hunter Holmes McGuire VAMC in Richmond, Virginia, and work supported in part by the Defense and Veterans Brain Injury Center, U.S. Army Medical Research and Materiel Command.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; [Anonymous], 2008, DOD VA COD PROP FIN; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; CEVETTE MJ, 1995, OTOLARYNG HEAD NECK, V112, P676, DOI 10.1016/S0194-5998(95)70175-3; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chaudhry H, 2004, J REHABIL RES DEV, V41, P713, DOI 10.1682/JRRD.2003.09.0140; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cripps A, 2013, J SPORT REHABIL, V22, P67, DOI 10.1123/jsr.22.1.67; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; RUBIN AM, 1995, AM J OTOL, V16, P216; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Walker WC, 2011, PM&R, V3, P6, DOI 10.1016/j.pmrj.2010.11.001; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Yardley L, 2000, OTOLARYNG CLIN N AM, V33, P603, DOI 10.1016/S0030-6665(05)70229-2; Yardley L, 1998, J NEUROL NEUROSUR PS, V65, P679, DOI 10.1136/jnnp.65.5.679	48	16	16	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2015	52	5					591	603		10.1682/JRRD.2014.08.0197			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CT2HQ	WOS:000362623000008	26437003	Bronze			2022-02-06	
J	Woodacre, T; Waydia, SE; Wienand-Barnett, S				Woodacre, Timothy; Waydia, Shree Eesh; Wienand-Barnett, Sophie			Aetiology of injuries and the need for protective equipment for surfers in the UK	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Surfing injuries; Trauma; Accident prevention; Emergency medical services; UK	SURFING INJURIES; RIDERS	Background: Surfing is a popular UK water-sport. Previous studies investigating surfing injuries have been principally based on trauma from large waves and reef breaks in the US and Australia. Subsequent conclusions and recommendations for the use of protective equipment in surfing may therefore not be relevant in the UK. Aims: This study examines the aetiology of surfing injuries in the UK. Methods: Data was collected in 2012 using a web-based survey distributed to UK surfing clubs. Surfers recorded time/experience as a surfer, number of episodes spent surfing per month, different breaks surfed and type, frequency and method of any injuries sustained whilst surfing in the UK, including treatment received. Results: Completed surveys were obtained from 130 individuals, M:F division 85: 45, median age 28 (range 17-65). 122 surfers reported a total of 335 injuries. Head injuries were the most common (24%) followed by ankle (19%), knee (13%), back (10%), hand/wrist (9%), elbow/shoulder (7%), trunk (7%), neck (4%), hip (4%) and genitalia (3%) injuries. Surfers collided most often with their own boards (31%). The other collisions were with rocks/coral (15%), the sea (11%), other surf boards (10%) the sea bed (7%), other water vessels (2%) and by paddle-boards (1%). Of 327 injuries, cuts/lacerations (31%) were the commonest type of injury, followed by bruises/peri-orbital ecchymoses (24%), joint/ligament sprains (15%), muscle or tendon tears/ruptures (9%), concussion (5%), fractures (3%) and teeth injuries (1%). The remaining 8 injuries were not categorized. 65% of the surfers never required professional medical treatment for their differing injuries. There were no skull fractures and no head injuries required neurosurgical intervention. Conclusion: Surfing injuries in the UK are common. They appear of a similar aetiology to those reported in the literature in countries with a high surfing population, but generally of a lower severity, with few requiring professional treatment, hospital admission or operative intervention. Concussion appears rare and in this study there were no head injuries that required neurosurgical intervention. Surfing helmets aim to prevent such serious head injuries; whilst they should be considered for injury prevention their routine use is unlikely to be warranted whilst surfing in the UK. (C) 2014 Elsevier Ltd. All rights reserved.	[Woodacre, Timothy; Waydia, Shree Eesh; Wienand-Barnett, Sophie] Royal Cornwall Hosp, Truro TR1 3LJ, Cornwall, England		Woodacre, T (corresponding author), Royal Cornwall Hosp, Dept Trauma & Orthopaed, Truro TR1 3LJ, Cornwall, England.	timwoodacre@yahoo.co.uk					ALLEN RH, 1977, JAMA-J AM MED ASSOC, V237, P668, DOI 10.1001/jama.237.7.668; British Marine Federation, 2007, BMF WAT SPORT LEIS P; Fitzjones O, 1998, STORMRIDER GUIDE EUR, P2; Hay CSM, 2009, WILD ENVIRON MED, V20, P335, DOI 10.1580/1080-6032-020.004.0335; LOWDON BJ, 1983, MED J AUSTRALIA, V2, P613, DOI 10.5694/j.1326-5377.1983.tb122722.x; Nathanson A, 2002, AM J EMERG MED, V20, P155, DOI 10.1053/ajem.2002.32650; Nathanson A, 2007, AM J SPORT MED, V35, P113, DOI 10.1177/0363546506293702; Pikora TJ, 2012, MED SPORT SCI, V58, P80, DOI 10.1159/000338583; Royal Life Saving Society Australia, 2012, NAT DROWN REP; Taylor DM, 2005, WILD ENVIRON MED, V16, P75, DOI 10.1580/1080-6032(2005)16[75:POSRRT]2.0.CO;2; Taylor DM, 2004, J SCI MED SPORT, V7, P429, DOI 10.1016/S1440-2440(04)80260-3	11	16	18	0	21	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					162	165		10.1016/j.injury.2014.07.019			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600030	25173670				2022-02-06	
J	Gardizi, E; Hanks, RA; Millis, SR; Figueroa, MJ				Gardizi, Elmar; Hanks, Robin A.; Millis, Scott R.; Figueroa, Maritza J.			Comorbidity and Insurance as Predictors of Disability After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Comorbidity; Insurance; Rehabilitation; Traumatic brain injury	PHYSICAL-ACTIVITY; RATING-SCALE; HEAD-INJURY; REHABILITATION; COMPLICATIONS; OUTCOMES; TRACHEOTOMY; HYPOTHERMIA; DISORDERS; DISEASE	Objective: To examine the unique contribution of self-reported medical comorbidity and insurance type on disability after traumatic brain injury (TBI). Design: Inception cohort design at 1-year follow up. Setting: A university affiliated rehabilitation hospital. Participants: Adults with mild-complicated to severe TBI (N=70). Intervention: Not applicable. Main Outcome Measures: Self-reported medical comorbidities were measured using the Modified Cumulative Illness Rating Scale, while insurance type was classified as commercial or government-funded; disability was measured using the Disability Rating Scale. Results: Two models were run using multiple linear regression, and the best-fitting model was selected on the basis of Bayesian information criterion. The full model, which included self-reported medical comorbidity and insurance type, was significantly better fitting than the reduced model. Participants with a longer duration of posttraumatic amnesia, more self-reported medical comorbidities, and government insurance were more likely to have higher levels of disability. Meanwhile, individual organ systems were not predictive of disability. Conclusions: The cumulative effect of self-reported medical comorbidities and type of insurance coverage predict disability above and beyond well-known prognostic variables. Early assessment of medical complications and improving services provided by government-funded insurance may enhance quality of life and reduce long-term health care costs. (C) 2014 by the American Congress of Rehabilitation Medicine	[Gardizi, Elmar] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; [Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Figueroa, Maritza J.] Nexus Hlth Syst, Touchstone Neurorecovery Ctr, Conroe, TX USA		Gardizi, E (corresponding author), Univ Windsor, Dept Psychol, Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	gardizi@uwindsor.ca			US Department of Education-National Institute of Disability Research and RehabilitationUS Department of Education [H133A020515]	Supported by the US Department of Education-National Institute of Disability Research and Rehabilitation (grant no. H133A020515).	Adelmann PK, 2003, ADM POLICY MENT HLTH, V31, P111, DOI 10.1023/B:APIH.0000003017.78877.56; [Anonymous], 2012, CHOIC OLD DIS PERS W; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Benumof J, 2007, BENUMOFS AIRWAY MANA; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bihari M, 2010, HMOS VS PPOS WHAT AR; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Chan L, 2000, ARCH PHYS MED REHAB, V81, P715, DOI 10.1016/S0003-9993(00)90098-4; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Corrigan JD, 2011, J HEAD TRAUMA REHAB, V26, P1; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Faul M, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Giaquinto S, 2001, DISABIL REHABIL, V23, P296; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Liou TH, 2005, NUTR REV, V63, P321, DOI [10.1301/nr.2005.oct.321.331, 10.1111/j.1753-4887.2005.tb00110.x]; Lucas JA, 2009, CLIN NEUROPSYCHOLOGY, P351; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Pituch K.A., 2016, APPL MULTIVARIATE ST APPL MULTIVARIATE ST; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Retchin SM, 1997, JAMA-J AM MED ASSOC, V278, P119; Richard I, 2005, ANN FR ANESTH, V24, P659, DOI 10.1016/j.annfar.2005.03.010; Rimmer James H, 2005, Phys Med Rehabil Clin N Am, V16, P41, DOI 10.1016/j.pmr.2004.06.013; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tabachnick B. G., 1989, USING MULTIVARIATE S; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Zafonte RD, 2002, J HEAD TRAUMA REHAB, V17, P322, DOI 10.1097/00001199-200208000-00006	53	16	16	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2014	95	12					2396	2401		10.1016/j.apmr.2014.06.004			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AW0AY	WOS:000345954000022	24972339				2022-02-06	
J	Mauri, MC; Paletta, S; Colasanti, A; Miserocchi, G; Altamura, AC				Mauri, M. C.; Paletta, S.; Colasanti, A.; Miserocchi, G.; Altamura, A. C.			Clinical and neuropsychological correlates of major depression following post-traumatic brain injury, a prospective study	ASIAN JOURNAL OF PSYCHIATRY			English	Article						Traumatic brain injury; Major depression disorder; Psychopathological pattern; Neuropsychological profile	PSYCHIATRIC-DISORDERS; STRESS-DISORDER; RATING-SCALE; AXIS-I; MILD; PSYCHOPATHOLOGY; INDIVIDUALS	Objectives: Major depression disorder (MDD) is the most frequent psychiatric complication after traumatic brain injury (TBI), with a prevalence of 14-77%. The aim of this study was to analyse the psychiatric sequelae of TBI, and to identify the neuropsychological and psychopathological correlates of post-TBI MDD in order to highlight their differences from those of primary MDD. Methods: This was a longitudinal, prospective, case-control study. Sixteen patients with closed brain injury, and a lesion revealed by computed tomography (CT), were recruited and were evaluated one (T1), three (T3) and six (T6) months after discharge from Neurosurgery Department; the controls were six patients with MDD. The psychiatric symptoms were evaluated using brief psychiatric rating scale (BPRS), Hamilton depression rating scale (HRSD), Beck depression inventory scale (BDI), Hamilton anxiety rating scale (HRSA), global assessment of functioning (GAF) and instrumental activity of daily living (IADL). Neuropsychological profiles were assessed by using neuropsychological tests, focused on memory and frontal- executive functioning. Results: At T1, MDD was observed in 10 cases (62.5%), a manic episode in 12.5%, and post- traumatic stress disorder in 6.5%. At T3 and T6, MDD was diagnosed in, respectively, eight (50%) and six cases (37.5%). Post TBI MDD had less severe depressive symptoms, showed greater social isolation and hostility and more cognitive deficits in comparison with the control group. Conclusions: MDD is a frequent TBI complication. Patients with post-TBI MDD have a specific psychopathological profile characterised by a less severe depressive symptomatology and a neuropsychological pattern that is significantly associated with greater deficits in cognitive functions than those with primary MDD. (C) 2014 Elsevier B.V. All rights reserved.	[Mauri, M. C.; Paletta, S.; Altamura, A. C.] IRCCS Fdn, Clin Psychiat Neuropsychopharmacol Unit, Osped Maggiore Policlin, Milan, Italy; [Colasanti, A.] Imperial Coll London, Div Expt Med, Neuropsychopharmacol Unit, London, England; [Miserocchi, G.] IRCCS Fdn, Clin Neurosurg, Osped Maggiore Policlin, Milan, Italy		Mauri, MC (corresponding author), IRCCS Fdn, Clin Psychiat Neuropsychopharmacol Unit, Osped Maggiore Policlin, Milan, Italy.	maurimc@policlinico.mi.it		Colasanti, Alessandro/0000-0001-6017-801X			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; [Anonymous], PREVALENCE SYMPTOM R; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bowen A., 1993, BRAIN INJURY, V13, P547; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Deb S, 1999, AM J PSYCHIAT, V156, P374; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; ELLIOTT FA, 1992, ARCH NEUROL-CHICAGO, V49, P595, DOI 10.1001/archneur.1992.00530300027006; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; First M., 1997, STRUCTURED CLIN INTE; First M.B., 1996, STRUCTURED CLIN INTE; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267, DOI 10.1016/S0033-3182(95)71666-8; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lishman W. A., 1998, ORGANIC PSYCHIAT PSY, p[2, 922]; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; McAllister Thomas W., 1994, P357; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Milner B., 1964, FRONTAL GRANULAR COR, P313; National Center for Injury Prevention and Control, 2006, EL DAT NONF INJ REP; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; OVERALL JE, 1988, PSYCHOPHARMACOL BULL, V24, P97; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Raven J, 1962, COLOURED PROGR MATRI; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468	57	16	17	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1876-2018	1876-2026		ASIAN J PSYCHIATR	Asian J. Psychiatr.	DEC	2014	12						118	124		10.1016/j.ajp.2014.07.003			7	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	V3L2I	WOS:000218357500020	25193507				2022-02-06	
J	Lee, YK; Lee, CW; Huang, MY; Hsu, CY; Su, YC				Lee, Yi-Kung; Lee, Chen-Wen; Huang, Ming-Yuan; Hsu, Chen-Yang; Su, Yung-Cheng			Increased risk of ischemic stroke in patients with mild traumatic brain injury: a nationwide cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Stroke; Traumatic brain injury; National health insurance	LOGISTIC-REGRESSION MODELS; PROPORTIONAL HAZARDS; OUTCOMES; EPIDEMIOLOGY; DISEASE; ADULTS	Background: It is known that the risk of stroke in patients with traumatic brain injury might be increased. However, the relationship between mild traumatic brain injury and ischemic stroke has never been established. We conducted a study of patients in Taiwan with mild traumatic brain injury to evaluate if they had a higher risk of stroke compared with the general population. Methods: We utilized a sampled National Health Insurance claims database containing one million beneficiaries. We followed all adult beneficiaries older than 18 years from January 1, 2007 to December 31, 2010 to determine if they were diagnosed with ischemic stroke. We further identified patients with mild traumatic brain injury and compared their risk of ischemic stroke with the general population. Results: We identified 24,905 patients with mild traumatic brain injury and 719,811 patients without mild traumatic brain injury. After controlling for age, gender, urbanization level, socioeconomic status, diabetes, hypertension, coronary artery disease, hyperlipidemia, history of alcohol intoxication, malignancies, heart failure, atrial fibrillation, smoking, obesity, epilepsy, peripheral artery disease and Charlson Comorbidity Index score, the adjusted hazard ratio for ischemic stroke was 1.46 (95% confidence interval, 1.33-1.62). Conclusion: Mild traumatic brain injury is an independent significant risk factor for ischemic stroke.	[Lee, Yi-Kung; Lee, Chen-Wen; Su, Yung-Cheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Emergency Dept, Dalin Township 622, Chiayi County, Taiwan; [Lee, Yi-Kung; Lee, Chen-Wen; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Ming-Yuan] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Hsu, Chen-Yang] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan		Su, YC (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Emergency Dept, 2 Minsheng Rd, Dalin Township 622, Chiayi County, Taiwan.	drsu119@gmail.com					Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; INGRAM DD, 1989, STAT MED, V8, P525, DOI 10.1002/sim.4780080502; Lazzarino AI, 2013, PSYCHOSOM MED, V75, P311, DOI 10.1097/PSY.0b013e3182898e6d; Lee YK, 2013, EMERG MED J, V30, P620, DOI 10.1136/emermed-2012-201440; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Rodriguez-Sainz Aida, 2013, Curr Treat Options Cardiovasc Med, V15, P322, DOI 10.1007/s11936-013-0236-7; Romero Jose Rafael, 2008, Ther Adv Cardiovasc Dis, V2, P287, DOI 10.1177/1753944708093847; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; van der Net JB, 2008, EUR J HUM GENET, V16, P1111, DOI 10.1038/ejhg.2008.59; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wright MJ, 2014, J CLIN EXP NEUROPSYC, V36, P268, DOI 10.1080/13803395.2014.884543; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	28	16	16	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 19	2014	22								66	10.1186/s13049-014-0066-y			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AX3XX	WOS:000346870100001	25406859	gold, Green Published			2022-02-06	
J	Binder, LM; Larrabee, GJ; Millis, SR				Binder, Laurence M.; Larrabee, Glenn J.; Millis, Scott R.			Intent to Fail: Significance Testing of Forced Choice Test Results	CLINICAL NEUROPSYCHOLOGIST			English	Article						Motivation; Response bias; Performance validity testing; Malingering; Effort	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; DIGIT RECOGNITION TEST; SYMPTOM VALIDITY TEST; RESPONSE BIAS; CLASSIFICATION ACCURACY; BASE RATES; PERFORMANCE; MEMORY	A score that is significantly below the level of chance on a forced choice (FC) performance validity test results from the deliberate production of wrong answers. In order to increase the power of significance testing of a below chance result on standardized FC tests with empirically derived cutoff scores, we recommend using one-tailed tests of significance and selecting probability levels greater than .05 (.20 for most standardized FC tests with empirically derived cutoff scores). Under certain circumstances, we also recommend combining scores from different sections of the same FC test and combining scores across different FC tests. These recommendations require modifications when applied to non-standardized FC tests that lack empirically derived cutoff scores or to FC tests with a non-random topographical distribution of correct and incorrect answers.	[Millis, Scott R.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Binder, LM (corresponding author), 4900 SW Griffith Dr,Suite 244, Beaverton, OR 97005 USA.	pdxlarry@aol.com					Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Binder L. M., 2007, PORTLAND DIGIT RECOG; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Boone K. B., 2007, ASSESSMENT FEIGNED C; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Green P., 2008, ADV INTERPRETATION S; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; PANKRATZ L, 1990, CLIN NEUROPSYCHOL, V4, DOI DOI 10.1080/13854049008401832; Reynolds CR, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P351, DOI 10.1007/978-1-4614-0442-2_13; Reynolds CR, 1998, CRIT ISS NE, P261; Runyon R. P., 2000, FUNDAMENTALS BEHAV S; SIEGEL S, 1956, NONPAREMETRIC STAT B; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Thompson G. B., 2005, VSVT VICTORIA SYMPTO; Tombaugh T.N., 1996, TEST MEMORY MALINGER	28	16	16	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 17	2014	28	8					1366	1375		10.1080/13854046.2014.978383			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AY0KY	WOS:000347286600011	25386898				2022-02-06	
J	Eskandari, R; Abdullah, O; Mason, C; Lloyd, KE; Oeschle, AN; McAllister, JP				Eskandari, Ramin; Abdullah, Osama; Mason, Cameron; Lloyd, Kelley E.; Oeschle, Amanda N.; McAllister, James P., II			Differential vulnerability of white matter structures to experimental infantile hydrocephalus detected by diffusion tensor imaging	CHILDS NERVOUS SYSTEM			English	Article						Infantile hydrocephalus; Diffusion tensor imaging; White matter	NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL OBSTRUCTIVE HYDROCEPHALUS; EXPERIMENTAL NEONATAL HYDROCEPHALUS; KAOLIN-INDUCED HYDROCEPHALUS; FRACTIONAL ANISOTROPY; ALZHEIMER-DISEASE; VENTRICULOPERITONEAL SHUNTS; CORTICOSPINAL TRACT; CLINICAL ARTICLE	The differential vulnerability of white matter (WM) to acute and chronic infantile hydrocephalus and the related effects of early and late reservoir treatment are unknown, but diffusion tensor imaging (DTI) could provide this information. Thus, we characterized WM integrity using DTI in a clinically relevant model. Obstructive hydrocephalus was induced in 2-week-old felines by intracisternal kaolin injection. Ventricular reservoirs were placed 1 (early) or 2 (late) weeks post-kaolin and tapped frequently based solely on neurological deficit. Hydrocephalic and age-matched control animals were sacrificed 12 weeks postreservoir. WM integrity was evaluated in the optic system, corpus callosum, and internal capsule prereservoir and every 3 weeks using DTI. Analyses were grouped as acute (< 6 weeks) or chronic (a parts per thousand yen6 weeks). In the corpus callosum during acute stages, fractional anisotropy (FA) decreased significantly with early and late reservoir placement (p = 0.0008 and 0.0008, respectively), and diffusivity increased significantly in early (axial, radial, and mean diffusivity, p = 0.0026, 0.0012, and 0.0002, respectively) and late (radial and mean diffusivity, p = 0.01 and 0.0038, respectively) groups. Chronically, the corpus callosum was thinned and not detectable by DTI. FA was significantly lower in the optic chiasm and tracts (p = 0.0496 and 0.0052, respectively) with late but not early reservoir placement. In the internal capsule, FA in both reservoir groups increased significantly with age (p < 0.05) but diffusivity remained unchanged. All hydrocephalic animals treated with intermittent ventricular reservoir tapping demonstrated progressive ventriculomegaly. Both reservoir groups demonstrated WM integrity loss, with the CC the most vulnerable and the optic system the most resilient.	[Eskandari, Ramin] Lucile Packard Childrens Hosp, Stanford Childrens Hlth, Palo Alto, CA USA; [Abdullah, Osama; McAllister, James P., II] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Mason, Cameron; Lloyd, Kelley E.; Oeschle, Amanda N.; McAllister, James P., II] Univ Utah, Primary Childrens Med Ctr, Dept Neurosurg, Div Pediat Neurosurg, Salt Lake City, UT USA		Eskandari, R (corresponding author), 96 Jonathon Lucas St,Suite 301 MSC 606, Charleston, SC 29425 USA.	eskandar@musc.edu	McAllister, James P./N-9657-2019		Mentored Young Investigator award from the Hydrocephalus Association; Department of Neurosurgery at the University of Utah	This work was supported in part by the Mentored Young Investigator award from the Hydrocephalus Association to Ramin Eskandari, MD, and James P. McAllister, PhD, and by the Department of Neurosurgery at the University of Utah. We thank Kristin Kraus, MSc, for her superb scientific editing skills; Marion L. Walker, MD, John R. W. Kestle, MD, and Jay Riva-Cambrin, MD for their inspiration and advice; Eric Burdett, DVM, Jack Taylor, DVM, Greg Burns, DVM, Ron Nielsen, DVM, Yunuen Coria, Liana Roberson, Reesha Dennis-Bishop, Jacqueline Brown, Brittani Delaney, Annette Rowberry, Misty Seppi, Kris Carlson, and Chase Bryan for their assistance with animal care and surgery. Implanted ventricular catheters and reservoirs were provided by Integra Scientific (Plainsboro, NJ, USA) and Medtronic (Medtronic Inc USA, Minneapolis, MN, USA).	Air EL, 2010, J NEUROSURG-PEDIATR, V5, P385, DOI 10.3171/2009.11.PEDS09343; Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cancelliere A, 2013, AM J NEURORADIOL, V34, P1443, DOI 10.3174/ajnr.A3350; Castillo EM, 2009, NEUROREPORT, V20, P1188, DOI 10.1097/WNR.0b013e32832f0ca6; CHUMAS PD, 1994, J NEUROSURG, V80, P491, DOI 10.3171/jns.1994.80.3.0491; Ciumas C, 2014, BRAIN, V137, P1095, DOI 10.1093/brain/awu039; Del Bigio MR, 2012, J NEUROPATH EXP NEUR, V71, P274, DOI 10.1097/NEN.0b013e31824c1b44; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; Del Bigio MR, 2004, BRAIN PATHOL, V14, P317; Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453; Demura K, 2012, ACTA NEUROCHIR SUPPL, V113, P29, DOI 10.1007/978-3-7091-0923-6_6; Di Curzio DL, 2013, EXP NEUROL, V248, P112, DOI 10.1016/j.expneurol.2013.06.004; Eskandari R, 2004, J NEUROSURG, V101, P196, DOI 10.3171/ped.2004.101.2.0196; Eskandari R, 2012, CHILD NERV SYST, V28, P1849, DOI 10.1007/s00381-012-1848-z; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; Feldman HM, 2012, DEV MED CHILD NEUROL, V54, P809, DOI 10.1111/j.1469-8749.2012.04378.x; George E, 2014, CHILD NERV SYST, V30, P1135, DOI 10.1007/s00381-013-2351-x; Griffith JL, 2012, PEDIATR RES, V71, P185, DOI 10.1038/pr.2011.33; Hasan KM, 2008, J NEUROSURG-PEDIATR, V2, P75, DOI 10.3171/PED/2008/2/7/075; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hattori T, 2012, AM J NEURORADIOL, V33, P274, DOI 10.3174/ajnr.A2780; Hattori T, 2012, AM J NEURORADIOL, V33, P97, DOI 10.3174/ajnr.A2706; Hattori T, 2011, AM J NEURORADIOL, V32, P1681, DOI 10.3174/ajnr.A2570; Heemskerk AM, 2013, AM J NEURORADIOL, V34, P1496, DOI 10.3174/ajnr.A3465; HOCHWALD GM, 1969, EXP NEUROL, V25, P190, DOI 10.1016/0014-4886(69)90043-0; Ivkovic M, 2013, AM J NEURORADIOL, V34, P1168, DOI 10.3174/ajnr.A3368; Jang SH, 2011, NEUROREHABILITATION, V28, P345, DOI 10.3233/NRE-2011-0662; Jang SH, 2013, INT J NEUROSCI, V123, P420, DOI 10.3109/00207454.2012.763164; Jurcoane A, 2014, NEURORADIOLOGY, V56, P5, DOI 10.1007/s00234-013-1289-8; Kanno S, 2011, J NEUROL, V258, P1949, DOI 10.1007/s00415-011-6038-5; Kaur S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085807; KEONG NC, 2008, CLIN NEUROL NEUROSUR, V110, pS4; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kim MJ, 2011, AM J NEURORADIOL, V32, P1496, DOI 10.3174/ajnr.A2531; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Koyama T, 2013, NEUROL MED-CHIR, V53, P601; Koyama T, 2012, NEUROL MED-CHIR, V52, P68, DOI 10.2176/nmc.52.68; KRIEBEL RM, 1993, EXP NEUROL, V119, P89, DOI 10.1006/exnr.1993.1009; Kwon SH, 2014, CLIN PERINATOL, V41, P257, DOI 10.1016/j.clp.2013.10.003; Langevin LM, 2014, J PEDIATR-US, V164, P1157, DOI 10.1016/j.jpeds.2014.01.018; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Lepomaki V, 2012, PEDIATR RADIOL, V42, P692, DOI 10.1007/s00247-012-2352-z; Lepomaki VK, 2012, PEDIATR RADIOL, V42, P175, DOI 10.1007/s00247-011-2234-9; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; LOVELY TJ, 1989, J NEUROSCI METH, V29, P201, DOI 10.1016/0165-0270(89)90144-1; LOVELY TJ, 1989, NEUROSURGERY, V24, P43, DOI 10.1227/00006123-198901000-00007; Mahoney CJ, 2014, HUM BRAIN MAPP, V35, P4163, DOI 10.1002/hbm.22468; Marumoto K, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-20; Mathur AM, 2010, SEMIN PERINATOL, V34, P57, DOI 10.1053/j.semperi.2009.10.006; McAllister II JP, 2011, YOUMANS TXB NEUROLOG, P2002; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; MCALLISTER JP, 1991, NEUROSURGERY, V29, P329, DOI 10.1227/00006123-199109000-00001; McAllister JP, 1998, NEUROSURG CLIN N AM, V9, P73; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Nicot B, 2014, ACTA RADIOL, V55, P614, DOI 10.1177/0284185113504570; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Rajagopal A, 2013, AM J NEURORADIOL, V34, P2379, DOI 10.3174/ajnr.A3737; SAHAR A, 1969, ARCH NEUROL-CHICAGO, V21, P638, DOI 10.1001/archneur.1969.00480180094009; Scheel M, 2012, ACTA NEUROCHIR, V154, P1699, DOI 10.1007/s00701-012-1377-2; Song YJC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084825; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sun M, 2012, CHILD NERV SYST, V28, P199, DOI 10.1007/s00381-011-1651-2; Sun SW, 2014, J ALZHEIMERS DIS, V38, P93, DOI 10.3233/JAD-130236; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Teipel SJ, 2014, EUR ARCH PS IN PRESS; Teipel SJ, 2013, MED CLIN N AM, V97, P399, DOI 10.1016/j.mcna.2012.12.013; Thompson DK, 2014, CORTEX, V52, P60, DOI 10.1016/j.cortex.2013.11.010; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; WRIGHT LC, 1991, PEDIATR NEUROSURG, V16, P139; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan W, 2013, AM J NEURORADIOL, V34, P439, DOI 10.3174/ajnr.A3218; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663; Yuan W, 2009, CEREBROSPINAL FLUID, V6, pS14; Yuan W, 2013, J PEDIATR NEURORADIO, V2, P119, DOI 10.3233/PNR-13052; Yuan WH, 2012, CHILD NERV SYST, V28, P47, DOI 10.1007/s00381-011-1590-y; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19; Zhang X, 2013, J CLIN CELL IMMUNO S, V7; Zhang X, 2014, CHINESE MED J-PEKING, V127, P532, DOI 10.3760/cma.j.issn.0366-6999.20123147	91	16	16	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2014	30	10					1651	1661		10.1007/s00381-014-2500-x			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AP7US	WOS:000342283200004	25070594	Bronze			2022-02-06	
J	Kramer, CL; Rabinstein, AA; Wijdicks, EFM; Hocker, SE				Kramer, Christopher L.; Rabinstein, Alejandro A.; Wijdicks, Eelco F. M.; Hocker, Sara E.			Neurologist Versus Machine: Is the Pupillometer Better than the Naked Eye in Detecting Pupillary Reactivity	NEUROCRITICAL CARE			English	Article						Pupillometer; Neurological examination; Brain death; Uncal herniation; Neurocritical care; Pupillary reactivity	QUALITY STANDARDS SUBCOMMITTEE; AMERICAN ACADEMY; SCALE; COMA	A 62-year-old man with severe traumatic brain injury developed postsurgical anisocoria in which there was a discrepancy between pupillometer and manual testing. Case report. The patient's larger pupil was read as unreactive by the pupillometer but constricted 1 mm over 7-9 s of continuous light stimulation. While pupillometry assessment is a valuable adjunct to the manual pupillary assessment, this case demonstrates that nonreactive pupils read on the pupillometer should be confirmed with the manual examination because it can miss very slowly reacting pupils.	[Kramer, Christopher L.; Rabinstein, Alejandro A.; Wijdicks, Eelco F. M.; Hocker, Sara E.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA		Kramer, CL (corresponding author), Mayo Clin, Dept Neurol, Mary Brigh 8-D,200 First St SW, Rochester, MN 55905 USA.	kramer.christopher1@mayo.edu; Rabinstein.Alejandro@mayo.edu; wijde@mayo.edu; Hocker.Sara@mayo.edu					Bushnell CD, 1999, NEUROLOGY, V52, P1374, DOI 10.1212/WNL.52.7.1374; Clark A, 2006, EMERG MED J, V23, P440, DOI 10.1136/emj.2005.030247; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; LARSON MD, 1995, ARCH NEUROL-CHICAGO, V52, P369, DOI 10.1001/archneur.1995.00540280051018; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; VANDENBERGE JH, 1979, J NEUROL NEUROSUR PS, V42, P1163, DOI 10.1136/jnnp.42.12.1163; Walters BC, 2000, BRAIN TRAUMA FDN GUI, P186; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wilson S F, 1988, J Neurosci Nurs, V20, P189	12	16	17	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					309	311		10.1007/s12028-014-9988-5			3	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900019	24865269				2022-02-06	
J	Ploplis, VA; Donahue, DL; Sandoval-Cooper, MJ; MorenoCaffaro, M; Sheets, P; Thomas, SG; Walsh, M; Castellino, FJ				Ploplis, Victoria A.; Donahue, Deborah L.; Sandoval-Cooper, Mayra J.; MorenoCaffaro, Maria; Sheets, Patrick; Thomas, Scott G.; Walsh, Mark; Castellino, Francis J.			Systemic Platelet Dysfunction Is the Result of Local Dysregulated Coagulation and Platelet Activation in the Brain in a Rat Model of Isolated Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; coagulopathy; platelet dysfunction	TISSUE FACTOR; COAGULOPATHY	Coagulopathy after severe traumatic brain injury (TBI) has been extensively reported. Clinical studies have identified a strong relationship between diminished platelet-rich thrombus formation, responsiveness to adenosine diphosphate agonism, and severity of TBI. The mechanisms that lead to platelet dysfunction in the acute response to TBI are poorly understood. The development of a rodent model of TBI that mimics the coagulopathy observed clinically has recently been reported. Using immunohistochemical techniques and thromboelastography platelet mapping, the current study demonstrated that the expression of coagulation (tissue factor and fibrin) and platelet activation (P-selectin) markers in the injured brain paralleled the alteration in systemic platelet responsiveness to the agonists, adenosine diphosphate and arachodonic acid. Results of this study demonstrate that local procoagulant changes in the injured brain have profound effects on systemic platelet function.	[Ploplis, Victoria A.; Donahue, Deborah L.; Sandoval-Cooper, Mayra J.; MorenoCaffaro, Maria; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Sheets, Patrick] Indiana Univ Sch Med South Bend, South Bend, IN USA; [Thomas, Scott G.; Walsh, Mark] Mem Hosp South Bend, South Bend, IN USA		Ploplis, VA (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA.	vploplis@nd.edu		Walsh, Mark/0000-0002-5795-1144	NIH NHLBI grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL019982]; Haemonetics Corporation (Braintree, MA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL019982] Funding Source: NIH RePORTER	This study was supported in parts from a NIH NHLBI grant (HL019982 to FJC) and a reagent grant from Haemonetics Corporation (Braintree, MA).	Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Utter GH, 2002, J TRAUMA, V52, P1071, DOI 10.1097/00005373-200206000-00008	17	16	16	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2014	31	19					1672	1675		10.1089/neu.2013.3302			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AP5VI	WOS:000342146400009	24605991	Green Published			2022-02-06	
J	Hwang, DW; Jin, Y; Lee, DH; Kim, HY; Cho, HN; Chung, HJ; Park, Y; Youn, H; Lee, SJ; Lee, HJ; Kim, SU; Wang, KC; Lee, DS				Hwang, Do Won; Jin, Yeona; Lee, Do Hun; Kim, Han Young; Cho, Han Na; Chung, Hye Jin; Park, Yunwoong; Youn, Hyewon; Lee, Seung Jin; Lee, Hong J.; Kim, Seung U.; Wang, Kyu-Chang; Lee, Dong Soo			In Vivo Bioluminescence Imaging for Prolonged Survival of Transplanted Human Neural Stem Cells Using 3D Biocompatible Scaffold in Corticectomized Rat Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; PROGENITOR CELLS; FIREFLY LUCIFERASE; MOTOR FUNCTION; SPINAL-CORD; TISSUE; DIFFERENTIATION; EXPRESSION	Stem cell-based treatment of traumatic brain injury has been limited in its capacity to bring about complete functional recovery, because of the poor survival rate of the implanted stem cells. It is known that biocompatible biomaterials play a critical role in enhancing survival and proliferation of transplanted stem cells via provision of mechanical support. In this study, we noninvasively monitored in vivo behavior of implanted neural stem cells embedded within poly-L-lactic acid (PLLA) scaffold, and showed that they survived over prolonged periods in corticectomized rat model. Corticectomized rat models were established by motor-cortex ablation of the rat. F3 cells expressing enhanced firefly luciferase (F3-effLuc) were established through retroviral infection. The F3-effLuc within PLLA was monitored using IVIS-100 imaging system 7 days after corticectomized surgery. F3-effLuc within PLLA robustly adhered, and gradually increased luciferase signals of F3-effLuc within PLLA were detected in a day dependent manner. The implantation of F3-effLuc cells/PLLA complex into corticectomized rats showed longer-lasting luciferase activity than F3-effLuc cells alone. The bioluminescence signals from the PLLA-encapsulated cells were maintained for 14 days, compared with 8 days for the non-encapsulated cells. Immunostaining results revealed expression of the early neuronal marker, Tuj-1, in PLLA-F3-effLuc cells in the motor-cortexablated area. We observed noninvasively that the mechanical support by PLLA scaffold increased the survival of implanted neural stem cells in the corticectomized rat. The image-guided approach easily proved that scaffolds could provide supportive effect to implanted cells, increasing their viability in terms of enhancing therapeutic efficacy of stem-cell therapy.	[Hwang, Do Won; Jin, Yeona; Kim, Han Young; Park, Yunwoong; Youn, Hyewon; Lee, Dong Soo] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Hwang, Do Won; Kim, Han Young; Lee, Dong Soo] Seoul Natl Univ, WCU Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Lee, Do Hun] Univ Miami, Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Cho, Han Na; Chung, Hye Jin; Lee, Seung Jin] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ, Canc Hosp, Canc Imaging Ctr, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Hong J.; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Wang, Kyu-Chang] Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea		Wang, KC (corresponding author), Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea.	kcwang@sun.ac.kr; dsl@plaza.snu.ac.kr		Youn, Hyewon/0000-0003-1006-2689	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2008799]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1299]	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2008799), and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1299). The funders had no role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gonzalez CLR, 2004, EUR J NEUROSCI, V20, P3442, DOI 10.1111/j.1460-9568.2004.03751.x; Hermanns S, 2001, J NEUROSCI METH, V110, P141, DOI 10.1016/S0165-0270(01)00427-7; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Hwang DW, 2008, EUR J NUCL MED MOL I, V35, P1887, DOI 10.1007/s00259-008-0751-z; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jung MR, 2011, J CONTROL RELEASE, V152, P294, DOI 10.1016/j.jconrel.2011.03.002; Lee DH, 2009, CHILD NERV SYST, V25, P1547, DOI 10.1007/s00381-009-0973-9; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Payne RG, 2002, BIOMATERIALS, V23, P4373, DOI 10.1016/S0142-9612(02)00185-0; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023; Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sitthinamsuwan Bunpot, 2013, Journal of the Medical Association of Thailand, V96, P121; Srouji S, 2006, REGEN MED, V1, P519, DOI 10.2217/17460751.1.4.519; Tabata Yasuhiko, 2004, Congenital Anomalies, V44, P111, DOI 10.1111/j.1741-4520.2004.00024.x; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Zhang X, 2013, SEIZURE, V9, P1059	41	16	16	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105129	10.1371/journal.pone.0105129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4JX	WOS:000341304700014	25198726	Green Published, Green Submitted, gold			2022-02-06	
J	Grant, M; Radford, K; Sinclair, E; Walker, M				Grant, Mary; Radford, Kathryn; Sinclair, Emma; Walker, Marion			Return to work after stroke: recording, measuring, and describing occupational therapy intervention	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Stroke; vocational rehabilitation; research	TRAUMATIC BRAIN-INJURY; VOCATIONAL-REHABILITATION; BLACK-BOX; BARRIERS; IMPACT	Introduction: Existing research on vocational rehabilitation following stroke has been criticised for not describing intervention in sufficient detail for replication or clinical implementation. The purpose of this study was to test the feasibility of recording and measuring the content of an early stroke-specific vocational rehabilitation intervention delivered to participants in a feasibility randomized controlled trial, using a proforma previously developed for a study of vocational rehabilitation following traumatic brain injury. Method: The proforma was adapted for use in stroke with input from an expert panel and was used to record intervention content, in 10-minute units, following each intervention session. Findings: Twenty-five people, working or in education at the time of stroke, participated in the study. Two thirds of the therapists' time was spent in face-to-face contact (43%) and liaison with the patient and others (20%). Intervention mainly focused on work preparation (21%) and the return to work process (24%). The remaining time was consumed by administration (19%) and travel (18%). Conclusion: The proforma was quick and easy to use and captured the main focus of intervention. This study suggests that it can be used to record stroke-specific vocational rehabilitation intervention content and has potential for wider use in research and clinical practice.	[Grant, Mary; Radford, Kathryn; Sinclair, Emma; Walker, Marion] Univ Nottingham, Div Rehabil & Ageing, Nottingham NG7 2UH, England		Grant, M (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Div Rehabil & Ageing, B114 B Floor, Nottingham NG7 2UH, England.	mcxmig@nottingham.ac.uk	Radford, Kate A/F-8571-2013	Radford, Kate A/0000-0001-6246-3180; Walker, Marion/0000-0002-3534-591X	National Institute of Health Research - Collaborative Leadership in Health Research and Care - Nottinghamshire, Derbyshire and Lincolnshire; Elizabeth Casson Trust through the United Kingdom Occupational Therapy Research Foundation; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10092] Funding Source: researchfish	The study was funded by National Institute of Health Research - Collaborative Leadership in Health Research and Care - Nottinghamshire, Derbyshire and Lincolnshire. It is also part of the first author's PhD study, funded by the Elizabeth Casson Trust through the United Kingdom Occupational Therapy Research Foundation. The funders had no other part in the direction of the study.	Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; [Anonymous], 2005, CLIN REHABIL, V19, P811, DOI 10.1191/0269215505cr923ed; Baldwin C, 2011, TOP STROKE REHABIL, V18, P562, DOI 10.1310/tsr1805-562; Black C., 2008, WORKING HLTH TOMORRO; Care Quality Commission, 2011, SUPP LIF STROK REV S; CLAHRC-NDL, 2013, STROK REH RES; Coole C, 2013, J OCCUP REHABIL, V23, P406, DOI 10.1007/s10926-012-9401-1; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; *DEP WORK PENS, 2004, BUILD CAP WORK UK FR; *DEP WORK PENS, 2005, HLTH WORK WELLB CAR; Department for Work and Pensions, 2012, DIS EMPL SUPP FULF P; Department of Health, 2005, NAT SERV FRAM LONG T; Department of Health, 2010, NHS OUTC FRAM 2011 1; Deshpande P, 2004, VOCATIONAL ASSESSMEN; Doucet T., 2012, Annals of Physical and Rehabilitation Medicine, V55, P112, DOI 10.1016/j.rehab.2012.01.007; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Frost D., 2011, HLTH WORK INDEPENDEN; Grant MI, 2012, INT J STROKE, V7, P20; Hart T, 2009, NEUROPSYCHOL REHABIL, V19; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Lock S, 2005, DISABIL SOC, V20, P33, DOI 10.1080/0968759042000283629; Medical Research Council (MRC), 2008, DEV EVALUATING COMPL; Office for National Statistics, 2000, STAND OCC CLASS 2000; Phillips J, 2010, BRIT J OCCUP THER, V73, P422, DOI 10.4276/030802210X12839367526138; Playford ED, 2011, MAPPING VOCATIONAL R; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Radford KA, 2008, BRAIN IMPAIR, V9, P161, DOI 10.1375/brim.9.2.161; Saeki S, 2010, J REHABIL MED, V42, P254, DOI 10.2340/16501977-0503; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Stroke Association, 2012, WHAT IS STROK; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Tyerman A, 2004, VOCATIONAL ASSESSMEN; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Wade DT, 2003, CLIN REHABIL, V17, P1, DOI 10.1191/0269215503cr578ed; Wade DT, 2001, CLIN REHABIL, V15, P1, DOI 10.1191/026921501675961253; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D	36	16	16	1	26	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	SEP	2014	77	9					457	465		10.4276/030802214X14098207541072			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AP0HJ	WOS:000341741800006		Green Submitted, Green Accepted			2022-02-06	
J	Lacny, S; Marshall, DA; Currie, G; Kulin, NA; Meeuwisse, WH; Kang, J; Emery, CA				Lacny, Sarah; Marshall, Deborah A.; Currie, Gillian; Kulin, Nathalie A.; Meeuwisse, Willem H.; Kang, Jian; Emery, Carolyn A.			Reality check: the cost-effectiveness of removing body checking from youth ice hockey	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RISK-FACTORS; SPORT PARTICIPATION; ECONOMIC-EVALUATION; INJURY RATES; SURVEILLANCE; CONCUSSION; PLAYERS; PROGRAM; CALGARY	Background/aim The risk of injury among Pee Wee (ages 11-12 years) ice hockey players in leagues that allow body checking is threefold greater than in leagues that do not allow body checking. We estimated the cost-effectiveness of a no body checking policy versus a policy that allows body checking in Pee Wee ice hockey. Methods Cost-effectiveness analysis alongside a prospective cohort study during the 2007-2008 season, including players in Quebec (n=1046), where policy did not allow body checking, and in Alberta (n=1108), where body checking was allowed. Injury incidence rates (injuries/1000 player-hours) and incidence proportions (injuries/100 players), adjusted for cluster using Poisson regression, allowed for standardised comparisons and meaningful translation to community stakeholders. Based on Alberta fee schedules, direct healthcare costs (physician visits, imaging, procedures) were adjusted for cluster using bootstrapping. We examined uncertainty in our estimates using cost-effectiveness planes. Results Associated with significantly higher injury rates, healthcare costs where policy allowed body checking were over 2.5 times higher than where policy disallowed body checking ($C473/1000 player-hours (95% CI $C358 to $C603) vs $C184/1000 player-hours (95% CI $C120 to $C257)). The difference in costs between provinces was $C289/1000 player-hours (95% CI $C153 to $C432). Projecting results onto Alberta Pee Wee players registered in the 2011-2012 season, an estimated 1273 injuries and $C213 280 in healthcare costs would be avoided during just one season with the policy change. Conclusion Our study suggests that a policy disallowing body checking in Pee Wee ice hockey is cost-saving (associated with fewer injuries and lower costs) compared to a policy allowing body checking. As we did not account for long-term outcomes, our results underestimate the economic impact of these injuries.	[Lacny, Sarah; Marshall, Deborah A.; Currie, Gillian; Kulin, Nathalie A.; Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Marshall, Deborah A.] Alberta Bone & Joint Hlth Inst, Calgary, AB, Canada; [Marshall, Deborah A.] McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Currie, Gillian; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Currie, Gillian; Emery, Carolyn A.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Meeuwisse, Willem H.; Kang, Jian; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada		Emery, CA (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca	Emery, Carolyn/AAI-2761-2020; Marshall, Deborah/J-7248-2015	Marshall, Deborah/0000-0002-8467-8008	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Max Bell Foundation; Alberta Innovates [201201160] Funding Source: researchfish	This study was funded by the Canadian Institutes of Health Research and Max Bell Foundation.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Billette J., 2011, INJURIES CANADA INSI; Canadian Heritage, 2012, SPORT PART 2010; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Currie G, 2000, Inj Prev, V6, P175, DOI 10.1136/ip.6.3.175; Cusimano Michael D, 2011, Open Med, V5, pe57; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Drawer S, 2001, BRIT J SPORT MED, V35, P402, DOI 10.1136/bjsm.35.6.402; Drummond M. F., 2005, METHODS EVALUATION H; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Gillquist J, 1999, SPORTS MED, V27, P143, DOI 10.2165/00007256-199927030-00001; Goldberg AS, 2007, SPORTS MED, V37, P265, DOI 10.2165/00007256-200737030-00005; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Harris AW, 2012, CLIN J SPORT MED, V22, P455, DOI 10.1097/JSM.0b013e318259ed09; Hockey Alberta, HOCK ALB 2012 ANN RE; Hupperets MDW, 2010, AM J SPORT MED, V38, P2194, DOI 10.1177/0363546510373470; Krist MR, 2013, J PHYSIOTHER, V59, P15, DOI 10.1016/S1836-9553(13)70142-5; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; SMARTRISK, 2009, EC BURD INJ CAN, P12; StataCorp, 2011, STAT STAT SOFTW REL; Statistics Canada, 2012, CANSIM TABL 326 0021; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Verhagen EALM, 2005, BRIT J SPORT MED, V39, P111, DOI 10.1136/bjsm.2003.011031; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783	30	16	16	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2014	48	17					1299	1305		10.1136/bjsports-2014-093493			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AM9ZQ	WOS:000340241000008	24907373				2022-02-06	
J	Reed, N; Murphy, J; Dick, T; Mah, K; Paniccia, M; Verweel, L; Dobney, D; Keightley, M				Reed, Nick; Murphy, James; Dick, Talia; Mah, Katie; Paniccia, Melissa; Verweel, Lee; Dobney, Danielle; Keightley, Michelle			A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 91; concussion; children; youth; athletes; assessment; management; rehabilitation	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; ICE HOCKEY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; CHILDREN; REHABILITATION; DYSFUNCTION; MANAGEMENT; ZURICH	Concussion is one of the most commonly reported injuries amongst children and youth involved in sport participation. Following a concussion, youth can experience a range of short and long term neurobehavioral symptoms (somatic, cognitive and emotional/behavioral) that can have a significant impact on one's participation in daily activities and pursuits of interest (e. g., school, sports, work, family/social life, etc.). Despite this, there remains a paucity in clinically driven research aimed specifically at exploring concussion within the youth sport population, and more specifically, multi-modal approaches to measuring recovery. This article provides an overview of a novel and multi-modal approach to measuring recovery amongst youth athletes following concussion. The presented approach involves the use of both pre-injury/baseline testing and postinjury/follow-up testing to assess performance across a wide variety of domains (post-concussion symptoms, cognition, balance, strength, agility/motor skills and resting state heart rate variability). The goal of this research is to gain a more objective and accurate understanding of recovery following concussion in youth athletes (ages 10-18 years). Findings from this research can help to inform the development and use of improved approaches to concussion management and rehabilitation specific to the youth sport community.	[Reed, Nick; Murphy, James; Dick, Talia; Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Reed, Nick; Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada; [Reed, Nick; Mah, Katie; Paniccia, Melissa; Verweel, Lee; Dobney, Danielle; Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada		Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	NReed@hollandbloorview.ca	Meijer, Anna/K-5118-2016		Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	We would like to thank the Canadian Institutes of Health Research (CIHR) who have provided funding for this research. Further, we would like to acknowledge Dr. Tim Taha and Dr. Scott Thomas from the University of Toronto for their assistance with the development of our protocol for the collection of resting state heart rate variability data.	Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Keightley M, 2013, INT J SPORTS MED, V34, P756, DOI 10.1055/s-0032-1327574; Khan F., MED J AUSTR, V178, P290; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Korpelainen JT, 1996, ACTA NEUROL SCAND, V94, P337, DOI 10.1111/j.1600-0404.1996.tb07076.x; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Reed N, 2012, BRAIN INJURY, V26, P766; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	22	16	16	0	14	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	SEP	2014		91							e51892	10.3791/51892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB0FM	WOS:000349301100056	25285728	Green Published			2022-02-06	
J	Zhou, L; Lin, JH; Lin, JM; Kui, GJ; Zhang, JH; Yu, YG				Zhou, Long; Lin, Jinhuang; Lin, Junming; Kui, Guoju; Zhang, Jianhua; Yu, Yigang			Neuroprotective effects of vagus nerve stimulation on traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injury; vagus nerve stimulation; tumor necrosis factor-alpha; interleukin-1 beta; interleukin-10; brain tissue pathology; protection; explosive injury; mechanisms; hydrocephalus; neural regeneration	SYSTEMIC INFLAMMATORY RESPONSE; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; CLINICAL-TRIAL; RATS; SECONDARY; EPILEPSY; BARRIER; NEURONS	Previous studies have shown that vagus nerve stimulation can improve the prognosis of traumatic brain injury. The aim of this study was to elucidate the mechanism of the neuroprotective effects of vagus nerve stimulation in rabbits with brain explosive injury. Rabbits with brain explosive injury received continuous stimulation (10 V, 5 Hz, 5 ms, 20 minutes) of the right cervical vagus nerve. Tumor necrosis factor-alpha, interleukin-1 beta and interleulcin-10 concentrations were detected in serum and brain tissues, and water content in brain tissues was measured. Results showed that vagus nerve stimulation could reduce the degree of brain edema, decrease tumor necrosis factor-alpha and interleuldn-1 beta concentrations, and increase interleukin-10 concentration after brain explosive injury in rabbits. These data suggest that vagus nerve stimulation may exert neuroprotective effects against explosive injury via regulating the expression of tumor necrosis factor-alpha, interleukin-1 beta and interleukin-10 in the serum and brain tissue.	[Zhou, Long; Lin, Jinhuang; Lin, Junming; Kui, Guoju; Yu, Yigang] Xiamen Univ, Affiliated Dongnan Hosp, Hosp Chinese PLA 175, Trauma Neurosurg Ctr Nanjing Mil Reg, Xiamen 363000, Fujian, Peoples R China; [Zhang, Jianhua] 73131 Corps Chinese PLA, Xiamen, Fujian, Peoples R China		Yu, YG (corresponding author), Xiamen Univ, Affiliated Dongnan Hosp, Hosp Chinese PLA 175, Trauma Neurosurg Ctr Nanjing Mil Reg, Xiamen 363000, Fujian, Peoples R China.	yu-yg@tom.com					Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Kumaria A, 2012, BRIT J NEUROSURG, V26, P316, DOI 10.3109/02688697.2012.663517; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Jimenez CM, 2013, WORLD NEUROSURG, V79, P749, DOI 10.1016/j.wneu.2012.06.025; Merrill CA, 2006, J CLIN PSYCHIAT, V67, P1171, DOI 10.4088/JCP.v67n0801; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Shi C, 2013, NEUROL RES, V35, P263, DOI 10.1179/1743132813Y.0000000167; Sjogren MJC, 2002, J CLIN PSYCHIAT, V63, P972, DOI 10.4088/JCP.v63n1103; Stella N, 2012, SCIENCE, V338, P1303, DOI 10.1126/science.1232331; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang XL, 2013, ZHONGHUA SHIYAN WAIK, V30, P1484; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	23	16	19	0	6	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	SEP	2014	9	17					1585	1591		10.4103/1673-5374.141783			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AQ7AK	WOS:000342964800004	25368644	Green Published, gold			2022-02-06	
J	Kushner, DS; Alvarez, G				Kushner, David S.; Alvarez, Gemayaret			Dual Diagnosis Traumatic Brain Injury with Spinal Cord Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Dual diagnosis; Traumatic brain injury; Spinal cord trauma; Diagnosis; Prognosis; Complications; Rehabilitation	POSTTRAUMATIC HYDROCEPHALUS; SWALLOWING DISORDERS; RISK-FACTORS; MILD; REHABILITATION; TBI; HYPOPITUITARISM; MANAGEMENT; SPASTICITY; DYSPHAGIA	Spinal cord injury (SCI) patients should be assessed for a co-occurring traumatic brain injury (TBI) on admission to a rehabilitation program. Incidence of a dual diagnosis may approach 60% with certain risk factors. Diagnosis of mild-moderate severity TBIs may be missed during acute care hospitalizations of SCI. Neuropsychological symptoms of a missed TBI diagnosis may be perceived during rehabilitation as noncompliance, inability to learn, maladaptive reactions to SCI, and poor motivation. There are life-threatening and quality-of-life threatening complications of TBI that also may be missed if a dual diagnosis is not made.	[Kushner, David S.; Alvarez, Gemayaret] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33101 USA		Kushner, DS (corresponding author), Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, POB 016960 D-461, Miami, FL 33101 USA.	dkushner@med.miami.edu	Kushner, David S./AAW-4951-2020	Kushner, David S./0000-0001-6090-6304			Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Aimaretti G, 2005, THESCIENTIFICWORLDJO, V5, P777, DOI 10.1100/tsw.2005.100; [Anonymous], 2011, Continuum (Minneap Minn), V17, P646, DOI 10.1212/01.CON.0000399079.30556.03; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Guyot LL, 2000, NEUROL RES, V22, P25; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; HINOKI M, 1985, ACTA OTO-LARYNGOL, P9; Hsieh JTC, 2007, TOP SPINAL CORD INJ, V13, P81; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kirshblum S, 1999, ARCH PHYS MED REHAB, V80, P1101, DOI 10.1016/S0003-9993(99)90068-0; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Kushner DS, 2013, AM J PHYS MED REHAB, V92, P486, DOI 10.1097/PHM.0b013e31828762ec; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; National Data and Statistical Center, TRAUM BRAIN INJ MOD; National Institute on Disabilities Rehabilitation and Research Spinal Cord Injury Model Systems, SPIN CORD INJ MOD SY; OTT DJ, 1993, AM J ROENTGENOL, V161, P507, DOI 10.2214/ajr.161.3.8352094; Roberts A, 2013, J CHILD ORTHOP, V7, P389, DOI 10.1007/s11832-013-0512-9; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Saout V., 2011, Annals of Physical and Rehabilitation Medicine, V54, P259, DOI 10.1016/j.rehab.2011.04.003; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Thompson AJ, 2005, J NEUROL NEUROSUR PS, V76, P459, DOI 10.1136/jnnp.2004.035972; Tian W, 2013, DYSPHAGIA, V28, P131, DOI 10.1007/s00455-012-9421-1; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WILSON PR, 1991, CLIN J PAIN, V7, P5, DOI 10.1097/00002508-199103000-00003; Zafonte R, 2004, J HEAD TRAUMA REHAB, V19, P89, DOI 10.1097/00001199-200403000-00002; [No title captured]	50	16	18	1	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	AUG	2014	25	3					681	+		10.1016/j.pmr.2014.04.005			18	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	AN6UU	WOS:000340734700013	25064795				2022-02-06	
J	Lange, RT; Shewchuk, JR; Rauscher, A; Jarrett, M; Heran, MKS; Brubacher, JR; Iverson, GL				Lange, Rael T.; Shewchuk, Jason R.; Rauscher, Alexander; Jarrett, Michael; Heran, Manraj K. S.; Brubacher, Jeffrey R.; Iverson, Grant L.			A Prospective Study of the Influence of Acute Alcohol Intoxication Versus Chronic Alcohol Consumption on Outcome Following Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Alcohol intoxication; Traumatic brain injury; Concurrent; Diffusion tensor imaging; Lifetime alcohol abuse	SERUM ETHANOL LEVELS; SUBSTANCE-ABUSE; WHITE-MATTER; HEAD-INJURY; POLYSUBSTANCE ABUSE; CORPUS-CALLOSUM; LEVEL; DISRUPTION; RECOVERY; ROBUST	The purpose of the study was to disentangle the relative contributions of day-of-injury alcohol intoxication and pre-injury alcohol misuse on outcome from TBI. Participants were 142 patients enrolled from a Level 1 Trauma Center (in Vancouver, Canada) following a traumatic brain injury (TBI; 43 uncomplicated mild TBI and 63 complicated mild-severe TBI) or orthopedic injury [36 trauma controls (TC)]. At 6-8 weeks post-injury, diffusion tensor imaging (DTI) of the whole brain was undertaken using a Phillips 3T scanner. Participants also completed neuropsychological testing, an evaluation of lifetime alcohol consumption (LAC), and had blood alcohol levels (BALs) taken at the time of injury. Participants in the uncomplicated mild TBI and complicated mild-severe TBI groups had higher scores on measures of depression and postconcussion symptoms (d = 0.45-0.83), but not anxiety, compared with the TC group. The complicated mild-severe TBI group had more areas of abnormal white matter on DTI measures (all p < .05; d = 0.54-0.61) than the TC group. There were no difference between groups on all neurocognitive measures. Using hierarchical regression analyses and generalized linear modeling, LAC and BAL did provide a unique contribution toward the prediction of attention and executive functioning abilities; however, the variance accounted for was small. LAC and BAL did not provide a unique and meaningful contribution toward the prediction of self-reported symptoms, DTI measures, or the majority of neurocognitive measures. In this study, BAL and LAC were not predictive of mental health symptoms, postconcussion symptoms, cognition, or white-matter changes at 6-8 weeks following TBI.	[Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Lange, Rael T.; Shewchuk, Jason R.; Rauscher, Alexander; Jarrett, Michael; Heran, Manraj K. S.; Brubacher, Jeffrey R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Shewchuk, Jason R.; Heran, Manraj K. S.; Brubacher, Jeffrey R.] Vancouver Gen Hosp, Vancouver, BC, Canada; [Rauscher, Alexander; Jarrett, Michael] UBC MRI Res Ctr, Vancouver, BC, Canada; [Rauscher, Alexander] UBC Brain Res Ctr, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Univ, Sch Med, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 8,Room 2264,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rael.t.lange@us.army.mil		Iverson, Grant/0000-0001-7348-9570; Jarrett, Michael/0000-0002-3702-2014; Rauscher, Alexander/0000-0002-1961-8252; Brubacher, Jeffrey/0000-0002-4866-4231	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200903MOP-200377-BSB-CAAA-161276]; Alcohol Beverage Medical Research Foundation	This work was primarily supported by the Canadian Institutes of Health Research (200903MOP-200377-BSB-CAAA-161276 to RL, GI, JB, and MH); and in part by the Alcohol Beverage Medical Research Foundation (to RL, GI, JB, and MH).	Akshoomoff N A, 1989, Arch Clin Neuropsychol, V4, P275, DOI 10.1016/0887-6177(89)90018-8; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Altura BM, 1999, ALCOHOL, V19, P119, DOI 10.1016/S0741-8329(99)00025-7; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Barba M, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-23; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Beatty M. E., 1994, DRUG ALCOHOL DEPEN, V37, P247; Beck AT, 1993, BECK ANXIETY INVENTO; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; BRANDT J, 1983, ARCH GEN PSYCHIAT, V40, P435; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Canadian Institute for Health Information, 2002, ONT TRAUM REG B ALC; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CHARNESS ME, 1993, ALCOHOL CLIN EXP RES, V17, P2, DOI 10.1111/j.1530-0277.1993.tb00718.x; Cohen J., 2013, STAT POWER ANAL BEHA; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cowie S. E., 2005, CAN TRAUM SCI M WHIS; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; Errico A. L., 1991, PSYCHOL ASSESSMENT, V3, P693; ERRICO AL, 1990, PSYCHOL ASSESSMENT, V2, P45, DOI DOI 10.1037/1040-3590.2.1.45; Fan AZ, 2006, EUR J EPIDEMIOL, V21, P129, DOI 10.1007/s10654-005-5457-y; Fein G, 1998, ALCOHOL CLIN EXP RES, V22, p196S, DOI 10.1111/j.1530-0277.1998.tb04000.x; Freudenheim JL, 2003, J NUTR, V133, P3619, DOI 10.1093/jn/133.11.3619; GORDON SM, 1988, J SUBST ABUSE TREAT, V5, P99, DOI 10.1016/0740-5472(88)90019-0; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Gururaj G, 2004, J Indian Med Assoc, V102, P157; HARPER CG, 1985, BRIT MED J, V290, P501, DOI 10.1136/bmj.290.6467.501; Hayashi PH, 2004, AM J GASTROENTEROL, V99, P76, DOI 10.1046/j.1572-0241.2003.04013.x; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JENSEN GB, 1993, LANCET, V342, P1201; JERNIGAN T, 1992, IMAGING ALCOHOL RES, P121; Kamphaus, 2003, REYNOLDS INTELLECTUA; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; KRAMER JH, 1989, ALCOHOL CLIN EXP RES, V13, P240, DOI 10.1111/j.1530-0277.1989.tb00320.x; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kreutzer J. S., 1990, COGNITIVE REHABILITA, V8, P14; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Ma XY, 2005, ALCOHOL CLIN EXP RES, V29, P1214, DOI 10.1097/01.ALC.0000171934.22755.6D; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; McCann SE, 1999, AM J EPIDEMIOL, V150, P334, DOI 10.1093/oxfordjournals.aje.a010012; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; Miller Norman S., 1994, P471; MUURONEN A, 1989, ALCOHOL CLIN EXP RES, V13, P137, DOI 10.1111/j.1530-0277.1989.tb00298.x; National Institute on Alcoholism and Alcohol Abuse, 2005, HELP PAT WHO DRINK T; Nixon SJ, 1999, PSYCHOL SCI, V10, P181, DOI 10.1111/1467-9280.00130; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Paraherakis A, 2001, SUBST USE MISUSE, V36, P257, DOI 10.1081/JA-100102625; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; PARSONS OA, 1993, NEUROL CLIN, V11, P205, DOI 10.1016/S0733-8619(18)30178-6; PARSONS OA, 1990, ALCOHOL CLIN EXP RES, V14, P746, DOI 10.1111/j.1530-0277.1990.tb01239.x; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1111/j.1530-0277.2000.tb02086.x; Pfefferbaum A, 2005, NEUROPSYCHOPHARMACOL, V30, P423, DOI 10.1038/sj.npp.1300623; Pfefferbaum A, 2002, ALCOHOL CLIN EXP RES, V26, P1031, DOI 10.1097/01.ALC.0000021146.01778.55; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Pfefferbaum A, 2006, NEUROBIOL AGING, V27, P994, DOI 10.1016/j.neurobiolaging.2005.05.007; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.3.CO;2-J; *PSYCH CORP, 2001, WECHSL TEST AD READ; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rosenbloom M, 2003, ALCOHOL RES HEALTH, V27, P146; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Russell M, 1998, DRUG ALCOHOL REV, V17, P377, DOI 10.1080/09595239800187221; Russell M, 2001, SUBST USE MISUSE, V36, P1417, DOI 10.1081/JA-100106958; Russell M, 1997, AM J EPIDEMIOL, V146, P975; SACHS H, 1987, ARCH NEUROL-CHICAGO, V44, P1242, DOI 10.1001/archneur.1987.00520240024007; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schunemann Holger J, 2002, Sleep Breath, V6, P161, DOI 10.1007/s11325-002-0161-6; Schunemann Holger J, 2002, BMC Pulm Med, V2, P3, DOI 10.1186/1471-2466-2-3; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Stranges S, 2004, HEPATOLOGY, V39, P754, DOI 10.1002/hep.20149; Sullivan EV, 1996, ALCOHOL CLIN EXP RES, V20, P348, DOI 10.1111/j.1530-0277.1996.tb01651.x; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Tate PS, 1999, BRAIN INJURY, V13, P767; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Turner AP, 2006, REHABIL PSYCHOL, V51, P78, DOI 10.1037/0090-5550.51.1.78; Van Zijl, 2004, MRI ATLAS HUMAN WHIT; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; White T, 2003, NEUROPSYCHOLOGICAL A; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296; [No title captured]	123	16	16	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2014	29	5					478	495		10.1093/arclin/acu027			18	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AM6AZ	WOS:000339944200008	24964748	hybrid			2022-02-06	
J	Yang, DB; Yu, WH; Dong, XQ; Du, Q; Shen, YF; Zhang, ZY; Zhu, Q; Che, ZH; Liu, QJ; Wang, H; Jiang, L; Du, YF				Yang, Ding-Bo; Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Shen, Yong-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Jiang, Li; Du, Yuan-Feng			Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury	PEPTIDES			English	Article						Copeptin; Traumatic brain injury; Acute traumatic coagulopathy; Progressive hemorrhagic injury; Biomarker	BIOMARKER; DISEASE	Higher plasma copeptin levels correlate with poor clinical outcomes after traumatic brain injury. Nevertheless, their links with acute traumatic coagulopathy and progressive hemorrhagic injury are unknown. Therefore, we aimed to investigate the relationship between plasma copeptin levels, acute traumatic coagulopathy and progressive hemorrhagic injury in patients with severe traumatic brain injury. We prospectively studied 100 consecutive patients presenting within 6 h from head trauma. Progressive hemorrhagic injury was present when the follow-up computerized tomography scan reported any increase in size or number of the hemorrhagic lesion, including newly developed ones. Acute traumatic coagulopathy was defined as an activated partial thromboplastic time greater than 40s and/or international normalized ratio greater than 1.2 and/or a platelet count less than 120 x 10(9)/L. We measured plasma copeptin levels on admission using an enzyme-linked immunosorbent assay in a blinded fashion. In multivariate logistic regression analysis, plasma copeptin level emerged as an independent predictor of progressive hemorrhagic injury and acute traumatic coagulopathy. Using receiver operating characteristic curves, we calculated areas under the curve for progressive hemorrhagic injury and acute traumatic coagulopathy. The predictive performance of copeptin was similar to that of Glasgow Coma Scale score. However, copeptin did not obviously improve the predictive value of Glasgow Coma Scale score. Thus, copeptin may help in the prediction of progressive hemorrhagic injury and acute traumatic coagulopathy after traumatic brain injury. (C) 2014 Elsevier Inc. All rights reserved.	[Yang, Ding-Bo; Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Shen, Yong-Feng; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Jiang, Li; Du, Yuan-Feng] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou Peoples Hosp 1, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Zhejiang Province Medical and Health Project [2014KYA177]	This study was supported by a grant from Zhejiang Province Medical and Health Project (No. 2014KYA177).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anand T, 2012, J SURG RES, V178, P321, DOI 10.1016/j.jss.2012.02.062; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.021; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Giannopoulos G, 2013, CURR TOP MED CHEM, V13, P231, DOI 10.2174/15680266113139990088; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lin C, 2013, PEPTIDES, V42, P43, DOI 10.1016/j.peptides.2013.01.015; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Wu X, 2014, J TRAUMA ACUTE CARE, V76, P114, DOI 10.1097/TA.0b013e3182a8fe48; Yalta K, 2013, INT J CARDIOL, V167, P1750, DOI 10.1016/j.ijcard.2012.12.039; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	25	16	21	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	AUG	2014	58						26	29		10.1016/j.peptides.2014.05.015			4	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AN0XR	WOS:000340307800005	24905622				2022-02-06	
J	Bosch, M; McKenzie, JE; Mortimer, D; Tavender, EJ; Francis, JJ; Brennan, SE; Knott, JC; Ponsford, JL; Pearce, A; O'Connor, DA; Grimshaw, JM; Rosenfeld, JV; Gruen, RL; Green, SE				Bosch, Marije; McKenzie, Joanne E.; Mortimer, Duncan; Tavender, Emma J.; Francis, Jill J.; Brennan, Sue E.; Knott, Jonathan C.; Ponsford, Jennie L.; Pearce, Andrew; O'Connor, Denise A.; Grimshaw, Jeremy M.; Rosenfeld, Jeffrey V.; Gruen, Russell L.; Green, Sally E.		NET Program	Implementing evidence-based recommended practices for the management of patients with mild traumatic brain injuries in Australian emergency care departments: study protocol for a cluster randomised controlled trial	TRIALS			English	Article						Mild traumatic brain injury; Cluster trial; Emergency department	MINOR HEAD-INJURY; GENERALIZED ESTIMATING EQUATIONS; NEW-ORLEANS CRITERIA; GLASGOW COMA SCALE; WESTMEAD PTA SCALE; COMPUTED-TOMOGRAPHY; QUALITY IMPROVEMENT; ORGANIZATIONAL READINESS; POSTTRAUMATIC AMNESIA; COGNITIVE IMPAIRMENT	Background: Mild head injuries commonly present to emergency departments. The challenges facing clinicians in emergency departments include identifying which patients have traumatic brain injury, and which patients can safely be sent home. Traumatic brain injuries may exist with subtle symptoms or signs, but can still lead to adverse outcomes. Despite the existence of several high quality clinical practice guidelines, internationally and in Australia, research shows inconsistent implementation of these recommendations. The aim of this trial is to test the effectiveness of a targeted, theory- and evidence-informed implementation intervention to increase the uptake of three key clinical recommendations regarding the emergency department management of adult patients (18 years of age or older) who present following mild head injuries (concussion), compared with passive dissemination of these recommendations. The primary objective is to establish whether the intervention is effective in increasing the percentage of patients for which appropriate post-traumatic amnesia screening is performed. Methods/design: The design of this study is a cluster randomised trial. We aim to include 34 Australian 24-hour emergency departments, which will be randomised to an intervention or control group. Control group departments will receive a copy of the most recent Australian evidence-based clinical practice guideline on the acute management of patients with mild head injuries. The intervention group will receive an implementation intervention based on an analysis of influencing factors, which include local stakeholder meetings, identification of nursing and medical opinion leaders in each site, a train-the-trainer day and standardised education and interactive workshops delivered by the opinion leaders during a 3 month period of time. Clinical practice outcomes will be collected retrospectively from medical records by independent chart auditors over the 2 month period following intervention delivery (patient level outcomes). In consenting hospitals, eligible patients will be recruited for a follow-up telephone interview conducted by trained researchers. A cost-effectiveness analysis and process evaluation using mixed-methods will be conducted. Sample size calculations are based on including 30 patients on average per department. Outcome assessors will be blinded to group allocation.	[Bosch, Marije; Tavender, Emma J.; Rosenfeld, Jeffrey V.; Gruen, Russell L.] Monash Univ, Dept Surg, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Bosch, Marije; Tavender, Emma J.; Ponsford, Jennie L.; Rosenfeld, Jeffrey V.; Gruen, Russell L.] Alfred & Monash Univ, Natl Trauma Res Inst, Melbourne, Vic, Australia; [McKenzie, Joanne E.; Brennan, Sue E.; O'Connor, Denise A.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Mortimer, Duncan] Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia; [Francis, Jill J.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Knott, Jonathan C.] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Knott, Jonathan C.] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Pearce, Andrew] MedSTAR Emergency Med Retrieval Serv, Adelaide, SA, Australia; [Pearce, Andrew] Royal Adelaide Hosp, Emergency Dept, Adelaide, SA 5000, Australia; [Grimshaw, Jeremy M.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Gruen, Russell L.] Alfred Hosp, Dept Trauma, Melbourne, Vic, Australia		Bosch, M (corresponding author), Monash Univ, Dept Surg, Cent Clin Sch, Melbourne, Vic 3004, Australia.	marije.bosch@monash.edu	Morley, Peter/G-5280-2017; Harris, Claire/J-1899-2019; O'Connor, Denise/ABC-6655-2020; Cooper, D. James/G-7961-2013; McDonald, Steve/AAE-1613-2020; McKenzie, Joanne E/I-2925-2014; MUNOZ, ROSA ANA/H-3964-2018	Morley, Peter/0000-0003-2653-090X; Harris, Claire/0000-0002-5367-8144; O'Connor, Denise/0000-0002-6836-122X; Cooper, D. James/0000-0002-5872-9051; McDonald, Steve/0000-0003-2832-5205; McKenzie, Joanne E/0000-0003-3534-1641; MUNOZ, ROSA ANA/0000-0002-7504-2163; Mortimer, Duncan Stuart/0000-0002-7211-6454; Francis, Jill/0000-0001-5784-8895; Meares, Susanne/0000-0002-3859-9974; Green, Sally Elizabeth/0000-0002-9564-9050; Tavender, Emma/0000-0002-7230-712X; Morokoff, Andrew/0000-0002-5159-3438; Kaye, Andrew Henry/0000-0001-5049-8861; Brennan, Sue/0000-0003-1789-8809; Fitzgerald, Mark/0000-0003-0183-7761; Cameron, Peter/0000-0002-1443-557X	Victorian Transport Accident Commission (TAC), Australia; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian NHMRC Public Health FellowshipNational Health and Medical Research Council of Australia [606726]	This protocol is part of a 5-year grant (the Neurotrauma Evidence Translation (NET) Program), funded by the Victorian Transport Accident Commission (TAC), Australia. The TAC has had no involvement in the study design, preparation of the manuscript, or the decision to submit the manuscript for publication. RLG is supported by a Practitioner Fellowship from the Australian National Health and Medical Research Council. DAO is supported by an Australian NHMRC Public Health Fellowship (606726). JMG holds a Canada Research Chair in Health Knowledge and Transfer.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson NR, 1998, J ORGAN BEHAV, V19, P235, DOI 10.1002/(SICI)1099-1379(199805)19:3<235::AID-JOB837>3.3.CO;2-3; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Australasian Society for Emergency Medicine (ASEM), 2009, DIR EM DEP AUSTR NZ; Baker DP, 2006, HEALTH SERV RES, V41, P1576, DOI 10.1111/j.1475-6773.2006.00566.x; Bay E, 2011, ADV EMERG NURS J, V33, P181, DOI 10.1097/TME.0b013e318217c958; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Berger VW, 2010, CONTEMP CLIN TRIALS, V31, P406, DOI 10.1016/j.cct.2010.05.001; Bosch M, 2013, J EVAL CLIN PRACT, V19, P763, DOI 10.1111/j.1365-2753.2012.01835.x; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brazier JE, 2008, PRONEWSL, V40, P14; Brown R, 2009, INT J EMERG MED, V2, P161, DOI 10.1007/s12245-009-0124-9; Campbell A, 2005, CLIN GOVT INT J, V10, P2, DOI DOI 10.1108/14777270510579305; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Carlin JB, 1999, STAT MED, V18, P2655, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2655::AID-SIM202>3.0.CO;2-#; Compton S, 2007, ACAD EMERG MED, V14, P991, DOI 10.1197/j.aem.2007.06.031; Copas AJ, 2010, J APPL STAT, V37, P911, DOI 10.1080/02664760902939604; Dillman DA., 2007, MAIL INTERNET SURVEY; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Fitzmaurice GM, 2004, APPL LONGITUDINAL AN, P353; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Frambach RT, 2002, J BUS RES, V55, P163, DOI 10.1016/S0148-2963(00)00152-1; Francis J., 2004, CONSTRUCTING QUESTIO; Francis JJ, 2010, PSYCHOL HEALTH, V25; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gallo A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-116; Glynn RJ, 2007, MED CARE, V45, pS38, DOI 10.1097/MLR.0b013e318070c0a0; Goh S., 1997, EUR MANAG J, V15, P575, DOI [10.1016/S0263-2373(97)00036-4, DOI 10.1016/S0263-2373(97)00036-4]; Green SE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-74; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grimshaw JM, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-38; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P788, DOI 10.1136/jech.2003.014415; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Health Services Research Unit, DAT ICCS; Helfrich CD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-38; Hemming K, 2013, STATA J, V13, P114, DOI 10.1177/1536867X1301300109; Heng K. W. J., 2007, SMJ Singapore Medical Journal, V48, P1107; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hrisos S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-37; Hulscher MEJL, 2003, QUAL SAF HEALTH CARE, V12, P40, DOI 10.1136/qhc.12.1.40; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kerr J, 2007, EMERG MED J, V24, P330, DOI 10.1136/emj.2006.044230; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kissane DW, 2006, AM J PSYCHIAT, V163, P1208, DOI 10.1176/appi.ajp.163.7.1208; Kivimaki M, 1999, J OCCUP ORGAN PSYCH, V72, P241, DOI 10.1348/096317999166644; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McDonald AM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-74; McRae AD, 2011, TRIALS, V12, DOI [10.1186/1745-6215-12-183, 10.1186/1745-6215-12-202]; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Miller L, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-7; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Norman R, 2013, AUST NZ J PUBL HEAL, V37, P17, DOI 10.1111/1753-6405.12005; NSW Institute of Trauma and Injury Management, 2011, IN MAN CLOS HEAD INJ; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Pare G, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-15; Peachey T, 2011, EMERG MED J, V28, P707, DOI 10.1136/emj.2010.093872; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Scott SD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-65; SENN SJ, 1989, STAT MED, V8, P467, DOI 10.1002/sim.4780080410; Sharpe S, 2012, J PAEDIATR CHILD H, V48, P170, DOI 10.1111/j.1440-1754.2011.02068.x; Sheehan A, 2012, EMERG MED J, V29, P899, DOI 10.1136/emermed-2011-200155; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; StataCorp, 2011, STAT STAT SOFTW REL; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI [10.1007/s11606-006-0267-9, 10.1111/j.1525-1497.2006.00355.x]; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taljaard M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2496; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; TEASDALE G, 1974, LANCET, V2, P81; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Treweek S., 2011, TRIALS S1, V12, pA110; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub4, 10.1002/14651858.MR000013.pub5]; Ukoumunne O.C., 1999, HEALTH TECHNOL ASSES, V3, P3, DOI DOI 10.3310/hta3050; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; von Wild KRH, 2008, ACT NEUR S, V101, P55; Walker AE, 2000, J EVAL CLIN PRACT, V6, P185, DOI 10.1046/j.1365-2753.2000.00235.x; Walshe K, 2007, INT J QUAL HEALTH C, V19, P57, DOI 10.1093/intqhc/mzm004; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	116	16	16	6	30	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 11	2014	15								281	10.1186/1745-6215-15-281			20	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	AL7ZD	WOS:000339355100001	25012235	gold, Green Published, Green Accepted			2022-02-06	
J	Di Battista, A; Godfrey, C; Soo, C; Catroppa, C; Anderson, V				Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki			Depression and Health Related Quality of Life in Adolescent Survivors of a Traumatic Brain Injury: A Pilot Study	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; ANXIETY DISORDERS; SYMPTOMS; RELIABILITY; PREVALENCE; PREDICTORS; CHILDHOOD; SEVERITY; VALIDITY; IMPACT	Traumatic brain injury is (TBI) a leading cause of morbidity and mortality in youth. Adult survivors of a severe pediatric TBI are vulnerable to global impairments, including greater employment difficulties, poor quality of life (HRQoL) and increased risk of mental health problems. When estimating the health related quality of life in adolescents, the presence of anxiety and depression and the quality of social relationships are important considerations, because adolescents are entrenched in social development during this phase of maturation. The influence of anxiety, depression and loneliness on health related quality of life in adolescent survivors of TBI has not been documented. This pilot study aimed to identify and measure the relationship between anxiety, depression and loneliness and perceived health related quality of life in adolescent survivors of a TBI. Method: mixed method/cohort pilot study (11 adolescents, mild to severe TBI; 9 parents), using self-report and proxy-report measures of anxiety, depression, health related quality of life, loneliness and clinical psychiatric interviews (adolescent only). Results: Self-reported depression was significantly correlated with self-reported HRQoL (rs [11] = 20.88, p<0.001). Age at injury was significantly correlated with self-reported HRQoL (rs [11] = -0.68, p = 0.02). Self-reported depression predicted self-reported HRQoL (R-2 = 0.79, F [1,10] = 33.48, p<0.001), but age at injury did not (R-2 = 0.19, F [1,10] = 2.09, p = 0.18). Conclusions: Our results suggest that depression is a predictor of health related quality of life in youth post-TBI. The possibility of using targeted assessment and therapy for depression post-TBI to improve health related quality of life should be explored.	[Di Battista, Ashley; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia; [Di Battista, Ashley] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Di Battista, A (corresponding author), Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia.	ashley.dibattista@sickkids.ca	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Victorian Government; Victorian Neurotrauma Initiative; Australian National Health & Medical Research CouncilNational Health and Medical Research Council of Australia; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research (CIHR), CanadaCanadian Institutes of Health Research (CIHR); Victorian Government, Australia	Funding provided by Victorian Government Operational Infrastructure Scheme, Victorian Neurotrauma Initiative - fellowship to CS, Australian National Health & Medical Research Council - fellowships to VA and CC and Canadian Institutes of Health Research - Doctoral Research Award to AD. This research was supported in part by grants from the Canadian Institutes of Health Research (CIHR) Doctoral Research Award (DRA), Canada - awarded to ADB, and the Victorian Government Operations Infrastructure Funding, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Anderson VA, 2010, J NEUROTRAUM, V27, P1; Avenevoli S, 2001, BIOL PSYCHIAT, V49, P1071, DOI 10.1016/S0006-3223(01)01142-8; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bloom D, 1997, J INT NEUROPSYCH SOC, V5, P127; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Eapen V, 2012, CURR OPIN PSYCHIATR, V25, P7, DOI 10.1097/YCO.0b013e32834de3bd; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Gibbon M., 1997, USERS GUIDE STRUCTUR; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HODGES K, 1993, J CHILD PSYCHOL PSYC, V34, P49, DOI 10.1111/j.1469-7610.1993.tb00967.x; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Hoza B, 2000, J CLIN CHILD PSYCHOL, V29, P119, DOI 10.1207/S15374424jccp2901_12; Irons C, 2005, J ADOLESCENCE, V28, P325, DOI 10.1016/j.adolescence.2004.07.004; Juvonen J., 2001, PEER HARASSMENT SCH; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kazadin AE, 1983, J AM ACAD CHILD ADOL, V22, P157; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kovacs M., 1992, CHILDRENS DEPRESSION; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCarthy ML, 2006, ARCH PHYS MED REHAB, V160, P253; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Saro J, 2013, BEST PRACTICES USING; SCHMIDT N, 1983, J PERS SOC PSYCHOL, V44, P1038, DOI 10.1037/0022-3514.44.5.1038; Spielberger C.D., 1989, STATE TRAIT ANXIETY; Statistics ABo, 2008, STAT ABO ED UPD 17 J; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Ware JE, 1994, SF 36 PHYSL MENTAL H; Wechsler D, 1999, CORPORATION TP	42	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101842	10.1371/journal.pone.0101842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	WOS:000338763800045	25010719	gold, Green Published, Green Submitted			2022-02-06	
J	Matsuda, PN; Taylor, CS; Shumway-Cook, A				Matsuda, Patricia Noritake; Taylor, Catherine S.; Shumway-Cook, Anne			Evidence for the Validity of the Modified Dynamic Gait Index Across Diagnostic Groups	PHYSICAL THERAPY			English	Article							MULTIPLE-SCLEROSIS; VESTIBULAR DISORDERS; DETECTABLE CHANGE; OLDER-ADULTS; BALANCE; PEOPLE; RELIABILITY; STROKE; AMBULATION	Background. The modified Dynamic Gait Index (mDGI) measures the capacity to adapt gait to complex tasks utilizing 8 tasks and 3 facets of performance. The measurement stability of the mDGI in specific diagnostic groups is unknown. Objective. This study examined the psychometric properties of the mDGI in 5 diagnostic groups. Design. This was a cross-sectional, descriptive study. Methods. A total of 794 participants were included in the study: 140 controls, 239 with stroke, 140 with vestibular dysfunction, 100 with traumatic brain injury, 91 with gait abnormality, and 84 with Parkinson disease. Differential item functioning analysis was used to examine the comparability of scores across diagnoses. Internal consistency was computed using Cronbach alpha. Factor analysis was used to examine the factor loadings for the 3 performance facet scores. Minimal detectable change at the 95% confidence level (MDC95%) was calculated for each of the groups. Results. Less than 5% of comparisons demonstrated moderate to large differential item functioning, suggesting that item scores had the same order of difficulty for individuals in all 5 diagnostic groups. For all 5 patient groups, 3 factors had eigen-values >1.0 and explained 80% of the variability in scores, supporting the importance of characterizing mobility performance with respect to time, level of assistance, and gait pattern. Limitations. There were uneven sample sizes in the 6 groups. Conclusions. The strength of the psychometric properties of the mDGI across the 5 diagnostic groups further supports the validity and usefulness of scores for clinical and research purposes. In addition, the meaning of a score from the mDGI, regardless of whether at the task, performance facet, or total score level, was comparable across the 5 diagnostic groups, suggesting that the mDGI measured mobility function independent of medical diagnosis.	[Matsuda, Patricia Noritake; Shumway-Cook, Anne] Univ Washington, Dept Rehabil Med, Div Phys Therapy, Seattle, WA 98195 USA; [Taylor, Catherine S.] Univ Washington, Coll Educ, Seattle, WA 98195 USA		Matsuda, PN (corresponding author), Univ Washington, Dept Rehabil Med, Div Phys Therapy, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA.	pmatsuda@u.washington.edu	Matsuda, Patricia/T-3606-2019		Department of Rehabilitation Medicine, University of Washington; Walter C. and Anita C. Stolov Research Fund	This study was supported by a grant from the Walter C. and Anita C. Stolov Research Fund, Department of Rehabilitation Medicine, University of Washington. The authors thank the testing sites, physical therapists, and all of the participants for their contributions to this study.	Cattaneo D, 2006, DISABIL REHABIL, V28, P789, DOI 10.1080/09638280500404289; Chiu YP, 2006, PHYS THER, V86, P778, DOI 10.1093/ptj/86.6.778; Dye DC, 2013, PHYS THER, V93, P809, DOI 10.2522/ptj.20120163; Fidalgo AM, 2004, EDUC PSYCHOL MEAS, V64, P925, DOI 10.1177/0013164404267288; Forsberg A, 2013, PHYS THER, V93, P1369, DOI 10.2522/ptj.20120284; Hall Courtney D, 2006, J Neurol Phys Ther, V30, P74; Huang SL, 2011, PHYS THER, V91, P114, DOI 10.2522/ptj.20090126; Jonsdottir J, 2007, ARCH PHYS MED REHAB, V88, P1410, DOI 10.1016/j.apmr.2007.08.109; Kerlinger F.N., 1973, MULTIPLE REGRESSION; Lin JH, 2010, STROKE, V41, P2021, DOI 10.1161/STROKEAHA.110.589739; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Marchetti GF, 2008, PHYS THER, V88, P640, DOI 10.2522/ptj.20070130; Marchetti GF, 2006, PHYS THER, V86, P1651, DOI 10.2522/ptj.20050402; MAZOR KM, 1992, EDUC PSYCHOL MEAS, V52, P443, DOI 10.1177/0013164492052002020; McConvey J, 2005, ARCH PHYS MED REHAB, V86, P130, DOI 10.1016/j.apmr.2003.11.033; Messick S., 1989, ED MEASUREMENT, V3, P13; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; Pett MA., 2003, MAKING SENSE FACTOR; Portney LG., 2008, FDN CLIN RES APPL PR, V3rd ed; Romero S, 2011, J GERIATR PHYS THER, V34, P131, DOI 10.1519/JPT.0b013e3182048006; Shumway-Cook A., 2011, MOTOR CONTROL TRANSL, V4th; Shumway-Cook A, 2013, PHYS THER, V93, P1493, DOI 10.2522/ptj.20130035; Tristan A, 2006, RASCH MEASUREMENT T, V20, P1070; Wert DM, 2013, ARCH GERONTOL GERIAT, V57, P198, DOI 10.1016/j.archger.2013.04.007; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; [No title captured]	27	16	16	1	16	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2014	94	7					996	1004		10.2522/ptj.20130294			9	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	AK1IZ	WOS:000338170100010	24557650	Bronze			2022-02-06	
J	Seifi, A; Asadi-Pooya, AA; Carr, K; Maltenfort, M; Emami, M; Bell, R; Moussouttas, M; Yazbeck, M; Rincon, F				Seifi, Ali; Asadi-Pooya, Ali Akbar; Carr, Kevin; Maltenfort, Mitchell; Emami, Mehrdad; Bell, Rodney; Moussouttas, Michael; Yazbeck, Moussa; Rincon, Fred			The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematoma in the United States	SPRINGERPLUS			English	Article						Subdural hematoma; Status epilepticus; Risk factors; Mortality	TRAUMATIC BRAIN-INJURY; NONCONVULSIVE STATUS EPILEPTICUS; SUBARACHNOID HEMORRHAGE; POSTTRAUMATIC EPILEPSY; BURR-HOLE; SEIZURES; POPULATION; EVACUATION; PREVALENCE; DISCHARGES	Introduction: Subdural hematoma (SDH) is a well described risk factor in the development of Status Epilepticus (SE), however the epidemiology of SE after SDH is unknown. In this study, we sought to determine the epidemiology of SE, the prevalence of risk factors, and impact on hospital mortality using a large administrative dataset. Methods: Data was derived from the Nationwide Inpatient Sample from 1988 through 2011. We queried the NIS database for patients older than 18 years, with a diagnosis of SDH and SE. Diagnoses were defined by ICD 9 CM codes 432.1, 852.2, 852.3 and 345.3 for SE. Adjusted incidence rates of admission and prevalence proportions were calculated. Multivariate logistic models were then fitted to assess for the impact of status epilepticus on hospital mortality. Results: Over the 23-year period, we identified more than 1,583,255 admissions with a diagnosis of SDH. The prevalence of SE in this cohort was 0.5% (7,421 admissions). The population adjusted incidence rate of admissions of SDH increased from 13/100,000 in 1988 to 38/100,000 in 2011. The prevalence of SE in SDH, increased from 0.5% in 1988 to 0.7% in 2011. In hospital mortality of patients with SDH and without SE decreased from 17.9% to 10.3% while in hospital mortality of patients with SDH and SE did not statistically change. Mortality increased over the same period (2.3/100,000 in 1988 to 3.9/100.000 in 2011) and the diagnosis of SE increased mortality in this cohort (OR 2.17, p < 0.0001). The risk of SE remained stable throughout the study period, but was higher among older patients, blacks, and in those with respiratory, metabolic, hematological, and renal system dysfunction. Conclusion: Our study demonstrates that the incidence of admissions of SDH is increasing in the United States. Despite a decline in the overall SDH related mortality, SE increased the risk of in-hospital death in patients with a primary diagnosis of SDH.	[Seifi, Ali; Carr, Kevin] Univ Texas Hlth Sci Ctr San Antonio, Div Neurocrit Care, Dept Neurosurg, San Antonio, TX 78229 USA; [Asadi-Pooya, Ali Akbar; Emami, Mehrdad] Shiraz Univ Med Sci, Neurosci Res Ctr, Shiraz, Iran; [Asadi-Pooya, Ali Akbar] Thomas Jefferson Univ, Dept Neurol, Jefferson Comprehens Epilepsy Ctr, Philadelphia, PA 19107 USA; [Maltenfort, Mitchell; Bell, Rodney] Rothman Inst, Philadelphia, PA USA; [Rincon, Fred] Thomas Jefferson Univ, Dept Neurol & Neurosurg, Philadelphia, PA 19107 USA; [Moussouttas, Michael] Capital Inst Neurosci, Div Neuro Crit Care, Trenton, NJ USA; [Yazbeck, Moussa] John Muir Med Ctr, Dept Neurosurg, Walnut Creek, CA USA		Seifi, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Neurocrit Care, Dept Neurosurg, Mail Code 7843,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	seifi@uthscsa.edu	Asadi-Pooya, Ali/AAD-4353-2019; Seifi, Ali/AAR-6163-2020	Asadi-Pooya, Ali/0000-0002-2598-7601; Rincon, Fred/0000-0002-8510-118X			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Balser D, 2013, NEUROL RES, V35, P233, DOI 10.1179/1743132813Y.0000000166; Becker DP, 1986, ADV NEUROTRAUMATOLOG, V1, P51; Bleck Thomas P, 2012, Continuum (Minneap Minn), V18, P560, DOI 10.1212/01.CON.0000415428.61277.90; BRODERSEN P, 1975, ACTA NEUROL SCAND, V51, P233, DOI 10.1111/j.1600-0404.1975.tb07604.x; CAMERON MM, 1978, J NEUROL NEUROSUR PS, V41, P834, DOI 10.1136/jnnp.41.9.834; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2007, NEUROSURGERY, V61, P4; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; COLE M, 1961, NEW ENGL J MED, V265, P628, DOI 10.1056/NEJM196109282651304; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gupta Y K, 2006, Indian J Physiol Pharmacol, V50, P7; HAERER AF, 1986, EPILEPSIA, V27, P66, DOI 10.1111/j.1528-1157.1986.tb03503.x; Halpern NA, 2006, CRIT CARE MED, V34, P2105, DOI 10.1097/01.CCM.0000227174.30337.3E; Huang YH, 2011, NEUROCRIT CARE, V14, P253, DOI 10.1007/s12028-011-9509-8; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; JONES SC, 1989, BMJ-BRIT MED J, V299, P439, DOI 10.1136/bmj.299.6696.439; Ko BS, 2008, J KOREAN NEUROSURG S, V43, P11, DOI 10.3340/jkns.2008.43.1.11; KOTWICA Z, 1991, British Journal of Neurosurgery, V5, P461, DOI 10.3109/02688699108998474; KRUPP WF, 1995, BRIT J NEUROSURG, V9, P619, DOI 10.1080/02688699550040909; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Little AS, 2007, J NEUROSURG, V106, P805, DOI 10.3171/jns.2007.106.5.805; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; MPAC (U.S.), 2007, REP C PROM GREAT EFF; OHNO K, 1993, J NEUROL NEUROSUR PS, V56, P1231, DOI 10.1136/jnnp.56.11.1231; Pahatouridis D, 2013, NEUROSURG REV, V36, P151, DOI 10.1007/s10143-012-0412-3; PAYAN H, 1970, EPILEPSIA, V11, P81, DOI 10.1111/j.1528-1157.1970.tb03869.x; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263; RUBIN G, 1993, ACTA NEUROCHIR, V123, P39, DOI 10.1007/BF01476283; RUBIN JJ, 1980, EXP NEUROL, V67, P472, DOI 10.1016/0014-4886(80)90119-3; Rudzinski LA, 2011, J CLIN NEUROPHYSIOL, V28, P633, DOI 10.1097/WNP.0b013e31823cc494; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Schulte S, 2008, CARDIOVASC INTER RAD, V31, P870, DOI 10.1007/s00270-008-9311-y; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Steg R E, 1993, Nebr Med J, V78, P27; Storti SF, 2012, MAGN RESON MATER PHY, V25, P345, DOI 10.1007/s10334-012-0316-9; SUNG CY, 1989, ACTA NEUROL SCAND, V80, P51, DOI 10.1111/j.1600-0404.1989.tb03842.x; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; URTECHO J, 2013, CRIT CARE MED, V41, P1853, DOI DOI 10.1097/CCM.0b013e31828a3994; VONELM E, 2007, LANCET, V370, P1453, DOI DOI 10.1016/S0140-6736(07)61602-X; Westmoreland BF, 2001, J CLIN NEUROPHYSIOL, V18, P20, DOI 10.1097/00004691-200101000-00005; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	60	16	16	0	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	JUL 1	2014	3								332	10.1186/2193-1801-3-332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3JH	WOS:000359052700003	25077058	gold, Green Published			2022-02-06	
J	Speicher, SM; Walter, KH; Chard, KM				Speicher, Sarah M.; Walter, Kristen H.; Chard, Kathleen M.			Interdisciplinary Residential Treatment of Posttraumatic Stress Disorder and Traumatic Brain Injury: Effects on Symptom Severity and Occupational Performance and Satisfaction	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; depression; outcome and process assessment (health care); residential treatment; stress disorders, post-traumatic; veterans	COGNITIVE PROCESSING THERAPY; SELF-IDENTIFIED GOALS; PSYCHOMETRIC PROPERTIES; ADULTS; ACHIEVEMENT; OUTCOMES	OBJECTIVE. This study examined outcomes of an 8-wk residential treatment program for veterans with posttraumatic stress disorder (PTSD) and a history of traumatic brain injury (TBI). METHOD. Twenty-six veterans completed the Canadian Occupational Performance Measure, Clinician-Administered PTSD Scale, Beck Depression Inventory-2nd Edition, and PTSD Checklist before and after treatment. RESULTS. Veterans demonstrated significant improvements in occupational performance and satisfaction with their performance, as well as in PTSD and depression symptom severity after residential PTSD/TBI treatment. Additionally, improvements in occupational performance and satisfaction were associated with decreases in depression symptom severity. CONCLUSION. Although preliminary, results suggest that veterans with PTSD and a history of TBI experienced significant decreases in PTSD and depression symptom severity and improvement in self-perception of performance and satisfaction in problematic occupational areas. Changes in occupational areas and depression symptom severity were related, highlighting the importance of interdisciplinary treatment.	[Speicher, Sarah M.] Cincinnati Vet Affairs Med Ctr, Trauma Recovery Ctr, Cincinnati, OH 45220 USA; [Walter, Kristen H.] Vet Med Res Fdn, San Diego, CA USA; [Walter, Kristen H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Chard, Kathleen M.] Cincinnati Vet Affairs Med Ctr, Trauma Recovery Ctr, Ft Thomas, KY 41075 USA; [Chard, Kathleen M.] Univ Cincinnati, Dept Psychiat, Sch Med, Cincinnati, OH USA		Speicher, SM (corresponding author), Cincinnati Vet Affairs Med Ctr, Trauma Recovery Ctr, Cincinnati, OH 45220 USA.	Kathleen.Chard@va.gov	Walter, Kristen H/S-1827-2019				American Occupational Therapy Association, 2008, AM J OCCUP THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bejerholm U, 2007, AM J OCCUP THER, V61, P21, DOI 10.5014/ajot.61.1.21; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chard K. M., 2009, COGNITIVE PROCESSING; Christiansen CH, 1999, AM J OCCUP THER, V53, P91, DOI 10.5014/ajot.53.1.91; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Eklund Mona, 2007, Can J Occup Ther, V74, P303; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; First M.B., 1996, STRUCTURED CLIN INTE; Hand CL, 2011, CAN J OCCUP THER, V78, P147, DOI 10.2182/cjot.2011.78.3.2; Iannelli S, 2007, AUST OCCUP THER J, V54, P285, DOI 10.1111/j.1440-1630.2006-00650.x; Jaycox, 2008, INVISIBLE WOUNDS WAR; Law M, 1994, Can J Occup Ther, V61, P191; Lopez A, 2011, WORK, V38, P33, DOI 10.3233/WOR-2011-1102; McColl M A, 2000, Can J Occup Ther, V67, P22; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Pollock N., 2005, CANADIAN OCCUPATIONA; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Trombly CA, 1998, AM J OCCUP THER, V52, P810, DOI 10.5014/ajot.52.10.810; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Twamley E. W., 2008, COGNITIVE SYMP UNPUB; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Weathers F., 1994, PTSD RES Q, V5, P2, DOI [DOI 10.1037/E572192010-003, DOI 10.1037/PAS0000486]; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zanarini MC, 2000, J PERS DISORD, V14, P291, DOI 10.1521/pedi.2000.14.4.291	37	16	16	0	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2014	68	4					412	421		10.5014/ajot.2014.011304			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AL4FR	WOS:000339088800006	25005504	Green Published			2022-02-06	
J	Bata, SC; Yung, M				Bata, Sonny C.; Yung, Michael			Role of routine repeat head imaging in paediatric traumatic brain injury	ANZ JOURNAL OF SURGERY			English	Article						children; CT scan; head injuries; TBI; traumatic brain injury	SERIAL COMPUTED-TOMOGRAPHY; INFLUENCE MANAGEMENT; UTILITY; CT; PROGRESSION; MODERATE	Background Paediatric traumatic brain injuries (TBI) remain a leading cause of morbidity and mortality in Australia. There are clear guidelines on head imaging for children with TBI, but there is conflicting evidence on the role of routine repeat head computed tomography (CT) scan. This study aims to determine whether routine repeat head CT scans in paediatric TBI alter surgical or medical management. Methods A retrospective study was performed at a level 1 tertiary paediatric trauma centre between January 2002 and July 2012. Patients with TBI who were admitted with acute intracranial injury and at least one repeat head CT scan were included. Mechanism of injury, severity of TBI, Glasgow Coma Score, use of intracranial pressure monitoring and operative procedures were listed. The need for operative management was compared for routine and clinically indicated head scans. Results Routine head CT scan was done in 36 out of 71 patients (51%). None from this group required craniotomy, but two children (6%) needed delayed ICP monitoring. Three patients with moderate to severe TBI required intracranial pressure monitor or external ventricular drain insertion based on a clinically indicated repeat head CT. Conclusion Repeat head imaging is more likely to alter management of children with moderate to severe TBI. There is no role for routine repeat CT scan on mild TBI. Results of repeat cranial imaging should be correlated with the clinical status of the patient.	[Bata, Sonny C.; Yung, Michael] Womens & Childrens Hosp, Dept Crit Care Med, Adelaide, SA, Australia		Bata, SC (corresponding author), Womens & Childrens Hosp, Dept Crit Care Med, 72 King William Rd, Adelaide, SA 5006, Australia.	sonnycyrusbata@gmail.com					Australian Institute of Health and Welfare, 2012, PICT AUSTR CHILDR 20; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Figg RE, 2006, PEDIATR SURG INT, V22, P215, DOI 10.1007/s00383-005-1560-0; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	17	16	17	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JUN	2014	84	6					438	441		10.1111/ans.12582			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AJ3JB	WOS:000337561300011	24697988				2022-02-06	
J	Dolle, JP; Morrison, B; Schloss, RS; Yarmush, ML				Dolle, Jean-Pierre; Morrison, Barclay, III; Schloss, Rene S.; Yarmush, Martin L.			Brain-on-a-chip microsystem for investigating traumatic brain injury: Axon diameter and mitochondrial membrane changes play a significant role in axonal response to strain injuries	TECHNOLOGY			English	Article								Diffuse axonal injury (DAI) is a devastating consequence of traumatic brain injury, resulting in signifi cant axon and neuronal degeneration. Currently, therapeutic options are limited. Using our brain-on-a-chip device, we evaluated axonal responses to DAI. We observed that axonal diameter plays a signifi cant role in response to strain injury, which correlated to delayed elasticity and inversely correlated to axonal beading and axonal degeneration. When changes in mitochondrial membrane potential (MMP) were monitored an applied strain injury threshold was noted, below which delayed hyperpolarization was observed and above which immediate depolarization occurred. When the NHE-1 inhibitor EIPA was administered before injury, inhibition in both hyperpolarization and depolarization occurred along with axonal degeneration. Therefore, axonal diameter plays a signifi cant role in strain injury and our brain-on-a-chip technology can be used both to understand the biochemical consequences of DAI and screen for potential therapeutic agents.	[Dolle, Jean-Pierre; Schloss, Rene S.; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA; [Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Yarmush, Martin L.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA		Yarmush, ML (corresponding author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.	ireis@sbi.org			New Jersey Commission for Brain Injury Research [BIR-1.08.016]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [NIH P41 EB002503]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI063795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER	This work was supported by grants from the New Jersey Commission for Brain Injury Research (BIR-1.08.016), the National Institute of Biomedical Imaging and Bioengineering (NIH P41 EB002503), and the National Institute of General Medical Sciences (Rutgers-UMDNJ Biotechnology Training Program: T32 GM008339).	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Belzacq AS, 2003, CANCER RES, V63, P541; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; CHAUDHRY V, 1992, NEUROL CLIN, V10, P613, DOI 10.1016/S0733-8619(18)30200-7; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dolle JP, 2013, LAB CHIP, V13, P432, DOI 10.1039/c2lc41063j; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Gergely P, 2002, J IMMUNOL, V169, P1092, DOI 10.4049/jimmunol.169.2.1092; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Komary Z, 2010, BBA-BIOENERGETICS, V1797, P922, DOI 10.1016/j.bbabio.2010.03.010; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; LUBINSKA L, 1977, BRAIN RES, V130, P47, DOI 10.1016/0006-8993(77)90841-1; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Meaney D.F., 1990, INT C BIOM IMP LYON, P215; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MILEDI R, 1970, J PHYSIOL-LONDON, V207, P507, DOI 10.1113/jphysiol.1970.sp009076; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rochlin MW, 1996, J NEUROSCI, V16, P3236; Ruiz-Meana M, 2003, AM J PHYSIOL-HEART C, V285, pH999, DOI 10.1152/ajpheart.00035.2003; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Teshima Y, 2003, CIRCULATION, V108, P2275, DOI 10.1161/01.CIR.0000093277.20968.C7; Toda T, 2007, AM J PHYSIOL-HEART C, V293, pH3517, DOI 10.1152/ajpheart.00483.2006; Troyan MB, 1997, EXP CELL RES, V233, P274, DOI 10.1006/excr.1997.3570; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Villa-Abrille MC, 2011, AM J PHYSIOL-HEART C, V300, pH1237, DOI 10.1152/ajpheart.00840.2010; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; WYSS JM, 1980, ANAT EMBRYOL, V158, P303, DOI 10.1007/BF00301819; Xu MF, 2001, AM J PHYSIOL-HEART C, V281, pH1295, DOI 10.1152/ajpheart.2001.281.3.H1295	59	16	18	0	3	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	2339-5478	2345-7740		TECHNOLOGY	Technology	JUN	2014	2	2					106	116		10.1142/S2339547814500095			11	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	V1G6O	WOS:000216886500003	25101309	Green Accepted			2022-02-06	
J	Ulutabanca, H; Hatipoglu, N; Tanriverdi, F; Gokoglu, A; Keskin, M; Selcuklu, A; Kurtoglu, S; Kelestimur, F				Ulutabanca, Halil; Hatipoglu, Nihal; Tanriverdi, Fatih; Gokoglu, Abdulkerim; Keskin, Mehmet; Selcuklu, Ahmet; Kurtoglu, Selim; Kelestimur, Fahrettin			Prospective investigation of anterior pituitary function in the acute phase and 12 months after pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Pituitary function; Traumatic brain injury; Children	GROWTH-HORMONE DEFICIENCY; HEAD TRAUMA; SUBARACHNOID HEMORRHAGE; ILL PATIENTS; LONG-TERM; HIGH-RISK; FACTOR-I; CHILDREN; HYPOPITUITARISM; DYSFUNCTION	Although head trauma is common in childhood, there is no enough prospective study investigating both acute phase and 12 months after injury. Therefore, a prospective clinical trial was planned to evaluate the pituitary function in childhood in the acute and chronic phase after traumatic brain injury (TBI). Forty-one children (27 boys and 14 girls, mean age 7 +/- 4.3), who were admitted to neurosurgery intensive care unit due to head trauma, were included. Twenty-one (51.2 %) patients had mild, 10 (24.4 %) had moderate, and 10 (24.4 %) had severe TBI. Twenty-two of them were reevaluated 12 months after TBI. Basal pituitary hormone levels were measured during acute (first 24 h) and chronic phase of TBI. Additionally, in the chronic phase, GHRH-arginine test was used for the diagnosis of growth hormone (GH) deficiency. In the acute phase, 10 patients (24.4 %) had ACTH deficiency, and the overall 44.3 % of patients had at least one pituitary hormone dysfunction. All the pituitary hormone deficiencies during the acute phase were recovered after 12 months. Two patients (9.1 %) had new-onset GH deficiency in the chronic phase, and in one of them, ACTH deficiency was also present. Present prospective data clearly demonstrated that most of the hormonal changes in the early acute phase were transient, suggesting an adaptive response, and these changes did not predict the hormone deficiencies after 1 year. In the chronic phase, although GH deficiency was present, the frequency of TBI-induced hypopituitarism was clearly lower than the adult patients.	[Ulutabanca, Halil; Gokoglu, Abdulkerim; Selcuklu, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; [Hatipoglu, Nihal; Kurtoglu, Selim] Erciyes Univ, Sch Med, Dept Pediat Endocrinol, TR-38039 Kayseri, Turkey; [Tanriverdi, Fatih; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Keskin, Mehmet] Gaziantep Univ, Sch Med, Dept Pediat Endocrinol, Kayseri, Turkey		Hatipoglu, N (corresponding author), Erciyes Univ, Sch Med, Dept Pediat Endocrinol, TR-38039 Kayseri, Turkey.	nihalhatipoglu@yahoo.com	Hatipoglu, Nihal/AAW-1933-2020; kelestimur, f/ABE-9873-2021	Hatipoglu, Nihal/0000-0002-0991-6539; 			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Altunay C, 2011, J CLIN RES PEDIATR E, V3, P184, DOI 10.4274/jcrpe.452; [Anonymous], 2000, EXP VAL 6 SI UN CONV; BANG P, 1994, J ENDOCRINOL, V143, pC1; Bardoni A, 2013, BRAIN INJURY, V27, P1395, DOI 10.3109/02699052.2013.823652; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Capalbo D, 2012, MINERVA ENDOCRINOL, V37, P379; Casano-Sancho P, 2013, CLIN ENDOCRINOL, V79, P853, DOI 10.1111/cen.12237; Casanueva FF, 2007, HORM RES, V67, P208, DOI 10.1159/000097584; CHIOLERO RL, 1988, ACTA ENDOCRINOL-COP, V117, P80, DOI 10.1530/acta.0.1170080; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; EIHOLZER U, 1986, EUR J PEDIATR, V145, P128, DOI 10.1007/BF00441873; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Einaudi S, 2007, CURR OPIN PEDIATR, V19, P465, DOI 10.1097/MOP.0b013e3281ab6eeb; Ekbote VH, 2012, J PEDIATR ENDOCR MET, V25, P969, DOI 10.1515/jpem-2012-0177; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gonzalez H, 2006, CRIT CARE CLIN, V22, P105, DOI 10.1016/j.ccc.2005.09.001; Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Hatipoglu Nihal, 2009, J Clin Res Pediatr Endocrinol, V1, P129, DOI 10.4008/jcrpe.v1i3.47; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Kaiserman KB, 1998, J PEDIATR-US, V133, P300, DOI 10.1016/S0022-3476(98)70242-2; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Lamberts SWJ, 1998, LANCET, V352, P127; LEE PDK, 1990, PEDIATR RES, V27, P45, DOI 10.1203/00006450-199001000-00015; Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Radovic S, 2003, PEDIAT ENDOCRINOLOGY; Rahim A, 1996, CLIN ENDOCRINOL, V45, P557; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; ROSS R, 1991, CLIN ENDOCRINOL, V35, P47, DOI 10.1111/j.1365-2265.1991.tb03495.x; Schmidt H, 2000, EUR J ENDOCRINOL, V143, P213, DOI 10.1530/eje.0.1430213; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Seoane LM, 2006, J ENDOCRINOL INVEST, V29, DOI 10.1007/BF03344190; Sizonenko PC, 2001, GROWTH HORM IGF RES, V11, P137, DOI 10.1054/ghir.2001.0203; Sockalosky SH, 1987, J PEDIAT, V3, P373; Srinivas R, 2010, CHILD NERV SYST, V26, P647, DOI 10.1007/s00381-009-1038-9; Stockigt JR, 1996, CLIN CHEM, V42, P188; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; TEASDALE G, 1974, LANCET, V2, P81; Vahl N, 2000, J CLIN ENDOCR METAB, V85, P1874, DOI 10.1210/jc.85.5.1874; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; YAMANAKA C, 1993, EUR J PEDIATR, V152, P99, DOI 10.1007/BF02072482; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	69	16	17	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUN	2014	30	6					1021	1028		10.1007/s00381-013-2334-y			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AH8NZ	WOS:000336396100006	24322605				2022-02-06	
J	Rosema, S; Muscara, F; Anderson, V; Godfrey, C; Eren, S; Catroppa, C				Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Eren, Senem; Catroppa, Cathy			Agreement on and Predictors of Long-Term Psychosocial Development 16 Years Post-Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						predictors; agreement; adulthood; childhood traumatic brain injury; psychosocial outcomes	PSYCHIATRIC-DISORDERS; FUNCTIONAL RECOVERY; BEHAVIOR PROBLEMS; CHILDREN; ADOLESCENTS; HEAD; OUTCOMES; RATINGS; INDIVIDUALS; PATIENT	Childhood traumatic brain injury (CTBI) is one of the most common causes of childhood mortality and morbidity, with psychosocial impairment being among the most debilitating persisting consequences. Child and adolescent survivors of CTBI have fewer friends and lower self-esteem with a higher risk of developing a psychiatric disorder. In most research to date, findings in the psychosocial domain have been based on parent reports, with the child or adolescent only consulted infrequently. If there is a discrepancy identified between parent and child reported symptoms and behaviors, this is generally interpreted as resulting from impaired self-awareness in the child. The aim of this study was to 1) examine the agreement between self- and proxy-reported long-term psychosocial outcomes and 2) investigate the predictors of outcome 16 years post-CTBI. Thirty-three young adults (mean, 21.36 years; standard deviation, 2.75), with a CTBI sustained between 1 and 7 years of age, and a significant other completed questionnaires assessing the young adults' social and psychological functioning. Young adults and their significant other had good-to-excellent agreement on communication as well as alcohol and drug use scales. There was poorer agreement for the overall internalizing symptoms, anxious/depressed, withdrawn, thought, and rule-breaking behaviors. On the scales with poor agreement, there was no consistent contribution identified for any injury or preinjury factors. Preinjury adaptive behavior partly predicted withdrawn and overall internalizing symptoms, with a trend to also partly predict anxious/depressed and rule-breaking behavior reported by the significant other. Because young adults and significant others had poor agreement on the less-overt symptoms, these young adults may be at a higher risk of developing more-severe symptoms or disorders if it is not identified in time.	[Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Eren, Senem; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Muscara, Frank; Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Rosema, Stefanie; Muscara, Frank; Anderson, Vicki; Godfrey, Celia; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic, Australia		Rosema, S (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Child Neuropsychol, 4th Floor West,Flemington Rd, Parkville, Vic 3053, Australia.	stefanie.rosema@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Victorian Neurotrauma Institute; Murdoch Childrens Research Institute Critical Care and Neuroscience Theme; Victorian Government's Operational Infrastructure Scheme	This work was funded through research grants awarded by the Victorian Neurotrauma Institute and the Murdoch Childrens Research Institute Critical Care and Neuroscience Theme and supported by the Victorian Government's Operational Infrastructure Scheme.	Achenbach TM., 2003, MANUAL ASEBA ADULT F; Anderson V., 2012, DEV SOCIAL NEUROSCIE, P3; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; Crowe LM, 2012, INJURY, V43, P2141, DOI 10.1016/j.injury.2012.07.195; Daniel A., 1983, POWER PRIVILEGE PRES; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hellawell DJ, 2000, DISABIL REHABIL, V22, P446, DOI 10.1080/09638280050045910; IBM Corp Released, 2011, IBM SPSS STAT WIND V; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kurtz JE, 2006, CLIN NEUROPSYCHOL, V20, P453, DOI 10.1080/13854040590967090; Lachar D., 1992, PERSONALITY INVENTOR; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Leadbeater BJ, 1999, DEV PSYCHOL, V35, P1268, DOI 10.1037/0012-1649.35.5.1268; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; TEASDALE G, 1974, LANCET, V2, P81; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	35	16	16	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					899	905		10.1089/neu.2013.3226			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200002	24417184				2022-02-06	
J	Cartagena, CM; Phillips, KL; Tortella, FC; Dave, JR; Schmid, KE				Cartagena, Casandra M.; Phillips, Katie L.; Tortella, Frank C.; Dave, Jitendra R.; Schmid, Kara E.			Temporal alterations in aquaporin and transcription factor HIF1 alpha et expression following penetrating ballistic-like brain injury (PBBI)	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Penetrating brain injury; PBBI; Edema; Aquaporins	EDEMA FORMATION; WATER CHANNELS; RAT-BRAIN; BLOOD; MODEL; MECHANISMS; HEMORRHAGE; CELLS; HIF-1; FLUID	Objectives: Brain edema is a primary factor in the morbidity and mortality of traumatic brain injury (TBI). The various isoforms of aquaporin 4 (AQP4) and aquaporin 9 (AQP9) are important factors influencing edema following TBI. Others have reported that these AQPs are regulated by the transcription factor hypoxia inducible factor (HIF)1 alpha. Therefore, we examined the temporal alterations in the multiple isoforms of AQP4 and AQP9, and its possible upstream regulation by HIF1 alpha, and evaluated whether different severities of penetrating injury influence these mechanisms. Methods: In the penetrating ballistic-like brain injury (PBBI) model, a temporary cavity and resultant injury was formed by the rapid inflation/deflation (i.e. <40 ms) of an elastic balloon attached to the end of the custom probe, injuring 10% of total rat brain volume. Tissue from the ipsilateral core and perilesional injury zones was collected. Total RNA was isolated at 4, 12, and 24 h, 3 and 7 days post-injury (sham and PBBI, n = 6 per group). cDNA was synthesized using oligodT primers. Quantitative real time PCR was performed using Taqman expression assays for aqp4 (recognizing all isoforms), aqp9, and hif1 alpha. Using separate animals, tissue lysate was collected at 4 and 24 h, 3 and 7 days post-injury and analyzed by immunoblot for protein expression of multiple isoforms of AQP4, the single known isoform of AQP9 and for expression of transcription factor HIF1 alpha (sham, probe only control, and PBBI, n = 8-10 per group). Results: Global aqp4 mRNA was decreased at 24 h (p < 0.01) with PBBI. Three of the four known protein isoforms of AQP4 were detected, M1 (34 kDa), M23 (32 kDa) and isoform 3 (30 kDa). AQP4 M1 decreased at 3 and 7 days post-injury (p < 0.001; p < 0.01). AQP4 M23 levels were highly variable with no significant changes. AQP4 isoform 3 levels were decreased 3 days post-PBBI (p < 0.05). From 4, 12, and 24 h aqp9 mRNA levels were decreased with injury (p < 0.01, p < 0.05, p < 0.01) while AQP9 levels were decreased at 3 and 7 days after PBBI (p < 0.001, p < 0.01). At 12 and 24 h post-PBBI hif1 alpha mRNA levels increased (p < 0.05, p < 0.01) but at 3 and 7 days mRNA levels decreased (p < 0.05, p < 0.01). From 24 h and 3 and 7 days HIF1 alpha protein levels were decreased (p < 0.0001, p < 0.0001, p < 0.0001). In comparison to probe control, PBBI led to greater decreases in protein for AQP4 M1 (trend), AQP4 isoform 3 (trend), AQP9 (p < 0.05) and HIFI (p < 0.05). Conclusion: PBBI is characterized by a loss of AQP4 Ml, AQP4 isoform 3 and AQP9 at delayed time-points. The severity of the injury (PBBI versus probe control) increased these effects. Therefore, AQP9 and the AQP4 M1 isoform may be regulated by HIF1 alpha, but not AQP4 isoform 3. This delayed loss of aquaporins may markedly reduce the ability of the brain to efflux water, contributing to the protracted edema that is a characteristic following severe penetrating TBI. Factors contributing to edema differ with different types and severities of TBI. For example, cellular based edema is more prominent in diffuse non-penetrating TBI whereas vasogenic edema is more prevalent with TBI involving hemorrhage. Molecular regulation leading to edema will likely also differ, such that treatments which have been suggested for non-hemorrhagic moderate TBI, such as the suppression of aquaporins, may be detrimental in more severe forms of TBI. Published by Elsevier Inc.	[Cartagena, Casandra M.; Phillips, Katie L.; Tortella, Frank C.; Dave, Jitendra R.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA		Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA.	casandra.m.cartagena.civ@mail.mil; katie.phillips1@us.army.mil; frank.c.tortella.civ@mail.mil; jitendra.r.dave.civ@mail.mil; kara.e.schmid.mil@mail.mil					Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mosbasheri A, 2004, AM J PHYSIOL-CELL PH, V286, pC529, DOI 10.1152/ajpcell.00408.2003; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022	26	16	16	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAY	2014	60						81	87		10.1016/j.mcn.2014.04.005			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI5DX	WOS:000336886700009	24769105				2022-02-06	
J	Khosravizadeh, Z; Razavi, S; Bahramian, H; Kazemi, M				Khosravizadeh, Zahra; Razavi, Shahnaz; Bahramian, Hamid; Kazemi, Mohammad			The beneficial effect of encapsulated human adipose-derived stem cells in alginate hydrogel on neural differentiation	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						tissue engineering; proliferation; neural differentiation; human adipose-derived stem cells; alginate hydrogel	SPINAL-CORD; TISSUE; TRANSPLANTATION; CHONDROCYTES; SCAFFOLD; CULTURE	Tissue engineering employs combination of biomaterials and cell therapy to develop new therapeutic strategies for neurodegenerative diseases, spinal cord, and traumatic brain injuries. Alginate is a biocompatible hydrogel, which has been used broadly to encapsulate many types of cells. Human adipose-derived stem cells (hADSCs) have appropriate property to differentiate into neuron-like cells. Therefore, the aim of this study was to evaluate the effect of alginate hydrogel on the viability and neural differentiation potential of induced hADSCs. After neural induction of isolated hADSCs and encapsulated in alginate hydrogel, the cell viability using MTT assay and their neural differentiation potential by immunocytochemical and real time RT-PCR analysis for neural markers (Nestin, GFAP, and MAP2) were evaluated. Expression of Nestin, GFAP, and MAP2 markers was significantly increased compare to monolayer induced cells (p < 0.001), but we did not found any significant effect on viability of induced cells relative to monolayer induced cells. Although neural differentiation of encapsulated cells was increased relative to monolayer induced cells, the viability of these cells was not significantly different in alginate hydrogel as compared with monolayer induced cells. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 749-755, 2014.	[Khosravizadeh, Zahra; Razavi, Shahnaz; Bahramian, Hamid; Kazemi, Mohammad] Isfahan Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, Esfahan 81744176, Iran		Razavi, S (corresponding author), Isfahan Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, Esfahan 81744176, Iran.	razavi@med.mui.ac.ir	Razavi, Shahnaz/I-7599-2019; kazemi, mohammad/E-6492-2012	Razavi, Shahnaz/0000-0003-1726-9324; kazemi, mohammad/0000-0002-6794-6891; bahramian, hamid/0000-0003-2282-840X	Isfahan University of Medical Sciences	This research was supported by Isfahan University of Medical Sciences.	Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111; Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334; Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007; Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca; Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003; Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Carlson KB, 2011, GLIA, V59, P267, DOI 10.1002/glia.21099; Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Chernousov MA, 2008, GLIA, V56, P1498, DOI 10.1002/glia.20740; Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt228; Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606; Huang TT, 2007, J SPINAL CORD MED, V30, pS35, DOI 10.1080/10790268.2007.11753967; Hunt NC, 2010, ACTA BIOMATER, V6, P3649, DOI 10.1016/j.actbio.2010.03.026; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027; Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5; Kemp MR, 2007, INNOV FOOD SCI EMERG, V8, P143, DOI 10.1016/j.ifset.2006.09.001; Kim MH, 2010, BIOMATERIALS, V31, P1213, DOI 10.1016/j.biomaterials.2009.10.057; Kong HJ, 2003, CELL TRANSPLANT, V12, P779, DOI 10.3727/000000003108747253; Li T, 2007, J BIOMED MATER RES A, V83A, P383, DOI 10.1002/jbm.a.31322; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Matyash M, 2012, TISSUE ENG PT A, V18, P55, DOI [10.1089/ten.tea.2011.0097, 10.1089/ten.TEA.2011.0097]; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Schipper BM, 2008, ANN PLAS SURG, V60, P538, DOI 10.1097/SAP.0b013e3181723bbe; Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0; Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003; Tsang VL, 2007, ADV BIOCHEM ENG BIOT, V103, P189, DOI 10.1007/10_010; Xie XW, 2011, J HUAZHONG U SCI-MED, V31, P174, DOI 10.1007/s11596-011-0246-1; Yasuda A, 2006, TISSUE ENG, V12, P1237, DOI 10.1089/ten.2006.12.1237; Ying CC, 2012, CELL MOL NEUROBIOL, V32, P1255, DOI 10.1007/s10571-012-9850-2; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	44	16	19	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	MAY	2014	102	4					749	755		10.1002/jbm.b.33055			7	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	AE8IT	WOS:000334244300012	24142904				2022-02-06	
J	Schriever, VA; Studt, F; Smitka, M; Grosser, K; Hummel, T				Schriever, Valentin A.; Studt, Friederike; Smitka, Martin; Grosser, Kay; Hummel, Thomas			Olfactory Function After Mild Head Injury in Children	CHEMICAL SENSES			English	Article						children; head injury; olfaction	POST-TRAUMATIC ANOSMIA; ODOR DISCRIMINATION; BRAIN-INJURY; DYSFUNCTION; IDENTIFICATION; EPITHELIUM; DISORDERS; SMELL	Olfactory impairment has been shown to be linked to head injury. In addition, it is believed that measurement of olfactory function after head trauma represents a sensitive tool for measuring frontal brain damage. Aim of the study was to evaluate the effect of mild head trauma in children on olfactory function over a time period of up to 1 year after head trauma. The olfactory function of 114 children who suffered mild head trauma according to the Glasgow Coma Scale was assessed 3 times with an interval of 4 months. In addition, healthy, age-matched controls were tested for comparison of olfactory function. Patients scored significantly lower on the odor threshold test compared to the control groupubut still within normal range. Between the 2 groups, no difference was found for suprathreshold testing. Neither olfactory threshold scores nor olfactory discrimination scores changed significantly over the study period of 1 year. This data prove an impact of mild head trauma on olfactory function of children. It seems unlikely that children who suffered mild head trauma will become hyposmic or anosmic.	[Schriever, Valentin A.; Studt, Friederike; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, D-01307 Dresden, Germany; [Smitka, Martin] Tech Univ Dresden, Dept Neuropediat, D-01307 Dresden, Germany; [Grosser, Kay] Helios Clin Erfurt, Dept Pediat Surg, D-99089 Erfurt, Germany		Hummel, T (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Fetscherstr 74, D-01307 Dresden, Germany.	thummel@mail.zih.tu-dresden.de					Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Collet S, 2009, B-ENT, P97; Correia S, 2001, ARCH CLIN NEUROPSYCH, V16, P477, DOI 10.1016/S0887-6177(00)00059-7; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Haxel BR, 2005, HNO, V53, P682, DOI 10.1007/s00106-004-1217-7; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2007, BEHAV BRAIN RES, V180, P133, DOI 10.1016/j.bbr.2007.02.040; JACOBI G, 1986, Acta Paediatrica Hungarica, V27, P173; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Loo AT, 1996, INT J DEV NEUROSCI, V14, P881, DOI 10.1016/S0736-5748(96)00046-9; Ogle W, 1870, Med Chir Trans, V53, P263; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Roberts M A, 1996, Appl Neuropsychol, V3, P86, DOI 10.1207/s15324826an0302_7; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; SCHECHTER PJ, 1974, J NEUROL NEUROSUR PS, V37, P802, DOI 10.1136/jnnp.37.7.802; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Suzukawa K, 2011, J COMP NEUROL, V519, P2154, DOI 10.1002/cne.22611; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Tomii M, 2012, NEUROSURG REV, V35, P555, DOI 10.1007/s10143-012-0378-1; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	33	16	16	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	MAY	2014	39	4					343	347		10.1093/chemse/bju005			5	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	AF8ZL	WOS:000335004400008	24554732	Bronze, Green Published			2022-02-06	
J	Willmott, C; Ponsford, J; Downing, M; Carty, M				Willmott, Catherine; Ponsford, Jennie; Downing, Marina; Carty, Meagan			Frequency and Quality of Return to Study Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury; education; rehabilitation; study; outcomes	CLOSED-HEAD INJURY; STRATEGY APPLICATION; STUDENTS; SCHOOL; SCALE; WORK; TBI; IMPAIRMENTS; ATTENTION; EDUCATION	Objective: To examine the frequency and experience of return to secondary or tertiary study over a 10-year period following traumatic brain injury (TBI). Participants: A group of 295 students with moderate to severe TBI followed prospectively. Setting: Epworth HealthCare TBI outpatient rehabilitation program follow-up clinic 1 to 10 years postinjury. Main Outcome Measures: Frequency of return to study. Also, for a subset, changes in course enrollment, utilization of additional educational supports, and experience of return to study postinjury. Results: Of those studying preinjury, 295 attended the follow-up clinic appointments, with 167 (56%) having returned to study. Those who did not return to study had significantly longer posttraumatic amnesia duration. The cross-sectional follow-up revealed that 60.4% were studying at 1 year postinjury, 37.5% at 2 years postinjury, 50.0% at 3 years postinjury, 31.1% at 5 years postinjury, and 2.0% at 10 years postinjury. Many had migrated into employment. A subsample of 95 participants reported on their educational experience. Of those, 28.7% changed their course enrollment from full-time to part-time. While supports such as tuition and special consideration were greatly increased postinjury, students reported the proportion of subjects passed of 79.0%. However, they experienced cognitive difficulties and fatigue and felt less satisfied with their studies. Conclusions: Return to study was relatively successful; however, this was associated with the experience of fatigue and need for far greater effort, assistance and reduced study hours, and somewhat less overall satisfaction.	[Willmott, Catherine; Ponsford, Jennie; Downing, Marina] Monash Univ, Sch Psychol & Psychiat, Monash Psychol Ctr, Notting Hill, Vic 3168, Australia; [Willmott, Catherine; Ponsford, Jennie; Downing, Marina; Carty, Meagan] Monash Univ, Monash Epworth Rehabil Res Ctr, Notting Hill, Vic 3168, Australia; [Ponsford, Jennie] Monash Univ, Natl Trauma Res Inst, Notting Hill, Vic 3168, Australia		Willmott, C (corresponding author), Monash Univ, Sch Psychol & Psychiat, Monash Psychol Ctr, Bldg 1-270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@.monash.edu	Willmott, Catherine/AAA-5105-2019; Downing, Marina/AAX-2380-2020	Willmott, Catherine/0000-0001-8517-9035; Downing, Marina/0000-0002-3126-6632	Victorian Government Transport Accident Commission; Institute for Safety Compensation and Recovery Research	This project was supported by the Victorian Government Transport Accident Commission and the Institute for Safety Compensation and Recovery Research. The authors thank Professor John Olver, Dr Michael Ponsford, and Dr Rose Acher, who conducted the follow-up interviews with participants. The authors also thank all participants involved in this project, who gave so generously of their time.	*AUSTR I HLTH WELF, 2004, AUSTR HLTH 2004; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fortune N, 2000, DEFINITION INCIDENCE; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Jennett B, 1981, MANAGEMENT HEAD INJU; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; MCCULLAGH S, 2005, TXB TRAUMATIC BRAIN; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; O'Rance L., 2007, DISABILITY AUSTR ACQ; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Ponsford J, 2013, TRAUMATIC BRAIN INJU, P1; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sloan S., 2013, TRAUMATIC BRAIN INJU, P66; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Tate R, 2011, FINAL REPORT LIFETIM, P1; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wagner M., 2005, HIGH SCH 1 LOOK POST; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	47	16	16	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					248	256		10.1097/HTR.0000000000000014			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100013	24413073				2022-02-06	
J	Yang, Y; Zhang, YG; Lin, GA; Xie, HQ; Pan, HT; Huang, BQ; Liu, JD; Liu, H; Zhang, N; Li, L; Chen, JH				Yang, Yang; Zhang, Yong-Gang; Lin, Guo-An; Xie, He-Qiu; Pan, Hai-Tao; Huang, Ben-Qing; Liu, Ji-Dong; Liu, Hui; Zhang, Nan; Li, Li; Chen, Jian-Hua			The effects of different hyperbaric oxygen manipulations in rats after traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Hyperbaric oxygenation; Traumatic brain injury; Treatment	FLUID-PERCUSSION INJURY; ACCELERATES NEUROLOGIC RECOVERY; MITOCHONDRIAL-FUNCTION; CEREBRAL-ISCHEMIA; THERAPY; CLEARANCE; EXPOSURE	The protective effects of hyperbaric oxygenation following traumatic brain injury have been widely investigated; however, few studies have made systematic comparisons between the different hyperbaric oxygenation manipulations and their corresponding effects. In this study, male Sprague-Dawley rats were observed at 4 h, 15 d and 75 d after traumatic brain injury. The effects of the different hyperbaric oxygenation manipulations on the rats were compared based on morphological, molecular biological and behavioral tests. Our results showed that hyperbaric oxygenation inhibited cell apoptosis in the rat hippocampus and improved their physiological functions. The effects observed in the hyperbaric oxygen-early group were better than the hyperbaric oxygen-delayed group, and the hyperbaric oxygen-early-delayed group demonstrated the best effects among all the groups. Our results showed the hyperbaric oxygenation was recommended early and delayed post-traumatic brain injury and exposure to hyperbaric oxygenation should be prolonged. These findings provide new ideal therapeutic insight for the clinical treatment of traumatic brain injury. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yang, Yang; Liu, Ji-Dong; Liu, Hui; Li, Li; Chen, Jian-Hua] Zhumadian City Ctr Hosp, Dept Neurosurg, Zhumadian 463000, Peoples R China; [Zhang, Yong-Gang] Zhumadian City Ctr Hosp, Dept ICU, Zhumadian 463000, Peoples R China; [Lin, Guo-An] PLA, Hosp 159, Dept Burn, Zhumadian 463008, Peoples R China; [Xie, He-Qiu] Zhumadian City Ctr Hosp, Dept Pain, Zhumadian 463000, Peoples R China; [Pan, Hai-Tao] Xian Univ Finance & Econ, Sch Stat, Xian 710061, Peoples R China; [Huang, Ben-Qing] PLA, Hosp 159, Dept Oncol, Zhumadian 463008, Peoples R China; [Zhang, Nan] Xinxiang Med Univ, Dept Student Affairs, Xinxiang 453003, Peoples R China		Li, L (corresponding author), Zhumadian City Ctr Hosp, Dept Neurosurg, 747 Zhonghua Rd, Zhumadian 463000, Peoples R China.	zmdlil@163.com; yangyang19800627@163.com	Pan, Haitao/N-2529-2018	Pan, Haitao/0000-0003-4457-7349			Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Demchenko IT, 1998, UNDERSEA HYPERBAR M, V25, P147; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; HUNT RC, 1978, EXP NEUROL, V62, P698, DOI 10.1016/0014-4886(78)90278-9; IWATSUKI N, 1994, CRIT CARE MED, V22, P858, DOI 10.1097/00003246-199405000-00024; IZAWA K, 1993, GASTROENTEROL JPN, V28, P284; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; KLEIN J, 1990, ANESTH ANALG, V70, P195; KOHSHI K, 1991, Neurologia Medico-Chirurgica, V31, P575, DOI 10.2176/nmc.31.575; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Manor T, 2003, ADV EXP MED BIOL, V510, P409; Mayumi P.L., 1996, DEV BRAIN RES, V95, P272; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pierson David J, 2002, Respir Care, V47, P249; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Speit G, 2002, MUTAT RES-REV MUTAT, V512, P111, DOI 10.1016/S1383-5742(02)00045-5; TAKAHASHI M, 1992, CRIT CARE MED, V20, P1588, DOI 10.1097/00003246-199211000-00018; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WEINSTEIN PR, 1987, NEUROSURGERY, V20, P518, DOI 10.1227/00006123-198704000-00002; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	27	16	18	1	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 20	2014	563						38	43		10.1016/j.neulet.2014.01.002			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AE5CR	WOS:000334005900008	24412131				2022-02-06	
J	Petrasek, T; Prokopova, I; Sladek, M; Weissova, K; Vojtechova, I; Bahnik, S; Zemanova, A; Schonig, K; Berger, S; Tews, B; Bartsch, D; Schwab, ME; Sumova, A; Stuchlik, A				Petrasek, Tomas; Prokopova, Iva; Sladek, Martin; Weissova, Kamila; Vojtechova, Iveta; Bahnik, Stepan; Zemanova, Anna; Schoenig, Kai; Berger, Stefan; Tews, Bjoern; Bartsch, Dusan; Schwab, Martin E.; Sumova, Alena; Stuchlik, Ales			Nogo-A-deficient transgenic rats show deficits in higher cognitive functions, decreased anxiety, and altered circadian activity patterns	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						Nogo-A; AAPA; Carousel maze; passive avoidance; neophobia; anhedonia; circadian rhythmicity	NEURITE OUTGROWTH INHIBITOR; TRAUMATIC BRAIN-INJURY; PLACE AVOIDANCE TASK; DOWN-REGULATION; SYNAPTIC PLASTICITY; GENETIC DELETION; CAROUSEL MAZE; RECEPTOR 1; SCHIZOPHRENIA; ASSOCIATION	Decreased levels of Nogo-A-dependent signaling have been shown to affect behavior and cognitive functions. In Nogo-A knockout and knockdown laboratory rodents, behavioral alterations were observed, possibly corresponding with human neuropsychiatric diseases of neurodevelopmental origin, particularly schizophrenia. This study offers further insight into behavioral manifestations of Nogo-A knockdown in laboratory rats, focusing on spatial and non-spatial cognition, anxiety levels, circadian rhythmicity, and activity patterns. Demonstrated is an impairment of cognitive functions and behavioral flexibility in a spatial active avoidance task, while non-spatial memory in a step-through avoidance task was spared. No signs of anhedonia, typical for schizophrenic patients, were observed in the animals. Some measures indicated lower anxiety levels in the Nogo-A-deficient group. Circadian rhythmicity in locomotor activity was preserved in the Nogo-A knockout rats and their circadian period (tau) did not differ from controls. However, daily activity patterns were slightly altered in the knockdown animals. We conclude that a reduction of Nogo-A levels induces changes in CNS development, manifested as subtle alterations in cognitive functions, emotionality, and activity patterns.	[Petrasek, Tomas; Prokopova, Iva; Vojtechova, Iveta; Zemanova, Anna; Stuchlik, Ales] Acad Sci Czech Republ, Inst Physiol, Dept Neurophysiol Memory, Prague 14220 4, Czech Republic; [Petrasek, Tomas] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Sladek, Martin; Weissova, Kamila; Sumova, Alena] Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Prague 14220 4, Czech Republic; [Bahnik, Stepan] Univ Wurzburg, Dept Psychol 2, D-97070 Wurzburg, Germany; [Schoenig, Kai; Berger, Stefan; Bartsch, Dusan] Cent Inst Mental Hlth, Dept Mol Biol, Mannheim, Germany; [Tews, Bjoern; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Tews, Bjoern; Schwab, Martin E.] Swiss Fed Inst Technol Zurich, Dept Biol, Zurich, Switzerland; [Tews, Bjoern] German Canc Res Ctr, Div Mol Mech Tumor Invas, Heidelberg, Germany		Petrasek, T (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Neurophysiol Memory, Videnska 1083, Prague 14220 4, Czech Republic.	disworlds@gmail.com; stuchlik@biomed.cas.cz	Petrasek, Tomas/G-3977-2014; Stuchlik, Ales/V-8543-2019; Sladek, Martin/C-3383-2012; Weissova, Kamila/X-1856-2018; Vojtechova, Iveta/R-8878-2017; Schwab, Martin E/B-6818-2016; Sumova, Alena/C-3390-2012	Petrasek, Tomas/0000-0002-3793-8364; Stuchlik, Ales/0000-0002-5394-6305; Sladek, Martin/0000-0002-9744-9386; Weissova, Kamila/0000-0002-3023-4751; Vojtechova, Iveta/0000-0001-7029-7936; Sumova, Alena/0000-0003-4126-5470; Miskova, Iva/0000-0001-6601-418X; Bahnik, Stepan/0000-0002-0579-6808	GAUK [365911]; GACRGrant Agency of the Czech Republic [14-03627S]; IGA MZ CR [NT13386]; AVCR [M200111204]; German Ministry for Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01GQ1003B]; National Bernstein Network for Computational Neuroscience [HEALTH-F2-2007-201714 DEVANX]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG-RTG 1253/2];  [31-122527/1]	This work was funded mainly by GAUK grant 365911 (awarded to Tomas Petrasek) and GACR 14-03627S (awarded to Ales Stuchlik). Additional support came from IGA MZ CR NT13386 and AVCR M200111204 awarded to Ales Stuchlik. Support for foreign partners was provided by grants from the German Ministry for Education and Research (BMBF, 01GQ1003B), National Bernstein Network for Computational Neuroscience, HEALTH-F2-2007-201714 DEVANX (awarded to Dusan Bartsch), and the Grant No. 31-122527/1 (awarded to Martin E. Schwab). The work of Stepan Bahnik was partly supported by the Deutsche Forschungsgemeinschaft (DFG-RTG 1253/2).	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Bahnik S, 2013, CAROUSEL MAZE MANAGE; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Bubenikova-Valesova V, 2008, NEUROSCI BIOBEHAV R, V32, P1014, DOI 10.1016/j.neubiorev.2008.03.012; Bubenikova-Valesova V, 2008, P NATL ACAD SCI USA, V105, P1061, DOI 10.1073/pnas.0711273105; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; Carr ZJ, 2011, J NEUROSURG ANESTH, V23, P138, DOI 10.1097/ANA.0b013e3182049f19; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hsu R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001234; Huber AB, 2002, J NEUROSCI, V22, P3553; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; Jitoku D, 2011, AM J MED GENET B, V156B, P581, DOI 10.1002/ajmg.b.31199; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kristofikova Z, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00090; Le Pen G, 2002, PSYCHOPHARMACOLOGY, V161, P434, DOI 10.1007/s00213-002-1092-4; Lecourtier L, 2012, NEUROSCIENCE, V207, P110, DOI 10.1016/j.neuroscience.2012.01.040; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Lobellova V, 2013, BEHAV BRAIN RES, V246, P55, DOI 10.1016/j.bbr.2013.03.006; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Masliah E, 2010, NEUROSCIENCE, V169, P488, DOI 10.1016/j.neuroscience.2010.04.045; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI [10.1177/0748730403018003006, 10.1177/0748730403253370]; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Novak G, 2002, MOL BRAIN RES, V107, P183, DOI 10.1016/S0169-328X(02)00492-8; Pelizza Lorenzo, 2009, Ann Gen Psychiatry, V8, P22, DOI 10.1186/1744-859X-8-22; Pernet V, 2008, J NEUROSCI, V28, P7435, DOI 10.1523/JNEUROSCI.0727-08.2008; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Petrasek T, 2014, NEUROBIOL LEARN MEM, V107, P42, DOI 10.1016/j.nlm.2013.10.015; Phillips WA, 2003, BEHAV BRAIN SCI, V26, P65, DOI 10.1017/S0140525X03000025; Prokopova I, 2012, PHARMACOL BIOCHEM BE, V102, P151, DOI 10.1016/j.pbb.2012.04.003; R Development Core Team, 2012, R LANG ENV STAT COMP; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; STEPHAN FK, 1978, BEHAV BIOL, V22, P456, DOI 10.1016/S0091-6773(78)92565-8; Stuchlik A, 2004, NEUROSCI LETT, V366, P162, DOI 10.1016/j.neulet.2004.05.037; Stuchlik A, 2007, BEHAV BRAIN RES, V178, P47, DOI 10.1016/j.bbr.2006.11.046; Swerdlow NR, 2012, DEV NEUROSCI-BASEL, V34, P240, DOI 10.1159/000336841; Tan EC, 2005, MOL BRAIN RES, V139, P212, DOI 10.1016/j.molbrainres.2005.05.010; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Tews B, 2013, P NATL ACAD SCI USA, V110, P6583, DOI 10.1073/pnas.1217665110; Vales K, 2006, NEUROSCI RES, V55, P383, DOI 10.1016/j.neures.2006.04.007; VanGuilder HD, 2012, J NEUROCHEM, V121, P77, DOI 10.1111/j.1471-4159.2012.07671.x; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Voineskos AN, 2009, J NEUROSCI, V29, P5045, DOI 10.1523/JNEUROSCI.0477-09.2009; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Willi R, 2009, GENES BRAIN BEHAV, V8, P181, DOI 10.1111/j.1601-183X.2008.00460.x; Willi R, 2013, NEUROBIOL DIS, V54, P150, DOI 10.1016/j.nbd.2013.01.011; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010	64	16	16	0	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	MAR 18	2014	8								90	10.3389/fnbeh.2014.00090			15	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AD0NH	WOS:000332930600001	24672453	Green Published, gold, Green Accepted			2022-02-06	
J	Cossman, JP; Morrison, CS; Taylor, HO; Salter, AB; Klinge, PM; Sullivan, SR				Cossman, Jack P.; Morrison, Clinton S.; Taylor, Helena O.; Salter, Amanda B.; Klinge, Petra M.; Sullivan, Stephen R.			Traumatic Orbital Roof Fractures: Interdisciplinary Evaluation and Management	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							GROWING SKULL FRACTURES; REPEATED COMPUTED-TOMOGRAPHY; CERVICAL-SPINE INJURY; SURGICAL-MANAGEMENT; HEAD-INJURY; RECONSTRUCTION	Background: The orbital roof forms part of the anterior skull base and is positioned for potential concomitant ophthalmologic and neurologic injury. Despite potential morbidity and mortality, orbital roof fractures have garnered little attention compared with orbital floor fractures. The authors' purpose is to review and describe key points when treating these fractures. Methods: The authors reviewed 1171 consecutive patient at a trauma center with orbital or skull base fractures from 2009 to 2011. Patient demographics, mechanism of injury, associated injuries, treatment, outcomes, and complications were recorded. Results: Among the 1171 patients, the authors identified 60 with an orbital roof fracture (5 percent). All were evaluated by plastic surgery, neurosurgery, and ophthalmology. Average age was 38.1 years, and the male-to-female ratio was 4:1. Frequent mechanisms of injury were fall (33 percent), followed by assault (25 percent). Concomitant craniofacial skeletal fractures were common (87 percent), as were ophthalmologic injuries (47 percent), and traumatic brain injury with intracranial hemorrhage (65 percent). Six patients (10 percent) required operative repair of the orbital roof, all of whom had a dural laceration and cerebrospinal fluid leak. Most patients (90 percent) had minimal displacement and no clinically evident cerebrospinal fluid leak and were treated with observation without complications. Conclusions: Orbital roof fractures are a less common but potentially serious craniofacial injury. Most can be safely observed; however, intracranial or intraorbital injury may warrant surgical intervention to remove impinging bony fragments, repair dura, or reconstruct the orbital roof. An interdisciplinary approach with plastic surgery, ophthalmology, and neurosurgery is crucial to providing comprehensive care. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.	Brown Univ, Warren Alpert Med Sch, Div Plast Surg, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Plast Surg, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Ophthalmol, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02905 USA; Rhode Isl Hosp, Providence, RI USA; [Sullivan, Stephen R.] Hasbro Childrens Hosp, Providence, RI 02905 USA		Sullivan, SR (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Plast & Reconstruct Surg,Rhode Isl Hosp, Dept Pediat,Dept Plast & Reconstruct Surg, 2 Dudley St,MOC 180, Providence, RI 02905 USA.	stephen.sullivan@brown.edu					ANTONYSHYN O, 1989, PLAST RECONSTR SURG, V84, P10, DOI 10.1097/00006534-198907000-00002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clauser L, 2004, CHILD NERV SYST, V20, P168, DOI 10.1007/s00381-003-0868-0; Cobb ARM, 2013, BRIT J ORAL MAX SURG, V51, P41, DOI 10.1016/j.bjoms.2012.03.006; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Donahue DJ, 1997, PEDIATR NEUROSURG, V26, P261, DOI 10.1159/000121201; Ersahin Y, 2000, NEUROSURG REV, V23, P139, DOI 10.1007/PL00011945; Fattahi T, 2009, INT J ORAL MAX SURG, V38, P1263, DOI 10.1016/j.ijom.2009.09.006; FLANAGAN JC, 1980, OPHTHALMOLOGY, V87, P325; Foster JA, 2004, AM ORTHOPT J, V54, P13; Fulcher TP, 2003, OPHTHALMIC PLAST REC, V19, P359, DOI 10.1097/01.IOP.0000083646.20672.6B; Gaziolu N, 2008, ULUS TRAVMA ACIL CER, V14, P247; GREENWALD MJ, 1989, OPHTHALMOLOGY, V96, P491; Gupta SK, 1997, ACTA NEUROCHIR, V139, P928, DOI 10.1007/BF01411301; Haug RH, 2002, ORAL SURG ORAL MED O, V93, P238, DOI 10.1067/moe.2002.120975; HAVLIK RJ, 1995, J CRANIOFAC SURG, V6, P103, DOI 10.1097/00001665-199503000-00003; Hoffman JR, 1998, ANN EMERG MED, V32, P461, DOI 10.1016/S0196-0644(98)70176-3; Karabekir HS, 2012, J CRANIO MAXILL SURG, V40, pE189, DOI 10.1016/j.jcms.2011.10.006; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kim JW, 2012, ARCH PLAST SURG-APS, V39, P31, DOI 10.5999/aps.2012.39.1.31; KOLTAI PJ, 1995, ARCH OTOLARYNGOL, V121, P1375; Manson PN, 2009, PLAST RECONSTR SURG, V124, P2096, DOI 10.1097/PRS.0b013e3181bf8394; Marion DW, 2006, NEUROSURGERY, V58, P655; MESSINGER A, 1989, PLAST RECONSTR SURG, V84, P213, DOI 10.1097/00006534-198908000-00003; Mithani SK, 2009, PLAST RECONSTR SURG, V123, P1293, DOI 10.1097/PRS.0b013e31819e26f2; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; O-Lee TJ., 2008, OPER TECH OTOLARYNGO, V19, P98; PENFOLD CN, 1992, BRIT J ORAL MAX SURG, V30, P97, DOI 10.1016/0266-4356(92)90078-W; PIOTROWSKI WP, 1995, J CRANIO MAXILL SURG, V23, P6, DOI 10.1016/S1010-5182(05)80247-1; RYALL RG, 1992, J NEUROSURG, V77, P737, DOI 10.3171/jns.1992.77.5.0737; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Shah AD, 2011, INDIAN J OPHTHALMOL, V59, P501, DOI 10.4103/0301-4738.86325; Stahel PF, 2005, ORTHOPADE, V34, P823, DOI 10.1007/s00132-005-0842-5; SULLIVAN WG, 1991, PLAST RECONSTR SURG, V87, P657, DOI 10.1097/00006534-199104000-00008; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039	40	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	MAR	2014	133	3					335E	343E		10.1097/01.prs.0000438051.36881.e0			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AD4TN	WOS:000333243600013	24572878				2022-02-06	
J	Gulin, SL; Perrin, PB; Stevens, LF; Villasenor-Cabrera, TJ; Jimenez-Maldonado, M; Martinez-Cortes, ML; Arango-Lasprilla, JC				Gulin, Shaina L.; Perrin, Paul B.; Stevens, Lillian F.; Villasenor-Cabrera, Teresita J.; Jimenez-Maldonado, Miriam; Martinez-Cortes, Ma. Luisa; Arango-Lasprilla, Juan Carlos			Health-Related Quality of Life and Mental Health Outcomes in Mexican TBI Caregivers	FAMILIES SYSTEMS & HEALTH			English	Article						TBI caregivers; Latin America	TRAUMATIC BRAIN-INJURY; FAMILY CAREGIVERS; SURVEY SF-36; BURDEN; SCALE; SATISFACTION; INDIVIDUALS; DEPRESSION; REHABILITATION; PERSPECTIVE	Research has documented the deleterious effects on caregivers of providing care for an individual with traumatic brain injury (TBI). TBI caregivers in Mexico specifically have reduced health-related quality of life (HRQOL) across both physical and mental health domains. The purpose of the current study was to uncover the system of connections between Mexican TBI caregivers' HRQOL and their mental health. A cross-sectional survey was conducted at a public medical facility in Guadalajara, Mexico. Ninety family caregivers of individuals with TBI completed measures of HRQOL, satisfaction with life, depression, and burden. A canonical correlation analysis revealed that the better the caregivers' HRQOL, the better their mental health was, with the effect reaching a largesized effect. A distinct pattern emerged linking caregivers' higher energy levels and better social functioning to lower depression and greater satisfaction with life. A series of multiple regressions similarly uncovered that the most robust independent HRQOL predictors of caregiver mental health were vitality and social functioning. Especially for TBI caregivers with poor health, behavioral health interventions in Latin America that target the HRQOL domains of social functioning and vitality may significantly improve caregiver mental health, and as a result, informal care for TBI.	[Gulin, Shaina L.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian F.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Villasenor-Cabrera, Teresita J.; Jimenez-Maldonado, Miriam; Martinez-Cortes, Ma. Luisa] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Arango-Lasprilla, Juan Carlos] Univ Deusto, Dept Psychol, Bilbao 48007, Spain; [Arango-Lasprilla, Juan Carlos] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, Avda Univ 24, Bilbao 48007, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Atienza FL, 2000, PSICOTHEMA, V12, P314; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Beery LC, 1997, OMEGA-J DEATH DYING, V35, P261, DOI 10.2190/9QT0-XBD0-V8E9-U650; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cohen J., 2013, STAT POWER ANAL BEHA; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Grant JS, 2000, BRAIN INJURY, V14, P1089; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hanson SL, 2007, REHABIL PSYCHOL, V52, P409, DOI 10.1037/0090-5550.52.4.409; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karlikaya G., 2005, INTERNET J NEUROLOGY, V4, DOI [10.5580/2587, DOI 10.5580/2587]; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Marin G, 1991, RES HISPANIC POPULAT; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin M., 1996, REV GERONTOLOGIA, V6, P338; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Nanda U, 1998, EVAL HEALTH PROF, V21, P179, DOI 10.1177/016327879802100204; Pavot L, 1993, PSYCHOL ASSESSMENTS, V5, P164; Perrin P. B., 2012, MODELING CONNE UNPUB; Perrin P. B., NEUROREHABI IN PRESS; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sanchez-Ayendez M, 1998, J GERONTOL SOC WORK, V30, P75, DOI 10.1300/J083v30n01_06; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; SPSS Inc, 2010, SPSS BAS 19 0 WIND C; Stewart AL, 1992, MEASURING FUNCTIONIN; Stull D., 1996, J CLIN GEROPSYCHOL, V2, P175; TEASDALE G, 1974, LANCET, V2, P81; Villarreal R, 2005, HISPANIC J BEHAV SCI, V27, P409, DOI 10.1177/0739986305281125; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZEA MC, 1994, J SOC BEHAV PERS, V9, P185; Zsembik BA, 2000, J FAM ISSUES, V21, P652, DOI 10.1177/019251300021005007	51	16	16	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1091-7527	1939-0602		FAM SYST HEALTH	Fam. Syst. Health	MAR	2014	32	1					53	66		10.1037/a0032623			14	Health Care Sciences & Services; Family Studies; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Family Studies; Public, Environmental & Occupational Health	AD9OO	WOS:000333594600013	24417652				2022-02-06	
J	Kronvall, E; Valdemarsson, S; Saveland, H; Nilsson, OG				Kronvall, Erik; Valdemarsson, Stig; Saveland, Hans; Nilsson, Ola G.			Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage Is Associated with Impaired Early Outcome	WORLD NEUROSURGERY			English	Article						Growth hormone deficiency; Hypopituitarism; Outcome; Pituitary deficiency; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; CEREBRAL VASOSPASM; HYPOPITUITARISM; MANAGEMENT; DIAGNOSIS; DEFICIENCY; GUIDELINES; NEUROENDOCRINE; HYPONATREMIA; PREVALENCE	OBJECTIVE: Poor outcome and neuropsychological sequelae after aneurysmal subarachnoid hemorrhage (SAH) is a persistent problem. Pituitary dysfunction has been proposed as a contributing factor. Clinical studies have given variable and conflicting results on its importance and incidence after SAH. The aim of this study was to prospectively examine SAH patients with assessment of endocrine function in the acute stage and at early follow-up and to compare clinical SAH features to endocrine abnormalities indicating pituitary dysfunction. METHODS: Endocrine function was assessed by basal hormonal concentrations at 5 to 10 days and 3 to 6 months after SAH. Growth hormone deficiency also was evaluated by the growth hormone releasing hormoneearginine stimulation test at follow-up. Clinical outcome was assessed and scored according to the Glasgow Outcome Scale. RESULTS: Fifty-one SAH patients were included and assessed in the acute stage after the bleed. Six were lost to follow-up. The overall prevalence of pituitary dysfunction was 37% and 27% in the acute stage and at follow-up, respectively. Patients with evidence of pituitary dysfunction had significantly worse outcome according to Glasgow Outcome Scale at both occasions. The ruptured aneurysm was more commonly located in the circle of Willis among patients with pituitary dysfunction in the acute stage. CONCLUSIONS: The present results support earlier findings that hormonal abnormalities are not infrequent after SAH. Furthermore, our data suggest that pituitary dysfunction is associated with worse clinical outcome and is more common among patients with bleeding sites close to the hypothalamus.	[Kronvall, Erik; Saveland, Hans; Nilsson, Ola G.] Lund Univ, Skane Univ Hosp, Dept Neurosurg, Lund, Sweden; [Valdemarsson, Stig] Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden		Kronvall, E (corresponding author), Lund Univ, Skane Univ Hosp, Dept Neurosurg, Lund, Sweden.	erik.kronvall@med.lu.se					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Cesarini KG, 1999, J NEUROSURG, V90, P664, DOI 10.3171/jns.1999.90.4.0664; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Finucane FM, 2008, CLIN ENDOCRINOL, V69, P603, DOI 10.1111/j.1365-2265.2008.03240.x; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fraser JF, 2006, NEUROSURGERY, V59, P222, DOI 10.1227/01.NEU.0000223440.35642.6E; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Grossman AB, 2010, J CLIN ENDOCR METAB, V95, P4855, DOI 10.1210/jc.2010-0982; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; HUTTER BO, 1993, NEUROSURGERY, V33, P999; JENNETT B, 1975, LANCET, V7905, P480; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Rosen Thord, 2012, Lakartidningen, V109, P629; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Vora YY, 1999, NEUROSURGERY, V44, P1237, DOI 10.1097/00006123-199906000-00039; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d	36	16	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR-APR	2014	81	3-4					529	537		10.1016/j.wneu.2013.10.038			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AG7EP	WOS:000335581200032	24140998	Green Submitted			2022-02-06	
J	Albuquerque, CEL; Arcanjo, FPN; Cristino, G; Lopes, AM; de Almeida, PC; Prado, R; Pereira-Stabile, CL				Lopes Albuquerque, Carlos Eduardo; Nogueira Arcanjo, Francisco Placido; Cristino-Filho, Gerardo; Lopes-Filho, Antonio Mont'Alverne; de Almeida, Paulo Cesar; Prado, Roberto; Pereira-Stabile, Cecilia Luiz			How Safe Is Your Motorcycle Helmet?	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							DEATH; SEVERITY; SOCIETY; BURDEN; IMPACT; LAWS	Purpose: Motorcycle crash helmets do not totally prevent head and facial trauma. The aim of this study was to investigate if protection offered by helmets differs according to helmet type. Materials and Methods: In this retrospective cohort study, outpatient records of motorcyclists were analyzed for the Facial Injury Severity Scale (FISS), traumatic brain injury (TBI), facial fractures, and helmet use. Statistical analysis was conducted using the Fisher and Bonferroni tests, bivariate regression analysis, and 1-way analysis of variance. Results: There were 253 motorcyclists who sustained craniomaxillofacial injuries and were referred for outpatient treatment (men, 88.9%; mean age, 29.64 +/- 11.6 yr); 60.1% had up to 9 years of formal education; 156 patients reported not using crash helmets, 51 were using open-face helmets, and 46 were using full-face helmets. The mean FISS score was significantly higher for unhelmeted riders compared with full-face helmet riders (P = .047), with no difference between unhelmeted riders and open-face helmet users (P = 1.00). Results for TBI were statistically greater for those wearing open-face helmets compared with full-face helmets (P = .035). Conclusion: In this study, a large percentage of motorcyclists had facial fractures and TBI, and crash helmets did not always offer adequate protection against craniomaxillofacial injury, especially open-face helmets. Thus, further investigation into helmet types and quality of protection offered is recommended. (C) 2014 American Association of Oral and Maxillofacial Surgeons			Albuquerque, CEL (corresponding author), Rua Finlandia 35, Sobral, CE, Brazil.	petergilmara2@gmail.com			Research Initiative Grant from Santa Casa de Misericordia de Sobral Hospital	This project was funded by a Research Initiative Grant from Santa Casa de Misericordia de Sobral Hospital.	Abbas AK, 2012, ACCIDENT ANAL PREV, V49, P249, DOI 10.1016/j.aap.2011.09.033; Bagheri SC, 2006, J ORAL MAXIL SURG, V64, P408, DOI 10.1016/j.joms.2005.11.013; Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Cook LJ, 2009, 811208 DOT HS NAT HI; Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Eastridge BJ, 2006, J TRAUMA, V60, P978, DOI 10.1097/01.ta.0000215582.86115.01; Faul M, 2010, TRAUMATIC BRAIN INJU; Houston DJ, 2008, ACCIDENT ANAL PREV, V40, P200, DOI 10.1016/j.aap.2007.05.005; Hundley JC, 2004, J TRAUMA, V57, P944, DOI 10.1097/01.TA.0000149497.20065.F4; Instituto Sangari, 2012, MAP VIOL 2012; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Majdan M, 2012, EUR J PUBLIC HEALTH, V10, P1; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; Norvell DC, 2002, AM J EPIDEMIOL, V156, P483, DOI 10.1093/aje/kwf081; Oginni FO, 2009, TRAFFIC INJ PREV, V10, P70, DOI 10.1080/15389580802496968; Ouellet James V, 2006, Traffic Inj Prev, V7, P49, DOI 10.1080/15389580500338652; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; TSAI YJ, 1995, AM J EPIDEMIOL, V142, P974, DOI 10.1093/oxfordjournals.aje.a117746; Waiselfisz JJ, 2012, MAPA VIOLENCIA 2012; WHO, 2006, HELM ROAD SAF MAN DE; World Health Organization, 2009, GLOB STAT REP ROAD S; Yu WY, 2011, INT J EPIDEMIOL, V40, P794, DOI 10.1093/ije/dyr040	24	16	16	0	24	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAR	2014	72	3					542	549		10.1016/j.joms.2013.10.017			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	AA5OZ	WOS:000331150800014	24326016				2022-02-06	
J	Rodgers, KM; Deming, YK; Bercum, FM; Chumachenko, SY; Wieseler, JL; Johnson, KW; Watkins, LR; Barth, DS				Rodgers, Krista M.; Deming, Yuetiva K.; Bercum, Florencia M.; Chumachenko, Serhiy Y.; Wieseler, Julie L.; Johnson, Kirk W.; Watkins, Linda R.; Barth, Daniel S.			Reversal of Established Traumatic Brain Injury-Induced, Anxiety-Like Behavior in Rats after Delayed, Post-Injury Neuroimmune Suppression	JOURNAL OF NEUROTRAUMA			English	Article						glial cell response to injury; inflammation; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; CORPUS-CALLOSUM; LIFE-SPAN; MILD; MRI; QUANTIFICATION; SEGMENTATION; VALIDATION; ANISOTROPY	Traumatic brain injury (TBI) increases the risk of neuropsychiatric disorders, particularly anxiety disorders. Yet, there are presently no therapeutic interventions to prevent the development of post-traumatic anxiety or effective treatments once it has developed. This is because, in large part, of a lack of understanding of the underlying pathophysiology. Recent research suggests that chronic neuroinflammatory responses to injury may play a role in the development of post-traumatic anxiety in rodent models. Acute peri-injury administration of immunosuppressive compounds, such as Ibudilast (MN166), have been shown to prevent reactive gliosis associated with immune responses to injury and also prevent lateral fluid percussion injury (LFPI)-induced anxiety-like behavior in rats. There is evidence in both human and rodent studies that post-traumatic anxiety, once developed, is a chronic, persistent, and drug-refractory condition. In the present study, we sought to determine whether neuroinflammation is associated with the long-term maintenance of post-traumatic anxiety. We examined the efficacy of an anti-inflammatory treatment in decreasing anxiety-like behavior and reactive gliosis when introduced at 1 month after injury. Delayed treatment substantially reduced established LFPI-induced freezing behavior and reactive gliosis in brain regions associated with anxiety and continued neuroprotective effects were evidenced 6 months post-treatment. These results support the conclusion that neuroinflammation may be involved in the development and maintenance of anxiety-like behaviors after TBI.	[Rodgers, Krista M.; Deming, Yuetiva K.; Bercum, Florencia M.; Chumachenko, Serhiy Y.; Wieseler, Julie L.; Watkins, Linda R.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Johnson, Kirk W.] MediciNova Inc, La Jolla, CA USA		Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, UCB 345, Boulder, CO 80309 USA.	dbarth@psych.colorado.edu	Robles, Yuetiva/AAS-3610-2020; Rodgers, Krista/AAC-5063-2020	Robles, Yuetiva/0000-0001-7512-5703; RODGERS, KRISTA/0000-0003-4393-6389	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040]; Craig Hospital Gift Fund, a University of Colorado Innovative Seed Grant; Autism Speaks Pilot Study [7153]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS36981, DA024044, DA01767]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K05DA024044] Funding Source: NIH RePORTER	This work was supported by the U.S. Army Medical Research and Material Command (grant PR100040), the Craig Hospital Gift Fund, a University of Colorado Innovative Seed Grant, the Autism Speaks Pilot Study (grant 7153), and the National Institutes of Health (grant nos. NS36981 [to D. S. B.] and DA024044 and DA01767 [to L.R.W.].	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Assistant Secretary D. O. D, 2007, TRAUM BRAIN INJ DEF; Barzo P, 1997, ACT NEUR S, V70, P115; Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Hasan KM, 2008, MAGN RESON MED, V59, P7, DOI 10.1002/mrm.21434; Hasan KM, 2007, NEUROREPORT, V18, P1735, DOI 10.1097/WNR.0b013e3282f0d40c; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2007, NEUROIMAGE, V34, P1497, DOI 10.1016/j.neuroimage.2006.10.029; Hasan KM, 2013, MAGN RESON IMAGING, V31, P1445, DOI 10.1016/j.mri.2013.04.010; Hasan KM, 2013, J CHILD NEUROL, V28, P874, DOI 10.1177/0883073812452917; Hasan KM, 2011, COMPUT BIOL MED, V41, P1062, DOI 10.1016/j.compbiomed.2010.10.008; Hasan KM, 2011, HUM BRAIN MAPP, V32, P107, DOI 10.1002/hbm.21004; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hunsche S, 2001, RADIOLOGY, V221, P550, DOI 10.1148/radiol.2212001823; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kempton MJ, 2011, NEUROIMAGE, V58, P1051, DOI 10.1016/j.neuroimage.2011.06.080; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kreipke C. W., 2013, CEREBRAL BLOOD FLOW, P1; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	60	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					487	497		10.1089/NEU.2013.3090			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600247	24041015	Green Published			2022-02-06	
J	Shih, CC; Hsu, YT; Wang, HH; Chen, TL; Tsai, CC; Lane, HL; Yeh, CC; Sung, FC; Chiu, WT; Cherng, YG; Liao, CC				Shih, Chun-Chuan; Hsu, Yi-Ting; Wang, Hwang-Huei; Chen, Ta-Liang; Tsai, Chin-Chuan; Lane, Hsin-Long; Yeh, Chun-Chieh; Sung, Fung-Chang; Chiu, Wen-Ta; Cherng, Yih-Giun; Liao, Chien-Chang			Decreased Risk of Stroke in Patients with Traumatic Brain Injury Receiving Acupuncture Treatment: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ADVERSE OUTCOMES; WEIGHT-LOSS; TAIWAN; COUNTRIES; EPILEPSY; STRATEGY; CHILDREN; RECOVERY	Background: Patients with traumatic brain injury (TBI) face increased risk of stroke. Whether acupuncture can help to protect TBI patients from stroke has not previously been studied. Methods: Taiwan's National Health Insurance Research Database was used to conduct a retrospective cohort study of 7409 TBI patients receiving acupuncture treatment and 29,636 propensity-score-matched TBI patients without acupuncture treatment in 2000-2008 as controls. Both TBI cohorts were followed until the end of 2010 and adjusted for immortal time to measure the incidence and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) of new-onset stroke in the multivariable Cox proportional hazard models. Results: TBI patients with acupuncture treatment (4.9 per 1000 person-years) had a lower incidence of stroke compared with those without acupuncture treatment (7.5 per 1000 person-years), with a HR of 0.59 (95% CI = 0.50-0.69) after adjustment for sociodemographics, coexisting medical conditions and medications. The association between acupuncture treatment and stroke risk was investigated by sex and age group (20-44, 45-64, and >= 65 years). The probability curve with log-rank test showed that TBI patients receiving acupuncture treatment had a lower probability of stroke than those without acupuncture treatment during the follow-up period (p < 0.0001). Conclusion: Patients with TBI receiving acupuncture treatment show decreased risk of stroke compared with those without acupuncture treatment. However, this study was limited by lack of information regarding lifestyles, biochemical profiles, TBI severity, and acupuncture points used in treatments.	[Shih, Chun-Chuan; Tsai, Chin-Chuan; Lane, Hsin-Long] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Hsu, Yi-Ting] China Med Univ Hosp, Neurosci Lab, Dept Neurol, Taichung, Taiwan; [Wang, Hwang-Huei] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Cherng, Yih-Giun] Taipei Med Univ, Dept Anesthesiol, Shuang Ho Hosp, New Taipei City, Taiwan; [Liao, Chien-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan		Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/Y-3304-2019; Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Cherng, Yih-Giun/0000-0002-0201-4380	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP98-RD-038, CCMP99-RD-035]; National Science Council, TaiwanMinistry of Science and Technology, Taiwan [102-2314-B-038-021-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	This study is supported in part by a Grant from the Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (CCMP98-RD-038 and CCMP99-RD-035), the National Science Council, Taiwan (102-2314-B-038-021-MY3), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cabioglu MT, 2005, AM J CHINESE MED, V33, P525, DOI 10.1142/S0192415X05003132; Chang CC, 2013, BRIT J SURG, V100, P684, DOI 10.1002/bjs.9065; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Flachskampf FA, 2007, CIRCULATION, V115, P3121, DOI 10.1161/CIRCULATIONAHA.106.661140; He Jing, 2005, J Tradit Chin Med, V25, P171; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hsieh CH, 2010, AM J CHINESE MED, V38, P675, DOI 10.1142/S0192415X10008147; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Kim DD, 2006, MICROCIRCULATION, V13, P577, DOI 10.1080/10739680600885210; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin JA, 2013, ANN RHEUMATOL DIS; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Quah-Smith I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012619; Shih CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/262039; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Shih CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032540; Shih CC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-27; Shih CC, 2009, CHINESE MED J-PEKING, V122, P1544, DOI 10.3760/cma.j.issn.0366-6999.2009.13.013; Sze FKH, 2002, STROKE, V33, P2604, DOI 10.1161/01.STR.0000035908.74261.C9; Tseng YJ, 2013, J ALTERN COMPLEM MED, V19, P474, DOI 10.1089/acm.2012.0163; Wong V, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007700.PUB3; Wu P, 2010, STROKE, V41, pE171, DOI 10.1161/STROKEAHA.109.573576; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	40	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89208	10.1371/journal.pone.0089208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	WOS:000331711900105	24586597	Green Published, gold, Green Submitted			2022-02-06	
J	Auble, BA; Bollepalli, S; Makoroff, K; Weis, T; Khoury, J; Colliers, T; Rose, SR				Auble, Bethany A.; Bollepalli, Sureka; Makoroff, Kathi; Weis, Tammy; Khoury, Jane; Colliers, Tracy; Rose, Susan R.			Hypopituitarism in Pediatric Survivors of Inflicted Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						pituitary; prolactin; shaken baby syndrome; short stature; traumatic brain injury	PITUITARY-FUNCTION; CHILDREN; DYSFUNCTION; CHILDHOOD; PHASE	Endocrine dysfunction is common after accidental traumatic brain injury (TBI). Prevalence of endocrine dysfunction after inflicted traumatic brain injury (iTBI) is not known. The aim of this study was to examine endocrinopathy in children after moderate-to-severe iTBI. Children with previous iTBI (n=14) were evaluated for growth/endocrine dysfunction, including anthropometric measurements and hormonal evaluation (nocturnal growth hormone [GH], thyrotropin surge, morning and low-dose adrenocorticotropin stimulated cortisol, insulin-like growth factor 1, IGF-binding protein 3, free thyroxine, prolactin [PRL], and serum/urine osmolality). Analysis used Fisher's exact test and Wilcoxon's rank-sum test, as appropriate. Eighty-six percent of subjects had endocrine dysfunction with at least one abnormality, whereas 50% had two or more abnormalities, significantly increased compared to an estimated 2.5% with endocrine abnormality in the general population (p<0.001). Elevated prolactin was common (64%), followed by abnormal thyroid function (33%), short stature (29%), and low GH peak (17%). High prolactin was common in subjects with other endocrine abnormalities. Two were treated with thyroid hormone and 2 may require GH therapy. In conclusion, children with a history of iTBI show high risk for endocrine dysfunction, including elevated PRL and growth abnormalities. This effect of iTBI has not been well described in the literature. Larger, multi-center, prospective studies would provide more data to determine the extent of endocrine dysfunction in iTBI. We recommend that any child with a history of iTBI be followed closely for growth velocity and pubertal changes. If growth velocity is slow, PRL level and a full endocrine evaluation should be performed.	[Auble, Bethany A.; Bollepalli, Sureka; Weis, Tammy; Rose, Susan R.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Endocrinol, Cincinnati, OH 45229 USA; [Makoroff, Kathi; Colliers, Tracy] Cincinnati Childrens Hosp Med Ctr, Ctr Safe & Hlth Children, Cincinnati, OH 45229 USA; [Khoury, Jane] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; Univ Cincinnati, Sch Med, Cincinnati, OH USA		Auble, BA (corresponding author), Med Coll Wisconsin, Childrens Hosp Wisconsin, MS C520,9000 West Wisconsin Ave,POB 1997, Milwaukee, WI 53201 USA.	bethanyauble@gmail.com	Khoury, Jane/O-2068-2015		Pfizer Global PharmaceuticalsPfizer; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [8 UL1 TR000077-04]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	Partial support for this work was received from a grant from Pfizer Global Pharmaceuticals for investigator-initiated research, as well as from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (NIH; through grant no. 8 UL1 TR000077-04). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; DONS RF, 1998, ENDOCRINE METABOLIC, P8; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Kappy MS, 2010, PEDIAT PRACTICE ENDO; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; ROSE SR, 1995, PEDIATR RES, V38, P967, DOI 10.1203/00006450-199512000-00023; Rose SR, 1999, J PEDIATR ENDOCR MET, V12, P167; ROSE SR, 1989, J CLIN ENDOCR METAB, V68, P1086, DOI 10.1210/jcem-68-6-1086; Rose SR, 1999, HORM RES, V52, P73, DOI 10.1159/000023438; Rose SR, 2010, J PEDIATR-US, V157, P662, DOI 10.1016/j.jpeds.2010.04.047; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476	18	16	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					321	326		10.1089/neu.2013.2916			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600004	24028400	Green Published			2022-02-06	
J	Howe, J; Fitzpatrick, CM; Lakam, DR; Gleisner, A; Vane, DW				Howe, Jarett; Fitzpatrick, Colleen M.; Lakam, Dana Rachel; Gleisner, Ana; Vane, Dennis W.			Routine repeat brain computed tomography in all children with mild traumatic brain injury may result in unnecessary radiation exposure	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Repeat CT scan; pediatric; traumatic brain injury; radiation exposure	BLUNT HEAD TRAUMA; PEDIATRIC-PATIENTS; MODERATE; CT	BACKGROUND: Computed tomography (CT) for pediatric traumatic brain injury (TBI) is common. Evidence suggests that 1 in 1,200 children undergoing CT will die of malignancy from radiation exposure. Presently, there is no protocol for surveying children with mild TBI; repeat CT (rCT) is often performed. We hypothesized that rCT could be avoided. Outcomes of similar patients who underwent rCT were compared with those of patients followed by clinical examination alone. METHODS: An 8-year retrospective review was performed of patients admitted to a Level I pediatric trauma center with TBI, CT evidence of TBI, and Glasgow Coma Scale (GCS) score of 14 to 15. There were two groups, those who underwent rCT (rCT+) and those who did not (rCT(-)). Data included age, Injury Severity Score (ISS), mechanism of injury, type of TBI, and outcome. Patients with coagulopathies, ventriculoperitoneal shunts, developmental disabilities, nonaccidental trauma, concomitant injuries, or medical problems resulting in intubation or sedation not attributed to TBI were excluded. RESULTS: Of 391 patients admitted with TBI, 120 were included in the study. A total of 106 patientswere rCT+, and 14 were rCT-.rCT+ children were older (mean, 98.7 +/- 7.3 vs. 35.3 +/- 11.5 months; p = 0.0025) and more likely to have epidural hematoma (EDH) (100% rCT with EDH vs. 76% rCT all other TBI, p = 0.044). Mechanism of injury and mean ISS (15.2 +/- 0.6 vs. 13.0 +/- 1.1, p = 0.195) were not different between the groups. There were no worsening neurologic symptoms or need for surgery in rCT- children. rCT identified seven patients (6.6%) with CT progression of their injury. Five had an EDH, and two had a subarachnoid hemorrhage. Two children with EDH underwent operation. CONCLUSION: Our study indicates that routine rCT without evidence of clinical deterioration is not indicated in children with admission GCS score of 14 to 15 and TBI on CT scan. Children with EDH seem to have a higher potential for progression, and rCT seems to be indicated in this subgroup. Copyright (C) 2014 by Lippincott Williams& Wilkins	[Howe, Jarett; Lakam, Dana Rachel; Gleisner, Ana; Vane, Dennis W.] Cardinal Glennon Childrens Med Ctr, St Louis, MO 63104 USA; [Fitzpatrick, Colleen M.] St Louis Univ, St Louis CSTARS, St Louis, MO 63103 USA		Vane, DW (corresponding author), Cardinal Glennon Childrens Med Ctr, 1465 S Grand Blvd, St Louis, MO 63104 USA.	dvane@slu.edu					Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Carlos VR, 2004, J TRAUMA, V57, P939; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Langlois JA, 2006, TRAUMATIC BRAIN INJU; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; VANE DW, 1995, J TRAUMA, V38, P867, DOI 10.1097/00005373-199506000-00006; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	13	16	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2014	76	2					292	296		10.1097/TA.0000000000000119			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AH8KG	WOS:000336386100006	24458036				2022-02-06	
J	Hu, MH; Huang, GS; Wu, CT; Lin, JJ; Hsia, SH; Wang, HS; Lin, KL				Hu, Mei-Hua; Huang, Go-Shine; Wu, Chang-Teng; Lin, Jainn-Jim; Hsia, Shao-Hsuan; Wang, Huei-Shyong; Lin, Kuang-Lin		CHEESE Study Grp	Analysis of Plasma Multiplex Cytokines for Children With Febrile Seizures and Severe Acute Encephalitis	JOURNAL OF CHILD NEUROLOGY			English	Article						cytokine; febrile seizures; severe acute encephalitis; interleukin-6; inflammation	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; INTERLEUKIN-6; NEURONS; IL-6	We investigated the plasma cytokine profiles of children with febrile seizures or severe acute encephalitis using multiplex cytometry to evaluate the role of cytokines in these diseases. Interleukin-6, -10, -12p70, -17A, -2, -4, -5, -9, -13, -22, and -1, interferon-, and tumor necrosis factor- were measured in the plasma from children with febrile seizures (n = 9) or severe acute encephalitis (n = 21). In multivariate analysis, interleukin-6 was significantly increased in the plasma of the febrile seizure patients compared to those with severe acute encephalitis, suggesting that interleukin-6 is activated during the acute stage of a febrile seizure. A lower plasma interleukin-6 concentration was significantly associated with severe acute encephalitis. The cytokine network may be deregulated in severe acute encephalitis via the persistence of an uncontrolled inflammatory state in the brain.	[Hu, Mei-Hua] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Hu, Mei-Hua] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hu, Mei-Hua; Wu, Chang-Teng] Chang Gung Univ, Coll Med, Dept Gen Pediat, Chang Gung Childrens Hosp, Tao Yuan, Taiwan; [Hu, Mei-Hua; Wu, Chang-Teng; Lin, Jainn-Jim; Hsia, Shao-Hsuan; Wang, Huei-Shyong; Lin, Kuang-Lin] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Hu, Mei-Hua; Lin, Jainn-Jim] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Huang, Go-Shine] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Lin, Jainn-Jim; Hsia, Shao-Hsuan] Chang Gung Univ, Coll Med, Div Pediat Crit Care & Emergency Med, Chang Gung Childrens Hosp, Tao Yuan, Taiwan; [Lin, Jainn-Jim; Wang, Huei-Shyong; Lin, Kuang-Lin] Chang Gung Univ, Coll Med, Dept Pediat Neurol, Chang Gung Childrens Hosp, Tao Yuan, Taiwan; [Lin, Jainn-Jim; Wang, Huei-Shyong; Lin, Kuang-Lin; CHEESE Study Grp] Chang Gung Childrens Hosp, Study Grp Children Encephalitis Encephalopathy Re, Tao Yuan, Taiwan		Lin, KL (corresponding author), Chang Gung Childrens Hosp, Dept Pediat Neurol, 5 Fu Shin St,Kweishan 333, Tao Yuan, Taiwan.	lincgh@adm.cgmh.org.tw			Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPG 391261]	The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This study was supported by a grant from the Chang Gung Memorial Hospital (CMRPG 391261), Taiwan.	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Asano T, 2010, SCAND J IMMUNOL, V71, P447, DOI 10.1111/j.1365-3083.2010.02391.x; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Falchek SJ, 2012, PEDIATR REV, V33, P122, DOI 10.1542/pir.33-3-122; Fukuda M, 2007, BRAIN DEV-JPN, V29, P644, DOI 10.1016/j.braindev.2007.04.007; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Tran HYP, 2012, FREE RADICAL BIO MED, V52, P1159, DOI 10.1016/j.freeradbiomed.2011.12.008; Ishizaki Y, 2009, EPILEPSIA, V50, P761, DOI 10.1111/j.1528-1167.2008.01861.x; Kalita J, 2010, NEUROSCI LETT, V473, P48, DOI 10.1016/j.neulet.2010.02.017; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Lin JJ, 2012, J CHILD NEUROL; Morichi S, 2012, PEDIATR INT, V54, P536, DOI 10.1111/j.1442-200X.2011.03483.x; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; Pizzi M, 2004, MOL CELL NEUROSCI, V25, P301, DOI 10.1016/j.mcn.2003.10.022; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Straussberg R, 2001, PEDIATR NEUROL, V24, P49, DOI 10.1016/S0887-8994(00)00234-4; Thompson C, 2012, ARCH DIS CHILD, V97, P150, DOI 10.1136/archdischild-2011-300100; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; Yu N, 2012, NEUROSCI LETT, V514, P110, DOI 10.1016/j.neulet.2012.02.070	20	16	17	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	FEB	2014	29	2					182	186		10.1177/0883073813488829			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	289MT	WOS:000329687300005	23674232				2022-02-06	
J	Phillips, LL; Chan, JL; Doperalski, AE; Reeves, TM				Phillips, Linda L.; Chan, Julie L.; Doperalski, Adele E.; Reeves, Thomas M.			Time dependent integration of matrix metalloproteinases and their targeted substrates directs axonal sprouting and synaptogenesis following central nervous system injury	NEURAL REGENERATION RESEARCH			English	Article						neuroregeneration; reactive synaptogenesis; matrix metalloproteinases; brain injury; adaptive and maladaptive neuroplasticity; metalloproteinase inhibition; osteopontin; lipocalin 2	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CHONDROITIN SULFATE PROTEOGLYCAN; LONG-TERM POTENTIATION; COMBINED FLUID PERCUSSION; EXTRACELLULAR-MATRIX; SYNAPTIC PLASTICITY; KAINIC ACID; TEMPORAL EXPRESSION; FUNCTIONAL RECOVERY	Over the past two decades, many investigators have reported how extracellular matrix molecules act to regulate neuroplasticity. The majority of these studies involve proteins which are targets of matrix metalloproteinases. Importantly,. these enzyme/substrate interactions can regulate degenerative and regenerative phases of synaptic plasticity, directing axonal and dendritic reorganization after brain insult. The present review first summarizes literature support for the prominent role of matrix metalloproteinases during neuroregeneration, followed by a discussion of data contrasting adaptive and maladaptive neuroplasticity that reveals time-dependent metalloproteinase/substrate regulation of postinjury synaptic recovery. The potential for these enzymes to serve as therapeutic targets for enhanced neuroplasticity after brain injury is illustrated with experiments demonstrating that metalloproteinase inhibitors can alter adaptive and maladaptive outcome. Finally, the complexity of metalloproteinase role in reactive synaptogenesis is revealed in new studies showing how these enzymes interact with immune molecules to mediate cellular response in the local regenerative environment, and are regulated by novel binding partners in the brain extracellular matrix. Together, these different examples show the complexity with which metalloproteinases are integrated into the process of neuroregeneration, and point to a promising new angle for future studies exploring how to facilitate brain plasticity.	[Phillips, Linda L.; Chan, Julie L.; Doperalski, Adele E.; Reeves, Thomas M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23284 USA.	llphilli@vcu.edu		Chan, Julie/0000-0002-0782-6548	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044372, R01NS057758, R01NS056247] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS044372, R01 NS057758, R01 NS056247] Funding Source: Medline		Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahina M, 2001, CLIN NEUROPATHOL, V20, P60; Bakos SR, 2010, CHEM SENSES, V35, P655, DOI 10.1093/chemse/bjq056; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chan JL, 2013, OSTEOPONTIN IN PRESS; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Clement AB, 2008, NEUROSCIENCE, V152, P459, DOI 10.1016/j.neuroscience.2007.10.060; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; Costanzo RM, 2008, NEUROREPORT, V19, P327, DOI 10.1097/WNR.0b013e3282f50c7b; Costanzo RM, 2006, NEUROREPORT, V17, P1787, DOI 10.1097/WNR.0b013e32800fef87; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Deller T, 2001, RESTOR NEUROL NEUROS, V19, P159; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Fercakova A, 2001, Bratisl Lek Listy, V102, P552; Fredrich M, 2010, NEUROREPORT, V21, P324, DOI 10.1097/WNR.0b013e328335b518; Garwood J, 1999, J NEUROSCI, V19, P3888; Gonthier B, 2007, CEREB CORTEX, V17, P1712, DOI 10.1093/cercor/bhl082; Gonthier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005099; Gonzalez-Perez F, 2013, INT REV NEUROBIOL, V108, P257, DOI 10.1016/B978-0-12-410499-0.00010-1; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Grimpe B, 2002, PROG BRAIN RES, V137, P333; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Handsley MM, 2005, MATRIX METALLOPROTEINASES IN THE CENTRAL NERVOUS SYSTEM, P3, DOI 10.1142/9781860947179_0001; Harris JL, 2011, HIPPOCAMPUS, V21, P81, DOI 10.1002/hipo.20725; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Howell MD, 2012, NEUROSCIENCE, V217, P6, DOI 10.1016/j.neuroscience.2012.05.034; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jones LL, 2003, J NEUROSCI, V23, P9276; Kaliszewska A, 2012, CEREB CORTEX, V22, P2160, DOI 10.1093/cercor/bhr303; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Le AP, 2012, J NEUROSCI, V32, P703, DOI 10.1523/JNEUROSCI.4128-11.2012; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; Li Ru-Bo, 2009, Leg Med (Tokyo), V11 Suppl 1, pS176, DOI 10.1016/j.legalmed.2009.02.029; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Luo J, 2005, CEREBELLUM, V4, P239, DOI 10.1080/14734220500247646; Maier O, 2006, EXP CELL RES, V312, P500, DOI 10.1016/j.yexcr.2005.11.014; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mizoguchi H, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/681385; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Noble LJ, 2002, J NEUROSCI, V22, P7526; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Oh LYS, 1999, J NEUROSCI, V19, P8464; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Penedo LA, 2009, EXP NEUROL, V217, P108, DOI 10.1016/j.expneurol.2009.01.021; Peng H, 2012, PROTEIN CELL, V3, P875, DOI 10.1007/s13238-012-2092-8; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Piccolini VM, 2012, BRAIN RES, V1484, P15, DOI 10.1016/j.brainres.2012.09.025; Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Reeves TM, 2003, J NEUROSCI, V23, P10182; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Safciuc F, 2007, CURR NEUROVASC RES, V4, P228, DOI 10.2174/156720207782446351; Sagane K, 2010, J RECEPT SIG TRANSD, V30, P72, DOI 10.3109/10799891003614790; Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Shin T, 2005, BRAIN RES, V1041, P95, DOI 10.1016/j.brainres.2005.02.019; SNOW DM, 1991, DEVELOPMENT, V113, P1473; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Treloar HB, 2009, J NEUROSCI, V29, P9405, DOI 10.1523/JNEUROSCI.2356-09.2009; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Tsukatani T, 2003, NEUROREPORT, V14, P1135, DOI 10.1097/00001756-200306110-00007; Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Van Hove I, 2012, J NEUROCHEM, V123, P203, DOI 10.1111/j.1471-4159.2012.07900.x; Vansaun M, 2003, J NEUROCYTOL, V32, P1129, DOI 10.1023/B:NEUR.0000021907.68461.9c; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yang P, 2005, J COMP NEUROL, V490, P163, DOI 10.1002/cne.20659; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yong VW, 2007, J NEUROL SCI, V259, P79, DOI 10.1016/j.jns.2006.11.021; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Ziemianska K, 2012, POSTEP HIG MED DOSW, V66, P959, DOI 10.5604/17322693.1021851	123	16	17	0	8	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2014	9	4			SI		362	376		10.4103/1673-5374.128237			15	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AD3LD	WOS:000333139700004	25206824	Green Published, Green Submitted, gold			2022-02-06	
J	Chang, CM; Su, YF; Chang, CZ; Chung, CL; Tsai, YJ; Loh, JK; Lin, CL				Chang, Chia-Mao; Su, Yu-Feng; Chang, Chih-Zen; Chung, Chia-Li; Tsai, Yee-Jean; Loh, Joon-Khim; Lin, Chih-Lung			Progesterone Attenuates Experimental Subarachnoid Hemorrhage-Induced Vasospasm by Upregulation of Endothelial Nitric Oxide Synthase via Akt Signaling Pathway	BIOMED RESEARCH INTERNATIONAL			English	Article							ADENOSINE A(2A) RECEPTOR; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; PROTECTIVE ROLE; PROTEIN-KINASE; 17-BETA-ESTRADIOL; ACTIVATION; ESTROGEN; STRESS	Cerebral vasospasm is the leading cause of mortality and morbidity in patients after aneurysmal subarachnoid hemorrhage (SAH). However, the mechanism and adequate treatment of vasospasm are still elusive. In the present study, we evaluate the effect and possible mechanism of progesterone on SAH-induced vasospasm in a two-hemorrhage rodent model of SAH. Progesterone (8 mg/kg) was subcutaneously injected in ovariectomized female Sprague-Dawley rats one hour after SAH induction. The degree of vasospasm was determined by averaging the cross-sectional areas of basilar artery 7 days after first SAH. Expressions of endothelial nitric oxide synthase (eNOS) and phosphorylated Akt (phospho-Akt) in basilar arteries were evaluated. Prior to perfusion fixation, there were no significant differences among the control and treated groups in physiological parameters recorded. Progesterone treatment significantly (P < 0.01) attenuated SAH-induced vasospasm. The SAH-induced suppression of eNOS protein and phospho-Akt were relieved by progesterone treatment. This result further confirmed that progesterone is effective in preventing SAH-induced vasospasm. The beneficial effect of progesterone might be in part related to upregulation of expression of eNOS via Akt signaling pathway after SAH. Progesterone holds therapeutic promise in the treatment of cerebral vasospasm following SAH.	[Chang, Chia-Mao; Chung, Chia-Li] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan; [Chang, Chia-Mao; Su, Yu-Feng; Chang, Chih-Zen; Chung, Chia-Li; Tsai, Yee-Jean; Loh, Joon-Khim; Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 80708, Taiwan; [Chang, Chia-Mao; Chung, Chia-Li] Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Kaohsiung 81267, Taiwan; [Su, Yu-Feng; Chang, Chih-Zen; Lin, Chih-Lung] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Fac Med, Kaohsiung 80708, Taiwan; [Chang, Chih-Zen] Kaohsiung Municipal Tatung Hosp, Dept Surg, Kaohsiung 80145, Taiwan		Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, 100,Tzyou 1st Rd, Kaohsiung 80708, Taiwan.	chihlung1@yahoo.com		Su, Yu-feng/0000-0003-0355-3981	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 100-2314-B-037-004]; Kaohsiung Medical University Hospital [KMUH 100-0R14]	This work was supported by the National Science Council, Taiwan, under Grant NSC 100-2314-B-037-004, and Kaohsiung Medical University Hospital (KMUH 100-0R14).	Busse R, 1998, J VASC RES, V35, P73, DOI 10.1159/000025568; Chou CH, 2010, NEUROSURGERY, V67, P345, DOI 10.1227/01.NEU.0000371980.08391.71; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Florian M, 2004, STEROIDS, V69, P637, DOI 10.1016/j.steroids.2004.05.016; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Kao CH, 2013, J SURG RES, V183, pE23, DOI 10.1016/j.jss.2013.01.033; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Khorram O, 2009, FERTIL STERIL, V91, P2157, DOI 10.1016/j.fertnstert.2008.05.019; Khurana VG, 2002, STROKE, V33, P782, DOI 10.1161/hs0302.103735; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Lin CL, 2007, J NEUROSURG, V106, P436, DOI 10.3171/jns.2007.106.3.436; Lin CL, 2009, J SURG RES, V157, P208, DOI 10.1016/j.jss.2008.08.021; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; MEES SMD, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Peng XQ, 2010, ACTA PHARMACOL SIN, V31, P175, DOI 10.1038/aps.2009.190; Roviezzo F, 2007, BRIT J PHARMACOL, V151, P377, DOI 10.1038/sj.bjp.0707233; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Selles J, 2001, LIFE SCI, V69, P815, DOI 10.1016/S0024-3205(01)01174-2; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Simoncini T, 2007, HUM REPROD, V22, P2325, DOI 10.1093/humrep/dem109; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079	35	16	16	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								207616	10.1155/2014/207616			6	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AH7FP	WOS:000336298700001	24949428	gold, Green Published, Green Submitted			2022-02-06	
J	Donat, CK; Fischer, F; Walter, B; Deuther-Conrad, W; Brodhun, M; Bauer, R; Brust, P				Donat, Cornelius K.; Fischer, Felix; Walter, Bernd; Deuther-Conrad, Winnie; Brodhun, Michael; Bauer, Reinhard; Brust, Peter			Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						traumatic brain injury; autoradiography; cannabinoid receptors; neuroprotection	LATERAL FLUID PERCUSSION; 18 KDA TSPO; TRANSLOCATOR PROTEIN; BLOOD-FLOW; CORPUS-CALLOSUM; AXONAL INJURY; CB2 RECEPTOR; IN-VITRO; RAT; LOCALIZATION	Paediatric traumatic brain injury (TBI) is a leading cause of death and disability. Previous studies showed neuroprotection after TBI by (endo)cannabinoid mechanisms, suggesting involvement of cannabinoid receptors (CBR). We therefore determined CBR densities and expression of the translocator protein 18 kDA (TSPO) in newborn piglets after experimental TBI. Newborn female piglets were subjected to sham operation (n=6) or fluid-percussion (FP) injury (n=7) under controlled physiological conditions. After six hours, brains were frozen, sagittally cut and incubated with radioligands for CBR ([(HCP)-H-3-55,940, [H-3]SR141716A) and TSPO ([H-3]PK11195), an indicator of gliosis/brain injury. Early after injury, FP-TBI elicited a significant ICP increase at a temporary reduced cerebral perfusion pressure; however, CBF and CMRO2 remained within physiological range. At 6 hours post injury, we found a statistically significant increase in binding of the non-selective agonist [H-3]CP-55,940 in 15 of the 24 investigated brain regions of injured animals. By contrast, no significant changes in binding of the CB1R-selective antagonist [H-3]SR141716A were observed. A non-significant trend towards increased binding of [H-3]PK11195 was observed, suggesting an incipient microglial activation. We therefore conclude that in this model and time span after injury, the increase in [H-3]CP-55,940 binding reflects changes in CB2R density, while CB1R density is not affected. The results may provide explanation for the neuroprotective properties of cannabinoid ligands and future therapeutic strategies of TBI.	[Donat, Cornelius K.; Fischer, Felix; Deuther-Conrad, Winnie; Brust, Peter] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Leipzig, Germany; [Walter, Bernd] Heinrich Braun Hosp, Zwickau, Germany; [Brodhun, Michael] Helios Klinikum Erfurt, Dept Pathol, Erfurt, Germany; [Bauer, Reinhard] Jena Univ Hosp, Inst Mol Cell Biol, Jena, Germany; [Bauer, Reinhard] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany		Donat, CK (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Res Site Leipzig, Leipzig, Germany.	cdonat@nru.dk	Deuther-Conrad, Winnie/B-7558-2015	Deuther-Conrad, Winnie/0000-0003-3168-3062; , Peter/0000-0001-5555-7058			Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Bahr BA, 2006, EXPERT OPIN INV DRUG, V15, P351, DOI 10.1517/13543784.15.4.351; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Capettini LSA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/824093; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; COYLE MG, 1993, AM J PHYSIOL, V264, pH141, DOI 10.1152/ajpheart.1993.264.1.H141; Cumming P, 2006, SYNAPSE, V59, P418, DOI 10.1002/syn.20257; Donat CK, 2010, NEUROPATH APPL NEURO, V36, P225, DOI 10.1111/j.1365-2990.2009.01050.x; Donat CK, 2010, INT J DEV NEUROSCI, V28, P31, DOI 10.1016/j.ijdevneu.2009.10.001; EISENHAUER CL, 1994, LAB ANIM SCI, V44, P245; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; FELDER CC, 1992, MOL PHARMACOL, V42, P838; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Finnie JW, 2012, AUST VET J, V90, P301, DOI 10.1111/j.1751-0813.2012.00955.x; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; Gallyas F, 1979, Neurol Res, V1, P203; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Harkany T, 2005, NEUROSCIENCE, V135, P595, DOI 10.1016/j.neuroscience.2005.06.043; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Herkenham M, 1991, NIDA Res Monogr, V112, P129; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Hohmann AG, 1999, NEUROSCIENCE, V92, P1171, DOI 10.1016/S0306-4522(99)00220-1; Horvath B, 2012, BRIT J PHARMACOL, V165, P2462, DOI 10.1111/j.1476-5381.2011.01381.x; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Lopez-Rodriguez A. B., 2013, CEREB CORTEX; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; MAKOWSKI EL, 1968, CIRC RES, V23, P623, DOI 10.1161/01.RES.23.5.623; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mauler F, 2003, BRAIN RES, V989, P99, DOI 10.1016/S0006-8993(03)03376-6; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; Miller LK, 2011, PHARMACOL REV, V63, P461, DOI 10.1124/pr.110.003491; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pertwee RG, 2000, EXPERT OPIN INV DRUG, V9, P1553, DOI 10.1517/13543784.9.7.1553; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Pazos MR, 2013, NEUROPHARMACOLOGY, V71, P282, DOI 10.1016/j.neuropharm.2013.03.027; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sarne Y, 2011, BRIT J PHARMACOL, V163, P1391, DOI 10.1111/j.1476-5381.2011.01280.x; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Walter B, 1997, BASIC RES CARDIOL, V92, P191, DOI 10.1007/s003950050037; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; WESTLAKE TM, 1994, NEUROSCIENCE, V63, P637, DOI 10.1016/0306-4522(94)90511-8; White R, 1998, BRIT J PHARMACOL, V125, P689, DOI 10.1038/sj.bjp.0702127	78	16	16	0	3	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400	1689-0035		ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2014	74	2					197	210					14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AL4FG	WOS:000339087700006	24993629				2022-02-06	
J	Heinzelmann, M; Reddy, SY; French, LM; Wang, D; Lee, H; Barr, T; Baxter, T; Mysliwiec, V; Gill, J				Heinzelmann, Morgan; Reddy, Swarnalatha Y.; French, Louis M.; Wang, Dan; Lee, Hyunhwa; Barr, Taura; Baxter, Tristin; Mysliwiec, Vincent; Gill, Jessica			Military personnel with chronic symptoms following blast traumatic brain injury have differential expression of neuronal recovery and epidermal growth factor receptor genes	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; military; post-concussive disorder; gene-expression		Objective: Approximately one-quarter of military personnel who deployed to combat stations sustained one or more blast-related, closed-head injuries. Blast injuries result from the detonation of an explosive device. The mechanisms associated with blast exposure that give rise to traumatic brain injury (TBI), and place military personnel at high risk for chronic symptoms of post-concussive disorder (PCD), post-traumatic stress disorder (PTSD), and depression are not elucidated. Methods:To investigate the mechanisms of persistent blast-related symptoms, we examined expression profiles of transcripts across the genome to determine the role of gene activity in chronic symptoms following blast-TBI. Active duty military personnel with (1) a medical record of a blast-TBI that occurred during deployment (n= 19) were compared to control participants without TBI (n = 17). Controls were matched to cases on demographic factors including age, gender, and race, and also in diagnoses of sleep disturbance, and symptoms of PTSD and depression. Due to the high number of PCD symptoms in the TBI+ group, we did not match on this variable. Using expression profiles of transcripts in microarray platform in peripheral samples of whole blood, significantly differentially expressed gene lists were generated. Statistical threshold is based on criteria of 1.5 magnitude fold-change (up or down) and p-values with multiple test correction (false discovery rate <0.05). Results:There were 34 transcripts in 29 genes that were differentially regulated in blast-TBI participants compared to controls. Up-regulated genes included epithelial cell transforming sequence and zinc finger proteins, which are necessary for astrocyte differentiation following injury. Tensin-1, which has been implicated in neuronal recovery in pre-clinical TBI models, was down-regulated in blast-TBI participants. Protein ubiquitination genes, such as epidermal growth factor receptor, were also down-regulated and identified as the central regulators in the gene network determined by interaction pathway analysis. Conclusion: In this study, we identified a gene-expression pathway of delayed neuronal recovery in military personnel a blast-TBI and chronic symptoms. Future work is needed to determine if therapeutic agents that regulate these pathways may provide novel treatments for chronic blast-TBI-related symptoms.	[Heinzelmann, Morgan; Reddy, Swarnalatha Y.; Wang, Dan; Lee, Hyunhwa; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Barr, Taura] W Virginia Univ, Hlth Sci Ctr, Morgantown, WV 26506 USA; [Baxter, Tristin; Mysliwiec, Vincent] Madigan Army Med Ctr, Sleep Med Clin, Tacoma, WA 98431 USA		Gill, J (corresponding author), NINR, 1 Cloister Court,Room 256, Bethesda, MD 20814 USA.	gillj@mail.nih.gov	Gill, Gill M/Q-2020-2017; french, louis/AAB-2083-2020; Reddy, Swarna/G-5349-2013	Lee, Hyunhwa/0000-0002-5625-3141; Heinzelmann, Morgan/0000-0002-4399-6229; french, louis/0000-0002-9451-0604	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027] Funding Source: NIH RePORTER	This study was funded, in part, by the Center for Neuroscience and Regenerative Medicine (Grant 60855).	Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Caldeira MV, 2014, PROG NEUROBIOL, V112, P50, DOI 10.1016/j.pneurobio.2013.10.003; Chen YH, 2012, J NEUROTRAUM, V29, P1328, DOI 10.1089/neu.2011.2235; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Hanissian SH, 2005, BRAIN RES, V1047, P56, DOI 10.1016/j.brainres.2005.04.017; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Jerg-Bretzke Lucia, 2013, Psychosoc Med, V10, pDoc03, DOI 10.3205/psm000093; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kotepui M, 2012, ASIAN PAC J CANCER P, V13, P5879, DOI 10.7314/APJCP.2012.13.11.5879; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu B, 2004, GLIA, V46, P153, DOI 10.1002/glia.10358; Liu B, 2007, J NEUROSCI RES, V85, P3523, DOI 10.1002/jnr.21364; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reynolds JJ, 2013, DNA REPAIR, V12, P588, DOI 10.1016/j.dnarep.2013.04.011; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Sun KJ, 2013, BRAIN RES, V1506, P132, DOI 10.1016/j.brainres.2013.02.011; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tsai JCG, 2010, NEUROREHABILITATION, V26, P85, DOI [10.3233/NRE-2010-0538, 10.3233/NRE-2011-0538]; Vigodner M, 2013, HUM REPROD, V28, P210, DOI 10.1093/humrep/des317; Wan CH, 2014, J NEUROSCI RES, V92, P1, DOI 10.1002/jnr.23305; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yao XL, 2006, NEUROSCI LETT, V409, P65, DOI 10.1016/j.neulet.2006.09.015; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z; Zhou Yi-wu, 2002, Fa Yi Xue Za Zhi, V18, P146	54	16	16	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								198	10.3389/fneur.2014.00198			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300186	25346719	Green Published, gold			2022-02-06	
J	Liu, Y; Yi, XC; Guo, G; Long, QF; Wang, XA; Zhong, J; Liu, WP; Fei, Z; Wang, DM; Liu, J				Liu, Yang; Yi, Xi-Cai; Guo, Geng; Long, Qian-Fa; Wang, Xiao-An; Zhong, Jun; Liu, Wei-Ping; Fei, Zhou; Wang, Dong-Mei; Liu, Jun			Basic fibroblast growth factor increases the transplantation-mediated therapeutic effect of bone mesenchymal stem cells following traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						basic fibroblast growth factor; bone mesenchymal stem cells; traumatic brain injury; transplantation	MARROW STROMAL CELLS; RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; TIRILAZAD MESYLATE; CORTICAL INJURY; RAT MODEL; NEUROGENESIS; METHYLPREDNISOLONE; PROLIFERATION	Basic fibroblast growth factor (bFGF) has proven useful for neural stem and progenitor cells during the transplantation-mediated therapeutic effect of bone mesenchymal stem cells (BMSCs). Endogenous bFGF expression levels increase during brain development and gradually diminish with aging. To date, few studies have been conducted on exogenous bFGF promoting BMSC transplantation-mediated functional recovery in adult rats following traumatic brain injury (TBI). The results of the present study showed that BMSCs in the TBI cortex and dentate gyrus showed differentiation along the glial and neuronal lines, which are possibly enhanced by bFGF. The neuronal differentiation rate was not consistent with neurological functional recovery rate over time. bFGF may promote the transplantation-mediated therapeutic effect of BMSCs more significantly and rapidly in rats following TBI, with a small proportion of differentiated neurons. In conclusion, exogenous bFGF functions as a booster of the transplantation-mediated therapeutic effect of BMSCs following TBI.	[Liu, Yang; Wang, Dong-Mei] Third Hosp Mianyang, Dept Neurosurg, Mianyang 621000, Sichuan, Peoples R China; [Liu, Yang; Yi, Xi-Cai; Long, Qian-Fa; Wang, Xiao-An; Zhong, Jun; Liu, Wei-Ping; Fei, Zhou] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Guo, Geng] Shanxi Med Univ, Dept Neurosurg, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China; [Liu, Jun] Third Mil Med Univ, Dept Neurosurg, Xinqiao Hosp, Chongqing 400037, Peoples R China		Liu, J (corresponding author), Third Mil Med Univ, Dept Neurosurg, Xinqiao Hosp, 83 Zheng St, Chongqing 400037, Peoples R China.	JUNLIUCN@126.com	Long, Qianfa/F-6461-2017; guo, geng/M-4108-2014	Long, Qianfa/0000-0001-8848-9688; guo, geng/0000-0003-4197-0399	Foundation of Health Department Scientific Research Project in Sichuan Province [2010-100301, 2011-110547]; Mianyang City Health Bureau [201102]; Third Hospital of Mianyang [2010-2012]	The authors would like to thank Ling Sun and Xiaoyan Chen for their assistance in this study. This study was funded by grants from the Foundation of Health Department Scientific Research Project in Sichuan Province (grant nos. 2010-100301 and 2011-110547), Mianyang City Health Bureau (grant no. 201102) and the Third Hospital of Mianyang (grant no. 2010-2012).	Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; CADAY CG, 1990, DEV BRAIN RES, V52, P241, DOI 10.1016/0165-3806(90)90240-Y; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LIAU LM, 1996, NEUROLOGICAL SURG, P1549; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Monfils MH, 2008, EXP BRAIN RES, V185, P453, DOI 10.1007/s00221-007-1172-0; Ourednik J, 2004, CELL TRANSPLANT, V13, P307, DOI 10.3727/000000004783983963; Raballo R, 2000, J NEUROSCI, V20, P5012; Ramirez JJ, 1999, NEUROREPORT, V10, P1201, DOI 10.1097/00001756-199904260-00008; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200	27	16	18	0	11	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2014	9	1					333	339		10.3892/mmr.2013.1803			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AA0KJ	WOS:000330783700053	24248266	Bronze			2022-02-06	
J	Nageli, M; Fasshauer, M; Sommerfeld, J; Fendel, A; Brandi, G; Stover, JF				Naegeli, Mirjam; Fasshauer, Mario; Sommerfeld, Jutta; Fendel, Angela; Brandi, Giovanna; Stover, John F.			Prolonged continuous intravenous infusion of the dipeptide L-alanine-L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury	CRITICAL CARE			English	Article							SUPPLEMENTED PARENTERAL-NUTRITION; CRITICALLY-ILL PATIENTS; ALANYL-L-GLUTAMINE; AMINO-ACID LEVELS; DOUBLE-BLIND; INDUCED THERMOGENESIS; ENERGY-EXPENDITURE; ABDOMINAL-SURGERY; RANDOMIZED-TRIAL; INTENSIVE-CARE	Introduction: Low plasma glutamine levels are associated with worse clinical outcome. Intravenous glutamine infusion dose-dependently increases plasma glutamine levels, thereby correcting hypoglutaminemia. Glutamine may be transformed to glutamate which might limit its application at a higher dose in patients with severe traumatic brain injury (TB. To date, the optimal glutamine dose required to normalize plasma glutamine levels without increasing plasma and cerebral glutamate has not yet been defined. Methods: Changes in plasma and cerebral glutamine, alanine, and glutamate as well as indirect signs of metabolic impairment reflected by increased intracranial pressure (ICP), lactate, lactate-to-pyruvate ratio, electroencephalogram (EEG) activity were determined before, during, and after continuous intravenous infusion of 0.75 g L-alanine-L-glutamine which was given either for 24 hours (group 1, n = 6) or 5 days (group 2, n = 6) in addition to regular enteral nutrition. Lab values including nitrogen balance, urea and ammonia were determined daily. Results: Continuous L-alanine-L-glutamine infusion significantly increased plasma and cerebral glutamine as well as alanine levels, being mostly sustained during the 5 day infusion phase (plasma glutamine: from 295 +/- 62 to 500 145 mu mol/I; brain glutamine: from 183 +/- 188 to 549 +/- 120 mu mol/I; plasma alanine: from 327 +/- 91 to 622 182 mu mol/I; brain alanine: from 48 55 to 89 129 mu mol/I; p<0.05, ANOVA, post hoc Dunn's test). Plasma glutamate remained unchanged and cerebral glutamate was decreased without any signs of cerebral impairment. Urea and ammonia were significantly increased within normal limits without signs of organ dysfunction (urea: from 2.7 +/- 1.6 to 5.5 +/- 1.5 mmol/I; ammonia: from 12 +/- 6.3 to 26 +/- 8.3 mu mol/ I; p<0.05, ANOVA, post hoc Dunn's test). Conclusions: High dose L-alanine-L-glutamine infusion (0.75 g/kg/d up to 5 days) increased plasma and brain glutamine and alanine levels. This was not associated with elevated glutamate or signs of potential glutamate-mediated cerebral injury. The increased nitrogen load should be considered in patients with renal and hepatic dysfunction.	[Naegeli, Mirjam; Fasshauer, Mario; Sommerfeld, Jutta; Fendel, Angela; Brandi, Giovanna; Stover, John F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland		Stover, JF (corresponding author), Univ Zurich Hosp, Raemistr 100, CH-8091 Zurich, Switzerland.	john.stover@access.uzh.ch			Swiss National Science Foundation (SNE); Division of Surgical Research; SUVA Fonds; Fresenius Kabi Switzerland	The assistance of the ICU nurses in data collection and Ursula Steckholzer in blood sampling is gratefully acknowledged. This study was supported by the Swiss National Science Foundation (SNE) to IFS, the Division of Surgical Research to JFS, the SUVA Fonds to JFS, and a research grant by Fresenius Kabi Switzerland to JFS. The funding bodies had no role in the design, collection, analysis and interpretation of data, writing of the manuscript, and in the decision to submit the manuscript for publication.	Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Berg A, 2006, INTENS CARE MED, V32, P1741, DOI 10.1007/s00134-006-0375-3; Berg A, 2005, AMINO ACIDS, V29, P221, DOI 10.1007/s00726-005-0230-9; Berg A, 2008, CLIN NUTR, V27, P816, DOI 10.1016/j.clnu.2008.06.006; Biolo G, 2000, CLIN SCI, V99, P189, DOI 10.1042/CS19990254; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Bruins MJ, 2003, CLIN SCI, V104, P127, DOI 10.1042/CS20020275; Curi R, 2007, FRONT BIOSCI-LANDMRK, V12, P344, DOI 10.2741/2068; Dechelotte P, 2006, CRIT CARE MED, V34, P598, DOI 10.1097/01.CCM.0000201004.30750.D1; Druml W, 2001, AM J CLIN NUTR, V73, P908; El Hage M, 2011, NEUROCHEM INT, V58, P896, DOI 10.1016/j.neuint.2011.02.018; Estivariz CF, 2008, JPEN-PARENTER ENTER, V32, P389, DOI 10.1177/0148607108317880; Fuentes-Orozco C, 2004, CLIN NUTR, V23, P13, DOI 10.1016/S0261-5614(03)00055-4; Gleeson M, 2008, J NUTR, V138, p2045S, DOI 10.1093/jn/138.10.2045S; Goeters C, 2002, CRIT CARE MED, V30, P2032, DOI 10.1097/00003246-200209000-00013; Griffiths RD, 2002, NUTRITION, V18, P546, DOI 10.1016/S0899-9007(02)00817-1; Griffiths RD, 1997, NUTRITION, V13, P295; HAMMARQVIST F, 1989, ANN SURG, V209, P455, DOI 10.1097/00000658-198904000-00011; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Hertz L, 2011, MAGN RESON IMAGING, V29, P1319, DOI 10.1016/j.mri.2011.04.013; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Johnston CS, 2002, J AM COLL NUTR, V21, P55, DOI 10.1080/07315724.2002.10719194; Kempski O, 1990, Adv Neurol, V52, P219; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; LOCHS H, 1990, JPEN-PARENTER ENTER, V14, pS114, DOI 10.1177/014860719001400416; MACBURNEY M, 1994, J AM DIET ASSOC, V94, P1263, DOI 10.1016/0002-8223(94)92457-0; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Melis GC, 2005, BRIT J NUTR, V94, P19, DOI 10.1079/BJN20051463; Mertes N, 2000, CLIN NUTR, V19, P395, DOI 10.1054/clnu.2000.0142; Mirtendorfer B, 1999, JPEN J PARENTER ENTE, V23, P243; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; Pouw EM, 1998, AM J RESP CRIT CARE, V158, P797, DOI 10.1164/ajrccm.158.3.9708097; Rodas PC, 2012, CLIN SCI, V122, P591, DOI 10.1042/CS20110520; Schousboe A, 2003, NEUROCHEM INT, V43, P311, DOI 10.1016/S0197-0186(03)00017-2; Sellden E, 1999, ANESTH ANALG, V89, P1551, DOI 10.1097/00000539-199912000-00045; Sellden E, 1998, ANESTH ANALG, V87, P641, DOI 10.1097/00000539-199809000-00029; STEGINK LD, 1982, J NUTR, V112, P1953, DOI 10.1093/jn/112.10.1953; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Suliman ME, 2005, AM J CLIN NUTR, V82, P342, DOI 10.1093/ajcn/82.2.342; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Tjader I, 2004, INTENS CARE MED, V30, P266, DOI 10.1007/s00134-003-2048-9; van Acker BAC, 2000, J NUTR, V130, P1566, DOI 10.1093/jn/130.6.1566; Vanek VW, 2011, NUTR CLIN PRACT, V26, P479, DOI 10.1177/0884533611410975; Wischmeyer PE, 2001, CRIT CARE MED, V29, P2075, DOI 10.1097/00003246-200111000-00006; ZIEGLER TR, 1992, ANN INTERN MED, V116, P821, DOI 10.7326/0003-4819-116-10-821	49	16	16	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2014	18	4							R139	10.1186/cc13962			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA4MJ	WOS:000348878200023	24992948	Green Published, gold, Green Accepted			2022-02-06	
J	Sang, G; Du, JM; Chen, YY; Chen, YB; Chen, JX; Chen, YC				Sang, Gao; Du, Jian-Min; Chen, Yong-Yi; Chen, Yang-Bo; Chen, Jun-Xian; Chen, Yong-Can			Plasma copeptin levels are associated with prognosis of severe acute pancreatitis	PEPTIDES			English	Article						Copeptin; Severe acute pancreatitis; Prognosis; Biomarker	TRAUMATIC BRAIN-INJURY; ORGAN FAILURE; MARKER; VASOPRESSIN; PRECURSOR; MORTALITY; NECROSIS; SCORE	Copeptin reflects the individual stress level, and is correlated with outcomes of critical illness. This study was designed to evaluate its relationship with disease severity, local complications, organ failure and mortality of severe acute pancreatitis (SAP). Seventy-eight SAP patients and 78 sex- and age-matched healthy individuals were recruited. Plasma samples were obtained on admission from SAP patients and at study entry from healthy individuals. Copeptin concentration was determined using enzyme-linked immunosorbent assay. Plasma copeptin level was obviously higher in patients than in healthy individuals, was identified as an independent predictor of local complications, organ failure and in-hospital mortality, was highly associated with traditional predictors of disease severity and mortality including the Acute Physiology and Chronic Health Care Evaluation II score, Ranson score, multiple organ dysfunction score, sequential organ failure assessment score, and predicted local complications, organ failure, and in-hospital mortality of SAP patients with high areas under receiver operating characteristic curve. Furthermore, its predictive value was similar to the traditional predictors'. However, it could not improve these traditional predictors' predictive values. Therefore, increased plasma copeptin level is associated with disease severity and identified as a novel prognostic marker of local complications, organ failure and mortality after SAP. (C) 2013 Elsevier Inc. All rights reserved.	[Sang, Gao] Chinese Med Univ, Tongde Hosp Zhejiang, Dept Paediat, Hangzhou 310012, Zhejiang, Peoples R China; [Du, Jian-Min] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Paediat, Hangzhou 310006, Zhejiang, Peoples R China; [Chen, Yong-Yi] Chinese Med Univ, Tongde Hosp Zhejiang, Dept Tradit Chinese Internal Med, Hangzhou 310012, Zhejiang, Peoples R China; [Chen, Yang-Bo] Chinese Med Univ, Tongde Hosp Zhejiang, Intens Care Unit, Hangzhou 310012, Zhejiang, Peoples R China; [Chen, Jun-Xian; Chen, Yong-Can] Chinese Med Univ, Tongde Hosp Zhejiang, Dept Gastroenterol, Hangzhou 310012, Zhejiang, Peoples R China		Chen, YY (corresponding author), Chinese Med Univ, Tongde Hosp Zhejiang, Dept Tradit Chinese Internal Med, Hangzhou 310012, Zhejiang, Peoples R China.	gstongde@63.com					Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Barat C, 2004, BIOCHEMISTRY-US, V43, P8191, DOI 10.1021/bi0400094; De Marchis GM, 2013, NEUROLOGY, V80, P1278, DOI 10.1212/WNL.0b013e3182887944; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Hoque R, 2012, PANCREAS, V41, P353, DOI 10.1097/MPA.0b013e3182321500; Isman FK, 2013, AM J EMERG MED, V31, P690, DOI 10.1016/j.ajem.2012.12.016; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Katan M, 2008, CRIT CARE, V12, DOI 10.1186/cc6799; Kolditz M, 2012, RESP MED, V106, P1320, DOI 10.1016/j.rmed.2012.06.008; Lin C, 2013, PEPTIDES, V42, P43, DOI 10.1016/j.peptides.2013.01.015; Malangoni MA, 2005, AM J SURG, V189, P273, DOI 10.1016/j.amjsurg.2004.11.013; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Petrov MS, 2010, GASTROENTEROLOGY, V139, P813, DOI 10.1053/j.gastro.2010.06.010; Rahman SH, 2007, ANN SURG, V245, P282, DOI 10.1097/01.sla.0000245471.33987.4b; RANSON JHC, 1977, J SURG RES, V22, P79, DOI 10.1016/0022-4804(77)90045-2; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Singh RG, 2002, INT J CLIN PRACT, V56, P777; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Haehling S, 2012, CLIN CHEM, V58, P307, DOI 10.1373/clinchem.2011.173658	22	16	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JAN	2014	51						4	8		10.1016/j.peptides.2013.10.019			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	282XO	WOS:000329208100002	24184419				2022-02-06	
S	Stemper, BD; Pintar, FA		Niranjan, A; Lunsford, LD		Stemper, Brian D.; Pintar, Frank A.			Biomechanics of Concussion	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							CHRONIC TRAUMATIC ENCEPHALOPATHY; POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; DIFFUSE AXONAL INJURY; BRAIN-INJURY; INTRACRANIAL-PRESSURE; RECURRENT CONCUSSION; COGNITIVE IMPAIRMENT; ANIMAL-MODEL; HEAD-INJURY	This report provides an overview of the biomechanics associated with mild traumatic brain injury (TBI), also known as concussion. Specifically, the role of angular acceleration in modulating concussion onset and severity is highlighted. Studies conducted and published from the 1960s to the 1980s provided initial estimates for TBI tolerance due to high rate head rotation. However, injury levels in those studies were more severe than what is considered to be concussion in the contemporary environment. Therefore, this issue deserves additional attention to provide quantitative estimates for concussive tolerance due to head rotational acceleration focusing on the types of clinical outcomes described today. Likewise, concussion in military personnel has notably increased in current conflicts due to the incorporation of improvised explosive devices and roadside bombs. Clinical evidence indicates that outcomes from concussion due to blast may be quite different from those due to head rotational acceleration. This report also provides an overview of blast concussion mechanisms and highlights some of the recent preclinical work in this area. As with head rotational acceleration, blast tolerance is necessary to understand the scope of this problem, better protect these personnel, and provide more informed return-to-duty guidelines for service members. (C) 2014 S. Karger AG, Basel	[Stemper, Brian D.; Pintar, Frank A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Pintar, Frank A.] VA Med Ctr, Milwaukee, WI USA		Stemper, BD (corresponding author), Zablocki VA Med Ctr, Dept Neurosurg, Neurosci Res Labs 151, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	bstemper@mcw.edu	Stemper, Brian/AAX-7611-2020				ABEL JM, 1978, 22 STAPP CAR CRASH C; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; [Anonymous], 1969, J AMER MED ASSOC, V210, P2272; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bazarian JJ, 2004, ANN EMERG MED, V44, P142, DOI 10.1016/j.annemergmed.2004.03.029; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Fijalkowski RJ, 2007, P INT IRCOBI C BIOM, P161; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Gennarelli T.A., 1990, 34 ANN P ASS ADV AUT; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 2003, 47 ANN P ASS ADV AUT; Gennarelli TA, 1971, 15 STAPP CAR CRASH C; Gennarelli TA, 1987, 31 STAPP CAR CRASH C; GENNARELLI TA, 1972, 16 STAPP CAR CRASH C; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HIGGINS LS, 1967, 11 STAPP CAR CRASH C; Hirsch AE, 1970, 14 STAPP CAR CRASH C; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbourn AHS, 1943, LANCET, V2, P438; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Lamy Michael, 2011, Ann Adv Automot Med, V55, P125; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MORTIMER JA, 1985, MINN MED, V68, P299; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Ommaya AK, 1967, 11 STAPP CAR CRASH C; Ommaya AK, 1970, COMP TOLERANCES CERE; Ommaya AK, 1966, 10 STAPP CAR CRASH C; Ono K, 1980, 24 STAPP CAR CRASH C; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabharwal R K, 1987, J Assoc Physicians India, V35, P571; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Shah AS, 2011, ASME 2011 INT MECH E; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Talavage TM, 2013, J NEUROTRAUMA; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; Versace J., 1971, REV SEVERITY INDEX; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	71	16	17	0	21	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						14	27		10.1159/000358748	10.1159/isbn.978-3-318-02649-8		14	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000003	24923389				2022-02-06	
J	Wan, CH; Chen, J; Hu, BY; Zou, HF; Li, AH; Guo, AH; Jiang, JK				Wan, Chunhua; Chen, Jian; Hu, Baoying; Zou, Huifei; Li, Aihong; Guo, Aihang; Jiang, Junkang			Downregulation of UBE2Q1 Is Associated With Neuronal Apoptosis in Rat Brain Cortex Following Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						UBE2Q1; traumatic brain injury; neuronal apoptosis; p53; rat	NEURITE OUTGROWTH; OXIDATIVE STRESS; CEREBRAL-CORTEX; ADULT BRAIN; CELL-DEATH; ACTIVATION; EXPRESSION; P53; UBIQUITIN; HIPPOCAMPUS	Aberrant functionality of the ubiquitin proteasome system (UPS) has been implicated in the pathology of various neurological disorders. Although it has been reported that the expressions of various UPS components were altered significantly following traumatic brain injury (TBI), detailed information on the subject remains largely unclear. In the study, using microarray assay, we identified a gene encoding ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) that was significantly downregulated during TBI. Western blot and immunohistochemical analyses verified the reduced expression of UBE2Q1 in ipsilateral brain cortex adjacent to the lesion site compared with the contralateral and sham-operated ones. Double-immunofluorescence staining indicated that UBE2Q1 was expressed mainly in the nucleus of neurons, with a minority in astrocytes in normal cortex. In addition, we observed a remarkable reduction in the number of UBE2Q1-positive neurons following brain trauma. Furthermore, we showed that TBI resulted in a significant increase in the levels of p53, bax, p21 and active caspase 3 in brain cortex, which was correlated with decreased expression of UBE2Q1. We also found that knockdown of UBE2Q1 apparently increased the level of p53, whereas overexpressing UBE2Q1 attenuated cellular p53 level in PC12 neuronal cells. Accordingly, interference with UBE2Q1 augmented H2O2-induced apoptosis of PC12 cells. Taken together, our findings indicate that UBE2Q1 might play an important role in the neuropathological process of TBI through modulating p53 signaling. (c) 2013 Wiley Periodicals, Inc.	[Wan, Chunhua; Jiang, Junkang] Nantong Univ, Sch Publ Hlth, Nantong 226001, Peoples R China; [Chen, Jian; Zou, Huifei; Li, Aihong; Guo, Aihang] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong, Jiangsu, Peoples R China; [Hu, Baoying] Nantong Univ, Coll Med, Nantong, Peoples R China		Jiang, JK (corresponding author), Nantong Univ, Sch Publ Hlth, 9 Seyuan St, Nantong 226001, Peoples R China.	jiang_junkang@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300720, 81371367]	Contract grant sponsor: National Natural Science Foundation of China, Contract grant numbers: 81300720 (to C. W.); 81371367 (to J.C.).	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Cregan SP, 1999, J NEUROSCI, V19, P7860; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Klimaschewski L, 2003, NEWS PHYSIOL SCI, V18, P29, DOI 10.1152/nips.01408.2002; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Lee BK, 2012, J NEUROSCI RES, V90, P860, DOI 10.1002/jnr.22818; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Liu YH, 2012, MOL BIOL CELL, V23, P4506, DOI 10.1091/mbc.E12-05-0362; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakamura T, 2008, MOL CELL ENDOCRINOL, V281, P47, DOI 10.1016/j.mce.2007.10.007; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Povlishock J T, 1992, Hum Cell, V5, P345; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saha MN, 2010, CANCER BIOL THER, V10, P567, DOI 10.4161/cbt.10.6.12535; Saito A, 2005, J CEREBR BLOOD F MET, V25, P267, DOI 10.1038/sj.jcbfm.9600028; Seghatoleslam A, 2012, MOL BIOL REP, V39, P5135, DOI 10.1007/s11033-011-1309-x; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Tao T, 2012, MOL BIOL CELL, V23, P2635, DOI 10.1091/mbc.E11-09-0805; Wan C, 2013, J MOL NEURO IN PRESS; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; Zhuang Z, 2013, J NEUROSCI RES, V91, P1599, DOI [10.1002/jnr.23186, 10.1002/jnr.23281]	40	16	17	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2014	92	1					1	12		10.1002/jnr.23305			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	254LK	WOS:000327167000001	24166684				2022-02-06	
J	Fernandes, FAO; de Sousa, RJA				Fernandes, Fabio A. O.; Alves de Sousa, R. J.			Finite element analysis of helmeted oblique impacts and head injury evaluation with a commercial road helmet	STRUCTURAL ENGINEERING AND MECHANICS			English	Article						biomechanics; finite element method; head injury; motorcycle helmet; oblique impact	ENERGY-ABSORPTION; TOLERANCE; CRITERION; FOAMS	In this work, the safety performance of a commercial motorcycle helmet already placed on the market is assessed. The assessed motorcycle helmet is currently homologated by several relevant motorcycle standards. Impacts including translational and rotational motions are accurately simulated through a finite element numerical framework. The developed model was validated against experimental results: firstly, a validation concerning the constitutive model for the expanded polystyrene, the material responsible for energy absorption during impact; secondly, a validation regarding the acceleration measured at the headform's centre of gravity during the linear impacts defined in the ECE R22.05 standard. Both were successfully validated. After model validation, an oblique impact was simulated and the results were compared against head injury thresholds in order to predict the resultant head injuries. From this comparison, it was concluded that brain injuries such as concussion and diffuse axonal injury may occur even with a helmet certified by the majority of the motorcycle helmet standards. Unfortunately, these standards currently do not contemplate rotational components of acceleration. Conclusion points out to a strong recommendation on the necessity of including rotational motion in forthcoming motorcycle helmet standards and improving the current test procedures and head injury criteria used by the standards, to improve the safety between the motorcyclists.	[Fernandes, Fabio A. O.; Alves de Sousa, R. J.] Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, P-3810193 Aveiro, Portugal		de Sousa, RJA (corresponding author), Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Campus Santiago, P-3810193 Aveiro, Portugal.	fabiofernandes@ua.pt; rsousa@ua.pt	de Sousa, Ricardo Alves/E-4405-2010; Fernandes, Fabio A.O./H-2680-2012	de Sousa, Ricardo Alves/0000-0002-5848-6424; Fernandes, Fabio A.O./0000-0001-9751-8807	Portuguese Foundation for Science and Technology (FCT)Portuguese Foundation for Science and Technology [PTDC/EME-TME/109856/2009]; COMPETE Program; CMS helmets, Portugal;  [SFRH/BD/91292/2012]	The authors are grateful to the Portuguese Foundation for Science and Technology (FCT) who financially supported this work, through grant PTDC/EME-TME/109856/2009, COMPETE Program and the scholarship SFRH/BD/91292/2012, and also to CMS helmets, Portugal.	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aare Magnus, 2003, Inj Control Saf Promot, V10, P131, DOI 10.1076/icsp.10.3.131.14556; ABNT (AssociacAo Brasileira de Normas Tecnicas), 2001, 74712001 ABNT NBR; Advani SH, 1982, HUMAN BODY DYNAMICS; Alves de Sousa R.J., 2012, SIMUL-T SOC MOD SIM, V88, P579; [Anonymous], 2001, COST327; [Anonymous], 2010, AB 6 10 DOC; [Anonymous], 2008, CATIA V5; ANSR Autoridade Nacional Seguranca Rodoviaria, 2010, OBS SEG ROD SIN ROD; ANSR Autoridade Nacional Seguranca Rodoviaria, 2011, OBS SEG ROD SIN ROD; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Coelho RM, 2013, MATER DESIGN, V43, P384, DOI 10.1016/j.matdes.2012.07.020; Davidsson J., 2009, P IRCOBI C YORK SEPT; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; ERSO European Road Safety Observatory, 2012, ANN STAT REP BAS DAT; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; Fernandes F.A.O., 2013, P IRCOBI C GOTH SEPT; Fijalkowski R.J., 2006, P IRCOBI C MADR SEPT; Gennarelli T., 2003, ANN P ASS ADV AUTOMO, V47, P624; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; King A., 2003, P IRCOBI C LISB SEP; Kleiven S., 2003, P RTO SEPC M NATO KO; Kleiven S., 2007, BIOMECHANICS NEURONI; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; LOWENHIELM P, 1974, Z RECHTSMED, V75, P131, DOI 10.1007/BF02114709; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mellor A., 2005, P 19 INT TECHN C ENH; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Morrison III B., 2003, P 47 STAPP CAR CRASH; Newman J., 2000, P IRCOBI C MONTP SEP; Newman J., 2005, P IRCOBI C PRAG SEPT; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J.A., 1986, P IRCOBI C ZUR SEPT; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; Ommaya A.K., 1985, BIOMECHANICS HEAT IN; Otte D., 1999, CONTRIBUTION FINAL D; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Shreiber D. I., 1997, P 41 STAPP CAR CRASH; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P422, DOI 10.1016/S0924-0136(02)00047-X; Thibault L.E., 1990, P IRCOBI C SEPT; Thomson R., 2001, P IRCOBI C ISL MAN S; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Vallee H., 1984, P IRCOBI C DELFT SEP; World Health Organization, 2009, GLOB STAT REP ROAD S; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	48	16	16	2	34	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	1225-4568	1598-6217		STRUCT ENG MECH	Struct. Eng. Mech.	DEC 10	2013	48	5					661	679		10.12989/sem.2013.48.5.661			19	Engineering, Civil; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	269YK	WOS:000328280600004					2022-02-06	
J	Heather, NL; Derraik, JGB; Beca, J; Hofman, PL; Dansey, R; Hamill, J; Cutfield, WS				Heather, Natasha L.; Derraik, Jose G. B.; Beca, John; Hofman, Paul L.; Dansey, Rangi; Hamill, James; Cutfield, Wayne S.			Glasgow Coma Scale and Outcomes after Structural Traumatic Head Injury in Early Childhood	PLOS ONE			English	Article							BRAIN-INJURY; CHILDREN; MORTALITY; SCORE; RELIABILITY; SEVERITY	Objective: To assess the association of the Glasgow Coma Scale (GCS) with radiological evidence of head injury (the Abbreviated Injury Scale for the head region, AIS-HR) in young children hospitalized with traumatic head injury (THI), and the predictive value of GCS and AIS-HR scores for long-term impairment. Methods: Our study involved a 10-year retrospective review of a database encompassing all patients admitted to Starship Children's Hospital (Auckland, New Zealand, 2000-2010) with THI. Results: We studied 619 children aged <5 years at the time of THI, with long-term outcome data available for 161 subjects. Both GCS and AIS-HR scores were predictive of length of intensive care unit and hospital stay (all p<0.001). GCS was correlated with AIS-HR (rho=-0.46; p<0.001), although mild GCS scores (13-15) commonly undere-stimated the severity of radiological injury: 42% of children with mild GCS scores had serious-critical THI (AIS-HR 3-5). Increasingly severe GCS or AIS-HR scores were both associated with a greater likelihood of long-term impairment (neurological disability, residual problems, and educational support). However, long-term impairment was also relatively common in children with mild GCS scores paired with structural THI more severe than a simple linear skull fracture. Conclusion: Severe GCS scores will identify most cases of severe radiological injury in early childhood, and are good predictors of poor long-term outcome. However, young children admitted to hospital with structural THI and mild GCS scores have an appreciable risk of long-term disability, and also warrant long-term follow-up.	[Heather, Natasha L.; Derraik, Jose G. B.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; [Beca, John] Starship Childrens Hosp, Auckland Dist Hlth Board, Paediat Intens Care Unit, Auckland, New Zealand; [Dansey, Rangi; Hamill, James] Starship Childrens Hosp, Auckland Dist Hlth Board, Trauma Serv, Auckland, New Zealand		Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, Jose Guilherme Behrensdorf/A-1925-2008; Heather, Natasha/AAV-8425-2020	Derraik, Jose Guilherme Behrensdorf/0000-0003-1226-1956; 	Health Research Council of New ZealandHealth Research Council of New Zealand; Australasian Paediatric Endocrine Group; Starship Foundation Fellowship	This study was supported by grants from the Health Research Council of New Zealand and the Australasian Paediatric Endocrine Group. NLH was supported by a Starship Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Association for the Advancement of Automatic Medicine, 2001, ABBR INJ SCAL; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Salmond C, 2007, NZDEP2006 INDEX DEPR; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5	28	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82245	10.1371/journal.pone.0082245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	WOS:000327944500131	24312648	Green Submitted, Green Published, gold			2022-02-06	
J	Casano-Sancho, P; Suarez, L; Ibanez, L; Garcia-Fructuoso, G; Medina, J; Febrer, A				Casano-Sancho, Paula; Suarez, Larisa; Ibanez, Lourdes; Garcia-Fructuoso, Gemma; Medina, Julita; Febrer, Anna			Pituitary dysfunction after traumatic brain injury in children: is there a need for ongoing endocrine assessment?	CLINICAL ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; LONG-TERM; HYPOPITUITARISM; ADOLESCENTS; CHILDHOOD; PREVALENCE; DIAGNOSIS; SURVIVORS; THERAPY	Background Hypopituitarism has been widely described in adults after traumatic brain injury (TBI); however, the available data in paediatric populations are scarce. Here, we report the results of a prospective, long-term study in children, adolescents and young adults. Study group Thirty-seven children (age, 2 months to 19.9 years) of 51 eligible patients were followed for 1 year. Clinical and baseline endocrine variables were assessed in all 3 and 12 months after TBI; children >= 6 years underwent two stimulation tests (glucagon stimulation and megatest). Results In the group >= 6 years, 11 of 23 patients (47.8%) had a subnormal GH peak 3 months after TBI that persisted in 8 of 23 patients (34%) after 1 year. The GH response showed no correlation with injury severity (GCS, Marshall classification). Growth velocity was normal in all patients, except for one. Body mass index (BMI) SDS increased significantly in the group with low GH response. A suboptimal cortisol was observed in 10 of 23 subjects, which normalized in all but three, 1 year thereafter. All patients but one showed a pubertal response to GnRH testing. No clinical or hormonal abnormalities were detectable in children <6years. Conclusion Our results recommend to prospectively follow children after TBI: firstly, because the impairment of pituitary function cannot be predicted, and secondly, to avoid the potential consequences of pituitary dysfunction. Prospective clinical trials are needed before recommending a systematic screening after TBI and/or GH therapy either in postpubertal children or in prepubertal children who grow normally.	[Casano-Sancho, Paula; Ibanez, Lourdes; Garcia-Fructuoso, Gemma; Medina, Julita; Febrer, Anna] Hosp St Joan de Deu, Barcelona, Spain; [Casano-Sancho, Paula; Ibanez, Lourdes] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain		Casano-Sancho, P (corresponding author), St Joan de Deu Hosp, Pediat Endocrinol Unit, Barcelona, Spain.	pcasano@hsjdbcn.org	Ibanez, Lourdes/F-8316-2014; Ibanez, Lourdes/F-8316-2014	Ibanez, Lourdes/0000-0003-4595-7191; Ibanez, Lourdes/0000-0002-5058-1603			Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Acerini CL, 2007, HORM RES, V68, P14, DOI 10.1159/000110465; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bellone S., 2012, PITUITARY; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; IBANEZ L, 1994, J CLIN ENDOCR METAB, V78, P30, DOI 10.1210/jc.78.1.30; Ibanez L, 2009, J CLIN ENDOCR METAB, V94, P1049, DOI 10.1210/jc.2008-2176; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; Phillip M, 2002, J PEDIATR ENDOCR MET, V15, P1267; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Rosenfeld RG, 1997, J CLIN ENDOCR METAB, V82, P349, DOI 10.1210/jc.82.2.349; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; YUEN KC, 2011, ENDOCRINE, V40, P130	29	16	16	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	DEC	2013	79	6					853	858		10.1111/cen.12237			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	247SM	WOS:000326640500016	23650946				2022-02-06	
J	Pretz, CR; Malec, JF; Hammond, FM				Pretz, Christopher R.; Malec, James F.; Hammond, Flora M.			Longitudinal Description of the Disability Rating Scale for Individuals in the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems National Database	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Disability Rating Scale; Longitudinal studies; Rehabilitation; Rehabilitation outcome; Traumatic brain injuries	FUNCTIONAL INDEPENDENCE MEASURE; OUTCOME MEASURES; MULTICENTER; COMMUNITY; MODERATE; COHORT	Objective: To develop a detailed understanding of temporal change (ie, estimated trajectories) at the individual level as measured by the Disability Rating Scale (DRS). Design: Individual growth curve (IGC) analysis of retrospective data obtained from the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury (TBI) Model Systems National Database. Setting: Multicenter longitudinal database study. Participants: Individuals with TBI (N=8816) participating in the TBI Model Systems National Database project. Interventions: Not applicable. Main Outcome Measure: DRS. Results: The negative exponential consisting of 3 growth parameters (pseudointercept, asymptote, rate) was successfully used to predict trajectory of recovery on the DRS qualified by the following covariates: race, sex, level of education and age at admission, rehabilitation length of stay, and cognitive and motor FIM scores at rehabilitation admission. Based on these results, an interactive tool was developed to allow prediction of the trajectory of recovery for individuals and subgroups with specified characteristics on the selected covariates. Conclusions: With the use of IGC analysis, the longitudinal trajectory of recovery on the DRS for individuals sharing common characteristics and traits can be described. This methodology allows researchers and clinicians to predict numerous individual-level trajectories through use of a web-based computer automated interactive tool. Archives of Physical Medicine and Rehabilitation 2013;94:2478-85 (C) 2013 by the American Congress of Rehabilitation Medicine	[Pretz, Christopher R.] Craig Hosp, Englewood, CO 80132 USA; [Pretz, Christopher R.] Traumat Brain Injury Natl Stat & Data Ctr, Englewood, CO 80132 USA; [Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Malec, James F.; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA		Pretz, CR (corresponding author), Craig Hosp, 3425 South Clarkson St, Englewood, CO 80132 USA.	cpretz@craighospital.org			National Institute on Disability and Rehabilitation Research (NIDRR) Traumatic Brain Injury Model Systems National Data and Statistical Center [H133A110006]; NIDRR Rehabilitation Research Training Center on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; NIDRR Traumatic Brain Injury Model Systems grant at the Indiana University School of Medicine [H133120035]	Supported by the National Institute on Disability and Rehabilitation Research (NIDRR) Traumatic Brain Injury Model Systems National Data and Statistical Center (grant no. H133A110006), the NIDRR Rehabilitation Research Training Center on Improving Measurement of Medical Rehabilitation Outcomes (grant no. H133B090024), and the NIDRR Traumatic Brain Injury Model Systems grant at the Indiana University School of Medicine (grant no. H133120035).	Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Johnston MV, 2006, AM J PHYS MED REHAB, V85, P292, DOI 10.1097/01.phm.0000202079.58567.3b; Kothari S, 2012, BRAIN INJURY MED PRI; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570	22	16	16	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2013	94	12					2478	2485		10.1016/j.apmr.2013.06.019			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	264UD	WOS:000327905600022	23827348				2022-02-06	
J	Radomski, KL; Zhou, Q; Yi, KJ; Doughty, ML				Radomski, Kryslaine L.; Zhou, Qiong; Yi, Kevin J.; Doughty, Martin L.			Cortical contusion injury disrupts olfactory bulb neurogenesis in adult mice	BMC NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); Controlled cortical impact (CCI); Subventricular zone (SVZ); Neural stem cell (NSC); Olfactory bulb	TRAUMATIC BRAIN-INJURY; SUBVENTRICULAR ZONE CELLS; CEREBRAL-CORTEX; STEM-CELLS; FOREBRAIN NEUROGENESIS; NEUROBLAST MIGRATION; IMPACT; PROLIFERATION; RECOVERY; BEHAVIOR	Background: Experimental brain trauma activates quiescent neural stem cells (NSCs) to increase neuronal progenitor cell proliferation in the adult rodent brain. Previous studies have shown focal brain contusion in the form of a unilateral controlled cortical impact (CCI) stimulates NSCs to bilaterally increase neurogenesis in the adult hippocampus. Results: In this study we clarified the bi-lateral effects of a unilateral CCI on proliferation in the subventricular zone (SVZ) NSC niche and on neurogenesis in the olfactory bulb of adult mice. By varying the depth of impact from 1 mm to 2 mm depth, we show CCI to the left somatosensory cortex resulted in graded changes in mouse behavior and cellular pathology in the forebrain. As expected, contusion to the sensorimotor cortex resulted in motor coordination deficits in adult mice. During the first 3 days after injury, CCI increased proliferation in the impacted cortex, deeper striatum and SVZ of the forebrain ipsilateral to the CCI. In each of these regions proliferation was increased with increasing injury severity. At 30 days post-procedure, CCI resulted in a significant reduction in neurogenesis in the olfactory bulb ipsilateral to the CCI. Olfactory avoidance testing indicated disruptions in olfactory bulb neurogenesis were associated with impaired olfactory discrimination in mice post-injury. Conclusion: The data demonstrate a focal cortical contusion injury to the left somatosensory cortex disrupts SVZ-olfactory bulb neurogenesis and impairs olfactory discrimination and motor coordination in adult mice.	[Radomski, Kryslaine L.; Zhou, Qiong; Yi, Kevin J.; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, CNRM, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Doughty, ML (corresponding author), Uniformed Serv Univ Hlth Sci, CNRM, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	martin.doughty@usuhs.edu		Radomski, Kryslaine/0000-0001-9624-623X	Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense	We are grateful for assistance with surgical and behavioral procedures from Laura Tucker, Oz Malkesman and Amanda Fu in the Animal Models Core at the Center for Neuroscience and Regenerative Medicine (CNRM) at USU. We also thank Dennis McDaniel in the Bio-instrumentation Center (BIC) at USU for assistance with microscopy and stereology. This work was supported by a grant from the Center for Neuroscience and Regenerative Medicine (CNRM).	Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gotts JE, 2005, J COMP NEUROL, V488, P201, DOI 10.1002/cne.20609; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	31	16	16	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	NOV 13	2013	14								142	10.1186/1471-2202-14-142			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	285XF	WOS:000329427600003	24224996	Green Published, gold			2022-02-06	
J	Trontel, HG; Hall, S; Ashendorf, L; O'Connor, MK				Trontel, Haley G.; Hall, Stuart; Ashendorf, Lee; O'Connor, Maureen K.			Impact of diagnosis threat on academic self-efficacy in mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological tests; Head injury; Self efficacy; Memory; Attention; Mild concussion	MIDDLE SCHOOL STUDENTS; GOOD-OLD-DAYS; HEAD-INJURY; POSTCONCUSSION-SYNDROME; COGNITIVE PERFORMANCE; AGREEMENT STATEMENT; CLINICAL MANAGEMENT; STEREOTYPE THREAT; COLLEGE OUTCOMES; BELIEFS	The current study examined the effect of diagnosis threat on self-efficacy and neuropsychological performance in mild traumatic brain injury (TBI). Forty-nine participants with a history of mild TBI were randomized to a diagnosis threat or control group. The diagnosis threat group were told they were selected based on their history of TBI, while control group participants were told to perform their best. Individuals in the diagnosis threat group reported significantly lower academic self-efficacy than control participants. The groups performed differently on only one neuropsychological measure. These results suggest that diagnosis threat may have a greater impact on psychological factors than on cognitive performance.	[Trontel, Haley G.; Hall, Stuart] Univ Montana, Dept Psychol, Missoula, MT 59812 USA; [Trontel, Haley G.; Ashendorf, Lee; O'Connor, Maureen K.] Edith Nourse Rogers Mem Vet Adm Hosp, Dept Psychol, Bedford, MA 01730 USA		Trontel, HG (corresponding author), Univ Montana, 1210 E Harrison Ave, Salt Lake City, UT 84105 USA.	htrontel@gmail.com		O'Connor, Maureen/0000-0002-2466-0367			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BANDURA A, 1993, EDUC PSYCHOL, V28, P117, DOI 10.1207/s15326985ep2802_3; Bandura A, 2001, CHILD DEV, V72, P187, DOI 10.1111/1467-8624.00273; Bandura A, 1996, CHILD DEV, V67, P1206, DOI 10.2307/1131888; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Britner SL, 2006, J RES SCI TEACH, V43, P485, DOI 10.1002/tea.20131; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, NAT CTR INJ PREV CON; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Delis D.C., 2000, CALIFORNIA VERBAL LE; Faul M, 2010, TRAUMATIC BRAIN INJU; FEINGOLD A, 1983, EDUC PSYCHOL MEAS, V43, P1127, DOI 10.1177/001316448304300422; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gore PA, 2006, J CAREER ASSESSMENT, V14, P92, DOI 10.1177/1069072705281367; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kathol Roger, 1996, P321; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; Klassen RM, 2004, INT J PSYCHOL, V39, P205, DOI 10.1080/00207590344000330; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levin H.S., 1989, MILD HEAD INJURY; Linnenbrink E.A., 2003, READ, V19, P119, DOI [10.1080/10573560308223, DOI 10.1080/10573560308223]; Lucio R, 2012, DEV PSYCHOL, V48, P422, DOI 10.1037/a0025939; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mattern KD, 2010, J COLL STUDENT DEV, V51, P665, DOI 10.1353/csd.2010.0017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Owen S. V., 1988, P ANN M NAT COUNC ME; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pajares F, 2000, CONTEMP EDUC PSYCHOL, V25, P406, DOI 10.1006/ceps.1999.1027; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Salazar R., 2011, COGNITIVE PERF UNPUB; Schunk, 1996, MOTIVATION ED THEORY; Schunk DH., 2003, READ WRIT Q, V19, P159, DOI [DOI 10.1080/10573560308219, 10.1080/10573560308219]; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Sosin DM, 1996, BRAIN INJURY, V10, P47; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zuffiano A, 2013, LEARN INDIVID DIFFER, V23, P158, DOI 10.1016/j.lindif.2012.07.010	63	16	16	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV 1	2013	35	9					960	970		10.1080/13803395.2013.844770			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	238PF	WOS:000325959200007	24099494				2022-02-06	
J	Irimia, A; Goh, SYM; Torgerson, CM; Stein, NR; Chambers, MC; Vespa, PM; Van Horn, JD				Irimia, Andrei; Goh, S. -Y. Matthew; Torgerson, Carinna M.; Stein, Nathan R.; Chambers, Micah C.; Vespa, Paul M.; Van Horn, John D.			Electroencephalographic inverse localization of brain activity in acute traumatic brain injury as a guide to surgery, monitoring and treatment	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Electroencephalography; Traumatic brain injury; Localization; Monitoring; Outcome; Epilepsy	INTENSIVE-CARE-UNIT; SPREADING DEPOLARIZATIONS; ELECTROGRAPHIC SEIZURES; EEG; MEG; MODEL; MAGNETOENCEPHALOGRAPHY; SEGMENTATION; SIMULATION; ANISOTROPY	Objective: To inverse-localize epileptiform cortical electrical activity recorded from severe traumatic brain injury (TBI) patients using electroencephalography (EEG). Methods: Three acute TBI cases Were imaged using computed tomography (CT) and multimodal magnetic resonance imaging (MRI). Semi-automatic segmentation was performed to partition the complete TBI head into 25 distinct tissue types, including 6 tissue types accounting for pathology. Segmentations were employed to generate a finite element method model of the head, and EEG activity generators were modeled as dipolar currents distributed over the cortical surface. Results: We demonstrate anatomically faithful localization of EEG generators responsible for epileptiform discharges in severe TBI. By accounting for injury-related tissue conductivity changes, our work offers the most realistic implementation currently available for the inverse estimation of cortical activity in TBI. Conclusion: Whereas standard localization techniques are available for electrical activity mapping in uninjured brains, they are rarely applied to acute TBI. Modern models of TBI-induced pathology can inform the localization of epileptogenic foci, improve surgical efficacy, contribute to the improvement of critical care monitoring and provide guidance for patient-tailored treatment. With approaches such as this, neurosurgeons and neurologists can study brain activity in acute TBI and obtain insights regarding injury effects upon brain metabolism and clinical outcome. Published by Elsevier B.V.	[Irimia, Andrei; Goh, S. -Y. Matthew; Torgerson, Carinna M.; Van Horn, John D.] Univ So Calif, Inst Neuroimaging & Informat, Keck Sch Med, Los Angeles, CA 90089 USA; [Stein, Nathan R.; Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA USA; [Chambers, Micah C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA		Van Horn, JD (corresponding author), Univ So Calif, Inst Neuroimaging & Informat, Keck Sch Med, 2001 North Soto St,Room 102,MC 9232, Los Angeles, CA 90089 USA.	jvanhorn@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	National Alliance for Medical Image Computing (NA-MIC) under NIH Roadmap Initiative [2U54EB005149]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922, U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by the National Alliance for Medical Image Computing (NA-MIC; www.na-mic.org), under NIH Roadmap Initiative grant 2U54EB005149, sub-award to J. D. V. H. and by the NINDS, grant P01NS058489 to P. M. V.	Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Acar Z., 2004, PHYS MED BIOL, V49, P5011; Acar ZA, 2010, J NEUROSCI METH, V190, P258, DOI 10.1016/j.jneumeth.2010.04.031; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Babiloni F, 2003, NEUROIMAGE, V19, P1, DOI 10.1016/S1053-8119(03)00052-1; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; EBERSOLE J S, 1990, Brain Topography, V3, P21, DOI 10.1007/BF01128858; Ebersole JS, 1999, EEG CL N SU, V50, P167; EBERSOLE JS, 1991, NEUROLOGY, V41, P1425, DOI 10.1212/WNL.41.9.1425; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gramfort A, 2013, NEUROIMAGE, V70, P410, DOI 10.1016/j.neuroimage.2012.12.051; Halgren E, 2011, HUM BRAIN MAPP, V32, P1260, DOI 10.1002/hbm.21106; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Irimia A, 2013, CLIN NEUROPHYSIOLOGY; Irimia A, 2012, NEUROIMAGE, V59, P2464, DOI 10.1016/j.neuroimage.2011.08.104; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Kikinis R, 2011, IEEE ENG MED BIO, P6982, DOI 10.1109/IEMBS.2011.6091765; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; McDonald CR, 2009, EPILEPSIA, V50, P2256, DOI 10.1111/j.1528-1167.2009.02172.x; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Ramon C, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-55; Rosenthal ES, 2012, NEUROTHERAPEUTICS, V9, P24, DOI 10.1007/s13311-011-0101-x; Shiraishi H, 2005, EPILEPSIA, V46, P1264, DOI 10.1111/j.1528-1167.2005.65504.x; Steinbaugh LA, 2012, EPILEPSY BEHAV, V23, P280, DOI 10.1016/j.yebeh.2011.12.005; Tanaka N, 2009, EPILEPSY RES, V85, P279, DOI 10.1016/j.eplepsyres.2009.03.023; Vatta F, 2002, J CLIN NEUROPHYSIOL, V19, P1, DOI 10.1097/00004691-200201000-00001; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2009, STROKE, V40, P1547, DOI 10.1161/STROKEAHA.108.542803; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Zumer JM, 2007, NEUROIMAGE, V37, P102, DOI 10.1016/j.neuroimage.2007.04.054	52	16	17	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2159	2165		10.1016/j.clineuro.2013.08.003			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200041	24011495	Green Accepted			2022-02-06	
J	Shahaduzzaman, M; Acosta, S; Bickford, PC; Borlongan, CV				Shahaduzzaman, Md; Acosta, Sandra; Bickford, Paula C.; Borlongan, Cesar V.			alpha-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury	MEDICAL HYPOTHESES			English	Article							REPEAT KINASE 2; HEAD-INJURY; OXIDATIVE STRESS; ANIMAL-MODELS; PROGRESSION; LRRK2; DJ-1; ACTIVATION; MECHANISMS; MICROGLIA	Parkinson's disease (PD) affects more than 1% of population over 65 and it is characterized by gradual loss of nigrostriatal dopaminergic neurons and wide spread accumulation of alpha-synuclein. Collectively 30% of familial and 3-5% of sporadic form of PD are associated with genetic mutation. Compelling evidence implicates that in addition to inherited factors, acquired co-morbidities contribute to PD pathology. Here, we hypothesize that traumatic brain injury (TBI) exacerbates nigrostriatal dopaminergic degeneration by modulating PD-associated genes including alpha-synuclein, DJ-1. LRRK2, among others. Thus this article will present speculative arguments of a genetic component contributing to this TBI and PD pathological overlap. Published by Elsevier Ltd.	[Shahaduzzaman, Md; Acosta, Sandra; Bickford, Paula C.; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; [Bickford, Paula C.] James A Haley Vet Affairs Hosp, Tampa, FL USA; [Bickford, Paula C.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA		Shahaduzzaman, M (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.	mshahad@health.usf.edu	Borlongan, Cesar/I-5696-2012; Bickford, Paula C/J-5970-2012	Borlongan, Cesar/0000-0002-2966-9782; Bickford, Paula C/0000-0001-9657-7725			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Billia F, 2013, P NATL ACAD SCI USA, V110, P6085, DOI 10.1073/pnas.1303444110; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Choi DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005482; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Cuny GD, 2009, CURR PHARM DESIGN, V15, P3919, DOI 10.2174/138161209789649330; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gao HM, 2011, ENVIRON HEALTH PERSP, V119, P807, DOI 10.1289/ehp.1003013; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Greggio E, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-6; Guerreiro PS, 2013, J MOL MED, V91, P513, DOI 10.1007/s00109-012-0984-y; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jeong HJ, 2012, EXP MOL MED, V44, P586, DOI 10.3858/emm.2012.44.10.067; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kuldip Dave D., 2012, MJFF ANIMAL MODELS 2; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Li TX, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/942412; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu GX, 2012, FUTUR NEUROL, V7, P145, DOI 10.2217/FNL.12.2; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Malpass K, 2013, NAT REV NEUROL, V9, P179, DOI [10.1038/nrneurol.2012.245, 10.1038/nrneurol.2012.35, 10.1038/nrneurol.2013.64, 10.1038/nrneurol.2013.55, 10.1038/nrneurol.2013.35, 10.1038/nrneurol.2013.138, 10.1038/nrneurol.2013.77, 10.1038/nrneurol.2013.119, 10.1038/nrneurol.2013.158]; Markopoulou K, 2013, NEUROLOGY, V80; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Moore DJ, 2008, CURR NEUROL NEUROSCI, V8, P288, DOI 10.1007/s11910-008-0045-7; Mukhida K, 2005, MED HYPOTHESES, V64, P1120, DOI 10.1016/j.mehy.2004.12.020; Pabon MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045256; Protter D, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/829207; [乔森(综述) Qiao Sen], 2012, [浙江大学学报. 医学版, Journal of Zhejiang University. Medical Sciences], V41, P210; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Ramsey CP, 2010, HUM MOL GENET, V19, P1425, DOI 10.1093/hmg/ddq017; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Rousseaux MWC, 2012, P NATL ACAD SCI USA, V109, P15918, DOI 10.1073/pnas.1205102109; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Siebert H, 2010, J NEUROCHEM, V114, P1007, DOI 10.1111/j.1471-4159.2010.06832.x; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spangenberg S, 2009, PARKINSONISM RELAT D, V15, P12, DOI 10.1016/j.parkreldis.2008.02.004; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tufekci KU, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/487450; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Wan OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038545; Wilms H, 2009, INT J IMMUNOPATH PH, V22, P897, DOI 10.1177/039463200902200405; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamaguchi H, 2007, MOL NEUROBIOL, V2; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	64	16	16	0	17	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2013	81	4					675	680		10.1016/j.mehy.2013.07.025			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	243ZO	WOS:000326357100033	23920272				2022-02-06	
J	Tham, SW; Palermo, TM; Wang, J; Jaffe, KM; Temkin, N; Durbin, D; Rivara, FP				Tham, See Wan; Palermo, Tonya M.; Wang, Jin; Jaffe, Kenneth M.; Temkin, Nancy; Durbin, Dennis; Rivara, Frederick P.			Persistent Pain in Adolescents Following Traumatic Brain Injury	JOURNAL OF PAIN			English	Article						Traumatic brain injury; adolescents; pain; longitudinal study; health-related quality of life	QUALITY-OF-LIFE; PATIENT HEALTH QUESTIONNAIRE-9; GLASGOW COMA SCALE; FUNCTIONAL DISABILITY; SEVERITY SCORE; HEAD-INJURY; CHILDREN; DEPRESSION; VALIDITY; PREDICTORS	Traumatic brain injury (TBI) is a leading cause of pediatric disability. Although persistent pain has been recognized as a significant postinjury complication, there is a paucity of data concerning the postinjury pain experience of youth. This study aimed to examine the prevalence of persistent pain in adolescents after TBI, identify risk factors for pain, and evaluate the impact of pain on adolescent health-related quality of life. Participants included 144 adolescents with mild to severe TBI who were followed over 36 months after injury. At 3-, 12-, 24-, and 36-Month assessments, measures of pain intensity, depression, posttraumatic stress disorder, and health-related quality of life were completed by adolescents. Findings demonstrated that 24.3% of adolescents reported persistent pain (defined as usual pain intensity -3/10) at all assessment points after TBI. Female sex (odds ratio = 2.73, 95% confidence interval = 1.12-6.63) and higher levels of depressive symptoms at 3 months after injury (odds ratio = 1.26, 95% confidence interval = 1.12-1.43) were predictors of persistent pain at 36 months. Furthermore, mixed linear models indicated that early pain experience at 3 months following TBI was associated with a significantly poorer long-term health-related quality of life. Perspective: This is the first study to examine the prevalence of persistent pain over long-term follow-up in adolescents after TIM and its impact on health-related quality of life. These findings indicate that adolescents with TBl may benefit from timely evaluation and intervention to minimize the development and impact of pain. (C) 2013 by the American Pain Society	[Tham, See Wan; Palermo, Tonya M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Palermo, Tonya M.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Wang, Jin; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Dept Emergency Med, Philadelphia, PA 19104 USA		Tham, SW (corresponding author), Seattle Childrens Res Inst, M-S-CW8-6,POB 5371, Seattle, WA 98145 USA.	see.tham@seattlechildrens.org	Durbin, Dennis/AAD-7829-2022		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32GM086270-03, K24HD060068]; National Center for Injury Prevention and Control, Centers for Diseases Control and Prevention [R49 CE 001021]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD060068] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086270] Funding Source: NIH RePORTER	Support for this project was provided by the National Institutes of Health grants 5T32GM086270-03 (S.W.T.) and K24HD060068 (T.M.P.) and National Center for Injury Prevention and Control, Centers for Diseases Control and Prevention, grant R49 CE 001021 (ERR.).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Claar RL, 2006, PAIN, V121, P77, DOI 10.1016/j.pain.2005.12.002; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; COPES WS, 1988, J TRAUMA, V28, P78, DOI 10.1097/00005373-198801000-00011; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Demyttenaere S, 2001, CLIN J PAIN, V17, P173, DOI 10.1097/00002508-200106000-00010; Eccleston C, 2004, PAIN, V108, P221, DOI 10.1016/j.pain.2003.11.008; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gauntlett-Gilbert J, 2007, PAIN, V131, P132, DOI 10.1016/j.pain.2006.12.021; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hunfeld JAM, 2001, J PEDIATR PSYCHOL, V26, P145, DOI 10.1093/jpepsy/26.3.145; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Kashikar-Zuck S, 2001, CLIN J PAIN, V17, P341, DOI 10.1097/00002508-200112000-00009; Keogh E, 2006, PAIN, V123, P275, DOI 10.1016/j.pain.2006.03.004; King S, 2011, PAIN, V152, P2729, DOI 10.1016/j.pain.2011.07.016; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LANSER JBK, 1988, HEADACHE, V28, P176, DOI 10.1111/j.1526-4610.1988.hed2803176.x; Logan DE, 2008, J PAIN, V9, P407, DOI 10.1016/j.jpain.2007.12.003; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marr A., 2004, CENTRAL NERVOUS SYST; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ruperto N, 2010, ARTHRIT CARE RES, V62, P1542, DOI 10.1002/acr.20283; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stanford EA, 2008, PAIN, V138, P11, DOI 10.1016/j.pain.2007.10.032; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Voepel-Lewis T, 2011, ANESTH ANALG, V112, P415, DOI 10.1213/ANE.0b013e318203f495; von Baeyer CL, 2009, PAIN, V143, P223, DOI 10.1016/j.pain.2009.03.002	53	16	16	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	OCT	2013	14	10					1242	1249		10.1016/j.jpain.2013.05.007			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	236GB	WOS:000325782400024	23911979	Green Accepted			2022-02-06	
J	Willmott, C; Ponsford, J; McAllister, TW; Burke, R				Willmott, Catherine; Ponsford, Jennie; McAllister, Thomas W.; Burke, Richard			Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury	BRAIN INJURY			English	Article						Attention; catechol-O-methyltransferase (COMT); methylphenidate; traumatic brain injury	CLOSED-HEAD INJURY; DEFICITS; GENE	Primary objective: To investigate whether COMT Val158Met allele status was associated with (i) attentional performance and (ii) response to methylphenidate (MP) following traumatic brain injury (TBI). Methods: Forty healthy controls and 32 patients with moderate-severe TBI (Mean time post-injury = 68 days) completed a baseline cognitive assessment. The TBI cohort then participated in a randomized, cross-over, double blind, placebo controlled 2-week MP trial. MP was administered at 0.3 mg/kg twice daily. TBI genotype distribution: val/val n = 11; val/met n = 14; met/met n = 7. Results: There were no significant differences across genotypes on baseline attentional measures. When compared with controls, the val/val group performed significantly more poorly on most measures. The met/met group performed more poorly than controls on measures of speed, but not in strategic control of attention. MP resulted in faster speed of information processing. Repeated measures mixed ANOVAs found only one significant drug x genotype interaction: (F-(2,F-29) = 4.257, p = 0.024) the met/met group demonstrated a greater response to MP on the Symbol Digit Modalities Test. Conclusions: COMT allele status was not strongly associated with attentional performance or response to MP in the TBI sample. The met/met group, whilst performing slowly, had relatively preserved strategic control of attention.	[Willmott, Catherine; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Notting Hill, Vic 3168, Australia; [McAllister, Thomas W.] Dartmouth Med Sch, Lebanon, NH USA; [Burke, Richard] Monash Univ, Sch Biol Sci, Notting Hill, Vic 3168, Australia		Willmott, C (corresponding author), Monash Univ, Sch Psychol & Psychiat, Neuropsychol Clin, Bldg 1-270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@monash.edu	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035; Burke, Richard/0000-0003-0086-0767	Victorian Neurotrauma Initiative Pty Ltd; Wenkart Foundation	The authors report that, over the past 3 years or anticipated in the near future, no financial support or compensation for research or professional services has been received from any individual or corporate entity that may gain or lose financially through this publication. The authors report they have no personal financial interests that could be perceived as constituting a potential conflict of interest. This study was supported by the Victorian Neurotrauma Initiative Pty Ltd and the Wenkart Foundation, neither of which had any involvement in study design; collection, analysis and interpretation of data; writing of the report; or the decision to submit the article for publication. Drugs were purchased for the trial on a commercial basis, and the company that manufactures Ritalin (R) made no contribution to the study.	Arnsten AFT, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-2; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Cornish K., 2010, ATTENTION GENES DEV; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Karakucuk EI, 1997, NEUROPEPTIDES, V31, P259, DOI 10.1016/S0143-4179(97)90057-3; Leonard BE, 2004, HUM PSYCHOPHARM CLIN, V19, P151, DOI 10.1002/hup.579; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; McAllister, 2004, J NEUROPSYCHIATRY CL, V16, P238; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Ruff RM., 1995, RUFF 2 7 SELECTIVE A; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Smith A., 1991, SYMBOL DIGIT MODALIT; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Vernon-Wilkinson R., 1993, ARCH CLIN NEUROPSYCH, V9, P2; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	27	16	16	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1281	1286		10.3109/02699052.2013.809553			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800007	23924290				2022-02-06	
J	Blum, K; Olive, MF; Wang, KKW; Febo, M; Borsten, J; Giordano, J; Hauser, M; Gold, MS				Blum, Kenneth; Olive, M. Foster; Wang, Kevin K. W.; Febo, Marcelo; Borsten, Joan; Giordano, John; Hauser, Mary; Gold, Mark S.			Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; METHAMPHETAMINE EXPOSURE; SYNTHETIC CATHINONES; MEPHEDRONE; ABUSE; 4-METHYLMETHCATHINONE; PHARMACOLOGY; ACTIVATION; DOPAMINE; ECSTASY	Consensus in the most recent literature indicates that psychoactive "bath salts" is a relatively new drug-combination that was added to Schedule I classification in October 2011. Common ingredients include the cathinone analogs: mephedrone and methylenedioxypyrovalerone (MDPV). The mechanism of action of these synthetic cathinone analogs has not yet been well studied. We propose an intensive systematic investigation to determine the potential for cathinones to produce neurotoxic effects in various brain regions. In spite of a lack of evidence, for neurotoxicity there are number of horrific cases now on record that suggest intensification of research is needed. For example, a suicide by hanging had high 3,4-MDPV concentration while a driver under the influence had the highest reported methylone (MEPH) concentration. More interestingly, there have been consistent case reports indicating delayed responses, including: severe agitation with possible psychosis, suicidal ideation, rhabdomyolysis, hypertension, tachycardia, and death. In animal studies, amphetamine (AMPH), methamphetamine (METH) and cocaine release dopamine (DA), similarly to the action of cathinone and particular cathinone analogues. Two components of bath salts, MEPH and MDPV produce opposite effects at human dopamine transporter (hDAT) comparable to METH and cocaine, respectively. Moreover, it has already been found by others that MEPH is almost as potent as METH; and MDPV is much more potent than cocaine with longer lasting effects. It has been conjectured correctly that bath salts containing MDPV and MEPH (or a similar drug) might be expected both, to initially release DA and subsequently prevent its reuptake via hDAT. The null hypothesis, that cathinones do not cause neurotoxicity to dopamine nerve endings of the striatum, seems parsimonious and requires intensive investigation. Our hypothesis is that when consumed by humans, cathinones may induce neurotoxic pathways involving the neuro-glial-microglia and/or specific inflammation, that may help explain the clinically observed delayed response. We intend to explore this hypothesis utilizing a novel proteomic and biomarker technique developed by scientists at the McKnight Brain Institute, University of Florida as well as magnetic-resonance imaging across pre-frontal orbital cortex-cingulate gyrus and mesolimbic pathways of the brain of rodents. (C) 2013 Elsevier Ltd. All rights reserved.	[Blum, Kenneth; Wang, Kevin K. W.; Febo, Marcelo; Gold, Mark S.] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA; [Blum, Kenneth; Wang, Kevin K. W.; Febo, Marcelo; Gold, Mark S.] Univ Florida, McKnight Brain Inst, Coll Med, Gainesville, FL 32611 USA; [Olive, M. Foster] Arizona State Univ, Dept Psychol, Behav Neurosci Program, Tempe, AZ 85287 USA; [Blum, Kenneth; Borsten, Joan] Malibu Beach Recovery Ctr, Dept Addict Res & Therapy, Malibu Beach, CA USA; [Blum, Kenneth; Giordano, John] G&G Holist Hlth Care Serv LLC, Dept Holist Res, North Miami Beach, FL USA; [Blum, Kenneth; Hauser, Mary] Domin Diagnost Inc, North Kingstown, RI USA; [Blum, Kenneth] Path Fdn NY, Dept Clin Neurol, New York, NY USA; [Blum, Kenneth] Univ Vermont, Coll Med, Dept Psychiat, Burlington, VT USA; [Blum, Kenneth] Univ Vermont, Coll Med, Global Serv Unit, Burlington, VT USA; [Blum, Kenneth] Univ Vermont, Coll Med, Ctr Clin & Translat Sci, Burlington, VT USA; [Blum, Kenneth] IIOAB, Ctr Genom & Appl Gene Technol, Purbe Medinpur, W Bengal, India		Blum, K (corresponding author), McKnight Brain Inst, POB 100256, Gainesville, FL 32610 USA.	drd2gene@ufl.edu	Febo, Marcelo/G-5718-2011; Febo, Marcelo/X-6769-2019	Febo, Marcelo/0000-0001-8981-4163; Olive, Foster/0000-0002-2517-0351; Wang, Kevin/0000-0002-9343-6473	PATH Foundation NY, New York though Life-Extension foundation; LifeGen, Inc. Lederoch, Pennsylvania; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA019946, DA025606]; University of Florida, College of Medicine faculty fund; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA019946, R01DA025606] Funding Source: NIH RePORTER	The authors are grateful the staff of Malibu Beach Recovery Center, Malibu Beach, California. The authors are grateful for the expert editorial comments of Margaret A. Madigan. The authors acknowledge the financial support of PATH Foundation NY, New York though a grant from Life-Extension foundation to Kenneth Blum and Eric R. Braverman, and LifeGen, Inc. Lederoch, Pennsylvania. Febo Marcelo is the recipient of NIH Grant # R01DA019946; M. Foster Olive is the recipient of NIH Grant # DA025606; Kevin Wang has received a grant from the University of Florida, College of Medicine faculty fund.	Angoa-Perez M, 2012, J NEUROCHEM, V120, P1097, DOI 10.1111/j.1471-4159.2011.07632.x; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Benzie Fred, 2011, Morbidity and Mortality Weekly Report, V60, P624; Coppola M, 2012, TOXICOL LETT, V208, P12, DOI 10.1016/j.toxlet.2011.10.002; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Hadlock GC, 2011, J PHARMACOL EXP THER, V339, P530, DOI 10.1124/jpet.111.184119; Karila Laurent, 2012, Rev Prat, V62, P664; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; Kobeissy FH, 2008, J PROTEOME RES, V7, P1971, DOI 10.1021/pr800029h; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2009, METHODS MOL BIOL, V566, P217, DOI 10.1007/978-1-59745-562-6_15; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Lisek R, 2012, DRUG ALCOHOL DEPEN, V126, P257, DOI 10.1016/j.drugalcdep.2012.04.021; Meyer MR, 2012, J MASS SPECTROM, V47, P253, DOI 10.1002/jms.2960; Murray BL, 2012, J MED TOXICOL, V8, P69, DOI 10.1007/s13181-011-0196-9; Penders TM, 2012, GEN HOSP PSYCHIAT, V34, P647, DOI 10.1016/j.genhosppsych.2012.06.005; Prosser JM, 2012, J MED TOXICOL, V8, P33, DOI 10.1007/s13181-011-0193-z; Ramoz L, 2012, NEUROSCIENCE, V208, P79, DOI 10.1016/j.neuroscience.2012.01.019; Robinson JE, 2012, BEHAV BRAIN RES, V234, P76, DOI 10.1016/j.bbr.2012.06.012; Ross EA, 2012, AM J MED, V125, P854, DOI 10.1016/j.amjmed.2012.02.019; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Spiller HA, 2011, CLIN TOXICOL, V49, P499, DOI 10.3109/15563650.2011.590812; Thornton SL, 2012, J MED TOXICOL, V8, P310, DOI 10.1007/s13181-012-0232-4; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; Watterson LB, 2012, J ADDICT RES THER, V3, P101; Watterson LR, 2012, ADDICT BIOL, DOI DOI 10.1111/11369-1600.2012.00474.X.[EPUB; Wieland DM, 2012, J PSYCHOSOC NURS MEN, V50, P17, DOI 10.3928/02793695-20120120-01	29	16	16	0	32	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	SEP	2013	81	3					450	455		10.1016/j.mehy.2013.06.007			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	210ZR	WOS:000323874400021	23845561				2022-02-06	
J	Borich, MR; Cheung, KL; Jones, P; Khramova, V; Gavrailoff, L; Boyd, LA; Virji-Babul, N				Borich, Michael R.; Cheung, Katharine L.; Jones, Paul; Khramova, Vera; Gavrailoff, Lauren; Boyd, Lara A.; Virji-Babul, Naznin			Concussion: Current Concepts in Diagnosis and Management	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						clinical outcomes; exercise; mild traumatic brain injury; neuroimaging; rehabilitation	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HEAD-INJURY; HIGH-SCHOOL; STANDARDIZED ASSESSMENT; UP-REGULATION; RISK-FACTORS; EPIDEMIOLOGY; EXERCISE; RECOVERY	Current understanding of the term "concussion" is fraught with misconceptions regarding the extent and nature of brain injury. Despite increasing attention in popular media and within the context of sports, considerable gaps exist in our knowledge of the diagnosis, underlying brain pathology, recovery of function, and optimal interventions for concussion. In this special interest article, we discuss the definition and risk factors associated with concussion, summarize and highlight some of the most widely used assessment tools, and critique the evidence for current principles of concussion management. Our evaluation has identified opportunities for novel neuroimaging techniques to improve the understanding of the pathophysiology of concussion and to evaluate the changes in the recovering brain in response to rehabilitation. In summary, a clear definition of the underlying brain pathology, the potential long-term consequences, and the risk factors of injury and recovery will help guide future research aiming to minimize the impact of injury and develop innovative and successful therapeutic approaches aimed at ameliorating the functional impairments associated with concussion. Video Abstract available (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A51) for more insights from the authors.	[Borich, Michael R.; Boyd, Lara A.; Virji-Babul, Naznin] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V6T 1Z3, Canada; [Cheung, Katharine L.; Jones, Paul; Gavrailoff, Lauren; Boyd, Lara A.] Univ British Columbia, Grad Program Neurosci, Vancouver, BC V6T 1Z3, Canada; [Khramova, Vera; Virji-Babul, Naznin] Child & Family Res Inst, Vancouver, BC, Canada		Virji-Babul, N (corresponding author), Univ British Columbia, Dept Phys Therapy, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	naznin.virji-babul@ubc.ca	Meijer, Anna/K-5118-2016; Borich, Michael Robert/E-1683-2011	Borich, Michael Robert/0000-0002-0469-6282; Virji-Babul, Naznin/0000-0002-8984-5848			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Almasi Stephen J, 2012, WMJ, V111, P21; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; GEVINS A, 1995, TRENDS NEUROSCI, V18, P429, DOI 10.1016/0166-2236(95)94489-R; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Koscs M, 2009, ATHL TRAIN SPORTS HL, V1, P24; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lovell MR, 2000, IMPACT IMMEDIATE P S; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2000, STANDARDIZED ASSES S; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, P1; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NAATANEN R, 1994, TRENDS NEUROSCI, V17, P389, DOI 10.1016/0166-2236(94)90048-5; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Silverberg ND, 2012, J HEAD TRAUMA REHA S, P1; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005	75	16	16	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	SEP	2013	37	3					133	139		10.1097/NPT.0b013e31829f7460			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	299FF	WOS:000330380500007	23872682				2022-02-06	
J	Brophy, GM; Mazzeo, AT; Brar, S; Alves, OL; Bunnell, K; Gilman, C; Karnes, T; Hayes, RL; Bullock, R				Brophy, Gretchen M.; Mazzeo, Anna Teresa; Brar, Satjit; Alves, Oscar Luis; Bunnell, Kristen; Gilman, Charlotte; Karnes, Tom; Hayes, Ron L.; Bullock, Ross			Exposure of Cyclosporin A in Whole Blood, Cerebral Spinal Fluid, and Brain Extracellular Fluid Dialysate in Adults with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cyclosporin; neuroprotection; TBI	MITOCHONDRIAL PERMEABILITY TRANSITION; REPERFUSION INJURY; HEALTHY-SUBJECTS; DOSE-RESPONSE; PHARMACOKINETICS; MICRODIALYSIS; DAMAGE; RAT; QUANTIFICATION; CORRELATE	Cyclosporin A (CsA), an immunosuppressive medication traditionally used in the prevention of post-transplant rejection, is a promising neuroprotective agent for traumatic brain injury (TBI). Preliminary studies in animals and humans describe the efficacy and safety of CsA when administered following neurotrauma. The objective of this study is to describe CsA exposure in adults with severe TBI by assessing concentrations in whole blood, cerebrospinal fluid (CSF), and brain extracellular fluid (ECF) dialysate as measured by brain microdialysis. Severe TBI patients were enrolled in a randomized controlled trial following the written informed consent of their legal guardians. Patients received either CsA 5 mg/kg as a continuous infusion over 24 h, or matching placebo. Noncompartmental exposure analyses were performed using CsA concentrations in whole blood, CSF, and ECF dialysate. There were 37 patients randomized to the CsA arm of the trial and included in this exposure analysis. CsA was detected in the ECF dialysate and CSF at a fraction of the whole blood concentration. Mean CsA maximum concentrations were achieved at 24 and 30 h from the start of the 24 h infusion, in the CSF and ECF dialysate, respectively. A correlation was found between ECF dialysate and CSF concentrations. CsA was detected in the blood, CSF, and brain ECF dialysate. CsA exposure characteristic differences exist for whole blood, CSF, and ECF dialysate in severe TBI patients when administered as a continuous intravenous infusion. These exposure characteristics should be used for safer CsA dose optimization to achieve target CsA concentrations for neuroprotection in future TBI studies.	[Brophy, Gretchen M.; Karnes, Tom] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23298 USA; [Bunnell, Kristen] Virginia Commonwealth Univ, Dept Pharm, Richmond, VA 23298 USA; [Brophy, Gretchen M.; Gilman, Charlotte] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Mazzeo, Anna Teresa] Univ Turin, Osped San Gioranni Betista, Dept Anaesthesia & Intens Care, Turin, Italy; [Brar, Satjit] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Silver Spring, MD USA; [Alves, Oscar Luis] Univ Porto, Serv Neurocirugia, Ctr Hosp Vila Nova Gaia, Fac Med, P-4100 Oporto, Portugal; [Hayes, Ron L.] Banyan Biomarkers Inc, Alachua, FL USA; [Bullock, Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Miami, FL 33136 USA		Brophy, GM (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia Campus,410 N 12th St,POB 980533, Richmond, VA 23298 USA.	gbrophy@vcu.edu		Mazzeo, Anna Teresa/0000-0002-8454-7243; Brophy, Gretchen/0000-0002-4749-2693; Bunnell, Kristen/0000-0002-7646-0594	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS 12587-27]; Reynolds Foundation; Lind-Lawrence Foundation; Fundacao para a Ciencia e TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/BD/3421/2000]; Fulbright Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587] Funding Source: NIH RePORTER	Funding for this study was provided by NIH NINDS grant N. P50 NS 12587-27, and Ross Bullock was supported by the Reynolds and Lind-Lawrence Foundations. Oscar L Alves was supported by grant number SFRH/BD/3421/2000 from Fundacao para a Ciencia e Tecnologia, and by a Fulbright Fellowship.	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; DELANGE ECM, 1995, BRAIN RES, V702, P261, DOI 10.1016/0006-8993(95)01184-X; DYKSTRA KH, 1992, J NEUROCHEM, V58, P931, DOI 10.1111/j.1471-4159.1992.tb09346.x; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; FLECHNER SM, 1989, TRANSPLANTATION, V47, P806, DOI 10.1097/00007890-198905000-00012; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; GUPTA SK, 1990, J CLIN PHARMACOL, V30, P643, DOI 10.1002/j.1552-4604.1990.tb01868.x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Iyer SS, 2007, J LIQ CHROMATOGR R T, V30, P1733, DOI 10.1080/10826070701360301; KAHAN BD, 1986, TRANSPLANTATION, V41, P459, DOI 10.1097/00007890-198604000-00009; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Miller RJ, 1998, TRENDS NEUROSCI, V21, P95, DOI 10.1016/S0166-2236(97)01206-X; Min DI, 2004, THER DRUG MONIT, V26, P524, DOI 10.1097/00007691-200410000-00010; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; PTACHCINSKI RJ, 1985, CLIN PHARMACOL THER, V38, P296, DOI 10.1038/clpt.1985.174; PTACHCINSKI RJ, 1987, J CLIN PHARMACOL, V27, P243, DOI 10.1002/j.1552-4604.1987.tb02193.x; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P141, DOI 10.2165/11317350-000000000-00000; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282	39	16	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1484	1489		10.1089/neu.2012.2524			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800003	23540442	Green Published			2022-02-06	
J	Jung, R; Aull-Watschinger, S; Moser, D; Czech, T; Baumgartner, C; Bonelli-Nauer, S; Pataraia, E				Jung, Rebekka; Aull-Watschinger, Susanne; Moser, Doris; Czech, Thomas; Baumgartner, Christoph; Bonelli-Nauer, Sivlia; Pataraia, Ekaterina			Is reoperation an option for patients with temporal lobe epilepsy after failure of surgery?	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Temporal lobe epilepsy; Epilepsy surgery; Surgery failure; Reoperation; Postoperative outcome	ICTAL SCALP EEG; HIPPOCAMPAL SCLEROSIS; SURGICAL-TREATMENT; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; SEIZURE RECURRENCE; RESECTION; PREDICTORS; LOBECTOMY; MEMORY	Purpose: Epilepsy surgery is the most efficacious therapeutic modality for patients with medically refractory focal epilepsies, but surgical failures remain a challenge to the epilepsy treatment team. The aim of present study was to evaluate the postoperative outcome of patients who underwent reoperation after a failed epilepsy surgery on the temporal lobe. Methods: We systematically analyzed the results of comprehensive preoperative evaluations before the first surgery, and before and after reoperation in 17 patients with drug resistant temporal lobe epilepsies. Results: Overall, 13 of 17 patients (76.5%) improved after reoperation: five patients (29.4%) were completely seizure free after reoperation (median duration 60 months, range 12-72); six patients (35.3%) were seizure free at least 12 month before observation points (median duration 120.5 months, range 35-155) and two patients (11.8%) had a decrease in seizure frequency. Four patients (23.5%) remained unchanged with respect to seizure frequency and severity. There was no correlation between the improvement in seizure outcome after reoperation and other clinical data except of the history of traumatic brain injury (TBI). The patients who had no history of TBI improved after reoperation, compared to patients with TBI (p = 0.044). The postoperative seizure outcome of patients with incongruent Video-EEG results before the first surgery (p = 0.116) and before reoperation (p = 0.622) was not poorer compared to patients with congruent Video-EEG results. Conclusions: Reoperation can considerably improve the operative outcome of the first failed epilepsy surgery in patients with drug resistant temporal lobe epilepsies. Epilepsy centres should be encouraged to report the results of failed epilepsy surgeries. (C) 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Jung, Rebekka; Aull-Watschinger, Susanne; Moser, Doris; Bonelli-Nauer, Sivlia; Pataraia, Ekaterina] Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; [Czech, Thomas] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Baumgartner, Christoph] Gen Hosp Hietzing, Neurol Ctr Rosenhugel, Dept Neurol 2, Vienna, Austria		Pataraia, E (corresponding author), Med Univ Vienna, Dept Neurol, Spitalgasse 23, A-1090 Vienna, Austria.	ekaterina.pataraia@meduniwien.ac.at		Bonelli, Silvia/0000-0002-6346-8474; Pataraia, Ekaterina/0000-0002-1454-7600			Aull-Watschinger S, 2008, EPILEPSIA, V49, P1308, DOI 10.1111/j.1528-1167.2008.01732.x; CHUNG MY, 1991, EPILEPSIA, V32, P195, DOI 10.1111/j.1528-1157.1991.tb05244.x; Commission on neuroimaging of the international league against epilepsy, 1998, EPILEPSIA, V39, P1375; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Helmstaedter C, 2008, EPILEPSIA, V49, P88, DOI 10.1111/j.1528-1167.2007.01386.x; Hennessy MJ, 2000, BRAIN, V123, P2445, DOI 10.1093/brain/123.12.2445; Hennessy MJ, 2001, ACTA NEUROL SCAND, V103, P344, DOI 10.1034/j.1600-0404.2001.103006344.x; Jehi LE, 2010, J NEUROSURG, V113, P1186, DOI 10.3171/2010.8.JNS10180; Loddenkemper T, 2005, EPILEPSY BEHAV, V7, P1, DOI 10.1016/j.yebeh.2005.04.004; Lowe AJ, 2004, EPILEPSIA, V45, P237, DOI 10.1111/j.0013-9580.2004.35903.x; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Paglioli E, 2006, J NEUROSURG, V104, P70, DOI 10.3171/jns.2006.104.1.70; Pataraia E, 1998, EPILEPSIA, V39, P608, DOI 10.1111/j.1528-1157.1998.tb01429.x; Ramos E, 2009, J NEUROSURG, V110, P1127, DOI 10.3171/2009.1.JNS08638; Ryvlin P, 2005, CURR OPIN NEUROL, V18, P125, DOI 10.1097/01.wco.0000162852.22026.6f; Salanova V, 2005, ACTA NEUROL SCAND, V111, P126, DOI 10.1111/j.1600-0404.2005.00371.x; Schulz R, 2011, NEUROSURGERY, V68, P89, DOI 10.1227/NEU.0b013e3181fdf8f8; Schwartz TH, 2001, J NEUROSURG, V95, P615, DOI 10.3171/jns.2001.95.4.0615; Siegel AM, 2004, NEUROLOGY, V63, P2298, DOI 10.1212/01.WNL.0000147476.86575.A7; STEINHOFF BJ, 1995, NEUROLOGY, V45, P889, DOI 10.1212/WNL.45.5.889; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; WIESER HG, 1982, SURG NEUROL, V17, P445, DOI 10.1016/S0090-3019(82)80016-5; Zachenhofer I, 2011, ACTA NEUROCHIR, V153, P239, DOI 10.1007/s00701-010-0802-7	25	16	17	0	6	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	SEP	2013	22	7					502	506		10.1016/j.seizure.2012.11.011			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	204JV	WOS:000323362500002	23273881	Bronze			2022-02-06	
J	Koo, HM; Lee, SM; Kim, MH				Koo, Hyun Mo; Lee, Sun Min; Kim, Min Hee			Spontaneous Wheel Running Exercise Induces Brain Recovery via Neurotrophin-3 Expression Following Experimental Traumatic Brain Injury in Rats	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Neurotrophin-3; Traumatic brain injury; Wheel running exercise	CLOSED-HEAD INJURY; PROTEIN; PLASTICITY; MOTOR; BDNF	[Purpose] The aim of the present study was to investigate the expression of neurotrophin-3 (NT-3) after applying spontaneous wheel running exercises (SWR) after experimental traumatic brain injury (TBI). [Subjects and Methods] Thirty male Sprague-Dawley rats were divided into 3 groups; 20 rats were subjected to controlled cortical impact for TBI, and then, animals were randomly collected from the SWR group and subjected to wheel running exercise for 3 weeks. Ten rats were not subjected to any injury or running exercise to compare with the effect of TBI and SWR. Immunohistochemistry, Western blotting, skilled ladder rung walking test, and 2,3,5-triphenyltetrazolium chloride staining analysis for the evaluation of NT-3 expression were used to assess brain damage and recovery. [Results] The TBI-induced decrease in NT-3 expression was recovered by wheel running exercise. Moreover, decreased ischemic volume and progressive neurobehavioral outcome were observed in the SWR group. [Conclusion] Spontaneous running exercise promotes brain recovery and motor function through an increase in expression of NT-3.	[Koo, Hyun Mo] Kyungsung Univ, Coll Sci, Dept Phys Therapy, Gyeonggi 461713, South Korea; [Lee, Sun Min] Dongju Univ, Dept Occupat Therapy, Gyeonggi 461713, South Korea; [Kim, Min Hee] Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Gyeonggi 461713, South Korea		Kim, MH (corresponding author), Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Gyeonggi 461713, South Korea.	kmh12@eulji.ac.kr			Kyungsung University	This research was supported by Kyungsung University Research Grants in 2013.	Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Emerick AJ, 2004, BEHAV BRAIN RES, V152, P315, DOI 10.1016/j.bbr.2003.10.010; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gwag BJ, 2003, ANTIOXID REDOX SIGN, V5, P621, DOI 10.1089/152308603770310284; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Jackson R.G.M., 2002, CURR ANAESTHESIA CRI, V13, P343; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Newcomb JK, 1999, J NEUROTRAUM, V16, P1, DOI 10.1089/neu.1999.16.1; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; WOODSIDE B, 1995, BRAIN RES, V690, P48, DOI 10.1016/0006-8993(95)00586-F	23	16	17	0	2	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	SEP	2013	25	9					1103	1107					5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	246QT	WOS:000326554900012	24259924	Green Published, Green Submitted, Bronze			2022-02-06	
J	Micarelli, A; Jacobsson, H; Larsson, SA; Jonsson, C; Pagani, M				Micarelli, A.; Jacobsson, H.; Larsson, S. A.; Jonsson, C.; Pagani, M.			Neurobiological insight into hyperbaric hyperoxia	ACTA PHYSIOLOGICA			English	Article						attention system; hyperbaric hyperoxia; posterior cingulated cortex; rCBF; SPECT	CEREBRAL-BLOOD-FLOW; ACUTE HYPOBARIC HYPOXIA; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; OXYGEN-CONSUMPTION; 30-PERCENT OXYGEN; DEFAULT NETWORK; ACTIVATION; CORTEX; LEVEL	Aim: Hyperbaric hyperoxia (HBO) is known to modulate aerobic metabolism, vasoreactivity and blood flow in the brain. Nevertheless, mechanisms underlying its therapeutic effects, especially in traumatic brain injury (TBI) and stroke patients, are debated. The present study aimed at investigating regional cerebral blood flow (rCBF) distribution during acute HBO exposure. Methods: Regional cerebral blood flow response was investigated in seven healthy subjects exposed to either normobaric normoxia or HBO with ambient pressure/inspired oxygen pressure of 101/21 and 250/250 kPa respectively. After 40 min at the desired pressure, they were injected a perfusion tracer and subsequently underwent brain single photon emission computed tomography. rCBF distribution changes in the whole brain were assessed by Statistical Parametric Mapping. Results: During HBO, an increased relative rCBF distribution was found in sensory-motor, premotor, visual and posterior cingulate cortices as well as in superior frontal gyrus, middle/inferior temporal and angular gyrus and cerebellum, mainly in the dominant hemisphere. During normobaric normoxia, a higher 99m Tc-HMPAO distribution in the right insula and subcortical structures as well as in bilateral hippocampi and anterior cingulated cortex was found. Conclusions: The present study firstly confirmed the rCBF distribution increase during HBO in sensory-motor and visual cortices, and it showed for the first time a higher perfusion tracer distribution in areas encompassed in dorsal attention system and in default mode network. These findings unfold both the externally directed cognition performance improvement related to the HBO and the internally directed cognition states during resting-state conditions, suggesting possible beneficial effects in TBI and stroke patients.	[Micarelli, A.] Univ Roma Tor Vergata, Dept Med Sci & Translat Med, Rome, Italy; [Jacobsson, H.; Larsson, S. A.; Jonsson, C.; Pagani, M.] Karolinska Univ Hosp, Dept Nucl Med, Stockholm, Sweden; [Pagani, M.] CNR, Inst Cognit Sci & Technol, Rome, Italy		Micarelli, A (corresponding author), Univ Roma Tor Vergata, Dept Med Sci & Translat Med, Viale Oxford 81, Rome, Italy.	alessandromicarelli@yahoo.it	pagani, marco/AAV-9176-2020				ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; Belda FJ, 2005, JAMA-J AM MED ASSOC, V294, P2035, DOI 10.1001/jama.294.16.2035; BERGOFSKY EH, 1966, J APPL PHYSIOL, V21, P567, DOI 10.1152/jappl.1966.21.2.567; Boakye M, 2002, NEUROSCI LETT, V321, P5, DOI 10.1016/S0304-3940(01)02406-5; Brett M, 2001, NEUROIMAGE, V13, pS85; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Choi MH, 2010, NEUROSCI LETT, V471, P70, DOI 10.1016/j.neulet.2010.01.013; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Chung SC, 2004, BRAIN COGNITION, V56, P279, DOI 10.1016/j.bandc.2004.07.005; Chung SC, 2006, INT J PSYCHOPHYSIOL, V62, P103, DOI 10.1016/j.ijpsycho.2006.02.006; Chung SC, 2009, NEUROSCI LETT, V453, P175, DOI 10.1016/j.neulet.2009.02.050; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2012, DEV PSYCHOBIOL, V54, P239, DOI 10.1002/dev.20507; Di Piero V, 2002, EUR J NEUROL, V9, P419, DOI 10.1046/j.1468-1331.2002.00436.x; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; INGVAR DH, 1960, ACTA PHYSIOL SCAND, V48, P373, DOI 10.1111/j.1748-1716.1960.tb01870.x; Ishii K, 1998, Ann Nucl Med, V12, P29; Ishii K, 1996, J NUCL MED, V37, P1086; Ito H, 2000, J CEREBR BLOOD F MET, V20, P1264, DOI 10.1097/00004647-200008000-00011; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kanno I., 1996, J CEREB BLOOD FLOW M, V17, pS646; Kashikura K, 2001, NEUROSCI LETT, V299, P53, DOI 10.1016/S0304-3940(00)01781-X; Kashikura K, 2000, NEUROREPORT, V11, P903, DOI 10.1097/00001756-200004070-00001; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kolbitsch C, 2002, MAGN RESON IMAGING, V20, P535, DOI 10.1016/S0730-725X(02)00534-9; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Liu WW, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-13; Macey PM, 2007, PLOS MED, V4, P828, DOI 10.1371/journal.pmed.0040173; Mathieu D, 2006, HDB HYPERB MED, P103, DOI [10.1007/1-4020-4448-8_7, DOI 10.1007/1-4020-4448-8_7]; Mazard A, 2002, J COGNITIVE NEUROSCI, V14, P172, DOI 10.1162/089892902317236821; Melsom MN, 1999, ACTA PHYSIOL SCAND, V166, P151; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Omae T, 1998, STROKE, V29, P94, DOI 10.1161/01.STR.29.1.94; Pagani M, 2011, ACTA PHYSIOL, V202, P203, DOI 10.1111/j.1748-1716.2011.02264.x; Pagani M, 2000, ACTA PHYSIOL SCAND, V168, P377; Pagani M, 2012, J AUTISM DEV DISORD, V42, P313, DOI 10.1007/s10803-011-1240-y; Papo D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00045; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Regli F, 1970, STROKE, V1, P314, DOI 10.1161/01.STR.1.5.314; Ren H, 2001, Chin J Traumatol, V4, P239; Rousseau A, 2005, ACTA PHYSIOL SCAND, V183, P231, DOI 10.1111/j.1365-201X.2005.01405.x; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Schellart NAM, 2011, CANCER-AM CANCER SOC, V117, P3434, DOI 10.1002/cncr.25874; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zeyu Xie, 2007, Neural Regeneration Research, V2, P314; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	51	16	17	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-1708	1748-1716		ACTA PHYSIOL	Acta Physiol.	SEP	2013	209	1					69	76		10.1111/apha.12116			8	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	198VK	WOS:000322950400011	23692702				2022-02-06	
J	Rangarajan, P; Eng-Ang, L; Dheen, ST				Rangarajan, Parakalan; Eng-Ang, Ling; Dheen, S. Thameem			Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Microglia; inflammation; brain injury; neurodegeneration; retinoic acid; glucocorticoids; minocycline; miRNA; epigenetics	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; PERIVENTRICULAR WHITE-MATTER; ACTIVATED RAT MICROGLIA; SPHINGOSINE KINASE 1; RETINOIC ACID; PROINFLAMMATORY CYTOKINES; MULTIPLE-SCLEROSIS; AMEBOID MICROGLIA; HIV-1 INFECTION	Inflammation in the central nervous system (CNS) may occur as a result of trauma, infection or neurodegenerative stimuli and is characterized by activation of microglia, the resident immune cells of the CNS. Activated microglia proliferate rapidly, migrate to the site of injury or infection and elicit immune response by phagocytosis of cell debris, production of cytokines, chemokines and reactive oxygen species, and presentation of antigens to other immune cells. In addition, microglia participate in tissue repair by producing neurotrophic factors. However, when microglia are chronically activated, they become neurotoxic to the surrounding CNS parenchyma. Chronic activation of microglia has been shown to augment neurodegeneration in Parkinson's disease (PD), Alzheimer's disease (AD), brain injury and number of other CNS pathologies. Identification of factors that control microglial activation, therefore, has become the major focus of recent research. A number of herbal and chemical compounds have been shown to attenuate microglial activation. However, these compounds exhibit non-specificity and produce unpleasant side-effects. Here, we provide a comprehensive review on some of the currently available drugs known to reduce microglial activation, their molecular targets and the subcellular signaling networks on which they act. We also review some of the newly emerging therapeutic avenues such as 'epidrugs' and finally emphasize on the importance of targeted drug delivery systems for alleviating microglia-mediated neurotoxicity.	[Rangarajan, Parakalan; Eng-Ang, Ling; Dheen, S. Thameem] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore		Dheen, ST (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Md10,4 Med Dr, Singapore 117597, Singapore.	thameem_dheen@nuhs.edu.sg	Dheen, S. Thameem/AAU-8627-2020	Dheen, S. Thameem/0000-0001-9600-6789	National Medical Research Council, SingaporeNational Medical Research Council, Singapore [NMRC/EDG/1039/2011, R-181-000-139-275]	The authors would like to acknowledge the National Medical Research Council, Singapore for the NMRC Exploratory/Developmental Grant (NMRC/EDG/1039/2011; R-181-000-139-275).	Baud O, 2004, BRAIN PATHOL, V14, P1; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Boillee S, 2008, J CLIN INVEST, V118, P474, DOI [10.1172/JC134613, 10.1172/JCI34613]; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Brooke SM, 2002, EXP NEUROL, V177, P151, DOI 10.1006/exnr.2002.7956; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Choi J., 2009, ENV HLTH PERSPECT, V118; Cucchiarini M, 2003, GENE THER, V10, P657, DOI 10.1038/sj.gt.3301925; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Dheen ST, 2005, GLIA, V50, P21, DOI 10.1002/glia.20153; Diab A, 2004, J NEUROIMMUNOL, V148, P116, DOI 10.1016/j.jneuroim.2003.11.010; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Drager Ursula C, 2006, Sci STKE, V2006, ppe10, DOI 10.1126/stke.3242006pe10; Enderlin V, 1997, NEUROSCI LETT, V229, P125, DOI 10.1016/S0304-3940(97)00424-2; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Hutter E, 2010, ACS NANO, V4, P2595, DOI 10.1021/nn901869f; INNOCENTI GM, 1983, DEV BRAIN RES, V11, P55, DOI 10.1016/0165-3806(83)90201-8; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; KAUR C, 1994, ARCH HISTOL CYTOL, V57, P449, DOI 10.1679/aohc.57.449; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Keller AF, 2011, EXP NEUROL, V228, P69, DOI 10.1016/j.expneurol.2010.12.010; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Koedel U, 1999, BRAIN PATHOL, V9, P57; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Li H, 1996, NEUROPATH APPL NEURO, V22, P207; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Lieb K, 2003, NEUROCHEM INT, V42, P131, DOI 10.1016/S0197-0186(02)00076-1; Lin HY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-13; Ling E A, 2001, Prog Brain Res, V132, P61; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luo X.-G., 2010, BIOMED CENTRAL; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mallat M, 2005, CURR OPIN NEUROBIOL, V15, P101, DOI 10.1016/j.conb.2005.01.006; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Murugan M, 2011, GLIA, V59, P521, DOI 10.1002/glia.21121; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nair A, 2006, J NEUROIMMUNOL, V171, P72, DOI 10.1016/j.jneuroim.2005.09.012; Nau R, 2002, TRENDS NEUROSCI, V25, P38, DOI 10.1016/S0166-2236(00)02024-5; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Orlowski D, 2003, INT J DEV NEUROSCI, V21, P445, DOI 10.1016/j.ijdevneu.2003.09.001; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Rayan Nirmala Arul, 2011, Front Biosci (Elite Ed), V3, P1079; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Ros-Bernal F, 2011, P NATL ACAD SCI USA, V108, P6632, DOI 10.1073/pnas.1017820108; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schildknecht S, 2011, J BIOL CHEM, V286, P4991, DOI 10.1074/jbc.M110.169565; Sen CK, 2011, PHYSIOL GENOMICS, V43, P517, DOI 10.1152/physiolgenomics.00037.2011; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Vallat-Decouvelaere AV, 2003, J NEUROPATH EXP NEUR, V62, P475, DOI 10.1093/jnen/62.5.475; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WOOD PL, 1995, NEUROL RES, V17, P242, DOI 10.1080/01616412.1995.11740321; Xu HH, 2006, J NEUROIMMUNOL, V171, P135, DOI 10.1016/j.jneuroim.2005.10.004; Xu JH, 2005, J NEUROSCI RES, V81, P403, DOI 10.1002/jnr.20518; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	90	16	16	0	30	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	SEP	2013	12	6					799	806		10.2174/18715273113126660175			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	263HD	WOS:000327797200012	24047522				2022-02-06	
J	Rigby, J; Vela, L; Housman, J				Rigby, Justin; Vela, Luzita; Housman, Jeff			Understanding Athletic Trainers' Beliefs Toward a Multifacted Sport-Related Concussion Approach: Application of the Theory of Planned Behavior	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion management; traumatic brain injuries; practice guidelines	HIGH-SCHOOL; MANAGEMENT; STATEMENT; WORKING; BURNOUT; IMPACT	Context: Practice guidelines recommend a multifaceted approach for managing concussions, but a relatively small percentage of athletic trainers (ATs) follow these recommendations. Understanding ATs' beliefs toward the recommended concussion practice guidelines is the first step in identifying interventions that could increase compliance. The theory of planned behavior (TPB) allows us to measure ATs' beliefs toward the recommended concussion practice guidelines. Objective: To examine the influence of ATs' beliefs toward the current recommended concussion guidelines on concussion- management practice through an application of the TPB. Design: Cross-sectional study. Setting: A Web link with a survey was e-mailed to 1000 randomly selected members of the National Athletic Trainers' Association (NATA). Patients or Other Participants: A total of 221 certified ATs working in secondary school/clinic, high school, and college/ university settings. Main Outcome Measure(s): A 66-item survey reflecting the current recommended concussion guidelines of the NATA and International Conference on Concussion in Sport was created to measure beliefs using the TPB constructs attitude toward the behavior (BA), subjective norms (SN), perceived behavioral control (PBC), and behavioral intention (BI) of ATs. We used a linear multiple regression to determine if the TPB constructs BA, SN, and PBC predicted BI and if PBC and BI predicted behavior according to the TPB model. Results: We found that BA, SN, and PBC predicted BI (R = 0.683, R-2 = 0.466, F-3,F-202 = 58.78, P < .001). The BA (t(202) = 5.53, P < .001) and PBC (t(202) = 9.64, P < .001) contributed to the model, whereas SN (t(202) = -0.84, P = .402) did not. The PBC and BI predicted behavior (R = 0.661, R-2 = 0.437, F-2,F-203 = 78.902, P < .001). Conclusions: In this sample, the TPB constructs predicted BI and behavior of ATs' compliance with recommended concussion-management guidelines. The BA and PBC were the most influential constructs, indicating that those with positive attitudes toward concussion-management recommendations are more likely to implement them, and ATs are less likely to implement them when they do not believe they have the power to do so. We theorize that interventions targeting ATs' attitudes and control perceptions will lead to improved compliance.	[Rigby, Justin] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Vela, Luzita; Housman, Jeff] Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX USA		Rigby, J (corresponding author), Brigham Young Univ, Dept Exercise Sci, 106 SFH, Provo, UT 84602 USA.	justin.h.rigby@gmail.com					AIKEN LR, 1985, EDUC PSYCHOL MEAS, V45, P131, DOI 10.1177/0013164485451012; Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I., 1991, THEORY PLANNED BEHAV; AJZEN I, CONSTRUCTION THEORY; Ajzen I., 1988, ATTITUDES PERSONALIT; Ajzen I, 2007, PREDICTION CHANGE HL; Armitage CJ, 1999, J APPL SOC PSYCHOL, V29, P72, DOI 10.1111/j.1559-1816.1999.tb01375.x; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Conatser P, 2002, ADAPT PHYS ACT Q, V19, P172, DOI 10.1123/apaq.19.2.172; Conatser P, 2009, J ATHL TRAINING, V44, P279, DOI 10.4085/1062-6050-44.3.279; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Darker CD, 2010, PSYCHOL HEALTH, V25, P71, DOI 10.1080/08870440902893716; Dunn J. G. H., 1999, MEASUREMENT PHYS ED, V3, P15, DOI [10.1207/s15327841mpee0301_2, DOI 10.1207/S15327841MPEE0301_2]; Ferrara Michael S., 2001, J Athl Train, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fishbeinand M., 1987, HLTH ED RES, V2, P361, DOI [DOI 10.1093/HER/2.4.361, 10.1093/her/2.4.361]; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hales D, 2010, AM J HEALTH BEHAV, V34, P387; Hendrix AE, 2000, J ATHL TRAINING, V35, P139; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mazerolle SM, 2011, J ATHL TRAINING, V46, P194, DOI 10.4085/1062-6050-46.2.194; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Rigby J, 2011, J ATHL TRAIN S, V46, pS63; Scheid D., 2011, NATA NEWS        MAR, P10; Walter JM, 2009, J ATHL TRAINING, V44, P190, DOI 10.4085/1062-6050-44.2.190	32	16	16	0	17	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2013	48	5					636	644		10.4085/1062-6050-48.3.10			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	268AR	WOS:000328140600007	23848518	Green Published			2022-02-06	
J	Takayanagi, Y; Gerner, G; Takayanagi, M; Rao, V; Vannorsdall, TD; Sawa, A; Schretlen, DJ; Cascella, NG				Takayanagi, Yoichiro; Gerner, Gwendoly; Takayanagi, Mizuho; Rao, Vani; Vannorsdall, Tracy D.; Sawa, Akira; Schretlen, David J.; Cascella, Nicola G.			Hippocampal Volume Reduction Correlates With Apathy in Traumatic Brain Injury, But Not Schizophrenia	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							NEGATIVE-SYMPTOMS; TEMPORAL-LOBE; WHITE-MATTER; HEAD-INJURY; DEFICIT SCHIZOPHRENIA; ATROPHY; ABNORMALITIES; DISEASE; REGIONS; STROKE	Apathy commonly accompanies both traumatic brain injury (TBI) and deficit syndrome schizophrenia (DSZ), despite unclear neurological bases. The authors examined differences in cortical thickness and subcortical/cerebellar regional volumes between adult TBI survivors, patients with DSZ, and healthy-control subjects by use of 3-D magnetic resonance imaging (MRI), and correlated imaging findings with clinical ratings of apathy and selected cognitive test scores. Imaging findings revealed specific areas of volume reduction in TBI survivors and areas of cortical thinning among patients with DSZ. The severity of apathy symptoms was similar across patient groups; however, severity of apathy was only correlated with imaging findings in TBI survivors.	[Cascella, Nicola G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA		Cascella, NG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA.	dschret@jhmi.edu; ncascel1@gmail.com			NARSADNARSAD; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH060504, R01 MH077852, P50 MH094268, R01 MH078175, R33 MH079017]; Stanley Foundation; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH078175, P50MH094268, R01MH060504, R01MH077852, R33MH079017] Funding Source: NIH RePORTER	This study was supported by a NARSAD Young Investigator Award (to Dr. Cascella) and NIH grants R01 MH060504 and R01 MH077852 (to Dr. Schretlen); P50 MH094268 (to Dr. Sawa); R01 MH078175 and R33 MH079017 (to Dr. Cascella); and a grant from the Stanley Foundation (to Dr. Cascella).	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arango C, 2004, EUR PSYCHIAT, V19, P21, DOI 10.1016/j.eurpsy.2003.10.004; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578; Cascella NG, 2008, J PSYCHIATR RES, V42, P930, DOI 10.1016/j.jpsychires.2007.10.002; Cascella NG, 2010, SCHIZOPHR RES, V120, P63, DOI 10.1016/j.schres.2010.03.039; Clarke DE, 2011, J PSYCHOSOM RES, V70, P73, DOI 10.1016/j.jpsychores.2010.01.012; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Hampshire A, 2012, NEUROIMAGE, V59, P4102, DOI 10.1016/j.neuroimage.2011.10.072; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; LIDDLE PF, 1991, BRIT J PSYCHIAT, V158, P340, DOI 10.1192/bjp.158.3.340; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; MATSUSHITA M, 1981, ACTA NEUROPATHOL, V54, P89, DOI 10.1007/BF00689400; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Roth RM, 2004, AM J PSYCHIAT, V161, P157, DOI 10.1176/appi.ajp.161.1.157; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Schrag A, 2004, J NEUROL, V251, P795, DOI 10.1007/s00415-004-0483-3; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STOLAR N, 1994, BIOL PSYCHIAT, V35, P164, DOI 10.1016/0006-3223(94)91148-7; Stuss DT, 2000, NEUROPSYCHOLOGY EMOT; Szabo K, 2009, STROKE, V40, P2042, DOI 10.1161/STROKEAHA.108.536144; Takayanagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021047; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; TURETSKY B, 1995, ARCH GEN PSYCHIAT, V52, P1061; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; WING JK, 1996, SCHEDULES CLIN ASSES	44	16	16	0	6	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2013	25	4					292	301		10.1176/appi.neuropsych.12040093			10	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	286TN	WOS:000329491700037	24247856				2022-02-06	
J	Espinosa-Garcia, C; Vigueras-Villasenor, RM; Rojas-Castaneda, JC; Aguilar-Hernandez, A; Monfil, T; Cervantes, M; Morali, G				Espinosa-Garcia, Claudia; Maria Vigueras-Villasenor, Rosa; Cesar Rojas-Castaneda, Julio; Aguilar-Hernandez, Alejandra; Monfil, Tomas; Cervantes, Miguel; Morali, Gabriela			Post-ischemic administration of progesterone reduces caspase-3 activation and DNA fragmentation in the hippocampus following global cerebral ischemia	NEUROSCIENCE LETTERS			English	Article						Global cerebral ischemia; Progesterone; Neuroprotection; Caspase-3; DNA fragmentation	DELAYED NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; NEUROPROTECTIVE FACTOR; FOREBRAIN ISCHEMIA; CYTOCHROME-C; CA1 NEURONS; CELL-DEATH; RATS; DAMAGE; MODEL	Delayed death of hippocampal CA1 pyramidal neurons following global cerebral ischemia/reperfusion may be mediated, in part, by caspase-3 activation resulting in DNA fragmentation. Progesterone (P-4) is known to exert neuroprotective effects in several models of brain injury. This study was designed to assess the effect of P-4 on caspase-3 levels and activation, and DNA fragmentation in the hippocampus following global cerebral ischemia/reperfusion. Adult male Sprague-Dawley rats were subjected to global ischemia by the four-vessel occlusion model. P-4 (8 mg/kg), or its vehicle were administered i.v. at 15 min, 2, 6, 24, 48 and 70 h of reperfusion. Remaining pyramidal neurons were assesed by the Nissl staining technique, caspase-3 levels and activation by immunohistochemistiy and an in situ activity assay, and DNA fragmentation by the TUNEL method. Post-ischemic progesterone treatment significantly reduced the ischemia/reperfusion-induced increase in caspase-3 levels and activation at 72 h, and DNA fragmentation and CA1 neuronal loss at 7 days. Present results suggest the reduction of caspase-3 levels/activation, and DNA fragmentation, as a part of the neuroprotective effects of progesterone against global cerebral ischemia/reperfusion injury. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Espinosa-Garcia, Claudia; Aguilar-Hernandez, Alejandra; Monfil, Tomas; Morali, Gabriela] CMN Siglo XXI, Unidad Invest Med Farmacol, Mexico City, DF, Mexico; [Maria Vigueras-Villasenor, Rosa; Cesar Rojas-Castaneda, Julio] Inst Nacl Pediat Mexico, Subdirecc Med Expt, Mexico City, DF, Mexico; [Cervantes, Miguel] UMSNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico		Morali, G (corresponding author), IMSS, Ctr Medico Nacl Siglo XXI, Unidad Invest Med Farmacol, Eugenia 626 Girasol 302, Mexico City 03100, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Espinosa-Garcia, Claudia/0000-0002-9909-9092	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/G11-2/1029, 2010020]; Secretaria de Educacion Publica [PROMEP/103.5/0914106]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [229241]	This paper constitutes a partial fulfillment of the requirements for the Ph.D. of CEG at the PDCB, UNAM. This study was partially supported by Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G11-2/1029, and CEG fellowship 2010020); Secretaria de Educacion Publica (PROMEP/103.5/0914106); and CONACYT (CEG fellowship 229241). Authors thank Mr. Pedro Medina and Ms. Patricia Quintanar for their skillful technical assistance.	Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen J, 1998, J NEUROSCI, V18, P4914; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gillardon F, 1997, MOL BRAIN RES, V50, P16, DOI 10.1016/S0169-328X(97)00162-9; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Karanjia N, 2011, CURR TREAT OPTION NE, V13, P191, DOI 10.1007/s11940-011-0112-2; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Morali G, 2012, RESTOR NEUROL NEUROS, V30, P1, DOI 10.3233/RNN-2011-0605; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Petito CK, 1997, J CEREBR BLOOD F MET, V17, P967, DOI 10.1097/00004647-199709000-00006; PULSINELLI WA, 1988, STROKE, V19, P913, DOI 10.1161/01.STR.19.7.913; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rami A, 2003, NEUROCHEM INT, V43, P211, DOI 10.1016/S0197-0186(03)00002-0; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Tanaka H, 2004, J NEUROSCI, V24, P2750, DOI 10.1523/JNEUROSCI.5475-03.2004; Teschendorf P, 2008, NEUROSCI LETT, V448, P194, DOI 10.1016/j.neulet.2008.10.030; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhan RZ, 2001, J CEREBR BLOOD F MET, V21, P529, DOI 10.1097/00004647-200105000-00007	31	16	17	1	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	AUG 29	2013	550						98	103		10.1016/j.neulet.2013.06.023			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	210RE	WOS:000323851400019	23810799				2022-02-06	
J	Arentsen, TJ; Boone, KB; Lo, TTY; Goldberg, HE; Cottingham, ME; Victor, TL; Ziegler, E; Zeller, MA				Arentsen, Timothy J.; Boone, Kyle Brauer; Lo, Tracy T. Y.; Goldberg, Hope E.; Cottingham, Maria E.; Victor, Tara L.; Ziegler, Elizabeth; Zeller, Michelle A.			Effectiveness of the Comalli Stroop Test as a Measure of Negative Response Bias	CLINICAL NEUROPSYCHOLOGIST			English	Article						Stroop; Malingering; Symptom validity testing; Forensic neuropsychology	RECOGNITION TRIAL; HEAD-INJURY; SENSITIVITY; SCORES; SPECIFICITY; PERFORMANCE; DYSFUNCTION; IQ	Practice guidelines recommend the use of multiple performance validity tests (PVTs) to detect noncredible performance during neuropsychological evaluations, and PVTs embedded in standard cognitive tests achieve this goal most efficiently. The present study examined the utility of the Comalli version of the Stroop Test as a measure of response bias in a large sample of real world noncredible patients (n = 129) as compared with credible neuropsychology clinic patients (n=233). The credible group performed significantly better than the noncredible group on all trials, but particularly on word-reading (Stroop A) and color-naming (Stroop B); cut-scores for Stroop A and Stroop B trials were associated with moderate sensitivity (49-53%) as compared to the low sensitivity found for the color interference trial (29%). Some types of diagnoses (including learning disability, severe traumatic brain injury, psychosis, and depression), very advanced age (80), and lowered IQ were associated with increased rates of false positive identifications, suggesting the need for some adjustments to cut-offs in these subgroups. Despite some previous reports of an inverted Stroop effect (i.e., color-naming worse than color interference) in noncredible subjects, individual Stroop word reading and color naming trials were much more effective in identifying response bias.	[Arentsen, Timothy J.] Fuller Grad Sch Psychol, Pasadena, CA USA; [Boone, Kyle Brauer] Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA USA; [Lo, Tracy T. Y.] City Hope Med Ctr, Duarte, CA USA; [Goldberg, Hope E.] Olive View UCLA Med Ctr, Sylmar, CA 91342 USA; [Victor, Tara L.] Calif State Univ Dominguez Hills, Carson, CA 90747 USA; [Ziegler, Elizabeth] VA Med Ctr Spokane, Spokane, WA USA; [Zeller, Michelle A.] West Los Angeles VA, Los Angeles, CA USA		Arentsen, TJ (corresponding author), Fuller Grad Sch Psychol, 135 N Oakland Ave, Pasadena, CA USA.	TimArentsen@fuller.edu	Victor, Tara/K-6581-2019				Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Boone K., 2002, DOT COUNTING TEST; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K. B., 2002, B TEST; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Buckley TC, 2003, J TRAUMA STRESS, V16, P59, DOI 10.1023/A:1022063412056; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cannon BJ, 2003, PERCEPT MOTOR SKILL, V96, P827, DOI 10.2466/PMS.96.3.827-834; Chafetz MD, 2004, ARCH CLIN NEUROPSYCH, V19, P555, DOI 10.1016/j.acn.2003.08.004; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Giger P, 2010, J FORENSIC PSYCHOL P, V10, P440, DOI 10.1080/15228932.2010.489875; Golden CJ, 1978, STROOP COLOR WORD TE; Golden ZL, 2002, PSYCHOL SCHOOLS, V39, P489, DOI 10.1002/pits.10047; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lu PH, 2004, J CLIN EXP NEUROPSYC, V26, P180, DOI 10.1076/jcen.26.2.180.28082; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Rosselli M, 2002, J INT NEUROPSYCH SOC, V8, P819, DOI 10.1017/S1355617702860106; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet J.J., 2007, ASSESSMENT FEIGNED C; Thomas TA, 2009, J FORENSIC PSYCHI PS, V20, P936, DOI 10.1080/14789940903174162; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Willcutt EG, 2001, J ABNORM PSYCHOL, V110, P157, DOI 10.1037//0021-843X.1001.1.157	45	16	16	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG 1	2013	27	6					1060	1076		10.1080/13854046.2013.803603			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	197RA	WOS:000322867100011	23742292				2022-02-06	
J	Austin, CA; Slomine, BS; DeMatt, EJ; Salorio, CF; Suskauer, SJ				Austin, Cynthia A.; Slomine, Beth S.; DeMatt, Ellen J.; Salorio, Cynthia F.; Suskauer, Stacy J.			Time to follow commands remains the most useful injury severity variable for predicting WeeFIM (R) scores 1 year after paediatric TBI	BRAIN INJURY			English	Article						Child; coma; outcome; PTA; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC AMNESIA DURATION; CLOSED-HEAD INJURY; FUNCTIONAL INDEPENDENCE; PRACTICAL SCALE; CHILDREN; REHABILITATION; RECOVERY; MULTICENTER; ORIENTATION	Objective: To investigate the relationship between injury severity variables, particularly time to follow commands (TFC) and long-term functional outcomes in paediatric traumatic brain injury (TBI). Methods and procedure: Participants included 40 children with moderate-to-severe TBI discharged from inpatient rehabilitation. Measures of severity were initial Glasgow Coma Scale score, TFC, duration of Post Traumatic Amnesia (PTA) and total duration of impaired consciousness (TFC + PTA). Functional outcome was measured by age-corrected Functional Independence Measure for Children (WeeFIM (R)) scores at 1-year after discharge. Results: Correlations indicated that injury severity variables (TFC, PTA and TFC + PTA) were all associated with functional outcome. Regression analyses revealed that TFC and TFC + PTA similarly accounted for 49% or 47% of the variance, respectively, in total WeeFIM (R) score. Thirty-seven of 40 children had good outcome; of the three children with TFC>26 days, two had poor outcome. Conclusion: PTA and TFC + PTA do not provide a benefit over TFC alone for prediction of long-term outcome and TFC is identified earlier in the recovery course. TFC remains an important predictor of functional outcome 1-year after discharge from inpatient rehabilitation after paediatric TBI.	[Austin, Cynthia A.; Slomine, Beth S.; DeMatt, Ellen J.; Salorio, Cynthia F.; Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Slomine, Beth S.; Salorio, Cynthia F.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Slomine, Beth S.; Salorio, Cynthia F.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 707 North Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org	Austin, Cynthia/AAM-2814-2021		National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611] Funding Source: NIH RePORTER	This work was supported by grant funding from the National Institute of Child Health and Human Development (K23HD061611).	Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cohen J., 2013, STAT POWER ANAL BEHA; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Howard M, 1986, MEMORY ORIENTATION A; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Kane RL, 1997, UNDERSTANDING HLTH C, P233; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith T.Z., 2006, MULTIPLE REGRESSION; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Kramer ME, 2012, J HEAD TRAUMA REHABI; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Poon WS, 2005, ACT NEUR S, V93, P207; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sanders JO, 2006, J PEDIATR ORTHOPED, V26, P542, DOI 10.1097/01.bpo.0000226272.78330.bb; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Serghiou MH, 2008, DEV NEUROREHABIL, V11, P39, DOI 10.1080/17518420701520644; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TEASDALE G, 1974, LANCET, V2, P81; Uniform Data System for Medical Rehabilitation, 2006, WEEFIM 2 CLIN GUID V; Uniform Data System for Medical Rehabilitation, 2009, FIM SYST CLIN GUID V; WAGSTYL J, 1987, J PEDIATR SURG, V22, P127, DOI 10.1016/S0022-3468(87)80427-X; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91	41	16	17	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1056	1062		10.3109/02699052.2013.794964			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100010	23781827	Green Accepted			2022-02-06	
J	Zakzanis, KK; McDonald, K; Troyer, AK				Zakzanis, Konstantine K.; McDonald, Krysta; Troyer, Angela K.			Component analysis of verbal fluency scores in severe traumatic brain injury	BRAIN INJURY			English	Article						Component analysis scores; neuropsychology; severe traumatic brain injury; verbal fluency	LONGITUDINAL ANALYSIS; FOLLOW-UP; MODERATE; PERFORMANCE; MEMORY; TBI; REHABILITATION; IMPAIRMENTS; RETURN	Primary objective: This study set out to examine the sensitivity of verbal fluency component scores in severe traumatic brain injury (TBI). Research design: A retrospective cross-sectional design was used, with control participants chosen at random from the community and TBI patients from litigation cases. Methods and procedures: Fifty-four healthy controls and 28 patients who had incurred a severe TBI were included in the study. The Controlled Oral Word Association test was rescored to include clustering and switching scores for phonemic and semantic fluency separately. The scores were compared between controls and TBI patients using independent samples t-tests. Main outcomes and results: The findings demonstrate that component scores for semantic fluency yielded the largest effect sizes overall (d = 1.32 and d = 1.53), but not phonemic fluency. Total words generated in phonemic fluency yielded the largest effect size, although still modest (d = 0.62). Conclusions: While verbal fluency may be a useful test tool to elicit evidence of neuropsychological impairment after TBI, these findings are consistent with previous research demonstrating that component scores are more sensitive indices. There is potential clinical utility in using component scores for examining the specific severity of verbal fluency impairment in TBI and guiding rehabilitation efforts.	[Zakzanis, Konstantine K.; McDonald, Krysta] Univ Toronto Scarborough, Dept Psychol, Toronto, ON M1C 1A4, Canada; [Troyer, Angela K.] Univ Toronto, Baycrest Neuropsychol & Cognit Hlth Program, Toronto, ON, Canada; [Troyer, Angela K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada		Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca		Troyer, Angela K./0000-0001-5660-4127			Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Cohen J., 2013, STAT POWER ANAL BEHA; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; ESTES WK, 1974, AM PSYCHOL, V29, P740, DOI 10.1037/h0037458; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Ho AK, 2002, NEUROPSYCHOLOGIA, V40, P1277, DOI 10.1016/S0028-3932(01)00217-2; Jurado MA, 2000, BRAIN INJURY, V14, P789; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V4th ed, P1016; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Moore DJ, 2006, SCHIZOPHR RES, V87, P254, DOI 10.1016/j.schres.2006.06.005; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rich JB, 1999, NEUROPSYCHOLOGY, V13, P525, DOI 10.1037/0894-4105.13.4.525; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Slick D., 1997, VSVT VICTORIA SYMPTO; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P419, DOI 10.1076/jcen.20.3.419.821; Zakzanis KK, 2000, NEUROPSY NEUROPSY BE, V13, P239; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	49	16	16	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					903	908		10.3109/02699052.2013.775505			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200018	23758471				2022-02-06	
J	Okahashi, S; Seki, K; Nagano, A; Luo, ZW; Kojima, M; Futaki, T				Okahashi, Sayaka; Seki, Keiko; Nagano, Akinori; Luo, Zhiwei; Kojima, Maki; Futaki, Toshiko			A virtual shopping test for realistic assessment of cognitive function	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Virtual reality; Cognitive function; Realistic assessment; Development; Brain injury	SIMULATED NATURALISTIC ENVIRONMENT; CONTINUOUS PERFORMANCE-TEST; TRAUMATIC BRAIN-INJURY; PROSPECTIVE MEMORY; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTION; REALITY; REHABILITATION; DISTRACTION; RELIABILITY	Background: Cognitive dysfunction caused by brain injury often prevents a patient from achieving a healthy and high quality of life. By now, each cognitive function is assessed precisely by neuropsychological tests. However, it is also important to provide an overall assessment of the patients' ability in their everyday life. We have developed a Virtual Shopping Test (VST) using virtual reality technology. The objective of this study was to clarify 1) the significance of VST by comparing VST with other conventional tests, 2) the applicability of VST to brain-damaged patients, and 3) the performance of VST in relation to age differences. Methods: The participants included 10 patients with brain damage, 10 age-matched healthy subjects for controls, 10 old healthy subjects, and 10 young healthy subjects. VST and neuropsychological tests/questionnaires about attention, memory and executive function were conducted on the patients, while VST and the Mini-Mental State Examination (MMSE) were conducted on the controls and healthy subjects. Within the VST, the participants were asked to buy four items in the virtual shopping mall quickly in a rational way. The score for evaluation included the number of items bought correctly, the number of times to refer to hints, the number of movements between shops, and the total time spent to complete the shopping. Results: Some variables on VST correlated with the scores of conventional assessment about attention and everyday memory. The mean number of times referring to hints and the mean number of movements were significantly larger for the patients with brain damage, and the mean total time was significantly longer for the patients than for the controls. In addition, the mean total time was significantly longer for the old than for the young. Conclusions: The results suggest that VST is able to evaluate the ability of attention and everyday memory in patients with brain damage. The time of VST is increased by age.	[Okahashi, Sayaka; Futaki, Toshiko] Kyoto Univ, Div Occupat Therapy, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Okahashi, Sayaka; Nagano, Akinori; Luo, Zhiwei] Kobe Univ, Dept Computat Sci, Grad Sch Syst Informat, Kobe, Hyogo 657, Japan; [Seki, Keiko] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Kobe, Hyogo 657, Japan; [Kojima, Maki] Nishiyamato Rehabil Hosp, Dept Rehabil Med, Nara, Japan		Okahashi, S (corresponding author), Kyoto Univ, Div Occupat Therapy, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan.	okahashi.sayaka.7c@kyoto-u.ac.jp	Kojima, Maki/V-9473-2019	Okahashi, Sayaka/0000-0001-9200-0259	KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21240019, 23800029]	The authors would like to thank all the volunteers, and especially those patients who participated in this study. Furthermore, we are grateful to Rumi Tanemura, PhD OT, Ho Kenneth Hung Lit, PhD, Motomi Toichi, PhD MD, Hiromi Sakai, PhD OT, Yuki Yamanaka, MSc, Tatsuo Oshiumi, MSc, Shin-ichi Nagai, MSc, Tomoko Tanaka, MSc OT, Hiromi Endo, MSc OT, Masumi Sawa, MSc SLP. This research was supported by KAKENHI; Grant-in-Aid for Scientific Research (A) (21240019) and Grant-in-Aid for Research Activity Start-up (23800029).	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Clark JM, 2004, BEHAV RES METH INS C, V36, P371, DOI 10.3758/BF03195584; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Ishiai S., 1999, BEHAV INATTENTION TE; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Kazui H, 2006, J GERIATR PSYCH NEUR, V19, P3, DOI 10.1177/0891988705277543; Kazui Hiroaki, 2003, No To Shinkei, V55, P317; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2008, INT PSYCHOGERIATR, V20, P124, DOI 10.1017/S1041610207005923; Kondo T., 2000, LEXICAL PROPERTIES J; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Mani TM, 2005, ARCH CLIN NEUROPSYCH, V20, P575, DOI 10.1016/j.acn.2004.12.008; Morganti F, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-26; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith A., 1982, SYMBOL DIGIT MODALIT; Titov N, 2000, BRAIN INJURY, V14, P877; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; Vincelli F, 2001, STUD HEALTH TECHNOL, V81, P551; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, J GERIATR PSYCH NEUR; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	38	16	18	0	23	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	JUN 18	2013	10								59	10.1186/1743-0003-10-59			13	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	171JP	WOS:000320923100001	23777412	Green Published, gold			2022-02-06	
J	Deye, KP; Berger, RP; Lindberg, DM				Deye, Katherine P.; Berger, Rachel P.; Lindberg, Daniel M.		ExSTRA Investigators	Occult abusive injuries in infants with apparently isolated skull fractures	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Skull fracture; child abuse; skeletal survey	SUSPECTED PHYSICAL ABUSE; TRAUMATIC BRAIN-INJURY; CHILD-ABUSE; SKELETAL SURVEYS; HEAD TRAUMA; PREVALENCE; EVALUATE; YIELD	BACKGROUND: There is currently no consensus about which screening studies should be undertaken to identify abusive injuries in infants with apparently isolated skull fractures. Our objective was to determine rates of screening, rates of injury identification, and rates of reporting to child protective services among infants who underwent subspecialty evaluation for abuse after presenting with an apparently isolated skull fracture. METHODS: This was a retrospectively planned, secondary analysis of index children enrolled in a large network of children with concerns for physical abuse. For this analysis, we included infants (<12 months) who presented with signs and symptoms attributable to a skull fracture. We determined rates of skeletal survey, dedicated ophthalmologic examination and abdominal injury screening, rates of injury identification by testing and reports to child protective services. RESULTS: A total of 215 infants underwent abuse consultation for apparently isolated skull fractures. Skeletal surveys were performed in 201 subjects (93.4%) and identified additional fractures in 12 (5.6%; 95% confidence interval, 2.9-9.6%). Patient age, trauma history, and fracture type (simple/complex) were not sensitive predictors of finding additional fractures on skeletal survey. Only one additional fracture was associated with clinical signs or symptoms. Dedicated ophthalmologic examination was undertaken in 100 subjects (46.5%); one child had retinal hemorrhages. Hepatic transaminases were obtained in 135 subjects (62.7%), and 5 subjects (2.3%) had abdominal computed tomography. No abdominal injuries were identified. A total of 146 subjects (67.9%) were reported to child protective services. CONCLUSION: Infants with apparently isolated skull fractures are an important fraction of consultations for physical abuse. Additional fractures are identified in a small subset of the skeletal surveys completed in these children. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Deye, Katherine P.] George Washington Univ, Sch Med & Hlth Sci, Childrens Natl Med Ctr, Freddie Mac Fdn,Child & Adolescent Protect Ctr, Washington, DC 20052 USA; [Berger, Rachel P.] Univ Pittsburgh, Dept Pediat, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Lindberg, Daniel M.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Lindberg, Daniel M.] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA		Lindberg, DM (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St,Neville House, Boston, MA 02115 USA.	dlindberg@partners.org			Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program [H34MC19346-01-02]; Eleanor and Miles Shore Fellowship for Scholars in Medicine from Harvard Medical School	This project was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program (H34MC19346-01-02). D.M.L.'s effort is funded in part by an Eleanor and Miles Shore Fellowship for Scholars in Medicine from Harvard Medical School. D. M. L. has provided paid expert testimony for prosecution and defense in cases of alleged child physical abuse. K. P. D. and R. P. B. declare that they have no conflicts of interest.	ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; [Anonymous], 2012, CHILD MALTR 2011; Bennett BL, 2011, PEDIATR EMERG CARE, V27, P941, DOI 10.1097/PEC.0b013e3182307afe; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Drubach LA, 2010, RADIOLOGY, V255, P173, DOI 10.1148/radiol.09091368; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Dupuis O, 2005, AM J OBSTET GYNECOL, V192, P165, DOI 10.1016/j.ajog.2004.06.035; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Karmazyn B, 2011, AM J ROENTGENOL, V197, pW159, DOI 10.2214/AJR.10.5733; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Lane WG, 2009, PEDIATRICS, V124, P1595, DOI 10.1542/peds.2009-0904; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; Laskey AL, 2013, J PEDIATR-US, V162, P86, DOI 10.1016/j.jpeds.2012.06.038; Leventhal JM, 2012, PEDIATRICS, V130, P847, DOI 10.1542/peds.2012-0922; Levi BH, 2005, PEDIATRICS, V116, pE5, DOI 10.1542/peds.2004-2649; Levin AV, 2010, PEDIATRICS, V126, P376, DOI 10.1542/peds.2010-1397; Lindberg D, 2009, PEDIATRICS, V124, P509, DOI 10.1542/peds.2008-2348; Lindberg DM, 2012, PEDIATRICS, V130, P193, DOI 10.1542/peds.2012-0085; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Oral R, 2011, PEDIATR EMERG CARE, V27, P490, DOI 10.1097/PEC.0b013e31821d860f; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Ravichandiran N, 2010, PEDIATRICS, V125, P60, DOI 10.1542/peds.2008-3794; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Sege RD, 2008, ARCH DIS CHILD, V93, P822, DOI 10.1136/adc.2006.100545; Thackeray JD, 2010, PEDIATRICS, V125, pE1066, DOI 10.1542/peds.2009-2184; Thackeray JD, 2007, PEDIATR EMERG CARE, V23, P735, DOI 10.1097/PEC.0b013e3181568039; Wood JN, 2012, PEDIATRICS, V130, pE358, DOI 10.1542/peds.2011-3755; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; WORLOCK P, 1986, BRIT MED J, V293, P100, DOI 10.1136/bmj.293.6539.100	34	16	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2013	74	6					1553	1558		10.1097/TA.0b013e31828b7fc4			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AB4DO	WOS:000331739800026	23694887				2022-02-06	
J	Billiard, M; Podesta, C				Billiard, Michel; Podesta, Claudio			Recurrent hypersomnia following traumatic brain injury	SLEEP MEDICINE			English	Article						Recurrent hypersomnia; Traumatic brain injury; Post-traumatic recurrent hypersomnia; Kleine-Levin syndrome	KLEINE-LEVIN-SYNDROME; HEAD TRAUMA; GIRL	Background: Recurrent hypersomnia (RH) following a traumatic brain injury (TBI) is a rare form of RH. According to the International Classification of Sleep Disorders, 2nd edition (ICSD-2), RH must be considered in the differential diagnosis as secondary to an organic insult of the central nervous system and not as the clinical subtype of RH, Kleine-Levin syndrome (KLS). The aim of our study was to investigate if cases of RH following TBI should be considered in the differential diagnosis of RH as indicated by the International Classification of Sleep Disorders, 2nd edition or as genuine, or indicated by ICSD-2, RH must cases of KLS. Methods: Twelve cases of RH developed after TBI were collected and analyzed for circumstance at onset, severity of TBI, delay between TBI and occurrence of first episode of RH, symptoms of RH, duration and cycle length of episodes of hypersomnia, physical signs, and brain morphological imaging at the time of hypersomnia episodes. Results: Factors such as the delay between TBI and the first episode of RH, the presence of other triggering factors and potential genetic factors, the degree of the severity of TBI, the presence or absence of any consistent brain imaging abnormality, provided the following results: (1) two of the cases could be considered as symptomatic of the underlying pathological brain process, (2) eight of the cases could be considered as simply triggered by TBI in patients at risk for KLS, and (3) two cases could be considered neither symptomatic nor triggered by TBI, due to the long delay between TBI and occurrence of symptoms. Conclusion: Cases of RH following TBI do not present under a single mechanism. Clinical assessment and laboratory tests are necessary to correctly classify them. (c) 2013 Published by Elsevier B.V.	[Billiard, Michel] Gui de Chauliac Hosp, Dept Neurol, F-34090 Montpellier, France; [Podesta, Claudio] FLENI, Dept Neurol, Sleep Lab, Buenos Aires, DF, Argentina		Billiard, M (corresponding author), Gui de Chauliac Hosp, Dept Neurol, 70 Allee James Anderson, F-34090 Montpellier, France.	mbilliard@wanadoo.fr					American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Arnulf I, 2012, LANCET NEUROL, V11, P918, DOI 10.1016/S1474-4422(12)70187-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Billiard M, 2011, SLEEP MED REV, V15, P247, DOI 10.1016/j.smrv.2010.08.001; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cheung G, 2006, GEN HOSP PSYCHIAT, V28, P443, DOI 10.1016/j.genhosppsych.2006.03.011; CHIU HFK, 1989, AUST NZ J PSYCHIAT, V23, P425, DOI 10.3109/00048678909068302; Critchley M, 1962, BRAIN, V85, P41; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Janicki S, 2001, PSYCHOSOMATICS, V42, P350, DOI 10.1176/appi.psy.42.4.350; Kostic VS, 1998, BEHAV NEUROL, V11, P105, DOI 10.1155/1998/413989; Nose I, 2002, PSYCHIAT CLIN NEUROS, V56, P277, DOI 10.1046/j.1440-1819.2002.00979.x; Pelin Z, 2004, EUR PSYCHIAT, V19, P521, DOI 10.1016/j.eurpsy.2004.06.005; Podesta C, 2006, SLEEP MED, V7, P649, DOI 10.1016/j.sleep.2006.07.003; Ramnath B, 2008, INDIAN PEDIATR, V45, P1007; Smolik P, 1988, ACTA U CAROLINAE PRA, VXXXVIII; WILL RG, 1988, BRIT J PSYCHIAT, V152, P410, DOI 10.1192/bjp.152.3.410	18	16	16	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457			SLEEP MED	Sleep Med.	MAY	2013	14	5					462	465		10.1016/j.sleep.2013.01.009			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	139VC	WOS:000318612100013	23499199				2022-02-06	
J	Huston, JM; Field, AS				Huston, Jason M.; Field, Aaron S.			Clinical Applications of Diffusion Tensor Imaging	MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA			English	Article						Diffusion tensor imaging; Tractography; Tissue characterization; Lesion localization; Tract mapping; Preoperative planning; Image guided therapy	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; APPEARING WHITE-MATTER; SPINAL-CORD-INJURY; WATER DIFFUSION; FRACTIONAL ANISOTROPY; ALZHEIMERS-DISEASE; FIBER TRACTOGRAPHY; CORPUS-CALLOSUM; MULTIPLE-SCLEROSIS	The potential utility of diffusion tensor (DT) imaging in clinical practice is broad, and new applications continue to evolve as technology advances:Clinical applications of DT imaging and tractography include tissue characterization, lesion localization, and mapping of white matter tracts. DT imaging metrics are sensitive to microstructural changes associated with central nervous system disease; however, further research is needed to enhance specificity so as to facilitate more widespread clinical application. Preoperative tract mapping, with either directionally encoded color maps or tractography, provides useful information to the neurosurgeon and has been shown to improve clinical outcomes.	[Huston, Jason M.; Field, Aaron S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Madison, WI 53792 USA		Field, AS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, 600 Highland Ave,M-C 3252, Madison, WI 53792 USA.	AField@uwhealth.org					Akpinar E, 2007, J COMPUT ASSIST TOMO, V31, P657, DOI 10.1097/RCT.0b013e318033df1a; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Assaf BA, 2003, AM J NEURORADIOL, V24, P1857; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Barkovich A., 2011, PEDIAT NEUROIMAGING, V5, P20; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Bastin ME, 2000, NEUROREPORT, V11, P2867, DOI 10.1097/00001756-200009110-00008; Bastin ME, 2002, NEUROREPORT, V13, P1335, DOI 10.1097/00001756-200207190-00024; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Bozzali M, 2007, MAGN RESON IMAGING, V25, P969, DOI 10.1016/j.mri.2007.03.017; Bozzali M, 2012, HUM BRAIN MAPP, V33, P1295, DOI 10.1002/hbm.21287; Briganti C, 2012, EPILEPSY RES, V98, P251, DOI 10.1016/j.eplepsyres.2011.09.001; Brown R., 1828, EDINBURGH N PHIL J, V4, P358; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Castillo M, 2001, AM J NEURORADIOL, V22, P60; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chen ZQ, 2008, NEUROL RES, V30, P720, DOI 10.1179/174313208X297968; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Davis DP, 2006, J EMERG MED, V31, P269, DOI 10.1016/j.jemermed.2005.10.003; Dombovy Mary L, 2011, Continuum (Minneap Minn), V17, P584, DOI 10.1212/01.CON.0000399074.07686.76; Ducreux D, 2006, AM J NEURORADIOL, V27, P214; Einstein A., 1956, INVESTIGATIONS THEOR, P17; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Field AS, 2004, J MAGN RESON IMAGING, V20, P555, DOI 10.1002/jmri.20169; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Fischer FU, 2012, J MAGN RESON IMAGING, V36, P84, DOI 10.1002/jmri.23621; Fonseca Viviane de Carvalho, 2012, Front Neurol, V3, P121, DOI 10.3389/fneur.2012.00121; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Ge YL, 2005, ANN NY ACAD SCI, V1064, P202, DOI 10.1196/annals.1340.039; Groen WB, 2011, J PSYCHIATR NEUROSCI, V36, P32, DOI 10.1503/jpn.090100; Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x; Hagmann P., 2004, INT S MAGN RES MED I, V12, P623; Hesseltine SM, 2006, AM J NEURORADIOL, V27, P1189; Holodny AI, 2005, RADIOLOGY, V234, P649, DOI 10.1148/radiol.2343032087; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Hughes JR, 2009, EPILEPSY BEHAV, V16, P569, DOI 10.1016/j.yebeh.2009.09.023; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Huppi PS, 2002, CLIN PERINATOL, V29, P827, DOI 10.1016/S0095-5108(02)00049-0; Cruz LCH, 2009, ARQ NEURO-PSIQUIAT, V67, P391, DOI 10.1590/S0004-282X2009000300004; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Knopman DS, 2003, MAYO CLIN PROC, V78, P1290, DOI 10.4065/78.10.1290; Konishi J, 2005, NEUROLOGY, V64, P108, DOI 10.1212/01.WNL.0000148477.65273.0C; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Langen M, 2012, CORTEX, V48, P183, DOI 10.1016/j.cortex.2011.05.018; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JE, 2010, J NEUROL NEUROSUR PS, V81, P320, DOI 10.1136/jnnp.2009.184747; Lee SK, 2010, YONSEI MED J, V51, P590, DOI 10.3349/ymj.2010.51.4.590; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Lee SK, 2004, NEUROIMAGE, V22, P1826, DOI 10.1016/j.neuroimage.2004.04.028; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Lin X, 2005, J NEUROL SCI, V237, P13, DOI 10.1016/j.jns.2005.04.019; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Love S, 2006, J CLIN PATHOL, V59, P1151, DOI 10.1136/jcp.2005.031195; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Lu S, 2003, AM J NEURORADIOL, V24, P937; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Maier SE, 2005, ANN NY ACAD SCI, V1064, P50, DOI 10.1196/annals.1340.011; Maldjian JA, 2001, AM J NEURORADIOL, V22, P112; Maniega SM, 2004, J NEUROL NEUROSUR PS, V75, P1714, DOI 10.1136/jnnp.2003.033852; McKeith I., 2004, DIALOGUES CLIN NEURO, V6, P333, DOI DOI 10.1016/S1474-4422(03)00619-7; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Murphy ML, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-3; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Nimsky C, 2005, RADIOLOGY, V234, P218, DOI 10.1148/radiol.2341031984; Nimsky C, 2005, NEUROSURGERY, V56, P130, DOI 10.1227/01.NEU.0000144842.18771.30; Ohgiya Y, 2007, EUR RADIOL, V17, P2499, DOI 10.1007/s00330-007-0672-4; Ota M, 2009, NMR BIOMED, V22, P280, DOI 10.1002/nbm.1321; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Pipe JG, 2002, MAGNET RESON MED, V47, P42, DOI 10.1002/mrm.10014; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Poupon C, 2001, MED IMAGE ANAL, V5, P1, DOI 10.1016/S1361-8415(00)00030-X; Provenzale JM, 2004, RADIOLOGY, V232, P451, DOI 10.1148/radiol.2322030959; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Radlinska B, 2010, NEUROLOGY, V75, P1048, DOI 10.1212/WNL.0b013e3181f39aa0; Ratcliffe MR, 2011, NEUROGRAPHICS, V1, P17; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Roberts TPL, 2005, AM J NEURORADIOL, V26, P2183; Rollins N, 2005, AM J NEURORADIOL, V26, P2148; Romano A, 2009, EUR RADIOL, V19, P2798, DOI 10.1007/s00330-009-1483-6; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shanmuganathan K, 2008, AM J NEURORADIOL, V29, P655, DOI 10.3174/ajnr.A0916; Sinha S, 2002, AM J NEURORADIOL, V23, P520; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Stadnik TW, 2001, AM J NEURORADIOL, V22, P969; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Tartaglia MC, 2012, CAN J NEUROL SCI, V39, P304, DOI 10.1017/S0317167100013421; Tham MW, 2011, J AFFECT DISORDERS, V132, P26, DOI 10.1016/j.jad.2010.09.013; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Ture U, 1997, NEUROSURGERY, V40, P1226; Ulmer JL, 2004, TECHNOL CANCER RES T, V3, P567, DOI 10.1177/153303460400300606; Vargas MI, 2008, NEURORADIOLOGY, V50, P25, DOI 10.1007/s00234-007-0309-y; Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361; Wahl M, 2010, PEDIATR RADIOL, V40, P59, DOI 10.1007/s00247-009-1448-6; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wei CW, 2008, ARCH PHYS MED REHAB, V89, pS85, DOI 10.1016/j.apmr.2008.07.005; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894; Welker KM, 2012, SEMIN NEUROL, V32, P15, DOI 10.1055/s-0032-1306382; Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Whitford TJ, 2011, SCHIZOPHR RES TREAT, V2011, DOI 10.1155/2011/709523; Widjaja E, 2011, AM J NEURORADIOL, V32, P1789, DOI 10.3174/ajnr.A2801; Widjaja E, 2009, RADIOLOGY, V251, P206, DOI 10.1148/radiol.2511081092; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu JS, 2007, NEUROSURGERY, V61, P935, DOI 10.1227/01.neu.0000303189.80049.ab; Wu YC, 2004, MAGN RESON MED, V52, P1146, DOI 10.1002/mrm.20254; Xu Q, 2010, DEMENT GERIATR COGN, V30, P317, DOI 10.1159/000320491; Yamada K, 2004, J MAGN RESON IMAGING, V20, P923, DOI 10.1002/jmri.20215; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Yu CS, 2005, EUR J RADIOL, V56, P197, DOI 10.1016/j.ejrad.2005.04.010; Zuo NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037561	167	16	19	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-9689	1557-9786		MAGN RESON IMAGING C	Magn. Reson. Imaging Clin. N. Am.	MAY	2013	21	2					279	+		10.1016/j.mric.2012.12.003			21	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	161PC	WOS:000320204800006	23642554				2022-02-06	
J	Korley, FK; Morton, MJ; Hill, PM; Mundangepfupfu, T; Zhou, TT; Mohareb, AM; Rothman, RE				Korley, Frederick K.; Morton, Melinda J.; Hill, Peter M.; Mundangepfupfu, Tichaendepi; Zhou, Tingting; Mohareb, Amir M.; Rothman, Richard E.			Agreement Between Routine Emergency Department Care and Clinical Decision Support Recommended Care in Patients Evaluated for Mild Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							CT HEAD RULE; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY	Objectives Emergency department (ED) computed tomography (CT) use has increased significantly during the past decade. It has been suggested that adherence to clinical decision support (CDS) may result in a safe decrease in CT ordering. In this study, the authors quantified the percentage agreement between routine and CDS-recommended care and the anticipated consequence of strict adherence to CDS on CT use in mild traumatic brain injury (mTBI). Methods This was a prospective observational study of patients with mTBI who presented to an urban academic ED of a tertiary care hospital. Patients 18years or older, presenting within 24hours of nonpenetrating trauma to the head, from August 2010 to July 2011, were eligible for enrollment. Structured data forms were completed by trained research assistants (RAs). The primary outcome was the percentage agreement between routine head CT use and CDS-recommended head CT use. CDS examined were: the 2008 American College of Emergency Physicians [ACEP] neuroimaging, the New Orleans rule, and the Canadian head CT rule. Differences between outcome groups were assessed using the chi-square test for categorical variables and the Kruskal-Wallis rank test for continuous variables. The percentage agreement between routine practice and CDS-recommended practice was calculated. Results Of the 169 patients enrolled, 130 (76.9%) received head CT scans, and five of the 130 (3.8%) had acute traumatic intracranial findings. For all subjects, agreement between routine practice and CDS-recommended practice was 77.5, 65.7, and 78.1%, for the ACEP, Canadian, and New Orleans CDS, respectively. Strict adherence to the 2008 ACEP neuroimaging CDS would result in no statistically significant difference in head CT use (routine care, 76.9%; CDS-recommended, 82.8%; p=0.17). Strict adherence to the New Orleans CDS would result in an increase in head CT use (routine care, 76.9%; CDS-recommended, 94.1%; p<0.01). Strict adherence to the Canadian CDS would result in a decrease in head CT use (routine care, 76.9%; CDS-recommended, 56.8%; p<0.01). Conclusions There is a 60% to 80% agreement between routine and CDS-recommended head CT use. Of the three CDS systems examined, the only one that may result in a reduction in head CT use if strictly followed was the Canadian head CT CDS. Further studies are needed to examine reasons for the less than optimal agreement between routine care and care recommended by the Canadian head CT CDS. (C) 2013 by the Society for Academic Emergency Medicine	[Korley, Frederick K.; Morton, Melinda J.; Hill, Peter M.; Rothman, Richard E.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Mundangepfupfu, Tichaendepi] Lincoln Med & Mental Hlth Ctr, Bronx, NY 10451 USA; [Zhou, Tingting; Mohareb, Amir M.] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA		Korley, FK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	fkorley1@jhmi.edu		Rothman, Richard/0000-0002-1017-9505; Hamer, Melinda/0000-0002-6736-1738			Brehaut JC, 2010, MED DECIS MAKING, V30, P398, DOI 10.1177/0272989X09344747; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; Godbout BJ, 2011, EMERG RADIOL, V18, P381, DOI 10.1007/s10140-011-0966-3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Pathman DE, 1996, MED CARE, V34, P873, DOI 10.1097/00005650-199609000-00002; Raja AS, 2011, ARCH INTERN MED, V171, P260, DOI 10.1001/archinternmed.2010.520; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	21	16	16	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2013	20	5					463	469		10.1111/acem.12136			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	144GO	WOS:000318927900006	23672360	Bronze			2022-02-06	
J	Pierce, JE; Cotton, S; Perry, A				Pierce, John E.; Cotton, Susan; Perry, Alison			Alternating and sequential motion rates in older adults	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article							TRAUMATIC BRAIN-INJURY; TONGUE STRENGTH; READING RATES; SPEECH; DIADOCHOKINESIS; AGE; ARTICULATION; DISORDERS; SPEAKING	Background Alternating motion rate (AMR) and sequential motion rate (SMR) are tests of articulatory diadochokinesis that are widely used in the evaluation of motor speech. However, there are no quality normative data available for adults aged 65 years and older. Aims There were two aims: (1) to obtain a representative, normative dataset of diadochokinetic rates from adults aged 65 years and older; and (2) to examine the effects of age and gender on those rates. Methods & Procedures Seventy-six healthy adults (6586 years) were recruited; 45 females and 31 males. Participants were divided across two age groups (6574 and 7586 years) and audio-recorded while undertaking AMR (/pa/, /ta/ and /ka/) and SMR (/pataka/). The rate of the first nine syllables for each task was measured using acoustic analysis software, and age and gender effects were examined using a series of generalized linear models. The effect of age on rate variability between groups was also assessed. Outcomes & Results Normative data were obtained for both age groups and across gender. Age was not a significant factor for any task. Males had significantly higher AMR than females (/pa/ p = 0.001, /ta/ p = 0.001, /ka/ p = 0.010). No such gender difference was found for SMR. There was no significant difference in rate variability between the age groups. Conclusions & Implications Normative values for AMR and SMR in both genders and across two older age groups were acquired. Diadochokinetic rates outside such values cannot be attributed to normal ageing, so will merit further clinical investigation.	[Pierce, John E.] Peninsula Hlth, Frankston, Vic, Australia; [Cotton, Susan] Univ Melbourne, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Cotton, Susan] Univ Melbourne, Ctr Youth Mental Hlth, Parkville, Vic 3052, Australia; [Perry, Alison] Univ Limerick, Fac Educ & Hlth Sci, Dept Clin Therapies, Limerick, Ireland		Pierce, JE (corresponding author), Peninsula Hlth, Frankston, Vic, Australia.	pierce.john.e@gmail.com		Cotton, Sue/0000-0002-9386-8348; Pierce, John E./0000-0001-5164-5106			Amerman J. D., 1982, J NATL STUDENT SPEEC, V10, P55; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Boersma P., 2010, PRAAT DOING PHONETIC; Bubach A., 1993, LOGOP PHONIATR VOCO, V18, P131; Dembowski J., 1993, ANN B RES I LOGOPEDI, V27, P13; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; DWORKIN JP, 1980, J SPEECH HEAR RES, V23, P828, DOI 10.1044/jshr.2304.828; Gadesmann M, 2008, INT J LANG COMM DIS, V43, P41, DOI 10.1080/13682820701234444; Gress C., 1997, ASHA C BOST MA US; Kent RD, 2003, CLIN LINGUIST PHONET, V17, P427, DOI 10.1080/0269920031000086248; Kikutani T, 2009, GERODONTOLOGY, V26, P291, DOI 10.1111/j.1741-2358.2008.00258.x; Kikutani T, 2009, ODONTOLOGY, V97, P38, DOI 10.1007/s10266-008-0094-z; KREUL EJ, 1972, J SPEECH HEAR RES, V15, P72, DOI 10.1044/jshr.1501.72; Lass NJ., 1971, TODAYS SPEECH, V19, P49; Lundeen DJ, 1950, J SPEECH HEAR DISORD, V15, P54, DOI 10.1044/jshd.1501.54; Maslan J, 2011, J VOICE, V25, P709, DOI [10.1016/j.jvoice.2010.10.002, 10.1016/j.jvoicc.2010.10.002]; Maturo S. C., 2011, OTOLARYNGOLOGY HEAD, V145, pP112; Meurer EM, 2004, J VOICE, V18, P369, DOI 10.1016/j.jvoice.2003.02.001; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Neel AT, 2006, J MED SPEECH-LANG PA, V14, P273; Nishio M, 2006, FOLIA PHONIATR LOGO, V58, P114, DOI 10.1159/000089612; Ogar J, 2006, BRAIN LANG, V97, P343, DOI 10.1016/j.bandl.2006.01.008; Ozawa Y., 1996, B HIROSHIMA PREF COL, V2, P39; Padovani M, 2009, ARQ NEURO-PSIQUIAT, V67, P58, DOI 10.1590/S0004-282X2009000100015; PORTNOY RP, 1976, THESIS U MISSOURI CO; PTACEK PH, 1966, J SPEECH HEAR RES, V9, P353, DOI 10.1044/jshr.0903.353; RAMIG LA, 1983, J GERONTOL, V38, P223, DOI 10.1093/geronj/38.2.223; RAMIG LA, 1983, J COMMUN DISORD, V16, P217, DOI 10.1016/0021-9924(83)90035-7; SIGURD B, 1973, LANG SPEECH, V16, P373, DOI 10.1177/002383097301600408; Torre P, 2009, J COMMUN DISORD, V42, P324, DOI 10.1016/j.jcomdis.2009.03.001; Uhlenberg P., 2009, INT HDB POPULATION A, V1; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Wang YT, 2009, FOLIA PHONIATR LOGO, V61, P1, DOI 10.1159/000184539; Ziegler W, 1996, NEUROLOGY, V47, P208, DOI 10.1212/WNL.47.1.208; [No title captured]	35	16	17	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822			INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAY-JUN	2013	48	3					257	264		10.1111/1460-6984.12001			8	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	139HF	WOS:000318572000002	23650883				2022-02-06	
J	Tominaga, GT; Schaffer, KB; Dandan, IS; Kraus, JF				Tominaga, Gail T.; Schaffer, Kathryn B.; Dandan, Imad S.; Kraus, Jess F.			Epidemiological and clinical features of an older high-risk population of skateboarders	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Adults; Injury; Epidemiology; Skateboard	INJURIES; CHILDREN	Background: Skateboard injuries have been described in the media and scientific journals as a problem prevalent among children and adolescents. Skateboarding popularity has continued to grow since the 1970s with ridership increasing to include all age groups. Recently, surgeons at one trauma centre at an urban hospital noted an increase in the number of older skateboarders with life-threatening injuries. We hypothesise that the clinical and epidemiological features of skateboard-related injuries from one trauma centre (TC) will be different from injured skateboarders identified in the U. S. National Trauma Data Bank (NTDB). We also sought to identify factors related to poor outcomes in the TC and NTDB patient groups. Methods: Two injured skateboarder patient groups were identified and compared using proportional morbidity odds ratios (PMORs) and multivariable methods to estimate differences among factors common to both groups of patients. Clinical and demographic features were evaluated for hospital admitted patients injured whilst riding a skateboard. Chi-square tests, PMORs and logistic regression were used to determine outcome differences between patients in both groups. Results: Patients in the TC group were on average older, with higher Injury Severity Scores (ISS), more head injuries requiring neurosurgical intervention, longer ICU and hospital stays, and injured more frequently on local streets than patients in the NTDB series. Poor outcomes in the TC group were related to moderate or severe head injuries and presence of a head/face injury. For NTDB patients, a GCS of <13, a head/face injury and an ISS of 25+ were related to poor outcomes. Conclusions: From our Trauma Centre we describe an older injured skateboarding population, clinically and epidemiologically different from injured patients identified in the NTDB as well as those described in the literature. The greater severity of injury, including traumatic brain injury, has direct implications for preventive and educational measures and the planning of emergency surgical response. (C) 2012 Elsevier Ltd. All rights reserved.			Tominaga, GT (corresponding author), Scripps Mem Hosp La Jolla, 9888 Genesee Ave,LJ 601, La Jolla, CA 92037 USA.	Tominaga.gail@scrippshealth.org	Tominaga, Gail/ABE-6303-2021	SCHAFFER, KATHRYN/0000-0002-3550-1679	N. Paul Whittier Trauma Endowment Fund	This study was funded in part by the N. Paul Whittier Trauma Endowment Fund.	Adams I D, 1979, Nurs Times, V75, P707; ALLUM RL, 1978, INJURY, V10, P152; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; ATIENZA F, 1976, PEDIATRICS, V57, P793; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAKER SP, 1994, AM J PUBLIC HEALTH, V84, P649, DOI 10.2105/AJPH.84.4.649; Banas M P, 1992, J Orthop Trauma, V6, P301, DOI 10.1097/00005131-199209000-00006; CASS DT, 1990, MED J AUSTRALIA, V153, P140, DOI 10.5694/j.1326-5377.1990.tb136832.x; Chapman S, 2001, J PAEDIATR CHILD H, V37, P567, DOI 10.1046/j.1440-1754.2001.00763.x; Christian M S, 1980, Br J Sports Med, V14, P102; Everett WW, 2002, J EMERG MED, V23, P269, DOI 10.1016/S0736-4679(02)00528-0; Forsman L, 2001, BRIT J SPORT MED, V35, P325, DOI 10.1136/bjsm.35.5.325; Fountain JL, 1996, SPORTS MED, V22, P360, DOI 10.2165/00007256-199622060-00004; FYFE IS, 1978, INJURY, V10, P149; Greenland S, 1998, MODERN EPIDEMIOLOGY, P214; HAWKINS RW, 1978, AM J DIS CHILD, V132, P751, DOI 10.1001/archpedi.1978.02120330023004; Homser DW, 1989, APPL LOGISTIC REGRES; ILLINGWORTH CM, 1978, CLIN PEDIATR, V17, P781, DOI 10.1177/000992287801701012; JACOBS RA, 1977, PEDIATRICS, V59, P939; KEMM I, 1978, BRIT MED J, V1, P894, DOI 10.1136/bmj.1.6117.894; KIRKPATRICK SML, 1980, CAN MED ASSOC J, V122, P159; Klein A, 2002, SAFETY GEAR SOME PRO, P73; Konkin DE, 2006, AM J SURG, V191, P615, DOI 10.1016/j.amjsurg.2006.02.012; Kyle SB, 2002, J TRAUMA, V53, P686, DOI 10.1097/00005373-200210000-00011; Little R, 2000, ENCY EPIDEMIOLOGIC M, P585; Lustenberger T, 2010, J TRAUMA, V69, P924, DOI 10.1097/TA.0b013e3181b9a05a; Maddox D, 1976, PHYSICIAN SPORTSMED, V4, P24; MAITRA AK, 1979, BRIT J CLIN PRACT, V33, P281; McGeehan J, 2004, PEDIATRICS, V114, P124, DOI 10.1542/peds.114.1.124; Osberg JS, 1998, ARCH PEDIAT ADOL MED, V152, P985; PENDERGRAST RA, 1990, J ADOLESCENT HEALTH, V11, P408, DOI 10.1016/0197-0070(90)90087-I; Rethnam Ulfin, 2008, BMC Res Notes, V1, P59, DOI 10.1186/1756-0500-1-59; RETSKY J, 1991, AM J DIS CHILD, V145, P188, DOI 10.1001/archpedi.1991.02160020080022; Rutherford G, 2004, HAZARD SCREENING REP; SCHIEBER RA, 1994, JAMA-J AM MED ASSOC, V271, P1856, DOI 10.1001/jama.271.23.1856; SCHUMAN SH, 1967, CLIN PEDIATR, V6, P252, DOI 10.1177/000992286700600421; SENTURIA YD, 1993, ACCIDENT ANAL PREV, V25, P473, DOI 10.1016/0001-4575(93)90077-A; SMITH RG, 1979, CAN MED ASSOC J, V121, P510; Sorensen L, 2001, J PAEDIT CHILD HLTH, V3, P567; WIDOME MD, 1989, PEDIATRICS, V83, P1070; WILSON DH, 1977, BRIT MED J, V2, P1349; Zalavras C, 2005, AM J SPORT MED, V33, P568, DOI 10.1177/0363546504269256	42	16	16	1	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2013	44	5					645	649		10.1016/j.injury.2012.01.022			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	122VE	WOS:000317345400014	22480946				2022-02-06	
J	Beseoglu, K; Roussaint, N; Steiger, HJ; Hanggi, D				Beseoglu, Kerim; Roussaint, Nina; Steiger, Hans-Jakob; Haenggi, Daniel			Quality of life and socio-professional reintegration after mild traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						employment; epidemiology; mild traumatic brain injury; quality of life; short form 36	HEAD-INJURY; PSYCHOSOCIAL OUTCOMES; HEMORRHAGE PATIENTS; HEALTH; CT; CLASSIFICATION; SYMPTOMS; DISORDER; MODERATE	Background. Controversy exists about the influence of intracranial injuries in mild traumatic brain injury (mTBI) on quality of life (QoL). Some patients do not fully recover from mTBI and experience neurocognitive impairment and reduction in quality of life. We evaluated the influence of structural brain damage on QoL and employment status (ES) after mTBI. Methods. In a partially prospective design we evaluated QoL using Short-Form-36 (SF36) and current ES three years after trauma in 36 patients with mTBI in a matched pair design with two groups of 18 patients each with and without structural brain damage. Results. Both groups showed a reduction in physical (Physical Functioning, Role Physical, Bodily Pain and General Health) and emotional parameters (Vitality, Social Functioning, Role Emotional and Mental Health) without significant difference between both groups (p = 0.305, p = 0.406, p = 0.624, p = 0.720, p = 0.934, p = 0.282, p = 0.811 and p = 0.270 respectively). ES was independent of structural brain damage and an influential factor for QoL. Conclusion. MTBI specific QoL assessment including focus on ES is necessary to identify patients at risk for impaired recovery. Structural brain injury as seen on CT scan is not useful as a prognostic tool to predict QoL or ES after mTBI.	[Beseoglu, Kerim; Roussaint, Nina; Steiger, Hans-Jakob; Haenggi, Daniel] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany		Beseoglu, K (corresponding author), Univ Dusseldorf, Dept Neurosurg, Univ Klin Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany.	beseoglu@med.uni-duesseldorf.de	Steiger, Hans-Jakob/AAN-8307-2021	Steiger, Hans-Jakob/0000-0002-8249-2998			Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cantor JB, 2008, J HEAD TRAUMA REHAB, P2341; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kim JS, 2009, J KOREAN NEUROSURG S, V46, P459, DOI 10.3340/jkns.2009.46.5.459; Kurth BM, 2002, SOZ PRAVENTIV MED, V47, P266, DOI 10.1007/BF01326408; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Merritta C, 2009, INT J REHABIL RES; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Pickard JD, 2004, J ROY SOC MED, V97, P384, DOI 10.1258/jrsm.97.8.384; Pritchard C, 2004, BRIT J NEUROSURG, V18, P347, DOI 10.1080/02688690400004993; Pritchard C, 2004, SURG NEUROL, V62, P7, DOI 10.1016/j.surneu.2004.01.018; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462	32	16	16	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	APR	2013	27	2					202	206		10.3109/02688697.2012.717984			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	117LK	WOS:000316954700013	22938593				2022-02-06	
J	Bruins, B; Kilbaugh, TJ; Margulies, SS; Friess, SH				Bruins, Benjamin; Kilbaugh, Todd J.; Margulies, Susan S.; Friess, Stuart H.			The Anesthetic Effects on Vasopressor Modulation of Cerebral Blood Flow in an Immature Swine Model	ANESTHESIA AND ANALGESIA			English	Article							TRAUMATIC BRAIN-INJURY; ISOFLURANE ANESTHESIA; OXYGEN-CONSUMPTION; NITROUS-OXIDE; MIDAZOLAM; AUTOREGULATION; PROPOFOL; VELOCITY; METABOLISM; PERFUSION	BACKGROUND: The effect of various sedatives and anesthetics on vasopressor modulation of cerebral blood flow (CBF) in children is unclear. In adults, isoflurane has been described to decrease CBF to a lesser extent than fentanyl and midazolam. Most large-animal models of neurocritical care use inhaled anesthetics for anesthesia. Investigations involving modulations. CBF would have improved translatability within a model that more closely approximates the current practice in the pediatric intensive care unit. METHODS: Fifteen 4-week-old piglets were given 1 of 2 anesthetic protocols: total IV anesthesia (TIVA) (midazolam 1 mg/kg/h and fentanyl 100 mu g/kg/h, n = 8) or ISO (isoflurane 1.5%-2% and fentanyl 100 mu g/kg/h, n = 7). Mean arterial blood pressure, intracranial pressure (ICP), CBF, and brain tissue oxygen tension were measured continuously as piglets were exposed to escalating doses of arginine vasopressin, norepinephrine (NE), and phenylephrine (PE). RESULTS: Baseline CBF was similar in the 2 groups (ISO 38 +/- 10 vs TIVA 35 +/- 26 mL/100 g/min) despite lower baseline cerebral perfusion pressure in the ISO group (45 +/- 11 vs 71 +/- 11 mm Hg; P < 0.0005). Piglets in the ISO group displayed increases in ICP with PE and NE (11 +/- 4 vs 16 +/- 4 mm Hg, and 11 +/- 8 vs 18 +/- 5 mm Fig; P < 0.05), but in the TIVA group, only exposure to PE resulted in increases in ICP when comparing maximal dose values with baseline data (11 +/- 4 vs 15 +/- 5 mm Hg; P < 0.05). Normalized CBF displayed statistically significant increases regarding anesthetic group and vasopressor dose when piglets were exposed to NE and PE (P < 0.05), suggesting an impairment of autoregulation within ISO, but not TIVA. CONCLUSION: The vasopressor effect on CBF was limited when using a narcotic-benzodiazepine based anesthetic protocol compared with volatile anesthetics, consistent with a preservation of autoregulation. Selection of anesthetic drugs is critical to investigate mechanisms of cerebrovascular hemodynamics, and in translating critical care investigations between the laboratory and bedside. (Anesth Analg 2013;116:838-44)	[Bruins, Benjamin; Kilbaugh, Todd J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Friess, Stuart H.] Washington Univ, Dept Pediat, St Louis Sch Med, St Louis, MO 63110 USA		Friess, SH (corresponding author), Washington Univ, Dept Pediat, St Louis Sch Med, Campus Box 8028,5th Floor MPRB,660 S Euclid Ave, St Louis, MO 63110 USA.	Friess_S@kids.wustl.edu		Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08NS064051, U01NS069545, R01NS39679]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545, R01NS039679, K08NS064051] Funding Source: NIH RePORTER	Supported by NIH grants K08NS064051, U01NS069545, and R01NS39679.	Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; CHENG MA, 1993, J NEUROSURG ANESTH, V5, P232; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHI OZ, 1992, ANESTHESIOLOGY, V76, P426, DOI 10.1097/00000542-199203000-00016; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; CUCCHIARA RF, 1974, ANESTHESIOLOGY, V40, P571, DOI 10.1097/00000542-197406000-00011; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; FORSTER A, 1982, ANESTHESIOLOGY, V56, P453, DOI 10.1097/00000542-198206000-00009; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; GELMAN S, 1984, ANESTH ANALG, V63, P557; HOFFMAN WE, 1986, ANESTH ANALG, V65, P729; KNUDSEN L, 1990, ANAESTHESIA, V45, P1016, DOI 10.1111/j.1365-2044.1990.tb14877.x; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Muller S, 2008, CRIT CARE, V12, DOI 10.1186/cc6794; Myburgh JA, 2002, ANAESTH INTENS CARE, V30, P725, DOI 10.1177/0310057X0203000602; Nachar RA, 2011, PEDIATR RES, V70, P473, DOI 10.1203/PDR.0b013e31822e178e; Nouira S, 2005, CRIT CARE MED, V33, P2339, DOI 10.1097/01.CCM.0000182801.48137.13; NUGENT M, 1982, ANESTHESIOLOGY, V56, P172, DOI 10.1097/00000542-198203000-00003; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Ogawa Y, 2010, ANESTH ANALG, V111, P1279, DOI 10.1213/ANE.0b013e3181f42fc0; OLSEN KS, 1992, BRIT J ANAESTH, V69, P263, DOI 10.1093/bja/69.3.263; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Rosengarten B, 2012, CRIT CARE, V16, DOI 10.1186/cc11310; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schramm P, 2012, CRIT CARE, V16, DOI 10.1186/cc11665; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Simon F, 2009, CRIT CARE, V13, DOI 10.1186/cc7959; Smith JH, 2005, ACTA ANAESTH SCAND, V49, P23, DOI 10.1111/j.1399-6576.2004.00535.x; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Swindle MM., 2007, SWINE LAB SURG ANEST; Todd MM, 1996, J NEUROSURG ANESTH, V8, P296, DOI 10.1097/00008506-199610000-00007; Tsuneyoshi I, 2001, CRIT CARE MED, V29, P487, DOI 10.1097/00003246-200103000-00004; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642; WOLFF J, 1990, ACTA ANAESTH SCAND, V34, P75, DOI 10.1111/j.1399-6576.1990.tb03189.x	42	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	APR	2013	116	4					838	844		10.1213/ANE.0b013e3182860fe7			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	113EA	WOS:000316648100014	23460561	Green Accepted, Green Submitted			2022-02-06	
J	Dijkers, MP; Zanca, JM				Dijkers, Marcel P.; Zanca, Jeanne M.			Factors Complicating Treatment Sessions in Spinal Cord Injury Rehabilitation: Nature, Frequency, and Consequences	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Allied health personnel; Comorbidity; Health services; Health services research; Hospitals; Patient participation; Rehabilitation; Spinal cord injuries	SCIREHAB PROJECT SERIES; TRAUMATIC BRAIN-INJURY; LENGTH-OF-STAY; INPATIENT REHABILITATION; RISK-FACTORS; MEDICAL COMPLICATIONS; STROKE REHABILITATION; THERAPY TAXONOMY; PHYSICAL-THERAPY; ACUTE-CARE	Objective: To describe therapist-reported factors affecting therapy sessions in spinal cord injury (SCI) inpatient rehabilitation and explore their impact on the patient's rehabilitation program. Design: Prospective observational longitudinal cohort design. Data were obtained from systematic recordings of interventions by clinicians and from medical record abstraction. Setting: Six inpatient rehabilitation programs. Participants: Patients (N=1376) with traumatic SCI admitted for initial rehabilitation. Interventions: Not applicable. Main Outcome Measures: Factors recorded as impacting the objective or content of treatment sessions by physical therapy, occupational therapy, speech therapy, and therapeutic recreation, patients' participation in treatment as rated using a modified Pittsburgh Rehabilitation Participation Scale (PRPS), length of stay (LOS), medical morbidity measured using the Comprehensive Severity Index, hours of therapy per week, and missed therapy minutes. Results: Patients received 151,172 treatment sessions from 483 therapists. Pain, fatigue, and spasticity were commonly reported factors; other medical, behavioral, and logistical factors were also frequent, with 30% of sessions being affected by at least 1 factor. The number of factors was correlated with missed therapy minutes and with the PRPS score. Patients with more reported factors, overall or per average session, had a longer LOS and fewer hours of treatment per week. Conclusions: Medical and other factors complicating therapy are common. Those who need a longer stay because of their injury level or for other reasons have more opportunity to have sessions affected, but having many treatment sessions impacted by 1 or more factors also is likely to increase LOS. The nature of these factors and their impact on rehabilitation processes and outcomes deserve further study. Archives of Physical Medicine and Rehabilitation 2013;94(4 Suppl 2):S115-24 (C) 2013 by the American Congress of Rehabilitation Medicine	[Dijkers, Marcel P.; Zanca, Jeanne M.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Dijkers, MP (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 Gustave L Levy Pl, New York, NY 10029 USA.	marcel.dijkers@mssm.edu		Dijkers, Marcel/0000-0002-8362-5596	Craig Hospital [H133A060103]; National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education [H133N060027]	Supported in part by Craig Hospital (grant no. H133A060103) and the National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education (grant no. H133N060027).	Abeyta N, 2009, J SPINAL CORD MED, V32, P336, DOI 10.1080/10790268.2009.11760787; Aito S, 2003, SPINAL CORD, V41, P629, DOI 10.1038/sj.sc.3101513; Alam E, 2008, ARCH PHYS MED REHAB, V89, P1284, DOI 10.1016/j.apmr.2008.01.014; Burnett DM, 2000, J NEUROTRAUM, V17, P765, DOI 10.1089/neu.2000.17.765; Cahow C, 2009, J SPINAL CORD MED, V32, P298, DOI 10.1080/10790268.2009.11760783; Chen D, 1999, ARCH PHYS MED REHAB, V80, P1397, DOI 10.1016/S0003-9993(99)90250-2; CREIGHTON C, 1995, AM J OCCUP THER, V49, P311, DOI 10.5014/ajot.49.4.311; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Evans CT, 2008, INFECT CONT HOSP EP, V29, P234, DOI 10.1086/527509; Frisbie JH, 2005, J SPINAL CORD MED, V28, P60, DOI 10.1080/10790268.2005.11753799; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; Haisma J, 2007, CLIN REHABIL, V21, P932, DOI 10.1177/0269215507079134; Haisma JA, 2007, ARCH PHYS MED REHAB, V88, P1694, DOI 10.1016/j.apmr.2007.07.044; Haisma JA, 2007, J REHABIL MED, V39, P393, DOI 10.2340/16501977-0067; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS106, DOI 10.1016/j.apmr.2012.12.023; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS98, DOI 10.1016/j.apmr.2012.11.051; Horn SD, 2013, ARCH PHYS MED REHAB, V94, pS75, DOI 10.1016/j.apmr.2012.10.036; Irwin ZN, 2004, SPINE, V29, P796, DOI 10.1097/01.BRS.0000119400.92204.B5; Johnson K, 2009, J SPINAL CORD MED, V32, P329, DOI 10.1080/10790268.2009.11760786; JUDD FK, 1989, BRIT J PSYCHIAT, V154, P668, DOI 10.1192/bjp.154.5.668; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; McKinley W, 2006, J SPINAL CORD MED, V29, P501, DOI 10.1080/10790268.2006.11753899; McKinley William O, 2002, J Spinal Cord Med, V25, P88; Meikle B, 2002, ARCH PHYS MED REHAB, V83, P1222, DOI 10.1053/apmr.2002.33657; Nair KPS, 2005, SPINAL CORD, V43, P558, DOI 10.1038/sj.sc.3101752; Natale A, 2009, J SPINAL CORD MED, V32, P270, DOI 10.1080/10790268.2009.11760781; Ozelie R, 2009, J SPINAL CORD MED, V32, P283, DOI 10.1080/10790268.2009.11760782; PAYTON OD, 1985, PHYS THER, V65, P924, DOI 10.1093/ptj/65.6.924; Ploumis A, 2011, SPINAL CORD, V49, P411, DOI 10.1038/sc.2010.132; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; Suyama T, 2001, J PHYS THER SCI, V13, P59; Unsal-Delialioglu S, 2010, J SPINAL CORD MED, V33, P243, DOI 10.1080/10790268.2010.11689701; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022; Wilson C, 2009, J SPINAL CORD MED, V32, P319, DOI 10.1080/10790268.2009.11760785; Yokoyama O, 2006, ARCH PHYS MED REHAB, V87, P1189, DOI 10.1016/j.apmr.2006.05.017	42	16	16	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2013	94	4		2			S115	S124		10.1016/j.apmr.2012.11.047			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	120LP	WOS:000317172100007	23465468				2022-02-06	
J	Hanten, G; Li, XQ; Ibarra, A; Wilde, EA; Barnes, A; McCauley, SR; McCarthy, J; Hoxhaj, S; Mendez, D; Hunter, JV; Levin, HS; Smith, DH				Hanten, Gerri; Li, Xiaoqi; Ibarra, Alyssa; Wilde, Elisabeth A.; Barnes, Amanda; McCauley, Stephen R.; McCarthy, James; Hoxhaj, Shkelzen; Mendez, Donna; Hunter, Jill V.; Levin, Harvey S.; Smith, Douglas H.			Updating Memory after Mild Traumatic Brain Injury and Orthopedic Injuries	JOURNAL OF NEUROTRAUMA			English	Article						cognition; executive function, mild traumatic brain injury; memory	HEAD-INJURY; SYMPTOMS; MODERATE; CONCUSSION; IMPACT; TIME	Few studies have examined the trajectory of recovery of executive function (EF) after mild TBI (mTBI). Therefore, consensus has not been reached on the incidence and extent of EF impairment after mTBI. The present study investigated trajectory of change in executive memory over 3 months after mTBI on 59 right-handed participants with mTBI, as defined by Centers for Disease Control criteria, ages 14-30 years, recruited within 96 hours post-injury and tested < 1 week (baseline), 1 month, and 3 months after injury. Also included were 58 participants with orthopedic injury (OI) and 27 typically developing (TD) non-injured participants with similar age, socioeconomic status, sex, and ethnicity. MRI data were acquired at baseline and 3 months. Although criteria included a normal CT scan, lesions were detected by MRI in 19 mTBI patients. Participants completed the KeepTrack task, a verbal recall task placing demands on goal maintenance, semantic memory, and memory updating. Scores reflected items recalled and semantic categories maintained. The mTBI group was divided into two groups: high (score >= 12) or low (score < 12) symptoms based on the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). Mixed model analyses revealed the trajectory of change in mTBI patients (high and low RPQ), OI patients, and TD subjects were similar over time (although the TD group differed from other groups at baseline), suggesting no recovery from mTBI up to 90 days. For categories maintained, differences in trajectory of recovery were discovered, with the OI comparison group surprisingly performing similar to those in the mTBI group with high RPQ symptoms, and different from low RPQ and the TD groups, bringing up questions about utility of OIs as a comparison group for mTBI. Patients with frontal lesions (on MRI) were also found to perform worse than those without lesions, a pattern that became more pronounced with time.	[Hanten, Gerri; Li, Xiaoqi; Wilde, Elisabeth A.; Barnes, Amanda; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hoxhaj, Shkelzen] Baylor Coll Med, Dept Emergency Med, Houston, TX 77030 USA; [Mendez, Donna] Baylor Coll Med, Dept Pediat Emergency Med, Houston, TX 77030 USA; [Hanten, Gerri] Rice Univ, Dept Psychol, Houston, TX 77251 USA; [Wilde, Elisabeth A.; McCauley, Stephen R.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Neurorehabil Neurons Networks Ctr TBI Rehabil Res, Houston, TX USA; [McCarthy, James] Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA; [McCarthy, James] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX USA; [Hoxhaj, Shkelzen] Ben Taub Gen Hosp, Dept Med, Houston, TX 77030 USA; [Mendez, Donna] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Hunter, Jill V.] Texas Childrens Hosp, Houston, TX 77030 USA; [Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Ibarra, Alyssa] Univ Rochester, Dept Psychol, Rochester, NY 14627 USA		Hanten, G (corresponding author), Baylor Coll Med, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ghanten@bcm.edu			NINDS grant [5 P01 NS056202]; DoD grant [W81XWH-08-2-0133 PT074693P2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, P01NS056202] Funding Source: NIH RePORTER	The authors gratefully acknowledge support from the following grants: NINDS grant 5 P01 NS056202 and DoD grant W81XWH-08-2-0133 PT074693P2.	Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; YNTEMA DB, 1967, ACTA PSYCHOL, V27, P325, DOI 10.1016/0001-6918(67)90075-3	24	16	16	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	8			SI		618	624		10.1089/neu.2012.2392			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PO	WOS:000318151500003	23227898	Green Published			2022-02-06	
J	Lopez, MR; Cheng, JY; Kanner, AM; Carvalho, DZ; Diamond, JA; Wallace, DM				Lopez, M. R.; Cheng, J. Y.; Kanner, A. M.; Carvalho, D. Z.; Diamond, J. A.; Wallace, D. M.			Insomnia symptoms in South Florida military veterans with epilepsy	EPILEPSY & BEHAVIOR			English	Article						Veterans; Epilepsy; Insomnia; Sleep disturbances; Post-traumatic epilepsy; Lamotrigine; Levetiracetam	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCE; DISORDERS; PREVALENCE; LAMOTRIGINE; COMORBIDITY; MANAGEMENT; RISK; CBTI	Background: Despite the high prevalence of insomnia in veterans with epilepsy, it remains understudied. Our aim was to identify the associations of insomnia with epilepsy, comorbidities, and treatment-related variables in South Florida veterans. Methods: We performed a cross-sectional analysis of veterans attending an epilepsy clinic over 18 months. Participants completed standardized assessments of seizure and sleep. Insomnia was defined as 1) difficulty with sleep onset, maintenance, or premature awakenings with daytime consequences or 2) sedative-hypnotic use on most nights of the previous month. Results: One hundred sixty-five veterans (87% male, age 56 +/- 15 years) were included: 66 reporting insomnia (40%). In logistic regression analysis, insomnia was significantly associated with post-traumatic seizure etiology, lamotrigine prescription, and mood and psychotic disorders. Female gender and levetiracetam treatment were associated with lower odds for insomnia. Conclusion: Insomnia was associated with post-traumatic epilepsy, mood/psychotic comorbidities, and antiepileptic regimen. Insomnia represents an under-recognized opportunity to improve comprehensive epilepsy care. Published by Elsevier Inc.	[Lopez, M. R.; Cheng, J. Y.; Kanner, A. M.; Diamond, J. A.; Wallace, D. M.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Lopez, M. R.; Cheng, J. Y.; Kanner, A. M.; Diamond, J. A.; Wallace, D. M.] Vet Affairs Med Ctr, Bruce W Carter Dept, Dept Neurol, Miami, FL 33125 USA; [Carvalho, D. Z.] Univ Fed Rio Grande do Sul, Sch Med, Hosp Clin Porto Alegre, Sleep Lab, Porto Alegre, RS, Brazil		Wallace, DM (corresponding author), Vet Affairs Med Ctr, Bruce W Carter Dept, 1201 NW 16th St, Miami, FL 33125 USA.	dwallace@med.miami.edu	Wallace, Douglas/AAL-3719-2020	Carvalho, Diego/0000-0002-8822-1638; Wallace, Douglas/0000-0002-8982-1088; Cheng, Jocelyn/0000-0001-5318-5668	VA Epilepsy Center of Excellence	This study was funded by a grant from the VA Epilepsy Center of Excellence.	Alanis-Guevara I, 2005, EPILEPSY BEHAV, V7, P481, DOI 10.1016/j.yebeh.2005.06.010; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bell C, 2002, J SLEEP RES, V11, P255, DOI 10.1046/j.1365-2869.2002.00301.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bootzin RR, 2012, J CLIN SLEEP MED, V8, P219, DOI 10.5664/jcsm.1788; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Cho YW, 2011, SEIZURE-EUR J EPILEP, V20, P336, DOI 10.1016/j.seizure.2011.01.006; Daley M, 2009, SLEEP, V32, P55; de Weerd A, 2004, EPILEPSIA, V45, P1397, DOI 10.1111/j.0013-9580.2004.46703.x; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Foldvary N, 2001, EPILEPSIA, V42, P1569, DOI 10.1046/j.1528-1157.2001.46100.x; Foldvary-Schaefer N, 2009, SEMIN NEUROL, V29, P419, DOI 10.1055/s-0029-1237115; Freeman D, 2009, SCHIZOPHR RES, V108, P280, DOI 10.1016/j.schres.2008.12.001; Harden C, 2001, EPILEPSIA, V42, P36, DOI 10.1046/j.1528-1157.2001.0420s4036.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ishak Waguih W, 2012, Innov Clin Neurosci, V9, P13; Kessler RC, 2012, SLEEP, V35, P825, DOI 10.5665/sleep.1884; Khatarni R, 2006, SEIZURE-EUR J EPILEP, V15, P299, DOI 10.1016/j.seizure.2006.02.018; Krishnan P, 2012, EPILEPSY BEHAV, V23, P305, DOI 10.1016/j.yebeh.2011.12.018; Krystal AD, 2008, ANN CLIN PSYCHIATRY, V20, P39, DOI 10.1080/10401230701844661; Kwan P, 2009, EPILEPSIA, V50, P1059, DOI 10.1111/j.1528-1167.2008.01938.x; Lee YJ, 2012, SLEEP, V35, P455, DOI 10.5665/sleep.1722; Legros B, 2003, SLEEP MED, V4, P51, DOI 10.1016/S1389-9457(02)00217-4; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Manni R, 2000, ACTA NEUROL SCAND, V101, P301, DOI 10.1034/j.1600-0404.2000.90369a.x; Manni R, 2010, EPILEPSY RES, V90, P171, DOI 10.1016/j.eplepsyres.2010.05.006; Mayer G, 2011, SLEEP MED REV, V15, P369, DOI 10.1016/j.smrv.2011.01.005; Sanchez-Ortuno MM, 2012, CURR PSYCHIAT REP, V14, P519, DOI 10.1007/s11920-012-0312-9; Nierenberg AA, 2010, PSYCHOL MED, V40, P41, DOI 10.1017/S0033291709006011; Ohayon MM, 2005, J PSYCHIAT RES, V39, P151, DOI 10.1016/j.jpsychires.2004.07.001; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2005, ARCH INTERN MED, V165, P35, DOI 10.1001/archinte.165.1.35; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Pigeon WR, 2012, BEHAV RES THER, V50, P685, DOI 10.1016/j.brat.2012.07.005; Piperidou C, 2008, SEIZURE-EUR J EPILEP, V17, P588, DOI 10.1016/j.seizure.2008.02.005; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Sadler M, 1999, EPILEPSIA, V40, P322, DOI 10.1111/j.1528-1157.1999.tb00712.x; Sateia M. J., 2005, INT CLASS SLEEP DIS, P1; Siebern AT, 2010, MED CLIN N AM, V94, P581, DOI 10.1016/j.mcna.2010.02.005; Vendrame MYB, J CLIN SLEE IN PRESS, V9; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Wallace DM, 2012, INT J STROKE, V7, P231, DOI 10.1111/j.1747-4949.2011.00760.x	44	16	16	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	APR	2013	27	1					159	164		10.1016/j.yebeh.2013.01.008			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	118MG	WOS:000317029000030	23434722				2022-02-06	
J	Shi, C; Flanagan, SR; Samadani, U				Shi, Chen; Flanagan, Steven R.; Samadani, Uzma			Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial	NEUROLOGICAL RESEARCH			English	Article						Clinical trial; Epilepsy; Minimally conscious state; Traumatic brain injury; Vagus nerve stimulation; Vegetative states	QUALITY-OF-LIFE; DELTA-FOSB IMMUNOREACTIVITY; DORSAL MOTOR NUCLEUS; BLOOD-FLOW CHANGES; LONG-TERM; REFRACTORY EPILEPSY; VAGAL-STIMULATION; VEGETATIVE STATE; HEAD-INJURY; BARRIER DISRUPTION	Objectives: Traumatic brain injury (TBI) has high morbidity and mortality in both civilian and military populations. Blast and other mechanisms of TBI damage the brain by causing neurons to disconnect and atrophy. Such traumatic axonal injury can lead to persistent vegetative and minimally conscious states (VS and MCS), for which limited treatment options exist, including physical, occupational, speech, and cognitive therapies. More than 60 000 patients have received vagus nerve stimulation (VNS) for epilepsy and depression. In addition to decreased seizure frequency and severity, patients report enhanced mood, reduced daytime sleepiness independent of seizure control, increased slow wave sleep, and improved cognition, memory, and quality of life. Early stimulation of the vagus nerve accelerates the rate and extent of behavioral and cognitive recovery after fluid percussion brain injury in rats. Methods: We recently obtained Food and Drug Administration (FDA) approval for a pilot prospective randomized crossover trial to demonstrate objective improvement in clinical outcome by placement of a vagus nerve stimulator in patients who are recovering from severe TBI. Our hypothesis is that stimulation of the vagus nerve results in increased cerebral blood flow and metabolism in the forebrain, thalamus, and reticular formation, which promotes arousal and improved consciousness, thereby improving outcome after TBI resulting in MCS or VS. Discussion: If this study demonstrates that VNS can safely and positively impact outcome, then a larger randomized prospective crossover trial will be proposed.	[Shi, Chen; Samadani, Uzma] NYU, Dept Neurosurg, Sch Med, New York, NY 10016 USA; [Shi, Chen; Flanagan, Steven R.; Samadani, Uzma] NYU Langone Med Ctr, New York, NY USA; [Flanagan, Steven R.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Samadani, Uzma] New York Harbor Healthcare Syst, Div Neurosurg, Dept Vet Affairs, New York, NY USA		Samadani, U (corresponding author), New York Harbor Healthcare Syst Manhattan Vet Hos, Div Neurosurg, 4168N,MC 112 423 East 23rd St, New York, NY 10010 USA.	uzma.samadani@med.nyu.edu		Flanagan, Steven/0000-0001-9005-5897	Department of Veterans Affairs, Veterans Health Administration Office of Research and Development Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1I01RX000319-01]; AOA Carolyn L. Kuckein Medical Student Summer Research Fellowship; Veterans AffairsUS Department of Veterans Affairs [I01RX000319] Funding Source: NIH RePORTER	This material is based on work supported by the Department of Veterans Affairs, Veterans Health Administration Office of Research and Development Rehabilitation Research and Development Service (1I01RX000319-01). CS was supported by the AOA Carolyn L. Kuckein Medical Student Summer Research Fellowship.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Ammori JB, 2008, SURGERY, V144, P159, DOI 10.1016/j.surg.2008.03.008; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annegers JF, 2000, EPILEPSIA, V41, P549, DOI 10.1111/j.1528-1157.2000.tb00208.x; [Anonymous], 2002, PHYS MAN NEUR PROSTH; Ardesch JJ, 2007, SEIZURE-EUR J EPILEP, V16, P579, DOI 10.1016/j.seizure.2007.04.005; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bailey P, 1938, J NEUROPHYSIOL, V1, P405, DOI 10.1152/jn.1938.1.5.405; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Benbadis SR, 2001, SEIZURE-EUR J EPILEP, V10, P512, DOI 10.1053/seiz.2001.0540; Benbadis SR, 2000, NEUROLOGY, V55, P1780, DOI 10.1212/WNL.55.12.1780; BENMENACHEM E, 1995, EPILEPSY RES, V20, P221, DOI 10.1016/0920-1211(94)00083-9; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bohning DE, 2001, INVEST RADIOL, V36, P470, DOI 10.1097/00004424-200108000-00006; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2011, CURR OPIN NEUROL, V24, P394, DOI 10.1097/WCO.0b013e328347da94; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chae JH, 2003, J PSYCHIATR RES, V37, P443, DOI 10.1016/S0022-3956(03)00074-8; CHASE MICHAEL H., 1967, BRAIN RES, V5, P236, DOI 10.1016/0006-8993(67)90089-3; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Conway CR, 2006, PSYCHIAT RES-NEUROIM, V146, P179, DOI 10.1016/j.pscychresns.2005.12.007; Cunningham JT, 2008, NEUROPSYCHOPHARMACOL, V33, P1884, DOI 10.1038/sj.npp.1301570; De Herdt V, 2009, J NEUROIMMUNOL, V214, P104, DOI 10.1016/j.jneuroim.2009.06.008; Dedeurwaerdere S, 2005, EPILEPSY RES, V67, P133, DOI 10.1016/j.eplepsyres.2005.09.008; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Dodrill CB, 2001, EPILEPSY BEHAV, V2, P46, DOI 10.1006/ebeh.2000.0148; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Fornai F, 2011, EUR J NEUROSCI, V33, P2169, DOI 10.1111/j.1460-9568.2011.07707.x; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Furmaga H, 2012, J PHARMACOL EXP THER, V341, P317, DOI 10.1124/jpet.111.188953; Ghacibeh GA, 2006, COGN BEHAV NEUROL, V19, P119, DOI 10.1097/01.wnn.0000213908.34278.7d; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giorgi FS, 2008, NEUROBIOL DIS, V30, P388, DOI 10.1016/j.nbd.2008.02.008; Giorgi FS, 2004, NEUROSCI BIOBEHAV R, V28, P507, DOI 10.1016/j.neubiorev.2004.06.008; Goldfine AM, 2011, NEUROL CLIN, V29, P723, DOI 10.1016/j.ncl.2011.08.001; Gorny KR, 2010, J MAGN RESON IMAGING, V31, P475, DOI 10.1002/jmri.22037; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Grill MF, 2010, SEMIN PEDIATR NEUROL, V17, P54, DOI 10.1016/j.spen.2010.02.009; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Groves DA, 2005, NEUROSCI LETT, V379, P174, DOI 10.1016/j.neulet.2004.12.055; Hallbook T, 2005, EUR J PAEDIATR NEURO, V9, P399, DOI 10.1016/j.ejpn.2005.08.004; Hallbook T, 2005, SEIZURE-EUR J EPILEP, V14, P527, DOI 10.1016/j.seizure.2005.07.004; Hallbook T, 2005, SEIZURE-EUR J EPILEP, V14, P504, DOI 10.1016/j.seizure.2005.08.007; HAMMOND EJ, 1990, EPILEPSIA, V31, pS51, DOI 10.1111/j.1528-1157.1990.tb05850.x; Hassert DL, 2004, BEHAV NEUROSCI, V118, P79, DOI 10.1037/0735-7044.118.1.79; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Helmers SL, 2012, EUR J PAEDIATR NEURO, V16, P449, DOI 10.1016/j.ejpn.2012.01.001; Helmers SL, 2001, J CHILD NEUROL, V16, P843, DOI 10.1177/08830738010160111101; Henry TR, 2004, EPILEPSIA, V45, P1064, DOI 10.1111/j.0013-9580.2004.03104.x; Henry TR, 1998, EPILEPSIA, V39, P983, DOI 10.1111/j.1528-1157.1998.tb01448.x; Henry TR, 1999, NEUROLOGY, V52, P1166, DOI 10.1212/WNL.52.6.1166; Jaseja H, 2008, CLIN NEUROL NEUROSUR, V110, P755, DOI 10.1016/j.clineuro.2008.05.005; Jaseja H, 2010, MED HYPOTHESES, V74, P855, DOI 10.1016/j.mehy.2009.11.031; Klinkenberg S, 2012, CLIN NEUROL NEUROSUR, V114, P336, DOI 10.1016/j.clineuro.2011.11.016; Klinkenberg S, 2012, DEV MED CHILD NEUROL, V54, P855, DOI 10.1111/j.1469-8749.2012.04305.x; Koo B, 2001, J CLIN NEUROPHYSIOL, V18, P434, DOI 10.1097/00004691-200109000-00008; Kosel M, 2011, PSYCHIAT RES-NEUROIM, V191, P153, DOI 10.1016/j.pscychresns.2010.11.004; Krahl SE, 2001, EPILEPSIA, V42, P586, DOI 10.1046/j.1528-1157.2001.09700.x; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Kuba R, 2002, EPILEPSIA, V43, P1181, DOI 10.1046/j.1528-1157.2002.08202.x; Kuba R, 2010, SEIZURE-EUR J EPILEP, V19, P352, DOI 10.1016/j.seizure.2010.05.009; Kumaria A, 2012, BRIT J NEUROSURG, V26, P316, DOI 10.3109/02688697.2012.663517; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; LOCKARD JS, 1990, EPILEPSIA, V31, pS20, DOI 10.1111/j.1528-1157.1990.tb05844.x; Lomarev M, 2002, J PSYCHIATR RES, V36, P219, DOI 10.1016/S0022-3956(02)00013-4; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Majoie HJM, 2011, NEUROIMMUNOMODULAT, V18, P52, DOI 10.1159/000315530; Malow BA, 2000, NEUROLOGY, V55, P1450, DOI 10.1212/WNL.55.10.1450; Malow BA, 2001, NEUROLOGY, V57, P879, DOI 10.1212/WNL.57.5.879; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; Marrosu F, 2003, EPILEPSY RES, V55, P59, DOI 10.1016/S0920-1211(03)00107-4; Marzec M, 2003, EPILEPSIA, V44, P930, DOI 10.1046/j.1528-1157.2003.56202.x; Merrill CA, 2006, J CLIN PSYCHIAT, V67, P1171, DOI 10.4088/JCP.v67n0801; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mu QW, 2004, BIOL PSYCHIAT, V55, P816, DOI 10.1016/j.biopsych.2003.12.004; Narayanan JT, 2002, EPILEPSIA, V43, P1509, DOI 10.1046/j.1528-1157.2002.16102.x; NARITOKU DK, 1995, EPILEPSY RES, V22, P53, DOI 10.1016/0920-1211(95)00035-9; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Nichols JA, 2011, NEUROSCIENCE, V189, P207, DOI 10.1016/j.neuroscience.2011.05.024; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Patel NC, 2004, PEDIATR INFECT DIS J, V23, P681, DOI 10.1097/01.inf.0000131632.25375.c7; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; PENRY JK, 1990, EPILEPSIA, V31, pS40, DOI 10.1111/j.1528-1157.1990.tb05848.x; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; RANDALL WC, 1985, AM J PHYSIOL, V249, pH133, DOI 10.1152/ajpheart.1985.249.1.H133; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; REID SA, 1990, EPILEPSIA, V31, pS38, DOI 10.1111/j.1528-1157.1990.tb05847.x; Revesz D, 2008, EXP NEUROL, V214, P259, DOI 10.1016/j.expneurol.2008.08.012; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Roosevelt RW, 2006, BRAIN RES, V1119, P124, DOI 10.1016/j.brainres.2006.08.048; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ruffoli R, 2011, J CHEM NEUROANAT, V42, P288, DOI 10.1016/j.jchemneu.2010.12.002; RUTECKI P, 1990, EPILEPSIA, V31, pS1, DOI 10.1111/j.1528-1157.1990.tb05843.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Santiago-Rodriguez E, 2006, SEIZURE-EUR J EPILEP, V15, P615, DOI 10.1016/j.seizure.2006.09.006; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2007, CURR OPIN NEUROL, V20, P638, DOI 10.1097/WCO.0b013e3282f1c6e4; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shaw GY, 2006, ANN OTO RHINOL LARYN, V115, P260, DOI 10.1177/000348940611500403; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Sirven JI, 2000, NEUROLOGY, V54, P1179, DOI 10.1212/WNL.54.5.1179; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Spanaki MV, 2004, SEIZURE-EUR J EPILEP, V13, P587, DOI 10.1016/j.seizure.2004.01.009; STERIADE M, 1982, J NEUROPHYSIOL, V48, P352, DOI 10.1152/jn.1982.48.2.352; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sucholeiki R, 2002, SEIZURE-EUR J EPILEP, V11, P157, DOI 10.1053/seiz.2001.0601; Tatum WO, 2004, EPILEPSY BEHAV, V5, P411, DOI 10.1016/j.yebeh.2004.02.009; Tatum WO, 1999, NEUROLOGY, V52, P1267, DOI 10.1212/WNL.52.6.1267; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Turner-Stokes L, 2002, DISABIL REHABIL, V24, P383, DOI 10.1080/096382801101550; UTHMAN BM, 1990, EPILEPSIA, V31, pS44, DOI 10.1111/j.1528-1157.1990.tb05849.x; Uthman BM, 2004, NEUROLOGY, V63, P1124, DOI 10.1212/01.WNL.0000138499.87068.C0; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Van Laere K, 2002, J NUCL MED, V43, P733; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vezzani A, 2011, EXP NEUROL; Vezzani A, 2012, NEUROPHARMACOLOGY; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vonck K, 2001, J CLIN NEUROPHYSIOL, V18, P394, DOI 10.1097/00004691-200109000-00002; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang HY, 2009, J NEUROL SCI, V284, P96, DOI 10.1016/j.jns.2009.04.012; WOODBURY DM, 1990, EPILEPSIA, V31, pS7, DOI 10.1111/j.1528-1157.1990.tb05852.x; WOODBURY JW, 1991, PACE, V14, P94, DOI 10.1111/j.1540-8159.1991.tb04053.x; Xiong J, 2009, MED HYPOTHESES, V73, P938, DOI 10.1016/j.mehy.2009.06.033; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353; ZABARA J, 1988, PHARMACOL TOXICOL, V63, P70, DOI 10.1111/j.1600-0773.1988.tb00913.x; Zamponi N, 2011, EUR J PAEDIATR NEURO, V15, P8, DOI 10.1016/j.ejpn.2010.09.003; Zhang WZ, 2004, J PHYSIOL-LONDON, V559, P729, DOI 10.1113/jphysiol.2004.064121	169	16	22	2	34	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					263	276		10.1179/1743132813Y.0000000167			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104QW	WOS:000316010700007	23485054	Green Accepted			2022-02-06	
J	Tyagi, E; Agrawal, R; Zhuang, YM; Abad, C; Waschek, JA; Gomez-Pinilla, F				Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Abad, Catalina; Waschek, James A.; Gomez-Pinilla, Fernando			Vulnerability Imposed by Diet and Brain Trauma for Anxiety-Like Phenotype: Implications for Post-Traumatic Stress Disorders	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; CHRONIC DISEASES; ANIMAL-MODELS; BDNF FUNCTION; DEPRESSION; INJURY; EXPRESSION; COGNITION; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION	Mild traumatic brain injury (mTBI, cerebral concussion) is a risk factor for the development of psychiatric illness such as posttraumatic stress disorder (PTSD). We sought to evaluate how omega-3 fatty acids during brain maturation can influence challenges incurred during adulthood (transitioning to unhealthy diet and mTBI) and predispose the brain to a PTSD-like pathobiology. Rats exposed to diets enriched or deficient in omega-3 fatty acids (n-3) during their brain maturation period, were transitioned to a western diet (WD) when becoming adult and then subjected to mTBI. TBI resulted in an increase in anxiety-like behavior and its molecular counterpart NPY1R, a hallmark of PTSD, but these effects were more pronounced in the animals exposed to n-3 deficient diet and switched to WD. The n-3 deficiency followed by WD disrupted BDNF signaling and the activation of elements of BDNF signaling pathway (TrkB, CaMKII, Akt and CREB) in frontal cortex. TBI worsened these effects and more prominently in combination with the n-3 deficiency condition. Moreover, the n-3 deficiency primed the immune system to the challenges imposed by the WD and brain trauma as evidenced by results showing that the WD or mTBI affected brain IL1b levels and peripheral Th17 and Treg subsets only in animals previously conditioned to the n-3 deficient diet. These results provide novel evidence for the capacity of maladaptive dietary habits to lower the threshold for neurological disorders in response to challenges.	[Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Abad, Catalina; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724; Abad, Catalina/0000-0001-9144-9310	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465, NS056413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413, R01NS050465] Funding Source: NIH RePORTER	This work was supported by National Institute of Health Grants NS050465 and NS056413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Bazarian JJ, 2012, J HEAD TRAUMA REHABI; Bowen A, 2010, ANXIETY STRESS COPIN, V23, P449, DOI 10.1080/10615800903414315; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Freeman MP, 2010, AM J PSYCHIAT, V167, P244, DOI 10.1176/appi.ajp.2009.09121746; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Issazadeh-Navikas S, 2012, MOL MED, V18, P95, DOI 10.2119/molmed.2011.00311; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Lewis MD, 2011, J CLIN PSYCHIAT, V72, P1585, DOI 10.4088/JCP.11m06879; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; Primeaux SD, 2005, NEUROPSYCHOPHARMACOL, V30, P1589, DOI 10.1038/sj.npp.1300705; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Rices D, 2000, ENVIRON HEALTH PERSP, V108, P511; Robidoux J, 2000, ENDOCRINOLOGY, V141, P2795, DOI 10.1210/en.141.8.2795; Sah R, 2009, BIOL PSYCHIAT, V66, P705, DOI 10.1016/j.biopsych.2009.04.037; Segman RH, 2005, MOL PSYCHIATR, V10, P514, DOI [10.1038/sj.mp.4001654, 10.1038/sj.mp.4001636]; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872	39	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57945	10.1371/journal.pone.0057945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	WOS:000316936100059	23483949	gold, Green Submitted, Green Published			2022-02-06	
J	Chen, Y; Huang, W; Constantini, S				Chen, Yun; Huang, Wei; Constantini, Shlomi			Concepts and Strategies for Clinical Management of Blast-Induced Traumatic Brain Injury and Posttraumatic Stress Disorder	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							OIF/OEF SERVICE MEMBERS; SUBARACHNOID HEMORRHAGE; EMOTION DYSREGULATION; MENTAL-DISORDERS; MILD TBI; THERAPY; IMPACT; HEALTH; DEPRESSION; SYMPTOMS	After exposure of the human body to blast, kinetic energy of the blast shock waves might be transferred into hydraulic energy in the cardiovascular system to cause a rapid physical movement or displacement of blood (a volumetric blood surge). The volumetric blood surge moves through blood vessels from the high-pressure body cavity to the low-pressure cranial cavity, causing damage to tiny cerebral blood vessels and the blood-brain barrier (BBB). Large-scale cerebrovascular insults and BBB damage that occur globally throughout the brain may be the main causes of non-impact, blast-induced brain injuries, including the spectrum of traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). The volumetric blood surge may be a major contributor not only to blast-induced brain injuries resulting from physical trauma, but may also be the trigger to psychiatric disorders resulting from emotional and psychological trauma. Clinical imaging technologies, which are able to detect tiny cerebrovascular insults, changes in blood flow, and cerebral edema, may help diagnose both TBI and PTSD in the victims exposed to blasts. Potentially, prompt medical treatment aiming at prevention of secondary neuronal damage may slow down or even block the cascade of events that lead to progressive neuronal damage and subsequent long-term neurological and psychiatric impairment.	[Chen, Yun] BrightstarTech Inc, Clarksburg, MD USA; [Huang, Wei] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Constantini, Shlomi] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Neurosurg, IL-69978 Tel Aviv, Israel		Chen, Y (corresponding author), BrightstarTech Inc, Pleasanton, CA USA.	yun.chen@brightstartechinc.com					American Association of Neurological Surgeons, 2011, TRAUM BRAIN INJ; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Baker DG, 2009, MIL MED, V174, P773; Baschnagel JS, 2009, J ANXIETY DISORD, V23, P915, DOI 10.1016/j.janxdis.2009.05.005; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bhardwaj A, 2007, CURR NEUROL NEUROSCI, V7, P513, DOI 10.1007/s11910-007-0079-2; Bleich A, 2005, AM J GERIAT PSYCHIAT, V13, P705; Bodvarsdottir I, 2004, SCAND J PSYCHOL, V45, P3, DOI 10.1111/j.1467-9450.2004.00373.x; Bradley B, 2011, J CLIN PSYCHIAT, V72, P685, DOI 10.4088/JCP.10m06409blu; Breslau J, 2011, ACTA PSYCHIAT SCAND, V124, P474, DOI 10.1111/j.1600-0447.2011.01712.x; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Collombet JM, 2011, BEHAV BRAIN RES, V221, P261, DOI 10.1016/j.bbr.2011.03.006; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; De Deyn PP, 1999, PHARMACOPSYCHIATRY, V32, P17, DOI 10.1055/s-2007-979232; DeKosky ST, 2003, J AM GERIATR SOC, V51, pS314, DOI 10.1046/j.1532-5415.5157.x; DiGiovanni Cleto Jr, 2003, Prehosp Disaster Med, V18, P253; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Flaherty ML, 2010, SEMIN NEUROL, V30, P565, DOI 10.1055/s-0030-1268866; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fosse Gunilla Klensmeden, 2006, Eat Behav, V7, P404, DOI 10.1016/j.eatbeh.2005.12.006; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; FUJITA N, 1994, AM J NEURORADIOL, V15, P335; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Granacher RP, 2007, TRAUMATIC BRAIN INJU, P26; Hall KM, 2011, ASS PRESS       0523; Hoge C. W., 2008, US ARMY MED DEP J; Hoozemans JJM, 2003, CURR DRUG TARGETS, V4, P461, DOI 10.2174/1389450033490902; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johannesson KB, 2011, J NERV MENT DIS, V199, P162, DOI 10.1097/NMD.0b013e31820c73d1; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kamran M, 2010, NEURORADIOLOGY, V52, P319, DOI 10.1007/s00234-009-0609-5; Katsuki H, 2010, J PHARMACOL SCI, V114, P366, DOI 10.1254/jphs.10R05CR; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kim H, 2005, NEUROL RES, V27, P287, DOI 10.1179/016164105X25234; Kline NS, 1951, AM J MENT DEF, V56, P547; KOOPMAN C, 1995, J TRAUMA STRESS, V8, P29, DOI 10.1007/BF02105405; Kwako Laura E, 2011, J Am Psychiatr Nurses Assoc, V17, P237, DOI 10.1177/1078390311402498; Lesaca T, 1996, PSYCHIAT SERV, V47, P424; Lescot T, 2008, CURR OPIN CRIT CARE, V14, P129, DOI 10.1097/MCC.0b013e3282f63c51; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lim S, 2008, J APPL PSYCHOL, V93, P95, DOI 10.1037/0021-9010.93.1.95; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu YQ, 1990, J TRAUMA, V6, P16; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mansdorf IJ, 2008, BRIT MED BULL, V88, P7, DOI 10.1093/bmb/ldn041; Marion DW, 2003, INTENSIVE CARE IN NEUROSURGERY, P47; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Papangelou A, 2009, CURR TREAT OPTION NE, V11, P64, DOI 10.1007/s11940-009-0009-5; Petty MA, 2001, BRAIN RES REV, V36, P23, DOI 10.1016/S0165-0173(01)00062-5; PLUTA R, 1989, J CEREBR BLOOD F MET, V9, P163, DOI 10.1038/jcbfm.1989.24; Qureshi AI, 2007, NEUROCRIT CARE, V6, P56, DOI 10.1385/NCC:6:1:56; Rasanen HT, 1999, STROKE, V30, P827, DOI 10.1161/01.STR.30.4.827; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Salcioglu E, 2008, WORLD J PEDIATR, V4, P165, DOI 10.1007/s12519-008-0032-8; Santillan A, 2011, NEUROSURGERY, V69, P102; Santillan A, 2011, NEUROSURGERY, V69, P95, DOI 10.1227/NEU.0b013e31821424f9; SCALEA TM, 2005, NEUROTRAUMA EVIDENCE, P3; Schneider B, 2011, PSYCHIAT RES, V190, P265, DOI 10.1016/j.psychres.2011.07.037; Scott J, 1998, ADDICT BEHAV, V23, P919, DOI 10.1016/S0306-4603(98)00074-4; Shields A, 2001, J CLIN CHILD PSYCHOL, V30, P349, DOI 10.1207/S15374424JCCP3003_7; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; Stuhmiller JH, 2008, BIQPJHSCH10 ARM MED; Suk K, 2005, NEUROSIGNALS, V14, P23, DOI 10.1159/000085383; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Summerall EL, 2007, TRAUMATIC BRAIN INJU; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TIKOFSKY RS, 1991, SEMIN NUCL MED, V21, P40, DOI 10.1016/S0001-2998(05)80078-9; TrilloPazos G, 1997, GENITOURIN MED, V73, P343; Ullman JS, 1996, CRIT CARE CLIN, V12, P697, DOI 10.1016/S0749-0704(05)70273-6; Veenema Tener Goodwin, 2002, J Pediatr Health Care, V16, P235; Vinkers DJ, 2011, CRIM BEHAV MENT HEAL, V21, P307, DOI 10.1002/cbm.819; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; WAKADE AR, 1986, J NEUROSCI, V6, P2625; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Waterloo K, 2001, J NEUROL, V248, P595, DOI 10.1007/s004150170138; Weant KA, 2010, PHARMACOTHERAPY, V30, P405, DOI 10.1592/phco.30.4.405; Wieland D, 2010, PA NURSE, P12; Wieland Diane, 2010, Pa Nurse, V65, P4; Yank V, 2011, ANN INTERN MED, V154, P529, DOI 10.7326/0003-4819-154-8-201104190-00004	88	16	16	1	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2013	25	2					103	110					8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	156FX	WOS:000319808300042	23686026				2022-02-06	
J	Drummond, M; Douglas, J; Olver, J				Drummond, Melanie; Douglas, Jacinta; Olver, John			'If I haven't got any smell ... I'm out of work': Consequences of olfactory impairment following traumatic brain injury	BRAIN INJURY			English	Article						Post-traumatic anosmia; acquired brain injury; rehabilitation	PENNSYLVANIA SMELL; DYSFUNCTION; ANOSMIA; SECONDARY; DEFICITS; IMPACT	Primary objective: Although estimates of the incidence of post-traumatic olfactory dysfunction range from 10-66.8%, there has been little research into its functional implications. The objective of this study was to describe the impact of olfactory impairment on daily activities and social participation from the perspective of adults who are living with the impairment. Research design: A qualitative research design based on a constructivist grounded theory approach. Methods and procedures: Purposive sampling of five participants with severe traumatic brain injury (TBI) who reported post-injury changes in their olfactory function was utilized. No participant had a pre-injury history of olfactory disturbance. The presence of olfactory disturbance was confirmed using the University of Pennsylvania Smell Identification Test (UPSIT). A semi-structured interview was employed to ascertain the participants' experiences. All interviews were transcribed verbatim and thematic analyses applied. Conclusions: The themes that emerged demonstrated olfactory dysfunction has significant impact on a range of activities and social roles.	[Drummond, Melanie; Olver, John] Epworth Monash Rehabil Med Unit, Richmond, Vic, Australia; [Drummond, Melanie; Olver, John] Epworth Rehabil, Richmond, Vic, Australia; [Drummond, Melanie; Douglas, Jacinta] La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic, Australia		Drummond, M (corresponding author), Epworth Rehabil, 50 Burwood Rd, Hawthorn, Vic 3122, Australia.	melanie.drummond@epworth.org.au		Olver, John/0000-0001-7069-1191; Douglas, Jacinta/0000-0003-0940-6624			[Anonymous], MOSB MED DICT; Brewer WJ, 1996, BIOL PSYCHIAT, V40, P1021, DOI 10.1016/0006-3223(95)00594-3; Bromley S, 2000, AM FAM PHYSICIAN, V1, P15; Browne J., 2004, RES METHODS NURSING, P624; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Charmaz K., 2014, BROKERAGE CLOSURE IN; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; DAVIDSON TM, 1995, POSTGRAD MED, V98, P107, DOI 10.1080/00325481.1995.11946020; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; DOTY RL, 1989, LARYNGOSCOPE, V99, P402, DOI 10.1288/00005537-198904000-00008; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 1995, SMELL IDENTIFICATION, Vthird; Drummond M., 2007, BRAIN IMPAIR, V8, P31; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Henkin RI, 1982, LOOSELEAF SERIES OTO, P1; Hirsh A, 2003, TASTE SMELL; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Holbrook Eric H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P54, DOI 10.1097/00020840-200302000-00012; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Marosszeky NEV, 1997, PTA PROTOCOL GUIDELI; MATTES RD, 1990, AM J CLIN NUTR, V51, P233, DOI 10.1093/ajcn/51.2.233; MATTES RD, 1994, J AM DIET ASSOC, V94, P50, DOI 10.1016/0002-8223(94)92041-9; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schiffman S, 1990, FIGHTING LOSS SMELL; Sensonics Inc., POCK SMELL TEST; Solomon GS, 1998, J NEUROPSYCH CLIN N, V10, P64, DOI 10.1176/jnp.10.1.64; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; WHO, 2000, INT CLASS FUNCT DIS; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	44	16	16	0	26	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2013	27	3					332	345		10.3109/02699052.2012.750743			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400011	23438353				2022-02-06	
J	Kowalczyk, M; Nestorowicz, A; Fijalkowska, A; Kwiatosz-Muc, M				Kowalczyk, Michal; Nestorowicz, Andrzej; Fijalkowska, Anna; Kwiatosz-Muc, Magdalena			Emotional sequelae among survivors of critical illness: a long-term retrospective study	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article							QUALITY-OF-LIFE; RESPIRATORY-DISTRESS-SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; CARE-UNIT SURVIVORS; INTENSIVE-CARE; PSYCHOLOGICAL DISTRESS; DEPRESSION SCALE; HOSPITAL ANXIETY; MENTAL-HEALTH; ICU SURVIVORS	Context Treatment in an ICU can be stressful and traumatic for patients, and can lead to various physical, psychological and cognitive sequelae. Objectives The aim of the study was to assess the influence of the social, economic and working status of individuals in regard to long-term anxiety and depression among ICU convalescents. Design Retrospective, cross-sectional, 5-year survey between 2005 and 2009. Setting The general ICUs of two hospitals in Lublin (Poland): the Teaching Hospital, Medical University of Lublin and the District Hospital. Patients All adults surviving an ICU stay of more than 24 h were eligible. In December 2010, 533 questionnaires were sent to discharged ICU survivors, and 195 (36.6%) were returned. One hundred and eighty-six patients were enrolled in the study. Patients with brain injuries were excluded. Main outcome measures The questionnaire consisted of the Hospital Anxiety and Depression Scale (HADS); questions defining social, economic and working status before and after intensive care stay, health status before intensive care stay, as well as questions about memories and readmissions to intensive care were included. Results According to HADS, 34.4% patients had an anxiety disorder and 27.4% were depressed. There was a strong positive correlation between anxiety and depression (r = +0.726, P < 0.001). Better material and housing conditions correlated with lower anxiety and depression rates. Acute Physiology and Chronic Health Evaluation II scores on admission positively correlated with both anxiety (r = +0.187; P = 0.011) and depression (r = +0.239; P = 0.001). A negative correlation between health status before intensive care admission and HADS scores was observed (anxiety r(s) = -0.193; P = 0.008; depression r(s) = -0.227; P = 0.002); better health resulted in less anxiety and depression disorders. Conclusion Adverse social and economic status is associated with higher rates of anxiety and depression following ICU stay. Eur J Anaesthesiol 2013; 30:111-118	[Kowalczyk, Michal; Nestorowicz, Andrzej; Fijalkowska, Anna; Kwiatosz-Muc, Magdalena] Med Univ Lublin, Dept Anaesthesiol & Intens Care 1, Lublin, Poland		Kowalczyk, M (corresponding author), Ul Szwajcarska 10-16, PL-20861 Lublin, Poland.	michalkowalczyk@vp.pl	Kowalczyk, Michal/AAN-1914-2021	Kowalczyk, Michal/0000-0002-1991-190X; Kwiatosz-Muc, Magdalena/0000-0002-0064-1604			Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Brooks R, 1997, INTENS CARE MED, V23, P581, DOI 10.1007/s001340050376; Cuthbertson BH, 2005, ANAESTHESIA, V60, P332, DOI 10.1111/j.1365-2044.2004.04109.x; Davydow DS, 2009, INTENS CARE MED, V35, P796, DOI 10.1007/s00134-009-1396-5; Eddleston JM, 2000, CRIT CARE MED, V28, P2293, DOI 10.1097/00003246-200007000-00018; Griffiths RD, 1999, BRIT MED J, V319, P427, DOI 10.1136/bmj.319.7207.427; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; KATZ IR, 1982, PSYCHOSOMATICS, V23, P846; Katz IR, 1996, AM J GERIAT PSYCHIAT, V4, P1, DOI 10.1097/00019442-199624410-00001; Kiekkas P, 2010, INT NURS REV, V57, P288, DOI 10.1111/j.1466-7657.2010.00809.x; Kowalczyk Michal, 2008, Anestezjol Intens Ter, V40, P162; Nelson BJ, 2000, CRIT CARE MED, V28, P3626, DOI 10.1097/00003246-200011000-00013; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Orwelius L, 2005, CRIT CARE MED, V33, P1557, DOI 10.1097/01.CCM.0000168208.32006.1C; PEARLSON GD, 1989, PSYCHOL MED, V19, P573, DOI 10.1017/S003329170002417X; Rattray JE, 2005, ANAESTHESIA, V60, P1085, DOI 10.1111/j.1365-2044.2005.04336.x; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Snaith RP, 1994, HOSP ANXIETY DEPRESS, P1; Sukantarat KT, 2007, ANAESTHESIA, V62, P239, DOI 10.1111/j.1365-2044.2006.04948.x; Sukantarat K, 2007, BRIT J HEALTH PSYCH, V12, P65, DOI 10.1348/135910706X94096; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Toien K, 2010, J TRAUMA, V69, P1552, DOI 10.1097/TA.0b013e3181e125f3; Truman Brenda, 2003, Crit Care Nurse, V23, P25; Wojcik M., 2003, THESIS MED U LUBLIN, P286; Zifko UA, 2000, MUSCLE NERVE, pS49; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	16	19	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	MAR	2013	30	3					111	118		10.1097/EJA.0b013e32835dcc45			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	085QT	WOS:000314630000005	23358098				2022-02-06	
J	Lustenberger, T; Talving, P; Lam, L; Inaba, K; Bass, M; Plurad, D; Demetriades, D				Lustenberger, Thomas; Talving, Peep; Lam, Lydia; Inaba, Kenji; Bass, Margarita; Plurad, David; Demetriades, Demetrios			Effect of diabetes mellitus on outcome in patients with traumatic brain injury: A national trauma databank analysis	BRAIN INJURY			English	Article						Diabetes mellitus; head injury; traumatic brain injury; outcome; mortality	CRITICALLY-ILL PATIENTS; PREEXISTING CONDITIONS; HEAD-INJURY; HYPERGLYCEMIA; IMPACT; MORTALITY; APOPTOSIS; RATS	Background: Diabetes mellitus (DM) is associated with worsened outcomes following severe injury. However, clinical studies evaluating the effect of DM on outcomes in patients suffering traumatic brain injury (TBI) are currently lacking. Methods: This was a National Trauma Databank (NTDB) study over a 5-year period. Patients with DM were matched with victims of isolated TBI without DM in a 1: 2 ratio. Outcomes included mortality, hospital and surgical intensive care unit (SICU) length of stay, ventilator days and discharge disposition. Results: Of the 35 005 patients with isolated TBI, 636 (1.8%) cases had documented DM. After matching 1272 counterparts without DM, no differences with regards to demographic and injury characteristics were observed comparing the two groups. Overall mortality in the study population was 18.8% (n = 358), with a significantly increased in-hospital mortality in patients with vs without DM [22.6% vs 16.8%; OR (95% CI): 1.45 (1.14-1.83); p = 0.002]. Patients with DM were significantly less frequently discharged home compared to their counterparts without DM [38.9% vs 46.1%; OR (95% CI): 0.75 (0.60-0.93); p = 0.008]. Conclusion: Traumatic brain injury in conjunction with diabetes mellitus is associated with an almost 1.5-fold increased mortality while compared to patients with isolated TBI without diabetes mellitus. Prospective validation of these findings is warranted to determine the underlying aetiology.	[Lustenberger, Thomas; Talving, Peep; Lam, Lydia; Inaba, Kenji; Bass, Margarita; Plurad, David; Demetriades, Demetrios] Univ So Calif, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, Dept Surg,Med Ctr, Los Angeles, CA 90033 USA		Talving, P (corresponding author), Univ So Calif, Los Angeles Cty Gen Hosp LAC USC, Keck Sch Med, Div Acute Care Surg Trauma Emergency Surg & Surg, 1200 North State St,C5L100, Los Angeles, CA 90033 USA.	peep.talving@surgery.usc.edu	Talving, Peep/G-8621-2015; Talving, Peep/E-6015-2013; INABA, KENJI/AAC-8532-2020	Talving, Peep/0000-0002-9741-2073; 			Ahmad R, 2007, ARCH SURG-CHICAGO, V142, P613, DOI 10.1001/archsurg.142.7.613; American College of Surgeons Committee on Trauma, 2007, US MAN NAT TRAUM DAT; Bochicchio GV, 2006, WORLD J SURG, V30, P114, DOI 10.1007/s00268-005-0203-x; Cole FJ, 2007, J TRAUMA, V63, P1358; Dubey A, 2000, Bull Hosp Jt Dis, V59, P94; Elangovan V, 2000, J NEUROTRAUM, V17, P1013, DOI 10.1089/neu.2000.17.1013; FIETSAM R, 1991, AM SURGEON, V57, P551; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Halkos ME, 2010, ANN THORAC SURG, V90, P124, DOI 10.1016/j.athoracsur.2010.03.111; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kao LS, 2006, AM J SURG, V192, P710, DOI 10.1016/j.amjsurg.2006.08.031; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Li ZG, 2004, LIFE SCI, V76, P249, DOI 10.1016/j.lfs.2004.03.039; Lieberman D, 1996, DISABIL REHABIL, V18, P224, DOI 10.3109/09638289609166305; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Malmberg K, 1997, CARDIOVASC RES, V34, P248, DOI 10.1016/S0008-6363(96)00263-5; McCampbell B, 2002, J BURN CARE REHABIL, V23, P157, DOI 10.1097/00004630-200205000-00004; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; Rizk NN, 2005, BRAIN RES, V1053, P1, DOI 10.1016/j.brainres.2005.05.036; Thourani VH, 1999, ANN THORAC SURG, V67, P1045, DOI 10.1016/S0003-4975(99)00143-5; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	24	16	16	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2013	27	3					281	285		10.3109/02699052.2012.743178			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400004	23252407				2022-02-06	
J	Radomski, MV; Weightman, MM; Davidson, LF; Finkelstein, M; Goldman, S; McCulloch, K; Roy, TC; Scherer, M; Stern, EB				Radomski, Mary Vining; Weightman, Margaret M.; Davidson, Leslie Freeman; Finkelstein, Marsha; Goldman, Sarah; McCulloch, Karen; Roy, Tanja C.; Scherer, Matthew; Stern, Erica B.			Development of a Measure to Inform Return-to-Duty Decision Making After Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							ECOLOGICAL VALIDITY; COGNITIVE TASKS; CONCUSSION; PERFORMANCE; ATTENTION; RECOVERY; DEFICITS; GAIT; INTERFERENCE; STABILITY	Mild traumatic brain injury (mTBI), a principal injury of the wars in Iraq and Afghanistan, can result in significant morbidity. To make accurate return-to-duty decisions for soldiers with mTBI, military medical personnel require sensitive, objective, and duty-relevant data to characterize subtle cognitive and sensorimotor injury sequelae. A military-civilian research team reviewed existing literature and obtained input from stakeholders, end users, and experts to specify the concept and develop a preliminary assessment protocol to address this need. Results of the literature review suggested the potential utility of a test based on dual-task and multitask assessment methods. Thirty-three individuals representing a variety of military and civilian stakeholders/experts participated in interviews. Interview data suggested that reliability/validity, clinical feasibility, usability across treatment facilities, military face validity, and capacity to challenge mission-critical mTBI vulnerabilities were important to ultimate adoption. The research team developed the Assessment of Military Multitasking Performance, a tool composed of eight dual and multitasking test-tasks. A concept test session with 10 subjects indicated preliminary face validity and informed modifications to scoring and design. Further validation is needed. The Assessment of Military Multitasking Performance may fill a gap identified by stakeholders for complex cognitive/motor testing to assist return-to-duty decisions for service members with mTBI.	[Radomski, Mary Vining; Weightman, Margaret M.; Finkelstein, Marsha] Sister Kenny Res Ctr, Minneapolis, MN 55407 USA; [Davidson, Leslie Freeman] Shenandoah Univ, Div Occupat Therapy, Winchester, VA 22601 USA; [Goldman, Sarah; Roy, Tanja C.; Scherer, Matthew] US Army Res Inst Environm Med, Natick, MA 01760 USA; [McCulloch, Karen] Univ N Carolina, Sch Med, Div Phys Therapy, Chapel Hill, NC 27599 USA; [Stern, Erica B.] Univ Minnesota, Ctr Allied Hlth Programs, Program Occupat Therapy, Minneapolis, MN 55455 USA		Radomski, MV (corresponding author), Sister Kenny Res Ctr, 800 East 28th St & Chicago Ave, Minneapolis, MN 55407 USA.				U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-2-0149]	The research team acknowledges the contribution of those interviewed and the following partners and experts who have helped to shape the AMMP protocol: Amanda Antczalc, MS; Kristin Heaton, PhD; Val Kelly PT, PhD; Lynne M. Lowe, PT, DPT, OCS; Tracy Morrison, OTD, OTR/L; Lars Oddsson, PhD; John Whyte, MD, PhD; and Tim Wolf, OTD, MSCI, OTR/L. This project was funded by the U.S. Army Medical Research and Materiel Command (award number W81XWH-09-2-0149).	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Armed Forces Health Surveillance Center, TBI NUMB SEV ALL ARM; Arnadottir A, 1990, BRAIN BEHAV ASSESSIN; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P465; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cockburn J, 2003, CLIN REHABIL, V17, P167, DOI 10.1191/0269215503cr597oa; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Department of the Army, 2006, SOLD MAN COMM TASKS; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Grant I., 2010, NEUROPSYCHOLOGY EVER, P93; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kenworthy L, 2008, NEUROPSYCHOL REV, V18, P320, DOI 10.1007/s11065-008-9077-7; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; LAWTON MP, 1971, J AM GERIATR SOC, V19, P465, DOI 10.1111/j.1532-5415.1971.tb01206.x; Lynn WJI, 2010, 09033 DTM DEP DEF; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; Maylor EA, 2001, BRIT J PSYCHOL, V92, P319, DOI 10.1348/000712601162211; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Meher I, 2004, J AM GERIATR SOC, V52, P1255, DOI 10.1111/j.1532-5415.2004.52353.x; Moore DJ, 2007, J PSYCHIATR RES, V41, P97, DOI 10.1016/j.jpsychires.2005.10.008; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Siu KC, 2009, BRAIN RES, V1248, P59, DOI 10.1016/j.brainres.2008.10.078; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vaskinn A, 2009, J NERV MENT DIS, V197, P700, DOI 10.1097/NMD.0b013e3181b3ae62; Wolf TJ, 2008, WORK, V31, P221	48	16	16	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2013	178	3					246	253		10.7205/MILMED-D-12-00144			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7TX	WOS:000340805000003	23707109	Green Submitted, Bronze			2022-02-06	
J	Takeuchi, S; Nawashiro, H; Wada, K; Takasato, Y; Masaoka, H; Hayakawa, T; Nagatani, K; Otani, N; Osada, H; Shima, K				Takeuchi, Satoru; Nawashiro, Hiroshi; Wada, Kojiro; Takasato, Yoshio; Masaoka, Hiroyuki; Hayakawa, Takanori; Nagatani, Kimihiro; Otani, Naoki; Osada, Hideo; Shima, Katsuji			Ventriculomegaly after decompressive craniectomy with hematoma evacuation for large hemispheric hypertensive intracerebral hemorrhage	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Decompressive craniectomy; Ventriculomegaly; Intracerebral hemorrhage; Hypertensive	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; QUALITY-OF-LIFE; MALIGNANT INFARCTION; RANDOMIZED-TRIAL; SURGICAL TRIAL; HEAD-INJURY; HEMICRANIECTOMY; HYDROCEPHALUS	Objective: The aim of the present study was to investigate factors associated with the development of ventriculomegaly suggestive of hydrocephalus (VSOH) after decompressive craniectomy with hematoma evacuation for hemispheric hypertensive intracerebral hemorrhage. Methods: This study focused on 21 patients who underwent decompressive craniectomy with hematoma evacuation for hemispheric hypertensive intracerebral hemorrhage. The patients' clinical and radiological findings were retrospectively reviewed. Results: Eleven patients were male and ten were female, with an age range from 22 to 75 years (mean, 56.6 years). The preoperative Glasgow Coma Scale score ranged from 3 to 13 (mean, 6.9). Hematoma volumes ranged from 33.4 to 98.1 ml (mean, 74.2 ml). Hematoma locations were the basal ganglia in 10 patients and the subcortex in 11 patients. The presence of intraventricular hemorrhage was significantly associated with the development of VSOH (P=0.023). The distance of the decompressive defect to the midline and the presence of meningitis showed a strong trend for association with VSOH (P=0.051, P=0.090, respectively). Conclusion: Careful attention should be paid to the occurrence of VSOH after decompressive craniectomy with hematoma evacuation in intracerebral hemorrhage patients with intraventricular extension, meningitis, and/or a short distance of the decompressive defect to the midline. (C) 2012 Elsevier B.V. All rights reserved.	[Takeuchi, Satoru; Nawashiro, Hiroshi; Wada, Kojiro; Nagatani, Kimihiro; Otani, Naoki; Osada, Hideo; Shima, Katsuji] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan; [Takasato, Yoshio; Masaoka, Hiroyuki; Hayakawa, Takanori] Natl Hosp Org Disaster Med Ctr, Dept Neurosurg, Tokyo, Japan		Takeuchi, S (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	s.takeuchi@room.ocn.ne.jp					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; ANDERSON CS, 1994, J NEUROL NEUROSUR PS, V57, P936, DOI 10.1136/jnnp.57.8.936; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; GIROUD M, 1991, J NEUROL NEUROSUR PS, V54, P595, DOI 10.1136/jnnp.54.7.595; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Ma L, 2010, J STROKE CEREBROVASC, V19, P294, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.002; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mendelow AD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-124; Mendelow AD, 2005, LANCET, V365, P387; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murthy JMK, 2005, NEUROCRIT CARE, V2, P258, DOI 10.1385/NCC:2:3:258; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Ramnarayan R, 2009, J STROKE CEREBROVASC, V18, P1, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.001; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Staykov D, 2009, STROKE, V40, P3275, DOI 10.1161/STROKEAHA.109.551945; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	37	16	22	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2013	115	3					317	322		10.1016/j.clineuro.2012.05.026			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	095BJ	WOS:000315309200013	22727212				2022-02-06	
J	Aungst, S; England, PM; Thompson, SM				Aungst, Stephanie; England, Pamela M.; Thompson, Scott M.			Critical role of trkB receptors in reactive axonal sprouting and hyperexcitability after axonal injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						traumatic brain injury; hippocampus; lesion; plasticity; posttraumatic epilepsy	TRAUMATIC BRAIN-INJURY; MOSSY FIBER PATHWAY; SYNAPTIC-TRANSMISSION; POSTTRAUMATIC EPILEPSY; HIPPOCAMPAL-NEURONS; KAINIC ACID; RAT HIPPOCAMPUS; CEREBRAL-CORTEX; MESSENGER-RNA; DENTATE GYRUS	Aungst S, England PM, Thompson SM. Critical role of trkB receptors in reactive axonal sprouting and hyperexcitability after axonal injury. J Neurophysiol 109: 813-824, 2013. First published November 14, 2012; doi:10.1152/jn.00869.2012.-Traumatic brain injury (TBI) causes many long-term neurological complications. Some of these conditions, such as posttraumatic epilepsy, are characterized by increased excitability that typically arises after a latent period lasting from months to years, suggesting that slow injury-induced processes are critical. We tested the hypothesis that trkB activation promotes delayed injury-induced hyperexcitability in part by promoting reactive axonal sprouting. We modeled penetrative TBI with transection of the Schaffer collateral pathway in knock-in mice having an introduced mutation in the trkB receptor (trkB(F616A)) that renders it susceptible to inhibition by the novel small molecule 1NMPP1. We observed that trkB activation was increased in area CA3 1 day after injury and that expression of a marker of axonal growth, GAP43, was increased 7 days after lesion. Extracellular field potentials in stratum pyramidale of area CA3 in acute slices from sham-operated and lesioned mice were normal in control saline. Abnormal bursts of population spikes were observed under conditions that were mildly proconvulsive but only in slices taken from mice lesioned 7-21 days earlier and not in slices from control mice. trkB activation, GAP43 upregulation, and hyperexcitability were diminished by systemic administration of 1NMPP1 for 7 days after the lesion. Synaptic transmission from area CA3 to area CA1 recovered 7 days after lesion in untreated mice but not in mice treated with 1NMPP1. We conclude that trkB receptor activation and reactive axonal sprouting are critical factors in injury-induced hyperexcitability and may contribute to the neurological complications of TBI.	[Aungst, Stephanie; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Aungst, Stephanie; Thompson, Scott M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [England, Pamela M.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA		Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Thompson, Scott M/K-8921-2015		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-40338, F31 NS-071981-01A1]; Epilepsy Foundation of America; Sandler Foundation; Whitehall Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040338, F31NS071981] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (R01 NS-40338 to S. M. Thompson, F31 NS-071981-01A1 to S. Aungst), the Epilepsy Foundation of America Predoctoral Fellowship to S. Aungst, and the Sandler Foundation and Whitehall Foundation to P. M. England.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bausch SB, 2004, J NEUROPHYSIOL, V92, P3582, DOI 10.1152/jn.01028.2003; Bendotti C, 1997, EUR J NEUROSCI, V9, P93, DOI 10.1111/j.1460-9568.1997.tb01357.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENOWITZ LI, 1990, MOL BRAIN RES, V8, P17, DOI 10.1016/0169-328X(90)90004-W; Binder DK, 1999, J NEUROSCI, V19, P4616; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; da Silva A M, 1992, Acta Neurochir Suppl (Wien), V55, P56; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Emery DL, 2000, J COMP NEUROL, V424, P521; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; HAAS HL, 1980, J PHYSIOL-LONDON, V308, P315, DOI 10.1113/jphysiol.1980.sp013473; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; NADLER JV, 1980, BRAIN RES, V182, P1; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; SCHWARTZKROIN PA, 1980, BRAIN RES, V183, P61, DOI 10.1016/0006-8993(80)90119-5; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; TASKER RR, 1991, SYMP PAIN R, P31; Tian GF, 2002, J NEUROPHYSIOL, V88, P236, DOI 10.1152/jn.00572.2001; Traub RD., 1991, NEURONAL NETWORKS HI; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	54	16	17	0	9	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	FEB	2013	109	3					813	824		10.1152/jn.00869.2012			12	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	085TI	WOS:000314636800020	23155176	Green Published			2022-02-06	
J	Bell, ED; Kunjir, RS; Monson, KL				Bell, E. David; Kunjir, Rahul S.; Monson, Kenneth L.			Biaxial and failure properties of passive rat middle cerebral arteries	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Rat cerebral arteries; Passive biaxial mechanical properties	MECHANICAL-PROPERTIES; BLOOD-VESSELS	Rodents are commonly used as test subjects in research on traumatic brain injury and stroke. However, study of rat cerebral vessel properties has largely been limited to pressure-diameter response within the physiological loading range. A more complete, multiaxial description is needed to guide experiments on rats and rat vessels and to appropriately translate findings to humans. Accordingly, we dissected twelve rat middle cerebral arteries (MCAs) and subjected them to combined inflation and axial stretch tests around physiological loading conditions while in a passive state. The MCAs were finally stretched axially to failure. Results showed that MCAs under physiological conditions were stiffer in the axial than circumferential direction by a mean (+/- standard deviation) factor of 1.72 (+/- 0.73), similar to previously reported behavior of human cerebral arteries. However, the stiffness for both directions was lower in rat MCA than in human cerebral arteries (p < 0.01). Failure stretch values were higher in rat MCA (1.35 +/- 0.08) than in human vessels (1.24 +/- 0.09) (p=0.003), but corresponding 1st Piola Kirchhoff stress values for rats (0.42 +/- 0.09 MPa) were considerably lower than those for humans (3.29 +/- 0.64 MPa) (p < .001). These differences between human and rat vessel properties should be considered in rat models of human cerebrovascular injury and disease. (C) 2012 Elsevier Ltd. All rights reserved.	[Bell, E. David; Monson, Kenneth L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Kunjir, Rahul S.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA		Monson, KL (corresponding author), Univ Utah, 50 S Cent Campus Dr,MEB 2132, Salt Lake City, UT 84112 USA.	ken.monson@mech.utah.edu	Monson, Ken/L-4702-2019; Bell, E David/K-7196-2013	Monson, Ken/0000-0002-8461-6034	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K25HD048643]; Department of DefenseUnited States Department of Defense [W81XWH-08-1-0295]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K25HD048643] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health (5K25HD048643) and the Department of Defense (W81XWH-08-1-0295).	Baek S, 2007, COMPUT METHOD APPL M, V196, P3070, DOI 10.1016/j.cma.2006.06.018; BUSBY DE, 1965, CAN J PHYSIOL PHARM, V43, P185, DOI 10.1139/y65-018; CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600; Coulson RJ, 2004, J BIOMECH ENG-T ASME, V126, P76, DOI 10.1115/1.1645525; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; Faul M, 2010, TRAUMATIC BRAIN INJU; Fung Y. C., 1993, BIOMECHANICS MECH PR; Gonzalez JM, 2005, EXP PHYSIOL, V90, P463, DOI 10.1113/expphysiol.2005.030056; HAJDU MA, 1994, AM J PHYSIOL, V266, pH1027, DOI 10.1152/ajpheart.1994.266.3.H1027; HAYASHI K, 1980, BIORHEOLOGY, V17, P211; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P340, DOI 10.1115/1.2891194; Humphrey JD, 2002, CARDIOVASCULAR SOLID; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Monson KL, 2008, ANN BIOMED ENG, V36, P2028, DOI 10.1007/s10439-008-9578-9; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SAE (Society of Automotive Engineers), 1995, J2111 SAE; SCOTT S, 1972, CAN J PHYSIOL PHARM, V50, P328, DOI 10.1139/y72-049; Steelman SM, 2010, J BIOMECH, V43, P2717, DOI 10.1016/j.jbiomech.2010.06.024; VANLOON P, 1977, BIORHEOLOGY, V14, P181; Wagner HP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003873; Wicker BK, 2008, COMPUT METHOD BIOMEC, V11, P539, DOI 10.1080/10255840801949793	25	16	16	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JAN 4	2013	46	1					91	96		10.1016/j.jbiomech.2012.10.015			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	080QJ	WOS:000314258000016	23141521	Green Accepted			2022-02-06	
J	Baek, SO; Kim, OL; Kim, SH; Kim, MS; Son, SM; Cho, YW; Byun, WM; Jang, SH				Baek, Seung Ok; Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Soo; Son, Su Min; Cho, Yoon Woo; Byun, Woo Mok; Jang, Sung Ho			Relation between cingulum injury and cognition in chronic patients with traumatic brain injury; diffusion tensor tractography study	NEUROREHABILITATION			English	Article						Cognition; memory; traumatic brain injury; cingulum; diffusion tensor imaging	RHESUS-MONKEY; CORTEX; ANTERIOR; TRACTS; PATHWAYS; CHILDREN; NUCLEUS; BUNDLES; MEMORY	OBJECTIVES: Many diffusion tensor imaging (DTI) studies have reported an association between cingulum injury and cognition in patients with traumatic brain injury (TBI) using DTI parameters. In this study, we attempted to investigate the relation between cingulum injury and cognition in chronic patients with TBI, using the integrity of the cingulum as well as DTI parameters. METHOD: Thirty five consecutive chronic patients with TBI were recruited. The intelligence quotient (IQ) of the Wechsler Intelligence Scale and Memory Assessment Scale (MAS) was used for assessment of cognition. The patients were classified into three groups, according to continuity to the lower portion of the genu of the corpus callosum: type A-both sides of the cingulum showed intact continuity, type B-either cingulum showed a discontinuation, and, type C-both cingulums showed discontinuation. We measured the fractional anisotropy (FA), apparent diffusion coefficient (ADC), and voxel number of both cingulums. RESULTS: The IQ and MAS scores of type A and B were significantly higher than those of type C, respectively (p < 0.05), however, we did not observe a significant difference between type A and type B (p > 0.05). A positive correlation was observed between the FA value of the cingulum, and IQ and MAS, respectively (IQ r = 0.373, p < 0.05, MAS r = 0.357, p < 0.05), and between the voxel number and MAS (r = 0.500, p < 0.05). By contrast, we observed a negative correlation between the ADC value and IQ (r = -0.353, p < 0.05). CONCLUSION: In terms of integrity to the basal forebrain and DTI parameters of the injured cingulum, DTI findings showed a close association with whole cognition and memory in chronic patients with TBI.	[Baek, Seung Ok; Son, Su Min; Cho, Yoon Woo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Soo] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Byun, Woo Mok] Yeungnam Univ, Coll Med, Dept Diagnost Radiol, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			National Research Foundation of Korea(NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A0 1001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A0 1001873).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Baev K. V., 1998, BIOL NEURAL NETWORKS, Vxxxvii; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; FitzGerald M. J. T., 2011, CLIN NEUROANATOMY NE, Vxi; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Jung YJ, 2012, AM J NEURORADIOL, V33, P1775, DOI 10.3174/ajnr.A3027; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Nieuwenhuys R, 2008, HUMAN CENTRAL NERVOU, Vxiv; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pagani E, 2007, MAGN RESON MED, V58, P527, DOI 10.1002/mrm.21346; Paxinos G, 2004, RAT NERVOUS SYSTEM, Vxvii; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D, 1981, WECHSLER ADULT INTEL; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williams J. M., 1991, MEMORY ASSESSMENT SC, Viv; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeo SS, 2012, NEUROREHABILITATION, V31, P143, DOI 10.3233/NRE-2012-0783	36	16	16	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	3					465	471		10.3233/NRE-130979			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	252DY	WOS:000326986400013	23949082				2022-02-06	
S	Cummings, L		Capone, A; LoPiparo, F; Carapezza, M		Cummings, Louise			Clinical Pragmatics and Theory of Mind	PERSPECTIVES ON LINGUISTIC PRAGMATICS	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; FRAGILE-X-SYNDROME; HIGH-FUNCTIONING AUTISM; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDRENS COMMUNICATION CHECKLIST; DEFICIT HYPERACTIVITY DISORDER; RIGHT-HEMISPHERE; LANGUAGE IMPAIRMENT; PARKINSONS-DISEASE; ASPERGER-SYNDROME	Theory of mind (ToM) describes the cognitive ability to attribute mental states both to one's own mind and to the minds of others. In recent years, ToM has been credited with playing a significant role in developmental and acquired pragmatic disorders. In this way, ToM deficits have been linked to pragmatic deficits in individuals with autism spectrum disorders (e. g. Martin and McDonald, Journal of Autism and Developmental Disorders, 34, 311-328, 2004), emotional and behavioural disorders (e. g. Buitelaar et al., Development and Psychopathology, 11, 39-58, 1999), intellectual disability (e. g. Cornish et al., Journal of Intellectual Disability Research, 49, 372-378, 2005), right-hemisphere damage (e. g. Winner et al., Brain and Language, 62, 89-106, 1998), schizophrenia (e. g. Brune and Bodenstein, Schizophrenia Research, 75, 233-239, 2005), traumatic brain injury (e. g. McDonald and Flanagan, Neuropsychology, 18, 572-579, 2004) and neurodegenerative disorders such as Alzheimer's disease (e. g. Cuerva et al., Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14, 153-158, 2001). In this chapter, I examine the central role of ToM reasoning in utterance interpretation. The chapter addresses what is known about ToM development during childhood and adolescence as well as changes in ToM skills as part of the aging process. The role of ToM in developmental and acquired pragmatic disorders is discussed. The contribution of ToM research into pragmatic disorders is critically evaluated. Finally, several ToM theories are examined. The question is addressed of which, if any, of these theories is able to capture the pragmatic features of utterance interpretation.	[Cummings, Louise] Nottingham Trent Univ, Nottingham, England		Cummings, L (corresponding author), Nottingham Trent Univ, Nottingham, England.	louise.cummings@ntu.ac.uk		Cummings, Louise/0000-0002-8947-8195			Abbecluto L, 2008, AM J MENT RETARD, V113, P214, DOI 10.1352/0895-8017(2008)113[214:SNOLAC]2.0.CO;2; Abbeduto L, 2004, J INTELL DISABIL RES, V48, P150, DOI 10.1111/j.1365-2788.2004.00524.x; Abbeduto L, 2001, Downs Syndr Res Pract, V7, P9, DOI 10.3104/reports.109; Abbeduto L, 2006, AM J MENT RETARD, V111, P170, DOI 10.1352/0895-8017(2006)111[170:CIRCCO]2.0.CO;2; Adachi T, 2004, BRAIN DEV-JPN, V26, P301, DOI 10.1016/S0387-7604(03)00170-0; Adams C, 2009, INT J LANG COMM DIS, V44, P301, DOI 10.1080/13682820802051788; Adrian JE, 2007, CHILD DEV, V78, P1052, DOI 10.1111/j.1467-8624.2007.01052.x; Annaz D, 2009, INT J LANG COMM DIS, V44, P962, DOI 10.3109/13682820802525005; Armstrong K, 2012, SCHIZOPHRENIA BULL, V38, P622, DOI 10.1093/schbul/sbq145; Averbeck BB, 2011, SCHIZOPHR RES, V127, P115, DOI 10.1016/j.schres.2010.08.009; Bach LJ, 2006, BRAIN COGNITION, V60, P196; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S., 2000, UNDERSTANDING OTHER, P3, DOI DOI 10.1093/ACPROF:OSO/9780199692972.001.0001; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Beeke S, 2003, CLIN LINGUIST PHONET, V17, P291, DOI 10.1080/0269920031000080055; Berthiaume KS, 2010, J ATTEN DISORD, V14, P31, DOI 10.1177/1087054709347197; Bignell S, 2007, BRIT J DEV PSYCHOL, V25, P499, DOI 10.1348/026151006X171343; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1017/S0021963098002832; Bishop DVM, 2000, DEV PSYCHOPATHOL, V12, P177, DOI 10.1017/S0954579400002042; Bishop DVM, 2001, DEV MED CHILD NEUROL, V43, P809, DOI 10.1017/S0012162201001475; Blake ML, 2006, AM J SPEECH-LANG PAT, V15, P255, DOI 10.1044/1058-0360(2006/024); Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; Borod JC, 2000, NEUROPSYCHOLOGY, V14, P112, DOI 10.1037/0894-4105.14.1.112; Bosco FM, 2006, COGNITIVE DEV, V21, P3, DOI 10.1016/j.cogdev.2005.09.006; Botting N, 2005, INT J LANG COMM DIS, V40, P49, DOI 10.1080/13682820410001723390; Brownell H, 1999, BRAIN LANG, V68, P442, DOI 10.1006/brln.1999.2122; BRUNDAGE S, 1996, CLIN APHASIOLOGY, V24, P215; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947; Carlomagno S, 2005, CORTEX, V41, P520, DOI 10.1016/S0010-9452(08)70192-8; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Carlson SM, 2004, J EXP CHILD PSYCHOL, V87, P299, DOI 10.1016/j.jecp.2004.01.002; Carruthers Peter, 1996, THEORIES THEORIES MI, P1; Castelli I, 2011, AGING MENT HEALTH, V15, P157, DOI 10.1080/13607863.2010.513038; Chapman SB, 1997, APHASIOLOGY, V11, P337, DOI 10.1080/02687039708248475; Charman T, 2000, COGNITIVE DEV, V15, P481, DOI 10.1016/S0885-2014(01)00037-5; Cheang HS, 2006, CLIN LINGUIST PHONET, V20, P447, DOI 10.1080/02699200500135684; Coelho C, 2003, APHASIOLOGY, V17, P173, DOI 10.1080/729255216; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Cohen DJ., 2000, UNDERSTANDING OTHER, P21; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; Corcoran Rhiannon, 2003, Cogn Neuropsychiatry, V8, P223, DOI 10.1080/13546800244000319; Cornish K, 2005, J INTELL DISABIL RES, V49, P372, DOI 10.1111/j.1365-2788.2005.00678.x; Cuerva AG, 2001, NEUROPSY NEUROPSY BE, V14, P153; Cummings L, 2009, CLINICAL PRAGMATICS, P1; Cummings L., 2014, CAMBRIDGE HDB COMMUN, P559; Cummings L., 2012, HDB PRAGMATICS, V4, P291; CUMMINGS L, 2005, PRAGMATICS MULTIDISC; Cummings L., 2010, ROUTLEDGE PRAGMATICS, P40; Cummings L., 2014, COMMUNICATION DISORD; Cummings L., 2012, WHAT IS CONTEXT LING, P55, DOI DOI 10.1075/LA.196.06CUM; Cummings L., 2014, OXFORD HDB PRAGMATIC; Cummings L, 2007, LANG COMMUN, V27, P396, DOI 10.1016/j.langcom.2007.06.001; Cummings L, 2011, PRAGMAT SOC, V2, P17, DOI 10.1075/ps.2.1.02cum; Cummings Louise, 2007, SEMINARS SPEECH LANG, V28, P98; Cummings Louise, 2008, CLIN LINGUISTICS; Cutica I, 2006, BRAIN LANG, V98, P12, DOI 10.1016/j.bandl.2006.01.001; David N, 2010, J AUTISM DEV DISORD, V40, P290, DOI 10.1007/s10803-009-0867-4; de Marchena A, 2010, AUTISM RES, V3, P311, DOI 10.1002/aur.159; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Donno R, 2010, BRIT J PSYCHIAT, V196, P282, DOI 10.1192/bjp.bp.108.061341; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Farrant BM, 2006, CHILD DEV, V77, P1842, DOI 10.1111/j.1467-8624.2006.00977.x; Fernandez-Duque D, 2009, J CLIN EXP NEUROPSYC, V31, P489, DOI 10.1080/13803390802282688; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Feyereisen P, 2007, INT J LANG COMM DIS, V42, P1, DOI 10.1080/13682820600624216; Fodor Jerry A., 1983, MODULARITY MIND ESSA; Frith R C, 1996, Cogn Neuropsychiatry, V1, P305, DOI 10.1080/135468096396460; FRYE D, 2000, CHILDRENS REASONING, P149; Geurts HM, 2008, J AUTISM DEV DISORD, V38, P1931, DOI 10.1007/s10803-008-0587-1; Gibbons ZC, 2007, NEUROPSYCHOLOGIA, V45, P1196, DOI 10.1016/j.neuropsychologia.2006.10.008; Gilmour J, 2004, J CHILD PSYCHOL PSYC, V45, P967, DOI 10.1111/j.1469-7610.2004.t01-1-00289.x; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Golan O, 2008, J AUTISM DEV DISORD, V38, P1534, DOI 10.1007/s10803-007-0533-7; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Gold R, 2010, BRAIN LANG, V113, P124, DOI [10.1016/j.band1.2010.03.002, 10.1016/j.bandl.2010.03.002]; GOLDMAN AI, 1993, BEHAV BRAIN SCI, V16, P15, DOI 10.1017/S0140525X00028648; Gopnik A, 2000, UNDERSTANDING OTHER, P50; Gordon R., 1986, MIND LANGUAGE, V1, P158, DOI DOI 10.1111/J.1468-0017.1986.TB00324.X; Gordon R., 1996, THEORIES THEORY MIND, P11, DOI DOI 10.1017/CB09780511597985.003; Grant CM, 2007, J ABNORM CHILD PSYCH, V35, P17, DOI 10.1007/s10802-006-9077-0; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Griffin R, 2006, LATERALITY, V11, P195, DOI 10.1080/13576500500450552; Hale CM, 2005, AUTISM, V9, P157, DOI 10.1177/1362361305051395; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Holtgraves T, 2010, J CLIN EXP NEUROPSYC, V32, P388, DOI 10.1080/13803390903130729; Hughes C, 2005, CHILD DEV, V76, P356, DOI 10.1111/j.1467-8624.2005.00850_a.x; JENKINS JM, 1995, INFANT BEHAV DEV, V18, P273, DOI 10.1016/0163-6383(95)90016-0; John AE, 2009, AJIDD-AM J INTELLECT, V114, P85, DOI 10.1352/2009.114.85-99; Johnston JR, 2001, INT J LANG COMM DIS, V36, P349, DOI 10.1080/13682820110045838; Jones CD, 2009, J AUTISM DEV DISORD, V39, P432, DOI 10.1007/s10803-008-0642-y; Kasher A, 1999, BRAIN LANG, V68, P566, DOI 10.1006/brln.1999.2129; Kertesz A, 2010, ARCH NEUROL-CHICAGO, V67, P483, DOI 10.1001/archneurol.2010.55; Kleinman J, 2001, J AUTISM DEV DISORD, V31, P29, DOI 10.1023/A:1005657512379; Kuperberg GR, 2000, PSYCHOL MED, V30, P345, DOI 10.1017/S0033291700001744; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; Laws G, 2004, INT J LANG COMM DIS, V39, P45, DOI 10.1080/13682820310001615797; Liddle B., 2006, J CULTURAL EVOLUTION, V4, P231, DOI [10.1556/jcep.4.2006.3-4.3, DOI 10.1556/JCEP.4.2006.3-4.3]; Lind SE, 2010, J AUTISM DEV DISORD, V40, P479, DOI 10.1007/s10803-009-0889-y; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2; MacLennan D. L., 2002, PREMIER OUTLOOK, V3, P38; Marini A, 2005, BRAIN LANG, V93, P46, DOI 10.1016/j.bandl.2004.08.002; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; Marton I, 2009, J ABNORM CHILD PSYCH, V37, P107, DOI 10.1007/s10802-008-9262-4; Maylor EA, 2002, BRIT J PSYCHOL, V93, P465, DOI 10.1348/000712602761381358; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McInnes A, 2003, J ABNORM CHILD PSYCH, V31, P427, DOI 10.1023/A:1023895602957; McNamara P, 2003, BRAIN LANG, V84, P414, DOI 10.1016/S0093-934X(02)00558-8; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miller CA, 2004, INT J LANG COMM DIS, V39, P191, DOI 10.1080/13682820310001616994; Miller CA, 2001, J COMMUN DISORD, V34, P73, DOI 10.1016/S0021-9924(00)00042-3; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Monetta L, 2007, BRAIN LANG, V101, P80, DOI 10.1016/j.bandl.2006.06.007; Monetta L, 2009, CORTEX, V45, P972, DOI 10.1016/j.cortex.2009.02.021; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Murphy MM, 2007, J INTELL DISABIL RES, V51, P387, DOI 10.1111/j.1365-2788.2006.00888.x; Mutter B, 2006, PERCEPT MOTOR SKILL, V102, P819, DOI 10.2466/PMS.102.3.819-835; Myers Penelope S., 1979, CLIN APHASIOLOGY C P, P38; Nelson PB, 2008, DEVELOPMENTAL SCI, V11, P847, DOI 10.1111/j.1467-7687.2008.00733.x; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Papagno C, 2001, BRAIN, V124, P1450, DOI 10.1093/brain/124.7.1450; Papagno C, 2001, J INT NEUROPSYCH SOC, V7, P516, DOI 10.1017/S1355617701744086; Papagno C, 2006, NEUROPSYCHOLOGY, V20, P598, DOI 10.1037/0894-4105.20.5.598; Pardini M, 2009, EXP AGING RES, V35, P98, DOI 10.1080/03610730802545259; Pelc K, 2006, PEDIATR NEUROL, V35, P93, DOI 10.1016/j.pediatrneurol.2006.01.014; Rinaldi W, 2000, INT J LANG COMM DIS, V35, P1, DOI 10.1080/136828200247223; Ripich DN, 2000, INT J LANG COMM DIS, V35, P49; Roncone R, 2004, NEUROPSYCHOL REHABIL, V14, P421, DOI 10.1080/09602010343000291; Rousseaux M, 2010, NEUROPSYCHOLOGIA, V48, P3884, DOI 10.1016/j.neuropsychologia.2010.09.026; Ruffman T, 1998, DEV PSYCHOL, V34, P161, DOI 10.1037/0012-1649.34.1.161; Ruffman T, 2002, CHILD DEV, V73, P734, DOI 10.1111/1467-8624.00435; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Ryder N, 2008, INT J LANG COMM DIS, V43, P427, DOI 10.1080/13682820701633207; Saldert C, 2010, INT J LANG COMM DIS, V45, P656, DOI 10.3109/13682820903494742; Saltzman J, 2000, J INT NEUROPSYCH SOC, V6, P781, DOI 10.1017/S1355617700677056; Scholl BJ, 1999, MIND LANG, V14, P131, DOI 10.1111/1468-0017.00106; Siegal M, 2006, SOC NEUROSCI-UK, V1, P167, DOI 10.1080/17470910600985597; Spanoudis G, 2007, INT J LANG COMM DIS, V42, P487, DOI 10.1080/13682820601010027; Speechley WJ, 2010, EUR PSYCHIAT, V25, P80, DOI 10.1016/j.eurpsy.2009.05.012; Spek AA, 2010, J AUTISM DEV DISORD, V40, P280, DOI 10.1007/s10803-009-0860-y; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Sudhalter V, 2001, AM J MENT RETARD, V106, P389, DOI 10.1352/0895-8017(2001)106<0389:CCOCWF>2.0.CO;2; Sullivan K, 1999, AM J MENT RETARD, V104, P523, DOI 10.1352/0895-8017(1999)104<0523:SBAIWS>2.0.CO;2; Sullivan K, 2003, DEV NEUROPSYCHOL, V23, P85, DOI 10.1207/S15326942DN231&2_5; Sullivan S, 2004, BRIT J PSYCHOL, V95, P1, DOI 10.1348/000712604322779424; Surian L, 2001, BRAIN LANG, V78, P224, DOI 10.1006/brln.2001.2465; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; Swettenham J, 2000, UNDERSTANDING OTHER, P442; Symons D, 1997, J EXP CHILD PSYCHOL, V67, P423, DOI 10.1006/jecp.1997.2416; Tager-Flusberg H., 2000, UNDERSTANDING OTHER, V2, P124; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Taylor M, 1997, CHILD DEV, V68, P436, DOI 10.2307/1131670; Tenyi T, 2002, PSYCHOPATHOLOGY, V35, P25, DOI 10.1159/000056212; Titone D, 2004, SCHIZOPHR RES, V68, P235, DOI 10.1016/s0920-9964(03)00152-x; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Varley R, 2000, CURR BIOL, V10, P723, DOI 10.1016/S0960-9822(00)00538-8; Varley R, 2001, NEUROCASE, V7, P489, DOI 10.1093/neucas/7.6.489; Watson AC, 2001, J COGN DEV, V2, P449, DOI 10.1207/S15327647JCD0204_5; Weed E, 2010, BRAIN LANG, V113, P65, DOI 10.1016/j.bandl.2010.01.009; Weed E, 2008, INT J SPEECH-LANG PA, V10, P414, DOI 10.1080/17549500802455429; Williams D, 2010, DEVELOPMENTAL SCI, V13, P307, DOI 10.1111/j.1467-7687.2009.00885.x; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Yirmiya N, 1996, J CHILD PSYCHOL PSYC, V37, P1003, DOI 10.1111/j.1469-7610.1996.tb01497.x	175	16	16	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-01014-4; 978-3-319-01013-7	PERSP PRAGMAT PHILO			2013	2						23	56		10.1007/978-3-319-01014-4_2	10.1007/978-3-319-01014-4		34	Linguistics; Language & Linguistics; Philosophy	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Linguistics; Philosophy	BG4AT	WOS:000388560000004					2022-02-06	
J	Ehinger, KHJ; Hansson, MJ; Sjovall, F; Elmer, E				Ehinger, Karl Henrik Johannes; Hansson, Magnus Joakim; Sjovall, Fredrik; Elmer, Eskil			Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor (R) EL	CLINICAL DRUG INVESTIGATION			English	Article							TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; ANAPHYLACTIC REACTION; MICROEMULSION FORMULATION; DIETHYLHEXYL PHTHALATE; AFRICAN-AMERICAN; PHARMACOKINETICS; PROPOFOL; DIAZEPAM; BIOAVAILABILITY	Background Ciclosporin is used as an immunosuppressant in current clinical practice but recent research implies novel indications for the drug, such as neuro-and cardio-protection. The intravenous formulation currently on the market, Sandimmune (R) Injection (Sandimmune (R)), uses Cremophor (R) EL as emulsifying excipient. Cremophor (R) EL is known to cause hypersensitivity reactions in some patients, ranging from skin reactions to potentially fatal anaphylactic shock. Objectives The primary objective was to assess if CicloMulsion (R), a Cremophor (R) EL-free lipid emulsion of ciclosporin for intravenous administration, is bioequivalent to Sandimmune (R), and the secondary objective was to compare the tolerability profiles of the two preparations. Methods This was a single-centre, open-label, subject-blind, laboratory-blind, single-dose, randomized, two-treatment, two-period, two-sequence crossover study of the pharmacokinetics of two formulations of intravenous ciclosporin. Fifty-two healthy volunteer subjects were administered 5 mg/kg of each of the two formulations of ciclosporin as a 4-h intravenous infusion. The last blood sample was acquired 48 h after the end of the infusion. Bioequivalence assessments according to current guidelines were performed. Results The geometric mean ratios for CicloMulsion (R)/Sandimmune (R) (90 % confidence interval [CI]) were 0.90 (0.88, 0.92) for AUC(0-last) (area under the blood concentration-time curve from time zero to time of last measurable concentration) and 0.95 (0.92, 0.97) for C-max (maximum blood concentration). For all additional variables analysed, the 90 % CIs were also within the accepted bioequivalence range of 0.80-1.25. One anaphylactoid and one anaphylactic reaction, both classified as serious adverse events, were reported after treatment with Sandimmune (R). No serious adverse events were recorded after treatment with CicloMulsion (R). Conclusion We have assessed the pharmacokinetics and tolerability of a new Cremophor (R) EL-free lipid emulsion of ciclosporin, CicloMulsion (R), compared to Sandimmune (R). The proportion of adverse events was significantly higher for the Cremophor (R) EL-based product Sandimmune (R). We conclude that CicloMulsion (R) is bioequivalent to Sandimmune (R) and exhibits fewer adverse reactions.	[Ehinger, Karl Henrik Johannes; Hansson, Magnus Joakim; Sjovall, Fredrik; Elmer, Eskil] NeuroVive Pharmaceut AB Publ, Medicon Village, S-22381 Lund, Sweden; [Ehinger, Karl Henrik Johannes; Hansson, Magnus Joakim; Sjovall, Fredrik; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Pathophysiol Unit, Lund, Sweden		Ehinger, KHJ (corresponding author), NeuroVive Pharmaceut AB Publ, Medicon Village, S-22381 Lund, Sweden.	johannes.ehinger@neurovive.com	Elmer, Eskil/F-9341-2014; Hansson, Magnus/G-4486-2014; Ehinger, Johannes/D-7120-2013	Elmer, Eskil/0000-0001-7901-1826; Hansson, Magnus/0000-0002-0201-0638; Ehinger, Johannes/0000-0002-2417-5767; Sjovall, Fredrik/0000-0001-5612-0325	NeuroVive Pharmaceutical AB (publ)	All authors receive salary support from, and are stockholders of, NeuroVive Pharmaceutical AB (publ). In addition, Eskil Elmer is co-founder and officer of Maas Biolab, LLC, and NeuroVive Pharmaceutical AB, which hold intellectual property rights and develop cyclophilin-D-inhibiting ciclosporins primarily for the treatment of acute brain injury and reperfusion injury in myocardial infarction. There are no other conflicts of interest to disclose. The authors are grateful to Marcus F. Keep, Daniel Wermeling and Torben Balchen for extensive input on the clinical trial protocol.	Baker MT, 2005, ANESTHESIOLOGY, V103, P860, DOI 10.1097/00000542-200510000-00026; BOWERS VD, 1991, TRANSPLANTATION, V51, P847, DOI 10.1097/00007890-199104000-00021; BRIGGS LP, 1982, ANAESTHESIA, V37, P1099, DOI 10.1111/j.1365-2044.1982.tb01753.x; CHAPUIS B, 1985, NEW ENGL J MED, V312, P1259; Christians U, 2000, THER DRUG MONIT, V22, P330, DOI 10.1097/00007691-200006000-00017; Christians Uwe, 2005, Expert Opin Drug Metab Toxicol, V1, P641, DOI 10.1517/17425255.1.4.641; Christians U, 2010, KIDNEY INT, V77, pS1, DOI 10.1038/ki.2009.504; Cook AM, 2009, EXPERT OPIN DRUG SAF, V8, P411, DOI 10.1517/14740330903066742; DILETTI E, 1992, INT J CLIN PHARM TH, V30, pS51; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Dutta S, 1997, J PHARM SCI-US, V86, P967, DOI 10.1021/js970118m; DYE D, 1980, BRIT MED J, V280, P1353, DOI 10.1136/bmj.280.6228.1353; EMA, 2001, NOT GUID INV BIOAV B; FEE JPH, 1986, ACTA ANAESTH SCAND, V30, P337, DOI 10.1111/j.1399-6576.1986.tb02426.x; FEE JPH, 1984, LANCET, V2, P813; FRIEDMAN LS, 1985, AM J MED, V78, P343, DOI 10.1016/0002-9343(85)90447-4; Fritsche L, 2004, TRANSPLANT P, V36, p130S, DOI 10.1016/j.transproceed.2003.12.038; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Gotardo MA, 2005, J PHARMACEUT BIOMED, V38, P709, DOI 10.1016/j.jpba.2005.02.005; Griveas I, 2010, ARTIF ORGANS, V34, P234, DOI 10.1111/j.1525-1594.2009.00838.x; GUPTA SK, 1990, J CLIN PHARMACOL, V30, P643, DOI 10.1002/j.1552-4604.1990.tb01868.x; Hijnen DJ, 2007, J EUR ACAD DERMATOL, V21, P85, DOI 10.1111/j.1468-3083.2006.01877.x; HOWRIE DL, 1985, DRUG INTEL CLIN PHAR, V19, P425, DOI 10.1177/106002808501900603; HUTTEL MS, 1980, BRIT J ANAESTH, V52, P77, DOI 10.1093/bja/52.1.77; Kacmaz RO, 2010, OPHTHALMOLOGY, V117, P576, DOI 10.1016/j.ophtha.2009.08.010; KAHAN BD, 1995, TRANSPLANTATION, V59, P505; KAHAN BD, 1984, LANCET, V1, P52; KANTO JH, 1988, INT J CLIN PHARM TH, V26, P41; Kees F, 2007, N-S ARCH PHARMACOL, V375, P393, DOI 10.1007/s00210-007-0169-3; Kloover JS, 2004, BRIT J CANCER, V90, P304, DOI 10.1038/sj.bjc.6601303; KOVARIK JM, 1994, TRANSPLANTATION, V58, P658; Lee M, 2001, J CLIN PHARMACOL, V41, P317, DOI 10.1177/00912700122010131; LEUNISSEN KML, 1985, LANCET, V1, P636; LiauChu M, 1997, ANN PHARMACOTHER, V31, P1287, DOI 10.1177/106002809703101101; Mackie F E, 2000, Pediatr Transplant, V4, P35, DOI 10.1034/j.1399-3046.2000.00081.x; MATTILA MAK, 1981, BRIT J ANAESTH, V53, P1265, DOI 10.1093/bja/53.12.1265; Micha JP, 2006, GYNECOL ONCOL, V100, P437, DOI 10.1016/j.ygyno.2005.09.012; Min DI, 2000, CLIN PHARMACOL THER, V68, P478, DOI 10.1067/mcp.2000.111255; MONERETVAUTRIN DA, 1983, BRIT J ANAESTH, V55, P469, DOI 10.1093/bja/55.5.469; MORGAN M, 1985, ANAESTHESIA, V40, P121; Naganuma M, 2011, J GASTROENTEROL, V46, P129, DOI 10.1007/s00535-010-0352-z; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Sanchez H, 2000, J MOL CELL CARDIOL, V32, P323, DOI 10.1006/jmcc.1999.1078; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Storb R, 2010, BIOL BLOOD MARROW TR, V16, pS18, DOI 10.1016/j.bbmt.2009.10.016; THEIS JGW, 1995, J CLIN ONCOL, V13, P2508, DOI 10.1200/JCO.1995.13.10.2508; THIEL G, 1986, CLIN NEPHROL, V25, pS40; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; U.S. Department of Health and Human Services, 2001, GUID IND BIOAN METH; US Department of Health and Human Services Food and Drug Administration, 2001, GUID IND STAT APPR E; VANHOOFF JP, 1987, LANCET, V2, P1456; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; VENKATARAMANAN R, 1986, AM J HOSP PHARM, V43, P2800, DOI 10.1093/ajhp/43.11.2800; VERANI R, 1986, CLIN NEPHROL, V25, pS9; Volcheck GW, 1998, ANN ALLERG ASTHMA IM, V80, P159, DOI 10.1016/S1081-1206(10)62949-3; Warren RB, 2008, CLIN DERMATOL, V26, P438, DOI 10.1016/j.clindermatol.2007.11.006; WINDEBANK AJ, 1994, J PHARMACOL EXP THER, V268, P1051	60	16	18	1	7	ADIS INT LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW ZEALAND	1173-2563			CLIN DRUG INVEST	Clin. Drug Invest.		2013	33	1					25	34		10.1007/s40261-012-0029-x			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	109ZQ	WOS:000316411300003	23179472	Green Published, Green Submitted, hybrid			2022-02-06	
S	Gray, ST; Wu, AW		Bleier, BS		Gray, Stacey T.; Wu, Arthur W.			Pathophysiology of latrogenic and Traumatic Skull Base Injury	COMPREHENSIVE TECHNIQUES IN CSF LEAK REPAIR AND SKULL BASE RECONSTRUCTION	Advances in Oto-Rhino-Laryngology		English	Article; Book Chapter							CEREBROSPINAL-FLUID LEAKS; ENDOSCOPIC SINUS SURGERY; COMPLICATIONS; MANAGEMENT; EXPERIENCE; REPAIR; RHINORRHEA; FISTULAS; RECONSTRUCTION; METAANALYSIS	Traumatic skull base injuries can be divided into iatrogenic injuries from surgery and accidental traumatic injuries. The most common cause of iatrogenic skull base injury is endoscopic sinus surgery. The reported rate of cerebrospinal fluid (CSF) leak as a complication of endoscopic sinus surgery is less than 1%. Intraoperative injury most commonly occurs at the ethmoid roof and the lateral lamella of the cribiform plate. Case complexity, such as revision surgery, as well as surgical experience has been shown to be a contributing factor to iatrogenic CSF leaks during endoscopic sinus surgery. Other causes of iatrogenic CSF leaks include endoscopic skull base and open neurosurgical procedures. CSF leak occurs in 2.6% of all closed head traumas and is more likely in the case of a definitive skull base fracture. The majority of accidental trauma CSF leaks can be managed conservatively, but those that persist beyond a week are typically managed surgically to avoid the risk of meningitis. Copyright (C) 2013 S. Karger AG, Basel	[Gray, Stacey T.; Wu, Arthur W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA		Gray, ST (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otol & Laryngol, 243 Charles St, Boston, MA 02114 USA.	stacey_gray@meei.harvard.edu		Wu, Arthur/0000-0001-8993-6355			Anderson P, 2009, LARYNGOSCOPE, V119, P1828, DOI 10.1002/lary.20565; Banks CA, 2009, OTOLARYNG HEAD NECK, V140, P826, DOI 10.1016/j.otohns.2008.12.060; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bernal-Sprekelsen M, 2000, AM J RHINOL, V14, P257, DOI 10.2500/105065800779954473; Bolger WE, 1999, OTOLARYNG HEAD NECK, V120, P308, DOI 10.1016/S0194-5998(99)70267-6; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Bumm K, 2009, AURIS NASUS LARYNX, V36, P671, DOI 10.1016/j.anl.2009.03.004; Chi JH, 2006, NEUROSURGERY, V59, P101, DOI 10.1227/01.NEU.0000219962.15984.34; Church CA, 2003, OTOLARYNG HEAD NECK, V129, P204, DOI 10.1016/S0194-5998(03)00521-7; Deschler DG, 1996, SKULL BASE SURG, V6, P113, DOI 10.1055/s-2008-1058652; Germani RM, 2007, AM J RHINOL, V21, P615, DOI 10.2500/ajr.2007.21.3080; Gil Z, 2009, OTOLARYNG HEAD NECK, V140, P218, DOI 10.1016/j.otohns.2008.10.042; Kacker A, 2005, OTOLARYNG CLIN N AM, V38, P473, DOI 10.1016/j.otc.2004.10.021; Kassam AB, 2011, J NEUROSURG, V114, P1544, DOI 10.3171/2010.10.JNS09406; Keerl R, 1999, LARYNGOSCOPE, V109, P546, DOI 10.1097/00005537-199904000-00005; KEROS P, 1962, Z Laryngol Rhinol Otol, V41, P809; Lee DH, 2011, J CRANIOFAC SURG, V22, P1266, DOI 10.1097/SCS.0b013e31821c6ad3; Leng LZ, 2008, NEUROSURGERY, V62, P342, DOI [10.1227/01.neu.0000326017.84315.1f, 10.1227/01.NEU.0000312720.93685.17]; Lindstrom DR, 2004, LARYNGOSCOPE, V114, P969, DOI 10.1097/00005537-200406000-00003; Manolidis S, 2007, PLAST RECONSTR SURG, V120, p32S, DOI 10.1097/01.prs.0000260732.58496.1b; MAY M, 1994, LARYNGOSCOPE, V104, P1080; Mosher HP, 1929, T AM ACAD OPHTHALMOL, V34, P376; Platt MP, 2007, AM J RHINOL, V21, P611, DOI 10.2500/ajr.2007.21.3073; Reh DD, 2008, ARCH OTOLARYNGOL, V134, P1187, DOI 10.1001/archotol.134.11.1187; Samaha M, 2003, ARCH OTOLARYNGOL, V129, P854, DOI 10.1001/archotol.129.8.854; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Smith TL, 2007, AM J RHINOL, V21, P80, DOI 10.2500/ajr.2007.21.2962; STANKIEWICZ JA, 1987, LARYNGOSCOPE, V97, P1270, DOI 10.1288/00005537-198711000-00004; Stankiewicz JA, 2011, LARYNGOSCOPE, V121, P2684, DOI 10.1002/lary.21446; Tabaee A, 2005, OTOLARYNG HEAD NECK, V133, P936, DOI 10.1016/j.otohns.2005.07.028; Tabaee A, 2007, LARYNGOSCOPE, V117, P1133, DOI 10.1097/MLG.0b013e31805c08c5; White DR, 2003, AM J OTOLARYNG, V24, P213, DOI 10.1016/S0196-0709(03)00031-0; Zuckerman JD, 2008, AM J RHINOL, V22, P151, DOI 10.2500/ajr.2008.22.3150; Zweig JL, 2000, OTOLARYNG HEAD NECK, V123, P195, DOI 10.1067/mhn.2000.107452; [No title captured]	35	16	16	0	0	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0065-3071	1662-2847	978-3-8055-9953-5; 978-3-8055-9952-8	ADV OTO-RHINO-LARYNG	Adv.Otorhinolaryngol.		2013	74						12	23		10.1159/000342264			12	Otorhinolaryngology; Surgery	Book Citation Index – Science (BKCI-S)	Otorhinolaryngology; Surgery	BDY61	WOS:000315658300003	23257548				2022-02-06	
J	Martini, RP; Deem, S; Treggiari, MM				Martini, Ross P.; Deem, Steven; Treggiari, Miriam M.			Targeting Brain Tissue Oxygenation in Traumatic Brain Injury	RESPIRATORY CARE			English	Article						oxygen; brain injury; trauma; brain; oxygenation	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; POSITRON-EMISSION-TOMOGRAPHY; INTRA-CRANICAL PRESSURE; ACUTE LUNG INJURY; INTRACRANIAL-PRESSURE; METABOLISM; HYPOXIA; HYPERTENSION; EXPERIENCE	The management of patients with traumatic brain injury has evolved in the last several years, due to the introduction of new, invasive monitoring devices. The ability to monitor parameters other than measurements related to pressures has generated substantial interest. Brain tissue oxygenation monitoring has been consistently shown to provide prognostic information, as indicated by poor prognosis associated with low brain tissue oxygen values. Furthermore, various physiologic manipulations, including increasing the P-aO2, have been associated with an increase in brain tissue oxygenation. Whether brain-oxygenation-guided therapy results in improvement in outcomes is debatable. Retrospective studies suggest benefit, while prospective studies have shown a higher intensity of therapeutic interventions with no outcome differences. Data from high quality randomized trials are necessary to determine if brain-oxygenation-guided therapy is beneficial. An oxygen challenge (transient increase in F-IO2 to 0.6 up to 1.0) to assess the responsiveness of the monitoring and ascertain the presence of technical malfunction is an accepted practice.	[Martini, Ross P.] Oregon Hlth & Sci Univ Hosp, Dept Anesthesiol & Perioperat Med, Portland, OR USA; [Deem, Steven; Treggiari, Miriam M.] Univ Washington, Harborview Med Ctr, Sch Med, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA		Treggiari, MM (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Anesthesiol & Pain Med, Box 359724, Seattle, WA 98104 USA.	treggmm@u.washington.edu		Martini, Ross/0000-0001-8811-6558			Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Bardt TF, 1998, ACT NEUR S, V71, P153; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gupta AK, 2002, J NEUROSURG, V96, P263, DOI 10.3171/jns.2002.96.2.0263; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hoffman WE, 1998, NEUROL RES, V20, pS81; JENNETT B, 1975, LANCET, V1, P480; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marmarou A, 1991, J NEUROSURG, V75, pS59; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Servadei F, 2002, ACT NEUR S, V81, P81; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	54	16	17	0	12	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	JAN	2013	58	1			SI		162	169		10.4187/respcare.01942			8	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	071PG	WOS:000313606100020	23271826	Bronze			2022-02-06	
J	Schimizze, B; Son, SF; Goel, R; Vechart, AP; Young, L				Schimizze, Benjamin; Son, Steven F.; Goel, Rahul; Vechart, Andrew P.; Young, Laurence			An experimental and numerical study of blast induced shock wave mitigation in sandwich structures	APPLIED ACOUSTICS			English	Article						Shock waves; Finite elements; Inhomogeneous material; Acoustics; Blast mitigation	ATTENUATION; AFGHANISTAN; IRAQ	The liners of US military helmets are typically made using common soft foams. In order to better protect troops from Traumatic Brain Injury resulting from Improvised Explosive Devices, it is necessary to better understand the material properties involved in air blast mitigation. In this work, mitigation properties are studied using sandwich samples made from a vinyl-nitrile foam shell filled with materials which were selected to span a range of material properties. These materials-water, glycerin, glass beads, Aerogel (R), CAB-O-SIL (R), tuff volcanic rock, and expanding foam-were compared to both uniform vinyl-nitrile foam and a US Army helmet pad. Possible modes of shock attenuation include inertial effects based on density and acoustic impedance, dispersion based on porosity, and thermal effects. Since no standard test exists, we developed two experimental configurations to evaluate performance. The results were additionally used to verify a numerical model made using ABAQUS (R) software. Both the numerical model and the experimental results were consistent in showing that most materials attenuate the peak blast pressure while Aerogel (R) actually enhances the blast. Density and acoustic impedance mismatch are shown to be of primary importance while porosity is shown to have an effect as well. Furthermore, a differentiation is made between reflective and absorptive shock mitigation. (C) 2012 Elsevier Ltd. All rights reserved.	[Schimizze, Benjamin] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Son, Steven F.] Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA; [Goel, Rahul] MIT, Sch Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Vechart, Andrew P.] MIT, Computat Design & Optimizat Program, Cambridge, MA 02139 USA; [Young, Laurence] MIT, Dept Biomed Engn, Cambridge, MA 02139 USA		Schimizze, B (corresponding author), 4220 Bramble Ave,Apt 3, Cincinnati, OH 45227 USA.	bschimizze@gmail.com; sson@purdue.edu; rahulg@mit.edu; avechart@mit.edu; lry@mit.edu	Goel, Rahul/C-4480-2016	Goel, Rahul/0000-0002-3516-6938; Son, Steven/0000-0001-7498-2922	Office of Naval ResearchOffice of Naval Research [N00014-08-1-0261]; Deshpande Center at MIT	Authors are thankful to the financial support provided by Office of Naval Research (#N00014-08-1-0261) and Deshpande Center at MIT.	Allen RM, 2003, AIP C P; Calogne R, 1998, US Patent, Patent No. 5815846; Gel'fand BE, 2001, COMBUST EXPLO SHOCK+, V37, P607, DOI 10.1023/A:1012309623934; Gerber U, 1987, US Patent, Patent No. 4665794; Gooding ER, 1983, US Patent, Patent No. 4375108; Groves TK, 1992, US Patent, Patent No. 5087516; Hartman W. F., 2006, SAND20060533 SAND NA; Holt MC, 1974, US Patent, Patent No. 3849801; Hosaka, 1992, US Patent, Patent No. 5148950; Li QM, 2002, INT J IMPACT ENG, V27, P1049, DOI 10.1016/S0734-743X(02)00016-7; Mendoza ID, 2003, US Patent, Patent No. 6560787; Morgan G.E., 1971, US Patent, Patent No. 3609764; Nesterenko V. F., 2003, MATER RES SOC S P, P759; Ponomarev V., 2006, US Patent, Patent No. 7017705; Resnyansky AD, 2006, DSTOTR1944 WEAP SYST; Rhoades L. J., 2004, Patent US, Patent No. [6,701,529, 6701529]; Schardin H, 1950, WORLD WAR 2, P1207; Stewart D, 2008, THESIS UCD DUBLIN; Stuhmiller JH, 2008, US Patent, Patent No. 250548; Villari FK, 1976, US Patent, Patent No. 3994021; Wakabayashi TH, 2007, SHOCK COMPRESS CONDE; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhuang SM, 2003, J MECH PHYS SOLIDS, V51, P245, DOI 10.1016/S0022-5096(02)00100-X	25	16	18	1	81	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0003-682X			APPL ACOUST	Appl. Acoust.	JAN	2013	74	1					1	9		10.1016/j.apacoust.2012.05.011			9	Acoustics	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics	018EH	WOS:000309642400001					2022-02-06	
S	Shi, YJ; Kim, D; Caldwell, M; Sun, DD		Annunziato, L		Shi, Yejie; Kim, Dong; Caldwell, Marie; Sun, Dandan			The Role of Na+/H+ Exchanger Isoform 1 in Inflammatory Responses: Maintaining H+ Homeostasis of Immune Cells	SODIUM CALCIUM EXCHANGE: A GROWING SPECTRUM OF PATHOPHYSIOLOGICAL IMPLICATIONS	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	6th International Conference on Sodium Calcium Exchange	OCT 01-05, 2011	Lacco Ameno, ITALY			Na+/H+ exchange; Na+/Ca2+ exchange; Inflammation; H+ homeostasis	CENTRAL-NERVOUS-SYSTEM; DENDRITIC CELLS; HUMAN-NEUTROPHILS; INTERFERON-GAMMA; NADPH OXIDASES; RAT MYOCARDIUM; UP-REGULATION; MICROGLIA; ACTIVATION; STROKE	The Na+/H+ exchangers (NHEs) are a family of membrane transporter proteins which catalyze the electroneutral exchange of one Na+ for one H+ and thus regulate intracellular pH (pH(i)) and cell volume. It is shown that Na+/H+ exchanger isoform 1 (NHE-1), but not other isoforms, is the important mechanism in extruding H+ and regulating pH(i) in the immune system. Immune cells, such as monocytes and neutrophils, generate reactive oxygen species (ROS) and cytokines in response to various stimuli and provide the first line of defense in the immune system. NHE-1 is activated during this respiratory burst and required to maintain an optimal pH(i) for the immune cells. In the central nervous system, NHE-1 is important for microglial (macrophage) activation and participates in the inflammatory response under pathological conditions including cerebral ischemia and traumatic brain injury. NHE-1 also affects Ca2+ homeostasis in microglia and contributes to the increase of [Ca2+](i) by coupling to the Na+/Ca2+ exchanger (NCX) stimulation, thus regulating immune cell function and participating in ischemic cell death. A better understanding of the function of NHE-1 in inflammatory responses will provide insight into its role in brain damage under disease conditions.	[Shi, Yejie; Kim, Dong; Caldwell, Marie; Sun, Dandan] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA		Sun, DD (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, S-598 South Biomed Sci Tower BST,3500 Terrace St, Pittsburgh, PA 15213 USA.	sund@upmc.edu	Shi, Yejie/C-2355-2018	Shi, Yejie/0000-0001-7502-9201	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS 48216, R01NS 38118]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048216, R01NS038118] Funding Source: NIH RePORTER	This work was supported by NIH grants R01NS 48216 and R01NS 38118 (D. Sun). We would like to thank Douglas B. Kintner for his critical comments of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bennett CL, 2012, TRENDS IMMUNOL, V33, P8, DOI 10.1016/j.it.2011.09.008; Bernardes-Silva M, 2001, J CEREBR BLOOD F MET, V21, P1115, DOI 10.1097/00004647-200109000-00009; Bhandaru M, 2012, PFLUG ARCH EUR J PHY, V463, P355, DOI 10.1007/s00424-011-1015-5; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; De Vito P, 2006, CELL IMMUNOL, V240, P69, DOI 10.1016/j.cellimm.2006.07.001; Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218; Felger JC, 2010, BRAIN BEHAV IMMUN, V24, P724, DOI 10.1016/j.bbi.2009.11.002; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Fukushima T, 1996, J CELL BIOL, V132, P1037, DOI 10.1083/jcb.132.6.1037; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Harrigan TJ, 2008, J NEUROCHEM, V106, P2449, DOI 10.1111/j.1471-4159.2008.05553.x; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; Hsu C Y, 2000, J Stroke Cerebrovasc Dis, V9, P24, DOI 10.1053/jscd.2000.19318; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Luo J, 2007, CURR NEUROVASC RES, V4, P205; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; Matsuda T, 2006, J PHARMACOL SCI, V102, P22, DOI 10.1254/jphs.FMJ06002X4; Moor AN, 2001, J BIOL CHEM, V276, P16113, DOI 10.1074/jbc.M100519200; Nagano T, 2004, J NEUROCHEM, V90, P784, DOI 10.1111/j.1471-4159.2004.02511.x; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Petrecca K, 1999, AM J PHYSIOL-HEART C, V276, pH709, DOI 10.1152/ajpheart.1999.276.2.H709; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Reichmann G, 2002, J NEUROIMMUNOL, V129, P125, DOI 10.1016/S0165-5728(02)00184-4; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Rotte A, 2010, CELL PHYSIOL BIOCHEM, V26, P553, DOI 10.1159/000322323; Rotte A, 2010, PFLUG ARCH EUR J PHY, V460, P1087, DOI 10.1007/s00424-010-0879-0; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Soeiro-Pereira PV, 2012, BRIT J PHARMACOL, V166, P1617, DOI 10.1111/j.1476-5381.2011.01764.x; SWALLOW CJ, 1993, J CELL PHYSIOL, V157, P453, DOI 10.1002/jcp.1041570304; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Zhang L, 2003, STROKE, V34, P1790, DOI 10.1161/01.STR.0000077016.55891.2E; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	43	16	18	0	4	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0065-2598		978-1-4614-4756-6	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2013	961						411	418		10.1007/978-1-4614-4756-6_35			8	Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Physiology	BA3PQ	WOS:000334582100036	23224899				2022-02-06	
J	Vazan, P; Golub, A; Bennett, AS				Vazan, Peter; Golub, Andrew; Bennett, Alex S.			Substance Use and Other Mental Health Disorders Among Veterans Returning to the Inner City: Prevalence, Correlates, and Rates of Unmet Treatment Need	SUBSTANCE USE & MISUSE			English	Article						veterans' reintegration; substance use and mental health disorders; prevalence estimates; unmet treatment need; respondent-driven sampling (RDS)	POSTTRAUMATIC-STRESS-DISORDER; DRUG-USERS; AFGHANISTAN VETERANS; SERVICE MEMBERS; ALCOHOL MISUSE; IRAQ; DEPLOYMENT; VA; PTSD; CARE	Estimates of substance use and other mental health disorders of veterans (N = 269) who returned to predominantly low-income minority New York City neighborhoods between 2009 and 2012 are presented. Although prevalences of posttraumatic stress disorder, traumatic brain injury, and depression clustered around 20%, the estimated prevalence rates of alcohol use disorder, drug use disorder, and substance use disorder were 28%, 18%, and 32%, respectively. Only about 40% of veterans with any diagnosed disorder received some form of treatment. For alcohol use disorder, the estimate of unmet treatment need was 84%, which is particularly worrisome given that excessive alcohol use was the greatest substance use problem.	[Vazan, Peter; Golub, Andrew; Bennett, Alex S.] Natl Dev & Res Inst Inc, New York, NY 10010 USA		Vazan, P (corresponding author), Natl Dev & Res Inst Inc, 71 West 23rd St,8th Floor, New York, NY 10010 USA.	vazan@ndri.org			National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA020178]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA020178] Funding Source: NIH RePORTER	This research was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (R01 AA020178). Points of view expressed in this paper do not necessarily represent the official position of the U.S. Government, NIAAA, or NDRI. The authors express their deep appreciation to the project interviewers *Mr. Gary Huggins (U. S. Marines, retired), Mr. Atiba Marson-Quinones (U. S. Navy Reserves), and Ms. Morgan Cooley (U. S. Army, retired)* and all of the veterans who participated in the study.	Abdul-Quader AS, 2006, AIDS BEHAV, V9, P403; Anderson GL, 2009, EDUC POLICY, V23, P267, DOI 10.1177/0895904808328514; Bass E, 2012, VETERANS HLTH ADM TR; Bennett A. S., 2013, SUBST USE MISUSE, V48; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bourgois P., 2003, SEARCH RESPECT SELLI; Bray RM., 2009, 2008 DEP DEFENSE SUR; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Finley EP, 2011, FIELDS COMBAT UNDERS; Golub A., 2013, SUBST USE MISUSE, V48; Golub Andrew, 2007, Criminol Public Policy, V6, P131, DOI 10.1111/j.1745-9133.2007.00426.x; Golub A, 2013, MIL MED, V178, P107, DOI 10.7205/MILMED-D-12-00131; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heckathorn D., 2012, RESPONDENT DRIVEN SA; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hosmer D, 1989, APPL LOGISTIC REGRES; Iguchi MY, 2009, J URBAN HEALTH, V86, pS5, DOI 10.1007/s11524-009-9365-4; Institute of Medicine (IOM), 2009, COMB TOB US MIL VET; IOM, 2012, TREATM POSTTR STRESS; IOM (Institute of Medicine), 2012, SUBST US DIS US ARM; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jaycox, 2008, INVISIBLE WOUNDS WAR; Jeffri J., 2003, RESPONDENT DRIVEN SA, V3, P48; Johnson CV, 2009, AM J PUBLIC HEALTH, V99, pS187, DOI 10.2105/AJPH.2007.127464; Karney B. R., 2008, INVISIBLE WOUNDS PRE; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kirby AC, 2008, ADDICT BEHAV, V33, P1448, DOI 10.1016/j.addbeh.2008.05.007; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lansky A, 2007, PUBLIC HEALTH REP, V122, P48, DOI 10.1177/00333549071220S108; Luchins DJ, 2008, ADM POLICY MENT HLTH, V35, P270, DOI 10.1007/s10488-008-0169-8; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Maust DT, 2011, PSYCHIAT SERV, V62, P310, DOI 10.1176/ps.62.3.pss6203_0310; Nelson JP, 2008, NICOTINE TOB RES, V10, P775, DOI 10.1080/14622200802027123; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; References Substance Abuse and Mental Health Services Administration (SAMHSA), 2012, NSDUH SER H, VH-44; Rusch ML, 2009, J URBAN HEALTH, V86, P760, DOI 10.1007/s11524-009-9377-0; SAMHSA, 2012, TREATM EP DAT SET TE; *SAMHSA, 2005, NSDUH REP SUBST US D; SAMHSA, 2010, 2009 NAT SURV DRUG U; Schell T.L., 2011, NEEDS ASSESSMENT NEW; Schiller J. S., 2012, VITAL HLTH STAT, V10, P10; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Shahmanesh M, 2009, AM J PUBLIC HEALTH, V99, P1239, DOI 10.2105/AJPH.2008.149930; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Substance Abuse and Mental Health Services Administration (SAMHSA), 2010, RES 2009 NAT SURV DR, VI; Substance Abuse and Mental Health Services Administration [SAMHSA] Office of Applied Studies, 2008, NSDUH REP MAJ DEPR E; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Army, 2010, ARM HLTH PROM RISK R; US Department of Defense, 2008, ENH POSTD HLTH ASS P; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; WAGNER TH, 2007, PSYCHOL SERVICES, V0004; Wang JC, 2007, ADDICT BEHAV, V32, P924, DOI 10.1016/j.addbeh.2006.06.031; Wattana W, 2007, DRUG ALCOHOL DEPEN, V90, P228, DOI 10.1016/j.drugalcdep.2007.03.013; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Yano EM, 2012, J GEN INTERN MED, V27, P331, DOI 10.1007/s11606-011-1904-5	65	16	16	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2013	48	10					880	893		10.3109/10826084.2013.796989			14	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	186ES	WOS:000322025400008	23869460	Green Accepted			2022-02-06	
J	Walker, WC; McDonald, SD; Ketchum, JM; Nichols, M; Cifu, DX				Walker, William C.; McDonald, Scott D.; Ketchum, Jessica M.; Nichols, Michelle; Cifu, David X.			Identification of Transient Altered Consciousness Induced by Military-Related Blast Exposure and Its Relation to Postconcussion Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; explosive blast; military injury; questionnaire	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYNDROME; CLOSED-HEAD INJURY; POSTTRAUMATIC AMNESIA; PSYCHOMETRIC PROPERTIES; PTSD CHECKLIST; RELIABILITY; VALIDITY; QUESTIONNAIRE; INTERVIEW	Background: The ongoing controversy whether mild traumatic brain injury (TBI) can cause chronic sequel is partly due to diagnostic limitations. Diagnosing mild TBI is particularly challenging when assessment is not immediate, and when informed, first responder documentation or witness corroboration is absent. In this common scenario, the diagnosis is made entirely on self-report of an initial period of alteration of consciousness (AOC) associated with a plausible injury mechanism. Yet, there is scant published empirical guidance on methods for accurately detecting historical AOC. Objectives: To assess the value that recalled AOC symptoms collected via questionnaire have in evaluating individuals exposed to blast during recent military deployment. More specifically, to analyze the concrete AOC items (those signifying unconsciousness and/or posttraumatic amnesia) for their (1) frequency and distribution of positive versus negative responses, (2) interitem agreement, and (3) relation to current neuropsychiatric symptoms including those consistent with postconcussion syndrome (PCS). Participants: Eighty-seven active duty or Veteran subjects who experienced acute effects from a blast within the past 2 years while deployed for Operations Enduring and Iraqi Freedom. Results: Twenty-nine participants (33.3%) responded positively to at least 1 of 3 concrete AOC items: gap in memory (17.2%), memory not continuous (13.8%), and/or told by observer they had loss of consciousness (20.7%). Alteration of consciousness items were associated with but nondiscriminate of current symptom distress on standardized measures of PCS (Rivermead Postconcussion Symptom Questionnaire), posttraumatic stress disorder (PTSD; PTSD Checklist), depression (Centers for Epidemiological Studies Depression Scale), and pain (Short Form McGill Pain Questionnaire). Conclusions: The positive association between subjects' questionnaire-based AOC item responses and current symptom complex measures suggests that mild TBI has a role in the development of chronic neuropsychiatric symptoms after blast exposure. The lack of symptom-complex discrimination, and the inconsistencies found in subjects' item responses suggest that a structured interview may improve postacute diagnostic specificity for mild TBI.	[Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, MCV Stn, Richmond, VA 23298 USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Psychol Humanities & Sci, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Walker, William C.; McDonald, Scott D.; Nichols, Michelle] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, William C.; Nichols, Michelle] Def & Vet Brain Injury Ctr, Rockville, MD USA; [Nichols, Michelle] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Cifu, David X.] Dept Vet Affairs, Off Rehabil Serv, Washington, DC USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, MCV Stn, Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Walker, William C/N-3162-2014; Ketchum, Jessica/AAE-8200-2020; Nichols, Michelle/AAV-2740-2020	Cifu, David/0000-0003-1600-9387; Nichols, Michelle/0000-0002-2078-9649; Ketchum, Jessica/0000-0002-5566-3691	US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP) [W91ZSQ8118N6200001]	This study was supported by a grant from US Army Medical Research & Material Command, Congressionally Directed Medical Research Program (CDMRP) grant no. W91ZSQ8118N6200001; Epidemiological Study of Mild Traumatic Brain Injury Sequelae Caused by Blast Exposure during Operations Iraq Freedom and Enduring Freedom.	Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Flaherty S A, 1996, AANA J, V64, P133; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	35	16	16	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2013	28	1					68	76		10.1097/HTR.0b013e318255dfd0			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	070ZW	WOS:000313555400008	22647964				2022-02-06	
J	Bandt, SK; Greenberg, JK; Yarbrough, CK; Schechtman, KB; Limbrick, DD; Leonard, JR				Bandt, S. Kathleen; Greenberg, Jacob K.; Yarbrough, Chester K.; Schechtman, Kenneth B.; Limbrick, David D.; Leonard, Jeffrey R.			Management of pediatric intracranial gunshot wounds: predictors of favorable clinical outcome and a new proposed treatment paradigm Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						gunshot wound; head injury; clinical outcome; patient management; traumatic brain injury; trauma	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; PROGNOSTIC-FACTORS; CHILDREN; MORTALITY; SCALE; AGE	Object. There has been an increase in civilian gun violence since the late 1980s, with a disproportionately high increase occurring within the pediatric population. To date, no definite treatment paradigm exists for the management of these patients, nor is there a full understanding of the predictors of favorable clinical outcome in this population. Methods. The authors completed a retrospective review of all victims of intracranial gunshot injury from birth to age 18 years at a major metropolitan Level 1 trauma center (n = 48) from 2002 to 2011. The predictive values of widely accepted adult clinical and radiographic factors for poor prognosis were investigated. Results. Eight statistically significant factors (p < 0.05) for favorable outcome were identified. These factors include single hemispheric involvement, absence of a transventricular trajectory, < 3 lobes involved, >= 1 reactive pupil on arrival, systolic blood pressure > 100 mm Hg on arrival, absence of deep nuclei and/or third ventricular involvement, initial ICP < 30 mm Hg when monitored, and absence of midline shift. Of these 8 factors, 5 were strong predictors of favorable clinical outcome as defined by Glasgow Outcome Scale score of 4 or 5. These predictive factors included absence of a transventricular trajectory, < 3 lobes involved, >= 1 reactive pupil on arrival, absence of deep nuclei and/or third ventricular involvement, and initial ICP < 30 mm Hg. These findings form the basis of the St. Louis Scale for Pediatric Gunshot Wounds to the Head, a novel metric to inform treatment decisions for pediatric patients who sustain these devastating injuries. Conclusions. The pediatric population tends to demonstrate more favorable outcomes following intracranial gunshot injury when compared with the adult population; therefore some patients may benefit from more aggressive treatment than is considered for adults. The St. Louis Scale for Pediatric Gunshot Wounds to the Head may provide critical data toward evidence-based guidelines for clinical decision making. (http://thejns.org/doi/abs/10.3171/2012.8.PEDS123)	[Bandt, S. Kathleen; Yarbrough, Chester K.; Limbrick, David D.; Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Schechtman, Kenneth B.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Limbrick, David D.; Leonard, Jeffrey R.] St Louis Childrens Hosp, Dept Pediat Neurosurg, St Louis, MO 63178 USA		Bandt, SK (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, Campus Box 8057,660 S Euclid Ave, St Louis, MO 63110 USA.	bandtk@wudosis.wustl.edu		yarbrough, chester/0000-0003-0546-6435			BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; JENNETT B, 1975, LANCET, V1, P480; Karch Debra L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; LEVY ML, 1993, NEUROSURGERY, V33, P1018; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; Missouri Department of Health and Senior Services, 2011, MISS INF COMM ASS; Murano T, 2005, AM SURGEON, V71, P1009; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; Petridis AK, 2011, CENT EUR NEUROSURG, V72, P5, DOI 10.1055/s-0029-1241850; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002	27	16	16	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2012	10	6					511	517		10.3171/2012.8.PEDS123			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	042IE	WOS:000311464100011	23020154				2022-02-06	
J	Friedman, LS				Friedman, Lee S.			Dose-response relationship between in-hospital mortality and alcohol following acute injury	ALCOHOL			English	Article						Alcohol; Ethanol; Injury; Mortality; Dose-response; Trauma	ACUTE ETHANOLISM; BRAIN; INTOXICATION; LEVEL; ABUSE; ASSOCIATION; MORBIDITY; SEVERITY; MODERATE; IMPACT	Although the relationship between alcohol and injury incidence is well researched, there continues to be dispute about the relationship between alcohol and mortality following an injury. Findings from past studies have varied primarily because of methodological issues and have failed to characterize the dose response relationship. The main objective of this study was to evaluate the dose response relationship of in-hospital mortality and blood alcohol concentration (BAC). This study was a retrospective analysis of traumatic injuries occurring between 1995 and 2009 as reported by all level 1 and 2 trauma units in the State of Illinois. The study includes all patients with blood alcohol toxicological examination levels ranging from zero to 500 mg/dl (N = 190,612). The Illinois trauma registry includes all patients sustaining traumatic injuries and admitted to a trauma center for >= 12 h. A total of 6733 patients meeting the inclusion criteria died following admission. Patients that were dead on arrival and those that died during the initial assessment within the emergency room were excluded. In the adjusted multivariable model, a decrease in in-hospital mortality was strongly associated with an increase in blood alcohol concentration (adjusted OR = 0.83 per 100 mg/dl units change in BAC; CI 95%: 0.80, 0.85; p < 0.001). The direction of the dose response relationship was consistent across the stratified models, with the exception of patients suffering burns. The largest reduction of in-hospital case fatality rates by blood alcohol concentration was observed among patients suffering penetrating or severe injuries (Injury Severity Score >= 16). In the clinical setting, it is important to understand not only how to recognize intoxicated patients, but also how alcohol may affect the course of treatment. The consistency of the findings across the multivariable models indicates that blood alcohol concentration is strongly associated with lower in-hospital mortality among those that survive long enough to receive treatment in specialized trauma units. (C) 2012 Elsevier Inc. All rights reserved.	[Friedman, Lee S.] Univ Illinois, Sch Publ Hlth, Div Environm & Occupat Hlth Sci, Chicago, IL 60612 USA; [Friedman, Lee S.] Social Policy Res Inst, Skokie, IL 60076 USA		Friedman, LS (corresponding author), Social Policy Res Inst, 4001 Emerson, Skokie, IL 60612 USA.	lfriedman@tspri.org	Friedman, Lee/G-9799-2011	Friedman, Lee/0000-0001-9312-6099			Allison P. D, 2002, MISSING DATA; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHERPITEL CJ, 1995, ACCIDENT ANAL PREV, V27, P651, DOI 10.1016/0001-4575(95)00011-N; Cherpitel CJ, 2003, ADDICTION, V98, P1277, DOI 10.1046/j.1360-0443.2003.00459.x; Choudhry MA, 2006, FRONT BIOSCI-LANDMRK, V11, P998, DOI 10.2741/1857; Fabbri A, 2001, J TRAUMA, V50, P521, DOI 10.1097/00005373-200103000-00018; Friedman LS, 2007, J OCCUP ENVIRON MED, V49, P401, DOI 10.1097/JOM.0b013e31803b9527; Griffin R, 2009, J BURN CARE RES, V30, P395, DOI 10.1097/BCR.0b013e3181a28966; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KELLEY D, 1992, Journal of Burn Care and Rehabilitation, V13, P218, DOI 10.1097/00004630-199203000-00008; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; LOWENFELS AB, 1984, ANN EMERG MED, V13, P1056, DOI 10.1016/S0196-0644(84)80070-0; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Madan AK, 1999, J TRAUMA, V47, P568, DOI 10.1097/00005373-199909000-00026; McKim W. A., 1991, DRUGS BEHAV; Mitchell M C, 1985, J Stud Alcohol Suppl, V10, P109; Molina PE, 2004, ALCOHOL, V33, P217, DOI 10.1016/j.alcohol.2004.07.002; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Peck RC, 2008, J SAFETY RES, V39, P311, DOI 10.1016/j.jsr.2008.02.030; Phelan H, 2002, J TRAUMA, V52, P675, DOI 10.1097/00005373-200204000-00010; Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; Subramanian R., 2003, MULTIPLE IMPUTATION; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; von Heymann C, 2002, J TRAUMA, V52, P95, DOI 10.1097/00005373-200201000-00017; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; World Health Organisation (WHO), 2008, WHO COLL STUD ALC IN; Yaghoubian A, 2009, AM SURGEON, V75, P950; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004	45	16	16	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0741-8329	1873-6823		ALCOHOL	Alcohol	DEC	2012	46	8					769	775		10.1016/j.alcohol.2012.08.006			7	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse; Pharmacology & Pharmacy; Toxicology	047VX	WOS:000311870700007	23085114	Green Submitted			2022-02-06	
J	Nolin, P; Stipanicic, A; Henry, M; Joyal, CC; Allain, P				Nolin, Pierre; Stipanicic, Annie; Henry, Mylene; Joyal, Christian C.; Allain, Philippe			Virtual reality as a screening tool for sports concussion in adolescents	BRAIN INJURY			English	Article						Virtual reality; virtual classroom; ClinicaVR: Classroom; sports concussion; mTBI; mild traumatic brain injury; adolescents	TRAUMATIC BRAIN-INJURY; CONTINUOUS PERFORMANCE-TEST; UNITED-STATES; ENRICHED ENVIRONMENTS; EXERCISE PROGRAMS; MILD; REHABILITATION; CHILDREN; CLASSROOM; SYMPTOMS	Primary objective: There is controversy surrounding the cognitive effects of sports concussion. This study aimed to verify whether the technique of virtual reality could aid in the identification of attention and inhibition deficits in adolescents. Study design: A prospective design was used to assess 25 sports-concussed and 25 non-sports-concussed adolescents enrolled in a sport and education programme. Methods and procedures: Participants were evaluated in immersive virtual reality via ClinicaVR: Classroom-CPT and in real life via the traditional VIGIL-CPT. Main outcomes and results: The neuropsychological assessment using virtual reality showed greater sensitivity to the subtle effects of sports concussion compared to the traditional test, which showed no difference between groups. The results also demonstrated that the sports concussion group reported more symptoms of cybersickness and more intense cybersickness than the control group. Conclusions: Sports concussion was associated with subtle deficits in attention and inhibition. However, further studies are needed to support these results.	[Nolin, Pierre; Stipanicic, Annie; Henry, Mylene; Joyal, Christian C.; Allain, Philippe] Univ Quebec Trois Rivieres, Dept Psychol, Lab Rech Interdisciplinaire Realite Virtuelle LAR, Trois Rivieres, PQ G9A 5H7, Canada; [Allain, Philippe] Univ Angers, Lab Psychol Proc Pensee & Intervent, Angers, France		Nolin, P (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Lab Rech Interdisciplinaire Realite Virtuelle, CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	pierre.nolin@uqtr.ca		ALLAIN, Philiooe/0000-0003-0668-0986			Adams R, 2009, CHILD NEUROPSYCHOL, V15, P120, DOI 10.1080/09297040802169077; Alexander GE, 1992, DISS ABSTR INT B 1, V52, P6651; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cegalis J., 1991, VIGIL SOFTWARE ASSES; De Beaumont L., 2010, LONG TERM EFFECTS SP; De Brito SA, 2009, CRIM JUSTICE BEHAV, V36, P1173, DOI 10.1177/0093854809342883; de Kenedy, 2002, TRADUCTION POSTEXPOS; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Egeland J, 2010, J ATTEN DISORD, V13, P339, DOI 10.1177/1087054708323019; Fauzy, 2004, J INTERACTIVE LEARNI, V15, P147; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Kelly JP, 1997, NEUROLOGY, V48, P581; Kenedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203; Larson EB, 2011, BRAIN INJURY, V25, P274, DOI 10.3109/02699052.2010.551648; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Levin HS, 1987, MINOR HEAD INJURY PO; Levin MF, 2011, EXPERT REV NEUROTHER, V11, P153, DOI 10.1586/ERN.10.201; Martin C, 2009, A N A E APPROCHE NEU, V21, P28; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McAllister WR, 2006, LEARN BEHAV, V34, P44, DOI 10.3758/BF03192870; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory Paul, 2005, Clin J Sport Med, V15, P48; MIDDLETON J, 1989, J CHILD PSYCHOL PSYC, V30, P663, DOI 10.1111/j.1469-7610.1989.tb00780.x; Moreau G, 2006, ANN REV CYBERTHERAPY, V4, P59; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Nolin P, 2001, REV NEUROPSYCHOL, V11, P23; Nolin P, 2009, STUD HEALTH TECHNOL, V144, P240, DOI 10.3233/978-1-60750-017-9-240; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Penn PR, 2009, DEV NEUROREHABIL, V12, P32, DOI 10.1080/17518420902739365; Pollak Y, 2010, CNS SPECTRUMS, V15, P125, DOI 10.1017/S109285290002736X; Pollak Y, 2009, J DEV BEHAV PEDIATR, V30, P2, DOI 10.1097/DBP.0b013e3181969b22; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; PRATT DR, 1995, COMPUTER, V28, P17; Ptito A, 2007, NEUROREHABILITATION, V22, P217; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rizzo AA, 2006, CNS SPECTRUMS, V11, P35, DOI 10.1017/S1092852900024196; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schatz P., 2011, HDB SPORT NEUROPSYCH, P173; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trepagnier CG, 1999, NEUROREHABILITATION, V12, P63; UQO Cyberpsychology Laboratory, 2004, TRAD PRES QUEST WITM; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Yen HL, 2007, ANN ACAD MED SINGAP, V36, P62; Yip BCB, 2009, BRAIN INJURY, V23, P1017, DOI 10.3109/02699050903379412; Zhang J, 2003, INT J E LEARNING, V2, P17	84	16	17	1	28	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1564	1573		10.3109/02699052.2012.698359			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700003	22775556				2022-02-06	
J	Peters, M; Trembovler, V; Alexandrovich, A; Parnas, M; Birnbaumer, L; Minke, B; Shohami, E				Peters, Maximilian; Trembovler, Victoria; Alexandrovich, Alexander; Parnas, Moshe; Birnbaumer, Lutz; Minke, Baruch; Shohami, Esther			Carvacrol Together with TRPC1 Elimination Improve Functional Recovery after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						head trauma; neuronal cell death; TBI	NF-KAPPA-B; CHANNELS; NEUROPROTECTION; OVEREXPRESSION; ACTIVATION; APOPTOSIS; STROKE	Death of Central Nervous System (CNS) neurons following traumatic brain injury (TBI) is a complex process arising from a combination of factors, many of which are still unknown. It has been found that inhibition of transient receptor potential (TRP) channels constitutes an effective strategy for preventing death of CNS neurons following TBI. TRP channels are classified into seven related subfamilies, most of which are Ca2+ permeable and involved in many cellular functions, including neuronal cell death. We hypothesized that TRP channels of the TRPC subfamily may be involved in post-TBI pathophysiology and that the compound 5-isopropyl-2-methylphenol (carvacrol), by inhibition of TRP channels, may exert neuroprotective effect after TBI. To test these suppositions, carvacrol was given to mice after TBI and its effect on their functional recovery was followed for several weeks. Our results show that neurological recovery after TBI was significantly enhanced by application of carvacrol. To better define the type of the specific channel involved, the effect of carvacrol on the extent and speed of recovery after TBI was compared among mice lacking TRPC1, TRPC3, or TRPC5, relative to wild type controls. We found that neurological recovery after TBI was significantly enhanced by combining carvacrol with TRPC1 elimination, but not by the absence of TRPC3 or TRPC5, showing a synergistic effect between carvacrol application and TRPC1 elimination. We conclude that TRPC1-sensitive mechanisms are involved in TBI pathology, and that inhibition of this channel by carvacrol enhances recovery and should be considered for further studies in animal models and humans.	[Trembovler, Victoria; Alexandrovich, Alexander; Shohami, Esther] Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, Inst Drug Res,Sch Pharm, IL-91120 Jerusalem, Israel; [Peters, Maximilian; Parnas, Moshe; Minke, Baruch] IMRIC, Dept Med Neurobiol, Jerusalem, Israel; [Peters, Maximilian; Parnas, Moshe; Minke, Baruch] Edmond & Lily Safra Ctr Brain Sci ELSC, Jerusalem, Israel; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, Inst Drug Res,Sch Pharm, IL-91120 Jerusalem, Israel.	esty.shohami@mail.huji.ac.il	Peters, Maximilian/AAA-3509-2020; Peters, Maximilian/B-7406-2008	Parnas, Moshe/0000-0001-9726-1511	Rosetrees TrustRosetrees Trust; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z01-ES-101684]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES101684, ZIAES101684] Funding Source: NIH RePORTER	This study was approved by the Institutional Animal Care Committee of the Hebrew University. We thank Ben Katz for critical reading of the manuscript. This research was supported by grants from the Rosetrees Trust (to Dr. Minke) and by the Intramural Research Program of the National Institutes of Health (NIH) (project Z01-ES-101684 to Dr. Lutz Birnbaumer).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Andersen A, 2006, INT J TOXICOL, V25, P1, DOI [10.1080/10915810600716570, 10.1080/10915810600716653, 10.1080/10915910600716612]; Beni SM, 2006, J CEREBR BLOOD F MET, V26, P478, DOI 10.1038/sj.jcbfm.9600209; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Dadon D, 2010, INT J BIOCHEM CELL B, V42, P1430, DOI 10.1016/j.biocel.2010.04.006; De Vincenzi M, 2004, FITOTERAPIA, V75, P801, DOI 10.1016/j.fitote.2004.05.002; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Metna-Laurent M, 2012, J NEUROSCI, V32, P7109, DOI 10.1523/JNEUROSCI.1054-12.2012; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; Narayanan KL, 2008, NEUROSCI LETT, V446, P117, DOI 10.1016/j.neulet.2008.09.034; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nishida M, 2006, MICROCIRCULATION, V13, P535, DOI 10.1080/10739680600885111; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Parnas M, 2011, COMPREHENSIVE BIOPHYSICS, VOL 6: CHANNELS, P68, DOI 10.1016/B978-0-12-374920-8.00617-2; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Shan D, 2008, AM J PHYSIOL-CELL PH, V294, pC833, DOI 10.1152/ajpcell.00313.2007; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Yu H., 2012, PLOS ONE, V7; Yuan JP, 2012, ACTA PHYSIOL, V204, P238, DOI 10.1111/j.1748-1716.2011.02319.x; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784	33	16	17	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2831	2834		10.1089/neu.2012.2575			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800013	22994850	Green Published			2022-02-06	
J	Zhu, ZD; Ma, GJ; Wu, CW; Chen, Z				Zhu, Zhao Dan; Ma, Guo Jun; Wu, Cheng Wei; Chen, Zhen			Numerical study of the impact response of woodpecker's head	AIP ADVANCES			English	Article							BRAIN-INJURY; VISCOSITY	Woodpecker can beat trees 20-25 times per second and lasts for several seconds, with a 1200 g deceleration, but it appears that they never get brain concussion. How does the stress wave propagate from the beak tip to brain and how does a woodpecker protect itself from brain damage? In this paper, we establish a finite element model of typical woodpecker head based on its X-ray tomography images and conduct the numerical analysis of the impact response of the woodpecker's head by using a viscoelasticity material model. Especially, the woodpecker head response to an impact speed of 7 m/s is investigated to explore the stress concentration zone and how the stress wave propagates in its head. The numerical results show that the stress wave in the head propagates from the upper beak to back skull and is reduced by the specific structure of hyoid and viscoelasticity of biomaterials. The maximum stresses in skull and brain are both below the safe level. The stress in skull almost disappears before the next impact. The stress in brain lasts for a little longer but shows smaller value with little variation. The stress is impossible to accumulate in the limited pecking time, so the brain damage can be avoided. Copyright 2012 Author(s). This article is distributed under a Creative Commons Attribution 3.0 Unported License. [http://dx.doi.org/10.1063/1.4770305]	[Zhu, Zhao Dan; Ma, Guo Jun; Wu, Cheng Wei] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian, Peoples R China; [Chen, Zhen] Univ Missouri, Dept Civil & Environm Engn, Columbia, MO 65211 USA		Zhu, ZD (corresponding author), Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian, Peoples R China.	cwwu@dlut.edu.cn; chenzh@missouri.edu	WU, ChengWei/B-2590-2019	WU, ChengWei/0000-0003-1284-9442; Chen, Zhen/0000-0002-9231-8395	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [10972050, 90816025]; doctoral education foundation of China Education Ministry [20110041110021]	This work was supported by the National Natural Science Foundation of China (10972050, 90816025) and the doctoral education foundation of China Education Ministry (20110041110021)	GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gibson LJ, 2006, J ZOOL, V270, P462, DOI 10.1111/j.1469-7998.2006.00166.x; Gindl W, 2002, COMPOS PART A-APPL S, V33, P1141, DOI 10.1016/S1359-835X(02)00080-5; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Lunde KB, 2008, J MECH BEHAV BIOMED, V1, P199, DOI 10.1016/j.jmbbm.2007.10.001; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Neubauer S, 2004, CAN ASSOC RADIOL J, V55, P271; O'Toole M, 2008, BIOPHYS J, V94, P2610, DOI 10.1529/biophysj.107.117424; Oda J, 2006, JSME INT J A-SOLID M, V49, P390, DOI 10.1299/jsmea.49.390; Ono K., 1980, STAPP CAR CRASH C 24, V101, P60; Pithioux M, 2004, MED ENG PHYS, V26, P647, DOI 10.1016/j.medengphy.2004.05.002; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schwab IR, 2002, BRIT J OPHTHALMOL, V86, P843, DOI 10.1136/bjo.86.8.843; Stark RD, 1998, CONDOR, V100, P350, DOI 10.2307/1370276; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Vincent IFV, 2007, P I MECH ENG C-J MEC, V221, P1141, DOI 10.1243/09544062JMES574; Wang L.Z., 2011, PLOS ONE, V6; Wang LZ, 2011, SCI CHINA LIFE SCI, V54, P1036, DOI 10.1007/s11427-011-4242-2; Yoon SH, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016003; Zhou P, 2009, J BIONIC ENG, V6, P214, DOI 10.1016/S1672-6529(08)60126-2	20	16	16	2	56	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	DEC	2012	2	4							042173	10.1063/1.4770305			8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science; Physics	061DX	WOS:000312828700086		gold			2022-02-06	
J	Ma, M; Shofer, FS; Neumar, RW				Ma, Marek; Shofer, Frances S.; Neumar, Robert W.			Calpastatin Overexpression Protects Axonal Transport in an In Vivo Model of Traumatic Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; axonal transport; head trauma; traumatic brain injury; viral mediated transfection	CALPAIN INHIBITOR MDL-28170; BRAIN-INJURY; STRETCH-INJURY; OPTIC-NERVE; HEAD-INJURY; CASPASE ACTIVATION; CORPUS-CALLOSUM; GENE-THERAPY; MICROTUBULES; MICE	Traumatic brain injury (TBI) causes substantial morbidity and mortality worldwide. A key component of both mild and severe TBI is diffuse axonal injury. Except in cases of extreme mechanical strain, when axons are torn at the moment of trauma, axonal stretch injury is characterized by early cytoskeletal proteolysis, transport disruption, and secondary axotomy. Calpains, a family of Ca2+-dependent proteases, have been implicated in this pathologic cascade, but direct in vivo evidence is lacking. To test the hypothesis that calpains play a causal role in axonal stretch injury in vivo, we used our rat optic nerve stretch model following adeno-associated viral (AAV) vector-mediated overexpression of the endogenous calpain inhibitor calpastatin in optic nerve axons. AAV vectors were designed for optimal expression of human calpastatin (hCAST) in retinal ganglion cells (RGCs). Calpain inhibition by the expressed protein was then confirmed in primary cortical cultures. Finally, we performed bilateral intravitreal injections of AAV vectors expressing hCAST or the reporter protein ZsGreen 3 weeks prior to unilateral optic nerve stretch. Immediately after stretch injury, Fluoro-Gold was injected into the superior colliculi for assessment of retrograde axonal transport. Rats were euthanized 4 days after stretch injury. Both hCAST and ZsGreen were detected in axons throughout the optic nerve to the chiasm. Calpastatin overexpression partially preserved axonal transport after stretch injury (58.3 +/- 15.6% reduction in Fluoro-Gold labeling relative to uninjured contralateral controls in ZsGreen-expressing RGCs, versus 33.8 +/- 23.9% in hCAST-expressing RGCs; p = 0.038). These results provide direct evidence that axonal calpains play a causal role in transport disruption after in vivo stretch injury.	[Ma, Marek; Neumar, Robert W.] Univ Penn, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA; [Ma, Marek; Shofer, Frances S.; Neumar, Robert W.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA		Ma, M (corresponding author), Univ Penn, Ctr Resuscitat Sci, 125 S 31st St,Suite 1200, Philadelphia, PA 19104 USA.	marekma@mail.med.upenn.edu			Penn Vector Core NIDDK P30 Molecular Therapy Center Grant; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS055880]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS055880] Funding Source: NIH RePORTER	We thank Xinran Wang for helpful technical assistance, Margaret Maronski for preparing cultured cortical neurons, and David Meaney for the use of his optic nerve stretch device. We would like to acknowledge the University of Pennsylvania Preclinical Vector Core facility for providing vector production services, and partial funding through the Penn Vector Core NIDDK P30 Molecular Therapy Center Grant. Additional support was provided by the National Institutes of Health grant NS055880 (M.M.).	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; BILLGER M, 1988, CELL CALCIUM, V9, P33, DOI 10.1016/0143-4160(88)90036-X; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Czeiter E, 2009, MOLECULES, V14, P5115, DOI 10.3390/molecules14125115; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; GASKIN F, 1975, ANN NY ACAD SCI, V253, P133, DOI 10.1111/j.1749-6632.1975.tb19197.x; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Hirano Asao, 1995, P49; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; JOHNSON GVW, 1989, BIOCHEM BIOPH RES CO, V163, P1505, DOI 10.1016/0006-291X(89)91150-9; KEITH C, 1983, J CELL BIOL, V97, P1918, DOI 10.1083/jcb.97.6.1918; Ma MR, 2012, J NEUROTRAUM, V29, P445, DOI 10.1089/neu.2011.2060; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; OBrien ET, 1997, CELL MOTIL CYTOSKEL, V36, P125, DOI 10.1002/(SICI)1097-0169(1997)36:2<125::AID-CM3>3.0.CO;2-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SAHENK Z, 1988, BRAIN RES, V460, P199, DOI 10.1016/0006-8993(88)91224-3; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200	53	16	17	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	16					2555	2563		10.1089/neu.2012.2473			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	035CS	WOS:000310920900004	22776025	Green Published			2022-02-06	
J	Nelson, DW; Rudehill, A; MacCallum, RM; Holst, A; Wanecek, M; Weitzberg, E; Bellander, BM				Nelson, David W.; Rudehill, Anders; MacCallum, Robert M.; Holst, Anders; Wanecek, Michael; Weitzberg, Eddie; Bellander, Bo-Michael			Multivariate Outcome Prediction in Traumatic Brain Injury with Focus on Laboratory Values	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Coma Score; Glasgow Outcome Scale; hematologic tests; outcome; traumatic brain injury (TBI)	GLASGOW COMA SCALE; PROGNOSTIC VALUE; CLINICAL-TRIALS; HEAD-INJURY; IMPACT; MODELS; HYPERGLYCEMIA; COAGULOPATHY; ENROLLMENT; ALBUMIN	Traumatic brain injury (TBI) is a major cause of morbidity and mortality. Identifying factors relevant to outcome can provide a better understanding of TBI pathophysiology, in addition to aiding prognostication. Many common laboratory variables have been related to outcome but may not be independent predictors in a multivariate setting. In this study, 757 patients were identified in the Karolinska TBI database who had retrievable early laboratory variables. These were analyzed towards a dichotomized Glasgow Outcome Scale (GOS) with logistic regression and relevance vector machines, a non-linear machine learning method, univariately and controlled for the known important predictors in TBI outcome: age, Glasgow Coma Score (GCS), pupil response, and computed tomography (CT) score. Accuracy was assessed with Nagelkerke's pseudo R-2. Of the 18 investigated laboratory variables, 15 were found significant (p < 0.05) towards outcome in univariate analyses. In contrast, when adjusting for other predictors, few remained significant. Creatinine was found an independent predictor of TBI outcome. Glucose, albumin, and osmolarity levels were also identified as predictors, depending on analysis method. A worse outcome related to increasing osmolarity may warrant further study. Importantly, hemoglobin was not found significant when adjusted for post-resuscitation GCS as opposed to an admission GCS, and timing of GCS can thus have a major impact on conclusions. In total, laboratory variables added an additional 1.3-4.4% to pseudo R-2.	[Nelson, David W.; Rudehill, Anders; Wanecek, Michael; Weitzberg, Eddie] Karolinska Inst, Sect Anesthesiol & Intens Care, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Inst, Neurosurg Sect, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [MacCallum, Robert M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Immunogen Grp, London SW7 2AZ, England; [Holst, Anders] SICS, Kista, Sweden		Nelson, DW (corresponding author), Karolinska Inst, Sect Anesthesiol & Intens Care, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	david.nelson@karolinska.se	Wanecek, Michael/AAE-7998-2021	Nelson, David/0000-0003-2530-8207	Regional Agreement on Medical Training and Clinical Research (ALF); Stockholm County CouncilStockholm County Council; Karolinska InstitutetKarolinska Institutet; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Cancer and Traffic Injury Fund (CTRF)	Funding for this study was provided in part by the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and the Karolinska Institutet, funds from the Karolinska Institutet, The Swedish Research Council, and The Swedish Cancer and Traffic Injury Fund (CTRF).	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Bishop CM., 2006, PATTERN RECOGN; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Farin A, 2004, ACT NEUR S, V89, P101; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Helmy A, 2010, ACTA NEUROCHIR, V152, P953, DOI 10.1007/s00701-009-0584-y; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; R Development Core Team, 2008, R LANG ENV STAT COMP; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Salehpour F, 2011, J CRIT CARE, V26, P352, DOI 10.1016/j.jcrc.2010.12.005; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Young B, 1989, ANN SURG, V210, P472	47	16	17	0	11	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2613	2624		10.1089/neu.2012.2468			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400003	22994879				2022-02-06	
J	Neyens, DM; Boyle, LN				Neyens, David M.; Boyle, Linda Ng			Crash risk factors related to individuals sustaining and drivers following traumatic brain injuries	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Traumatic brain injuries (TBI); Cognitive impairments; Crash data; Case-control study	ACCIDENT RATE; SEVERITY; DAMAGE; YOUNG; COMA	Objective: Some crashes result in drivers experiencing (or sustaining) a traumatic brain injury (TBI) while other crashes involve drivers that have already experienced a TBI. The objective of this study is to examine the factors that influence these two TBI crash groups. Methods: Data from the Iowa Department of Public Health's Brain Injury Registry and Department of Transportation's crash records were linked together and used in logistic regression models to predict the likelihood of a driver sustaining a TBI in a crash and those who drive after a TBI. Results: Between 2001 and 2006, there were 2382 crashes in which an individual sustained a TBI. As expected, a higher likelihood of sustaining a TBI was observed for motorcycle drivers who did not wear a helmet and in crashes that resulted in total or disabling vehicle damage. Focusing specifically on the post-TBI drivers (and not occupants), 1583 were involved in crashes. These post-TBI drivers were less likely to wear seatbelts or have passengers in the vehicle at the time of the crash, and were more likely to crash at night. Post-TBI drivers were also involved in significantly more multiple crashes (about 14%) when compared to drivers who have not experienced a TBI (about 10%) during the study period. When controlling for gender, date of injury, and severity of TBI (using Glasgow Coma Scale), individuals that sustained a TBI when they were younger were more likely to be involved in multiple crashes. Conclusions: Different factors influence the crash likelihood for those that sustain a TB! in a crash and those that crash following a TBI. In general, post-TBI drivers have a higher occurrence of multiple crashes and this should be further explored to guide driver rehabilitation, evaluation, and training. (C) 2012 Elsevier Ltd. All rights reserved.	[Neyens, David M.] Clemson Univ, Dept Ind Engn, Clemson, SC USA; [Boyle, Linda Ng] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA		Boyle, LN (corresponding author), Univ Washington, Dept Ind & Syst Engn, Box 352650, Seattle, WA 98195 USA.	linda@uw.edu					Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Brenner LA, 2008, REHABIL PSYCHOL, V53, P18, DOI 10.1037/0090-5550.53.1.18; Bunn TL, 2005, ACCIDENT ANAL PREV, V37, P862, DOI 10.1016/j.aap.2005.04.004; Dimarco F, 2001, EURA MEDICOPHYS, V37, P215; Donmez B, 2010, J TRANSP ENG, V136, P403, DOI 10.1061/(ASCE)TE.1943-5436.0000068; Farmer Charles M, 2003, Traffic Inj Prev, V4, P38, DOI 10.1080/15389580309855; Fisk GD, 1998, BRAIN INJURY, V12, P683; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; FORMISANO R, 2001, EUROPA MEDICOPHYSICA, V37, P257; Grossman DC, 1997, ACCIDENT ANAL PREV, V29, P313, DOI 10.1016/S0001-4575(96)00085-1; HANDLER BS, 1995, J REHABIL, V61, P43; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Hill JD, 2007, TRANSPORT RES F-TRAF, V10, P177, DOI 10.1016/j.trf.2006.09.002; IDPH, 2007, IOW PLAN BRAIN INJ 2; IDPH, 2007, IOW COD FACT SHEET T; IIHS, 2009, CURR US MOT BIC HELM; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Kegler SR, 2003, J HEAD TRAUMA REHAB, V18, P469, DOI 10.1097/00001199-200311000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lowenstein SR, 2001, J TRAUMA, V50, P313, DOI 10.1097/00005373-200102000-00019; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; MacLennan PA, 2004, INJURY PREV, V10, P363, DOI 10.1136/ip.2003.005025; MASSIE DL, 1995, ACCIDENT ANAL PREV, V27, P73, DOI 10.1016/0001-4575(94)00050-V; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; McGwin G, 1999, ACCIDENT ANAL PREV, V31, P181; Neyens DM, 2008, ACCIDENT ANAL PREV, V40, P254, DOI 10.1016/j.aap.2007.06.005; Neyens DM, 2007, ACCIDENT ANAL PREV, V39, P206, DOI 10.1016/j.aap.2006.07.004; NINDS, 2007, TRAUM BRAIN INJ HOP; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Peden M., 2004, WORLD REPORT ROAD TR; PeekAsa C, 1996, J TRAUMA, V41, P989, DOI 10.1097/00005373-199612000-00008; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Segui-Gomez M, 2000, AM J PUBLIC HEALTH, V90, P1575, DOI 10.2105/AJPH.90.10.1575; Stutts J., 2003, DISTRACTIONS EVERYDA; Tagliaferri F., 2006, ACTA NEUROCHIRURGICA, P148; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Woodward M., 2005, EPIDEMIOLOGY STUDY D	44	16	16	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2012	49				SI		266	273		10.1016/j.aap.2012.01.008			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	074WI	WOS:000313845300034	23036405				2022-02-06	
J	Sherman, MD; Perlick, DA; Straits-Troster, K				Sherman, Michelle D.; Perlick, Deborah A.; Straits-Troester, Kristy			Adapting the Multifamily Group Model for Treating Veterans With Posttraumatic Stress Disorder	PSYCHOLOGICAL SERVICES			English	Article						multifamily groups; family psychoeducation; PTSD; veterans; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; MALE VIETNAM VETERANS; FAMILY PSYCHOEDUCATION; MILITARY FAMILIES; SOCIAL SUPPORT; SAFE PROGRAM; RISK-FACTORS; THERAPY; IRAQ	The Department of Veterans Affairs (VA) health care system's leadership has endorsed family involvement in veterans' mental health care as an important component of treatment. Both veterans and families describe family participation as highly desirable, and research has documented that having healthy social support is a strong protective factor for posttraumatic stress disorder (PTSD). Family psychoeducation has been shown to be effective in preventing relapse among severely mentally ill, and preliminary evidence suggests that family interventions for PTSD may improve veteran and family outcomes. The multifamily group (MFG) treatment model incorporates psychoeducation, communication training, and problem-solving skill building, and it increases social support through its group format. This article describes the rationale for further adaptation of the MFG model for PTSD, and it reviews issues related to its implementation as a promising adjunctive treatment as part of the continuum of PTSD services available in VA.	[Sherman, Michelle D.] Oklahoma City VA Med Ctr, Oklahoma City, OK 73104 USA; [Perlick, Deborah A.] VISN 3 Mental Illness Res Educ & Clin Ctr, Bronx, NY USA; [Perlick, Deborah A.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Straits-Troester, Kristy] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27706 USA		Sherman, MD (corresponding author), Oklahoma City VA Med Ctr, 921 NE 13th St 116A, Oklahoma City, OK 73104 USA.	michelle.sherman@va.gov		Sherman, Michelle/0000-0003-1055-9433			Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; Breitborde NJK, 2009, PSYCHIAT SERV, V60, P1477, DOI 10.1176/appi.ps.60.11.1477; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Carter Center, 2003, PRES NEW FREED COMM; Christianson A., 2000, RECONCILABLE DIFFERE; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Garcia HA, 2011, PSYCHOL SERV, V8, P1, DOI 10.1037/a0022705; Gewirtz AH, 2011, PROF PSYCHOL-RES PR, V42, P56, DOI 10.1037/a0022345; Glynn SM, 1999, J CONSULT CLIN PSYCH, V67, P243, DOI 10.1037/0022-006X.67.2.243; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horrell SCV, 2011, PROF PSYCHOL-RES PR, V42, P79, DOI 10.1037/a0022297; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; Lee TC, 2006, PSYCHIAT CLIN NEUROS, V60, P546, DOI 10.1111/j.1440-1819.2006.01556.x; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Makin-Byrd K, 2011, PROF PSYCHOL-RES PR, V42, P47, DOI 10.1037/a0022292; McFarlane W.R., 2002, MULTIFAMILY GROUPS T; McFarlane WR, 2003, J MARITAL FAM THER, V29, P223, DOI 10.1111/j.1752-0606.2003.tb01202.x; Miklowitz DJ, 2008, ARCH GEN PSYCHIAT, V65, P1053, DOI 10.1001/archpsyc.65.9.1053; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; Mueser K. T., 1999, BEHAV FAMILY THERAPY; Nezu CM., 2007, SOLVING LIFES PROBLE; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Perlick DA, 2011, PROF PSYCHOL-RES PR, V42, P70, DOI 10.1037/a0022319; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sherman M. D., 2011, NAT VA MENT HLTH C W; Sherman MD, 2005, PROF PSYCHOL-RES PR, V36, P626, DOI 10.1037/0735-7028.36.6.626; Sherman MD, 2005, PSYCHIAT SERV, V56, P1624, DOI 10.1176/appi.ps.56.12.1624; Sherman MD, 2005, PSYCHIAT SERV, V56, P1150, DOI 10.1176/appi.ps.56.9.1150; Sherman MD, 2005, COMMUNITY MENT HLT J, V41, P115, DOI 10.1007/s10597-005-2647-8; Sherman MD, 2003, PROF PSYCHOL-RES PR, V34, P42, DOI 10.1037/0735-7028.34.1.42; SHERMAN MD, 2008, SAFE PROGRAM SUPPORT; Sherman MD, 2008, PROF PSYCHOL-RES PR, V39, P443, DOI 10.1037/0735-7028.39.4.443; Sherman MD, 2006, COMMUNITY MENT HLT J, V42, P213, DOI 10.1007/s10597-005-9018-3; Sherman MD, 2009, PROF PSYCHOL-RES PR, V40, P593, DOI 10.1037/a0016333; Sherman MD, 2009, PSYCHIAT SERV, V60, P254, DOI 10.1176/appi.ps.60.2.254; Straits-Troster K., 2011, BRAIN IMPAIR, V12, P15; Substance Abuse and Mental Health Services Administration, 2011, HHS PUBL; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th	47	16	16	0	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	NOV	2012	9	4			SI		349	360		10.1037/a0028963			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	036ZP	WOS:000311071100003	22731838				2022-02-06	
J	Jeon, SJ; Han, SH; Yang, SI; Choi, JW; Kwon, KJ; Park, SH; Kim, HY; Cheong, JH; Ryu, JH; Ko, KH; Wells, DG; Shin, CY				Jeon, Se Jin; Han, Seol-Heui; Yang, Sung-Il; Choi, Ji Woong; Kwon, Kyoung Ja; Park, Seung Hwa; Kim, Hahn Young; Cheong, Jae Hoon; Ryu, Jong Hoon; Ko, Kwang Ho; Wells, David G.; Shin, Chan Young			Positive feedback regulation of Akt-FMRP pathway protects neurons from cell death	JOURNAL OF NEUROCHEMISTRY			English	Article						Akt; Bcl-xL; FMRP; glutamate; ischemia; neuronal survival	MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; LONG-TERM DEPRESSION; RNA-BINDING-PROTEIN; NEURAL STEM-CELLS; MESSENGER-RNA; SIGNALING PATHWAY; TARGET; SURVIVAL; GENE	J. Neurochem. (2012) 123, 226238. Abstract Fragile X syndrome (FXS), the most common single genetic cause of mental retardation and autistic spectrum disease, occurs when FMR1 gene is mutated. FMR1 encodes fragile X mental retardation protein (FMRP) which regulates translation of mRNAs playing important roles in the development of neurons as well as formation and maintenance of synapses. To examine whether FMRP regulates cell viability, we induced apoptosis in rat primary cortical neurons with glutamate in vitro and with middle cerebral artery occlusion (MCAO) in striatal neurons in vivo. Both conditions elicited a rapid, but transient FMRP expression in neurons. This up-regulated FMRP expression was abolished by pre-treatment with PI3K and Protein Kinase B (Akt) inhibitors: LY294002, Akt inhibitor IV, and VIII. Reduced FMRP expression in vitro or in vivo using small hairpin Fmr1 virus exacerbated cell death by glutamate or MCAO, presumably via hypophosphorylation of Akt and reduced expression of B-cell lymphoma-extra large (Bcl-xL). However, over-expression of FMRP using enhanced green fluorescent protein (eGFP)-FMRP constructs alleviated cell death, increased Akt activity, and enhanced Bcl-xL production. The pro-survival role of Akt-dependent up-regulation of FMRP in glutamate-stimulated cultured neuron as well as in ischemic brain may have a clinical importance in FXS as well as in neurodegenerative disorders and traumatic brain injury.	[Yang, Sung-Il; Shin, Chan Young] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul 143701, South Korea; [Jeon, Se Jin; Ko, Kwang Ho] Seoul Natl Univ, Dept Pharmacol, Coll Pharm, Seoul, South Korea; [Jeon, Se Jin; Han, Seol-Heui; Kwon, Kyoung Ja; Park, Seung Hwa; Kim, Hahn Young; Shin, Chan Young] Konkuk Univ, Inst SMART IABS, Neurosci Res Ctr, Seoul 143701, South Korea; [Cheong, Jae Hoon] Sahmyook Univ, Dept Pharm, Seoul, South Korea; [Ryu, Jong Hoon] Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul, South Korea; [Wells, David G.] Yale Univ, New Haven, CT USA; [Choi, Ji Woong] Gachon Univ, Coll Pharm, Dept Pharmacol, Inchon 406799, South Korea		Shin, CY (corresponding author), Konkuk Univ, Sch Med, Dept Pharmacol, 1 Hwayang Dong, Seoul 143701, South Korea.	chanyshin@kku.ac.kr	Jeon, Sangchoon/E-3800-2013	Jeon, Sangchoon/0000-0003-2855-2053	National Research Foundation of KoreaNational Research Foundation of Korea [2011-0014258]	This work was supported by a grant (2011-0014258) from National Research Foundation of Korea.	Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Berry-Kravis E, 1998, J NEUROSCI RES, V51, P41, DOI 10.1002/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Callan MA, 2011, GENESIS, V49, P424, DOI 10.1002/dvg.20745; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Castren M, 2005, P NATL ACAD SCI USA, V102, P17834, DOI 10.1073/pnas.0508995102; Castren M, 2006, CELL CYCLE, V5, P1528, DOI 10.4161/cc.5.14.3096; Chakrabarti L, 1997, CURR OPIN NEUROL, V10, P142, DOI 10.1097/00019052-199704000-00012; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dong X. X., 2009, ACTA PHARMACOL SIN, V30, P9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng Y, 1997, J NEUROSCI, V17, P1539; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jeon SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-17; Jeon SJ, 2011, NEUROSCI RES, V69, P214, DOI 10.1016/j.neures.2010.11.008; Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Kim JW, 2011, NEUROCHEM INT, V58, P423, DOI 10.1016/j.neuint.2010.12.020; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; Schultz-Pedersen S, 2001, AM J MED GENET, V103, P226, DOI 10.1002/ajmg.1533; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; de la Torre AV, 2012, PHARMACOL RES, V65, P66, DOI 10.1016/j.phrs.2011.08.006; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Wagner-Golbs A, 2012, J NEUROCHEM, V120, P495, DOI 10.1111/j.1471-4159.2011.07591.x; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Ye Z, 2012, NEUROCHEM RES, V37, P321, DOI 10.1007/s11064-011-0615-y; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang Hao, 2010, Yaoxue Xuebao, V45, P945; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104; Zhao WF, 2011, J NEUROSCI, V31, P725, DOI 10.1523/JNEUROSCI.2915-10.2011; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	67	16	16	1	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042			J NEUROCHEM	J. Neurochem.	OCT	2012	123	2					226	238		10.1111/j.1471-4159.2012.07886.x			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	015NX	WOS:000309454300003	22817682				2022-02-06	
J	Kolakowsky-Hayner, SA; Hammond, FM; Wright, J; Novack, TA; Englander, J; Diaz-Arrastia, R; Dennison, A; Sueno, P				Kolakowsky-Hayner, Stephanie A.; Hammond, Flora M.; Wright, Jerry; Novack, Thomas A.; Englander, Jeffrey; Diaz-Arrastia, Ramon; Dennison, Andrew; Sueno, Paul			Ageing and traumatic brain injury: Age, decline in function and level of assistance over the first 10 years post-injury	BRAIN INJURY			English	Article						Aging; decline; functional change; level of assistance; traumatic brain injury; TBI model systems	DISABILITY RATING-SCALE; LONG-TERM RECOVERY; INPATIENT REHABILITATION; OLDER-ADULTS; OUTCOMES; PREDICTORS	Objectives: To understand the course of changes in function and need for assistance in the chronic stages of TBI; and to identify factors associated with these changes. Design: Longitudinal review of participants in the TBI Model Systems Database, who have been prospectively followed for at least 10 years. Participants: Four hundred and seventy-eight individuals with TBI that occurred between 25 October 1988 and 31 December 1998, enrolled in the TBI Model Systems National Database, eligible for 10-year follow-up when data was extracted, with completed data collection at either year 1 or 2 and year 10. Results: Significant between age group differences were found for FIM toileting, bladder, bowel, toilet transfers, locomotion, problem-solving and memory; SRS; DRS level of functioning, employability and total; and GOS. With regard to functional independence, there were significant differences by age category for all FIM components except memory. Significant differences were noted for age category and level of dependence as measured by the DRS (LOF 1.5-5) and GOS (GOS 2-4). Supervision needs significantly increased as a function of age. Significant differences were found for diminished function over time. Significant differences were noted for residence at 10 years post-injury. Conclusions: For those individuals that survive to 10 years post-TBI, age is a major factor in requiring assistance of another person for supervision as well as assistance in basic self-care, continence and mobility.	[Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Englander, Jeffrey; Sueno, Paul] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; [Hammond, Flora M.; Dennison, Andrew] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46204 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Spain Rehabil Ctr, Birmingham, AL USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Kolakowsky-Hayner, SA (corresponding author), Rehabil Res Ctr, Dept PM&R, 751S Bascom Ave, San Jose, CA 95128 USA.	stephanie.hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Diaz-Arrastia, Ramon/0000-0001-6051-3594	TBI Model System Center; National Data and Statistical Center; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A070038, H13 3A070042, H133A070039, H133A070027]	The authors wish to thank all of the data collectors, project staff and project directors at each participating TBI Model System Center, the National Data and Statistical Center and the National Institute on Disability and Rehabilitation Research (NIDRR) for the continued support and funding.; This study was partially supported by NIDRR Grants # H133A070038, H13 3A070042, H133A070039 and H133A070027. The authors report no conflicts of interest.	Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; IOM, 2009, GULF WAR HLTH, V7; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; The Traumatic Brain Injury Model Systems National Data and Statistical Center (TBINDSC), 2010, 2010 TBI MOD SYST PR; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	29	16	16	3	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2012	26	11					1328	1337		10.3109/02699052.2012.706353			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	005AQ	WOS:000308723100006	22897421				2022-02-06	
J	Amantini, A; Carrai, R; Lori, S; Peris, A; Amadori, A; Pinto, F; Grippo, A				Amantini, A.; Carrai, R.; Lori, S.; Peris, A.; Amadori, A.; Pinto, F.; Grippo, A.			Neurophysiological monitoring in adult and pediatric intensive care	MINERVA ANESTESIOLOGICA			English	Article						Coma; Electroencephalography; Evoked potentials, Somatosensory; Intensive care unit; Monitoring	SOMATOSENSORY-EVOKED POTENTIALS; TRAUMATIC BRAIN-INJURY; NONCONVULSIVE STATUS EPILEPTICUS; CONTINUOUS EEG; PROGNOSTIC VALUE; HEAD-INJURY; INTRACRANIAL-PRESSURE; COMATOSE CHILDREN; MILD HYPOTHERMIA; CEREBRAL ANOXIA	Clinical neurophysiology is both an extension of clinical examination and an integration of neuroimaging. It plays a role in diagnosis, prognosis and monitoring in the Intensive Care Unit (ICU). Electroencephalography (EEG) and somatosensory evoked potentials (SEPs) are the most informative neurophysiological tests. Both have a major prognostic role in the hypoxic-ischemic encephalopathy and traumatic brain injury (TBI). In the former the absence of bilateral cortical SEPs has an unfavorable prognostic significance of 100%, whereas bilateral normal SEPs has uncertain prognostic value. In TBI these SEP patterns have high early prognostic value for both bad and good outcome. Continuous EEG monitoring is indicated for diagnosis and treatment of non convulsive seizures and status epilepticus (NCSE), whereas SEPs are more able to indicate the occurrence of neurological deterioration. In our opinion EEG-SEP monitoring is also valuable for interpretation and management of ICP trends, contributing to optimise treatment in a single patient. The EEG seems to have the same prognostic utility in pediatric as in adult ICU. Recent reviews supported the use of SEPs in the integrated process of outcome prediction after acute brain injury in children. However differences in interpretation are needed and the issue is whether it is possible to establish an age limit over which the prediction of SEPs is similar to that in adults. There are only a few studies of seizure prevalence in pediatric ICU. The variability of frequency of NCSE in comatose children is high as in adults and, similar to the adult, remains unclear the impact on outcome. (Minerva Anestesiol 2012;78:1067-75)	[Amantini, A.; Carrai, R.; Lori, S.; Pinto, F.; Grippo, A.] AOU Careggi Teaching Hosp, Dept Neurosci, I-50134 Florence, Italy; [Peris, A.] Careggi Teaching Hosp, Intens Care Unit, Emergency Dept, Florence, Italy; [Amadori, A.] Careggi Teaching Hosp, Neurointens Care Unit, Dept Neurosci, Florence, Italy; [Carrai, R.; Grippo, A.] IRCCS, Neurol Rehabil Unit, Don Carlo Gnocchi Fdn, ONLUS, Florence, Italy		Amantini, A (corresponding author), AOU Careggi Teaching Hosp, Dept Neurosci, Viale Morgagni 85, I-50134 Florence, Italy.	aldo.amantini@unifi.it	grippo, antonello/AAP-6926-2020; Pinto, Fausto/G-9363-2015	Pinto, Fausto/0000-0002-8034-4529; Grippo, Antonello/0000-0002-9997-8564			Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Al Thenayan E, 2008, NEUROLOGY, V71, P1535, DOI 10.1212/01.wnl.0000334205.81148.31; Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; Amantini A, 2011, CLIN NEUROPHYSIOL, V122, pS114; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Bosco E, 2012, ALINA GONZALEZ QUEVE, P257; Bosco E, 2011, CRIT CARE, V15, DOI 10.1186/cc10315; Bouwes A, 2009, NEUROLOGY, V73, P1457, DOI 10.1212/WNL.0b013e3181bf98f4; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Carrai R, 2011, CLIN NEUROPHYSIOL, V122, pS111; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Drislane FW, 2008, J CLIN NEUROPHYSIOL, V25, P181, DOI 10.1097/WNP.0b013e31817be70e; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Forsyth R, 2010, COCHRANE DB SYST REV, V2; Fossi S, 2006, NEUROPHYSIOL CLIN, V36, P195, DOI 10.1016/j.neucli.2006.09.001; Fossi S, 2007, NEUROL SCI, V28, pS59; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gagliardo A, 2008, EUR J NEUROL, V15, P408; Geocadin RG, 2008, CURR OPIN CRIT CARE, V14, P261, DOI 10.1097/MCC.0b013e3282fd68ea; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit JM, 2010, CURR OPIN CRIT CARE, V16, P98, DOI 10.1097/MCC.0b013e328337541a; Guerit JM., 2008, INTRAOPERATIVE MONIT, P829; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; HOCKADAY JM, 1965, ELECTROEN CLIN NEURO, V18, P575, DOI 10.1016/0013-4694(65)90075-1; Holtkamp Martin, 2011, Ther Adv Neurol Disord, V4, P169, DOI 10.1177/1756285611403826; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; HUGHES JR, 1976, ELECTROEN CLIN NEURO, V40, P261, DOI 10.1016/0013-4694(76)90150-4; Husain AM, 2003, J NEUROL NEUROSUR PS, V74, P189, DOI 10.1136/jnnp.74.2.189; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; KONASIEWICZ SJ, 1994, CAN J NEUROL SCI, V21, P219, DOI 10.1017/S0317167100041196; Lee YC, 2010, NEUROLOGY, V74, P572, DOI 10.1212/WNL.0b013e3181cff761; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Moulton RJ, 1998, CAN J NEUROL SCI, V25, pS7, DOI 10.1017/S031716710003465X; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; RamachandranNair R, 2005, CAN J NEUROL SCI, V32, P518, DOI 10.1017/S0317167100004546; RamachandranNair R, 2005, PEDIATR NEUROL, V33, P345, DOI 10.1016/j.pediatrneurol.2005.05.007; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rossetti AO, 2010, CURR OPIN CRIT CARE; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Shewmon DA, 2000, J CLIN NEUROPHYSIOL, V17, P467, DOI 10.1097/00004691-200009000-00005; SYNEK VM, 1990, CLIN ELECTROENCEPHAL, V21, P25, DOI 10.1177/155005949002100111; Tiainen M, 2005, CRIT CARE MED, V33, P1736, DOI 10.1097/01.CCM.0000171536.63641.D9; Treiman DM, 2006, EPILEPSY RES, V68, pS77, DOI 10.1016/j.eplepsyres.2005.07.020; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wohlrab G, 2001, NEUROPEDIATRICS, V32, P271, DOI 10.1055/s-2001-19123; Young GB, 2010, NEUROLOGY, V75, P760, DOI 10.1212/WNL.0b013e3181f32141; Young GB, 2009, NEUROCRIT CARE, V11, P411, DOI 10.1007/s12028-009-9248-2; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Zanatta P, 2012, MINERVA ANESTESIOL; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f; Zhang Y, 2011, J CLIN NEUROPHYSIOL, V28, P497, DOI 10.1097/WNP.0b013e318231c852	70	16	19	0	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	SEP	2012	78	9					1067	1075					9	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	021QX	WOS:000309901500014	22672930				2022-02-06	
J	Auxemery, Y				Auxemery, Y.			Mild traumatic brain injury and postconcussive syndrome: A re-emergent questioning	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						Postconcussive syndrome; Mild traumatic brain injury; Blast injuries; Physiopathology; Psychopathology; Comorbidities; Post traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; SYMPTOMS; POPULATION; CONCUSSION; MECHANISMS; IRAQ	Introduction. - Blast injuries are psychologically and physically devastating. Notably, primary blast injury occurs as a direct effect of changes in atmospheric pressure caused by a blast wave. The combat-related traumatic brain injuries (TBI) resulting from exposure to explosions is highly prevalent among military personnel who have served in current wars. Traumatic brain injury is a common cause of neurological damage and disability among civilians and servicemen. Most patients with TBI suffer a mild traumatic brain injury with transient loss of consciousness. A controversial issue in the field of head injury is the outcome of concussion. Literature findings. - Most individuals with such injuries are not admitted to emergency units and receive a variable degree of medical attention. Nevertheless, cranial traumas vary in their mechanisms (blast, fall, road accident, bullet-induced craniocerebral injury) and in their gravity (from minor to severe). The majority of subjects suffering concussion have been exposed to explosion or blast injuries, which have caused minor cranial trauma. Although some authors refuse to accept the reality of post-concussion syndrome (PCS) and confuse it with masked depression, somatic illnesses or post-traumatic stress, we have raised the question again of its existence, without denying the intricate links with other psychiatric or neurological disorders. Although the mortality rate is negligible, the traumatic sequel after mild traumatic brain injury is clear. A difference in initial somatic severity is noted between the serious somatic consequences of a severe cranial trauma compared with the apparently benign consequences of a minor cranial trauma. However, the long-term consequences of the two types of impacts are far from negligible: PCS is a source of morbidity. The prognosis for minor cranial traumas is benign at vital level but a number of patients will develop long-term complaints, which contrast with the negativity of the clinical examination and complementary explorations. The origin of these symptoms questions their organic and psychological aetiologies, which are potentially associated or intricately linked. After a cerebral concussion patients report a cluster of symptoms referred to as postconcussive. Clinical findings. - Post-concussion syndrome lies within the confines of somatic symptoms (headaches, dizziness, and fatigue), cognitive symptoms (memory and concentration problems) and affective symptoms (irritability, emotional lability, depression, anxiety, trouble sleeping). The nosographical entity of post-concussion syndrome is still in the process of elaboration following the input of new research intended to determine a cluster of specific symptoms. The persistent post-concussion syndrome is believed to be due to the psychological effects of the injury, biological factors, or a combination of both. Considered in isolation, the symptoms of post-concussion syndrome are non-specific and come together with other diagnostic frameworks such as characterised depressive episodes and post-traumatic stress. Post-concussion syndrome is not specific to concussion but can be present in subjects without any previous cranial trauma. Discussion. Blast trauma can thus be understood as experiencing a shockwave on the brain and as a psycho-traumatic event. The major methodological problem of the studies is the quantification of the functional symptoms present in different nosographical frameworks, which are often co-morbid. Post-traumatic stress disorder is one of several psychiatric disorders that may increase suffering and disability among people with mild traumatic brain injury; in addition mood disorders also seem to be frequent psychiatric complications among these patients. Psychotic disorders after TBI have been associated with several brain regions. The establishment of a causative relationship between TBI and psychiatric disorders is interesting in terms of our understanding of these possible sequelae of TBI. The grey substance of the grey nuclei of the base can also be altered by a scissoring mechanism of the perforating arteries. A cortical contusion through impression of the cortex on the contours of the cranium is frequent. The most common type of injury is traumatic axonal injury. Cerebral lesions that are secondary to TBI associate cell deaths through the mechanisms of apoptosis and necrosis concerning the nerve and glial cells. The scientific objective is to discover an anatomoclinical correlation between the symptoms of post-concussion syndrome and objectifiable brain damage. The predictive value of serum concentrations of the specific serum markers S-100B and neurone specific enolase has been established. Conclusion. - Cerebral imaging will allow the mechanisms concerned in cranial trauma to be better understood and thus may allow these mechanisms to be linked with co-morbid post-traumatic psychiatric disorders such as depression. The pyschopathological approach provides supplementary enlightenment where neuroimaging studies struggle to establish precise anatomoclinical correlations between neurotraumatic lesions, state of post-traumatic stress, and PCS. Moving away from a purely scientific view to focus on subjectivity, PCS can establish itself in subjects with no history of head trauma thus showing purely psychic suffering. Is the former name of "subjective post-head injury syndrome" no longer pertinent since the neurobiological affections can be objectified? Yet, the tatter does not necessarily explain the somatic symptoms. Beyond any opposition of a psychic or somatic causality, it shows the complexity of this interaction. Admittedly, looking for a neuropathological affection is particularly cardinal to propose an aetiological model and objectify the lesions, which should be documented using a forensic approach. However, within the context of treatment, this theoretical division of the brain and the mind becomes less operative: the psychotherapeutic support will on the contrary back the indivisibility of the subject, he/she, who faced the "clatter". (C) L'Encephale, Paris, 2011.	Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, F-57070 Metz 3, France		Auxemery, Y (corresponding author), Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, 27 Ave Plantieres,BP 90001, F-57070 Metz 3, France.	yann.auxemery@hotmail.fr					American Psychiatric Association, 2000, DSM 4 TR MAN DIAGN S; [Anonymous], 1993, ARCH PHYS MED REHAB, V74, pS8; [Anonymous], 2006, CLIN PRACTICE GUIDEL; Auxemery Y, 2011, ENCEPHALE IN PRESS, DOI [10.1016/j.encep.2011.12.001, DOI 10.1016/J.ENCEP.2011.12.001]; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kemp S, 2005, BRAIN INJURY, V19, P1269, DOI 10.1080/02699050500309353; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; *ORG MOND SANT, 1993, CLASS INT TROUBL MEN; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2007, J NEUROPSYCH CLIN N, V19, P100; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Waddington A, 2003, ENCEPHALE, V29, P20; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	38	16	16	3	56	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	SEP	2012	38	4					329	335		10.1016/j.encep.2011.07.003			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	028EL	WOS:000310405500008	22980474				2022-02-06	
J	Frisch, S; Forstl, S; Legler, A; Schope, S; Goebel, H				Frisch, Stefan; Foerstl, Sabine; Legler, Angela; Schoepe, Sabine; Goebel, Hans			The interleaving of actions in everyday life multitasking demands	JOURNAL OF NEUROPSYCHOLOGY			English	Article							ANTERIOR PREFRONTAL CORTEX; EXECUTIVE DEFICITS; FRONTAL-LOBE; VALIDITY; STROKE; RELIABILITY; DISORDER; AREA-10; TASK	It has been argued that executive tests should capture central aspects of executive functions in everyday life such as initiating and monitoring parallel actions in low-structured environments (so-called multitasking; see Burgess, 2000). We present a cooking task in order to assess executive function impairments in brain-damaged patients, which focuses on a central feature of multitasking, the interleaving of tasks (Burgess, 2000). Behavioural performance of 21 brain-damaged patients (stroke, traumatic brain injury) and of a group of matched controls was analysed on the basis of a standardized protocol. In comparison to controls, the patients explored less, were less successful in monitoring their actions and corrected errors less efficiently. Interleaving of actions was observed less frequently in patients, with respect to both cooking itself as well as to subordinate goals (e.g., cleaning up). Interleaving proved efficient, as it was associated with less time to complete the task. Patients scores in the cooking task correlated with performance in both the Behavioural Assessment of the Dysexecutive Syndrome (BADS) Zoo Map Test and the BADS Six Elements Test, but not with tests of attention, verbal memory, or figural fluency, thus demonstrating convergent and discriminant validity. In summary, our task demonstrates that cooking can provide a valid testing ground for assessing a central aspect of everyday multitasking demands, namely, the interleaving of actions.	[Frisch, Stefan] Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany; [Frisch, Stefan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Frisch, Stefan; Foerstl, Sabine; Legler, Angela; Goebel, Hans] Univ Clin, Day Care Clin Cognit Neurol, Leipzig, Germany; [Foerstl, Sabine; Legler, Angela; Goebel, Hans] Univ Clin, Dept Phys Therapy, Leipzig, Germany; [Schoepe, Sabine] Sozialwerk St Michael, Leipzig, Germany		Frisch, S (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Schleusenweg 2-16,Haus 95, D-60528 Frankfurt, Germany.	frisch@cbs.mpg.de		Frisch, Stefan/0000-0002-7294-4786			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Alderman N, 2009, REHABILITATION EXECU, P97; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Brasil P., 2009, R PACKAGE DIAGNOSISM; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess P.W., 2005, EFFECTIVENESS REHABI, P211, DOI DOI 10.1093/ACPROF:OSO/9780198526544.001.0001; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Camchong J, 2006, BIOL PSYCHIAT, V60, P235, DOI 10.1016/j.biopsych.2005.11.014; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Haid T., 2002, Z NEUROPSYCHOL, V13, P233; Harting C., 2000, WECHSLER GEDACHTNIST; Hartman-Maeir A, 2009, AM J OCCUP THER, V63, P592, DOI 10.5014/ajot.63.5.592; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Horn W., 1983, L P S LEISTUNGSPRUFS; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lazar RM, 2007, COGN BEHAV NEUROL, V20, P157, DOI 10.1097/WNN.0b013e31804c703f; Luria A.R., 1973, WORKING BRAIN; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Metzler P., 2000, STANDARDISIERTE LINK; Nieuwenhuis R, 2008, HUMAN CENTRAL NERVOU; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; ZIMMERMANN P, 1993, TEST ATTENTIONAL PER	38	16	16	0	16	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645			J NEUROPSYCHOL	J. Neuropsychol.	SEP	2012	6		2				257	269		10.1111/j.1748-6653.2012.02026.x			13	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	000ZN	WOS:000308429700007	22329754				2022-02-06	
J	Goecks, CSB; Horst, A; Moraes, MS; Scheid, T; Kolberg, C; Bello-Klein, A; Partata, WA				Goecks, Cristina S. B.; Horst, Andrea; Moraes, Maira S.; Scheid, Taina; Kolberg, Carolina; Bello-Klein, Adriane; Partata, Wania A.			Assessment of Oxidative Parameters in Rat Spinal Cord After Chronic Constriction of the Sciatic Nerve	NEUROCHEMICAL RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; SUPEROXIDE-DISMUTASE; NEUROPATHIC PAIN; XYLENOL ORANGE; FREE-RADICALS; NITRIC-OXIDE; STRESS; ACTIVATION; ASSAY	Although reactive oxygen species (ROS) are involved in neuropathic pain, the direct relationship between these species and chronic constriction of sciatic nerve (CCI) has not been studied in spinal cord. Thus, this study induced CCI in rats and these animals were sacrificed 3 and 10 days after the surgical procedure to determine the superoxide dismutase (SOD) and catalase activities, as well as ascorbic acid, hydrogen peroxide (H2O2) and lipid hydroperoxide levels in lumbosacral spinal cord. Von Frey Hair and hot plate tests were performed to assess the degree of mechanical and thermal hyperalgesia at days 0, 3 and 10. The results showed that CCI significantly induced mechanical and thermal hyperalgesia at days 3 and 10. Parallel there was increase in spinal cord lipid hydroperoxide at days 3 and 10 in rats submitted to CCI. In Sham rats a significant increase in this parameter occurred at day 10. H2O2 decreased at day 10 only in CCI group. SOD activity was decreased in Sham and CCI groups at day 3, while catalase activity was increased in CCI rats at days 3 and 10. Ascorbic acid levels were reduced only in CCI rats at day 3. Although the role of such changes is unclear, many were not specific to neuropathic pain and the differences could be related to different degrees of central sensitization in Sham and CCI rats.	[Goecks, Cristina S. B.; Horst, Andrea; Moraes, Maira S.; Scheid, Taina; Kolberg, Carolina; Bello-Klein, Adriane; Partata, Wania A.] Univ Fed Rio Grande do Sul, Dept Fisiol, Inst Ciencias Basicas Saude, BR-90050170 Porto Alegre, RS, Brazil		Partata, WA (corresponding author), Univ Fed Rio Grande do Sul, Dept Fisiol, Inst Ciencias Basicas Saude, Rua Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.	partataw@gmail.com			Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Byers M.R., 2001, BONICAS MANAGEMENT P, V1, P26; Clemens JA, 2000, FREE RADICAL BIO MED, V28, P1526, DOI 10.1016/S0891-5849(00)00258-6; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Guedes RP, 2006, NEUROCHEM RES, V31, P603, DOI 10.1007/s11064-006-9058-2; Guedes R, 2008, CELL MOL NEUROBIOL, V28, P1049, DOI 10.1007/s10571-008-9279-9; Guedes RP, 2009, BRAIN RES BULL, V80, P422, DOI 10.1016/j.brainresbull.2009.08.007; IASP-InternationaL Association for the Study of Pain, 2008, PAIN S, V3, pS1; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Joe B, 1997, MOL CELL BIOCHEM, V168, P87, DOI 10.1023/A:1006834924854; Khalil Z, 2001, FREE RADICAL BIO MED, V31, P430, DOI 10.1016/S0891-5849(01)00597-4; Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007; Latremoliere A, 2008, J NEUROSCI, V28, P8489, DOI 10.1523/JNEUROSCI.2552-08.2008; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mruk DD, 2002, CONTRACEPTION, V65, P305, DOI 10.1016/S0010-7824(01)00320-1; Muthuraman A, 2008, EUR J PHARMACOL, V587, P104, DOI 10.1016/j.ejphar.2008.03.042; Nalk AK, 2006, EUR J PAIN, V10, P573, DOI 10.1016/j.ejpain.2005.08.006; Nishikawa M, 2009, ADV DRUG DELIVER REV, V61, P319, DOI 10.1016/j.addr.2009.01.001; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Rhee S G, 2000, Sci STKE, V2000, ppe1; Roe JH, 1943, J BIOL CHEM, V147, P399; Rossato MF, 2010, J PAIN, V11, P545, DOI 10.1016/j.jpain.2009.09.016; Sodergren E, 1998, J BIOCHEM BIOPH METH, V37, P137, DOI 10.1016/S0165-022X(98)00025-6; SPECTOR R, 1977, BIOCHEM PHARMACOL, V26, P1507, DOI 10.1016/0006-2952(77)90423-3; Tsai CC, 2005, J PERIODONTAL RES, V40, P378, DOI 10.1111/j.1600-0765.2005.00818.x; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vaculin S, 2010, NEUROSCI LETT, V477, P82, DOI 10.1016/j.neulet.2010.04.037; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vanderah TW, 2007, MED CLIN N AM, V91, P1, DOI 10.1016/j.mcna.2006.10.006; Varija D, 2009, INDIAN J MED RES, V129, P587; Viggiano A, 2005, BRAIN RES, V1050, P72, DOI 10.1016/j.brainres.2005.05.021; Yowtak J, 2011, PAIN, V152, P844, DOI 10.1016/j.pain.2010.12.034	38	16	18	0	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2012	37	9					1952	1958		10.1007/s11064-012-0815-0			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	985PP	WOS:000307280100014	22674084	Bronze			2022-02-06	
J	Olson-Madden, JH; Forster, JE; Huggins, J; Schneider, A				Olson-Madden, Jennifer H.; Forster, Jeri E.; Huggins, Joseph; Schneider, Alexandra			Psychiatric Diagnoses, Mental Health Utilization, High-Risk Behaviors, and Self-Directed Violence Among Veterans With Comorbid History of Traumatic Brain Injury and Substance Use Disorders	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						risky behaviors; substance use disorder; suicide; traumatic brain injury; utilization; veterans	TBI IDENTIFICATION METHOD; ABUSE; ALCOHOL; RELIABILITY; SUICIDALITY; PREVALENCE; VALIDITY; OUTCOMES	Objectives: To describe various characteristics of veterans with co-occurring histories of traumatic brain injury (TBI) and substance use disorder (SUD) for purposes of hypothesis generation. Study Design: Archival data collected over a period of 4 years. Participants: Sixty-five veterans across eras of service with confirmed histories of TBI and SUD. Methods: Demographic and TBI information were obtained from an archival clinical database. Electronic medical records were reviewed for mental health utilization, psychiatric diagnoses, self-directed violence, and risk-taking behaviors. Results: In addition to a SUD, veterans were reported to have an average of 3 additional psychiatric diagnoses and a median of 3 TBIs per person. All utilized various mental health services in addition to substance use treatment. Individuals were found to have engaged in a variety of risky behaviors. There were significant associations between suicidal ideation and assaultive behaviors, as well as between suicide attempt and impulsivity. Conclusions: This study describes a sample of veterans with co-occurring histories of TBI, SUD, risk-taking behaviors, and self-directed violence. More research is needed to examine these complex interrelationships and to identify specific risk factors for intervention/prevention strategies.	[Olson-Madden, Jennifer H.; Huggins, Joseph; Schneider, Alexandra] Mental Illness Res Educ & Clin Ctr, VISN 19, Denver, CO 80220 USA; [Olson-Madden, Jennifer H.] Univ Colorado, Dept Psychiat, Denver, CO 80202 USA; [Forster, Jeri E.] Univ Colorado, Dept Pediat, Denver, CO 80202 USA; [Forster, Jeri E.] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Forster, Jeri E.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Denver, CO 80202 USA		Olson-Madden, JH (corresponding author), Mental Illness Res Educ & Clin Ctr, VISN 19, 1055 Clermont St, Denver, CO 80220 USA.	jennifer.olson-madden@va.gov		Huggins, Joe/0000-0001-8151-5062	Eastern Colorado Health Care System Veterans Affairs Medical Center in Denver, Colorado; VISN 19 MIRECC	This material is the result of work supported with resources and the use of facilities at the Eastern Colorado Health Care System Veterans Affairs Medical Center in Denver, Colorado, and the VISN 19 MIRECC.	Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Defense Task Force on Prevention of Suicide by Members of the Armed Forces, 2010, EX SUMM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hufford MR, 2001, CLIN PSYCHOL REV, V21, P797, DOI 10.1016/S0272-7358(00)00070-2; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Miller N. S., 2005, TXB TRAUMATIC BRAIN, P509; Office of Applied Studies, 2007, DAWN SER D; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; Tate PS, 1999, BRAIN INJURY, V13, P767; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Zuckerman, 2007, SENSATION SEEKING RI; Zuckerman M., 1994, BEHAV EXPRESSION BIO	30	16	16	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2012	27	5					370	378		10.1097/HTR.0b013e318268d496			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004OQ	WOS:000308691400091	22955102				2022-02-06	
J	Stuart, B; Mandleco, B; Wilshaw, R; Beckstrand, RL; Heaston, S				Stuart, Barbara; Mandleco, Barbara; Wilshaw, Russell; Beckstrand, Renea L.; Heaston, Sondra			MILD TRAUMATIC BRAIN INJURY: ARE ED PROVIDERS IDENTIFYING WHICH PATIENTS ARE AT RISK?	JOURNAL OF EMERGENCY NURSING			English	Article						MTBI; Head injury; Concussion; Post-concussive syndrome	POST-CONCUSSION SYNDROME; GENDER-DIFFERENCES; HEAD-INJURIES; COMPLAINTS; SYMPTOMS; IMPACT	Objective: To identify patients with specific ED discharge diagnoses reporting symptoms associated with a mild traumatic brain injury (MTBI), compare frequency/severity of MTBI symptoms by discharge diagnosis, investigate head injury education provided at ED discharge, and learn about changes made by MTBI patients after injury. Methods: The Post Concussion Symptom Scale, a demographic questionnaire, and open-ended questions about the impact the injury had on patients' lives were completed by 52 ED patients, at least 2 weeks after injury, discharged with concussion/closed head injury, head laceration, motor vehicle crash (MVC), or whiplash/cervical strain diagnoses. Results: Between 1 and 23 MTBI symptoms were reported by 84.6% of the participants. Headache and fatigue were the most common; female patients had almost twice as many symptoms on average as male patients. Of MVC patients, 83.3% reported moderate severity scores for all 4 Post Concussion Symptom Scale categories, and these represented the highest overall severity scores. Concussion/closed head injury diagnosis patients received the most head injury education. The majority of patients were more cautious after injury. Conclusion: Most participants reported having MTBI symptoms. Although MVC participants reported the most severe MTBI symptoms, they had the least head injury education. Emergency nurses need to be aware patients may have an MTBI regardless of their presenting symptoms or injury severity.	[Mandleco, Barbara; Heaston, Sondra] Brigham Young Univ, Coll Nursing, Provo, UT 84602 USA; [Stuart, Barbara] Utah Valley Reg Med Ctr, Emergency Dept, Provo, UT USA; [Wilshaw, Russell] Univ Utah Hlth Care, Salt Lake City, UT USA		Mandleco, B (corresponding author), Brigham Young Univ, Coll Nursing, 474 SWKT, Provo, UT 84602 USA.	barbara_mandleco@byu.edu	Beckstrand, Renea/AAL-9507-2020	Beckstrand, Renea/0000-0002-9456-6536	Brigham Young University Graduate Studies research grant	This project was funded by a Brigham Young University Graduate Studies research grant.	Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bergman K, 2010, J EMERG NURS, V36, P221, DOI 10.1016/j.jen.2009.07.001; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; *CDCP, HEADS BRAIN INJ YOUR; Centers for Disease Control and Prevention, TBI PUBL; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Jennett B, 1981, MANAGEMENT HEAD INJU; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kozak G S, 1989, J Emerg Nurs, V15, P18; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Polit DF, 2010, ESSENTIALS NURSING R, V7th; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Wei HG, 2000, ACAD EMERG MED, V7, P710, DOI 10.1111/j.1553-2712.2000.tb02052.x; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	35	16	16	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	SEP	2012	38	5					435	442		10.1016/j.jen.2011.04.006			8	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	007SG	WOS:000308907800014	21774974	Green Published			2022-02-06	
J	Fujieda, Y; Ueno, S; Ogino, R; Kuroda, M; Jonsson, TJ; Guo, LN; Bamba, T; Fukusaki, E				Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko; Joensson, Thomas J.; Guo, Lining; Bamba, Takeshi; Fukusaki, Eiichiro			Metabolite Profiles Correlate Closely with Neurobehavioral Function in Experimental Spinal Cord Injury in Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYL-ASPARTATE; ORNITHINE-DECARBOXYLASE; MULTIPLE-SCLEROSIS; BRAIN ISCHEMIA; RECOVERY; DISEASE; ACETYLASPARTATE; METABOLOMICS; MAINTENANCE	Traumatic spinal cord injury (SCI) results in direct physical damage and the generation of local factors contributing to secondary pathogenesis. Untargeted metabolomic profiling was used to uncover metabolic changes and to identify relationships between metabolites and neurobehavioral functions in the spinal cord after injury in rats. In the early metabolic phase, neuronal signaling, stress, and inflammation-associated metabolites were strongly altered. A dynamic inflammatory response consisting of elevated levels of prostaglandin E2 and palmitoyl ethanolamide as well as pro- and anti-inflammatory polyunsaturated fatty acids was observed. N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-aspartate (NAA) were significantly decreased possibly reflecting neuronal cell death. A second metabolic phase was also seen, consistent with membrane remodeling and antioxidant defense response. These metabolomic changes were consistent with the pathology and progression of SCI. Several metabolites, including NAA, NAAG, and the omega-3 fatty acids docosapentaenoate and docosahexaenoate correlated greatly with the established Basso, Beattie and Bresnahan locomotive score (BBB score). Our findings suggest the possibility of a biochemical basis for BBB score and illustrate that metabolites may correlate with neurobehavior. In particular the NAA level in the spinal cord might provide a meaningful biomarker that could help to determine the degree of injury severity and prognosticate neurologic recovery.	[Fujieda, Yusuke; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Joensson, Thomas J.; Guo, Lining] Metabolon Inc, Durham, NC USA		Fujieda, Y (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	fujieda.yusuke.aw@asubio.co.jp; fukusaki@bio.eng.osaka-u.ac.jp					Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bazan NG, 2006, CELL MOL NEUROBIOL, V26, P901, DOI 10.1007/s10571-006-9064-6; Blamire AM, 2007, MAGN RESON MED, V58, P880, DOI 10.1002/mrm.21382; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Dabney A, 2010, Q VALUE Q VALUE ESTI; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; Erschbamer M, 2011, EUR J NEUROSCI, V33, P678, DOI 10.1111/j.1460-9568.2010.07562.x; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Falconer JC, 1996, J NEUROCHEM, V66, P717; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Giroud M, 1996, NEUROL RES, V18, P241; Griffith HR, 2008, ALZ DIS ASSOC DIS, V22, P54, DOI 10.1097/WAD.0b013e3181611011; Hayashi S, 2009, BIOCHEM BIOPH RES CO, V386, P268, DOI 10.1016/j.bbrc.2009.06.041; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kendi ATK, 2004, NEURORADIOLOGY, V46, P764, DOI 10.1007/s00234-004-1231-1; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Marliani AF, 2007, MAGN RESON MED, V57, P160, DOI 10.1002/mrm.21113; Mautes AEM, 1999, NEUROSCI LETT, V264, P153, DOI 10.1016/S0304-3940(99)00197-4; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; SAGER TN, 1995, J CEREBR BLOOD F MET, V15, P639, DOI 10.1038/jcbfm.1995.79; Schott JM, 2010, BRAIN, V133, P3315, DOI 10.1093/brain/awq208; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Tator C H, 1996, J Spinal Cord Med, V19, P206; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Vera-Portocarrero LP, 2002, BRAIN RES, V927, P104, DOI 10.1016/S0006-8993(01)03329-7; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007	42	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43152	10.1371/journal.pone.0043152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	WOS:000307500100068	22912814	Green Published, Green Submitted, gold			2022-02-06	
J	Maggio, DM; Chatzipanteli, K; Masters, N; Patel, SP; Dietrich, WD; Pearse, DD				Maggio, Dominic M.; Chatzipanteli, Katina; Masters, Neil; Patel, Samik P.; Dietrich, W. Dalton; Pearse, Damien D.			Acute Molecular Perturbation of Inducible Nitric Oxide Synthase with an Antisense Approach Enhances Neuronal Preservation and Functional Recovery after Contusive Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						neuronal cell death; nitric oxide; nitric oxide synthase; oligonucleotides; spinal cord injury	OLFACTORY ENSHEATHING GLIA; TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; SCHWANN-CELLS; MOUSE MODEL; PEROXYNITRITE; INHIBITION; MICE; INOS	Inducible nitric oxide synthase (iNOS) is a key mediator of inflammation and oxidative stress produced during pathological conditions, including neurodegenerative diseases and central nervous system (CNS) injury. iNOS is responsible for the formation of high levels of nitric oxide (NO). The production of highly reactive and cytotoxic NO species, such as peroxynitrite, plays an important role in secondary tissue damage. We have previously demonstrated that acute administration of iNOS antisense oligonucleotides (ASOs) 3 h after moderate contusive spinal cord injury (SCI) potently inhibits iNOS-mediated increases in NO levels, leading to reduced blood spinal cord barrier permeability, decreased neutrophil accumulation, and less neuronal cell death. In the current study we investigated if iNOS ASOs could also provide long-term (10-week) histological and behavioral improvements after moderate thoracic 18 contusive SCI. Adult rats were randomly assigned to three groups (n = 10/group): SCI alone, SCI and mixed base control oligonucleotides (MBOs), or SCI and iNOS ASOs (200 nM). Oligonucleotides were administered by spinal superfusion 3 h after injury. Behavioral analysis (Basso-Beattie-Bresnahan [BBB] score and subscore) was employed weekly for 10 weeks post-SCI. Although animals treated with iNOS ASOs demonstrated no significant differences in BBB scores compared to controls, subscore analysis revealed a significant improvement in foot positioning, trunk stability, and tail clearance. Histologically, while no gross improvement in preserved white and gray matter was observed, greater numbers of surviving neurons were present adjacent to the lesion site in iNOS ASO-treated animals than controls. These results support the effectiveness of targeting iNOS acutely as a therapeutic approach after SCI.	[Pearse, Damien D.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Maggio, Dominic M.; Chatzipanteli, Katina; Masters, Neil; Patel, Samik P.; Dietrich, W. Dalton; Pearse, Damien D.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Neurosci Program,Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA		Pearse, DD (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace, Miami, FL 33136 USA.	DPearse@med.miami.edu	Pearse, Damien D/D-3176-2011	Pearse, Damien D/0000-0003-1783-221X; Masters, Neil/0000-0001-8725-6356	NIH National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [POI NS38665]; Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038665] Funding Source: NIH RePORTER	We gratefully acknowledge the Miami Project Animal Core Facility for performing spinal cord contusion injuries and providing post-operative animal care and functional testing, in particular Alexander Marcillo, Paulo Diaz, Santiago Castro, Denise Koivisto, Kim Loor, and Rosa Abril. In addition, we thank Devin Bustin for help with histology, Raisa Puzis for immunohistochemistry, and Wai-Man Chan for proofreading. This work was supported by NIH National Institute of Neurological Disorders and Stroke (NINDS) grant POI NS38665, The Miami Project to Cure Paralysis, and The Buoniconti Fund.	Armstrong R, 2001, INT IMMUNOPHARMACOL, V1, P1501, DOI 10.1016/S1567-5769(01)00094-7; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BELENKY SN, 1993, J LEUKOCYTE BIOL, V53, P498, DOI 10.1002/jlb.53.5.498; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI 10.1089/neu.2008-0870; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Chatzipanteli K, 2002, J NEUROTRAUM, V19, P639, DOI 10.1089/089771502753754109; Cifone MG, 1999, BLOOD, V93, P3876, DOI 10.1182/blood.V93.11.3876.411k25_3876_3884; DASH P, 1987, P NATL ACAD SCI USA, V84, P7896, DOI 10.1073/pnas.84.22.7896; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Genovese T, 2009, FREE RADICAL RES, V43, P631, DOI 10.1080/10715760902954126; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Iadecola C, 1997, J NEUROSCI, V17, P9157; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Karras JG, 2007, AM J RESP CELL MOL, V36, P276, DOI 10.1165/rcmb.2005-0456OC; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Laroux FS, 2001, ACTA PHYSIOL SCAND, V173, P113, DOI 10.1046/j.1365-201X.2001.00891.x; Liu C, 2001, Chin J Traumatol, V4, P231; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; Okamura T, 2001, HYPERTENS RES, V24, P47, DOI 10.1291/hypres.24.47; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Parmentier-Batteur S, 2001, J CEREBR BLOOD F MET, V21, P15, DOI 10.1097/00004647-200101000-00003; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Pearse DD, 2004, J NEUROTRAUM, V21, P1223, DOI 10.1089/0897715041953876; Pearse DD, 2003, J NEUROPATH EXP NEUR, V62, P1096, DOI 10.1093/jnen/62.11.1096; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rubbo H, 2008, BBA-GEN SUBJECTS, V1780, P1318, DOI 10.1016/j.bbagen.2008.03.007; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Sipski ML, 2006, NAT CLIN PRACT NEURO, V2, P402, DOI 10.1038/ncpneuro0221; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; TAYLOR WF, 1993, AM J PHYSIOL, V264, pH1355, DOI 10.1152/ajpheart.1993.264.5.H1355; Wen WY, 2006, NEUROSCI RES, V55, P87, DOI 10.1016/j.neures.2006.02.004; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323	45	16	16	3	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2012	29	12					2244	2249		10.1089/neu.2012.2371			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	993KZ	WOS:000307859900011	22708918	Green Published			2022-02-06	
J	Nikitidou, L; Kanter-Schlifke, I; Dhondt, J; Carmeliet, P; Lambrechts, D; Kokaia, M				Nikitidou, Litsa; Kanter-Schlifke, Irene; Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether; Kokaia, Merab			VEGF Receptor-2 (Flk-1) Overexpression in Mice Counteracts Focal Epileptic Seizures	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; STIMULATES AXONAL OUTGROWTH; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; IN-VITRO; HIPPOCAMPAL NEUROGENESIS; CELL PROLIFERATION; GENE-EXPRESSION; SEX-DIFFERENCES; NERVOUS-SYSTEM	Vascular endothelial growth factor (VEGF) was first described as an angiogenic agent, but has recently also been shown to exert various neurotrophic and neuroprotective effects in the nervous system. These effects of VEGF are mainly mediated by its receptor, VEGFR-2, which is also referred to as the fetal liver kinase receptor 1 (Flk-1). VEGF is up-regulated in neurons and glial cells after epileptic seizures and counteracts seizure-induced neurodegeneration. In vitro, VEGF administration suppresses ictal and interictal epileptiform activity caused by AP4 and 0 Mg2+ via Flk-1 receptor. We therefore explored whether increased VEGF signaling through Flk-1 overexpression may regulate epileptogenesis and ictogenesis in vivo. To this extent, we used transgenic mice overexpressing Flk-1 postnatally in neurons. Intriguingly, Flk-1 overexpressing mice were characterized by an elevated threshold for seizure induction and a decreased duration of focal after discharges, indicating anti-ictal action. On the other hand, the kindling progression in these mice was similar to wild-type controls. No significant effects on blood vessels or glia cells, as assessed by Glut1 and GFAP immunohistochemistry, were detected. These results suggest that increased VEGF signaling via overexpression of Flk-1 receptors may directly affect seizure activity even without altering angiogenesis. Thus, Flk-1 could be considered as a novel target for developing future gene therapy strategies against ictal epileptic activity.	[Nikitidou, Litsa; Kanter-Schlifke, Irene; Kokaia, Merab] Univ Lund Hosp, Expt Epilepsy Grp, Wallenberg Neurosci Ctr, S-22185 Lund, Sweden; [Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium; [Dhondt, Joke; Carmeliet, Peter; Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, Louvain, Belgium		Nikitidou, L (corresponding author), Univ Lund Hosp, Expt Epilepsy Grp, Wallenberg Neurosci Ctr, BMC A-11, S-22185 Lund, Sweden.	Merab.Kokaia@med.lu.se	Carmeliet, Peter/AAQ-5140-2020; Lambrechts, Diether/AAJ-3167-2020; Verdrengh, Evelien/H-4571-2012	Carmeliet, Peter/0000-0001-7961-1821; Lambrechts, Diether/0000-0002-3429-302X	Swedish Research CouncilSwedish Research CouncilEuropean Commission; EU commissionEuropean CommissionEuropean Commission Joint Research Centre [LSH-037315]; Segerfalk Foundation; Kock foundation; Crafoord Foundation; Long term Structural funding: Methusalem	This study was supported by grants from the Swedish Research Council, EU commission grant (LSH-037315), Segerfalk Foundation, Kock foundation, Crafoord Foundation and Long term Structural funding: Methusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boer K, 2008, ACTA NEUROPATHOL, V115, P683, DOI 10.1007/s00401-008-0354-6; Cammalleri M, 2011, EUR J NEUROSCI, V33, P482, DOI 10.1111/j.1460-9568.2010.07529.x; Cornford E M, 1999, Adv Neurol, V79, P845; Croll SD, 2004, ADV EXP MED BIOL, V548, P57; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; EBERT U, 1994, BRAIN RES, V638, P45, DOI 10.1016/0006-8993(94)90631-9; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fujiki M, 2010, EXP NEUROL, V225, P377, DOI 10.1016/j.expneurol.2010.07.010; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gotzsche CR, 2011, NEUROBIOL DIS; Gronlund KM, 1996, J NEUROPATH EXP NEUR, V55, P832, DOI 10.1097/00005072-199607000-00008; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; LI J, 1995, J BIOL CHEM, V270, P308, DOI 10.1074/jbc.270.1.308; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Newton SS, 2003, J NEUROSCI, V23, P10841; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Nicoletti JN, 2010, EPILEPSY BEHAV, V19, P272, DOI 10.1016/j.yebeh.2010.07.011; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, V33; Peltola J, 2002, SEIZURE-EUR J EPILEP, V11, P44, DOI 10.1053/seiz.2001.0575; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shimakawa S, 2002, BRAIN RES, V956, P67, DOI 10.1016/S0006-8993(02)03482-0; Shimotake J, 2010, STROKE, V41, P343, DOI 10.1161/STROKEAHA.109.564229; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Teskey GC, 1999, CEREB CORTEX, V9, P675, DOI 10.1093/cercor/9.7.675; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Woldbye DPD, 2010, BRAIN, V133, P2778, DOI 10.1093/brain/awq219; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	49	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40535	10.1371/journal.pone.0040535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	WOS:000306366400032	22808185	Green Published, gold, Green Submitted			2022-02-06	
J	Kaldoja, ML; Kolk, A				Kaldoja, Mari-Liis; Kolk, Anneli			Social-emotional behaviour in infants and toddlers with mild traumatic brain injury	BRAIN INJURY			English	Article						Mild brain injury; outcome; paediatric; traumatic brain injury; behaviour; prevention	CHILDHOOD HEAD-INJURY; NEUROBEHAVIORAL RECOVERY; CHILDREN; IMPACT; AGE; ADOLESCENTS; DISORDERS; MODERATE; OUTCOMES	Background: Paediatric head trauma is a serious health concern often leading to neurological, behavioural and cognitive impairments. In Estonia head trauma incidence is especially high in children up to 4 years. Objective: The aim was to investigate young children's pre-injury social-emotional behaviour to discover potential risk signs for brain trauma and to study social-emotional outcome 9 months post-injury. Methods: Thirty-five 3-65 month old children with mild traumatic brain injury (MTBI) and 70 matched controls were retrospectively assessed with child monitoring system Ages and Stages Questionnaires: Social-Emotional. During follow-up 27 patients and 54 controls were re-assessed after 9 months. Results: Children with MTBI showed altered social-emotional development already before the injury. Deficits were evident in self-regulation and autonomy. Age-specific social-emotional risk signs for MTBI were found. Compared to controls more pre-injury affective problems were seen in 12-month olds, self-regulation, and communication difficulties in 30-month olds and autonomy disturbances in 60-month old children. 9 months post-injury impairments in autonomy and self-regulation were still present and new difficulties in interaction had developed. Conclusions: Childhood MTBI has a serious negative effect on further development of interaction skills. To prevent possible traumas, parents should be informed of different age-specific pre-injury social-emotional risk signs.	[Kaldoja, Mari-Liis; Kolk, Anneli] Tartu Univ Hosp, Dept Neurol & Neurorehabil, Childrens Clin, EE-51014 Tartu, Estonia; [Kaldoja, Mari-Liis] Univ Tartu, Inst Psychol, EE-50090 Tartu, Estonia; [Kolk, Anneli] Univ Tartu, Dept Pediat, EE-50090 Tartu, Estonia		Kaldoja, ML (corresponding author), Tartu Univ Hosp, Dept Neurol & Neurorehabil, Childrens Clin, Lunini 6-B422, EE-51014 Tartu, Estonia.	mari-liis.kaldoja@kliinikum.ee		Kaldoja, Mari-Liis/0000-0002-7471-5813	European Social Fund's Doctoral Studies and Internationalisation programme DoRa; Estonian Ministry of Education and ResearchMinistry of Education and Research, Estonia [TARLA 2695]	The work was supported by European Social Fund's Doctoral Studies and Internationalisation programme DoRa and by the Estonian Ministry of Education and Research TARLA 2695. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Baumeister AA, 1997, JAMA-J AM MED ASSOC, V277, P1278; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Cohen J., 2013, STAT POWER ANAL BEHA; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Ministry of Social Affairs, 1995, INT STAT CLASS DIS R; Posne MI, 2001, DEV PSYCHOPATHOL, V12, P427; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Squires J, 2001, EARLY CHILD RES Q, V16, P405, DOI 10.1016/S0885-2006(01)00115-6; Squires J, 2003, ASQ SE USERS GUIDE A; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Ventsel G, 2008, NEUROEPIDEMIOLOGY, V30, P20, DOI 10.1159/000113302; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	31	16	17	0	34	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					1005	1013		10.3109/02699052.2012.660516			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100012	22632684				2022-02-06	
J	Li, WL; Jiang, DY				Li, Wenlin; Jiang, Deyong			Effect of Resveratrol on Bcl-2 and VEGF Expression in Oxygen-Induced Retinopathy of Prematurity	JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; TUMOR-GROWTH; KAPPA-B; CANCER; HYPOXIA; ANGIOGENESIS; APOPTOSIS; CELLS; SUPPRESSION	Purpose: To explore the effect of resveratrol on B-cell leukemia/lymphoma-2 (Bcl-2) and vascular endothelial growth factor (VEGF) expression in rats with oxygen-induced retinopathy of prematurity (ROP). Methods: Seven-day-old Sprague-Dawley rats (N = 60) were randomly assigned to five groups. Group A received normal partial oxygen pressure and groups B, C, D, and E received 75% +/- 2% oxygen for 5 days to induce ROP. The rats in groups C, D, and E were intragastrically treated with resveratrol (10, 30, and 60 mg/kg/d, respectively) once daily for 5 days. Rats were killed at 17 days of age and the retina was collected. Results: Western blot analysis revealed increased Bcl-2 protein expression in group B versus group A. Levels of Bcl-2 decreased with the increase of resveratrol concentration in groups C, D, and E. The optical density of Bcl-2 protein expression in group B was four times higher than that in group A (P < .01). When compared with group B, expression of Bcl-2 and VEGF in groups C, D, and E decreased in a dose-dependent manner. Significant differences in expression of Bcl-2 and VEGF were also noted among the three treatment groups with resveratrol (P < .01). After treatment with resveratrol at 10, 30, and 60 mg/kg/d, the inhibition rate of Bcl-2 expression was 11.1%, 38.1%, and 69.8% and that of VEGF expression was 3.4%, 23.0%, and 43.7%, respectively. Conclusion: Resveratrol can significantly inhibit expression of Bcl-2 and VEGF in the retina of neonatal rats with oxygen-induced ROP. It may provide a protective effect on retinal neovascular diseases, including ROP.	[Li, Wenlin] Shenzhen Childrens Hosp, Dept Ophthalmol, Shenzhen, Peoples R China; [Jiang, Deyong] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China		Li, WL (corresponding author), Shenzhen Childrens Hosp, Dept Ophthalmol, 7019 Yitian Rd, Shenzhen, Peoples R China.	wenlinli6688@hotmail.com			Shenzhen Science and Technology Projects, China [200603162]	Supported by the Shenzhen Science and Technology Projects (200603162), China.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Arakawa M, 2007, LIFE SCI, V80, P2076, DOI 10.1016/j.lfs.2007.03.012; Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Burke C, 2006, BRAIN RES, V1098, P19, DOI 10.1016/j.brainres.2006.04.129; Burkitt MJ, 2000, ARCH BIOCHEM BIOPHYS, V381, P253, DOI 10.1006/abbi.2000.1973; Cao ZX, 2004, CLIN CANCER RES, V10, P5253, DOI 10.1158/1078-0432.CCR-03-0588; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Chen JC, 2006, ANTICANCER RES, V26, P1237; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen MK, 2008, HEAD NECK-J SCI SPEC, V30, P1052, DOI 10.1002/hed.20839; Contu Paulo C., 2006, Arq. Gastroenterol., V43, P284, DOI 10.1590/S0004-28032006000400008; Das S, 2006, FREE RADICAL RES, V40, P1066, DOI 10.1080/10715760600833085; Dieudonne SC, 2007, OPHTHALMIC RES, V39, P148, DOI 10.1159/000103234; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Fujiuchi Y, 2003, ONCOL REP, V10, P1001; Gao DK, 2006, LIFE SCI, V78, P2564, DOI 10.1016/j.lfs.2005.10.030; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gobe G, 1999, IMMUNOL CELL BIOL, V77, P279, DOI 10.1046/j.1440-1711.1999.00826.x; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; Hua J, 2011, INVEST OPHTH VIS SCI, V52, P2809, DOI 10.1167/iovs.10-6496; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; Jay SM, 2008, FASEB J, V22, P2949, DOI 10.1096/fj.08-108803; Khor LY, 2007, CLIN CANCER RES, V13, P3585, DOI 10.1158/1078-0432.CCR-06-2972; Kienle K, 2005, TRANSPL P, V37, P439, DOI 10.1016/j.transproceed.2004.12.268; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Lee EO, 2006, CARCINOGENESIS, V27, P2059, DOI 10.1093/carcin/bgl055; Lee KH, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-63; Li C, 2010, NEUROCHEM INT, V56, P495, DOI 10.1016/j.neuint.2009.12.009; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Nor JE, 2001, CANCER RES, V61, P2183; O'Connor DJ, 2011, PHYTOTHER RES, V25, P1727, DOI 10.1002/ptr.3501; Olas B, 2002, THROMB RES, V106, P143, DOI 10.1016/S0049-3848(02)00101-9; Park SY, 2007, CANCER LETT, V258, P63, DOI 10.1016/j.canlet.2007.08.011; Raymond MA, 2002, BIOCHEM BIOPH RES CO, V291, P261, DOI 10.1006/bbrc.2002.6449; Reynolds JD, 2001, PEDIATR DRUGS, V3, P263, DOI 10.2165/00128072-200103040-00003; Robinson GS, 1998, INT OPHTHALMOL CLIN, V38, P89, DOI 10.1097/00004397-199838020-00007; Roemer K, 2002, DRUG TODAY, V38, P571, DOI 10.1358/dot.2002.38.8.820097; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Sharma R, 2007, J TROP PEDIATRICS, V53, P52, DOI 10.1093/tropej/fml071; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Sun CY, 2006, CANCER GENET CYTOGEN, V165, P9, DOI 10.1016/j.cancergencyto.2005.06.016; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wirostko BM, 2007, OPHTHALMOLOGY, V114, P1954, DOI 10.1016/j.ophtha.2007.05.018; Wu HZ, 2008, BIOMED PHARMACOTHER, V62, P613, DOI 10.1016/j.biopha.2008.06.036; Yu H, 2007, CHINESE MED J-PEKING, V120, P1672, DOI 10.1097/00029330-200710010-00006	53	16	16	0	8	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0191-3913	1938-2405		J PEDIAT OPHTH STRAB	J. Pediatr. Ophthalmol. Strabismus.	JUL-AUG	2012	49	4					230	235		10.3928/01913913-20111129-01			6	Ophthalmology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology; Pediatrics	981OM	WOS:000306977700007	22148982				2022-02-06	
J	Link, TW; Woodworth, GF; Chaichana, KL; Grossman, SA; Mayer, RS; Brem, H; Weingart, JD; Quinones-Hinojosa, A				Link, Thomas W.; Woodworth, Graeme F.; Chaichana, Kaisorn L.; Grossman, Stuart A.; Mayer, Robert S.; Brem, Henry; Weingart, Jon D.; Quinones-Hinojosa, Alfredo			Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Function; Glioblastoma; Hyperglycemia; Rehabilitation	QUALITY-OF-LIFE; INSULIN THERAPY; BLOOD-GLUCOSE; SURVIVAL; STROKE; MORTALITY; COMPLICATIONS; EPIDEMIOLOGY; PREDICTORS; INCREASES	The poor prognosis for patients with glioblastoma (GB) heightens the importance of maintaining function throughout treatment. Hyperglycemia has been linked to poor neurological outcomes following stroke, traumatic brain and spinal cord injury. We hypothesized this may also be true following the resection of GB. We assessed associations with post-operative function with the goal of identifying modifiable factors in the pen-operative period with a particular focus on blood glucose levels. Independent associations with worse post-operative function included: patient age, pre-operative motor deficit, deep tumor location, post-operative motor deficit, and elevated mean pen-operative glucose. Interestingly, controlling for associated factors including dexamethasone dosing, patients with elevated pen-operative glucose levels were nearly twice as likely to have new post-operative neurological deficits. These results suggest, together with the broad literature supporting a role for hyperglycemia in neurological injury, that this may represent a modifiable factor in the pen-operative care of these patients. (C) 2012 Elsevier Ltd. All rights reserved.	[Link, Thomas W.; Woodworth, Graeme F.; Chaichana, Kaisorn L.; Grossman, Stuart A.; Brem, Henry; Weingart, Jon D.; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Grossman, Stuart A.; Brem, Henry; Weingart, Jon D.; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Sch Med, Dept Oncol, Dept Neurooncol, Baltimore, MD 21205 USA; [Mayer, Robert S.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA		Quinones-Hinojosa, A (corresponding author), 4940 Eastern Ave,301 Mason Lord Dr,Suite 2100, Baltimore, MD 21224 USA.	aquinon2@jhmi.edu			NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006973] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA006973] Funding Source: Medline		Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Barber M, 2004, GERONTOLOGY, V50, P102, DOI 10.1159/000075561; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bhalla A, 2002, CEREBROVASC DIS, V13, P95, DOI 10.1159/000047757; Brown PD, 2006, J NEURO-ONCOL, V76, P283, DOI 10.1007/s11060-005-7020-9; Brown PD, 2005, NEUROSURGERY, V57, P495, DOI 10.1227/01.NEU.0000170562.25335.C7; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Bussiere M, 2005, CAN J NEUROL SCI, V32, P50, DOI 10.1017/S0317167100016875; Casartelli G, 2009, CANCER BIOL THER, V8, P1719, DOI 10.4161/cbt.8.18.9209; Chaichana KL, 2011, J NEUROSURG, V114, P604, DOI 10.3171/2010.4.JNS091340; Christensen H, 2002, EUR J NEUROL, V9, P297, DOI 10.1046/j.1468-1331.2002.00409.x; CLEMENTS RS, 1985, AM J MED, V79, P2, DOI 10.1016/0002-9343(85)90503-0; HARIK SI, 1988, J NEUROCHEM, V51, P1924, DOI 10.1111/j.1471-4159.1988.tb01179.x; Henry RMA, 2004, STROKE, V35, P671, DOI 10.1161/01.STR.0000115752.58601.0B; Kawai N, 1998, ACT NEUR S, V71, P219; Kernan Walter N, 2004, Curr Treat Options Neurol, V6, P443, DOI 10.1007/s11940-004-0002-y; Khoury W, 2004, J TRAUMA, V57, P1132, DOI 10.1097/01.TA.0000141889.31903.9C; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Krolewski AS, 1996, ENDOCRIN METAB CLIN, V25, P217, DOI 10.1016/S0889-8529(05)70322-4; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Li SW, 2009, CHINESE MED J-PEKING, V122, P1245, DOI 10.3760/cma.j.issn.0366-6999.2009.11.002; MATCHAR DB, 1992, ANN INTERN MED, V117, P449, DOI 10.7326/0003-4819-117-6-449; McGirt MJ, 2007, J NEUROSURG, V107, P1080, DOI 10.3171/JNS-07/12/1080; McGirt MJ, 2006, NEUROSURGERY, V58, P1066, DOI 10.1227/01.NEU.0000215887.59922.36; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Mcgirt MJ, 2009, J NEUROSURG-SPINE, V10, P9, DOI 10.3171/2008.10.SPI08333; McGirt MJ, 2005, J NEUROSURG, V102, P897, DOI 10.3171/jns.2005.102.5.0897; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Recht L, 2003, J NEURO-ONCOL, V61, P127, DOI 10.1023/A:1022187502917; Resl M, 2010, WIEN MED WOCHENSCHR, V160, P3, DOI 10.1007/s10354-010-0744-y; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sala F, 1999, ANN NY ACAD SCI, V890, P133, DOI 10.1111/j.1749-6632.1999.tb07989.x; Stark AM, 2010, EUR J CANCER CARE, V19, P39, DOI 10.1111/j.1365-2354.2008.00956.x; Taphoorn MJB, 2005, LANCET ONCOL, V6, P937, DOI 10.1016/S1470-2045(05)70432-0; TRACEY F, 1993, Q J MED, V86, P439; TRACEY F, 1994, STROKE, V25, P524, DOI 10.1161/01.STR.25.2.524; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; Williams LS, 2002, NEUROLOGY, V59, P67, DOI 10.1212/WNL.59.1.67; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	42	16	16	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2012	19	7					996	1000		10.1016/j.jocn.2011.09.031			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040LJ	WOS:000311323800014	22595358	Green Accepted			2022-02-06	
J	Moran, C; Kirk, C; Powell, E				Moran, Catherine; Kirk, Cecilia; Powell, Emma			Spoken Persuasive Discourse Abilities of Adolescents With Acquired Brain Injury	LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS			English	Article						adolescents; brain injury; discourse analysis	CLOSED-HEAD-INJURY; SCHOOL-AGE-CHILDREN; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; EXPOSITORY DISCOURSE; CAPACITY THEORY; LANGUAGE; COMPREHENSION; NARRATIVES; ADULTS	Purpose: The aim of this study was to examine the performance of adolescents with acquired brain injury (ABI) during a spoken persuasive discourse task. Persuasive discourse is frequently used in social and academic settings and is of importance in the study of adolescent language. Method: Participants included 8 adolescents with ABI and 8 peers without ABI who were matched for age, gender, and education. A spoken persuasive discourse task requiring participants to express their opinion on a topic was administered, and the 2 groups were compared on measures of language productivity, syntactic complexity, and language content. In addition, the relationship between working memory and discourse production was explored. Results: There were no statistically significant group differences on measures of language productivity or syntactic complexity, with the exception of the use of mazes, which was more prevalent in the discourse of the group with ABI. However, there were significant differences in language content, with age-matched peers producing more than twice as many supporting reasons and far fewer tangentially related utterances than the adolescents with ABI. Conclusions: Persuasive discourse production was affected following ABI. Given the importance of persuasive discourse in social and academic situations, further investigations into factors that influence discourse production in adolescents with ABI are warranted.	[Moran, Catherine] Univ Canterbury, Christchurch 1, New Zealand; [Kirk, Cecilia] Univ Oregon, Eugene, OR 97403 USA; [Powell, Emma] Accident Compensat Corp New Zealand, Wellington, New Zealand		Moran, C (corresponding author), Univ Canterbury, Christchurch 1, New Zealand.	catherine.moran@canterbury.ac.nz					Accident Compensation Corporation, 2010, ACT REH SERV TRAUM B; Baddeley A. D., 1976, PSYCHOL MEMORY; Bartsch K, 2007, DEV PSYCHOL, V43, P111, DOI 10.1037/0012-1649.43.1.111; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; CLARK RA, 1976, CHILD DEV, V47, P1008, DOI 10.1111/j.1467-8624.1976.tb02281.x; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cohen J., 2013, STAT POWER ANAL BEHA; Crowhurst Marion., 1990, CANADIAN J ED, V15, P348, DOI [10.2307/1495109, DOI 10.2307/1495109]; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DeVito Joseph A, 2003, ESSENTIAL ELEMENTS P; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Felton M, 2001, DISCOURSE PROCESS, V32, P135; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Hagen C., 1998, RANCHO LEVELS COGNIT; Hammill D. D., 1994, TEST ADOLESCENT ADUL; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kellogg RT, 2004, AM J PSYCHOL, V117, P341, DOI 10.2307/4149005; Knudson RuthE., 1992, CHILD STUDY J, V22, P167; KROLL BM, 1984, WRIT COMMUN, V1, P407; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LIGHT LL, 1985, J GERONTOL, V40, P737, DOI 10.1093/geronj/40.6.737; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; McCutchen D, 1996, EDUC PSYCHOL REV, V8, P299, DOI 10.1007/BF01464076; Miller J. F., 2010, SALT SYSTEMATIC ANAL; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A., 1999, MODELS WORKING MEMOR; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; New Zealand Qualifications Authority, 2007, LEV 1 ENGL EX PROD F; Nippold M. A., 2007, LATER LANGUAGE DEV S; Nippold MA, 2005, J SPEECH LANG HEAR R, V48, P1048, DOI 10.1044/1092-4388(2005/073); Nippold MA, 2005, LANG SPEECH HEAR SER, V36, P125, DOI 10.1044/0161-1461(2005/012); Nippold MA, 2010, CHILD LANG TEACH THE, V26, P238, DOI 10.1177/0265659009349979; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Scott, 2004, LANGUAGE DEV CHILDHO, P111; Scott CM, 2000, J SPEECH LANG HEAR R, V43, P324, DOI 10.1044/jslhr.4302.324; Semel W, 2003, CLIN EVALUATION LANG; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; YEKOVICH FR, 1990, PSYCHOL LEARN MOTIV, V25, P259, DOI DOI 10.1016/S0079-7421(08)60259-5; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	55	16	16	0	11	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	0161-1461	1558-9129		LANG SPEECH HEAR SER	Lang. Speech Hear. Serv. Sch.	JUL 1	2012	43	3					264	275		10.1044/0161-1461(2011/10-0114)			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	083YF	WOS:000314501600003	22269583				2022-02-06	
J	Niu, LJ; Xu, RX; Zhang, P; Du, MX; Jiang, XD				Niu, L. -J.; Xu, R. -X.; Zhang, P.; Du, M-X; Jiang, X. -D.			SUPPRESSION OF FRIZZLED-2-MEDIATED WNT/CA(2+) SIGNALING SIGNIFICANTLY ATTENUATES INTRACELLULAR CALCIUM ACCUMULATION IN VITRO AND IN A RAT MODEL OF TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						Wnt5a; Frizzled-2; Wnt/Ca2+ pathway; calcium; astrocytes; TBI	NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; CELL-DEATH; FRIZZLED HOMOLOGS; CA2+ HOMEOSTASIS; WNT/BETA-CATENIN; NEURONAL CELLS; WNT; PATHWAY; TRANSDUCTION	Traumatic brain injury (TBI) can dramatically increase levels of intracellular calcium (Ca2+). The association between Wnt5a/Frizzled-2 (wingless-type mouse mammary tumor virus integration site family member 5a/Fzd2) signaling and Ca2+ cellular homeostasis in lower vertebrates has been well documented. However, little is known about Wnt5a/Fzd2 signaling in mammalian nerve cells, or whether Ca2+ accumulation after TBI is mediated through this pathway. We hypothesized that an activated Wnt5a/Fzd2 pathway following TBI may play a role in Ca2+ overloading. To elucidate the influence of Fzd2 and the Wnt5a signal transduction pathway on an increase in intracellular Ca2+, we assessed the expression of Wnt5a/Fzd2 in rat hippocampal cells both in vitro and in vivo. We found that transfection of the rat Fzd2 gene in rat neonatal hippocampal astrocytes significantly increased gene expressions of both Wnt5a and Frd2 by fourfold when compared to non-transfected cells (P < 0.01 in both cases). Expressions of the proteins Wnt5a and Fzd2 were significantly increased approximately two- and threefold, respectively, when compared to non-transfected control cells (P < 0.01 in both cases). Moreover, intracellular Ca2+, as manifested by the fluorescent intensity of the intracellular Ca2+ indicator Fluo-3/AM, was significantly increased by 1.75-fold (P < 0.01). The blocking of Fzd2 signaling using Stealth RNAi markedly inhibited the elevated gene and protein expression of Wnt5a in the transfected cells by two- and fourfold, respectively (P < 0.01), and suppressed intracellular Ca2+ by 1.5-fold (P < 0.01). Furthermore, in vivo, we demonstrated that TBI-induced dramatic upregulation of gene and protein expression of Wnt5a/Fzd2 by two- and five-fold (P < 0.01) in injured hippocampi, and intracellular Ca2+ increased in isolated injured hippocampal cells. Whereas, the in vivo blocking of Fzd2 signaling by hippocampal delivery of Stealth RNA1 and Invivofectamine significantly suppressed the increased gene and protein expression of Wnt5a and Fzd2 induced by TBI by 1- to 3.5-fold (P < 0.01) and also inhibited Ca(2+)accumulation by 1.5-fold (P < 0.01). These findings demonstrated that the Wnt5a/Fzd2 signaling pathway contributed to increasing intracellular Ca2+ in nerve cells under physiological and pathological conditions. Furthermore, our findings provide evidence that specifically expressed components of this signal pathway, such as Wnt5a and Fzd2, are potential therapeutic targets following brain trauma. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Niu, L. -J.; Xu, R. -X.] Mil Gen Hosp Beijing PLA, Affiliated Brain Hosp, Beijing 100041, Peoples R China; [Niu, L. -J.; Xu, R. -X.; Zhang, P.; Du, M-X; Jiang, X. -D.] So Med Univ, Inst Neurol, Zhujiang Hosp, Guangzhou 510282, Guangdong, Peoples R China; [Niu, L. -J.; Xu, R. -X.; Zhang, P.; Du, M-X; Jiang, X. -D.] Lab Brain Funct & Repair, Guangzhou 510282, Guangdong, Peoples R China		Xu, RX (corresponding author), Mil Gen Hosp Beijing PLA, Affiliated Brain Hosp, 5 S Gate, Beijing 100041, Peoples R China.	jz_xuruxiang@163.com					Alberdi E, 2005, CELL CALCIUM, V38, P417, DOI 10.1016/j.ceca.2005.06.020; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Conti AC, 1998, J NEUROSCI, V18, P5663; FARBER JL, 1981, LIFE SCI, V29, P1289, DOI 10.1016/0024-3205(81)90670-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Liu M, 2006, EUR J NEUROSCI, V23, P2027, DOI 10.1111/j.1460-9568.2006.04724.x; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; MIYAKE T, 1992, BRAIN RES, V590, P300, DOI 10.1016/0006-8993(92)91109-R; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P273; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P193; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; SCHUMANN MA, 1993, J BIOL CHEM, V268, P2134; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	33	16	21	0	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JUN 28	2012	213						19	28		10.1016/j.neuroscience.2012.03.057			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	960GM	WOS:000305376000002	22521824				2022-02-06	
J	Hussain, ZM; Fitting, S; Watanabe, H; Usynin, I; Yakovleva, T; Knapp, PE; Scheff, SW; Hauser, KF; Bakalkin, G				Hussain, Zubair Muhammad; Fitting, Sylvia; Watanabe, Hiroyuki; Usynin, Ivan; Yakovleva, Tatjana; Knapp, Pamela E.; Scheff, Stephen W.; Hauser, Kurt F.; Bakalkin, Georgy			Lateralized Response of Dynorphin A Peptide Levels after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						dynorphins; lateralization; neurodegeneration; neuronal networks; traumatic brain injury	SPINAL-CORD-INJURY; CONTROLLED CORTICAL IMPACT; POSTURAL ASYMMETRY; HEAD-INJURY; RAT; MICE; RECEPTOR; DEFICITS; MECHANISMS; OPIOIDS	Traumatic brain injury (TBI) induces a cascade of primary and secondary events resulting in impairment of neuronal networks that eventually determines clinical outcome. The dynorphins, endogenous opioid peptides, have been implicated in secondary injury and neurodegeneration in rodent and human brain. To gain insight into the role of dynorphins in the brain's response to trauma, we analyzed short-term (1-day) and long-term (7-day) changes in dynorphin A (Dyn A) levels in the frontal cortex, hippocampus, and striatum, induced by unilateral left-side or right-side cortical TBI in mice. The effects of TBI were significantly different from those of sham surgery (Sham), while the sham surgery also produced noticeable effects. Both sham and TBI induced short-term changes and long-term changes in all three regions. Two types of responses were generally observed. In the hippocampus, Dyn A levels were predominantly altered ipsilateral to the injury. In the striatum and frontal cortex, injury to the right (R) hemisphere affected Dyn A levels to a greater extent than that seen in the left (L) hemisphere. The R-TBI but not L-TBI produced Dyn A changes in the striatum and frontal cortex at 7 days after injury. Effects of the R-side injury were similar in the two hemispheres. In naive animals, Dyn A was symmetrically distributed between the two hemispheres. Thus, trauma may reveal a lateralization in the mechanism mediating the response of Dyn A-expressing neuronal networks in the brain. These networks may differentially mediate effects of left and right brain injury on lateralized brain functions.	[Hussain, Zubair Muhammad; Watanabe, Hiroyuki; Yakovleva, Tatjana; Bakalkin, Georgy] Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden; [Fitting, Sylvia; Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Knapp, Pamela E.; Hauser, Kurt F.] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA; [Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Usynin, Ivan] Russian Acad Med Sci, Inst Biochem, Siberian Div, Novosibirsk, Russia; [Scheff, Stephen W.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Bakalkin, G (corresponding author), Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, Box 591, S-75124 Uppsala, Sweden.	Georgy.Bakalkin@farmbio.uu.se	Polyakov, Lev Mikhailovith/R-7853-2016; Usynin, Ivan F/A-4945-2017; Evgeny, Usynin/D-1505-2012; Hauser, Kurt/AAX-8361-2020	Evgeny, Usynin/0000-0001-7127-0188; Hauser, Kurt/0000-0001-7886-0332; Bakalkin, Georgy/0000-0002-8074-9833; Usynin, Ivan/0000-0003-1752-9034; Fitting, Sylvia/0000-0002-8906-3133	Swedish Science Research Council [DA015097]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS39828]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K02DA027374, R01DA015097] Funding Source: NIH RePORTER	This work was supported by grants from the Swedish Science Research Council to G. B., DA015097 to P. E. K., and from the NIH NS39828 to S.W.S.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adjan VV, 2007, NEUROSCIENCE, V148, P724, DOI 10.1016/j.neuroscience.2007.05.053; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001; BAKALKIN GY, 1986, PEPTIDES, V7, P551, DOI 10.1016/0196-9781(86)90025-2; BAKALKIN GY, 1989, INT J NEUROSCI, V47, P217, DOI 10.3109/00207458908987436; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; BAKSHI R, 1992, BRAIN RES, V580, P255, DOI 10.1016/0006-8993(92)90952-6; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Banghart MR, 2012, NEURON, V73, P249, DOI 10.1016/j.neuron.2011.11.016; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; CHRISTENSSONNYLANDER I, 1985, REGUL PEPTIDES, V11, P65, DOI 10.1016/0167-0115(85)90032-1; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Duggan AW, 2000, PROG BRAIN RES, V125, P369; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; Faden A I, 1996, NIDA Res Monogr, V163, P318; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Gao HM, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-57; Gieryk A, 2010, PSYCHOPHARMACOLOGY, V208, P291, DOI 10.1007/s00213-009-1730-1; Goody RJ, 2003, NEUROSCIENCE, V116, P807, DOI 10.1016/S0306-4522(02)00563-8; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; HEADRICK JP, 1995, NEUROCHEM INT, V26, P489, DOI 10.1016/0197-0186(94)00153-L; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; Hu WH, 1996, NEUROSCI LETT, V203, P13, DOI 10.1016/0304-3940(95)12246-X; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kerkhoff G, 2001, PROG NEUROBIOL, V63, P1, DOI 10.1016/S0301-0082(00)00028-9; KHACHATURIAN H, 1985, TRENDS NEUROSCI, V8, P111, DOI 10.1016/0166-2236(85)90048-7; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Merg F, 2006, J NEUROCHEM, V97, P292, DOI 10.1111/j.1471-4159.2006.03732.x; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; Murphy M, 2004, FRONT BIOSCI-LANDMRK, V9, P40, DOI 10.2741/1203; Neveu PJ, 2003, STRESS, V6, P5, DOI 10.1080/1025389031000087472; Pavlovskaya M, 2007, BRAIN COGNITION, V64, P21, DOI 10.1016/j.bandc.2006.10.003; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Povlishock JT, 1999, ACT NEUR S, V73, P15; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Soares HD, 1995, J NEUROSCI, V15, P8223; Sullivan RM, 2012, NEUROSCIENCE, V202, P192, DOI 10.1016/j.neuroscience.2011.12.001; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; VINK R, 1990, J NEUROSCI, V10, P3524; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Woods AS, 2006, J PROTEOME RES, V5, P1017, DOI 10.1021/pr060016+	68	16	17	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2012	29	9					1785	1793		10.1089/neu.2011.2286			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	954CN	WOS:000304924000008	22468884	Green Published			2022-02-06	
J	Mayer, F; Bonaventura, K; Cassel, M; Mueller, S; Weber, J; Scharhag-Rosenberger, F; Carlsohn, A; Baur, H; Scharhag, J				Mayer, Frank; Bonaventura, Klaus; Cassel, Michael; Mueller, Steffen; Weber, Josefine; Scharhag-Rosenberger, Friederike; Carlsohn, Anja; Baur, Heiner; Scharhag, Juergen			Medical results of preparticipation examination in adolescent athletes	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORT-RELATED CONCUSSION; RECOMMENDATIONS; STATEMENT; PREVENTION; INJURY	Background Preparticipation examinations (PPE) are frequently used to evaluate eligibility for competitive sports in adolescent athletes. Nevertheless, the effectiveness of these examinations is under debate since costs are high and its validity is discussed controversial. Purpose To analyse medical findings and consequences in adolescent athletes prior to admission to a sports school. Methods In 733 adolescent athletes (318 girls, 415 boys, age 12.3+/-0.4, 16 sports disciplines), history and clinical examination (musculoskeletal, cardiovascular, general medicine) was performed to evaluate eligibility. PPE was completed by determination of blood parameters, ECG at rest and during ergometry, echocardiography and x-rays and ultrasonography if indicated. Eligibility was either approved or rated with restriction. Recommendations for therapy and/or prevention were given to the athletes and their parents. Results Historical (h) and clinical (c) findings (eg, pain, verified pathologies) were more frequent regarding the musculoskeletal system (h: 120, 16.4%; c: 247, 33.7%) compared to cardiovascular (h: 9, 1.2%; c: 23, 3.1%) or general medicine findings (h: 116, 15.8%; c: 71, 9.7%). ECG at rest was moderately abnormal in 46 (6.3%) and severely abnormal in 25 athletes (3.4%). Exercise ECG was suspicious in 25 athletes (3.4%). Relevant echocardiographic abnormalities were found in 17 athletes (2.3%). In 52 of 358 cases (14.5%), x-rays led to diagnosis (eg, Spondylolisthesis). Eligibility was temporarily restricted in 41 athletes (5.6%). Three athletes (0.4%) had to be excluded from competitive sports. Therapy (eg, physiotherapy, medication) and/or prevention (sensorimotor training, vaccination) recommendations were deduced due to musculoskeletal (t:n = 76,10.3%; p:n = 71,9.8%) and general medicine findings (t:n = 80, 10.9%; p:n = 104, 14.1%). Conclusion Eligibility for competitive sports is restricted in only 5.5% of adolescent athletes at age 12. Eligibility refusals are rare. However, recommendations for therapy and prevention are frequent, mainly regarding the musculoskeletal system. In spite of time and cost consumption, adolescent preparticipation before entering a career in high-performance sports is supported.	[Mayer, Frank; Bonaventura, Klaus; Cassel, Michael; Mueller, Steffen; Weber, Josefine; Scharhag-Rosenberger, Friederike; Carlsohn, Anja; Scharhag, Juergen] Univ Potsdam, Dept Sports Med, Potsdam, Germany; [Scharhag-Rosenberger, Friederike] Deutsch Hsch Pravent & Gesundheitsmanagement, Saarbrucken, Germany; [Baur, Heiner] Bern Univ Appl Sci, Dept Hlth, Bern, Switzerland; [Scharhag, Juergen] Univ Clin, Heidelberg, Germany		Mayer, F (corresponding author), Univ Outpatient Clin, Ctr Sports Med, Neuen Palais 10, D-14469 Potsdam, Germany.	fmayer@uni-potsdam.de	Baur, Heiner/M-9995-2019; Baur, Heiner/A-8673-2017	Baur, Heiner/0000-0002-4780-225X; Baur, Heiner/0000-0002-4780-225X			Abernethy L, 2007, BRIT J SPORT MED, V41, P627, DOI 10.1136/bjsm.2007.035691; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; [American Medical Association Board of Trustees Group on Science and technology], 1992, ARCH PEDIAT ADOLESC, V148, P93; [Anonymous], 2001, MED SCI SPORT EXER, V33, P1789; Baggish AL, 2010, ANN INTERN MED, V152, P269, DOI 10.7326/0003-4819-152-5-201003020-00004; Beck CK, 2000, MED SCI SPORT EXER, V32, pS431, DOI 10.1097/00005768-200007001-00008; Behera SK, 2011, CURR SPORT MED REP, V10, P90, DOI 10.1249/JSR.0b013e3182141c1e; Burns RD, 2004, J AM DIET ASSOC, V104, P246, DOI 10.1016/j.jada.2003.11.013; Carek PJ, 2003, BJM, V327, P170; Casa Douglas J, 2005, Curr Sports Med Rep, V4, P115; Corrado D, 2010, EUR HEART J, V31, P243, DOI 10.1093/eurheartj/ehp473; Davis KW, 2010, RADIOL CLIN N AM, V48, P1199, DOI 10.1016/j.rcl.2010.07.020; Davis KW, 2010, RADIOL CLIN N AM, V48, P1213, DOI 10.1016/j.rcl.2010.07.004; Delise Pietro, 2005, Ital Heart J, V6, P661; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Dickinson DF, 2005, HEART, V91, P1626, DOI 10.1136/hrt.2004.057307; Donnelly Diane K, 2006, Curr Sports Med Rep, V5, P67; Earnest Conrad, 2002, Curr Sports Med Rep, V1, P172, DOI 10.1249/00149619-200206000-00008; Faigenbaum AD, 2000, PEDIATR ANN, V29, P156, DOI 10.3928/0090-4481-20000301-08; Garrick JG, 2004, CLIN J SPORT MED, V14, P123, DOI 10.1097/00042752-200405000-00003; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hubscher M, 2010, MED SCI SPORT EXER, V42, P413, DOI 10.1249/MSS.0b013e3181b88d37; Iwamoto J, 2005, SCAND J MED SCI SPOR, V15, P163, DOI 10.1111/j.1600-0838.2004.00414.x; Kurowski K, 2000, AM FAM PHYSICIAN, V61, P2683; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Ljungqvist A, 2009, BRIT J SPORT MED, V43, P631, DOI 10.1136/bjsm.2009.064394; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; Metzl J D, 2001, Pediatr Rev, V22, P227, DOI 10.1542/pir.22-7-227; Metzl J D, 2001, Pediatr Rev, V22, P199, DOI 10.1542/pir.22-6-199; Nesmith J Darrell, 2010, J Ark Med Soc, V107, P111; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Pelliccia A, 2000, CIRCULATION, V102, P278; Rao AL, 2010, ARCH PHYS MED REHAB, V91, P958, DOI 10.1016/j.apmr.2010.02.006; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Steffen K, 2010, EUR J SPORT SCI, V10, P223, DOI 10.1080/17461390903585173; Steffen K, 2010, BRIT J SPORT MED, V44, P485, DOI 10.1136/bjsm.2010.073833; Unnithan Viswanath B, 2004, Curr Sports Med Rep, V3, P206, DOI 10.1249/00149619-200408000-00006	37	16	16	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2012	46	7					524	530		10.1136/bjsports-2011-090966			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	958ZW	WOS:000305280500014	22576783				2022-02-06	
J	Quigley, KS; McAndrew, LM; Almeida, L; D'Andrea, EA; Engel, CC; Hamtil, H; Ackerman, AJ				Quigley, Karen S.; McAndrew, Lisa M.; Almeida, Liliana; D'Andrea, Elizabeth A.; Engel, Charles C.; Hamtil, Heather; Ackerman, Adam J.			Prevalence of Environmental and Other Military Exposure Concerns in Operation Enduring Freedom and Operation Iraqi Freedom Veterans	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							GULF-WAR VETERANS; TRAUMATIC BRAIN-INJURY; PHYSICAL SYMPTOMS; HEALTH; CARE; SEEKING; ASSOCIATION; DEPLOYMENT; COMMUNITY; VALIDITY	Objective: This study examined the prevalence of self-reported exposures in returning Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) veterans and the relationship of exposure reports to current physical symptoms. Methods: Using self-reports obtained immediately after return from deployment in a cohort of 760 enlisted Army reserve component military personnel, we assessed prevalence rates of environmental and other exposures and the association of these exposures to severity of physical symptoms. Results: Reporting of environmental exposures was relatively low in veterans of OEF/OIF, but reporting more environmental and other exposures, in particular screening positive for a traumatic brain injury, was related to greater physical symptom severity immediately after deployment. Conclusions: Non-treatment-seeking, enlisted Army reserve component personnel reported relatively few exposures immediately after return from deployment; however, more exposures was modestly associated with greater severity of physical symptoms when controlling for predeployment symptoms, gender, and other deployment-related exposures.	[Quigley, Karen S.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Quigley, Karen S.] Edith Nourse Rogers Mem Vet Adm Hosp, Bedford, MA 01730 USA; [Quigley, Karen S.; McAndrew, Lisa M.; Almeida, Liliana; Hamtil, Heather; Ackerman, Adam J.] NJ WRIISC, Dept Vet Affairs New Jersey Healthcare Syst, E Orange, NJ USA; [Quigley, Karen S.; McAndrew, Lisa M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; [D'Andrea, Elizabeth A.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Engel, Charles C.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Engel, Charles C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Psychiat, Bethesda, MD 20814 USA; [Almeida, Liliana] Alliant Int Univ, CSPP, Los Angeles, CA USA; [Hamtil, Heather] Rutgers State Univ, Ctr Behav Hlth Serv & Criminal Justice Res, New Brunswick, NJ 08903 USA		Quigley, KS (corresponding author), Northeastern Univ, Dept Psychol, 125 Nightingale Hall, Boston, MA 02115 USA.	k.quigley@neu.edu	Quigley, Karen S./B-9003-2013; McAndrew, Lisa/H-7035-2017	Quigley, Karen S./0000-0001-8844-990X; McAndrew, Lisa/0000-0002-1350-8773; Engel, Charles/0000-0002-9232-3389	Department of Veterans AffairsUS Department of Veterans Affairs [IIR 02-296]; NJ WRIISC; Jersey Healthcare System at Department of Veterans Affairs; Deployment Health Clinical Center, Walter Reed Army Medical Center	This work was supported by a Department of Veterans Affairs, Health Services Research and Development grant (IIR 02-296) to Dr Quigley while she was employed. at the NJ WRIISC. Additional funds were provided by the NJ WRIISC and the Center for Healthcare Knowledge Management (NJ REAP; VA Health Services Research and Development) at the Department of Veterans Affairs Now Jersey Healthcare System, and by the Deployment Health Clinical Center, Walter Reed Army Medical Center.	[Anonymous], 2006, UPD PRE POSTDEPL HLT, P10; Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; Brewer NT, 2008, RISK ANAL, V28, P1737, DOI 10.1111/j.1539-6924.2008.01118.x; Brix Kelley, 2011, Mil Med, V176, P91; CAMERON L, 1995, PSYCHOSOM MED, V57, P37, DOI 10.1097/00006842-199501000-00006; CAMERON L, 1993, HEALTH PSYCHOL, V12, P171, DOI 10.1037/0278-6133.12.3.171; Cherry N, 2001, OCCUP ENVIRON MED, V58, P299, DOI 10.1136/oem.58.5.299; Department of Livestock Services, 2010, AFGH IR DOD SHOULD I, P1; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; Engel CC, 2006, PHILOS T R SOC B, V361, P707, DOI 10.1098/rstb.2006.1829; Engel CC, 2002, ENVIRON HEALTH PERSP, V110, P641, DOI 10.1289/ehp.02110s4641; Furlong CE, 2000, GENOME RES, V10, P153, DOI 10.1101/gr.10.2.153; Greenhill J, 2009, SENATORS HEAR GUARD; Institute of Medicine, 2009, VET AG OR UPD 2008; Interian A, 2006, PSYCHOSOMATICS, V47, P392, DOI 10.1176/appi.psy.47.5.392; King D. W., 2003, MANUAL DEPLOYMENT RI; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Kroenke K, 1998, J OCCUP ENVIRON MED, V40, P520, DOI 10.1097/00043764-199806000-00004; Kroenke K, 1994, Arch Fam Med, V3, P774; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; McAndrew LM, 2012, J OCCUP ENVIRON MED, V54, P665, DOI 10.1097/JOM.0b013e318255ba1b; McCauley LA, 2002, ARCH ENVIRON HEALTH, V57, P340, DOI 10.1080/00039890209601419; Murphy D, 2008, BRIT MED J, V337, P220; Office of Public Health and Environmental Hazards, 2010, OP END FREED OP IR F, V6, P1; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Richardson RD, 2004, NEUROLOGIST, V10, P18, DOI 10.1097/01.nrl.0000106921.76055.24; Riddle Mark, 2011, Mil Med, V176, P105; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Santos SL, 2012, J OCCUP ENVIRON MED, V54, P752, DOI 10.1097/JOM.0b013e31824fe11e; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smith TC, 2003, AM J EPIDEMIOL, V158, P457, DOI 10.1093/aje/kwg178; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; US Army Public Health Command, 2010, HLTH ASS 2003 QARM A, P1; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wolfe J, 1998, AM J IND MED, V33, P104, DOI 10.1002/(SICI)1097-0274(199802)33:2<104::AID-AJIM2>3.0.CO;2-Y	40	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	JUN	2012	54	6			SI		659	664		10.1097/JOM.0b013e3182570506			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	957MA	WOS:000305165900002	22588478				2022-02-06	
J	Stergiou-Kita, M; Dawson, D; Rappolt, S				Stergiou-Kita, Mary; Dawson, Deirdre; Rappolt, Susan			Inter-Professional Clinical Practice Guideline for Vocational Evaluation Following Traumatic Brain Injury: A Systematic and Evidence-Based Approach	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Brain injuries; Rehabilitation vocational; Work assessment; Employment; Practice guidelines	COMMUNITY INTEGRATION; NEUROPSYCHOLOGICAL ASSESSMENT; EMPLOYMENT OUTCOMES; ACUTE PREDICTORS; PRODUCTIVE WORK; RETURN; TBI; REHABILITATION; MODERATE; PERSPECTIVES	Introduction This paper introduces an inter-professional clinical practice guideline for vocational evaluation following traumatic brain injury. This guideline aims to explicate the processes and factors relevant to vocational evaluation to assist evaluators (i.e. health care teams, individuals and employers) in collaboratively determining if clients are able to work and to make recommendations for work entry, re-entry or vocational planning. Methods Methods in the Canadian Medical Association's (CMA) Handbook on Clinical Practice Guideline and the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument were utilized to ensure rigour. Steps in the CMA handbook were followed and included: (1) identifying the guideline's objective and questions; (2) systematic literature review; (3) study selection and quality appraisal; (4) development of clear recommendations by key stakeholders; (5) guideline pilot testing and endorsement. Results The resulting guideline includes 17 key recommendations within the seven domains: (1) evaluation purpose and rationale; (2) initial intake process; (3) assessment of the personal domain; (4) assessment of the environment; (5) assessment of occupational/job requirements; (6) analysis and synthesis; (7) evaluation recommendations. Conclusions The guideline may be useful to individually practicing clinicians, health care teams, employers and individuals with TBI. Future research will formally examine the success of the guideline's implementation.	[Stergiou-Kita, Mary; Dawson, Deirdre; Rappolt, Susan] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre; Rappolt, Susan] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre] Baycrest, Rotman Res Inst, Toronto, ON, Canada		Stergiou-Kita, M (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	mary.kita@utoronto.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121			[Anonymous], 2006, TRAUM BRAIN INJ DIAG; [Anonymous], 2011, DIAB EMPL; [Anonymous], WORK LOSS DATA I GUI; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2007, J HEAD TRAUMA REHAB, V22, P73, DOI 10.1097/01.HTR.0000265094.98940.e0; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Archer-Heese G, 2002, OTNOW, V4, P4; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; Barisa MT, 2001, NEUROREHABILITATION, V16, P289; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Black N, 1999, J Health Serv Res Policy, V4, P236; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bootes Kylie, 2002, Work, V19, P255; Brand C, 2006, INTERN MED J, V36, P170, DOI 10.1111/j.1445-5994.2006.01018.x; Canadian Medical Association, 2007, CAN MED ASS HDB CLIN; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chappell Irene, 2003, Can J Occup Ther, V70, P163; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Cook D, 1999, JAMA-J AM MED ASSOC, V281, P1950, DOI 10.1001/jama.281.20.1950; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Dartnell Jonathan, 2008, Evid Based Nurs, V11, P6, DOI 10.1136/ebn.11.1.6; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Detsky AS, 2006, CAN MED ASSOC J, V175, P1033, DOI 10.1503/cmaj.061181; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Ellingsen G, 2003, INFORMATION ORG, V13, P203, DOI DOI 10.1016/S1471-7727(03)00011-3; Escorpizo R, 2011, J OCCUP REHABIL, V21, P134, DOI 10.1007/s10926-011-9290-8; Escorpizo R, 2011, J OCCUP REHABIL, V21, P147, DOI 10.1007/s10926-010-9276-y; Escorpizo R, 2010, J OCCUP REHABIL, V20, P502, DOI 10.1007/s10926-010-9241-9; Field M, 1991, CLIN PRACTICE GUIDEL; Finger ME, 2011, J OCCUP REHABIL, V21, P156, DOI 10.1007/s10926-011-9308-2; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Fraser RT, 2003, J HEAD TRAUMA REHAB, V6, P46; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Giaquinto S, 2007, DISABIL REHABIL, V29, P1313, DOI 10.1080/09638280701415282; Green S, 2003, AUST J PHYSIOTHER, V49, P3, DOI 10.1016/S0004-9514(14)60182-3; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HIGGINS JPT, 2009, COCHRANE HDB SYSTEMA; Hirsh A, 1996, J VOCAT REHABIL, V7, P217; Holtzberg E, 2001, WORK, V16, P246; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hurwitz B, 1999, BRIT MED J, V318, P661, DOI 10.1136/bmj.318.7184.661; Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P172, DOI 10.1258/135581906777641659; Innes E, 1998, Work, V11, P191, DOI 10.3233/WOR-1998-11209; Innes E, 1998, Work, V11, P183, DOI 10.3233/WOR-1998-11208; Innes E, 1998, Work, V11, P207, DOI 10.3233/WOR-1998-11210; Innes Ev, 2002, Work, V18, P51; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kaskutus V, OCCUPATIONAL THERAPY; Kendall E, 2003, J VOCAT REHABIL, V19, P31; Kent B, 2007, WORLDV EVID-BASED NU, V2, P106; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kirschner KL, 2009, PM&R, V1, P674, DOI 10.1016/j.pmrj.2009.05.016; Kirsh B, 2009, WORK, V32, P391, DOI 10.3233/WOR-2009-0851; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; Kowalske K, 2000, J HEAD TRAUMA REHAB, V15, P989, DOI 10.1097/00001199-200008000-00003; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lysaght R, 2005, AM J OCCUP THER, V59, P209, DOI 10.5014/ajot.59.2.209; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Marteau, 1998, HEALTH TECHNOL ASSES, V2, pI, DOI DOI 10.3310/hta2030; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McMahon Brian T, 2005, Work, V25, P67; Michie S, 2004, BRIT MED J, V328, P343, DOI 10.1136/bmj.328.7435.343; Michie S, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-29; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Moreira T, 2006, J CLIN EPIDEMIOL, V59, P1199, DOI 10.1016/j.jclinepi.2005.08.021; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; National Institute of Clinical Excellence, 2001, NAT I CLIN EXC GUID; National Institute of Clinical Excellence Guideline Manuals, 2001, NAT I CLIN EXC GUID; New Zealand Guideline Group, 2001, NZ GUID GROUP HDB PR; NHS Plus Evidence Based Guideline Project, 2006, OCC ASP MAN CHRON FA; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; North South Wales Faculty of Australasian College of Emergency Medicine, 2008, MILD TRAUM BRIAN INJ; NYU Langone Medical Centre, NYU LANG MED CTR DEF; O'Brien L, 2007, BRAIN INJURY, V21, P465, DOI 10.1080/02699050701315134; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pagliari C, 2002, J EVAL CLIN PRACT, V8, P145, DOI 10.1046/j.1365-2753.2002.00333.x; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; Royal College of Physicians, 2004, ROYAL COLL PHYS INT; Rubenson C, 2006, SCAND J OCCUP THER, V14, P205; Rycroft-Malone J, 2001, QUAL HEALTH CARE, V10, P238, DOI 10.1136/qhc.0100238..; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P158, DOI 10.1097/HTR.0b013e3181e7537e; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Simpson A, 2002, BRAIN INJURY, V16, P1075, DOI 10.1080/02699050210155249; Stergiou-Kita M, 2006, OCCUP THER NOW, V8, P5; Stergiou-Kita M, DISABIL REH IN PRESS; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stergiou-Kita M, 2009, CAN J OCCUP THER, V76, P276, DOI 10.1177/000841740907600406; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; The AGREE Collaboration, 2001, AGREE COLL APPR GUID; The National Stroke Foundation, 2010, NAT STROK FDN CLIN G; Thomas DF, 1996, J VOCATIONAL REHABIL, V7, P243; Thompson SB, 2011, NEUROLOGY, V2; Travis J., 2002, WORK, V19, P269; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; University of Sydney, 2006, U SYDN CLIN PRACT GU; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Walters C, 1996, J VOC REHABIL, V7, P139; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2007, J HEAD TRAUMA REHAB, V22, P95, DOI 10.1097/01.HTR.0000265097.44683.22; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; Wollersheim H, 2005, NETH J MED, V63, P188; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zasler ND, 2003, NEUROPSYCHOL REHABIL, V13, P31, DOI 10.1080/09602010	129	16	16	0	16	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	JUN	2012	22	2					166	181		10.1007/s10926-011-9332-2			16	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	926DS	WOS:000302812100003	21968612				2022-02-06	
J	Yelleswarapu, NK; Tay, JK; Fryer, WM; Shah, MA; Garcia, AN; Cheng, JP; Kline, AE				Yelleswarapu, Narayana K.; Tay, Justin K.; Fryer, William M.; Shah, Mansi A.; Garcia, Alexandra N.; Cheng, Jeffrey P.; Kline, Anthony E.			Elucidating the role of 5-HT1A and 5-HT7 receptors on 8-OH-DPAT-induced behavioral recovery after experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Controlled cortical impact; Functional recovery; Learning and memory; Morris water maze; Neurobehavior; Serotonin receptor agonists; Traumatic brain injury	BAY X 3702; AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; NEUROPROTECTIVE PROPERTIES; NEUROBEHAVIORAL BENEFIT; COGNITIVE DEFICITS; HYPOTHERMIA; ANTAGONIST; INDUCTION; EFFICACY	8-OH-DPAT is a 5-HT1A/7 receptor agonist that enhances behavioral recovery after traumatic brain injury (TBI). This study is a first attempt to decipher whether the benefits induced by 8-OH-DPAT after TBI are mediated by 5-HT1A or 5-HT7 receptors. A single i.p. injection of 8-OH-DPAT (0.5 mg/kg) alone or co-administered with either the 5-HT1A or 5-HT7 receptor antagonists WAY 100635 (0.5 mg/kg) or SB 269970 HCI (2.0 mg/kg), respectively, or vehicle control (1.0 mL/kg) was given 15 min after cortical impact or sham injury. Function was assessed by established motor and cognitive tests. No difference in motor performance was observed among the TBI groups. Spatial acquisition was enhanced, relative to vehicle controls, by 8-OH-DPAT alone and when co-administered with WAY 100635, but not when combined with SB 269970 HCI. These data imply that 5-HT1A receptor antagonism does not abate the 8-OH-DPAT-induced cognitive benefits, but 5-HT7 recepi:or antagonism does, which suggests that the 8-OH-DPAT-induced benefits in this single administration, paradigm may be mediated more by 5-HT7 versus 5-HT1A receptors. Evaluation of a specific 5-HT7 receptor agonist will further elucidate the contribution of 5-HTIA and 5-HT7 receptors on behavioral recovery conferred by acute 8-OH-DPAT treatment after TBI. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Yelleswarapu, Narayana K.; Tay, Justin K.; Fryer, William M.; Shah, Mansi A.; Garcia, Alexandra N.; Cheng, Jeffrey P.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Shah, Mansi A.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Cheng, Jeffrey/0000-0001-8285-3207	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD043851, HD046700, NS060005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD043851, R01HD046700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005] Funding Source: NIH RePORTER	Supported, in part, by NIH grants HD043851, HD046700, and NS060005 (AEK)	Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berends AC, 2005, CNS DRUG REV, V11, P379; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2007, NEUROSCI LETT, V416, P165, DOI 10.1016/j.neulet.2007.02.006; Cryan JF, 1999, J PSYCHOPHARMACOL, V13, P278, DOI 10.1177/026988119901300310; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; De Vry J, 1998, J PHARMACOL EXP THER, V284, P1082; De Vry Jean, 1997, Drugs of the Future, V22, P341; Eriksson TM, 2008, EUR J PHARMACOL, V596, P107, DOI 10.1016/j.ejphar.2008.08.026; Gasbarri A, 2008, BEHAV BRAIN RES, V195, P164, DOI 10.1016/j.bbr.2007.12.020; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hedlund PB, 2004, EUR J PHARMACOL, V487, P125, DOI 10.1016/j.ejphar.2004.01.031; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Landry ES, 2006, EUR J NEUROSCI, V24, P535, DOI 10.1111/j.1460-9568.2006.04917.x; Lapointe NP, 2008, J NEUROPHYSIOL, V100, P160, DOI 10.1152/jn.90339.2008; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Meneses A, 2007, NEUROSCI BIOBEHAV R, V31, P705, DOI 10.1016/j.neubiorev.2007.02.001; MILLAN MJ, 1993, J PHARMACOL EXP THER, V264, P1364; Naumenko VS, 2011, NEUROPHARMACOLOGY, V61, P1360, DOI 10.1016/j.neuropharm.2011.08.022; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; PREHN JHM, 1991, EUR J PHARMACOL, V203, P213, DOI 10.1016/0014-2999(91)90717-5; Roberts AJ, 2004, EUR J NEUROSCI, V19, P1913, DOI 10.1111/j.1460-9568.2004.03288.x; Semkova I, 1998, EUR J PHARMACOL, V359, P251, DOI 10.1016/S0014-2999(98)00634-7	27	16	16	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 2	2012	515	2					153	156		10.1016/j.neulet.2012.03.033			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	936YD	WOS:000303625000011	22465320	Green Accepted			2022-02-06	
J	Katsnelson, M; Mackenzie, L; Frangos, S; Oddo, M; Levine, JM; Pukenas, B; Faerber, J; Dong, CH; Kofke, WA; le Roux, PD				Katsnelson, Michael; Mackenzie, Larami; Frangos, Suzanne; Oddo, Mauro; Levine, Joshua M.; Pukenas, Bryan; Faerber, Jennifer; Dong, Chuanhui; Kofke, W. Andrew; le Roux, Peter D.			Are Initial Radiographic and Clinical Scales Associated With Subsequent Intracranial Pressure and Brain Oxygen Levels After Severe Traumatic Brain Injury?	NEUROSURGERY			English	Article						Acute Physiology and Chronic Health Evaluation; Brain tissue oxygen tension; Computed tomography; Glasgow Coma Scale; Injury Severity Score; Intracranial pressure; Marshall CT classification; Rotterdam CT Score; Traumatic brain injury	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; PULMONARY-ARTERY CATHETERS; TISSUE OXYGEN; INTENSIVE-CARE; SUBARACHNOID HEMORRHAGE; SECONDARY INSULTS; PROGNOSTIC VALUE; CONTROLLED TRIAL; APACHE-II	BACKGROUND: Prediction of clinical course and outcome after severe traumatic brain injury (TBI) is important. OBJECTIVE: To examine whether clinical scales (Glasgow Coma Scale [GCS], Injury Severity Score [ISS], and Acute Physiology and Chronic Health Evaluation II [APACHE II]) or radiographic scales based on admission computed tomography (Marshall and Rotterdam) were associated with intensive care unit (ICU) physiology (intracranial pressure [ICP], brain tissue oxygen tension [Pbto(2)]), and clinical outcome after severe TBI. METHODS: One hundred one patients (median age, 41.0 years; interquartile range [26-55]) with severe TBI who had ICP and Pbto(2) monitoring were identified. The relationship between admission GCS, ISS, APACHE II, Marshall and Rotterdam scores and ICP, Pbto(2), and outcome was examined by using mixed-effects models and logistic regression. RESULTS: Median (25%-75% interquartile range) admission GCS and APACHE II without GCS scores were 3.0 (3-7) and 11.0 (8-13), respectively. Marshall and Rotterdam scores were 3.0 (3-5) and 4.0 (4-5). Mean ICP and Pbto(2) during the patients' ICU course were 15.5 +/- 10.7 mm Hg and 29.9 +/- 10.8 mm Hg, respectively. Three-month mortality was 37.6%. Admission GCS was not associated with mortality. APACHE II (P = .003), APACHE-non-GCS (P = .004), Marshall (P < .001), and Rotterdam scores (P < .001) were associated with mortality. No relationship between GCS, ISS, Marshall, or Rotterdam scores and subsequent ICP or Pbto(2) was observed. The APACHE II score was inversely associated with median Pbto(2) (P = .03) and minimum Pbto(2) (P = .008) and had a stronger correlation with amount of time of reduced Pbto(2). CONCLUSION: Following severe TBI, factors associated with outcome may not always predict a patient's ICU course and, in particular, intracranial physiology.	[Mackenzie, Larami; Frangos, Suzanne; Oddo, Mauro; Levine, Joshua M.; Kofke, W. Andrew; le Roux, Peter D.] Univ Penn, Dept Neurosurg, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Katsnelson, Michael; Mackenzie, Larami; Levine, Joshua M.] Univ Penn, Dept Neurol, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Levine, Joshua M.; Kofke, W. Andrew] Univ Penn, Dept Anesthesiol & Crit Care, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Pukenas, Bryan] Univ Penn, Dept Radiol, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Faerber, Jennifer] Univ Penn, Dept Biostat, Med Ctr, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19106 USA; [Dong, Chuanhui] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA		le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, Med Ctr, Ctr Clin Epidemiol & Biostat, 235 S 8th St,4th Floor, Philadelphia, PA 19106 USA.	lerouxp@uphs.upenn.edu	Oddo, Mauro/R-3370-2016	Oddo, Mauro/0000-0002-6155-2525	Integra Foundation; Integra Neurosciences; Mary Elisabeth Groff Surgical and Medical Research Trust	Dr le Roux was supported in part by research grants from the Integra Foundation, Integra Neurosciences, and the Mary Elisabeth Groff Surgical and Medical Research Trust. Dr le Roux is a member of the Integra Speaker's Bureau. All other authors have no financial disclosures to report.	American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP C; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brain Trauma Foundation, 2000, GUID MAN PROGN SEV T; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clinical Trials Unit, CLIN RAND ANT SIGN H; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Faul M, 2010, TRAUMATIC BRAIN INJU; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Grmec S, 2001, CRIT CARE, V5, P19; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nangunoori RM, 2010, NEUROSURGERY; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, V4, P5103; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Tbi Impact, INT MISS PROGN AN CL; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278	83	16	16	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2012	70	5					1095	1105		10.1227/NEU.0b013e318240c1ed			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	933VA	WOS:000303390400021	22076531				2022-02-06	
J	Saadat, S; Akbari, H; Khorramirouz, R; Mofid, R; Rahimi-Movaghar, V				Saadat, Soheil; Akbari, Hesam; Khorramirouz, Reza; Mofid, Roza; Rahimi-Movaghar, Vafa			Determinants of mortality in patients with traumatic brain injury	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Mortality; outcome; prognosis; traumatic brain injury	PROGNOSTIC VALUE; HEAD-INJURY; ALCOHOL; IMPACT; RISK; AGE	BACKGROUND We aimed to determine factors associated with mortality rates in patients with traumatic brain injury (TBI). METHODS Registered data of a national trauma project conducted in eight major cities in Iran during a five-year period were used. Patients with a TBI were identified and both univariate and multivariate analyses were performed. RESULTS 2274 brain-injured patients including 1794 males (78.9%) were identified. The mean age of the patients was 30.1 +/- 19.11 years. The age of 345 patients was less than 12, while 137 patients were older than 65. 383 patients (16.9%) died as a result of their injury. Univariate analysis showed a significant association between mortality and the following factors: age, sex, Glasgow Coma Scale (GCS), Injury Severity Score (ISS), systolic, diastolic and mean arterial blood pressure (BP), and respiratory rate (RR) (p<0.05). The logistic regression analysis revealed a statistically significant association between death and age (odds ratio [OR]=1.04), GCS (OR=0.59), ISS (OR=1.03), mean arterial BP (OR=0.71), and RR (OR=0.82) one-half hour after hospital arrival. CONCLUSION Our results demonstrated that age, GCS, ISS, BP, and RR as prognostic factors in patients with TBI indicate those that need special care during the initial management in the emergency department.	[Saadat, Soheil; Akbari, Hesam; Khorramirouz, Reza; Mofid, Roza; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, SSRC, Tehran, Iran		Rahimi-Movaghar, V (corresponding author), Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Sina Hosp, Hassan Abad Sq,Imam Khomeini Ave, Tehran 113653876, Iran.	v_rahimi@sina.tums.ac.ir	Saadat, Soheil/J-1595-2014; Rahimi-Movaghar, Vafa/L-6339-2019	Saadat, Soheil/0000-0002-2744-7983; adibzadeh, amir/0000-0002-5703-0759; Khorramirouz, Reza/0000-0003-2143-6068			Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; Farace E, 2000, NEUROSURG FOCUS, V8, P6; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Saadat S, 2011, ULUS TRAVMA ACIL CER, V17, P149, DOI 10.5505/tjtes.2011.26043; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	23	16	16	0	4	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2012	18	3					219	224		10.5505/tjtes.2012.03453			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	958VM	WOS:000305269000005	22864713	Bronze			2022-02-06	
J	Corrigan, F; Vink, R; Blumbergs, PC; Masters, CL; Cappai, R; van den Heuvel, C				Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; Masters, Colin L.; Cappai, Roberto; van den Heuvel, Corinna			Evaluation of the effects of treatment with sAPP alpha on functional and histological outcome following controlled cortical impact injury in mice	NEUROSCIENCE LETTERS			English	Article						Amyloid precursor protein; sAPP alpha; Traumatic brain injury	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; SECRETED FORMS; HIPPOCAMPAL-NEURONS; HEAD-INJURY; DOMAIN; RATS; NEURODEGENERATION; PATHOPHYSIOLOGY; NEUTRALIZATION	Treatment with sAPP alpha, the product of non-amyloidogenic processing of the amyloid precursor protein (APP) has been shown to be protective following diffuse traumatic brain injury (TBI), by improving motor outcome and reducing axonal injury. However the effects of treatment with sAPP alpha following a focal TBI have yet to be determined. To investigate this, mice were subjected to a controlled cortical impact injury and treated with either sAPP alpha or its vehicle at 30 min post-injury. Following treatment with sAPP alpha the mice showed a significant improvement in motor and cognitive function early following injury, as determined on the ledged beam and Barnes Maze, respectively, relating to a more rapid rate of recovery. However the effect of treatment with sAPP alpha was not as dramatic as that seen previously following a diffuse injury. Nonetheless, these improvements in functional outcome were acompanied by a small but significant improvement in the amount of cortical and hippocampal at 7 days post-injury, and provide further support for the efficacy of sAPP alpha as a potential neuroprotective agent following TBI. Crown Copyright (C) 2012 Published by Elsevier Ireland Ltd. All rights reserved.	[Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; van den Heuvel, Corinna] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; [Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; van den Heuvel, Corinna] Hanson Inst, Ctr Neurol Dis, Adelaide, SA 5005, Australia; [Masters, Colin L.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Cappai, Roberto] Univ Melbourne, Mol Sci & BioTechnol Inst Bio21, Melbourne, Vic 3010, Australia		Corrigan, F (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	corinna.vandenheuvel@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019; Cappai, Roberto/B-3347-2010	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; , Corinna/0000-0003-0664-8935; Corrigan, Frances/0000-0001-6150-8893; Cappai, Roberto/0000-0002-9505-8496	Brain Foundation; Neurological Research Foundation	We thank Dr Mark Habgood for his assistance in setting up the controlled cortical impact model. This work was funded in part by grants from the Brain Foundation and the Neurological Research Foundation. Roberto Cappai is a National Health and Medical Research Council Senior Research Fellow.	Bell K.F., 2006, NEUROBIOL AGING; BHASIN R, 1991, P NATL ACAD SCI USA, V88, P10307, DOI 10.1073/pnas.88.22.10307; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Furukawa K, 1998, NEUROSCIENCE, V83, P429, DOI 10.1016/S0306-4522(97)00398-9; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han X., 2011, J NEUROTRAUMA; Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903; Paxinos G., 2007, MOUSE BRAIN STEREOTA; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Siopi E., 2011, J NEUROTRAUMA; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44	34	16	17	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	APR 25	2012	515	1					50	54		10.1016/j.neulet.2012.03.017			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932LW	WOS:000303293600010	22445885				2022-02-06	
J	Bolouri, H; Saljo, A; Viano, DC; Hamberger, A				Bolouri, H.; Saljo, A.; Viano, D. C.; Hamberger, A.			Animal model for sport-related concussion; ICP and cognitive function	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cognitive function; intracranial pressure; Morris Water Maze; open field activity	TRAUMATIC BRAIN-INJURY; LATERAL FLUID-PERCUSSION; PROFESSIONAL FOOTBALL; INTRACRANIAL-PRESSURE; WATER-MAZE; STRESS; RATS; GAME	Background - We have recently developed and characterized a rat model of mild traumatic brain injury which simulates the concussive injuries frequently encountered by players in American professional football. Objectives - To study the effect of multiple impacts to the head on intracranial pressure, cognitive function, and exploratory behavior. Materials and methods - The model was employed to cause concussion. Intracranial pressure, cognitive function, and exploratory behavior were examined following the multiple impacts of a 50 or 100 g projectile at a velocity of 9.3 or 11.2 m/s to the helmet protected head. Results - Intracranial pressure measured at 6 and 10 h, and 1, 2, 3, 5, and 7 days. It was maximally elevated 10 h after impact and returned to the control levels 7 days later. Morris Water Maze assessment, 48 h after impact, revealed impaired cognitive function. Open field testing 2-4 days and 1 and 2 weeks after impacts indicated consistently reduced spontaneous exploratory activity. Conclusion - Multiple impacts to the head raise intracranial pressure and impair cognitive function and exploratory activity in this animal model.	[Bolouri, H.; Saljo, A.; Hamberger, A.] Univ Gothenburg, Dept Med Chem & Cell Biol, Sahlgren Acad, Inst Biomed, SE-40530 Gothenburg, Sweden; [Bolouri, H.] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgren Acad, SE-40530 Gothenburg, Sweden; [Viano, D. C.] Pro Biomech, Bloomfield Hills, MI USA		Bolouri, H (corresponding author), Univ Gothenburg, Dept Med Chem & Cell Biol, Sahlgren Acad, Inst Biomed, SE-40530 Gothenburg, Sweden.	hayde.bolouri@gu.se	Lachance, Claude/A-4214-2012	Lachance, Claude/0000-0002-1974-1787	National Football League charities (USA)	The authors want to express their gratitude to Mr. Berndt Svensson, Karlsborg, Sweden, for independently performing the ICP measurements. This work was supported by grants from the National Football League charities (USA).	Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Patel PM, 1998, ANESTH ANALG, V86, P773, DOI 10.1097/00000539-199804000-00018; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2004, NEUROSURGERY, V55, P303; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Vallee M, 1997, J NEUROSCI, V17, P2626; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vink R, 2003, ACT NEUR S, V86, P257	35	16	16	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	APR	2012	125	4					241	247		10.1111/j.1600-0404.2011.01614.x			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	904UJ	WOS:000301223100006	22034961				2022-02-06	
J	Bukur, M; Mosheni, S; Ley, E; Salim, A; Margulies, D; Talving, P; Demetriades, D; Inaba, K				Bukur, Marko; Mosheni, Shahin; Ley, Eric; Salim, Ali; Margulies, Daniel; Talving, Peep; Demetriades, Demetrios; Inaba, Kenji			Efficacy of beta-blockade after isolated blunt head injury: Does race matter?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	63rd Annual Meeting of the Southwestern-Surgical-Congress	APR 03-08, 2011	HI	SW Surg Congress		Trauma; head injury; beta-blocker; ethnicity; mortality	TRAUMATIC BRAIN-INJURY; ADULT BURN PATIENTS; IMPROVED OUTCOMES; FUNCTIONAL OUTCOMES; CEREBRAL PERFUSION; ORGAN DYSFUNCTION; MYOCARDIAL DAMAGE; IMPROVED SURVIVAL; EPIDEMIOLOGY; PROPRANOLOL	BACKGROUND: Several retrospective clinical studies and recent prospective animal models demonstrate improved outcomes with beta-blocker administration after isolated blunt head injury. However, no investigations to date have examined the influence of race on the potential therapeutic effectiveness of these medications. Our hypothesis was that mortality benefits associated with beta-blocker exposure after isolated blunt head injury varies based on ethnicity. METHODS: The trauma registry and the surgical intensive care unit (ICU) databases of an academic Level I trauma center were used to identify all patients sustaining blunt head injury requiring ICU admission from July 1998 to December 2009. Patients sustaining major associated extracranial injuries (Abbreviated Injury Scale [AIS] score >= 3 in any body region) were excluded. Patient demographics, injury profile, Injury Severity Score, and beta-blocker exposure were abstracted. The primary outcome evaluated was in-hospital mortality stratified by ethnicity. RESULTS: During the 11-year study period, 3,750 patients were admitted to the Los Angeles County + University of Southern California Medical Center trauma ICU because of blunt trauma. Of these, 65% (n = 2,446) had an "isolated" head injury. When stratified by race, most patients were Hispanics (60%), followed by Whites (21%), Asians (11%), and African Americans (8%). After adjusting for confounding variables with multivariate regression, only those of Asian and Hispanic descent demonstrated significantly improved outcomes associated with beta-blocker administration. CONCLUSIONS: Our results indicate that beta-blockade after traumatic brain injury may not benefit all races equally. Further prospective research is necessary to assess this discrepancy in treatment benefit and explore other possible therapeutic interventions. (J Trauma. 2012;72:1013-1018. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Bukur, Marko; Ley, Eric; Salim, Ali; Margulies, Daniel] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA 90048 USA; [Mosheni, Shahin; Talving, Peep; Demetriades, Demetrios; Inaba, Kenji] Univ So Calif, Los Angeles Cty Med Ctr, Dept Acute Care Surg, Los Angeles, CA 90033 USA		Bukur, M (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, 8635 W 3rd St,Suite 650, Los Angeles, CA 90048 USA.	bukurm@cshs.org	INABA, KENJI/AAC-8532-2020; Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015	Talving, Peep/0000-0002-9741-2073; Bukur, Marko/0000-0002-1850-7147			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; COLGAN FJ, 1983, CRIT CARE MED, V11, P368, DOI 10.1097/00003246-198305000-00010; Collins FS, 2004, NAT GENET, V36, pS13, DOI 10.1038/ng1436; CONNOR RCR, 1969, AM HEART J, V78, P145, DOI 10.1016/0002-8703(69)90001-5; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Enderson BL, 2007, J TRAUMA, V62, P33; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; GILLUM RF, 1979, HYPERTENSION, V1, P468, DOI 10.1161/01.HYP.1.5.468; Girasek DC, 2010, TRAFFIC INJ PREV, V11, P151, DOI 10.1080/15389580903531598; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; HAWKINS WE, 1971, CARDIOVASC RES, V5, P524, DOI 10.1093/cvr/5.4.524; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kemp CD, 2008, AM SURGEON, V74, P866; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lipsky RH, 2003, ANN NY ACAD SCI, V1003, P22, DOI 10.1196/annals.1300.003; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489, DOI 10.1152/ajplegacy.1976.231.2.489; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McEwen BS, 2008, METABOLISM, V57, pS11, DOI 10.1016/j.metabol.2008.07.006; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; MEYER JS, 1976, STROKE, V7, P158, DOI 10.1161/01.STR.7.2.158; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Pryor JP, 2007, J TRAUMA, V62, P61; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Simon RJ, 2004, J TRAUMA, V56, P269; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Stallion A, 2007, J TRAUMA, V62, P1262; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Voas RB, 2009, ACCIDENT ANAL PREV, V41, P522, DOI 10.1016/j.aap.2009.02.004; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Yancy CW, 2003, AM HEART J, V146, P203, DOI 10.1016/S0002-8703(03)00241-2; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	58	16	17	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2012	72	4					1013	1018		10.1097/TA.0b013e318241bc5b			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	925TO	WOS:000302784600046	22491619				2022-02-06	
J	Cohen, ML; Heaton, SC; Ginn, N; Eyberg, SM				Cohen, Matthew L.; Heaton, Shelley C.; Ginn, Nicole; Eyberg, Sheila M.			Parent-Child Interaction Therapy as a Family-Oriented Approach to Behavioral Management Following Pediatric Traumatic Brain Injury: A Case Report	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						behavior problems; case study; parent-child interaction therapy; pediatric traumatic brain injury; traumatic brain injury	CLOSED-HEAD-INJURY; SHORT-TERM; PSYCHIATRIC-DISORDERS; DISRUPTIVE BEHAVIOR; OUTCOMES; ADOLESCENTS; MAINTENANCE; EFFICACY; INTERVENTION; FEASIBILITY	Objective To present a case study illustrating the application of parent-child interaction therapy (PCIT) for management of a child's externalizing behaviors related to a severe traumatic brain injury (TBI). Methods An 11-year-old boy's history and injury are described, followed by a description of PCIT and the course of therapy. Results After 9 sessions of PCIT, the child displayed fewer negative behaviors, and his mother's distress was reduced. Conclusions This case demonstrates the feasibility of using PCIT with a child older than the recommended age range to address behavior problems associated with TBI.	[Cohen, Matthew L.] Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32610 USA		Cohen, ML (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Coll Publ Hlth & Hlth Profess, POB 100165, Gainesville, FL 32610 USA.	mlcohen@phhp.ufl.edu	Cohen, Mathew/W-3982-2019	Cohen, Matthew/0000-0001-9609-2461			Anderson V., 2010, PEDIAT TRAUMATIC BRA, P179; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bagner DM, 2007, J CLIN CHILD ADOLESC, V36, P418, DOI 10.1080/15374410701448448; Bagner DM, 2010, J DEV BEHAV PEDIATR, V31, P209, DOI 10.1097/DBP.0b013e3181d5a294; Bagner DM, 2004, J CLIN PSYCHOL MED S, V11, P1, DOI 10.1023/B:JOCS.0000016264.02407.fd; BAUMRIND D, 1967, GENET PSYCHOL MONOGR, V75, P43; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Chaffin M, 2004, J CONSULT CLIN PSYCH, V72, P500, DOI 10.1037/0022-006X.72.3.500; EISENSTADT TH, 1993, J CLIN CHILD PSYCHOL, V22, P42, DOI 10.1207/s15374424jccp2201_4; EISENSTADT TH, 1994, CHILD FAM BEHAV THER, V16, P21, DOI 10.1300/J019v16n01_02; Eyberg S. M., 2011, PARENT CHILD INTERAC; Eyberg SM, 2008, J CLIN CHILD ADOLESC, V37, P215, DOI 10.1080/15374410701820117; Eyberg SM, 2010, CLINICAL HANDBOOK OF ASSESSING AND TREATING CONDUCT PROBLEMS IN YOUTH, P139, DOI 10.1007/978-1-4419-6297-3_6; Eyberg SM., 2004, MANUAL DYADIC PARENT; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Funderburk B.W., 2003, EARLY EDUC DEV, V14, DOI [10.1207/s15566935eed1401_5, DOI 10.1207/s15566935eed1401_5, DOI 10.1207/S15566935EED1401_5]; Funderburk BW, 1998, CHILD FAM BEHAV THER, V20, P17, DOI 10.1300/J019v20n02_02; Gioia GA IP, 2000, BEHAV RATING INVENTO; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Hood KK, 2003, J CLIN CHILD ADOLESC, V32, P419, DOI 10.1207/S15374424JCCP3203_10; Jacobson N. S., J CONSULTING CLIN PS, V59, P12; JENNETT B, 1975, LANCET, V1, P480; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; MCNEIL CB, 1991, J CLIN CHILD PSYCHOL, V20, P140, DOI 10.1207/s15374424jccp2002_5; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Pincus, 1999, EYBERG CHILD BEHAV I; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.3.CO;2-T; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor H. G., 2010, PEDIAT TRAUMATIC BRA, P145; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; WAALAND PK, 1998, TRAUMATIC BRAIN INJU, P345; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WADE SL, 2006, TREATING NEURODEVELO, P170; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zisser A., 2010, EVIDENCE BASED PSYCH, V2nd, P179, DOI DOI 10.1111/J.1467-8624.2010.01548.X	54	16	16	0	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693			J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	2012	37	3					251	261		10.1093/jpepsy/jsr086			11	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	915IJ	WOS:000302017400001	22004884	Bronze			2022-02-06	
J	Tanguy, M; Seguin, P; Laviolle, B; Bleichner, JP; Morandi, X; Malledant, Y				Tanguy, Michele; Seguin, Philippe; Laviolle, Bruno; Bleichner, Jean-Paul; Morandi, Xavier; Malledant, Yannick			Cerebral Microdialysis Effects of Propofol versus Midazolam in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						lactate:pyruvate ratio; microdialysis; sedative agents; trauma brain injury	OXIDATIVE STRESS; CULTURED ASTROCYTES; METABOLIC CRISIS; HEAD-INJURY; RATS; TOMOGRAPHY; PROTECTION; GLUTAMATE; ISCHEMIA; CELLS	Propofol, an anesthetic agent acting as an analogue of vitamin E, has been advocated to be an ideal neuroprotective agent both in animal models and in clinical practice, due to its positive effects on oxidative stress. Nevertheless, no studies have compared this agent to another sedative agent used for sedation after traumatic brain injury (TBI). The objective was to compare the effects of propofol to midazolam on cerebral biomarkers at the acute phase of severe TBI patients. Thirty patients aged 35 +/- 18 years were prospectively randomized to receive propofol or midazolam and 29 were analyzed (n = 15 for propofol, and n = 14 for midazolam). A cerebral microdialysis catheter was used to measure the lactate: pyruvate (L:P) ratio, glutamate, glycerol, and glucose for 72 h. No difference between groups was observed for the L:P ratio (time effect p = 0.201, treatment effect p = 0.401, time x treatment interaction p = 0.101). Similarly, no difference was observed for glutamate (time effect p = 0.930, treatment effect p = 0.651, time x treatment interaction p = 0.353), glycerol (time effect p = 0.223, treatment effect p = 0.922, time x treatment interaction p = 0.308), or glucose (time effect p = 0.116, treatment effect p = 0.088, time x treatment interaction p = 0.235). These results do not support a difference between propofol and midazolam for sedation for the cerebral metabolic profile in severe TBI.	[Tanguy, Michele; Seguin, Philippe; Bleichner, Jean-Paul; Malledant, Yannick] Univ Rennes 1, Dept Anesthesie Reanimat 1, INSERM, Serv Reanimat Chirurg,U991, F-35014 Rennes, France; [Laviolle, Bruno] Univ Rennes 1, Serv Pharmacol, INSERM, Serv Reanimat Chirurg,U991, F-35014 Rennes, France; [Laviolle, Bruno] Univ Rennes 1, Ctr Invest Clin, INSERM, Serv Reanimat Chirurg,U991, F-35014 Rennes, France; [Morandi, Xavier] Hop Pontchaillou, Serv Neurochirurg, Rennes 9, France		Seguin, P (corresponding author), Hop Pontchaillou, Serv Anesthesie Reanimat 1, 2 Rue Henri Le Guilloux, Rennes 9, France.	philippe.seguin@chu-rennes.fr	Seguin, Philippe/P-9487-2019; MORANDI, Xavier/ABC-5851-2020	Seguin, Philippe/0000-0002-7774-4257; MORANDI, Xavier/0000-0002-8031-7221; Malledant, yannick/0000-0001-6680-5184	Programme Hospitalier de Recherche Clinique (PHRC) of Rennes [R0903]	The study was supported by a grant from Programme Hospitalier de Recherche Clinique (PHRC) of Rennes, October 2005 (R0903).	Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Clausen F., 2011, J NEUROTRAUMA; DEROUESNE C, 1993, INT J GERIATR PSYCH, V8, P599, DOI 10.1002/gps.930080712; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kerr ME, 2003, CRIT CARE MED, V31, P2371, DOI 10.1097/01.CCM.0000080484.72004.C4; Kobayashi K, 2008, ANESTHESIOLOGY, V109, P426, DOI 10.1097/ALN.0b013e318182a903; Li X, 2003, BIOCHEM BIOPH RES CO, V305, P656, DOI 10.1016/S0006-291X(03)00836-2; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nakahata K, 2008, ANESTHESIOLOGY, V108, P269, DOI 10.1097/01.anes.0000299830.13203.60; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Peters CE, 2001, ANESTHESIOLOGY, V94, P313, DOI 10.1097/00000542-200102000-00022; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sarnowska A, 2009, NEUROCHEM INT, V55, P164, DOI 10.1016/j.neuint.2009.01.024; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sitar SM, 1999, ANESTHESIOLOGY, V90, P1446, DOI 10.1097/00000542-199905000-00030; Smith H, 2009, NEUROCRIT CARE, V10, P166, DOI 10.1007/s12028-008-9163-y; Tanabe K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-68; Tsuchiya M, 2002, AM J RESP CRIT CARE, V165, P54, DOI 10.1164/ajrccm.165.1.2010134; Tsuchiya M, 2001, AM J RESP CRIT CARE, V163, P26, DOI 10.1164/ajrccm.163.1.9911120; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D	32	16	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1105	1110		10.1089/neu.2011.1817			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100010	22182405				2022-02-06	
J	Farinelli, M; Heitz, FD; Grewe, BF; Tyagarajan, SK; Helmchen, F; Mansuy, IM				Farinelli, Melissa; Heitz, Fabrice D.; Grewe, Benjamin F.; Tyagarajan, Shiva K.; Helmchen, Fritjof; Mansuy, Isabelle M.			Selective Regulation of NR2B by Protein Phosphatase-1 for the Control of the NMDA Receptor in Neuroprotection	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; ORGANOTYPIC HIPPOCAMPAL CULTURES; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; KINASE-II; ISCHEMIC BRAIN; CELL-DEATH; CA-2+-INDEPENDENT ACTIVITY; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY	An imbalance between pro-survival and pro-death pathways in brain cells can lead to neuronal cell death and neurodegeneration. While such imbalance is known to be associated with alterations in glutamatergic and Ca2+ signaling, the underlying mechanisms remain undefined. We identified the protein Ser/Thr phosphatase protein phosphatase-1 (PP1), an enzyme associated with glutamate receptors, as a key trigger of survival pathways that can prevent neuronal death and neurodegeneration in the adult hippocampus. We show that PP1 alpha overexpression in hippocampal neurons limits NMDA receptor overactivation and Ca2+ overload during an excitotoxic event, while PP1 inhibition favors Ca2+ overload and cell death. The protective effect of PP1 is associated with a selective dephosphorylation on a residue phosphorylated by CaMKII alpha on the NMDA receptor subunit NR2B, which promotes pro-survival pathways and associated transcriptional programs. These results reveal a novel contributor to the mechanisms of neuroprotection and underscore the importance of PP1-dependent dephosphorylation in these mechanisms. They provide a new target for the development of potential therapeutic treatment of neurodegeneration.	[Farinelli, Melissa; Heitz, Fabrice D.; Grewe, Benjamin F.; Helmchen, Fritjof; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Farinelli, Melissa; Heitz, Fabrice D.; Mansuy, Isabelle M.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Tyagarajan, Shiva K.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland		Farinelli, M (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	mansuy@hifo.uzh.ch	Grewe, Benjamin/E-7044-2017; Tyagarajan, Shiva/P-3135-2015; Mansuy, Isabelle M/N-3042-2015; Helmchen, Fritjof/A-6255-2008	Grewe, Benjamin/0000-0001-8560-2120; Tyagarajan, Shiva/0000-0003-0074-1805; Mansuy, Isabelle M/0000-0001-7785-5371; Helmchen, Fritjof/0000-0002-8867-9569	National Center for Competence in Research "Neural Plasticity and Repair''; University of Zurich; Swiss Federal Institute of Technology; Human Frontier Science ProgramHuman Frontier Science Program; Swiss National FoundationSwiss National Science Foundation (SNSF); Slack-Gyr Foundation; Bitterlin Foundation	Funding by the National Center for Competence in Research "Neural Plasticity and Repair'', the University of Zurich, the Swiss Federal Institute of Technology, The Human Frontier Science Program, The Swiss National Foundation, Slack-Gyr Foundation, and Bitterlin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Camacho A, 2007, NEUROSCIENCE, V145, P873, DOI 10.1016/j.neuroscience.2006.12.069; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fields RD, 2005, CELL CALCIUM, V37, P433, DOI 10.1016/j.ceca.2005.01.011; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gee CE, 2006, EUR J NEUROSCI, V23, P2595, DOI 10.1111/j.1460-9568.2006.04786.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kollen M, 2008, NEUROSCIENCE, V154, P1308, DOI 10.1016/j.neuroscience.2008.04.045; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lennmyr F, 2004, ACTA NEUROL SCAND, V110, P175, DOI 10.1111/j.1600-0404.2004.00306.x; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Martel MA, 2008, NEUROSCIENCE; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; NEWELL DW, 1995, J NEUROSCI, V15, P7702; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schubert P, 1994, J Neural Transm Suppl, V44, P73; SCHWORER H, 1988, BRIT J PHARMACOL, V93, P715, DOI 10.1111/j.1476-5381.1988.tb10330.x; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Strack S, 1997, J NEUROCHEM, V68, P2119; STRASSER U, 1995, J NEUROSCI METH, V57, P177, DOI 10.1016/0165-0270(94)00147-9; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tu W, CELL, V140, P222; Walton M, 1996, MOL BRAIN RES, V43, P21, DOI 10.1016/S0169-328X(96)00144-1; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	62	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34047	10.1371/journal.pone.0034047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	WOS:000305339100108	22479519	Green Published, Green Accepted, gold, Green Submitted			2022-02-06	
J	Auriat, AM; Klahr, AC; Silasi, G; MacLellan, CL; Penner, M; Clark, DL; Colbourne, F				Auriat, Angela M.; Klahr, Ana C.; Silasi, Gergely; MacLellan, Crystal L.; Penner, Mark; Clark, Darren L.; Colbourne, Frederick			Prolonged Hypothermia in Rat: A Safety Study Using Brain-Selective and Systemic Treatments	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article								Hypothermia is an effective neuroprotectant for cardiac arrest and perinatal ischemic injury. Hypothermia also improves outcome after traumatic brain injury and stroke. Although the ideal treatment parameters (duration, delay, and depth) are not fully delineated, prolonged cooling is usually more effective than shorter periods. There is the concern that extended cooling may be hazardous to brain plasticity and cause damage. In order to evaluate this possibility, we assessed the effects of 3 days of systemic hypothermia (32 degrees C) in rats subjected to a sham stroke surgery. There were no detrimental behavioral effects or signs of brain damage. As even longer cooling may be needed in some patients, we cooled (similar to 32 degrees C) the right hemisphere of rats for 3 or 21 days. Physiological variables, functional outcome, and measures of cell injury were examined. Focal brain cooling for 21 days modestly decreased heart rate, blood pressure, and core temperature. However, focal hypothermia did not affect subsequent behavior (e.g., spontaneous limb usage), cell morphology (e.g., dendritic arborization, ultrastructure), or cause cell death. In conclusion, prolonged mild hypothermia did not harm the brain of normal animals. Further research is now needed to evaluate whether such treatments affect plasticity after brain injury.	[Colbourne, Frederick] Univ Alberta, Dept Psychol, Frederick, AB T6G 2E9, Canada; Univ Alberta, Ctr Neurosci, Frederick, AB T6G 2E9, Canada		Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, P217 Biol Sci Bldg, Frederick, AB T6G 2E9, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082; Clark, Darren/0000-0002-9152-6539; Silasi, Gergely/0000-0003-1036-1304	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	Research supported primarily by a grant to F. Colbourne from the Canadian Institutes of Health Research (CIHR).	Auriat AM, 2010, BEHAV BRAIN RES, V214, P42, DOI 10.1016/j.bbr.2010.04.025; Boris-Moller F, 1998, MOL BRAIN RES, V63, P163, DOI 10.1016/S0169-328X(98)00286-1; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Clark DL, 2009, EXP NEUROL, V220, P391, DOI 10.1016/j.expneurol.2009.10.002; Clark DL, 2007, J CEREBR BLOOD F MET, V27, P115, DOI 10.1038/sj.jcbfm.9600327; Colbourne F, 1999, J NEUROSCI, V19, P4200; Corbett D, 1997, STROKE, V28, P2238, DOI 10.1161/01.STR.28.11.2238; Covaciu L, 2008, RESUSCITATION, V76, P83, DOI 10.1016/j.resuscitation.2007.07.002; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; Dong H, 2001, STROKE, V32, P788, DOI 10.1161/01.STR.32.3.788; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; MacLellan CL, 2004, J CEREBR BLOOD F MET, V24, P432, DOI 10.1097/00004647-200404000-00008; MacLellan CL, 2009, J NEUROTRAUM, V26, P313, DOI 10.1089/neu.2008.0580; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; Nguyen AP, 2008, CURR NEUROVASC RES, V5, P171, DOI 10.2174/156720208785425710; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Silasi G, 2012, J CEREBR BLOOD F MET, V32, P1525, DOI 10.1038/jcbfm.2012.38; Silasi G, 2011, J CEREBR BLOOD F MET, V31, P1725, DOI 10.1038/jcbfm.2011.25; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083	33	16	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2012	2	1					37	43		10.1089/ther.2012.0005			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38PJ	WOS:000209355000009	24717136				2022-02-06	
J	Tate, R; Simpson, G; Lane-Brown, A; Soo, C; de Wolf, A; Whiting, D				Tate, Robyn; Simpson, Grahame; Lane-Brown, Amanda; Soo, Cheryl; de Wolf, Annelies; Whiting, Diane			Sydney Psychosocial Reintegration Scale (SPRS-2): Meeting the Challenge of Measuring Participation in Neurological Conditions	AUSTRALIAN PSYCHOLOGIST			English	Article						assessment; brain injuries; community integration; participation; psychometric properties; Sydney Psychosocial Reintegration Scale	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION MEASURE; PSYCHOMETRIC PROPERTIES; INTERNATIONAL CLASSIFICATION; OUTCOMES; REHABILITATION; DISABILITY; RECOVERY; HEALTH; ADULTS	This three-part article presents: (1) a review of the construct of participation; (2) an overview of the 12-item Sydney Psychosocial Reintegration Scale (SPRS) as a measure of participation and as a description of new developments resulting in its revision (SPRS-2); and (3) as an application in different neurological groups. Psychometrically, the SPRS performs very well. There are no significant floor or ceiling effects, and both Form A (change since injury) and Form B (current status) show excellent inter-rater and testretest reliability. There is also substantial evidence for its validity (concurrent, discriminant, and convergent/divergent), and it shows good fit to a Rasch model, providing evidence for its construct validity. Rasch logit scores are used to provide reliable change index values to determine whether an individual patient's scores have improved or deteriorated. In Part 3, three samples were compared: traumatic brain injury (TBI; n = 130), primary brain tumour (PBT; n = 54), and spinal cord injury (SCI; n = 50) on the SPRS-2 Form B. The TBI sample performed more poorly than the PBT and SCI samples on the interpersonal relationships and occupational activity domains. On the living skills domain, the TBI and SCI groups both performed more poorly than the PBT sample. These data demonstrate the differential levels of participation observed in different neurological groups.	[Tate, Robyn; Simpson, Grahame; Lane-Brown, Amanda; de Wolf, Annelies] Univ Sydney, Rehabil Studies Unit, Sydney Med Sch, No Clin Sch, Sydney, NSW 1680, Australia; [Tate, Robyn] Royal Rehabil Ctr Sydney, Sydney, NSW, Australia; [Simpson, Grahame; Whiting, Diane] Liverpool Hosp, Brain Injury Rehabilitat Unit, Liverpool, Merseyside, England; [Soo, Cheryl] Royal Childrens Hosp, Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia		Tate, R (corresponding author), Univ Sydney, Rehabil Studies Unit, Sydney Med Sch, No Clin Sch, POB 6, Sydney, NSW 1680, Australia.	rtate@med.usyd.edu.au	Whiting, Diane/AAN-2522-2021; Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060; Whiting, Diane/0000-0003-1912-6626			Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cameron I. D., 2007, MOTOR ACCIDENT AUTHO; Cameron ID, 2010, DISABIL REHABIL, V32, P1051, DOI 10.3109/09638281003672377; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; De Wolf A., 2008, J REHABILITATION S47, V40, P106; De Wolf A, 2010, QUAL LIFE RES, V19, P1185, DOI 10.1007/s11136-010-9685-6; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Fleming J, 2009, BRAIN IMPAIR, V10, P34, DOI 10.1375/brim.10.1.34; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Kervick RB, 2005, BRAIN INJURY, V19, P881, DOI 10.1080/02699050400025273; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Ley P., 1972, QUANTITATIVE ASPECTS; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Long E, 2008, BRAIN IMPAIR, V9, P274, DOI 10.1375/brim.9.3.274; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Magasi S, 2010, ARCH PHYS MED REHAB, V91, pS17, DOI 10.1016/j.apmr.2010.07.011; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; OWNSWORTH T, 2004, BRAIN IMPAIR, V5, P53, DOI DOI 10.1375/BRIM.5.1.53.35407; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; PERDICES M, 2005, BRAIN IMPAIRMENT, V0006, P00219; Perenboom RJM, 2003, DISABIL REHABIL, V25, P577, DOI 10.1080/0963828031000137081; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; SIMPSON G, 2004, BRAIN IMPAIR, V5, DOI DOI 10.1375/BRIM.5.1.67.35401; Simpson G. K, 2010, BRAIN IMPAIR, V11, P50; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R, TRAUMATIC B IN PRESS; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whiting D., 2010, NSWOG NEUROONCOLOGY; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; World Health Organization, 2007, INT CLASS FUNCT DIS	62	16	16	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	MAR	2012	47	1			SI		20	32		10.1111/j.1742-9544.2011.00060.x			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	879MQ	WOS:000299334300004					2022-02-06	
J	Zhang, LL; Liu, J; Cheng, C; Yuan, Y; Yu, BY; Shen, AG; Yan, MJ				Zhang, Lili; Liu, Jie; Cheng, Chun; Yuan, Ying; Yu, Biyun; Shen, Aiguo; Yan, Meijuan			The Neuroprotective Effect of Pyrroloquinoline Quinone on Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						galactosidase beta-1; beta-1,4-galactosyltransferase I; 4-galactosyltransferase V; 4-galactosyltransferase N-acylsphingosine group; Morris water maze; pyrroloquinoline quinone; training; traumatic brain injury	CELL-ADHESION MOLECULE; REDOX MODULATORY SITE; OXIDATIVE STRESS; MOUSE-BRAIN; ALPHA-SYNUCLEIN; N-GLYCANS; PQQ; RAT; EXPRESSION; COENZYME	Pyrroloquinoline quinone (PQQ) is a water-soluble, anionic, quinonoid substance that has been established as an essential nutrient in animals. Owing to the inherent properties of PQQ as an antioxidant and redox modulator in various systems, PQQ is expected to be used in pharmacological applications in the near future. Although many recent studies have investigated its neuroprotective effects, the effect of PQQ on traumatic brain injury (TBI) has not been examined. In this study we employed Morris water maze (MWM) training, the results of which showed that PQQ led to improved behavioral performance in post-TBI animals. Considering that many experiments have suggested that beta-1,4-galactosyltransferase I (beta-1,4-GalT-I) and -V play significant roles in inflammation and the nervous system, in the present study we used Western blot analysis to study the effect of PQQ on the expression of beta-1,4-GalT-I and -V. We found apparent expression upregulation of beta-1,4-GalT-I and -V after PQQ was systemically administered. Lectin-fluorescent staining with RCA-I also revealed that PQQ contributed to expression upregulation of the galactosidase beta-1 (Gal beta-1), 4-galactosyltransferase N-acylsphingosine (4-GlcNAc) group in microglia and neurons of the cortex and hippocampal CA2 region. In summary, our experiment established that PQQ may play an important role in recovery post-TBI.	[Zhang, Lili; Liu, Jie; Cheng, Chun; Yuan, Ying; Yu, Biyun; Shen, Aiguo; Yan, Meijuan] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China		Yan, MJ (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	ymz_888@yahoo.com.cn	yan, mei/AAA-1379-2022		National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070275, 31070723, 30970996]; College and University Natural Scientific Research Program of Jiangsu Province [08KJB320011]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Nantong University [10ZY013]	This work was supported by the National Nature Science Foundation of China (grant nos. 81070275, 31070723, and 30970996), the College and University Natural Scientific Research Program of Jiangsu Province (08KJB320011), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Natural Science Foundation of Nantong University (10ZY013).	AIZENMAN E, 1992, J NEUROSCI, V12, P2362; Alexandrova ML, 2005, FREE RADICAL BIO MED, V39, P297, DOI 10.1016/j.freeradbiomed.2005.04.017; Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; GALLOP PM, 1989, TRENDS BIOCHEM SCI, V14, P343, DOI 10.1016/0968-0004(89)90169-2; GALLOP PM, 1993, CONNECT TISSUE RES, V29, P153, DOI 10.3109/03008209309014242; GALLOP PM, 1989, BIOCHEM BIOPH RES CO, V163, P755, DOI 10.1016/0006-291X(89)92287-0; HAMAGISHI Y, 1990, J PHARMACOL EXP THER, V255, P980; He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Kim J, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-20; Kobayashi M, 2006, BIOCHEM BIOPH RES CO, V349, P1139, DOI 10.1016/j.bbrc.2006.08.144; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Mori R, 2004, AM J PATHOL, V164, P1303, DOI 10.1016/S0002-9440(10)63217-8; Nakamura N, 2001, J NEUROCHEM, V76, P29, DOI 10.1046/j.1471-4159.2001.00004.x; Niu SQ, 2008, J CHEM NEUROANAT, V35, P245, DOI 10.1016/j.jchemneu.2008.01.002; Nunome K, 2008, BIOL PHARM BULL, V31, P1321, DOI 10.1248/bpb.31.1321; Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005; PAZ MA, 1989, CONNECT TISSUE RES, V20, P251, DOI 10.3109/03008208909023895; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; Sanchez RM, 2000, J NEUROSCI, V20, P2409; Scanlon JM, 1997, EUR J PHARMACOL, V326, P67, DOI 10.1016/S0014-2999(97)00137-4; Shen AG, 2002, NEUROSCI LETT, V327, P45, DOI 10.1016/S0304-3940(02)00381-6; TSUCHIDA T, 1993, J GASTROEN HEPATOL, V8, P342, DOI 10.1111/j.1440-1746.1993.tb01525.x; Venkatesh YP, 1997, GLYCOBIOLOGY, V7, P329, DOI 10.1093/glycob/7.3.329; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yan MJ, 2008, J MOL HISTOL, V39, P317, DOI 10.1007/s10735-008-9168-z; Zhang JJ, 2009, NEUROSCI LETT, V464, P165, DOI 10.1016/j.neulet.2009.08.037; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111; Zhou DP, 1998, BBA-GEN SUBJECTS, V1425, P204, DOI 10.1016/S0304-4165(98)00070-1; Zhu BQ, 2004, CARDIOVASC DRUG THER, V18, P421, DOI 10.1007/s10557-004-6219-x	37	16	19	1	17	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					851	864		10.1089/neu.2011.1882			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900013	22040225	Green Published			2022-02-06	
J	Meierhans, R; Brandi, G; Fasshauer, M; Sommerfeld, J; Schupbach, R; Bechir, M; Stover, JF				Meierhans, R.; Brandi, G.; Fasshauer, M.; Sommerfeld, J.; Schuepbach, R.; Bechir, M.; Stover, J. F.			Arterial lactate above 2 mM is associated with increased brain lactate and decreased brain glucose in patients with severe traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Critical care; Microdialysis; Lactic acid	NUCLEAR-MAGNETIC-RESONANCE; ENERGY-METABOLISM; RAT-BRAIN; COGNITIVE DEFICITS; BLOOD LACTATE; TRANSPORT; MICRODIALYSIS; HYPERGLYCEMIA; DEPRIVATION; ASTROCYTES	Background. Lactate fuels cerebral energy-consuming processes and it is neuroprotective. The impact of arterial lactate on brain metabolism determined by microdialysis was investigated retrospectively in patients with severe traumatic brain injury (FBI). Methods. Cerebral microdialysis (glucose, lactate), neuromonitoring (ICP, CPP, ptiO(2), SjvO(2)) and blood gas data collected in 20 patients during pharmacologic coma were grouped within predefined arterial lactate clusters (<1, 1-2, >2 mM). Microdialysis samples were only taken from time points characterized by normoventilation (paCO(2) 34.5-42 mmHg), sufficient oxygenation (paO(2)>75 mmHg) and hematocrit (>= 24%) to exclude confounding influences. Results. Elevated arterial lactate >= 2 mM was associated with significantly increased brain lactate which coincided with markedly decreased brain glucose despite significantly increased arterial glucose levels and sufficient cerebral perfusion indirectly determined by normal SjvO(2) and ptiO(2) values. At elevated arterial lactate levels signs of significantly increased cerebral lactate uptake coincided with markedly decreased cerebral glucose uptake. Infused lactate above 50 mM per 24 hours was associated with significantly decreased cerebral glucose. Conclusion. Increased arterial lactate levels were associated with increased cerebral lactate uptake and elevated brain lactate. At the same time brain glucose uptake and brain glucose were significantly reduced. It remains unclear whether arterial lactate is the driving force for the increased cerebral lactate levels or if the reduced glucose uptake also contributed to the increased cerebral lactate levels. Further studies are required to assess the impact of lactate infusion under clinical conditions. (Minerva Anestesiol 2012;78:185-93)	[Meierhans, R.; Brandi, G.; Fasshauer, M.; Sommerfeld, J.; Schuepbach, R.; Bechir, M.; Stover, J. F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Brandi, G.] Fdn IRCCS Osped Maggiore Policlin Mangiag & Regin, Neurosurg Intens Care Unit, Dept Anesthesia, Milan, Italy; [Brandi, G.] Fdn IRCCS Osped Maggiore Policlin Mangiag & Regin, Crit Care Med, Milan, Italy		Stover, JF (corresponding author), Univ Spital Zurich, Chirurg Intensivmed, Zurich, Switzerland.	john.stover@access.uzh.ch	Schuepbach, Reto A/J-9737-2012; Schuepbach, Reto/AAO-6360-2020	Schuepbach, Reto A/0000-0002-7058-4377; Schuepbach, Reto/0000-0002-7058-4377	Swiss National Science Foundation (SNP)Swiss National Science Foundation (SNSF); SUVA	The help of the nursing staff in collecting and analyzing cerebral microdialysis samples is gratefully acknowledged. The study was supported by grants from the Swiss National Science Foundation (SNP) and the SUVA Fonds to JFS.	Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bechir M, 2010, MINERVA ANESTESIOL, V76, P896; Bhatia A, 2007, INTENS CARE MED, V33, P1322, DOI 10.1007/s00134-007-0660-9; Bliss TM, 2004, J NEUROSCI, V24, P6202, DOI 10.1523/JNEUROSCI.0805-04.2004; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Canis M, 2009, BRAIN RES, V1257, P32, DOI 10.1016/j.brainres.2008.12.005; Cater HL, 2003, J NEUROCHEM, V87, P1381, DOI 10.1046/j.1471-4159.2003.02100.x; Cater HL, 2001, J PHYSIOL-LONDON, V531, P459, DOI 10.1111/j.1469-7793.2001.0459i.x; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Clemmesen Otto, 2004, Curr Opin Crit Care, V10, P152, DOI 10.1097/00075198-200404000-00012; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cureton EL, 2010, J SURG RES, V159, P468, DOI 10.1016/j.jss.2009.04.020; EDLUND GL, 1988, BIOCHEM J, V249, P117, DOI 10.1042/bj2490117; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; LARRABEE MG, 1995, J NEUROCHEM, V64, P1734; Levy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.15; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Mason GF, 2006, DIABETES, V55, P929, DOI 10.2337/diabetes.55.04.06.db05-1325; Maurer MH, 2004, NEUROSCI LETT, V355, P105, DOI 10.1016/j.neulet.2003.10.056; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; NEIMOTO EM, 1974, STROKE, V5, P81; NEMOTO EM, 1974, STROKE, V5, P48, DOI 10.1161/01.STR.5.1.48; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Schurr A, 2001, J NEUROSCI RES, V66, P782, DOI 10.1002/jnr.10065; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; Schurr A, 1997, BRAIN RES, V744, P105, DOI 10.1016/S0006-8993(96)01106-7; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; TILDON JT, 1993, NEUROCHEM RES, V18, P177, DOI 10.1007/BF01474682; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35	41	16	16	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	FEB	2012	78	2					185	193					9	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	912BI	WOS:000301768200010	21971438				2022-02-06	
J	Ragan, DK; McKinstry, R; Benzinger, T; Leonard, J; Pineda, JA				Ragan, Dustin K.; McKinstry, Robert; Benzinger, Tammie; Leonard, Jeffrey; Pineda, Jose A.			Depression of whole-brain oxygen extraction fraction is associated with poor outcome in pediatric traumatic brain injury	PEDIATRIC RESEARCH			English	Article							CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; MITOCHONDRIAL DYSFUNCTION; MAGNETIC-SUSCEPTIBILITY; METABOLIC-RATE; HEAD-INJURY; O-15 PET; ISCHEMIA; CHILDREN; MRI	INTRODUCTION: Traumatic brain injury (TBI) is a leading cause of death and disability in children. Metabolic failure is an integral component of the pathological aftermath of TBI. The oxygen extraction fraction (OEF) is a valuable parameter for characterization and description of metabolic abnormalities; however, OEF measurement has required either invasive procedures or the use of ionizing radiation, which significantly limits its use in pediatric research. RESULTS: Patients with TBI had depressed OEF levels that correlated with the severity of injury. In addition, the OEF measured within 2 weeks of injury was predictive of patient outcome at 3 mo after injury. In pediatric TBI patients, low OEF-a marker of metabolic dysfunction-correlates with the severity of injury and outcome. DISCUSSION: Our findings support previous literature on the role of metabolic dysfunction after TBI. METHODS: Using a recently developed magnetic resonance (MR) technique for the measurement of oxygen saturation, we determined the whole-brain OEF in both pediatric TBI patients and in healthy controls. Injury and outcome were classified using pediatric versions of the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale-Extended (GOS-E), respectively.	[Ragan, Dustin K.; Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [McKinstry, Robert; Benzinger, Tammie] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Leonard, Jeffrey] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA		Pineda, JA (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	Pineda_j@kids.wustl.edu	Benzinger, Tammie/L-6104-2013; Benzinger, Tammie L. S./ABA-8534-2020; Pineda, Jose/W-2806-2019	Benzinger, Tammie L. S./0000-0002-8114-0552; 	Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); Washington University Institute of Clinical and Translational Sciences [KL2 RR024994, UL1 RR024992]; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HDO62171]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD062171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024992, KL2RR024994] Funding Source: NIH RePORTER	Financial support for this study was received from the Robert Wood Johnson Foundation, the Washington University Institute of Clinical and Translational Sciences (KL2 RR024994 and UL1 RR024992), and the Eunice Kennedy Shriver National Institute of Child Health & Human Development (P30HDO62171).	An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Barker SJ, 2008, CURR OPIN ANESTHESIO, V21, P805, DOI 10.1097/ACO.0b013e328316bb6f; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US E; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Coles JP, 2006, J CEREBR BLOOD F MET, V26, P48, DOI 10.1038/sj.jcbfm.9600179; Dave KR, 2001, J CEREBR BLOOD F MET, V21, P1401, DOI 10.1097/00004647-200112000-00004; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; He X, 2007, MAGN RESON MED, V57, P115, DOI 10.1002/mrm.21108; HOFFMAN WE, 1986, ANESTH ANALG, V65, P729; HOFFMAN WE, 1986, ANESTH ANALG, V65, P639; Ito H, 2005, ANN NUCL MED, V19, P65, DOI 10.1007/BF03027383; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; LANIER WL, 1985, ANESTHESIOLOGY, V63, P589, DOI 10.1097/00000542-198512000-00007; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Mellon EA, 2009, J NEUROSCI METH, V179, P29, DOI 10.1016/j.jneumeth.2009.01.008; MICHENFELDER JD, 1971, BRIT J ANAESTH, V43, P630, DOI 10.1093/bja/43.7.630; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Patel SC, 2008, NEUROSCIENCE MED, P147; Pearson ES, 1931, J AM STAT ASSOC, V26, P128, DOI 10.2307/2277761; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sedlacilk J, 2009, Z MED PHYS, V19, P48, DOI 10.1016/j.zemedi.2008.07.005; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Zhan RZ, 2002, ANESTHESIOLOGY, V97, P896, DOI 10.1097/00000542-200210000-00022; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342	45	16	16	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	FEB	2012	71	2					199	204		10.1038/pr.2011.31			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	934OZ	WOS:000303455000011	22258132	Green Published, Bronze			2022-02-06	
J	Servia, L; Badia, M; Baeza, I; Montserrat, N; Justes, M; Cabre, X; Valdres, P; Trujillano, J				Servia, Luis; Badia, Mariona; Baeza, Ignacio; Montserrat, Neus; Justes, Margarida; Cabre, Xavier; Valdres, Pedro; Trujillano, Javier			Time spent in the emergency department and mortality rates in severely injured patients admitted to the intensive care unit: An observational study	JOURNAL OF CRITICAL CARE			English	Article						Multiple traumas; Intensive care; Emergency department; Time management	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL; RESUSCITATION; MANAGEMENT; SYSTEM; CENTERS; PROGRAM; IMPACT	Purpose: The aim of this study was to identify the determinants of a shorter emergency department time (EDt) in patients with severe trauma (STPs) admitted to the intensive care unit and determine whether EDt influences mortality. Patients and Methods: A prospective observational study of STPs (2005-2007) was conducted. With the variables available from the ED, 2 multiple logistic regression models (MLRM) were created: one for the factors associated with EDt less than or equal to median and the other with mortality. Results: A total of 243 patients were included. The mean age was 43 years; 76% were male. The overall mortality rate was 20%. The median EDt was 120 minutes. The independent factors that were associated with the MLRM for an EDt of 120 minutes or less included age less than 60 years, mechanical ventilation, severe traumatic brain injury, and a trauma and injury severity score of 20 or higher. The MLRM for mortality was age greater than 60 years, mechanical ventilation, traumatic brain injury and shock. An EDt of 120 minutes or less was associated with an increased risk of death in the univariate analysis but not in the MLRM. Conclusions: Patients in the ED with indicators of high trauma severity have a reduced EDt but a higher mortality rate. Advanced age increases both mortality and EDt. With the factors included in the model, EDt was not an independent factor for mortality in STPs. (C) 2012 Elsevier Inc. All rights reserved.	[Servia, Luis; Badia, Mariona; Baeza, Ignacio; Montserrat, Neus; Justes, Margarida; Trujillano, Javier] Hosp Arnau Vilanova, Intens Care Unit, Lleida 25198, Spain; [Cabre, Xavier; Valdres, Pedro] Hosp Arnau Vilanova, Emergency Dept, Lleida 25198, Spain; [Trujillano, Javier] Univ Lleida, Dept Ciencias Med Basicas, IRBLLEIDA, Lleida 25198, Spain		Trujillano, J (corresponding author), Hosp Arnau Vilanova, Intens Care Unit, Lleida 25198, Spain.	jtruji@cmb.udl.es	Trujillano, Javier/A-4325-2010; Badia, Mariona/AAB-5513-2020; Valdres, Pedro/AAP-1201-2021; Goixart, Lluis Servia/C-6561-2011; Trujillano, Javier/AAZ-8142-2021; Montserrat, Nuria/F-3136-2016	Trujillano, Javier/0000-0001-8071-7711; Badia, Mariona/0000-0002-0923-1417; Goixart, Lluis Servia/0000-0001-9513-1465; Trujillano, Javier/0000-0001-8071-7711; Montserrat, Nuria/0000-0002-1603-1755			*AM COLL SURG COMM, 2000, AM RES OPT CAR INJ P; Bernhard M, 2007, RESUSCITATION, V73, P362, DOI 10.1016/j.resuscitation.2006.09.014; Brooks A, 2004, INJURY, V35, P407, DOI 10.1016/S0020-1383(03)00219-5; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cowan RM, 2005, CRIT CARE, V9, P291, DOI 10.1186/cc2981; COWLEY RA, 1973, J TRAUMA, V13, P1029, DOI 10.1097/00005373-197312000-00001; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Di Bartolomeo S, 2004, INJURY, V35, P391, DOI 10.1016/S0020-1383(03)00246-8; Di Bartolomeo S, 2007, INJURY, V38, P305, DOI 10.1016/j.injury.2006.10.005; Eastes LS, 2001, J TRAUMA, V50, P908, DOI 10.1097/00005373-200105000-00022; Haas B, 2008, CRIT CARE, V12, DOI 10.1186/cc6980; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; LOWE DK, 1991, J TRAUMA, V31, P1265, DOI 10.1097/00005373-199109000-00011; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Richardson JD, 2009, J AM COLL SURGEONS, V208, P671, DOI 10.1016/j.jamcollsurg.2008.11.018; Ruchholtz S, 2002, INTENS CARE MED, V28, P1395, DOI 10.1007/s00134-002-1446-8; Santora RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8008; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Theodorou D, 2009, RESUSCITATION, V80, P350, DOI 10.1016/j.resuscitation.2008.10.015; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; van Olden GDJ, 2003, INJURY, V34, P191, DOI 10.1016/S0020-1383(02)00202-4; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wurmb TE, 2008, EUR J EMERG MED, V15, P311, DOI 10.1097/MEJ.0b013e3283036ce6	30	16	16	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2012	27	1					58	65		10.1016/j.jcrc.2011.07.001			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	898VX	WOS:000300771600010	21958981				2022-02-06	
J	Arenth, PM; Russell, KC; Scanlon, JM; Kessler, LJ; Ricker, JH				Arenth, Patricia M.; Russell, Kathryn C.; Scanlon, Joelle M.; Kessler, Lauren J.; Ricker, Joseph H.			Encoding and recognition after traumatic brain injury: Neuropsychological and functional magnetic resonance imaging findings	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Magnetic resonance imaging; Episodic memory; Encoding; Recognition	POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; MEMORY; PATTERNS; STRATEGY; MODERATE; ATLAS; FMRI	Although impairment of episodic memory is common after traumatic brain injury (TBI), the complex nature of human memory suggests the need to study more than recall alone. For this reason, we are presenting an extension with additional analyses of persons reported in a previous publication (Russell, Arenth, Scanlon, Kessler, & Ricker, 2011). We examined both the encoding and recognition components of an episodic memory paradigm containing both word and letter string blocks using functional magnetic resonance imaging (fMRI) and neuropsychological testing. This paradigm was completed by 12 persons with complicated mild, moderate, or severe TBI and 12 matched uninjured controls. Comparisons were made between groups and stimulus types. While task behavioral performance was not significantly different between groups, imaging results showed greater activation for the TBI group during the encoding portion of the task, while the control group exhibited more activation on the recognition portion. Observed areas of activation suggest that the TBI group may have used a less effective, but more automatic verbal strategy for encoding the nonpronounceable letter strings, while controls may have opted for more of a recognition-focused strategy. Group differences in California Verbal Learning Test-Second Edition (CVLT-II) performance supported these ideas, and further neuropsychological testing also suggested limitations in executive functioning in the TBI group that may have influenced performance. Implications for intervention are discussed.	[Ricker, Joseph H.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Arenth, Patricia M.; Russell, Kathryn C.; Ricker, Joseph H.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA		Ricker, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Kaufmann Med Bldg,Suite 201,3471 5th Ave, Pittsburgh, PA 15213 USA.	ricker@pitt.edu		Ricker, Joseph/0000-0003-3415-991X	National Institutes of Health-National Institute of Neurological Disorders and Stroke, NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048178-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048178] Funding Source: NIH RePORTER	This study was supported in part by a grant (National Institutes of Health-National Institute of Neurological Disorders and Stroke, NIH-NINDS R01NS048178-01) awarded to J. H. Ricker. The first two authors contributed equally to this manuscript. First authorship was determined randomly. The authors have no conflicts of interest to report. No competing financial interests exist.	Army Individual Test Battery, 1944, MAN DIR SCOR; Benton A., 1976, MULTILINGUAL APHASIA; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Delis D.C., 2000, CALIFORNIA VERBAL LE; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Golden CJ., 2002, STROOP COLOR WORD TE; GRANT AD, 1948, J EXP PSYCHOL, V38, P404, DOI DOI 10.1037/H0059831; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Miller MB, 2009, NEUROIMAGE, V48, P625, DOI 10.1016/j.neuroimage.2009.06.033; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Raskin S. A., 2000, NEUROPSYCHOLOGICAL M, P93; Raye CL, 2000, PSYCHOBIOLOGY, V28, P197; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Spreen O., 1969, NEUROSENSORY CTR COM; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Talairach J., 1988, COPLANAR STEREOTAXIC; Teasdale G, 1974, LANCET, V2, P480; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; WechslerD, 2001, WECHSLER TEST ADULT; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010	42	16	16	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	4					333	344		10.1080/13803395.2011.633896			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	935ZY	WOS:000303561900001	22360275	Green Accepted			2022-02-06	
B	Bodin, D; Yeates, KO; Klamar, K		Apps, JN; Walter, KD		Bodin, Doug; Yeates, Keith Owen; Klamar, Karl			Definition and Classification of Concussion	PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; POSTCONCUSSIONAL-SYNDROME; INTERNATIONAL-CONFERENCE; CHILDREN; MANAGEMENT; SYMPTOMS; STATEMENT; ADOLESCENTS; AGREEMENT		[Bodin, Doug; Yeates, Keith Owen] Ohio State Univ, Dept Psychol, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Yeates, Keith Owen] Ohio State Univ, Ctr Biobehav Hlth, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Klamar, Karl] Ohio State Univ, Med Ctr, Nationwide Childrens Hosp, Columbus, OH 43210 USA		Bodin, D (corresponding author), Ohio State Univ, Dept Psychol, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA.	doug.bodin@NationwideChildrens.org	Bodin, Doug/AAS-9534-2021; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; [Anonymous], 1966, CLIN NEUROSURG, V12, P386; Ashwal S., 2010, PEDIAT TRAUMATIC BRA; Bergman DA, 1999, PEDIATRICS, V104, P1407; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Bodin D., 2010, TXB PEDIAT PSYCHOSOM; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.4, DOI 10.3171/FOC.2006.21.4.4]; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; *CO MED SOC, 1991, REP SPORTS MED COMM; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Matz P. G., 2003, SEM NEUROSURGERY, V14, P125; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Ruff RM, 1999, BRAIN INJURY, V13, P943; Slobounov S., 2008, INJURIES ATHLETICS C, P399; Tator CH, 2009, CAN J NEUROL SCI, V36, P405, DOI 10.1017/S031716710000771X; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	47	16	17	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-89544-4				2012							9	19		10.1007/978-0-387-89545-1_2	10.1007/978-0-387-89545-1		11	Psychology, Clinical; Clinical Neurology; Pediatrics	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Pediatrics	BZV30	WOS:000303027500002					2022-02-06	
J	Bulson, R; Jun, W; Hayes, J				Bulson, Ryan; Jun, Weon; Hayes, John			Visual symptomatology and referral patterns for Operation Iraqi Freedom and Operation Enduring Freedom veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Neurobehavioral Symptom Inventory; Operation Enduring Freedom; Operation Iraqi Freedom; postconcussive syndrome; postdeployment; posttraumatic stress disorder; symptom; traumatic brain injury; veteran; vision	POLYTRAUMA; IMPAIRMENT; HEALTH	Advances in protective armor technology and changes in the "patterns of war" have created a population of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) veterans with traumatic brain injury (TBI) that provide a unique challenge to Department of Veterans Affairs (VA) healthcare practitioners. The purpose of the study was to determine the frequency of symptomatic ocular and visual sequelae of TBI in OIF/OEF veterans at the Portland VA Medical Center, a Polytrauma Support Clinic Team site. A retrospective analysis of 100 OIF/OEF veterans with TBI was conducted to determine the prevalence of ocular and visual complaints. Referral patterns were also investigated. Visual symptoms were reported in approximately 50% of veterans with TBI. Loss of consciousness, but not number of deployments or number of blast exposures, was found to have a statistically significant association with severity of reported visual symptoms. The most commonly reported symptoms included blurred vision (67%), photosensitivity (50%), and accommodative problems (40%). Visual symptoms of OIF/OEF veterans at the Portland VA Medical Center are reported at slightly lower rates than similar studies conducted at the Palo Alto and Edward Hines Jr VA facilities.	[Bulson, Ryan; Jun, Weon] Portland Dept Vet Affairs Med Ctr, Portland, OR USA; [Bulson, Ryan; Jun, Weon; Hayes, John] Univ Pacific, Coll Optometry, Forest Grove, OR USA		Bulson, R (corresponding author), 2043 Coll Way,Jefferson Hall, Forest Grove, OR 97116 USA.	ryan.bulson@pacificu.edu					Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Han ME, 2007, ACQUIRED BRAIN INJUR, P146; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kapoor N, 2009, MED MANAGEMENT ADULT, P407; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; *VET HLTH ADM, 2008, PERF TRAUM BRAIN INJ	20	16	16	0	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1075	1082		10.1682/JRRD.2011.02.0017			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100010	23341280	Bronze			2022-02-06	
J	Carrasco, CE; Godinho, M; Barros, MBD; Rizoli, S; Fraga, GP				Carrasco, Carlos Eduardo; Godinho, Mauricio; de Azevedo Barros, Marilisa Berti; Rizoli, Sandro; Fraga, Gustavo Pereira			Fatal motorcycle crashes: a serious public health problem in Brazil	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article								Introduction: The numbers of two-wheel vehicles are growing across the world. In comparison to other vehicles, motorcycles are cheaper and thus represent a significant part of the automobile market. Both the mobility and speed are attractive factors to those who want to use them for work or leisure. Crashes involving motorcyclists have become an important issue, especially fatal ones. Specific severe injuries are responsible for the deaths. Defining them is necessary in order to offer better prevention and a more suitable medical approach. Methods: All fatal motorcycle crashes between January 2001 and December 2009 in Campinas, Brazil, were analyzed in this study. Official data have been collected from police incident reports, hospitals' registers and autopsies. Both incidents and casualties were analyzed according to relevant variables. The Injury Severity Score (ISS) was calculated, describing the most potentially fatal injuries. Results: There were 479 deaths; 90.8% were male; the mean age was 27.8 (range 0-73); 86.4% were conductors of the vehicles; blood alcohol was positive in 42.3%; 49.7% died at a hospital; 32.6% died at the scene; 26.1% of the accidents occurred at night, 69.1% were urban and 30.9% occurred on highways. The main causes of injury were collisions (63%) and falls (14%). The mean ISS was 38.5 (range 9-75). With regard to injuries, head trauma (67%) and thoracic trauma (40%) were the most common, followed by abdominal trauma (35%). Traumatic brain injury (67%) and hypovolemic shock (38%) were the most frequent causes of death. Conclusions: Alcohol was a significant factor in relation to the accidents. Head trauma was the most frequent and severe injury. Half of the victims died before receiving adequate medical attention, suggesting that prevention programs and laws should be implemented and applied in order to save future lives.	[Carrasco, Carlos Eduardo] Univ Campinas FCM UNICAMP, Fac Med Sci, Campinas, SP, Brazil; [Godinho, Mauricio; Fraga, Gustavo Pereira] Univ Campinas FCM UNICAMP, Div Trauma Surg, Dept Surg, Fac Med Sci, Campinas, SP, Brazil; [de Azevedo Barros, Marilisa Berti] Univ Campinas FCM UNICAMP, Dept Publ Hlth, Fac Med Sci, Campinas, SP, Brazil; [Rizoli, Sandro] Univ Toronto, Dept Surg, Sunnybrook Hlth Sci Ctr, Toronto, ON M5S 1A1, Canada; [Rizoli, Sandro] Univ Toronto, Dept Crit Care Med, Sunnybrook Hlth Sci Ctr, Toronto, ON M5S 1A1, Canada		Fraga, GP (corresponding author), Univ Campinas FCM UNICAMP, Div Trauma Surg, Dept Surg, Fac Med Sci, Campinas, SP, Brazil.	fragagp2008@gmail.com			Foundation of Support to the Research of the State of Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	This study has been financed by the Foundation of Support to the Research of the State of Sao Paulo (FAPESP).	Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; [Anonymous], 2004, Epidemiol Bull, V25, P2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barros Aluísio J. D., 2003, Cad. Saúde Pública, V19, P979, DOI 10.1590/S0102-311X2003000400021; Empresa Municipal para o Desenvolvimento de Campinas, 2010, AC TRANS CAMP 2009; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P212, DOI 10.1590/S1415-790X2002000200008; LaTorre G, 2002, EUR J PUBLIC HEALTH, V12, P99, DOI 10.1093/eurpub/12.2.99; Ledesma RD, 2008, REV SAUDE PUBL, V42, P143, DOI 10.1590/S0034-89102008000100019; Leong QM, 2009, WORLD J SURG, V33, P870, DOI 10.1007/s00268-008-9915-z; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Lin MR, 2001, J TRAUMA, V50, P24, DOI 10.1097/00005373-200101000-00004; Marin-Leon L, 2012, CAD SAUDE PUBLICA, V28, P39, DOI 10.1590/S0102-311X2012000100005; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; Montilla M., 2011, REV SAUDE PUBL, V45, P1; Nunn S, 2011, J FORENSIC SCI, P1; O'Keeffe T, 2007, J TRAUMA, V63, P1006, DOI 10.1097/TA.0b013e31815644cd; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Savolainen P, 2007, ACCIDENT ANAL PREV, V39, P955, DOI 10.1016/j.aap.2006.12.016; Scalassara MB, 1998, REV SAUDE PUBL, V32, P125, DOI 10.1590/S0034-89101998000200004; Zargar M., 2006, Eastern Mediterranean Health Journal, V12, P81	20	16	20	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.		2012	7			1					S5	10.1186/1749-7922-7-S1-S5			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	V41OM	WOS:000209555500005	23531421	Green Published, gold			2022-02-06	
J	Davis, JJ; McHugh, TS; Axelrod, BN; Hanks, RA				Davis, Jeremy J.; McHugh, Tara S.; Axelrod, Bradley N.; Hanks, Robin A.			Performance Validity and Neuropsychological Outcomes in Litigants and Disability Claimants	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; Effort assessment; Forensic neuropsychology; Traumatic brain injury	ADULT INTELLIGENCE SCALE; RECOGNITION MEMORY TEST; TEST-SCORES; NONCLINICAL SAMPLE; BRAIN-INJURY; HEAD-INJURY; TESTS; DEFICITS; VALIDATION	This study examined the relationship of performance validity and neuropsychological outcomes in a sample of individuals referred for independent neuropsychological examination in the context of reported traumatic brain injury (82% mild). Archival data were examined on 175 participants aged 20 to 65 who were administered at least two performance validity measures. Participants who passed all effort measures (Pass; n = 61) outperformed those who failed two or more (Fail; n = 70) on the majority of tests in the neuropsychological battery. The Fail group showed a higher percentage of impaired test scores than the Pass group with impairment defined at three levels (T scores < 40, 35, and 30). At the most conservative impairment cutoff (T < 30), 16% of the Pass group demonstrated impaired scores on more than three measures, while 79% of the Fail group showed impaired scores on more than three measures. The number of effort measures failed correlated highly with the overall test battery mean (r = -.73). On cognitive domain summary scores, effect sizes based on levels of effort (d = 1.12 to 1.86) were higher than those based on injury severity (d = 0.03 to 0.36).	[Davis, Jeremy J.; McHugh, Tara S.] Rehabil Inst Michigan, Detroit, MI USA; [Axelrod, Bradley N.] John Dingell VA Med Ctr, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Detroit, MI USA		Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2008, APPL NEUROPSYCHOL, V15, P170, DOI 10.1080/09084280802324184; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Boone K.B., 2007, ASSESSMENT FEIGNED C; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Fox D. D., 2009, MANUAL COMPUTERIZED; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gladsjo JA, 1999, NORMS LETT CATEGORY; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2002, GREENS WORD MEMORY T; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heaton RK, 1991, COMPREHENSIVE NORMS; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Leiter RG., 1949, PSYCHOL SERVICE CTR, V1, P11; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Matthews CG., 1964, INSTRUCTION MANUAL A; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilkinson G., 1993, WIDE RANGE ACHIEVEME, V3; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wolfson, 1993, HALSTEAD REITAN NEUR	51	16	16	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	5					850	865		10.1080/13854046.2012.686631			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	970EU	WOS:000306111700006	22630329				2022-02-06	
J	Kiewel, NA; Wisdom, NM; Bradshaw, MR; Pastorek, NJ; Strutt, AM				Kiewel, Nicole A.; Wisdom, Nick M.; Bradshaw, Major R.; Pastorek, Nicholas J.; Strutt, Adriana M.			A Retrospective Review of Digit Span-Related Effort Indicators in Probable Alzheimer's Disease Patients	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; Symptom validity testing; Forensic neuropsychology; Dementia assessment; Professional issues	SYMPTOM VALIDITY TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; CLASSIFICATION ACCURACY; MEMORY IMPAIRMENT; TEST-PERFORMANCE; WAIS-III; COGNITIVELY INTACT; NORMATIVE DATA; TEST-SCORES	There has been extensive research on the use of both stand-alone and embedded measures of effort in neuropsychological testing; however, relatively few studies have reported on their utility in the context of dementia. Previous studies that have examined the specificity of traditionally used cut-scores on embedded measures of effort with dementia samples have largely found high rates of false positive errors. The present study examined the specificity of several Digit Span derived embedded measures of effort in a large clinical sample of patients with probable Alzheimer's disease stratified by level of dementia severity. Of the measures that were examined, only the Vocabulary - Digit Span score demonstrated promising specificity through the moderate level of dementia severity. All of the remaining indices, including Reliable Digit Span, Digit Span Age-Corrected Scaled Score, and Longest Digits Forward (1 & 2 Trials), yielded unacceptable rates of false positive errors as dementia severity increased. The implications for these findings are discussed, including the limitations of importing methods of assessing effort from one sample to another.	[Bradshaw, Major R.; Strutt, Adriana M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Kiewel, Nicole A.] Univ Houston, Dept Psychol, Houston, TX USA; [Wisdom, Nick M.] Mental Hlth Care Line, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA; [Wisdom, Nick M.; Strutt, Adriana M.] Baylor Coll Med, Menninger Dept Psychiat, Houston, TX 77030 USA; [Pastorek, Nicholas J.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Pastorek, Nicholas J.] Rehabil Care Line, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA		Strutt, AM (corresponding author), Baylor Coll Med, Dept Neurol, 6550 Fannin,Smith Tower 1801, Houston, TX 77030 USA.	adrianam@bcm.edu		Pastorek, Nicholas/0000-0002-9290-380X			Ardila A, 2007, ARCH CLIN NEUROPSYCH, V22, P1003, DOI 10.1016/j.acn.2007.08.004; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Doody R, 2005, DEMENT GERIATR COGN, V20, P198, DOI 10.1159/000087300; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Hirschman KB, 2004, J GERIATR PSYCH NEUR, V17, P55, DOI 10.1177/0891988704264540; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; KASZNIAK AW, 1979, CORTEX, V15, P285, DOI 10.1016/S0010-9452(79)80032-5; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Slick DJ, 2003, CLIN NEUROPSYCHOL, V17, P390, DOI 10.1076/clin.17.3.390.18090; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; STORANDT M, 1986, HDB CLIN MEMORY ASSE; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; [No title captured]	35	16	17	1	11	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	6					965	974		10.1080/13854046.2012.694478			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	984ZK	WOS:000307232300008	22703555				2022-02-06	
J	Kool, B; Raj, N; Wainiqolo, I; Kafoa, B; McCaig, E; Ameratunga, S				Kool, Bridget; Raj, Naina; Wainiqolo, Iris; Kafoa, Berlin; McCaig, Eddie; Ameratunga, Shanthi			Hospitalised and Fatal Head Injuries in Viti Levu, Fiji: Findings from an Island-Wide Trauma Registry (TRIP 4)	NEUROEPIDEMIOLOGY			English	Article						Head injuries; Epidemiology; Traumatic brain injury; Surveillance; Fiji	BRAIN-INJURY; NEW-ZEALAND; EPIDEMIOLOGY; MANAGEMENT; ADMISSIONS; MORTALITY; CHILDREN; DEATHS; TRENDS; IMPACT	Background: Globally, head injury is a substantial cause of mortality and morbidity. A disproportionately greater burden is borne by low-and middle-income countries. The incidence and characteristics of fatal and hospitalised head injuries in Fiji are unknown. Methods: Using prospective data from the Fiji Injury Surveillance in Hospital system, the epidemiology of fatal and hospitalised head injuries was investigated (2004-2005). Results: In total, 226 hospital admissions and 50 fatalities (66% died prior to admission) with a principal diagnosis of head injury were identified (crude annual rates of 34.7 and 7.7/100,000, respectively). Males were more likely to die and be hospitalised as a result of head injury than females. The highest fatality rate was among those in the 30-44-year age group. Road traffic crashes were the leading causes of injuries resulting in death (70%), followed by 'hit by person or object' and falls (14% each). Among people admitted to hospital, road traffic crashes (34.5%) and falls (33.2%) were the leading causes of injury. The leading cause of head injuries in children was falls, in 15-29-year-olds road traffic crashes, and in adults aged 30-44 years or 45 years and older 'hit by person or object'. Among the two major ethnic groups, Fijians had higher rates of falls and 'hit by person or object' and Indians higher rates for road traffic crashes. There were no statistically significant differences between the overall rates of head injuries or the fatal and nonfatal rates among Fijians or Indians by gender following age standardisation to the total Fijian national population. Conclusion: Despite underestimating the overall burden, this study identified head injury to be a major cause of death and hospitalisation in Fiji. The predominance of males and road traffic-related injuries is consistent with studies on head injuries conducted in other low-and middle-income countries. The high fatality rate among those aged 30-44 years in this study has not been noted previously. The high case fatality rate prior to admission to the hospital requires urgent attention. Copyright (C) 2012 S. Karger AG, Basel	[Kool, Bridget; Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1142, New Zealand; [Raj, Naina] Auckland Reg Publ Hlth Serv, Environm Hlth Protect Team, Auckland, New Zealand; [Wainiqolo, Iris; Kafoa, Berlin; McCaig, Eddie] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Suva, Fiji		Kool, B (corresponding author), Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Private Bag 92019, Auckland 1142, New Zealand.	b.kool@auckland.ac.nz		Ameratunga, Shanthi/0000-0001-8042-2251	Wellcome Trust (UK)Wellcome Trust; New Zealand Health Research CouncilHealth Research Council of New Zealand; Fiji Ministry of Health; Fiji School of Medicine	This study was funded by an international collaborative research grant from the Wellcome Trust (UK) and the New Zealand Health Research Council. The authors gratefully acknowledge the support of the Permanent Secretary of Health, Dr. Lepani Waqatakirewa, and the Fiji Ministry of Health staff at national, divisional, and subdivisional levels, the doctors and nurses in the surveillance hospitals, and the final-year medical students of 2005-2006 at the Fiji School of Medicine.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Fiji Bureau of Statistics, 2007 CENS DAT; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Holder Y, 2001, INJURY SURVEILLANCE, P80; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jat Afzal Ali, 2004, Asian J Surg, V27, P58, DOI 10.1016/S1015-9584(09)60247-5; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Matthew PK, 1996, AUST NZ J SURG, V66, P659, DOI 10.1111/j.1445-2197.1996.tb00712.x; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mukhida K, 2006, CHILD NERV SYST, V22, P352, DOI 10.1007/s00381-005-1235-0; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; ROY PD, 1987, CAN J SURG, V30, P17; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SINHA SN, 1981, PAPUA NEW GUINEA MED, V24, P222; SINHA SN, 1989, ACCIDENT ANAL PREV, V21, P297, DOI 10.1016/0001-4575(89)90021-3; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Wainiqolo I, 2011, INJURY; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Zhao YD, 2001, WORLD J SURG, V25, P1202	34	16	16	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2012	38	3					179	185		10.1159/000337261			7	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	941TP	WOS:000303989000008	22472517	Green Published, Bronze			2022-02-06	
J	Levack, WMM				Levack, William			The role of qualitative metasynthesis in evidence-based physical therapy	PHYSICAL THERAPY REVIEWS			English	Article						Evidence-based practice; Qualitative metasynthesis; Qualitative research; Physiotherapy	TRAUMATIC BRAIN-INJURY; META-SYNTHESIS; EXPERIENCE; REFLECTIONS; RECOVERY; STROKE; ADULTS; RETURN; WORK	Background: Qualitative metasynthesis is a method for systematically identifying, examining, comparing, and interpreting findings from multiple published qualitative studies on specific topics. It has been argued that qualitative metasynthesis may be useful for increasing the transferability of findings from single qualitative studies to broader contexts, in part addressing the limitations of qualitative research regarding its generalizability and thus its application to evidence-based practice. Objectives: The aim of this paper is to provide an introduction to qualitative metasynthesis, to examine its potential application to physical therapy, and to discuss and debate its strengths and limitations. Major findings: Only one qualitative metasynthesis appears to have been published in physical therapy journals to date, although many other qualitative metasyntheses potentially relevant to physical therapy (on topics such as neurological, musculoskeletal, and cardiac conditions) have been published in journals intended for interprofessional audiences. Qualitative metasynthesis may be beneficial in terms of its capacity to progress theory related to physical therapy, and as a way of introducing qualitative research into public policy and development of clinical practice. Some challenges exist regarding aspects of qualitative metasynthesis, such as the place of critical appraisal of qualitative studies and the representativeness of findings from qualitative metasyntheses. These challenges continue to be enthusiastically debated. Conclusion: Uptake of qualitative metasynthesis in journals dedicated to physical therapy has been limited, but physical therapists may find qualitative metasyntheses relevant to their work outside these professionspecific forums. Qualitative metasynthesis may in the future play an important role in the development of physical therapy practice.	[Levack, William] Univ Otago, Dept Med, Rehabil Teaching & Res Unit, POB 7343, Wellington 6242, New Zealand		Levack, WMM (corresponding author), Univ Otago, Dept Med, Rehabil Teaching & Res Unit, POB 7343, Wellington 6242, New Zealand.	william.levack@otago.ac.nz					Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Bridges J, 2010, INT J NURS STUD, V47, P89, DOI 10.1016/j.ijnurstu.2009.09.009; Britten N, 2011, PATIENT EDUC COUNS, V82, P384, DOI 10.1016/j.pec.2010.12.021; Charmaz K., 2014, BROKERAGE CLOSURE IN; Edwards I, 2004, ADV PHYSIOTHERAPY, V6, P70; Finfgeld DL, 2003, QUAL HEALTH RES, V13, P893, DOI 10.1177/1049732303253462; Finfgeld-Connett D, 2010, J ADV NURS, V66, P246, DOI 10.1111/j.1365-2648.2009.05250.x; Flemming K, 2010, J ADV NURS, V66, P201, DOI 10.1111/j.1365-2648.2009.05173.x; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Gewurtz Rebecca, 2008, Can J Occup Ther, V75, P301; Gewurtz R, 2009, WORK, V34, P33, DOI 10.3233/WOR-2009-0900; Giddens, 1987, SOCIAL THEORY MODERN; Green J., 2009, QUALITATIVE METHODS, V2nd; Hammell KW, 2007, SPINAL CORD, V45, P260, DOI 10.1038/sj.sc.3102034; Hammell KW, 2007, SPINAL CORD, V45, P124, DOI 10.1038/sj.sc.3101992; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hildingh C, 2007, HEART LUNG, V36, P410, DOI 10.1016/j.hrtlng.2007.02.008; Kemp S, 2001, Br J Perioper Nurs, V11, P348; Lawson S, 2008, THER RECREAT J, V42, P236; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lindquist I, 2010, PHYSIOTHER RES INT, V15, P103, DOI 10.1002/pri.461; MacEachen E, 2006, SCAND J WORK ENV HEA, V32, P257, DOI 10.5271/sjweh.1009; McInnes E, 2011, J ADV NURS, V67, P2525, DOI 10.1111/j.1365-2648.2011.05707.x; Nelson AM, 2002, QUAL HEALTH RES, V12, P515, DOI 10.1177/104973202129120043; O'Neill T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-52; Oliver M., 1992, DISABILITY HANDICAP, V7, P101, DOI DOI 10.1080/02674649266780141; Parry RH, 2004, CLIN REHABIL, V18, P668, DOI 10.1191/0269215504cr745oa; Paterson BL, 2001, METASTUDY QUALITATIV; Richardson B, 2010, PHYSIOTHER RES INT, V15, P111, DOI 10.1002/pri.463; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Salter K, 2008, J REHABIL MED, V40, P595, DOI 10.2340/16501977-0238; Sandelowski M, 2006, NURS OUTLOOK, V54, P10, DOI 10.1016/j.outlook.2005.05.004; Sandelowski M., 2007, HDB SYNTHESIZING QUA; Shaw Rachel L, 2004, BMC Med Res Methodol, V4, P5, DOI 10.1186/1471-2288-4-5; Sim J, 2008, SOC SCI MED, V67, P57, DOI 10.1016/j.socscimed.2008.03.003; Stergiou-Kita M, 2012, DISABIL REHABIL, V34, P179, DOI 10.3109/09638288.2011.591881; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Thorne S, 2004, QUAL HEALTH RES, V14, P1342, DOI 10.1177/1049732304269888; Thorne S, 2009, INT J NURS STUD, V46, P569, DOI 10.1016/j.ijnurstu.2008.05.001; Travers J, 2007, THORAX, V62, P219, DOI 10.1136/thx.2006.066837; Weed M., 2005, FORUM QUALITATIVE SO, V6, P1; Wiles R, 2004, SOC SCI MED, V59, P1263, DOI 10.1016/j.socscimed.2003.12.022; Williams M, 2000, SOCIOLOGY, V34, P209, DOI 10.1017/S0038038500000146; Williams M., 2004, SAGE ENCY SOCIAL SCI, P728	47	16	16	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1083-3196	1743-288X		PHYS THER REV	Phys. Ther. Rev.		2012	17	6			SI		390	397		10.1179/1743288X12Y.0000000020			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V73FX	WOS:000211696400006					2022-02-06	
J	Pluck, G; Lee, KH; David, R; Spence, SA; Parks, RW				Pluck, Graham; Lee, Kwang Hyuk; David, Rajan; Spence, Sean A.; Parks, Randolph W.			Neuropsychological and Cognitive Performance of Homeless Adults	CANADIAN JOURNAL OF BEHAVIOURAL SCIENCE-REVUE CANADIENNE DES SCIENCES DU COMPORTEMENT			English	Article						cognition; homelessness; intelligence; IQ; memory; premorbid	TRAUMATIC BRAIN-INJURY; SUBSTANCE MISUSE; WECHSLER TEST; INTELLIGENCE; HOSTEL; MEN; CHILDREN; WELFARE; PEOPLE; ABUSE	Many homeless people may have been exposed to events and situations that could potentially produce neuropsychological impairments. In the current study, 80 homeless participants underwent a battery of tests designed to 1) estimate long-standing established memory and intelligence, which was assumed to indicate prehomeless function and 2) measure current memory and intelligence function. Mental health screening and substance misuse data were also obtained. Results indicated that current memory and IQ were significantly lower than the estimated normal population means and also their prehomeless estimates. The memory score change was from 100.5 to 90.3 (p < .001) and IQ change from 98.8 to 95.6 (p = .038). The interaction between task type (memory or IQ) and measure (prehomeless or current) was also significant (p = .003), signifying that there was a greater change in the domain of memory function than in IQ. Many participants reported substance misuse and clinically significant mental health concerns. We conclude that the homeless individuals in our sample appear to have suffered a reduction in cognitive function, which may have occurred either during homelessness or prior to it.	[Pluck, Graham] Univ Sheffield, Longley Ctr, Sheffield S5 7JT, S Yorkshire, England; [David, Rajan] Sheffield Care Trust, Homeless Assessment & Support Team, Sheffield, S Yorkshire, England		Pluck, G (corresponding author), Univ Sheffield, Longley Ctr, Norwood Grange Dr, Sheffield S5 7JT, S Yorkshire, England.	g.pluck@sheffield.ac.uk	Pluck, Graham/C-6482-2008; Lee, Kwang-Hyuk/B-5808-2009	Pluck, Graham/0000-0002-0368-0051; 			Adams CE, 1996, BRIT J PSYCHIAT, V168, P82, DOI 10.1192/bjp.168.1.82; American Psychological Association, 2010, HELP PEOPL HOM REP 2; Avramov D, 1999, COPING HOMELESSNESS; Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Berger PS, 1999, J SOC DISTRESS HOMEL, V8, P1, DOI 10.1023/A:1022994107792; Bousman CA, 2010, J NERV MENT DIS, V198, P790, DOI 10.1097/NMD.0b013e3181f97dff; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Caplan B, 2006, SCHIZOPHR RES, V83, P77, DOI 10.1016/j.schres.2005.11.013; Evans N, 1996, NUTR FOOD SCI, V96, P5, DOI 10. 1108/00346659610114699; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Gilchrist G, 2005, EUR J PUBLIC HEALTH, V15, P587, DOI 10.1093/eurpub/cki036; Gonzalez EA, 2001, J NERV MENT DIS, V189, P176, DOI 10.1097/00005053-200103000-00006; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hwang SW, 1999, CAN MED ASSOC J, V160, P1021; Jarrett C, 2010, PSYCHOLOGIST, V23, P284; KENWAY P., 2003, MANY MUCH SINGLE HOM; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LOUKS JL, 1988, HOSP COMMUNITY PSYCH, V39, P670; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Morey L. C., 1997, PERSONALITY ASSESSME; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; Murphy Barbara, 2000, STREET WE CREATED HO; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Oakes PM, 2008, J INTELLECT DISABILI, V12, P325, DOI 10.1177/1744629508100496; Parks RW, 2007, J ROY SOC MED, V100, P46, DOI 10.1258/jrsm.100.1.46; Pluck G, 2008, J PSYCHOL, V142, P159, DOI 10.3200/JRLP.142.2.159-168; Pluck G, 2007, CAN MED ASSOC J, V176, P489, DOI 10.1503/cmaj.1060229; Pluck G, 2011, BRIT J CLIN PSYCHOL, V50, P33, DOI 10.1348/014466510X490253; Rindermann H, 2008, INTELLIGENCE, V36, P127, DOI 10.1016/j.intell.2007.02.002; Schretlen DJ, 2005, J INT NEUROPSYCH SOC, V11, P784, DOI 10.1017/S1355617705050939; Seidman LJ, 2003, PSYCHIAT SERV, V54, P905, DOI 10.1176/appi.ps.54.6.905; Seidman LJ, 1997, J NERV MENT DIS, V185, P3, DOI 10.1097/00005053-199701000-00002; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Spence SA, 2006, PSYCHIAT CLIN NEUROS, V60, P259, DOI 10.1111/j.1440-1819.2006.01496.x; Spence SA, 2009, PSYCHIATR BULL, V33, P64, DOI 10.1192/pb.bp.107.018994; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Toro PA, 2007, J SOC ISSUES, V63, P461, DOI 10.1111/j.1540-4560.2007.00519.x; Vostanis P, 1998, BRIT MED J, V316, P899, DOI 10.1136/bmj.316.7135.899; Wechsler D., 2002, WECHSLER MEMORY SCAL; Wechsler D., 2011, WECHSLER ABBREVIATED; WechslerD, 2001, WECHSLER TEST ADULT	45	16	16	1	8	CANADIAN PSYCHOLOGICAL  ASSOC	OTTAWA	141 LAURIER AVE WEST, STE 702, OTTAWA, ONTARIO K1P 5J3, CANADA	0008-400X			CAN J BEHAV SCI	Can. J. Behav. Sci.-Rev. Can. Sci. Comport.	JAN	2012	44	1					9	15		10.1037/a0025382			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	878FW	WOS:000299241900002					2022-02-06	
J	Seipel, R; Langner, S; Platz, T; Lippa, M; Kuehn, JP; Hosten, N				Seipel, R.; Langner, S.; Platz, T.; Lippa, M.; Kuehn, J. P.; Hosten, N.			Neurogenic heterotopic ossification: epidemiology and morphology on conventional radiographs in an early neurological rehabilitation population	SKELETAL RADIOLOGY			English	Article						Heterotopic ossification; Neurological rehabilitation; Radiography	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MYOSITIS-OSSIFICANS; RISK-FACTORS; APPEARANCE; MANAGEMENT	To retrospectively evaluate neurogenic heterotopic ossification in an early neurological rehabilitation population (phases B and C) with respect to epidemiology and morphology on conventional radiographs. Over a 4-year period, 1,463 patients treated at a clinic for early neurological rehabilitation were evaluated for clinical symptoms of neurogenic heterotopic ossification. In case of clinical suspicion, plain radiographs of the expected sites were obtained. If heterotopic ossification was detected, the initial and subsequent radiographs were retrospectively analyzed for sites, size, and morphology. Immature lesions were categorized as small (< 10 mm) or large (10-100 mm). The prevalence rate of neurogenic heterotopic ossification was 2.05%. The condition was most common in young male adults. The hip was the most common site accounting for more than half of the cases. Two or more ossifications were seen in 56.7% of the affected patients with approximately two-thirds showing bilateral symmetric involvement of corresponding joint regions. The size of ossifications strongly varied interindividually. Small immature lesions demonstrated less progression in size than large lesions during maturation (P < 0.05). Standard radiographs, as a fast and inexpensive technique, allow the expected size progression of heterotopic ossifications during maturation to be estimated, which is relevant in terms of therapeutic decisions, patient mobilization, and neurological rehabilitation.	[Seipel, R.; Langner, S.; Lippa, M.; Kuehn, J. P.; Hosten, N.] Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, D-17487 Greifswald, Germany; [Platz, T.] Inst Ernst Moritz Arndt Univ, BDH Klin Greifswald GmbH, Neurol Rehabil Zentrum, D-17491 Greifswald, Germany; [Platz, T.] Inst Ernst Moritz Arndt Univ, Querschnittgelahmtenzentrum, D-17491 Greifswald, Germany		Langner, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, Ferdinand Sauerbruch Str, D-17487 Greifswald, Germany.	Soenke.langner@uni-greifswald.de	Langner, Soenke/ABB-6744-2021	Langner, Soenke/0000-0001-7241-1173; Platz, Thomas/0000-0003-2629-9744			AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Banovac K, 1997, SPINAL CORD, V35, P158, DOI 10.1038/sj.sc.3100380; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286, DOI 10.1302/0301-620X.43B2.286; DESMET AA, 1992, SKELETAL RADIOL, V21, P503, DOI 10.1007/BF00195231; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GOLDBERG MA, 1977, ARCH INTERN MED, V137, P619, DOI 10.1001/archinte.137.5.619; Guo JJ, 2009, CHINESE MED J-PEKING, V122, P219, DOI 10.3760/cma.j.issn.0366-6999.2009.02.020; KRAMER FL, 1979, SKELETAL RADIOL, V4, P19, DOI 10.1007/BF00350588; KRANSDORF MJ, 1991, AM J ROENTGENOL, V157, P1243, DOI 10.2214/ajr.157.6.1950874; MCATEER EJ, 1990, BRIT J RADIOL, V63, P809, DOI 10.1259/0007-1285-63-754-809; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; ORZEL JA, 1985, J NUCL MED, V26, P125; Popken F, 2003, UNFALLCHIRURG, V106, P28, DOI 10.1007/s00113-002-0461-0; RAGONE DJ, 1986, ARCH PHYS MED REHAB, V67, P339; Richards PJ, 2008, DISABIL REHABIL, V30, P1651, DOI 10.1080/09638280701785866; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SHIRKHODA A, 1995, JMRI-J MAGN RESON IM, V5, P287, DOI 10.1002/jmri.1880050312; Taly AB, 2001, NEUROL INDIA, V49, P37; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955	23	16	20	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2348	1432-2161		SKELETAL RADIOL	Skeletal Radiol.	JAN	2012	41	1					61	66		10.1007/s00256-011-1115-5			6	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	855DK	WOS:000297543700007	21331512				2022-02-06	
J	Staniloiu, A; Markowitsch, HJ				Staniloiu, Angelica; Markowitsch, Hans J.			Towards solving the riddle of forgetting in functional amnesia: recent advances and current opinions	FRONTIERS IN PSYCHOLOGY			English	Article						dissociative amnesia; psychogenic amnesia; head injury; psychosocial stress; mnestic block syndrome	TRAUMATIC BRAIN-INJURY; PERSISTENT ANTEROGRADE AMNESIA; POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; RETROGRADE-AMNESIA; AUTOBIOGRAPHICAL MEMORY; DISSOCIATIVE DISORDERS; PSYCHOGENIC AMNESIA; AUTONOETIC CONSCIOUSNESS; ALZHEIMERS-DISEASE	Remembering the past is a core feature of human beings, enabling them to maintain a sense of wholeness and identity and preparing them for the demands of the future. Forgetting operates in a dynamic neural connection with remembering, allowing the elimination of unnecessary or irrelevant information overload and decreasing interference. Stress and traumatic experiences could affect this connection, resulting in memory disturbances, such as functional amnesia. An overview of clinical, epidemiological, neuropsychological, and neurobiological aspects of functional amnesia is presented, by preponderantly resorting to own data from patients with functional amnesia. Patients were investigated medically, neuropsychologically, and neuroradiologically. A detailed report of a new case is included to illustrate the challenges posed by making an accurate differential diagnosis of functional amnesia, a condition that may encroach on the boundaries between psychiatry and neurology. Several mechanisms may play a role in "forgetting" in functional amnesia, such as retrieval impairments, consolidating defects, motivated forgetting, deficits in binding and reassembling details of the past, deficits in establishing a first person autonoetic connection with personal events, and loss of information. In a substantial number of patients, we observed a synchronization abnormality between a frontal lobe system, important for autonoetic consciousness, and a temporo-amygdalar system, important for evaluation and emotions, which provides empirical support for an underlying mechanism of dissociation (a failure of integration between cognition and emotion). This observation suggests a mnestic blockade in functional amnesia that is triggered by psychological or environmental stress and is underpinned by a stress hormone mediated synchronization abnormality during retrieval between processing of affect-laden events and fact-processing.	[Staniloiu, Angelica; Markowitsch, Hans J.] Univ Bielefeld, D-33501 Bielefeld, Germany; [Markowitsch, Hans J.] Univ Bielefeld, Ctr Excellence Cognit Interact Technol, D-33501 Bielefeld, Germany; [Markowitsch, Hans J.] Hanse Inst Adv Study, Delmenhorst, Germany		Staniloiu, A (corresponding author), Univ Bielefeld, POB 100131, D-33501 Bielefeld, Germany.	astaniloiu@uni-bielefeld.de					Abe N, 2007, NEUROPSYCHOLOGIA, V45, P2902, DOI 10.1016/j.neuropsychologia.2007.06.003; Abeles M, 1935, ARCH NEURO PSYCHIATR, V34, P587, DOI 10.1001/archneurpsyc.1935.02250210108008; Aben B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00301; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Admon R., 2012, CEREB CORTEX, DOI [10.1093/cer-cor/bhr369, DOI 10.1093/CER-COR/BHR369]; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson AK, 2006, P NATL ACAD SCI USA, V103, P1599, DOI 10.1073/pnas.0506308103; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2011, PSYCHOL AGING, V26, P397, DOI 10.1037/a0022505; [Anonymous], 1992, CLASS MENT BEH DIS C; Arzy S, 2011, EUR J NEUROL, V18, P1422, DOI 10.1111/j.1468-1331.2011.03423.x; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; Barnabe A, 2012, HIPPOCAMPUS, V22, P1809, DOI 10.1002/hipo.22015; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bass C, 2007, J ROY SOC MED, V100, P81, DOI 10.1258/jrsm.100.2.81; Beck AT, 1995, BECK DEPRESSIONS INV; Becker-Blease KA, 2004, J CHILD PSYCHOL PSYC, V45, P522, DOI 10.1111/j.1469-7610.2004.00242.x; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bell V, 2011, J NEUROL NEUROSUR PS, V82, P332, DOI 10.1136/jnnp.2009.199158; Black DN, 2004, J NEUROPSYCH CLIN N, V16, P245, DOI 10.1176/appi.neuropsych.16.3.245; Bogousslavsky J, 2011, FRONT NEUROL NEUROSC, V29, P1; Boone K.B., 2007, ASSESSMENT FEIGNED C; Borsutzky S, 2008, NEUROPSYCHOLOGIA, V46, P3133, DOI 10.1016/j.neuropsychologia.2008.07.005; Borsutzky S, 2010, NEUROPSYCHOLOGIA, V48, P2811, DOI 10.1016/j.neuropsychologia.2010.05.023; Bowers D., 1991, FLORIDA AFFECT BATTE; Brand M, 2006, ORBITOFRONTAL CORTEX, P285, DOI DOI 10.1093/ACPR0F:0S0/9780198565741.003.0011; Brand M, 2009, PSYCHIAT RES-NEUROIM, V174, P32, DOI 10.1016/j.pscychresns.2009.03.008; Brandt J, 2006, SEMIN NEUROL, V26, P331, DOI 10.1055/s-2006-945519; Briquet P., 1859, ANTHOLOGY FRENCH LAN, P131; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Burnham WH, 1903, AM J PSYCHOL, V14, P382; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Calabrese P, 2001, FORTSCHR NEUROL PSYC, V69, P42, DOI 10.1055/s-2001-10467; Calabrese P., 2000, DEMTECT; Carter RB, 1853, PATHOLOGY TREATMENT; Casey EdwardS., 2000, REMEMBERING PHENOMEN; Charney E, 2012, BEHAV BRAIN IN PRESS; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Coons PM, 1992, DISSOCIATION, V5, P73; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Croft KE, 2010, NEUROPSYCHOLOGIA, V48, P1789, DOI 10.1016/j.neuropsychologia.2010.03.001; Dahl G, 1972, WIP REDUZIERTER WECH; Dalenberg CJ, 2012, PSYCHOL BULL, V138, P550, DOI 10.1037/a0027447; Dalfen AK, 2000, BRAIN INJURY, V14, P1101; Davis N, 2008, MEMORY, V16, P465, DOI 10.1080/09658210802077082; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; Dorahy M, 2007, TRAUMATIC DISSOCIATI, P3; Draijer N, 1999, AM J PSYCHIAT, V156, P379; Duff MC, 2008, APHASIOLOGY, V22, P866, DOI 10.1080/02687030701844196; During EH, 2011, CAN J PSYCHIAT, V56, P235, DOI 10.1177/070674371105600407; Dwyer J, 2004, LANCET, V364, P471, DOI 10.1016/S0140-6736(04)16772-X; Eco U., 1999, CONVERSATIONS END TI; Eich E, 2009, NEUROPSYCHOLOGIA, V47, P2239, DOI 10.1016/j.neuropsychologia.2009.02.019; Enzi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008429; Erdelyi MH, 2006, BEHAV BRAIN SCI, V29, P499, DOI 10.1017/S0140525X06009113; Eustache F, 2008, NEUROPSYCHOL REV, V18, P53, DOI 10.1007/s11065-008-9052-3; Fast K, 2001, Neurocase, V7, P269, DOI 10.1076/neur.7.4.269.16252; Fast K., 2012, ERWEITERTES AUTOBIOG; Fink GR, 1996, J NEUROSCI, V16, P4275; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Fujii Y, 1998, PSYCHIAT CLIN NEUROS, V52, P299, DOI 10.1046/j.1440-1819.1998.00394.x; Fujiwara E., 2004, THESIS U BIELEFELD B; Fujiwara E., 2006, BINDING HUMAN MEMORY, P379; Fujiwara E, 2003, TRAUMA PSYCHISCHE ER, P19; Fujiwara E, 2008, CORTEX, V44, P29, DOI 10.1016/j.cortex.2005.09.001; Fulton D, 2006, J NEUROSCI, V26, P10935, DOI 10.1523/JNEUROSCI.3694-06.2006; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Ganser S. J., 1904, ARCH PSYCHIAT NERVEN, V38, P34; Ganser SJ, 1898, ARCH PSYCHIATRIE NER, V30:, P633, DOI 10.1007/BF02036039; Glisky EL, 2004, NEUROPSYCHOLOGIA, V42, P1132, DOI 10.1016/j.neuropsychologia.2003.08.016; Goldsmith RE, 2009, J TRAUMA DISSOCIATIO, V10, P237, DOI 10.1080/15299730902956572; Hacking Ian, 1995, REWRITING SOUL MULTI; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Harpaz-Rotem I, 2005, MEMORY, V13, P51, DOI 10.1080/09658210344000567; Harting C., 2000, WECHSLER MEMORY SCAL; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Hinton DE, 2008, TRANSCULT PSYCHIATRY, V45, P142, DOI 10.1177/1363461508089763; HOFF H, 1938, DTSCH Z NERVENHEILK, V145, P150; HUPPERT FA, 1979, CORTEX, V15, P385, DOI 10.1016/S0010-9452(79)80065-9; James W, 1984, PSYCHOL BRIEFER COUR; Janet P, 2001, HIST PSYCHIATR, V12, P481, DOI 10.1177/0957154X0101204806; JANET P, 2007, MAJOR SYMPTOMS HYSTE; Janet Pierre, 1892, ARCH NEUROLOGIE, V24, P29; Jenkins KG, 2009, CURR OPIN NEUROL, V22, P601, DOI 10.1097/WCO.0b013e32833299bb; Johnson JG, 2006, J PSYCHIAT RES, V40, P131, DOI 10.1016/j.jpsychires.2005.03.003; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kanaan RA, 2012, J NEUROL NEUROSUR PS, V83, P248, DOI 10.1136/jnnp-2011-300992; Kanzer M, 1939, AM J PSYCHIAT, V96, P711, DOI 10.1176/ajp.96.3.711; Kessler J, 1997, J CLIN EXP NEUROPSYC, V19, P604, DOI 10.1080/01688639708403746; KIERSCH TA, 1962, AM J PSYCHIAT, V119, P57, DOI 10.1176/ajp.119.1.57; KOPELMAN MD, 1994, NEUROPSYCHOLOGIA, V32, P675, DOI 10.1016/0028-3932(94)90028-0; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Krahn LE, 2008, PSYCHOSOMATICS, V49, P277, DOI 10.1176/appi.psy.49.4.277; Kritchevsky M, 2004, LEARN MEMORY, V11, P213, DOI 10.1101/lm.71404; Kumar S, 2007, PSYCHIAT CLIN NEUROS, V61, P583, DOI 10.1111/j.1440-1819.2007.01735.x; Kundera, 1985, UNBEARABLE LIGHTNESS; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Ladowsky-Brooks RL, 2003, J CLIN EXP NEUROPSYC, V25, P761, DOI 10.1076/jcen.25.6.761.16473; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Lennox WG, 1943, AM J PSYCHIAT, V99, P732, DOI 10.1176/ajp.99.5.732; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Levine B, 2009, NEUROPSYCHOLOGIA, V47, P2188, DOI 10.1016/j.neuropsychologia.2008.12.026; Lewis A., 1963, MED AFFECTIONS MIND; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Linden SC, 2012, EUR ARCH PSY CLIN N, V262, P253, DOI 10.1007/s00406-011-0272-9; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Loewenstein R, 1991, ANN REV PSYCHIAT, P189; Lundholm H, 1931, J ABNORM SOC PSYCH, V26, P355; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Luria A. R., 1987, MIND MNEMONIST LITTL; Lynn SJ, 2012, CURR DIR PSYCHOL SCI, V21, P48, DOI 10.1177/0963721411429457; Magnin E, 2012, NEUROCASE; Maldonado J.R., 2008, AM PSYCHIAT PUBLISHI, V5th ed., P665; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch HJ, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 2: H-O, P131; Markowitsch H. J., 2003, BEHAV NEUROLOGY NEUR, P431; Markowitsch H.J., 1992, INTELLECTUAL FUNCTIO; Markowitsch H. J., 2012, CORTEX; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Markowitsch HJ, 2011, CONSCIOUS COGN, V20, P16, DOI 10.1016/j.concog.2010.09.005; Markowitsch Hans J, 2008, Handb Clin Neurol, V88, P155, DOI 10.1016/S0072-9752(07)88007-9; Markowitsch Hans J., 1995, P765; MARKOWITSCH HJ, 1985, INT J NEUROSCI, V27, P191, DOI 10.3109/00207458509149767; Markowitsch HJ, 2000, NEUROPSY NEUROPSY BE, V13, P60; Markowitsch HJ, 1999, NEUROCASE, V5, P189, DOI 10.1093/neucas/5.3.189; MARKOWITSCH HJ, 1988, BRAIN RES REV, V13, P351, DOI 10.1016/0165-0173(88)90012-4; Markowitsch HJ, 2003, NEUROIMAGE, V20, pS132, DOI 10.1016/j.neuroimage.2003.09.010; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; Markowitsch HJ, 1996, NEUROCASE, V2, P357; MARKOWITSCH HJ, 1994, NEUROREPORT, V5, P1349, DOI 10.1097/00001756-199406270-00013; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; Markowitsch HJ, 2000, BEHAV NEUROL, V12, P181, DOI 10.1155/2000/303651; Markowitsch HJ, 1999, MEMORY, V7, P561, DOI 10.1080/096582199387751; Markowitsch HJ, 1999, CURR OPIN PSYCHIATR, V12, P331, DOI 10.1097/00001504-199905000-00014; MARKOWITSCH HJ, 2005, ENDOPHYSICS TIME QUA, P131; Marsh R, 2009, ARCH GEN PSYCHIAT, V66, P51, DOI 10.1001/archgenpsychiatry.2008.504; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McKay G. C. M., 2009, ADV PSYCHIAT TREAT, V15, P152, DOI [10.1192/apt.bp.105.001586, DOI 10.1192/APT.BP.105.001586]; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Metcalfe J., 2005, MISSING LINK COGNITI, P4, DOI DOI 10.1093/ACPROF:OSO/9780195161564.003.0001; Metzinger T, 2008, PROG BRAIN RES, V168, P215, DOI 10.1016/S0079-6123(07)68018-2; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miller P, 1997, J AM ACAD CHILD PSY, V36, P112, DOI 10.1097/00004583-199701000-00024; Mishkin M., 1984, NEUROPSYCHOL MEM, V1984, P287; Mitchell Stephen A., 1995, FREUD HIST MODERN PS; Nadel L, 2012, NEUROSCI BIOBEHAV R, V36, P1640, DOI 10.1016/j.neubiorev.2012.03.001; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; NARDI TJ, 1977, AM J PSYCHIAT, V134, P453; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Newcombe V., 2012, BRAIN INJURY, V26, P323; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22356, DOI 10.1073/pnas.1016823108; Ortega A, 2012, ARCH CLIN NEUROPSYCH, V27, P453, DOI 10.1093/arclin/acs038; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Parker ES, 2006, NEUROCASE, V12, P35, DOI 10.1080/13554790500473680; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Peigneux P, 2010, CURR ISS MEM, P165; Picard L, 2009, CONSCIOUS COGN, V18, P864, DOI 10.1016/j.concog.2009.07.008; Piolino P, 2007, CONSCIOUS COGN, V16, P84, DOI 10.1016/j.concog.2005.09.010; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Pommerenke K, 2012, NEUROL REHAB, V18, P106; Pope HG, 2007, PSYCHOL MED, V37, P225, DOI 10.1017/S0033291706009500; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Post RM, 1995, ANN NY ACAD SCI, V771, P677, DOI 10.1111/j.1749-6632.1995.tb44720.x; Putnam F.W., 1997, DISSOCIATION CHILDRE; Reinhold N, 2006, CURR MED IMAGING, V2, P35, DOI 10.2174/157340506775541668; Reinhold N, 2007, J NEUROPSYCHOL, V1, P53, DOI 10.1348/174866407X180819; Reinhold N, 2009, NEUROPSYCHOLOGIA, V47, P2197, DOI 10.1016/j.neuropsychologia.2009.01.037; Ribot T., 1882, DIS MEMORY; Rinne T., 2007, TRAUMATIC DISSOCIATI, P139; Rosenbaum RS, 2009, NEUROPSYCHOLOGIA, V47, P2181, DOI 10.1016/j.neuropsychologia.2008.11.028; SCHACTER DL, 1982, NEUROPSYCHOLOGIA, V20, P523, DOI 10.1016/0028-3932(82)90026-4; Schmidtke K, 1999, Z NEUROPSYCHOL, V10, P13, DOI [DOI 10.1024/1016-264X.10.1.13, DOI 10.1024//1016-264X.10.1.13]; Schneider K, 1912, Z GESAMTE NEUROL PSY, V8, P553, DOI 10.1007/BF02866053; Schneider K., 1928, HDB GEISTESKRANKHEIT, V1, P508; Schore AN, 2002, AUST NZ J PSYCHIAT, V36, P9, DOI 10.1046/j.1440-1614.2002.00996.x; Schultz IH, 1924, Z GESAMTE NEUROL PSY, V89, P107, DOI 10.1007/BF02885806; Sehm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026538; Seligman R, 2008, CULT MED PSYCHIAT, V32, P31, DOI 10.1007/s11013-007-9077-8; Semon R., 1904, MNEME ALS ERHALTENDE; Serra L, 2007, BEHAV NEUROL, V18, P53, DOI 10.1155/2007/193140; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; Simeon D, 2007, BIOL PSYCHIAT, V61, P966, DOI 10.1016/j.biopsych.2006.07.030; SLATER ETO, 1965, J PSYCHOSOM RES, V9, P9, DOI 10.1016/0022-3999(65)90004-8; Smith CN, 2010, NEUROPSYCHOLOGIA, V39, P2823; Sollier P., 1892, GENESE NATURE HYSTER; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Souques A., 1892, REV MED, V13, P367; SPIEGEL D, 1991, J ABNORM PSYCHOL, V100, P366, DOI 10.1037/0021-843X.100.3.366; Spiegel D, 2011, DEPRESS ANXIETY, V28, P824, DOI 10.1002/da.20874; Squire LR, 2009, NEURON, V61, P6, DOI 10.1016/j.neuron.2008.12.023; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Staniloiu A, 2010, J GEN MED, V22, P41; Staniloiu A., 2010, ASCS09, P316; STANILOIU A, 2010, J PSYCHOL, V218, P96, DOI DOI 10.1027/0044-3409/A000017; Staniloiu A, 2010, CONSCIOUS COGN, V19, P778, DOI 10.1016/j.concog.2010.06.024; Staniloiu Angelica, 2009, Cogn Neuropsychiatry, V14, P180, DOI 10.1080/13546800902931036; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stickgold R, 2005, TRENDS NEUROSCI, V28, P408, DOI 10.1016/j.tins.2005.06.004; Stone J, 2006, BRIT J PSYCHIAT, V188, P204, DOI 10.1192/bjp.188.3.204; Stone J., 2009, NEUROL NEUROSURG PSY, V9, P179; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; SULLIVAN HS, 1972, PERSONAL PSYCHOPATHO; Takahashi Y., 1991, DISSOCIATION, V3, P57; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Thom DA, 1920, AM J INSANITY, V76, P437, DOI 10.1176/ajp.76.4.437; Thomas-Anterion C, 2010, J NEUROL NEUROSUR PS, V81, P468, DOI 10.1136/jnnp.2008.163808; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tramoni E, 2009, NEUROPSYCHOLOGIA, V47, P611, DOI 10.1016/j.neuropsychologia.2008.11.012; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Tulving E., 1972, ORG MEMORY, P381; Tulving E., 1983, ELEMENTS EPISODIC ME; Tulving Endel, 1995, P839; van Huijzen, 2008, HUMAN CENTRAL NERVOU; VANDERKOLK BA, 1989, AM J PSYCHIAT, V146, P1530; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Venugopal S., 2012, BRAIN INJURY, V26, P474; Vits S, 2011, PHILOS T R SOC B, V366, P1799, DOI 10.1098/rstb.2010.0392; von Cramon D. Yves, 2000, P380; VONCRAMON DY, 1993, NEUROPSYCHOLOGIA, V31, P1159, DOI 10.1016/0028-3932(93)90065-8; Vrij A., 2000, DETECTING LIES DECEI; Wang Q, 2001, J PERS SOC PSYCHOL, V81, P220, DOI 10.1037//0022-3514.81.2.220; Wang Q, 2008, COGNITION, V108, P117, DOI 10.1016/j.cognition.2008.02.002; WEINRICH H, 1997, LETHE KUNST KRITIK V; Welzer H, 2005, MEMORY, V13, P63, DOI 10.1080/09658210344000576; Willoughby KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00053; WILSON FAW, 1990, EXP BRAIN RES, V80, P104; WILSON G, 1950, AM J PSYCHIAT, V106, P481, DOI 10.1176/ajp.106.7.481; Wilson RS, 2007, J NEUROL NEUROSUR PS, V78, P30, DOI 10.1136/jnnp.2006.099721; Wood H, 2003, NAT REV NEUROSCI, V4, P774; Xiao ZP, 2006, AM J PSYCHIAT, V163, P1388, DOI 10.1176/appi.ajp.163.8.1388; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Ziehen T., 1908, GEDACHTNIS	248	16	16	0	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.		2012	3								403	10.3389/fpsyg.2012.00403			23	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	V31DJ	WOS:000208864000119	23125838	Green Published, gold			2022-02-06	
J	Walker, CT; Stone, JJ; Jacobson, M; Phillips, V; Silberstein, HJ				Walker, Corey T.; Stone, Jonathan J.; Jacobson, Max; Phillips, Valerie; Silberstein, Howard J.			Indications for Pediatric External Ventricular Drain Placement and Risk Factors for Conversion to a Ventriculoperitoneal Shunt	PEDIATRIC NEUROSURGERY			English	Article						Cerebrospinal fluid diversion; External ventricular drain; Hydrocephalus; Intracranial pressure; Trauma; Ventriculoperitoneal shunt; Ventriculostomy	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CLINICAL ARTICLE; UNITED-STATES; BRAIN-TUMORS; HYDROCEPHALUS; CHILDREN	Background/Aims: The external ventricular drain (EVD) is commonly used for the treatment of hydrocephalus and intracranial pressure (ICP) monitoring. In this study, we retrospectively reviewed indications for EVD placement over the last 20 years in pediatric patients at our institution. Additionally, we evaluated the rate that an EVD needed to be converted to a ventriculoperitoneal shunt (VPS) and ascertained how hydrocephalus etiology impacted long-term drainage requirements. Methods: Patients that received an EVD between 1990 and 2010 at our institution were identified using billing codes. Demographics, etiology of hydrocephalus, length of stay (LOS) and EVD duration were recorded. Only patients receiving their first EVD were included; those with any prior ventricular catheter (including prior shunts) were excluded from this study. Results: A total of 180 patients underwent first-time placement of an EVD over the 20-year period. Of these, 78.9% were placed on the right side and 81.7% were performed through a frontal burr hole site. The average age of all patients at their initial procedure was 9.3 years (median 9.8; range 0-18), hospital LOS was 22.5 days (median 16; range 1-174) and EVD duration was 7.8 days (median 7; range 1-37). Trauma (43.3%) and neoplasms (32.2%) were the most common indications. Approximately, one quarter of the patients were unable to become EVD independent and, therefore, required a VPS. Only patients receiving an EVD for traumatic brain injury were significantly less likely to be converted to a shunt than other causes of hydrocephalus (relative risk, RR = 0.18, 95% confidence interval, CI = 0.07-0.46). Conversely, patients with neoplasms (RR = 3.56, 95% CI = 1.74-7.31), obstructive hydrocephalus (RR = 5.48, 95% CI = 1.37-22.0) and intraventricular hemorrhage (RR = 9.86, 95% CI = 1.05-92.3) were more likely to need a shunt. Conclusion: Traumatic brain injuries and neoplasms represent the most common indications for EVD placement in the pediatric population. While patients with neoplasm were much more likely to need conversion to a VPS for long-term cerebrospinal fluid diversion, the majority of EVDs in patients with head injuries were successfully weaned. Copyright (C) 2013 S. Karger AG, Basel	[Walker, Corey T.; Stone, Jonathan J.; Jacobson, Max; Phillips, Valerie; Silberstein, Howard J.] Univ Rochester, Med Ctr, Dept Neurol Surg, Rochester, NY 14642 USA		Stone, JJ (corresponding author), Univ Rochester, Sch Med & Dent, 601 Elmwood Ave,Box 670, Rochester, NY 14642 USA.	jonathan_stone@urmc.rochester.edu			Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship	C.T.W. received support for this study from the Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship.	Brandner S, 2012, Acta Neurochir Suppl, V114, P217, DOI 10.1007/978-3-7091-0956-4_42; Chan M, 2009, J NEUROSURG, V110, P44, DOI 10.3171/2008.5.17560; FRIEDMAN WA, 1980, J NEUROSURG, V53, P662, DOI 10.3171/jns.1980.53.5.0662; Kang DH, 2010, NEUROSURGERY, V66, P904, DOI 10.1227/01.NEU.0000368385.74625.96; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Klopfenstein JD, 2004, J NEUROSURG, V100, P225, DOI 10.3171/jns.2004.100.2.0225; KUSSKE JA, 1973, J NEUROSURG, V38, P591, DOI 10.3171/jns.1973.38.5.0591; Mayer SA, 2005, LANCET NEUROL, V4, P662, DOI 10.1016/S1474-4422(05)70195-2; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Notarianni C, 2009, J NEUROSURG-PEDIATR, V4, P547, DOI 10.3171/2009.7.PEDS08371; Rammos S, 2008, J NEUROSURG, V109, P1001, DOI 10.3171/JNS.2008.109.12.1001; Reddy GK, 2012, NEUROSURGERY, V70, P380, DOI 10.1227/NEU.0b013e318231d551; Sekula RF, 2008, BRIT J NEUROSURG, V22, P213, DOI 10.1080/02688690701832084; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Stone JJ, 2013, J NEUROSURG-PEDIATR, V11, P15, DOI 10.3171/2012.9.PEDS1298; Tuli S, 2000, J NEUROSURG, V92, P31, DOI 10.3171/jns.2000.92.1.0031; Wong TT, 2011, CHILD NERV SYST, V27, P1723, DOI 10.1007/s00381-011-1523-9	17	16	16	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		2012	48	6					342	347		10.1159/000353608			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	220PR	WOS:000324597900002	23941907				2022-02-06	
J	Zlotnik, A; Klin, Y; Gruenbaum, BF; Gruenbaum, SE; Ohayon, S; Leibowitz, A; Kotz, R; Dubilet, M; Boyko, M; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Klin, Yael; Gruenbaum, Benjamin Fredrick; Gruenbaum, Shaun Evan; Ohayon, Sharon; Leibowitz, Akiva; Kotz, Ruslan; Dubilet, Michael; Boyko, Matthew; Shapira, Yoram; Teichberg, Vivian I.			beta 2 Adrenergic-mediated Reduction of Blood Glutamate Levels and Improved Neurological Outcome After Traumatic Brain Injury in Rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						beta 2 adrenergic receptors; glutamate; recovery; traumatic brain injury	TRANSIENT FOREBRAIN ISCHEMIA; EXCITATORY AMINO-ACIDS; CLOSED-HEAD-INJURY; CEREBROSPINAL-FLUID; CEREBRAL-ISCHEMIA; PROVIDES NEUROPROTECTION; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; INFARCT SIZE; IN-VITRO	Background: Isoflurane-anesthetized rats subjected to traumatic brain injury (TBI) show a transient reduction in blood L-glutamate levels. Having previously observed that isoproterenol produces a sustained decrease in blood glutamate levels in naive rats, we investigated the possible effects of nonselective and selective beta 1 and beta 2 adrenergic agonists and antagonists both on blood glutamate levels and on the neurological outcomes of rats subjected to TBI. Methods: Rats received either 10mL/kg of isotonic saline 1 hour after TBI, 50 mu g/kg of isoproterenol pretreatment 30 minutes before TBI, 10mg/kg of propranolol pretreatment 60 minutes before TBI, 10mg/kg of metoprolol pretreatment 60 minutes before TBI, or 10mg/kg of butaxamine pretreatment 40 minutes before TBI and 10 minutes before pretreatment with 50 mu g/kg isoproterenol or 10 mg/kg of propranolol 60 minutes after TBI. A neurological severity score (NSS) was measured at 1, 24, and 48 hours after TBI. Blood glutamate, blood glucose, mean arterial blood pressure, and heart rate were measured at the time of drug injection, at the time of TBI, 60 minutes after TBI, and 90 minutes after TBI. Results: Blood glutamate levels decreased spontaneously by 60 minutes after TBI in the control group (P< 0.05), reverting to baseline levels by 90 minutes after TBI. A pretreatment with either 10mg/kg of metoprolol 60 minutes before TBI or with 50 mu g/kg of isoproterenol 30 minutes before TBI also reduced blood glutamate levels (P< 0.05) both at 90 minutes after TBI and improved the NSS measured 24 and 48 hours after TBI in comparison with the control saline-treated group. However, a 10-mg/kg butoxamine pretreatment 40 minutes before TBI and 10 minutes before pretreatment with 50 mu g/kg of isoproterenol or 10mg/kg of propranolol 60 minutes before TBI neither affected blood glutamate levels across time after TBI nor caused any significant change in the NSS measured 24 and 48 hours after TBI in comparison with the control saline-treated group. A strong correlation (r(2) = 0.73) was demonstrated between the percent decrease in blood glutamate levels at 90 minutes after TBI and the percent improvement of NSS measured 24 hours after TBI. Conclusions: The results suggest that the transient blood glutamate reduction seen after TBI is the result of a stress response and of the activation of the sympathetic nervous system through the beta 2 adrenergic receptors, causing an increase of the brain-to-blood efflux of glutamate observed with excess brain glutamate levels after a brain insult. This strongly correlates with the neurological improvement observed 24 hours after TBI.	[Zlotnik, Alexander] Soroka Med Ctr, Dept Anesthesiol & Crit Care, Div Anesthesiol, IL-84105 Beer Sheva, Israel; [Zlotnik, Alexander; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Leibowitz, Akiva; Kotz, Ruslan; Dubilet, Michael; Boyko, Matthew; Shapira, Yoram] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Gruenbaum, Shaun Evan] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA		Zlotnik, A (corresponding author), Soroka Med Ctr, Dept Anesthesiol & Crit Care, Div Anesthesiol, POB 151, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	Leibowitz, Akiva/F-1397-2012	Leibowitz, Akiva/0000-0003-4244-1915; Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd; Irwin Green Fund for Studying the Development of the Brain; Carl and Micaela Einhorn-Dominic Institute for Brain Research	The authors gratefully acknowledge the help of Valeria Frishman, lab assistant at the Department of Clinical Biochemistry, Soroka Medical Center, Ben-Gurion University of the Negev, for her outstanding help with the biochemical analysis. This work was supported in part by grants to VIT from the Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd, the Irwin Green Fund for Studying the Development of the Brain, the Carl and Micaela Einhorn-Dominic Institute for Brain Research. The data obtained are part of A.Z's PhD thesis. VIT is the incumbent of the Louis and Florence Katz-Cohen Chair of Neuropharmacology.	Berger C, 2008, EXP NEUROL, V210, P543, DOI 10.1016/j.expneurol.2007.12.002; Brown DR, 2004, ANESTH ANALG, V99, P1427, DOI 10.1213/01.ANE.0000135638.60722.E3; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Culmsee C, 1999, NEUROCHEM INT, V35, P47, DOI 10.1016/S0197-0186(99)00032-7; Culmsee C, 2007, EUR J PHARMACOL, V575, P57, DOI 10.1016/j.ejphar.2007.07.066; Culmsee C, 2009, ANESTH ANALG, V108, P3, DOI 10.1213/ane.0b013e31818db6f6; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Goyagi T, 2006, ANESTH ANALG, V103, P658, DOI 10.1213/01.ane.0000228859.95126.69; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Iwata M, 2010, ANESTH ANALG, V110, P1126, DOI 10.1213/ANE.0b013e3181d278f7; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Junker V, 2002, EUR J PHARMACOL, V446, P25, DOI 10.1016/S0014-2999(02)01814-9; KEENAN D, 1995, CIRC RES, V77, P973, DOI 10.1161/01.RES.77.5.973; Koura SS, 1998, ACT NEUR S, V71, P244; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Martin SW, 1999, CAN J PHYSIOL PHARM, V77, P156, DOI 10.1139/cjpp-77-3-156; MOTOMURA S, 1990, AM HEART J, V119, P608, DOI 10.1016/S0002-8703(05)80284-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneider AM, 2000, BEHAV NEUROSCI, V114, P1256; Semkova I, 1996, BRAIN RES, V717, P44, DOI 10.1016/0006-8993(95)01567-1; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sharma AB, 2008, RESUSCITATION, V76, P108, DOI 10.1016/j.resuscitation.2007.04.028; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stoffel M, 2002, J NEUROTRAUM, V19, P467, DOI 10.1089/08977150252932415; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zhu Y, 1998, J CEREBR BLOOD F MET, V18, P1032, DOI 10.1097/00004647-199809000-00013; Zhu Y, 2001, NEUROSCIENCE, V107, P593, DOI 10.1016/S0306-4522(01)00357-8; Zhu Y, 1999, NEUROSCIENCE, V90, P1255, DOI 10.1016/S0306-4522(98)00564-8; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2011, NEUROCHEM RES, V36, P732, DOI 10.1007/s11064-010-0388-8; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	52	16	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2012	24	1					30	38		10.1097/ANA.0b013e318232deaa			9	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	863EB	WOS:000298144500007	21979171				2022-02-06	
J	Sharma, R; Vannabouathong, C; Bains, S; Marshall, A; MacDonald, SJ; Parvizi, J; Bhandari, M				Sharma, Rajrishi; Vannabouathong, Christopher; Bains, Simrit; Marshall, Amanda; MacDonald, Steven J.; Parvizi, Javad; Bhandari, Mohit			Meta-Analyses in joint Arthroplasty: A Review of Quantity, Quality, and Impact	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							RANDOMIZED CONTROLLED-TRIALS; TRAUMATIC BRAIN-INJURY; SYSTEMATIC REVIEWS; ORTHOPEDIC-SURGERY; HYPOTHERMIA; ARTICLES; CARE		[Sharma, Rajrishi] McMaster Univ, Dept Surg, Div Orthopaed Surg, Hamilton, ON L8L 2X2, Canada		Sharma, R (corresponding author), McMaster Univ, Dept Surg, Div Orthopaed Surg, 293 Wellington St N,Suite 110, Hamilton, ON L8L 2X2, Canada.	rajrishisharma@gmail.com	MacDonald, Steven J/B-6173-2015	Vannabouathong, Christopher/0000-0002-9694-6364			Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Bereza BG, 2008, ANN PHARMACOTHER, V42, P1402, DOI 10.1345/aph.1L204; Bhandari M, 2004, J BONE JOINT SURG AM, V86A, P1012, DOI 10.2106/00004623-200405000-00019; Bhandari M, 2001, J BONE JOINT SURG AM, V83A, P15, DOI 10.2106/00004623-200101000-00003; Breslow N., 1980, STAT METHODS CANC RE, V1; Celermajer DS, 2001, MED J AUSTRALIA, V174, P293, DOI 10.5694/j.1326-5377.2001.tb143274.x; Christensen E, 2001, J HEPATOL, V34, P342, DOI 10.1016/S0168-8278(00)00002-7; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M; Crowther Mark A, 2007, Hematology Am Soc Hematol Educ Program, P493; Delaney A, 2005, CRIT CARE, V9, pR575, DOI 10.1186/cc3803; Dijkman BG, 2010, J BONE JOINT SURG AM, V92A, P48, DOI 10.2106/JBJS.I.00251; Dixon E, 2005, ANN SURG, V241, P450, DOI 10.1097/01.sla.0000154258.30305.df; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Glass, 1976, ED RES, V5, P3, DOI [10.2307/1174772ISSN0536-1036, 10.3102/0013189x005010003, DOI 10.3102/0013189X005010003]; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, BMJ BRIT MED J, V6, DOI [10.1371/journal.pmed.1000097, DOI 10.1371/JOURNAL.PMED.1000097]; Mulrow CD, 1997, ANN INTERN MED, V126, P389, DOI 10.7326/0003-4819-126-5-199703010-00008; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Oxman AD, 1988, CMAJ, V138, P679; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; Sacks HS, 1996, MT SINAI J MED, V63, P216; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184	32	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	DEC 21	2011	93A	24					2304	2309		10.2106/JBJSJ.01289			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	871WV	WOS:000298769300010	22258777				2022-02-06	
J	Barberan, S; McNair, K; Iqbal, K; Smith, NC; Prendergast, GC; Stone, TW; Cobb, SR; Morris, BJ				Barberan, Sara; McNair, Kara; Iqbal, Khalil; Smith, Nicola C.; Prendergast, George C.; Stone, Trevor W.; Cobb, Stuart R.; Morris, Brian J.			Altered apoptotic responses in neurons lacking RhoB GTPase	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						cortex; hippocampus; mice; neurodegeneration; Rho GTPase; TUNEL	SPINAL-CORD-INJURY; TRANSIENT CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; LONG-TERM DEPRESSION; NF-KAPPA-B; FARNESYLTRANSFERASE INHIBITORS; CORTICAL-NEURONS; CELL-DEATH; CNS INJURY; SYNAPTIC-TRANSMISSION	Caspase 3 activation has been linked to the acute neurotoxic effects of central nervous system damage, as in traumatic brain injury or cerebral ischaemia, and also to the early events leading to long-term neurodegeneration, as in Alzheimers disease. However, the precise mechanisms activating caspase 3 in neuronal injury are unclear. RhoB is a member of the Rho GTPase family that is dramatically induced by cerebral ischaemia or neurotrauma, both in preclinical models and clinically. In the current study, we tested the hypothesis that RhoB might directly modulate caspase 3 activity and apoptotic or necrotic responses in neurons. Over-expression of RhoB in the NG108-15 neuronal cell line or in cultured corticohippocampal neurons elevated caspase 3 activity without inducing overt toxicity. Cultured corticohippocampal neurons from RhoB knockout mice did not show any differences in sensitivity to a necrotic stimulus acute calcium ionophore exposure compared with neurons from wild-type mice. However, corticohippocampal neurons lacking RhoB exhibited a reduction in the degree of DNA fragmentation and caspase 3 activation induced by the apoptotic agent staurosporine, in parallel with increased neuronal survival. Staurosporine induction of caspase 9 activity was also suppressed. RhoB knockout mice showed reduced basal levels of caspase 3 activity in the adult brain. These data directly implicate neuronal RhoB in caspase 3 activation and the initial stages of programmed cell death, and suggest that RhoB may represent an attractive target for therapeutic intervention in conditions involving elevated caspase 3 activity in the central nervous system.	[Barberan, Sara; McNair, Kara; Iqbal, Khalil; Smith, Nicola C.; Stone, Trevor W.; Cobb, Stuart R.; Morris, Brian J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland; [Prendergast, George C.] Lankenau Inst Med Res, Wynnewood, PA USA		Morris, BJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland.	brian.morris@glasgow.ac.uk	Stone, Trevor/M-7904-2015	Stone, Trevor/0000-0002-5532-0031	BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research CouncilUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C001028/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA100123] Funding Source: NIH RePORTER	This work was supported by the BBSRC. We thank Dr H. Mellor (University of Bristol) for the gift of the constitutively active RhoB vector.	Ader I, 2002, ONCOGENE, V21, P5998, DOI 10.1038/sj.onc.1205746; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Andreau K, 2004, J BIOL CHEM, V279, P55937, DOI 10.1074/jbc.M406411200; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Brabeck C, 2003, ARCH NEUROL-CHICAGO, V60, P1245, DOI 10.1001/archneur.60.9.1245; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Caballero-Benitez A, 2003, J NEUROSCI RES, V71, P383, DOI 10.1002/jnr.10493; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Chen J, 1998, J NEUROSCI, V18, P4914; Citron BA, 2008, SPINE, V33, P2269, DOI 10.1097/BRS.0b013e3181831f7e; Clark CJ, 2007, J NEUROCHEM, V102, P1024, DOI 10.1111/j.1471-4159.2007.04601.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Conway AM, 2004, EXP CELL RES, V300, P35, DOI 10.1016/j.yexcr.2004.06.022; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; DeWard AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007102; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Erdo F, 2004, ACTA NEUROPATHOL, V107, P127, DOI 10.1007/s00401-003-0789-8; Focking M, 2004, NEUROSCI LETT, V355, P41, DOI 10.1016/j.neulet.2003.10.022; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harada J, 1999, BRAIN RES, V842, P311, DOI 10.1016/S0006-8993(99)01808-9; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Johansson T, 2007, J STEROID BIOCHEM, V104, P215, DOI 10.1016/j.jsbmb.2007.03.024; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li YD, 2011, J CELL PHYSIOL, V226, P729, DOI 10.1002/jcp.22394; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma SA, 2011, MOL CELL NEUROSCI, V46, P573, DOI 10.1016/j.mcn.2010.12.008; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mannherz HG, 2006, EUR J CELL BIOL, V85, P785, DOI 10.1016/j.ejcb.2006.02.012; Martin LJ, 2009, CEREB CORTEX, V19, P1273, DOI 10.1093/cercor/bhn167; McDermott CJ, 2003, J NEUROCHEM, V86, P383, DOI 10.1046/j.1471-4159.2003.01853.x; McNair K, 2010, J NEUROSCI, V30, P3508, DOI 10.1523/JNEUROSCI.5386-09.2010; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Moore JD, 2002, BRIT J PHARMACOL, V135, P1069, DOI 10.1038/sj.bjp.0704538; MORRIS BJ, 1995, J BIOL CHEM, V270, P24740; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Movsesyan VA, 2002, BIOCHEM BIOPH RES CO, V299, P201, DOI 10.1016/S0006-291X(02)02593-7; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Prendergast GC, 2000, CURR OPIN CELL BIOL, V12, P166, DOI 10.1016/S0955-0674(99)00072-1; Prendergast GC, 2001, HISTOL HISTOPATHOL, V16, P269, DOI 10.14670/HH-16.269; Rakhit S, 2005, MOL PHARMACOL, V67, P1158, DOI 10.1124/mol.104.005447; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Sebti SM, 2000, EXPERT OPIN INV DRUG, V9, P2767, DOI 10.1517/13543784.9.12.2767; Sherstnev V V, 2006, Neurosci Behav Physiol, V36, P915, DOI 10.1007/s11055-006-0107-8; Simpson CS, 2000, J BIOL CHEM, V275, P16879, DOI 10.1074/jbc.275.22.16879; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tomiyoshi G, 2004, GENES CELLS, V9, P591, DOI 10.1111/j.1356-9597.2004.00745.x; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Trapp T, 2001, MOL CELL NEUROSCI, V17, P883, DOI 10.1006/mcne.2001.0971; West T, 2006, NEUROBIOL DIS, V22, P523, DOI 10.1016/j.nbd.2005.12.017; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yoshimori Atsushi, 2007, BMC Pharmacology, V7, P8, DOI 10.1186/1471-2210-7-8; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zeron MM, 2004, MOL CELL NEUROSCI, V25, P469, DOI 10.1016/j.mcn.2003.11.014; Zhan RZ, 2001, J CEREBR BLOOD F MET, V21, P529, DOI 10.1097/00004647-200105000-00007; Zhang YJ, 2007, EUR J NEUROSCI, V25, P1341, DOI 10.1111/j.1460-9568.2007.05404.x	85	16	18	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2011	34	11					1737	1746		10.1111/j.1460-9568.2011.07891.x			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	854AB	WOS:000297465800004	22098422	Green Accepted			2022-02-06	
J	Gilley, JA; Kernie, SG				Gilley, Jennifer A.; Kernie, Steven G.			Excitatory amino acid transporter 2 and excitatory amino acid transporter 1 negatively regulate calcium-dependent proliferation of hippocampal neural progenitor cells and are persistently upregulated after injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						glutamate; hippocampus; Mus musculus; neural stem cells; neuroregeneration	TRAUMATIC BRAIN-INJURY; METABOTROPIC GLUTAMATE RECEPTORS; STEM/PROGENITOR CELLS; DENTATE GYRUS; NEUROGENESIS; MICE; NEUROPROTECTION; EXPRESSION; ISCHEMIA; RAT	Using a transgenic mouse (Mus musculus) in which nestin-expressing progenitors are labeled with enhanced green fluorescent protein, we previously characterized the expression of excitatory amino acid transporter 2 (GltI) and excitatory amino acid transporter 1 (Glast) on early neural progenitors in vivo. To address their functional role in this cell population, we manipulated their expression in P7 neurospheres isolated from the dentate gyrus. We observed that knockdown of GltI or Glast was associated with decreased bromodeoxyuridine incorporation and neurosphere formation. Moreover, we determined that both glutamate transporters regulated progenitor proliferation in a calcium-dependent and metabotropic glutamate receptor-dependent manner. To address the relevance of this in vivo, we utilized models of acquired brain injury, which are known to induce hippocampal neurogenesis. We observed that GltI and Glast were specifically upregulated in progenitors following brain injury, and that this increased expression was maintained for many weeks. Additionally, we found that recurrently injured animals with increased expression of glutamate transporters within the progenitor population were resistant to subsequent injury-induced proliferation. These findings demonstrate that GltI and Glast negatively regulate calcium-dependent proliferation in vitro and that their upregulation after injury is associated with decreased proliferation after brain trauma.	[Gilley, Jennifer A.; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Gilley, Jennifer A.; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA		Kernie, SG (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	sk3516@columbia.edu	Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS048192]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048192] Funding Source: NIH RePORTER	This work was supported by NIH grant R01 NS048192 (S. G. Kernie). The authors have no other financial interest to disclose. The authors would like to thank Gui Zhang, Kyle Lieppman and Darryl Miles for their technical support and assistance with this publication.	ANDINE P, 1991, DEV BRAIN RES, V64, P115, DOI 10.1016/0165-3806(91)90214-4; Bigdeli MR, 2009, J STROKE CEREBROVASC, V18, P336, DOI 10.1016/j.jstrokecerebrovasdis.2008.12.005; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHOI DW, 1988, J NEUROSCI, V8, P185; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Cimarosti H, 2005, NEUROSCI LETT, V385, P52, DOI 10.1016/j.neulet.2005.05.006; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; DIETER P, 1993, BIOL CHEM H-S, V374, P171, DOI 10.1515/bchm3.1993.374.1-6.171; Fonnum F, 2004, J NEUROCHEM, V88, P513, DOI 10.1046/j.1471-4159.2003.02211.x; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Jensen FE, 2002, INT J DEV NEUROSCI, V20, P339, DOI 10.1016/S0736-5748(02)00012-6; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Luk KC, 2003, J NEUROSCI, V23, P2239; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Matsugami TR, 2006, P NATL ACAD SCI USA, V103, P12161, DOI 10.1073/pnas.0509144103; Melchiorri D, 2007, NEUROPHARMACOLOGY, V53, P473, DOI 10.1016/j.neuropharm.2007.05.031; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Miles DK, 2006, PROG BRAIN RES, V157, P187, DOI 10.1016/S0079-6123(06)57012-8; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nacher J, 2007, NEUROSCIENCE, V144, P855, DOI 10.1016/j.neuroscience.2006.10.021; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Shi J, 2007, EUR J NEUROSCI, V25, P3499, DOI 10.1111/j.1460-9568.2007.05624.x; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Suzuki M, 2006, EUR J NEUROSCI, V24, P645, DOI 10.1111/j.1460-9568.2006.04957.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Weller ML, 2008, NEUROSCIENCE, V155, P1204, DOI 10.1016/j.neuroscience.2008.05.059; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	45	16	16	1	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2011	34	11					1712	1723		10.1111/j.1460-9568.2011.07888.x			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	854AB	WOS:000297465800002	22092549	Green Accepted			2022-02-06	
J	Ley, EJ; Singer, MB; Clond, MA; Gangi, A; Mirocha, J; Bukur, M; Brown, CV; Salim, A				Ley, Eric J.; Singer, Matthew B.; Clond, Morgan A.; Gangi, Alexandra; Mirocha, Jim; Bukur, Marko; Brown, Carlos V.; Salim, Ali			Elevated Admission Systolic Blood Pressure After Blunt Trauma Predicts Delayed Pneumonia and Mortality	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	41st Annual Meeting of the Western-Trauma-Association	FEB 27-MAR 05, 2011	Big Sky, MO	Western Trauma Assoc		Trauma; Traumatic brain injury; Elevated blood pressure; Pneumonia; Mortality; Hypertension; Sympathetic hyperactivity; Adrenergic activation	BETA-BLOCKER EXPOSURE; SERUM ETHANOL LEVELS; BRAIN-INJURY TBI; CEREBRAL PERFUSION; IMPROVED SURVIVAL; IMPROVED OUTCOMES; NERVOUS-SYSTEM; PROPRANOLOL; STRESS; ACTIVATION	Background: Although avoiding hypotension is a primary focus after trauma, elevated systolic blood pressure (SBP) is frequently disregarded. The purpose of this study was to determine the association between elevated admission SBP and delayed outcomes after trauma. Methods: The Los Angeles County Trauma System Database was queried for all patients between 2003 and 2008 with blunt injuries who survived for at least 2 days after admission. Demographics and outcomes (pneumonia and mortality) were compared at various admission SBP subgroups (>= 160 mm Hg, >= 170 mm Hg, >= 180 mm Hg, >= 190 mm Hg, >= 200 mm Hg,>= 210 mm Hg, and >= 220 mm Hg). Patients with moderate-to-severe traumatic brain injury (TBI), defined as head Abbreviated Injury Score >= 3, were then identified and compared with those without using multivariable logistic regression. Results: Data accessed from 14,382 blunt trauma admissions identified 2,601 patients with moderate-to-severe TBI (TBI group) and 11,781 without moderate-to-severe TBI (non-TBI group) who were hospitalized >= 2 days. Overall mortality was 2.9%, 7.1% for TBI patients, and 1.9% for non-TBI patients. Overall pneumonia was 4.6%, 9.5% for TBI patients, and 3.6% for non-TBI patients. Regression modeling determined SBP >= 160 mm Hg was a significant predictor of mortality in TBI patients (adjusted odds ratio [AOR], 1.59; confidence interval [CI], 1.10-2.29; p = 0.03) and non-TBI patients (AOR, 1.47; CI, 1.14-1.90; p = 0.003). Similarly, SBP >= 160 mm Hg was a significant predictor for increased pneumonia in TBI patients (AOR, 1.79; CI, 1.30-2.46; p = 0.0004), compared with non-TBI patients (AOR, 1.28; CI, 0.97-1.69; p = 0.08). Conclusions: In blunt trauma patients with or without TBI, elevated admission SBP was associated with worse delayed outcomes. Prospective research is necessary to determine whether algorithms that manage elevated blood pressure after trauma, especially after TBI, affect mortality or pneumonia.	[Ley, Eric J.; Singer, Matthew B.; Clond, Morgan A.; Gangi, Alexandra; Mirocha, Jim; Bukur, Marko; Brown, Carlos V.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215,North Tower, Los Angeles, CA 90048 USA.	eric.ley@cshs.org		Clond, Morgan/0000-0002-3036-4193; Gangi, Afshin/0000-0002-0952-7760; Bukur, Marko/0000-0002-1850-7147			[Anonymous], WISQARS FATAL INJURI; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Arima H, 2010, HYPERTENSION, V56, P852, DOI 10.1161/HYPERTENSIONAHA.110.154328; Ballard-Croft C, 2002, SHOCK, V18, P38, DOI 10.1097/00024382-200207000-00008; Beiermeister KA, 2010, J TRAUMA, V69, P338, DOI 10.1097/TA.0b013e3181e5d35e; BENEDICT CR, 1979, BRIT HEART J, V42, P214; Berry C, 2010, AM SURGEON, V76, P1067; BRYAN RM, 1990, AM J PHYSIOL, V259, pH269, DOI 10.1152/ajpheart.1990.259.2.H269; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chi OZ, 1999, ANESTH ANALG, V89, P690, DOI 10.1097/00000539-199909000-00030; Chiu W, 2007, J TRAUMA, V63, P510; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Enderson BL, 2007, J TRAUMA, V62, P33; Friese RS, 2008, J TRAUMA, V64, P1061, DOI 10.1097/TA.0b013e3181684cf0; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; Muthu K, 2009, J BURN CARE RES, V30, P8, DOI 10.1097/BCR.0b013e3181921f22; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; Pryor JP, 2007, J TRAUMA, V62, P61; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	35	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1689	1693		10.1097/TA.0b013e31823cc5df			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	869RT	WOS:000298616400044	22182876				2022-02-06	
J	Huong, NQ; Nakamura, Y; Kuramoto, N; Yoneyama, M; Nagashima, R; Shiba, T; Yamaguchi, T; Hasebe, S; Ogita, K				Nguyen Quynh Huong; Nakamura, Yukary; Kuramoto, Nobuyuki; Yoneyama, Masanori; Nagashima, Reiko; Shiba, Tatsuo; Yamaguchi, Taro; Hasebe, Shigeru; Ogita, Kiyokazu			Indomethacin Ameliorates Trimethyltin-Induced Neuronal Damage in Vivo by Attenuating Oxidative Stress in the Dentate Gyrus of Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cyclooxygenase; neuronal degeneration; indomethacin; oxidative stress; trimethyltin	TRAUMATIC BRAIN-INJURY; CA1 PYRAMIDAL NEURONS; NITRIC-OXIDE SYNTHASE; FACTOR-ALPHA RELEASE; MICROGLIAL ACTIVATION; FOREBRAIN ISCHEMIA; INDUCED APOPTOSIS; CELL-DEATH; CYCLOOXYGENASE-2; EXPRESSION	The organotin trimethyltin (TMT) is well known to cause neuronal degeneration in the hippocampal dentate gyrus of mice. The first purpose of the present study was to examine whether the cyclooxygenase (COX) inhibitor indomethacin could ameliorate neuronal degeneration in the dentate gyrus of mice following TMT treatment in vivo. The systemic injection into mice of TMT at 2.8 mg/kg produced activation of endogenous caspase-3 and calpain, enhanced the gene expression of COX-1 and COX-2, activated microglial cells, and caused the formation of the lipid peroxidation product 4-hydroxynonenal in the hippocampus. Given at 12-h post-TMT treatment, the systemic injection of indomethacin (5 or 10 mg/kg, subcutaneously) significantly decreased the TMT-induced damage to neurons having active caspase-3 and single-stranded DNA in the dentate granule cell layer of the hippocampus. The results of the alpha-Fodrin degradation test revealed that the post-treatment with indomethacin was effective in attenuating TMT-induced activation of endogenous caspases and calpain in the hippocampus. In TMT-treated animals, interestingly, the post-treatment with indomethacin produced not only activation of microglial cells in the dentate gyrus but also the formation of 4-hydroxynonenal in the dentate granule cell layer. Taken together, our data suggest that COX inhibition by indomethacin ameliorated TMT-induced neuronal degeneration in the dentate gyrus by attenuating intensive oxidative stress.	[Nguyen Quynh Huong; Nakamura, Yukary; Kuramoto, Nobuyuki; Yoneyama, Masanori; Nagashima, Reiko; Shiba, Tatsuo; Yamaguchi, Taro; Hasebe, Shigeru; Ogita, Kiyokazu] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacol, Hirakata, Osaka 5730101, Japan		Ogita, K (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacol, Hirakata, Osaka 5730101, Japan.	ogita@pharm.setsunan.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This work was supported in part by Grants-in-Aid for Scientific Research to M.Y. and K.O. from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arai K, 2003, BRAIN RES, V985, P176, DOI 10.1016/S0006-8993(03)03156-1; Asanuma M, 2001, J NEUROCHEM, V76, P1895, DOI 10.1046/j.1471-4159.2001.00205.x; Boldyrev AA, 1999, BIOCHEM BIOPH RES CO, V256, P320, DOI 10.1006/bbrc.1999.0325; BOULDIN TW, 1981, AM J PATHOL, V104, P237; Caggiano AO, 1996, J COMP NEUROL, V376, P447, DOI 10.1002/(SICI)1096-9861(19961216)376:3<447::AID-CNE7>3.0.CO;2-2; CHANG LW, 1985, J TOXICOL ENV HEALTH, V16, P641, DOI 10.1080/15287398509530770; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Collaco-Moreaes Y., 1996, BLOOD, V16, P1366; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Eskes C, 2003, J NEUROSCI RES, V71, P583, DOI 10.1002/jnr.10508; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Geloso MC, 2002, EXP NEUROL, V175, P152, DOI 10.1006/exnr.2002.7866; Godin JD, 2010, EMBO J, V29, P2433, DOI 10.1038/emboj.2010.117; Gunasekar PG, 1998, J PHARMACOL EXP THER, V285, P236; Harry GJ, 2001, NEUROTOX RES, V3, P307, DOI 10.1007/BF03033270; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Kawada K, 2008, J NEUROSCI RES, V86, P1635, DOI 10.1002/jnr.21612; Kim EJ, 2001, BRAIN RES, V908, P1, DOI 10.1016/S0006-8993(01)02432-5; Kinouchi H, 1999, J NEUROSURG, V91, P1005, DOI 10.3171/jns.1999.91.6.1005; Kondo F, 1998, BRAIN RES, V791, P352, DOI 10.1016/S0006-8993(98)00211-X; Kondo F, 2000, BRAIN RES, V853, P93, DOI 10.1016/S0006-8993(99)02256-8; Kuramoto N, 2011, J NEUROSCI RES, V89, P552, DOI 10.1002/jnr.22588; Kurkowska-Jastrzebska I, 2002, INT IMMUNOPHARMACOL, V2, P1213, DOI 10.1016/S1567-5769(02)00078-4; Kurkowska-Jastrzebska I, 2010, J NEUROSCI RES, V88, P24, DOI 10.1002/jnr.22187; Nagashima R, 2010, J PHARMACOL SCI, V113, P267, DOI 10.1254/jphs.09158SC; Ogita K, 2005, J NEUROSCI RES, V82, P609, DOI 10.1002/jnr.20678; Ogita K, 2004, NEUROPHARMACOLOGY, V47, P619, DOI 10.1016/j.neuropharm.2004.06.012; Ogita K, 2003, J NEUROCHEM, V85, P1336, DOI 10.1046/j.1471-4159.2003.01778.x; Pantovic R, 2005, SPINAL CORD, V43, P519, DOI 10.1038/sj.sc.3101763; Pasinetti GM, 1998, NEUROSCIENCE, V87, P319, DOI 10.1016/S0306-4522(98)00218-8; Rohl C, 2009, TOXICOL IN VITRO, V23, P1541, DOI 10.1016/j.tiv.2009.04.013; Shin EJ, 2005, NEUROSCIENCE, V133, P715, DOI 10.1016/j.neuroscience.2005.02.030; Shuto M, 2009, J PHARMACOL SCI, V110, P424, DOI 10.1254/jphs.09107FP; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Strohmeyer R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-18; Viviani B, 2001, TOXICOL APPL PHARM, V172, P93, DOI 10.1006/taap.2001.9136; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yoneyama M, 2008, NEUROCHEM INT, V52, P761, DOI 10.1016/j.neuint.2007.09.003; Yoneyama M, 2009, NEUROCHEM INT, V55, P257, DOI 10.1016/j.neuint.2009.03.008; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4; Zhang L, 2006, TOXICOL APPL PHARM, V216, P34, DOI 10.1016/j.taap.2006.05.004	43	16	18	0	4	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2011	34	12					1856	1863		10.1248/bpb.34.1856			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	853AS	WOS:000297399200015	22130242	Bronze			2022-02-06	
J	Vandromme, MJ; Melton, SM; Griffin, R; McGwin, G; Weinberg, JA; Minor, M; Rue, LW; Kerby, JD				Vandromme, Marianne J.; Melton, Sherry M.; Griffin, Russell; McGwin, Gerald; Weinberg, Jordan A.; Minor, Michael; Rue, Loring W., III; Kerby, Jeffrey D.			Intubation Patterns and Outcomes in Patients With Computed Tomography-Verified Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Intubation; Prehospital care	GLASGOW COMA SCALE; PREHOSPITAL ENDOTRACHEAL INTUBATION; SCORE; FIELD; CLASSIFICATION; MORTALITY; SURVIVAL; ALCOHOL	Background: Studies evaluating traumatic brain injury (TBI) patients have shown an association between prehospital (PH) intubation and worse outcomes. However, previous studies have used surrogates, e. g., Glasgow Coma Scale (GCS) score <= 8 and Abbreviated Injury Severity Scale (AIS) score >= 3, which may overestimate the true presence of TBI. This study evaluated the impact of PH intubation in patients with PH GCS score <8 and radiographically proven TBI. Methods: Trauma patients routed to a Level I trauma center over a 3-year period with blunt injury and PH GCS score <= 8 were included. PH and in-hospital records were linked and head computed tomography scans were assigned a Marshall Score (MS). Patients with TBI (MS >1) were categorized into groups based on intubation status (PH, emergency department [ED], and no intubation). Comparisons were made using analysis of variance and chi(2) statistics. Mortality differences, crude and adjusted risk ratios (RRs), and 95% confidence intervals (CIs) were calculated using proportions hazards modeling. Results: Of 334 patients with PH GCS score <= 8, 149 (50%) had TBI by MS. Among the TBI patients, 42.7% of patients were PH intubated, 47.7% were ED intubated, and 9.4% were not intubated during the initial resuscitation. Intubated patients had lower ED GCS score (PH: 4.1 and ED: 5.9 vs. 14.0; p < 0.0001) compared with patients not intubated. Also PH intubated patients had higher mean Injury Severity Score (38.0 vs. 33.7 vs. 23.5, p < 0.001) when compared with ED intubated and nonintubated patients. None of the nonintubated patients had a MS >2. Mortality for TBI patients who required PH intubation was 46.9% and 41.4% among ED-intubated patients. The crude RR of mortality for PH compared with ED intubation was 1.13 (95% CI, 0.68 - 1.89), and remained nonsignificant (RR, 0.68; 95% CI, 0.36 - 1.19) when adjusted for key markers of injury severity. Conclusions: Patients with PH GCS score <= 8 and proven TBI had a high overall rate of intubation (>90%). PH intubation seems to be a marker for more severe injury and conveyed no increased risk for mortality over ED intubation.	[Vandromme, Marianne J.; Melton, Sherry M.; Griffin, Russell; McGwin, Gerald; Rue, Loring W., III; Kerby, Jeffrey D.] Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; [Weinberg, Jordan A.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA; [Minor, Michael] Univ Alabama Birmingham, Birmingham Reg Emergency Med Serv Syst, Birmingham, AL 35294 USA		Kerby, JD (corresponding author), Univ Alabama Birmingham, Dept Surg Emergency Med & Mech Engn, Alabama Resuscitat Ctr, Sect Trauma Burns & Crit Care, LHRB 112,701 19th St S, Birmingham, AL 35294 USA.	jeffrey.kerby@ccc.uab.edu					Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baker CC, 2005, J TRAUMA, V58, P723; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Chesnut RM, 2008, J TRAUMA, V65, P500, DOI 10.1097/TA.0b013e31818020b3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	24	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1615	1619		10.1097/TA.0b013e31822a30a1			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400031	21841511				2022-02-06	
J	Barabasz, AF; Barabasz, M; Watkins, JG				Barabasz, Arreed F.; Barabasz, Marianne; Watkins, John G.			SINGLE-SESSION MANUALIZED EGO STATE THERAPY (EST) FOR COMBAT STRESS INJURY, PTSD, AND ASD, PART 1: The Theory	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS			English	Article							POSTTRAUMATIC-STRESS; AGE REGRESSION; DISORDER; HYPNOSIS; HYPNOTIZABILITY	Ego state therapy (EST) evolved from a psychodynamic understanding of personality as a product of an individual's ego states to a conceptualization of how ego-energized and object-energized elements are bound together to cope with a traumatic event. Neurobiological studies now substantiate Watkins's war neuroses conceptualizations. Because of their severity, trauma memories are encoded in the subcortical-subconscious brain regions that are accessed by the single-session manualized EST procedure but not by the popular cognitive-behavioral management therapies. The imprint of the trauma is not accessible or resolvable by such top-down verbal understanding or reframing; EST is a bottom-up therapy. Abreactive hypnosis facilitates ego state expression at physiologically and psychologically intense levels sufficient to activate subcortical processes to release affect in the presence of the therapist, who adds ego strength to the patient. This is followed by interpretation and reintegration. The result is a reconstructed personality that is adaptive and resilient.	[Barabasz, Arreed F.; Barabasz, Marianne] Washington State Univ, Pullman, WA 99163 USA; [Watkins, John G.] Univ Montana, Missoula, MT 59812 USA		Barabasz, AF (corresponding author), Washington State Univ, Cleveland Hall,POB 642136, Pullman, WA 99163 USA.	arreed_barabasz@wsu.edu					Abramowitz EG, 2010, INT J CLIN EXP HYP, V58, P316, DOI 10.1080/00207141003760926; BARABASZ A, INT J CLIN IN PRESS; Barabasz A., 2008, 5 GERM NEP INT MED C; Barabasz A., 2008, GERM ANN NAT HYPN C; Barabasz A., 2011, EGO STATE THERAPY MA; Barabasz A, 2006, AM J CLIN HYPN, V48, P251, DOI 10.1080/00029157.2006.10401532; Barabasz A, 2010, MEDICAL HYPNOSIS PRIMER: CLINICAL AND RESEARCH EVIDENCE, P1; Christensen C., INT J CLIN IN PRESS; Christensen C, 2009, INT J CLIN EXP HYP, V57, P402, DOI 10.1080/00207140903098817; Connor K. M., 2003, FOCUS, VI, P247, DOI DOI 10.1176/F0C.1.3.247; EMMERSON G, 2003, EGO STATE THERAPY; Emmerson G., 2006, ADV SKILLS INTERVENT; Everly GS., 1999, CRITICAL INCIDENT ST; Federn P., 1952, EGO PSYCHOL PSYCHOSE; Figley C.R., 2007, COMBAT STRESS INJURY; Foa E.B., 2007, PROLONGED EXPOSURE T; Frederick C, 2005, INT J CLIN EXP HYP, V53, P339, DOI 10.1080/00207140591007518; Hilgard E.R., 1986, DIVIDED CONSCIOUSNES, VExpanded; Hinterberger T, 2011, INT J CLIN EXP HYP, V59, P165, DOI 10.1080/00207144.2011.546188; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Hunter M., 2008, HEALING SCRIPTS USIN; JACKSON JH, 1958, SELECTED WRITINGS J, P45; Keuroghlian AS, 2010, INT J CLIN EXP HYP, V58, P39, DOI 10.1080/00207140903310790; Krakauer S, 2008, INT J CLIN EXP HYP, V57, P47, DOI 10.1080/00207140802463633; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; LITZ BT, 1992, CLIN PSYCHOL REV, V12, P417, DOI 10.1016/0272-7358(92)90125-R; Lynn SJ, 2007, INT J CLIN EXP HYP, V55, P167, DOI 10.1080/00207140601177905; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Panksepp J., 1994, TXB BIOL PSYCHIAT, P319; Patterson DR, 2010, INT J CLIN EXP HYP, V58, P288, DOI 10.1080/00207141003760595; Spiegel D, 1992, Psychiatr Med, V10, P21; Spiegel D., 2007, AM SOC CLIN HYPN ASC; SPIEGEL H, 2004, TRANCE TREATMENT CLI; Tobis IP, 2010, INT J CLIN EXP HYP, V58, P367, DOI 10.1080/00207144.2010.499330; Van der Kolk B., 2007, I ADV HUM BEH SEATTL; Vermetten E, 2010, MEDICAL HYPNOSIS PRIMER: CLINICAL AND RESEARCH EVIDENCE, P41; Watkins H. H., 1978, THERAPEUTIC SELF, P360; Watkins J. G., 1982, NEWER THERAPIES SOUR, P137; Watkins J. G., 1951, J PERS, V1, P318; Watkins J. G., 1949, HYPNOTHERAPY WAR NEU; Watkins J. G., 1997, EGO STATES THEORY TH; Watkins J. G., 2008, ADV HYPNOTHERAPY HYP; Watkins J. G., 1986, HDB STATES CONSCIOUS, P133; Watkins JG, 1942, J CONSULT PSYCHOL, V6, P117, DOI 10.1037/h0056480; Weiss E., 1960, STRUCTURE DYNAMICS H; Yard SS, 2008, INT J CLIN EXP HYP, V56, P334, DOI 10.1080/00207140802042007; [No title captured]	48	16	17	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7144	1744-5183		INT J CLIN EXP HYP	Int. J. Clin. Exp. Hypn.	OCT-DEC	2011	59	4					379	391		10.1080/00207144.2011.595349			13	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	826YT	WOS:000295392200001	21867374				2022-02-06	
J	McDonald, S; Rushby, J; Li, S; de Sousa, A; Dimoska, A; James, C; Tate, R; Togher, L				McDonald, Skye; Rushby, Jacqueline; Li, Sophie; de Sousa, Arielle; Dimoska, Aneta; James, Charlotte; Tate, Robyn; Togher, Leanne			The influence of attention and arousal on emotion perception in adults with severe traumatic brain injury	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Traumatic brain injury; Emotion perception; Arousal; Attention	EVOKED CARDIAC RESPONSE; CLOSED-HEAD-INJURY; FACIAL EXPRESSIONS; ORIENTING REFLEX; GENDER-DIFFERENCES; SOCIAL-BEHAVIOR; SKIN-CONDUCTANCE; HABITUATION; RECOGNITION; ACTIVATION	Many people with traumatic brain injury (TIN) have poor emotion recognition, with negative emotions more frequently impaired. They can also display abnormal affective responses to emotionally charged material, however, the mechanisms underpinning such deficits are unclear. This study examined whether affective responsivity can be improved by focusing attention and whether responsivity is associated with perception accuracy. Eighteen adults with moderate-to-severe TBI and 18 control participants viewed facial expressions while skin conductance (SCR) and evoked cardiac deceleration (ECD) (used as indices of orientation) and skin conductance levels (SCL) (used as an index of phasic arousal) were monitored. They viewed two blocks of faces (8 angry and 8 happy per block), passively in the first block and with the instruction to identify the emotional expression in the second. No differences between conditions, emotions or groups were found using SCR. Both groups demonstrated increasing ECD for the attend condition relative to the passive condition. For the passive task the control group showed increasing SCL (sensitisation) over trials when viewing angry faces and decreasing SCL (habituation) to happy faces. No differences between emotions were shown for the TBI group who rapidly habituated to both expressions. For the attend task, there was no evidence of habituation for either expression for either the control or TBI participants. Physiological measures did not correlate to accuracy in recognising emotions. The results suggest that increasing attentional demands improves orientation and emotional engagement (arousal) to emotional faces following TBI. However, the relationship to this and emotion perception accuracy remains unclear. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.	[McDonald, Skye; Rushby, Jacqueline; Li, Sophie; de Sousa, Arielle; Dimoska, Aneta; James, Charlotte] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Tate, Robyn] Univ Sydney, Dept Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Rushby, Jacqueline/D-1820-2010; McDonald, Skye/G-4118-2014; Togher, Leanne/AAC-7083-2019	Rushby, Jacqueline/0000-0002-5018-638X; McDonald, Skye/0000-0003-0723-6094; Li, Sophie/0000-0002-4762-6911; Togher, Leanne/0000-0002-4518-6748	Australian National Medical and Health Research CouncilNational Health and Medical Research Council of Australia	This research was funded by a grant from the Australian National Medical and Health Research Council. We are grateful to the Ryde, Westmead and Liverpool Brain Injury Units in Sydney, Australia, for their assistance with recruitment. We are indebted to the people with traumatic brain injuries and their families, as well as our volunteers from the general community, who gave willingly of their time to make this research possible.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Andersson S, 1999, J PSYCHOPHYSIOL, V13, P109, DOI 10.1027//0269-8803.13.2.109; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; BARRY RJ, 1984, PHYSIOL PSYCHOL, V12, P35, DOI 10.3758/BF03332162; Barry RJ, 2005, CLIN NEUROPHYSIOL, V116, P2693, DOI 10.1016/j.clinph.2005.08.008; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Barry RJ, 2004, INTEGR PHYS BEH SCI, V39, P166, DOI 10.1007/BF02734437; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Codispoti M, 2008, INT J PSYCHOPHYSIOL, V69, P90, DOI 10.1016/j.ijpsycho.2008.03.004; CONNOLLY JF, 1978, PHYSIOL BEHAV, V21, P511, DOI 10.1016/0031-9384(78)90121-X; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1017/S0048577200990759; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hoffman M. L., 1984, EMOTIONS COGNITION B, P103; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; IACONO WG, 1983, PSYCHOPHYSIOLOGY, V20, P71, DOI 10.1111/j.1469-8986.1983.tb00905.x; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LACEY BC, 1978, AM PSYCHOL, V33, P99, DOI 10.1037/0003-066X.33.2.99; LACEY BC, 1980, PSYCHOPHYSIOLOGY, V17, P209, DOI 10.1111/j.1469-8986.1980.tb00137.x; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lang P. J., 1999, A4 U FLOR CTR RES PS; Lawrence CA, 2009, ACTA NEUROBIOL EXP, V69, P552; Lipps T, 1907, PSYCHOL UNTERSUCHUNG, V1; Luria A.R., 1973, WORKING BRAIN; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; MALMO RB, 1959, PSYCHOL REV, V66, P367, DOI 10.1037/h0047858; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; MERCKELBACH H, 1989, BEHAV RES THER, V27, P289, DOI 10.1016/0005-7967(89)90048-X; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pavlov I.P., 1927, CONDITIONED REFLEXES; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Rushby JA, 2005, CLIN NEUROPHYSIOL, V116, P2363, DOI 10.1016/j.clinph.2005.06.008; Rushby JA, 2007, BIOL PSYCHOL, V75, P248, DOI 10.1016/j.biopsycho.2007.03.003; Rushby JA, 2009, INT J PSYCHOPHYSIOL, V74, P120, DOI 10.1016/j.ijpsycho.2009.08.003; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Sokolov E, 1963, PERCEPTION CONDITION; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Trumbull R., 1967, PSYCHOL STRESS ISSUE, P14; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P461; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P179; Vrana SR, 2004, BIOL PSYCHOL, V66, P63, DOI 10.1016/j.biopsycho.2003.07.004; Watson RI, 1978, GREAT PSYCHOL; WEBSTER WR, 1965, SCIENCE, V148, P654, DOI 10.1126/science.148.3670.654; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6	75	16	16	1	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2011	82	1			SI		124	131		10.1016/j.ijpsycho.2011.01.014			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	859PZ	WOS:000297889600014	21315778				2022-02-06	
J	Burov, S; Leko, M; Dorosh, M; Dobrodumov, A; Veselkina, O				Burov, Sergey; Leko, Maria; Dorosh, Marina; Dobrodumov, Anatoliy; Veselkina, Olga			Creatinyl amino acids - new hybrid compounds with neuroprotective activity	JOURNAL OF PEPTIDE SCIENCE			English	Article						creatinyl amino acids; sarcosine guanidinylation; creatine p-toluenesulfonate; brain stroke; neuroprotective activity	MODEL	Prolonged oral creatine administration resulted in remarkable neuroprotection in experimental models of brain stroke. However, because of its polar nature creatine has poor ability to penetrate the blood-brain barrier (BBB) without specific creatine transporter (CRT). Thus, synthesis of hydrophobic derivatives capable of crossing the BBB by alternative pathway is of great importance for the treatment of acute and chronic neurological diseases including stroke, traumatic brain injury and hereditary CRT deficiency. Here we describe synthesis of new hybrid compounds - creatinyl amino acids, their neuroprotective activity in vivo and stability to degradation in different media. The title compounds were synthesized by guanidinylation of corresponding sarcosyl peptides or direct creatine attachment using isobutyl chloroformate method. Addition of lipophilic counterion (p-toluenesulfonate) ensures efficient creatine dissolution in DMF with simultaneous protection of guanidino group towards intramolecular cyclization. It excludes the application of expensive guanidinylating reagents, permits to simplify synthetic procedure and adapt it to large-scale production. The biological activity of creatinyl amino acids was tested in vivo on ischemic stroke and NaNO2-induced hypoxia models. One of the most effective compounds - creatinyl-glycine ethyl ester increases life span of experimental animals more than two times in hypoxia model and has neuroprotective action in brain stroke model when applied both before and after ischemia. These data evidenced that creatinyl amino acids can represent promising candidates for the development of new drugs useful in stroke treatment. Copyright (C) 2011 European Peptide Society and John Wiley & Sons, Ltd.	[Burov, Sergey] Russian Acad Sci, Inst Macromol Cpds, VO, St Petersburg 199004, Russia; [Veselkina, Olga] Closed Joint Stock Co Vertex, St Petersburg 199026, Russia		Burov, S (corresponding author), Russian Acad Sci, Inst Macromol Cpds, VO, Bolshoi Pr 31, St Petersburg 199004, Russia.	burov@hq.macro.ru	Burov, Sergey V/P-7225-2015; Dobrodumov, Anatoliy V/I-9151-2017	Burov, Sergey V/0000-0003-3607-5680; Dobrodumov, Anatoliy V/0000-0002-4554-6002			AN L, 1999, Patent No. 99118985; Andrushchenko VV, 2007, J PEPT SCI, V13, P37, DOI 10.1002/psc.793; Belayev L, 1999, BRAIN RES, V833, P181, DOI 10.1016/S0006-8993(99)01528-0; BUROV SV, 2007, Patent No. 2354645; Christie David L., 2007, V46, P99; CRIADO M, 1980, ANAL BIOCHEM, V103, P289, DOI 10.1016/0003-2697(80)90612-0; GIBSON GE, 1981, J NEUROCHEM, V37, P192, DOI 10.1111/j.1471-4159.1981.tb05308.x; Giese MW, 2009, INT J SPORTS MED, V30, P766, DOI 10.1055/s-0029-1231045; Giese MW, 2009, BIOCHEM BIOPH RES CO, V388, P252, DOI 10.1016/j.bbrc.2009.07.151; HOFMANN E, 1958, NATURWISSENSCHAFTEN, V45, P338, DOI 10.1007/BF00640225; KATRITZKY AR, 1995, SYNTHETIC COMMUN, V25, P1173, DOI 10.1080/00397919508012681; Klein Autumn M., 2007, V46, P205; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Koizumi J, 1986, JPN J STROKE, V8, P1, DOI DOI 10.3995/JSTROKE.8.1; Kristensen CA, 1999, BRIT J CANCER, V79, P278, DOI 10.1038/sj.bjc.6690045; Li FH, 1997, J CEREBR BLOOD F MET, V17, P1132, DOI 10.1097/00004647-199710000-00016; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lunardi G, 2006, NEUROSCIENCE, V142, P991, DOI 10.1016/j.neuroscience.2006.06.058; Matthews RT, 1998, J NEUROSCI, V18, P156; Musiol HJ, 2001, ORG LETT, V3, P3859, DOI 10.1021/ol010191q; Prass K, 2007, J CEREBR BLOOD F MET, V27, P1290, DOI 10.1038/sj.jcbfm.9600442; VENNERSTROM JL, 2002, Patent No. 2002022135; WEISS S, 1995, Patent No. 0754679; Zhu S, 2004, J NEUROSCI, V24, P5909, DOI 10.1523/JNEUROSCI.1278-04.2004	24	16	17	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	SEP	2011	17	9					620	626		10.1002/psc.1379			7	Biochemistry & Molecular Biology; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	814JF	WOS:000294444100004	21644247				2022-02-06	
J	Dinocourt, C; Aungst, S; Yang, K; Thompson, SM				Dinocourt, Celine; Aungst, Stephanie; Yang, Kun; Thompson, Scott M.			Homeostatic increase in excitability in area CA1 after Schaffer collateral transection in vivo	EPILEPSIA			English	Article						Traumatic brain injury; Axonal injury; Hippocampus; Lesion; Plasticity	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; PARVALBUMIN-IMMUNOREACTIVE NEURONS; SPONTANEOUS RECURRENT SEIZURES; GABA-MEDIATED INHIBITION; POSTTRAUMATIC EPILEPSY; RAT HIPPOCAMPUS; PILOCARPINE MODEL; PYRAMIDAL NEURONS; DENTATE GYRUS	Purpose: Epilepsy is a significant long-term consequence of traumatic brain injury (TBI) and is likely to result from multiple mechanisms. One feature that is common to many forms of TBI is denervation. We asked whether chronic partial denervation in vivo would lead to a homeostatic increase in the excitability of a denervated cell population. Methods: To answer this question, we took advantage of the unique anatomy of the hippocampus where the input to the CA1 neurons, the Schaffer collaterals, could be transected in vivo with preservation of their outputs and only minor cell death. Key Findings: We observed a delayed increase in neuronal excitability, as apparent in extracellular recordings from hippocampal brain slices prepared 14 days (but not 3 days) post lesion. Although population spikes in slices from control and lesioned animals were comparable under resting conditions, application of solutions that were mildly proconvulsive (high K(+), low Mg(2+), low concentrations of bicuculline) produced increases in the number of population spikes in slices from lesioned rats, but not in slices from unlesioned sham controls. Denervation did not produce changes in several markers of c-aminobutyric acid (GABA)ergic synaptic inhibition, including the number of GABAergic neurons, alpha 1 GABA(A) receptor subunits, the vesicular GABA transporter, or miniature inhibitory postsynaptic currents. Significance: We conclude that chronic partial denervation does lead to a delayed homeostatic increase in neuronal excitability, and may, therefore, contribute to the long-term neurologic consequences of TBI.	[Dinocourt, Celine; Aungst, Stephanie; Yang, Kun; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Aungst, Stephanie; Thompson, Scott M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA		Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Thompson, Scott M/K-8921-2015		Epilepsy Foundation of America; CURE Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS40388]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040338] Funding Source: NIH RePORTER	Supported with a postdoctoral fellowship to CD from the Epilepsy Foundation of America, and funds from the CURE Foundation (SMT), and the National Institutes of Health (SMT, NS40388). We thank Sandra Naumann for technical assistance.	Abdulla FA, 2001, J NEUROPHYSIOL, V85, P630, DOI 10.1152/jn.2001.85.2.630; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BEST N, 1993, NEUROSCI LETT, V155, P1, DOI 10.1016/0304-3940(93)90660-D; BEST N, 1994, ACTA NEUROPATHOL, V87, P187; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cai X, 2007, J NEUROSCI, V27, P59, DOI 10.1523/JNEUROSCI.4502-06.2007; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; GRAFSTEIN B, 1957, ELECTROEN CLIN NEURO, V9, P723, DOI 10.1016/0013-4694(57)90096-2; Hagemann G, 2000, J NEUROPHYSIOL, V84, P600, DOI 10.1152/jn.2000.84.1.600; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Jacobs KM, 1996, CEREB CORTEX, V6, P514, DOI 10.1093/cercor/6.3.514; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LU WX, 1992, BRAIN RES, V578, P155, DOI 10.1016/0006-8993(92)90243-3; Luhmann H J, 1996, Epilepsy Res Suppl, V12, P119; MAJKOWSKI J, 1990, COMPREHENSIVE EPILEP, P281; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCBAIN CJ, 1994, J NEUROPHYSIOL, V72, P2853, DOI 10.1152/jn.1994.72.6.2853; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Morin F, 1998, EPILEPSY RES, V32, P363, DOI 10.1016/S0920-1211(98)00033-3; Mun-Bryce S, 2004, BRAIN RES, V1026, P218, DOI 10.1016/j.brainres.2004.08.023; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Rosenblueth, 1949, SUPERSENSITIVITY DEN; RUTECKI PA, 1985, J NEUROPHYSIOL, V54, P1363, DOI 10.1152/jn.1985.54.5.1363; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; THOMSON AM, 1986, NEUROSCIENCE, V19, P1161, DOI 10.1016/0306-4522(86)90130-2; Toth Z, 1997, J NEUROSCI, V17, P8106; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Waldbaum S, 2009, EPILEPSIA, V50, P904, DOI 10.1111/j.1528-1167.2008.01939.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	54	16	16	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0013-9580			EPILEPSIA	Epilepsia	SEP	2011	52	9					1656	1665		10.1111/j.1528-1167.2011.03113.x			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KK	WOS:000294973700019	21635239	Green Accepted			2022-02-06	
J	Jin, W; Wu, J; Wang, HD; Kong, J; Ni, HB; Liang, WB				Jin, Wei; Wu, Jun; Wang, Handong; Kong, Jie; Ni, Hongbin; Liang, Weibang			Erythropoietin Administration Modulates Pulmonary Nrf2 Signaling Pathway After Traumatic Brain Injury in Mice	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Erythropoietin; Traumatic brain injury; Nuclear factor erythroid 2-related factor 2; Acute lung injury	ACUTE LUNG INJURY; HEME OXYGENASE-1 EXPRESSION; CLOSED-HEAD INJURY; RAT MODEL; NEURONAL APOPTOSIS; OXIDATIVE STRESS; INFLAMMATION; MECHANISM; PERMEABILITY; ISCHEMIA	Background: In our previous studies, antioxidant transcription factor, nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway has been shown to play an important role in protecting traumatic brain injury (TBI)-induced acute lung injury (ALI). This study was designed to explore whether recombinant human erythropoietin (rhEPO) administration modulates pulmonary Nrf2 signaling pathway in a murine TBI model. Methods: Closed head injury was made by Hall's weight-dropping method. The rhEPO was administered at a dose of 5,000 IU/kg 30 minutes after TBI. Pulmonary capillary permeability, wet or dry weight ratio, apoptosis, Nrf2 and its downstream cytoprotective enzymes including NAD(P) H: quinone oxidoreductase 1, and glutathione S-transferase were investigated at 24 hours after TBI. Results: We found that treatment with rhEPO markedly ameliorated TBI-induced ALI, as characterized by decreased pulmonary capillary permeability, wet or dry weight ratio, and alveolar cells apoptosis. Administration of rhEPO also significantly upregulated the mRNA expressions and activities of Nrf2 signaling pathway-related agents, including Nrf2, NAD(P) H: quinone oxidoreductase 1, and glutathione S-transferase. Conclusions: The results of this study suggest that post-TBI rhEPO administration may induce Nrf2-mediated cytoprotective response in the lung, and this may be a mechanism whereby rhEPO reduces TBI-induced ALI.	[Jin, Wei; Wu, Jun; Kong, Jie; Ni, Hongbin; Liang, Weibang] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Handong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China		Liang, WB (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	njneurosurgery@yahoo.com.cn			Drum Tower Hospital	Supported by grants from Drum Tower Hospital.	Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; DETTBARN CL, 1989, HEART LUNG, V18, P583; Genc K, 2010, CELL BIOCHEM FUNCT, V28, P197, DOI 10.1002/cbf.1639; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Katavetin P, 2007, BIOCHEM BIOPH RES CO, V359, P928, DOI 10.1016/j.bbrc.2007.05.207; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lv R, 2005, ANN CLIN LAB SCI, V35, P174; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Tascilar O, 2007, WORLD J GASTROENTERO, V13, P6172, DOI 10.3748/wjg.13.6172; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Ware LB, 2005, EUR RESPIR J, V26, P101, DOI 10.1183/09031936.05.00106604; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu HW, 2006, EUR J CARDIO-THORAC, V29, P902, DOI 10.1016/j.ejcts.2006.02.036; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yoshimi M, 2008, RESPIROLOGY, V13, P639, DOI 10.1111/j.1440-1843.2008.01324.x; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	33	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2011	71	3					680	686		10.1097/TA.0b013e3181f6b984			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	818MX	WOS:000294756900034	21394044				2022-02-06	
J	Meirelles, CMJ; de Aguilar-Nascimento, JE				Justo Meirelles, C. Ma; de Aguilar-Nascimento, J. E.			Enteral or parenteral nutrition in traumatic brain injury: a prospective randomised trial	NUTRICION HOSPITALARIA			English	Article						Enteral nutrition; Parenteral nutrition; Brain injury; Trauma; Nutritional therapy	SEVERE HEAD-INJURY; CRITICALLY-ILL; INFLAMMATORY RESPONSE; METABOLIC-RESPONSE; GLUCOSE CONTROL; SUPPORT; PATIENT; PNEUMONIA; MORTALITY; ONSET	Introduction: Few studies have evaluated the route of nutritional therapy in patients with head trauma. Objective: We aimed at investigating whether early enteral (EN) or parenteral nutrition (TPN) may differ in protein/ calorie supply, serum glucose modifications, and acute phase response in patients with traumatic brain injury (TBI). Methods: Twenty two patients with moderate TBI (Glasgow score between 9-12) were randomized to receive isocaloric and isonitrogeneous either EN (n = 12) or TPN (n = 10). The daily amount of calories and nitrogen (N) supplied, the nitrogen balance, and the daily serum level of glucose, C-reactive protein, and albumin were collected for 5 consecutive days. Clinical endpoints as length of stay and mortality were also compared. Results: Mortality was 9.1% (two cases) with one case in each group. A progressive caloric deficit occurred in both groups (p = 0.001) without difference between them. The mean serum glucose level in TNP patients (134.4, 95% CI = 122.6 to 146.2 mg/dl) was significantly higher than in the EN group (102,4; 95% CI 91.6 to 113.2 mg/dL) (p < 0.001). There was a trend (p = 0.06) of 24 h urinary N loss to be greater in TPN group which received higher amounts of N than the NE group (p < 0.05). However, nitrogen balance was similar in the two groups. There was no difference in either the clinical outcome variables or the acute phase response. Conclusion: Both routes were able to supply increasing provision of calories to brain injured patients. TPN provided significantly greater amount of nitrogen but losses were also greater. Nitrogen balance was similar with both types of therapy. Parenteral compared to enteral nutrition lead to greater hyperglycemia. There was no influence of the route in both the early inflammatory response and clinical outcome.	[de Aguilar-Nascimento, J. E.] Univ Fed Mato Grosso, Sch Med Sci, Dept Surg, Cuiaba, Brazil; [Justo Meirelles, C. Ma] Univ Fed Mato Grosso, Sch Med Sci, Hlth Sci Postgrad Course, Cuiaba, Brazil		de Aguilar-Nascimento, JE (corresponding author), Hosp Univ Julio Muller, Rua Estevao de Mendonca 81,Apto 801, BR-78043300 Cuiaba, Mato Grosso, Brazil.	aguilar@terra.com.br					BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS77, DOI DOI 10.1089/NEU.2006.9984; Bratton SL, 2007, J NEUROTRAUM, V24, P77; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Collier B, 2008, NUTR CLIN PRACT, V23, P3, DOI 10.1177/011542650802300103; Borges Dock-Nascimento D., 2005, Nutr. Hosp., V20, P343; ESCRIBANO JAA, 2001, NUTR HOSP, V16, P262; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; Davila JG, 2010, NUTR HOSP, V25, P443, DOI 10.3305/nh.2010.25.3.4414; Goiburu ME, 2006, NUTR HOSP, V21, P604; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; HADFIELD RJ, 1995, AM J RESP CRIT CARE, V152, P1545, DOI 10.1164/ajrccm.152.5.7582291; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Nataloni S, 1999, CLIN NUTR, V18, P247, DOI 10.1016/S0261-5614(99)80077-6; Niinikoski H, 2004, J NUTR, V134, P1467, DOI 10.1093/jn/134.6.1467; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Vizzini A, 2010, NUTRITION       0623; Wernerman J, 2008, CURR OPIN CLIN NUTR, V11, P160, DOI 10.1097/MCO.0b013e3282f53370; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076	28	16	17	0	6	AULA MEDICA EDICIONES	MADRID	C/ISABEL COLBRAND, 10-12 NAVE 78 S PLANTA CIUDAD INDUSTRIAL VENECIA-EDIFICIO ALFA, MADRID, 28050, SPAIN	0212-1611	1699-5198		NUTR HOSP	Nutr. Hosp.	SEP-OCT	2011	26	5					1120	1124		10.3305/nh.2011.26.5.5133			5	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	817SC	WOS:000294694100030	22072362				2022-02-06	
J	Krpan, KM; Stuss, DT; Anderson, ND				Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.			Coping behaviour following traumatic brain injury: What makes a planner plan and an avoider avoid?	BRAIN INJURY			English	Article						Traumatic brain injury; coping; stress; neuropsychology; behaviour; autonomic response	PERFORMANCE; DYSFUNCTION; PREDICTORS; STRATEGIES; HEALTH; DAMAGE; LIFE	Primary objective: Avoidant coping has consistently been related to negative outcomes following traumatic brain injury (TBI), although the mechanisms of this relationship are not clear. A recent study demonstrated that people with moderate-to-severe TBI engaged in more avoidant than planful coping behaviour during a psychosocial stress test, while their matched healthy counterparts engaged in the opposite pattern. The purpose of the current study was to evaluate the neuropsychological, physiological and psychological differences between planners and avoiders with TBI. Methods and procedures: Eighteen people with moderate-to-severe TBI completed the Baycrest Psychosocial Stress Test (BPST) where coping behaviour was evaluated and physiological measures recorded. Participants also completed a series of questionnaires and a neuropsychological test battery. Main outcomes and results: Compared to avoiders, planners had better executive function, were more psychologically and physiologically reactive and performed better on the BPST. Dysfunction on tests assessing executive abilities was the best predictor of avoidant coping, while physiological and psychological reactivity were the best predictors of planful coping. Conclusions: This study is the first to document differences between planners and avoiders with TBI. Understanding the determinants of coping following TBI will allow for more sophisticated and targeted rehabilitative intervention.	[Stuss, Donald T.; Anderson, Nicole D.] Baycrest, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Krpan, Katherine M.; Stuss, Donald T.; Anderson, Nicole D.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Krpan, Katherine M.; Anderson, Nicole D.] Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; [Stuss, Donald T.] Univ Toronto, Fac Med Neurol Rehabil Sci, Toronto, ON M5S 1A1, Canada; [Anderson, Nicole D.] Univ Toronto, Fac Med Psychiat, Toronto, ON M5S 1A1, Canada		Anderson, ND (corresponding author), Baycrest, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	nanderson@klaru-baycrest.on.ca	Anderson, Nicole D/E-9101-2011	Anderson, Nicole D/0000-0002-5979-2220	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR); Ontario Research Coalition; Toronto Rehabilitation InstituteUniversity of Toronto; Max and Ruth Wiseman Award; Mary Gertrude l'Anson Scholarship	The authors report no conflicts of interest. This work was supported by an NSERC grant to N. D. Anderson. K. M. Krpan was a doctoral student in the Department of Psychology at the University of Toronto during the project and was funded by CIHR Doctoral Fellowship, Ontario Research Coalition, Toronto Rehabilitation Institute, Max and Ruth Wiseman Award and the Mary Gertrude l'Anson Scholarship.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Army Individual Test Battery, 1944, MAN DIR SCOR; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck A., 1996, BECK DEPRESSION INVE; BENDIG AW, 1956, EDUC PSYCHOL MEAS, V16, P516, DOI 10.1177/001316445601600410; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; COHEN RA, 1985, NEUROPSYCHOLOGIA, V23, P243, DOI 10.1016/0028-3932(85)90108-3; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; CRAIK FIM, 1990, ADV NEUROL, V51, P210; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Dawson M. E., 1990, PRINCIPLES PSYCHOPHY, P295; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Finset A, 2000, BRAIN INJURY, V14, P887; Folkman S., 1988, WAYS COPING QUESTION; FREEDMAN M, 1990, BRAIN COGNITION, V14, P134, DOI 10.1016/0278-2626(90)90025-J; Frydenberg E., 1996, COPING SCALE ADULTS; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Kendall E, 2001, BRAIN IMPAIR, V2, P81; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Ouellet MC, 2009, J REHABIL MED, V41, P179, DOI 10.2340/16501977-0306; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; SOSNOWSKI T, 1991, PSYCHOPHYSIOLOGY, V28, P665, DOI 10.1111/j.1469-8986.1991.tb01011.x; Spielberger CD., 1983, STATE TRAIT ANXIETY; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2008, COGNITIVE NEUROREHAB, P39; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; ZACHARY RA, 1982, SHIPLEY I LIVING SCA; [No title captured]	58	16	16	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2011	25	10					989	996		10.3109/02699052.2011.597045			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800009	21749191				2022-02-06	
J	Moran, LM; Taylor, HG; Rusin, J; Bangert, B; Dietrich, A; Nuss, KE; Wright, M; Yeates, KO				Moran, Lisa M.; Taylor, H. Gerry; Rusin, Jerome; Bangert, Barbara; Dietrich, Ann; Nuss, Kathryn E.; Wright, Martha; Yeates, Keith Owen			Do Postconcussive Symptoms Discriminate Injury Severity in Pediatric Mild Traumatic Brain Injury?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; child; postconcussion symptoms	POST-CONCUSSIVE SYMPTOMS; CLOSED-HEAD INJURIES; NEUROBEHAVIORAL SYMPTOMS; UNITED-STATES; CHILDREN; MANAGEMENT; STABILITY	Objectives: To assess whether postconcussive symptoms (PCS) can be used to discriminate injury severity among children with mild traumatic brain injury (TBI). Participants: One hundred eighty-six children with mild TBI, divided into high and low injury severity depending on whether the injury was associated with a loss of consciousness (LOC), and a comparison group of 99 children with orthopedic injuries (OI), all aged 8 to 15 years at the time of injury. Main Measures: Parent-rated frequency and severity of PCS at initial assessment within 2 weeks postinjury and again at 3 and 12 months postinjury. Results: Ratings of PCS obtained at the initial and 3-month assessments differentiated children with mild TBI from OI, although only ratings at the initial assessment discriminated among all 3 groups. Somatic PCS accounted for most of the discriminatory power. Conclusions: Overall, the accuracy of group classification was relatively modest, with a large proportion of misclassifications of children in the mild-TBI groups. Although children with mild TBI have more PCS than children with OI, PCS do not permit sufficiently accurate discrimination of mild TBI and injury severity to warrant diagnostic decisions at this time.	[Moran, Lisa M.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Dietrich, Ann; Nuss, Kathryn E.; Yeates, Keith Owen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Rusin, Jerome] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA; [Dietrich, Ann; Nuss, Kathryn E.] Nationwide Childrens Hosp, Dept Emergency Med, Columbus, OH USA; [Moran, Lisa M.; Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Taylor, H. Gerry; Wright, Martha] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Wright, Martha] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Radiol, Cleveland, OH USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Neurosurg, Cleveland, OH USA		Yeates, KO (corresponding author), Nationwide Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH USA.	keith.yeates@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Nuss, Kathryn/0000-0003-2185-7364	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD44099, HD39834]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039834, K02HD044099] Funding Source: NIH RePORTER	This work was supported by grants HD44099 and HD39834 from the National Institutes of Health to the senior author (K.O.Y.).	Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W., 1997, CLIN NEUROPSYCHOL, V11, P305; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	34	16	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2011	26	5					348	354		10.1097/HTR.0b013e3181f8d32e			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	814VO	WOS:000294485500003	21900857	Green Submitted, Green Accepted			2022-02-06	
J	Eide, PK; Bakken, A				Eide, Per K.; Bakken, Andre			The baseline pressure of intracranial pressure (ICP) sensors can be altered by electrostatic discharges	BIOMEDICAL ENGINEERING ONLINE			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL-EVALUATION; CODMAN MICROSENSOR; TECHNICAL REPORT; EPIDURAL SPACE; COMPLICATIONS; DEVICE; SAFETY; HYDROCEPHALUS; TRANSDUCERS	Background: The monitoring of intracranial pressure (ICP) has a crucial role in the surveillance of patients with brain injury. During long-term monitoring of ICP, we have seen spontaneous shifts in baseline pressure (ICP sensor zero point), which are of technical and not physiological origin. The aim of the present study was to explore whether or not baseline pressures of ICP sensors can be affected by electrostatics discharges (ESD's), when ESD's are delivered at clinically relevant magnitudes. Methods: We performed bench-testing of a set of commercial ICP sensors. In our experimental setup, the ICP sensor was placed in a container with 0.9% NaCl solution. A test person was charged 0.5 - 10 kV, and then delivered ESD's to the sensor by touching a metal rod that was located in the container. The continuous pressure signals were recorded continuously before/after the ESD's, and the pressure readings were stored digitally using a computerized system Results: A total of 57 sensors were tested, including 25 Codman ICP sensors and 32 Raumedic sensors. When charging the test person in the range 0.5-10 kV, typically ESD's in the range 0.5 - 5 kV peak pulse were delivered to the ICP sensor. Alterations in baseline pressure >= 2 mmHg was seen in 24 of 25 (96%) Codman sensors and in 17 of 32 (53%) Raumedic sensors. Lasting changes in baseline pressure > 10 mmHg that in the clinical setting would affect patient management, were seen frequently for both sensor types. The changes in baseline pressure were either characterized by sudden shifts or gradual drifts in baseline pressure. Conclusions: The baseline pressures of commercial solid ICP sensors can be altered by ESD's at discharge magnitudes that are clinically relevant. Shifts in baseline pressure change the ICP levels visualised to the physician on the monitor screen, and thereby reveal wrong ICP values, which likely represent a severe risk to the patient.	[Eide, Per K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway; [Eide, Per K.] Univ Oslo, Fac Med, Oslo, Norway; [Bakken, Andre] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Clin & Biomed Engn, N-0027 Oslo, Norway		Eide, PK (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurosurg, N-0027 Oslo, Norway.	per.kristian.eide@ous-hf.no					Abenstein JP, 2007, MAYO CLIN PROC, V82, P276; ALLEN R, 1986, J MED ENG TECHNOL, V10, P299, DOI 10.3109/03091908609022923; Allin D, 2008, NEUROSURGERY, V62, P1158, DOI 10.1227/01.neu.0000325878.67752.eb; BRUNER J M R, 1972, JAAMI Journal of the Association for the Advancement of Medical Instrumentation, V6, P222; BRUNER JMR, 1967, ANESTHESIOLOGY, V28, P396, DOI 10.1097/00000542-196703000-00023; Citerio G, 2004, ACTA NEUROCHIR, V146, P1221, DOI 10.1007/s00701-004-0351-z; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Eide PK, 2010, J NEUROSURG, V112, P616, DOI 10.3171/2009.7.JNS081593; Eide PK, 2008, MED ENG PHYS, V30, P34, DOI 10.1016/j.medengphy.2007.01.005; Eide PK, 2006, MED ENG PHYS, V28, P542, DOI 10.1016/j.medengphy.2005.09.003; Eide PK, 2010, J NEUROSURG, V113, P1317, DOI 10.3171/2010.7.JNS10483; Fernandes HM, 1998, ACT NEUR S, V71, P44; GAMBARDELLA G, 1992, NEUROSURGERY, V31, P918, DOI 10.1227/00006123-199211000-00014; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gray WP, 1996, NEUROSURGERY, V39, P927, DOI 10.1097/00006123-199611000-00008; Guyot LL, 1998, ACT NEUR S, V71, P47; HOLDSTOCK P, 1996, FOS FSD S, P356; Janny P, 1950, THESIS; Kathirgamanathan P, 2000, J ELECTROSTAT, V49, P51, DOI 10.1016/S0304-3886(00)00003-6; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lang JM, 2003, NEUROSURGERY, V52, P1455, DOI 10.1227/01.NEU.0000065136.70455.6F; LEONARD PF, 1972, ANESTH ANAL CURR RES, V51, P797; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Morgalla MH, 2002, ACTA NEUROCHIR, V144, P57, DOI 10.1007/s701-002-8274-2; Morgalla MH, 1999, J MED ENG TECHNOL, V23, P144; Morgalla MH, 2001, J NEUROSURG, V95, P529, DOI 10.3171/jns.2001.95.3.0529; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; PIPER IR, 1995, NEUROSURGERY, V36, P1142, DOI 10.1227/00006123-199506000-00012; Poca MA, 2008, J NEUROSURG, V108, P934, DOI 10.3171/JNS/2008/108/5/0934; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Rossi S, 1998, ACT NEUR S, V71, P91; Signorini DF, 1998, BRIT J NEUROSURG, V12, P223; Smallwood J, 2005, J ELECTROSTAT, V63, P501, DOI 10.1016/j.elstat.2005.03.009; Stendel R, 2003, ACTA NEUROCHIR, V145, P185, DOI 10.1007/s00701-002-1052-0; WEIBELL FJ, 1974, ANN BIOMED ENG, V2, P126, DOI 10.1007/BF02368486; Yau YH, 2000, J NEUROSURG, V93, P1072, DOI 10.3171/jns.2000.93.6.1072; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	41	16	16	0	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-925X			BIOMED ENG ONLINE	Biomed. Eng. Online	AUG 22	2011	10								75	10.1186/1475-925X-10-75			16	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	824RX	WOS:000295220900001	21859487	Green Published, Green Submitted, gold			2022-02-06	
J	Roscigno, CI; Swanson, KM; Vavilala, MS; Solchany, J				Roscigno, Cecelia I.; Swanson, Kristen M.; Vavilala, Monica S.; Solchany, Joanne			Children's longing for everydayness: Life following traumatic brain injury in the USA	BRAIN INJURY			English	Article						Adjustment; children; community integration; disability; head injury; psychology	QUALITY-OF-LIFE; DOWN-SYNDROME; INDIVIDUALS; PEDIATRICIANS; DISABILITY; MENINGOMYELOCELE; PROGNOSTICATIONS; PROFESSIONALS; SATISFACTION; SUICIDALITY	Primary objective: Little is known about life after traumatic brain injury (TBI) from the child's perspective. Research design: This descriptive phenomenological investigation explored themes of children's experiences following moderate-to-severe TBI. Research design: This descriptive phenomenological investigation explored themes of children's experiences following moderate-to-severe TBI. Methods and procedures: Inclusion criteria: (1) 6--18 years of age at injury; (2) moderate-to-severe TBI; (3) < a parts per thousand currency sign3 years since injury; and (4) English speaking and could participate in an interview. Children participated (n == 39) in two interviews at least 1 year apart. A preliminary model was developed and shared for participants'' input. Main outcomes and results: Six themes emerged: (1) it is like waking up in a bad dream; (2) I thought going home would get me back to my old life, but it did not; (3) everything is such hard work; (4) you feel like you will never be like the person you were before; (5) it is not all bad; and (6) some people get it, but many people do not. Conclusions: Social support was important to how children adjusted to changes or losses. Most children did adjust to functional changes by second interviews. Children had a more difficult time adjusting to how others defined them and limited their possibilities for a meaningful life.	[Roscigno, Cecelia I.] Univ Illinois, Coll Nursing, Chicago, IL USA; [Swanson, Kristen M.] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA; [Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Solchany, Joanne] Univ Washington, Sch Nursing, Seattle, WA 98195 USA		Roscigno, CI (corresponding author), 845 S Damen Ave MC 802, Chicago, IL 60612 USA.	roscigno@uic.edu			Integra LifeSciences Corporation; NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation; University of Washington School of NursingUniversity of Washington; University of WashingtonUniversity of Washington [6 T73 MC 00041-11-03]; Irving B. Harris Foundation Faculty Scholars Initiative; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007091, F31NR009599] Funding Source: NIH RePORTER	The first author received grant funding from Integra LifeSciences Corporation, but the authors alone are responsible for the research and content of this paper.; The authors would also like to acknowledge the following for their assistance with recruitment: the Rehabilitation Department at Seattle Children's; the University of Washington's Rehabilitation Department; the Florida Department of Health's Brain and Spinal Cord Injury Program (Ft. Lauderdale Region); the Harborview Medical Center Pediatric Trauma Registry; and the Brain Injury Association of USA. The authors would like to acknowledge Pamela Mitchell for her participation on the author's dissertation committee. Most of all, the authors would like to thank the children who shared their insights about living with TBI. The study received funding support from: a NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02); a Psi Chapter of Sigma Theta Tau Grant; a 2006 American Nurses Foundation Martha E. Brill Scholars Award; a University of Washington School of Nursing Hester McLaws Scholarship Fund; a University of Washington LEND Training Grant (TG # 6 T73 MC 00041-11-03); the University of Washington Gatzert Child Welfare Fellowship; and an Integra LifeSciences Grant. The first author's postdoctoral training, in which this manuscript was written, was funded by the Irving B. Harris Foundation Faculty Scholars Initiative.	ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; BACH JR, 1994, ARCH PHYS MED REHAB, V75, P626, DOI 10.1016/0003-9993(94)90183-X; Bier JAB, 1996, CLIN PEDIATR, V35, P113, DOI 10.1177/000992289603500301; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Chisholm J, 2001, Axone, V23, P12; Colaizzi P., 1978, EXISTENTIAL PHENOMEN; COOLEY WC, 1990, AM J DIS CHILD, V144, P1112, DOI 10.1001/archpedi.1990.02150340056023; Cremeens J, 2007, CHILD CARE HLTH DEV, V33, P83, DOI 10.1111/j.1365-2214.2006.00665.x; CUSHMAN LA, 1990, ARCH PHYS MED REHAB, V71, P191; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; Fox RC, 2005, NEW ENGL J MED, V353, P1316, DOI 10.1056/NEJMp058066; GERHART KA, 1994, ANN EMERG MED, V23, P807, DOI 10.1016/S0196-0644(94)70318-3; Goode D. A., 1994, QUALITY LIFE PERSONS; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Griffin J., 1986, WELL BEING ITS MEANI; Haley Stephen M, 2004, J Intensive Care Med, V19, P205, DOI 10.1177/0885066604265798; Hawley C A, 2005, Pediatr Rehabil, V8, P117; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Husserl Edmund, 1965, PHENOMENOLOGY CRISIS; Janvier A, 2008, J PERINATOL, V28, P821, DOI 10.1038/jp.2008.103; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; LONGMORE PK, 1995, J LAW MED ETHICS, V23, P82, DOI 10.1111/j.1748-720X.1995.tb01335.x; MARRIS P, 1975, GARDEN CITY; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Patton MQ, 2002, QUALITATIVE RES EVAL, P37; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; SIPERSTEIN GN, 1988, J PEDIATR-US, V113, P835, DOI 10.1016/S0022-3476(88)80010-6; SIPERSTEIN GN, 1994, AM J MENT RETARD, V98, P519; Thomasgard M, 2004, CLIN PEDIATR, V43, P119, DOI 10.1177/000992280404300201; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; WOLRAICH ML, 1991, DEV MED CHILD NEUROL, V33, P336; WOLRAICH ML, 1987, PEDIATRICS, V80, P643; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; World Health Organization, 1993, MEAS QUAL LIF CHILDR; Wright B. A., 1988, ATTITUDES PERSONS DI, P3; WRIGHT BA, 1960, ATTITUDES PERSONS DI	44	16	16	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2011	25	9					882	894		10.3109/02699052.2011.581638			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300008	21631183	Green Accepted, Green Submitted			2022-02-06	
J	Zhang, Y; Su, YY; Ye, H; Xiao, SY; Chen, WB; Zhao, JW				Zhang, Yan; Su, Ying Ying; Ye, Hong; Xiao, Shu Ying; Chen, Wei Bi; Zhao, Jing Wei			Predicting comatose patients with acute stroke outcome using middle-latency somatosensory evoked potentials	CLINICAL NEUROPHYSIOLOGY			English	Article						Middle-latency somatosensory evoked potentials; Severe stroke; Glasgow Coma Scale; Outcome prediction	CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; POSTANOXIC COMA; PROGNOSIS; RESPONSES; SURVIVORS; CORTEX; SCALE	Objective: To evaluate the prognostic value of middle-latency somatosensory evoked potential (MLSEP) in comatose patients with acute severe supratentorial stroke, considering both unfavourable outcome and death. Methods: Eighty-eight patients with acute severe supratentorial stroke underwent MLSEP, short-latency somatosensory evoked potential (SLSEP), Glasgow Coma Scale (GCS) and cerebral computed tomography (CCT) within 1 week from onset. MLSEP and SLSEP were recorded in 25 normal controls. All patients were evaluated with two criteria of outcome as unfavourable outcome (modified Rankin Scale 4-6) and death 6 months after onset. N60 of MLSEP predictive value was compared with N20 of SLSEP, GCS and CCT. Results: Sixty-seven patients (76.1%) suffered from cerebral infarction; and 21 patients (23.9%) suffered from intracerebral haemorrhage. Seventy-one patients (80.7%) had unfavourable outcomes and 39 patients (44.3%) died. The peak latencies of MLSEP were prolonged and some waves of MLSEP were absent in stroke patients, and the proportion of absent waves in lesion-ipsilateral MLSEP was higher than in contralateral MLSEP. By using the prognostic authenticity analysis of predictors, the lesion-ipsilateral absence of N60 showed the highest sensitivity for unfavourable outcome (97.2%, confidence interval (CI): 89.3-99.5%) and death (100%, CI: 88.8-100%), which was superior to GCS, CCT and N20. Bilateral absence of N60 showed a high specificity of 100% for unfavourable outcome, which was as good as bilateral absence of N20. However, it showed a specificity of 89.8% (CI: 77.0-96.2%) for death, not as good as bilateral absence of N20 (98%, CI: 87.8-99.9%). The false positive rate of lesion-ipsilateral absence of N60 for unfavourable outcome and death was 12.7% (CI: 6.6-22.5%) and 50.6% (CI: 39.2-62.0%), respectively, and that of bilateral absence of N60 was 0 (CI: 0-12.3%) and 14.3% (CI: 5.4-31.0%), respectively. Conclusions: We confirm the high predictive value of MLSEP in severe stroke. MLSEP showed higher sensitivity than SLSEP for predicting unfavourable outcome and death. Combined MLSEP with SLSEP results produced even greater predictive value. Significance: The combination of MLSEP and SLSEP would increase the sensitivity and maintain the high specificity not only for predicting outcome in coma after cardiopulmonary resuscitation but also after severe stroke. (C) 2011 Published by Elsevier Ireland Ltd. on behalf of International Federation of Clinical Neurophysiology.	[Zhang, Yan; Su, Ying Ying; Ye, Hong; Xiao, Shu Ying; Chen, Wei Bi; Zhao, Jing Wei] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing 100053, Peoples R China		Su, YY (corresponding author), Capital Med Univ, Dept Neurol, Xuanwu Hosp, 45 Changchun St, Beijing 100053, Peoples R China.	tangsuyingying@sina.com			Capital Developing Medical Research Fund, China (CDMRF) [2007-1043]	The study was sponsored by the Capital Developing Medical Research Fund, China (CDMRF, 2007-1043). We received helpful comments from Prof. Y.C. Ding.	Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Barba C, 2002, CLIN NEUROPHYSIOL, V113, P981, DOI 10.1016/S1388-2457(02)00104-9; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; CHIANG T-R, 1989, Taiwan yixuehui zazhi, V88, P778; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; Fischer C, 2006, CRIT CARE MED, V34, P1520, DOI 10.1097/01.CCM.0000215823.36344.99; Forss N, 1999, BRAIN, V122, P1889, DOI 10.1093/brain/122.10.1889; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; GARRAGHTY PE, 1990, BRAIN RES, V528, P165, DOI 10.1016/0006-8993(90)90213-U; Gendo A, 2001, INTENS CARE MED, V27, P1305, DOI 10.1007/s001340101008; Haring HP, 1999, STROKE, V30, P1076, DOI 10.1161/01.STR.30.5.1076; Hofmeijer J, 2008, CEREBROVASC DIS, V25, P176, DOI 10.1159/000113736; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Madl C, 2000, CRIT CARE MED, V28, P721, DOI 10.1097/00003246-200003000-00020; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; Reid JM, 2010, AGE AGEING, V39, P360, DOI 10.1093/ageing/afq027; SACCO RL, 1990, ARCH NEUROL-CHICAGO, V47, P1181, DOI 10.1001/archneur.1990.00530110035013; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Sherman AL, 2000, NEUROLOGY, V54, P889, DOI 10.1212/WNL.54.4.889; Su YY, 2010, J CLIN NEUROPHYSIOL, V27, P25, DOI 10.1097/WNP.0b013e3181cb4282; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; TEASDALE G, 1974, LANCET, V2, P81; vonKummer R, 1996, AM J NEURORADIOL, V17, P1743; Wang YL, 2007, INT J STROKE, V2, P211, DOI 10.1111/j.1747-4949.2007.00142.x; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Young GB, 2005, NEUROCRIT CARE, V2, P159, DOI 10.1385/NCC:2:2:159; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	34	16	18	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	AUG	2011	122	8					1645	1649		10.1016/j.clinph.2010.11.016			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	791AX	WOS:000292633300025	21317029				2022-02-06	
J	Risher, WC; Lee, MR; Fomitcheva, IV; Hess, DC; Kirov, SA				Risher, W. Christopher; Lee, Mark R.; Fomitcheva, Ioulia V.; Hess, David C.; Kirov, Sergei A.			Dibucaine Mitigates Spreading Depolarization in Human Neocortical Slices and Prevents Acute Dendritic Injury in the Ischemic Rodent Neocortex	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTRINSIC OPTICAL SIGNALS; IN-VIVO; ANOXIC DEPOLARIZATION; PERIINFARCT DEPOLARIZATIONS; HIPPOCAMPAL SLICES; BRAIN-SLICES; GLUCOSE DEPRIVATION; LOCAL-ANESTHETICS; NA+ CHANNELS	Background: Spreading depolarizations that occur in patients with malignant stroke, subarachnoid/intracranial hemorrhage, and traumatic brain injury are known to facilitate neuronal damage in metabolically compromised brain tissue. The dramatic failure of brain ion homeostasis caused by propagating spreading depolarizations results in neuronal and astroglial swelling. In essence, swelling is the initial response and a sign of the acute neuronal injury that follows if energy deprivation is maintained. Choosing spreading depolarizations as a target for therapeutic intervention, we have used human brain slices and in vivo real-time two-photon laser scanning microscopy in the mouse neocortex to study potentially useful therapeutics against spreading depolarization-induced injury. Methodology/Principal Findings: We have shown that anoxic or terminal depolarization, a spreading depolarization wave ignited in the ischemic core where neurons cannot repolarize, can be evoked in human slices from pediatric brains during simulated ischemia induced by oxygen/glucose deprivation or by exposure to ouabain. Changes in light transmittance (LT) tracked terminal depolarization in time and space. Though spreading depolarizations are notoriously difficult to block, terminal depolarization onset was delayed by dibucaine, a local amide anesthetic and sodium channel blocker. Remarkably, the occurrence of ouabain-induced terminal depolarization was delayed at a concentration of 1 mu M that preserves synaptic function. Moreover, in vivo two-photon imaging in the penumbra revealed that, though spreading depolarizations did still occur, spreading depolarization-induced dendritic injury was inhibited by dibucaine administered intravenously at 2.5 mg/kg in a mouse stroke model. Conclusions/Significance: Dibucaine mitigated the effects of spreading depolarization at a concentration that could be well-tolerated therapeutically. Hence, dibucaine is a promising candidate to protect the brain from ischemic injury with an approach that does not rely on the complete abolishment of spreading depolarizations.	[Risher, W. Christopher] Georgia Hlth Sci Univ, Grad Program Neurosci, Augusta, GA USA; [Lee, Mark R.; Fomitcheva, Ioulia V.; Kirov, Sergei A.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA; [Hess, David C.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Risher, W. Christopher; Hess, David C.; Kirov, Sergei A.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA		Risher, WC (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	skirov@georgiahealth.edu	Risher, W Christopher/AAZ-3982-2020	Risher, W Christopher/0000-0002-2230-2865	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS064753, NS057113, NS062154]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS064753, R01NS057113, R21NS062154] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NS064753 (W.C.R.), NS057113 (S.A.K.), and NS062154 (S.A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; ALEXANDER JT, 1975, J APPL PHYSIOL, V39, P1041, DOI 10.1152/jappl.1975.39.6.1041; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Davies ML, 2007, J NEUROSCI METH, V166, P203, DOI 10.1016/j.jneumeth.2007.07.012; Dayan PS, 1996, ANN EMERG MED, V28, P442, DOI 10.1016/S0196-0644(96)70013-6; Dietz RM, 2009, J NEUROCHEM, V109, P145, DOI 10.1111/j.1471-4159.2009.05853.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Donnan GA, 2008, STROKE, V39, P242, DOI 10.1161/STROKEAHA.107.493296; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fung ML, 1999, NEUROSCI LETT, V275, P41, DOI 10.1016/S0304-3940(99)00728-4; Hartings JA, 2003, J NEUROSCI, V23, P11602; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Jarvis CR, 1999, NEUROIMAGE, V10, P357, DOI 10.1006/nimg.1999.0473; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; JIANG C, 1992, J NEUROPHYSIOL, V68, P2165, DOI 10.1152/jn.1992.68.6.2165; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; Momota Y, 2000, ANESTH ANALG, V91, P362, DOI 10.1097/00000539-200008000-00024; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; PARDRIDGE WM, 1983, J CLIN INVEST, V71, P900, DOI 10.1172/JCI110844; Petzold GC, 2005, STROKE, V36, P1270, DOI 10.1161/01.STR.0000166023.51307.e0; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; SHIBATA M, 1994, REGION ANESTH, V19, P255; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Somjen GG, 2004, IONS BRAIN NORMAL FU; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; TAYLOR CP, 1995, TRENDS PHARMACOL SCI, V16, P309, DOI 10.1016/S0165-6147(00)89060-4; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, CHANNELS, V2, P81, DOI 10.4161/chan.2.2.6003; Urenjak J, 1996, PHARMACOL REV, V48, P21; WEBER ML, 1994, BRAIN RES, V664, P167, DOI 10.1016/0006-8993(94)91967-4; WESTER P, 1995, STROKE, V26, P444, DOI 10.1161/01.STR.26.3.444; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Yamada A, 2004, NEUROSCI RES, V50, P291, DOI 10.1016/j.neures.2004.07.008; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	59	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22351	10.1371/journal.pone.0022351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	WOS:000292811700042	21789251	Green Published, Green Submitted, gold			2022-02-06	
J	Lok, J; Leung, WD; Zhao, S; Pallast, S; van Leyen, K; Guo, SZ; Wang, XY; Yalcin, A; Lo, EH				Lok, Josephine; Leung, Wendy; Zhao, Song; Pallast, Stefanie; van Leyen, Klaus; Guo, Shuzhen; Wang, Xiaoying; Yalcin, Ayfer; Lo, Eng H.			Gamma-glutamylcysteine ethyl ester protects cerebral endothelial cells during injury and decreases blood-brain barrier permeability after experimental brain trauma	JOURNAL OF NEUROCHEMISTRY			English	Article						blood-brain barrier; endothelial; GCEE; glutathione; neuroprotection; oxidative stress	INDUCED OXIDATIVE STRESS; PARKINSONS-DISEASE; THERAPEUTIC STRATEGY; GLUTATHIONE; NEURODEGENERATION; ELEVATION; MICE; MONOCHLOROBIMANE; EXCITOTOXICITY; METABOLISM	Oxidative stress is a pathway of injury that is common to almost all neurological conditions. Hence, methods to scavenge radicals have been extensively tested for neuroprotection. However, saving neurons alone may not be sufficient in treating CNS disease. In this study, we tested the cytoprotective actions of the glutathione precursor gamma-glutamylcysteine ethyl ester (GCEE) in brain endothelium. First, oxidative stress was induced in a human brain microvascular endothelial cell line by exposure to H(2)O(2). Addition of GCEE significantly reduced formation of reactive oxygen species, restored glutathione levels which were reduced in the presence of H(2)O(2), and decreased cell death during H(2)O(2)-mediated injury. Next, we asked whether GCEE can also protect brain endothelial cells against oxygen-glucose deprivation OGD). As expected, OGD disrupted mitochondrial membrane potentials. GCEE was able to ameliorate these mitochondrial effects. Concomitantly, GCEE significantly decreased endothelial cell death after OGD. Lastly, our in vivo experiments using a mouse model of brain trauma show that post-trauma (10 min after controlled cortical impact) administration of GCEE by intraperitoneal injection results in a decrease in acute blood-brain barrier permeability. These data suggest that the beneficial effects of GCEE on brain endothelial cells and microvessels may contribute to its potential efficacy as a neuroprotective agent in traumatic brain injury.	[Lok, Josephine; Leung, Wendy; Zhao, Song; Pallast, Stefanie; van Leyen, Klaus; Guo, Shuzhen; Wang, Xiaoying; Lo, Eng H.] Massachusetts Gen Hosp, Neuroprotect Res Lab, Boston, MA 02114 USA; [Lok, Josephine; Leung, Wendy] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Zhao, Song] Jilin Univ, Hosp 1, Spine Div, Dept Orthoped, Changchun 130023, Jilin, Peoples R China; [Yalcin, Ayfer] Ege Univ, Fac Pharm, Dept Biochem, Izmir, Turkey; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA		Lok, J (corresponding author), Massachusetts Gen Hosp, Neuroprotect Res Lab, 175 Cambridge St,5th Floor, Boston, MA 02114 USA.	jlok1@partners.org	Yalcin, Ayfer/AAK-6337-2021; Yalcin, Ayfer/AAE-5332-2019; Yalcin, Ayfer/AAK-3010-2020; van Leyen, Klaus/C-9126-2013	Yalcin, Ayfer/0000-0003-0407-3218; van Leyen, Klaus/0000-0003-1032-3754	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08NS057339, R01NS049430, R01NS53560, P01NS555104]; American Heart AssociationAmerican Heart Association; Fulbright Program; Technological and Scientific Council of TurkeyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [SBAG-K69-104S280]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053560, R01NS049430, K08NS057339] Funding Source: NIH RePORTER	This study was supported by NIH grants (K08NS057339 to J.L., R01NS049430 to K.v.L., R01NS53560 and P01NS555104 to E.H.L.), a Scientist Development Grant from the American Heart Association (to K.v.L.), a fellowship from the Fulbright Program (to A.Y.), and by the Technological and Scientific Council of Turkey (SBAG-K69-104S280 to A.Y). The authors thank Dr Michael J. Whalen for helpful discussions regarding the CCI model. The authors declare no conflicts of interest.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Anderson ME, 1998, SEMIN LIVER DIS, V18, P415, DOI 10.1055/s-2007-1007174; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Boyd-Kimball D, 2005, J NEUROSCI RES, V79, P707, DOI 10.1002/jnr.20393; Butterfield DA, 2002, DRUG DEVELOP RES, V56, P428, DOI 10.1002/ddr.10095; Callahan MK, 2004, J NEUROIMMUNOL, V153, P150, DOI 10.1016/j.jneuroim.2004.05.004; Chinta SJ, 2006, NEUROSCI LETT, V402, P137, DOI 10.1016/j.neulet.2006.03.056; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Drake J, 2003, J NEUROSCI RES, V74, P917, DOI 10.1002/jnr.10810; Drake J, 2002, J NEUROSCI RES, V68, P776, DOI 10.1002/jnr.10266; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fernandez-Gomez FJ, 2005, NEUROBIOL DIS, V20, P384, DOI 10.1016/j.nbd.2005.03.019; FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Huet O, 2008, CRIT CARE MED, V36, P2328, DOI 10.1097/CCM.0b013e3181800387; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kwon KJ, 2010, J CLIN NEUROL, V6, P127, DOI 10.3988/jcn.2010.6.3.127; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nishida K, 1996, BBA-MOL CELL RES, V1313, P47, DOI 10.1016/0167-4889(96)00054-7; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; SHRIEVE DC, 1988, J BIOL CHEM, V263, P14107; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sun XJ, 2006, J BIOL CHEM, V281, P17420, DOI 10.1074/jbc.M601567200; Turunc E, 2010, J PHARM PHARMACOL, V62, P1010, DOI 10.1111/j.2042-7158.2010.01122.x; Yalcin A, 2010, FREE RADICAL RES, V44, P513, DOI 10.3109/10715761003645964; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	40	16	16	0	4	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	JUL	2011	118	2					248	255		10.1111/j.1471-4159.2011.07294.x			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	791HH	WOS:000292655300009	21534958	Bronze, Green Accepted			2022-02-06	
J	Smith, CM; Adelson, PD; Chang, YF; Brown, SD; Kochanek, PM; Clark, RSB; Bayir, H; Hinchberger, J; Bell, MJ				Smith, Craig M.; Adelson, P. David; Chang, Yue-Fang; Brown, S. Danielle; Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Hinchberger, Jessica; Bell, Michael J.			Brain-systemic temperature gradient is temperature-dependent in children with severe traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						pediatric; brain injury; temperature; hypothermia; TBI	TISSUE OXYGEN-TENSION; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; RECTAL TEMPERATURES; UNITED-STATES; CARE; HYPERTHERMIA; MANAGEMENT; BLADDER; IMPACT	Objectives: To understand the gradient between rectal and brain temperature in children after severe traumatic brain injury. We hypothesized that the rectal temperature and brain temperature gradient will be influenced by the child's body surface area and that this relationship will persist over physiologic temperature ranges. Design: Retrospective review of a prospectively collected pediatric neurotrauma registry. Setting: Academic, university-based pediatric neurotrauma program. Patients: Consecutive children (n = 40) with severe traumatic brain injury (Glasgow coma scale of <8) who underwent brain temperature monitoring (July 2003 to December 2008) were studied after informed consent was obtained. A subset of children (n = 24) were concurrently enrolled in a randomized, controlled clinical trial of early-moderate hypothermia for neuroprotection. Interventions: Data extraction of multiple clinical variables, including demographic data, body surface area, and rectal and brain temperature at recorded at hourly intervals. Measurements and Main Results: Paired brain and rectal temperature measurements (in degrees Celsius, n = 4369) were collected hourly and compared by using Pearson correlations. Patients were stratified according to body surface area (<1.0 m(2), 1.0-1.99 m(2), 2.0-2.99 m(2), and >3.0 m(2)) and based on brain temperature (<= 34.0, 34.1-36.0; 36.1-38, >= 38.1). Body surface area and brain temperature were compared between groups by using Pearson correlations with correction for repeated measures. Mean brain temperature-rectal temperature difference was calculated for stratified brain temperature ranges. Overall, brain and rectal temperatures were highly correlated (r = .86, p < .001). During brain hyperthermia, brain temperature-rectal temperature was similar to that reported in previous studies with brain temperature higher than rectal temperature (1.75 +/- 0.4; r = .54). Surprisingly, this relationship was reversed during brain hypothermia (brain temperature-rectal temperature = -1.87 +/- 0.8; r = .37), indicating a reversal of the brain-systemic temperature gradient. When stratified for body surface area, the correlation between rectal temperature and brain temperature remained strong (r = .78, 0.91, 0.79 and 0.95, respectively, p < .001). However, the correlation between brain temperature and rectal temperature was substantially decreased when stratified for brain temperature (r = .37, 0.58, 0.48, 0.54, p < .001). In particular, during moderate brain hypothermia (brain temperature < 34), the correlation between brain temperature and rectal temperature was weakest, indicating the greatest variability during this condition which is often targeted for therapeutic trials. Conclusions: Brain temperature and rectal temperature are generally well-correlated in children with traumatic brain injury. This relationship is different at the extremes of the physiologic temperature range, with the temperature gradient reversed during brain hypothermia and hyperthermia. Given that studies showing neuroprotection from hypothermia in animal models of brain injury generally target brain temperature, our data suggest the possibility that, if brain temperature were the therapeutic target in clinical trials, this would result in somewhat higher systemic temperature and potentially fewer side effects. This relationship may be exploited in future clinical trials to maintain brain hypothermia (for neurologic protection) at slightly higher systemic temperatures (and potentially fewer systemic side effects). (Pediatr Crit Care Med 2011; 12:449-454)	[Smith, Craig M.; Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Chang, Yue-Fang; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA USA; [Hinchberger, Jessica] Univ Pittsburgh, Sch Med, Dept Nursing, Pittsburgh, PA USA; [Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Bell, Michael J.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kochanek, Patrick M.; Clark, Robert S. B.; Bayir, Huelya; Bell, Michael J.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Adelson, P. David; Brown, S. Danielle] Phoenix Childrens Hosp, Dept Neurosurg, Phoenix, AZ USA		Smith, CM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	smithcm3@upmc.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	National Institutes of Health, Bethesda, MDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD40686, NS30318]; Cyberomics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P01NS030318, P20NS030318] Funding Source: NIH RePORTER	Supported, in part, by the National Institutes of Health, Bethesda, MD (T32HD40686) (CMS) and NS30318 (PMK). Dr. Adelson consulted for Traumic and received honoraria/speaking fees from Cyberomics. The remaining authors have not disclosed potential conflicts of interest.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Ao HS, 2000, RESUSCITATION, V45, P111, DOI 10.1016/S0300-9572(00)00154-4; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; Childs C, 2008, BRAIN INJURY, V22, P603, DOI 10.1080/02699050802189719; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jaeger M, 2005, ACT NEUR S, V95, P117; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; WEISEND MP, 1994, J NEUROSURG, V80, P120, DOI 10.3171/jns.1994.80.1.0120	41	16	16	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2011	12	4					449	454		10.1097/PCC.0b013e3181f390dd			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	788ME	WOS:000292448200018	20711083	Green Accepted			2022-02-06	
J	Jeon, SW; Choi, JH; Jang, TW; Moon, SM; Hwang, HS; Jeong, JH				Jeon, Sei Woong; Choi, Jong Hun; Jang, Tae Won; Moon, Seung-Myung; Hwang, Hyung-Sik; Jeong, Je Hoon			Risk Factors Associated with Subdural Hygroma after Decompressive Craniectomy in Patients with Traumatic Brain Injury: A Comparative Study	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Subdural hygroma; Decompressive craniectomy; Traumatic brain injury; Risk factor; Cerebrospinal fluid	SURGICAL DECOMPRESSION; PATHOGENESIS; SPACE; HYDROCEPHALUS; COMPLICATIONS; SECONDARY; EFFUSION; FLUID	Objective : Subdural hygroma (SDG) is a complication occurring after head trauma that may occur secondary to decompressive craniectomy (DC). However, the mechanism underlying SDG formation, is not fully understood. Also, the relationship between the operative technique of DC or the decompressive effect and the occurrence and pathophysiology of SDG has not been clarified. Purpose of this study was to investigate the risk factors of SDG after DC in our series. Methods : From January 2004 to December 2008, DC was performed in 85 patients who suffered from traumatic brain injury. We retrospectively reviewed the clinical and radiological features. For comparative analysis, we divided the patients into 2 groups : one group with SDG after craniectomy (19 patients; 28.4% of the total sample), the other group without SDG (48 patients; 71.6%). The risk factors for developing SDG were then analyzed. Results : The mean Glasgow Outcome Scale (GOS) scores at discharge of the groups with and without SDG were 2.8 and 3.1, respectively (p<0.0001). Analysis of radiological factors showed that a midline shift in excess of 5 mm on CT scans was present in 19 patients (100%) in the group with SDG and in 32 patients (66.7%) in the group without SDG (p<0.05). An accompanying subarachnoid hemorrhage (SAH) was seen in 17 patients (89.5%) in the group with SDG and in 29 patients (60.4%) in the group without SDG (p<0.05). Delayed hydrocephalus accompanied these findings in 10 patients (52.6%) in the group with SDG, versus 5 patients (10.4%) in the group without SDG (p<0.05). On CT, compression of basal cisterns was observed in 14 members (73.7%) in the group with SDG and in 18 members of the group without SDG (37.5%) (p<0.007). Furthermore, tearing of the arachnoid membrane, as observed on CT, was more common in all patients in the group with SDG (100%) than in the group without SDG (31 patients; 64.6%) (p<0.05). Conclusion : GOS showed statistically significant difference in the clinical risk factors for SDG between the group with SDG and the group without SDG. Analysis of radiological factors indicated that a midline shifting exceeding 5 mm, SAH, delayed hydrocephalus, compression of basal cisterns, and tearing of the arachnoid membrane were significantly more common in patients with SDG.	[Jeon, Sei Woong; Choi, Jong Hun; Moon, Seung-Myung; Hwang, Hyung-Sik; Jeong, Je Hoon] Hallym Univ, Coll Med, Dept Neurosurg, Seoul 150030, South Korea; [Jang, Tae Won] Hallym Univ, Coll Med, Dept Occupat & Environm Med, Seoul 150030, South Korea		Jeong, JH (corresponding author), Hallym Univ, Coll Med, Dept Neurosurg, 94-195 Yeongdeungpo Dong, Seoul 150030, South Korea.	neuri71@gmail.com		MOON, Seung-Myung/0000-0001-6248-9049			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; CSERR HF, 1974, EXP NEUROL, V45, P50, DOI 10.1016/0014-4886(74)90099-5; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Johnston I, 2000, CHILD NERV SYST, V16, P776, DOI 10.1007/s003810000383; Kawaguchi T, 1998, NEUROSURGERY, V43, P1033, DOI 10.1097/00006123-199811000-00017; Lang JK, 1999, SURG NEUROL, V52, P630, DOI 10.1016/S0090-3019(99)00144-5; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Liu YG, 2009, INJURY, V40, P968, DOI 10.1016/j.injury.2009.01.006; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; OHNO K, 1987, J NEUROL NEUROSUR PS, V50, P1694, DOI 10.1136/jnnp.50.12.1694; SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc	24	16	21	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JUN	2011	49	6					355	358		10.3340/jkns.2011.49.6.355			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	787YR	WOS:000292413100008	21887394	Green Published, gold			2022-02-06	
J	Rahimi-Movaghar, V; Saadat, S; Rasouli, MR; Ghahramani, M; Eghbali, A				Rahimi-Movaghar, Vafa; Saadat, Soheil; Rasouli, Mohammad Reza; Ghahramani, Maryam; Eghbali, Aliashraf			The Incidence of Traumatic Brain Injury in Tehran, Iran: A Population Based Study	AMERICAN SURGEON			English	Article									[Rahimi-Movaghar, Vafa; Saadat, Soheil; Ghahramani, Maryam; Eghbali, Aliashraf] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Rasouli, Mohammad Reza] Thomas Jefferson Univ, Rothman Inst Orthoped, Philadelphia, PA 19107 USA		Rahimi-Movaghar, V (corresponding author), Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.	v_rahimi@sina.tums.ac.ir	Saadat, Soheil/J-1595-2014	Saadat, Soheil/0000-0002-2744-7983			Annoni J M, 1992, Disabil Rehabil, V14, P23; Rahimi-Movaghar V, 2009, INT J INJ CONTROL SA, V16, P179, DOI 10.1080/17457300903024277; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wrightson P, 1998, NEW ZEAL MED J, V111, P99	4	16	17	0	5	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	JUN	2011	77	6					E112	E114					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	775ZC	WOS:000291501400040	21679621				2022-02-06	
J	Reinstrup, P; Nordstrom, CH				Reinstrup, Peter; Nordstrom, Carl-Henrik			Prostacyclin Infusion May Prevent Secondary Damage in Pericontusional Brain Tissue	NEUROCRITICAL CARE			English	Article						Brain trauma; Neuro critical care; Microdialysis; Prostacyclin	LOW-DOSE PROSTACYCLIN; INTRACEREBRAL MICRODIALYSIS; INJURY; THERAPY; TRAUMA; RAT	Background Prostacyclin is a potent vasodilator, inhibitor of leukocyte adhesion, and platelet aggregation, and has been suggested as therapy for cerebral ischemia. A case of focal traumatic brain lesion that was monitored using intracerebral microdialysis, and bedside analysis and display is reported here. When biochemical signs of cerebral ischemia progressed, i.v. infusion of prostacyclin was started. Methods Two microdialysis catheters were placed in the penumbra zones surrounding evacuated focal brain contusions. The samples were analyzed for glucose, pyruvate, lactate, glutamate, and glycerol. Results When biochemical deterioration indicated progressive secondary ischemia (increase in lactate/pyruvate ratio, decrease in glucose, and increase in glutamate levels), continuous infusion of prostacyclin (0.5-1.0 ng kg(-1) min(-1) i.v.) was started. The treatment resulted in an improvement of the lactate/pyruvate ratios and a normalization of the interstitial levels of glucose and glutamate. The glycerol levels remained within normal limits indicating that degradation of cellular membranes had not occurred. Conclusion The above case supports the view that new therapies directed toward protection of the sensitive biochemical penumbra zones surrounding focal brain lesions may be evaluated by intracerebral microdialysis.	[Nordstrom, Carl-Henrik] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark; [Reinstrup, Peter] Univ Lund Hosp, Dept Intens & Perioperat Care, S-22185 Lund, Sweden		Nordstrom, CH (corresponding author), Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark.	carl-henrik.nordstrom@med.lu.se			Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [14X-003574-28D]; Lund University Hospital	The study was supported by grants from the Swedish Medical Research Council (14X-003574-28D), and Lund University Hospital. We thank Katarina Nielsen, Department of Neurosurgery, Lund University Hospital, for her help with the microdialysis equipment and biochemical analyses.	BATH P, 2004, COCHRANE DB SYST REV, V3; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BRANDT L, 1981, J NEUROSURG, V55, P877, DOI 10.3171/jns.1981.55.6.0877; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Gardenfors F, 2004, ACTA ANAESTH SCAND, V48, P1316, DOI 10.1111/j.1399-6576.2004.00522.x; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; GRYGLEWSKI RJ, 1983, STROKE, V14, P197, DOI 10.1161/01.STR.14.2.197; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; JORGENSEN MB, 1982, ACTA NEUROL SCAND, V66, P536; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MONCADA S, 1983, STROKE, V14, P157, DOI 10.1161/01.STR.14.2.157; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; NORDSTROM CH, 1996, BRAIN PROTECTION SEV, P117; NORDSTROM CH, 2003, NEUROSURG FOCUS, V15, P1; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; TEASDALE G, 1974, LANCET, V2, P81	24	16	22	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2011	14	3					441	446		10.1007/s12028-010-9486-3			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	759FT	WOS:000290226800019	21161698				2022-02-06	
J	Benech, A; Arcuri, F; Baragiotta, N; Nicolotti, M; Brucoli, M				Benech, Arnaldo; Arcuri, Francesco; Baragiotta, Nicola; Nicolotti, Matteo; Brucoli, Matteo			Retroauricular Transmeatal Approach to Manage Mandibular Condylar Head Fractures	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Condylar head fractures; retroauricular approach; transmeatal access; facial nerve	OPEN REDUCTION; INTERNAL-FIXATION; CLOSED TREATMENT; RETROMANDIBULAR APPROACH; INTRACAPSULAR FRACTURES; TEMPOROMANDIBULAR-JOINT; SURGICAL-TREATMENT; FOLLOW-UP; MOTION; SCREW	Background: There is a multitude of reported surgical approaches and technical variants with some unresolved technical problems to gain direct access to mandibular condylar head fractures; they can be divided into 2 groups: intraoral and extraoral. In 2005, Neff et al (Mund Kiefer Gesichtschir 2005;9:80), supported by a previous experimental work, reported a successful clinical study of condylar head fractures treated by a retroauricular approach; this article is in German, and the later English-language literature does not mention about this approach to open reduction and internal fixation of mandibular condylar fractures. The retroauricular transmeatal access, selected and performed by the senior author to treat 14 patients affected by highly located condylar head fracture, is illustrated in details. Methods: We collected data of 14 consecutive adult patients who, after the discussion about all options, had consented to have 16 mandibular condylar head fractures treated with open reduction and internal fixation by miniplates and screws via a retroauricular transmeatal approach. We exposed the temporomandibular joint area easily and better by dissecting via a retroauricular route with identification, ligation, and transection of the retromandibular vein; because of the posterior access, the frontal branch of the facial nerve and the auriculotemporal nerve are located and protected within the substance of the anteriorly retracted flap, superficial to the retromandibular vein. The follow-up clinical examination showed temporary weakness of the frontal branch of the facial nerve in 1 case with a recovery to normal function of 1.6 months; no patients had permanent weakness of the facial nerve or injury of the auriculotemporal nerve. There was absence of any salivary fistula, sialocele, and Frey syndrome; hearing was preserved in all cases, without any auditory stenosis or aesthetic deformity, and there was absence of any infections, hematoma, or scarring. Conclusions: Retroauricular approach provides good exposure of the temporomandibular joint and satisfactory protection from nerve injuries and vascular lesions, allowing an adequate osteosynthesis. The scar is hidden behind the ear, and the morbidity is low in terms of auditory stenosis, aesthetic deformity, and salivary fistulas.	[Benech, Arnaldo; Arcuri, Francesco; Baragiotta, Nicola; Nicolotti, Matteo; Brucoli, Matteo] Univ Piemonte Orientale Amedeo Avogadro, Azienda Osped Maggiore della Carita, Dept Maxillofacial Surg, Novara, Italy		Arcuri, F (corresponding author), Osped Maggiore della Carita, SCDU Chirurgia Maxillofacciale, Corso Mazzini 18, I-28100 Novara, Italy.	fraarcuri@libero.it		BRUCOLI, Matteo/0000-0002-2867-1936; BENECH, Arnaldo/0000-0003-1905-1089			Anastassov GE, 1997, J CRANIO MAXILL SURG, V25, P9, DOI 10.1016/S1010-5182(97)80018-2; Biglioli F, 2008, J CRANIO MAXILL SURG, V36, P378, DOI 10.1016/j.jcms.2008.05.001; BLAIR VP, 1913, S SURG GYNECOL, V26, P436; Bos RRM, 1999, BRIT J ORAL MAX SURG, V37, P87; Cascone P, 2003, J CRANIOFAC SURG, V14, P184, DOI 10.1097/00001665-200303000-00009; Choi BH, 1997, INT J ORAL MAX SURG, V26, P344, DOI 10.1016/S0901-5027(97)80794-1; Eckelt U., 1995, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V96, P158; Eckelt U, 2006, J CRANIO MAXILL SURG, V34, P306, DOI 10.1016/j.jcms.2006.03.003; Ellis E, 2000, J ORAL MAXIL SURG, V58, P950, DOI 10.1053/joms.2000.8734; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Ellis E, 2000, J ORAL MAXIL SURG, V58, P260, DOI 10.1016/S0278-2391(00)90047-8; ELLIS E, 1993, ORAL SURG ORAL MED O, V76, P6, DOI 10.1016/0030-4220(93)90285-C; Ellis E 3rd, 2000, Facial Plast Surg, V16, P193, DOI 10.1055/s-2000-12579; Ellis ED, 2001, J ORAL MAXIL SURG, V59, P389, DOI 10.1053/joms.2001.21873; Eulert S, 2007, ANN ANAT, V189, P377, DOI 10.1016/j.aanat.2007.02.010; Gerbino G, 2009, J ORAL MAXIL SURG, V67, P1009, DOI 10.1016/j.joms.2008.06.009; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Haug RH, 2007, PLAST RECONSTR SURG, V120, p90S, DOI 10.1097/01.prs.0000260730.43870.1b; He D, 2008, J ORAL MAXIL SURG, V66, P77, DOI 10.1016/j.joms.2007.08.013; He DM, 2010, J ORAL MAXIL SURG, V68, P1578, DOI 10.1016/j.joms.2009.07.076; He DM, 2009, J ORAL MAXIL SURG, V67, P1672, DOI 10.1016/j.joms.2009.02.012; Hlawitschka M, 2005, INT J ORAL MAX SURG, V34, P597, DOI 10.1016/j.ijom.2005.02.004; Hlawitschka M, 2002, J ORAL MAXIL SURG, V60, P784, DOI 10.1053/joms.2002.33246; Hovinga J, 1999, INT J ORAL MAX SURG, V28, P429, DOI 10.1034/j.1399-0020.1999.280606.x; Jacobovicz J, 1998, PLAST RECONSTR SURG, V101, P437, DOI 10.1097/00006534-199802000-00030; Jensen T, 2006, J ORAL MAXIL SURG, V64, P1771, DOI 10.1016/j.joms.2005.12.069; KALLELA I, 1995, J ORAL MAXIL SURG, V53, P1397, DOI 10.1016/0278-2391(95)90663-0; KELLMAN RM, 2009, FACIAL PLAST SURG, V25; Kermer C, 1998, INT J ORAL MAX SURG, V27, P191, DOI 10.1016/S0901-5027(98)80008-8; Loukota RA, 2007, BRIT J ORAL MAX SURG, V45, P399, DOI 10.1016/j.bjoms.2005.12.002; Loukota RA, 2006, BRIT J ORAL MAX SURG, V44, P480, DOI 10.1016/j.bjoms.2005.11.019; MACLENNAN WD, 1952, BRIT J PLAST SURG, V5, P122; MALKIN M, 1964, Oral Surg Oral Med Oral Pathol, V17, P152, DOI 10.1016/0030-4220(64)90133-1; Manisali M, 2003, INT J ORAL MAX SURG, V32, P253, DOI 10.1054/ijom.2002.0270; Martin Mark, 2003, Atlas Oral Maxillofac Surg Clin North Am, V11, P169, DOI 10.1016/S1061-3315(02)00025-2; Narayanan V, 2009, INT J ORAL MAX SURG, V38, P835, DOI 10.1016/j.ijom.2009.04.008; Neff A, 2005, Mund Kiefer Gesichtschir, V9, P80, DOI 10.1007/s10006-005-0600-1; Neff A, 2004, Mund Kiefer Gesichtschir, V8, P63, DOI 10.1007/s10006-004-0529-9; Palmieri C, 1999, J ORAL MAXIL SURG, V57, P764, DOI 10.1016/S0278-2391(99)90810-8; Pilling E, 2006, J ORAL MAXIL SURG, V64, P868, DOI 10.1016/j.joms.2005.11.049; Schneider M, 2007, J CRANIO MAXILL SURG, V35, P151, DOI 10.1016/j.jcms.2007.01.003; Schoen R, 2008, INT J ORAL MAX SURG, V37, P111, DOI 10.1016/j.ijom.2007.06.017; SILVENNOINEN U, 1992, J ORAL MAXIL SURG, V50, P1032, DOI 10.1016/0278-2391(92)90484-H; TASANEN A, 1976, Journal of Maxillofacial Surgery, V4, P200, DOI 10.1016/S0301-0503(76)80036-7; Throckmorton GS, 2004, J ORAL MAXIL SURG, V62, P127, DOI 10.1016/j.joms.2003.01.003; Throckmorton GS, 2000, INT J ORAL MAX SURG, V29, P421, DOI 10.1034/j.1399-0020.2000.290605.x; Vesnaver A, 2005, J CRANIO MAXILL SURG, V33, P169, DOI 10.1016/j.jcms.2005.01.008; Vesnaver A, 2008, J ORAL MAXIL SURG, V66, P2123, DOI 10.1016/j.joms.2008.06.010; Wilson AW, 2005, BRIT J ORAL MAX SURG, V43, P57, DOI 10.1016/j.bjoms.2004.09.011; Ziccardi VB, 1997, J ORAL MAXIL SURG, V55, P602, DOI 10.1016/S0278-2391(97)90492-4	50	16	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2011	22	2					641	647		10.1097/SCS.0b013e318207f495			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	736ZT	WOS:000288535800063	21403547				2022-02-06	
J	Brougham, R; David, DS; Adornato, V; Gordan, W; Dale, B; Georgeadis, AC; Gassaway, J				Brougham, Rebecca; David, Dana Spivak; Adornato, Viki; Gordan, Wendy; Dale, Beverly; Georgeadis, Amy C.; Gassaway, Julie			Speech-language pathology treatment time during inpatient spinal cord injury rehabilitation: the SCIRehab project	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; traumatic; Tetraplegia; Paraplegia; Brain injury; traumatic; Rehabilitation; Health services research; Outcomes research; Speech-language pathology; Cognitive therapy; Communication disorders; Dysphagia; Practice-based evidence	TRAUMATIC BRAIN-INJURY; OUTCOMES; DYSPHAGIA; SEVERITY; ILLNESS	Background/objective: Following spinal cord injury (SCI), speech-language pathologists (SLPs) perform assessments and provide treatment for swallowing, motor speech, voice, and cognitive-communication disorders that result from the SCI and/or co-occurring brain injuries. This paper describes the nature and distribution of speech-language pathology (SLP) activities delivered during inpatient SCI rehabilitation and discusses predictors (patient and injury characteristics) of the amount of time spent in specific SLP treatment activities. Methods: Six rehabilitation centers enrolled 600 patients with traumatic SCI for an observational study of acute inpatient rehabilitation treatment (SCIRehab). SLPs documented the details of assessment and treatment and time spent on each of a set of specific SLP activities during each patient encounter. Patterns of time use are described for all patients by neurological injury category. Ordinary least squares stepwise regression models are used to identify patient and injury characteristics predictive of treatment time in the specific SLP activities identified. Results: SLP consults were requested for 40% of SCIRehab patients. Fifty-seven percent of these patients received intense therapy (defined as more than five sessions during the rehabilitation stay); the remainder received primarily evaluation or less intense services (one to five sessions). The patients who participated in intense treatment received a mean total of 16.1 hours (range 2.5-105.2 hours, standard deviation (SD) 16.5, median 9.7 hours) of SLP; significant differences were seen in the amount of time spent in each activity among neurological injury groups. Cognitive-communication and swallowing therapy were the most common SLP activities. Patients with motor levels of injury at C1-C4 spent the highest percentage of their therapy time working on swallowing therapy while patients with low tetraplegia and paraplegia, and those classified as AIS D (regardless of motor level of injury) focused the greatest percentage of time on cognitive-communication work. Patient and injury characteristics explained a portion of the variation in time spent on cognitive-communication therapy but did not explain the variation in time spent on swallowing and other SLP treatment activities. Conclusion: The need for swallowing and cognitive treatment by SLP is common during inpatient rehabilitation due to dysfunction resulting from use of artificial airways and feeding approaches, as well as secondary brain injuries. The large amount of variability seen in SLP treatment time, which is not explained well by patient and injury characteristics, sets the stage for future analyses to associate treatments with outcomes.	[Gassaway, Julie] Inst Clin Outcomes Res, Salt Lake City, UT 84102 USA; [Brougham, Rebecca] Shepherd Ctr, Atlanta, GA USA; [David, Dana Spivak] Mt Sinai Med Ctr, New York, NY 10029 USA; [Adornato, Viki] Carolina Rehabil, Charlotte, NC USA; [Gordan, Wendy] Craig Hosp, Englewood, CO USA; [Dale, Beverly] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Georgeadis, Amy C.] Natl Rehabil Hosp, Washington, DC USA		Gassaway, J (corresponding author), Inst Clin Outcomes Res, 699 E South Temple, Salt Lake City, UT 84102 USA.	jgassaway@isiscor.com			National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, NIDRRUS Department of Education [H133A060103, H133N060005, H133N060028, H133N060009, H133N060027, H133N060014]; Craig Hospital	The contents of this paper were developed under grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, NIDRR grant numbers H133A060103 and H133N060005 to Craig Hospital, H133N060028 to National Rehabilitation Hospital, H133N060009 to Shepherd Center, H133N060027 to The Mount Sinai School of Medicine, H133N060014 to Rehabilitation Institute of Chicago, and to Carolinas Rehabilitation by subcontract from Craig Hospital. The contents of this manuscript do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	AVERILL RF, 1992, HEALTH SERV RES, V27, P587; BRADY S, 2004, APPL RES CLIN EXP TH, V4, P1; Clemmer TP, 1999, CRIT CARE MED, V27, P1768, DOI 10.1097/00003246-199909000-00011; DAHLBERG C, 1997, TOP SPINAL CORD INJ, V2, P41; Fiedler R., 1996, FUNCTIONAL ELEVATION, P75; Fiedler RC, 2000, AM J PHYS MED REHAB, V79, P184, DOI 10.1097/00002060-200003000-00012; Frempong-Boadu A, 2002, J SPINAL DISORD TECH, V15, P362, DOI 10.1097/00024720-200210000-00004; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; HOIT JD, 1990, J SPEECH HEAR RES, V33, P798, DOI 10.1044/jshr.3304.798; HORN S, 1997, ONCOL ISSUES, V12, P16; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; HORN SD, 1991, MED CARE, V29, P305, DOI 10.1097/00005650-199104000-00001; Logemann JA, 1998, EVALUATION TREATMENT; MacBean N, 2006, J MED SPEECH-LANG PA, V14, P167; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Marino R., 2003, REFERENCE MANUAL INT; Martin RE, 1997, DYSPHAGIA, V12, P2, DOI 10.1007/PL00009513; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Stevens J, 1999, INTERMEDIATE STAT MO; Stevens J., 2003, PARTIAL SEMIPARTIAL; Tervonen H, 2007, J NEUROSURG-SPINE, V7, P124, DOI 10.3171/SPI-07/08/124; Whiteneck G., 2011, J SPINAL CORD MED, V34, P135; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Winslow CP, 1999, AM J OTOLARYNG, V20, P16, DOI 10.1016/S0196-0709(99)90046-7	27	16	17	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	MAR	2011	34	2					186	195		10.1179/107902611X12971826988174			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744FR	WOS:000289080800007	21675357	Green Published			2022-02-06	
J	Tume, LN; Baines, PB; Lisboa, PJG				Tume, Lyvonne N.; Baines, Paul B.; Lisboa, Paulo J. G.			The effect of nursing interventions on the intracranial pressure in paediatric traumatic brain injury	NURSING IN CRITICAL CARE			English	Article						Head injuries; Intensive care nursing; Paediatric intensive care	INTRA-CRANICAL PRESSURE; HEAD-INJURY; INTENSIVE-CARE; HYPERVENTILATION; CHILDREN; ADULTS; EPIDEMIOLOGY; STIMULATION; SCALE; ICP	Aims and objectives: The aim of this research was to investigate the effect of five selected intensive care nursing interventions on the intracranial pressure (ICP) of moderate to severe traumatic brain-injured children in intensive care. Background: The physiological effects of many nursing interventions in paediatric intensive care (PIC) are not known. This results in the lack of an evidence base for many PIC nursing practices. Design: Prospective observational cohort study conducted over 3 years in a single tertiary referral paediatric intensive care unit (PICU) in the North West of England. Methods: Five selected commonly performed nursing interventions were studied: endotracheal suctioning and manual ventilation (ETSMV), turning via a log-rolling (LR) approach, eye care, oral care and washing. These were studied in the first 72 h after injury. Results: A total of 25 children with moderate to severe traumatic brain injury and intraparenchymal ICP monitoring in intensive care (aged 2-17 years) were enrolled. Both ETSMV and LR were associated with clinically and statistically significant changes in ICP from baseline to maximal ICP (p = 0.001 ETSMV; p = < 0.001 LR) and from maximal post-ICP (p = < 0.001 ETSMV; p = < 0.001 LR). Eye care, oral care or washing did not cause any clinically significant change in ICP from baseline. After decompressive craniectomy, none of the interventions caused significant changes in ICP. Conclusions: Only two of the five nursing interventions, endotracheal suctioning and LR, caused intracranial hypertension in moderate to severe traumatic brain-injured children, and after craniectomy, no care interventions caused any significant change in ICP. Relevance to clinical practice: Knowledge about the physiological effects of many intensive care nursing interventions is lacking and this is magnified in paediatrics. This study provides a significant addition to the evidence base in this area and allows intensive care nurses to plan, implement and evaluate more effectively their nursing care for brain-injured children.	[Tume, Lyvonne N.] Liverpool John Moores Univ, Alder Hey Childrens NHS Fdn Trust, PICU, Liverpool L3 5UX, Merseyside, England		Tume, LN (corresponding author), Liverpool John Moores Univ, Alder Hey Childrens NHS Fdn Trust, PICU, Liverpool L3 5UX, Merseyside, England.	lyvonne.tume@alderhey.nhs.uk					ADELSON D, 2003, PEDIAT CRITICAL CA S, V4, pS28; AMBUEL B, 1992, J PEDIATR PSYCHOL, V17, P95, DOI 10.1093/jpepsy/17.1.95; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brucia J, 1996, HEART LUNG, V25, P295, DOI 10.1016/S0147-9563(96)80065-3; CAMPBELL V, 1991, RES BRIEFS, V4, P138; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Crosby L J, 1992, J Neurosci Nurs, V24, P40; ERSSON U, 1990, ACTA ANAESTH SCAND, V34, P99, DOI 10.1111/j.1399-6576.1990.tb03051.x; FISHER DM, 1982, ANESTHESIOLOGY, V57, P416, DOI 10.1097/00000542-198211000-00013; Garradd J, 1986, Aust J Physiother, V32, P107, DOI 10.1016/S0004-9514(14)60647-4; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Hobdell E F, 1989, Crit Care Nurse, V9, P75; JENNETT B, 1975, LANCET, V1, P480; JONES B, 1995, AUSTR J ADV NURSING, V12, P32; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kerr M E, 1998, Am J Crit Care, V7, P205; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; LEE ST, 1989, HEART LUNG, V18, P411; MACKWAYJONES K, 2005, ADV PAEDIAT LIFE SUP, pCH22; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; MITCHELL PH, 1981, NURS RES, V30, P212; Paratz Jennifer, 1993, Physiotherapy Theory and Practice, V9, P3, DOI 10.3109/09593989309036480; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; PARSONS C, 1984, NURS RES, V33, P68; PARSONS LC, 1985, RES NURS HEALTH, V8, P173, DOI 10.1002/nur.4770080211; PARSONS LC, 1984, HEART LUNG, V13, P372; Prendergast V, 2009, AM J CRIT CARE, V18, P368, DOI 10.4037/ajcc2009621; RUDY EB, 1991, HEART LUNG, V20, P667; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; TUME L, 2008, BRIT J INTENSIVE AUT, P84; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Yanko J R, 2001, Crit Care Nurs Q, V23, P1	34	16	16	0	8	WILEY PERIODICALS, INC	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN, MA 02148-529 USA	1362-1017			NURS CRIT CARE	Nurs. Crit. Care	MAR-APR	2011	16	2					77	84		10.1111/j.1478-5153.2010.00412.x			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	796SZ	WOS:000293073800006	21299760				2022-02-06	
J	Zatzick, DF; Grossman, DC				Zatzick, Douglas F.; Grossman, David C.			Association Between Traumatic Injury and Psychiatric Disorders and Medication Prescription to Youths Aged 10-19	PSYCHIATRIC SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; QUALITY-OF-LIFE; BRAIN-INJURY; CHILDREN; SYMPTOMS; ADOLESCENTS; CARE; PREDICTORS; PTSD	Objective: Few clinical epidemiologic investigations have assessed whether youths exposed to a traumatic injury demonstrate elevations in the full spectrum of provider-recognized psychiatric disorders compared with unexposed, noninjured youths. Methods: In a population-based prospective cohort study, data for children and adolescents aged ten to 19 who were enrolled in the Group Health Cooperative health plan were screened for injury visits in the index year of 2001 (N=20,507). Psychiatric diagnoses, including anxiety and acute stress, depressive, substance use, and disruptive behavior disorders, given to these youths over the next three years (2002-2004) were documented, as were psychotropic medication prescriptions. Regression analyses assessed for an independent association between injury and psychiatric disorders and prescription of psychotropic medication. Results: In adjusted regression analyses, injury in the index year was independently associated with significantly increased odds of receiving a diagnosis of anxiety or acute stress (odds ratio [OR]=1.21, 95% confidence interval [CI]=1.02-1.44), depression (OR=1.30, CI=1.10-1.53), and a substance use disorder (OR=1.56, CI=1.21-2.00) and of receiving a psychotropic medication prescription (OR=1.37, CI=1.20-1.57). Youths with traumatic brain injuries also were significantly more likely to receive psychotropic medication prescriptions. Conclusions: Traumatic injury was independently associated with an increased risk of receiving a full spectrum of anxiety, depressive, and substance use diagnoses among youths aged ten to 19. Population-based surveillance procedures that incorporate screening and stepped-care interventions targeting the spectrum of postinjury emotional disturbances have the potential to improve the quality of mental health care for youths treated in general medical settings. (Psychiatric Services 62:264-271, 2011)	[Zatzick, Douglas F.] Univ Washington, Harborview Med Ctr, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Grossman, David C.] Univ Washington, Sch Med, Grp Hlth Res Inst, Seattle, WA 98104 USA; [Grossman, David C.] Univ Washington, Sch Med, Dept Hlth Sci, Seattle, WA 98104 USA		Zatzick, DF (corresponding author), Univ Washington, Harborview Med Ctr, Dept Psychiat & Behav Sci, 325 9th Ave, Seattle, WA 98104 USA.	dzatzick@u.washington.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073613, K24-MH086914]; National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49-CCR316840]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073613, K24MH086814] Funding Source: NIH RePORTER	This work was supported by grants R01-MH073613 and K24-MH086914 from the National Institute of Mental Health and by grant R49-CCR316840 from the National Center for Injury Prevention and Control and the Centers for Disease Control and Prevention.	Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; *AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; [Anonymous], 2006, CDC INJ FACT BOOK; [Anonymous], 1990, ABBR INJ SCAL 1990 R; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bonnie R.J., 1999, REDUCING BURDEN INJU; Borse N. N., 2008, PATTERNS UNINTENTION; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; BUTLER JA, 2001, CENTRAL NERVOUS SYST; Civil ID, 1985, ABBREVIATED INJURY S; Cohen JA, 2008, ARCH PEDIAT ADOL MED, V162, P447, DOI 10.1001/archpedi.162.5.447; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Cox CM, 2008, J SPEC PEDIATR NURS, V13, P98, DOI 10.1111/j.1744-6155.2008.00141.x; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Dunn C, 2008, J TRAUMA, V65, P736, DOI 10.1097/TA.0b013e31817de40f; Ehlers A, 2003, BEHAV RES THER, V41, P1, DOI 10.1016/S0005-7967(01)00126-7; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Grossman DC, 2000, FUTURE CHILD, V10, P23, DOI 10.2307/1602824; Grupp-Phelan J, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-12; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Hosmer D, 1989, APPL LOGISTIC REGRES; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2006, EM CAR CHILDR GROW P; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; KEENAN HT, 2008, BRIT MED J, V7680, P1208; Kenardy JA, 2006, PEDIATRICS, V118, P1002, DOI 10.1542/peds.2006-0406; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Koenen KC, 2008, J ABNORM PSYCHOL, V117, P460, DOI 10.1037/0021-843X.117.2.460; Langeland W, 2008, NEUROSCI BIOBEHAV R, V32, P161, DOI 10.1016/j.neubiorev.2007.07.002; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; MAX JE, 1998, J NERV MENT DIS, V186, P446; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; Mueser KT, 2008, PSYCHIAT SERV, V59, P627, DOI 10.1176/appi.ps.59.6.627; Owens PL, 2008, AMBUL PEDIATR, V8, P219, DOI 10.1016/j.ambp.2008.03.032; RIVARA FP, 1989, AM J PUBLIC HEALTH, V79, P990, DOI 10.2105/AJPH.79.8.990; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Sabin JA, 2006, PEDIATRICS, V117, P130, DOI 10.1542/peds.2005-1042; Saxe GN, 2005, AM J PSYCHIAT, V162, P1299; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shemesh E, 2003, PSYCHIAT SERV, V54, P1277, DOI 10.1176/appi.ps.54.9.1277; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stein BD, 2007, PSYCHIAT SERV, V58, P1563, DOI 10.1176/appi.ps.58.12.1563; Stein MB, 2006, PSYCHIAT SERV, V57, P673, DOI 10.1176/appi.ps.57.5.673; Stoddard FJ, 2006, J AM ACAD CHILD PSY, V45, P87, DOI 10.1097/01.chi.0000184934.71917.3a; Stoddard FJ, 2001, J AM ACAD CHILD PSY, V40, P1128, DOI 10.1097/00004583-200110000-00007; Sturms LM, 2005, CLIN REHABIL, V19, P312, DOI 10.1191/0269215505cr867oa; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021; Thurman DJ., 1995, GUIDELINES SURVEILLA; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Weiss NS., 2003, EPIDEMIOLOGIC METHOD; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2006, J AM ACAD CHILD PSY, V45, P1188, DOI 10.1097/01.chi.0000231975.21096.45; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zink Kathleen A, 2003, J Spec Pediatr Nurs, V8, P99, DOI 10.1111/j.1088-145X.2003.00099.x	66	16	16	0	6	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	MAR	2011	62	3					264	271		10.1176/appi.ps.62.3.264			8	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	728AL	WOS:000287845800005	21363897	Green Accepted			2022-02-06	
J	Petridis, AK; Doukas, A; Barth, H; Mehdorn, M				Petridis, A. K.; Doukas, A.; Barth, H.; Mehdorn, M.			Outcome of Craniocerebral Gunshot Injuries in the Civilian Population. Prognostic Factors and Treatment Options	CENTRAL EUROPEAN NEUROSURGERY			English	Article						gunshot; cranial injury; handgun; brain edema	HEAD-INJURY; WOUNDS; BRAIN; WAR	Aim: Gunshot wounds to the head are rare in Europe. They may be inflicted by low-velocity handguns, captive bolt guns and tear gas cartridges and mostly result from suicide attempts. The experience of neurosurgeons with this kind of traumatic injury is decreasing; the aim of this study was therefore to analyse prognostic factors which help to decide whether or not to operate and to discuss treatment options. Methods: Thirty patients with gunshot head injuries treated in our hospital from 1993 to 2008 were retrospectively evaluated. Glasgow Coma Scale (GCS) score, pupil reactivity, lesion localisation, number of bone fragments, intracranial pressure (ICP), midline shift, hypotension, and dural penetration were analysed for their prognostic value. Surgically and non-surgically treated patients were evaluated separately. Complications were registered. Results: A low GCS of 3-8, fixed pupils, > 2 bone fragments, bilobar or posterior fossa/brainstem lesions and ICP > 45 mmHg were indicators of a poor prognosis. Conclusion: Patients with a GCS of 3-8 and two non-reactive pupils should not be operated. If one or both of the pupils are reactive, surgery should be performed irrespective of the GCS score, except in patients with translobar/transventricular wounds. Even if there are no clear contraindications to surgery, the outcome is expected to be poor in patients with a low GCS score, midline shift > 10 mm, > 2 bone fragments in the brain, and a bilobar, posterior fossa/brainstem or ventricular lesion and ICP > 45 mmHg. When surgery is performed the wound and the missile or bone track should be debrided meticulously, the wound and dura should be closed in a watertight fashion and antibiotic prophylaxis as well as tetanus serum should be given.	[Petridis, A. K.; Doukas, A.; Barth, H.; Mehdorn, M.] Univ Kiel, D-24106 Kiel, Germany		Petridis, AK (corresponding author), Univ Kiel, Schittenhelmstr 10, D-24106 Kiel, Germany.	opticdisc@aol.com	Mehdorn, Maximilian/D-2495-2010				AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Aarabi Bizhan, 2001, Journal of Trauma Injury Infection and Critical Care, V51, pS1; ASKENASY JJM, 1989, ACTA NEUROL SCAND, V79, P47, DOI 10.1111/j.1600-0404.1989.tb03708.x; BRANDT F, 1983, NEUROCHIRURGIA, V26, P164; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Crevenna Richard, 2003, Wien Med Wochenschr, V153, P37, DOI 10.1046/j.1563-258X.2003.02050.x; Doctor Vishal S, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P213, DOI 10.1097/MOO.0b013e3281fbd3ef; Dosoglu M, 1999, NEUROCHIRURGIE, V45, P201; Gajdos M, 1997, Rozhl Chir, V76, P518; Giese A, 2002, SURG NEUROL, V57, P268, DOI 10.1016/S0090-3019(02)00643-2; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; Harat M, 2000, Neurol Neurochir Pol, V34, P487; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kohlmeier RE, 2001, AM J FOREN MED PATH, V22, P337, DOI 10.1097/00000433-200112000-00001; Kon T, 2002, NEUROL SURG TOKYO, V30, P517; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MOSDAL C, 1985, ACTA NEUROCHIR, V74, P31, DOI 10.1007/BF01413273; Murano T, 2005, AM SURGEON, V71, P1009; Reiss M, 1998, Praxis (Bern 1994), V87, P832; Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002; SUDDABY L, 1987, CAN J NEUROL SCI, V14, P268, DOI 10.1017/S0317167100026597; Tsuei Yuang-Seng, 2005, J Chin Med Assoc, V68, P126, DOI 10.1016/S1726-4901(09)70233-3; Vrankovic D, 1998, INJURY, V29, P369, DOI 10.1016/S0020-1383(98)00054-0	30	16	16	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			CENT EUR NEUROSURG	Cent. Eur. Neurosurg.	FEB	2011	72	1					5	14		10.1055/s-0029-1241850			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	722PM	WOS:000287446800002	20309801				2022-02-06	
J	Su, YL; Chen, W; Zhang, Q; Li, BJ; Li, ZY; Guo, MK; Pan, JS; Zhang, YZ				Su, Yanling; Chen, Wei; Zhang, Qi; Li, Baojun; Li, Zhiyong; Guo, Mingke; Pan, Jinshe; Zhang, Yingze			An irreducible variant of femoral neck fracture: A minimally traumatic reduction technique	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Irreducible femoral neck fracture; Displaced-impacted fracture; Dislocated fracture; Surgical technique	COMPRESSION SCREW FIXATION; INTRACAPSULAR FRACTURES; AVASCULAR NECROSIS; INTERNAL-FIXATION; HIP-FRACTURES; YOUNG-ADULTS; HEAD; FEMUR	We present 25 cases of irreducible variant femoral neck fractures that require surgical management after routine manipulative manoeuvre attempts have failed. In our study, an irreducible variant of femoral neck fractures is defined as a reduction that cannot be achieved after multiple attempts at closed reduction. This was evident radiographically, as seen in displaced-impacted femoral neck fractures when the proximal femur compacts and rotates along with the distal part, and anatomical reduction cannot be achieved with manipulative manoeuvres. Another rare situation also included is when the proximal fragment disconnects from the femur and dislocates as a 'floating' component, consequently resulting in failure of alignment of the distal fragment to the proximal femur. Here, we describe a technique, applied as a minimally traumatic procedure to achieve anatomic reduction in such cases. With the patient placed in supine position on the fracture table under general anaesthesia, the injury site is exposed and the procedure performed under intra-operative radiographic control. Location of the femoral artery is done first by palpation. The insertion site of the K-wires or Steinman pins on the proximal thigh is 1.5-3 cm lateral to the femoral artery. The K-wires or Steinman pins are inserted vertically into the middle 1/2-2/3 of the femoral head and more than 1 cm inferior to the sub-chondral bone of the femoral head to a depth of approximately, 1/2 diameter of the femoral head. The pins are then used as a joystick to control the movement of the proximal femur. With the help of the K-wires, surgeons can manually control the movement of the proximal femur and ensure anatomic reduction with the distal fragment using routine-closed reduction. Three cannulated screws are used to stabilise the fracture after anatomic reduction is achieved and maintained in a stable position. All cases were treated with this minimally invasive procedure and internal fixation, 25 fractures united, uneventfully, whilst two of them developed femoral head necrosis at 10 months and 4.5 years postoperatively, respectively. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.	[Su, Yanling; Chen, Wei; Zhang, Qi; Li, Baojun; Li, Zhiyong; Pan, Jinshe; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed, Shijiazhuang 050051, Hebei, Peoples R China; [Guo, Mingke] Chinese Peoples Liberat Army, Dept Orthopaed, Shijiazhuang 050041, Hebei, Peoples R China		Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China.	drchenwei1981@gmail.com; drzhangqi@yahoo.com.cn; jinshe.pan@gmail.com; dryzzhang@yahoo.com.cn					ARNOLD WD, 1974, J BONE JOINT SURG AM, VA 56, P254, DOI 10.2106/00004623-197456020-00003; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; BANKS HH, 1974, ORTHOP CLIN N AM, V5, P865; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; BONFIGLIO M, 1968, J BONE JOINT SURG AM, VA 50, P48, DOI 10.2106/00004623-196850010-00003; Bosch U, 2001, CHIRURG, V72, P1292, DOI 10.1007/s001040170034; CHAPMAN MW, 1975, J BONE JOINT SURG BR, V57, P735; CHRISTIE J, 1988, J BONE JOINT SURG BR, V70, P199, DOI 10.1302/0301-620X.70B2.3346287; DICKSON JA, 1953, J BONE JOINT SURG AM, V35-A, P805, DOI 10.2106/00004623-195335040-00001; FIELDING JW, 1974, J BONE JOINT SURG AM, VA 56, P1464, DOI 10.2106/00004623-197456070-00015; FRANDSEN PA, 1983, ACTA ORTHOP SCAND, V54, P681, DOI 10.3109/17453678308996611; GERBER C, 1993, CLIN ORTHOP RELAT R, P77; Hirata T, 2001, CLIN ORTHOP RELAT R, P294; HOAGLUND FT, 1980, CLIN ORTHOP RELAT R, P10; Johansson T, 2006, INT ORTHOP, V30, P1, DOI 10.1007/s00264-005-0037-z; KOFOED H, 1982, INJURY, V14, P146, DOI 10.1016/0020-1383(82)90049-3; Koval, 1994, J Am Acad Orthop Surg, V2, P141; LINDEQUIST S, 1995, J ORTHOP TRAUMA, V9, P215, DOI 10.1097/00005131-199506000-00006; LUCIE RS, 1981, CLIN ORTHOP RELAT R, P207; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; Molnar RB, 2007, J ORTHOP TRAUMA, V21, P490, DOI 10.1097/BOT.0b013e31804a7f7f; PARKER MJ, 1994, INJURY S2, V25, P3; PFORRINGER W, 1980, ACTA ORTHOP SCAND, V51, P91, DOI 10.3109/17453678008990774; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; REHNBERG L, 1989, J BONE JOINT SURG BR, V71, P173, DOI 10.1302/0301-620X.71B2.2925729; Roden M, 2003, ACTA ORTHOP SCAND, V74, P42, DOI 10.1080/00016470310013635; Schmidt AH, 2002, ORTHOP CLIN N AM, V33, P97, DOI 10.1016/S0030-5898(03)00074-9; SKINNER PW, 1986, J BONE JOINT SURG BR, V68, P78, DOI 10.1302/0301-620X.68B1.3941145; SWIONTKOWSKI MF, 1994, J BONE JOINT SURG AM, V76A, P129, DOI 10.2106/00004623-199401000-00019; SWIONTKOWSKI MF, 1987, J ORTHOPAED RES, V5, P433, DOI 10.1002/jor.1100050316; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; SWIONTKOWSKI MF, 1986, CLIN ORTHOP RELAT R, P248; Wazir N N, 2006, J Orthop Surg (Hong Kong), V14, P43; Zhang Q, 2009, SKELETAL RADIOL, V38, P1175, DOI 10.1007/s00256-009-0662-5	34	16	37	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	FEB	2011	42	2					140	145		10.1016/j.injury.2010.05.008			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	705LY	WOS:000286135100006	20570257				2022-02-06	
J	Thakor, DK; Teng, YD; Obata, H; Nagane, K; Saito, S; Tabata, Y				Thakor, Devang K.; Teng, Yang D.; Obata, Hideaki; Nagane, Kentaro; Saito, Shigeru; Tabata, Yasuhiko			Nontoxic Genetic Engineering of Mesenchymal Stem Cells Using Serum-Compatible Pullulan-Spermine/DNA Anioplexes	TISSUE ENGINEERING PART C-METHODS			English	Article							SPINAL-CORD-INJURY; STEM/PROGENITOR CELLS; STROMAL CELLS; PLASMID DNA; TRANSGENE EXPRESSION; PALMITIC ACID; DELIVERY; ADULT; TRANSFECTION; TRANSPLANTATION	Genetic modification of stem cells could be applied to initiate/enhance their secretion of therapeutic molecules, alter their biological properties, or label them for in vivo tracking. We recently developed a negatively charged gene carrier ("anioplex") based on pullulan-spermine, a conjugate prepared from a natural polysaccharide and polyamine. In rat mesenchymal stem cells (MSCs), anioplex-derived reporter gene activity was comparable to or exceeded that obtained using a commercial cationic lipid reagent. Transfection in the growth medium with 15% serum and antibiotics was approximately sevenfold more effective than in serum-free conditions. Cytotoxicity was essentially indiscernible after 24 h of anioplex transfection with 20 mu g/mL DNA, in contrast to cationic lipid transfection that resulted in 40%-60% death of target MSCs. Anioplex-derived reporter gene activity persisted throughout the entire 3-week study, with post-transfection MSCs appearing to maintain osteogenic, adipogenic, and chondrogenic multipotency. In particular, chondrogenic pellet formation of differentiating human MSCs was significantly inhibited after lipofection but not after aniofection, which further indicates the biological inertness of pullulan-spermine/DNA anioplexes. Collectively, these data introduce a straightforward technology for genetic engineering of adult stem/progenitor cells under physiological niche-like conditions. Moreover, reporter gene activity was observed in rat spinal cords after minimally invasive intrathecal implantation, suggesting effective engraftment of donor MSCs. It is therefore plausible that anioplex-transfected MSCs or other stem/progenitor cells with autologous potential could be applied to disorders such as neurotrauma or neuropathic pain that involve the spinal cord and brain.	[Thakor, Devang K.; Teng, Yang D.] Boston VA Healthcare Syst, Div SCI Res, Boston, MA 02132 USA; [Thakor, Devang K.; Nagane, Kentaro; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Thakor, Devang K.; Teng, Yang D.] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA USA; [Thakor, Devang K.; Teng, Yang D.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Obata, Hideaki; Saito, Shigeru] Gunma Univ, Sch Med, Dept Anesthesiol, Maebashi, Gunma 371, Japan		Teng, YD (corresponding author), Boston VA Healthcare Syst, Div SCI Res, 1400 VFW Pkwy,Bldg 3,Room 2B110, Boston, MA 02132 USA.	yang_teng@hms.harvard.edu; yasuhiko@frontier.kyoto-u.ac.jp			Japan Society for the Promotion of Science, as well as the TakanawakaiMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science; Clinical Implant Society of Japan; VAUS Department of Veterans Affairs; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; CIMIT-DOD; State of Massachusetts	D. K. T. has been supported by a foreign postdoctoral fellowship and grant-in-aid from the Japan Society for the Promotion of Science, as well as the Takanawakai, the Clinical Implant Society of Japan, and a VA Biomedical Merit Grant. Work at Y.D.T.'s labs are supported by VA, NIH, CIMIT-DOD, and the State of Massachusetts. We thank Dr. Jun-Ichiro Jo, Mr. Masataka Yoshida, and Mr. Norio Doi of Kyoto University for assistance in the preparation of pullulan-spermine. We thank Dr. Jyunichi Miyazaki of Osaka University for kindly providing luciferase. We thank Dr. Masaru Tobe of Gunma University for assistance with animal experiments. We thank Mr. Nirav Thakor for assistance with figure preparation.	Ahn HH, 2008, BIOMATERIALS, V29, P2415, DOI 10.1016/j.biomaterials.2008.02.006; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Brinchmann JE, 2008, J NEUROL SCI, V265, P127, DOI 10.1016/j.jns.2007.05.006; Callera F, 2006, EXP HEMATOL, V34, P130, DOI 10.1016/j.exphem.2005.11.006; Castellanos DA, 2002, CELL TRANSPLANT, V11, P297; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Clements BA, 2007, BIOMATERIALS, V28, P4693, DOI 10.1016/j.biomaterials.2007.07.023; Clements BA, 2006, BIOMACROMOLECULES, V7, P1481, DOI 10.1021/bm060073w; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0; Dokka S, 2000, PHARMACEUT RES, V17, P521, DOI 10.1023/A:1007504613351; Duplan H, 2004, NEUROSCI LETT, V370, P1, DOI 10.1016/j.neulet.2004.07.017; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hoelters J, 2005, J GENE MED, V7, P718, DOI 10.1002/jgm.731; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; Incani V, 2007, J BIOMED MATER RES A, V81A, P493, DOI 10.1002/jbm.a.31249; Jaderstad J, 2010, P NATL ACAD SCI USA, V107, P5184, DOI 10.1073/pnas.0915134107; Jo J, 2007, J CONTROL RELEASE, V118, P389, DOI 10.1016/j.jconrel.2007.01.005; Jo JI, 2007, TISSUE ENG, V13, P313, DOI 10.1089/ten.2006.0133; Kimelman N, 2007, TISSUE ENG, V13, P1135, DOI 10.1089/ten.2007.0096; Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Mitsui T, 2005, EXP NEUROL, V194, P410, DOI 10.1016/j.expneurol.2005.02.022; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nagane K, 2009, TISSUE ENG PT A, V15, P1655, DOI 10.1089/ten.tea.2008.0453; Nair RR, 2002, MOL THER, V5, P455, DOI 10.1006/mthe.2002.0567; Nakahara Y, 1996, CELL TRANSPLANT, V5, P191, DOI 10.1016/0963-6897(95)02028-4; Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Okazaki A, 2007, TISSUE ENG, V13, P245, DOI 10.1089/ten.2006.0185; Papapetrou EP, 2005, GENE THER, V12, pS118, DOI 10.1038/sj.gt.3302626; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Phillips MI, 2008, ADV DRUG DELIVER REV, V60, P160, DOI 10.1016/j.addr.2007.08.035; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Takamoto T, 2007, J BIOMAT SCI-POLYM E, V18, P865, DOI 10.1163/156856207781367738; Tanaka T, 2005, BIOL PHARM BULL, V28, P560, DOI 10.1248/bpb.28.560; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tey SK, 2007, MOL THER, V15, P666, DOI 10.1038/sj.mt.6300109; Thakor DK, 2009, BIOMATERIALS, V30, P1815, DOI 10.1016/j.biomaterials.2008.12.032; Thomas M, 2003, APPL MICROBIOL BIOT, V62, P27, DOI 10.1007/s00253-003-1321-8; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wang L, 2004, MOL THER, V9, P729, DOI 10.1016/j.ymthe.2004.02.009; Werkmeister JA, 2002, J PEPT RES, V60, P232, DOI 10.1034/j.1399-3011.2002.21011.x; Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807	56	16	16	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	FEB	2011	17	2					131	144		10.1089/ten.tec.2010.0120			14	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering; Materials Science	713GR	WOS:000286723900002	20698746	Green Published			2022-02-06	
J	Bauer, DF; McGwin, G; Melton, SM; George, RL; Markert, JM				Bauer, David F.; McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.; Markert, James M.			Risk Factors for Conversion to Permanent Ventricular Shunt in Patients Receiving Therapeutic Ventriculostomy for Traumatic Brain Injury	NEUROSURGERY			English	Article						Hemorrhage; Shunt; Trauma; Ventriculostomy	POSTTRAUMATIC HYDROCEPHALUS	BACKGROUND: Intracranial pressure is routinely monitored in patients with severe traumatic brain injury (TBI). Patients with TBI sometimes develop hydrocephalus, requiring permanent cerebrospinal fluid (CSF) diversion. OBJECTIVE: To quantify the need for permanent CSF diversion in patients with TBI. METHODS: Patients who received a ventriculostomy after TBI between June 2007 and July 2008 were identified, and their medical records were abstracted to a database. RESULTS: Sixteen of 71 patients (22.5%) receiving a ventriculostomy required a ventriculoperitoneal or ventriculoatrial shunt before discharge from the hospital. The average number of days between ventriculostomy and shunt was 18.3. Characteristics that predispose these patients to require permanent CSF diversion include the need for craniotomy within 48 hours of admission (odds ratio, 5.20; 95% confidence interval, 1.48-18.35) and history of culture-positive CSF (odds ratio, 5.52; 95% confidence interval, 1.19-25.52). Length of stay was increased in patients receiving permanent CSF diversion (average length of stay, 61 vs 31 days; P = .04). Patient discharge disposition was similar between shunted and nonshunted patients. CONCLUSION: In this retrospective study, 22% of TBI patients who required a ventriculostomy eventually needed permanent CSF diversion. Patients with TBI should be assessed for the need for permanent CSF diversion before discharge from the hospital. Care must be taken to prevent ventriculitis. Future studies are needed to evaluate more thoroughly the risk factors for the need for permanent CSF diversion in this patient population.	[Bauer, David F.; Markert, James M.] Univ Alabama Birmingham, Div Neurosurg, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.] Univ Alabama Birmingham, Sect Trauma Burns & Surg Crit Care, Dept Surg, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA		Markert, JM (corresponding author), Univ Alabama Birmingham, Div Neurosurg, FOT 1060,1530 3rd Ave S, Birmingham, AL 35294 USA.	markert@uab.edu		Bauer, David/0000-0003-3548-0887			*AM ASS NEUR SURG, 2006, NAT NEUR PROC STAT; BRAIN TRAUM FD, 2000, J NEUROTRAUM, V17, P457; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Chan M, 2009, J NEUROSURG, V110, P44, DOI 10.3171/2008.5.17560; Dorai Z, 2003, NEUROSURGERY, V52, P763, DOI 10.1227/01.NEU.0000053222.74852.2D; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; KELLY DF, 1995, OPERATIVE NEUROSURGI, P47; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; Licata C, 2001, J Neurosurg Sci, V45, P141; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; OKOR MO, 2008, GEN SURG PRINCIPLES; Phuenpathom Nakornchai, 1999, Journal of the Medical Association of Thailand, V82, P46; Rammos S, 2008, J NEUROSURG, V109, P1001, DOI 10.3171/JNS.2008.109.12.1001; Roitberg BZ, 2001, BRIT J NEUROSURG, V15, P324; Tribl G, 2000, BRAIN INJURY, V14, P345; VESPA PM, 2000, OPERATIVE NEUROSURGE, P1205	19	16	17	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2011	68	1					85	88		10.1227/NEU.0b013e3181fd85f4			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	694IE	WOS:000285288200034	21099716				2022-02-06	
J	Darrah, SH; Chuang, J; Mohler, LM; Chen, XB; Cummings, EE; Burnett, T; Reyes-Littaua, MC; Galang, GN; Wagner, AK				Darrah, Shaun H.; Chuang, Jerry; Mohler, Laura M.; Chen, Xiangbai; Cummings, Erin E.; Burnett, Tiffany; Reyes-Littaua, M. Christina; Galang, Gary N.; Wagner, Amy K.			Dilantin Therapy in an Experimental Model of Traumatic Brain Injury: Effects of Limited versus Daily Treatment on Neurological and Behavioral Recovery	JOURNAL OF NEUROTRAUMA			English	Article						CCI; cognition; Dilantin; neuroplasticity; phenytoin; post-traumatic seizures; TBI	CONTROLLED CORTICAL IMPACT; CHRONIC METHYLPHENIDATE TREATMENT; WATER MAZE PERFORMANCE; ENVIRONMENTAL ENRICHMENT; GLUTAMATE NEUROTOXICITY; POSTTRAUMATIC SEIZURES; MODERATE HYPOTHERMIA; GENDER ASSOCIATIONS; CEREBROSPINAL-FLUID; COGNITIVE DEFICITS	The mechanisms by which Dilantin confers anticonvulsant benefits may also be neuroprotective by attenuating the acute excitatory insult in cortical and subcortical structures when the drug is given in the acute phase after traumatic brain injury (TBI). However, when Dilantin is used for prolonged periods, we hypothesized that it may impede recovery, synaptic plasticity may be impaired, and neuroprotective benefits may be lost. As such, we assessed the effect of daily chronic administration (75mg/kg day 0 followed by 50mg/kg daily i.p.) and acute administration (75mg/kg day 0 followed by 50mg/kg i.p. day 1) of Dilantin in young adult male rats on motor performance, y-maze exploration, Morris Water Maze (MWM), hippocampal (HC) cell survival, contusion size, and regional expression of neuroplasticity markers after controlled cortical impact (CCI) injury. Chronic daily Dilantin administration resulted in beam walking impairments on day 6, whereas acute Dilantin administration resulted in beam walking impairments on days 3 and 4. Chronic Dilantin administration also resulted in worse MWM performance, more HC cell loss and no increases in neuroplasticity markers compared to rats with CCI receiving chronic vehicle. Conversely, rats receiving acute Dilantin administration exhibited more novel arm exploration in the y-maze, greater HC cell sparing, and greater growth-associated protein 43 (GAP-43) expression in the HC ipsilateral to the CCI, compared to injured rats receiving vehicle. MWM was not influenced by acute Dilantin administration. These results suggest that there are beneficial effects of limited acute Dilantin therapy after TBI, and that extended daily Dilantin therapy has deleterious effects on neural recovery. These findings support clinical guidelines for limited use of Dilantin in seizure prophylaxis after TBI.	[Darrah, Shaun H.; Mohler, Laura M.; Chen, Xiangbai; Cummings, Erin E.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Darrah, Shaun H.; Chuang, Jerry; Mohler, Laura M.; Chen, Xiangbai; Cummings, Erin E.; Burnett, Tiffany; Reyes-Littaua, M. Christina; Galang, Gary N.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu			Foundation for PMR; University of Pittsburgh Department of Physical Medicine and Rehabilitation	This work was supported by The Foundation for PM&R and the University of Pittsburgh Department of Physical Medicine and Rehabilitation.	Arckens L, 2000, EUR J NEUROSCI, V12, P4222, DOI 10.1046/j.0953-816X.2000.01328.x; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bergmann M, 1997, EXP BRAIN RES, V117, P80, DOI 10.1007/s002210050201; BOXER PA, 1990, STROKE, V21, P47; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; BROWN CM, 1995, BRIT J PHARMACOL, V115, P1425, DOI 10.1111/j.1476-5381.1995.tb16633.x; CARP JS, 1979, ARCH INT PHARMACOD T, V237, P139; Chan SA, 1998, ACTA NEUROCHIR, V140, P175, DOI 10.1007/s007010050080; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; Churchill JD, 2003, INTEGR PHYS BEH SCI, V38, P91, DOI 10.1007/BF02688828; CHWEH AY, 1986, PHARMACOL BIOCHEM BE, V24, P1301, DOI 10.1016/0091-3057(86)90188-7; Cunningham MO, 2000, NEUROSCIENCE, V95, P343; Dellu F, 2000, NEUROBIOL LEARN MEM, V73, P31, DOI 10.1006/nlme.1999.3919; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; MATTSON MP, 1989, BRAIN RES, V478, P337, DOI 10.1016/0006-8993(89)91514-X; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; PULLIAINEN V, 1995, EPILEPSIA, V36, P1195, DOI 10.1111/j.1528-1157.1995.tb01062.x; Ragsdale DS, 1998, BRAIN RES REV, V26, P16, DOI 10.1016/S0165-0173(97)00054-4; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; RUNDFELDT C, 1993, J PHARMACOL EXP THER, V266, P216; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schumacher TB, 1998, EPILEPSIA, V39, P355, DOI 10.1111/j.1528-1157.1998.tb01387.x; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Sitges M, 2007, NEUROPHARMACOLOGY, V52, P598, DOI 10.1016/j.neuropharm.2006.09.002; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; TAFT WC, 1989, BRAIN RES, V483, P143, DOI 10.1016/0006-8993(89)90045-0; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	54	16	16	0	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					43	55		10.1089/neu.2010.1521			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800005	20964534				2022-02-06	
J	Jones, HN; Story, TJ; Collins, TA; Dejoy, D; Edwards, CL				Jones, Harrison N.; Story, Tyler J.; Collins, Timothy A.; DeJoy, Daniel; Edwards, Christopher L.			Multidisciplinary assessment and diagnosis of conversion disorder in a patient with foreign accent syndrome	BEHAVIOURAL NEUROLOGY			English	Article						Foreign accent syndrome; conversion disorder; neuropsychological assessment; case study; speech disorders	ARTICULATION; SIGN	Multiple reports have described patients with disordered articulation and prosody, often following acute aphasia, dysarthria, or apraxia of speech, which results in the perception by listeners of a foreign-like accent. These features led to the term foreign accent syndrome (FAS), a speech disorder with perceptual features that suggest an indistinct, non-native speaking accent. Also correctly known as psuedoforeign accent, the speech does not typically match a specific foreign accent, but is rather a constellation of speech features that result in the perception of a foreign accent by listeners. The primary etiologies of FAS are cerebrovascular accidents or traumatic brain injuries which affect cortical and subcortical regions critical to expressive speech and language production. Far fewer cases of FAS associated with psychiatric conditions have been reported. We will present the clinical history, neurological examination, neuropsychological assessment, cognitive-behavioral and biofeedback assessments, and motor speech examination of a patient with FAS without a known vascular, traumatic, or infectious precipitant. Repeated multidisciplinary examinations of this patient provided convergent evidence in support of FAS secondary to conversion disorder. We discuss these findings and their implications for evaluation and treatment of rare neurological and psychiatric conditions.	[Jones, Harrison N.] Duke Univ, Med Ctr, Dept Surg, Div Speech Pathol & Audiol, Durham, NC 27710 USA; [Story, Tyler J.; Collins, Timothy A.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA; [Story, Tyler J.; DeJoy, Daniel] Duke Univ, Med Ctr, N Carolina State Univ, Dept Commun, Durham, NC 27710 USA; [Edwards, Christopher L.] Duke Univ, Med Ctr, Dept Psychiat, Div Med Psychol, Durham, NC 27710 USA; [Edwards, Christopher L.] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA		Jones, HN (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Speech Pathol & Audiol, 155 Baker Hose,Trent Dr,DUMC 3887, Durham, NC 27710 USA.	harrison.jones@duke.edu					Abel TJ, 2009, CLIN NEUROL NEUROSUR, V111, P97, DOI 10.1016/j.clineuro.2008.07.014; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Aronson A. E, 1990, CLIN VOICE DISORDERS; Avila C, 2004, NEUROREPORT, V15, P2267, DOI 10.1097/00001756-200410050-00025; Bakker JI, 2004, CAN J NEUROL SCI, V31, P271, DOI 10.1017/S0317167100053956; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton AL, 1994, MULTILINGUAL APHASIA; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; Briggs S. R., 1989, PERSONALITY PSYCHOL, P246, DOI [10.1007/978-1-4684-0634-4_19, DOI 10.1007/978-1-4684-0634-4_19]; Carbary TJ, 2000, BRAIN COGNITION, V43, P78; CHEN HI, 1989, J APPL PHYSIOL, V66, P943, DOI 10.1152/jappl.1989.66.2.943; Christoph DH, 2004, EUR NEUROL, V52, P198, DOI 10.1159/000082035; Coughlan T, 2004, J ROY SOC MED, V97, P242, DOI 10.1258/jrsm.97.5.242; Crow HC, 1996, J GERONTOL A-BIOL, V51, pM247, DOI 10.1093/gerona/51A.5.M247; Delis D.C., 2000, CALIFORNIA VERBAL LE; Derogatis LR., 1983, SCL 90 R ADM SCORING; Duffy, 2005, MOTOR SPEECH DISORDE; Edwards CL., 2005, CIENCIAS CONDUCTA, V20, P89; EDWARDS RJ, 2000, EUR NEUROL, V53, P87; Flipsen P, 2003, J SPEECH LANG HEAR R, V46, P724, DOI 10.1044/1092-4388(2003/058); FORD CV, 1985, PSYCHOSOMATICS, V26, P371, DOI 10.1016/S0033-3182(85)72845-9; Fridriksson J, 2005, NEUROCASE, V11, P319, DOI 10.1080/13554790591006302; GOLDEN GJ, 1978, STROOP COLOR WORD TE; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS EX; Gonzalez-Alvarez J, 2003, REV NEUROLOGIA, V36, P227, DOI 10.33588/rn.3603.2002306; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Gurd JM, 2001, CORTEX, V37, P715, DOI 10.1016/S0010-9452(08)70622-1; Haley KL, 2010, J NEUROLINGUIST, V23, P28, DOI 10.1016/j.jneuroling.2009.08.001; Hayes MW, 1999, MOVEMENT DISORD, V14, P914, DOI 10.1002/1531-8257(199911)14:6<914::AID-MDS1002>3.0.CO;2-B; Hem Erlend, 2006, Tidsskr Nor Laegeforen, V126, P3311; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kaplan E, 1983, BOSTON NAMING TEST; Keefe F. J., 1997, SEMINARS ANESTHESIA, V16, P117; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; LINDBLOM B, 1983, PRODUCTION SPEECH, P217, DOI DOI 10.1007/978-1-4613-8202-7_10; Lippert-Gruener M, 2005, BRAIN INJURY, V19, P955, DOI 10.1080/02699050500109506; Luzzi S, 2008, J NEUROL NEUROSUR PS, V79, P79, DOI 10.1136/jnnp.2006.113365; Mace CJ, 1996, BRIT J PSYCHIAT, V169, P282, DOI 10.1192/bjp.169.3.282; Marien P, 2007, FOLIA PHONIATR LOGO, V59, P210, DOI 10.1159/000102933; Marien P, 2006, CLIN NEUROL NEUROSUR, V108, P518, DOI 10.1016/j.clineuro.2005.06.006; McCrae RR, 1985, PSYCHOL ASSESSMENT R; Munson Patrick D, 2005, S D J Med, V58, P187; Okun MS, 2007, NEUROLOGIST, V13, P87, DOI 10.1097/01.nrl.0000256358.52613.cc; Poulin Stephane, 2007, Ann Gen Psychiatry, V6, P1, DOI 10.1186/1744-859X-6-1; Reeves RR, 2007, J NEUROPSYCH CLIN N, V19, P70, DOI 10.1176/appi.neuropsych.19.1.70; Reeves RR, 2001, NEUROPSY NEUROPSY BE, V14, P135; Reitan RM, 1992, TRAIL MAKING TEST MA; Roth EJ, 1997, ARCH PHYS MED REHAB, V78, P550, DOI 10.1016/S0003-9993(97)90176-3; Ruff RM, 1988, RUFF FIGURAL FLUENCY; Ryalls J, 2006, CLIN LINGUIST PHONET, V20, P157, DOI 10.1080/02699200400026900; SELIGER GM, 1992, STROKE, V23, P1655, DOI 10.1161/01.STR.23.11.1655; Spielberger CD., 1970, STATE TRAIT ANXIETY; Stone J, 2003, AM J PSYCHIAT, V160, P391, DOI 10.1176/appi.ajp.160.2.391; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsao YC, 1997, J SPEECH LANG HEAR R, V40, P858, DOI 10.1044/jslhr.4004.858; Van Borsel J, 2005, J COMMUN DISORD, V38, P421, DOI 10.1016/j.jcomdis.2005.03.004; Verhoeven J, 2005, BEHAV NEUROL, V16, P225, DOI 10.1155/2005/989602; Villaverde-Gonzalez R, 2003, REV NEUROLOGIA, V36, P1035, DOI 10.33588/rn.3611.2002609; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 1997, WECHSLER MEMORY SCAL; WILKERSON G, 1993, WIDE RANGE ACHIEVEME, V3	64	16	17	1	19	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2011	24	3					245	255		10.1155/2011/786560			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	834NC	WOS:000295967200007	21876264	Green Published, gold			2022-02-06	
J	Krave, U; Al-Olama, M; Hansson, HA				Krave, Ulrika; Al-Olama, Mohamed; Hansson, Hans-Arne			Rotational Acceleration Closed Head Flexion Trauma Generates More Extensive Diffuse Brain Injury than Extension Trauma	JOURNAL OF NEUROTRAUMA			English	Article						astrocytosis; beta-amyloid precursor protein; diffuse axonal injury; mild traumatic brain injury; neurofilaments	ADULT; DEFORMATION; PRESSURE; STRAIN; MODEL; BIOMECHANICS; IMPACT; DAMAGE; WAVE	Our aim was to investigate if seemingly identical head and neck trauma would generate differing types of brain damage. We experimentally evaluated induced brain injuries immediately after trauma exposure, and at 1 week post-injury. Anesthetized rabbits were exposed once to a sagittal rotational acceleration head and neck injury at either a high or a low load level, using either flexion or extension. A high-load extension trauma induced scattered meningeal petechial hemorrhages and no deaths, in contrast to a flexion trauma of the same level, which resulted in extensive parenchymal and meningeal hemorrhages, and all animals succumbed immediately. A low-level flexion trauma induced scattered meningeal petechiae, but no gross damage, while extension at the same force generated no macroscopically visible acute brain injury. Immunohistochemical investigations carried out at 7 days disclosed that a low-level flexion trauma, as well as both low-and high-level extension exposures, all induced diffuse brain injuries in the cerebral cortex and white matter, corpus callosum, hippocampus, brainstem, and cerebellum, as revealed by abnormal distribution of neurofilaments, a prevalence of beta-amyloid precursor protein, and astrogliosis. The diffuse brain injury seen after a low-level flexion trauma was equal to or more extensive than that seen after a high-level extension trauma. A low-level extension trauma induced only minor histopathological abnormalities. We conclude that a sagittal rotational acceleration trauma of the head and neck induced diffuse brain injury, and that flexion caused more extensive damage than extension at the same applied load.	[Al-Olama, Mohamed; Hansson, Hans-Arne] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Krave, Ulrika] Chalmers Univ Technol, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Al-Olama, Mohamed] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden		Hansson, HA (corresponding author), Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, POB 440, SE-40530 Gothenburg, Sweden.	hans-arne.hansson@gu.se			Swedish federal government [71570]; Sahlgrenska University Hospital, VinnovaVinnova [83030]; Ministry of High Education United Arab Emirates; Magnus Bergvall Foundation; W. and M. Lundgren Foundation; Frimurare-Barnhus direktionen; Goteborg Medical Society; AB Nectin; Lantmannen AS-Faktor AB	This study was funded in part by the Swedish federal government (grant no. 71570), Sahlgrenska University Hospital (grant no. 83030), Vinnova, the Ministry of High Education United Arab Emirates, the Magnus Bergvall Foundation, the W. and M. Lundgren Foundation, Frimurare-Barnhus direktionen, the Goteborg Medical Society, AB Nectin, and Lantmannen AS-Faktor AB.	Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elsayed NM., 2008, EXPLOSION BLAST RELA; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; GOSCH HH, 1970, J TRAUM, V10, P370, DOI 10.1097/00005373-197005000-00002; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Greenberg MS., 2010, HDB NEUROSURGERY, V7th; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; KOPATKA MJ, 1991, J NEUROTRAUM, V8, P247; Krave U, 2005, EUR J NEUROSCI, V21, P2876, DOI 10.1111/j.1460-9568.2005.04115.x; KRAVE U, 2010, IMPORTANCE IMP UNPUB; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Leestma JE., 2008, FORENSIC NEUROPATHOL, V2nd; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; NOLTE J, 2008, HUMAN BRAIN; Oehmichen M., 2005, Forensic Neuropathology and Associated Neurology; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Palay S, 1974, CEREBELLAR CORTEX CY; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; REILLY PL, 2005, HEAD INJUNY PATHOPHY; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; Wisniewski H. M, 1986, ATLAS RABBIT BRAIN S; Zhu H, 2005, BRAIN RES, V1036, P7, DOI 10.1016/j.brainres.2004.12.053; Zhu H, 2003, BRAIN RES, V977, P180, DOI 10.1016/S0006-8993(03)02627-1	47	16	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					57	70		10.1089/neu.2010.1431			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800006	21047148	Green Submitted			2022-02-06	
J	McMahon, CG; Kenny, R; Bennett, K; Little, R; Kirkman, E				McMahon, C. Geraldine; Kenny, RoseAnne; Bennett, Kathleen; Little, Roderick; Kirkman, Emrys			EFFECT OF ACUTE TRAUMATIC BRAIN INJURY ON BAROREFLEX FUNCTION	SHOCK			English	Article						Brain injuries; trauma; phenylephrine; homeostasis	CHOLINERGIC ANTIINFLAMMATORY PATHWAY; KAPPA-B ACTIVATION; SEVERE HEAD-INJURY; BLOOD-PRESSURE; CARDIOVASCULAR CONTROL; HEMORRHAGIC-SHOCK; RATS; REFLEX; HYPERTENSION; SENSITIVITY	The integrity of the arterial baroreflex is central to cardiovascular homeostasis. There is evidence of altered cardiovascular regulation after acute traumatic brain injury (TBI). We hypothesized that arterial baroreflex is modified by acute TBI. An experimental study using 18 terminally anesthetized male Wistar rats weighing 240 to 260 g was undertaken at a university laboratory setting. Brain injury was induced using the lateral fluid percussion brain injury model. The fluid percussion device delivered an applied cortical pressure of 1.2 atm and 1.8 atm, producing mild and moderate TBI, respectively. Control animals underwent identical surgical procedures but no applied cortical pressure. Arterial baroreflex was assessed by determining the relationship between heart period (R - R interval) and systolic blood pressure using the modified phenylephrine pressor test adapted for the rat. The arterial baroreflex was tested before (Tcon), post-TBI, at 10 min (T10), and 30 min (T30). Analysis of baroreflex function after moderate TBI using repeated-measures analysis of variance revealed significant differences in baroreflex sensitivity (BRS) at T10 and T30 (F(2,15) = 10.18; P = 0.005) compared with pre-TBI (weighted mean +/- SD; Tcon, 0.39 +/- 0.00 ms mmHg(-1); T10, 0.85 +/- 0.01 ms mmHg(-1); T30, 0.81 +/- 0.01 ms mmHg(-1)). The changes in BRS were not significant after mild TBI (P = 0.152). Repeated-measures analysis of variance comparing trends between the three groups indicated significant differences between the control and moderate TBI groups only (F(2,15) = 6.26; P = 0.01). Acute TBI of moderate severity is associated with an early significant modification in arterial BRS. This is a key component of cardiovascular homeostasis. The clinical implications of this observation require further investigation.	[McMahon, C. Geraldine] St James Hosp, Trinity Coll Dubin, Dublin 8, Ireland; Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland; Trinity Coll Dublin, Dept Pharmacol & Therapeut, Dublin 2, Ireland; Univ Manchester, N Western Injury Res Ctr, Manchester, Lancs, England		McMahon, CG (corresponding author), St James Hosp, Trinity Coll Dubin, Dublin 8, Ireland.	geraldinemcmahon@upcmail.ie	McMahon, C Geraldine/M-8684-2019	McMahon, C Geraldine/0000-0002-9870-3104	Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	This study was supported by the Medical Research Council, UK, as part of the North West Injury Research Program Grant. The authors have no other financial interests to disclose.	Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; Barcroft H, 1944, LANCET, V1, P489; Casadei B, 2000, J HYPERTENS, V18, P3, DOI 10.1097/00004872-200018010-00002; CERUTTI C, 1994, AM J PHYSIOL, V266, pH1993, DOI 10.1152/ajpheart.1994.266.5.H1993; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grassi G, 1998, HYPERTENSION, V31, P68, DOI 10.1161/01.HYP.31.1.68; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hammer PE, 2005, AM J PHYSIOL-REG I, V288, pR1637, DOI 10.1152/ajpregu.00050.2004; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JOHNSTON WE, 1994, ANESTH ANALG, V79, P14; JONES RO, 1990, EXP PHYSIOL, V75, P483, DOI 10.1113/expphysiol.1990.sp003425; Jordan J, 2000, CIRCULATION, V102, P2611; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Keyl C, 2001, J APPL PHYSIOL, V91, P283, DOI 10.1152/jappl.2001.91.1.283; Kongo M, 1999, EXP PHYSIOL, V84, P47, DOI 10.1111/j.1469-445X.1999.tb00071.x; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Mascarucci P, 1998, NEUROSCIENCE, V86, P1285, DOI 10.1016/S0306-4522(98)00105-5; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Oikawa S, 2005, AUTON NEUROSCI-BASIC, V117, P105, DOI 10.1016/j.autneu.2004.11.009; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699; REDFERN WS, 1984, Q J EXP PHYSIOL CMS, V69, P763, DOI 10.1113/expphysiol.1984.sp002867; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SEAR JW, 1979, BRIT J ANAESTH, V51, P867, DOI 10.1093/bja/51.9.867; Simms AE, 2007, J PHYSIOL-LONDON, V579, P473, DOI 10.1113/jphysiol.2006.124396; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; Song XM, 2008, SHOCK, V30, P468, DOI 10.1097/SHK.0b013e31816d5e49; SPYER KM, 1984, RECENT ADV PHYSL, V10, P163; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TIMMS RJ, 1976, J PHYSIOL-LONDON, V256, pP71; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	39	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	JAN	2011	35	1					53	58		10.1097/SHK.0b013e3181e687c6			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	695OK	WOS:000285381500009	20458265				2022-02-06	
J	Nelson, NW; Hoelzle, JB; McGuire, KA; Sim, AH; Goldman, DJ; Ferrier-Auerbach, AG; Charlesworth, MJ; Arbisi, PA; Sponheim, SR				Nelson, Nathaniel W.; Hoelzle, James B.; McGuire, Kathryn A.; Sim, Anita H.; Goldman, Daniel J.; Ferrier-Auerbach, Amanda G.; Charlesworth, Molly J.; Arbisi, Paul A.; Sponheim, Scott R.			Self-Report of Psychological Function Among OEF/OIF Personnel Who Also Report Combat-Related Concussion	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; Symptom validity; Operations Enduring Freedom and Iraqi Freedom	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MMPI-2 VALIDITY SCALES; MULTIPHASIC PERSONALITY INVENTORY-2; FAKE-BAD SCALE; HEAD-INJURY; RESTRUCTURED FORM; FORENSIC SETTINGS; RC SCALES; VALIDATION	MMPI-2 RF profiles of 128 U. S. soldiers and veterans with history of concussion were examined. Participants evaluated in forensic (n = 42) and clinical (n = 43) settings showed significantly higher validity and clinical elevations relative to a research group (n = 43). In the full sample, a multivariate GLM identified main effects for disability claim status and Axis I diagnosis across numerous MMPI-2 RF scales. Participants with co-morbid PTSD and concussion showed significant Restructured Clinical and Specific Problem scale elevations relative to those without Axis I diagnosis. Participants with PTSD and active disability claims were especially prone to elevate on FBS/FBS-r and RBS. Implications for neuropsychologists who routinely administer the MMPI-2/RF in the context of combatrelated concussion are discussed.	[Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, Minneapolis, MN 55403 USA; [Nelson, Nathaniel W.; McGuire, Kathryn A.; Sim, Anita H.; Ferrier-Auerbach, Amanda G.; Charlesworth, Molly J.; Arbisi, Paul A.; Sponheim, Scott R.] Minneapolis VA Med Ctr, Minneapolis, MN USA; [Hoelzle, James B.] Marquette Univ, Milwaukee, WI 53233 USA; [McGuire, Kathryn A.; Ferrier-Auerbach, Amanda G.; Arbisi, Paul A.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Goldman, Daniel J.; Arbisi, Paul A.; Sponheim, Scott R.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA		Nelson, NW (corresponding author), Univ St Thomas, Grad Sch Profess Psychol, 1000 LaSalle Ave, Minneapolis, MN 55403 USA.	nels0600@stthomas.edu	Sponheim, Scott/J-3857-2017	Sponheim, Scott/0000-0002-2782-0856	Congressionally Directed Medical Research ProgramsUnited States Department of Defense [PT074550, W81XWH-08-2-0038]; Minnesota Veterans Research Institute (MVRI)	This study was supported in part by Grants funded by the Congressionally Directed Medical Research Programs (number PT074550, contract W81XWH-08-2-0038) to Scott R. Sponheim Ph.D. and the Minnesota Veterans Research Institute (MVRI) to Nathaniel W. Nelson, Ph.D.	Arbisi PA, 1999, NEUROREHABILITATION, V13, P117; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; Boone K.B., 2007, ASSESSMENT FEIGNED C; Bury AS, 2002, PSYCHOL ASSESSMENT, V14, P472, DOI 10.1037//1040-3590.14.4.472; Butcher J, 1989, MANUAL ADM SCORING M; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Elhai JD, 2000, J PERS ASSESS, V75, P449, DOI 10.1207/S15327752JPA7503_06; Elhai JD, 2004, ASSESSMENT, V11, P139, DOI 10.1177/1073191104264965; Finn S.E., 1996, MANUAL USING MMPI 2; First M, 2007, STRUCTURED CLIN INTE; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Graham J. R, 2006, MMPI 2 ASSESSING PER; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Hoelzle J. B., 2010, ANN C AM AC CLIN NEU; Hoelzle JB, 2008, J PERS ASSESS, V90, P443, DOI 10.1080/00223890802248711; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rogers R., 2008, CLIN ASSESSMENT MALI; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Simms LJ, 2005, PSYCHOL ASSESSMENT, V17, P345, DOI 10.1037/1040-3590.17.3.345; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Smart CM, 2008, J INT NEUROPSYCH SOC, V14, P842, DOI 10.1017/S1355617708081034; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tellegen, 2008, MINNESOTA MULTIPHASI; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wygant D.B., 2004, 39 ANN S REC DEV MMP; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	55	16	16	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	5					716	740		10.1080/13854046.2011.579174			25	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JE	WOS:000299559000003	21722045				2022-02-06	
J	Paiva, WS; Bezerra, DAF; Amorim, RLO; Figueiredo, EG; Tavares, WM; De Andrade, AF; Teixeira, MJ				Paiva, Wellingson Silva; Franca Bezerra, Douglas Alexandre; Oliveira Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Tavares, Wagner Malago; De Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen			Serum sodium disorders in patients with traumatic brain injury	THERAPEUTICS AND CLINICAL RISK MANAGEMENT			English	Article						brain trauma; hypernatremia; hyponatremia	ANEURYSMAL SUBARACHNOID HEMORRHAGE; ATRIAL-NATRIURETIC-PEPTIDE; SALT WASTING SYNDROME; SYMPTOMATIC HYPONATREMIA; HEAD-INJURY; PATHOPHYSIOLOGY; HYPERNATREMIA	Sodium disorders are the most common and most poorly understood electrolyte disorders in neurological patients. The aim of this study was to determine the incidence of sodium disorders and its association with different traumatic brain injuries. This prospective study was conducted in 80 patients diagnosed with moderate and severe traumatic brain injuries. All patients underwent cerebral computed tomography. Incidence of sodium disorders, presence of injuries in the first computed tomography after traumatic brain injury, and level of consciousness were analyzed. Patients that presented other potential causes of sodium disorders and systemic trauma were excluded from the study. The incidence of sodium disturbances was 45%: 20 patients presented hypernatremia and 16 hyponatremia. Refers to all patients with sodium disturbances 53% were detected in the first sample. We recorded at least one measurement <125 mEq/L in 50% of the patients with hyponatremia. A greater incidence of sodium disorders was found in patients with subdural, intracerebral hematoma and with diffuse axonal injury. The incidence of sodium disorders among the patients with diffuse lesions was greater than in the group of patients with brain contusion (P = 0.022). The incidence of sodium disorders is higher in patients with diffuse traumatic brain injuries. No association was found between focal lesions and proportion of sodium disorders. Keywords: brain trauma, hypernatremia, hyponatremia	[Paiva, Wellingson Silva; Franca Bezerra, Douglas Alexandre; Oliveira Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Tavares, Wagner Malago; De Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Intens Care Unit, Div Neurosurg, Hosp Das Clin, BR-05403010 Sao Paulo, Brazil		Paiva, WS (corresponding author), Univ Sao Paulo, Intens Care Unit, Div Neurosurg, Hosp Das Clin, Eneas Aguiar St N 255,Off 4080, BR-05403010 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013; Figueiredo, Eberval Gadelha/H-3488-2012; Figueiredo, Eberval G/E-2071-2016; Teixeira, Manoel J/E-3110-2012; Amorim, Robson/AAK-1368-2021	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519			ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Belvins LS, 1992, CRIT CARE MED, V20, P69; Coenraad Minneke J., 2003, Eur J Intern Med, V14, P302, DOI 10.1016/S0953-6205(03)00100-6; DIRINGER MN, 1991, STROKE, V22, P577, DOI 10.1161/01.STR.22.5.577; Doc ZIT, 1981, NEUROSURGERY, V9, P394; Donati-Genet PCM, 2001, J PEDIATR SURG, V36, P1094, DOI 10.1053/jpsu.2001.24770; GOLDSMITH MF, 1987, JAMA-J AM MED ASSOC, V257, P287, DOI 10.1001/jama.257.3.287; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; Horn LJ, 1982, J HEAD TRAUMA REHAB, V3, P86; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Marshall LF, 1991, J NEUROSURG S, V75, P14; Mizobata Y, 2001, J TRAUMA, V50, P871, DOI 10.1097/00005373-200105000-00016; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Revilla-Pacheco FR, 2005, NEUROL RES, V27, P418, DOI 10.1179/016164105X17152; RICHARDS AM, 1985, HYPERTENSION, V7, P812, DOI 10.1161/01.HYP.7.5.812; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; STERNS RH, 1987, ANN INTERN MED, V107, P656, DOI 10.7326/0003-4819-107-5-656; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Taikkanen I, 1986, J CLIN INVEST, V77, P734; TEASDALE G, 1974, LANCET, V2, P81; WIJDICKS EFM, 1991, STROKE, V22, P1519, DOI 10.1161/01.STR.22.12.1519	22	16	17	0	9	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-203X			THER CLIN RISK MANAG	Therap. Clin. Risk Manag.		2011	7						345	349		10.2147/TCRM.S17692			5	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	879OD	WOS:000299339100040	21941440	Green Submitted, Green Published, gold			2022-02-06	
J	Stoller, KP				Stoller, Kenneth P.			Hyperbaric oxygen therapy (1.5 ATA) in treating sports related TBI/CTE: two case reports	MEDICAL GAS RESEARCH			English	Article							BRAIN-INJURY	Despite adequate evidence, including randomized controlled trials; hyperbaric oxygen is not yet recognized as efficacious for treating various forms of brain injury, specifically traumatic brain injury. Political-economic issues have kept this benign therapy from being widely adopted despite the lack of viable alternatives. Two football players with TBI/CTE are herewith shown to benefit from being treated with hyperbaric oxygen as documented by neurocognitive examinations and functional brain imaging, in one case treatment commenced decades after the brain injury. Perhaps the interest in HBOT by those participating in high-risk sports will help expand this orphan therapy into mainstream medicine.			Stoller, KP (corresponding author), 404 Brunn Sch Rd D, Santa Fe, NM 87505 USA.	info@hbotnm.com					Barrett KF, 1998, NEUROLOGY, V50, pA178; Chang DC, 2010, UNDERSEA HYPERBAR M, V37, P23; Clifton G L, 1995, New Horiz, V3, P474; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; COLLINS MW, 1999, JAMA-J AM MED ASSOC, V282, P989; DUFF JH, 1967, CAN MED ASSOC J, V97, P510; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Harch P, 2010, 8 WORLD C BRAIN INJ; Harch Paul G, 2009, Cases J, V2, P6538, DOI 10.4076/1757-1626-2-6538; Harch PG, 1996, TXB HYPERBARIC MED, P480; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P30; HARCH PG, 1999, TXB HYPERBARIC MED, P319; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; Hart GB, 1971, STROKE, V2, P247; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Senol MG, 2009, MED PRIN PRACT, V18, P67, DOI 10.1159/000163050; Shi XY, 2006, CHINESE MED J-PEKING, V119, P1978, DOI 10.1097/00029330-200612010-00007; SLUIJTER ME, 1963, P ROY SOC MED, V56, P1002, DOI 10.1177/003591576305601129; SMITH G, 1960, LANCET, V2, P905; Stoller KP, 2007, NEUROL RES, V29, P146, DOI 10.1179/016164107X181770; Workman RD, 1964, 264 US NAV EXP DIV U, P1; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391	27	16	16	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.		2011	1								17	10.1186/2045-9912-1-17			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V32YV	WOS:000215734000017	22146303	Green Published, hybrid			2022-02-06	
J	Wortzel, HS; Kraus, MF; Filley, CM; Anderson, CA; Arciniegas, DB				Wortzel, Hal S.; Kraus, Marilyn F.; Filley, Christopher M.; Anderson, C. Alan; Arciniegas, David B.			Diffusion Tensor Imaging in Mild Traumatic Brain Injury Litigation	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							WHITE-MATTER INTEGRITY; INDUCED AXONAL INJURY; CORPUS-CALLOSUM; YOUNG-ADULTS; ABNORMALITIES; MODERATE; DYSFUNCTION; PREDICTORS; MEMORY; COMA	A growing body of literature addresses the application of diffusion tensor imaging (DTI) to traumatic brain injury (TBI). Most TBIs are of mild severity, and their diagnosis and prognosis are often challenging. These challenges may be exacerbated in medicolegal contexts, where plaintiffs seek to present objective evidence that supports a clinical diagnosis of mild (m)TBI. Because DTI permits quantification of white matter integrity and because TBI frequently involves white matter injury, DTI represents a conceptually appealing method of demonstrating white matter pathology attributable to mTBI. However, alterations in white matter integrity are not specific to TBI, and their presence does not necessarily confirm a diagnosis of mTBI. Guided by rules of evidence shaped by Daubert v. Merrell Dow Pharmaceuticals, Inc., we reviewed and analyzed the literature describing DTI findings in mTBI and related neuropsychiatric disorders. Based on this review, we suggest that expert testimony regarding DTI findings will seldom be appropriate in legal proceedings focused on mTBI.	[Wortzel, Hal S.] Univ Colorado, Sch Med, Denver VA Med Ctr, VISN 19,MIRECC, Denver, CO USA; [Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Denver, CO USA; [Kraus, Marilyn F.] Walter Reed Natl Mil Med Ctr, Neurobehav Traumat Brain Injury Consult Serv, Bethesda, MD USA; [Filley, Christopher M.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Denver, CO USA; [Anderson, C. Alan] Univ Colorado, Sch Med, Neurobehavioral Disorders Program, Dept Psychiat, Denver, CO USA; [Anderson, C. Alan] Denver VA Med Ctr, Neurol Serv, Denver, CO USA		Wortzel, HS (corresponding author), VISN 19 MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	wortzel@ucdenver.edu					Adinoff B, 2010, AM J PSYCHIAT, V167, P598, DOI 10.1176/appi.ajp.2010.10020157; Amen D, 2010, AM J PSYCHIAT, V167, P1125, DOI 10.1176/appi.ajp.2010.10060814; [Anonymous], 2010, TRAUM BRAIN INJ SCI; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashtari M, 2008, J PSYCHIATR RES, V43, P189, DOI 10.1016/j.jpsychires.2008.12.002; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Macey PM, 2008, SLEEP, V31, P967; Mayberg, 1996, Semin Clin Neuropsychiatry, V1, P195; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Paul Robert, 2008, Neuropsychiatr Dis Treat, V4, P193; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reeves D, 2003, J AM ACAD PSYCHIATRY, V31, P89; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Society of Nuclear Medicine (SNM), 1999, SOC NUCL MED PROC GU, P113; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; Taber KH, 2002, J NEUROPSYCH CLIN N, V14, P1, DOI 10.1176/appi.neuropsych.14.1.1; TEASDALE G, 1974, LANCET, V2, P81; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilson J, 1996, J NUCL MED, V37, P1256; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Yudofsky SC, 2008, NEUROPSYCHIATRY BEHA, P245	57	16	17	0	6	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2011	39	4					511	523					13	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	881DV	WOS:000299461600008	22159979				2022-02-06	
J	Moon, Y; Choi, SY; Kim, K; Kim, H; Sun, W				Moon, Younghye; Choi, So Yoen; Kim, Kyungjin; Kim, Hyun; Sun, Woong			Expression of connexin29 and 32 in the penumbra region after traumatic brain injury of mice	NEUROREPORT			English	Article						connexin; gap junction; hemichannel; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; GAP-JUNCTION PROTEINS; GLOBAL-ISCHEMIA; GLIAL-CELLS; CX32; OLIGODENDROCYTES; COLOCALIZATION; VULNERABILITY; ASTROCYTES; CHANNELS	Connexins (Cx) are transmembrane proteins forming vertebrate gap junction channels for direct cell-cell communication. We found that the expressions of two Cx family members, Cx29 and Cx32, were progressively increased in the sharp border of injury penumbra regions after cryotraumatic brain injury. Although these two Cxs are expressed exclusively in the oligodendrocytes in the normal cerebral cortex, their expressions were increased in the astrocytes and microglia localized in the injury border. Highly selective induction of Cxs in the injury border suggests that altered Cxs may contribute to the propagations of injury-related and/or regeneration signals after acute brain injury. NeuroReport 21: 1135-1139 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Choi, So Yoen; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Brain & Neuroendocrine Lab, Seoul 151742, South Korea		Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, Div Brain Korea Biomed Sci 21, 126-1 Anam Dong, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Choi, So Yoen/AAV-1947-2020	Moon, Younghye/0000-0002-3737-0043; Kim, Hyun/0000-0002-7210-5798; sun, woong/0000-0003-1792-4894	Korea Ministry of Science and TechnologyMinistry of Science and Technology (MOST) Korea; National Research LaboratoryKorea Science and Engineering Foundation [2009K001259]	This study was supported by grants 2009K001259 from National Research Laboratory and Brain Research Center of the 21st Century Frontier Program in Neuroscience from Korea Ministry of Science and Technology.	Ahn M, 2008, J NEUROSCI RES, V86, P992, DOI 10.1002/jnr.21561; Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Altevogt BM, 2002, J NEUROSCI, V22, P6458; Chandross KJ, 1996, MOL CELL NEUROSCI, V7, P501, DOI 10.1006/mcne.1996.0036; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; HOSSAIN MZ, 1994, BRAIN RES, V652, P311, DOI 10.1016/0006-8993(94)90242-9; Kleopa KA, 2004, GLIA, V47, P346, DOI 10.1002/glia.20043; Leung DSY, 2002, INT J DEV NEUROSCI, V20, P63, DOI 10.1016/S0736-5748(01)00056-9; Murru MR, 2006, NEUROL SCI, V27, P18, DOI 10.1007/s10072-006-0560-8; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nagy JI, 2003, J COMP NEUROL, V464, P356, DOI 10.1002/cne.10797; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Nakase T, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/147946; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Paciaroni M, 2009, EUR NEUROL, V61, P321, DOI 10.1159/000210544; ROHLMANN A, 1993, NEUROSCI LETT, V154, P206, DOI 10.1016/0304-3940(93)90208-3; Sohl G, 2004, BRAIN RES REV, V47, P245, DOI 10.1016/j.brainresrev.2004.05.006; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007	25	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	DEC 29	2010	21	18					1135	1139		10.1097/WNR.0b013e32834051c7			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	685DL	WOS:000284607500001	20926974				2022-02-06	
J	Courtney, MW; Courtney, AC				Courtney, Michael W.; Courtney, Amy C.			Note: A table-top blast driven shock tube	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								The prevalence of blast-induced traumatic brain injury in conflicts in Iraq and Afghanistan has motivated laboratory scale experiments on biomedical effects of blast waves and studies of blast wave transmission properties of various materials in hopes of improving armor design to mitigate these injuries. This paper describes the design and performance of a table-top shock tube that is more convenient and widely accessible than traditional compression driven and blast driven shock tubes. The design is simple: it is an explosive driven shock tube employing a rifle primer that explodes when impacted by the firing pin. The firearm barrel acts as the shock tube, and the shock wave emerges from the muzzle. The small size of this shock tube can facilitate localized application of a blast wave to a subject, tissue, or material under test. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3518970]	[Courtney, Michael W.] USAF Acad, Colorado Springs, CO 80840 USA; [Courtney, Amy C.] Force Protect Ind Inc, Ladson, SC 29456 USA		Courtney, MW (corresponding author), USAF Acad, 2354 Fairchild Dr, Colorado Springs, CO 80840 USA.	Michael.Courtney@usafa.edu		Courtney, Amy/0000-0002-1925-8736			Alley M., 2009, THESIS PURDUE U W LA; ALLEY MD, NEUROIMAGE IN PRESS; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; COURTNEY MW, NEUROIMAGE IN PRESS; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Richmond D. R., 1966, 1854 DASA; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109	9	16	18	1	11	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	DEC	2010	81	12							126103	10.1063/1.3518970			3	Instruments & Instrumentation; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Instruments & Instrumentation; Physics	700UW	WOS:000285770800052	21198058	Green Submitted			2022-02-06	
J	Donaldson, RI; Hung, YW; Shanovich, P; Hasoon, T; Evans, G				Donaldson, Ross I.; Hung, Yuen Wai; Shanovich, Patrick; Hasoon, Tariq; Evans, Gerald			Injury Burden During an Insurgency: The Untold Trauma of Infrastructure Breakdown in Baghdad, Iraq	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Conflict; Injury; Iraq; War	HEALTH-CARE; MORTALITY; VIOLENCE; EPIDEMIOLOGY; PATTERNS; DARFUR; CONGO	Background: Injuries as a result of the ongoing violence in Iraq have been a topic of both lay and academic interest. However, to date, attempts to quantify injuries in the country have focused primarily on direct mortality, which represents only a small portion of overall injury burden and ignores those injuries indirectly resulting from the conflict-induced breakdown of Iraqi infrastructure. Methods: We performed a cross-sectional household survey from October to November, 2009, within the Baghdad Governorate of central Iraq. Using two-stage cluster-sampling with a proportional-to-size methodology, we randomized a total of 60 clusters to Baghdad's five governmental districts. Within each cluster, we interviewed heads of households regarding all injuries during the last 3 months. Results: We surveyed 1,172 households, gathering information regarding 7,396 individuals. Only 8.4% of injuries were intentional, and fatalities represented only a small fraction (1.7%) of overall injury burden. The well-publicized intentional explosions in Baghdad, although accounting for close to half (44%) of all intentional injuries, made up only 4% of the total. Other injuries at least partially attributable to the conflict-induced breakdown of Iraqi infrastructure proved a much larger burden, for example, those from electric shock, unintentional explosions, unintentional gunshot wounds, and falls. Conclusions: Past and current fighting in Baghdad continues to adversely affect the Iraqi populace, where the indirect effects of infrastructure breakdown are likely the primary source of injury. When measuring the burden of large-scale violence, health researchers should account for the full injury burden, including both injury morbidity and indirect injuries.	[Donaldson, Ross I.; Shanovich, Patrick] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA 90095 USA; [Donaldson, Ross I.; Hung, Yuen Wai; Shanovich, Patrick; Hasoon, Tariq; Evans, Gerald] Int Med Corps, Baghdad, Iraq		Donaldson, RI (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Box 21, Torrance, CA 90509 USA.	ross@rossdonaldson.com			Australian Agency for International Development (AusAID)Australian Aid (AusAID); Iraqi Ministry of Health; International Medical Corps	Supported by Australian Agency for International Development (AusAID), Iraqi Ministry of Health, and International Medical Corps.	Aboutanos MB, 1997, J TRAUMA, V43, P719, DOI 10.1097/00005373-199710000-00031; Ahoua L, 2006, Glob Public Health, V1, P195, DOI 10.1080/17441690600681869; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Awqati NA, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-40; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Cardona M, 2008, INJURY PREV, V14, P232, DOI 10.1136/ip.2007.018259; *CENTR ORG STAT IN, 2008, TAB REP IR HOUS SOC; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Count Iraq Body, DOC CIV DEATHS VIOL; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Fatmi Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-152; HICKS MH, N ENGL J MED, V360, P1585; Hyder AA, 2009, J TRAUMA, V66, P888, DOI 10.1097/TA.0b013e3181627614; *INT ORG MIGR, IR DISPL RET 2008 MI; Kobusingye O, 2001, Inj Prev, V7, P46, DOI 10.1136/ip.7.1.46; Maziak W, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-63; Olawale OA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-246; Rezapur-Shahkolai F, 2009, PUBLIC HEALTH, V123, P384, DOI 10.1016/j.puhe.2009.03.010; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Siegler A, 2008, PREHOSP DISASTER MED, V23, P369, DOI 10.1017/S1049023X00006026; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Tercero F, 2006, PUBLIC HEALTH, V120, P106, DOI 10.1016/j.puhe.2005.07.005; *UN OFF COORD HUM, 2009, BAGHD GOV PROF; Van Herp M, 2003, DISASTERS, V27, P141, DOI 10.1111/1467-7717.00225; WHO, 2004, GUID COND COMM SURV	26	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2010	69	6					1379	1385		10.1097/TA.0b013e318203190f			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	695RT	WOS:000285391000022	21150518				2022-02-06	
J	Sankhyan, N; Raju, KNV; Sharma, S; Gulati, S				Sankhyan, Naveen; Raju, K. N. Vykunta; Sharma, Suvasini; Gulati, Sheffali			Management of Raised Intracranial Pressure	INDIAN JOURNAL OF PEDIATRICS			English	Article						Coma; Critically ill child; Intracranial hypertension; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; HYPERTONIC SALINE; DECOMPRESSIVE CRANIECTOMY; CRITICAL-CARE; HYPOTHERMIA; THERAPY; TRIAL; EDEMA; FUROSEMIDE	Appropriate management of raised intracranial pressure begins with stabilization of the patient and simultaneous assessment of the level of sensorium and the cause of raised intracranial pressure. Stabilization is initiated with securing the airway, ventilation and circulatory function. The identification of surgically remediable conditions is a priority. Emergent use of external ventricular drain or ventriculo-peritoneal shunt may be lifesaving in selected patients. In children with severe coma, signs of herniation or acutely elevated intracranial pressure, treatment should be started prior to imaging or invasive monitoring. Emergent use of hyperventilation and mannitol are life saving in such situations. Medical management involves careful use of head elevation, osmotic agents, and avoiding hypotonic fluids. Appropriate care also includes avoidance of aggravating factors. For refractory intracranial hypertension, barbiturate coma, hypothermia, or decompressive craniectomy should be considered.	[Sankhyan, Naveen; Raju, K. N. Vykunta; Sharma, Suvasini; Gulati, Sheffali] All India Inst Med Sci, Dept Pediat, Child Neurol Div, New Delhi 110029, India		Gulati, S (corresponding author), All India Inst Med Sci, Dept Pediat, Child Neurol Div, New Delhi 110029, India.	sheffaligulati@gmail.com	SANKHYAN, NAVEEN/AAP-6531-2021				Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Berger C, 2005, STROKE, V36, pE4, DOI 10.1161/01.STR.0000151328.70519.e9; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Bilotta F, 2008, NEUROCRIT CARE, V8, P241, DOI 10.1007/s12028-007-9012-4; Biousse V, 2003, AM J OPHTHALMOL, V135, P437, DOI 10.1016/S0002-9394(02)02062-7; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Edwards P, 2005, LANCET, V365, P1957; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FRENCH L A, 1964, Clin Neurosurg, V10, P212; GOLDSTEIN B, 2008, ROGERS TXB PEDIAT IN; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; LAYON JA, 2004, TXB NEUROINTENSIVE C, P709; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; MARSH ML, 1977, ANESTHESIOLOGY, V47, P149, DOI 10.1097/00000542-197708000-00006; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SCHALEN W, 1992, ACTA NEUROCHIR, V117, P153, DOI 10.1007/BF01400613; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thenuwara K, 2002, ANESTHESIOLOGY, V96, P416, DOI 10.1097/00000542-200202000-00029; TORNHEIM PA, 1979, NEUROSURGERY, V4, P48, DOI 10.1227/00006123-197901000-00009; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	39	16	17	1	4	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0019-5456	0973-7693		INDIAN J PEDIATR	Indian J. Pediatr.	DEC	2010	77	12					1409	1416		10.1007/s12098-010-0190-2			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	693EI	WOS:000285207000007	20821277				2022-02-06	
J	Winkler, D; Farnworth, L; Sloan, S; Brown, T; Callaway, L				Winkler, Dianne; Farnworth, Louise; Sloan, Sue; Brown, Ted; Callaway, Libby			Comparison of People With ABI Living in Two Accommodation Settings: Shared Supported Accommodation and Residential Aged Care	BRAIN IMPAIRMENT			English	Article						community participation; social inclusion	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COMMUNITY INTEGRATION; NEEDS SCALE; REHABILITATION; OUTCOMES; PARTICIPATION; POSTDISCHARGE; INDIVIDUALS; PREDICTION	Background: People with severe acquired brain injury (AB!) often require high and ongoing levels of paid support, which is sometimes provided within a shared supported accommodation service (SSA). In Victoria there are more than 140 people with severe ABI living in shared supported accommodation services who have a similar level of disability as young people with ABI in residential aged care (RAC). Objectives: The aims of this article are twofold: (1) to describe the characteristics, support needs and level of community inclusion of people with an ABI living in shared SSA in Victoria and (2) to compare the characteristics, support needs, social contact, community integration and leisure participation of this group with a group of people with ABI under 50 years old living in RAC reported in a previous study. Participants: Information was obtained from SSA managers on 128 residents with an ABI, aged under 60 years, who were living in shared supported accommodation. Measures: Questionnaires were used to obtain information about the characteristics, support needs and occupational participation of participants. Support needs were measured utilising the Care and Needs Scale (CANS). Method: Questionnaires were sent to and completed by SSA managers. Results: Of the 39 SSA managers contacted, 32 provided information about the characteristics of 128 residents with ABI living in their facilities. While 72% of SSA residents accessed the community almost everyday or more often, 40% of this sample received a visit from a friend less often than once per year. Results of the CANS indicated that the SSA group required a similar level of support to the comparison group of people with ABI living in RAC, but went outside, participated in community based leisure activities, and visited friends significantly more often. There was no significant difference between the two groups in the frequency of visits to the facility from relatives or friends. Conclusion: Although the relationship between client outcomes and accommodation is a complex one, this study suggests that the type of accommodation and support has a significant impact on the frequency of community participation experienced people with ABI and high care needs.	[Winkler, Dianne] Monash Univ, Melbourne, Vic 3004, Australia; [Winkler, Dianne] Summer Fdn, Melbourne, Vic, Australia; [Farnworth, Louise; Brown, Ted; Callaway, Libby] Monash Univ Frankston, Dept Occupat Therapy, Frankston, Vic, Australia; [Sloan, Sue] Osborn Sloan & Associates, Melbourne, Vic, Australia		Winkler, D (corresponding author), POB 208, Blackburn, Vic 3130, Australia.	di.winkler@summerfoundation.org.au		Winkler, Di/0000-0003-3899-6248; Brown, Ted/0000-0001-9403-5877			*AUSTR I HLTH WELF, 2007, AIHW B, V67; *AUSTR I HLTH WELF, 2003, DAT GUID DAT IT DEF; *AUSTR I HLTH WELF, 2010, YOUNG PEOPL DIS RES; Baguley I, 2000, BRAIN INJURY, V14, P505; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cameron C, 2001, AUST NZ J PUBL HEAL, V25, P261, DOI 10.1111/j.1467-842X.2001.tb00574.x; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; *COMM DEP HLTH AG, 2002, INF YOUNG PEOPL DIS; *DEP FAM HOUS COMM, 2009, YOUNG PEOPL DIS RES; *DEP HLTH HUM SERV, 2001, ACQ BRAIN INJ STRAT; *DEP HLTH HUM SERV, 2005, CREAT NEW OPP RESP N; Dillman DA., 2000, MAIL INTERNET SURVEY; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Emerson E, 1996, J INTELLECT DEV DIS, V21, P17, DOI 10.1080/13668259600033021; Felce D., 1996, DEINSTITUTIONALISATI, P81; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; Fyffe C, 2003, YOUNG PEOPLE ABI LES; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Kim S, 2001, J INTELLECT DEV DIS, V26, P35, DOI 10.1080/13668250020032750; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Mansell J., 1996, DEINSTITUTIONALISATI, P242; Matthews S., 1983, AGEING SOC, V3, P141; McMillan TM, 2004, CLIN REHABIL, V18, P132, DOI 10.1191/0269215504cr712oa; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PAPASTRAT LA, 1992, J HEAD TRAUMA REHAB, V7, P11; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Senate Community Affairs References Committee, 2005, COMM AFF REF COMM QU; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Social Inclusion Unit, 2009, AUSTR PUBL SERV SOC; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; *SPSS, 2007, SPSS VERS 16 0 BAS; Strettles B, 2005, ACCOMMODATION NSW AD; Stringer K, 1999, STUDY ACCOMMODATION; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TATE RL, 2003, 26 ANN BRAIN IMP C S; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P11; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D., 2007, YOUNGER PEOPLE RESID; Winkler Dianne, 2006, Aust Health Rev, V30, P100; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; WISEMAN JP, 1986, J SOC PERS RELAT, V3, P191, DOI 10.1177/0265407586032005; World Health Organization, 2007, INT CLASS FUNCT DIS; Young L, 2001, J INTELLECT DEV DIS, V26, P51, DOI 10.1080/13668250020032769; Young L, 1998, J INTELLECT DEV DIS, V23, P155, DOI 10.1080/13668259800033661	54	16	16	0	5	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2010	11	3					313	325		10.1375/brim.11.3.313			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	710VJ	WOS:000286544800007					2022-02-06	
J	Meade, AJ; Meloni, BP; Mastaglia, FL; Watt, PM; Knuckey, NW				Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Watt, Paul M.; Knuckey, Neville W.			AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid	BRAIN RESEARCH			English	Article						Neuroprotection; Excitotoxicity; Phylomer peptide; TAT; c-Jun; JNKI	N-TERMINAL KINASE; ADULT-RAT BRAIN; C-JUN; INDUCED SEIZURE; CLUSTAL-W; KAINATE; EXCITOTOXICITY; ACTIVATION; ISCHEMIA; EXPRESSION	This study has assessed the neuroprotective efficacy of five AP-1 inhibitory peptides in an in vitro excitotoxicity model. The five AP-1 inhibitory peptides and controls of the INK inhibitor peptide (JNKI-1D-TAT) and TAT cell-penetrating-peptide were administered to primary cortical neuronal cultures prior to kainic acid exposure. All five AP-1 inhibitory peptides and JNKI-1D-TAT provided significant neuroprotection from kainic acid induced neuronal cell death. Kainic acid exposure induced caspase and calpain activation in neuronal cultures, with caspase-induced cleavage of a-fodrin reduced by administration of the AP-1 inhibitory peptides. Sequence analysis of the AP-1 inhibitory peptides did not reveal the presence of any secondary structures; however two peptides shared 66% amino-acid sequence homology. As a result, truncated sequences were designed and synthesised to identify the active region of the peptides. All truncated peptides were significantly neuroprotective following kainic acid and glutamate exposure. We have shown for the first time the neuroprotective efficacy of full-length and truncated AP-1 inhibitory peptides in kainic acid and glutamate neuronal excitotoxicity models. The identification of therapeutic targets, such as the AP-1 complex, is an important step for the development of pharmaceuticals to reduce neuronal loss in disorders with a prevalence of excitotoxic cell death such as epilepsy, cerebral ischaemia, and traumatic brain injury. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.	[Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Knuckey, Neville W.] QEII Med Ctr, Australian Neuromuscular Res Inst, Nedlands, WA 6009, Australia; [Meade, Amanda J.; Meloni, Bruno P.; Mastaglia, Frank L.; Knuckey, Neville W.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; [Meloni, Bruno P.; Knuckey, Neville W.] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; [Watt, Paul M.] Univ Western Australia, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia		Meloni, BP (corresponding author), QEII Med Ctr, Australian Neuromuscular Res Inst, A Block,4th Floor,Verdun St, Nedlands, WA 6009, Australia.	meloni@cyllene.uwa.edu.au	Craig, Amanda/F-6699-2013	Craig, Amanda/0000-0002-7197-4369	Neurotrauma Research Project Grant; University of Western Australia; Phylogica Ltd.	The authors would like to thank Dr Nadia Milech, Ms Kate Thomas, Ms Joanne Chieng and Mr Tom Hamilton for their technical support and Dr Kym Campbell for expert editing. This work was supported by a Neurotrauma Research Project Grant, The University of Western Australia and Phylogica Ltd.	Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; CHOI DW, 1987, J NEUROSCI, V7, P357; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Fahrig T, 2005, MOL PHARMACOL, V67, P1544, DOI 10.1124/mol.104.008177; Fernandez M, 2005, J NEUROSCI RES, V82, P115, DOI 10.1002/jnr.20608; Gill MB, 2008, NEUROCHEM RES, V33, P2379, DOI 10.1007/s11064-008-9649-1; Gillardon F, 1997, MOL BRAIN RES, V50, P16, DOI 10.1016/S0169-328X(97)00162-9; Hoyt KR, 1998, J PHYSIOL-LONDON, V509, P103, DOI 10.1111/j.1469-7793.1998.103bo.x; Jeon SH, 2000, EXP MOL MED, V32, P227, DOI 10.1038/emm.2000.37; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu W, 2001, BRAIN RES, V916, P239, DOI 10.1016/S0006-8993(01)03006-2; Manno A, 2007, NEUROREPORT, V18, P373; Meade AJ, 2010, J NEUROCHEM, V112, P258, DOI 10.1111/j.1471-4159.2009.06459.x; Meloni BP, 2001, NEUROSCIENCE, V108, P17, DOI 10.1016/S0306-4522(01)00396-7; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; NADLER JV, 1981, LIFE SCI, V29, P2031; Niebauer M, 1999, NEUROPHARMACOLOGY, V38, P1343, DOI 10.1016/S0028-3908(99)00059-3; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Pugazhenthi S, 2006, FREE RADICAL BIO MED, V40, P21, DOI 10.1016/j.freeradbiomed.2005.08.023; Schauwecker PE, 2000, BRAIN RES, V884, P116, DOI 10.1016/S0006-8993(00)02888-2; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.t01-1-00218.x; Vaslin A, 2009, NEUROTOX RES, V15, P123, DOI 10.1007/s12640-009-9012-6; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang L, 2008, J NEUROSURG ANESTH, V20, P124, DOI 10.1097/ANA.0b013e3181667c27; Xu W, 2008, NEUROSCIENTIST, V14, P409, DOI 10.1177/1073858407309762	34	16	17	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 11	2010	1360						8	16		10.1016/j.brainres.2010.09.007			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680RR	WOS:000284252600002	20833150				2022-02-06	
J	Feeney, TJ				Feeney, Timothy J.			Structured Flexibility: The Use of Context-Sensitive Self-regulatory Scripts to Support Young Persons with Acquired Brain Injury and Behavioral Difficulties	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior disorders; cognitive-behavioral intervention; ecological validity; functional assessment; multicomponent intervention; pediatric rehabilitation; positive behavior support; school-based treatment; traumatic brain injury	PSYCHIATRIC-DISORDERS; CHILDREN; TBI; INTERVENTIONS; ADOLESCENTS; CORTEX	Objective: This study investigated the effects of a cognitive-behavioral intervention on the escalating behavior problems observed in 2 children with severe traumatic brain injury. Design: Multiple baseline designs were used to document the effects of an intervention package that integrated cognitive and executive function interventions to address severe challenging behaviors in public school settings. Main outcomes and results: The results suggested that the intervention reduced the frequency and intensity of challenging behaviors and increased the quantity of work completed. Conclusions: These 2 successful single-subject experiments expand the findings of previous studies on the use of a support-oriented intervention that uses context-sensitive, flexible cognitive/behavioral scripts combined with positive behavior interventions and supports to reduce challenging behaviors.	Sch & Community Support Inc, Latham, NY 12110 USA		Feeney, TJ (corresponding author), Sch & Community Support Inc, 17 British Amer Blvd, Latham, NY 12110 USA.	tim@positivesupport.org	Berger, Emily/N-7268-2017	Berger, Emily/0000-0001-5550-807X			Aman MG., 1994, ABERRANT BEHAV CHECK; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BARLOW D, 1991, SINGLE CASE EXPT DES, P47; BIJOU SW, 1968, J APPL BEHAV ANAL, V1, P175, DOI 10.1901/jaba.1968.1-175; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; Carr EG, 2002, J POSIT BEHAV INTERV, V4, P4, DOI 10.1177/109830070200400102; COSTEFF H, 1985, SCAND J REHABIL MED, P10; Durand V.M., 1992, MOTIVATION ASSESSMEN; DURAND VM, 1991, J APPL BEHAV ANAL, V24, P251, DOI 10.1901/jaba.1991.24-251; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; FEENEY TJ, TXB TRAUMAT IN PRESS; Glesne C., 1992, BECOMING QUALITATIVE; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2008, EXECUTIVE FUNCTIONS, P409; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker M, 2009, DEV NEUROREHABIL, V12, P370, DOI 10.3109/17518420903087533; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	28	16	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2010	25	6					416	425		10.1097/HTR.0b013e3181fbc0a2			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	679HA	WOS:000284151300003	21076242				2022-02-06	
J	Begonia, MT; Prabhu, R; Liao, J; Horstemeyer, MF; Williams, LN				Begonia, Mark T.; Prabhu, Raj; Liao, Jun; Horstemeyer, Mark F.; Williams, Lakiesha N.			The Influence of Strain Rate Dependency on the Structure-Property Relations of Porcine Brain	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Strain rate dependence; Confocal microscopy; Area fraction	INJURY; TISSUE; BIOMECHANICS; BEHAVIOR; IMPACT; STATE; STEM	This study examines the internal microstructure evolution of porcine brain during mechanical deformation. Strain rate dependency of porcine brain was investigated under quasi-static compression for strain rates of 0.00625, 0.025, and 0.10 s(-1). Confocal microscopy was employed at 15, 30, and 40% strain to quantify microstructural changes, and image analysis was implemented to calculate the area fraction of neurons and glial cells. The nonlinear stress-strain behavior exhibited a viscoelastic response from the strain rate sensitivity observed, and image analysis revealed that the mean area fraction of neurons and glial cells increased according to the applied strain level and strain rate. The area fraction for the undamaged state was 7.85 +/- 0.07%, but at 40% strain the values were 11.55 +/- 0.35%, 13.30 +/- 0.28%, and 19.50 +/- 0.14% for respective strain rates of 0.00625, 0.025, and 0.10 s(-1). The increased area fractions were a function of the applied strain rate and were attributed to the compaction of neural constituents and the stiffening tissue response. The microstructural variations in the tissue were linked to mechanical properties at progressive levels of compression in order to generate structure-property relationships useful for refining current FE material models.	[Begonia, Mark T.; Liao, Jun; Williams, Lakiesha N.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Prabhu, Raj; Horstemeyer, Mark F.] Ctr Adv Vehicular Syst, Starkville, MS 39759 USA		Williams, LN (corresponding author), Mississippi State Univ, Dept Agr & Biol Engn, 130 Creelman St, Mississippi State, MS 39762 USA.	lwilliams@abe.msstate.edu	Liao, Jun/AAW-3591-2021; Prabhu, Raj/M-7188-2017	Liao, Jun/0000-0003-1049-5783; Prabhu, Raj/0000-0002-6073-4802; Horstemeyer, Mark/0000-0003-4230-0063	U.S. Army TACOM Life Cycle Command [W56HZV-08-C-0236]	This research was supported by the U.S. Army TACOM Life Cycle Command under Contract No. W56HZV-08-C-0236 through a subcontract with Mississippi State University and was performed for the Simulation Based Reliability and Safety (SimBRS) research program. The authors also recognize the Center for Advanced Vehicular Systems (CAVS) and the Department of Agricultural and Biological Engineering at Mississippi State University for their ongoing support of this research. Further acknowledgment must be given to Sansing Meat Services in Maben, MS for their assistance in providing porcine brain tissue specimens as well as Amanda Lawrence and Bill Monroe of the Mississippi State University Electron Microscopy Center for their assistance with the histological processing and operation of the con-focal laser scanning microscope, respectively. In addition, the authors recognize Dr. Jim Cooley for his assistance in the extraction procedure at the Mississippi State College of Veterinary Medicine. UNCLASSIFIED: Dist A. Approved for public release.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; ARBOGAST KB, 1997, 41 STAPP CAR CRASH C; BRANDS DWA, 2000, P 44 STAPP CAR CRASH; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; DEWEESE RL, 2004, EVALUATION HEAD INJU; Dickerson J. W. T., 1966, Proceedings of the Royal Society, V166B, P384; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; ESTES MS, 1970, 70BHF13 ASME; Finkelstein E., 2006, INCIDENCE EC BURDEN; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Miller N., 2000, J REAL ESTATE PORTFO, V6, P167; *NAT DISS CTR CHIL, 2006, FACTSH TRAUM BRAIN I; *NAT I NEUR DIS ST, 2006, TRAUM BRAIN INJ HOP; Nolte J., 2002, HUMAN BRAIN INTRO IT; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Prange M.T., 1998, ADV BIOENG, V39, P151; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; TAKHOUNTS EG, 1999, INJURY BIOMECHANICS, V11, P141; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Versace J., 1971, STAPP CAR CRASH C P; WIDMAIER EP, 2006, VANDERS HUMAN PHYSL, P191; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	46	16	16	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2010	38	10					3043	3057		10.1007/s10439-010-0072-9			15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	650ZX	WOS:000281895500001	20505994				2022-02-06	
J	Risselada, R; Lingsma, HF; Molyneux, AJ; Kerr, RSC; Yarnold, J; Sneade, M; Steyerberg, EW; Sturkenboom, MCJM				Risselada, Roelof; Lingsma, Hester F.; Molyneux, Andrew J.; Kerr, Richard S. C.; Yarnold, Julia; Sneade, Mary; Steyerberg, Ewout W.; Sturkenboom, Miriam C. J. M.			Prediction of two month modified Rankin Scale with an ordinal prediction model in patients with aneurysmal subarachnoid haemorrhage	BMC MEDICAL RESEARCH METHODOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL ANEURYSMS; REGRESSION-MODELS; ADJUSTMENT; TRIALS	Background: Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating event with a frequently disabling outcome. Our aim was to develop a prognostic model to predict an ordinal clinical outcome at two months in patients with aSAH. Methods: We studied patients enrolled in the International Subarachnoid Aneurysm Trial (ISAT), a randomized multicentre trial to compare coiling and clipping in aSAH patients. Several models were explored to estimate a patient's outcome according to the modified Rankin Scale (mRS) at two months after aSAH. Our final model was validated internally with bootstrapping techniques. Results: The study population comprised of 2,128 patients of whom 159 patients died within 2 months (8%). Multivariable proportional odds analysis identified World Federation of Neurosurgical Societies (WFNS) grade as the most important predictor, followed by age, sex, lumen size of the aneurysm, Fisher grade, vasospasm on angiography, and treatment modality. The model discriminated moderately between those with poor and good mRS scores (c statistic = 0.65), with minor optimism according to bootstrap re-sampling (optimism corrected c statistic = 0.64). Conclusion: We presented a calibrated and internally validated ordinal prognostic model to predict two month mRS in aSAH patients who survived the early stage up till a treatment decision. Although generalizability of the model is limited due to the selected population in which it was developed, this model could eventually be used to support clinical decision making after external validation.	[Risselada, Roelof; Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Molyneux, Andrew J.; Yarnold, Julia; Sneade, Mary] Univ Oxford, Oxford Neurovasc & Neuroradiol Res Unit, Oxford, England; [Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Kerr, Richard S. C.] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England		Risselada, R (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	r.risselada@erasmusmc.nl	Steyerberg, Ewout/C-1509-2018	Steyerberg, Ewout/0000-0002-7787-0122	European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC); French Ministry of Health [AOM 98150]; Assistance Publique, HOpitaux de Paris (AP-HP); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Stroke Association of the UK for the Neuropsychological assessments; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700479] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700479] Funding Source: UKRI	This study was performed within the scope of the @neurIST-project ('@neurIST, Integrated biomedical informatics for the management of cerebral aneurysms', http://www.aneurist.org), funded by the European Commission 6th Framework Programme. The International Subarachnoid Aneurysm Trial was supported by grants from: the Medical Research Council, UK; and Programme Hospitalier de Recherche Clinique 1998 of the French Ministry of Health (AOM 98150). It was sponsored by Assistance Publique, HOpitaux de Paris (AP-HP); the Canadian Institutes of Health Research; and the Stroke Association of the UK for the Neuropsychological assessments.	Ambler G, 2002, STAT MED, V21, P3803, DOI 10.1002/sim.1422; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Box G.E.P., 1979, ROBUSTNESS STRATEGY; Eriksson M, 2008, CEREBROVASC DIS, V25, P423, DOI 10.1159/000121343; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.0.CO;2-O; Hayakawa M, 2005, AM J NEURORADIOL, V26, P1366; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Langham J, 2009, STROKE, V40, P111, DOI 10.1161/STROKEAHA.108.517805; Machado SS, 1999, BIOCATAL BIOTRANSFOR, V17, P179, DOI 10.3109/10242429909040114; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Risselada R, 2010, EUR J EPIDEMIOL, V25, P261, DOI 10.1007/s10654-010-9432-x; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Starke RM, 2009, J CLIN NEUROSCI, V16, P26, DOI 10.1016/j.jocn.2008.02.010; Steyerberg E., 2009, PRACTICAL APPROACH D; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; YEE TW, 2010, J STAT SOFTW, P32; ZHANG C, 2009, IEEE T MED IMAGING	27	16	17	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	SEP 29	2010	10								86	10.1186/1471-2288-10-86			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	667UA	WOS:000283218700001	20920243	Green Published, gold			2022-02-06	
J	Giannotti, M; Al-Sahab, B; McFaull, S; Tamim, H				Giannotti, Maria; Al-Sahab, Ban; McFaull, Steve; Tamim, Hala			Epidemiology of acute head injuries in Canadian children and youth soccer players	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Soccer; Canada; Head injury; Youth; Children; Sport	MEDICAL-RESEARCH PROGRAM; BALL PROPERTIES; BRAIN-INJURY; FOOTBALL; RISK; PREVENTION; MECHANISMS; AUDIT	Background: Limited studies have been done to assess head injury characteristics for children and youth soccer players in Canada. Objectives: To describe acute head injury characteristics in children and youth soccer players and identify the characteristics of patients who required hospital admission. Methods: Analysis was based on the Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP). Soccer-related head injuries amongst 5-19 year old children presenting at 16 hospital emergency departments during 1994-2004 were selected in the study. All head injury-related variables (nature of injury, mechanism of injury, location of play, soccer type and season of play) were stratified by age and sex. A logistic regression model, consisting of the injury-related variables, sex and age as the independent variables, was performed to examine the characteristics of those head-injured patients who required hospital admission. Results: Overall, there were 4720 head injury cases identified (15% of all soccer-related emergency department visits). The highest proportion of head injuries was amongst males (70%) and children aged 10-14 years (50%). Of head injury cases, 35% were superficial and/or open wounds, 28% minor head injuries, 11% concussions, 9% eye injuries and 5% fractures. The total number of cases that required hospital admission was 164 (3.5%). Based on logistic regression analysis, head-injured youth aged 15-19 years were almost two times more likely to be admitted to hospital than their younger counterparts (OR = 2.2, 95% CI: 1.3-3.6). Compared to ball contact injuries, contact with structures/surfaces, other players/persons and other unspecified objects increased the odds of hospital admission at least by two-folds. Moreover, those who played unorganised soccer were significantly more likely to be admitted to the hospital as compared to those who played organised soccer (OR = 1.7, 95% CI: 1.2-2.6). Finally, playing in the non-winter seasons had increased likelihood of hospital admissions. Conclusions: Head injuries constituted a significant proportion of soccer-related injuries presenting to emergency departments. Future studies need to evaluate the nature and safety of the playing surfaces/turf and other structures on or around the field of play. (C) 2009 Elsevier Ltd. All rights reserved.	[Giannotti, Maria; Al-Sahab, Ban; Tamim, Hala] York Univ, Bethune Coll, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [McFaull, Steve] Publ Hlth Agcy Canada, Injury & Child Maltreatment Sect, Ottawa, ON, Canada		Tamim, H (corresponding author), York Univ, Bethune Coll, Sch Kinesiol & Hlth Sci, 4700 Keele St, Toronto, ON M3J 2R7, Canada.	htamim@yorku.ca	Al-Sahab, Ban/AAG-4430-2021				Adams AL, 2006, ACAD EMERG MED, V13, P571, DOI 10.1197/j.aem.2005.12.015; Adams J, 2007, CLIN J SPORT MED, V17, P304, DOI 10.1097/JSM.0b013e31803202c8; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Blond L, 1999, BRIT J SPORT MED, V33, P110, DOI 10.1136/bjsm.33.2.110; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; *CAN SOCC ASS, 2007, 2006 DEM REP, P1; Cerulli G, 2002, J CRANIOFAC SURG, V13, P627, DOI 10.1097/00001665-200209000-00006; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delilbasi C, 2004, ORAL SURG ORAL MED O, V97, P23, DOI 10.1016/j.tripleo.2003.10.008; DEMARCO J, 1994, JAMA-J AM MED ASSOC, V271, P1233; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Federation Internationale de Football Association (FIFA), FIFA BIG COUNT 2006; Filipe JAC, 2003, ARCH OPHTHALMOL-CHIC, V121, P687; FULLER CW, 2005, BR J SPORTS MED S1, V39, P3; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; *HLTH CAN, 2006, CAN HOSP INJ REP PRE; Horn EP, 2000, RETINA-J RET VIT DIS, V20, P604, DOI 10.1097/00006982-200011000-00003; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Kent JS, 2007, CAN J OPHTHALMOL, V42, P605, DOI 10.3129/canjophthalmol-i07-093; Kinnear P., 2008, SPSS 15 MADE SIMPLE; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kontos AP, 2004, J PEDIATR PSYCHOL, V29, P447, DOI 10.1093/jpepsy/jsh048; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Mackenzie S G, 1999, Inj Prev, V5, P208; Papakosta V, 2008, DENT TRAUMATOL, V24, P193, DOI 10.1111/j.1600-9657.2007.00536.x; Peterson L, 2000, AM J SPORT MED, V28, pS51; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; *PUBL HLTH AG CAN, 2005, INV INJ DAT SOURC SU; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vinger PF, 2004, BRIT J OPHTHALMOL, V88, P167, DOI 10.1136/bjo.2003.026229	40	16	16	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2010	41	9					907	912		10.1016/j.injury.2009.09.040			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	634SL	WOS:000280605500006	19878944				2022-02-06	
J	LeBlanc, J; Shultz, JR; Seresova, A; de Guise, E; Lamoureux, J; Fong, N; Marcoux, J; Maleki, M; Khwaja, K				LeBlanc, Joanne; Shultz, Judith Robillard; Seresova, Alena; de Guise, Elaine; Lamoureux, Julie; Fong, Nancy; Marcoux, Judith; Maleki, Mohammad; Khwaja, Kosar			Outcome in Tracheostomized Patients With Severe Traumatic Brain Injury Following Implementation of a Specialized Multidisciplinary Tracheostomy Team	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						early rehabilitation; speaking valves; tracheostomy; team; traumatic brain injury	SYSTEM; SCALE	Objective: To evaluate the effect of a specialized multidisciplinary tracheostomy team on outcome of patients with severe traumatic brain injury (sTBI). Design: Retrospective study with historical controls. Participants: Twenty-seven patients with sTBI tracheostomized before implementation of the tracheostomy team approach and 34 patients followed by the team. Setting: A regional level 1 tertiary care trauma center, McGill University Health Centre-Montreal General Hospital. Main outcome measures: Time to decannulation, length of stay (LOS), Passy-Muir speaking valve use, and extended Glasgow Outcome Scale (GOS-E) scores given at acute care discharge. Results: The groups were similar for injury severity, age, and premorbid health conditions. Postteam patients had a significantly shorter LOS (P = .025) and more of them used Passy-Muir speaking valves (P = .004). Furthermore, there was a trend toward decreased time to decannulation in the postteam group. GOS-E scores did not differ significantly between groups (P > .05). Conclusion: Implementation of the tracheostomy team appears to have had positive clinical benefits for this population.	[LeBlanc, Joanne] McGill Univ Hlth Ctr, Dept Speech Language Pathol & Audiol, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ H3C 3J7, Canada; [de Guise, Elaine; Marcoux, Judith; Maleki, Mohammad] McGill Univ Hlth Ctr, Dept Neurol & Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Khwaja, Kosar] McGill Univ Hlth Ctr, Dept Surg & Crit Care Med, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada		LeBlanc, J (corresponding author), McGill Univ Hlth Ctr, Dept Speech Language Pathol & Audiol, Montreal Gen Hosp, A2-141,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca					BAKER S, 1975, J TRAUMA INJURY INFE, V14, P187; BELLOMO R, 2007, 3 INT C RAP RESP SYS; Cohen J., 2013, STAT POWER ANAL BEHA; DEMESTRAL C, 2008, ANN CONV CAN ASS GEN; Frank U, 2007, DYSPHAGIA, V22, P20, DOI 10.1007/s00455-006-9036-5; GURKIN MA, 2001, 44 ANN M MIDW SURG A; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Norwood MGA, 2004, POSTGRAD MED J, V80, P478, DOI 10.1136/pgmj.2003.016956; RAUTELA L, 2007, WORLD PHYS THER JUN; TEASDALE G, 1974, LANCET, V2, P81; Tobin AE, 2008, CRIT CARE, V12, DOI 10.1186/cc6864	13	16	16	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2010	25	5					362	365		10.1097/HTR.0b013e3181cd67ea			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	649JR	WOS:000281765400009	20134335				2022-02-06	
J	Serin, GM; Derinsu, U; Sari, M; Gergin, O; Ciprut, A; Akdas, F; Batman, C				Serin, Gediz Murat; Derinsu, Ufuk; Sari, Murat; Gergin, Oezguel; Ciprut, Ayca; Akdas, Ferda; Batman, Caglar			Cochlear implantation in patients with bilateral cochlear trauma	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article							TEMPORAL BONE-FRACTURES	Purpose: Temporal bone fracture, which involves the otic capsule, can lead to complete loss of auditory and vestibular functions, whereas the patients without fractures may experience profound sensorineural hearing loss due to cochlear concussion. Cochlear implant is indicated in profound sensorineural hearing loss due to cochlear trauma but who still have an intact auditory nerve. Material and methods: This is a retrospective review study. We report 5 cases of postlingually deafened patients caused by cochlear trauma, who underwent cochlear implantation. Preoperative and postoperative hearing performance will be presented. These patients are cochlear implanted after the cochlear trauma in our department between 2001 and 2006. Results: All patients performed very well with their implants, obtained open-set speech understanding. They all became good telephone users after implantation. Their performance in speech understanding was comparable to standard postlingual adult patients implanted. Conclusion: Cochlear implantation is an effective aural rehabilitation in profound sensorineural hearing loss caused by temporal bone trauma. Preoperative temporal bone computed tomography, magnetic resonance imaging, and promontorium stimulation testing are necessary to make decision for the surgery and to determine the side to be implanted. Surgery could be challenging and complicated because of anatomical irregularity. Moreover, fibrosis and partial or total ossification within the cochlea must be expected. (C) 2010 Published by Elsevier Inc.	[Serin, Gediz Murat; Sari, Murat; Gergin, Oezguel; Batman, Caglar] Marmara Univ, Dept Otorhinolaryngol, Sch Med, Istanbul, Turkey; [Derinsu, Ufuk; Ciprut, Ayca; Akdas, Ferda] Marmara Univ, Dept Audiol, Sch Med, Istanbul, Turkey		Serin, GM (corresponding author), Marmara Univ Hastanesi KBB ABD, Tophanelioglu Cad 13-15, TR-34662 Istanbul, Turkey.	gedizserin@yahoo.com	Derinsu, Ufuk/M-3912-2014; Ciprut, Ayca/AAI-6358-2020	Derinsu, Ufuk/0000-0003-0438-0074; 			Camilleri AE, 1999, J LARYNGOL OTOL, V113, P454, DOI 10.1017/S0022215100144202; GRAEME C, 2003, COCHLEAR IMPLANTS FU; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Moody-Antonio S, 2005, OTOL NEUROTOL, V26, P649, DOI 10.1097/01.mao.0000178124.13118.76; MORGAN WE, 1994, LARYNGOSCOPE, V104, P426; Simons JP, 2005, OTOLARYNG HEAD NECK, V132, P809, DOI 10.1016/j.otohns.2004.06.711; Teoh SW, 2004, LARYNGOSCOPE, V114, P1714, DOI 10.1097/00005537-200410000-00007	7	16	16	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709			AM J OTOLARYNG	Am. J. Otolaryngol.	SEP-OCT	2010	31	5					350	355		10.1016/j.amjoto.2009.04.008			6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	648SY	WOS:000281715600008	20015779				2022-02-06	
J	Mozer, AB; Whittemore, SR; Benton, RL				Mozer, Anthony B.; Whittemore, Scott R.; Benton, Richard L.			Spinal Microvascular Expression of PV-1 is Associated with Inflammation, Perivascular Astrocyte Loss, and Diminished EC Glucose Transport Potential in Acute SCI	CURRENT NEUROVASCULAR RESEARCH			English	Article						Caveolae; inflammation; MECA-32; microvessels; neurovascular unit; NVU; PAL-E; PLVAP	BLOOD-BRAIN-BARRIER; VESICLE-ASSOCIATED PROTEIN-1; CORD-INJURY; NEUROVASCULAR UNIT; IN-VITRO; MOUSE; MARKER; PERMEABILITY; MODULATION; DIAPHRAGMS	The endothelial-specific expression of plasmalemmal vesicle associated protein-1 (PV-1) is typical of fenestrated endothelium observed in pulmonary capillaries and some endocrine organs. In the central nervous system (CNS) it is expressed during development but disappears concomitant with maturation of the blood-CNS barrier [1]. Consistent with observations made in models of stroke, Alzheimer's disease, and tumorigenesis, we show PV-1 expression in the spinal cord specifically upregulated by pathologically-activated endothelial cells (ECs) in response to traumatic spinal cord injury (SCI). Adult female C57B1/6 mice received a moderate T9/10 contusive SCI. PV-1 assessed by qRT-PCR and immunohistochemistry 3 hours to 14 days post-injury showed expression as early as 1 day post-SCI, with levels decreasing by 14 days. This expression was associated with microvessels in the injury epicenter and penumbral zone, with the time course and distribution correlated with progressing peripheral inflammatory cell infiltration. PV-1-immunoreactive ECs were angiogenic as demonstrated by intravascular binding of Griffonia simplicifolia isolectin B4 (IB4). ECs expressing high levels of PV-1 were anatomically and physiologically abnormal with altered/absent immunostaining for occludin and zonula occludens-1 (ZO-1), and decreased expression of glial fibrillary acidic protein (GFAP) and aquaporin-4 (AQP4). Glucose transporter type I (Glut-1) expression decreased in affected, PV-1 positive microvessels with little colocalization of PV-1 and Glut-1 apparent by 7 days post-SCI. These data suggest that upregulation of microvascular expression of PV-1 post-SCI may promote major components of secondary injury including extravasation of cellular and acellular mediators of inflammation and may accelerate loss of neuropil and decline in the functional and anatomical integrity of the neurovascular unit (NVU).	[Mozer, Anthony B.; Whittemore, Scott R.; Benton, Richard L.] Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Whittemore, Scott R.; Benton, Richard L.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Mozer, Anthony B.; Whittemore, Scott R.; Benton, Richard L.] Univ Louisville, Sch Med, Dept Neurol Surg, Louisville, KY 40292 USA; [Mozer, Anthony B.] Univ Louisville, Sch Med, MD Program, Louisville, KY 40292 USA		Benton, RL (corresponding author), Univ Louisville, Sch Med, Kentucky Spinal Cord Injury Res Ctr, 511 S Floyd St,MDR 616, Louisville, KY 40292 USA.	rlbent01@louisville.edu			Kentucky Spinal Cord and Head Injury Research Trust; Commonwealth of Kentucky Challenge for Excellence;  [RR15576];  [NS045734]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045734] Funding Source: NIH RePORTER	The authors wish to thank Ms. Christine Nunn and Mrs. Kim Fentress for superb surgical support and perioperative care of experimental animals. Thanks also to Ms. Darlene Burke for assistance with statistical analyses, to Mr. Mark Gruenthal for assistance in developing analytical methods using the Nikon Elements software, and to Mrs. Melissa Maddie and Mrs. Amanda Ribble for immunohistochemical and tissue harvesting expertise. This research was supported by RR15576, NS045734, and the Kentucky Spinal Cord and Head Injury Research Trust (SRW, RLB), and the Commonwealth of Kentucky Challenge for Excellence (SRW). The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Baba T, 2009, INVEST OPHTH VIS SCI, V50, P3503, DOI 10.1167/iovs.08-2614; Benton RL, 2008, J CEREBR BLOOD F MET, V28, P1771, DOI 10.1038/jcbfm.2008.76; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Ciofi P, 2009, ENDOCRINOLOGY, V150, P5509, DOI 10.1210/en.2009-0584; Coisne C, 2005, LAB INVEST, V85, P734, DOI 10.1038/labinvest.3700281; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Hamm S, 2004, CELL TISSUE RES, V315, P157, DOI 10.1007/s00441-003-0825-y; Han HS, 2005, CURR NEUROVASC RES, V2, P409, DOI 10.2174/156720205774962647; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hnasko R, 2002, J ENDOCRINOL, V175, P649, DOI 10.1677/joe.0.1750649; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Lutty GA, 2010, EYE, V24, P408, DOI 10.1038/eye.2009.318; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Noble LJ, 1996, J COMP NEUROL, V376, P542; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Noble LJ, 2002, J NEUROSCI, V22, P7526; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.0.CO;2-Z; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Saville LR, 2004, J NEUROIMMUNOL, V156, P42, DOI 10.1016/j.jneuroim.2004.07.002; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Simard M, 2003, J NEUROSCI, V23, P9254; Stan RV, 2007, J CELL MOL MED, V11, P621, DOI 10.1111/j.1582-4934.2007.00075.x; Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189; Stan RV, 2001, GENOMICS, V72, P304, DOI 10.1006/geno.2000.6489; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Takigawa T, 2010, J NEUROTRAUM, V27, P739, DOI 10.1089/neu.2009.1111; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Yamamoto I, 2007, AM J TRANSPLANT, V7, P1954, DOI 10.1111/j.1600-6143.2007.01876.x; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yuan J, 2010, AM J PHYSIOL-RENAL, V299, pF265, DOI 10.1152/ajprenal.00071.2010; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	16	16	0	5	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	AUG	2010	7	3					238	250					13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	633MG	WOS:000280506500007	20590523				2022-02-06	
J	Finley, DS; Chang, A; Morales, B; Osann, K; Skarecky, D; Ahlering, T				Finley, David S.; Chang, Alexandra; Morales, Blanca; Osann, Kathryn; Skarecky, Douglas; Ahlering, Thomas			Impact of Regional Hypothermia on Urinary Continence and Potency After Robot-Assisted Radical Prostatectomy	JOURNAL OF ENDOUROLOGY			English	Article; Proceedings Paper	27th World Congress of Endourology	OCT 06-10, 2009	Munich, GERMANY	Endourol Soc			TRAUMATIC BRAIN-INJURY; PENILE ERECTION; APOPTOTIC PATHWAYS; SURGICAL MARGINS; MECHANISM; NEUROINFLAMMATION; HEMODYNAMICS; ACTIVATION; NEURONS	Background and Purpose: This is the third publication that updates clinical outcomes using a novel technique to apply locoregional hypothermia to the pelvis during robot-assisted radical prostatectomy (RARP) to reduce inflammatory injury. This report updates urinary and sexual clinical outcomes with a minimum of 1 year follow-up. Patients and Methods: Regional pelvic cooling (<300 degrees C) was achieved with a prototype endorectal cooling balloon (ECB) during the course of RARP. All clinical data were entered prospectively into an electronic database for historic (cases 1-666) and hypothermic groups (115 pts). Urinary and sexual outcomes were obtained using self-administered validated questionnaires. Continence was defined as no pads, and potency was defined as two affirmative answers to "erections adequate for penetration'' and "were the erections satisfactory.'' Results: Six patients were excluded: three ECB malfunction, three previous radiation/surgery. Median time to zero pad use was 39 days vs 62 days (hypothermic vs controls, P = 0.0003). At 1 year, overall pad-free continence was 96.3% (105/109) vs controls of 86.6%, P < 0.001. Potency was evaluated in all men (40-78 years) with preoperative International Index of Erectile Function-5 scores of 22 to 25. At 3 months, potency results were unchanged between groups: 24% vs 23%. At 15 months, the potency rates were significantly better for the hypothermic group, 83% vs controls 66%, P = 0.045. No difference in oncologic outcome was noted with cooling. Conclusions: Using a prototype cooling balloon, hypothermic RARP significantly improved time to continence and overall continence. Hypothermia also resulted in a modest but statistically significant improvement in potency at 15 months. Once cooling parameters have been optimized, a randomized multicenter clinical trial will be needed for validation.	[Chang, Alexandra; Morales, Blanca; Osann, Kathryn; Skarecky, Douglas; Ahlering, Thomas] Univ Calif Irvine, Dept Urol, Orange, CA 92868 USA; [Finley, David S.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Urol Oncol, Los Angeles, CA 90095 USA		Ahlering, T (corresponding author), Univ Calif Irvine, Dept Urol, 101 City Dr,Bldg 26,Route 81, Orange, CA 92868 USA.	tahlerin@uci.edu		Ahlering, Thomas/0000-0002-6492-4910; Skarecky, Douglas/0000-0002-9234-6716			ABOSEIF SR, 1988, CARDIOVASC INTER RAD, V11, P185, DOI 10.1007/BF02577002; Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; BENOIT G, 1987, SURG RADIOL ANAT, V9, P263, DOI 10.1007/BF02105295; Borin JF, 2007, UROLOGY, V70, P173, DOI 10.1016/j.urology.2007.03.050; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120; Finley DS, 2009, J ENDOUROL, V23, P1443, DOI 10.1089/end.2009.0411; Finley DS, 2009, UROLOGY, V73, P691, DOI 10.1016/j.urology.2008.09.085; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; GOLDSTEIN AMB, 1985, BRIT J UROL, V57, P574, DOI 10.1111/j.1464-410X.1985.tb05869.x; Hildebrand Frank, 2005, Surg Technol Int, V14, P41; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lue T F, 1986, Semin Urol, V4, P217; LUE TF, 1983, J UROLOGY, V130, P1237, DOI 10.1016/S0022-5347(17)51768-1; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; NEWMAN HF, 1981, UROLOGY, V17, P399, DOI 10.1016/0090-4295(81)90177-1; Ning XH, 2002, J APPL PHYSIOL, V92, P2200, DOI 10.1152/japplphysiol.01035.2001; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Povlishock JT, 1999, ACT NEUR S, V73, P15; SEDDON HJ, 1948, J NERV MENT DIS, V108, P160; SIROKY MB, 1979, SURG FORUM, V30, P545; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; WALSH PC, 1983, PROSTATE, V4, P473, DOI 10.1002/pros.2990040506; WALSH PC, 1982, J UROLOGY, V128, P492, DOI 10.1016/S0022-5347(17)53012-8; Weiss H D, 1973, Med Aspects Hum Sex, V7, P35; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yee DS, 2009, J ENDOUROL, V23, P1461, DOI 10.1089/end.2009.0144	35	16	17	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0892-7790			J ENDOUROL	J. Endourol.	JUL	2010	24	7					1111	1116		10.1089/end.2010.0122			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Urology & Nephrology	623WZ	WOS:000279779300013	20624082				2022-02-06	
J	Fornander, L; Nyman, T; Hansson, T; Ragnehed, M; Brismar, T				Fornander, Lotta; Nyman, Torbjorn; Hansson, Thomas; Ragnehed, Mattias; Brismar, Tom			Age- and time-dependent effects on functional outcome and cortical activation pattern in patients with median nerve injury: a functional magnetic resonance imaging study Clinical article	JOURNAL OF NEUROSURGERY			English	Article						median nerve; hand injury; neuronal plasticity; functional magnetic resonance imaging	PRIMARY SOMATOSENSORY CORTEX; TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; SENSORIMOTOR CORTEX; SENSORY STIMULATION; TACTILE STIMULATION; ADULT MONKEYS; HAND FUNCTION; REORGANIZATION; REPAIR	Object. The authors conducted a study to determine age- and time-dependent effects on the functional outcome after median nerve injury and repair and how such effects are related to changes in the pattern of cortical activation in response to tactile stimulation of the injured hand. Methods. The authors studied 11 patients with complete unilateral median nerve injury at the wrist repaired with epineural suture. In addition, 8 patients who were reported on in a previous study were included in the statistical analysis. In the entire study cohort, the mean age at injury was 23.3 +/- 13.4 years (range 7-57 years) and the time after injury ranged from 1 to 11 years. Sensory perception was measured with the static 2-point discrimination test and monofilaments. Functional MR imaging was conducted during tactile stimulation (brush strokes) of Digits II-III and IV-V of both hands, respectively. Results. Tactile sensation was diminished in the median territory in all patients. The strongest predictor of 2-point discrimination was age at injury (p < 0.0048), and when this was accounted for in the regression analysis, the other age- and time-dependent predictors had no effect. The activation ratios (injured/healthy hand) for Digit II-III and Digit IV-V stimulation were positively correlated (rho 0.59, p < 0.011). The activation ratio for Digit II-III stimulation correlated weakly with time after injury (p < 0.041). The activation ratio of Digits IV-V correlated weakly with both age at injury (p < 0.048) and time after injury (p < 0.033), but no predictor reached significance in the regression model. The mean ratio of ipsi- and contralateral hemisphere activation after stimulation of the injured hand was 0.55, which was not significantly different from the corresponding ratio of the healthy hand (0.66). Conclusions. Following a median nerve injury (1-11 years after injury) there may be an initial increase in the volume of the cortical representation, which subsequently declines during the restoration phase. These dynamic changes may involve both median and ulnar nerve cortical representation, because both showed negative correlation with time after injury. These findings are in agreement with animal studies showing that cortical plasticity is an important mechanism for functional recovery after peripheral nerve injury and repair. (DOI: 10.3171/2009.10.JNS09698)	[Fornander, Lotta; Brismar, Tom] Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; Vrinnevi Hosp, Dept Orthopaed, Norrkoping, Sweden; [Ragnehed, Mattias] Linkoping Univ, Div Radiol Sci, IMH, Linkoping, Sweden; [Fornander, Lotta; Hansson, Thomas] Univ Hosp, Dept Plast Surg, Dept Hand Surg & Burns, Linkoping, Sweden; [Nyman, Torbjorn] Univ Hosp, Dept Anaesthesiol, Linkoping, Sweden		Fornander, L (corresponding author), Karolinska Inst, Dept Clin Neurosci, SE-17176 Stockholm, Sweden.	lotta.b.fornander@lio.se		Fornander, Lotta/0000-0003-2077-8445	Ostergotlands Lans Landsting	Ostergotlands Lans Landsting provided financial support.	Allan CH, 2000, HAND CLIN, V16, P67; *AM SOC SURG HAND, 1978, HAND EX DIAGN; BELLKROTOSKI J, 1991, HAND CLIN, V7, P527; Blatow M, 2007, NEUROIMAGE, V37, P927, DOI 10.1016/j.neuroimage.2007.05.038; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; Callahan AD., 2002, REHABILITATION HAND; Duteille F, 2001, J HAND SURG-BRIT EUR, V26, P58, DOI 10.1054/jhsb.2000.0493; Florence SL, 1996, NATURE, V381, P69, DOI 10.1038/381069a0; FRAHM J, 1993, MAGNET RESON MED, V29, P139, DOI 10.1002/mrm.1910290126; GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P632, DOI 10.2106/00004623-198365050-00008; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Guerra WKW, 2007, ZBL NEUROCHIR, V68, P195, DOI 10.1055/s-2007-985859; HALLIN RG, 1981, EXP NEUROL, V73, P90, DOI 10.1016/0014-4886(81)90047-9; HAMMEKE TA, 1994, NEUROSURGERY, V35, P677, DOI 10.1227/00006123-199410000-00014; Hansson T, 1999, NEUROSCI LETT, V271, P29, DOI 10.1016/S0304-3940(99)00508-X; Hansson T, 2003, J NEUROSURG, V99, P100, DOI 10.3171/jns.2003.99.1.0100; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Hudson DA, 1997, J HAND SURG-BRIT EUR, V22B, P54, DOI 10.1016/S0266-7681(97)80017-4; Koller R, 1998, Handchir Mikrochir Plast Chir, V30, P109; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lin WL, 1996, J MAGN RESON IMAGING, V6, P565, DOI 10.1002/jmri.1880060402; Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MOBERG E, 1958, J BONE JOINT SURG BR, V40, P454, DOI 10.1302/0301-620X.40B3.454; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ONNE L, 1962, Acta Chir Scand Suppl, VSuppl 300, P1; Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069; Porro CA, 2004, MAGN RESON IMAGING, V22, P1539, DOI 10.1016/j.mri.2004.10.003; PUCE A, 1995, J NEUROSURG, V83, P262, DOI 10.3171/jns.1995.83.2.0262; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; RUMEAU C, 1994, AM J NEURORADIOL, V15, P567; Shin HC, 1997, NEUROSCI LETT, V230, P137, DOI 10.1016/S0304-3940(97)00486-2; Silva AC, 1996, J COMP NEUROL, V366, P700, DOI 10.1002/(SICI)1096-9861(19960318)366:4<700::AID-CNE9>3.0.CO;2-8; Soros P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-48; Staudt M, 2002, BRAIN, V125, P2222, DOI 10.1093/brain/awf227; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Tomei F, 2000, Chir Main, V19, P23, DOI 10.1016/S1297-3203(00)73456-1; WALL JT, 1986, J NEUROSCI, V6, P218; Wall JT, 2002, BRAIN RES REV, V39, P181, DOI 10.1016/S0165-0173(02)00192-3; Ward NS, 2006, ARCH PHYS MED REHAB, V87, pS30, DOI 10.1016/j.apmr.2006.08.334; YETKIN FZ, 1995, NEUROSURGERY, V36, P921, DOI 10.1227/00006123-199505000-00005; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	48	16	16	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2010	113	1					122	128		10.3171/2009.10.JNS09698			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	615BX	WOS:000279107300030	19911892				2022-02-06	
J	Lunney, M; McGuire, M; Endozo, N; McIntosh-Waddy, D				Lunney, Margaret; McGuire, Maria; Endozo, Nancy; McIntosh-Waddy, Dorothy			Consensus-Validation Study Identifies Relevant Nursing Diagnoses, Nursing Interventions, and Health Outcomes for People with Traumatic Brain Injuries	REHABILITATION NURSING			English	Article						health outcomes; nursing diagnosis; nursing interventions; rehabilitation; standards of care; traumatic brain injury	REHABILITATION; CLIENTS	A consensus-validation study used action research methods to identify relevant nursing diagnoses, nursing interventions, and patient outcomes for a population of adults with traumatic brain injury (TBI) in long-term care. In meetings totaling 159 hours to reach 100% consensus through group discussions, the three classifications of NANDA International's (NANDA-I's) approved nursing diagnoses, the Nursing Interventions Classification (NIC), and the Nursing Outcomes Classification (NOC) were used as the basis for three nurses experienced in working with adults with TBI to select the elements of nursing care. Among almost 200 NANDA-I nursing diagnoses, 29 were identified as relevant for comprehensive nursing care of this population. Each nursing diagnosis was associated with 3-11 of the more than 500 NIC interventions and 1-13 of more than 300 NOC outcomes. The nurses became aware of the complexity and the need for critical thinking. The findings were used to refine the facility's nursing standards of care, which were to be combined with the interdisciplinary plan of care and included in future electronic health records.	[Lunney, Margaret] CUNY Coll Staten Isl, Staten Isl, NY USA; [McGuire, Maria; Endozo, Nancy; McIntosh-Waddy, Dorothy] Sea View Hosp Rehabil Ctr & Home, Staten Isl, NY USA		Lunney, M (corresponding author), CUNY Coll Staten Isl, Staten Isl, NY USA.	margaret.lunney@gmail.com	da Cruz, Dina Monteiro/C-3639-2012	da Cruz, Dina Monteiro/0000-0003-1373-409X			Alverzo Joan, 2004, Rehabil Nurs, V29, P85; *AM ASS NEUR NURS, 2004, AANN COR CURR NEUR N; *AM NURS ASS, 2003, NURS SOC POL STAT; American Nurse Association, 2004, NURS SCOP STAND PRAC; *ASS REH NURS, ROL DESCR REH STAFF; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; BROADWAY JO, 2009, REHABILITATION NURSI, V34, P9; Bulechek G., 2008, NURSING INTERVENTION; CARLSON J, 2006, NANDA NIC NOC C PHIL; Casey D, 2007, NURS HEALTH SCI, V9, P5, DOI 10.1111/j.1442-2018.2007.00297.x; *CDCP, 2006, FACTS TRAUM BRAIN IN; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cruz DM, 2009, J CONTIN EDUC NURS, V40, P121, DOI 10.3928/00220124-20090301-05; FITZWATER E, 2004, REHABILITATION NURSI, V29, P13; Fitzwater Evelyn, 2004, Rehabil Nurs, V29, P13; Holley UA, 2007, REHABIL NURS, V32, P51, DOI 10.1002/j.2048-7940.2007.tb00152.x; Jacelon CS, 2007, REHABIL NURS, V32, P23, DOI 10.1002/j.2048-7940.2007.tb00145.x; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lunney M, 2005, J NURS ADMIN, V35, P1; Lunney M., 2001, CRITICAL THINKING NU; Lunney M., 2009, CRITICAL THINKING AC; Moorhead S, 2008, NURSING OUTCOMES CLA; Mullins Maria, 2005, Rehabil Nurs, V30, P92; NANDA-International, 2009, NURS DIAGN DEF CLASS; *NY STAT OFF PROF, 2009, ED LAW ART 139 DEF N; Pesut D.J., 1999, CLIN REASONING ART S; Reitzel E, 2009, REHABIL NURS, V34, P52; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Stringer E., 2007, ACTION RES; Yu F, 2008, REHABIL NURS, V33, P124, DOI 10.1002/j.2048-7940.2008.tb00216.x	30	16	18	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	JUL-AUG	2010	35	4					161	166		10.1002/j.2048-7940.2010.tb00042.x			6	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	616CG	WOS:000279185100006	20681391				2022-02-06	
J	Bae, JW; Kim, MJ; Jang, CG; Lee, SY				Bae, Jung-Woo; Kim, Mi-Jeong; Jang, Choon-Gon; Lee, Seok-Yong			Protective effects of heme oxygenase-1 against MPP+-induced cytotoxicity in PC-12 cells	NEUROLOGICAL SCIENCES			English	Article						Heme oxygenase-1 (HO-1); Cytotoxicity; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinium (MPP+); PC-12 cell	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NITRIC-OXIDE; INTRACEREBRAL HEMORRHAGE; CARBON-MONOXIDE; BILIRUBIN; NEURONS; HO-1; 1-METHYL-4-PHENYLPYRIDINIUM; OVEREXPRESSION	Heme oxygenase-1 (HO-1) catalyses the rate-limiting step of heme degradation to biliverdin, which is in turn reduced to bilirubin, CO and free iron. HO-1 can be induced by several harmful stimuli including oxidative stress, and it has a protective role against the cytotoxicity in different cells. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinium (MPP+) is a neurotoxic substance that induces the degeneration of dopaminergic neurons. This study examined whether HO-1 can be induced by MPP+ and whether HO-1 has a protective role against the MPP+-induced cytotoxicity in PC-12 cells. MPP+ triggered a relatively rapid induction of HO-1. The MPP+-induced cytotoxicity and reactive oxygen species (ROS) production markedly increased by HO-1 inhibitor, zinc protoporphyrin-IX (ZnPP-IX). The increase of ROS production by ZnPP-IX was completely abrogated by either two products of HO (biliverdin or bilirubin) while the increase of cytotoxicity by ZnPP-IX was attenuated partially. These suggest that HO-1 expression might have some cytoprotective effect against MPP+-induced cytotoxicity.	[Bae, Jung-Woo; Kim, Mi-Jeong; Jang, Choon-Gon; Lee, Seok-Yong] Sungkyunkwan Univ, Pharmacol Lab, Coll Pharm, Suwon 440746, South Korea		Lee, SY (corresponding author), Sungkyunkwan Univ, Pharmacol Lab, Coll Pharm, Suwon 440746, South Korea.	sylee@skku.ac.kr	LEE, SEOK-YONG/A-8012-2012				ADAMS JD, 1991, FREE RADICAL BIO MED, V10, P161, DOI 10.1016/0891-5849(91)90009-R; Ahmad AS, 2006, NEUROSCIENCE, V141, P1703, DOI 10.1016/j.neuroscience.2006.05.035; Asad SF, 2001, CHEM-BIOL INTERACT, V137, P59, DOI 10.1016/S0009-2797(01)00209-5; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; BATES TE, 1994, J NEUROCHEM, V63, P640; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; CHAN P, 1991, J NEUROCHEM, V57, P348, DOI 10.1111/j.1471-4159.1991.tb02134.x; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chlopicki S, 2006, CARDIOVASC RES, V71, P393, DOI 10.1016/j.cardiores.2006.03.011; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Hartsfield CL, 1997, AM J PHYSIOL-LUNG C, V273, pL980; Huang E, 2005, J NEUROSCI RES, V80, P268, DOI 10.1002/jnr.20444; Jing CR, 2005, J NEUROSCI RES, V82, P802, DOI 10.1002/jnr.20681; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; Koeppen AH, 2004, J NEUROPATH EXP NEUR, V63, P587, DOI 10.1093/jnen/63.6.587; KRUEGER MJ, 1990, BIOCHEM BIOPH RES CO, V169, P123, DOI 10.1016/0006-291X(90)91442-U; LANGSTON JW, 1986, CLIN NEUROPHARMACOL, V9, P485, DOI 10.1097/00002826-198612000-00001; Le W, 1999, J NEUROSCI RES, V56, P652; Lee DW, 2006, TOXICOL SCI, V90, P159, DOI 10.1093/toxsci/kfj052; Lin Y, 2007, J CEREBR BLOOD F MET, V27, P1010, DOI 10.1038/sj.jcbfm.9600412; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MINISINI MP, 1994, MUTAT RES-DNA REPAIR, V315, P169, DOI 10.1016/0921-8777(94)90016-7; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Panahian N, 1999, J NEUROCHEM, V72, P1187; Panizzon KL, 1996, NEUROREPORT, V7, P662, DOI 10.1097/00001756-199601310-00067; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; Takeda A, 2000, J BIOL CHEM, V275, P5395, DOI 10.1074/jbc.275.8.5395; Tanaka T, 2000, J CARDIOVASC PHARM, V36, pS1, DOI 10.1097/00005344-200000006-00002; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Yuan Y, 2008, EUR J PHARMACOL, V586, P100, DOI 10.1016/j.ejphar.2008.02.033	34	16	18	0	4	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2010	31	3					307	313		10.1007/s10072-010-0216-6			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	595WP	WOS:000277644700009	20127499				2022-02-06	
J	Bremmer, R; de Jong, BM; Wagemakers, M; Regtien, JG; van der Naalt, J				Bremmer, Rosette; de Jong, Bauke M.; Wagemakers, Michiel; Regtien, Joost G.; van der Naalt, Joukje			The Course of Intracranial Pressure in Traumatic Brain Injury: Relation with Outcome and CT-characteristics	NEUROCRITICAL CARE			English	Article						Intracranial pressure (ICP); Traumatic brain injury; ICP profiles; Opening pressure; CT-scan characteristics; Outcome	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; HYPERTENSION; GUIDELINES; PATTERNS; SCALE	One of the predictive factors of outcome in traumatic brain injury is high intracranial pressure (ICP). Recently, the time course of ICP has been described but few data are available on the relation of these ICP profiles and outcome. The aim of this study is to investigate the relation of the time course of ICP with CT-findings and outcome. Retrospective analysis of prospectively collected data of 246 patients with traumatic brain injury admitted to the neurosurgical intensive care unit. Early rise in ICP (within the first 2 days) was present in 32%, an intermediate rise (between days 3 and 5) in 34% and a late rise (after day 5) in 34% of patients. Half of the patients with a normal opening pressure (76%) developed intermediate or late ICP rise profiles. More mass lesions and sub/epidural hematomas were present in the late rise group. Patients with a late ICP rise required significant more intensive treatment (65% vs. 37 and 33%) when compared to the early and intermediate rise groups. In multiple regression analysis both ICP profiles and extracranial hematomas were related to outcome. With late ICP rise more unfavorable outcome (46 vs. 17%, P < 0.001) was seen although one in four patients showed a favorable outcome. During ICP monitoring different ICP profiles are present over time. These profiles are related to CT-characteristics and outcome. The importance of early and late monitoring of ICP is underlined.	[Bremmer, Rosette; de Jong, Bauke M.; van der Naalt, Joukje] Univ & Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands; [Wagemakers, Michiel] Univ & Med Ctr Groningen, Dept Neurosurg, NL-9713 GZ Groningen, Netherlands; [Regtien, Joost G.] Univ & Med Ctr Groningen, Dept Crit Care, NL-9713 GZ Groningen, Netherlands		van der Naalt, J (corresponding author), Univ & Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.naalt@neuro.umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; de Jong, Bauke M./0000-0002-6568-5739			Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Souter MJ, 1999, CRIT CARE MED, V27, P177, DOI 10.1097/00003246-199901000-00048; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	20	16	16	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2010	12	3					362	368		10.1007/s12028-009-9329-2			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	590RJ	WOS:000277244700009	20087687				2022-02-06	
J	Miller, R; Miller, M				Miller, Rubin; Miller, Marvin			Overrepresentation of Males in Traumatic Brain Injury of Infancy and in Infants With Macrocephaly Further Evidence That Questions the Existence of Shaken Baby Syndrome	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						forensic science; shaken baby syndrome; traumatic brain injury of infancy; increased extra-axial fluid spaces; macrocephaly; subdural hematoma; retinal hemorrhages; male gender	NONACCIDENTAL HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; EXTRACEREBRAL FLUID COLLECTIONS; PERIMACULAR RETINAL FOLDS; EXTERNAL HYDROCEPHALUS; BENIGN ENLARGEMENT; NATURAL-HISTORY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID SPACES; SURGICAL-TREATMENT	Shaken baby syndrome (SBS) has been thought to be caused by violent shaking of an infant and is characterized by the triad of findings: subdural hematoma (SDH), retinal hemorrhages, and neurologic abnormalities. The triad is not specific for SBS and can be seen in accidental trauma and in certain medical conditions. Recent observations, however, question whether SBS exists. Herein, we review the gender differences in 3 groups of infants with traumatic brain injury: (1) neonates with SDH from birth trauma, (2) infants with SDH from accidental trauma, and (3) infants with SDH from SBS. Gender differences are also presented in a fourth group of infants with macrocephaly related to increased extra-axial fluid spaces (IEAFS). Compared with the expected male frequency of 51.4% in newborns, there was a statistically significant overrepresentation of males in each of the 4 groups-65.3%, 62.2%, 62.6%, and 68.8%, respectively. We believe that the most likely explanation for these findings relates to the larger head size of the male compared with the female which has several relevant consequences. First, the larger head circumference of a male newborn compared with a female newborn may increase the likelihood that a male newborn will incur a small SDH from the minor trauma of the birthing process that can later rebleed and present with a symptomatic SDH that could be misdiagnosed as SBS and child abuse. Second, a short fall would have a greater likelihood of causing a SDH in a male infant than a female infant who could subsequently become symptomatic from hours to weeks later and could thus present as an unexplained SDH. Third, infants with macrocephaly related to IEAFS may be at increased risk for developing a SDH from the larger head size and greater tautness of the bridging vessels in the extra-axial fluid spaces. We believe that many infants who have been diagnosed with SBS have been given incorrect diagnoses of child abuse. Rather, their SDH may occur as a result of a small SDH from the birthing process that enlarges during early infancy, a short fall, or from macrocephaly with IEAFS.	[Miller, Rubin; Miller, Marvin] Wright State Univ, Dept Pediat Ob Gyn & Biomed Engn, Boonshoft Sch Med, Dayton, OH 45435 USA		Miller, M (corresponding author), Childrens Med Ctr, Dept Med Genet, 1 Childrens Plaza, Dayton, OH 45404 USA.	srmmem@aol.com					ALVAREZ LA, 1986, PEDIATRICS, V77, P901; AOKI N, 1994, J NEUROSURG, V81, P20, DOI 10.3171/jns.1994.81.1.0020; AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; ASCH AJ, 1976, PEDIATRICS, V57, P535; AVERY GB, 1994, NEONATOLOGY, P1146; BERGSTROM M, 1977, J COMPUT ASSIST TOMO, V1, P449, DOI 10.1097/00004728-197710000-00011; BRAY GL, 1987, AM J DIS CHILD, V141, P1215, DOI 10.1001/archpedi.1987.04460110085030; Brousseau TJ, 2005, J EMERG MED, V29, P283, DOI 10.1016/j.jemermed.2005.02.009; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAROLAN PL, 1986, PEDIATR NEUROSCI, V12, P140; Cho Jun Beom, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P273; COLE TRP, 1991, AM J MED GENET, V41, P115, DOI 10.1002/ajmg.1320410128; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; DAY RE, 1979, ARCH DIS CHILD, V54, P512, DOI 10.1136/adc.54.7.512; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Donohoe M, 2003, AM J FOREN MED PATH, V24, P239, DOI 10.1097/01.paf.0000083635.85457.97; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ersahin Y, 1997, CHILD NERV SYST, V13, P526, DOI 10.1007/s003810050131; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Fenton S, 1999, ARCH OPHTHALMOL-CHIC, V117, P1432; Fung ELW, 2002, PEDIATR INT, V44, P37, DOI 10.1046/j.1442-200X.2002.01500.x; Gago LC, 2003, RETINA-J RET VIT DIS, V23, P724, DOI 10.1097/00006982-200310000-00027; Gardner HB, 2004, NEUROPATH APPL NEURO, V30, P192, DOI 10.1111/j.1365-2990.2003.00503.x; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Golden N, 2005, J CLIN NEUROSCI, V12, P235, DOI 10.1016/j.jocn.2004.11.001; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Grech V, 2003, J EPIDEMIOL COMMUN H, V57, P612, DOI 10.1136/jech.57.8.612; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; HAMZA M, 1987, PEDIATR NEUROL, V3, P218, DOI 10.1016/0887-8994(87)90021-X; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; HOFFMAN J, 1998, NY TIMES        0330; HOWARD MA, 1993, BRIT J NEUROSURG, V7, P355, DOI 10.3109/02688699309103489; Hwang SK, 2000, CHILD NERV SYST, V16, P590, DOI 10.1007/s003810000312; HYMEL KP, 2004, CHILD MALTREATMENT, V7, P329; IKEDA A, 1987, CHILD NERV SYST, V3, P19, DOI 10.1007/BF00707188; ITO H, 1978, J NEUROSURG, V48, P197, DOI 10.3171/jns.1978.48.2.0197; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kairys SW, 2001, PEDIATRICS, V108, P206; Kaler S G, 1994, Adv Pediatr, V41, P263; KAYSER K, 1987, HEIGHT WEIGHT HUMAN; KELLY P, 2004, NZJM, V117, P1201; King WJ, 2003, CAN MED ASSOC J, V168, P155; KUKARNI R, 1999, J PEDIAT HEMATOL ONC, V21, P289; Lantz P, 2006, 58 ANN SCI M AM AC F; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; LAUBSCHER B, 1990, EUR J PEDIATR, V149, P502, DOI 10.1007/BF01959405; Le Fanu J, 2005, J ROY SOC MED, V98, P249, DOI 10.1258/jrsm.98.6.249; Lee A. C. W., 1999, Hong Kong Medical Journal, V5, P337; Leestma, 2006, J AM PHYS SURG, V11, P14; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Leo RA, 1998, J CRIM LAW CRIM, V88, P429, DOI 10.2307/1144288; Loh JK, 2002, SURG NEUROL, V58, P218, DOI 10.1016/S0090-3019(02)00830-3; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Medina LS, 2001, AM J NEURORADIOL, V22, P564; Miller M, 2003, JAMA-J AM MED ASSOC, V290, P2542, DOI 10.1001/jama.290.19.2542-b; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; MORI K, 1980, J COMPUT ASSIST TOMO, V4, P466, DOI 10.1097/00004728-198008000-00009; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; NATELSON SE, 1973, PEDIATRICS, V51, P169; NICKEL RE, 1987, DEV MED CHILD NEUROL, V29, P181; ODITA JC, 1992, CHILD NERV SYST, V8, P36, DOI 10.1007/BF00316560; Ofshe RJ, 1997, DENVER U LAW REV, V74, P979; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Perrin RG, 1997, NEUROSURGERY, V40, P1190, DOI 10.1097/00006123-199706000-00016; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; PIERREKAHN A, 1986, CHILD NERV SYST, V2, P191, DOI 10.1007/BF00706809; Pittman T, 2003, PEDIATR NEUROSURG, V39, P57, DOI 10.1159/000071315; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; ROBERTSON WC, 1979, J PEDIATR-US, V94, P382, DOI 10.1016/S0022-3476(79)80575-2; ROMODANOV AP, 1987, SURG NEUROL, V28, P253, DOI 10.1016/0090-3019(87)90302-8; Rooms L, 2003, PEDIATRICS, V111, pE636, DOI 10.1542/peds.111.5.e636; Roshan K, 1998, J TROP PEDIATRICS, V44, P153, DOI 10.1093/tropej/44.3.153; Rutty GN, 1999, AM J FOREN MED PATH, V20, P48, DOI 10.1097/00000433-199903000-00012; SAUNDERS C, 1948, BRIT J OBSTET GYNAEC, V55, P55; SCHIPKE R, 1954, PEDIATRICS, V14, P468; SCHULZ DM, 1962, ARCH PATHOL, V74, P244; Shen W C, 1986, Acta Radiol Suppl, V369, P689; Sherwood D, 1930, AM J DIS CHILD, V39, P980; SPARACIO RR, 1971, NEW YORK STATE J MED, V71, P212; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Sun DTF, 2006, CHILD NERV SYST, V22, P593, DOI 10.1007/s00381-006-0094-7; TAKAGI T, 1982, CHILD BRAIN, V9, P102; Takitani K, 2002, PEDIATR INT, V44, P680, DOI 10.1046/j.1442-200X.2002.01620.x; Tolias C, 2000, PEDIATR NEUROSURG, V33, P194, DOI 10.1159/000055952; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Uscinski RH, 2004, J NEUROSURG, V100, P574; Uscinski Ronald, 2004, J AM PHYS SURG, V9, P76; Van Calenbergh F, 2000, CHILD NERV SYST, V16, P429, DOI 10.1007/PL00007287; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Wells RG, 2002, ARCH PEDIAT ADOL MED, V156, P252, DOI 10.1001/archpedi.156.3.252; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; WILMS G, 1993, AM J NEURORADIOL, V14, P855; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687; Zou KH, 2003, RADIOLOGY, V226, P609, DOI 10.1148/radiol.2263011500; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512; 2000 GROWTH CHARTS	116	16	17	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2010	31	2					165	173		10.1097/PAF.0b013e3181d96a8e			9	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine; Pathology	603KI	WOS:000278207100014	20308871				2022-02-06	
J	Roberta, A; Rossella, B				Roberta, Albertini; Rossella, Bianchi			Aquaporins and Glia	CURRENT NEUROPHARMACOLOGY			English	Article						Aquaporins; glial cells	WATER CHANNEL PROTEIN; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; CELL CHIP28 PROTEIN; SPINAL-CORD-INJURY; TRANSGENIC MICE; RAT-BRAIN; NEUROGLIAL ACTIVATION; FUNCTIONAL EXPRESSION	Glial cells coordinate the differentiation, metabolism, and excitability of neurons; they modulate synaptic transmission and integrate signals emanating from neurons and other glial cells. Several evidences underlying the relation between these pathways and the regulatory mechanisms of ion concentration, supporting the role of Aquaporins (AQPs) in these processes. The goal of this review is to summarize the localization of different isoforms of AQPs in relation to glial cells both in central and peripheral nervous system, underlying AQP involvement in physiological and in pathophysiological conditions such as brain edema, glioma and epilepsy.	[Roberta, Albertini] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Human Anat, I-25123 Brescia, Italy; [Rossella, Bianchi] Univ Milan, Dept Human Morphol, Milan, Italy		Roberta, A (corresponding author), Univ Brescia, Dept Biomed Sci & Biotechnol, Div Human Anat, Vle Europa 11, I-25123 Brescia, Italy.	roberta_albertini@alice.it					AHLSEN G, 1993, BIOL PSYCHIAT, V33, P734, DOI 10.1016/0006-3223(93)90124-V; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; ARCURI C, 1995, J NEUROSCI RES, V40, P622, DOI 10.1002/jnr.490400507; Badaut J, 2000, J NEUROENDOCRINOL, V12, P960, DOI 10.1046/j.1365-2826.2000.00539.x; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Basaldella Luca, 2007, Neurosurg Focus, V22, pE4; Bauman M. L., 1994, NEUROBIOLOGY AUTISM, P19; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Borsani E, 2009, NEUROSCI LETT, V449, P183, DOI 10.1016/j.neulet.2008.11.014; Buffoli B, 2009, J ANAT, V215, P498, DOI 10.1111/j.1469-7580.2009.01143.x; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; CHEBABO SR, 1995, BRAIN RES, V695, P203, DOI 10.1016/0006-8993(95)00778-O; Chen CH, 2007, NEUROCRIT CARE, V7, P92, DOI 10.1007/s12028-007-0033-9; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; DUDEK FE, 1990, NEUROSCI LETT, V120, P267, DOI 10.1016/0304-3940(90)90056-F; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Evans A, 2002, Curr Probl Diagn Radiol, V31, P79; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; FATEMI SH, 2002, INT J NEUROPSYCHOPH, V5, P153; FISCHBARG J, 1990, P NATL ACAD SCI USA, V87, P3244, DOI 10.1073/pnas.87.8.3244; Gao HW, 2006, GLIA, V53, P783, DOI 10.1002/glia.20336; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; He Q, 1997, J NEUROSCI, V17, P3515; Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P18; KRUGER L, 1993, J COMP NEUROL, V333, P417, DOI 10.1002/cne.903330308; Kwon TH, 2001, SEMIN NEPHROL, V21, P231, DOI 10.1053/snep.2001.21647; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Lee TS, 2004, ACTA NEUROPATHOL, V108, P493, DOI 10.1007/s00401-004-0910-7; Lehmann GL, 2004, CURR NEUROVASC RES, V1, P293, DOI 10.2174/1567202043362081; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li X, 2009, NEUROSCIENCE, V162, P67, DOI 10.1016/j.neuroscience.2009.04.044; Longatti P, 2006, NEUROSCI LETT, V392, P178, DOI 10.1016/j.neulet.2005.09.083; MANGIARDI JR, 1990, NEUROSURGERY, V26, P1, DOI 10.1227/00006123-199001000-00001; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; Masseguin C, 2000, J APPL PHYSIOL, V88, P843, DOI 10.1152/jappl.2000.88.3.843; Meng SZ, 2004, EUR J NEUROSCI, V19, P2261, DOI 10.1111/j.0953-816X.2004.03315.x; Merves M, 2000, LARYNGOSCOPE, V110, P1925, DOI 10.1097/00005537-200011000-00030; Mobasheri A, 2005, J MOL HISTOL, V36, P1, DOI 10.1007/s10735-004-2633-4; Mosbasheri A, 2004, AM J PHYSIOL-CELL PH, V286, pC529, DOI 10.1152/ajpcell.00408.2003; Nagahama M, 2006, NEUROSCI LETT, V395, P206, DOI 10.1016/j.neulet.2005.10.092; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nandasena BGTL, 2007, BRAIN RES, V1157, P32, DOI 10.1016/j.brainres.2007.04.033; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Newman Eric A., 1995, P717; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Nicchia GP, 2001, J HISTOCHEM CYTOCHEM, V49, P1547, DOI 10.1177/002215540104901208; Nielsen S, 1997, J NEUROSCI, V17, P171; Oshio K, 2005, NEUROSURGERY, V56, P375, DOI 10.1227/01.NEU.0000148904.57841.6B; Oshio K, 2006, BIOCHEM BIOPH RES CO, V341, P1022, DOI 10.1016/j.bbrc.2006.01.062; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Pan EH, 1996, NEUROSCI LETT, V207, P9, DOI 10.1016/0304-3940(96)12477-0; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; QUAGLIARELLO VJ, 1986, J CLIN INVEST, V77, P1084, DOI 10.1172/JCI112407; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Rodriguez A, 2006, ACTA NEUROPATHOL, V112, P573, DOI 10.1007/s00401-006-0117-1; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; SAADOUN S, 2002, J ANAT, V200, P528; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schwartzkroin PA, 1998, EPILEPSY RES, V32, P275, DOI 10.1016/S0920-1211(98)00058-8; Shields SD, 2007, PAIN, V131, P8, DOI 10.1016/j.pain.2006.11.018; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Solenov EI, 2002, J NEUROSCI METH, V113, P85, DOI 10.1016/S0165-0270(01)00481-2; Speake T, 2003, BBA-BIOMEMBRANES, V1609, P80, DOI 10.1016/S0005-2736(02)00658-2; St Hillaire C, 2005, J NEUROVIROL, V11, P535, DOI 10.1080/13550280500385203; Stevens AL, 2000, AM J PHYSIOL-CELL PH, V278, pC791, DOI 10.1152/ajpcell.2000.278.4.C791; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Suzuki R, 2006, ACTA NEUROCHIR SUPPL, V96, P398; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tan G, 2008, J INT MED RES, V36, P777, DOI 10.1177/147323000803600420; Tomas-Camardiel M, 2004, J NEUROCHEM, V91, P891, DOI 10.1111/j.1471-4159.2004.02759.x; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Verkman AS, 2006, SEMIN NEPHROL, V26, P200, DOI 10.1016/j.semnephrol.2006.02.002; WALZ W, 1987, CAN J PHYSIOL PHARM, V65, P1051, DOI 10.1139/y87-166; WALZ W, 1992, NEUROSCI LETT, V135, P243, DOI 10.1016/0304-3940(92)90446-E; Warth A, 2005, ACTA NEUROPATHOL, V109, P418, DOI 10.1007/s00401-005-0984-x; Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0; Warth A, 2007, J NEUROSCI RES, V85, P1336, DOI 10.1002/jnr.21224; Warth A, 2007, APPL IMMUNOHISTO M M, V15, P193, DOI 10.1097/01.pai.0000213110.05108.e9; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Yamamoto N, 2002, MOL BRAIN RES, V104, P96, DOI 10.1016/S0169-328X(02)00322-4; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhang D, 2002, J GEN PHYSIOL, V119, P561, DOI 10.1085/jgp.20028597; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	111	16	18	0	1	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1570-159X	1875-6190		CURR NEUROPHARMACOL	Curr. Neuropharmacol.	JUN	2010	8	2					84	91		10.2174/157015910791233178			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	599KE	WOS:000277910000002	21119878	Green Published			2022-02-06	
J	Pourrier, SD; Nieuwstraten, W; Van Cranenburgh, B; Schreuders, TAR; Stam, HJ; Selles, RW				Pourrier, Salima D.; Nieuwstraten, Wilbert; Van Cranenburgh, Ben; Schreuders, Ton A. R.; Stam, Henk J.; Selles, Ruud W.			THREE CASES OF REFERRED SENSATION IN TRAUMATIC NERVE INJURY OF THE HAND: IMPLICATIONS FOR UNDERSTANDING CENTRAL NERVOUS SYSTEM REORGANIZATION	JOURNAL OF REHABILITATION MEDICINE			English	Article						referred sensation; arm injury; neuroplasticity	UPPER EXTREMITY AMPUTEES; REGIONAL PAIN SYNDROME; PHANTOM LIMB PAIN; CORTICAL REORGANIZATION; SOMATOSENSORY CORTEX; PLASTICITY; STIMULATION; AMPUTATION; BRAIN	Objective: The aim of this observational study was to explore whether patients with traumatic peripheral nerve injury of the hand perceive referred sensations; sensations that are perceived to emanate from other areas of the body than the part being stimulated. Referred sensations have been reported following amputation, somatosensory deafferentation, local anaesthesia, stroke, brachial plexus avulsion injury, spinal cord injury and complex regional pain syndrome type 1. Design: Ten patients with ulnar or median nerve injuries underwent sensory testing of the face, upper body and legs, involving light touch with a cotton swab. Patients were asked to describe the location of the stimulated site, the sensations emanating from it and any other sensations experienced. Three patients with referred sensations were identified and followed over a period of time. Results: Clear and reproducible referred sensations were found in 3 out of 10 patients examined. Conclusion: Referred sensations were found in traumatic nerve injury, providing evidence of reorganization of the central nervous system after peripheral injury.	[Pourrier, Salima D.; Schreuders, Ton A. R.; Stam, Henk J.; Selles, Ruud W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Rehabil, NL-3000 CA Rotterdam, Netherlands; [Selles, Ruud W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Reconstruct & Hand Surg, NL-3000 CA Rotterdam, Netherlands; [Pourrier, Salima D.; Nieuwstraten, Wilbert] Rehabil Ctr Sophia Revalidatie, The Hague, Netherlands; [Nieuwstraten, Wilbert; Van Cranenburgh, Ben] Inst Appl Neurosci ITON, Haarlem, Netherlands		Selles, RW (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Rehabil Med, Room H016,POB 2040, NL-3000 CA Rotterdam, Netherlands.	rselles@erasmusmc.nl	Selles, Ruud/N-9665-2019; Selles, Ruud W/B-5209-2009	Selles, Ruud/0000-0002-2432-6756; 			AGLIOTI S, 1994, P BIOL SCI, V1344, P273; Borsook D, 1998, NEUROREPORT, V9, P1013, DOI 10.1097/00001756-199804200-00011; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Finger S., 1982, BRAIN DAMAGE RECOVER; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Htut M, 2006, J HAND SURG-BRIT EUR, V31B, P596, DOI 10.1016/j.jhsb.2006.04.027; Kaas J., 2001, MUTABLE BRAIN DYNAMI; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Knecht S, 1998, BRAIN, V121, P717, DOI 10.1093/brain/121.4.717; Lundborg G, 2003, J PERIPHER NERV SYST, V8, P209, DOI 10.1111/j.1085-9489.2003.03027.x; Lundborg G, 2006, SCAND J PLAST RECONS, V40, P234, DOI 10.1080/02844310600787005; Maihofner C, 2006, J NEUROL, V253, P772, DOI 10.1007/s00415-006-0117-z; McCabe CS, 2003, RHEUMATOLOGY, V42, P1067, DOI 10.1093/rheumatology/keg298; MERZENICH MM, 1983, NEUROSCIENCE, V10, P639, DOI 10.1016/0306-4522(83)90208-7; Moore CI, 2000, P NATL ACAD SCI USA, V97, P14703, DOI 10.1073/pnas.250348997; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rivers WHR, 1908, BRAIN, V31, P323, DOI 10.1093/brain/31.3.323; Turton AJ, 2001, NEUROCASE, V7, P397, DOI 10.1076/neur.7.5.397.16251; Wall JT, 2002, BRAIN RES REV, V39, P181, DOI 10.1016/S0165-0173(02)00192-3	20	16	16	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2010	42	4					357	361		10.2340/16501977-0526			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	598HY	WOS:000277827500011	20461338	gold, Green Submitted			2022-02-06	
J	van den Elsen, MJLJ; Leenen, LPH; Kesecioglu, J				van den Elsen, Maarten J. L. J.; Leenen, Luke P. H.; Kesecioglu, Jozef			Hemodynamic support of the trauma patient	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						colloids; crystalloids; endpoints of resuscitation; fluids; hemorrhagic shock; hypertonic saline; inotropes; trauma; traumatic brain injury; vasopressors	ABDOMINAL COMPARTMENT SYNDROME; UNCONTROLLED HEMORRHAGIC-SHOCK; HYPERTONIC SALINE RESUSCITATION; INCREASED INTRACRANIAL-PRESSURE; RANDOMIZED CONTROLLED-TRIAL; LACTATED RINGERS SOLUTION; INTENSIVE-CARE-UNIT; OF-THE-LITERATURE; FLUID RESUSCITATION; BRAIN-INJURY	Purpose of review The aim of this review is to address and summarize some key issues and recent insights into the hemodynamic support of the trauma patient related to fluid administration. Recent findings Colloids are not superior to crystalloids in treating hypovolemia in the trauma patient and show no survival benefit. Furthermore, several adverse effects (renal failure, bleeding complications and anaphylaxis) have been reported with the use of artificial colloids. Hypertonic saline is effective and well tolerated in the treatment of hypovolemic shock and traumatic brain injury. Potential benefits are reduced fluid requirements and immune modulation. Resuscitation strategies should depend on the type of injury (penetrating vs. blunt; concomitant brain injury). Excessive fluid resuscitation, which can cause acute respiratory distress syndrome, abdominal compartment syndrome and brain edema, should be avoided. Dynamic parameters to guide volume therapy are probably more reliable than static parameters and minimally invasive techniques to monitor the microcirculation are becoming more important to determine the endpoints of resuscitation. Summary Hemodynamic support is an early goal in the treatment of the trauma patient. The use of crystalloids is currently recommended in trauma resuscitation. The amount of fluid we give should be tailored to the individual trauma patient in which clear endpoints of resuscitation are of vital importance to maximize the chances of survival.	[van den Elsen, Maarten J. L. J.; Kesecioglu, Jozef] Univ Med Ctr Utrecht, Dept Intens Care Med, NL-3584 CX Utrecht, Netherlands; [Leenen, Luke P. H.] Univ Med Ctr Utrecht, Dept Surg, NL-3584 CX Utrecht, Netherlands		van den Elsen, MJLJ (corresponding author), Univ Med Ctr Utrecht, Dept Intens Care, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	melsen1@planet.nl		Leenen, Luke/0000-0001-8385-1801			Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Balogh ZJ, 2009, WORLD J SURG, V33, P1134, DOI 10.1007/s00268-009-0002-x; Baron BJ, 2007, J TRAUMA, V62, P120, DOI 10.1097/TA.0b013e31802d96ec; Barron ME, 2004, ARCH SURG-CHICAGO, V139, P552, DOI 10.1001/archsurg.139.5.552; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bauer M, 2009, BEST PRACT RES-CLIN, V23, P173, DOI 10.1016/j.bpa.2008.12.002; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Boldt J, 2009, INTENS CARE MED, V35, P1331, DOI 10.1007/s00134-009-1520-6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; BUNN F, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002045.PUB.2; Cammarata GAAM, 2009, SHOCK, V31, P207, DOI 10.1097/SHK.0b013e31817c0eb7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; Chytra I, 2007, CRIT CARE, V11, DOI 10.1186/cc5703; Cohn SM, 2007, J TRAUMA, V62, P44, DOI 10.1097/TA.0b013e31802eb817; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Crookes BA, 2005, J TRAUMA, V58, P806, DOI 10.1097/01.TA.0000158269.68409.1C; Carvalho Werther Brunow de, 2003, J. Pediatr. (Rio J.), V79, pS187, DOI 10.1590/S0021-75572003000800008; Dellinger R Phillip, 2008, Crit Care Med, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Drobin D, 2002, ANESTHESIOLOGY, V96, P1371, DOI 10.1097/00000542-200206000-00016; Durairaj L, 2008, CHEST, V133, P252, DOI 10.1378/chest.07-1496; Ernest D, 1999, CRIT CARE MED, V27, P46, DOI 10.1097/00003246-199901000-00025; Ertmer C, 2009, BEST PRACT RES-CLIN, V23, P193, DOI 10.1016/j.bpa.2008.11.001; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Gunst M, 2008, J TRAUMA, V65, P509, DOI 10.1097/TA.0b013e3181825bc5; HANNEMANN L, 1994, ADV EXP MED BIOL, V345, P101; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hartog C, 2009, INTENS CARE MED, V35, P1337, DOI 10.1007/s00134-009-1521-5; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Husain FA, 2003, AM J SURG, V185, P485, DOI 10.1016/S0002-9610(03)00044-8; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Ikossi DG, 2006, J TRAUMA, V61, P780, DOI 10.1097/01.ta.0000239500.71419.58; Jarrar D, 1999, INT J MOL MED, V4, P575; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Kiraly LN, 2006, J TRAUMA, V61, P57, DOI 10.1097/01.ta.0000220373.29743.69; Kirkpatrick AW, 2006, J AM COLL SURGEONS, V202, P668, DOI 10.1016/j.jamcollsurg.2005.11.020; Knudson MM, 2003, J TRAUMA, V54, P242, DOI 10.1097/01.TA.0000037776.28201.75; Kolsen-Petersen JA, 2008, BRIT J ANAESTH, V100, P478, DOI 10.1093/bja/aen015; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Lienhart HG, 2008, CURR OPIN CRIT CARE, V14, P247, DOI 10.1097/MCC.0b013e3282fce62a; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; Magder Sheldon, 2007, J Intensive Care Med, V22, P44, DOI 10.1177/0885066606295303; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; McKinley BA, 2000, J TRAUMA, V48, P637, DOI 10.1097/00005373-200004000-00009; McNelis J, 2001, AM J SURG, V182, P481, DOI 10.1016/S0002-9610(01)00755-3; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nydam TL, 2009, SHOCK, V31, P466, DOI 10.1097/SHK.0b013e31818ec47d; Oda J, 2006, J TRAUMA, V60, P64, DOI 10.1097/01.ta.0000199431.66938.99; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Ogino R, 1998, J TRAUMA, V44, P59, DOI 10.1097/00005373-199801000-00005; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Phillips CR, 2009, CRIT CARE, V13, DOI 10.1186/cc7736; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Renner J, 2009, BEST PRACT RES-CLIN, V23, P159, DOI 10.1016/j.bpa.2008.12.001; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; Rossaint R, 2006, SHOCK, V26, P322, DOI 10.1097/01.shk.0000225403.15722.e9; Rotstein OD, 2000, J TRAUMA, V49, P580, DOI 10.1097/00005373-200010000-00002; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Schierhout G, 1998, BMJ-BRIT MED J, V316, P961, DOI 10.1136/bmj.316.7136.961; Schroth M, 2006, PEDIATRICS, V118, pE76, DOI 10.1542/peds.2005-2795; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Sperry JL, 2008, J TRAUMA, V64, P9, DOI 10.1097/TA.0b013e31815dd029; Stadlbauer KH, 2007, CRIT CARE, V11, DOI 10.1186/cc5977; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; STURM JA, 1986, J TRAUMA, V26, P409, DOI 10.1097/00005373-198605000-00001; Thompson R, 2006, J R Army Med Corps, V152, P6; Tisherman SA, 2004, J TRAUMA, V57, P898, DOI 10.1097/01.TA.0000133577.25793.E5; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; Verheij J, 2006, BRIT J ANAESTH, V96, P21, DOI 10.1093/bja/aei286; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vincent JL, 2009, BEST PRACT RES-CLIN, V23, P183, DOI 10.1016/j.bpa.2008.11.004; Vincenzi R, 2009, AM J SURG, V198, P407, DOI 10.1016/j.amjsurg.2009.01.017; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Waxman AB, 2005, CRIT CARE, V9, DOI 10.1186/cc2940; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; WISNER DH, 1986, INJURY, V17, P295, DOI 10.1016/0020-1383(86)90149-X; Yanagawa Y, 2007, J TRAUMA, V63, P1245, DOI 10.1097/TA.0b013e318068d72b; Zhao L, 2009, RESUSCITATION, V80, P253, DOI 10.1016/j.resuscitation.2008.10.014; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	94	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2010	23	2					269	275		10.1097/ACO.0b013e328336b8d0			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	572GZ	WOS:000275817300023	20061942				2022-02-06	
J	Johnson-Greene, D				Johnson-Greene, Doug			Informed Consent Issues in Traumatic Brain Injury Research: Current Status of Capacity Assessment and Recommendations for Safeguards	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							RACISM		Univ Miami, Leonard M Miller Sch Med, Dept Rehabil Med, Miami, FL 33157 USA		Johnson-Greene, D (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Rehabil Med, 1120 NW 14th St,Clin Res Bldg,Ste 954, Miami, FL 33157 USA.	djgreene@med.miami.edu					[Anonymous], 1979, NAT COMM PROT HUM SU; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Appelbaum PS, 2002, AM J GERIAT PSYCHIAT, V10, P120, DOI 10.1176/appi.ajgp.10.2.120; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Ayala C, 2001, AM J EPIDEMIOL, V154, P1057, DOI 10.1093/aje/154.11.1057; Berg JW, 2001, INFORM CONSENT LEGAL; BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468; del Carmen MG, 2005, ONCOLOGIST, V10, P636, DOI 10.1634/theoncologist.10-8-636; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dunn LB, 2001, NEUROPSYCHOPHARMACOL, V24, P595, DOI 10.1016/S0893-133X(00)00218-9; FADEN RR, 1986, HISTORY THEORY INFOR; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; Karlawish JHT, 2003, NEW ENGL J MED, V348, P1389, DOI 10.1056/NEJMsb030172; Karlsen S, 2002, SOCIOL HEALTH ILL, V24, P1, DOI 10.1111/1467-9566.00001; Lederer Susan, 1995, SUBJECTED SCI HUMAN; LEVINE RJ, 1995, ETHICS, V2, P1241; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; National Health and Medical Research Council, 1999, GUID DEV IMPL EV CLI, P1; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; Palmer BW, 2007, J INT NEUROPSYCH SOC, V13, P1047, DOI 10.1017/S1355617707071299; Sturman ED, 2005, CLIN PSYCHOL REV, V25, P954, DOI 10.1016/j.cpr.2005.04.010; Sugarman J, 2005, CLIN TRIALS, V2, P34, DOI 10.1191/1740774505cn066oa; Sugarman J, 2007, J AM GERIATR SOC, V55, P556, DOI 10.1111/j.1532-5415.2007.01101.x; Titus SL, 1996, J CLIN ETHIC, V7, P60; United States Department of Health and Human Services, 1991, FED REGISTER, V56, P28012; Wendler D, 2001, ANN INTERN MED, V135, P514, DOI 10.7326/0003-4819-135-7-200110020-00011; Winslade WJ, 2004, J HEAD TRAUMA REHAB, V19, P513, DOI 10.1097/00001199-200411000-00008; Winslade WJ, 2004, J HEAD TRAUMA REHAB, V19, P178, DOI 10.1097/00001199-200403000-00008; 1964, 18 WORLD MED ASS JUN; 2007, FED REG, V72, P50966	30	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2010	25	2					145	150		10.1097/HTR.0b013e3181d8287d			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	578EJ	WOS:000276276000010	20234229				2022-02-06	
J	Lee, J; Yoo, MS; Jung, D				Lee, J.; Yoo, M. S.; Jung, D.			Caregiving appraisal of family caregivers for older stroke patients in Korea	INTERNATIONAL NURSING REVIEW			English	Article						Disease Process; Family Health Nursing; International Issues; Stroke	TRAUMATIC BRAIN-INJURY; DEMENTIA CAREGIVERS; FUNCTIONAL STATUS; FILIAL PIETY; BURDEN; TRANSLATION; SURVIVORS; AMERICAN; DISTRESS; RACE	Purpose: The purpose of this study was to investigate factors related to caregiving appraisal for family caregivers of older stroke patients in Korea. Method: A descriptive, cross-sectional survey of a sample of 242 family caregivers (95.7% response rate) was conducted in Korea from 1 January 2005 to 4 January 2007. Data were collected from outpatient stroke centres at three hospitals and two home health agencies located in Seoul, the capital city of Korea, its suburban area of Kyunggi-do, and the rural areas Gyeongsangbuk-do and Chungcheongbuk-do. The questionnaire was self-administered. spss 13.0 (SPSS, Inc., Chicago, IL, USA) was used to perform frequency, percentage, mean standard deviation, t-test or analysis of variance, and Pearson's correlation calculations. Results: Caregiving appraisal was statistically different based on the caregiver's location of residency and the relationship between the caregiver and the recipient. The caregivers who resided in urban areas reported higher scores of caregiving appraisal compared with those who resided in rural areas. With regard to the caregiver-recipient relationship, spouses reported the highest caregiving distress status, followed by daughters-in-law, sons and, finally, daughters. In addition, caregiving distress significantly correlated with age (r = 0.151, P = 0.022), the number of caregiving hours per week (r = 0.198, P = 0.003) and filial obligations (r = 0.336, P = 0.000). Discussion: The study results helped to better understand the caregiving process of Korean family caregivers. The data emphasized the importance of examining the expression of cultural roles and individual values on the caregivers' quality of life in diverse cultures. The knowledge gained from this study will be utilized to develop culture-specific interventions and social policies to directly support Korean family caregivers and to indirectly support stroke patients.	[Jung, D.] Ewha Womans Univ, Div Nursing Sci, Coll Hlth Sci, Seoul 120750, South Korea; [Lee, J.] Yonsei Univ, Coll Nursing, Seoul 120749, South Korea; [Yoo, M. S.] Catholic Univ Daegu, Coll Nursing, Taegu, South Korea		Jung, D (corresponding author), Ewha Womans Univ, Div Nursing Sci, Coll Hlth Sci, 11-1 Deahyun Dong, Seoul 120750, South Korea.	dyjung@ewha.ac.kr		Lee, JuHee/0000-0002-2805-1622			BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; CHOI H, 1993, GERONTOLOGIST, V33, P8, DOI 10.1093/geront/33.1.8; Cicirelli V. G., 1991, FAMILY CAREGIVING AU; CICIRELLI VG, 1993, PSYCHOL AGING, V8, P144, DOI 10.1037/0882-7974.8.2.144; Clark Patricia C, 2003, J Gerontol Nurs, V29, P45; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Farran C J, 2001, J Gerontol Nurs, V27, P38; Farran CJ, 1997, J AGING HEALTH, V9, P316, DOI 10.1177/089826439700900303; Foster M, 2003, SCAND J CARING SCI, V17, P205, DOI 10.1046/j.1471-6712.2003.00230.x; Grant JS, 2004, INT J REHABIL RES, V27, P105, DOI 10.1097/01.mrr.0000127639.47494.e3; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; IM MY, 2007, J WELFARE AGED, V34, P169; Kim JH, 2007, HEALTH PSYCHOL, V26, P564, DOI 10.1037/0278-6133.26.5.564; King RB, 2006, J GERONTOL NURS, V32, P37, DOI 10.3928/00989134-20060401-07; Kington RS, 1997, AM J PUBLIC HEALTH, V87, P805, DOI 10.2105/AJPH.87.5.805; KOH JY, 1987, GERONTOLOGIST, V27, P66, DOI 10.1093/geront/27.1.66; Lawton MP, 2000, GERONTOLOGIST, V40, P437, DOI 10.1093/geront/40.4.437; Lee J, 2007, J ADV NURS, V59, P407, DOI 10.1111/j.1365-2648.2007.04346.x; Lee YR, 1998, INT J AGING HUM DEV, V46, P125, DOI 10.2190/PM2C-V93R-NE8H-JWGV; Peters-Davis ND, 1999, GERONTOLOGIST, V39, P66, DOI 10.1093/geront/39.1.66; Sander AM, 2007, NEUROREHABILITATION, V22, P9; SEELBACH WC, 1977, GERONTOLOGIST, V17, P492, DOI 10.1093/geront/17.6.492; SUNG KT, 1995, GERONTOLOGIST, V35, P240, DOI 10.1093/geront/35.2.240; SUNG KT, 1990, GERONTOLOGIST, V30, P610, DOI 10.1093/geront/30.5.610; Yoon H. K, 2000, J KOREAN ASS SCI ED, V20, P137; Youn GY, 1999, PSYCHOL AGING, V14, P355, DOI 10.1037/0882-7974.14.3.355	26	16	16	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-8132	1466-7657		INT NURS REV	Int. Nurs. Rev.	MAR	2010	57	1					107	112		10.1111/j.1466-7657.2009.00751.x			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	552UI	WOS:000274318700023	20487482				2022-02-06	
J	Figaji, AA; Kent, SJ				Figaji, Anthony A.; Kent, Samuel J.			Brain Tissue Oxygenation in Children Diagnosed With Brain Death	NEUROCRITICAL CARE			English	Article						MeSH-brain tissue oxygenation; Children; Brain death; Traumatic brain injury	CEREBRAL OXYGENATION; DELIVERY; TENSION; CARE	Background Diagnosing brain death in children is challenging. Guidelines recommend using confirmatory testing to provide ancillary information to support the diagnosis. Brain tissue oxygenation (PbtO(2)) is being increasingly used in the adult neurocritical care for continuous monitoring of the adequacy of brain oxygenation; however, data in pediatrics is limited. Evidence from adult studies suggests that persistent PbtO(2) of 0 mmHg is associated with brain death, but this relationship has not yet been demonstrated in children; therefore, we examined our experience with PbtO(2) monitoring and brain death in children with acute neurological pathology. Methods We retrospectively reviewed patient records from a prospectively maintained database of 85 children who were ventilated for coma due to acute neurological injury and who received intracerebral monitoring. Results We identified five children who had suffered brain death while being monitored. PbtO(2) had decreased to 0 mmHg in all five children at the time of brain death diagnosis. In contrast, PbtO(2) in patients, who did not develop brain death, never decreased to 0 mmHg. We review the benefits and drawbacks of using brain tissue oxygenation as ancillary information in diagnosing brain death in children. Conclusions Preliminary data from this study suggest that PbtO(2) decreases to 0 mmHg when brain death occurs in children. Further study is needed to determine the limitations, and the sensitivity and specificity of this finding in a larger group of children.	[Kent, Samuel J.] Univ Aberdeen, Aberdeen, Scotland; [Figaji, Anthony A.] Univ Cape Town, ZA-7925 Cape Town, South Africa		Kent, SJ (corresponding author), Univ Aberdeen, Aberdeen, Scotland.	s.kent.02@aberdeen.ac.uk		Figaji, Anthony/0000-0002-3357-6490			*AC MED ROYAL COLL, 1998, COD PRACT DIAGN BRAI; Academy of Medical Royal Colleges, 2008, COD PRACT DIAGN CONF; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; *AUSTR NZ INT CAR, 1998, REC BRAIN DEATH ORG; BAINES P, 2005, CURR PAEDIAT, V15, P301; Bell MDD, 2004, BRIT J ANAESTH, V92, P633, DOI 10.1093/bja/aeh108; BLEND MJ, 1986, NEUROPEDIATRICS, V17, P168, DOI 10.1055/s-2008-1052521; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Doppenberg EMR, 1997, J NEUROSURG, V87, P809, DOI 10.3171/jns.1997.87.6.0809; DRAKE B, 1986, PEDIATRICS, V78, P107; FIGAJI AA, 2009, BRAIN TISSUE OXYGE 1; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; GREEN JB, 1972, J NEUROL NEUROSUR PS, V35, P103, DOI 10.1136/jnnp.35.1.103; Heran MKS, 2008, CAN J NEUROL SCI, V35, P409, DOI 10.1017/S0317167100009069; KOHRMAN MH, 1990, PEDIATR NEUROL, V6, P47, DOI 10.1016/0887-8994(90)90078-F; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Monteiro LM, 2006, INTENS CARE MED, V32, P1937, DOI 10.1007/s00134-006-0353-9; MONTES JE, 1980, CAN ANAESTH SOC J, V27, P172, DOI 10.1007/BF03007783; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Palmer S, 2005, NEUROCRIT CARE, V2, P17, DOI 10.1385/NCC:2:1:017; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Shemie SD, 2007, LANCET NEUROL, V6, P87, DOI 10.1016/S1474-4422(06)70680-9; Smith ML, 2007, NEUROL RES, V29, P755, DOI 10.1179/016164107X208121; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Task Force for the Determination of Brain Death in Children, 1987, ARCH NEUROL-CHICAGO, V44, P587; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20	32	16	17	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2010	12	1					56	61		10.1007/s12028-009-9298-5			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	571HL	WOS:000275742800010	19847675				2022-02-06	
J	Namdari, S; Pill, SG; Makani, A; Keenan, MA				Namdari, Surena; Pill, Stephan G.; Makani, Amun; Keenan, Mary Ann			Rectus Femoris to Gracilis Muscle Transfer With Fractional Lengthening of the Vastus Muscles: A Treatment for Adults With Stiff Knee Gait	PHYSICAL THERAPY			English	Article							CEREBRAL-PALSY; CHILDREN; SURGERY; RELEASE; MOTION	Background. Stiff knee gait, which may be seen in patients With upper motor neuron injury, describes a gait pattern with a relative loss of sagittal knee motion. It interferes with foot clearance during swing, often leading to inefficient compensatory mechanisms and ambulatory dysfunction. Distal rectus femoris Muscle transfers and fractional lengthening of the vastus Muscles have been performed in adult patients. Objective. The purpose of this study was to describe a unique Surgical technique and report on initial outcomes. Design. A retrospective case-series study design was used. Methods. The patients were adults with stiff knee gait Clue to stroke or traumatic brain injury who underwent distal rectus femoris muscle transfer with fractional lengthening of the vastus muscles. The patients (19 men and 18 women) had an average age of 51 years at the time of Surgery. Lower-extremity examinations, clinical gait analyses, and satisfaction levels were recorded preoperatively and postoperatively. Results. At a mean follow-up time of 10 months, 36 (97%) of the 37 patients were satisfied with their clinical and functional results, and the average Viosca score improved from 3.1 to 3.5. Limitations. Limitations of the study include use of a retrospective design, lack of a control group, and quantitative measures of gait. Conclusion. Distal rectus femoris muscle transfer and fractional lengthening of the vastus muscles were found to be a possible treatment for adults With stiff-knee gait caused by stroke or traumatic brain injury.	[Keenan, Mary Ann] Hosp Univ Penn, Neuroorthopaed Program, Philadelphia, PA 19104 USA; [Namdari, Surena; Pill, Stephan G.; Makani, Amun; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Keenan, MA (corresponding author), Hosp Univ Penn, Neuroorthopaed Program, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA.	maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				BAUMANN JU, 1980, INT ORTHOP, V3, P305; Chambers H, 1998, J PEDIATR ORTHOPED, V18, P703, DOI 10.1097/00004694-199811000-00003; COTTRELL GW, 1963, J BONE JOINT SURG AM, V45, P1556; DUNCAN WR, 1955, J BONE JOINT SURG AM, V37, P634; GAGE JR, 1987, DEV MED CHILD NEUROL, V29, P159; GAGE JR, 1990, CLIN ORTHOP RELAT R, V253, P45; Goldberg SR, 2006, J BIOMECH, V39, P689, DOI 10.1016/j.jbiomech.2005.01.015; OUNPUU S, 1993, J PEDIATR ORTHOPED, V13, P331, DOI 10.1097/01241398-199305000-00011; OUNPUU S, 1993, J PEDIATR ORTHOPED, V13, P325, DOI 10.1097/01241398-199305000-00010; PERRY J, 1987, DEV MED CHILD NEUROL, V29, P153; PERRY J, 1985, ATLAS ORTHOTICS BIOM, P223; Reinbolt JA, 2008, J BIOMECH, V41, P2362, DOI 10.1016/j.jbiomech.2008.05.030; SUTHERLAND DH, 1990, J PEDIATR ORTHOPED, V10, P433; SUTHERLAND DH, 1975, DEV MED CHILD NEUROL, V17, P26; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1234, DOI 10.1016/j.apmr.2004.11.016; WATERS RL, 1979, J BONE JOINT SURG AM, V61, P927, DOI 10.2106/00004623-197961060-00022	16	16	17	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	FEB	2010	90	2					261	268		10.2522/ptj.20090151			8	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	550LT	WOS:000274130000015	20023004	Bronze			2022-02-06	
J	Shin, BS; Won, SJ; Yoo, BH; Kauppinen, TM; Suh, SW				Shin, Byung Seop; Won, Seok Joon; Yoo, Byung Hoon; Kauppinen, Tiina M.; Suh, Sang Won			Prevention of hypoglycemia-induced neuronal death by hypothermia	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						hypoglycemia; hypothermia; hyperthermia; zinc; superoxide; microglia	TRAUMATIC BRAIN-INJURY; HISTOCHEMICALLY REACTIVE ZINC; NITRIC-OXIDE; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; MILD HYPOTHERMIA; FOCAL ISCHEMIA; CELL-DEATH	Hypothermia reduces neuronal damage after cerebral ischemia and traumatic brain injury, while hyperthermia exacerbates damage from these insults. Previously we have shown that temperature-dependent modulation of excitotoxic neuronal death is mediated in part by temperature-dependent changes in the synaptic release/translocation of Zn2+. In this study, we hypothesize that brain temperature also affects hypoglycemia-induced neuronal death by modulation of vesicular Zn2+ release from presynaptic terminals. To test our hypothesis, we used a rat model of insulin-induced hypoglycemia. Here we found that hypoglycemia-induced neuronal injury was significantly affected by brain temperature, that is, hypothermia inhibited while hyperthermia aggravated neuronal death. To investigate the mechanism of temperature-dependent neuronal death after hypoglycemia, we measured zinc release/translocation, reactive oxygen species (ROS) production, and microglia activation. Here we found that hypoglycemia-induced Zn2+ release/translocation, ROS production, and microglia activation were inhibited by hypothermia but aggravated by hyperthermia. Even when the insult was accompanied by hyperthermic conditions, zinc chelation inhibited ROS production and microglia activation. Zinc chelation during hyperthermia reduced neuronal death, superoxide production, and microglia activation, which was comparable to the protective effects of hypothermia. We conclude that neuronal death after hypoglycemia is temperature-dependent and is mediated by increased Zn2+ release, superoxide production, and microglia activation. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 390-402; doi: 10.1038/jcbfm.2009.229; published online 28 October 2009	[Shin, Byung Seop; Won, Seok Joon; Yoo, Byung Hoon; Kauppinen, Tiina M.; Suh, Sang Won] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Shin, Byung Seop] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol, Seoul, South Korea; [Shin, Byung Seop] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pain Med, Seoul, South Korea; [Yoo, Byung Hoon] Inje Univ, Sch Med, Sanggye Paik Hosp, Dept Anesthesiol, Seoul, South Korea; [Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea		Suh, SW (corresponding author), UCSF, VAMC, Dept Neurol 127, 4150 Clement St, San Francisco, CA 94121 USA.	sang.suh@ucsf.edu	Kauppinen, Tiina/I-1009-2019	Kauppinen, Tiina/0000-0001-7219-9862	Juvenile Diabetes Research FoundationJuvenile Diabetes Research Foundation [2-2006-113, SWS, KOSEF2009-0078399]	We greatly appreciate Dr Midori Yenari's critical comments on this study, and technical assistance provided by Aaron Hamby. This work was supported by the Juvenile Diabetes Research Foundation (2-2006-113, SWS.) and KOSEF2009-0078399 (SWS).	AGARDH CD, 1992, ACTA NEUROPATHOL, V83, P379, DOI 10.1007/BF00713529; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; ARAI H, 1993, NEUROSCI LETT, V163, P132, DOI 10.1016/0304-3940(93)90363-P; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; AUER RN, 1986, STROKE, V17, P442, DOI 10.1161/01.STR.17.3.442; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHAO CC, 1992, J IMMUNOL, V149, P2736; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1992, J CHEM NEUROANAT, V5, P521, DOI 10.1016/0891-0618(92)90007-D; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Inamasu J, 2000, J NEUROIMMUNOL, V109, P66, DOI 10.1016/S0165-5728(00)00211-3; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar K, 1997, NEUROREPORT, V8, P947, DOI 10.1097/00001756-199703030-00026; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; MCCRIMMON RJ, 1994, DIABETES METAB, V20, P503; Murakami K, 1998, J NEUROSCI, V18, P205; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SELTZER HS, 1989, ENDOCRIN METAB CLIN, V18, P163, DOI 10.1016/S0889-8529(18)30395-5; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2000, BRAIN RES, V879, P7, DOI 10.1016/S0006-8993(00)02675-5; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; VAUGHAN DW, 1974, J NEUROCYTOL, V3, P405, DOI 10.1007/BF01098730; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Yanamoto H, 2001, STROKE, V32, P232, DOI 10.1161/01.STR.32.1.232	41	16	21	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2010	30	2					390	402		10.1038/jcbfm.2009.229			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	551TS	WOS:000274233800015	19861976	Bronze, Green Published			2022-02-06	
J	Hou, QH; Ling, L; Wang, F; Xing, SH; Pei, Z; Zeng, JS				Hou, Qinghua; Ling, Li; Wang, Fang; Xing, Shihui; Pei, Zhong; Zeng, Jinsheng			Endostatin expression in neurons during the early stage of cerebral ischemia is associated with neuronal apoptotic cell death in adult hypertensive rat model of stroke	BRAIN RESEARCH			English	Article						Endostatin; Apoptosis; Cathepsin B; Cerebral infarction	ANGIOGENESIS INHIBITOR ENDOSTATIN; TRAUMATIC BRAIN-INJURY; ENDOTHELIAL-CELLS; IN-VIVO; CATHEPSIN; XVIII; GENERATION; OCCLUSION; GROWTH; DOMAIN	Endostatin (ES) has been recognized as a potent anti-angiogenic factor We here investigated the expression of ES in ischemic brain and the consequence of cells expressing ES after stroke in adult stroke-prone renovascular hypertensive rats A single dose of Ca-074ME, a membrane-permeable cathepsin B (CB) specific inhibitor, or vehicle was given by intraperitoneal injection immediately after distal middle cerebral artery occlusion (dMCAO), ES expression was evaluated using fluorescent immunohistochemistry staining, and CB enzyme activity was tested by measuring the free 7-amino-4-methylcoumarin (AMC) released by CB from its' specific substrate, the Z-Arg-Arg-7-amido-4-methylcoumarin ES immunoreactivity (IR) was significantly up-regulated as early as 6 h and returned to baseline level at 3 days in pen-infarct area following dMCAO Double-staining experiment revealed that the majority of ischemia-induced ES positive cells were neurons Furthermore, ES was co-labeled with CB and Cleaved Caspase-3(Asp175) whereas treatment with Ca-074ME reduced up-regulation of ES expression and attenuated apoptosis in pen-infarct neurons Collectively, our data suggest that pen-infarct neurons express ES during the early stage of cerebral ischemia and treatment with Ca-074ME attenuates ES expression and apoptosis in pen-infarct neurons (C) 2009 Elsevier B V All rights reserved	[Hou, Qinghua; Ling, Li; Xing, Shihui; Pei, Zhong; Zeng, Jinsheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; [Hou, Qinghua; Ling, Li; Xing, Shihui; Pei, Zhong; Zeng, Jinsheng] Sun Yat Sen Univ, Affiliated Hosp 1, Stroke Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Hou, Qinghua] GuangZhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou 510260, Guangdong, Peoples R China; [Wang, Fang] Shenzhen Baoan Peoples Hosp, Dept Neurol, Shengzhen 518101, Peoples R China		Zeng, JS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.				Teaching and Research Award Program for Outstanding Young Teachers in Higher Education Institutions of the Ministry of Education, ChinaMinistry of Education, China; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [39940012, 30271485, 30770764]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [990065, 21906, 2003C30610]; China Medical Board of New York Inc [CMB00-730]; Fund for Priority Subjects in Clinical Medicine, Chinese Ministry of Health; Key and Scientific Project of the Natural Science Foundation of Guangdong Province, China [2003C30610, 2003B30303, 2003D30301]; Natural Science Foundation for Doctorial Research of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [5300761]; First Affiliated Hospital and Life Science Institute in Sun Yet-Sen University; Foundation for Scientific and technologic Project of Guangzhou City [2006 Z1-E0111, Z1-E0113]	This study was supported by the grants from the Teaching and Research Award Program for Outstanding Young Teachers in Higher Education Institutions of the Ministry of Education, China (2002), the National Natural Science Foundation of China (Nos 39940012, 30271485 and 30770764), the Natural Science Foundation of Guangdong Province, China (Nos. 990065, 21906, and 2003C30610), China Medical Board of New York Inc (No. CMB00-730), the Fund for Priority Subjects in Clinical Medicine, Chinese Ministry of Health (2004), the Key and Scientific Project of the Natural Science Foundation of Guangdong Province, China (Nos. 2003B30303,2003C30610 and 2003D30301), the Natural Science Foundation for Doctorial Research of Guangdong Province (No 5300761) and the fund on collaboration study for First Affiliated Hospital and Life Science Institute in Sun Yet-Sen University (2006), the Foundation for Scientific and technologic Project of Guangzhou City (Nos. 2006 Z1-E0111 and Z1-E0113).	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Deininger MH, 2006, J NEUROTRAUM, V23, P1103, DOI 10.1089/neu.2006.23.1103; Deininger MH, 2002, J NEUROSCI, V22, P10621; Deininger MH, 2002, J NEUROIMMUNOL, V131, P216, DOI 10.1016/S0165-5728(02)00276-X; FATIMA D, 2003, HUM GENE THER, V14, P997; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Hanai J, 2002, J BIOL CHEM, V277, P16464, DOI 10.1074/jbc.M112274200; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Ma DHK, 2007, INVEST OPHTH VIS SCI, V48, P644, DOI 10.1167/iovs.06-0884; MATSUSHITA K, 1994, HYPERTENSION, V23, P565, DOI 10.1161/01.HYP.23.5.565; Mihalik R, 2004, CELL DEATH DIFFER, V11, P1357, DOI 10.1038/sj.cdd.4401493; Miosge N, 2003, J HISTOCHEM CYTOCHEM, V51, P285, DOI 10.1177/002215540305100303; Miosge N, 1999, FASEB J, V13, P1743, DOI 10.1096/fasebj.13.13.1743; Mueller CA, 2007, EXP NEUROL, V208, P228, DOI 10.1016/j.expneurol.2007.07.020; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Seyfried DM, 2001, BRAIN RES, V901, P94, DOI 10.1016/S0006-8993(01)02289-2; Skovseth DK, 2005, BLOOD, V105, P1044, DOI 10.1182/blood-2004-03-1164; Tian Heng-Li, 2007, Neurosci Bull, V23, P35, DOI 10.1007/s12264-007-0005-2; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Zeng JS, 1998, STROKE, V29, P1708, DOI 10.1161/01.STR.29.8.1708; Zeng JS, 1998, CHINESE MED J-PEKING, V111, P741	24	16	16	2	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 22	2010	1311						182	188		10.1016/j.brainres.2009.11.033			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	554GY	WOS:000274424700018	19941836				2022-02-06	
J	Chow, JW; Yablon, SA; Horn, TS; Stokic, DS				Chow, John W.; Yablon, Stuart A.; Horn, Terry S.; Stokic, Dobrivoje S.			Temporospatial characteristics of gait in patients with lower limb muscle hypertonia after traumatic brain injury	BRAIN INJURY			English	Article						Gait analysis; walking; brain injuries; muscle spasticity; lower extremity	BOTULINUM TOXIN INJECTION; STEP WIDTH MEASUREMENT; INTERRATER RELIABILITY; INTRATHECAL BACLOFEN; CONCURRENT VALIDITY; WALKING SPEED; SPASTICITY; PEOPLE; LENGTH; KINEMATICS	Objective: To characterize gait characteristics of adults with traumatic brain injury (TBI) and lower limb muscle hypertonia, distinguishing gait adaptations inherent to TBI motor impairment from those of healthy subjects walking at slower speed. Methods: Temporospatial and kinematic data of 31 patients with TBI (41 +/- 30 months post-injury) walking at self-selected speed (free speed) were compared with 31 healthy subjects walking at free and very slow speeds using an optoelectronic motion analysis system. Results: All step parameters differed (p < 0.05) between more affected (MA) and less affected (LA) sides in TBI except foot angle and toe clearance. Significant differences existed between TBI and controls in most parameters regardless of speed. These differences frequently involved the LA side. In TBI, most temporospatial parameters significantly correlated with stride velocity, whereas the averaged lower limb Ashworth score on the MA side (2.1 +/- 0.4) showed few significant correlations. Conclusions: Gait deviations in subjects with TBI and lower limb muscle hypertonia cannot be solely explained by slower walking. The preponderance of changes involving the LA side particularly suggests prevalent use of compensatory walking strategies. Temporospatial gait parameters are not closely related to static measures of muscle hypertonia after TBI.	[Chow, John W.; Yablon, Stuart A.; Horn, Terry S.; Stokic, Dobrivoje S.] Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS 39216 USA		Chow, JW (corresponding author), Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, 1350 E Woodrow Wilson Dr, Jackson, MS 39216 USA.	jchow@mmrcrehab.org		Stokic, Dobrivoje/0000-0002-1891-5730	Wilson Research Foundation, Jackson, MS; Medtronic Inc. Minneapolis, MNMedtronic	We thank Mark Hemleben for assistance in data collection and processing. This study was supported in part by the Wilson Research Foundation, Jackson, MS.; The authors have received funding from Medtronic Inc. Minneapolis, MN for research not directly related to this manuscript.	BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOHANNON RW, 1990, ARCH PHYS MED REHAB, V71, P330; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cimolin V, 2007, Eura Medicophys, V43, P303; Cioni M, 2006, AM J PHYS MED REHAB, V85, P600, DOI 10.1097/01.phm.0000223216.50068.bc; Damiano DL, 1996, DEV MED CHILD NEUROL, V38, P389; Feve A, 1997, J NEUROL NEUROSUR PS, V63, P575, DOI 10.1136/jnnp.63.5.575; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; GRACIES JM, 2001, CLINICS, V12, P747; Gutierrez GM, 2005, ARCH PHYS MED REHAB, V86, P1824, DOI 10.1016/j.apmr.2005.04.008; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kerrigan DCC, 1999, J HEAD TRAUMA REHAB, V14, P136, DOI 10.1097/00001199-199904000-00004; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Lin PY, 2006, ARCH PHYS MED REHAB, V87, P562, DOI 10.1016/j.apmr.2005.12.042; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Norton B J, 1975, Phys Ther, V55, P355; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Remy-Neris O, 2003, ARCH PHYS MED REHAB, V84, P643, DOI 10.1016/S0003-9993(02)04906-7; Robertson JVG, 2009, GAIT POSTURE, V29, P108, DOI 10.1016/j.gaitpost.2008.07.005; Rousseaux M, 2008, EUR J NEUROL, V15, P506, DOI 10.1111/j.1468-1331.2008.02112.x; Stewart John D, 2008, Pract Neurol, V8, P158, DOI 10.1136/jnnp.2008.149393; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; van Loo MA, 2003, DISABIL REHABIL, V25, P1195, DOI 10.1080/09638280310001599989; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Westberry DE, 2008, J PEDIATR ORTHOPED, V28, P352, DOI 10.1097/BPO.0b013e318168d996; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, GAIT POSTURE, V29, P454, DOI 10.1016/j.gaitpost.2008.11.005; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wilson DJ, 1997, BRAIN INJURY, V11, P157, DOI 10.1080/026990597123610; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	38	16	16	0	16	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	13-14					1575	1584		10.3109/02699052.2010.523053			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800007	20973631				2022-02-06	
J	Ivins, BJ				Ivins, Brian J.			Hospitalization associated with traumatic brain injury in the active duty US Army: 2000-2006	NEUROREHABILITATION			English	Article						Traumatic brain injury; incidence rates; US Army; blasts; war-related	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIONAL SYNDROME; OPERATION-IRAQI-FREEDOM; POSTCONCUSSION SYNDROME; HEAD-INJURY; SYMPTOMS; CARE; AFGHANISTAN; DEPLOYMENT; MORTALITY	Objective: to determine the potential impacts of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) on the incidence of TBI-related hospitalization in the active duty US Army. Methods: All active duty Army personnel hospitalized with a TBI diagnosis during fiscal years 2000 through 2006 were identified in an administrative database. Annual crude incidence rates were calculated. Two-year adjusted incidence rates were calculated to compare TBI-related hospitalization rates in the Army to rates in the age-comparable segment of the US civilian population. Results: The overall incidence of TBI-related hospitalization in the active duty Army increased 105% from FY2000 to FY2006. There was a 60-fold increase in the hospitalization rate for TBIs attributed to weapons. The increases in TBI hospitalizations coincided with the occurrence of OEF/OIF. During OEF/OIF, the Army's hospitalization rates for moderate and severe TBIs were lower than civilian rates; however, the Army's hospitalization rate for mild TBIs was higher than civilian rates. Conclusion: OEF/OIF appear to have had a substantial impact on TBI-related hospitalization rates in the active duty US Army but differences between Army and civilian rates were not as excessive as expected.	Def & Vet Brain Injury Ctr, Rockville, MD 20852 USA		Ivins, BJ (corresponding author), Def & Vet Brain Injury Ctr, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.	brian.ivins@us.army.mil					Aharonson-Daniel L, 2006, ANN SURG, V244, P1018, DOI 10.1097/01.sla.0000225355.06362.0f; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Amoroso PJ, 2000, AM J PREV MED, V18, P174, DOI 10.1016/S0749-3797(00)00110-0; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Bochicchio GV, 2008, AM SURGEON, V74, P267; Brenner L. A., J HEAD TRAU IN PRESS; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; CAREY ME, 1987, MIL MED, V152, P6; Davis TP, 2003, J TRAUMA, V55, P1022, DOI 10.1097/01.TA.00000100837.38530.D1; DENNISON C, 2000, VITAL HLTH STAT, V1; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; *IOM, 2009, GULF WAR HLTH, V7, pCH11; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; *J HOPK U TRIAN IN, 1998, ICDMAP90 J HOPK U TR; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kahn HA, 1989, STAT METHODS EPIDEMI; Kashuk JL, 2009, J AM COLL SURGEONS, V209, P134, DOI 10.1016/j.jamcollsurg.2009.01.049; Keegan J., 1994, HIST WARFARE; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; *MIL AG STAND, 1989, STANAG 2050 MED STAN; MOORE DF, 2008, FUTURE NEUROL, V3, P1; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; ROPP T, 1962, WAR MODERN WORLD; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; STUHMILLER JH, 1990, CONVENTIONAL WARFARE, pCH7; TABOR KH, 2006, J NEUROPSYCHIATRY CL, V18, P141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wood RL, 2007, J NEUROL NEUROSUR PS, V78, P552, DOI 10.1136/jnnp.2006.113845	52	16	16	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	26	3					199	212		10.3233/NRE-2010-0556			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300004	20448310				2022-02-06	
J	Nielssen, O; Elliott, G; Large, M				Nielssen, Olav; Elliott, Gordon; Large, Matthew			The Reliability of Evidence About Psychiatric Diagnosis After Serious Crime: Part I. Agreement Between Experts	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							FIELD TRIALS; INJURY	The purpose of this study was to assess the extent of agreement on psychiatric diagnosis in written evidence provided by experts in serious criminal matters in Australia. We found good or very good inter-rater agreement on the diagnoses of acquired brain injury, schizophrenia-spectrum psychosis, substance-induced psychotic disorder, and intellectual disability. There was moderate agreement on the diagnosis of depressive and personality disorders. Agreement on anxiety disorders, in particular post-traumatic stress disorder, was poor. Agreement on the principal Axis I diagnosis was moderate, and there was a similar probability of agreement within pairs of experts engaged by the same side and those engaged by opposite sides. Concern about bias in expert psychiatric opinion in criminal cases appears to have been overstated. There was little evidence to suggest that experts' adversarial roles influenced their opinions on psychiatric diagnosis.	[Nielssen, Olav; Large, Matthew] Univ New S Wales, Sydney, NSW, Australia; [Nielssen, Olav; Elliott, Gordon] St Vincents Hosp, Sydney, NSW 2010, Australia; [Elliott, Gordon] New S Wales Justice Hlth, Sydney, NSW, Australia; [Large, Matthew] Prince Wales Hosp, Sydney, NSW, Australia		Large, M (corresponding author), Prince Wales Hosp, Euroa Ctr, Randwick, NSW 2031, Australia.	mmbl@bigpond.com		Nielssen, Olav/0000-0001-5172-2781			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; BECK AT, 1962, AM J PSYCHIAT, V119, P210, DOI 10.1176/ajp.119.3.210; Beck M, 1994, Mo Med, V91, P179; Bourget D, 2004, CAN PSYCHIAT ASS B, V9, P6; FAUST D, 1988, SCIENCE, V241, P31, DOI 10.1126/science.3291114; Fleiss J.L., 1981, STAT METHODS RATES P; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; KILPATRICK DG, 1998, EMPHASIS CRITERION A, V4, P303; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Large M, 2001, AUST NZ J PSYCHIAT, V35, P535, DOI 10.1046/j.1440-1614.2001.00939.x; Large M, 2009, AUST NZ J PSYCHIAT, V43, P446, DOI 10.1080/00048670902817745; Large MM, 2008, J AM ACAD PSYCHIATRY, V36, P515; MEZZICH JE, 1981, J PSYCHIAT RES, V16, P29, DOI 10.1016/0022-3956(81)90011-X; Miller PR, 2001, PSYCHIAT RES, V105, P265, DOI 10.1016/S0165-1781(01)00318-3; Mossman D, 1999, J AM ACAD PSYCHIATRY, V27, P414; Nielssen O, 2005, AUST NZ J PSYCHIAT, V39, P453, DOI 10.1080/j.1440-1614.2005.01603.x; Nielssen O, 2008, BRIT J PSYCHIAT, V192, P394, DOI 10.1192/bjp.192.5.394a; Rosen GM, 2008, BRIT J PSYCHIAT, V192, P3, DOI 10.1192/bjp.bp.107.043083; Rosenman SJ, 1997, J PSYCHIAT RES, V31, P581, DOI 10.1016/S0022-3956(97)00032-0; SARTORIUS N, 1995, AM J PSYCHIAT, V152, P1427; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Sim J, 2005, PHYS THER, V85, P257; SPITZER RL, 1979, AM J PSYCHIAT, V136, P815; SPITZER RL, 1974, BRIT J PSYCHIAT, V125, P341, DOI 10.1192/bjp.125.4.341; EXPERT WITNESS CODE; [No title captured]	26	16	16	0	5	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2010	38	4					516	523					8	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	712WL	WOS:000286696900010	21156911				2022-02-06	
J	Waldron, J; McCourty, A; Lecanu, L				Waldron, Jay; McCourty, Althea; Lecanu, Laurent			Neural stem cell sex dimorphism in aromatase (CYP19) expression: a basis for differential neural fate	STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS			English	Article						neuroregenerative medicine; brain repair strategy; sex dimorphism; aromatase; adult stem cells		Purpose: Neural stem cell (NSC) transplantation and pharmacologic activation of endogenous neurogenesis are two approaches that trigger a great deal of interest as brain repair strategies. However, the success rate of clinical attempts using stem cells to restore neurologic functions altered either after traumatic brain injury or as a consequence of neurodegenerative disease remains rather disappointing. This suggests that factors affecting the fate of grafted NSCs are largely understudied and remain to be characterized. We recently reported that aging differentially affects the neurogenic properties of male and female NSCs. Although the sex steroids androgens and estrogens participate in the regulation of neurogenesis, to our knowledge, research on how gender-based differences affect the capacity of NSCs to differentiate and condition their neural fate is lacking. In the present study, we explored further the role of cell sex as a determining factor of the neural fate followed by differentiating NSCs and its relationship with a potential differential expression of aromatase (CYP19), the testosterone-metabolizing enzyme. Results: Using NSCs isolated from the subventricular zone of three-month-old male and female Long-Evans rats and maintained as neurospheres, we showed that differentiation triggered by retinoic acid resulted in a neural phenotype that depends on cell sex. Differentiated male NSCs mainly expressed markers of neuronal fate, including beta III-tubulin, microtubule associated protein 2, growth-associated protein 43, and doublecortin. In contrast, female NSCs essentially expressed the astrocyte marker glial fibrillary acidic protein. Quantification of the expression of aromatase showed a very low level of expression in undifferentiated female NSCs, whereas aromatase expression in male NSCs was 14-fold greater than the female level. Conclusion: Our results confirm our previous data that the neural phenotype acquired by differentiating NSCs largely depends on cell sex, and that differential expression of aromatase in undifferentiated NSCs might contribute to this sex-based dimorphism. Although still preliminary, our discovery may have clinical application in the development of future brain repair strategies.	[Waldron, Jay; McCourty, Althea; Lecanu, Laurent] McGill Univ, Ctr Hlth, Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada; [Lecanu, Laurent] McGill Univ, Dept Med, Montreal, PQ, Canada		Lecanu, L (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	laurent.lecanu@mcgill.ca		lecanu, laurent/0000-0001-6935-1384	Royal Victoria Hospital Award; Canadian Institutes of Health Research catalystCanadian Institutes of Health Research (CIHR) [IAP 92827]	This work was funded by a Royal Victoria Hospital Award and by a Canadian Institutes of Health Research catalyst grant IAP 92827.	Brannvall K, 2005, EUR J NEUROSCI, V21, P871, DOI 10.1111/j.1460-9568.2005.03942.x; Chang CY, 2006, FERTIL STERIL, V85, P1195, DOI 10.1016/j.fertnstert.2005.11.031; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Gold JH, 1998, J NERV MENT DIS, V186, P769, DOI 10.1097/00005053-199812000-00005; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Laywell Eric D, 2002, Methods Mol Biol, V198, P15; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Matsumoto T, 2008, ARTHRITIS RHEUM-US, V58, P3809, DOI 10.1002/art.24125; Maxson SC, 1996, BEHAV GENET, V26, P471, DOI 10.1007/BF02359751; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; NAFTOLIN F, 1975, J STEROID BIOCHEM, V6, P993, DOI 10.1016/0022-4731(75)90340-4; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Rawson NE, 2006, J NEUROBIOL, V66, P653, DOI 10.1002/neu.20236; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMITH ER, 1967, AM J PHYSIOL, V212, P1385, DOI 10.1152/ajplegacy.1967.212.6.1385; TOWNSLEY JD, 1973, AM J OBSTET GYNECOL, V117, P345, DOI 10.1016/0002-9378(73)90036-7; Waldron J, 2010, STEM CELLS CLONING, V3, P119, DOI 10.2147/SCCAA.S13035; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	23	16	17	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-6957			STEM CELLS CLONING	Stem Cells Cloning		2010	3						175	182		10.2147/SCCAA.S15200			8	Cell Biology	Emerging Sources Citation Index (ESCI)	Cell Biology	V34XE	WOS:000215864900018	24198523	gold, Green Submitted, Green Published			2022-02-06	
J	Kobbe, P; Lichte, P; Wellmann, M; Hildebrand, F; Nast-Kolb, D; Waydhas, C; Oberbeck, R				Kobbe, P.; Lichte, P.; Wellmann, M.; Hildebrand, F.; Nast-Kolb, D.; Waydhas, C.; Oberbeck, R.			Impact of hypothermia on the severely injured patient	UNFALLCHIRURG			German	Article						Hypothermia; Polytrauma; Coagulopathy; Rewarming; Systemic inflammatory response syndrome (SIRS)	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; THERAPEUTIC HYPOTHERMIA; RATS; COAGULOPATHY; METAANALYSIS; MANAGEMENT; SURVIVAL	Accidental hypothermia is a common complication in severely injured patients. Risk factors include environmental exposure of the patient at the accident site or in the clinic, infusion of cold fluids, hemorrhagic shock and anesthetics which influence thermoregulation. In contrast to animal studies, human studies and clinical experiences have identified accidental hypothermia of the severely injured patient to be associated with increased complication and mortality rates. As a consequence, hypothermia together with acidosis and coagulopathy, have been coined the lethal triad in severely injured patients. On a cellular level hypothermia reduces cellular activity and metabolism resulting in reduced oxygen consumption, which is therapeutically used in patients following cardiac arrest. However, the activity of important enzymes, such as those of the coagulation pathway, is simultaneously down regulated. Hypothermia-induced coagulopathy, which is refractory to substitution of coagulation factors, is a major complication of hypothermia in traumatized patients. Therefore, hypothermic trauma patients with hemodynamic instability require aggressive rewarming.	[Kobbe, P.; Lichte, P.; Nast-Kolb, D.; Waydhas, C.; Oberbeck, R.] Univ Klinikum Essen, Unfallchirurg Klin, D-45127 Essen, Germany; [Wellmann, M.] Hannover Med Sch, Klin Orthopadie, Hannover, Germany; [Hildebrand, F.] Hannover Med Sch, Unfallchirurg Klin, Hannover, Germany		Kobbe, P (corresponding author), Univ Klinikum Essen, Unfallchirurg Klin, Hufelandstr 55, D-45127 Essen, Germany.	Kobbe.Philipp@uk-essen.de	Hildebrand, Frank/J-3176-2017; Lichte, Philipp/AAG-2263-2020; Kobbe, Philipp/F-5515-2010				ALDERSON R, 2004, COCHRANE DB SYST REV; BEIIMAN GJ, 2009, ANN SURG, V249, P845; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DANZL DF, 1987, ANN EMERG MED, V16, P1042, DOI 10.1016/S0196-0644(87)80757-6; GACLKARY CS, 2002, COCHRANE DB SYST REV; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Heinius G, 2002, J SURG RES, V108, P7, DOI 10.1006/jsre.2002.6470; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Hildebrand Frank, 2005, Surg Technol Int, V14, P41; JOHNSTON TD, 1994, J TRAUMA, V37, P413, DOI 10.1097/00005373-199409000-00014; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Kermode JC, 1999, BLOOD, V94, P199, DOI 10.1182/blood.V94.1.199.413k14_199_207; Krause KR, 2000, AM SURGEON, V66, P348; Lee SL, 2001, J SURG RES, V100, P150, DOI 10.1006/jsre.2001.6230; Leonov Y, 2002, RESUSCITATION, V52, P193, DOI 10.1016/S0300-9572(01)00453-1; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MICHELSON AD, 1994, THROMB HAEMOSTASIS, V71, P633; Peng RY, 1999, J AM COLL SURGEONS, V188, P685, DOI 10.1016/S1072-7515(99)00035-6; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Schneider A, 2008, ANAESTHESIST, V57, P197, DOI 10.1007/s00101-008-1311-4; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; STERNEMANN S, 1990, J TRAUMA, V30, P200; Tisherman Samuel A, 2004, Curr Opin Crit Care, V10, P512; Tsuei BJ, 2004, INJURY, V35, P7, DOI 10.1016/S0020-1383(03)00309-7; Vaagenes P, 2003, RESUSCITATION, V58, P103, DOI 10.1016/S0300-9572(03)00102-3; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Winkler M, 2000, ANESTH ANALG, V91, P978, DOI 10.1097/00000539-200010000-00039; Wu XR, 2003, J TRAUMA, V55, P308, DOI 10.1097/01.TA.0000079366.23533.1E; YENARI MA, 1995, THROMB RES, V77, P475, DOI 10.1016/0049-3848(95)93883-2	34	16	20	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	DEC	2009	112	12					1055	1059		10.1007/s00113-009-1711-1			5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	530DI	WOS:000272568700005	19998020				2022-02-06	
J	Oliveira, HM; Sallam, HS; Espana-Tenorio, J; Chinkes, D; Chung, DH; Chen, JDDZ; Herndon, DN				Oliveira, Hermes M.; Sallam, Hanaa S.; Espana-Tenorio, Jonathan; Chinkes, David; Chung, Dai H.; Chen, Jiande D. Z.; Herndon, David N.			Gastric and small bowel ileus after severe burn in rats: The effect of cyclooxygenase-2 inhibitors	BURNS			English	Article						Burn; COX-2 inhibitors; Gastric emptying; Small bowel ileus	TRAUMATIC BRAIN-INJURY; POSTOPERATIVE ILEUS; THERMAL-INJURY; COX-2; EXPRESSION; INFLAMMATION; KETOROLAC; MOTILITY; DISEASE; SURGERY	Gastrointestinal (GI) ileus is a common complication after severe burns. Selective cyclooxygenase-2 inhibitors (COX-2i) improved post-operative ileus, but its effect on burn-induced GI dysmotility is unknown. Our aim was to test whether a COX-2i improves gastric emptying (GE) and small bowel transit (SBT) after burn. Experiment on GE: rats were anesthetized and randomized into sham/scald burn, treated/untreated with COX-2i. Six hours after burn, rats received a phenol red meal and were sacrificed 30 min later. Gastric emptying was determined based on the percentage of phenol red recovered in harvested stomachs. Experiment on SBT: rats received a duodenostomy and were scald/sham burned 5 days later. Six hours after burn, rats received a phenol red meal through the duodenostomy catheter and were sacrificed 100 min later. Geometric center (GC) was calculated for SBT. GE was decreased significantly in burned vs. sham animals (p < 0.001). SBT was significantly impaired in burned vs. sham animals (p < 0.001). The COX-2i improved GE in the burn rats but not GE in the control rats or SBT in the burn rats. COX-2i improves bum-induced delayed GE, suggesting the mediation of the latter via the prostaglandin pathway. (C) 2009 Published by Elsevier Ltd and ISBI.	[Herndon, David N.] Shriners Hosp Children, Med Staff, Galveston, TX 77550 USA; [Espana-Tenorio, Jonathan; Chinkes, David; Chung, Dai H.; Herndon, David N.] Univ Texas Med Branch, Dept Surg, Galveston, TX USA; [Oliveira, Hermes M.; Sallam, Hanaa S.; Chen, Jiande D. Z.] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol, Galveston, TX USA; [Sallam, Hanaa S.] Suez Canal Univ, Dept Physiol, Fac Med, Ismailia, Egypt; [Oliveira, Hermes M.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil		Herndon, DN (corresponding author), Shriners Hosp Children, Med Staff, 815 Market St,7th Floor, Galveston, TX 77550 USA.	dherndon@utmb.edu	Sallam, Hanaa/ABD-7361-2020; Herndon, David/AAC-3354-2020	Sallam, Hanaa/0000-0003-3848-3055; 	Shriners Hospitals for Children [8556]	This study was supported by Shriners Hospitals for Children Grant # 8556 (Herndon).	ALICAN J, 1995, BURNS, V21, P171; Burns Smith J., 1998, EMERGEN MED, P1107; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; CHEN CF, 1982, BURNS, V9, P142, DOI 10.1016/0305-4179(82)90063-8; Cheng AZ, 1996, AM J SURG, V171, P85, DOI 10.1016/S0002-9610(99)80079-8; CZAJA AJ, 1974, NEW ENGL J MED, V291, P925, DOI 10.1056/NEJM197410312911801; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; FRANTZIDES CT, 1992, AM J PHYSIOL, V262, pG488, DOI 10.1152/ajpgi.1992.262.3.G488; Gan HT, 2007, AM J SURG, V193, P530, DOI 10.1016/j.amjsurg.2006.05.019; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; JONES WG, 1991, AM J PHYSIOL, V261, pH1190; Josephs MD, 1999, J SURG RES, V86, P50, DOI 10.1006/jsre.1999.5692; Kawata K, 2003, HEPATO-GASTROENTEROL, V50, P1970; KELLEY MC, 1993, AM J SURG, V165, P107, DOI 10.1016/S0002-9610(05)80412-X; Kim JT, 2005, J CLIN ANESTH, V17, P439, DOI 10.1016/j.jclinane.2004.09.008; Komenaka IK, 2000, DIGEST SURG, V17, P578, DOI 10.1159/000051965; Korolkiewicz RP, 2003, J SURG RES, V109, P161, DOI 10.1016/S0022-4804(02)00095-1; Kreiss C, 2003, GUT, V52, P527, DOI 10.1136/gut.52.4.527; Kyle C, 2008, INT J CLIN PRACT, V62, P1684, DOI 10.1111/j.1742-1241.2008.01906.x; Macfarlane RJ, 2008, EXPERT OPIN PHARMACO, V9, P767, DOI 10.1517/14656566.9.5.767; Nadarajah A., 2006, SMJ Singapore Medical Journal, V47, P534; Oktar BK, 2002, BURNS, V28, P209, DOI 10.1016/S0305-4179(02)00004-9; PILBEAM CC, 1993, J BIOL CHEM, V268, P25643; Porcher C, 2004, NEUROGASTROENT MOTIL, V16, P785, DOI 10.1111/j.1365-2982.2004.00568.x; Porcher C, 2002, GASTROENTEROLOGY, V122, P1442, DOI 10.1053/gast.2002.33065; Sallam HS, 2007, AM J PHYSIOL-REG I, V292, pR253, DOI 10.1152/ajpregu.00100.2006; SCARPIGNATO C, 1980, ARCH INT PHARMACOD T, V246, P286; Schmidt J, 2008, NEUROGASTROENT MOTIL, V20, P689, DOI 10.1111/j.1365-2982.2007.01078.x; Schwarz NT, 2001, GASTROENTEROLOGY, V121, P1354, DOI 10.1053/gast.2001.29605; Strong VEM, 2001, SURGERY, V130, P249, DOI 10.1067/msy.2001.115901; Strong VEM, 2001, J SURG RES, V98, P40, DOI 10.1006/jsre.2001.6154; Unluer EE, 2000, BURNS, V26, P335, DOI 10.1016/S0305-4179(99)00135-7; Wolf SE, 1999, J AM COLL SURGEONS, V188, P10, DOI 10.1016/S1072-7515(98)00260-9	33	16	16	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	DEC	2009	35	8					1180	1184		10.1016/j.burns.2009.02.022			5	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	526UY	WOS:000272321400018	19464805				2022-02-06	
J	Rekha, J; Chakravarthy, S; Veena, LR; Kalai, VP; Choudhury, R; Halahalli, HN; Alladi, PA; Dhanushkodi, A; Nirmala, M; Swamilingiah, GM; Agrahari, M; Raju, TR; Panicker, MM; Kutty, BM				Rekha, J.; Chakravarthy, Sridhara; Veena, L. R.; Kalai, Vani P.; Choudhury, Rupam; Halahalli, Harsha N.; Alladi, Phalguni Anand; Dhanushkodi, Anandh; Nirmala, M.; Swamilingiah, Geetha M.; Agrahari, Maulishree; Raju, T. R.; Panicker, M. M.; Kutty, Bindu M.			Transplantation of Hippocampal Cell Lines Restore Spatial Learning in Rats With Ventral Subicular Lesions	BEHAVIORAL NEUROSCIENCE			English	Article						brain lesion; neurodegeneration; learning impairment; hippocampal transplants; trophic factors; functional recovery	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; NERVE GROWTH-FACTOR; MORRIS WATER MAZE; ENTORHINAL CORTEX; FUNCTIONAL RECOVERY; IBOTENATE LESIONS; IN-VIVO; SUBVENTRICULAR ZONE; BEHAVIORAL RECOVERY	We have demonstrated in our previous studies that ventral subicular lesion induces neurodegeneration of the hippocampus and produces cognitive impairment in rats; In die present study, the efficacy of transplanted green fluorescent protein (GFP)-labeled hippocampal cell line (H3-GFP) cells in establishing functional recovery in ventral subicular lesioned rats has been evaluated. The survival of H3-GFP transplants and their ability to express trophic factors in vivo were also Investigated Adult male Wistar rats were subjected to selective lesioning of ventral subiculum and were transplanted with H3-GFP cells into die cornu ammonis 1 (CA1) hippocampus. The transplants sealed mainly in the dentate gyrus and expressed neurotrophic factors. brain-derived neurotrophic factor (BDNF), and basic fibroblast growth factor (bFGF) The ventral subicular lesioned (VSL) Rats with H3-GFP transplants showed enhanced expression of BDNF in the hippocampus and performed well in eight-arm radial maze and Moms water maze The VSL rats without hippocampal transplants continued to show cognitive impairments In task learning. The present study demonstrated the H3-GFP transplants mediated recovery of cognitive functions in VSL, rats. Our study supports the notion of graft meditated host regeneration and functional recovery through trophic support. although these mechanisms require further investigation	[Rekha, J.; Veena, L. R.; Kalai, Vani P.; Halahalli, Harsha N.; Alladi, Phalguni Anand; Dhanushkodi, Anandh; Nirmala, M.; Raju, T. R.; Kutty, Bindu M.] NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neurosci, Dept Neurophysiol, Bangalore 560029, Karnataka, India; [Chakravarthy, Sridhara; Choudhury, Rupam; Swamilingiah, Geetha M.; Panicker, M. M.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Agrahari, Maulishree] Peoples Educ Soc Inst Technol, Dept Biotechnol, Bangalore, Karnataka, India		Kutty, BM (corresponding author), NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neurosci, Dept Neurophysiol, Bangalore 560029, Karnataka, India.		Halahalli, Harsha/I-1564-2015; Alladi, Phalguni/AAY-6912-2020; Halahalli, Harsha/ABE-2908-2020	Halahalli, Harsha/0000-0003-3400-4395; Alladi, Phalguni/0000-0002-2876-3478; Panicker, Mitradas/0000-0002-0782-6222	Department of Biotechnology DBT New DelhiDepartment of Biotechnology (DBT) India [BT/PR 6567/Med/14/849/2005]; NIMHANS, Bangalore; NCBS, Bangalore	The authors greatly acknowledge the Department of Biotechnology (DBT New Delhi. for providing financial support to carry Out the research Study (project No. BT/PR 6567/Med/14/849/2005) Studies have been carried out at NIMHANS, Bangalore, and at NCBS, Bangalore	ANANDH D, 2007, BEHAV NEUROSCI, V121, P191; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Bindu B, 2005, BRAIN RES, V1063, P121, DOI 10.1016/j.brainres.2005.09.044; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; CHAKRAVARTHY S, 2001, THESIS MANIPAL ACAD; CHO YH, 1995, NEUROBIOL LEARN MEM, V64, P285, DOI 10.1006/nlme.1995.0011; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Corti S, 2002, EXP NEUROL, V177, P443, DOI 10.1006/exnr.2002.8004; DANIEL HL, 1996, J NEUROSCI, V16, P1759; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; Deng YB, 2003, CHINESE MED J-PEKING, V116, P1649; Devi L, 2003, BRAIN RES, V960, P9, DOI 10.1016/S0006-8993(02)03699-5; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Eaton MJ, 1997, PAIN, V72, P59, DOI 10.1016/S0304-3959(97)00015-8; Floresco SB, 1996, BEHAV BRAIN RES, V81, P163, DOI 10.1016/S0166-4328(96)00058-7; Galani R, 1997, NEUROBIOL LEARN MEM, V67, P43, DOI 10.1006/nlme.1996.3745; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GOVINDAIAH RBS, 1997, BRAIN RES, V745, P121; Herzog D, 2002, J HIST SEXUALITY, V11, P3, DOI 10.1353/sex.2002.0007; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hodges H, 2000, NEUROSCIENCE, V101, P945, DOI 10.1016/S0306-4522(00)00408-5; JARRARD LE, 1978, J COMP PHYSIOL PSYCH, V92, P1119, DOI 10.1037/h0077516; JARRARD LE, 1984, PHARMACOL BIOCHEM BE, V21, P273, DOI 10.1016/0091-3057(84)90226-0; JARRARD LE, 1986, HIPPOCAMPUS, P93; JAT PS, 1991, P NATL ACAD SCI USA, V92, P8935; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Laxmi TR, 1999, BRAIN RES, V816, P245, DOI 10.1016/S0006-8993(98)01187-1; Laxmi TR, 2000, BRAIN RES, V869, P236, DOI 10.1016/S0006-8993(00)02368-4; LINDSAY RM, 1984, NEUROSCIENCE, V12, P45, DOI 10.1016/0306-4522(84)90136-2; LUNBERG C, 1997, EXPT NEUROLOGY, V145, P342; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nutan K S, 1998, Indian J Physiol Pharmacol, V42, P460; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Oswald CJP, 2000, BEHAV NEUROSCI, V114, P211, DOI 10.1037/0735-7044.114.1.211; Paxinos G., 1982, RAT BRAIN; Rao MS, 2006, NEUROBIOL DIS, V21, P276, DOI 10.1016/j.nbd.2005.07.009; RAWLINS JNP, 1983, BEHAV BRAIN RES, V10, P233, DOI 10.1016/0166-4328(83)90033-5; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Riegert C, 2004, BEHAV BRAIN RES, V152, P23, DOI 10.1016/j.bbr.2003.09.011; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; SCHENK F, 1985, EXP BRAIN RES, V58, P11; SHANKARANARAYAN.RB, 2001, NEUROSCIENCE, V102, P319; Sharp PE, 1999, HIPPOCAMPUS, V9, P158; SHARP PE, 1990, J NEUROSCI, V10, P3093; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shobha K, 2007, J NEUROL SCI, V254, P9, DOI 10.1016/j.jns.2006.12.004; SINDEN JD, 1995, BEHAV BRAIN SCI, V18, P10, DOI 10.1017/S0140525X00037249; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; STRUBLE RG, 1991, J NEUROPATH EXP NEUR, V50, P82, DOI 10.1097/00005072-199101000-00007; SWANSON LW, 1979, J COMP NEUROL, V186, P621, DOI 10.1002/cne.901860408; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; TAUBE JS, 1992, BEHAV NEURAL BIOL, V57, P131, DOI 10.1016/0163-1047(92)90629-I; Tobias CA, 2001, J NEUROTRAUM, V18, P287, DOI 10.1089/08977150151070937; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Virley D, 1999, BRAIN, V122, P2321, DOI 10.1093/brain/122.12.2321; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wong AM, 2005, BRAIN RES, V1063, P140, DOI 10.1016/j.brainres.2005.09.049; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035; Zaman V, 2003, HIPPOCAMPUS, V13, P618, DOI 10.1002/hipo.10091; Zigova T, 2000, EXP NEUROL, V163, P31, DOI 10.1006/exnr.2000.7344	71	16	17	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7044	1939-0084		BEHAV NEUROSCI	Behav. Neurosci.	DEC	2009	123	6					1197	1217		10.1037/a0017655			21	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	532HP	WOS:000272738100006	20001104	Green Published			2022-02-06	
J	Tandon, A; Suri, A; Kasliwal, MK; Mahapatra, AK; Mehta, VS; Garg, A; Sarkar, C; Dogra, TD; Pandey, RM				Tandon, Asheesh; Suri, Ashish; Kasliwal, Manish Kumar; Mahapatra, Ashok Kumar; Mehta, Veer Singh; Garg, Ajay; Sarkar, Chitra; Dogra, T. D.; Pandey, R. M.			Assessment of endocrine abnormalities in severe traumatic brain injury: a prospective study	ACTA NEUROCHIRURGICA			English	Article						Endocrine; Hormone; Head injury; Pituitary	THYROTROPIN-RELEASING-HORMONE; HEAD-INJURY; POSTTRAUMATIC HYPOPITUITARISM; PANHYPOPITUITARISM; INSUFFICIENCY; PROLACTIN; SECONDARY; CORTISOL; FRACTURE; AXIS	The frequency and pattern of endocrine abnormalities among patients with traumatic brain injury have been the subject matter of very few studies. This study was intended to assess the pattern of endocrine dysfunction following severe head injury. Severe head injury patients admitted to the Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, from January to December in 1 year formed the study group. Apart from clinical assessment, NCCT of the head was performed on all patients on admission. A complete anterior pituitary hormone analysis was performed within 24 h of injury and was repeated at 2 weeks, 3 months and 6 months amongst patients who survived. A total of 99 patients were included in the study. Forty of our patients succumbed in the hospital. Rest of the patients were followed up for 6 months. Elevations of cortisol followed by prolactin were the most common hormonal derangements at admission. Midline shift on CT scans was inversely related to cortisol elevation and directly related to GH elevation. Infarct on CT scans was inversely related to cortisol and LH elevation. A significant alteration was found in the decreasing trend of the mean T4 values and normalisation or a decreasing trend from initially elevated mean cortisol and GH levels during follow-up (p < 0.05). This study reveals that abnormalities in hormonal profiles appear to be relatively common in severe traumatic brain injury and fluctuate significantly over at least 6 months; there is a correlation with age and radiological findings. Performance of hormonal analysis evaluation should be considered in patients with severe brain injury so that appropriate hormonal replacement can be done to optimise the clinical outcome.	[Suri, Ashish] All India Inst Med Sci, Ctr Neurosci, New Delhi 110029, India; [Tandon, Asheesh; Suri, Ashish; Kasliwal, Manish Kumar; Mahapatra, Ashok Kumar; Mehta, Veer Singh] All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India; [Garg, Ajay] All India Inst Med Sci, Dept Neuroradiol, New Delhi 110029, India; [Dogra, T. D.] All India Inst Med Sci, Dept Forens Med, New Delhi 110029, India; [Sarkar, Chitra] All India Inst Med Sci, Dept Neuropathol, New Delhi 110029, India; [Pandey, R. M.] All India Inst Med Sci, Dept Biostat, New Delhi 110029, India		Suri, A (corresponding author), All India Inst Med Sci, Ctr Neurosci, New Delhi 110029, India.	surineuro@hotmail.com	Garg, Ajay/AAM-2603-2020; Dogra, Tirath Das/R-6517-2019; GARG, RAKESH/H-4591-2011	Garg, Ajay/0000-0002-9385-291X; Dogra, Tirath Das/0000-0002-5398-2285; GARG, RAKESH/0000-0001-5842-8024			Acerini CL, 2008, J PEDIATR ENDOCR MET, V21, P611; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; BARRECA T, 1980, J CLIN ENDOCR METAB, V51, P1270; BECKPECCOZ P, 1985, NEW ENGL J MED, V312, P1085, DOI 10.1056/NEJM198504253121703; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; CHILDER MK, 1990, BRAIN INJURY, V12, P517; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CLARK JDA, 1992, CLIN ENDOCRINOL, V36, P481, DOI 10.1111/j.1365-2265.1992.tb02249.x; CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; DESAI D, 1989, J TRAUMA, V29, P719, DOI 10.1097/00005373-198906000-00003; EDWARDS OM, 1986, MEDICINE, V65, P281; JAMBART S, 1980, ACTA ENDOCRINOL-COP, V93, P264, DOI 10.1530/acta.0.0930264; KANADE A, 1978, J ENDOCRINOL INVEST, V1, P263, DOI 10.1007/BF03350391; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KING LR, 1981, NEUROSURGERY, V9, P229, DOI 10.1227/00006123-198109000-00002; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; LIDDLE GW, 1962, RECENT PROG HORM RES, V18, P125; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; MATSUURA H, 1985, NEUROSURGERY, V16, P791, DOI 10.1227/00006123-198506000-00009; MOSES AM, 1968, J CLIN ENDOCR METAB, V28, P1581, DOI 10.1210/jcem-28-11-1581; MULLER EE, 1979, CLIN ENDOCRINOL, V11, P645, DOI 10.1111/j.1365-2265.1979.tb03120.x; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; OPPENHEIMER IH, 1961, J CLIN ENDOCR, V21, P1023; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; SOULES MR, 1979, SOUTHERN MED J, V72, P1592, DOI 10.1097/00007611-197912000-00029; VALENTA LJ, 1980, AM J MED, V68, P614, DOI 10.1016/0002-9343(80)90314-9; WARTOFSKY L, 1982, ENDOCR REV, V3, P164, DOI 10.1210/edrv-3-2-164; WEISS SR, 1982, AM J MED, V72, P861; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	36	16	17	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2009	151	11					1411	1417		10.1007/s00701-009-0444-9			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	514NQ	WOS:000271402000009	19597761				2022-02-06	
J	Lemoyne, R; Coroian, C; Mastroianni, T; Grundfest, W				Lemoyne, Robert; Coroian, Cristian; Mastroianni, Timothy; Grundfest, Warren			WIRELESS ACCELEROMETER ASSESSMENT OF GAIT FOR QUANTIFIED DISPARITY OF HEMIPARETIC LOCOMOTION	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Wireless accelerometers; gait analysis; gait rehabilitation; locomotion; hemiparetic gait; traumatic brain injury	RELIABILITY; WALKING; STROKE	Assessment of locomotion quality subsequent to neurological trauma, such as stroke or traumatic brain injury is imperative for the correct allocation of therapy dosage and strategy. In light of the limited amount of medical professionals in contrast with the rising number of people with neurological disorders; a new paradigm for addressing therapeutic strategies for neurological trauma is advocated. An important aspect for therapy of neuro-motor disorders is the characterization of gait. There are devices presently used for evaluating gait, such as EMG, optical sensors, electrogoniometers, metabolic energy expenditure devices, foot stride analyzers, and ground reaction force sensors. These devices have inherent issues, such as spatial constraints, line of sight requirements, and specialization requirements. A solution for improved autonomy of gait assessment is demonstrated by the use of fully wireless 3D MEMS accelerometers, which are light weight and minimally intrusive. To minimize specialization issues, the accelerometers may be positioned at a standard anatomical anchor. The role of traumatic brain injury with respect to gait dysfunction is addressed. Enclosed is the initial test and evaluation of a wireless 3D MEMS accelerometer for gait analysis. The gait analysis is conducted in outdoor conditions, while walking on a sidewalk.	[Lemoyne, Robert; Grundfest, Warren] Univ Calif Los Angeles, Biomed Engn IDP, Los Angeles, CA 90095 USA; [Coroian, Cristian] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mastroianni, Timothy] Cognit Engn, Pittsburgh, PA USA		Lemoyne, R (corresponding author), Univ Calif Los Angeles, Biomed Engn IDP, 5121 Engn 5,Box 951600, Los Angeles, CA 90095 USA.	rlemoyne@ucla.edu	LeMoyne, Robert/AAI-9686-2020	LeMoyne, Robert/0000-0003-3587-3250			Bamberg SJM, 2008, IEEE T INF TECHNOL B, V12, P413, DOI 10.1109/TITB.2007.899493; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Culhane KM, 2005, AGE AGEING, V34, P556, DOI 10.1093/ageing/afi192; Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939; Dobkin BH, 2003, CLIN SCI NEUROLOGIC; Finney R. L., 1990, CALCULUS; Jafari R, 2005, PROCEEDINGS OF MOBIQUITOUS 2005, P479; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Lee JA, 2007, P ANN INT IEEE EMBS, P483, DOI 10.1109/IEMBS.2007.4352328; LEMOYNE R, 2008, 16 INT C MECH MED BI; LEMOYNE R, 2007, 3 ANN THER STRAT NEU; LEMOYNE R, 2007, IGERT STUDENT RES S; LEMOYNE R, 2007, 37 SOC NEUROSCIENCE; LEMOYNE R, 2006, 15 INT C MECH MED BI; LEMOYNE R, 2007, UCLA BRAIN RES I 200; LEMOYNE R, 2006, 36 SOC NEUROSCIENCE; Lemoyne R, 2008, J MECH MED BIOL, V8, P75, DOI 10.1142/S0219519408002462; LeMoyne R, 2008, IEEE ENG MED BIO, P4238, DOI 10.1109/IEMBS.2008.4650145; Lemoyne R, 2008, J MECH MED BIOL, V8, P317, DOI 10.1142/S0219519408002693; Lord SE, 2005, STROKE, V36, P1457, DOI 10.1161/01.STR.0000170698.20376.2e; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; NAKAMURA S, 1996, NUMERICAL ANAL GRAPH; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171	24	16	16	0	8	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	SEP	2009	9	3					329	343		10.1142/S0219519409003024			15	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	497FD	WOS:000270041400005					2022-02-06	
J	Moon, RJ; Wilson, P; Kirkham, FJ; Davies, JH				Moon, R. J.; Wilson, P.; Kirkham, F. J.; Davies, J. H.			Growth monitoring following traumatic brain injury	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							PITUITARY-FUNCTION; DEFICIENCY; CHILDREN	Hypopituitarism is an important consequence of traumatic brain injury (TBI). Growth monitoring can be used as an indicator of pituitary function in children. A retrospective audit of case notes of 123 children who required intensive care unit admission with TBI found that only 71 (33%) of 212 attendances in 38 of 85 children followed up had documented height and weight measurements. Children were reviewed in 11 different specialty clinics, which showed a wide variation in the frequency of growth monitoring. Serial growth measurements were available for only 22 patients (17%), which showed a reduction in height standard deviation scores (0.17 (SD 0.33), p=0.017) over a mean follow-up period of 25.2 (SD 21.6) months. In conclusion, growth monitoring following TBI was poorly performed in this cohort, highlighting the need for a co-ordinated approach by primary and secondary care and all departments in tertiary centres involved in the follow-up of children with TBI.	[Wilson, P.] Southampton Univ Hosp NHS Trust, Paediat Intens Care Unit, Southampton, Hants, England		Davies, JH (corresponding author), Southampton Univ Hosp Trust, Child Hlth Directorate, MP 43,Tremona Rd, Southampton SO16 3JE, Hants, England.	justin.davies@suht.swest.nhs.uk	Kirkham, Fenella/C-2442-2009	Kirkham, Fenella/0000-0002-2443-7958; Davies, Justin/0000-0001-7560-6320			Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; McDonald A, 2008, J PEDIATR-US, V152, P590, DOI 10.1016/j.jpeds.2007.12.046; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137	7	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	SEP	2009	94	9					699	701		10.1136/adc.2008.145235			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	486AQ	WOS:000269168200011	19036759				2022-02-06	
J	Saganova, K; Orendacova, J; Sulla, I; Filipcik, P; Cizkova, D; Vanicky, I				Saganova, Kamila; Orendacova, Judita; Sulla, Igor, Jr.; Filipcik, Peter; Cizkova, Dasa; Vanicky, Ivo			Effects of Long-Term FK506 Administration on Functional and Histopathological Outcome after Spinal Cord Injury in Adult Rat	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Tacrolimus; Compression; Secondary injury; White/gray matter; Neuroprotection	MAGNETIC-RESONANCE TRACKING; TRANSIENT FOCAL ISCHEMIA; GLOBAL CEREBRAL-ISCHEMIA; THERAPEUTIC TIME WINDOW; TRAUMATIC BRAIN-INJURY; EMBRYONIC STEM-CELLS; TACROLIMUS FK506; CYCLOSPORINE-A; IMMUNOSUPPRESSANT FK506; NEUROPROTECTIVE ACTION	FK506 (tacrolimus), a potent immunosuppressive drug primarily used for reduction of allograft rejection in organ transplantation, also offers neuroprotection after central nervous system injury. FK506-mediated immunosuppression and neuroprotection may occur through different mechanisms that could affect neurological recovery and the severity of spinal lesions where cells transplantation therapy is combined with FK506 application. We assessed effects of long-term FK506 administration using the same dose regiment (1 mg/kg/day for 6 weeks) as is used in spinal cord transplantation studies following a balloon-compression induced spinal cord injury (SCI). Body weight and locomotor recovery quantified by the BBB (Basso-Beattie-Bresnehan) locomotor rating scale were evaluated for up to 42 days post-injury. The area of the preserved spinal cord tissue within a 13 mm segment of the spinal cord (lesion epicenter and 6 mm rostral-caudal) was examined histologically. The results showed no significant effects of FK506 on spinal cord tissue sparing or improvement of locomotor recovery. However, body weight fell significantly (P < 0.05) with FK506 treatment when compared with placebo from day 7 until sacrifice. In our experimental design, long-term FK506 treatment did not affect the parameters of outcome following balloon-compression SCI in the rat; however, multiple effects of FK506 should be taken into account when evaluating the outcomes in transplantation studies.	[Saganova, Kamila; Orendacova, Judita; Cizkova, Dasa; Vanicky, Ivo] Slovak Acad Sci, Inst Neurobiol, Ctr Excellence, Dept Neuromorphol, Kosice 04001, Slovakia; [Sulla, Igor, Jr.] Univ Vet Med, Dept Anat Histol & Physiol, Kosice, Slovakia; [Filipcik, Peter] Slovak Acad Sci, Inst Neuroimmunol, Ctr Excellence, Bratislava, Slovakia		Saganova, K (corresponding author), Slovak Acad Sci, Inst Neurobiol, Ctr Excellence, Dept Neuromorphol, Soltesovej 6, Kosice 04001, Slovakia.	sagan@saske.sk	Vanicky, Ivo/ABB-2298-2021; Cizkova, Dasa/AAF-8976-2019	Filipcik, Peter/0000-0001-8919-5964; cizkova, dasa/0000-0002-2504-3993	Slovak Academy of Sciences [VEGA/2/0092/08, VEGA/2/0058/08, VEGA/2/0019/08, VEGA/2//6212/27, APVV 51-0314-06]	This research was supported by grants from the Slovak Academy of Sciences VEGA/2/0092/08, VEGA/2/0058/08, VEGA/2/0019/08, VEGA/2//6212/27 and APVV 51-0314-06 grant.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Arii T, 2001, NEUROL RES, V23, P755, DOI 10.1179/016164101101199135; Bareyre FM, 2008, J NEUROL SCI, V265, P63, DOI 10.1016/j.jns.2007.05.004; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Benetoli A, 2007, PHARMACOL BIOCHEM BE, V88, P28, DOI 10.1016/j.pbb.2007.07.001; Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Furuichi Y, 2004, BRAIN RES, V1014, P120, DOI 10.1016/j.brainres.2004.04.031; Furuichi Y, 2003, BRAIN RES, V965, P137, DOI 10.1016/S0006-8993(02)04151-3; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hayashi Y, 2005, J NEUROTRAUM, V22, P1267, DOI 10.1089/neu.2005.22.1267; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Vales R, 2006, NEUROBIOL DIS, V24, P443, DOI 10.1016/j.nbd.2006.08.001; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; Madsen JR, 1998, EXP NEUROL, V154, P673, DOI 10.1006/exnr.1998.6974; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Nito C, 2004, BRAIN RES, V1008, P179, DOI 10.1016/j.brainres.2004.02.031; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Ondrejcak T, 2004, BRAIN RES, V995, P267, DOI 10.1016/j.brainres.2003.10.009; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Saganova K, 2008, NEUROSCI LETT, V433, P246, DOI 10.1016/j.neulet.2008.01.041; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; Sosa I, 2005, EXP NEUROL, V195, P7, DOI 10.1016/j.expneurol.2005.04.016; Sykova E, 2005, ANN NY ACAD SCI, V1049, P146, DOI 10.1196/annals.1334.014; Tachibana T, 2005, J THORAC CARDIOV SUR, V129, P123, DOI 10.1016/j.jtcvs.2004.04.047; Takamatsu H, 2001, J NUCL MED, V42, P1833; Tokime T, 1996, NEUROSCI LETT, V206, P81, DOI 10.1016/S0304-3940(96)12438-1; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Vanicky I, 2002, NEUROSCI RES COMMUN, V31, P183, DOI 10.1002/nrc.10051; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Voda J, 2005, J NEUROTRAUM, V22, P1150, DOI 10.1089/neu.2005.22.1150; Voda J, 2007, NEUROSCI RES, V58, P95, DOI 10.1016/j.neures.2007.02.004; Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028; Yagita Y, 1996, LIFE SCI, V59, P1643, DOI 10.1016/0024-3205(96)00495-X; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092	42	16	18	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	SEP	2009	29	6-7					1045	1051		10.1007/s10571-009-9395-1			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	476YI	WOS:000268482300031	19350383				2022-02-06	
J	Inan, U; Kose, N; Omeroglu, H				Inan, Ulukan; Kose, Nusret; Omeroglu, Hakan			Pediatric femur neck fractures: a retrospective analysis of 39 hips	JOURNAL OF CHILDRENS ORTHOPAEDICS			English	Article						Femur neck fracture; Children; Hip; Avascular necrosis of the femoral head		Purpose The aim of this retrospective study was to analyze the radiological and clinical results of pediatric femur neck fractures. Methods This study included 39 children (mean age 11.1, range 4 to 16 years) who had a femur neck fracture and had at least one year of complete follow-up. The most common etiological factor was traffic accident and the most common associated skeletal injury was pelvis fracture. Results According to Delbet's classification system, there were no type I (transepiphyseal) fractures and 21 type II (transcervical), 14 type III (cervicotrochanteric), and four type IV (intertrochanteric) fractures. The mean follow-up was 3.4 (1-9.5) years. A satisfactory outcome according to Ratliff's radiological and clinical criteria was obtained in 28 (72%) hips. Avascular necrosis (AVN) of the femoral head was seen in 11 (28%) hips and the rate of satisfactory outcome was significantly higher in hips without AVN than in hips with AVN (P < 0.001). Transcervical fractures had the worst outcome (P = 0.014) and the highest rate of AVN (P = 0.077) when compared with cervicotrochanteric and intertrochanteric fractures. No significant correlation was found between both the outcome and development of AVN and age, gender, laterality, amount of fracture displacement, treatment time, and the type of reduction (open/closed) (P > 0.05). Conclusions It has been concluded that the development of AVN primarily influences the outcome in pediatric femur neck fractures and that fracture type is essentially correlated with the development of AVN and outcome.	[Inan, Ulukan; Kose, Nusret; Omeroglu, Hakan] Eskisehir Osmangazi Univ, Fac Med, Dept Orthopaed & Traumatol, TR-26480 Eskisehir, Turkey		Omeroglu, H (corresponding author), Eskisehir Osmangazi Univ, Fac Med, Dept Orthopaed & Traumatol, TR-26480 Eskisehir, Turkey.	homeroglu@superonline.com	Omeroglu, Hakan/AAD-3233-2022; Kose, Nusret/AAG-6118-2019	Kose, Nusret/0000-0002-1517-9635			Bagatur AE, 2002, J PEDIATR ORTHOP B, V11, P219; Bombaci Hasan, 2006, Acta Orthop Traumatol Turc, V40, P6; CANALE ST, 1977, J BONE JOINT SURG AM, V59, P431, DOI 10.2106/00004623-197759040-00001; Cheng JCY, 1999, J PEDIATR ORTHOPED, V19, P338; Colonna PC, 1929, AM J SURG, V6, P793, DOI [10.1016/S0002-9610(29)90726-1, DOI 10.1016/S0002-9610(29)90726-1, 10.1016/s0002-9610(29)90726-1]; Flynn JM, 2002, J BONE JOINT SURG BR, V84B, P108, DOI 10.1302/0301-620X.84B1.11972; Herring J.A., 2008, TACHDJIANS PEDIAT OR, V4th; HUGHES LO, 1994, J BONE JOINT SURG AM, V76A, P283, DOI 10.2106/00004623-199402000-00019; LEUNG PC, 1986, J BONE JOINT SURG BR, V68, P537, DOI 10.1302/0301-620X.68B4.3733826; Lorczynski Adam, 2007, Chir Narzadow Ruchu Ortop Pol, V72, P259; Maeda S, 2003, INJURY, V34, P283, DOI 10.1016/S0020-1383(02)00281-4; Magu NK, 2007, J ORTHOP TRAUMA, V21, P237, DOI 10.1097/BOT.0b013e31804cfdad; Moon ES, 2006, J ORTHOP TRAUMA, V20, P323, DOI 10.1097/00005131-200605000-00005; Morsy HA, 2001, INJURY, V32, P45, DOI 10.1016/S0020-1383(00)00109-1; PFORRINGER W, 1980, ACTA ORTHOP SCAND, V51, P91, DOI 10.3109/17453678008990774; RATLIFF AHC, 1962, J BONE JOINT SURG BR, V44, P528, DOI 10.1302/0301-620X.44B3.528; Shrader MW, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000238794.82466.3d; Song KS, 2001, J PEDIATR ORTHOP B, V10, P205, DOI 10.1097/00009957-200107000-00009; Togrul E, 2005, INJURY, V36, P123, DOI 10.1016/j.injury.2004.04.010; Wenger DR, 2005, RANGS CHILDRENS FRAC, P165	20	16	23	0	4	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	1863-2521	1863-2548		J CHILD ORTHOP	J. Child. Orthop.	AUG	2009	3	4					259	264		10.1007/s11832-009-0180-y			6	Orthopedics; Pediatrics	Emerging Sources Citation Index (ESCI)	Orthopedics; Pediatrics	V27NC	WOS:000215365500002	19468776	Green Published			2022-02-06	
J	Low, D; Kuralmani, V; Ng, SK; Lee, KK; Ng, I; Ang, BT				Low, David; Kuralmani, Vellaisamy; Ng, See Kiong; Lee, Kah Keow; Ng, Ivan; Ang, Beng Ti			Prediction of Outcome Utilizing Both Physiological and Biochemical Parameters in Severe Head Injury	JOURNAL OF NEUROTRAUMA			English	Article						decision tree; head injury prediction; logistic regression; severe traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL VASOMOTOR REACTIVITY; PRESSURE; OXYGEN; TREE	Traumatic brain injury is a major socioeconomic burden, and the use of statistical models to predict outcomes after head injury can help to allocate limited health resources. Earlier prediction models analyzing admission data have been used to achieve prediction accuracies of up to 80%. Our aim was to design statistical models utilizing a combination of both physiological and biochemical variables obtained from multimodal monitoring in the neurocritical care setting as a complement to earlier models. We used decision tree and logistic regression analysis on variables including intracranial pressure (ICP), mean arterial pressure (MAP), cerebral perfusion pressure (CPP), and pressure reactivity index (PRx), as well as multimodal monitoring parameters to assess brain tissue oxygenation (PbtO(2)), and microdialysis parameters to predict outcomes based on a dichotomized Glasgow Outcome Score. Further analysis was carried out on various subgroup combinations of physiological and biochemical parameters. The reliability of the head injury models was assessed using a 10-fold cross-validation technique. In addition, the confusion matrix was also used to assess the sensitivity, specificity, and the F-ratio. In all, 2,413 time series records were extracted from 26 patients treated at our neurocritical care unit over a 1-year period. Decision tree analysis was found to be superior to logistic regression analysis in predictive accuracy of outcome. The combined use of microdialysis variables and PbtO(2), in addition to ICP, MAP, and CPP was found have the best predictive accuracy. The use of physiological and biochemical variables based on a decision tree analysis model has shown to provide an improvement in predictive accuracy compared with other previous models. The potential application is for outcome prediction in the multivariate setting of advanced multimodality monitoring, and validates the use of multimodal monitoring in the neurocritical care setting to have a potential benefit in predicting outcomes of patients with severe head injury.	[Low, David; Lee, Kah Keow; Ng, Ivan; Ang, Beng Ti] Natl Inst Neurosci, Dept Neurosurg, Singapore 308433, Singapore; [Kuralmani, Vellaisamy; Ng, See Kiong] Inst Infocomm Res, Singapore, Singapore		Ang, BT (corresponding author), Natl Inst Neurosci, Dept Neurosurg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	beng_ti_ang@nni.com.sg			National Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [NMRC/0578/2001, NMRC/0778/2003]	This study was supported by the National Medical Research Council grants NMRC/0578/2001 and NMRC/0778/2003, awarded to Dr. Ivan Ng. We also appreciate the contributions made by our neurosurgical intensive care unit nurses to this study.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1996, NEUROTRAUMA, P779; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; JOHNSTON AJ, 2002, MICRODIALYSIS CURR O, V81, P121; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Quinlan R., 1993, C4 5 PROGRAMS MACHIN; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257	17	16	17	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1177	1182		10.1089/neu.2008.0841			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900001	19371145				2022-02-06	
J	Seyfried, DM; Han, Y; Yang, D; Ding, J; Chopp, M				Seyfried, D. M.; Han, Y.; Yang, D.; Ding, J.; Chopp, M.			Erythropoietin promotes neurological recovery after intracerebral haemorrhage in rats	INTERNATIONAL JOURNAL OF STROKE			English	Article						erythropoietin; intracerebral haemorrhage; neural regeneration	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; CARBAMYLATED ERYTHROPOIETIN; ENHANCES NEUROGENESIS; CEREBRAL-ISCHEMIA; MIGRATION; STROKE; ANGIOGENESIS; MEMORY; MOTOR	Background Attention has turned to neurorestorative therapies, including erythropoietin, for experimental ischaemic stroke and head injury. Treatments for intracerebral haemorrhage need to be developed, as this represents a particularly devastating and common form of neurological injury. Aim The aim of this study is to investigate the therapeutic potential of erythropoietin after intracerebral haemorrhage in rats and to measure its effects on mechanisms of recovery and neurogenesis. Methods Intracerebral haemorrhage was induced in 24 Wistar male rats by intrastriatal infusion of autologous blood. Recombinant human erythropoietin (5000 or 10 000 U/kg BW/day) or saline was administered starting 1 day after intracerebral haemorrhage and continued daily for 1 week (n=8 for each group). To label proliferating cells, 5'-bromo-2' deoxyuridine was injected daily for 13 days after intracerebral haemorrhage. All animals survived for 2 weeks after intracerebral haemorrhage. Functional outcome, area of tissue loss and immunohistochemical staining were measured at 14 days after intracerebral haemorrhage. Global test or anova was used to test the erythropoietin dose effect. Results Rats receiving recombinant human erythropoietin after intracerebral haemorrhage exhibited significant improvement in modified neurological severity score and corner test at 14 days (P < 0 center dot 05). Increased expression of phenotypes of synaptogenesis and proliferating immature neurons were shown by immunohistochemical staining. Only the group receiving a lower dose of recombinant human erythropoietin had significantly less tissue loss compared with the control group (P < 0 center dot 05). In rats treated with recombinant human erythropoietin, double staining for 5'-bromo-2' deoxyuridine and TUJ1 revealed a subpopulation of cells that express an immature neuronal marker while still dividing. Conclusions Erythropoietin improves neurological outcome and increases histochemical parameters of neurogenesis when given after intracerebral haemorrhage in rats. Intriguingly, only the lower dose of recombinant human erythropoietin was effective in reducing tissue loss in the region of intracerebral haemorrhage.	[Seyfried, D. M.; Han, Y.; Yang, D.; Ding, J.] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, M.] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA		Seyfried, DM (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsdos@neuro.hfh.edu			Internal (Departmental) Funds and National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NSO58581]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058581] Funding Source: NIH RePORTER	Special thanks to Susan MacPhee-Gray for editorial assistance. This work was supported by Internal (Departmental) Funds and National Institutes of Health grant NSO58581.	Bartesaghi S, 2005, NEUROTOXICOLOGY, V26, P923, DOI 10.1016/j.neuro.2005.01.016; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Fernandes HM, 2000, ACT NEUR S, V76, P463; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Schallert T, 1997, ADV NEUROL, V73, P229; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Torup L, 2007, BRIT J PHARMACOL, V151, P1141, DOI 10.1038/sj.bjp.0707287; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	25	16	16	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	AUG	2009	4	4					250	256		10.1111/j.1747-4949.2009.00292.x			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	482YP	WOS:000268927000006	19689750	Green Accepted			2022-02-06	
J	Joosse, P; Smit, G; Arendshorst, RJ; Soedarmo, S; Ponsen, KJ; Goslings, JC				Joosse, P.; Smit, G.; Arendshorst, R. J.; Soedarmo, S.; Ponsen, K. -J.; Goslings, J. C.			Outcome and prognostic factors of traumatic brain injury: a prospective evaluation in a Jakarta University hospital	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Developing countries; Prognostic factors; Trauma and injury severity score; Traumatic brain injury	SEVERE HEAD-INJURY; SEVERITY; MORTALITY; SCALE; TRISS; CARE	The aim of the study was to report management and outcome of traumatic brain injury (TBI) in a Jakarta University hospital, and to determine prognostic factors. All consecutive patients with an Abbreviated Injury Score (AIS) head of >= 4 or an AIS head score of >= 3 combined with an AIS score of _> 2 in any other body region were analyzed on patient characteristics and outcome. Prognostic factors evaluated were Glasgow Coma Scale (GCS) score, pupil reactions and probability of survival based on the Trauma and Injury Severity Score (TRISS) method. A total of 49 patients were included; overall mortality was 37%. The GCS and abnormal pupil reactions were associated with mortality with an odds ratio of 0.78 and 6.90, respectively. Thus, TBI has a poor prognosis in the population under study. The TRISS has limitations in evaluating trauma care for this selected group of patients. GCS and pupil reactions are valuable and simple for usage as prognostic factors. (C) 2008 Elsevier Ltd. All rights reserved.	[Joosse, P.] Sint Lucas Andreas Hosp, Dept Surg, NL-1061 AE Amsterdam, Netherlands; [Smit, G.] Katholieke Univ Nijmegen, Radboud Hosp, Dept Gen Practice, Nijmegen, Netherlands; [Arendshorst, R. J.] Vrije Univ Amsterdam, VU Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Soedarmo, S.] Univ Kristen Indonesia, UKI Hosp, Dept Surg, Jakarta, Indonesia; [Ponsen, K. -J.; Goslings, J. C.] Univ Amsterdam, Acad Med Ctr, Dept Surg, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands		Joosse, P (corresponding author), Sint Lucas Andreas Hosp, Dept Surg, Jan Tooropstr 164, NL-1061 AE Amsterdam, Netherlands.	pieterjoosse@hotmail.com					Ahmad FU, 2006, NEUROL INDIA, V54, P73; American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HARTONO B, 2007, INDONESIA HLTH PROFI; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1979, Acta Neurochir Suppl (Wien), V28, P149; Joosse P, 2001, J TRAUMA, V51, P134, DOI 10.1097/00005373-200107000-00021; KRAUS JF, 1995, J NEUROTRAUM, V12, P873, DOI 10.1089/neu.1995.12.873; MARKLE J, 1992, J TRAUMA, V33, P326, DOI 10.1097/00005373-199208000-00025; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Raja IA, 2001, WORLD J SURG, V25, P1230; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; The Brain TraumaFoundation, 2000, J NEUROTRAUM, V17, P583, DOI [10.1089/neu.2000.17.583, DOI 10.1089/NEU.2000.17.583]; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009	23	16	18	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2009	16	7					925	928		10.1016/j.jocn.2008.06.014			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	451YJ	WOS:000266506500014	19269829				2022-02-06	
J	Luo, YH; Li, ZD; Liu, LX; Dong, GH				Luo, Yu-Hong; Li, Zheng-Dong; Liu, Li-Xin; Dong, Gao-Hong			Pretreatment with erythropoietin reduces hepatic ischemia-reperfusion injury	HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL			English	Article						erythropoietin; ischemia-reperfusion injury; heme oxygenase-1	TRAUMATIC BRAIN-INJURY; SICKLE-CELL-DISEASE; HEME OXYGENASE-1; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; PROTECTS; HO-1; ISCHEMIA/REPERFUSION; INDUCTION; FAILURE	BACKGROUND: During hepatectomy, a period of ischemia and restoration of the blood supply can result in hepatic ischemia-reperfusion injury (IRI). Current research indicates that erythropoietin (EPO) has a protective effect in animal models of cerebral ischemia, myocardial infarction, and renal IRI. However there is lack of research into the role of EPO in hepatic IRI. This study aimed to explore the role of EPO in hepatic IRI and its possible mechanism of action. METHODS: Thirty male Sprague-Dawley rats were divided into three groups: (1) ten rats in the experimental group were given 1000 IU/kg EPO one day before the operation; (2) ten rats in a control group were given normal saline preoperatively as a placebo; and (3) ten rats served as a sham-operated group. Hepatic IRI was induced by occluding the hepatic arteries of the three cephalad hepatic segments and the portal vein for about 45 minutes, while in the sham-operated group only laparotomy was performed. The levels of ALT and AST were tested 24 hours pre- and post-operation. All rats were sacrificed 24 hours after the operation to assess the pathologic changes in the liver and measure the expression of heme oxygenase-1 (HO-1) through Western blotting and RT-PCR. RESULTS: Hepatic IRI was markedly mitigated in the experimental group as compared with the control group. Moreover, the expression of HO-1 at the level of both transcription and protein increased prominently (P<0.05) in the experimental group. CONCLUSION: These results demonstrate that EPO can up-regulate HO-1 in liver tissues and accordingly decrease hepatic injury through its anti-inflammatory property. (Hepatobiliary Pancreat Dis Int 2009; 8: 294-299)	[Luo, Yu-Hong; Li, Zheng-Dong; Liu, Li-Xin; Dong, Gao-Hong] Jinan Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou 510630, Peoples R China		Luo, YH (corresponding author), Jinan Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou 510630, Peoples R China.	Lubuson@126.com					Alcaraz MJ, 2004, BRIT J PHARMACOL, V142, P1191, DOI 10.1038/sj.bjp.0705821; Baan C, 2004, AM J TRANSPLANT, V4, P811, DOI 10.1111/j.1600-6143.2004.00420.x; Bahlmann FH, 2004, CIRCULATION, V110, P1006, DOI 10.1161/01.CIR.0000139335.04152.F3; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Blydt-Hansen TD, 2003, J AM SOC NEPHROL, V14, P745, DOI 10.1097/01.ASN.0000050760.87113.25; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Burger D, 2009, AM J PHYSIOL-HEART C, V296, pH84, DOI 10.1152/ajpheart.00372.2008; Calo LA, 2003, INT J CLIN PHARM TH, V41, P187; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; CARLINI RG, 1995, KIDNEY INT, V47, P740, DOI 10.1038/ki.1995.113; Cerami A, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_1.8; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Haller H, 1996, KIDNEY INT, V50, P481, DOI 10.1038/ki.1996.339; Kacimi R, 2000, CARDIOVASC RES, V46, P139, DOI 10.1016/S0008-6363(00)00007-9; Lipsic E, 2004, J CARDIOVASC PHARM, V44, P473, DOI 10.1097/01.fjc.0000140209.04675.c3; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Nath KA, 2004, MICROCIRCULATION, V11, P179, DOI 10.1080/10739680490278592; Nath KA, 1999, J CLIN INVEST, V104, P1485, DOI 10.1172/JCI8827; Nath KA, 2001, AM J PATHOL, V158, P893, DOI 10.1016/S0002-9440(10)64037-0; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Sepodes B, 2006, TRANSPL INT, V19, P919, DOI 10.1111/j.1432-2277.2006.00366.x; Shimizu H, 2000, CRIT CARE MED, V28, P809, DOI 10.1097/00003246-200003000-00033; Sola A, 2005, PEDIATR RES, V57, p110R, DOI 10.1203/01.PDR.0000159571.50758.39; Takahashi T, 2004, ANTIOXID REDOX SIGN, V6, P867, DOI 10.1089/1523086041798123	28	16	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1499-3872	2352-9377		HEPATOB PANCREAT DIS	Hepatob. Pancreatic. Dis. Int.	JUN	2009	8	3					294	299					6	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	457AW	WOS:000266898100011	19502171				2022-02-06	
J	Ross, LF; Harvey, LA; Lannin, NA				Ross, Leo F.; Harvey, Lisa A.; Lannin, Natasha A.			Do people with acquired brain impairment benefit from additional therapy specifically directed at the hand? A randomized controlled trial	CLINICAL REHABILITATION			English	Article							RESEARCH ARM TEST; UPPER EXTREMITY FUNCTION; INDUCED MOVEMENT THERAPY; CHRONIC STROKE PATIENTS; MOTOR FUNCTION-TEST; CLINICAL-TRIAL; SINGLE-BLIND; EXERCISE THERAPY; INTENSITY; REHABILITATION	Objective: To determine the benefits of additional therapy specifically directed at the hand in people with acquired brain impairment. Design: An assessor-blinded randomized controlled trial. Setting: Rehabilitation hospital. Participants: A sample of 39 adults with hand impairment following stroke (90%) or traumatic brain injury (10%). The median (interquartile) time since injury was 1.6 months (0.5-3.5 months). Intervention: The experimental group (n = 20) received an additional one-hour session of task-specific motor training for the hand five times a week over a six-week period. The training was administered on a one-to-one basis. The control group (n 19) received standard care which consisted of 10 minutes of hand therapy three times a week. Both groups continued to receive therapy directed at the shoulder and elbow. Outcome measures: Primary outcomes were the Action Research Arm and Summed Manual Muscle Tests measured at the beginning and end of the six-week period. Results: The mean (SD) Action Research Arm Test values for experimental participants improved from the beginning to the end of study from 10 points (15) to 21 points (23) and the equivalent values for the Summed Manual Muscle Test improved from 35% (33) to 49% (35). There were similar improvements in control participants. The mean between-group differences for the Action Research Arm and Summed Manual Muscle Tests were -6 points (95% confidence interval (CI), -20 to 8) and 3% (95% CI, -10 to 16), respectively. Conclusion: Hand and overall arm function of all participants improved over the six-week period, however there was not a clear benefit from providing additional hand therapy.	[Harvey, Lisa A.; Lannin, Natasha A.] Univ Sydney, Rehabil Studies Unit, No Clin Sch, Fac Med, Ryde 1680, Australia; [Ross, Leo F.] Ipswich Hosp, Brisbane, Qld, Australia		Harvey, LA (corresponding author), Univ Sydney, Rehabil Studies Unit, No Clin Sch, Fac Med, POB 6, Ryde 1680, Australia.	l.harvey@usyd.edu.au	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345; Harvey, Lisa A/0000-0002-4365-0236	Queensland Health Allied Health Research Scheme	This research was conducted with financial support from a Queensland Health Allied Health Research Scheme award.	Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; Beaton D E, 2001, J Hand Ther, V14, P128; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Brandsma J W, 2001, J Hand Ther, V14, P273; Desrosiers J, 2005, CLIN REHABIL, V19, P581, DOI 10.1191/0269215505cr896oa; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Harvey L, 1994, J Hand Ther, V7, P251; Hsueh IP, 2002, CLIN REHABIL, V16, P382, DOI 10.1191/0269215502cr509oa; Hyde SA, 2000, NEUROMUSCULAR DISORD, V10, P257, DOI 10.1016/S0960-8966(99)00135-2; Kwakkel G, 2002, J NEUROL NEUROSUR PS, V72, P473; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; Lannin NA, 2007, STROKE, V38, P111, DOI 10.1161/01.STR.0000251722.77088.12; Law M, 1990, Can J Occup Ther, V57, P82; Law M., 2005, COPM CANADIAN OCCUPA; MacDonald A, 2004, PHYS WORLD, V17, P18; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Pang MY, 2006, ARCH PHYS MED REHAB, V87, P1, DOI 10.1016/j.apmr.2005.08.113; Parry RH, 1999, CLIN REHABIL, V13, P187, DOI 10.1191/026921599676198929; Partridge C, 2000, Physiother Res Int, V5, P230, DOI 10.1002/pri.203; Platz T, 2005, CLIN REHABIL, V19, P714, DOI 10.1191/0269215505cr904oa; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; POLLACK M, 2005, CLIN GUIDELINES STRO; Rodgers H, 2003, CLIN REHABIL, V17, P579, DOI 10.1191/0269215503cr652oa; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; van der Lee JH, 2002, CLIN REHABIL, V16, P646, DOI 10.1191/0269215502cr534oa; van der Lee JH, 2001, J REHABIL MED, V33, P110; van der Lee JH, 2001, CLIN REHABIL, V15, P20, DOI 10.1191/026921501677557755; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Woldag H, 2003, CLIN REHABIL, V17, P723, DOI 10.1191/0269215503cr669oa; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	39	16	16	0	13	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUN	2009	23	6					492	503		10.1177/0269215508101733			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	457LI	WOS:000266929300002	19321521				2022-02-06	
J	Willmott, C; Ponsford, J; Olver, J; Ponsford, M				Willmott, Catherine; Ponsford, Jennie; Olver, John; Ponsford, Michael			SAFETY OF METHYLPHENIDATE FOLLOWING TRAUMATIC BRAIN INJURY: IMPACT ON VITAL SIGNS AND SIDE-EFFECTS DURING INPATIENT REHABILITATION	JOURNAL OF REHABILITATION MEDICINE			English	Article						methylphenidate; traumatic brain injury; rehabilitation; vital signs; side-effects	HEART-RATE; PLACEBO	Objective: The aim of the present study was to evaluate the safety of methylphenidate administered during inpatient rehabilitation following traumatic brain injury. Methods: Forty inpatients with moderate-severe traumatic brain injury (mean 68.4 days post-injury) participated in a randomized, cross-over, double-blind, placebo-controlled trial of methylphenidate administered at a dose of 0.3 mg/kg body weight twice daily. Results: Methylphenidate administration resulted in a statistically significant increase in pulse of 12.3 beats/min (95% confidence interval ( 9.25-15.36), diastolic blood pressure of 4.1 mmHg (95%. CI 2.11-6.10), and mean arterial pressure of 3.75 mmHg (95% CI 1.79-5.72). These changes did not, however, appear to be symptomatic, as no participants were withdrawn due to adverse events, and there was no significant self-report of increased heart rate with methylphenidate. Blinding was successful. Significantly greater reporting of irritability of 0.14 points (95%, CI 0.02-0.26), difficulty sleeping of 0.17 points (95% CI 0.02-0.31) and total side-effects of 0.68 points (95% CI 0.06-1.30) was associated with methylphenidate compared with placebo. Conclusion: Methylphenidate given at 0.3 mg/kg body weight appears to be safe in the inpatient rehabilitation phase. This trial is registered with the Australian New Zealand Clinical Trials Registry (12607000503426).	[Willmott, Catherine] Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia; [Olver, John; Ponsford, Michael] Epworth HealthCare, Epworth Rehabil, Richmond, Australia; [Willmott, Catherine; Ponsford, Jennie; Olver, John; Ponsford, Michael] Monash Epworth Rehabil Res Ctr, Richmond, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Prahran, Vic, Australia		Willmott, C (corresponding author), Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Bldg 17, Clayton, Vic 3800, Australia.	catherine.willmott@med.monash.edu.au	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035; Olver, John/0000-0001-7069-1191			Al-Adawi S., 2005, Journal of Applied Research, V5, P61; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Burke DT, 2003, AM J PHYS MED REHAB, V82, P493, DOI 10.1097/00002060-200307000-00001; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kimko HC, 1999, CLIN PHARMACOKINET, V37, P457, DOI 10.2165/00003088-199937060-00002; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86	13	16	16	0	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	JUN	2009	41	7					585	587		10.2340/16501977-0369			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	463HD	WOS:000267421100014	19543672	Green Submitted, gold			2022-02-06	
J	Dise-Lewis, JE; Lewis, HC; Reichardt, CS				Dise-Lewis, Jeanne E.; Lewis, Hal C.; Reichardt, Charles S.			BrainSTARS: Pilot Data on a Team-Based Intervention Program for Students Who Have Acquired Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						consultation; education; family; intervention; pediatric; traumatic brain injury	YOUNG-CHILDREN; REHABILITATION; TBI; RECOMMENDATIONS; ADOLESCENTS; OUTCOMES; MODEL; CARE	Objective: To conduct and evaluate an educational/consultation program for parents and teachers of children who have acquired brain injury (ABI). Participants: Parents, regular and special educators, and related school personnel of 30 students who had ABI and serious school problems. Intervention: BrainSTARS (Brain Injury: Strategies for Teams and Re-education for Students), an individualized consultation program that includes a comprehensive manual on pediatric ABI. The intervention included 3 meetings in the school of the child identified with ABI. Design: A pre/post single group design assessed the impact of BrainSTARS on ABI-related competencies in the adult participants as well as on measures of child behaviors. Results: Significant improvement was shown in the participants' self-rated proficiency in working with children who have ABI as well as on their ratings of student performance in targeted neurodevelopmental areas. There was no significant change on standardized measures of child behavior (the Behavior Rating Inventory of Executive Functions and the Behavior Assessment System for Children). Conclusions: BrainSTARS appears to increase the competencies of parents and educators related to students who have ABI; further study of BrainSTARS' impact on student performance and capacity to produce long-standing results is called for.	[Dise-Lewis, Jeanne E.] Univ Colorado Denver, Childrens Hosp, Aurora, CO 80045 USA; [Lewis, Hal C.] Univ Colorado Denver, JFK Partners, Aurora, CO 80045 USA; [Reichardt, Charles S.] Univ Denver, Dept Psychol, Denver, CO 80208 USA		Dise-Lewis, JE (corresponding author), Univ Colorado Denver, Childrens Hosp, Box B-285,13123 E 16th Ave, Aurora, CO 80045 USA.				US Department of EducationUS Department of Education [H324M9900602003]	This study was funded by the US Department of Education Model Demonstration Projects for Children and Youth with Disabilities grant H324M9900602003. The authors thank the contributions of the entire project team, in particular those of Margaret Lohr Calvery, PhD.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; [Anonymous], 1994, DIAGNOSTIC STAT MANU; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; *BRAIN INJ RES CTR, FACT SHEET; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; CHAPMAN SB, 2007, BRAIN INJ PROF, V3, P10; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Davis AS, 2004, J SCHOOL PSYCHOL, V42, P87, DOI 10.1016/j.jsp.2003.11.001; Dise-Lewis JE, 2006, BRAINSTARS BRAIN INJ; DISELEWIS JE, 2003, BRAINSTARS BRAIN INJ; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Erikson E., 1964, CHILDHOOD SOC; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fischer K, 1994, HUMAN BEHAV DEV BRAI; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Gioia G. A., 2003, BEHAV RATING INVENTO; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Hardy P, 2002, DEV MED CHILD NEUROL, V44, P436; Hendryx P. M., 1995, J COGN REHABIL, V13, P9; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Lehr E, 1990, PSYCHOL MANAGEMENT T; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Piaget J., 1936, ORIGINS INTELLIGENCE; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; REICHARDT CS, 2004, HDB PRACTICAL PROGRA; REICHARDT CS, 2007, SCALE UP ED, V1; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; SAVAGE R, 1999, CHILDS BRAIN; Savage R. C., 1995, ED MANUAL; Shadish WR., 2002, EXPT QUASI EXPT DESI; SZEKERES S, 1985, HEAD INJURY REHABILI; *US DEP HHS, 2006, 04064 US DEP HHS HRS; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P99, DOI 10.1097/00001199-200603000-00003; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P97, DOI 10.1097/00001199-200603000-00001; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	47	16	16	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2009	24	3					166	177		10.1097/HTR.0b013e3181a7ecb0			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	448HD	WOS:000266252800003	19461364				2022-02-06	
J	Claro, R; Sousa, R; Massada, M; Ramos, J; Lourenco, JM				Claro, Rui; Sousa, Ricardo; Massada, Marta; Ramos, Joaquim; Lourenco, Jose M.			Bilateral posterior fracture-dislocation of the shoulder: Report of two cases	INTERNATIONAL JOURNAL OF SHOULDER SURGERY			English	Article						Convulsive seizure; electrocution; posterior fracture-dislocation shoulder	PROXIMAL HUMERAL FRACTURES; MCLAUGHLIN PROCEDURE; CLOSED REDUCTION; HEAD	Bilateral posterior fracture-dislocation of the shoulder is a very rare injury. Almost 50 of bilateral posterior dislocations are due to a convulsive seizure, rising to 90 if the dislocations are associated with fractures. Electric shock accounts for less than 5 of bilateral posterior dislocations of the shoulder. A systematization of the clinical and radiological approach, followed by an early diagnosis and proper surgical treatment is essential. Authors report 2 cases of bilateral posterior fracture-dislocation of the shoulder, one caused by a convulsive seizure and the other by an electric shock. A review of literature and a treatment protocol are also presented.	[Claro, Rui; Sousa, Ricardo; Massada, Marta; Ramos, Joaquim; Lourenco, Jose M.] Hosp Santo Antonio, Ctr Hosp Porto, Dept Orthopaed, P-4099001 Oporto, Portugal		Claro, R (corresponding author), Hosp Santo Antonio, Ctr Hosp Porto, Dept Orthopaed, P-4099001 Oporto, Portugal.	ruiclaromed@yahoo.com	Claro, Rui/AAC-9689-2021	Claro, Rui/0000-0003-4836-2994; Sousa, Ricardo/0000-0003-4293-7347			Alta TDW, 2008, EUR J ORTHOP SURG TR, V18, P381, DOI 10.1007/s00590-008-0316-7; BELL HM, 1965, J BONE JOINT SURG AM, VA 47, P1521, DOI 10.2106/00004623-196547080-00006; Brackstone M, 2001, NEUROLOGY, V56, P1403, DOI 10.1212/WNL.56.10.1403; Checchia SL, 1998, J SHOULDER ELB SURG, V7, P53, DOI 10.1016/S1058-2746(98)90183-5; Cheng SL, 1997, J SHOULDER ELB SURG, V6, P11, DOI 10.1016/S1058-2746(97)90065-3; Clough T M, 2001, Eur J Emerg Med, V8, P161; Connor PM, 1997, J SHOULDER ELB SURG, V6, P480, DOI 10.1016/S1058-2746(97)80002-X; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Cooke SJ, 2005, INJURY, V36, P90; Dervin GF, 2002, J BONE JOINT SURG AM, V84A, P804, DOI 10.2106/00004623-200205000-00018; DeWall M, 2005, J ORTHOP TRAUMA, V19, P48, DOI 10.1097/00005131-200501000-00009; Duparc F, 2001, SURG RADIOL ANAT, V23, P185, DOI 10.1007/s00276-001-0185-9; GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486, DOI 10.2106/00004623-199072100-00009; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P376, DOI 10.2106/00004623-199603000-00008; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; KARPINSKI MRK, 1984, INJURY, V15, P274, DOI 10.1016/0020-1383(84)90013-5; Martens C, 1995, Acta Orthop Belg, V61, P249; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; Neyton L, 2008, NICE SHOULDER COURSE, P227; NICOLA FG, 1981, J BONE JOINT SURG AM, V63, P1175, DOI 10.2106/00004623-198163070-00018; SHAW JL, 1971, J BONE JOINT SURG AM, VA 53, P1437, DOI 10.2106/00004623-197153070-00023; Sperling JW, 2004, J SHOULDER ELB SURG, V13, P522, DOI 10.1016/j.jse.2004.02.012; WADLINGTON VR, 1992, J TRAUMA, V32, P113, DOI 10.1097/00005373-199201000-00024; WALCH G, 1990, REV CHIR ORTHOP, V76, P546	27	16	20	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0973-6042			INT J SHOULDER SURG	Int. J. Shoulder Surg.	APR-JUN	2009	3	2					41	45		10.4103/0973-6042.57935			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	V28IA	WOS:000208673300005	20661400	Green Published			2022-02-06	
J	Richardson, RM; Varenika, V; Forsayeth, JR; Bankiewicz, KS				Richardson, R. M.; Varenika, V.; Forsayeth, J. R.; Bankiewicz, K. S.			Future Applications: Gene Therapy	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Gene therapy; Convection enhanced delivery; Restorative neurosurgery	CONVECTION-ENHANCED DELIVERY; PHASE-I TRIAL; PARKINSON-DISEASE; NEUROTROPHIC FACTOR; MONKEY BRAIN; OPEN-LABEL; SAFETY; TOLERABILITY; IMPROVEMENT; LIPOSOMES	Gene therapy for brain disorders is one of the most promising frontiers in the practice of restorative neurosurgery. There are significant experimental gene therapy initiatives underway that have led to currently active clinical trials using direct intracerebral delivery of viral vectors, and these treatments have been reported as safe and well tolerated. In the future, other clinical trials will likely use viral vectors to transfer genes that bestow on recipient tissue a desired enzymatic or neurotrophic activity relevant to the treatment of other neurodegenerative diseases, stroke, and traumatic brain injury.	[Richardson, R. M.; Varenika, V.; Forsayeth, J. R.; Bankiewicz, K. S.] Univ Calif San Francisco, Dept Neurol Surg, Lab Mol Therapeut, San Francisco, CA 94103 USA		Richardson, RM (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Lab Mol Therapeut, 1855 Folsom St,Room 226, San Francisco, CA 94103 USA.	richardsonma@neurosurg.ucsf.edu	Richardson, R Mark/C-6819-2016	Richardson, R Mark/0000-0003-2620-7387	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32 NS064692-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS064692] Funding Source: NIH RePORTER		Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Hadaczek P, 2006, HUM GENE THER, V17, P291, DOI 10.1089/hum.2006.17.291; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Krauze MT, 2005, BRAIN RES PROTOC, V16, P20, DOI 10.1016/j.brainresprot.2005.08.003; Krauze MT, 2005, EXP NEUROL, V196, P104, DOI 10.1016/j.expneurol.2005.07.009; Lonser RR, 2007, NEUROLOGY, V68, P254, DOI 10.1212/01.wnl.0000247744.10990.e6; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Richardson RM, 2008, NEUROSURGERY, V63, P629, DOI 10.1227/01.NEU.0000325491.89984.CE; Saito R, 2005, EXP NEUROL, V196, P381, DOI 10.1016/j.expneurol.2005.08.016; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Szerlip NJ, 2007, J NEUROSURG, V107, P560, DOI 10.3171/JNS-07/09/0560; VALLES F, NEUROIMAGE IN PRESS; Varenika V, 2008, J NEUROSURG, V109, P874, DOI 10.3171/JNS/2008/109/11/0874	16	16	16	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680			NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2009	20	2					219	+		10.1016/j.nec.2009.04.004			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	480HM	WOS:000268724500011	19555883	Green Accepted			2022-02-06	
J	Hu, K; Lo, MT; Peng, CK; Novak, V; Schmidt, EA; Kumar, A; Czosnyka, M				Hu, Kun; Lo, Men-Tzung; Peng, C. K.; Novak, Vera; Schmidt, Eric A.; Kumar, Ajay; Czosnyka, Marek			Nonlinear Pressure-Flow Relationship Is Able to Detect Asymmetry of Brain Blood Circulation Associated with Midline Shift	JOURNAL OF NEUROTRAUMA			English	Article						blood flow velocity; blood pressure oscillations; multimodal pressure flow analysis; traumatic brain injury	HEAD-INJURED PATIENTS; CEREBRAL AUTOREGULATION; TRANSCRANIAL DOPPLER; DIABETES-MELLITUS; VELOCITY; FLUCTUATIONS; ARTERIAL	Reliable and noninvasive assessment of cerebral blood flow regulation is a major challenge in acute care monitoring. This study assessed dynamics of flow regulation and its relationship to asymmetry of initial computed tomography (CT) scan using multimodal pressure flow (MMPF) analysis. Data of 27 patients (38 +/- 15 years old) with traumatic brain injury (TBI) were analyzed. Patients were selected from bigger cohort according to criteria of having midline shift on initial CT scan and intact skull (no craniotomy or bone flap). The MMPF analysis was used to extract the oscillations in cerebral perfusion pressure (CPP) and blood flow velocity (BFV) signals at frequency of artificial ventilation, and to calculate the instantaneous phase difference between CPP and BFV oscillations. Mean CPP-BFV phase difference was used to quantify pressure and flow relationship. The TBI subjects had smaller mean BP-BFV phase shifts (left, 8.7 +/- 9.6; right 10.2 +/- 8.3 MCAs, mean +/- SD) than values previously obtained in healthy subjects (left, 37.3 +/- 7.6 degrees; right, 38.0 +/- 8.9 degrees; p < 0.0001), suggesting impaired blood flow regulation after TBI. The difference in phase shift between CPP and BFV in the left and right side was strongly correlated to the midline shift (R = 0.78; p < 0.0001). These findings indicate that the MMPF method allows reliable assessment of alterations in pressure and flow relationship after TBI. Moreover, mean pressure-flow phase shift is sensitive to the displacement of midline of the brain, and may potentially serve as a marker of asymmetry of cerebral autoregulation.	[Hu, Kun; Lo, Men-Tzung; Novak, Vera] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Chungli 32054, Taiwan; [Peng, C. K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Peng, C. K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Margret & HA Rey Inst Nonlinear Dynam Med, Boston, MA 02215 USA; [Schmidt, Eric A.] Hop Pourpan, Dept Neurosurg, Toulouse, France; [Czosnyka, Marek] Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge, England		Hu, K (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol, 330 Brookline Ave,Stoneman 812, Boston, MA 02215 USA.	khu@bidmc.harvard.edu	Peng, Chung-Kang/N-1308-2019; huang, yuting/T-4341-2019; Peng, Chung-Kang/E-1489-2011; Hu, Kun/AAJ-1897-2020	Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833; Hu, Kun/0000-0003-0350-3132	NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS045745]; NIH-NINDS STTRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R41NS053128-01A2]; NIH Older American Independence CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2P60 AG08812]; General Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [MO1-RR01302]; James S. McDonnell Foundation; Ellison Medical Foundation Senior Scholar in Aging AwardLawrence Ellison Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01EB008577]; MRC, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, ID 65883]; NSC Taiwan, ROCMinistry of Science and Technology, Taiwan [97-2627-B-008-006]; CGH [CNJRF-96CGH-NCU-A3]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G0001237, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U01EB008577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045745, R41NS053128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P60AG008812] Funding Source: NIH RePORTER	This study was supported by NIH-NINDS (R01-NS045745 to V.N.), NIH-NINDS STTR (grant 1R41NS053128-01A2 to V.N. in collaboration with DynaDx, Inc.), NIH Older American Independence Center (grant 2P60 AG08812), and General Clinical Research Center (GCRC; grant MO1-RR01302). C. K. P. was supported by the James S. McDonnell Foundation, the Ellison Medical Foundation Senior Scholar in Aging Award, the G. Harold and Leila Y. Mathers Charitable Foundation, the Defense Advanced Research Projects Agency, and the NIH grant U01EB008577). M. C. was supported by MRC, UK (grant G9439390, ID 65883). M. L. was supported by NSC Taiwan, ROC (Grant 97-2627-B-008-006), and joint foundation of CGH and NCU (Grant CNJRF-96CGH-NCU-A3). We especially thank Chris Peng who helped with data pre-processing and analysis.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Asil T, 2007, CLIN NEUROL NEUROSUR, V109, P1, DOI 10.1016/j.clineuro.2006.03.010; Chen Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031915; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; ENEVOLDSEN EM, 1977, ACTA NEUROL SCAND, V56, P514; Gabor D., 1946, Journal of the Institution of Electrical Engineers. III. Radio and Communication Engineering, V93, P429; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Hu K, 2008, PHYSICA A, V387, P2279, DOI 10.1016/j.physa.2007.11.052; Huang W, 1998, P NATL ACAD SCI USA, V95, P4816, DOI 10.1073/pnas.95.9.4816; JENNETT B, 1975, LANCET, V1, P480; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; Lo MT, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/785243; Novak V, 1998, STROKE, V29, P1876, DOI 10.1161/01.STR.29.9.1876; Novak V, 2003, NEUROLOGY, V60, P1657, DOI 10.1212/01.WNL.0000068023.14587.06; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; ZWEIG MH, 1993, CLIN CHEM, V39, P561	26	16	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2009	26	2					227	233		10.1089/neu.2008.0643			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	410NS	WOS:000263585100005	19196074	Green Published, Green Accepted			2022-02-06	
J	Palchak, MJ; Holmes, JF; Kuppermann, N				Palchak, Michael J.; Holmes, James F.; Kuppermann, Nathan			Clinician Judgment Versus a Decision Rule for Identifying Children at Risk of Traumatic Brain Injury on Computed Tomography After Blunt Head Trauma	PEDIATRIC EMERGENCY CARE			English	Article; Proceedings Paper	Annual Meeting of the Pediatric-Academic-Societies	MAY 01-04, 2004	San Francisco, CA	Pediat Acad Soc		head trauma; decision making	EMERGENCY PHYSICIANS; CANCER-RISKS; MANAGEMENT; RADIATION	Objective: To compare a decision rule with clinician judgment for identifying children at risk of traumatic brain injury (TBI) after blunt head trauma. Methods: We performed an observational study of children with blunt head trauma. Emergency department physicians documented suspicion for TBI before cranial computed tomography (CT), rating suspicion as very low, low, intermediate, or high. Our outcome variable was TBI on CT We compared clinician judgment (very low vs. higher suspicion) for TBI on CT with a decision rule derived from the same database. Results: Of 1865 children enrolled for whom physician suspicion was recorded, 1168 (62.6%) underwent CT and comprised the study Population. Eighty-nine (7.6%; 95% confidence interval [CI], 6.2% to 9.3%) of the 1168 had TBIs on CT. The decision rule had a sensitivity of 88 (98.9%) of 89 versus 84 (94.4%) of 89 for clinician judgment (difference, 4.5%; 95% CI, -0.9% to 9.9%). The specificity of the decision rule was 288 (26.7%) of 1079 versus 329 (30.5%) 1079 for clinician judgment (difference, 3.8%; 95% Cl, 0.5% to 7.1%). Application of the decision rule to the study population would have resulted in 289 (24.7%) fewer CT scans, although missing I child with a TBI (who was discharged home from the emergency department). Conclusions: A decision rule trended toward greater sensitivity than clinician judgment for identifying children with TBI on CT after blunt head trauma but was less specific. Because decisions to order cranial CT did not strictly follow clinician judgment, however, use of the decision rule would have resulted in less frequent use of CT.	[Kuppermann, Nathan] Univ Calif Davis, Med Ctr, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA; Univ Calif Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA		Kuppermann, N (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, PSSB 2110,2315 Stockton Blvd, Sacramento, CA 95817 USA.	nkuppermann@ucdavis.edu					Aitken ME, 1998, ARCH PEDIAT ADOL MED, V152, P1176; Bandiera G, 2003, ANN EMERG MED, V42, P395, DOI 10.1016/S0196-0644(03)00422-0; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; LANDIS JR, 1977, BIOMETRICS, V33, P174; *NAT CTR HLTH STAT, 2006, TRAUM BRAIN INJ US E; National Center for Injury Prevention and Control, 2002, TRAUM BRAIN INJ US A; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983	16	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	FEB	2009	25	2					61	65		10.1097/PEC.0b013e318196e9c0			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine; Pediatrics	408PA	WOS:000263445800001	19194349				2022-02-06	
J	Wostyn, P; Audenaert, K; De Deyn, PP				Wostyn, Peter; Audenaert, Kurt; De Deyn, Peter Paul			The Valsalva Maneuver and Alzheimer's Disease: Is there a link?	CURRENT ALZHEIMER RESEARCH			English	Article						Valsalva maneuver; Alzheimer's disease; Intracranial pressure; Intraocular pressure; Mechanical load; Hippocampus; Choroid plexus; Cerebral blood flow	NORMAL-PRESSURE HYDROCEPHALUS; CEREBROSPINAL-FLUID PRODUCTION; TRANSIENT GLOBAL AMNESIA; AMYLOID PRECURSOR PROTEIN; HIPPOCAMPAL-NEURONS; CHOROID-PLEXUS; NA-K-2CL COTRANSPORTER; INTRAOCULAR-PRESSURE; MECHANICAL STRETCH; CASPASE ACTIVATION	Recent research findings provide evidence for Alzheimer's disease-related changes in brain diseases, such as normal pressure hydrocephalus and traumatic brain injury, and in glaucoma at the level of the retinal ganglion cells. This is a group of diseases that affect central nervous system tissue and are characterized by elevation of intracranial or intraocular pressure and/or local shear stress and strain. This strengthens the possibility that Alzheimer-type changes in these diseases may result at least in part from exposure of central nervous system tissue to elevated mechanical load. As activities or diseases with significant Valsalva effort can generate increased intracranial pressures, we hypothesize that individuals who frequently perform strong Valsalva maneuvers (e. g., long hours of repetitive heavy lifting, sequences of blows during the playing of a wind instrument, forceful and repetitive cough, bearing-down efforts during parturition) may be more susceptible to developing Alzheimer's disease. In this paper, we discuss three hypotheses about the mechanisms by which extensive use of the Valsalva maneuver might contribute to the neuropathogenesis of Alzheimer's disease: via mechanical stress-induced events in the hippocampus and/or via changes in the secretory process of the choroid plexus and/or via hemodynamic changes in cerebral blood flow. If confirmed, this hypothesis could have implications in clinical practice.	[Wostyn, Peter] PC Sint Amandus, Dept Psychiat, B-8730 Beemem, Belgium; [Audenaert, Kurt] Ghent Univ Hosp, Dept Psychiat, B-9000 Ghent, Belgium; [De Deyn, Peter Paul] Middelheim Gen Hosp ZNA, Dept Neurol & Memory Clin, B-2020 Antwerp, Belgium; [De Deyn, Peter Paul] Univ Antwerp, Inst Born Bunge, Lab Neurochem & Behav, B-2610 Antwerp, Belgium		Wostyn, P (corresponding author), PC Sint Amandus, Dept Psychiat, Reigerlostr 10, B-8730 Beemem, Belgium.	wostyn.peter@skynet.be					ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; ATTUBATO MJ, 1994, AM J CARDIOL, V74, P408, DOI 10.1016/0002-9149(94)90417-0; Bech RA, 1999, ACTA NEUROCHIR, V141, P633, DOI 10.1007/s007010050353; BEERI MS, 2007, NEUROBIOL A IN PRESS; Bejvan SM, 1996, AM J ROENTGENOL, V166, P1041, DOI 10.2214/ajr.166.5.8615238; BORGIA JF, 1975, J OCCUP ENVIRON MED, V17, P696; Boycott HE, 2007, BIOCHEM BIOPH RES CO, V364, P100, DOI 10.1016/j.bbrc.2007.09.102; Bret P, 2002, J NEUROL NEUROSUR PS, V73, P9, DOI 10.1136/jnnp.73.1.9; Bullock R, 2003, ALZ DIS ASSOC DIS, V17, pS80, DOI 10.1097/00002093-200307003-00004; Calandre L, 1996, HEADACHE, V36, P251, DOI 10.1046/j.1526-4610.1996.3604251.x; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; COMPTON D, 1973, LANCET, V2, P1234; Cotman CW, 2005, J NEUROPATH EXP NEUR, V64, P104, DOI 10.1093/jnen/64.2.104; Czosnyka M, 2003, J NEUROSURG, V99, P206; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; de la Torre JC, 2000, ANN NY ACAD SCI, V924, P136; de Quervain DJF, 2004, HUM MOL GENET, V13, P47, DOI 10.1093/hmg/ddg361; Edwards ME, 2001, BIOTECHNOL PROGR, V17, P760, DOI 10.1021/bp010040m; Ertl-Wagner BB, 2001, EUR RADIOL, V11, P1998, DOI 10.1007/s003300100941; Fasulo L, 2000, J NEUROCHEM, V75, P624, DOI 10.1046/j.1471-4159.2000.0750624.x; Fletcher NH, 1999, J ACOUST SOC AM, V105, P874, DOI 10.1121/1.426276; Fritsch-Yelle JM, 1999, J APPL PHYSIOL, V86, P1852, DOI 10.1152/jappl.1999.86.6.1852; Gastard MC, 2003, ANN NEUROL, V54, P393, DOI 10.1002/ana.10680; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Golomb J, 2000, J NEUROL NEUROSUR PS, V68, P778, DOI 10.1136/jnnp.68.6.778; Grant WB, 2002, J ALZHEIMERS DIS, V4, P179, DOI 10.3233/JAD-2002-4308; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; HOCHWALD GM, 1969, EXP NEUROL, V25, P190, DOI 10.1016/0014-4886(69)90043-0; Jiang G, 2004, AM J PHYSIOL-HEART C, V286, pH1552, DOI 10.1152/ajpheart.00695.2003; Johanson CE, 2002, EUR J PEDIATR SURG, V12, pS47; Johanson Conrad, 2004, Cerebrospinal Fluid Res, V1, P3, DOI 10.1186/1743-8454-1-3; JOHNSON RT, 1968, J NEUROPATH EXP NEUR, V27, P591; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kahlon B, 2002, J NEUROL NEUROSUR PS, V73, P721, DOI 10.1136/jnnp.73.6.721; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kizu O, 2001, AM J NEURORADIOL, V22, P1659; Klotzsch C, 1996, ARCH NEUROL-CHICAGO, V53, P504, DOI 10.1001/archneur.1996.00550060046014; KNUCKEY NW, 1993, BRAIN RES, V618, P313, DOI 10.1016/0006-8993(93)91282-W; Laakso MP, 1998, NEUROBIOL AGING, V19, P23, DOI 10.1016/S0197-4580(98)00006-2; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Levine DN, 1999, B MATH BIOL, V61, P875, DOI 10.1006/bulm.1999.0116; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; MATTLE HP, 1995, NEUROLOGY, V45, P498, DOI 10.1212/WNL.45.3.498; MAY C, 1990, NEUROLOGY, V40, P500, DOI 10.1212/WNL.40.3_Part_1.500; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Mehta NR, 2000, AM J ROENTGENOL, V175, P221, DOI 10.2214/ajr.175.1.1750221; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nedelmann M, 2005, J NEUROL, V252, P1482, DOI 10.1007/s00415-005-0894-9; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; PORTH CJM, 1984, HEART LUNG, V13, P507; Pott F, 2000, J APPL PHYSIOL, V88, P1545, DOI 10.1152/jappl.2000.88.5.1545; Robertson NP, 1999, J NEUROL NEUROSUR PS, V66, P111, DOI 10.1136/jnnp.66.1.111; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Sander D, 2000, LANCET, V356, P1982, DOI 10.1016/S0140-6736(00)03313-4; Sander K, 2005, LANCET NEUROL, V4, P437, DOI 10.1016/S1474-4422(05)70121-6; Savolainen S, 1999, ACTA NEUROCHIR, V141, P849, DOI 10.1007/s007010050386; Sbeity ZH, 2004, GRAEF ARCH CLIN EXP, V242, P428, DOI 10.1007/s00417-003-0848-9; Schuman JS, 2000, OPHTHALMOLOGY, V107, P127, DOI 10.1016/S0161-6420(99)00015-9; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Shimohama S, 2000, APOPTOSIS, V5, P9, DOI 10.1023/A:1009625323388; Silverberg GD, 2004, BRAIN, V127, P947, DOI 10.1093/brain/awh178; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Silverberg GD, 2002, J NEUROSURG, V97, P1271, DOI 10.3171/jns.2002.97.6.1271; Silverberg GD, 2002, NEUROLOGY, V59, P1139, DOI 10.1212/01.WNL.0000031794.42077.A1; Silverberg GD, 2001, NEUROLOGY, V57, P1763, DOI 10.1212/WNL.57.10.1763; Silverberg Gerald D, 2004, Expert Rev Neurother, V4, P97, DOI 10.1586/14737175.4.1.97; SIMONEAUX SF, 1990, AM J SPORT MED, V18, P647, DOI 10.1177/036354659001800617; Singer W, 2001, CLIN SCI, V100, P433, DOI 10.1042/CS20000208; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; TIECKS FP, 1995, STROKE, V26, P1386, DOI 10.1161/01.STR.26.8.1386; Triyoso DH, 1999, J PHYSIOL-LONDON, V515, P355, DOI 10.1111/j.1469-7793.1999.355ac.x; UMEMURA A, 1992, STROKE, V23, P1163, DOI 10.1161/01.STR.23.8.1163; van Alem AP, 2001, CATHETER CARDIO INTE, V52, P110, DOI 10.1002/1522-726X(200101)52:1<110::AID-CCD1027>3.0.CO;2-Z; van Lieshout JJ, 2003, J APPL PHYSIOL, V94, P833, DOI 10.1152/japplphysiol.00260.2002; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; WILLIAMS B, 1981, ACTA NEUROCHIR, V58, P167, DOI 10.1007/BF01407124; Wostyn P, 2008, CLIN NEUROL NEUROSUR, V110, P101, DOI 10.1016/j.clineuro.2007.10.011; Zhang R, 2004, STROKE, V35, P843, DOI 10.1161/01.STR.0000120309.84666.AE; Zhao M, 2003, NEUROBIOL DIS, V14, P391, DOI 10.1016/j.nbd.2003.07.006	95	16	17	0	7	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050			CURR ALZHEIMER RES	Curr. Alzheimer Res.	FEB	2009	6	1					59	68		10.2174/156720509787313943			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	406HT	WOS:000263286300008	19199876				2022-02-06	
J	Ichihara, K; Venkatasubramanian, G; Abbas, JJ; Jung, R				Ichihara, Kazuhiko; Venkatasubramanian, Ganapriya; Abbas, James J.; Jung, Ranu			Neuromuscular electrical stimulation of the hindlimb muscles for movement therapy in a rodent model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Isometric joint torque; Muscle recruitment and strength duration curves; Intramuscular electrodes; Joint angle measurements; Rehabilitation; Hindlimb	SPINAL-CORD-INJURY; WALKING ABILITY; LOCOMOTION; REGENERATION; RECRUITMENT; PROMOTES; RECOVERY; EXERCISE; LIMBS; SCI	Neuromuscular electrical stimulation (NMES) can provide functional movements in people after central nervous system injury. The neuroplastic effects of long-term NMES-induced repetitive limb movement are not well understood. A rodent model of neurotrauma in which NMES can be implemented may be effective for such investigations. We present a rodent model for NMES of the flexor and extensor muscles of the hip, knee, and ankle hindlimb muscles. Custom fabricated intramuscular stimulating electrodes for rodents were implanted near identified motor points of targeted muscles in ten adult, female Long Evans rats. The effects of altering NMES pulse stimulation parameters were characterized using strength duration curves, isometric joint torque recruitment curves and joint angle measures. The data indicate that short pulse widths have the advantage of producing graded torque recruitment curves when current is used as the control parameter. A stimulus frequency of 75 Hz or more produces fused contractions. The data demonstrate ability to accurately implant the electrodes and obtain selective, graded, repeatable, strong muscle contractions. Knee and ankle angular excursions comparable to those obtained in normal treadmill walking in the same rodent species can be obtained by stimulating the target muscles. joint torques (normalized to body weight) obtained were larger than those reported in the literature for small tailed therian mammals and for peak isometric ankle plantarflexion in a different rodent species. This model system could be used for investigations of NMES assisted hindlimb movement therapy. (C) 2008 Elsevier B.V. All rights reserved.	[Ichihara, Kazuhiko; Venkatasubramanian, Ganapriya; Abbas, James J.; Jung, Ranu] Ctr Adapt Neural Syst, Tempe, AZ 85287 USA; [Venkatasubramanian, Ganapriya; Abbas, James J.; Jung, Ranu] Harrington Dept Bioengn, Tempe, AZ 85287 USA; [Abbas, James J.] Banner Good Samaritan Med Ctr, Phoenix, AZ 85006 USA		Jung, R (corresponding author), Arizona State Univ, POB 874404, Tempe, AZ 85287 USA.	blomechi@yamaguchi-u.ac.jp; ganapriya@gmail.com; james.abbas@asu.edu; ranu.jung@asu.edu	Jung, Ranu/AAA-5112-2019	Jung, Ranu/0000-0003-2042-0638; Abbas, James/0000-0002-3647-7041	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HD40335]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD040335] Funding Source: NIH RePORTER	We thank Alana Labelle and Elizabeth Ashton for assistance with data collection and analysis. This work was supported by a grant from the National Institutes of Health R01-HD40335.	Al-Majed AA, 2004, CELL MOL NEUROBIOL, V24, P379, DOI 10.1023/B:CEMN.0000022770.66463.f7; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Bajd T, 1999, ARTIF ORGANS, V23, P403, DOI 10.1046/j.1525-1594.1999.06360.x; Barbeau H, 2002, BRAIN RES REV, V40, P274, DOI 10.1016/S0165-0173(02)00210-2; Beaumont E, 2004, MUSCLE NERVE, V29, P234, DOI 10.1002/mus.10539; Burke R.E., 1981, COMPR PHYSIOL, V1981, P345, DOI [DOI 10.1002/CPHY.CP010210, 10.1002/cphy.cp010210]; Colombo G, 2000, J REHABIL RES DEV, V37, P693; CRAGO PE, 1974, ANN BIOMED ENG, V2, P252, DOI 10.1007/BF02368496; *CTR NSCIS, 2006, 2006 ANN STAT REP MO; Daly JJ, 2006, STROKE, V37, P172, DOI 10.1161/01.STR.0000195129.95220.77; DURFEE WK, 1989, IEEE T BIO-MED ENG, V36, P654, DOI 10.1109/10.32097; Ettema GJC, 1997, ANAT REC, V247, P1, DOI 10.1002/(SICI)1097-0185(199701)247:1<1::AID-AR1>3.0.CO;2-3; Field-Fote EC, 2001, ARCH PHYS MED REHAB, V82, P818, DOI 10.1053/apmr.2001.23752; Gazula VR, 2004, J COMP NEUROL, V476, P130, DOI 10.1002/cne.20204; Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040; Gorassini M, 2000, J NEUROPHYSIOL, V83, P2002, DOI 10.1152/jn.2000.83.4.2002; Gramsbergen A, 1996, EXP NEUROL, V137, P34, DOI 10.1006/exnr.1996.0004; Greene E.C., 1955, ANATOMY RAT; Grill W M Jr, 1996, IEEE Trans Rehabil Eng, V4, P49, DOI 10.1109/86.506402; GRILL WM, 2004, NEUROPROSTHETICS THE, P319; GRUNER J A, 1989, Journal of Rehabilitation Research and Development, V26, P1; Hesse S, 2004, SPINAL CORD, V42, P346, DOI 10.1038/sj.sc.3101595; Hicks AL, 2005, SPINAL CORD, V43, P291, DOI 10.1038/sj.sc.3101710; JUNG R, 2006, 11 ANN C INT FUNCT E, P118; Kanchiku T, 2008, J NEUROSCI METH, V167, P317, DOI 10.1016/j.jneumeth.2007.08.002; Kim SJ, 2007, J NEUROTRAUM, V24, P1288; LAN N, 1992, J BIOMECH, V25, P1075, DOI 10.1016/0021-9290(92)90043-Z; Lynskey JV, 2008, J REHABIL RES DEV, V45, P229, DOI 10.1682/JRRD.2007.03.0047; MARTIN TP, 1992, J APPL PHYSIOL, V72, P1401, DOI 10.1152/jappl.1992.72.4.1401; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Mohr T, 1997, CALCIFIED TISSUE INT, V61, P22, DOI 10.1007/s002239900286; MUIR GD, 1995, J NEUROPHYSIOL, V74, P358, DOI 10.1152/jn.1995.74.1.358; Mushahwar VK, 2000, IEEE T REHABIL ENG, V8, P11, DOI 10.1109/86.830944; NANNINI N, 1991, IEEE T BIO-MED ENG, V38, P769, DOI 10.1109/10.83589; Nash MS, 1997, ARCH PHYS MED REHAB, V78, P808, DOI 10.1016/S0003-9993(97)90192-1; Popovic MR, 2006, SPINAL CORD, V44, P143, DOI 10.1038/sj.sc.3101822; Riess J, 2001, IEEE T NEUR SYS REH, V9, P326, DOI 10.1109/7333.948462; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thota AK, 2005, J NEUROTRAUM, V22, P442, DOI 10.1089/neu.2005.22.442; VENKATASUBRAMAN.G, 2006, FUNCTIONAL ELECT STI; Venkatasubramanian G, 2005, J NEUROTRAUM, V22, P1241; Warren GL, 2004, EUR J APPL PHYSIOL, V93, P130, DOI 10.1007/s00421-004-1185-3; Witte H, 2002, J EXP BIOL, V205, P1339; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85, DOI 10.1152/jn.1965.28.1.85	46	16	16	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 30	2009	176	2					213	224		10.1016/j.jneumeth.2008.09.015			12	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	398UX	WOS:000262758100023	18848960	Green Accepted			2022-02-06	
J	Anderson, SW; Wisnowski, JL; Barrash, J; Damasio, H; Tranel, D				Anderson, Steven W.; Wisnowski, Jessica L.; Barrash, Joe; Damasio, Hanna; Tranel, Daniel			Consistency of neuropsychological outcome following damage to prefrontal cortex in the first years of life	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Prefrontal; Lesion; Development; Social; History	TRAUMATIC BRAIN-INJURY; BEHAVIOR; CHILDREN; LESIONS; PREDICTORS	The consistency of neuropsychological outcome following circumscribed damage to the prefrontal cortex (PFC) in the first years of life has not been systematically investigated. On the basis of a single well-studied case, Ackerly and Benton (1948) postulated that the core profile involves development of a primary social defect in the context of generally normal intellectual abilities. We evaluated the consistency of this profile across all patients in our registry who had focal PFC damage acquired between the prenatal period and 62 months of age (N = 7). Clinical ratings based on detailed evaluations, parental ratings, and neuropsychological testing confirmed this general profile in 5 of the 7 patients. The impairments of social function were evident in early childhood and persisted into adult life. Of the 2 patients who did not fit this profile, 1 had significant social impairment in the context of broader cognitive deficits, and 1 had no significant impairment of social or intellectual function. The profile was not observed in a comparison group with childhood-onset nonfrontal lesions. These findings support the notion that focal damage to PFC in the first years of life leads to the development of substantial impairment of social competencies, albeit with some variability in outcome. Further, the findings highlight the importance of emotional dysfunction and poor behavior regulation in the development of these impairments. Our studies recapitulate and confirm the core messages set forth by Ackerly and Benton more than a half-century ago.	[Anderson, Steven W.; Barrash, Joe; Damasio, Hanna; Tranel, Daniel] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA USA; [Wisnowski, Jessica L.; Damasio, Hanna] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Wisnowski, Jessica L.; Damasio, Hanna] Univ So Calif, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA USA		Anderson, SW (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Benton Neuropsychol Lab, Iowa City, IA 52242 USA.	steven-anderson@uiowa.edu		Barrash, Joseph/0000-0001-9827-0110; Anderson, Steven/0000-0002-7364-1680; Tranel, Daniel/0000-0002-1338-1389	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P019632]; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA022549]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA022549] Funding Source: NIH RePORTER	Supported by National Institute of Neurological Disorders and Stroke (NINDS) P019632 and National Institute on Drug Abuse (NIDA) R01 DA022549.	ACKERLY SS, 1947, RES PUBL ASSOC RES N, V27, P479; ACKERLY SS, 1964, FRONTAL GRANULAR COR; Anderson SW, 2007, CORTEX, V43, P806, DOI 10.1016/S0010-9452(08)70508-2; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643	15	16	18	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	2					170	179	PII 906311719	10.1080/13803390802360526			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	397FG	WOS:000262647600004	19051128	Green Accepted			2022-02-06	
J	Dressler, D; Pils, P				Dressler, Dominique; Pils, Peter			A qualitative study on cross-cultural communication in post-accident in-patient rehabilitation of migrant and ethnic minority patients in Austria	DISABILITY AND REHABILITATION			English	Article; Proceedings Paper	International Conference on Toward Culturally Responsive Disability Services	OCT, 2008	Niagara Fall, NY	Natl Inst Disabil & Rehabil Res, US Dept Educ		Post-accident rehabilitation; migrant; ethnic minority; cross-cultural communication; language; culture; Austria	TRAUMATIC BRAIN-INJURY; HEALTH-CARE	Purpose. The objective of this study was to examine how the staff of a post-accident in-patient rehabilitation centre in Austria perceived cross-cultural communication between the staff and migrant and ethnic minority patients. Methods. A qualitative study was conducted with 28 semi-structured expert interviews with staff members in a post-accident in-patient rehabilitation centre in Austria. The interviews were conducted along the pathway of rehabilitation. Results. Migrant and ethnic minority patients constitute about one-third of the patients, and often speak little or no German. Staff members (apart from those with migrant/ethnic minority origin) do not speak the languages of the majority of migrant and ethnic minority patients. The language barriers affect the whole rehabilitation process. The staff is unsure whether patients understand; it is difficult to explain the aim of therapies or rehabilitation, and therapies therefore hampered or impossible. To overcome these barriers, non-trained persons are used as interpreters, but the resulting communication is often perceived as unsatisfactory. External professional interpreters are used rarely because they are costly and difficult to organise. Cultural aspects also affect cross-cultural communication. Aspects mostly relating to daily life are dealt with in a pragmatic way. However, cultural aspects directly impacting rehabilitation, and particularly pain behaviour, are seen as more difficult to deal with. Conclusions. Effective and intensive communication between the individual patient and the rehabilitation team is essential for the outcome of rehabilitation, as patients must undertake their own rehabilitation and the rehabilitation team must be able to investigate the objectives, views and dreams of the individual patient to establish rehabilitation objectives in keeping with the patient's wishes.	[Dressler, Dominique] Austrian Workers Compensat Board AUVA, Dept Int Relat, A-1200 Vienna, Austria		Dressler, D (corresponding author), Austrian Workers Compensat Board AUVA, Dept Int Relat, Adalbert Stifter Str 65, A-1200 Vienna, Austria.	dominique.dressler@auva.at					*ALLG UNF, WE CAR YOUR SAF; Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8; [Anonymous], AMSTERDAM DECLARATIO; *AUSTR MUS SOC EC, 2008, WELL INS SOC SEC AUS; Bischoff A., 2003, CARING MIGRANT MINOR; Bogner Alexander, 2005, EXPERTENINTERVIEW TH, P33; BOLLPALIEVSKAYA D, 2005, DTSCH ARZTEBLATT, V102; Borbasi S, 2008, DISABIL REHABIL, V30, P837, DOI 10.1080/09638280701419359; BORDE T, THESIS TU BERLIN; Bowen S., 2001, LANGUAGE BARRIERS AC; BRUNS M, 2004, ERGOTHERAPIE REHABIL, V8, P6; *BUND GES FRAU, 2005, INT KOMP GES; *COLL NURS ONT, 2005, CULT SENS CAR; *COUNC EUR REC, 2006, 18 COMM MIN MEMB STA; CRABTREE JL, 2006, CULTURE REHABILITATI, P1; *CROSS CULT HLTH C, MOD INT SERV; CSITKOVICS M, 1997, GESUNDHEITLICHE SITU; DOWNING B, 2002, MODELS PROVISION LAN; Dreiig V, 2005, INTERKULTURELLE KOMM; EICHBAUER H, 2004, GELEBTE INTEGRATION; Elderkin-Thompson V, 2001, SOC SCI MED, V52, P1343, DOI 10.1016/S0277-9536(00)00234-3; ELLIOT T, 2000, PHYS MED REHABILITAT, P1820; Esser H., 2006, SPRACHE INTEGRATION; Groce NE., 1999, CROSS CULTURAL REHAB, P37; Helman C., 1986, CULTURE HLTH ILLNESS; *INT FRAU DSCH, MARH MUSL UNS SPIT; JACOBS B, 1995, J ROY SOC MED, V88, P474; JENNINGS B, 1993, AM J PHYS MED REHABI, V72, P25; Juckett G, 2005, AM FAM PHYSICIAN, V72, P2267; KELLY N, 2007, ATA CHRONICLE, V6, P18; KENTENICH H, 2001, MIGRATION GESUNDHEIT, P121; KOHNEN N, 2003, SCHMERZLICHKEIT SCHM; KREPLER R, 2002, RECHT KRANKENHAUSALL; Kvaren C, 2004, ADV PHYSIOTHER, V6, P2; Mead H, 2008, RACIAL ETHNIC DISPAR; Meuser M., 2005, EXPERTENINTERVIEW TH, P257; Meuser M., 2005, EXPERTENINTERVIEW TH, P71; Moffett Jennifer A. Klaber, 1997, Physiotherapy Theory and Practice, V13, P89; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Niemeier JP, 2003, ARCH PHYS MED REHAB, V84, P1240, DOI 10.1016/S0003-9993(03)00295-8; Normann T, 2004, HOLISTIC APPROACH RE; POCHHACKER F, 1997, KOMMUNIKATION NICHTD; POCHHACKER F, 1999, TRANSLATOR, V5, P161, DOI DOI 10.1080/13556509.1999; Saladin P, 2006, DIVERSITAT CHANCENGL; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; SMART J, 1995, J REHABIL, P14; USKE H, 2001, RISIKO MIGRA TION KR; Wimmer B, 2001, WIEN KLIN WOCHENSCHR, V113, P616; Yildrim-Fahlbusch Y, 2003, DTSCH ARZTEBLATT, V5, P213; 2007, MAGISTRAT STADT WIEN	50	16	16	0	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2009	31	14					1181	1190		10.1080/09638280902773786			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Rehabilitation	473MV	WOS:000268212000009	19479576				2022-02-06	
J	Johnstone, B; Yoon, DP; Rupright, J; Reid-Arndt, S				Johnstone, Brick; Yoon, Dong Pil; Rupright, Jon; Reid-Arndt, Stephanie			Relationships among spiritual beliefs, religious practises, congregational support and health for individuals with traumatic brain injury	BRAIN INJURY			English	Article						Religion; spirituality; rehabilitation; traumatic brain injury; Brief Multidimensional Measure of Religiousness; Spirituality	QUALITY-OF-LIFE; MEDICAL REHABILITATION; OUTCOMES; FORGIVENESS; PREDICTORS; PAIN	Objective: To determine relationships among spiritual beliefs, religious practises, congregational support and health for individuals with traumatic brain injury (TBI). Design: A cross-sectional analysis of 61 individuals with TBI evaluated in an outpatient clinic using the Brief Multidimensional Measure of Religiousness/Spirituality (BMMRS) and the Medical Outcomes Scale-Short Form 36 (SF-36). Results: For persons with TBI the BMMRS Meaning and Values/Beliefs sub-scales were significantly correlated with the SF-36 General Health Perception sub-scale and the BMMRS Religious Support sub-scale was significantly correlated with the SF-36 General Mental Health sub-scale. Hierarchical regressions indicated that the BMMRS Values/Beliefs and Forgiveness sub-scales accounted for 16% additional variance in SF-36 General Health Perception scores beyond that accounted for by demographic variables (i.e. age, income); no BMMRS sub-scales accounted for additional variance in predicting the SF-36 General Mental Health sub-scale beyond that accounted for by demographic variables (i.e. age, income). Conclusions: The physical health of individuals with TBI is associated with spiritual beliefs but not religious practises or congregational support. Better mental health is associated with increasing congregationally based social support for persons with TBI. Religious practises (i.e. praying, etc.) are not related to either physical or mental health, as some persons with TBI may increase prayer with declining health status.	[Johnstone, Brick; Reid-Arndt, Stephanie] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO 65212 USA; [Rupright, Jon] Univ Missouri, Dept Phys Med & Rehabil, Columbia, MO 65212 USA		Johnstone, B (corresponding author), Univ Missouri, Dept Hlth Psychol, DC116-88, Columbia, MO 65212 USA.	johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649	Centre on Religion; Professions at the University of Missouri; Pew Charitable Trusts	This article was supported with funding from the Centre on Religion and the Professions at the University of Missouri, funded by the Pew Charitable Trusts.	Baskin TW, 2004, J COUNS DEV, V82, P79, DOI 10.1002/j.1556-6678.2004.tb00288.x; Brant C.R., 1998, HDB RELIG MENTAL HLT, P111, DOI [10.1016/B978-012417645-4/50075-4, DOI 10.1016/B978-012417645-4/50075-4]; Carson JW, 2005, J PAIN, V6, P84, DOI 10.1016/j.jpain.2004.10.012; Cigrang JA, 2003, J CLIN PSYCHOL MED S, V10, P133, DOI 10.1023/A:1025494309495; COHEN S, 2002, LINK RELIG HLTH PSYC, P101; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333; Forchheimer M, 2004, AM J PHYS MED REHAB, V83, P390, DOI 10.1097/01.PHM.0000124441.78275.C9; Glass B, 2007, J RELIG DISABILITY H, V11, P65, DOI DOI 10.1300/J095V11N03_06; Haley KC, 2001, J RELIG HEALTH, V40, P305, DOI 10.1023/A:1012561909054; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Idler EL, 1997, J GERONTOL B-PSYCHOL, V52, pS306, DOI 10.1093/geronb/52B.6.S306; JOHNSTONE B, J RELIG HLT IN PRESS; Johnstone B, 2007, DISABIL REHABIL, V29, P1153, DOI 10.1080/09638280600955693; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kilpatrick SD, 1999, REHABIL PSYCHOL, V44, P388, DOI 10.1037/0090-5550.44.4.388; Kim J, 2000, REHABIL PSYCHOL, V45, P365, DOI 10.1037/0090-5550.45.4.365; Knight JR, 2007, SOUTH MED J, V100, P349, DOI 10.1097/SMJ.0b013e3180316a32; Koenig HaroldG., 2001, HDB RELIG HLTH; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; McCullough ME, 2001, CURR DIR PSYCHOL SCI, V10, P194, DOI 10.1111/1467-8721.00147; McNamara Patrick, 2006, Neuropsychiatr Dis Treat, V2, P341, DOI 10.2147/nedt.2006.2.3.341; Miller WR, 2003, AM PSYCHOL, V58, P24, DOI 10.1037/0003-066X.58.1.24; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; PARGAMENT KI, 1994, J SCI STUD RELIG, V33, P347, DOI 10.2307/1386494; Pargament KI, 1995, J SOC ISSUES, V51, P13, DOI 10.1111/j.1540-4560.1995.tb01321.x; PARGAMENT KI, 1990, AM J COMMUN PSYCHOL, V18, P793, DOI 10.1007/BF00938065; Piedmont RL., 2007, RES SOCIAL SCI STUDY, V17, P177; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Pruchno RA, 2006, MED DECIS MAKING, V26, P112, DOI 10.1177/0272989X06286482; Ray O, 2004, AM PSYCHOL, V59, P29, DOI 10.1037/0003-066X.59.1.29; Rippentrop AE, 2005, PAIN, V116, P311, DOI 10.1016/j.pain.2005.05.008; Seybold KS, 2001, CURR DIR PSYCHOL SCI, V10, P21, DOI 10.1111/1467-8721.00106; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Stewart C., 2006, INT J PSYCHOL RELIG, V16, P181, DOI [DOI 10.1207/S15327582IJPR1603_3, 10.1207/s15327582ijpr1603_3]; Tartaro J, 2005, J HEALTH PSYCHOL, V10, P753, DOI 10.1177/1359105305057311; Tasker SL., 2003, ILLN CRISES LOSS, V11, P337, DOI DOI 10.1177/1054137303256585; Tate DG, 2002, AM J PHYS MED REHAB, V81, P400, DOI 10.1097/00002060-200206000-00002; UnderwoodGordon L, 1997, AM J PHYS MED REHAB, V76, P255, DOI 10.1097/00002060-199705000-00021; Ware J.E., 1993, SF 36 HLTH SURVEY MA	43	16	18	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	5					411	419	PII 909745375	10.1080/02699050902788501			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology; Rehabilitation	439NL	WOS:000265633700005	19306162				2022-02-06	
J	Thomas, S; Mayer, L; Sperber, K				Thomas, Sunil; Mayer, Lloyd; Sperber, Kirk			Mitochondria Influence Fas Expression in GP120-Induced Apoptosis of Neuronal Cells	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						apoptosis; caspase; dementia; fas; HIV; mitochondria	TRAUMATIC BRAIN INJURY; DEATH; DEMENTIA; ASSOCIATION; MECHANISMS; INFECTION; MEMBRANE; SYSTEM; AIDS	The human immunodeficiency virus-1 (HIV-1) destroys the immune system and also induces neurological disease culminating into dementia (HIV-associated dementia). Though the HIV viral protein gp120 induces apoptosis in neuronal cells, the mechanism of action is still poorly defined. Recent studies show that cells die during apoptosis by Fas aggregation aided by the mitochondrial proapoptotic proteins. Our studies show an increase in expression of Fas and its associated downstream proteins after treatment of the neuroblastoma cells, SH-SY5Y, with gp120. Fas and its associated death proteins, FADD and caspase-8 (DISC), are downregulated when treated with the caspase inhibitors. The results indicate that mitochondrial-death proteins like caspases may influence the upregulation of the death receptor Fas, and the inhibition of caspases prevents gp120-induced apoptosis.	[Thomas, Sunil; Mayer, Lloyd; Sperber, Kirk] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY USA; [Thomas, Sunil] Univ Texas Med Branch Galveston, Dept Pathol, Galveston, TX 77550 USA		Thomas, S (corresponding author), Univ Texas Med Branch Galveston, Dept Pathol, Keiller Bldg,Room 1-138,301 Univ Blvd, Galveston, TX 77550 USA.	sunthoma@utmb.edu					AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Damdimopoulos AE, 2002, J BIOL CHEM, V277, P33249, DOI 10.1074/jbc.M203036200; Desbarats J, 1996, P NATL ACAD SCI USA, V93, P11014, DOI 10.1073/pnas.93.20.11014; Dianzani U, 2003, CURR HIV RES, V1, P405, DOI 10.2174/1570162033485131; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; LIPTON SA, 1992, NEUROLOGY, V42, P1403, DOI 10.1212/WNL.42.7.1403; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; OHMICHI M, 1994, J BIOL CHEM, V269, P1143; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Xu Y, 2004, P NATL ACAD SCI USA, V101, P7070, DOI 10.1073/pnas.0304859101; Zhang LL, 2004, J BIOL CHEM, V279, P33865, DOI 10.1074/jbc.M403499200	25	16	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2009	119	2					157	165	PII 907383722	10.1080/00207450802335537			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	390SD	WOS:000262183100001	19125371				2022-02-06	
J	Wei, CW; Tharmakulasingam, J; Crawley, A; Kideckel, DM; Mikulis, DJ; Bradbury, CL; Green, RE				Wei, Corie W.; Tharmakulasingam, Januthy; Crawley, Adrian; Kideckel, David M.; Mikulis, David J.; Bradbury, Cheryl L.; Green, Robin E.			Use of Diffusion-Tensor Imaging in Traumatic Spinal Cord Injury to Identify Concomitant Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Diffusion magnetic resonance imaging; Rehabilitation; Spinal cord injuries	CLOSED-HEAD-INJURY; WHITE-MATTER ABNORMALITIES; AXONAL INJURY; SPATIAL STATISTICS; VOXELWISE ANALYSIS; ANISOTROPY; DEFICITS	Objective: To characterize and differentiate cerebral white matter (WM) changes related selectively to traumatic brain injury (TBI) or spinal cord injury (SCI) in patients with SCIs in order to improve diagnostic accuracy of TBI in people with SCI. Design: Diffusion-tensor imaging (DTI)-derived fractional anisotropy (FA) data in WM tracts were compared between a healthy control and 2 patient groups. Between-subject comparisons of FA were performed using region of interest (ROI) analysis and tract-based spatial statistics. Setting: A large, urban inpatient SCI program. Participants: Three groups: SCI and concomitant TBI (SCI with TBI, n=7); SCI without TBI (SCI only, n=15); and healthy control subjects (n=12). Interventions: Not applicable. Main Outcome Measure: FA was used as a measure of cerebral WM integrity. Results: ROI analyses showed reduced FA in the genu and splenium of the corpus callosum and forceps minor in patients with SCI with TBI compared with both healthy controls and patients with SCI only. ROI analyses did not show evidence of FA differences in patients with SCI only compared with controls. Tract-based spatial statistics did not demonstrate between-group differences in FA. Conclusions: DTI is a sensitive tool to detect TBI-related WM damage in patients with SCI who have suffered concomitant TBI. No WM abnormalities on DTI could be attributed to SCI alone, although this finding should be further explored in future studies. Therefore, DTI may be a valuable tool to identify TBI in the SCI population. Further research to produce normative FA values is needed to allow identification of TBI in individual patients with SCI.	[Green, Robin E.] Toronto Rehabil Inst, Univ Ctr, Toronto, ON M5G 2A2, Canada; [Wei, Corie W.] Univ Toronto, Dept Med Imaging, Toronto, ON M5S 1A1, Canada; [Tharmakulasingam, Januthy] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 1A1, Canada; [Kideckel, David M.] Univ Toronto, Univ Hlth Network, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Crawley, Adrian; Mikulis, David J.] Univ Toronto, Toronto Western Hosp, Dept Med Imaging, Toronto, ON M5S 1A1, Canada; [Bradbury, Cheryl L.; Green, Robin E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada		Green, RE (corresponding author), Toronto Rehabil Inst, Univ Ctr, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	green.robin@torontorehab.on.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; Green, Robin/0000-0001-9451-3963	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Physicians' Services Incorporated; Ontario Mental Health Foundation [MOP-67072, 05-50, 2005-ABI-392]	Supported by the Canadian Institutes of Health Research, the Physicians' Services Incorporated, and the Ontario Mental Health Foundation (grant nos. MOP-67072, 05-50, 2005-ABI-392).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER AL, 2007, UNDERST COMPLEX SYST, P221; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BUCHANAN LE, 1987, SPINAL CORD INJURY C; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chang CW, 1998, AM J PHYS MED REHAB, V77, P118, DOI 10.1097/00002060-199803000-00006; DAMOISEAUX JS, 2008, HUMAN BRAIN MAPP; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GENTRY LR, 1994, RADIOLOGY, V191, P1; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; JENNET B, 1981, MANAGEMENT HEAD INJU; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NIOGI SN, 2008, AJNR AM J NEURORADIO; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; POVOLNY MA, 1993, J REHABIL, V59, P23; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SMITH SM, 2007, P 13 ANN M ORG HUM B; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; WAXMAN SG, 2002, CLIN NEUROANATOMY; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	55	16	16	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2008	89	12		2			S85	S91		10.1016/j.apmr.2008.07.005			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	388DB	WOS:000261999400011	19081446				2022-02-06	
J	Kaiser, C; Schnabel, A; Berkefeld, J; Bratzke, H				Kaiser, Ch; Schnabel, A.; Berkefeld, J.; Bratzke, H.			Traumatic rupture of the intracranial vertebral artery due to rotational acceleration	FORENSIC SCIENCE INTERNATIONAL			English	Article						Trauma; Subarachnoidal haemorrhage; Rupture; Rotational acceleration; Vertebral artery		The reason for blunt forces against the head to rupture the basal brain arteries has been discussed in forensic and trauma research. However, well-documented case reports demonstrating the mechanism of injury, the clinical course and the forensic work up are rare. We present the case of a 40-year-old man, who was assaulted with blunt force to the head resulting in death 34 h later from a longitudinal rupture of the distal left vertebral artery. Computer tomography of the brain and the face demonstrated a basal subarachnoidal haemorrhage, signs of increased intracranial pressure and a fracture of the right orbital bone. Angiography showed a long fusiform dilatation of both intracranial vertebral arteries with an active pseudoaneurysm on the left side. At autopsy signs of a blunt trauma to the head, extensive basal subarachnoidal haemorrhage and a minor subdural haemorrhage were found. Histological examination revealed a transmural longitudinal rupture of the left vertebral artery with vital reaction and no signs of preexisting vascular disease. We discuss the current literature regarding traumatic basal brain artery rupture, important clinical decision making processes as well as pitfalls in the forensic work up. In addition, this singular well-documented case gives new insights in the underlying pathophysiological mechanisms of traumatic basal artery rupture. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Kaiser, Ch; Schnabel, A.; Bratzke, H.] Univ Frankfurt Main, Ctr Legal Med, Inst Forens Med, D-60596 Frankfurt, Germany; [Berkefeld, J.] Univ Frankfurt Main, Ctr Radiol, D-60596 Frankfurt, Germany		Kaiser, C (corresponding author), Univ Frankfurt Main, Ctr Legal Med, Inst Forens Med, Kennedyallee 104, D-60596 Frankfurt, Germany.	kaiser@med.uni-frankfurt.de					BOLTZ W, 1965, BEITR GERICHTL MED, V23, P49; Bratzke H, 1989, Beitr Gerichtl Med, V47, P437; Hiraiwa K, 2005, NEUROL MED-CHIR, V45, P549, DOI 10.2176/nmc.45.549; KLAGES U, 1970, Z RECHTSMED, V67, P67; KRAULAND W, 1981, Z RECHTSMED, V87, P19; KRAULAND W, 1981, Z RECHTSMED, V87, P1; KRAULAND W, 1961, BEITR GERICHTL MED, V21, P171; KRAULAND W, 1955, HDB SPEZ PATH ANAT H, V13; LAMPERT K, 1926, FRANKFURT Z PATHOL, V33, P471; MACHEBOEUF M, 1948, CR SOC BIOL, V142, P61; MAXEINER H, 1980, THESIS BERLIN; METZ U, 1979, VIRCHOWS ARCH, V317, P385; PETERS G, 1969, NEUROTRAUMATOLOGIE; SAATHOFF E, 1905, DTSCH ARCH KLEIN MED, V84, P384; SELLIER K, 1963, Hefte Unfallheilkd, V76, P1; WEILER G, 1980, Z RECHTSMED, V85, P225, DOI 10.1007/BF02116324; [No title captured]; [No title captured]	18	16	18	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV 20	2008	182	1-3					E15	E17		10.1016/j.forsciint.2008.10.001			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	V15RK	WOS:000207818900004	19008059				2022-02-06	
J	Kaiser, C; Schnabel, A; Berkefeld, J; Bratzke, H				Kaiser, Ch.; Schnabel, A.; Berkefeld, J.; Bratzke, H.			Traumatic rupture of the intracranial vertebral artery due to rotational acceleration	FORENSIC SCIENCE INTERNATIONAL			English	Article						Trauma; Subarachnoidal haemorrhage; Rupture; Rotational acceleration; Vertebral artery	HEMORRHAGE	The reason for blunt forces against the head to rupture the basal brain arteries has been discussed in forensic and trauma research. However, well-documented case reports demonstrating the mechanism of injury, the clinical course and the forensic work up are rare. We present the case of a 40-year-old man, who was assaulted with blunt force to the head resulting in death 34 h later from a longitudinal rupture of the distal left vertebral artery. Computer tomography of the brain and the face demonstrated a basal subarachnoidal haemorrhage, signs of increased intracranial pressure and a fracture of the right orbital bone. Angiography showed a long fusiform dilatation of both intracranial vertebral arteries with an active pseudoaneurysm on the left side. At autopsy signs of a blunt trauma to the head, extensive basal subarachnoidal haemorrhage and a minor subdural haemorrhage were found. Histological examination revealed a transmural longitudinal rupture of the left vertebral artery with vital reaction and no signs of preexisting vascular disease. We discuss the current literature regarding traumatic basal brain artery rupture, important clinical decision making processes as well as pitfalls in the forensic work up. In addition, this singular well-documented case gives new insights in the underlying pathophysiological mechanisms of traumatic basal artery rupture. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Kaiser, Ch.] Goethe Univ Frankfurt, Ctr Legal Med, Inst Forens Med, D-60596 Frankfurt, Germany; [Berkefeld, J.] Goethe Univ Frankfurt, Ctr Radiol, D-60596 Frankfurt, Germany		Kaiser, C (corresponding author), Goethe Univ Frankfurt, Ctr Legal Med, Inst Forens Med, Kennedyallee 104, D-60596 Frankfurt, Germany.	kaiser@med.uni-frankfurt.de					BOLTZ W, 1965, BEITR GERICHTL MED, V23, P49; Bratzke H, 1989, Beitr Gerichtl Med, V47, P437; Hiraiwa K, 2005, NEUROL MED-CHIR, V45, P549, DOI 10.2176/nmc.45.549; KLAGES U, 1970, Z RECHTSMED, V67, P67; KRAULAND W, 1981, Z RECHTSMED, V87, P1; KRAULAND W, 1961, BEITR GERICHTL MED, V21, P171; KRAULAND W, 1981, BERECHNUNGEN MODELLV, V87, P19; KRAULAND W, 1955, ANAL HISTOL, V13, P3; LAMPERT H, 1926, FRANKFURT Z PATHOL, V33, P471; MACHEBOEUF M, 1948, CR SOC BIOL, V142, P61; MAXEINER H, 1980, THESIS MED BERLIN; METZ U, 1949, VIRCHOWS ARCH, V317, P385; PETERS G, 1969, NEUROTRAUMATOLOGIE; SAATHOFF E, 1905, DTSCH ARCH KLEIN MED, V84, P384; WEILER G, 1980, Z RECHTSMED, V85, P225, DOI 10.1007/BF02116324; [No title captured]; [No title captured]; [No title captured]	18	16	18	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV 20	2008	182	1-3					E15	E17		10.1016/j.forsciint.2008.10.001			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	389BP	WOS:000262065300014	19008059				2022-02-06	
J	Perel, P; Edwards, P; Shakur, H; Roberts, I				Perel, Pablo; Edwards, Phil; Shakur, Haleema; Roberts, Ian			Use of the Oxford Handicap Scale at hospital discharge to predict Glasgow Outcome Scale at 6 months in patients with traumatic brain injury	BMC MEDICAL RESEARCH METHODOLOGY			English	Article							PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; MRC CRASH; ADULTS	Background: Traumatic brain injury (TBI) is an important cause of acquired disability. In evaluating the effectiveness of clinical interventions for TBI it is important to measure disability accurately. The Glasgow Outcome Scale (GOS) is the most widely used outcome measure in randomised controlled trials (RCTs) in TBI patients. However GOS measurement is generally collected at 6 months after discharge when loss to follow up could have occurred. The objectives of this study were to evaluate the association and predictive validity between a simple disability scale at hospital discharge, the Oxford Handicap Scale (OHS), and the GOS at 6 months among TBI patients. Methods: The study was a secondary analysis of a randomised clinical trial among TBI patients (MRC CRASH Trial). A Spearman correlation was estimated to evaluate the association between the OHS and GOS. The validity of different dichotomies of the OHS for predicting GOS at 6 months was assessed by calculating sensitivity, specificity and the C statistic. Uni and multivariate logistic regression models were fitted including OHS as explanatory variable. For each model we analysed its discrimination and calibration. Results: We found that the OHS is highly correlated with GOS at 6 months (spearman correlation 0.75) with evidence of a linear relationship between the two scales. The OHS dichotomy that separates patients with severe dependency or death showed the greatest discrimination (C statistic: 84.3). Among survivors at hospital discharge the OHS showed a very good discrimination (C statistic 0.78) and excellent calibration when used to predict GOS outcome at 6 months. Conclusion: We have shown that the OHS, a simple disability scale available at hospital discharge can predict disability accurately, according to the GOS, at 6 months. OHS could be used to improve the design and analysis of clinical trials in TBI patients and may also provide a valuable clinical tool for physicians to improve communication with patients and relatives when assessing a patient's prognosis at hospital discharge.	[Perel, Pablo; Edwards, Phil; Shakur, Haleema; Roberts, Ian] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England		Perel, P (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	pablo.perel@lshtm.ac.uk; phil.edwards@lshtm.ac.uk; haleema.shakur@lshtm.ac.uk; ian.roberts@lshtm.ac.uk		Shakur-Still, Haleema/0000-0002-6511-109X; Edwards, Phil/0000-0003-4431-8822; /0000-0002-2342-301X			BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Bullock M Ross, 2002, Neurosurg Focus, V13, pECP1; *CRASH TRIAL COLL, 2008, BRIT MED J, V12, P12; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Edwards P, 2005, LANCET, V365, P1957; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136	9	16	17	0	3	BIOMED CENTRAL LTD	LONDON	CURRENT SCIENCE GROUP, MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1471-2288			BMC MED RES METHODOL	BMC Med. Res. Methodol.	NOV 6	2008	8								72	10.1186/1471-2288-8-72			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	391TL	WOS:000262256000001	18990202	Green Published, gold, Green Accepted			2022-02-06	
J	Thompson, JM; Scott, KC; Dubinsky, L				Thompson, James M.; Scott, Kenneth C.; Dubinsky, Leslie			Battlefield brain Unexplained symptoms and blast-related mild traumatic brain injury	CANADIAN FAMILY PHYSICIAN			English	Article									[Thompson, James M.] Vet Affairs Canada Head Off, Charlottetown, PE, Canada; [Dubinsky, Leslie] Vet Affairs Canada Reg Off, Halifax, NS, Canada		Thompson, JM (corresponding author), Vet Affairs Canada Head Off, Charlottetown, PE, Canada.			Thompson, James/0000-0001-7443-8732			Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; *DEF VET BRAIN IN, 2006, CLIN PRACT GUID REC; Engel CC, 2006, PHILOS T R SOC B, V361, P707, DOI 10.1098/rstb.2006.1829; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; KATES N, 1996, SHARED MENTAL HLTH C; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; *UK MIN DEF, 2008, MILD TRAUM BRAIN INJ; *US DEP DEF, 2006, MED RES PREV MIT TRE; *VET AFF CAN, 2008, OP STRESS INJ CIN	14	16	19	0	5	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X			CAN FAM PHYSICIAN	Can. Fam. Phys.	NOV	2008	54	11					1549	1551					3	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	394FU	WOS:000262432200018	19005124				2022-02-06	
J	Tsaousides, T; Ashman, T; Seter, C				Tsaousides, Theodore; Ashman, Teresa; Seter, Colette			The Psychological Effects of Employment After Traumatic Brain Injury: Objective and Subjective Indicators	REHABILITATION PSYCHOLOGY			English	Article						TBI; employment; traumatic brain injury; quality of life; depression	QUALITY-OF-LIFE; INDIVIDUALS; DEPRESSION; WORK; WORKPLACE; COMMUNITY; MOOD	Objectives: This study examines the effects of objective (level of engagement) and subjective (discrepancy between importance of work and the degree to which work needs are met) indicators of employment on self-reported psychological well-being, quality of life (QoL), and depression for individuals with traumatic brain injury (TBI). Design: Cross-sectional. Setting: Community-based research and training center. Participants: 317 individuals with self-reported TBI under the age of 65 were included in analysis. Main Outcome Measures: Living Life After Traumatic Brain Injury (LLATBI; 1998), Flanagan Scale of Needs (J. C. Flanagan, 1982), Beck Depression Inventory-II (BDI-II; A. T. Beck, R. Steer, & G. Brown, 1996). Results: Only 21% of the present sample experienced similar levels of pre- and postinjury employment. Multiple regressions revealed significant relationships between demographic, objective, and subjective employment indicators and perceived QoL and depression. In addition, significant increments in QoL and depression variance were accounted for by subjective indicators of employment per se. Conclusions: Subjective indicators are additional important measures when assessing the rehabilitation needs and planning treatment for individuals with TBI, as they contribute to further improvements in their QoL and mood.	[Tsaousides, Theodore; Ashman, Teresa; Seter, Colette] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Tsaousides, T (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 Gustave L Levy Pl, New York, NY 10029 USA.	theodore.tsaousides@mssm.edu	Ashman, Teresa/B-1621-2013	Ashman, Teresa/0000-0003-2401-7192			Andrews F. M., 1976, SOCIAL INDICATORS WE; Beck A., 1996, BECK DEPRESSION INVE; BIGELOW DA, 1990, PSYCHOSOC REHABIL, V14, P94; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dijkers M., 2002, QUAL LIFE RES, V11, P672; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MICHALOS AC, 1985, SOC INDIC RES, V16, P347, DOI 10.1007/BF00333288; *NY STAT DEP LAB, WORKF IND DAT; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200	29	16	17	0	4	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2008	53	4					456	463		10.1037/a0012579			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	381ER	WOS:000261518900004					2022-02-06	
J	MacDonald, CL; Schwarze, N; Vaishnavi, SN; Epstein, AA; Snyder, AZ; Raichle, ME; Shimony, JS; Brody, DL				MacDonald, C. L.; Schwarze, N.; Vaishnavi, S. N.; Epstein, A. A.; Snyder, A. Z.; Raichle, M. E.; Shimony, J. S.; Brody, D. L.			Verbal memory deficit following traumatic brain injury: Assessment using advanced MRI methods	NEUROLOGY			English	Article							DIFFUSE AXONAL INJURY		[Brody, D. L.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Vaishnavi, S. N.; Epstein, A. A.; Snyder, A. Z.; Raichle, M. E.; Shimony, J. S.] Washington Univ, Dept Radiol & Radiol Sci, St Louis, MO 63110 USA		Brody, DL (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS049237-02, K08 NS049237-05, K08 NS049237, K08 NS049237-01, K08 NS049237-04, K08 NS049237-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS049237] Funding Source: NIH RePORTER		Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; STRICH SJ, 1961, LANCET, V2, P443; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046	7	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	OCT 7	2008	71	15					1199	1201		10.1212/01.wnl.0000327521.69520.7f			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	356XE	WOS:000259810100013	18838668	Green Accepted, Green Published			2022-02-06	
J	Slomine, B; Eikenberg, J; Salorio, C; Suskauer, S; Trovato, M; Christensen, J				Slomine, Beth; Eikenberg, Janine; Salorio, Cynthia; Suskauer, Stacy; Trovato, Melissa; Christensen, James			Preliminary evaluation of the Cognitive and Linguistic Scale: A measure to assess recovery in inpatient rehabilitation following pediatric brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain injury; children and adolescents; cognition; language; measurement; rehabilitation	PERFORMANCE; ORIENTATION; CHILDREN; WEEFIM; COMA	Objective: A preliminary investigation of the psychometric properties of the Cognitive and Linguistic Scale (CALS), a measure of cognitive and linguistic recovery following brain injury in children and adolescents. Participants: One hundred children and adolescents (aged 2-14 years) with acquired or traumatic brain injury were included. Methods: The CALS was administered at inpatient rehabilitation admission and discharge. Results: Internal consistency and interrater reliability were high. Factor analysis revealed 2 factors (basic responding, higher-level cognitive skills). Correlations with the Functional Independence Measure for Children (WeeFIM) ranged from 0.51 to 0.89; highest correlation was between WeeFIM cognitive domain and CALS total score. CALS scores improved significantly between admission and discharge. Conclusion: On the basis of these preliminary analyses, the CALS is a promising measure to track cognitive and linguistic recovery in children and adolescents with brain injury during inpatient rehabilitation.	[Slomine, Beth] Johns Hopkins Univ, Sch Med, Dept Neuropsychol, Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Slomine, Beth] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Eikenberg, Janine] Kennedy Krieger Inst, Dept Commun Sci & Disorders Program, Baltimore, MD USA; [Salorio, Cynthia; Suskauer, Stacy; Trovato, Melissa; Christensen, James] Johns Hopkins Univ, Sch Med, Dept Rehabil, Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Salorio, Cynthia; Suskauer, Stacy; Trovato, Melissa; Christensen, James] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA		Slomine, B (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neuropsychol, Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	slomine@kennedykrieger.org					Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; BARON JS, 2004, NEUROPSYCHOLOGICAL E; Chen CC, 2004, AM J OCCUP THER, V58, P44, DOI 10.5014/ajot.58.1.44; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; de Vellis RF, 2003, SCALE DEV THEORY APP, V2nd; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Donders J, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P91; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Dunkleberger K, 2006, J HEAD TRAUMA REHAB, V21, P410, DOI 10.1097/00001199-200609000-00010; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; FORSYTH RJ, 2007, DEV NEUROREHABIL, V10, P288; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Haley S, 1992, PEDIAT EVALUATION DI; HALEY SM, 1991, PHYS MED REH CLIN N, V2, P689; Hotz G, 2001, J HEAD TRAUMA REHAB, V16, P426, DOI 10.1097/00001199-200110000-00003; Israelian MK, 2000, REHABIL PSYCHOL, V45, P284, DOI 10.1037/0090-5550.45.3.284; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Kane RL, 1997, UNDERSTANDING HLTH C, P17; Korkman M., 2007, CLIN INTERPRETIVE MA; Kothari DH, 2003, PHYS THER, V83, P776, DOI 10.1093/ptj/83.9.776; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; *NO CAL NEUR GROUP, 1995, COGN NEUR COGN STAT; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Nunnally JC., 1970, INTRO PSYCHOL MEASUR; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Sander AM, 2007, AM J SPEECH-LANG PAT, V16, P316, DOI 10.1044/1058-0360(2007/036); Sattler J. M., 2008, ASSESSMENT CHILDREN; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Slomine B, 2006, J HEAD TRAUMA REHAB, V21, P419, DOI 10.1097/00001199-200609000-00030; Slomine BS, 2004, ARCH PHYS MED REHAB, V85, P512, DOI 10.1016/S0003-9993(03)00769-X; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; *STAT U NEW YORK C, 1998, GUID UN DAT SET MED; Suskauer S, 2006, J HEAD TRAUMA REHAB, V21, P420, DOI 10.1097/00001199-200609000-00031; Thomas-Stonell N, 2006, Pediatr Rehabil, V9, P14, DOI 10.1080/13638490500050097; Wechsler D, 2003, WISC 4, VFourth; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	40	16	16	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2008	23	5					286	293		10.1097/01.HTR.0000336841.53338.2f			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	357GN	WOS:000259834400003	18815505				2022-02-06	
J	Hellmich, HL; Eidson, K; Cowart, J; Crookshanks, J; Boone, DK; Shah, S; Uchida, T; DeWitt, DS; Prough, DS				Hellmich, Helen L.; Eidson, Kristine; Cowart, Jeremy; Crookshanks, Jeanna; Boone, Deborah K.; Shah, Syed; Uchida, Tatsuo; DeWitt, Douglas S.; Prough, Donald S.			Chelation of neurotoxic zinc levels does not improve neurobehavioral outcorne after traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						traumatic brain injury; zinc chelation.; behavioral outcome	INTRACELLULAR ZINC; NEURONAL INJURY; HIPPOCAMPUS; RESPONSES; ISCHEMIA; DISEASE; STRESS	Increases of synaptically released zinc and intracellular accumulation of zinc in hippocampal neurons after traumatic or ischemic brain injury is neurotoxic and chelation of zinc has been shown to reduce neurodegeneration. Although our previous studies showed that zinc chelation in traumatically brain-injured rats correlated with an increase in whole-brain expression of several neuroprotective genes and reduced numbers of apoptotic neurons, the effect on functional outcome has not been determined, and the question of whether this treatment may actually be clinically relevant has not been answered. In the present study, we show that treatment of TBI rats with the zinc chelator calcium EDTA reduces the numbers of injured, Fluoro-jade-positive neurons in the rat hippocampus 24 h after injury but does not improve neurobehavioral outcome (spatial memory deficits) 2 weeks post-injury. Our data suggest that,zinc chelation, despite providing short-term histological neuroprotection, fails to improve long-term functional outcome, perhaps because long-term disruptions in homeostatic levels of zinc adversely influence hippocampus-dependent spatial memory. (c) 2008 Elsevier Ireland Ltd. All rights reserved.	[Hellmich, Helen L.; Eidson, Kristine; Cowart, Jeremy; Crookshanks, Jeanna; Boone, Deborah K.; Shah, Syed; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Galveston, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Uchida, Tatsuo] Univ Texas Galveston, Med Branch, Dept Prevent Med & Community Hlth, Off Biostat, Galveston, TX 77555 USA		Hellmich, HL (corresponding author), Univ Texas Galveston, Med Branch, Dept Anesthesiol, 301 Univ Blvd,Route 0830, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042849] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01 NS042849-01A1, R01 NS042849, R01 NS042849-04, R01 NS042849-05] Funding Source: Medline		Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bodnar LM, 2005, BIOL PSYCHIAT, V58, P679, DOI 10.1016/j.biopsych.2005.05.009; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Canzoniero LMT, 1999, J NEUROSCI, V19; Canzoniero LMT, 2003, NEUROPHARMACOLOGY, V45, P420, DOI 10.1016/S0028-3908(03)00171-0; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen WQ, 2006, EXP BIOL MED, V231, P1564, DOI 10.1177/153537020623100917; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Daumas S, 2004, EUR J NEUROSCI, V20, P597, DOI 10.1111/j.1460-9568.2004.03484.x; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Frassinetti S, 2006, J ENVIRON PATHOL TOX, V25, P597, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i3.40; Frazzini V, 2006, BIOGERONTOLOGY, V7, P307, DOI 10.1007/s10522-006-9045-7; Frederickson CJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1659, DOI 10.1177/002215540205001210; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hao Q, 2005, J ALZHEIMERS DIS, V8, P161; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hellmich HL, 2004, NEUROSCI LETT, V355, P221, DOI 10.1016/j.neulet.2003.10.074; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Lavoie N, 2007, J PHYSIOL-LONDON, V578, P275, DOI 10.1113/jphysiol.2006.121848; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lin DD, 2001, J NEUROPHYSIOL, V85, P1185, DOI 10.1152/jn.2001.85.3.1185; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Molnar P, 2001, BRAIN RES, V910, P205, DOI 10.1016/S0006-8993(01)02720-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Ruiz A, 2004, J NEUROPHYSIOL, V91, P1091, DOI 10.1152/jn.00755.2003; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAS Institute, 2004, SAS STAT 9 1 US GUID; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; White AR, 2006, EXPERT REV NEUROTHER, V6, P711, DOI 10.1586/14737175.6.5.711	37	16	16	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 1	2008	440	2					155	159		10.1016/j.neulet.2008.05.068			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	325XX	WOS:000257623400014	18556117	Green Accepted			2022-02-06	
J	Oosterman, J; van Harten, B; Vogels, R; Gouw, A; Weinstein, H; Scheltens, P; Scherder, E				Oosterman, J.; van Harten, B.; Vogels, R.; Gouw, A.; Weinstein, H.; Scheltens, P.; Scherder, E.			Distortions in rest-activity rhythm in aging relate to white matter hyperintensities	NEUROBIOLOGY OF AGING			English	Article						aging; rest-activity rhythm; white matter; actigraphy	EXTERNALLY TRIGGERED MOVEMENTS; TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SLEEP-WAKE; AGE; DISTURBANCES; ALZHEIMERS; DISEASE; LESIONS; LIGHT	Distortions in the rest-activity rhythm in aging are commonly observed. Neurodegenerative changes of the suprachiasmatic nucleus have been proposed to underlie this disrupted rhythm. However, based on previous studies, it can be proposed that white matter hyperimensities (WMH) may also play a role in the altered rest-activity rhythm in aging. The present study focused on the rest-activity rhythm, as assessed with actigraphy, and WMH in nondemented aging. With regard to the rest-activity rhythm, the interdaily stability (IS), intradaily variability (IV) and the amplitude (AMP) of the rhythm were of interest. The white matter hyperintensities were examined separately for the periventricular (PVH) and deep white matter (DWMH) regions, while distinguishing between the various locations within these regions (e.g. occipital PVH). The results indicated that frontal DWMH related to both IS and AMP. A reduction in the most active 10-h period mediated the relationship between frontal DWMH and AMP. Possible underlying mechanisms of these associations are discussed. (c) 2007 Elsevier Inc. All rights reserved.	[Oosterman, J.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands; [van Harten, B.; Vogels, R.; Weinstein, H.] Sint Lucas Andreas Hosp, Dept Neurol, NL-1061 AE Amsterdam, Netherlands; [Gouw, A.; Scheltens, P.] Vrije Univ Amsterdam, Univ Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands; [Gouw, A.; Scheltens, P.] Vrije Univ Amsterdam, Univ Med Ctr, Alzheimers Ctr, NL-1007 MB Amsterdam, Netherlands; [Scherder, E.] Univ Groningen, Inst Human Movement Sci, NL-9713 AV Groningen, Netherlands		Oosterman, J (corresponding author), Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands.	j.m.oosterman@fss.uu.nl	Scheltens, Philip/AAL-9631-2020; WEINSTEIN, HAREL/O-8245-2019; Scheltens, Philip/E-1205-2012; Oosterman, Joukje/D-6125-2012	Scheltens, Philip/0000-0002-1046-6408; WEINSTEIN, HAREL/0000-0003-3473-9818; Oosterman, Joukje/0000-0003-0549-8832			AHARONPERETZ J, 1991, NEUROLOGY, V41, P1616; Arrindell WA, 1986, HANDLEIDING BIJ MULT; Bliwise DL, 2005, AM J GERIAT PSYCHIAT, V13, P1077, DOI 10.1176/appi.ajgp.13.12.1077; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Duffy JF, 2007, NEUROBIOL AGING, V28, P799, DOI 10.1016/j.neurobiolaging.2006.03.005; Elia M, 2000, EUR J CLIN NUTR, V54, pS92, DOI 10.1038/sj.ejcn.1601030; Firbank MJ, 2005, INT J GERIATR PSYCH, V20, P674, DOI 10.1002/gps.1342; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRUT M, 1993, ACTA NEUROL SCAND, V87, P312, DOI 10.1111/j.1600-0404.1993.tb05514.x; Haimov I, 1997, SLEEP, V20, P294, DOI 10.1093/sleep/20.4.294; Harbison J, 2003, NEUROLOGY, V61, P959, DOI 10.1212/01.WNL.0000086818.57992.B8; Harper DG, 2001, ARCH GEN PSYCHIAT, V58, P353, DOI 10.1001/archpsyc.58.4.353; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Haynes PL, 2006, PSYCHOL MED, V36, P1363, DOI 10.1017/S0033291706008208; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Jo I, 2001, J HYPERTENS, V19, P1523, DOI 10.1097/00004872-200109000-00002; Kanda A, 2003, J AM GERIATR SOC, V51, P432, DOI 10.1046/j.1532-5415.2003.51125.x; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Lazarus R, 2005, INT J GERIATR PSYCH, V20, P274, DOI 10.1002/gps.1283; Liao DP, 1997, NEUROEPIDEMIOLOGY, V16, P149, DOI 10.1159/000368814; MEGURO K, 1995, SLEEP, V18, P109, DOI 10.1093/sleep/18.2.109; Miller AM, 1998, P NATL ACAD SCI USA, V95, P8957, DOI 10.1073/pnas.95.15.8957; Mishima K, 1997, NEUROBIOL AGING, V18, P105, DOI 10.1016/S0197-4580(96)00167-4; Moore RY, 2002, CELL TISSUE RES, V309, P89, DOI 10.1007/s00441-002-0575-2; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/jocn.2006.18.3.418; Olson LJ, 2006, CHEST, V129, P218, DOI 10.1378/chest.129.2.218; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; SATLIN A, 1992, AM J PSYCHIAT, V149, P1028; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Scherder EJA, 1999, BEHAV BRAIN RES, V101, P105, DOI 10.1016/S0166-4328(98)00150-8; Stolk RP, 1997, AM J EPIDEMIOL, V145, P24, DOI 10.1093/oxfordjournals.aje.a009028; Tobler I, 1993, Adv Space Biol Med, V3, P163; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; VanSomeren EJW, 1997, BIOL PSYCHIAT, V41, P955, DOI 10.1016/S0006-3223(97)89928-3; VanSomeren EJW, 1997, J BIOL RHYTHM, V12, P146, DOI 10.1177/074873049701200206; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Varma AR, 2002, ACTA NEUROL SCAND, V105, P355, DOI 10.1034/j.1600-0404.2002.01147.x; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2006, NEUROIMAGE, V30, P1292, DOI 10.1016/j.neuroimage.2005.11.012; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171; Yoon IY, 2003, J SLEEP RES, V12, P87, DOI 10.1046/j.1365-2869.2003.00345.x	47	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	AUG	2008	29	8					1265	1271		10.1016/j.neurobiolaging.2007.02.014			7	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	321KF	WOS:000257302900017	17368870				2022-02-06	
J	Sakoda, E; Igarashi, K; Sun, JY; Kurisu, K; Tashiro, S				Sakoda, Eiichirou; Igarashi, Kazuhiko; Sun, Jiying; Kurisu, Kaoru; Tashiro, Satoshi			Regulation of heme oxygenase-1 by transcription factor Bach1 in the mouse brain	NEUROSCIENCE LETTERS			English	Article						heme oxygenase-1; brain; transcription factor; Bach 1; cold injury model	NEURONAL APOPTOSIS; OXIDATIVE STRESS; GENETIC ABLATION; OLFACTORY-BULB; GRANULE CELLS; COLD INJURY; MICE; EXPRESSION; ADULT; INDUCTION	Oxidative stress has been implicated in tissue damage from traumatic brain injury. Heme oxygenase-1 (HO-1) is an inducible enzyme that degrades prooxidant heme to radical-scavenging biliverdin/bilirubin in order to protect cells from oxidative stress. Although HO-1 is induced after induction of brain damage, the regulatory mechanism of HO-1 in the brain is still unclear. Bach1 is a transcriptional repressor of the HO-1 gene, and plays a critical role in tissue protection from oxidative stress by reperfusion injury of the myocardium. In this study, we examined the role of Bach1 in HO-1 regulation of the various brain sites by investigating the expression of Bach1 and HO-1 in brain tissues of mice bearing Bach1-deficient (Bachl(-/-)) or wild-type (Bach1(+/+)) genes. While the expression levels of Bach1 mRNA in the olfactory bulb were significantly higher than other brain areas, those at the cortex showed the lowest activity. Bach1(-/-) mice showed significantly higher HO-1 mRNA expression levels than Bach1(+/+) mice in all brain sites studied. Moreover, higher induction of HO-1 was observed around damaged tissues after cold injury in Bach1(-/-) than Bach1(+/+) mice. Thus, Bach1 plays an important role in regulating the constitutive and inducible expression levels of HO-1 in the brain. Although a significantly higher level of HO-1 was observed in Bach1(-/-) than Bach1(+/+) mice, genetic ablation of the Bach1 gene failed to show any tissue protective effect after cold injury was inflicted on the cortex. (c) 2008 Elsevier Ireland Ltd. All rights reserved.	[Sakoda, Eiichirou] Natl Hosp Org, Kure Med Ctr, Dept Neurosurg, Hiroshima 7370023, Japan; [Sakoda, Eiichirou; Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed Sci, Dept Neurosurg, Hiroshima 730, Japan; [Sakoda, Eiichirou; Sun, Jiying; Tashiro, Satoshi] Hiroshima Univ, RIRBM, Dept Cellular Biol, Hiroshima 730, Japan; [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan		Sakoda, E (corresponding author), Natl Hosp Org, Kure Med Ctr, Dept Neurosurg, Aoyama chou 3-1, Hiroshima 7370023, Japan.	sakodae@kure-nh.go.jp		Igarashi, Kazuhiko/0000-0002-2470-2475			Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; IGARASHI Y, 2006, NIPPON SHOKAKIBYO GA, V103, P7; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Miwa N, 2005, J NEUROSCI, V25, P5404, DOI 10.1523/JNEUROSCI.1039-05.2005; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x; Ono S, 2002, J NEUROSURG, V96, P1094, DOI 10.3171/jns.2002.96.6.1094; Panahian N, 1999, J NEUROCHEM, V72, P1187; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 1999, J CLIN INVEST, V104, P59, DOI 10.1172/JCI5357; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	21	16	16	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	AUG 1	2008	440	2					160	165		10.1016/j.neulet.2008.04.082			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	325XX	WOS:000257623400015	18555605				2022-02-06	
J	Zeitzer, MB; Brooks, JM				Zeitzer, Mindy B.; Brooks, J. Margo			In the Line of Fire Traumatic Brain Injury Among Iraq War Veterans	AAOHN JOURNAL			English	Article								Soldiers returning home from Iraq are experiencing an increased number of head injuries related to blasts and explosions compared to soldiers of previous conflicts. These injuries are often undetected until the soldiers return home and have difficulty functioning as they did prior to the war. It is therefore important for occupational health nurses to understand blast injury, its pathophysiology, methods for detecting traumatic brain injury, and how these soldiers can be treated.	[Brooks, J. Margo] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA						National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [1F31NR010432-01, 1F31HS010294-01]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1F31NR010432-01, 1F31HS010294-01]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR010432] Funding Source: NIH RePORTER	This manuscript was developed with financial support by grants 1F31NR010432-01 and 1F31HS010294-01 from the National Institute of Nursing Research and the Agency for Healthcare Research and Quality, respectively. The content is solely the responsibility of. the authors and does not necessarily represent the official views of the National Institute of Nursing Research, the National Institutes of Health, or the Agency for Healthcare Research and Quality.	Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDRASIK F, 1994, SEMIN NEUROL, V14, P60, DOI 10.1055/s-2008-1041060; Arlinghaus K.A., 2007, TXB TRAUMATIC BRAIN, P59; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Centers for Disease Control and Prevention, 2003, REP C MILD TBI INJ U; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Covey CDC, 2002, J BONE JOINT SURG AM, V84A, P1221, DOI 10.2106/00004623-200207000-00022; Defense and Veterans Brain Injury Center, 2007, BLAST INJ; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; icasualties.org, 2007, IR COAL CAS COUNT; Kapoor N., 2007, TXB TRAUMATIC BRAIN, P405; Keane TM, 2000, EFFECTIVE TREATMENTS FOR PTSD, P18; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Moore B., 2006, J EMERGENCY PRIMARY, V4; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PACKARD RC, 1994, SEMIN NEUROL, V14, pU2; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Taylor L. A., 2007, BRAIN INJURY MED PRI, P791; TEASDALE G, 1974, LANCET, V2, P81; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Thurman J. D., 2007, BRAIN INJURY MED PRI, P45; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vanderploeg RD, 2000, CLIN GUIDE NEUROPSYC, P3; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906	46	16	16	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0891-0162			AAOHN J	AAOHN J.	AUG	2008	56	8					347	353		10.3928/08910162-20080801-03			7	Public, Environmental & Occupational Health; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Nursing	V15BW	WOS:000207778500005	18717301				2022-02-06	
J	Batchelor, PE; Wills, TE; Hewa, AP; Porritt, MJ; Howells, DW				Batchelor, Peter Egerton; Wills, Taryn Elizabeth; Hewa, Ajith Pedru; Porritt, Michelle Julie; Howells, David William			Stimulation of axonal sprouting by trophic factors immobilized within the wound core	BRAIN RESEARCH			English	Article						sprouting; BDNF; GDNF; dopamine; scaffold; mouse	NERVE GROWTH-FACTOR; ADULT-RAT BRAIN; GUIDE NEURITE OUTGROWTH; SPINAL-CORD; NEUROTROPHIC FACTOR; PERIPHERAL-NERVE; CONCENTRATION GRADIENTS; DOPAMINE TRANSPORTER; IN-VIVO; REACTIVE ASTROCYTES	Traumatic injury to the CNS results in peri-wound sprouting without significant axonal growth beyond the lesion edge. We have previously demonstrated that dopaminergic sprouting in the injured striatum follows an increasing gradient of BDNF and GDNF expression, with sprouting ceasing at the point of maximal factor expression. Progressively more complicated associations of sprouting fibers with increasingly activated microglia and macrophages suggest these factors are localized to the cell surface. To establish whether an increased concentration of immobilized BDNF and GDNF could stimulate axonal growth beyond the lesion edge, both factors were covalently attached to 10 mu m polycarbonate microspheres. These spheres were implanted into the site of striatal injury 1 week after lesioning. A profusion of axons grew from the region of the lesion edge across the surface of the spheres. Some axons traversed the entire site of injury. Ultrastructural examination demonstrated the juxtaposition of regenerating axons to the surface of implanted spheres. CSPG immunostaining demonstrated that, in animals implanted with neurotrophin-microspheres, axonal growth was induced beyond the area of maximal CSPG reactivity. Surprisingly however, CSPG production at the wound edge was greater in control animals than those implanted with neurotrophin-microspheres. overall, we show that axonal growth can be encouraged beyond the wound edge by an elevated concentration of immobilized trophic factors. This growth occurs despite the presence of inhibitory CSPGs at the lesion edge. Axonal growth appears to be stimulated mainly via the direct effects of neurotrophins. However, there also appears to be an indirect mechanism whereby neurotrophins reduce the synthesis of CSPG at the wound edge, making the peri-wound environment more permissive. (C) 2008 Elsevier B.V. All rights reserved.	[Howells, David William] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic 3084, Australia; Univ Melbourne, Austin Hlth, Dept Neurol, Heidelberg, Vic 3084, Australia		Howells, DW (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia.	david.howells@unimelb.edu.au		Howells, David/0000-0002-2512-7724			ALONSO G, 1993, J NEUROSCI RES, V34, P523, DOI 10.1002/jnr.490340505; ARGIRO V, 1985, J NEUROSCI RES, V13, P149, DOI 10.1002/jnr.490130111; Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Batchelor PE, 2000, EUR J NEUROSCI, V12, P3462, DOI 10.1046/j.1460-9568.2000.00239.x; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 2002, EUR J NEUROSCI, V15, P826, DOI 10.1046/j.1460-9568.2002.01914.x; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bresjanac M, 2000, EXP NEUROL, V164, P53, DOI 10.1006/exnr.2000.7416; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; CURTIS R, 1994, NEURON, V12, P191, DOI 10.1016/0896-6273(94)90163-5; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; HAGG T, 1993, EXP NEUROL, V119, P37, DOI 10.1006/exnr.1993.1005; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; Honda S, 1999, NEUROSCI LETT, V275, P203, DOI 10.1016/S0304-3940(99)00769-7; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168; Liebl DJ, 2001, EXP NEUROL, V167, P15, DOI 10.1006/exnr.2000.7548; LONGO FM, 1983, EXP NEUROL, V81, P756, DOI 10.1016/0014-4886(83)90342-4; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Meng SZ, 1999, BRAIN RES, V843, P136, DOI 10.1016/S0006-8993(99)01933-2; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267; Nakajima K, 1998, GLIA, V24, P272, DOI 10.1002/(SICI)1098-1136(199811)24:3<272::AID-GLIA2>3.0.CO;2-4; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Perez NL, 1997, EXP NEUROL, V145, P196, DOI 10.1006/exnr.1997.6454; POLITIS MJ, 1982, BRAIN RES, V253, P1, DOI 10.1016/0006-8993(82)90667-9; Ramon y Cajal S, 1928, DEGENERATION REGENER, V2; Ramon y Cajal S., 1928, DEGENERATION REGENER, VI; RUSH RA, 1984, NATURE, V312, P364, DOI 10.1038/312364a0; Ryan AF, 2006, AUDIOL NEURO-OTOL, V11, P134, DOI 10.1159/000090686; SHULTS CW, 1995, NEUROREPORT, V6, P1109, DOI 10.1097/00001756-199505300-00009; Takeda H, 2002, N-S ARCH PHARMACOL, V366, P620, DOI 10.1007/s00210-002-0640-0; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; Trupp M, 1997, J NEUROSCI, V17, P3554; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zheng M, 2000, J NEUROBIOL, V42, P212, DOI 10.1002/(SICI)1097-4695(20000205)42:2<212::AID-NEU5>3.0.CO;2-C	47	16	16	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 13	2008	1209						49	56		10.1016/j.brainres.2008.02.098			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304YK	WOS:000256144800006	18396265				2022-02-06	
J	Brewer-Smyth, K				Brewer-Smyth, Kathleen			Ethical, regulatory, and investigator considerations in prison research	ADVANCES IN NURSING SCIENCE			English	Article						ethics; prison; prisoner; regulatory; research	DEVELOPMENTAL TRAUMATOLOGY; PSYCHIATRIC-DISORDERS; WOMEN; LEGAL	Although numbers of prison inmates are increasing rapidly, limited research addresses health-related conditions prevalent in prisons. Compelling reasons exist for prison research to address high rates of psychiatric, neurological, and other health-related conditions that may precipitate or result from incarceration, high-risk behaviors, infectious disease transmission, traumatic brain injuries, and other issues related to incarceration. Prison research is critical because inmates are frequently re-incarcerated and released, posing potential risks to themselves and the community. The purpose of this article is to provide a pragmatic overview of ethical, regulatory, and investigator considerations to facilitate critically needed research with vulnerable prison populations.	Univ Delaware, Coll Hlth Sci, Sch Nursing, Newark, DE 19716 USA		Brewer-Smyth, K (corresponding author), Univ Delaware, Coll Hlth Sci, Sch Nursing, 313 McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu		Brewer-Smyth, PhD, RN, CRRN, FAAN, Kathleen/0000-0001-8468-6991	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [2 P20 RR0164720-07] Funding Source: Medline		BIGBY ME, 1999, ARCH DERMATOL, V135, P477; Bland RC, 1998, INT J LAW PSYCHIAT, V21, P273, DOI 10.1016/S0160-2527(98)00005-3; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth Kathleen, 2007, J Neurosci Nurs, V39, P361; Brewer-Smyth Kathleen, 2004, Rehabil Nurs, V29, P75; BREWERSMYTH K, 2001, THESIS U PENNSYLVANN; BREWERSMYTH K, 2002, HIGH RISK BEHAV FEMA; BREWERSMYTH K, 2001, NEUROREHAB NEURAL RE, V15, P87; Byrne MW, 2005, J PROF NURS, V21, P223, DOI 10.1016/j.profnurs.2005.05.001; Campbell R, 2005, J INTERPERS VIOLENCE, V20, P127, DOI 10.1177/0886260504268604; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1259, DOI 10.1016/S0006-3223(99)00044-X; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; De Groot A S, 2001, AIDS Read, V11, P34; *DEP HLTH HUM SERV, 2007, PROT HUM SUBJ OPR 46; Drake V K, 1998, Issues Ment Health Nurs, V19, P41, DOI 10.1080/016128498249204; FISHBEIN DH, 1990, CRIMINOLOGY, V28, P27, DOI 10.1111/j.1745-9125.1990.tb01317.x; Fruhwald S, 2005, LANCET, V366, P1242, DOI 10.1016/S0140-6736(05)67327-8; Harkness JM, 1996, JAMA-J AM MED ASSOC, V276, P1672, DOI 10.1001/jama.276.20.1672; HORNBLUM AM, 1999, ACRES SKIN HUMAN EXP; Hutton HE, 2001, PSYCHIATR SERV, V52, P508, DOI 10.1176/appi.ps.52.4.508; Kalmbach KC, 2003, BEHAV SCI LAW, V21, P671, DOI 10.1002/bsl.533; Krivo J, 1999, ARCH DERMATOL, V135, P469, DOI 10.1001/archderm.135.4.469; Krivo JM, 2000, ARCH DERMATOL, V136, P1567, DOI 10.1001/archderm.136.12.1567-a; Lazzarini Z, 2000, AIDS PUBLIC POLICY J, V15, P105; Motta Robert W, 2004, Int J Emerg Ment Health, V6, P67; *NAT I HLTH, 2007, CERT CONF KIOSK; Quina Kathryn, 2007, J Trauma Dissociation, V8, P123; Teplin LA, 1996, ARCH GEN PSYCHIAT, V53, P505; *US DEP JUST BUR J, 2007, CORR STAT	30	16	16	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0161-9268	1550-5014		ADV NURS SCI	Adv. Nurs. Sci.	APR-JUN	2008	31	2					119	127		10.1097/01.ANS.0000319562.84007.22			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	305FY	WOS:000256164400005	18497588				2022-02-06	
J	Pauldine, R; Beck, G; Salinas, J; Kaczka, DW				Pauldine, Ronald; Beck, George; Salinas, Jose; Kaczka, David W.			Closed-loop strategies for patient care systems	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						closed-loop; critical care medicine; mass casualty	CRITICALLY ILL PATIENTS; BISPECTRAL INDEX; MECHANICAL VENTILATION; INTRAHOSPITAL TRANSPORT; FUZZY-LOGIC; INTRAVENOUS ANESTHESIA; SODIUM-NITROPRUSSIDE; PROPOFOL ANESTHESIA; SECONDARY INSULTS; DECISION TABLES	Military operations, mass casualty events, and remote work sites present unique challenges to providers of immediate medical care, who may lack the necessary skills for optimal clinical management Moreover, the number of patients in these scenarios may overwhelm available health care resources. Recent applications of closed-loop control (CLC) techniques to critical care medicine may offer possible solutions for such environments. Here, feedback of a monitored variable or group of variables is used to control the state or output of a dynamic system. Some potential advantages of CLC in patient management include limiting task saturation when there is simultaneous demand for cognitive and active clinical intervention, improving quality of care through optimization of the titration of medications, conserving limited consumable supplies, preventing secondary insults in traumatic brain injury, shortening the duration of mechanical ventilation, and achieving appropriate goal-directed resuscitation. The uses of CLC systems in critical care medicine have been increasingly explored across a wide range of therapeutic modalities. This review will provide an overview of control system theory as applied to critical care medicine that must be considered in the design of autonomous CLC systems, and introduce a number of clinical applications under development in the context of deployment of such applications to austere environments.	[Pauldine, Ronald] Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21218 USA; [Beck, George] Impact Instrumentat Inc, W Caldwell, NJ USA; [Salinas, Jose] USA, Inst Surg Res, Trauma Informat Syst Dev, Ft Sam Houston, TX 78234 USA; [Kaczka, David W.] Johns Hopkins Univ, Dept Biomed Engn, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA		Pauldine, R (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care Med, A3W-387, Baltimore, MD 21218 USA.	rpauldi1@jhmi.edu	Kaczka, David W./A-2984-2008; Kaczka, David W./U-2580-2018	Kaczka, David W./0000-0003-4378-5242; Kaczka, David W./0000-0003-4378-5242			Absalom AR, 2003, BRIT J ANAESTH, V90, P737, DOI 10.1093/bja/aeg137; Alkins SA, 2002, AVIAT SPACE ENVIR MD, V73, P677; Anderson JP, 2002, BIOMED SCI INSTRUM, V38, P289; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; ASSEF SJ, 1993, MAYO CLIN PROC, V68, P1074, DOI 10.1016/S0025-6196(12)60901-X; Bacal K, 2004, MIL MED, V169, P631, DOI 10.7205/MILMED.169.8.631; Barker SJ, 2002, ANESTH ANALG, V95, P967, DOI 10.1213/01.ANE.0000029029.03601.08; Barr J, 2001, ANESTHESIOLOGY, V95, P324, DOI 10.1097/00000542-200108000-00011; Bekar A, 1998, NEUROSURG REV, V21, P98, DOI 10.1007/BF02389312; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Branson R, 2002, RESP CARE, V47, P451; Branson Richard D, 2002, Respir Care, V47, P427; Chase J Geoffrey, 2005, Diabetes Technol Ther, V7, P274, DOI 10.1089/dia.2005.7.274; Chee F, 2002, ANAESTH INTENS CARE, V30, P295, DOI 10.1177/0310057X0203000306; Claure N, 1997, J PEDIATR-US, V131, P910, DOI 10.1016/S0022-3476(97)70042-8; Cook RI, 1996, J CLIN ANESTH, V8, pS29, DOI 10.1016/S0952-8180(96)90009-4; Davey A L, 2001, Air Med J, V20, P27, DOI 10.1067/mmj.2001.116993; De Haes A, 2002, ANAESTHESIA, V57, P1237; DEASLA RA, 1985, J THORAC CARDIOV SUR, V89, P115; Dojat M, 2001, Respir Care Clin N Am, V7, P379, DOI 10.1016/S1078-5337(05)70048-4; DUMONT GA, 2002, CONCEPTS METHODS TEC; Egan TD, 2003, ANESTHESIOLOGY, V99, P1039, DOI 10.1097/00000542-200311000-00003; Eleveld DJ, 2005, ANESTH ANALG, V101, P758, DOI 10.1213/01.ane.0000167069.54613.50; FRUMIN MJ, 1957, J LAB CLIN MED, V49, P617; Gehring Hartmut, 2002, Respir Care, V47, P48; Glass PSA, 2001, ANESTHESIOLOGY, V95, P1, DOI 10.1097/00000542-200107000-00005; HOLLAND RR, 1975, JAMA-J AM MED ASSOC, V233, P455, DOI 10.1001/jama.233.5.455; Hoskins SL, 2006, J BURN CARE RES, V27, P377, DOI 10.1097/01.BCR.0000216512.30415.78; Jaber S, 2004, ANESTHESIOLOGY, V100, P782, DOI 10.1097/00000542-200404000-00006; Johannigman JA, 2008, J TRAUMA, V64, pS295, DOI 10.1097/TA.0b013e31816bce54; Johansen JW, 2006, BEST PRACT RES-CLIN, V20, P81, DOI 10.1016/j.bpa.2005.08.004; Kaczka David W, 2004, Respir Care Clin N Am, V10, P369, DOI 10.1016/j.rcc.2004.04.001; Kaczka DW, 2004, ANN BIOMED ENG, V32, P596, DOI 10.1023/B:ABME.0000019179.87974.7d; Kaczka DW, 2004, RESP CARE CLIN N AM, V10, p[369, vii]; Kenny GNC, 1999, BRIT J ANAESTH, V83, P223, DOI 10.1093/bja/83.2.223; Kern SE, 1997, ARTIF INTELL MED, V11, P9, DOI 10.1016/S0933-3657(97)00022-5; Konrad F, 1996, ANAESTHESIST, V45, P802, DOI 10.1007/s001010050313; Latorre F, 1998, ANESTH ANALG, V86, P867, DOI 10.1097/00000539-199804000-00035; Liu N, 2006, EUR J ANAESTH, V23, P465, DOI 10.1017/S0265021506000196; MACKENZIE AF, 1993, ANAESTHESIA, V48, P202, DOI 10.1111/j.1365-2044.1993.tb06901.x; MCKINLEY S, 1991, CRIT CARE MED, V19, P166, DOI 10.1097/00003246-199102000-00009; Milne SE, 1998, ANAESTHESIA, V53, P56, DOI 10.1111/j.1365-2044.1998.53s110.x; MITAMURA Y, 1971, IEEE T BIO-MED ENG, VBM18, P330, DOI 10.1109/TBME.1971.4502864; Nasraway SA, 2002, CRIT CARE MED, V30, P1483, DOI 10.1097/00003246-200207000-00014; Nemoto T, 1999, AM J RESP CRIT CARE, V160, P550, DOI 10.1164/ajrccm.160.2.9809013; OLKKOLA KT, 1994, EUR J ANAESTH, P99; PHILLIPS CL, 1988, FEEDBACK CONTROL SYS; Riess ML, 2002, EUR J ANAESTH, V19, P18, DOI 10.1017/S0265021502000030; Robinson Kathy, 2004, J Emerg Nurs, V30, P160, DOI 10.1016/j.jen.2004.01.004; SASTRY A, 1989, ADAPTIVE CONTROL STA; Schaublin J, 1996, BRIT J ANAESTH, V77, P636, DOI 10.1093/bja/77.5.636; Shiffman RN, 1997, J AM MED INFORM ASSN, V4, P382, DOI 10.1136/jamia.1997.0040382; Sneyd JR, 2004, BRIT J ANAESTH, V93, P725, DOI 10.1093/bja/aeh253; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Struys MMRF, 2006, BEST PRACT RES-CLIN, V20, P211, DOI 10.1016/j.bpa.2005.08.012; Struys Michel M R F, 2002, Curr Opin Anaesthesiol, V15, P421, DOI 10.1097/00001503-200208000-00003; Struys MMRF, 2004, ANESTHESIOLOGY, V100, P640, DOI 10.1097/00000542-200403000-00026; Tonner PH, 2006, BEST PRACT RES-CLIN, V20, P191, DOI 10.1016/j.bpa.2005.08.011; van den Nieuwenhuyzen MCO, 2000, CLIN PHARMACOKINET, V38, P181, DOI 10.2165/00003088-200038020-00003; Vivien B, 2003, ANESTHESIOLOGY, V99, P9, DOI 10.1097/00000542-200307000-00006	60	16	18	2	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2008	64	4		S			S289	S294		10.1097/TA.0b013e31816bce43			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	288WT	WOS:000255017400002	18385581				2022-02-06	
J	Young, AE; Wasiak, R; Webster, BS; Shayne, RGF				Young, Amanda E.; Wasiak, Radoslaw; Webster, Barbara S.; Shayne, Rebecca G. F.			Urban-rural differences in work disability after an occupational injury	SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH			English	Article						disability outcome; geographic variation; return to work; rural health; work-related injury	TRAUMATIC BRAIN-INJURIES; HEALTH; CARE; ILLNESS; CONSEQUENCES; RETURN	Objectives In comparison with their urban counterparts, people living in rural areas have been found to experience higher rates of morbidity and mortality and have inferior health outcomes after illnesses and injuries. The current study sought to determine if this trend extends to work-disability outcomes after work-related injuries. Methods This study was a retrospective cohort study using data on workers' compensation claims. Rurality was defined at the postal-code level on the basis of United States 2000 census data. Work disability was measured using the number of full days a person was off work in the 2 years following an injury. Regression analyses were used to test the association between rurality and the duration of work disability after a work-related bone fracture. Results The claimants with higher rurality experienced less work disability than those with lower rurality. This relationship remained after control for the impact of age, gender, part of body injured, occupation, and industry. Conclusions Rurality was found to be related to work disability. However, rather than being associated with more time off after an injury, as could be expected on the basis of past findings, increased rurality was found to. be associated with less time off work. The findings suggest that features of rural environments, cultures, and behavioral patterns may facilitate return to work.	[Young, Amanda E.; Wasiak, Radoslaw; Webster, Barbara S.; Shayne, Rebecca G. F.] Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA		Young, AE (corresponding author), Liberty Mutual Res Inst Safety, Ctr Disabil Res, 71 Frankland Rd, Hopkinton, MA 01748 USA.	AmandaE.Young@LibertyMutual.com	Young, Amanda/H-8851-2016	Young, Amanda/0000-0002-7288-3469			Adams CE, 2001, J NURS ADMIN, V31, P244; Blackwell TL, 2003, REHABIL COUNS BULL, V46, P54; BURTON JF, 2004, WORKERS COMPENS POLI, V4, P2; CRAFT BJ, 2001, RURAL MENTAL HLT WIN, P19; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; Dichraff R M, 1993, AAOHN J, V41, P491; Eberhardt MS, 2004, AM J PUBLIC HEALTH, V94, P1682, DOI 10.2105/AJPH.94.10.1682; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Hart LG, 2005, AM J PUBLIC HEALTH, V95, P1149, DOI 10.2105/AJPH.2004.042432; Hart LG, 2002, J RURAL HEALTH, V18, P211, DOI 10.1111/j.1748-0361.2002.tb00932.x; Heckman TG, 1998, AIDS CARE, V10, P365, DOI 10.1080/713612410; International Labour Office, 1990, INT STANDARD CLASSIF; John WG, 1996, INQUIRY-J HEALTH CAR, V33, P53; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Lee AH, 2003, MED J AUSTRALIA, V179, P289, DOI 10.5694/j.1326-5377.2003.tb05549.x; LEE HJ, 1993, NURS CLIN N AM, V28, P219; MAELAND JG, 1986, SCAND J SOC MED, V14, P183, DOI 10.1177/140349488601400404; Mahmud MA, 2000, J OCCUP ENVIRON MED, V42, P1178, DOI 10.1097/00043764-200012000-00012; Murphy PL, 1996, AM J IND MED, V30, P130, DOI 10.1002/(SICI)1097-0274(199608)30:2<130::AID-AJIM3>3.3.CO;2-A; Pransky G, 2001, CLIN OCCUPATIONAL EN, V1, P829; RICKETTS K, 1999, NONMETROPOLITAN HLTH, P7; Ruser JW, 1999, MON LABOR REV, V122, P11; Sanders KM, 2002, J EPIDEMIOL COMMUN H, V56, P466, DOI 10.1136/jech.56.6.466; Schlenker RE, 2002, J RURAL HEALTH, V18, P359, DOI 10.1111/j.1748-0361.2002.tb00897.x; Schootman M, 1999, BRAIN INJURY, V13, P995; *US BUR CENS, 2002, CENS 2000 URB RUR CL; *US BUR CENS, 2003, CENS POP HOUS 2000 S; *US OFF MAN BUDG E, 1987, STAND IND CLASS SIC; Veitch P C, 1996, Aust J Rural Health, V4, P104, DOI 10.1111/j.1440-1584.1996.tb00196.x; Wasiak Radoslaw, 2006, Work, V26, P3; Weil D, 2001, AM J IND MED, V40, P418, DOI 10.1002/ajim.1114; Young AE, 2004, DISABIL REHABIL, V26, P1013, DOI 10.1080/09638280410001702432; 1999, MMWR MORB MORTAL WKL, V48, P461	33	16	16	1	2	SCANDINAVIAN JOURNAL WORK ENVIRONMENT & HEALTH	HELSINKI	TOPELIUKSENKATU 41A, SF-00250 HELSINKI, FINLAND	0355-3140	1795-990X		SCAND J WORK ENV HEA	Scand. J. Work Environ. Health	APR	2008	34	2					158	164		10.5271/sjweh.1217			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	306VF	WOS:000256275200010	18470437	hybrid			2022-02-06	
J	Czeiter, E; Pal, J; Kovesdi, E; Bukovics, P; Luckl, J; Doczi, T; Buki, A				Czeiter, Endre; Pal, Jozsef; Kovesdi, Erzsebet; Bukovics, Peter; Luckl, Janos; Doczi, Tamas; Buki, Andras			Traumatic axonal injury in the spinal cord evoked by traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; axonal injury; models of injury; traumatic brain injury	AMYLOID PRECURSOR PROTEIN; HEAD-INJURY; ACCELERATION; MODEL; RATS	Although it is well known that traumatic brain injury ( TBI) evokes traumatic axonal injury ( TAI) within the brain, TBI-induced axonal damage in the spinal cord ( SC) has been less extensively investigated. Detection of such axonal injury in the spinal cord would further the complexity of TBI while also challenging some functional neurobehavioral endpoints frequently used to assess recovery in various models of TBI. To assess TAI in the spinal cord associated with TBI, we analyzed the craniocervical junction ( CCJ), cervico-thoracic ( CT), and thoraco-lumber ( ThL) spinal cord in a rodent model of impact acceleration of TBI of varying severities. Rats were transcardially fixed with aldehydes at 2, 6, and 24 h post-injury ( n = 36); each group included on sham-injured rodent. Semi-serial vibratome sections were reacted with antibodies targeting TAI via alteration in cytoskeletal integrity or impaired axonal transport. Consistent with previous observations in this model, the CCJ contained numerous injured axons. Immunoreactive, damaged axonal profiles were also detected as caudal, as the ThL spinal cord displayed morphological characteristics entirely consistent with those described in the brainstem and the CCJ. Quantitative analyses demonstrated that the occurrence and extent of TAI is positively associated with the impact/energy of injury and negatively with the distance from the brainstem. These observations show that TBI can evoke TAI in regions remote from the injury site, including the spinal cord itself. This finding is relevant to shaken baby syndrome as well as during the analysis of data in functional recovery in various models of TBI.	[Czeiter, Endre; Pal, Jozsef; Kovesdi, Erzsebet; Bukovics, Peter; Luckl, Janos; Doczi, Tamas; Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Bukovics, Peter] Hungarian Acad Sci, Clin Neurosci Res Grp, Pecs, Hungary		Buki, A (corresponding author), 2-7623 Ret Str 2, Pecs, Hungary.	2saturn@gmail.com	Buki, Andras/B-1960-2010; Czeiter, Endre/B-1404-2009; Pal, Jozsef/C-4073-2009; Doczi, Tamas/C-5750-2009; Bukovics, Peter/A-6019-2009; Pal, Jozsef/I-3416-2013; Luckl, Janos/ABF-7183-2021	Luckl, Janos/0000-0001-8094-771X; Pal, Jozsef/0000-0001-6468-6409			ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Blumbergs P. C., 2005, HEAD INJURY PATHOPHY, P41; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cornish R, 2000, SPINE, V25, P1227, DOI 10.1097/00007632-200005150-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; LEE VMY, 1987, J NEUROSCI, V7, P3474; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 2001, HEAD TRAUMA, P281; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996	21	16	17	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2008	25	3					205	213		10.1089/neu.2007.0331			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	282PJ	WOS:000254579400004	18352834	Green Accepted			2022-02-06	
J	Arco, L				Arco, Lucius			Neurobehavioural treatment for obsessive-compulsive disorder in an adult with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	29th Annual Conference of the Australian-Society-for-the-Study-of-Brain-Impairment	APR, 2006	Sydney, AUSTRALIA	Australian Soc Brain Impairment		brain injury rehabilitation; neurobehavioural rehabilitation; obsessive-compulsive disorder; self-regulation; traumatic brain injury	COGNITIVE-BEHAVIOR THERAPY; CLOSED-HEAD-INJURY; DEPRESSION; NEUROPSYCHOLOGY; REHABILITATION; INDIVIDUALS; ADOLESCENTS	Although obsessive-compulsive disorder has been reported as one of many anxiety-related sequelae of brain injury, few empirical data of its responsiveness to psychological intervention are available. In this study, a single participant changing criterion experimental design was used to evaluate a neurobehavioural intervention for compulsive behaviour of an adult with severe traumatic brain injury. The participant, a man aged 24 years, had sustained frontal-temporal lobe brain trauma 12 months earlier, and presented with compulsive counting and voiding of bladder. The neurobehavioural intervention consisted of regular in-home consultations, self-regulation procedures including self-recording of compulsive behaviour, stress-coping strategies, errorless remediation, social reinforcement, and gradual fading of intervention. Baseline showed counting occurred on average 80% of daily hourly intervals, and voiding 12 times per day. Intervention produced elimination of compulsive counting, acceptable voiding at 8 times per day, and reports of the participant's satisfaction with intervention methods and outcomes. At 6 months follow-up, counting remained at zero levels, and voiding had decreased further to 7 times per day.	Praxis Res, Yokine, WA 6060, Australia; [Arco, Lucius] Praxis Res, Perth, WA, Australia		Arco, L (corresponding author), Praxis Res, LPO Box 2065 Dog Swamp, Yokine, WA 6060, Australia.	arco.im@bigpond.com					Abramowitz JS, 1997, J CONSULT CLIN PSYCH, V65, P44, DOI 10.1037/0022-006X.65.1.44; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arco L, 2004, BEHAV THER, V35, P605, DOI 10.1016/S0005-7894(04)80034-0; Barlow DH, 1984, SINGLE CASE EXPT DES; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Franklin M.E., 2002, GUIDE TREATMENTS WOR, P367; Friedlander L, 2006, CLIN PSYCHOL REV, V26, P32, DOI 10.1016/j.cpr.2005.06.010; Greisberg S, 2003, CLIN PSYCHOL REV, V23, P95, DOI 10.1016/S0272-7358(02)00232-5; Hayes SC, 2004, BEHAV THER, V35, P639, DOI 10.1016/S0005-7894(04)80013-3; HAYES SC, 1996, ADV PSYCHOL, P279; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jacobs H. E., 2000, HDB APPL BEHAV ANAL, P211; Jacobson NS, 1997, BEHAV THER, V28, P435, DOI 10.1016/S0005-7894(97)80092-5; Kant R, 1996, BRAIN INJURY, V10, P55; KAZDIN AE, 1977, BEHAV MODIF, V1, P427, DOI 10.1177/014544557714001; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Kohlenberg R J, 1996, Prog Behav Modif, V30, P1; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEWIS FD, 1988, BEHAV THER, V19, P203, DOI 10.1016/S0005-7894(88)80043-1; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luria A.R., 1973, WORKING BRAIN INTRO; Manchester D, 2001, BRAIN DAM B, P157; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; PACE GM, 1994, J APPL BEHAV ANAL, V27, P301, DOI 10.1901/jaba.1994.27-301; Slifer KJ, 1997, BRAIN INJURY, V11, P877; Steketee G, 2002, ANXIETY ITS DISORDER, P516; Tallis F, 1997, BRIT J CLIN PSYCHOL, V36, P3, DOI 10.1111/j.2044-8260.1997.tb01226.x; Taylor I, 1997, J APPL BEHAV ANAL, V30, P43, DOI 10.1901/jaba.1997.30-43; Wesolowski M. D., 1993, BEHAV RESIDENTIAL TR, V8, P89, DOI DOI 10.1002/BIN; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; WOLF MM, 1978, J APPL BEHAV ANAL, V11, P203, DOI 10.1901/jaba.1978.11-203; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; [No title captured]	41	16	17	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN	2008	18	1					109	124		10.1080/09602010701656706			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychology	249HD	WOS:000252218000006	18058389				2022-02-06	
J	Bushnik, T; Englander, J; Wright, J				Bushnik, Tamara; Englander, Jeffrey; Wright, Jerry			Patterns of fatigue and its correlates over the first 2 years after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; fatigue; longitudinal studies; pain; sleep; traumatic brain injury	TRANSCRANIAL MAGNETIC STIMULATION; REHABILITATION OUTCOMES; HEAD-INJURY; RECOVERY; MODERATE; ASSOCIATION; INSTRUMENT; DISABILITY; DEPRESSION; INVENTORY	This study used a prospective longitudinal design to quantify fatigue and associated factors during the first 2 years after traumatic brain injury (TBI). Fifty-one individuals were assessed at 3 time points: within the first 6, 12, and 18-24 months after TBI. Self-reported fatigue improved during the first year, as did pain, sleep quality, cognitive independence, and involvement in productive activity. Further changes up to 2 years after TBI were not observed. The subset of individuals who reported significant increases in fatigue over the first 2 years demonstrated poorer outcomes in cognition, motor symptoms, and general functioning than those with decreased or stable fatigue.	[Bushnik, Tamara; Englander, Jeffrey; Wright, Jerry] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA		Bushnik, T (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	tamara@tbi-sci.org		Bushnik, Tamara/0000-0003-3328-257X			Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BAROSSO J, 2002, J ASSOC NURSE AIDS C, V13, P66; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BELZA BL, 1995, J RHEUMATOL, V22, P639; BERRIOS GE, 1990, COMPR PSYCHIAT, V31, P140, DOI 10.1016/0010-440X(90)90018-N; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bormann J, 2001, J Assoc Nurses AIDS Care, V12, P75, DOI 10.1016/S1055-3290(06)60146-5; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; BUSHNIK T, 2006, 2 FED INT C TBI MARC; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Cope Helen, 1992, International Review of Psychiatry, V4, P273, DOI 10.3109/09540269209066328; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; FISK JD, 1994, CLIN INFECT DIS   S1, V18, P79; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hillier SL, 1997, BRAIN INJURY, V11, P661; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LIEBERMAN SA, 1996, J PEDIAT, V128, P58; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Meek PM, 2000, NURS RES, V49, P181, DOI 10.1097/00006199-200007000-00001; Michael Kathleen, 2002, Rehabil Nurs, V27, P89; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; STOKES MJ, 1988, BRIT MED J, V297, P1014, DOI 10.1136/bmj.297.6655.1014; Substance Abuse and Mental Health Services Administration, NAT HOUS SURV DRUG A; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Taylor RR, 2002, PSYCHOSOM MED, V64, P319, DOI 10.1097/00006842-200203000-00016; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wambach K A, 1998, J Hum Lact, V14, P219, DOI 10.1177/089033449801400311; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; [No title captured]	54	16	17	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2008	23	1					25	32		10.1097/01.HTR.0000308718.88214.bb			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	256HS	WOS:000252719800006	18219232				2022-02-06	
J	Careau, E; Vincent, C; Noreau, L				Careau, Emmanuelle; Vincent, Claude; Noreau, Luc			Assessing interprofessional teamwork in a videoconference-based telerehabilitation setting	JOURNAL OF TELEMEDICINE AND TELECARE			English	Article							TRAUMATIC BRAIN-INJURY; WORK; DISABILITIES; PREVALENCE; PEOPLE; TEAMS	We studied the workings of a rehabilitation team in a videoconference setting to note the pros and cons of videoconferencing in the development of interprofessional care plans (ICPs). We recorded every videoconference held by the teams of the specialized centre and the regional centre for clients with traumatic brain injuries over an 18-month period. Thirteen recorded videoconferences, lasting for 30-98 min, were analysed through an observation grid. On the whole, efficient teamwork was observed: the mean productivity level was 96%, while the percentage of time dedicated to the resolution of technical issues was 2%. During the videoconferences, the clinical coordinator and the client addressed the group most often. One of the most commonly mentioned advantages was the good visual contact provided by videoconferencing. The most often quoted disadvantage was the poor sound quality. The findings from the study support the adoption of videoconferencing and suggest a few guidelines for the development of ICPs.	[Careau, Emmanuelle] Ctr Interdisciplinary Res Rehabil & Social Integr, Inst Readaptat Deficience Phys Quebec, Quebec City, PQ G1M 2S8, Canada; [Careau, Emmanuelle] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Vincent, Claude; Noreau, Luc] Univ Laval, Dept Rehabil, Quebec City, PQ G1K 7P4, Canada		Careau, E (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Inst Readaptat Deficience Phys Quebec, 525 Wilfrid Hamel Blvd E, Quebec City, PQ G1M 2S8, Canada.	enmanuelle.careau@rea.ulaval.ca			Centre de readaptation InterAction; Institut de readaptation en deficience physique de Quebec; Agence de developpement de reseaux locaux de services de sante et de services sociaux de la Capitale Nationale et du Bas-St-Laurent; University Laval's Centre for Interdisciplinary Research in Rehabilitation and Social Integration; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [2008-2011]	We thank everyone who took part in the study. Financial support was provided by the Centre de readaptation InterAction, the Institut de readaptation en deficience physique de Quebec, the Agence de developpement de reseaux locaux de services de sante et de services sociaux de la Capitale Nationale et du Bas-St-Laurent and University Laval's Centre for Interdisciplinary Research in Rehabilitation and Social Integration. The first author holds a doctoral scholarship from the Canadian Institute of Health Research (2008-2011).	Aas I. H. M., 2003, Behaviour and Information Technology, V22, P91, DOI 10.1080/0044929021000088407; Aas IHM, 2001, J TELEMED TELECARE, V7, P212, DOI 10.1258/1357633011936426; Bender A D, 1990, Med Group Manage J, V37, P30; BENDER AD, 1990, MED GROUP MANAGE J, V37, P35; Bernard M. M., 2005, VIE VIEILLISSEMENT, V4, P25; BLOUIN M, 1997, PLAN INTERVENTION DI, V2, P57; BROUSSEAU T, 2003, GUIDE ELABORATION PL; Casto M., 1994, INTERPROFESSIONAL CA; Creswell JW., 1998, QUAL INQ; Drahota A, 2008, NURS RES, V57, P293, DOI 10.1097/01.NNR.0000313489.49165.97; Elovic E, 1999, TOP SPINAL CORD INJ, V5, P1, DOI DOI 10.1310/V75J-RE76-20GH-X7BY; Finlayson M, 2005, NEUROREHABILITATION, V20, P267; GADOURY M, 1999, CADRE REFERENCE CLIN; Gervais M, 1999, ETUDE EXPLORATOIRE B; GRISE MC, 2007, PHYSIOQUEBEC, V31, P15; Guilfoyle C, 2003, J TELEMED TELECARE, V9, P230, DOI 10.1258/135763303322225571; Hegeman K M, 1988, Rehabil Nurs, V13, P254; JAMET C, 2005, RECHERCHE SOINS INFI, V82, P62; JESSIMAN SM, 2003, REV ORTHOPHONIE AUDI, V27, P45; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; KAIRY D, DISABIL REH IN PRESS; MARIANO C, 1989, NURS OUTLOOK, V37, P285; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; Roberts S, 2008, NURS EDUC TODAY, V28, P85, DOI 10.1016/j.nedt.2006.06.004; RUBIN IM, 1972, MILBANK MEML FUND Q, V50, P317, DOI 10.2307/3349352; Savard L, 2003, NEUROREHABILITATION, V18, P93; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; STARNAUD Y, 1989, PETITS GROUPES PARTI; SUNDSTROM E, 1990, AM PSYCHOL, V45, P120, DOI 10.1037/0003-066X.45.2.120; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TREMBLAY J, 2000, J READAPTATION MED, V20, P95; VINCENT C, SUIVI CLIENTELES TRA; Watts L., 1997, P C HUM FACT COMP SY, P534; WEBER MD, 1991, AM J PHYSL 3, V261, P12	35	16	17	0	5	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	1357-633X			J TELEMED TELECARE	J. Telemed. Telecare		2008	14	8					427	434		10.1258/jtt.2008.080415			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	393FH	WOS:000262355900006	19047453				2022-02-06	
J	Darkins, A; Cruise, C; Armstrong, M; Peters, J; Finn, M				Darkins, Adam; Cruise, Cathy; Armstrong, Michael; Peters, John; Finn, Michael			Enhancing access of combat-wounded veterans to specialist rehabilitation services: The VA polytrauma Telehealth Network	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						rehabilitation; telecommunication networks; telemedicine; wounds and injuries	TRAUMATIC BRAIN-INJURY; CASUALTIES	Operations Iraqi Freedom and Enduring Freedom have resulted in U.S. military personnel sustaining combat wounds of unprecedented severity and complexity that necessitate long-term rehabilitation. To meet what are often conflicting requirements in providing severely wounded veterans with timely and convenient access to specialist rehabilitation care, and to enable them to return to their local communities, the Veterans Health Administration has developed a state-of-the-art Polytrauma Telehealth Network that enhances access to such services by linking Veterans Administration rehabilitation facilities. This article describes the clinical, technical, and business process issues involved in the development of this network.	[Darkins, Adam; Peters, John; Finn, Michael] Off Care Coordinat 11CC, Dept Vet Affairs, Vet Hlth Adm, Washington, DC 20420 USA; [Cruise, Cathy] US Dept Vet Affairs, Vet Hlth Adm, Northport, MN USA; [Armstrong, Michael] US Dept Vet Affairs, Vet Hlth Adm, Minneapolis, MN USA		Darkins, A (corresponding author), Off Care Coordinat 11CC, Dept Vet Affairs, Vet Hlth Adm, 810 Vermont Ave NW, Washington, DC 20420 USA.						BABIARZ J, 2005, CONFIGURATION GUIDEL; BITA NLF, 2005, COMMUNICATIONS, V43, P119; BLACK D, 1998, ARCHITECTURE DIFFERE; Bricknell M C M, 2003, J R Army Med Corps, V149, P166; Childress DS, 2002, J REHABIL RES DEV, V39, P1; *DEP VET AFF, 2006, VHA DEC SUPP SYST DS; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Eldar R, 2003, DISABIL REHABIL, V25, P1019, DOI 10.1080/0963828031000137739; GOKA RS, 1994, BRAIN INJ REHABIL, V26, P420; GOODWIN K, 2000, STATE HLTH NOTES, V21, P330; JACOBSON V, 2000, IETF47; JOHNSON T, 2004, H350 INT SOC; King B, 2005, J NATL MED ASSOC, V97, P648; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; *OFF CAR COORD DEP, 2006, ROUT TEL HLTH ACT DA; *OFF CAR COORD DEP, 2006, ROUT HOM TEL ACT DAT; Pasquina PF, 2006, MIL MED, V171, P206, DOI 10.7205/MILMED.171.3.206; RADCLIFFE M, US LEGAL SYSTEM; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Tenuta Joachim J, 2006, J Am Acad Orthop Surg, V14, pS45; *US DEP HHS, HLTH IT STRAT FRAM A; Wetherall D. J., 1996, P 7 ACM SIGOPS EUR W, P33	23	16	16	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2008	89	1					182	187		10.1016/j.apmr.2007.07.027			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	249LB	WOS:000252228600031	18164352				2022-02-06	
J	Eikelmann, A; Petermann, F; Daseking, M				Eikelmann, Antje; Petermann, Franz; Daseking, Monika			Attention deficit disorders after stroke in childhood	ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE			German	Article						stroke in children; assessment of attention abilities; CBCL; attention deficit disorder	TRAUMATIC BRAIN-INJURY; HYPERACTIVITY DISORDER; CHILDREN; ADOLESCENTS; SKILLS; TERM; TBI; PERFORMANCE; SYMPTOMS; VALIDITY	Objective: The present study investigates whether attention deficits increase after stroke in childhood and identifies influencing factors. Methods: The attentional functions of 78 children who suffered strokes were evaluated by means of neuropsychological assessments for attention abilities, the CBCL/4-18, and a standardized observation of behavior. The results were compared for age at the time of the stroke, affected hemisphere, and localisation. Results: Children and adolescents develop attention deficits due to stroke. There seems to be no influence of sex, age at stroke or localisation of stroke. Children with right-hemispheric brain damage tend to develop more attention deficits than children with left-hemispheric stroke. Conclusions: There is a need for an early diagnosis and the initiation of an effective treatment to avoid collateral disorders and school problems.	[Eikelmann, Antje; Petermann, Franz; Daseking, Monika] Univ Bremen, Zentrum Klin Psychol & Rehabil, DE-28359 Bremen, Germany		Eikelmann, A (corresponding author), Univ Bremen, Zentrum Klin Psychol & Rehabil, Grazer Str 2, DE-28359 Bremen, Germany.	asimonis@uni-bremen.de					Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Daseking M, 2003, NERVENARZT, V74, P1088, DOI 10.1007/s00115-003-1588-0; Daseking M, 2008, FORTSCHR NEUROL PSYC, V76, P662, DOI 10.1055/s-2008-1038262; DASEKING M, 2005, SCHLAGANFALLE KINDES; Daseking M, 2007, Z KINDER JUG-PSYCH, V35, P311, DOI 10.1024/1422-4917.35.5.311; Desman C, 2005, KINDH ENTWICKL, V14, P244, DOI 10.1026/0942-5403.14.4.244; Jacobs C, 2007, MONATSSCHR KINDERH, V155, P921, DOI 10.1007/s00112-007-1596-4; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Konrad K, 2007, KINDH ENTWICKL, V16, P7, DOI 10.1026/0942-5403.16.1.7; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lienert, 1998, KURZGEFASSTE STAT KL; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P976, DOI 10.1017/S1355617704107066; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P698, DOI 10.1017/S1355617704105092; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2003, J INT NEUROPSYCH SOC, V9, P815, DOI 10.1017/S1355617703960012; Petermann F, 2007, KINDH ENTWICKL, V16, P1, DOI 10.1026/0942-5403.16.1.1; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Trauner DA, 2001, BRAIN, V124, P995, DOI 10.1093/brain/124.5.995; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; VONDERFECHT A, 2004, NEUROREHABILITATION, P71; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; ZIMMER O, 2002, EJPDIRECT A, V1, P1; Zimmermann P, 2002, TESTBATTERIE AUFMERK	31	16	17	0	5	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1422-4917	1664-2880		Z KINDER JUG-PSYCH	Z. Kinder-und Jugendpsy. Psychother.		2008	36	6					419	426		10.1024/1422-4917.36.6.419			8	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	382JA	WOS:000261600900006	19034857				2022-02-06	
J	Hermens, H; Huijgen, B; Giacomozzi, C; Ilsbroukx, S; Macellari, V; Prats, E; Rogante, M; Schifini, MF; Spitali, MC; Tasies, S; Zampolini, M; Vollenbroek-Hutten, M				Hermens, Hermie; Huijgen, Barbara; Giacomozzi, Claudia; Ilsbroukx, Stephan; Macellari, Velio; Prats, Elisabet; Rogante, Marco; Schifini, Maria Francesca; Spitali, Maria Cristina; Tasies, Sonia; Zampolini, Mauro; Vollenbroek-Hutten, Miriam			Clinical assessment of the HELLODOC tele-rehabilitation service	ANNALI DELL ISTITUTO SUPERIORE DI SANITA			English	Article						tele-rehabilitation; home rehabilitation; arm/hand function; neurologic patients	CHRONIC STROKE PATIENTS; BLIND	Within the EU project HELLODOC, the clinical effectiveness was investigated of the home care activity desk (H-CAD). Eighty-one patients with chronic stroke, traumatic brain injury (TBI) and multiple sclerosis (MS) were recruited; 50 out of 81 received 1 month of H-CAD intervention, with one training session a day lasting 30 minutes for 5 days a week. The overall satisfaction of both patients and therapists was high. The Action Research Arm (ARA) and the Nine Hole Peg Test (NHPT) were used as main outcome measures. They proved the H-CAD system to be at least as effective as usual care. Maybe due to limited length and intensity of treatment, during the training month subjects improved on the individual H-CAD exercises but, as in the usual care group, the arm/hand function remained at the same level.	[Giacomozzi, Claudia; Macellari, Velio; Rogante, Marco] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy; [Ilsbroukx, Stephan] Natl Multiple Sclerosis Ctr, Melsbroek, Belgium; [Prats, Elisabet; Tasies, Sonia] Fundacio Inst Guttmann, Barcelona, Spain; [Schifini, Maria Francesca; Spitali, Maria Cristina; Zampolini, Mauro] Unita Organ Riabilitaz Intens Neuromotoria, Trevi, Italy; [Hermens, Hermie; Huijgen, Barbara; Vollenbroek-Hutten, Miriam] Roessingh Res & Dev BV, Enschede, Netherlands		Hermens, H (corresponding author), Roessingh Res & Dev, Roessinghsbleekweg 33B, NL-7522 AH Enschede, Netherlands.	h.hermens@rrd.nl	Giacomozzi, Claudia/AAH-1640-2021; Giacomozzi, Claudia/G-5018-2016; Zampolini, Mauro/B-7749-2009	Giacomozzi, Claudia/0000-0001-6950-4934; Giacomozzi, Claudia/0000-0001-6950-4934; Vollenbroek-Hutten, Miriam/0000-0001-8730-1487			Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MAHONEY F I, 1965, Md State Med J, V14, P61; Penta M, 2001, STROKE, V32, P1627, DOI 10.1161/01.STR.32.7.1627; Senn S., 1997, STAT ISSUES DRUG DEV; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; Vaney C, 2004, MULT SCLER, V10, P417, DOI 10.1191/1352458504ms1048oa; VOLLENBROEKHUTT.MM, 2006, POWER ANAL CLIN TRIA; WAGENAAR RC, 1990, SCAND J REHABIL MED, V22, P1; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635	11	16	16	0	5	PENSIERO SCIENTIFICO	ROME	VIA SAN GIOVANNI VALDARNO 8, ROME, 00198, ITALY	0021-2571			ANN I SUPER SANITA	Ann. Ist. Super. Sanita		2008	44	2					154	163					10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	V15PB	WOS:000207812800005	18660565				2022-02-06	
J	Liu, WG; Ma, L; Wen, L; Shen, F; Sheng, HS; Zhou, B; Hu, WW; Zheng, XJ; Yang, XF				Liu, Weiguo; Ma, Li; Wen, Liang; Shen, Fang; Sheng, Hansong; Zhou, Bo; Hu, Weiwei; Zheng, Xiujue; Yang, Xiaofeng			Drilling skull plus injection of urokinase in the treatment of epidural haematoma: A preliminary study	BRAIN INJURY			English	Article						traumatic brain injury; epidural haematoma; drilling skull; urokinase; drainage	EXTRADURAL HEMATOMAS; MANAGEMENT; THROMBOLYSIS; ASPIRATION; HEMORRHAGE; DRAINAGE; THERAPY; MODEL; CT	Primary objective: This study was performed to evaluate the effectiveness of a minimally invasive approach to manage patients with epidural haematoma (EDH). The surgical indication and key points were investigated. Research design: Descriptive, retrospective study. Methods and procedures: Twenty-one patients with traumatic EDH were treated through the following method: After anaesthesia, twist drill trepanations were performed followed by a placement of drainage tubes. Twenty ku urokinase in 3 ml saline was injected into the haematoma cyst through the tube, which was closed for 3 hours before connection to a vacuum ball with negative pressure. The injection was repeated three times a day after operation. The fibrinolytic agents were not used in the 'acute group' because of the risk of rebleeding. CT scans were performed according to the changes of clinical manifestations. Main outcomes and results: The drainage tubes were left for 3-5 days before most clots were resolved. The patients discharged after 7 days' hospitalization on average. No infections or recurrence of EDHs were observed in this series. Conclusion: Drilling skull plus injection of urokinase through drainage tube is a safe and effective method with less injury in the treatment of a selected part of patients with EDHs.	[Yang, Xiaofeng] Zhejiang Univ, Dept Neurosurg, First Affiliated Hosp, Coll Med, Hangzhou 310027, Peoples R China; [Hu, Weiwei; Zheng, Xiujue] Zhejiang Univ, Coll Med, Second Affiliated Hosp, Dept Neurosurg, Hangzhou 310027, Peoples R China; [Liu, Weiguo; Ma, Li; Wen, Liang; Shen, Fang; Sheng, Hansong; Zhou, Bo] Zhejiang Univ, Coll Med, Inst Brain Med, Hangzhou 310027, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Dept Neurosurg, First Affiliated Hosp, Coll Med, Qing Chun Rd 79, Hangzhou 310027, Peoples R China.	martin735w@163.com	shen, fang/G-8439-2011				Bezircioglu H, 1996, J TRAUMA, V41, P696, DOI 10.1097/00005373-199610000-00016; Bonilha L, 2003, CLIN NEUROL NEUROSUR, V106, P69, DOI 10.1016/j.clineuro.2003.08.001; Bullock AR, 2006, NEUROSURGERY, V58, pVI; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; COOPER PR, 1986, NEUROSURGERY, V18, P700; DOI E, 1982, Neurologia Medico-Chirurgica, V22, P461, DOI 10.2176/nmc.22.461; FINDLAY JM, 1988, J NEUROSURG, V69, P723, DOI 10.3171/jns.1988.69.5.0723; GUPTA SK, 1992, CLIN NEUROL NEUROSUR, V94, P127, DOI 10.1016/0303-8467(92)90069-F; Kalita J, 2003, NEUROL INDIA, V51, P104; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Liu JT, 2006, ACTA NEUROCHIR, V148, P313, DOI 10.1007/s00701-005-0723-z; Maggi G, 1998, J Neurosurg Sci, V42, P95; MOHADJER M, 1990, J NEUROSURG, V73, P217, DOI 10.3171/jns.1990.73.2.0217; Montes JM, 2000, STROKE, V31, P834, DOI 10.1161/01.STR.31.4.834; NARAYAN RK, 1985, J NEUROSURG, V62, P580, DOI 10.3171/jns.1985.62.4.0580; Naval NS, 2007, J NEUROL SCI, V261, P80, DOI 10.1016/j.jns.2007.04.037; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; Rohde V, 2000, MINIM INVAS NEUROSUR, V43, P9, DOI 10.1055/s-2000-8411; Shah MV, 1999, AM J NEURORADIOL, V20, P115; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; van Eck ATCJ, 2002, J CLIN NEUROSCI, V9, P573, DOI 10.1054/jocn.2001.1061; Yilmazlar S, 2005, ACTA NEUROCHIR, V147, P1241, DOI 10.1007/s00701-005-0623-2	23	16	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	2					199	204		10.1080/02699050801895407			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	258DW	WOS:000252849600011	18240049				2022-02-06	
J	McIntosh, SE; Swanson, ER; McKeone, A; Barton, ED				McIntosh, Scott E.; Swanson, Eric R.; McKeone, Anna; Barton, Erik D.			LOCATION OF AIRWAY MANAGEMENT IN AIR MEDICAL TRANSPORT	PREHOSPITAL EMERGENCY CARE			English	Article						airway management; flight crews; air medical transport; helicopter; intubation; prehospital transport	TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; SUCCESS	Background. Prehospital providers are constantly challenged with the task of managing airways in unpredictable and often inhospitable environments. Air medical transport (AMT) crews must be prepared to work in restrictive spaces with limited resources while in the aircraft. This study examines flight crew success rate and circumstances surrounding airway management in different locations. Methods. This was a retrospective analysis of intubations performed by a university-based air medical transport team from January 1, 1995, to May 31, 2007. Patient records and prospectively gathered airway management quality assurance data were reviewed for location of intubation, patient characteristics, and success rates. Success was defined as placing a cuffed tube in the trachea nonsurgically. Results. Nine hundred thirty-eight patients required 939 advanced airway management procedures, and 936 cases had information sufficient for analysis. Six hundred twenty-seven (67%) of these intubations took place on scene, 235 (25.1%) at the referring hospital, 67 en-route (7.2%), and seven (0.7%) at the receiving hospital. The overall intubation success rate was 96% and the highest rate was for hospital intubations (98.8%), followed by scene (94.9%) and en-route (89.6%) airway encounters. Intubation success was more likely in the hospital setting (odds ratio [OR] = 8.7, 95% confidence interval [CI] 2.2-35.0, p = 0.002] and on the scene [OR = 2.3, 95% CI 0.95-5.7, p = 0.065] compared with those en-route. Unanticipated patient deterioration was noted as the most common reason for in-flight airway management. Type of aircraft was not significantly associated with intubation success (p = 0.132). Conclusions. Airway management was performed with a high success rate in a variety of locations and patient characteristics by our air medical crew. When in the hospital environment, flight crew success rates were comparable to those of other emergency personnel. Caution should be used, however, when considering intubating in-flight because of slightly lower success rates.	[McIntosh, Scott E.; Swanson, Eric R.; Barton, Erik D.] Univ Utah, Div Emergency Med, Salt Lake City, UT 84132 USA; [McKeone, Anna] Univ Utah, Affiliated Residency Emergency Med, Salt Lake City, UT 84132 USA		McIntosh, SE (corresponding author), Univ Utah, Div Emergency Med, 30 N Med Dr, Salt Lake City, UT 84132 USA.	scott.mcintosh@hsc.utah.edu					*BELL HEL, 2006, BELL HEL PROD SPEC M; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Duchynski R, 1998, Air Med J, V17, P46, DOI 10.1016/S1067-991X(98)90019-0; Foley LJ, 2000, CRIT CARE CLIN, V16, P429, DOI 10.1016/S0749-0704(05)70121-4; Harrison T, 1997, AM J EMERG MED, V15, P558, DOI 10.1016/S0735-6757(97)90156-X; Hunt R, 2007, HYBRIDOMA, V26, P231, DOI 10.1089/hyb.2007.0507; Ma OJ, 1998, AM J EMERG MED, V16, P125, DOI 10.1016/S0735-6757(98)90027-4; Rose W D, 1994, Air Med J, V13, P475, DOI 10.1016/S1067-991X(05)80289-5; Sakles JC, 1998, ANN EMERG MED, V31, P325, DOI 10.1016/S0196-0644(98)70342-7; Sing RF, 1996, ACAD EMERG MED, V3, P41, DOI 10.1111/j.1553-2712.1996.tb03301.x; Slater EA, 1998, J TRAUMA, V45, P588, DOI 10.1097/00005373-199809000-00031; Stone C K, 1994, Air Med J, V13, P319, DOI 10.1016/S1067-991X(05)80337-2; Thomas S H, 1999, Prehosp Emerg Care, V3, P310, DOI 10.1080/10903129908958960; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang Henry E, 2004, Prehosp Emerg Care, V8, P58; PC 12 SPECIFICATIONS	17	16	16	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1090-3127			PREHOSP EMERG CARE	Prehosp. Emerg. Care		2008	12	4					438	442		10.1080/10903120802301518			5	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	360RB	WOS:000260074100005	18924006				2022-02-06	
J	Schefft, BK; Dulay, MF; Fargo, JD				Schefft, Bruce K.; Dulay, Mario F.; Fargo, Jamison D.			The use of a self-generation memory encoding strategy to improve verbal memory and learning in patients with traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						generation effect; learning; memory; traumatic brain injury; verbal paired associates	CLOSED-HEAD INJURY; ALZHEIMER-TYPE; COGNITIVE REHABILITATION; 3-FACTOR THEORY; FREE-RECALL; DEMENTIA; WORDS; DEFICITS; MOOD; CUES	The generation effect refers to the theory that optimal acquisition and retention of information is achieved by active participation rather than by passive observation. The efficacy of a self-generation memory encoding strategy was tested using a verbal paired-associate task for free recall, cued recall, and recognition memory in 40 traumatically brain-injured outpatients in two studies. In study #1, self-generation encoding procedures improved recognition memory, but not free recall, compared with the didactic presentation of information. In study #2, self-generation procedures improved cued recall test performance, but the results demonstrated that the type of cue that is provided moderates the efficacy of self-generation procedures. Results provide preliminary empirical support for the use of self-generation encoding procedures in improving upon verbal memory and learning abilities in individuals with TBI.	[Schefft, Bruce K.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Schefft, Bruce K.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Dulay, Mario F.] Inst Rehabil & Res Hosp, Houston, TX USA; [Dulay, Mario F.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Fargo, Jamison D.] Utah State Univ, Dept Psychol, Res & Evaluat Methodol Program, Logan, UT 84322 USA		Schefft, BK (corresponding author), Univ Cincinnati, Dept Psychol, POB 210376, Cincinnati, OH 45221 USA.	scheffbk@email.uc.edu	Fargo, Jamison/E-8361-2010				Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; BASSO MR, 1994, J PERS SOC PSYCHOL, V66, P363, DOI 10.1037/0022-3514.66.2.363; BEGG I, 1989, J EXP PSYCHOL LEARN, V15, P977, DOI 10.1037/0278-7393.15.5.977; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J, 1977, STAT POWER ANAL BEHA; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CRUTCHER RJ, 1989, J EXP PSYCHOL LEARN, V15, P669, DOI 10.1037/0278-7393.15.4.669; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; GARDINER JM, 1984, MEM COGNITION, V12, P433; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; Green S.B., 2003, USING SPSS WINDOWS M, V4th ed.; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; Hamsher K. D., 1984, HDB PSYCHOL ASSESSME, P235; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; JOHNSON MMS, 1989, J GERONTOL, V44, P91; Kanfer F.H., 1988, GUIDING PROCESS THER; KLONOFF PS, 1996, THEORETICAL FDN CLIN; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LIPINSKA B, 1994, J CLIN EXP NEUROPSYC, V16, P809, DOI 10.1080/01688639408402695; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MARSHALL RC, 1992, APHASIOLOGY, V6, P567, DOI 10.1080/02687039208249492; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MCDANIEL MA, 1990, J EXP PSYCHOL LEARN, V16, P789, DOI 10.1037/0278-7393.16.5.789; MCDANIEL MA, 1988, J MEM LANG, V27, P521, DOI 10.1016/0749-596X(88)90023-X; MCGLYNN SM, 1990, PSYCHOL BULL, V108, P420, DOI 10.1037/0033-2909.108.3.420; MCNAMARA DS, 1995, LEARNING MEMORY KNOW, P132; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; OLOFSSON U, 1992, PSYCHOL RES-PSYCH FO, V54, P103, DOI 10.1007/BF00937138; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Schacter D. L., 1990, NEUROPSYCHOLOGY EVER, P231; SCHEFFT BK, 1985, INT J CLIN NEUROPSYC, V7, P207; SCHEFFT BK, 1990, J SOC CLIN PSYCHOL, V9, P354, DOI 10.1521/jscp.1990.9.3.354; SCHEFFT BK, 1992, ANN M ASS ADV BEH TH; Schefft BK, 1997, CLIN NEUROPSYCHOLOGY, P237; Sharifian F., 2001, ISSUES ED RES, V11, P15; Smith ML, 1996, NEUROPSYCHOLOGIA, V34, P553, DOI 10.1016/0028-3932(95)00139-5; Souliez L, 1996, CORTEX, V32, P347, DOI 10.1016/S0010-9452(96)80056-6; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; Steffens MC, 1998, Q J EXP PSYCHOL-A, V51, P705, DOI 10.1080/027249898391350; Taconnat L, 2003, ANN PSYCHOL, V103, P199; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; VANDAM G, 1988, J GEN PSYCHOL, V115, P151, DOI 10.1080/00221309.1988.9711098; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; WALSH KR, 1995, P 1 AM C INF SYST AS, P621	56	16	17	0	7	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2008	15	1					61	68		10.1080/09084280801917806			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	287KZ	WOS:000254917300008	18443942				2022-02-06	
J	Shiramizu, H; Masuko, A; Ishizaka, H; Shibata, M; Atsumi, H; Imai, M; Osada, T; Mizokami, Y; Baba, T; Matsumae, M				Shiramizu, Hideki; Masuko, Akihiko; Ishizaka, Hideo; Shibata, Masayoshi; Atsumi, Hideki; Imai, Masaaki; Osada, Takahiro; Mizokami, Yoshihito; Baba, Tanefumi; Matsumae, Mitsunori			Mechanism of injury to the corpus callosum, with particular reference to the anatomical relationship between site of injury and adjacent brain structures	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						corpus callosum injury; head injury; diffuse brain injury; magnetic resonance imaging	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; TRAUMATIC LESIONS; FEATURES; DAMAGE; MRI	The location of corpus callosum injury was investigated using magnetic resonance imaging in 92 patients. The anatomical relationships in the region around the corpus callosum were also evaluated to clarify involvement in the mechanism of corpus callosum injury in 20 normal volunteers. Lesions in the posterior half of the corpus callosum accounted for 80% of corpus callosum injuries. The falx was increasingly elongated toward the posterior portion of the corpus callosum and the corpus callosum was thinnest at the body-splenium junction in the normal volunteers. The mechanism of corpus callosum injury apparently involves the following factors. The posterior half of the falx is closer to the corpus callosum than the anterior half. Therefore, the anterior part of the corpus callosum easily moves with lateral movement of the cerebral hemispheres, and the strain is likely to be concentrated in the posterior half of the corpus callosum, because the falx greatly limits lateral movement of the hemisphere in the posterior region. The corpus callosum is easily distorted at the thinnest part of the body-splenium junction. Therefore, corpus callosum injury predominantly occurs in the posterior half of the corpus callosum.	[Shiramizu, Hideki; Masuko, Akihiko; Ishizaka, Hideo; Shibata, Masayoshi; Atsumi, Hideki; Imai, Masaaki; Osada, Takahiro; Mizokami, Yoshihito; Baba, Tanefumi; Matsumae, Mitsunori] Tokai Univ, Sch Med, Dept Neurosurg, Kanagawa 2591193, Japan		Matsumae, M (corresponding author), Tokai Univ, Sch Med, Dept Neurosurg, 143 Shimokasuya, Kanagawa 2591193, Japan.						ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; JUNET P, 1938, HELV MED ACTA, V5, P818; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lindenberg R, 1964, Clin Neurosurg, V12, P129; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; ROESSMAN U, 1968, ACTA NEUROPATHOL, V10, P151, DOI 10.1007/BF00691309; ROWBOTHAM GF, 1949, ACUTE INJURIES HEAD, P1; STRICH SJ, 1961, LANCET, V2, P443; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Tokutomi T, 1997, ACT NEUR S, V70, P80; Zarkovic K, 1991, Neurol Croat, V40, P129	22	16	16	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2008	48	1					1	6		10.2176/nmc.48.1			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	253FO	WOS:000252504300001	18219185				2022-02-06	
J	Stronach, ST; Turkstra, LS				Stronach, Sheri T.; Turkstra, Lyn S.			Theory of mind and use of cognitive state terms by adolescents with traumatic brain injury	APHASIOLOGY			English	Article							CLOSED-HEAD-INJURY; FALSE-BELIEF TASK; SOCIAL INFORMATION; EXECUTIVE FUNCTION; LOBE CONTRIBUTIONS; LANGUAGE; COMMUNICATION; CHILDREN; DISCOURSE; OUTCOMES	Background: There is growing evidence of impaired social cognition in individuals with traumatic brain injury (TBI). Social cognition tests, however, place demands on domain-general cognitive functions such as auditory working memory, so that test scores might reflect the influence of these factors on test performance rather than domain-specific social cognition impairments. As an alternative, we examined conversations of adolescents with TBI for evidence of cognitive state terms. Methods and Procedures: Participants were 16 adolescents with TBI, who were divided into two groups (TBI-Low and TBI-High) based on scores on a test of theory of mind (ToM), and 8 typically developing (TD) adolescents matched to participants in the TBI groups for age and race. Each participant completed a 3-minute conversation with a peer or researcher partner, and conversations were analysed to determine the number of cognitive state terms relative to total words produced. Outcomes and Results: The TBI-Low group expressed significantly fewer cognitive state terms and significantly fewer self-vs other-referenced terms than either the TBI-High or TD group. There was no significant difference between the TD and TBI-High groups. The findings were not related to generally impoverished language in the TBI-Low group, as the three groups were similar on measures of lexical diversity. Conclusions: The findings support the hypothesis that adolescents with TBI have domain-specific deficits in social cognition, beyond what might be accounted for by the cognitive demands of social cognition tests. Given the relation of social cognitive ability to important life outcomes, these skills should be included in the evaluation of individuals with cognitive-communication disorders after TBI.	[Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021; Stronach, Sheri/P-1176-2019	Stronach, Sheri/0000-0002-4794-6210; Turkstra, Lyn/0000-0002-6948-6921	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC00163]; Wisconsin Alumni Research Fund	This work was supported in part by Grant DC00163 from the National Institute on Deafness and Other Communication Disorders and funding from the Wisconsin Alumni Research Fund, to Dr Turkstra.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adrian JE, 2005, J CHILD LANG, V32, P673, DOI 10.1017/S0305000905006963; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037/0012-1649.15.6.608; BERNDT TJ, 1985, DEV PSYCHOL, V21, P1007, DOI 10.1037/0012-1649.21.6.1007; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Bosacki SL, 2003, J YOUTH ADOLESCENCE, V32, P141, DOI 10.1023/A:1021861902463; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Colle L, 2007, J AUTISM DEV DISORD, V37, P716, DOI 10.1007/s10803-006-0198-7; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Englund NM, 2000, CHILD DEV, V71, P1049, DOI 10.1111/1467-8624.00208; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1985, LANGUAGE NEUROLOGY; FURNISS F., 2004, CHILD LANG TEACH THE, V20, P1, DOI DOI 10.1191/0265659004CT260OA; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Garrett AS, 2004, ARCH GEN PSYCHIAT, V61, P281, DOI 10.1001/archpsyc.61.3.281; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Johnson P, 2006, BRAIN COGNITION, V60, P205; Johnston JR, 2001, INT J LANG COMM DIS, V36, P349, DOI 10.1080/13682820110045838; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; Miller CA, 2004, INT J LANG COMM DIS, V39, P191, DOI 10.1080/13682820310001616994; Miller CA, 2006, AM J SPEECH-LANG PAT, V15, P142, DOI 10.1044/1058-0360(2006/014); MILLER JF, 1994, SALT GUIDE STANDARD; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Mundy P, 1997, MENT RETARD DEV D R, V3, P343; Mutter B, 2006, PERCEPT MOTOR SKILL, V102, P819, DOI 10.2466/PMS.102.3.819-835; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Sabers DL, 1996, LANG SPEECH HEAR SER, V27, P102, DOI 10.1044/0161-1461.2702.102; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Silliman ER, 2003, LANG SPEECH HEAR SER, V34, P236, DOI 10.1044/0161-1461(2003/020); *SPSS INC, 2005, SPSS STAT AN SOFTW V; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Tager-Flusberg H, 1999, INT REV PSYCHIATR, V11, P325, DOI 10.1080/09540269974203; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; VANLEER E, 1999, J COMMUNICATIION DIS, V32, P348; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zanini S, 2005, APHASIOLOGY, V19, P1107, DOI 10.1080/02687030500268977	72	16	16	0	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2008	22	10					1054	1070		10.1080/02687030701632187			17	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	360IP	WOS:000260051500003					2022-02-06	
J	Vibert, D; Redfield, RC; Hausler, R				Vibert, Dominique; Redfield, Robin C.; Hausler, Rudolf			Benign paroxysmal positional vertigo in mountain bikers	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						benign paroxysmal positional vertigo; inner ear; mountain bike; otoconia; sport; vertigo	BIKING INJURIES; TRAUMA	We evaluated 4 men who had benign paroxysmal positional vertigo (BPPV) that occured several hours after intensive mountain biking but without head trauma. The positional maneuvers in the planes of the posterior and horizontal canals elicited BPPV, as well as transitory nystagmus. This was attributed to both the posterior and horizontal semicircular canals (SCCs) on the left side in 1 patient, in these 2 SCCs on the right side in another patient, and to the right posterior SCC in the other 2 patients. The symptoms disappeared after physiotherapeutic maneuvers in 2 patients and spontaneously in the other 2 patients. Cross-country or downhill mountain biking generates frequent vibratory impacts, which are only partially filtered through the suspension fork and the upper parts of the body. Biomechanically, during a moderate jump, before landing, the head is subjected to an acceleration close to negative 1g, and during impact it is subjected to an upward acceleration of more than 2g. Repeated acceleration-deceleration events during intensive off-road biking might generate displacement and/or dislocation of otoconia from the otolithic organs, inducing the typical symptoms of BPPV. This new cause of posttraumatic BPPV should be considered as an injury of minor severity attributed to the practice of mountain biking.	[Vibert, Dominique; Hausler, Rudolf] Univ Bern, Inselspital, Dept Otolaryngol Head & Neck Surg, CH-3010 Bern, Switzerland; [Redfield, Robin C.] USAF Acad, Dept Engn Mech, Colorado Springs, CO USA		Vibert, D (corresponding author), Univ Bern, Inselspital, Dept ENT Head & Neck Surg, CH-3010 Bern, Switzerland.						BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; BARBER H O, 1964, Laryngoscope, V74, P891; Bertholon P, 2005, ANN OTO RHINOL LARYN, V114, P105, DOI 10.1177/000348940511400204; BRANDT T, 1990, VERTIGO ITS MULTISEN, P261; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Gaulrapp H, 2001, KNEE SURG SPORT TR A, V9, P48, DOI 10.1007/s001670000145; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Kim PTW, 2006, J TRAUMA, V60, P312, DOI 10.1097/01.ta.0000202714.31780.5f; Kronisch RL, 2002, CLIN J SPORT MED, V12, P158, DOI 10.1097/00042752-200205000-00003; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; LONGRIDGE NS, 1978, J OTOLARYNGOL, V7, P395; MCCLURE JA, 1985, J OTOLARYNGOL, V14, P30; PARNES LS, 1992, LARYNGOSCOPE, V102, P988; Redfield RC, 2004, TECH PAPERS ISA, V449, P43; SCHUKNECHT HF, 1969, ARCH OTOLARYNGOL, V90, P765; Shang E., 1996, Deutsche Zeitschrift fuer Sportmedizin, V47, P283; Vibert D, 2003, ANN OTO RHINOL LARYN, V112, P246, DOI 10.1177/000348940311200310	17	16	16	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	DEC	2007	116	12					887	890		10.1177/000348940711601203			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	243VI	WOS:000251825000005	18217506				2022-02-06	
J	Conoyer, JM; Kaylie, DM; Jackson, CG				Conoyer, J. Matthew; Kaylie, David M.; Jackson, C. Gary			Otologic surgery following ear trauma	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article							OSSICULAR RECONSTRUCTION	OBJECTIVES: To investigate common presentations and expected outcomes in patients with traumatically induced otologic dysfunction. STUDY DESIGN: Retrospective case review of patients who underwent otologic surgery for sequelae of otologic trauma over a 28-year period. Patients were stratified into major and minor trauma cohorts. Major trauma was designated as closed head injury with or without temporal bone fracture; lower-energy insults comprised the minor trauma group. Preoperative and postoperative audiograms were obtained and correlated with extent of injury. SETTING: Tertiary referral center. RESULTS: Major trauma accounted for 44.9 percent of all patients. The remaining 55.1 percent suffered minor trauma, of which simple traumatic tympanic membrane perforation was the most common insult (33.6%). Two hundred twenty-seven cases were performed on 214 patients. Pure tone averages improved a significant 20.8 dB to essentially normal levels postoperatively. CONCLUSION: Regardless of injury extent, surgical rehabilitation of conductive losses attains excellent hearing results that surpass those historically reported for the chronic ear population. (C) 2007 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.	Vanderbilt Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Otol Grp Vanderbilt, Nashville, TN 37212 USA		Conoyer, JM (corresponding author), 7209 Med Ctr E,S Tower,1215 21st Ave S, Nashville, TN 37232 USA.	matthew.conoyer@vanderbilt.edu					[Anonymous], 1995, Otolaryngol Head Neck Surg, V113, P186; Brodie HA, 1997, AM J OTOL, V18, P188; CRABTREE JA, 1982, AM J OTOL, V4, P172; Gardner EK, 2004, LARYNGOSCOPE, V114, P65, DOI 10.1097/00005537-200401000-00011; GLASSCOCK ME, 1979, LARYNGOSCOPE, V89, P716; GLASSCOCK ME, 1976, LARYNGOSCOPE, V86, P211, DOI 10.1288/00005537-197602000-00009; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Jackson CG, 1996, AM J OTOL, V17, P7; JACKSON CG, 1983, LARYNGOSCOPE, V93, P981; Kaylie DM, 2006, OTOLARYNG HEAD NECK, V134, P443, DOI 10.1016/j.otohns.2005.10.044; McGrew BM, 2004, LARYNGOSCOPE, V114, P506, DOI 10.1097/00005537-200403000-00023; SHEEHY JL, 1985, AM J OTOL, V6, P80; SMYTH GDL, 1982, OTOLARYNG HEAD NECK, V90, P343; VARTIAINEN E, 1993, AM J OTOL, V14, P301; Wullstein HL., 1952, ARCH OHREN NASEN KEH, V161, P422	15	16	19	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	NOV	2007	137	5					757	761		10.1016/j.otohns.2007.07.017			5	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	229RK	WOS:000250821700012	17967641				2022-02-06	
J	Obonsawin, MC; Jefferis, S; Lowe, R; Crawford, JR; Fernandes, J; Holland, L; Woldt, K; Worthington, E; Bowie, G				Obonsawin, M. C.; Jefferis, S.; Lowe, R.; Crawford, J. R.; Fernandes, J.; Holland, L.; Woldt, K.; Worthington, E.; Bowie, G.			A model of personality change after traumatic brain injury and the development of the Brain Injury Personality Scales	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							HEAD-INJURY; RATINGS; RELATIVES; AWARENESS; VALIDITY; TRAITS	Objective: The aims of this study were to develop models of personality change after traumatic brain injury (TBI) based on information provided by the TBI survivor and a significant other (SO), and to compare the models generated from the two different sources of information. Methods: Individuals with and without TBI and an SO were interviewed separately about their current personality. The SOs were also interviewed about the personality of the TBI survivor before the injury. A subset of TBI survivors and their SOs were interviewed twice to assess test-retest reliability. Items which were not associated with personality change after TBI, which could not be measured reliably or which did not contribute to the model, were excluded. Results: Of the 123 original items, 29 items from the interview with the survivor and 31 items from the interview with the SO were retained to form the Brain Injury Personality Scales. Separate factor analyses of ratings from each interview (survivor and SO) resulted in seven first order factors. The second order factor analyses for each interview resulted in four factors. Concordance between the information obtained from the two interviews was low. Conclusions: The information obtained from the interviews with the TBI survivors and the SOs produced two models with a similar structure: three superordinate factors of personality items (affective regulation, behavioural regulation and engagement) and one superordinate factor of items relevant to mental state (restlessness and range of thought). Despite the similarity in structure, the content of the information obtained from the two interviews was different.	Univ Strathclyde, Dept Psychol, Glasgow G1 1XQ, Lanark, Scotland; Univ Aberdeen, Aberdeen, Scotland		Obonsawin, MC (corresponding author), Univ Strathclyde, Dept Psychol, 16 Richmond St, Glasgow G1 1XQ, Lanark, Scotland.	m.c.obonsawin@strath.ac.uk	Crawford, John R/A-4165-2008	Crawford, John R/0000-0003-3403-3428; Obonsawin, Marc/0000-0002-8314-2527			ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; Andreasen N.C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Cronbach LJ, 1972, DEPENDABILITY BEHAV; Eames P, 1985, Int Rehabil Med, V7, P130; Eysenck H.J., 1985, PERSONALITY INDIVIDU; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; MCCRAE RR, 1982, J PERS SOC PSYCHOL, V43, P293, DOI 10.1037/0022-3514.43.2.293; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; PRIDMORE S, 2000, PSYCHIAT INTERVIEW G; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Sachdev P, 1996, AUST NZ J PSYCHIAT, V30, P38, DOI 10.3109/00048679609076071; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Tatham, 1998, MULTIVARIATE DATA AN; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WATSON D, 1991, J PERS SOC PSYCHOL, V60, P927, DOI 10.1037/0022-3514.60.6.927; WATSON D, 2000, MOOD TEMPERAMENT, P31; [No title captured]	29	16	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2007	78	11					1239	1247		10.1136/jnnp.2004.052654			9	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	225LE	WOS:000250518600018	17259352	Green Published			2022-02-06	
J	Patel, P; Meltzer, CC; Mayberg, HS; Levine, K				Patel, Purvak; Meltzer, Carolyn Cidis; Mayberg, Helen S.; Levine, Kay			The role of imaging in United States courtrooms	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN INJURY; DIFFUSION-WEIGHTED MR; WHITE-MATTER CHANGES; CLINICAL-APPLICATIONS; GLUCOSE-METABOLISM; MALPRACTICE ISSUES; FDG-PET; PERFUSION; RADIOLOGY	The rapid evolution of brain imaging techniques has increasingly offered more detailed diagnostic and prognostic information about neurologic and psychiatric disorders and the structural and functional brain changes that may influence behavior. Coupled with these developments is the increasing use of neuroimages in courtrooms, where they are used as evidence in criminal cases to challenge a defendant's competency or culpability and in civil cases to establish physical injury or toxic exposure. Several controversies exist, including the admissibility of neuroimages in legal proceedings, the reliability of expert testimony, and the appropriateness of drawing conclusions in individual cases based on the findings of research uses of imaging technology. This article reviews and discusses the current state of these issues.	Emory Univ Hosp, Dept Radiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Woodruff Mem Res Bldg, Atlanta, GA 30322 USA; Emory Univ, Atlanta, GA 30322 USA		Meltzer, CC (corresponding author), Emory Univ Hosp, Dept Radiol, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.	cmeltze@emory.edu					Aizenstein HJ, 2004, J COGNITIVE NEUROSCI, V16, P786, DOI 10.1162/089892904970681; *AM MED ASS COUNC, 2000, COD MED ETH, P210; American Council on Education, 2002, SEPT 11 COMPR NAT PO, P7; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; BAILEY E, 2000, LOG ANGELES TIM 0615, P3; Benedict RHB, 1998, NEUROREPORT, V9, P121, DOI 10.1097/00001756-199801050-00024; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Berlin L, 2003, AM J ROENTGENOL, V181, P29, DOI 10.2214/ajr.181.1.1810029; Berlin L, 2003, AM J ROENTGENOL, V180, P1515, DOI 10.2214/ajr.180.6.1801515; BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P935; Castillo M, 2000, SEMIN ULTRASOUND CT, V21, P417, DOI 10.1016/S0887-2171(00)90034-9; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Claus JJ, 1996, EUR J NUCL MED, V23, P675, DOI 10.1007/BF00834530; Covarrubias DJ, 2004, ONCOLOGIST, V9, P528, DOI 10.1634/theoncologist.9-5-528; De Reuck J, 2003, EUR NEUROL, V49, P131, DOI 10.1159/000069075; Deshmukh A, 1996, CLIN NUCL MED, V21, P720, DOI 10.1097/00003072-199609000-00010; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Di Costanzo A, 2006, NEURORADIOLOGY, V48, P622, DOI 10.1007/s00234-006-0102-3; Dumit J, 1999, SCI CONTEXT, V12, P173, DOI 10.1017/S0269889700003355; Ge YL, 2005, ANN NY ACAD SCI, V1064, P202, DOI 10.1196/annals.1340.039; Korf J, 1997, ACTA NEUROL BELG, V97, P200; Kulynych J, 1997, STANFORD LAW REV, V49, P1249, DOI 10.2307/1229252; KULYNYCH J, 1996, JURIMETRICS J, V36, P235; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Lundbom N, 1999, MAGNET RESON MED, V41, P841, DOI 10.1002/(SICI)1522-2594(199904)41:4<841::AID-MRM25>3.0.CO;2-T; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Meltzer CC, 1999, J GERIATR PSYCH NEUR, V12, P137, DOI 10.1177/089198879901200307; MELTZER CC, 1990, J COMPUT ASSIST TOMO, V14, P561, DOI 10.1097/00004728-199007000-00011; MIRSEN TR, 1991, ARCH NEUROL-CHICAGO, V48, P1015, DOI 10.1001/archneur.1991.00530220031015; MORSE S, 2005, OHIO STATE J CRIMINA, V3, P1; Morse SJ, 2006, OHIO STATE J CRIMINA, V3, P397; Nakamizo A, 2002, J CLIN NEUROSCI, V9, P685, DOI 10.1054/jocn.2002.1146; Narr KL, 2007, NEUROIMAGE, V34, P939, DOI 10.1016/j.neuroimage.2006.08.052; Orbach DB, 2006, J MAGN RESON IMAGING, V24, P16, DOI 10.1002/jmri.20612; Powers WJ, 2003, NEUROIMAG CLIN N AM, V13, P741, DOI 10.1016/S1052-5149(03)00091-1; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Razavi M, 2003, HUM BRAIN MAPP, V20, P227, DOI 10.1002/hbm.10141; Reed LJ, 1999, MEMORY, V7, P599, DOI 10.1080/096582199387779; Ricker JH, 2000, J HEAD TRAUMA REHAB, V15, P859, DOI 10.1097/00001199-200004000-00007; Schaefer PW, 2001, J NEUROIMAGING, V11, P369, DOI 10.1111/j.1552-6569.2001.tb00065.x; Tieleman A, 2007, INVEST RADIOL, V42, P130, DOI 10.1097/01.rli.0000251579.05052.08; Tikkakoski T, 2006, ACTA RADIOL, V47, P445, DOI 10.1080/02841850600692880; TSURUDA JS, 1990, AM J NEURORADIOL, V11, P925; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x; Wilson J, 1996, J NUCL MED, V37, P1256; Yue NC, 1997, RADIOLOGY, V202, P33, DOI 10.1148/radiology.202.1.8988189; 2004, ACR CENSURES RADIOLO; 2005, Patent No. 1868046	53	16	16	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	NOV	2007	17	4					557	+		10.1016/j.nic.2007.07.001			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	236OT	WOS:000251313300015	17983970				2022-02-06	
J	Mao, H; Polensek, SH; Goldstein, FC; Holder, CA; Ni, CC				Mao, Hui; Polensek, Sharon H.; Goldstein, Felicia C.; Holder, Chad A.; Ni, Chunchun			Diffusion tensor and functional magnetic resonance imaging of diffuse axonal injury and resulting language impairment	JOURNAL OF NEUROIMAGING			English	Article						diffusion tensor imaging; brain injury; white matter; magnetic resonance imaging; connectivity; fMRI; aphasia	WHITE-MATTER; BRAIN-INJURY; ANATOMY	Diffuse axonal injury (DAI) is a common aftermath of brain trauma. The diagnosis of DAI is often difficult using conventional magnetic resonance imaging (MRI). We report a diffusion tensor imaging (DTI) study of a patient who sustained DAI presenting with language impairment. Fractional anisotropy (FA) and DTI tractography revealed a reduction of white matter integrity in the left frontal and medial temporal areas. White matter damage identified by DTI was correlated with the patient's language impairment as assessed by functional MRI (fMRI) and a neuropsychological exam. The findings demonstrate the utility of DTI for identifying white matter changes secondary to traumatic brain injury (TBI).	Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA		Mao, H (corresponding author), Emory Univ, Sch Med, Dept Radiol, EUH Suite AG10,1364 Clifton Rd, Atlanta, GA 30322 USA.	hmao@emory.edu					Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Mamata H, 2002, AM J NEURORADIOL, V23, P67; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Votaw JR, 1999, NEUROIMAGE, V10, P347, DOI 10.1006/nimg.1999.0471; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640	12	16	17	0	8	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1051-2284			J NEUROIMAGING	J. Neuroimaging	OCT	2007	17	4					292	294		10.1111/j.1552-6569.2007.00146.x			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	215RP	WOS:000249827000003	17894615				2022-02-06	
J	Oster, TJ; Anderson, A; Filley, CM; Wortzel, HS; Arciniegas, DB				Oster, Timothy J.; Anderson, Alan; Filley, Christopher M.; Wortzel, Hal S.; Arciniegas, David B.			Quetiapine for mania due to traumatic brain injury	CNS SPECTRUMS			English	Article							ATYPICAL ANTIPSYCHOTIC TREATMENT; BIPOLAR DISORDER; HEAD-INJURY; SCHIZOPHRENIA; HALOPERIDOL; RISPERIDONE; OLANZAPINE; PSYCHOSIS; VALPROATE; CARBAMAZEPINE	Secondary mania develops in as many as 9% of persons with traumatic brain injuries. The treatment of posttraumatic mania is not well defined, and agents traditionally used for the treatment of idiopathic manic episodes may not be well suited for use among individuals wit h traumatic brain injuries. Atypical antipsychotics are indicated for the treatment of idiopathic bipolar disorder, and have been used for other purposes among individuals with posttraumatic neu ro psychiatric disturbances. This article offers the first description of the treatment of posttraumatic mania using the atypical antipsychotic quetiapine. Beneficial effects of this agent on posttraumatic mania, cognitive impairments, and functional disability in the subacute post-injury period are described. Possible mechanisms of action are discussed and the need for additional investigation of quetiapine for posttraumatic mania is highlighted.	Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Denver, CO 80262 USA; HealthONE Spalding Rehabil Hosp, Brain Injury Rehabil Unit, Aurora, CO USA; Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Boulder, CO 80309 USA; Denver Vet Affairs Med Ctr, VISN MIRECC 19, Denver, CO USA		Arciniegas, DB (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Campus Box C268-25,4200 E 9th Ave, Denver, CO 80262 USA.	David.Arciniegas@UCHSC.edu	Arciniegas, David/A-3792-2009				[Anonymous], 1997, GUIDE UNIFORM DATA S; Arciniegas DB, 2003, INT REV PSYCHIATR, V15, P328, DOI 10.1080/09540260310001606719; Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; Bennouna M, 2005, J CLIN PSYCHOPHARM, V25, P505, DOI 10.1097/01.jcp.0000177851.31157.66; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; BOUVY PF, 1988, ACTA PSYCHIAT SCAND, V77, P361, DOI 10.1111/j.1600-0447.1988.tb05136.x; Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Bymaster FP, 2001, EUR J PHARMACOL, V430, P341, DOI 10.1016/S0014-2999(01)01399-1; Cole P, 2004, DRUG TODAY, V40, P837, DOI 10.1358/dot.2004.40.10.863744; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; Harvey PD, 2006, J NEUROPSYCH CLIN N, V18, P54, DOI 10.1176/appi.neuropsych.18.1.54; Harvey PD, 2006, J CLIN PSYCHIAT, V67, P14, DOI 10.4088/JCP.1006e13; Hornstein A, 1989, J Neuropsychiatry Clin Neurosci, V1, P446; Ichikawa J, 2002, BRAIN RES, V956, P349, DOI 10.1016/S0006-8993(02)03570-9; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Krieger D, 2003, NEUROREHABILITATION, V18, P205; MacQueen G, 2003, BIPOLAR DISORD, V5, P53, DOI 10.1111/j.1399-2406.2003.00059.x; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Monji A, 1999, PSYCHOSOMATICS, V40, P448, DOI 10.1016/S0033-3182(99)71215-6; Murai T, 2003, BRAIN INJURY, V17, P355, DOI 10.1080/0269905031000070170; Mustafa B, 2005, J NEUROPSYCH CLIN N, V17, P122, DOI 10.1176/appi.neuropsych.17.1.122; Nasrallah HA, 2002, J CLIN PSYCHIAT, V63, P12; Newman-Tancredi A, 1998, EUR J PHARMACOL, V355, P245, DOI 10.1016/S0014-2999(98)00483-X; Perlis RH, 2006, J CLIN PSYCHIAT, V67, P509, DOI 10.4088/JCP.v67n0401; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Randolph C., 1998, RBANS MANUAL REPEATA; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Serretti A, 2004, CURR MED CHEM, V11, P343, DOI 10.2174/0929867043456043; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temple M J, 2003, J R Army Med Corps, V149, P54; Tyson PJ, 2004, INT J NEUROSCI, V114, P593, DOI 10.1080/00207450490430552; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Velligan DI, 2003, J CLIN PSYCHIAT, V64, P524, DOI 10.4088/JCP.v64n0505; Vieta E, 2005, BIPOLAR DISORD, V7, P21, DOI 10.1111/j.1399-5618.2005.00212.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weickert TW, 2003, NEUROPSYCHOPHARMACOL, V28, P1491, DOI 10.1038/sj.npp.1300216; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; YASSA R, 1994, J GERIATR PSYCH NEUR, V7, P55, DOI 10.1177/089198879400700110; Yatham LN, 2005, J CLIN PSYCHIAT, V66, P40; Yumru M, 2007, J AFFECT DISORDERS, V98, P247, DOI 10.1016/j.jad.2006.08.009	59	16	16	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1092-8529	2165-6509		CNS SPECTRUMS	CNS Spectr.	OCT	2007	12	10					764	769		10.1017/S1092852900015455			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	223HE	WOS:000250359900010	17934381				2022-02-06	
J	Akpinar, E; Koroglu, M; Ptak, T				Akpinar, Erhan; Koroglu, Mert; Ptak, Thomas			Diffusion tensor MR imaging in pediatric head trauma	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						DTL; head trauma; pediatric	WHITE-MATTER INJURY; GLASGOW COMA SCALE; AXONAL INJURY; BRAIN-INJURY; CHILDREN; ABNORMALITIES; SCORE; CT	Purpose: We propose to investigate the fractional anisotropy (FA) values in pediatric patients with closed head trauma and correlate them with the initial Glasgow Coma Scale (GCS). Materials and Methods: A retrospective evaluation of 24 pediatric patients (15 men, 9 women; mean age, 13 years; range, 2-18 years) who underwent both unenhanced head computed tomography and cerebral magnetic resonance imaging (MRI), including the tenser diffusion sequence, within 30 days of the incident. Twenty-two atraumatic control patients (9 men, 13 women; mean age, 9 years; range, 4-17 years) were randomly selected from the records of the radiology department within the same period. Fractional anisotropy measurements were taken from each of 6 major white matter volumes. Data extracted from the record of each subject included GCS, initial head computed tomographic results, and length of hospital stay. Kruskal-Wallis and t tests were used for statistical evaluation. Results: The mean acute score on the GCS was 9.7 +/- 5. Mean duration of hospitalization days was 8.7 +/- 10. Statistically significant differences in mean FA values between trauma and control subjects were noted in corpus callosum. Trauma patients with positive findings on MRI and with GCS less than 10 also had lower FA values than patients with GCS greater than 10 and patients who had normal MRI findings. There was a negative correlation between time to discharge and FA values. Conclusions: In pediatric head trauma, MRI diffusion FA measurements can show abnormalities despite normal-appearing brain MRI findings. Larger investigations are required to verify the stability of correlations.	Hacettepe Univ, Fac Med, Dept Radiol, Ankara, Turkey; Massachusetts Gen Hosp, Harvard Med Sch, Div Emergency Radiol, Boston, MA USA; Suleyman Demirel Univ, Fac Med, Dept Radiol, Isparta, Turkey		Akpinar, E (corresponding author), Hacettepe Univ, Fac Med, Dept Radiol, Ankara, Turkey.	erhan.akpinar@gmail.com	Akpinar, Erhan/AAY-7646-2021				ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1984, GREENFIELDS NEUROPAT, V85, P124; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; DUHAIME AC, 1992, PEDIATRICS, V90, P179; GENNARELLI TA, 1991, J EMERGENCY MED, V11, P5; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; Gupta RK, 2006, J MAGN RESON IMAGING, V24, P549, DOI 10.1002/jmri.20677; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jang SH, 2006, RESTOR NEUROL NEUROS, V24, P25; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; SMITH NC, 1995, PARASITOL TODAY, V12, P4; STRICH SJ, 1961, LANCET, V1, P2443; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Teasdale G, 1992, J NEUROTRAUMA S1, V9, P249	28	16	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-8715			J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	SEP-OCT	2007	31	5					657	661		10.1097/RCT.0b013e318033df1a			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	217RK	WOS:000249964800001	17895772				2022-02-06	
J	Braga, LW; Souza, LN; Najjar, YJ; Dellatolas, G				Braga, Lucia W.; Souza, Ligia N.; Najjar, Yana J.; Dellatolas, Georges			Magnetic resonance imaging (MRI) findings and neuropsychological sequelae in children after severe traumatic brain injury: The role of cerebellar lesion	JOURNAL OF CHILD NEUROLOGY			English	Article						traumatic brain injury; MRI; cerebellum; neuropsychology	COGNITIVE-AFFECTIVE SYNDROME; POSTERIOR-FOSSA TUMORS; CLOSED-HEAD INJURY; LONG-TERM SEQUELAE; MEMORY IMPAIRMENT; EARLY-CHILDHOOD; CONSEQUENCES; ADOLESCENTS; DAMAGE; ATTENTION	We studied the relationships between magnetic resonance imaging (MRI) findings and neuropsychological sequelae in children after severe traumatic brain injury. Twenty-three children ages 7-13 years underwent MRI assessment of brain lesion topography and volume and neuropsychological evaluations, more than I year after sustaining severe traumatic brain injury. Most children had lesions to the corpus callosum and frontal lobes. Total lesion volume and extent of cerebral atrophy did not impact on the neuropsychological evaluation. Additional relationships were observed: left frontal lesions with lower semantic verbal fluency, right occipital lesions with lower visual recognition task scores, dyscalculia with cerebellar lesions, and cerebellar damage with lower cognitive performances and lower visual recognition memory. This study demonstrates the significance of the cerebellum's role in neuropsychological outcomes after traumatic brain injury and the importance of the lesion depth classification in predicting functional results.	Sarah Network Rehabil Hosp, BR-70335901 Brasilia, DF, Brazil; INSERM, U780, Villejuif, France		Braga, LW (corresponding author), Sarah Network Rehabil Hosp, Q501 Conj A Terro, BR-70335901 Brasilia, DF, Brazil.	luciabraga@sarah.br	Dellatolas, Georges/AAW-1377-2021; Braga, Lucia/AAQ-1030-2020				Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Beldarrain MG, 2002, NEUROLOGY, V59, P791; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Braga WL, 2000, INT HDB NEUROPSYCHOL, P283; Callu D, 2005, BRAIN COGNITION, V58, P217, DOI 10.1016/j.bandc.2004.11.008; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Dellatolas G, 2000, EUR CHILD ADOLES PSY, V9, P102; Dellatolas G, 2003, J INT NEUROPSYCH SOC, V9, P771, DOI 10.1017/S1355617703950107; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Gadian D G, 1999, Adv Neurol, V81, P307; Gebhart AL, 2002, ANN NY ACAD SCI, V978, P318, DOI 10.1111/j.1749-6632.2002.tb07577.x; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; Gottwald B, 2003, NEUROPSYCHOLOGIA, V41, P1452, DOI 10.1016/S0028-3932(03)00090-3; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Grill J, 2004, J NEUROSURG, V101, P152, DOI 10.3171/ped.2004.101.2.0152; Grodd W, 2005, NEUROSURG CLIN N AM, V16, P77, DOI 10.1016/j.nec.2004.07.008; Harrington DL, 2004, BRAIN, V127, P561, DOI 10.1093/brain/awh065; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoofien D, 2001, BRAIN INJURY, V15, P189; JAMBAQUE I, 1993, NEUROPSYCHOLOGIA, V31, P1321, DOI 10.1016/0028-3932(93)90101-5; JENKINS A, 1986, LANCET, V2, P445; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kesler SR, 2000, BRAIN INJURY, V14, P851; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Nelson J E, 2002, Pediatr Rehabil, V5, P37, DOI 10.1080/1363849021000007088; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Ronning C, 2005, PEDIATR NEUROSURG, V41, P15, DOI 10.1159/000084860; *SAR NETW REH HOSP, 1989, SAR SCAL MOT DEV; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Mier HI, 2002, ANN NY ACAD SCI, V978, P334; Verger K, 2001, BRAIN INJURY, V15, P211; Verger K, 2001, REV NEUROLOGIA, V33, P30, DOI 10.33588/rn.3301.2001103; WESCHSLER D, 2002, ESCALA INTELIGENCIA; Wood AG, 2004, NEUROLOGY, V63, P1035, DOI 10.1212/01.WNL.0000140707.61952.CA	50	16	17	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738			J CHILD NEUROL	J. Child Neurol.	SEP	2007	22	9					1084	1089		10.1177/0883073807306246			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	213MU	WOS:000249672600003	17890405				2022-02-06	
J	Quintana, A; Molinero, A; Florit, S; Manso, Y; Comes, G; Carrasco, J; Giralt, M; Borup, R; Nielsen, FC; Campbell, IL; Penkowa, M; Hidalgo, J				Quintana, Albert; Molinero, Amalia; Florit, Sergi; Manso, Yasmina; Comes, Gemma; Carrasco, Javier; Giralt, Mercedes; Borup, Rehannah; Nielsen, Finn Cilius; Campbell, Iain L.; Penkowa, Milena; Hidalgo, Juan			Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article; Proceedings Paper	Meeting on Molecular Aspects of Aging and Development Toxciology and Neuroimmuno Communications	2005	Barcelona, SPAIN				TUMOR-NECROSIS-FACTOR; ASTROCYTE-TARGETED EXPRESSION; KAPPA-B ACTIVATION; I PLUS II; METALLOTHIONEIN-I; TRANSGENIC MICE; NERVOUS-SYSTEM; OXIDATIVE STRESS; ISCHEMIC STROKE; MESSENGER-RNA	Cytokines, such as tumour necrosis factor (TNF)-alpha and lymphotoxin-alpha, have been described widely to play important roles in the brain in physiologic conditions and after traumatic injury. However, the exact mechanisms involved in their function have not been fully elucidated. We give some insight on their role by using animals lacking either Type 1 receptor (TNFR1 KO) or Type 2 (TNFR2KO) and their controls (C57Bl/6). Both TNFR1 KO and to a greater extent TNFR2KO mice showed increased exploration/activity neurobehavioral traits in the hole board test, such as rearings, head clippings, and ambulations, compared with wild-type mice, suggesting an inhibitory role of TNFR1/TNFR2 signaling. In contrast, no significant differences were observed in the elevated plus maze test, ruling out a major role of these receptors in the control of anxiety. We next evaluated the response to a freeze injury to the somatosensorial cortex. The effect of the cryolesion on motor function was evaluated with the horizontal ladder beam test, and the results showed that both TNFR1 KO and TNFR2KO mice made fewer errors, suggesting a detrimental role for TNFR1/TNFR2 signaling for coping with brain damage. Expression of similar to 22600 genes was analyzed using an Affymetrix chip (MOE430A) at 0 (unlesioned), 1, or 4 days post-lesion in the three strains. The results show a unique and major role of both TNF receptors on the pattern of gene expression elicited by the injury but also in normal conditions, and suggest that blocking of TNFR1/TNFR2 receptors may be beneficial after a traumatic brain injury. (C) 2006 Wiley-Liss, Inc.	Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Dept Biol Celular Fisiol & Immunol, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Inst Neurosci, E-08193 Barcelona, Spain; Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Univ Copenhagen, Fac Hlth Sci, Ctr Inflammat & Metab, Sect Neuroprot, DK-1168 Copenhagen, Denmark		Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Unidad Fisiol Anim, Dept Biol Celular Fisiol & Immunol, E-08193 Barcelona, Spain.	Juan.Hidalgo@uab.es	molinero, amalia/K-2147-2014; Quintana, Albert/N-5544-2015; Nielsen, Finn Cilius/AAA-4926-2020; Hidalgo, Juan/C-9082-2011; Giralt, Mercedes/K-1626-2014; Carrasco, Javier/C-9732-2011	molinero, amalia/0000-0001-8661-8570; Quintana, Albert/0000-0003-1674-7160; Hidalgo, Juan/0000-0003-0921-1122; Giralt, Mercedes/0000-0002-1806-1528; Carrasco, Javier/0000-0001-6436-0863; Manso Sanz, Yasmina/0000-0002-5788-4180; Nielsen, Finn Cilius/0000-0002-9829-1031	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH62231] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36979] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH062231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036979] Funding Source: NIH RePORTER		Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Armario A, 1998, J NEUROIMMUNOL, V92, P160, DOI 10.1016/S0165-5728(98)00199-4; BLUETHMANN H, 1994, J LEUKOCYTE BIOL, V56, P565, DOI 10.1002/jlb.56.5.565; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; CAMPBELL IL, 1994, J IMMUNOL, V152, P716; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Fiore M, 1998, PHYSIOL BEHAV, V63, P571, DOI 10.1016/S0031-9384(97)00514-3; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Gilks CB, 1998, AM J PATHOL, V152, P269; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hidalgo J, 2002, METHOD ENZYMOL, V348, P238, DOI 10.1016/S0076-6879(02)48642-9; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Kury P, 2004, EUR J NEUROSCI, V19, P1708, DOI 10.1111/j.1460-9568.2004.03226.x; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lee YS, 1999, J AM ASSOC GYN LAP, V6, P59, DOI 10.1016/S1074-3804(99)80042-5; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Pawlak CR, 2003, NEUROSCI LETT, V341, P205, DOI 10.1016/S0304-3940(03)00184-8; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2006, FEBS J, V273, P1857, DOI 10.1111/j.1742-4658.2006.05207.x; Penkowa M, 2006, J NEUROSCI RES, V84, P1452, DOI 10.1002/jnr.21043; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Raivich G, 2003, J NEUROSCI RES, V72, P726, DOI 10.1002/jnr.10621; Raivich G, 2002, EXP NEUROL, V178, P186, DOI 10.1006/exnr.2002.8024; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Read SJ, 2001, J CEREBR BLOOD F MET, V21, P755, DOI 10.1097/00004647-200107000-00001; Roth A, 2003, MOL CELL NEUROSCI, V22, P353, DOI 10.1016/S1044-7431(02)00039-8; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Sayer FT, 2002, EXP NEUROL, V175, P282, DOI 10.1006/exnr.2002.7901; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	67	16	16	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	SEP	2007	85	12					2668	2685		10.1002/jnr.21126			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	212BO	WOS:000249568800016	17131423				2022-02-06	
J	Thomale, UW; Griebenow, M; Mautes, A; Beyer, TF; Dohse, NK; Stroop, R; Sakowitz, OW; Unterberg, AW; Stover, JF				Thomale, Ulrich W.; Griebenow, Martin; Mautes, Angelika; Beyer, Thomas F.; Dohse, Nils-Kristian; Stroop, Ralf; Sakowitz, Oliver W.; Unterberg, Andreas W.; Stover, John F.			Heterogeneous regional and temporal energetic impairment following controlled cortical impact injury in rats	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; microdialysis; magnetic resonance imaging; bioluminescence imaging; energy metabolism	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID GLUTAMATE; MITOCHONDRIAL DYSFUNCTION; GLUCOSE-UTILIZATION; CEREBRAL PERFUSION; EDEMA FORMATION; TISSUE-DAMAGE; EEG ACTIVITY; AMINO-ACIDS; HEAD-INJURY	Objectives: Following traumatic brain injury metabolic stability is impaired. Duration and reversibility of these changes might be important to guide specific interventions. Methods: To characterize temporal and regional changes in cerebral metabolism, 68 male Sprague-Dawley rats were subjected to a focal cortical contusion. Lesion progression and mitochondrial impairment were determined by magnetic resonance imaging (MRI) and triphenyl tetrazolium chloride (TTC) staining, respectively. Metabolic alterations were determined at hours 6 and 24 and day 7 by measuring extracellular glucose, lactate and hypoxanthine levels with microdialysis catheters placed adjacent and distant to the contusion and by quantifying changes in tissue ATP, lactate and glucose using bioluminescence imaging. Results: The cortical lesion reached its maximal extent at hour 24 and remained confined to the ipsilateral hemisphere. In microdialysate, at hour 6, extracellular hypoxanthine and lactate reached maximal values, thereafter hypoxanthine normalized while lactate remained increased. Extracellular glucose reached the highest values at hour 24 and remained elevated. Bioluminescence imaging revealed heterogeneous changes in areas distant to the contusion. No significant changes were found in ATP content. Slightly elevated tissue glucose until 24 hours in the ipsilateral hemisphere was observed. Following a continuous increase, lactate levels were the highest by 6 hours in the ipsilateral cortex and hippocampus. Discussion: CCI is associated with disturbances in energetic metabolism. Metabolic perturbation is not restricted to the early phase and the contusional region following focal cortical contusion, but also involves hippocampus and primarily uninjured parts of the hemisphere.	Med Univ Berlin, Dept Neurosurg, D-13353 Berlin, Germany; Univ Saarland, Univ Saarlandes Kliniken, Neurosurg Res Lab, D-66421 Homburg, Germany; Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany; Univ Zurich Hosp, Div Surg Intens Care Med, CH-8006 Zurich, Switzerland		Thomale, UW (corresponding author), Med Univ Berlin, Dept Neurosurg, Augustenburger Platz 1,Charite,Campus Virchow, D-13353 Berlin, Germany.	uthomale@charite.de		Misch, Martin/0000-0001-5283-5753; Sakowitz, Oliver/0000-0003-3248-6335			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Deitmer JW, 2001, RESP PHYSIOL, V129, P71, DOI 10.1016/S0034-5687(01)00283-3; Dong GX, 2001, BRAIN RES, V903, P45, DOI 10.1016/S0006-8993(01)02379-4; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Gronlund KM, 1996, J NEUROPATH EXP NEUR, V55, P832, DOI 10.1097/00005072-199607000-00008; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; KELLY PAT, 1986, NEUROSCIENCE, V19, P257, DOI 10.1016/0306-4522(86)90019-9; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; LITSHITZ J, 2003, J CEREB BLOOD FLOW M, V23, P219; Maeda T, 1997, ACT NEUR S, V70, P102; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Marklund N, 2000, ACTA NEUROCHIR, V142, P1135, DOI 10.1007/s007010070042; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; Minervini M, 1997, BRAIN RES, V768, P57, DOI 10.1016/S0006-8993(97)00547-7; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Sims NR, 2000, DEV NEUROSCI-BASEL, V22, P366, DOI 10.1159/000017462; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Stover JF, 1997, NEUROSCI LETT, V238, P25, DOI 10.1016/S0304-3940(97)00840-9; Stover JF, 2003, J NEUROTRAUM, V20, P315, DOI 10.1089/089771503765172273; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; SUZUKI H, 1994, J AUTONOM NERV SYST, V49, pS173; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Waagepetersen HS, 2001, GLIA, V35, P246, DOI 10.1002/glia.1089; Weinzierl MR, 2002, J MOL NEUROSCI, V18, P247, DOI 10.1385/JMN:18:3:247; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2001, NEUROL RES, V23, P129, DOI 10.1179/016164101101198460; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	55	16	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	SEP	2007	29	6					594	603		10.1179/016164107X166272			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	218GY	WOS:000250005200013	17535559	Green Accepted			2022-02-06	
J	Hao, H; Shreiber, DI				Hao, Hailing; Shreiber, David I.			Axon kinematics change during growth and development	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD INJURY; CLOSED-HEAD INJURY; OPTIC-NERVE; QUANTITATIVE-ANALYSIS; CYTOSKELETAL CHANGES; MECHANICAL TENSION; STRETCH INJURY; WHITE-MATTER; RAT	The microkinematic response of axons to mechanical stretch was examined in the developing chick embryo spinal cord during a period of rapid growth and myelination. Spinal cords were isolated at different days of embryonic (E) development post-fertilization (E12, E14, E16, and E18) and stretched 0%, 5%, 10%, 15%, and 20%, respectively. During this period, the spinal cord grew similar to 55% in length, and white matter tracts were myelinated significantly. The spinal cords were fixed with paraformaldehyde at the stretched length, sectioned, stained inununohistochemically for neurofilament proteins, and imaged with epifluorescence microscopy. Axons in unstretched spinal cords were undulated, or tortuous, to varying degrees, and appeared to straighten with stretch. The degree of tortuosity (ratio of the segment's pathlength to its end-to-end length) was quantified in each spinal cord by tracing several hundred randomly selected axons. The change in tormosity distributions with stretch indicated that axons switched from non-affine, uncoupled behavior at low stretch levels to affine, coupled behavior at high stretch levels, which was consistent with previous reports of axon behavior in the adult. guinea pig optic nerve (Bain, Shreiber and Meaney, J. Biomech. Eng., 125(6), pp. 798-804). A mathematical model previously proposed by Bain et al. was applied to quantify the transition in kinematic behavior. The results indicated that significant percentages of axons demonstrated purely non-affine behavior at each stage, but that this percentage decreased from 64% at E12 to 30% at E18. The decrease correlated negatively to increases in both length and myelination with development, but the change in axon kinematics could not be explained by stretch applied during physical growth of the spinal cord. The relationship between tissue-level and axonal-level deformation changes with development, which can have important implications in the response to physiological forces experienced during growth and trauma.	Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA		Hao, H (corresponding author), Rutgers State Univ, Dept Biomed Engn, 617 Bowser Rd, Piscataway, NJ 08854 USA.	shreiber@rci.rutgers.edu	Shreiber, David/ABE-8254-2021	Shreiber, David/0000-0001-8248-419X			Abe I, 2004, J ORTHOP RES, V22, P571, DOI 10.1016/j.orthres.2003.08.019; Anderson ES, 2000, J NEUROCYTOL, V29, P755, DOI 10.1023/A:1010994505741; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; BRAY D, 1984, DEV BIOL, V102, P379, DOI 10.1016/0012-1606(84)90202-1; Breig, 1960, BIOMECHANICS CENTRAL; BUTT AM, 1994, J NEUROCYTOL, V23, P469, DOI 10.1007/BF01184071; Butt AM, 1998, J NEUROCYTOL, V27, P259; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; del Rio-Hortega P, 1922, B SOC ESP BIOL, V9, P25; del Rio-Hortega P., 1924, COMPT REND SOC BIOL, V91, P818; Fass JN, 2003, BIOPHYS J, V85, P623, DOI 10.1016/S0006-3495(03)74506-8; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Heidemann S R, 1991, Curr Opin Neurobiol, V1, P339, DOI 10.1016/0959-4388(91)90050-H; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Lindsey JK, 2000, BIOMETRICS, V56, P81, DOI 10.1111/j.0006-341X.2000.00081.x; MACKLIN WB, 1985, DEV NEUROSCI-BASEL, V7, P170, DOI 10.1159/000112285; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Meaney DF, 2001, J NEUROSURG, V95, P1108; Mills LR, 2004, NEUROIMAGE, V21, P1069, DOI 10.1016/j.neuroimage.2003.10.041; Mueller H, 1999, BIOPHYS J, V76, P1072, DOI 10.1016/S0006-3495(99)77272-3; Nicolet G., 1971, Adv Morphogen, V9, P231; NIEBROJDOBOSZ I, 1980, ACTA NEUROPATHOL, V49, P145, DOI 10.1007/BF00690754; NOLTE J, 1993, HUMAN BRAIN INTRO FU; ODONOVAN M, 1992, J EXP ZOOL, V261, P261, DOI 10.1002/jez.1402610306; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; SHRAGER R, 1994, LEASQ; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2001, TISSUE ENG, V7, P131, DOI 10.1089/107632701300062714; STATE FA, 1997, ACTA ANAT, V99, P469	49	16	16	0	1	ASME-AMER SOC MECHANICAL ENG	NEW YORK	THREE PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731			J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	AUG	2007	129	4					511	522		10.1115/1.2746372			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	200AT	WOS:000248737000006	17655472				2022-02-06	
J	Stippler, M; Fischer, MR; Puccio, AM; Wisniewski, SR; Carson-Walter, EB; Dixon, CE; Walter, KA				Stippler, Martina; Fischer, Michael R.; Puccio, Ava M.; Wisniewski, Stephen R.; Carson-Walter, Eleanor B.; Dixon, C. Edward; Walter, Kevin A.			Serum and cerebrospinal fluid magnesium in severe traumatic brain injury outcome	JOURNAL OF NEUROTRAUMA			English	Article						magnesium replacement; outcome; serum magnesium; traumatic brain injury	MAGNETIC-RESONANCE-SPECTROSCOPY; HEAD-INJURY; SULFATE; EDEMA; NEUROPROTECTION; ANTIOXIDANT; METABOLISM; CHILDREN; EFFICACY; HUMANS	Serum magnesium concentration has a neuroprotective effect in experimental models of traumatic brain injury (TBI). This study was designed to assess the relationship between initial serum magnesium, cerebrospinal fluid (CSF) magnesium, neurological outcome and the efficacy of magnesium replacement therapy (MgSO4). A retrospective analysis was performed on a prospectively collected dataset from 216 patients admitted during 1996-2006 to the University of Pittsburgh Medical Center with severe TBI. Admission serum and CSF magnesium were dichotomized into low and normal magnesium concentration groups for serum and normal and high concentration groups for CSF. A logistic-regression analysis was performed with 6-month Glasgow Outcome Scale (GOS) scores as outcome variable. The outcome of a subset of 31 patients who presented with low serum magnesium and who were rapidly corrected within 24 h of admission was also analyzed. Low initial serum magnesium was measured in 56.67% of all patients. Patients with an initial serum magnesium of < 1.3 mEq/ L were 2.37 times more likely to have a poor outcome (CI: 1.18-4.78, p = 0.016). The prognostic significance of depressed serum magnesium remained, even in patients whose serum magnesium levels were corrected within 24 h ( OR = 11.03, CI: 1.87-68.14, p = 0.008). Patients with an initial high CSF magnesium were 7.63 more likely to have a poor outcome ( p = 0.05). Elevated CSF magnesium correlated with depressed serum magnesium only in patients with poor outcome ( p = 0.013). Patients with low serum magnesium and high CSF magnesium are most likely to have poor outcome after severe TBI. Rapid correction of serum magnesium levels does not reverse the prognostic value of these markers.	Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA		Walter, KA (corresponding author), Univ Rochester, Dept Neurosurg, Box 670,601 Elmwood Ave, Rochester, NY 14642 USA.	Kevin_Walter@URMC.Rochester.edu		Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS030318-14A2] Funding Source: Medline		Altura BM, 1995, CELL MOL BIOL RES, V41, P347; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS, P7; Canavero S, 2003, SURG NEUROL, V60, P165, DOI 10.1016/S0090-3019(03)00159-9; CHUTKOW JG, 1974, NEUROLOGY, V24, P780, DOI 10.1212/WNL.24.8.780; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Fujimura M, 2005, NEUROCRIT CARE, V2, P59, DOI 10.1385/NCC:2:1:059; Ghabriel MN, 2006, ACTA NEUROCHIR SUPPL, V96, P402; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, MAGNESIUM RES, V12, P269; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; KEMP PA, 1993, CLIN SCI, V85, P175, DOI 10.1042/cs0850175; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Mendez DR, 2005, PEDIATR RES, V57, P347, DOI 10.1203/01.PDR.0000150803.36315.FF; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; Natale JE, 2007, PEDIATR CRIT CARE ME, V8, P1, DOI 10.1097/01.pcc.0000256620.55512.5f; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Rigg JL, 2005, J HEAD TRAUMA REHAB, V20, P389, DOI 10.1097/00001199-200507000-00010; Sakamoto T, 2005, J TRAUMA, V58, P1103, DOI 10.1097/01.TA.0000169950.51735.C4; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757	37	16	20	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2007	24	8					1347	1354		10.1089/neu.2007.0277			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202QQ	WOS:000248918500006	17711396				2022-02-06	
J	Zazzali, JL; Marshall, GN; Shetty, V; Yamashita, DDR; Sinha, UK; Rayburn, NR				Zazzali, James L.; Marshall, Grant N.; Shetty, Vivek; Yamashita, Dennis-Duke R.; Sinha, Uttam K.; Rayburn, Nadine R.			Provider perceptions of patient psychosocial needs after orofacial injury	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; MENTAL-ILLNESS; REHABILITATION; FRACTURES	Purpose: Vulnerable populations are at particular risk for developing psychosocial sequelae after they experience orofacial injury. To enhance understanding of awareness, perspectives, and beliefs regarding attendant psychosocial issues, surgeons who provide orofacial injury care to indigent patients were surveyed. Materials and Methods: We surveyed 26 oral and maxillofacial surgeons and 15 otolaryngology surgeons at a large, urban, Level I trauma center. The survey, which measured providers' perceptions of pertinent contextual elements and patients' psychosocial needs after assaultive orofacial injury, was based on semistructured interviews with 15 oral and maxillofacial surgeons. The overall survey response rate was 85.4% (35 of 41). Results: Respondents ranked interpersonal violence as the dominant cause of orofacial injury among patients. Anxiety (eg, post-traumatic stress), depression, and legal issues were the most significant psychosocial sequelae identified by respondents. Alcohol abuse, drug abuse, and homelessness were identified as the most important contributors to orofacial reinjury and patient noncompliance with postsurgical instructions. Less than half of respondents (44.7%) believed that patients' problems with depression, anxiety, or substance abuse were currently addressed in an adequate way in the hospital. The vast majority (94.7%) believed that a psychosocial aftercare program was needed, and most agreed that such a program would decrease the risk of reinjury and would promote patient compliance with aftercare instructions and return for scheduled follow-up care. Respondents identified the specialty mental health service in their hospital or a community-based setting as the preferred locations for such a program, and they indicated that lack of financial resources and trained personnel were the most significant barriers to implementation of such a program within the setting of trauma services. Conclusions: Surgeons who provide care to indigent patients with orofacial injury perceive a great need for psychosocial aftercare programs for patients, and they believe that such programs could reduce the risk of reinjury and promote patient compliance. (c) 2007 American Association of Oral and Maxillofacial Surgeons.	RAND Corp, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ So Calif, Los Angeles, CA USA		Zazzali, JL (corresponding author), RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	zazzali@rand.org			NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA016850] Funding Source: Medline; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R21DE014973] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R21DE014973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA016850] Funding Source: NIH RePORTER		Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Glynn SM, 2003, J ORAL MAXIL SURG, V61, P785, DOI 10.1016/S0278-2391(03)00239-8; HALL SC, 1991, J NATL MED ASSOC, V83, P421; Lee Shannon, 2004, WMJ, V103, P78; Lento J, 2004, J ORAL MAXIL SURG, V62, P925, DOI 10.1016/j.joms.2004.02.009; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Link BG, 1997, J HEALTH SOC BEHAV, V38, P177, DOI 10.2307/2955424; Sheffield C G 3rd, 1988, J Burn Care Rehabil, V9, P172, DOI 10.1097/00004630-198803000-00010; Shetty V, 2003, J ORAL MAXIL SURG, V61, P808, DOI 10.1016/S0278-2391(03)00156-3; Shetty Vivek, 2003, Dent Clin North Am, V47, P141, DOI 10.1016/S0011-8532(02)00059-9; Stewart MG, 1997, OTOLARYNG HEAD NECK, V117, P72, DOI 10.1016/S0194-5998(97)70210-9; Van Loey NEE, 2001, BURNS, V27, P103, DOI 10.1016/S0305-4179(00)00099-1; Zatzick DF, 2001, MED CARE, V39, P327, DOI 10.1097/00005650-200104000-00004; Zatzick DF, 2001, GEN HOSP PSYCHIAT, V23, P114, DOI 10.1016/S0163-8343(01)00140-2	16	16	17	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	AUG	2007	65	8					1584	1589		10.1016/j.joms.2006.09.028			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	199OV	WOS:000248706000023	17656287				2022-02-06	
J	Engberg, AW				Engberg, Aase W.			A Danish National Strategy for Treatment and Rehabilitation After Acquired Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						centralized rehabilitation; traumatic brain injury		This study describes the establishment of a Danish national strategy for treatment and rehabilitation of acquired brain injury, particularly traumatic brain injury, in 1997. The vision was to create a system of tax-financed continuous treatment, restoration of function, and outpatient rehabilitation. Recommendations and their fulfillment are described. Focus is on the establishment and function of early intensive interdisciplinary rehabilitation after severe traumatic brain injury, centralized as 2 units since the year 2000, each with half the country as uptake area, corresponding to populations of around 2.5 million. Advantages gained by this centralization are increased focus on brain injury so that everybody gets specialized rehabilitation, regardless of the prognosis, the introduction of a database for severe brain injuries with unified measures of function and outcome, and the creation of a basis for method development and interdisciplinary research. Results for the first 3 years also indicate that outcome is improved after centralization.	[Engberg, Aase W.] Copenhagen Univ Hosp, Brain Injury Unit, Dept Neurol Rehabil, Hvidovre, Denmark		Engberg, AW (corresponding author), 354 Copenhagen Univ Hosp, Dept Neurol Rehabil, Hvidovre Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	aae@dadlnet.dk					AFFOLTER F, 1980, INT REHABIL MED, V3, P3; Bullock R, 1995, GUIDELINES MANAGEMEN; Butler D., 1991, MOBILISATION NERVOUS; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; Coombes K, 1996, WEGE ANFANG FRUHREHA, P137; DAVIES PM, 1994, STARTING AGAIN EARLY; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; ENGBERG AW, 2002, UGESKR LAGER, V3, P199; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Heck G, 2000, NEUROL REHABIL, V6, P125; HOLLAND AD, 1984, LANGUAGE DISORDERS A, P245; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; LARSEN A, 1991, KAN GENOPTRANING BET; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Liebach Annette, 2007, Ugeskr Laeger, V169, P223; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; LIPP B, 1998, WEGE ANFANG FRUHREHA; PINNER M, 2002, KONSENSUSRAPPORT COM; RUSK H A, 1969, Medical Clinics of North America, V53, P677; Sundhedsstyrelsen (The Danish Health Authority), 1997, BEH TRAUM HJERN TILG; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260	25	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2007	22	4					221	228		10.1097/01.HTR.0000281837.62226.54			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	V87BQ	WOS:000205885400005	17667064				2022-02-06	
J	Hartshorne, TS; Nicholas, J; Grialou, TL; Russ, JM				Hartshorne, Timothy S.; Nicholas, Jude; Grialou, Tina L.; Russ, Joanna M.			Executive function in charge syndrome	CHILD NEUROPSYCHOLOGY			English	Article							BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; DEVELOPMENTAL DISORDERS; MULTIPLE ANOMALIES; CHOANAL ATRESIA; CHILDREN; ASSOCIATION; AUTISM; ATTENTION; PROFILES	This study addressed the presence of executive dysfunction in children with CHARGE syndrome, a genetic disorder with multiple physical anomalies and severe challenging behaviors. Ninety-eight children were included in the study. More than half received clinically significant scores on the Behavior Rating Inventory of Executive Function (BRIEF; Gioia et al., 2000) scales of Shift, Monitor, and the Behavioral Regulation Index, with additional high scores on Inhibit and the Global Executive Composite. Associations were found with the age the child first walked, scores on the Autism Behavior Checklist (ABC; Krug et al., 1993), and being classified as deafblind. Difficulties with making transitions and flexible problem solving, monitoring their work and their effect on others, and acting on impulse, may be related to the behavioral difficulties exhibited by children with CHARGE. Interventions targeting improved self-regulation may help to manage this challenging behavior.	Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; Vestlandet Resource Ctr, Bergen, Norway		Hartshorne, TS (corresponding author), Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.	hartslts@cmich.edu		Nicholas, Jude/0000-0002-6894-1929			Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bernstein V, 2005, AM J MED GENET A, V133A, P232, DOI 10.1002/ajmg.a.30542; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; BLAKEGREENBERG K, 2003, DISSERT ABSTR, V64, pB408; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Carlson SM, 2005, PSYCHOL SCI, V16, P609, DOI 10.1111/j.1467-9280.2005.01583.x; Carter A., 1997, REV GEN PSYCHOL, V1, P198, DOI [10.1037/1089-2680.1.2.198, DOI 10.1037/1089-2680.1.2.198]; Cicerone KD, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P246; DAVENPORT SLH, 1986, CLIN GENET, V29, P298; Eaves RC, 2000, PSYCHOL SCHOOLS, V37, P311, DOI 10.1002/1520-6807(200007)37:4<323::AID-PITS2>3.3.CO;2-J; ESLINGER P, 2002, NEUROPSYCHOLOGICAL I; Fernell E, 1999, DEV MED CHILD NEUROL, V41, P270, DOI 10.1017/S0012162299000572; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Gioia G., 2000, BEHAV RATING EXECUTI; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Godefroy O, 1997, NEUROLOGY, V49, P695, DOI 10.1212/WNL.49.3.695; Graham JM, 2001, AM J MED GENET, V99, P120, DOI 10.1002/1096-8628(2000)9999:999<00::AID-AJMG1132>3.0.CO;2-J; Graham S., 1996, ATTENTION MEMORY EXE, P349; HALL BD, 1979, J PEDIATR-US, V95, P395, DOI 10.1016/S0022-3476(79)80513-2; Hartshorne TS, 2005, AM J MED GENET A, V133A, P257, DOI 10.1002/ajmg.a.30545; Hartshorne TS, 2005, AM J MED GENET A, V133A, P228, DOI 10.1002/ajmg.a.30541; Hartshorne TS, 2004, MENT HLTH ASPEC DEV, V7, P41; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hughes C., 2002, CHILD ADOLESCENT MEN, V7, P131, DOI DOI 10.1111/1475-3588.00024; KENEALY LE, 2002, DISSERT ABSTR, V63, pB530; KILEYBRABECK K, 2004, DISSERT ABSTR, V64, pB6332; Krasnegor N.A., 1996, ATTENTION MEMORY EXE, P263; Krug DAAJ, 1993, AUTISM SCREENING INS; LIN AE, 1990, AM J MED GENET, V37, P304, DOI 10.1002/ajmg.1320370303; LUBINSKY MS, 1994, AM J MED GENET, V49, P21, DOI 10.1002/ajmg.1320490106; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Nicholas J, 2005, AM J MED GENET A, V133A, P300, DOI 10.1002/ajmg.a.30558; Norman D., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; PALENCIA B, 2003, DISSERT ABSTR, V64, pB1518; Pennington B., 1996, ATTENTION MEMORY EXE, P327; PRATT BM, 2000, DISSERT ABSTR, V60, pB4933; Raqbi F, 2003, DEV MED CHILD NEUROL, V45, P483, DOI 10.1017/S0012162203000896; Salem-Hartshorne N, 2005, AM J MED GENET A, V133A, P262, DOI 10.1002/ajmg.a.30546; Salem-Hartshorne N, 2004, J EARLY INTERVENTION, V26, P292, DOI 10.1177/105381510402600405; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1998, FRONTAL CORTEX, P22; Smith IM, 2005, AM J MED GENET A, V133A, P248, DOI 10.1002/ajmg.a.30544; Souriau J, 2005, AM J MED GENET A, V133A, P278, DOI 10.1002/ajmg.a.30549; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Williams DA, 2005, MOL THER, V12, P2	52	16	16	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JUL	2007	13	4					333	344		10.1080/09297040600850944			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	207ZU	WOS:000249290400003	17564850				2022-02-06	
J	Pedraza, O; Smith, GE; Ivnik, RJ; Willis, FB; Ferman, TJ; Petersen, RC; Graff-Radford, NR; Lucas, JA				Pedraza, Otto; Smith, Glenn E.; Ivnik, Robert J.; Willis, Floyd B.; Ferman, Tanis J.; Petersen, Ronald C.; Graff-Radford, Neill R.; Lucas, John A.			Reliable change on the Dementia Rating Scale	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						cognitive aging; Alzheimer's disease; RCI; DRS; MOANS; MOAANS	SPORT CONCUSSION RESEARCH; STANDARD ERROR; FUNCTIONAL DECLINE; CLASSICAL APPROACH; NORMATIVE DATA; CHANGE INDEX; OLDER; JACOBSON	A central role for neuropsychological evaluations is the measurement of change in cognitive functioning over time. However, change scores obtained from repeated neuropsychological assessments may be affected by normal variability because of measurement error and practice effects caused by repeated measurements. The current study uses reliable change estimates to establish normative rates of change on the Dementia Rating Scale from baseline to first follow-up testing among 1080 cognitively normal adults aged 65 and older. Results showed that a 6-point decline by European Americans or a 9-point decline by African American adults within a 9-15 month test-retest interval represents reliable change. Within a 16-24-month test-retest interval, a 7-point decline among European Americans or an 8-point decline among African American adults represents reliable change. In addition, preliminary cross-validation was performed in a clinical comparison sample of another 22 older adults. The findings are discussed in the context of potential clinical and research applications.	Mayo Clin, Coll Med, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA; Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; Mayo Clin, Dept Family Med, Jacksonville, FL 32224 USA; Mayo Clin, Dept Neurol, Rochester, MN USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA		Pedraza, O (corresponding author), Mayo Clin, Coll Med, Dept Psychiat & Psychol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	otto.pedraza@mayo.edu		Smith, Glenn/0000-0003-1506-9484	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016574] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [3P50 AG016574-07S1] Funding Source: Medline		Black SA, 2002, J AM GERIATR SOC, V50, P1978, DOI 10.1046/j.1532-5415.2002.50609.x; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre A, 2000, J INT NEUROPSYCH SOC, V6, P362, DOI 10.1017/S1355617700633118; Hinton-Bayre A, 2005, BRIT J SPORT MED, V39, P488; Hinton-Bayre AD, 2005, J INT NEUROPSYCH SOC, V11, P788, DOI 10.1017/S1355617705050940; Hinton-Bayre AD, 2004, J INT NEUROPSYCH SOC, V10, P894, DOI 10.1017/S1355617704106103; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Ivnik R.J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Lucas JA, 2005, CLIN NEUROPSYCHOL, V19, P162, DOI 10.1080/13854040590945265; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P536, DOI 10.1076/jcen.20.4.536.1469; Maassen GH, 2006, BRIT J SPORT MED, V40, P829, DOI 10.1136/bjsm.2005.023713; Maassen GH, 2005, BRIT J SPORT MED, V39, P483, DOI 10.1136/bjsm.2004.015594; Maassen GH, 2004, J INT NEUROPSYCH SOC, V10, P902, DOI 10.1017/S1355617704106127; Maassen GH, 2004, J INT NEUROPSYCH SOC, V10, P888, DOI 10.1017/S1355617704106097; Mattis S., 2001, DEMENTIA RATING SCAL; McGlinchey JB, 1999, BEHAV RES THER, V37, P1211; Moody-Ayers SY, 2005, J GERONTOL A-BIOL, V60, P933, DOI 10.1093/gerona/60.7.933; Rilling LM, 2005, CLIN NEUROPSYCHOL, V19, P229, DOI 10.1080/13854040590945328; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Temkin NR, 2004, J INT NEUROPSYCH SOC, V10, P899, DOI 10.1017/S1355617704106115	20	16	16	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2007	13	4					716	720		10.1017/S1355617707070920			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	186GJ	WOS:000247766800020	17521486				2022-02-06	
J	Pillay, NS; Kellaway, LA; Kotwal, GJ				Pillay, Nirvana S.; Kellaway, Laurie A.; Kotwal, Girish J.			Vaccinia virus complement control protein significantly improves sensorimotor function recovery after severe head trauma	BRAIN RESEARCH			English	Article						vaccinia virus complement control protein; head trauma; Morris Water Maze; angle board; sensorimotor; fluid percussion injury	PERCUSSION BRAIN-INJURY; ADULT-RAT; FLUID; ACTIVATION; SYSTEM; MODEL; CONSEQUENCES; INFLAMMATION; INHIBITION; CASCADE	Vaccinia virus complement control protein (VCP) is an immunomodulator that inhibits both the classical and alternate pathways of the complement system, therefore preventing cell death and inflammation. VCP has previously been shown to be therapeutically effective in mild and moderate traumatic brain injury models. in this study the efficacy of VCP in a severe head injury model is investigated in Wistar rats. Training in a Morris Water Maze (MWM) commenced 2 days prior stereotaxic surgery. Rats were anesthetized before being subjected to a severe (2.7-3.0 atm) lateral fluid percussion injury (FPI) 3.0 mm lateral to the sagittal suture and 4.5 mm posterior to bregma. Ten microliters of VCP (1.7 mu g/mu l) was injected into the injury site immediately after FPI. Fourteen days post-FPI, rats were tested for spatial learning and memory using the Morris Water Maze, followed by a battery of sensorimotor tests. The latter tests showed statistically significant differences between saline-treated and VCP-treated rats in lateral left pulsion (P=0.001) and tactile placing (p=0.002) on the first 5 days of testing. In addition, significant differences in right lateral pulsion in the first 4 days (p=0.007) of testing was evident. The results suggest that in a severe head injury model, VCP at this dosage favorably influences sensorimotor outcome. (c) 2007 Elsevier B.V. All rights reserved.	Univ Cape Town, Fac Hlth Sci, Div Neurosci, ZA-7700 Rondebosch, South Africa; Univ Cape Town, Fac Hlth Sci, Div Med Virol, ZA-7700 Rondebosch, South Africa; Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa		Kotwal, GJ (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Neurosci, ZA-7700 Rondebosch, South Africa.	gjkotw01@gmail.com					Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pillay NS, 2005, ANN NY ACAD SCI, V1056, P450, DOI 10.1196/annals.1352.021; Power AE, 2002, BEHAV BRAIN RES, V134, P307, DOI 10.1016/S0166-4328(02)00046-3; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; van der Sluis CK, 1998, INJURY, V29, P281, DOI 10.1016/S0020-1383(97)00199-X; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Yoshioka M, 1996, NEUROSCI LETT, V209, P201, DOI 10.1016/0304-3940(96)12631-8	29	16	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 11	2007	1153						158	165		10.1016/j.brainres.2007.03.056			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	181FZ	WOS:000247423800018	17467672				2022-02-06	
J	Kallakuri, S; Kreipke, CW; Rossi, N; Rafols, JA; Petrov, T				Kallakuri, Srinivasu; Kreipke, Christian W.; Rossi, Noreen; Rafols, Jose A.; Petrov, Theodor			Spatial alterations in endothelin receptor expression are temporally associated with the altered microcirculation after brain trauma	NEUROLOGICAL RESEARCH			English	Article						sensorimotor cortex; hippocampus; neurons; vascular wall; immunocytochemistry	CEREBRAL-ARTERY OCCLUSION; A RECEPTOR; BLOOD-FLOW; RAT MODEL; CORTEX; INJURY; VASOCONSTRICTION; HIPPOCAMPUS; ANTAGONIST; ASTROCYTES	Objectives: To study the cellular distribution of endothelin receptors A and B (ETrA and ETrB) in the post-traumatic sensorimotor cortex and hippocampus. Materials and methods: We inflicted closed head trauma to male Sprague - Dawley rats and visualized ETrA and ETrB immunoreactivity with 3,3'- diaminobenzidine. Results: ETrA immunolabeling was the most prominent in pyramidal neurons 24 and 48 hours post- trauma, while it reached its peak in the microvasculature at hour 4. ETrB immunolabeling was observed in endothelial cells, perivascular neurons, smooth muscle cells (SM) and pericytes, the expression being the most pronounced 24 hours post-trauma. Discussion: The results suggest that the vasoconstrictor effect of endothelin-1 (ET-1) is mediated primarily by ETrA. The dual effects of ETrB are reflected in its vasoconstrictor role at the vascular bed and conversely, in the attenuation of ET-1 availability and synthesis. We conclude that both receptors play a role in the disturbed microvascular autoregulation and in the sustained reduction of blood flow following trauma to the brain.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	tpetrov@med.wayne.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS039860] Funding Source: Medline		Andersson KE, 2001, UROL CLIN N AM, V28, P233, DOI 10.1016/S0094-0143(05)70134-8; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ARMSTEAD W, 1999, AM J PHYSIOL, V274, P1884; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; CLOZEL M, 1992, BIOCHEM BIOPH RES CO, V186, P867, DOI 10.1016/0006-291X(92)90826-7; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Granchi S, 2002, MOL HUM REPROD, V8, P1053, DOI 10.1093/molehr/8.12.1053; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; *I LAB AN RES COMM, 1996, NIH PUBL; Just A, 2004, AM J PHYSIOL-RENAL, V286, pF660, DOI 10.1152/ajprenal.00368.2003; Kurokawa K, 1997, J COMP NEUROL, V389, P348, DOI 10.1002/(SICI)1096-9861(19971215)389:2<348::AID-CNE11>3.0.CO;2-H; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Loo LS, 2002, NEUROSCIENCE, V112, P993, DOI 10.1016/S0306-4522(02)00043-X; MACCUMBER MW, 1990, P NATL ACAD SCI USA, V87, P2359, DOI 10.1073/pnas.87.6.2359; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MASAKI T, 1993, ENDOCR REV, V14, P256, DOI 10.1210/er.14.3.256; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; Nakagomi S, 2000, NEUROSCIENCE, V101, P441, DOI 10.1016/S0306-4522(00)00345-6; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters C. M., 2001, Society for Neuroscience Abstracts, V27, P2046; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; RANDALL MD, 1989, BRIT J PHARMACOL, V98, P685, DOI 10.1111/j.1476-5381.1989.tb12644.x; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SakuraiYamashita Y, 1997, EUR J PHARMACOL, V338, P199, DOI 10.1016/S0014-2999(97)81949-8; Sanchez R, 2002, J CARDIOVASC PHARM, V39, P652, DOI 10.1097/00005344-200205000-00005; Singer OC, 2003, J CEREBR BLOOD F MET, V23, P605, DOI 10.1097/01.WCB.0000062342.57257.28; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; TEERLINK JR, 1994, CIRCULATION, V90, P2510, DOI 10.1161/01.CIR.90.5.2510; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang Yundong, 2000, Chin J Traumatol, V3, P185; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083	38	16	18	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2007	29	4					362	368		10.1179/016164107X204675			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	192PM	WOS:000248214200005	17626731				2022-02-06	
J	Canter, HI; Kayikcioglu, A; Aksu, M; Mavili, ME				Canter, Halil Ibrahim; Kayikcioglu, Aycan; Aksu, Muge; Mavili, Mehmet Emin			Botulinum toxin in closed treatment of mandibular condylar fracture	ANNALS OF PLASTIC SURGERY			English	Article						botulinum toxin; closed treatment; condylar fracture	TEMPOROMANDIBULAR-JOINT; SPASM; AGE	Background: The topic of condylar injury in adults has generated more discussion and controversy than any other in the field of maxillofacial trauma. The treatment of condylar fractures in adults is still a highly debated theme. Methods: Patients with unilateral subcondylar or condylar neck fractures of the mandibula without any significant angulation of the condylar head were managed with closed-treatment protocol. Closed treatment was applied through the injection of 100 units of botulinum toxin A, diluted to a concentration of 20 IU/mL, into the muscles of mastication of the fractured side. Masseter and anterior fibers of temporalis muscles were reached through percutaneous extraoral route and 30 IU of the toxin was injected to each muscle. Additional 40 IU of the toxin was injected around the fractured bone fragments through transmucosal intraoral route to paralyze medial and lateral pterygoid muscles as much as possible. An asymmetric occlusal splint was applied for maxillomandibular fixation to restore the vertical height for 10 days. Functional therapy with intermaxillary guiding elastics was advocated for 2 months. Results: There were no complications related to either toxin injections or splint application procedures. The toxin was effective on all occasions. Fractured condylar process and ramus of the mandibula were in good approximation and remained in reduced positions. None of the patients had any occlusal disturbance, mandibular asymmetry, or joint dysfunction in the follow-up period. Conclusions: We believe that modification of treatment options concerning the clinical situation of the patients is the best method for condylar injury. The purpose of this study is to present and discuss the results achieved in closed treatment of a selected group of patients with mandibular condylar fractures to whom botulinum toxin A was injected to relieve the spasm of muscles of mastication, along with special splint application.	Hacettepe Univ, Fac Med, Dept Plast & Reconstruct Surg, Ankara, Turkey; Hacettepe Univ, Fac Dent, Dept Orthodont, Ankara, Turkey			hicanter@gmail.com					Albanese A, 1995, ALIMENT PHARM THERAP, V9, P599; Bos RRM, 1999, BRIT J ORAL MAX SURG, V37, P87; Brandt MT, 2003, J ORAL MAXIL SURG, V61, P1324, DOI 10.1016/S0278-2391(03)00735-3; Brisinda G, 1999, NEW ENGL J MED, V341, P65, DOI 10.1056/NEJM199907083410201; Carruthers J, 2004, PLAST RECONSTR SURG, V114, p1S, DOI 10.1097/01.PRS.0000144795.76040.D3; CARRUTHERS J, 1987, CAN J NEUROL SCI, V14, P42; CLARK RP, 1989, PLAST RECONSTR SURG, V84, P353, DOI 10.1097/00006534-198908000-00027; da Silveira Eduardo B V, 2002, Am J Ther, V9, P157, DOI 10.1097/00045391-200203000-00010; Ellis E, 2005, J ORAL MAXIL SURG, V63, P115, DOI 10.1016/j.joms.2004.02.019; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Freitag FG, 2003, CNS DRUGS, V17, P373, DOI 10.2165/00023210-200317060-00001; Glogau RG, 2002, CLIN J PAIN, V18, pS191, DOI 10.1097/00002508-200211001-00012; Karacalar A, 2005, J CRANIOFAC SURG, V16, P476, DOI 10.1097/04.SCS.0000157263.73768.64; Kayikcioglu A, 2003, PLAST RECONSTR SURG, V111, P341, DOI 10.1097/01.PRS.0000037870.07434.D0; Koman L Andrew, 2003, Paediatr Drugs, V5, P11, DOI 10.2165/00128072-200305010-00002; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; Miloro M, 2004, ARCH OTOLARYNGOL, V130, P1231, DOI 10.1001/archotol.130.10.1231; O'Brien CF, 2002, CLIN J PAIN, V18, pS182, DOI 10.1097/00002508-200211001-00011; PITANGUY I, 1981, PLAST RECONSTR SURG, V67, P157, DOI 10.1097/00006534-198167020-00005; Porta M, 2000, PAIN, V85, P101, DOI 10.1016/S0304-3959(99)00264-X; SATKO CR, 1986, J ORAL MAXIL SURG, V44, P871, DOI 10.1016/0278-2391(86)90224-7; SCOTT AB, 1980, OPHTHALMOLOGY, V87, P1044; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Talwar RM, 1998, J ORAL MAXIL SURG, V56, P430, DOI 10.1016/S0278-2391(98)90707-8; TASANEN A, 1976, Journal of Maxillofacial Surgery, V4, P200, DOI 10.1016/S0301-0503(76)80036-7; Villarreal PM, 2004, J ORAL MAXIL SURG, V62, P155, DOI 10.1016/j.joms.2003.08.010; Vural E, 2004, ARCH OTOLARYNGOL, V130, P1228, DOI 10.1001/archotol.130.10.1228	27	16	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	MAY	2007	58	5					474	478		10.1097/01.sap.0000244987.68092.6e			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	161RK	WOS:000246033000002	17452828				2022-02-06	
J	Turner, R; Vink, R				Turner, Renee; Vink, Robert			Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke	DRUG NEWS & PERSPECTIVES			English	Article							TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; PRIMARY SENSORY NEURONS; SUBSTANCE-P; EDEMA FORMATION; SPINAL-CORD; RECEPTOR EXPRESSION; TACHYKININ; RELEASE; RAT	Each year, 15 million people suffer a stroke, of which 5 million die and 5 million are left permanently disabled. Cerebral swelling is of particular concern following stroke as it accounts for much of the death and disability. However, the mechanisms leading to cerebral swelling are not yet fully understood. Recent studies from our laboratory suggest that neuropeptides, and specifically substance P, may be involved in the injury processes that occur following acute insults to the brain such as stroke and trauma, and may be responsible, in part, for edema formation. Levels of substance P are increased following CNS injury, indicative of neurogenic inflammation, and this is associated with injury to the blood-brain barrier, the development of cerebral edema, cell death and functional deficits. Subsequent studies inhibiting neuropeptide release have consistently shown decreased cerebral edema and improved neurological outcome, while substance P antagonists administered after the insult are efficacious in reducing post-stroke cerebral edema and neurological deficits. The current review summarizes the evidence supporting the benefits of inhibiting neurogenic inflammation to treat ischemic stroke. (C) 2007 Prous Science. All rights reserved.	Univ Adelaide, Discipline Pathol, Adelaide, SA 5005, Australia		Vink, R (corresponding author), Univ Adelaide, Discipline Pathol, Adelaide, SA 5005, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Turner, Renee/0000-0003-4278-8302			Alves RV, 1999, PEPTIDES, V20, P921, DOI 10.1016/S0196-9781(99)00082-0; ANDERSON JJ, 1993, BRAIN RES, V623, P189, DOI 10.1016/0006-8993(93)91426-S; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Bakhai A, 2004, PHARMACOECONOMICS, V22, P11, DOI 10.2165/00019053-200422004-00004; Bath PMW, 2000, BRIT MED BULL, V56, P422, DOI 10.1258/0007142001903067; Bayliss WM, 1901, J PHYSIOL-LONDON, V26, P173; BETZ AL, 1990, ACT NEUR S, V51, P256; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Bruno G, 2003, INT J IMMUNOPATH PH, V16, P67, DOI 10.1177/039463200301600110; Campos MM, 2000, NEUROPEPTIDES, V34, P314, DOI 10.1054/npep.2000.0823; Cao T, 1999, AM J PHYSIOL-REG I, V277, pR476, DOI 10.1152/ajpregu.1999.277.2.R476; CHEN HJ, 1992, STROKE, V23, P957, DOI 10.1161/01.STR.23.7.957; Dewey HM, 2001, STROKE, V32, P2409, DOI 10.1161/hs1001.097222; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Gaddum J H, 1934, J Physiol, V83, P1; Gartshore G, 1997, EXP NEUROL, V147, P353, DOI 10.1006/exnr.1997.6635; Gauchy C, 1996, NEUROSCIENCE, V73, P929, DOI 10.1016/0306-4522(96)00099-1; Green AR, 2002, CLIN EXP PHARMACOL P, V29, P1030, DOI 10.1046/j.1440-1681.2002.03767.x; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Heuschmann PU, 2003, STROKE, V34, P1106, DOI 10.1161/01.STR.0000065198.80347.C5; Hill MD, 1998, LANCET, V352, pSIII10; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Holzer P, 1998, GEN PHARMACOL, V30, P5, DOI 10.1016/S0306-3623(97)00078-5; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kramer JH, 1997, J MOL CELL CARDIOL, V29, P97, DOI 10.1006/jmcc.1996.0255; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; KUROIWA T, 1985, ACTA NEUROPATHOL, V66, P3, DOI 10.1007/BF00698288; Lanzino D J, 2000, Neurosurg Focus, V8, pe3; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Malcangio M, 2000, EUR J NEUROSCI, V12, P397, DOI 10.1046/j.1460-9568.2000.00946.x; MATSAS R, 1984, BIOCHEM J, V223, P433, DOI 10.1042/bj2230433; McCarson KE, 1999, NEUROSCIENCE, V93, P361, DOI 10.1016/S0306-4522(99)00102-5; MENZIES SA, 1993, J NEUROSURG, V78, P257, DOI 10.3171/jns.1993.78.2.0257; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOGUCHI K, 1988, MOL BRAIN RES, V4, P31, DOI 10.1016/0169-328X(88)90015-0; NORRIS JW, 1986, BMJ-BRIT MED J, V292, P21, DOI 10.1136/bmj.292.6512.21; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Parker D, 1998, J NEUROSCI, V18, P4800; PERSSON MG, 1991, EUR J PHARMACOL, V205, P295, DOI 10.1016/0014-2999(91)90913-B; QUAST MJ, 1993, MAGN RESON IMAGING, V11, P465, DOI 10.1016/0730-725X(93)90465-P; Ribeiro-da-Silva A, 2000, NEUROPEPTIDES, V34, P256, DOI 10.1054/npep.2000.0834; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; Rupniak NMJ, 2000, NEUROPHARMACOLOGY, V39, P1413, DOI 10.1016/S0028-3908(00)00052-6; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; SHARMA HS, 1990, NEUROSCIENCE, V38, P205, DOI 10.1016/0306-4522(90)90386-I; SHEN KZ, 1992, NEUROSCIENCE, V50, P345, DOI 10.1016/0306-4522(92)90428-5; SKIDGEL RA, 1987, CLIN EXP HYPERTENS A, V9, P243, DOI 10.3109/10641968709164184; Stumm RK, 2001, J NEUROSCI, V21, P798, DOI 10.1523/JNEUROSCI.21-03-00798.2001; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; WOIE K, 1993, CIRC RES, V73, P839, DOI 10.1161/01.RES.73.5.839; WOODCOCK J, 1982, STROKE, V13, P785, DOI 10.1161/01.STR.13.6.785; Yatsu FM, 1972, STROKE, V3, P726, DOI 10.1161/01.STR.3.6.726; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006	59	16	19	0	2	PROUS SCIENCE, SAU-THOMSON REUTERS	BARCELONA	398 PROVENCA, 08025 BARCELONA, SPAIN	0214-0934	2013-0139		DRUG NEWS PERSPECT	Drug News Perspect.	MAY	2007	20	4					221	226		10.1358/dnp.2007.20.4.1103527			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	190RO	WOS:000248076900002	17637934				2022-02-06	
J	Pueyrredon, F; Spaho, N; Arroyave, I; Vinters, H; Lazareff, J				Pueyrredon, Francisco; Spaho, Natalia; Arroyave, Ivonne; Vinters, Harry; Lazareff, Jorge			Histological findings in cerebellar tonsils of patients with Chiari type I malformation	CHILDS NERVOUS SYSTEM			English	Article						Arnold Chiari malformation; cerebellar disease; ischemia; Purkinje cell; treatment; tonsillectomy	TRAUMATIC BRAIN INJURY; DECOMPRESSION; MANAGEMENT; ISCHEMIA; FOSSA	Cerebellar tonsillectomy is often performed for relief of symptoms associated with Chiari type I malformation (CMI). Nonetheless, the idea of removing supposedly healthy central nervous tissue has been a source of concern for neurosurgeons. The aim of this paper is to determine the histological changes in the cerebellar tonsils of patients with a wide range of symptoms and conditions related to CMI. The cerebellar tonsils of 43 pediatric patients with CMI were sent to pathology for histological examination. The cerebellar tonsils in a great majority of CMI patients can be abnormal. We suggest that the reported histological findings are secondary to injury and ischemia.	Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Div Surg Pathol, Los Angeles, CA 90095 USA		Lazareff, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, POB 957039, Los Angeles, CA 90095 USA.	jlazareff@mednet.ucla.edu					Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Genitori L, 2000, CHILD NERV SYST, V16, P707, DOI 10.1007/s003810000338; Guyotat J, 1998, ACTA NEUROCHIR, V140, P745, DOI 10.1007/s007010050175; Koga H, 1995, No To Shinkei, V47, P1075; Lazareff JA, 2002, J NEUROSURG, V97, P1018, DOI 10.3171/jns.2002.97.5.1018; Martin LJ, 2000, J CEREBR BLOOD F MET, V20, P153, DOI 10.1097/00004647-200001000-00020; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Munshi I, 2000, NEUROSURGERY, V46, P1384, DOI 10.1097/00006123-200006000-00018; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Welsh JP, 2002, ADV NEUROL, V89, P331	13	16	19	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2007	23	4					427	429		10.1007/s00381-006-0252-y			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	143UH	WOS:000244750900011	17119980				2022-02-06	
J	Christ, M; Noack, F; Schroeder, T; Hagmueller, A; Koch, R; May, SA; Morgenstern, U; Ragaller, M; Steinmeier, R				Christ, Melanie; Noack, Frank; Schroeder, Tobias; Hagmueller, Andreas; Koch, Rainer; May, Sven-Axel; Morgenstern, Ute; Ragaller, Maximilian; Steinmeier, Ralf			Continuous cerebral autoregulation monitoring by improved cross-correlation analysis: comparison with the cuff deflation test	INTENSIVE CARE MEDICINE			English	Article						cerebral autoregulation; continuous neuromonitoring; cross-correlation; transcranial Doppler; head injury; subarachnoid hemorrhage	ARTERIAL-BLOOD-PRESSURE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; FLOW VELOCITY; TRANSCRANIAL DOPPLER; PERFUSION-PRESSURE; CEREBROVASCULAR AUTOREGULATION; HUMANS; OSCILLATIONS	Objectives: To improve the cross-correlation method for noninvasive, continuous monitoring of cerebral autoregulation, to evaluate this method in humans with intact and impaired autoregulatory capacity, and to compare it to the cuff deflation test. Design and setting: Prospective study in the intensive care unit of a university hospital. Patients and participants: Fourteen patients with severe head injury, six patients with subarachnoid hemorrhage, and nine healthy volunteers. Interventions and measurements: Middle cerebral artery flow velocities and arterial blood pressure were monitored continuously. Aaslid's thigh cuff tests were performed and results were scored using Tiecks' model for autoregulation index. Data were then collected without any patient manipulation. The mean time delay between slow spontaneous oscillations of blood pressure and middle cerebral artery flow velocity was calculated by cross-correlation analysis. Data are expressed as median (lower/upper quartile). Results: Healthy subjects had a higher autoregulation index than patients, 5.0 (5.0/5.5) vs. 3.3 (2.0/4.5). Slow oscillations of blood pressure and middle cerebral artery flow velocity showed a time delay of -2.0 s (-2.7/-1.7) in healthy subjects but were almost synchronal in patients, -0.07 s (-0.5/0.45). Inter-method agreement in diagnosing an intact or impaired cerebral autoregulation was obtained in 108 of 147 examinations of autoregulation (73.5%) and was considered moderate. Conclusions: Cross-correlation analysis may serve as a simple, noninvasive, and continuous measure of cerebral autoregulation. The time delay of -2.0 s in healthy subjects is in good agreement with other studies. Short-term autoregulation tests and monitoring techniques based on slow spontaneous oscillations should not be used interchangeably.	Tech Univ Dresden, Dept Anesthesiol & Intens Care Med, Carl Gustav Carus Univ Hosp, D-01307 Dresden, Germany; Tech Univ Dresden, Inst Biomed Engn, Dept Elect Engn & Informat Technol, D-01062 Dresden, Germany; Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA		Christ, M (corresponding author), Tech Univ Dresden, Dept Anesthesiol & Intens Care Med, Carl Gustav Carus Univ Hosp, Fetscherstasse 74, D-01307 Dresden, Germany.	Melanie.Christ@uniklinikum-dresden.de		Schroeder, Tobias/0000-0002-4439-8060			AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; CHRIST M, 2004, INTENS CARE MED S, V169, P651; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Eames PJ, 2004, CLIN SCI, V106, P155, DOI 10.1042/CS20030194; ENEVOLDSEN EM, 1977, ACTA NEUROL SCAND, V56, P514; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Johnston AJ, 2004, INTENS CARE MED, V30, P45, DOI 10.1007/s00134-003-2032-4; KIRKHAM FJ, 1986, ULTRASOUND MED BIOL, V12, P15, DOI 10.1016/0301-5629(86)90139-0; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; Kuo TBJ, 2003, CEREBROVASC DIS, V16, P402, DOI 10.1159/000072564; Kuusela Tom A, 2003, BMC Physiol, V3, P11, DOI 10.1186/1472-6793-3-11; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mascia L, 2003, INTENS CARE MED, V29, P1088, DOI 10.1007/s00134-003-1780-5; Myburgh JA, 2003, INTENS CARE MED, V29, P817, DOI 10.1007/s00134-003-1684-4; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Panerai RB, 2003, ULTRASOUND MED BIOL, V29, P31, DOI 10.1016/S0301-5629(02)00698-1; Panerai RB, 2001, AM J PHYSIOL-HEART C, V280, pH2162, DOI 10.1152/ajpheart.2001.280.5.H2162; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Reinhard M, 2003, PHYSIOL MEAS, V24, P27, DOI 10.1088/0967-3334/24/1/303; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Sahuquillo J, 2000, ACTA NEUROCHIR SUPPL, V76, P485; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Steinmeier R, 2002, J NEUROTRAUM, V19, P1127, DOI 10.1089/08977150260337949; Thees C, 2003, INTENS CARE MED, V29, P386, DOI 10.1007/s00134-002-1625-7; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zwiener U, 2003, INTENS CARE MED, V29, P2277, DOI 10.1007/s00134-003-2007-5	40	16	17	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2007	33	2					246	254		10.1007/s00134-006-0451-8			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QA	WOS:000244026200007	17143638				2022-02-06	
J	Ellis, DY; Davies, GE; Pearn, J; Lockey, D				Ellis, Daniel Y.; Davies, Gareth E.; Pearn, John; Lockey, David			Prehospital rapid-sequence intubation of patients with trauma with a Glasgow Coma Score of 13 or 14 and the subsequent incidence of intracranial pathology	EMERGENCY MEDICINE JOURNAL			English	Article							HOSPITAL ENDOTRACHEAL INTUBATION; EMERGENCY MEDICAL-SERVICE; HEAD-INJURED PATIENTS; BRAIN-INJURY; GUIDELINES; CARE; IMPACT; RISK	Aim: To identify the incidence of intracranial pathology in a population of patients with trauma with an on-scene Glasgow Coma Score ( GCS) of 13 or 14, and the proportion that required prehospital intubation and ventilation. Method: A retrospective review of a prehospital trauma database was carried out over a 12-month period, and 81 patients were reviewed. All had a traumatic mechanism of injury and had an on-scene GCS of 13 or 14 recorded by a prehospital doctor. 43 patients required prehospital rapid-sequence intubation. Overall, 31.5% of patients with a GCS of 13 or 14 had an abnormal computed tomography scan of the head and 20.5% had an intracranial haemorrhage. Results: For this group of patients with trauma with a drop of only one or two points on the GCS, the incidence of intracranial pathology was almost one in three and that of intracranial haemorrhage was one in five.	Royal London Hosp, Dept Prehosp Care, London E1 1BB, England		Ellis, DY (corresponding author), The Cottage,Upper St, Dyrham SN14 8HN, S Gloucestershi, England.	danellis@doctors.org.uk					*AM COLL SURG COMM, 2004, ADV TRAUM LIF SUPP A; Bernard Stephen, 2002, Emerg Med (Fremantle), V14, P406, DOI 10.1046/j.1442-2026.2002.00382.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Burton JH, 2006, ANN EMERG MED, V47, P542, DOI 10.1016/j.annemergmed.2006.01.023; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; Chesnut RM, 1997, J TRAUMA, V42, pS19, DOI 10.1097/00005373-199705001-00004; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Davis MJ, 2002, CHEM VAPOR DEPOS, V8, P7, DOI 10.1002/1521-3862(20020116)8:1<7::AID-CVDE7>3.0.CO;2-A; Dunham CM, 2003, J TRAUMA, V55, P162, DOI 10.1097/01.ta.0000083335.93868.2c; GORMAN DF, 1995, INJURY, V26, P51, DOI 10.1016/0020-1383(95)90553-A; Graham CA, 1997, J ACCID EMERG MED, V14, P219; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; HEDGES JR, 1988, ANN EMERG MED, V17, P469, DOI 10.1016/S0196-0644(88)80238-5; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; NICE, 2003, HEAD INJ TRIAG ASS I; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; Piek J, 1998, INTENS CARE MED, V24, P1221, DOI 10.1007/s001340050748; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; Wang H E, 2001, Prehosp Emerg Care, V5, P40, DOI 10.1080/10903120190940317; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014	30	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	FEB 1	2007	24	2					139	141		10.1136/emj.2006.040428			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	132UH	WOS:000243967200024	17251629	Green Published			2022-02-06	
J	Mikrogianakis, A; Shaye, RE; Griffin, P; Kawesa, S; Lockwood, J; Gendron, NH; Gaboury, I; Merali, Z; MacKenzie, AE; Hutchison, JS				Mikrogianakis, Angelo; Shaye, Rachel E.; Griffin, Phillip; Kawesa, Sarah; Lockwood, Julia; Gendron, Nathalie H.; Gaboury, Isabelle; Merali, Zul; MacKenzie, Alex E.; Hutchison, James S.			Hypoxia alters the expression of inhibitor of apoptosis proteins after brain trauma in the mouse	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; caspase; hypoxia; neuronal apoptosis inhibitor protein; TBI	ENERGY PHOSPHATE-METABOLISM; CORTICAL IMPACT INJURY; X-LINKED INHIBITOR; NEURONAL APOPTOSIS; RAT HIPPOCAMPUS; TRANSGENIC MICE; HEAD-INJURY; CELL-DEATH; XIAP; ISCHEMIA	Hypoxia worsens brain injury following trauma, but the mechanisms remain unclear. The purpose of this study was to determine the effect of traumatic brain injury (TBI) and secondary hypoxia (9% oxygen) on apoptosis-related protein expression, cell death, and behavior. Using a murine weight-drop model, TBI led to an early (6 h) increase followed by a later (24 h) decrease in neuronal apoptosis inhibitor protein (NAIP) expression in the olfactory and motor cortex; in contrast, TBI led to a sustained (6 h to 7 days) increase in NAIP in the striatum. The peak increase in the expression of NAIP (6-12 h) following TBI alone was delayed (1-7 days) when hypoxia was added to TBI. Hypoxia following TBI further depleted other apoptosis inhibitor proteins (IAPs) and activated caspases, as well as increased contusion size and worsened cell death. Hypoxia added to TBI also increased motor and feeding activity on days 2 and 4 compared to TBI alone. Hypoxia without TBI had no effect on the expression of IAPs or cell death. These findings show that IAPs have a potential role in the increased vulnerability of brain cells to hypoxia following TBI, and have implications for configuring future therapies for TBI.	Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Fac Med, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Fac Med, Interdept Div Crit Care, Toronto, ON, Canada; Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Inst Res, Integrat Biol Program, Toronto, ON M5G 1X8, Canada; Childrens Hosp Eastern Ontario, Inst Res, Genet Mol Lab, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Inst Res, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada; Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada; Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada; Univ Ottawa, Fac Med, Dept Biochem, Ottawa, ON, Canada		Hutchison, JS (corresponding author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	Jamie.Hutchison@sickkids.ca	Mikrogianakis, Angelo/AAW-5929-2021; Gaboury, Isabelle/B-6868-2011	Mikrogianakis, Angelo/0000-0002-8854-0620; Gendron, Nathalie/0000-0001-5636-7408			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Crocker SJ, 2003, NEUROBIOL DIS, V12, P150, DOI 10.1016/S0969-9961(02)00020-7; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Hutchison JS, 2001, J NEUROTRAUM, V18, P1333, DOI 10.1089/08977150152725632; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Johnston S A, 1988, Peptides, V9 Suppl 1, P245, DOI 10.1016/0196-9781(88)90250-1; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kugler S, 2000, CELL DEATH DIFFER, V7, P815, DOI 10.1038/sj.cdd.4400712; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; Merali Z, 2003, BIOL PSYCHIAT, V54, P552, DOI 10.1016/S0006-3223(02)01827-9; Mercer EA, 2000, EMBO J, V19, P3597, DOI 10.1093/emboj/19.14.3597; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Okada Y, 2005, J CEREBR BLOOD F MET, V25, P794, DOI 10.1038/sj.jcbfm.9600078; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Wang XY, 2004, NEUROBIOL DIS, V16, P179, DOI 10.1016/j.nbd.2004.01.014; Winter B, 2005, BIOL PSYCHIAT, V57, P1166, DOI 10.1016/j.biopsych.2005.02.010; Xu DG, 1999, J NEUROSCI, V19, P5026; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	44	16	18	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2007	24	2					338	353		10.1089/neu.2006.003615			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	150AL	WOS:000245187900013	17375998				2022-02-06	
J	Behan, LA; Agha, A				Behan, Lucy Ann; Agha, Amar			Endocrine consequences of adult traumatic brain injury	HORMONE RESEARCH			English	Article; Proceedings Paper	39th International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism	MAY 11-12, 2007	Berlin, GERMANY	Pfizer		traumatic brain injury; hypopituitarism; pituitary	ANTERIOR-PITUITARY DYSFUNCTION; ANTI-DIURETIC HORMONE; INAPPROPRIATE SECRETION; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM; INSUFFICIENCY	Background: Traumatic brain injury (TBI) is the most common cause of death and disability in young adults living in industrialised countries. Over the last few years, there has been an increasing awareness that hypopituitarism can complicate TBI in a significant proportion of survivors: at least 25% of TBI survivors develop one or more pituitary hormone deficiencies. This remarkably high frequency has changed the traditional concept that hypopituitarism was a rare complication of TBI and suggests that most cases of posttraumatic hypopituitarism remain undiagnosed and untreated in clinical practice. It is therefore reasonable to infer that posttraumatic hypopituitarism may make an important contribution to the high rates of physical and neuropsychiatric morbidity in patients with head injury. Conclusions: There is clearly a need for identification as well as appropriate and timely management of hormone deficiencies in TBI patients to reduce morbidity, aid recovery and rehabilitation and avoid the long-term complications of pituitary failure. Copyright (c) 2007 S. Karger AG, Basel.	[Behan, Lucy Ann; Agha, Amar] Beaumont Hosp, Div Endocrinol, Dublin 7, Ireland; [Behan, Lucy Ann; Agha, Amar] RCSI Med Sch, Dublin, Ireland		Agha, A (corresponding author), Beaumont Hosp, Div Endocrinol, Beaumont Rd, Dublin 7, Ireland.	amaragha@yahoo.com					Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; AGHA A, 2005, AM J MED, V118; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BECKER LH, 1973, J TRAUMA, V13, P112; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Boughey JC, 2004, AM SURGEON, V70, P500; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; ESCUMILLA RF, 1942, J CLIN ENDOCRINOLOGY, V2, P65; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KLASBEEK WD, 1980, J NEUROSURG, V53, P519; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; MONSON JP, 2003, EUR J ENDOCRINOL S2, V148, P9; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TWIJNSTRA A, 1980, CLIN NEUROL NEUROSUR, V82, P263, DOI 10.1016/0303-8467(80)90018-9; VIGERHOETS F, 1988, ACTA NEUROCHIR, V91, P50; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340	30	16	17	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-0163			HORM RES	Horm. Res.		2007	68			5			18	21		10.1159/000110466			4	Endocrinology & Metabolism	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	247OE	WOS:000252088400007	18174698				2022-02-06	
J	Thomale, UW; Bender, M; Casalis, P; Rupprecht, S; Griebenow, M; Neumann, K; Woiciechowsky, C; Unterberg, AW; Stover, JF				Thomale, Ulrich W.; Bender, Marcel; Casalis, Pablo; Rupprecht, Stefan; Griebenow, Martin; Neumann, Konrad; Woiciechowsky, Christian; Unterberg, Andreas W.; Stover, John F.			Tacrolimus depresses local immune cell infiltration but fails to reduce cortical contusion volume in brain-injured rats	IMMUNOBIOLOGY			English	Article						traumatic brain injury; ICAM-1; microglia; macrophages; granulocytes	NECROSIS-FACTOR-ALPHA; CLOSED-HEAD INJURY; FLUID PERCUSSION INJURY; NITRIC-OXIDE SYNTHASE; SPINAL-CORD-INJURY; CEREBRAL-ISCHEMIA; NEUTROPHIL INFILTRATION; NEUROPROTECTIVE ACTION; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS	The immunosuppressant drug tacrolimus (FK-506) failed to show an anti-edematous effect despite suppressing pro-inflammatory cytokines in cerebrospinal fluid following focal traumatic brain injury. By questioning the role of the inflammatory response as a pharmacological target, we investigated the effects of FK-506 on immune cell infiltration in brain-injured rats. Following induction of a cortical contusion, male Sprague-Dawley rats received FK-506 or physiological saline intraperitoneally. Brains were removed at 24 h, 72 h or 7 days, respectively. Frozen brain sections (7 mu m) were stained immunohistologically for markers of endothelial activation (intercellular adhesion molecule-1-ICAM-1), neutrophil infiltration (His-48), and microglial and macrophage activation (Ox-6; ED-1), respectively. Immunopositive cells were counted microscopically. Contusion volume (CV) was quantified morphometrically 7 days after trauma. Inflammatory response was confined to the ipsilateral cortex and hippocampal formation, predominating in the contusion and pericontusional cortex. Strongest ICAM-1 expression coincided with sustained granulocyte accumulation at 72 h which was suppressed by FK-506. Ox-6 + cells prevailing at 72 h were also significantly reduced by FK-506. ED-1 + cells reaching highest intensity at 7 days were significantly attenuated at 72 h. Cortical CV was not influenced. FK-506 significantly decreased post-traumatic local inflammation which, however, was not associated with a reduction in cortical CV. These results question the importance of post-traumatic local immune cell infiltration in the secondary growth of a cortical contusion. (c) 2007 Elsevier GmbH. All rights reserved.	Med Univ Berlin, Dept Neurosurg, Campus Virchow Med Ctr, D-13353 Berlin, Germany; Charite, Dept Biometry & Clin Epidemiol, D-10117 Berlin, Germany; Heidelberg Univ, Dept Neurosurg, D-69120 Heidelberg, Germany; Univ Zurich Hosp, Div Surg Intens Care Med, CH-8091 Zurich, Switzerland		Thomale, UW (corresponding author), Med Univ Berlin, Dept Neurosurg, Campus Virchow Med Ctr, D-13353 Berlin, Germany.	uthomale@charite.de		Misch, Martin/0000-0001-5283-5753			AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Benetoli A, 2004, PHARMACOL BIOCHEM BE, V77, P607, DOI 10.1016/j.pbb.2003.12.022; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Butcher SP, 1997, J NEUROSCI, V17, P6939; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cross AK, 2001, MICROSC RES TECHNIQ, V54, P10, DOI 10.1002/jemt.1115; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Furuichi Y, 2004, BRAIN RES, V1014, P120, DOI 10.1016/j.brainres.2004.04.031; GarciaCriado FJ, 1997, TRANSPLANTATION, V64, P594, DOI 10.1097/00007890-199708270-00008; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Gold BG, 1999, DRUG METAB REV, V31, P649, DOI 10.1081/DMR-100101940; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Klettner A, 2003, CNS NEUROL DISORD-DR, V2, P153, DOI 10.2174/1568007033482878; Kubes P, 2000, BRAIN PATHOL, V10, P127; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Madsen JR, 1998, EXP NEUROL, V154, P673, DOI 10.1006/exnr.1998.6974; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Masri MA, 2003, MOL IMMUNOL, V39, P1073, DOI 10.1016/S0161-5890(03)00075-0; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Price CJS, 2003, J NEUROL NEUROSUR PS, V74, P1476, DOI 10.1136/jnnp.74.11.1476; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schoning B, 2002, NEUROL SCI, V23, P211, DOI 10.1007/s100720200043; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Squadrito F, 1999, BRIT J PHARMACOL, V127, P498, DOI 10.1038/sj.bjp.0702528; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Tamura F, 1998, J GASTROEN HEPATOL, V13, P703, DOI 10.1111/j.1440-1746.1998.tb00717.x; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Tsujikawa A, 1998, STROKE, V29, P1431, DOI 10.1161/01.STR.29.7.1431; Vela JM, 2002, J NEUROTRAUM, V19, P1503, DOI 10.1089/089771502320914723; Whalen MJ, 2000, CRIT CARE MED, V28, P3710, DOI 10.1097/00003246-200011000-00029; Yoshimoto T, 2002, BRAIN RES, V947, P191, DOI 10.1016/S0006-8993(02)02922-0; ZHANG J, 1995, NEUROL RES, V17, P285, DOI 10.1080/01616412.1995.11740328	52	16	17	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology		2007	212	7					567	576		10.1016/j.imbio.2007.01.007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	209FV	WOS:000249375300004	17678714				2022-02-06	
J	Thomas, JB; Abo, BN; Wang, HE				Thomas, Jane Boyce; Abo, Benjamin N.; Wang, Henry E.			Paramedic perceptions of challenges in out-of-hospital endotracheal intubation	PREHOSPITAL EMERGENCY CARE			English	Article						emergency medicine; allied health personnel; perceptions; focus groups; qualitative research; intubation	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; EMERGENCY-MEDICINE; SUCCESS; PERSONNEL; EVENTS	Objective. Paramedics often perform endotracheal intubation (ETI), insertion of a breathing tube, on critically ill out-of-hospital patients. Recent studies highlight important paramedic ETI shortcomings including adverse events, errors, and poor outcomes resulting from this procedure. Little is known about workforce perceptions of these events. We sought to identify paramedic and physician perceptions regarding the challenges and pitfalls of out-of-hospital ETI. Methods. We conducted a qualitative study involving paramedic focus groups sessions and individual interviews with Emergency Medical Services ( EMS) physician medical directors. We recorded and transcribed all sessions. We used inductive theory construction to examine, organize, and classify thematic patterns. Results. Fourteen paramedics and 6 physicians participated. Although paramedics and physicians recognized problems with paramedic ETI, all participants strongly felt that paramedics should continue to perform the procedure. Physicians and paramedics disagreed about the ability of paramedics to perform neuromuscular blockade-assisted intubation. Both groups identified aspects of paramedic education, skills acquisition, and maintenance as core issues. Participants also identified broader factors about the structure of emergency services, the role of the medical director, and workforce culture and professionalism. Conclusion. Paramedics and EMS physicians attribute paramedic ETI performance to a myriad of factors involving EMS education, organization, oversight, retention, and professionalism. Efforts to improve ETI must include strategies to address multiple aspects of EMS operations and culture.	Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA		Wang, HE (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, 230 McKee Pl,Suite 400, Pittsburgh, PA 15213 USA.	wanghe@upmc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS013628] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08 HS013628] Funding Source: Medline		Bernard H. R., 2002, RES METHODS ANTHR QU; Bochicchio Grant V, 2003, Curr Opin Crit Care, V9, P524, DOI 10.1097/00075198-200312000-00010; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DELEO BC, 1977, HEART LUNG, V6, P851; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Gabrielli Andrea, 2002, Curr Opin Crit Care, V8, P199, DOI 10.1097/00075198-200206000-00002; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GUSS DA, 1984, AM J EMERG MED, V2, P399, DOI 10.1016/0735-6757(84)90041-X; Harper J., 2002, ENDANGERED SPECIES H; JACOBS LM, 1983, JAMA-J AM MED ASSOC, V250, P2175, DOI 10.1001/jama.250.16.2175; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Krathwohl D., 1997, METHODS ED SOCIAL SC; Krueger R.A., 1994, FOCUS GROUPS PRACTIC, V2d; Levitan RM, 2004, ANN EMERG MED, V43, P48, DOI 10.1016/S0196-0644(03)00638-3; Lindenbaum S., 1979, KURU SORCERY DIS DAN; Mason J., 2002, QUALITATIVE RES; McDonald C C, 1998, Prehosp Emerg Care, V2, P29, DOI 10.1080/10903129808958836; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Nolan J D, 2001, Curr Opin Crit Care, V7, P413, DOI 10.1097/00075198-200112000-00008; Scheper-Hughes N., 2001, SAINTS SCHOLARS SCHI; STEWART RD, 1984, CHEST, V85, P341, DOI 10.1378/chest.85.3.341; STRAUSS A, 1998, STRATEGIES QUALITATI; Tayal VS, 1999, ACAD EMERG MED, V6, P31, DOI 10.1111/j.1553-2712.1999.tb00091.x; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Zink BJ, 2004, ANN EMERG MED, V44, P451, DOI 10.1016/j.annemergmed.2004.05.001	32	16	16	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1090-3127			PREHOSP EMERG CARE	Prehosp. Emerg. Care		2007	11	2					219	223		10.1080/10903120701205802			5	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	156CW	WOS:000245626700013	17454812				2022-02-06	
J	Dizon, MLV; Shin, L; Sundholm-Peters, NL; Kang, E; Szele, FG				Dizon, M. L. V.; Shin, L.; Sundholm-Peters, N. L.; Kang, E.; Szele, F. G.			Subventricular zone cells remain stable in vitro after brain injury	NEUROSCIENCE			English	Article						migration; neurogenesis; traumatic brain injury; subependymal zone; fate; mouse	NEURAL STEM-CELLS; ROSTRAL MIGRATORY STREAM; NEURONAL MIGRATION; CORTICAL-LESIONS; CEREBRAL-CORTEX; ADULT MICE; PROGENITORS; ASTROCYTES; PRECURSORS; EXPRESSION	Subventricular zone (SVZ) cells emigrate toward brain injury but relatively few survive. Thus, if they are to be used for repair, ex vivo expansion and autologous transplantation of SVZ cells may be necessary. Since it is unclear how brain injury alters SVZ cell culture, we studied neurosphere formation, differentiation, and migration, after cortical lesions. The number of neurosphere forming cells from lesioned mice was comparable to controls. Also, the proportion of astrocytes and neurons generated in vitro remained unchanged after cortical lesions. Cell emigration from neurospheres was characterized by increased cell-cell contact after injury in adults and neonates. However, neither molecules implicated in SVZ migration nor the extent of migration changed after injury. Thus, neurospheres can be successfully cultured after extensive brain damage, and they are remarkably stable in vitro, suggesting suitability for ex vivo expansion and autologous transplantation. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.	Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Dept Pediat,CMRC Neurobiol Program, Chicago, IL 60614 USA		Szele, FG (corresponding author), Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Dept Pediat,CMRC Neurobiol Program, 2430 N Halsted St,209, Chicago, IL 60614 USA.	f-szele@northwestern.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS053529] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 NS/AG42253-01] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS053529, K08 NS053529-01] Funding Source: Medline		Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Dizon M. L. V., 2005, MAMMALIAN SUBVENTRIC, P210; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gotts JE, 2005, J COMP NEUROL, V488, P201, DOI 10.1002/cne.20609; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kearns SM, 2003, EXP NEUROL, V182, P240, DOI 10.1016/S0014-4886(03)00124-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Levison SW, 2003, DEV NEUROSCI-BASEL, V25, P184, DOI 10.1159/000072267; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Murase S, 2002, J NEUROSCI, V22, P3568; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Reid CB, 1999, J COMP NEUROL, V403, P106; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; SZELE FG, 1995, J NEUROSCI, V15, P4429; Thomas LB, 1996, GLIA, V17, P1; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477	35	16	17	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	OCT 27	2006	142	3					717	725		10.1016/j.neuroscience.2006.06.050			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098NW	WOS:000241530600010	16935433				2022-02-06	
J	Coles, JP				Coles, Jonathan P.			Imaging of cerebral blood flow and metabolism	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						cerebral blood flow; cerebral metabolism; imaging; ischaemia; perfusion	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; DIFFUSE AXONAL INJURY; ACUTE ISCHEMIC-STROKE; PERFUSION COMPUTED-TOMOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; PROTON MR SPECTROSCOPY; CT PERFUSION; HEAD-INJURY; XENON CT	Purpose of review To review the techniques for imaging cerebral blood flow and metabolism following injury to the brain. Recent findings Xenon enhanced computerized tomography (Xenon CT), CT perfusion and single photon emission CT provide measurements of cerebral perfusion, while positron emission tomography (PET), and magnetic resonance imaging and spectroscopy (MRI and MRS) are able to assess both perfusion and cerebral metabolism. Xenon CT and CT perfusion are readily available and have proved useful in a variety of causes of brain injury. PET is an extremely useful research tool for defining cerebral physiology, but is limited in its availability. Despite the continuing development of MRI and MRS imaging, the scanning environment remains hostile for critically ill patients, and further research is required before the techniques become generally available. Summary Imaging of cerebral blood flow and metabolism has been shown to be useful following a variety of causes of brain injury, as it can help to define the cause and extent of injury, identify appropriate treatments and predict outcome. Imaging based on CT techniques (Xenon CT and CT perfusion) can be implemented easily in most hospital centres, and are able to provide quantitative perfusion data in addition to structural images.	[Coles, Jonathan P.] Addenbrookes Hosp, Univ Dept Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England		Coles, JP (corresponding author), Addenbrookes Hosp, Univ Dept Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	jpc44@wbic.cam.ac.uk		Coles, Jonathan/0000-0003-4013-679X	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Technology Foresight Award from the UK Government; Royal College of Anaesthetists/British Journal of Anaesthesia project grant; Academy of Medical Sciences/Health Foundation; Addenbrooke's Charities; Wellcome Foundation; Beverley and Raymond Sackler studentship award	The studies published by this author were supported by the Medical Research Council, a Technology Foresight Award from the UK Government and by a Royal College of Anaesthetists/British Journal of Anaesthesia project grant. Dr Coles is currently a Clinician Scientist funded by the Academy of Medical Sciences/Health Foundation and has previously been funded by Research Training Fellowships from the Addenbrooke's Charities, the Wellcome Foundation and by a Beverley and Raymond Sackler studentship award.	Al-Rawi PG, 2005, ACTA NEUROCHIR SUPPL, V95, P123; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Association of Anaesthetists of Great Britain and Ireland, 2002, PROV AN SERV MAGN RE; Bandera E, 2006, STROKE, V37, P1334, DOI 10.1161/01.STR.0000217418.29609.22; Barber PA, 2005, J NEUROL NEUROSUR PS, V76, P1528, DOI 10.1136/jnnp.2004.059261; Barker PB, 2004, CLINICAL MR NEUROIMAGING: DIFFUSION, PERFUSION AND SPECTROSCOPY, P7, DOI 10.1017/CBO9780511544958.003; Baron JC, 2005, CEREBROVASC DIS, V20, P154, DOI 10.1159/000087199; BARON JC, 1989, J CEREBR BLOOD F MET, V9, P723, DOI 10.1038/jcbfm.1989.105; Baumgartner C, 2005, J DIGIT IMAGING, V18, P219, DOI 10.1007/s10278-004-1048-9; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; BUSZA AL, 1992, STROKE, V23, P1602, DOI 10.1161/01.STR.23.11.1602; Butcher KS, 2005, STROKE, V36, P1153, DOI 10.1161/01.STR.0000166181.86928.8b; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Chalela JA, 2005, NEUROLOGY, V64, P1979, DOI 10.1212/01.WNL.0000156360.70336.18; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Davis SM, 2005, CURR OPIN NEUROL, V18, P47, DOI 10.1097/00019052-200502000-00010; Derdeyn CP, 2005, NEUROIMAG CLIN N AM, V15, P341, DOI 10.1016/j.nic.2005.05.001; DRAYER BP, 1978, STROKE, V9, P123, DOI 10.1161/01.STR.9.2.123; Eskey CJ, 2005, NEUROIMAG CLIN N AM, V15, P367, DOI 10.1016/j.nic.2005.05.002; ESKEY CJ, 2005, NEUROIMAG CLIN N AM, V15, pR11; Ewing JR, 2005, J MAGN RESON IMAGING, V22, P737, DOI 10.1002/jmri.20451; FISHER M, 1995, JAMA-J AM MED ASSOC, V274, P908; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Gillard JH, 2000, NEUROL RES, V22, P457; Gomori JM, 2005, NEUROL RES, V27, pS50, DOI 10.1179/016164105X35558; Guadagno JV, 2005, CEREBROVASC DIS, V19, P239, DOI 10.1159/000084087; Gupta R, 2005, NEUROIMAG CLIN N AM, V15, P531, DOI 10.1016/j.nic.2005.08.007; Harrigan MR, 2005, NEUROCRIT CARE, V2, P352, DOI 10.1385/NCC:2:3:352; Hemphill JC, 2005, AM J NEURORADIOL, V26, P1095; Hendrikse J, 2005, NEUROSURGERY, V57, P486, DOI 10.1227/01.NEU.0000170563.70822.10; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Jost SC, 2005, J NEUROSURG, V103, P25, DOI 10.3171/jns.2005.103.1.0025; Karapanayiotides T, 2005, STROKE, V36, P21, DOI 10.1161/01.STR.0000149946.86087.e5; KETY SS, 1945, AM J PHYSIOL, V143, P53, DOI 10.1152/ajplegacy.1945.143.1.53; Kimura H, 2005, J MAGN RESON IMAGING, V22, P189, DOI 10.1002/jmri.20382; Kinoshita T, 2005, EUR J RADIOL, V56, P5, DOI 10.1016/j.ejrad.2005.04.001; Koenig M, 1998, RADIOLOGY, V209, P85, DOI 10.1148/radiology.209.1.9769817; Kucinski T, 2005, AM J NEURORADIOL, V26, P815; Latchaw RE, 2003, STROKE, V34, P1084, DOI 10.1161/01.STR.0000064840.99271.9E; Liu YJ, 2003, RADIOLOGY, V229, P366, DOI 10.1148/radiol.2292020639; MARION DW, 1991, J CEREBR BLOOD F MET, V11, P347, DOI 10.1038/jcbfm.1991.69; Marmarou A, 2005, ACT NEUR S, V95, P149; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Miles KA, 2004, NEURORADIOLOGY, V46, pS194, DOI 10.1007/s00234-004-1333-9; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; Munari M, 2005, CRIT CARE MED, V33, P2068, DOI 10.1097/01.CCM.0000179143.19233.6A; Nabavi DG, 1999, RADIOLOGY, V213, P141, DOI 10.1148/radiology.213.1.r99oc03141; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Ohashi M, 2005, J NEURORADIOLOGY, V32, P337, DOI 10.1016/S0150-9861(05)83165-7; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Parsons MW, 2000, NEUROLOGY, V55, P498, DOI 10.1212/WNL.55.4.498; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; Pereira AC, 1999, STROKE, V30, P1577, DOI 10.1161/01.STR.30.8.1577; Perkio J, 2005, STROKE, V36, P44, DOI 10.1161/01.STR.0000150495.96471.95; Pickard JD, 2005, ACT NEUR S, V95, P459; Rivers CS, 2006, STROKE, V37, P98, DOI 10.1161/01.STR.0000195197.66606.bb; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Saunders DE, 2000, BRIT MED BULL, V56, P334, DOI 10.1258/0007142001903256; Schaefer PW, 2006, AM J NEURORADIOL, V27, P20; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scharf J, 2006, J COMPUT ASSIST TOMO, V30, P105, DOI 10.1097/01.rct.0000187417.15321.ca; Schellinger PD, 2006, NEURORADIOLOGY, V48, P69, DOI 10.1007/s00234-005-0012-9; Seitz RJ, 2005, RADIOLOGY, V237, P1020, DOI 10.1148/radiol.2373041435; Seitz RJ, 2005, J MAGN RESON IMAGING, V22, P199, DOI 10.1002/jmri.20366; Shimosegawa E, 2005, ANN NEUROL, V57, P495, DOI 10.1002/ana.20427; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Silverman DHS, 2005, RADIOL CLIN N AM, V43, P67, DOI 10.1016/j.rcl.2004.09.012; Sobesky J, 2005, STROKE, V36, P980, DOI 10.1161/01.STR.0000160751.79241.a3; Stengel A, 2004, MAGN RESON MED, V52, P228, DOI 10.1002/mrm.20171; Ueda T, 2005, NEUROIMAG CLIN N AM, V15, P543, DOI 10.1016/j.nic.2005.07.003; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; von Oettingen G, 2000, NEURORADIOLOGY, V42, P168, DOI 10.1007/s002340050039; WELCH KMA, 1992, NEUROL CLIN, V10, P1; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Wintermark M, 2005, AM J NEURORADIOL, V26, P104; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Yamauchi H, 2005, J NUCL MED, V46, P1973; ZIERLER KL, 1962, CIRC RES, V10, P393, DOI 10.1161/01.RES.10.3.393	83	16	18	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2006	19	5					473	480		10.1097/01.aco.0000245270.90377.00			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	V42RZ	WOS:000209632200001	16960477				2022-02-06	
J	Ramani, R				Ramani, Ramachandran			Hypothermia for brain protection and resuscitation	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						brain protection; hypothermia; intracranial pressure; traumatic brain injury	HEAD-INJURED PATIENTS; THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; ANEURYSM-SURGERY; NEUROPROTECTION; MANAGEMENT; EFFICACY; TRIALS; STROKE	Purpose of review Clinicians are actively looking for an effective brain protection technique. With pharmacologic agents, several phase III trials in stroke, severe traumatic brain injury, and post-cardiac arrest survivors have failed. Hence there is renewed interest in mild to moderate hypothermia for brain protection. Phase III clinical trials with hypothermia have been successful only in post-cardiac arrest survivors and neonatal hypoxic encephalopathy. This review focuses on the possible reasons for our inability to translate into positive clinical trials what is observed consistently in laboratory models. Recent findings Several factors have been identified for the failure of successive hypothermia clinical trials. Patients with severe traumatic brain injury with Glasgow Coma Score of 4-7 on admission and those less than 45 years of age and neonates with hypoxic encephalopathy are more responsive to hypothermia. Similarly, early and effective cooling techniques and titration of hypothermia to a defined endpoint are likely to be more effective. New techniques such as local cooling of the brain and the combination of hypothermia with drugs are being evaluated. Summary Hypothermia can at present be recommended only for post-cardiac arrest survivors and in neonatal hypoxic encephalopathy.	[Ramani, Ramachandran] Yale Univ, Sch Med, New Haven, CT 06520 USA		Ramani, R (corresponding author), Yale Univ, Sch Med, Anesthesia, 333 Cedar St,POB 208051, New Haven, CT 06520 USA.	ramachandran.ramani@yale.edu					Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; De Keyser J, 1999, TRENDS NEUROSCI, V22, P535, DOI 10.1016/S0166-2236(99)01463-0; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; Plum F, 2001, JAMA-J AM MED ASSOC, V285, P1760, DOI 10.1001/jama.285.13.1760; Polderman KH, 2006, NEW ENGL J MED, V354, P1643; Polderman KH, 2004, CRIT CARE MED, V32, P2558, DOI 10.1097/01.CCM.0000148087.41418.0A; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Wagner KR, 2005, NEUROL RES, V27, P238, DOI 10.1179/016164105X25261; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272	25	16	25	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2006	19	5					487	491		10.1097/01.aco.0000245272.84539.97			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	V42RZ	WOS:000209632200003	16960479				2022-02-06	
J	Schopp, LH; Good, GE; Barker, KB; Mazurek, MO; Hathaway, SL				Schopp, Laura H.; Good, Glenn E.; Barker, Katharine B.; Mazurek, Micah O.; Hathaway, Stefani L.			Masculine role adherence and outcomes among men with traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; men; masculinity; rehabilitation outcome	REHABILITATION; PERSPECTIVE; RETURN; WORK	Primary objective: Traumatic brain injury ( TBI) is a significant health problem disproportionately affecting men and is often associated with changes in masculine role functioning in life domains such as vocational functioning, sexual and interpersonal functioning and personal independence. These changes could have serious implications for men's adjustment following injury. The aim of this study was to examine the relations among traditional masculine role adherence, psychosocial adjustment and rehabilitation outcomes in men with TBI. Research design: A correlational design was chosen to examine the relations among variables. Spearman correlations and Wilcoxon Rank Sum tests were used to examine relationships between masculine role variables and outcome variables. Methods and procedures: The study included 33 men with TBI who had been discharged from inpatient rehabilitation within 5 years. Participants completed surveys on traditional masculine gender role adherence and gender role conflict and additional data, including measures of functional outcome, life satisfaction, psychosocial outcomes and earnings, were obtained through the TBI Model System longitudinal data collection system. Main outcomes and results: The results revealed significant associations between masculine role adherence and satisfaction with life, follow- up earnings and FIM change from admission to discharge. Conclusions: In the current study, particular masculine role variables corresponded to different functional and psychological outcomes. Understanding these differences provides new directions for treatment and offers important information about aspects of traditional masculine roles that may enhance or hinder adjustment to injury.	Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA; Univ Missouri, Dept Educ Sch & Conseling Psychol, Columbia, MO 65212 USA		Schopp, LH (corresponding author), Univ Missouri, Dept Hlth Psychol, 1 Hosp Dr,DC046-46, Columbia, MO 65212 USA.	schoppl@health.missouri.edu	Mazurek, Micah/AAR-6192-2020; Mazurek, Micah/ABE-8748-2020	Mazurek, Micah/0000-0001-7715-6538; 			Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Crowe SF, 1999, BRAIN INJURY, V13, P347; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Eisler RM., 1995, NEW PSYCHOL MEN, P207; ELOVIC E, 1996, MED REHABILITATION T, P1; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; GOOD GE, 1995, J COUNS PSYCHOL, V42, P3, DOI 10.1037/0022-0167.42.1.3; GOOD GE, 2001, NEW HDB PSYCHOTHERAP, V2, P22; Gosling J, 1999, BRAIN INJURY, V13, P785; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Howes H, 2005, BRAIN INJURY, V19, P135, DOI 10.1080/02699050410001720077; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kraus Jess F., 1994, P3; KRAVETZ S, 2001, REHABIL PSYCHOL, V10, P437; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lueptow LB, 2001, SOC FORCES, V80, P1, DOI 10.1353/sof.2001.0077; Mahalik JR, 1999, PROF PSYCHOL-RES PR, V30, P333; Marongiu S, 2000, SCAND J PSYCHOL, V41, P175, DOI 10.1111/1467-9450.00185; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ONEIL JM, 1990, MEN CONFLICT PROBLEM, P23; ONEIL JM, 1995, J COUNS PSYCHOL, V42, P3; PLECK CG, 1974, MEN MASCULINITY; Pleck J., 1981, MYTH MASCULINITY; PRIDAL CG, 2001, NEW HDB PSYCHOTHERAP, V2, P309; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SCHEIN VE, 1989, SEX ROLES, V20, P103, DOI 10.1007/BF00288030; *U NY BUFF CTR FUN, 1990, GUID US UN DAT SET M; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; ZASLER ND, 1995, PHYS MED REHABIL STA, V9, P361; [No title captured], DOI DOI 10.1037/1524-9220.4.1.3	41	16	16	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2006	20	11					1155	1162		10.1080/02699050600983735			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	110DD	WOS:000242357600006	17123932				2022-02-06	
J	Mussack, T; Kirchhoff, C; Buhmann, S; Biberthaler, P; Ladurner, R; Gippner-Steppert, C; Mutschler, W; Jochum, M				Mussack, Thomas; Kirchhoff, Chlodwig; Buhmann, Sonja; Biberthaler, Peter; Ladurner, Roland; Gippner-Steppert, Cornelia; Mutschler, Wolf; Jochum, Marianne			Significance of Elecsys (R) S100 immunoassay for real-time assessment of traumatic brain damage in multiple trauma patients	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						multiple trauma; primary brain damage; receiver-operating characteristics; S100; traumatic brain injury	SEVERE HEAD-INJURY; CALCIUM-BINDING PROTEINS; SERUM S-100B PROTEIN; CARDIOPULMONARY-RESUSCITATION; CARDIAC-SURGERY; CEREBRAL INJURY; MARKER; MULTICENTER; TOMOGRAPHY; S100-BETA	Background: The neuroprotein S100 released into the circulation has been suggested as a reliable marker for primary brain damage. However, safe identification of relevant traumatic brain injury (TBI) may possibly be hampered by S100 release from peripheral tissue. The objective of this study was to measure early S100 levels using the Elecsys((R)) S100 immunoassay for real-time assessment of severe TBI in multiple trauma. Methods: Consecutively admitted multiple trauma patients (injury severity score >= 16 points) were stratified according to the results of the initial cerebral computed tomography (CCT) examination. S100 serum levels were determined at admission and at 6, 12, 24, 48 and 72 h after trauma. Data were correlated to creatine phosphokinase (CK) and lactate dehydrogenase (LDH) serum levels. Using receiver operating characteristic (ROC) analysis, the discriminating power of S100 measurement was calculated for the detection of CCT+ findings. Results: Median S100 levels of CCT+ patients (n=9; 37 years) decreased from 3.30 mu g/L at admission to 0.41 mu g/L 72 h after trauma. They revealed no significant differences to CCT- patients (n=18; 44 years), but remained elevated compared to controls. Median CK and LDH levels correlated with the corresponding S100 levels during the first 24 h after trauma. ROC analysis displayed a maximum area under the curve of only 0.653 at 12 h after trauma. No significant difference was calculated for the differentiation between CCT+ and CCT- patients. Conclusions: Measurements of S100 serum levels using the Elecsys((R)) S100 immunoassay are not reliable for the real-time detection of severe TBI in multiple trauma patients. Due to soft tissue trauma or bone fractures, S100 is mainly released from peripheral sources such as adipocytes or skeletal muscle cells.	Klinikum Univ Munchen, Dept Surg Innestadt, D-80336 Munich, Germany; Klinikum Univ Munchen, Inst Clin Radiol, D-80336 Munich, Germany; Klinikum Univ Munchen, Dept Clin Chem & Clin Biochem Innenstadt, D-80336 Munich, Germany		Mussack, T (corresponding author), Klinikum Univ Munchen, Dept Surg Innestadt, Nussbaumstr 20, D-80336 Munich, Germany.	thomas.mussack@med.uni-muenchen.de					Alber B, 2005, CLIN CHEM LAB MED, V43, P557, DOI 10.1515/CCLM.2005.097; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; HAIMOTO H, 1987, LAB INVEST, V57, P489; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; KAHN HJ, 1991, MODERN PATHOL, V4, P698; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mussack T, 2006, CLIN BIOCHEM, V39, P349, DOI 10.1016/j.clinbiochem.2005.12.007; Mussack T, 2003, EUR J MED RES, V8, P457; Mussack T, 2001, WORLD J SURG, V25, P539, DOI 10.1007/s002680020082; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Snyder-Ramos SA, 2004, ANAESTHESIA, V59, P344, DOI 10.1111/j.1365-2044.2004.03663.x; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; USUI A, 1989, CLIN CHEM, V35, P1942; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	39	16	18	0	2	WALTER DE GRUYTER & CO	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621			CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	SEP	2006	44	9					1140	1145		10.1515/CCLM.2006.190			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	093TT	WOS:000241193800019	16958611	Green Submitted			2022-02-06	
J	Rutner, D; Kapoor, N; Ciuffreda, KJ; Craig, S; Han, ME; Suchoff, IB				Rutner, Daniella; Kapoor, Neera; Ciuffreda, Kenneth J.; Craig, Shoshana; Han, M. E.; Suchoff, Irwin B.			Occurrence of ocular disease in traumatic brain injury in a selected sample: A retrospective analysis	BRAIN INJURY			English	Article						ocular disease; traumatic brain injury; cerebrovascular accident; relative risk		Primary objective: To determine retrospectively the relative risk of ocular disease in a selected, visually-symptomatic sample of clinic patients having traumatic brain injury (TBI; n = 160) vs. cerebrovascular accident (CVA; n = 60), with all initially presenting at the clinic with symptoms and/or signs of vision dysfunction. Methods and procedures: To review retrospectively 220 medical records of individuals with TBI (n = 160) vs. CVA (n = 60), as determined by a computer-based query spanning the years 2000-2003, to ascertain the frequency of occurrence of ocular disease in the two major sub-groups of acquired brain injury. Main outcomes and results: Conditions with high relative risk unique to TBI included corneal abrasion, blepharitis, chalazion/dhordeolum, dry eye, traumatic cataract, vitreal prolapse and optic atrophy. This is distinct from those ophthalmic conditions unique to CVA, which included sub-conjunctival haemorrhage and ptosis. Conclusion: These new findings should alert clinicians to the potential increased frequency of occurrence of specific ocular diseases in a selected, visually-symptomatic population with TBI and their associated rehabilitative and quality-of-life implications.	SUNY Coll Optometry, Dept Vis Sci, Raymond J Greenwald Rehabil Ctr, Dept Clin Sci, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Vis Sci, Raymond J Greenwald Rehabil Ctr, Dept Clin Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu					Benjamin W. J., 1998, BORISHS CLIN REFRACT; Birnbaum MH., 1993, OPTOMETRIC MANAGEMEN; Brewitt H, 2001, SURV OPHTHALMOL, V45, pS199, DOI 10.1016/S0039-6257(00)00202-2; Ciuffreda K, 2001, VISUAL VESTIBULAR CO, P1; GANLEY JP, 1983, VITAL HLTH STAT, V228, P1; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; HAN ME, 2003, J OPTOMETRIC VISUAL, V34, P119; HATCH SW, 1998, OPHTHALMIC RES EPIDE; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; HELLERSTEIN LF, 2002, UNDERSTANDING MANAGI, P178; JACKOWSKI MM, 2004, ANN M AM AC OPT PART; KAPOOR N, 2005, TXB TRAUMATIC BRAIN, P405; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; Miller NR, 1998, WALSH HOYTS CLIN NEU, V5th; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; REDING MJ, 1988, STROKE, V19, P1354, DOI 10.1161/01.STR.19.11.1354; Richter E. F., 2001, VISUAL VESTIBULAR CO, P10; Seiller BL, 2000, PHYS MED REHABILITAT, P342; SUCHOFF I, 2000, PHYS MED REHABILITAT, P608; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; SUCHOFF IB, 2000, LIGHTHOUSE HDB VISIO, V1, P517; Suter P. S., 2004, TRAUMATIC BRAIN INJU, P209; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TORNER JC, 1995, HEAD INJURY POSTCONC, P19; Vogel M S, 1992, J Am Optom Assoc, V63, P542; Wick, 2002, CLIN MANAGEMENT BINO; Zost MG, 2001, DIAGNOSIS MANAGEMENT, P75	29	16	16	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1079	1086		10.1080/02699050600909904			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100010	17060141				2022-02-06	
J	Boxberg, Y; Salim, C; Soares, S; Baloui, H; Alterio, J; Ravaille-Veron, M; Nothias, F				von Boxberg, Ysander; Salim, Claudio; Soares, Sylvia; Baloui, Hasna; Alterio, Jeanine; Ravaille-Veron, Michele; Nothias, Fatiha			Spinal cord injury-induced up-regulation of AHNAK, expressed in cells delineating cystic cavities, and associated with neoangiogenesis	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						barrier formation; cavitation; inflammation; neoangiogenesis; Wistar rat	BLOOD-BRAIN-BARRIER; PERIPHERAL NERVOUS-SYSTEM; GIANT PROTEIN AHNAK; GENE-EXPRESSION; INHIBITORY MOLECULES; IN-VIVO; REGENERATION; RATS; DEGENERATION; INFLAMMATION	To investigate the molecular basis for the poor regenerative capacity of the mammalian central nervous system (CNS) after injury, we searched for genes whose expression was affected by an adult rat spinal cord hemi-section. Differential screening of a rat spinal cord expression library was performed using polyclonal antibodies raised against lesioned spinal cord tissue. A striking overexpression was found for ahnak, encoding a 700-kDa protein, in normal CNS present only in the blood-brain barrier (BBB) forming vascular endothelial cells. Indeed, very early after spinal cord injury (SCI), high levels of membrane-associated AHNAK are observed on non-neuronal cells invading the lesion site. With time, AHNAK distribution spreads rostrally and caudally concomitant with the process of tissue inflammation and axon degeneration, delineating the interior surface of cystic cavities, mainly in front of barrier-forming astrocytes. Strong overexpression is also observed on vascular endothelial cells reacting to BBB breakdown. Based on our detailed analysis of its spatiotemporal and cellular expression, and its previously described function in BBB, we suggest that AHNAK expression is associated with cell types displaying tissue-protective barrier properties. Our study may thus contribute to the elucidation of the precise molecular and cellular events that eventually render traumatic spinal cord tissue non-permissive for regeneration.	Univ Paris 06, CNRS, UMR 7101, F-75005 Paris, France		Boxberg, Y (corresponding author), Univ Paris 06, CNRS, UMR 7101, 7 Quai St Bernard, F-75005 Paris, France.	ysander.boxberg@snv.jussieu.fr; fatiha.nothias@snv.jussieu.fr	Soares, Sylvia/ABE-7018-2021	Soares, Sylvia/0000-0003-2459-6956; von Boxberg, Ysander/0000-0001-5886-6155; Nothias, Fatiha/0000-0002-2497-2096			Alvarez J, 2004, J BIOL CHEM, V279, P12456, DOI 10.1074/jbc.M312177200; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Boveri M, 2006, NEUROSCIENCE, V137, P1193, DOI 10.1016/j.neuroscience.2005.10.011; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Derouiche A, 2001, GLIA, V36, P330, DOI 10.1002/glia.1120; Di Giovanni S, 2005, J BIOL CHEM, V280, P2084, DOI 10.1074/jbc.M411975200; FaberElman A, 1996, J CLIN INVEST, V97, P162, DOI 10.1172/JCI118385; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Gentil BJ, 2003, J HISTOCHEM CYTOCHEM, V51, P339, DOI 10.1177/002215540305100309; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Gentil EJ, 2005, J CELL PHYSIOL, V203, P362, DOI 10.1002/jcp.20232; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; Haase H, 2004, FASEB J, V18, P839, DOI 10.1096/fj.03-0446fje; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; HIEDA Y, 1989, J CELL BIOL, V109, P1511, DOI 10.1083/jcb.109.4.1511; Jones LL, 2003, J NEUROSCI, V23, P9276; Kingsley PD, 2001, DEV GROWTH DIFFER, V43, P133; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Kouno M, 2004, J INVEST DERMATOL, V123, P700, DOI 10.1111/j.0022-202X.2004.23412.x; Laskawi R, 1996, ORL J OTO-RHINO-LARY, V58, P13, DOI 10.1159/000276788; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Mason MRJ, 2003, EUR J NEUROSCI, V18, P789, DOI 10.1046/j.1460-9568.2003.02809.x; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Moriarty LJ, 1998, J NEUROL SCI, V155, P121, DOI 10.1016/S0022-510X(97)00203-7; NOTHIAS F, 1993, J COMP NEUROL, V334, P370, DOI 10.1002/cne.903340304; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Rezajooi K, 2004, MOL CELL NEUROSCI, V25, P572, DOI 10.1016/j.mcn.2003.10.009; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Stiff T, 2004, DNA REPAIR, V3, P245, DOI 10.1016/j.dnarep.2003.11.001; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; VONBOXBERG Y, 1994, ANAL BIOCHEM, V219, P32, DOI 10.1006/abio.1994.1227; VONBOXBERG Y, 1988, ANAL BIOCHEM, V169, P372; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Zhang KH, 2004, NEUROSCIENCE, V128, P375, DOI 10.1016/j.neuroscience.2004.07.008	51	16	16	0	9	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2006	24	4					1031	1041		10.1111/j.1460-9568.2006.04994.x			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	076TE	WOS:000239979800008	16930430				2022-02-06	
J	Matsui, T; Ishikawa, T; Takeuchi, H; Kabayashi, K; Maekawa, T				Matsui, Tomohiro; Ishikawa, Toshizo; Takeuchi, Hiroaki; Kabayashi, Kiyoshi; Maekawa, Tsuyoshi			Mild hypothermia promotes pro-inflammatory cytokine production in monocytes	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						hypothermia; monocytes; pro-inflammatory cytokines; anti-inflammatory cytokines; cytokine balance	BLOOD MONONUCLEAR-CELLS; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; MODERATE HYPOTHERMIA; PERIOPERATIVE HYPOTHERMIA; CARDIOPULMONARY BYPASS; ESCHERICHIA-COLI; INFECTION; RELEASE	Hypothermia is often associated with compromised host defenses and infection. Deteriorations of immune functions related to hypothermia have been investigated, but the involvement of cytokines in host defense mechanisms and in infection remains unclear. We have previously shown that mild hypothermia modifies cytokine production by peripheral blood mononuclear cells. In this study, the effects of hypothermia on the monocytic production of several cytokines and nitric oxide (NO) were determined. Monocytes obtained from 10 healthy humans were cultured with lipopolysaccharide (LPS) under hypothermic (33 degrees C) or normothermic (37 degrees C) conditions for 48 hours. We performed flow cytometric analysis for simultaneous measurement of interleukin (IL)-8, IL-1 beta, IL-6, IL-10, IL-12p70, and tumor necrosis factor (TNF)-alpha in culture supernatants. NO production was quantified as accumulation of nitrite in the medium by a colorimetric assay. Compared with normothermia, mild hypothermia raised the levels of IL-1 beta, IL-6, IL-12p70, and TNF-alpha produced by monocytes stimulated with LPS. On calculating the ratios of these elevated cytokines to IL-10, however, only IL-12p70/IL-10 and TNF-alpha/IL-10 ratios were significantly elevated under hypothermic conditions. In contrast, hypothermia did not affect NO production. This study demonstrates that mild hypothermia affects the balance of cytokines produced by monocytes, leading to a pro-inflammatory state. Specifically, monocytic IL-12 and TNF-alpha appear to be involved in the immune alterations observed in mild hypothermia. However, the clinical significance of these phenomena remains to be clarified.	Univ Yamanashi, Sch Med, Dept Lab Sci, Ube, Yamaguchi 7558505, Japan; Kochi Univ, Sch Med, Fac Med, Dept Clin Lab Med, Kochi 780, Japan; Kochi Univ, Sch Med, Dept Emergency & Crit Care Med, Kochi 780, Japan		Matsui, T (corresponding author), Univ Yamanashi, Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants-ygc@umin.ac.jp					Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aibiki M, 1999, RESUSCITATION, V41, P263, DOI 10.1016/S0300-9572(99)00052-0; AKRIOTIS V, 1985, J LEUKOCYTE BIOL, V37, P51, DOI 10.1002/jlb.37.1.51; Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cook EB, 2001, J IMMUNOL METHODS, V254, P109, DOI 10.1016/S0022-1759(01)00407-0; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; DE WMR, 1991, J EXP MED, V174, P1209; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Forstot RM, 1995, J CLIN ANESTH, V7, P657, DOI 10.1016/0952-8180(95)00099-2; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; GIRARDIN E, 1992, IMMUNOLOGY, V76, P20; Goebel A, 2000, ANN SURG, V231, P253, DOI 10.1097/00000658-200002000-00015; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; Ishikawa T, 1999, CELL MOL NEUROBIOL, V19, P199, DOI 10.1023/A:1005401926320; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Luhm J, 1998, EUR J BIOCHEM, V256, P325, DOI 10.1046/j.1432-1327.1998.2560325.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2004, ACTA ANAESTH SCAND, V48, P205, DOI 10.1111/j.0001-5172.2004.00293.x; MILLER LC, 1993, LANCET, V341, P146, DOI 10.1016/0140-6736(93)90006-3; OSuilleabhain C, 1996, SURGERY, V120, P290, DOI 10.1016/S0039-6060(96)80300-X; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pigula FA, 2001, J THORAC CARDIOV SUR, V121, P366, DOI 10.1067/mtc.2001.112207; Qing M, 2001, SHOCK, V15, P372, DOI 10.1097/00024382-200115050-00007; REILING N, 1994, EUR J IMMUNOL, V24, P1941, DOI 10.1002/eji.1830240836; Russwurm S, 2002, J INTERF CYTOK RES, V22, P215, DOI 10.1089/107999002753536185; SHEFFIELD CW, 1994, ACTA ANAESTH SCAND, V38, P201, DOI 10.1111/j.1399-6576.1994.tb03873.x; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505, DOI 10.1002/jlb.59.4.505; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; WAAGE A, 1988, J EXP MED, V167, P1987, DOI 10.1084/jem.167.6.1987; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023; ZARRABEITIA MT, 1991, BONE MINER, V14, P161, DOI 10.1016/0169-6009(91)90093-F; ZEMBALA M, 1994, EUR J IMMUNOL, V24, P435, DOI 10.1002/eji.1830240225	42	16	20	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2006	18	3					189	193		10.1097/01.ana.0000188639.39844.f6			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	059FQ	WOS:000238719100005	16799346				2022-02-06	
J	Gontkovsky, ST; Sherer, M; Nick, TG; Nakase-Thompson, R; Yablon, SA				Gontkovsky, Samuel T.; Sherer, Mark; Nick, Todd G.; Nakase-Thompson, Risa; Yablon, Stuart A.			Effect of urbanicity of residence on TBI outcome at one year post-injury	BRAIN INJURY			English	Article						disability rating scale; medical complications; outcome; traumatic brain injury; urbanicity	DISABILITY RATING-SCALE; TRAUMATIC BRAIN-INJURY; HEAD; RECOVERY	Objective: To determine the impact of urbanicity of residence and occurrence of medical complications on outcome after traumatic brain injury (TBI). Study design: A consecutive series of persons admitted for inpatient TBI rehabilitation followed for 1 year post-injury. Setting: Inpatient brain injury rehabilitation programme in the southeastern US. Participants: One hundred and eleven persons with severe (67%), moderate (18%) or mild (15%) TBI. Outcome measure: Functional status at 2 year post-injury as measured by the Disability Rating Scale (DRS). Results: Functional status at follow-up was predicted by age, DRS at admission for rehabilitation, injury severity, alcohol use, continued need for medications and medical complications (validated R-2 = 0.57; p < 0.0001). Urbanicity of residence was not predictive of functional status. Conclusions: As expected, participants who experienced more medical complications and required continued use of medications had poorer functional outcomes. Contrary to expectation, more rural residents did not have poorer outcomes than persons residing in more urban areas.	Methodist Rehabil Ctr, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Cincinnati Childrens Hosp, Med Ctr, Ctr Biostat & Epidemiol, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA		Sherer, M (corresponding author), Methodist Rehabil Ctr, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	marks@mmrcrehab.org					Anderson S., 2004, J COGNITIVE REHABILI, V22, P6; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A, P552; Dunn L, 2003, J NEUROL NEUROSUR PS, V74, P1060, DOI 10.1136/jnnp.74.8.1060; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Goodall CR, 1998, AM STAT, V52, P101, DOI 10.2307/2685467; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hanlon RE, 1999, BRAIN INJURY, V13, P873; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schootman M, 1999, BRAIN INJURY, V13, P995; Schootman M, 1998, BIOM HLTH R, V21, P73; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SIMPSON D, 1981, MED J AUSTRALIA, V2, P660, DOI 10.5694/j.1326-5377.1981.tb113043.x; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x	25	16	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2006	20	7					701	709		10.1080/02699050600744103			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	062LV	WOS:000238947200004	16809202				2022-02-06	
J	Landis, J; Hanten, G; Levin, HS; Li, XQ; Ewing-Cobbs, L; Duron, J; High, WM				Landis, Julie; Hanten, Gerri; Levin, Harvey S.; Li, Xiaoqi; Ewing-Cobbs, Linda; Duron, Jackie; High, Walter M., Jr.			Evaluation of the errorless learning technique in children with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Joint Annual Meeting of the American-Congress-of-Rehabilitation-Medicine/American-Society-of-Neurorehabilitation	OCT 25, 2003	Tucson, AZ	Amer Congress Rehabil Med, Amer Soc Neurorehabil		brain injuries; pediatrics; rehabilitation	CLOSED-HEAD INJURY; MEMORY; ADOLESCENTS; REHABILITATION; INDIVIDUALS; AMNESIA; MODEL	Objective: To compare errorless learning with trial-and-error (T&E) learning of declarative facts in children with memory disorders secondary to traumatic brain injury (TBI). Design: Retrospective within-subjects concurrent treatment design. Setting: Participants' school or home. Participants: Thirty-four children, ages 6 to 18 years, with mild, moderate, or severe postacute TBI who met criteria for memory impairment. Intervention: Conditions consisted of an errorless learning method and a T&E method. Within a session, half the items were taught with the errorless learning method and half with the T&E method. Each child received two I-hour sessions a week for 7 weeks. Main Outcome Measures: Relative effectiveness of errorless learning and T&E methods for (1) initial learning and (2) retention over time for learned items. Results: There was an advantage for T&E on initial learning. In children with mild, but not moderate or severe TBI, 2-day retention was better with the errorless learning technique; 7-day retention was better with errorless learning in young children with mild TBI. Seventy-seven-day retention revealed an advantage for errorless learning in younger children with severe TBI. Conclusions: Findings did not support errorless learning as a generalized intervention for learning difficulties after TBI or identify specific age- or injury-severity groups that benefited from this technique.	Univ Houston, Dept Educ Psychol, Houston, TX 77204 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77225 USA; Texas Inst Res & Rehabil, Brain Injury Res Ctr, Houston, TX 77225 USA		Landis, J (corresponding author), Univ Houston, Dept Educ Psychol, 491 Farish Hall, Houston, TX 77204 USA.	jalandis@uh.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133 B 990014-01] Funding Source: Medline		Anderson V A, 1999, Pediatr Rehabil, V3, P159; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; COHEN M, 1992, BRAIN COGNITION, V20, P315, DOI 10.1016/0278-2626(92)90024-G; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; EWINGCOBBS L, 1991, J CLIN EXP NEUROPSYC, V13, P93; GLISKY EL, 1993, J HEAD TRAUMA REHAB, V7, P1; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hunkin NM, 1998, NEUROPSYCHOL REHABIL, V8, P433, DOI 10.1080/713755581; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P1255, DOI 10.1016/0028-3932(95)00061-7; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lutz J, 2003, J GEN PSYCHOL, V130, P171, DOI 10.1080/00221300309601283; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Van T Hooft M., 2004, Journal of Educational Computing Research, V30, P295; Warschausky S, 1999, J HEAD TRAUMA REHAB, V14, P373, DOI 10.1097/00001199-199908000-00006; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463	29	16	16	1	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2006	87	6					799	805		10.1016/j.apmr.2006.02.017			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	052AP	WOS:000238203100009	16731215				2022-02-06	
J	Bartle, CJ; Goozee, JV; Scott, D; Murdoch, BE; Kuruvilla, M				Bartle, Carly J.; Goozee, Justine V.; Scott, Dion; Murdoch, Bruce E.; Kuruvilla, Mili			EMA assessment of tongue-jaw co-ordination during speech in dysarthria following traumatic brain injury	BRAIN INJURY			English	Article						dysarthria; traumatic brain injury; EMA assessment; tongue; jaw; co-ordination; articulation	KINEMATIC ANALYSIS; MOTOR CONTROL; MOVEMENTS; CHILDREN	Primary objective: To investigate the spatio-timing aspects of tongue-jaw co-ordination during speech in individuals with traumatic brain injury (TBI). It was hypothesized that both timing and spatial co-ordination would be affected by TBI. Research design: A group comparison design wherein Mann-Whitney U-tests were used to compare non-neurologically impaired individuals with individuals with TBI. Methods and procedures: Nine non-neurologically impaired adults and nine adults with TBI were involved in the study. Electromagnetic articulography (EMA) was used to track tongue and jaw movement during /t/ and /k/, embedded in sentence and syllable stimuli. Main outcomes and results: Analysis of group data did not reveal a significant difference in spatio-timing tongue-jaw co-ordination between the control group and TBI group. On an individual basis, a proportion of individuals with TBI differed from non- neurologically impaired participants with regard to articulatory order and percentage of jaw contribution to /t/. Conclusions: EMA assessment results supported perceptual data; those adults who presented with severe articulatory disturbances exhibited the most deviant spatio-timing tongue-jaw co-ordination patterns. This finding could provide a new and specific direction for treatment, directed at combined movement patterns.	Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia		Bartle, CJ (corresponding author), Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia.	c.bartle@uq.edu.au	Murdoch, Bruce E/C-1397-2012; Meyer, Carly/E-4519-2010; Meyer, Carly/L-7240-2019	Meyer, Carly/0000-0002-2268-3055; Meyer, Carly/0000-0002-2268-3055; Kuruvilla-Dugdale, Mili/0000-0001-7900-2364			ABBS JH, 1984, J MOTOR BEHAV, V16, P195; Alfonso PJ, 1997, INT CONGR SER, V1146, P151; BARLOW SM, 1988, ASS RES OT ABSTR, V11, P218; Bernstein NA., 1967, COORDINATION REGULAT; Brown J.R., 1975, MOTOR SPEECH DISORDE; COELHO CA, 1994, MOTOR SPEECH DISORDE, P103; Cotert HS, 1999, J ORAL REHABIL, V26, P75, DOI 10.1046/j.1365-2842.1999.00340.x; Duffy JR., 2020, MOTOR SPEECH DISORDE; FOWLER CA, 1993, LANG SPEECH, V36, P171, DOI 10.1177/002383099303600304; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 2002, FOLIA PHONIATR LOGO, V54, P177, DOI 10.1159/000063191; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; GRACCO VL, 1986, EXP BRAIN RES, V65, P156; GRACCO VL, 1988, J NEUROSCI, V8, P4628; Green JR, 2003, J ACOUST SOC AM, V113, P2820, DOI 10.1121/1.1562646; Green JR, 2000, J SPEECH LANG HEAR R, V43, P239, DOI 10.1044/jslhr.4301.239; HUGHES OM, 1976, PHONETICA, V33, P199; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; KELSO JAS, 1986, J PHONETICS, V14, P29, DOI 10.1016/S0095-4470(19)30608-4; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; KENT RD, 1977, J PHONETICS, V5, P115; LEE WA, 1984, J MOTOR BEHAV, V16, P135; LEVIN HS, 1981, ACQUIRED APHASIA, P427; Loh EWL, 2005, BRAIN INJURY, V19, P529, DOI 10.1080/02699050400025083; MCHENRY MA, 1984, J MED SPEECH-LANG PA, V2, P59; MOOSHAMMER C, 2003, 15 INT C PHON SCI AU, P81; Muller E. M., 1985, Mathematics and computers in biomedical applications, P363; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; Murdoch BE, 2001, TRAUMATIC BRAIN INJU, P1; MURDOCH BE, 1997, ACQUIRED SPEECH LANG, P120; NETSELL R, 1976, J SPEECH HEAR DISORD, V41, P93, DOI 10.1044/jshd.4101.93; NETSELL R, 1984, DYSARTHRIAS PHYSL AC, P1; Perkell J. S., 1997, HDB PHONETIC SCI, P333; PERKELL JS, 1995, J PHONETICS, V23, P23, DOI 10.1016/S0095-4470(95)80030-1; ROBIN DA, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P173; ROSENBEK JC, 1978, CLIN MANAGEMENT NEUR, P251; RUSK H, 1969, LATE EFFECTS HEAD IN, P327; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SCHONLE PW, 1987, BRAIN LANG, V31, P26, DOI 10.1016/0093-934X(87)90058-7; STEVENS KN, 1998, ACOUSTIC PHONETICS, P323; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, p[53, 75]; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; THEODOROS DG, 1998, DYSARTHRIA PHYSL APP, P337; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vatikiotis-Bateson E., 1999, IEEE SMC'99 Conference Proceedings. 1999 IEEE International Conference on Systems, Man, and Cybernetics (Cat. No.99CH37028), P442, DOI 10.1109/ICSMC.1999.825301; Weismer G, 2003, J SPEECH LANG HEAR R, V46, P1247, DOI 10.1044/1092-4388(2003/097); ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1983, PHONETICA, V40, P63; [No title captured]; [No title captured]	53	16	18	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2006	20	5					529	545		10.1080/02699050500487613			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	045GO	WOS:000237730800009	16716999				2022-02-06	
J	Dahl, E; von Wendt, L; Emanuelson, I				Dahl, E; von Wendt, L; Emanuelson, I			A prospective, population-based, follow-up study of mild traumatic brain injury in children	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						children; MTBI; population-based; prospective; symptoms	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; PROSPECTIVE COHORT; WESTERN SWEDEN; EPIDEMIOLOGY; ADOLESCENTS; SCALE; PAIN; DISABILITY; DISORDER	Objective: Outline the annual incidene of mild traumatic brain injury in children, aged 0-17 years, using the American Congress of Rehabilitation Medicine classification and record the presence of new symptoms up to six months after injury. Settings and methods: The study population comprised all the children in the age group of 0-17 years (a total of 40,984) in an administrative district in south-western Sweden. At[ the individuals registered in the Brain Injury Register, during the periods 1 January to 30 June 1999 and 1 April to 30 September 2000, fulfilling the inclusion criteria defined by American Congress of Rehabilitation Medicine, were included. New symptoms occurring three to six months after the injury were recorded using a mailed 21-item questionnaire. Results: 192 children fulfilled the criteria., yielding an annual incidence of 468/ 100,000 (95% Cl 402-535/100,000). Boys accounted for 57 per cent and fall injuries accounted for 61 per cent of the external causes. New symptoms were reported by 24 per cent of those who answered the questionnaire. Conclusion: This study revealed that the annual incidence of mild traumatic brain injury in children was almost as high as that among adults in the same area and population. (C) 2005 Elsevier Ltd. All rights reserved.	Local Habilitat Ctr So Alvsborg, SE-50182 Boras, Sweden; Univ Helsinki, Hosp Children & Adolescents, Dept Child Neurol, FIN-00014 Helsinki, Finland; Karolinska Inst, Dept Child Neurol, Stockholm, Sweden; Gothenburg Univ, Dept Hlth Women & Children, S-41124 Gothenburg, Sweden		Dahl, E (corresponding author), Local Habilitat Ctr So Alvsborg, SE-50182 Boras, Sweden.	ewa.dahl@vgregion.se					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANDERSSON EH, 2004, THESIS U GOTEBORG SW; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, V7, P117; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Breau LM, 2001, J PEDIATR-US, V138, P721, DOI 10.1067/mpd.2001.112247; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; CASEY R, 1986, PEDIATRICS, V78, P497; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Emanuelson I, 2003, Inj Control Saf Promot, V10, P139, DOI 10.1076/icsp.10.3.139.14553; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mott A, 1997, LANCET, V349, P1874, DOI 10.1016/S0140-6736(96)10343-3; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Roseveare C A, 1999, Inj Prev, V5, P124; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; Rune V, 1970, ACTA PAEDIATR SC   S, V209, P3; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Stallard P, 2002, J PEDIATR PSYCHOL, V27, P209, DOI 10.1093/jpepsy/27.2.209; Svensson E, 2002, J REHABIL MED, V34, P251, DOI 10.1080/165019702760390338; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Von Wild K, 2001, BRAIN INJURY, V15, P273; Walsh TM, 2004, ATTACH HUM DEV, V6, P53, DOI 10.1080/14616730410001663489; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	46	16	17	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2006	37	5					402	409		10.1016/j.injury.2005.09.008			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	037RH	WOS:000237164100007	16375904				2022-02-06	
J	Duhaime, AC; Saykin, AJ; McDonald, BC; Dodge, CP; Eskey, CJ; Darcey, TM; Grate, LL; Tomashosky, P				Duhaime, AC; Saykin, AJ; McDonald, BC; Dodge, CP; Eskey, CJ; Darcey, TM; Grate, LL; Tomashosky, P			Functional magnetic resonance imaging of the primary somatosensory cortex in piglets	JOURNAL OF NEUROSURGERY			English	Article						trauma; brain injury; functional magnetic resonance imaging; somatosensory cortex; pediatric neurosurgery; animal model; pig	HYPOTHERMIC CIRCULATORY ARREST; TOPOGRAPHIC ORGANIZATION; CARDIOPULMONARY BYPASS; DEPENDENT RESPONSES; NEWBORN PIGS; NEONATAL PIG; BRAIN; MRI; SWINE; REORGANIZATION	Object. The piglet is an excellent model for the developing human brain, and has been used increasingly in various centers for studies of traumatic brain injury and other insults. Unlike rodent or primate models, however, there are few behavioral scales for the piglet, and the available ones are used to test general responsiveness rather than specific functional outcome. The differing behavioral repertoires of animals of different ages provide an additional challenge when age-dependent injury responses are compared. To overcome these experimental limitations of piglets in brain injury research, the authors developed a functional magnetic resonance (fMR) imaging paradigm that can be used to track recovery in the somatosensory cortex over time in anesthetized animals of different ages. Methods. Fifteen fMR imaging studies in eight piglets were performed before and after scaled cortical impact injury to the primary somatosensory cortex subserving snout sensation. Specific anesthetic and imaging protocols enabled visualization of cortical activation, and comparison with somatosensory evoked potentials obtained before and after injury was obtained. A piglet brain template for group-level analysis of these data was constructed, similar to the fMR imaging techniques used in humans, to allow for group comparisons and longitudinal change analysis over time. Conclusions. Loss of function in a specifically traumatized cortical region and its subsequent recovery over time can now be demonstrated visually by fMR imaging in the piglet. Besides its value in understanding intrinsic recovery mechanisms and plasticity at different ages, this functional outcome measure will enable the use of the piglet model in treatment trials specifically designed for the immature brain.	Childrens Hosp Dartmouth, Dept Pediat Neurosurg, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Psychiat, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Anesthesiol, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Radiol, Lebanon, NH 03756 USA; Childrens Hosp Dartmouth, Dept Neurol, Lebanon, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; Dartmouth Coll Sch Med, Lebanon, NH 03766 USA		Duhaime, AC (corresponding author), Childrens Hosp Dartmouth, Dept Pediat Neurosurg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	acd@hitchcock.org	Saykin, Andrew/A-1318-2007	Saykin, Andrew/0000-0002-1376-8532	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: NIH RePORTER		Cioni G, 2001, NEUROREPORT, V12, P1335, DOI 10.1097/00001756-200105250-00009; CRANER SL, 1991, J COMP NEUROL, V306, P24, DOI 10.1002/cne.903060103; CRANER SL, 1991, J COMP NEUROL, V306, P39, DOI 10.1002/cne.903060104; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Hayashi T, 1999, EUR J NEUROSCI, V11, P4451, DOI 10.1046/j.1460-9568.1999.00892.x; Holloway V, 2000, BRAIN, V123, P2432, DOI 10.1093/brain/123.12.2432; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Lahti KM, 1999, MAGNET RESON MED, V41, P412, DOI 10.1002/(SICI)1522-2594(199902)41:2<412::AID-MRM28>3.0.CO;2-3; Leopold DA, 2002, EXP BRAIN RES, V143, P359, DOI 10.1007/s00221-001-0998-0; Loepke AW, 2002, ANESTHESIOLOGY, V97, P1521, DOI 10.1097/00000542-200212000-00026; Makiranta MJ, 2002, MAGN RESON MATER PHY, V15, P27, DOI 10.1016/S1352-8661(02)00121-7; McAllister TW., 2002, J NEUROPSYCHIATRY CL, V14, P116; MCDONALD BC, 2003, J NEUROPSYCHIATRY CL, V15, P282; Mun-Bryce S, 2001, BRAIN RES, V888, P248, DOI 10.1016/S0006-8993(00)03068-7; Okada Y, 1999, CLIN NEUROPHYSIOL, V110, P214, DOI 10.1016/S0013-4694(98)00111-4; Poldrack Russell A, 2002, Top Magn Reson Imaging, V13, P61, DOI 10.1097/00002142-200202000-00005; Priestley MA, 2001, J THORAC CARDIOV SUR, V121, P336, DOI 10.1067/mtc.2001.112338; Sakamoto T, 2001, J THORAC CARDIOV SUR, V122, P339, DOI 10.1067/mtc.2001.115242; Saykin AJ, 2004, BRAIN, V127, P1574, DOI 10.1093/brain/awh177; Saykin AJ, 1999, J INT NEUROPSYCH SOC, V5, P377, DOI 10.1017/S135561779955501X; Souweidane MM, 1999, PEDIATR NEUROSURG, V30, P86, DOI 10.1159/000028768; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x; Wishart HA, 2004, NEUROLOGY, V62, P234, DOI 10.1212/01.WNL.0000103238.91536.5F	26	16	17	1	7	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	APR	2006	104	4		S			259	264		10.3171/ped.2006.104.4.259			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	031NC	WOS:000236710300006	16619637				2022-02-06	
J	Yeoh, HK; Lind, CRP; Law, AJJ				Yeoh, HK; Lind, CRP; Law, AJJ			Acute transient cerebellar dysfunction and stuttering following mild closed head injury	CHILDS NERVOUS SYSTEM			English	Article						cerebellar dysfunction; stuttering; pediatric; closed head injury; neurogenic	CEREBRAL-BLOOD-FLOW	Introduction: A wide range of pathologies can cause cerebellar dysfunction but there have been few reports of transient dysfunction after mild head injury. There are none describing stuttering as an acute symptom after such injuries. Case report: We report a 12-year-old boy who presented with headache, stuttering speech and truncal and bilateral peripheral cerebellar dysfunction after falling prone from his skateboard. Computed tomographic brain imaging showed normal results. All clinical symptoms and signs had resolved within 24 h obviating further investigation. A follow up clinical interview and examination 4 weeks later revealed no recurrence of cerebellar or speech dysfunction. Conclusion: This is the first reported case of acute transient cerebellar dysfunction and stuttering after mild closed head injury. Neurogenic causes for stuttering are increasingly being recognised.	Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; Starship Childrens Hosp, Dept Neurosurg, Auckland, New Zealand		Lind, CRP (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Nedlands, WA 6009, Australia.	crplind@free.net.nz	Lind, Christopher/K-3629-2012	Lind, Christopher/0000-0001-9991-1725			Balasubramanian V, 2003, BRAIN COGNITION, V53, P185, DOI 10.1016/S0278-2626(03)00106-4; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cantu R C, 1969, Int Surg, V52, P392; CHESTER CS, 1987, ANN NEUROL, V22, P77; De Nil LF, 2001, NEUROSCI LETT, V302, P77, DOI 10.1016/S0304-3940(01)01671-8; Djaldetti R, 1996, ARCH NEUROL-CHICAGO, V53, P1214, DOI 10.1001/archneur.1996.00550120016003; Foundas AL, 2003, NEUROLOGY, V61, P1378, DOI 10.1212/01.WNL.0000094320.44334.86; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fumeya Hiroshi, 1994, Neurologia Medico-Chirurgica, V34, P612, DOI 10.2176/nmc.34.612; Gordon N, 2002, DEV MED CHILD NEUROL, V44, P278, DOI 10.1017/S0012162201002067; HAGGARD P, 1995, J NEUROL NEUROSUR PS, V58, P433, DOI 10.1136/jnnp.58.4.433; Helm-Estabrooks Nancy, 1998, Seminars in Speech and Language, V19, P23, DOI 10.1055/s-2008-1064032; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Ludlow CL, 2003, J FLUENCY DISORD, V28, P273, DOI 10.1016/j.jfludis.2003.07.001; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Michell AW, 2001, BRIT J NEUROSURG, V15, P526; Perkins WH, 2001, SCIENCE, V294, P786; World Health Organization,, 1977, MAN INT STAT CLASS D, VI	20	16	17	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2006	22	3					310	313		10.1007/s00381-005-1154-0			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	015IV	WOS:000235546000018	15821946				2022-02-06	
J	Ernst, C; Christie, BR				Ernst, C; Christie, BR			Temporally specific proliferation events are induced in the hippocampus following acute focal injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						dentate gyrus; latent period; neurogenesis; hippocampus; electrolytic lesion; Fluorojade-B; neuron; stem cell; glia	GRANULE CELL NEUROGENESIS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; NEURONAL DEGENERATION; MICROGLIAL REACTION; GENE-EXPRESSION; ADULT-RAT; ENHANCED NEUROGENESIS; RODENT HIPPOCAMPUS	In models of global brain injury, such as stroke or epilepsy, a large increase in neurogenesis occurs in the dentate gyrus (DG) days after the damage is induced. In contrast, more focal damage in the DG produces an increase in neurogenesis within 24 hr. To determine how cell proliferation and differentiation differs in the DG after acute injury in the DG, focal electrolytic lesions were made and mitotic activity was assessed at early (1 day) and late (5 day) time points. At the early time point, bromodeoxyuridine (BrdU)-positive cells were diffusely spread throughout the extent of the hippocampus that was ipsilateral to the lesion. No significant increase in the subgranular zone (SGZ) of the DG was observed. When BrdU was administered at the later time point, the number of BrdU(+) cells in the SGZ of the DG was significantly increased. This fourfold increase in BrdU(+) cells also resulted in a significant increase in neurogenesis, as measured 6 weeks following BrdU administration. This increase in neurogenesis was not observed when BrdU was administered at the early time point. These results indicate that focal injury in the DG activates two temporally specific proliferation events and that enhanced neurogenesis is observed only following a latent period after the lesion is made. (c) 2005 Wiley-Liss, Inc.	Univ British Columbia, Dept Psychol, Brain Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Program Neurosci, Vancouver, BC, Canada		Christie, BR (corresponding author), Univ British Columbia, Dept Psychol, Brain Res Ctr, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	bchristie@psych.ubc.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160			ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; BETHEA JR, 1992, J NEUROIMMUNOL, V36, P179, DOI 10.1016/0165-5728(92)90049-Q; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COFFEY PJ, 1990, NEUROSCIENCE, V35, P121, DOI 10.1016/0306-4522(90)90126-O; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Ferland RJ, 2002, NEUROSCIENCE, V115, P669, DOI 10.1016/S0306-4522(02)00514-6; FONTANA A, 1982, J IMMUNOL, V129, P2413; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; GEHRMANN J, 1991, ACTA NEUROPATHOL, V82, P442, DOI 10.1007/BF00293378; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; GEHRMANN J, 1992, ACTA NEUROPATHOL, V84, P588; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Harry GJ, 2004, NEUROTOX RES, V5, P623; Horner PJ, 2003, TRENDS NEUROSCI, V26, P597, DOI 10.1016/j.tins.2003.09.010; Ivacko JA, 1996, PEDIATR RES, V39, P39, DOI 10.1203/00006450-199601000-00006; Jiang W, 2003, BRAIN RES, V977, P141, DOI 10.1016/S0006-8993(03)02438-7; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Rosenblum WI, 1997, J NEUROTRAUM, V14, P313, DOI 10.1089/neu.1997.14.313; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SCHREIBER SS, 1995, TRENDS NEUROSCI, V18, P446, DOI 10.1016/0166-2236(95)94495-Q; Scott BW, 2000, EXP NEUROL, V165, P231, DOI 10.1006/exnr.2000.7458; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569	47	16	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB 15	2006	83	3					349	361		10.1002/jnr.20724			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	015BX	WOS:000235528000001	16342206				2022-02-06	
J	Boret, H; Fesselet, J; Meaudre, E; Gaillard, PE; Cantais, E				Boret, H; Fesselet, J; Meaudre, E; Gaillard, PE; Cantais, E			Cerebral microdialysis and PtiO2 for neuro-monitoring before decompressive craniectomy	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						craniectomy; microdialysis; PtiO2; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; BLOOD-FLOW; METABOLISM; PROSTACYCLIN; TOMOGRAPHY; PRESSURE; EDEMA	We report the case of a young patient with post-traumatic, intractable, intracranial hypertension leading to craniectomy. This intracranial hypertension was preceded by focal signs of ischemia diagnosed through P(ti)o(2) monitoring and cerebral microdialysis, and occurred a few hours prior to a decrease in cerebral perfusion pressure below 60 mmHg. The neurological outcome was satisfactory with a Glasgow Outcome Scale of 4 at 3 months. We discuss the potential interest of such neuro-monitoring to determine the optimal time for performing a craniectomy.	St Anne Teaching Mil Hosp, Dept Anesthesiol & Intens Care, Toulon, France; St Anne Teaching Mil Hosp, Dept Neurosurg, Toulon, France		Boret, H (corresponding author), HIA St Anne, Dept Anesthesie Reanimat, F-83500 Toulon, France.	hb-boret@wanadoo.fr					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Gardenfors F, 2004, ACTA ANAESTH SCAND, V48, P1316, DOI 10.1111/j.1399-6576.2004.00522.x; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Peerdeman SM, 2003, J NEUROL, V250, P797, DOI 10.1007/s00415-003-1079-z; Sarrafzadeh Asita S, 2003, Curr Neurol Neurosci Rep, V3, P517, DOI 10.1007/s11910-003-0057-2; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Strege RJ, 2003, NEUROL RES, V25, P510, DOI 10.1179/016164103101201742; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591	16	16	17	0	0	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	2006	50	2					252	254		10.1111/j.1399-6576.2005.00862.x			3	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	004EG	WOS:000234734200021	16430552				2022-02-06	
J	Hu, X; Nenov, V; Bergsneider, M; Martin, N				Hu, Xiao; Nenov, Valeriy; Bergsneider, Marvin; Martin, Neil			A Data mining framework of noninvasive intracranial pressure assessment	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Article						Noninvasive; Intracranial pressure; Data mining; System identification	CEREBRAL PERFUSION-PRESSURE; TRANSCRANIAL DOPPLER; BLOOD-PRESSURE; SPONTANEOUS FLUCTUATIONS; MATHEMATICAL-MODEL; BRAIN-DAMAGE; AUTOREGULATION; IDENTIFICATION; DYNAMICS	The only established technique for intracranial pressure (ICP) measurement is an invasive direct procedure that has been accepted into routine usage in neurosurgical services. However. there are many other scenarios where a noninvasive assessment of ICP is highly desirable. To make a full use of the vast amount Of signals Collected in a typical neurosurgical service environment to realize Such a noninvasive procedure of ICP assessment, a general data mining, framework is proposed in the present work. As a particular implementation of the proposed framework where continuous arterial blood pressure (ABP) and cerebral blood flow velocity (CBFV) are available. We Propose to simulate the unobserved ICP as the Output Of a model built from a database composed of arterial blood pressure. cerebral blood flow velocity and ICP. This model was discovered by exploring, the database with the hemodynamic features extracted from measured ABP and CBFV. This approach was evaluated Using a database composed of 30-min long measurements from nine traumatic brain injury patients. The approach achieved significant improvements of ICP simulation accuracy over several existing noninvasive ICP assessment methods. Particularly its median normalized prediction error for ICP is 39% compared to 51% as obtained by an existing method and its median correlation coefficient between estimated and measured normalized ICP is 0.80 compared to 0.35 achieved by the existing method. The proposed framework is flexible in incorporating other relevant signals besides ABP, CBFV and ICP into the database. It allows for new hemodynamic feature vectors and for adopting new models for ICP estimation. Hence it is worthwhile to evaluate the method using, a larger database and further develop the framework. (c) 2006 Elsevier Ltd. All rights reserved.	[Hu, Xiao; Nenov, Valeriy; Bergsneider, Marvin; Martin, Neil] Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA		Hu, X (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA.	xhu@mednet.ucla.edu; vnenov@mednet.ucla.edu; mbergsneider@mednet.ucla.edu; nmartin@mednet.ucla.edu		Martin, Neil/0000-0002-6565-4131	UCLA Brain Injury Research Center (BIRC) [NINDS RO1 40122-01]; UCLA SPOTRIAS	The present work was funded by, in part, UCLA Brain Injury Research Center (BIRC). NINDS RO1 40122-01, and UCLA SPOTRIAS project.	AASLID R, 1985, P 6 INT S INTR PRESS, P226; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; ANDERSSON P, 1985, INT J CONTROL, V42, P1175, DOI 10.1080/00207178508933420; Avan P, 2000, HEARING RES, V140, P189, DOI 10.1016/S0378-5955(99)00201-4; Belfort MA, 2000, HYPERTENS PREGNANCY, V19, P331, DOI 10.1081/PRG-100101995; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Hagan M.T., 1996, NEURAL NETWORK DESIG; HANLO PW, 1995, ULTRASOUND MED BIOL, V21, P613, DOI 10.1016/0301-5629(94)00147-6; Hu X, 2006, IEEE T BIO-MED ENG, V53, P195, DOI 10.1109/TBME.2005.862546; Hu X, 2004, CLIN NEUROPHYSIOL, V115, P1276, DOI 10.1016/j.clinph.2003.12.030; JENNETT B, 1975, LANCET, V1, P480; Kailath T, 2000, PR H INF SY, pXIX; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LJUNG L, 1999, SYSTEM IDENTIFICATIO; Michaeli D, 2002, J NEUROSURG, V96, P1132, DOI 10.3171/jns.2002.96.6.1132; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Overschee P., 1996, SUBSPACE IDENTIFICAT; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; PIPER IR, 1990, ACT NEUR S, V51, P387; Richards HK, 1999, ACTA NEUROCHIR, V141, P1221, DOI 10.1007/s007010050422; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Sherman RW, 2002, BRIT J ANAESTH, V89, P687, DOI 10.1093/bja/aef247; SIDI A, 1995, ANESTH ANALG, V80, P194, DOI 10.1097/00000539-199501000-00032; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; TEASDALE G, 1974, LANCET, V2, P81; Thalen E, 2002, EUR ARCH OTO-RHINO-L, V259, P174, DOI 10.1007/s00405-001-0431-0; Ueno T, 1998, ACT NEUR S, V71, P66; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; URSINO M, 1995, IEEE T BIO-MED ENG, V42, P529, DOI 10.1109/10.387192; URSINO M, 1988, ANN BIOMED ENG, V16, P379, DOI 10.1007/BF02364625; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; VERHAEGEN M, 1992, INT J CONTROL, V56, P1187, DOI 10.1080/00207179208934363; Zhang R, 2000, AM J PHYSIOL-HEART C, V278, pH1848, DOI 10.1152/ajpheart.2000.278.6.H1848; 1990, P 29 IEEE C DEC CONT, P596	41	16	17	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	JAN	2006	1	1					64	77		10.1016/j.bspc.2006.05.003			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	V83MW	WOS:000205644200007					2022-02-06	
J	Lin, JW; Tsai, SH; Tsai, WC; Chiu, WT; Chu, SF; Lin, CM; Yang, CM; Hung, CC				Lin, Jia-Wei; Tsai, Shih-Han; Tsai, Wan-Chen; Chiu, Wen-Ta; Chu, Shu-Fen; Lin, Chien-Min; Yang, Che-Ming; Hung, Ching-Chang			Survey of traumatic intracranial hemorrhage in Taiwan	SURGICAL NEUROLOGY			English	Article						head injury; traumatic intracranial hemorrhage; traumatic brain injury	HEAD-INJURY; AUSTRALIA; HELMETS; COUNTY	Background: Injury ranked third among the top 10 leading causes of death in Taiwan from 1964 to 1996 and is still among the top 10 presently. Among transportation accidents, motor vehicle -related injury had the highest incidence rate, often resulting in traumatic head injury. Methods: This survey was conducted from July 1, 1994, to June 30, 2002, and was collected from 55 major hospitals in Taiwan. A total of 90 250 patients with TBI were enrolled, and 27 585 cases were identified to have TIH. In this study, SPSS 10.0 (SPSS, Chicago, Ill) was used to process the data. Regarding the rating model itself, reliability and correlation tests were conducted to calculate the coefficiency, and factor analysis was carried out to verify its validity. Results: The incidence rate of male-to-female ratio was 2.65. Traffic injuries (67.6%) were the leading causes of TIH. Among the traffic injuries, motorcycle-related traumatic injuries had the highest incidence rate (69.6%). In the logistic regression analysis, older patients had the highest risk of developing TIH. Patients without a motorcycle helmet had a higher risk (odds ratio, 1.40) of developing TIH than those with a helmet. As regards the types of injuries, pedestrian injury (odds ratio, 1.61) had the highest risk of developing TIH. Conclusions: Although traffic injuries, especially those caused by motorcycles, are the major cause of intracranial hemorrhage, we have to pay due attention to falling, pedestrian, and bicycle injuries, as these are all major causes of intracranial hemorrhage. (c) 2006 Elsevier Inc. All rights reserved.	Taipei Med Univ, Municipal Wanfang Hosp, Dept Neurosci, Taipei 116, Taiwan; Taipei Med Univ, Municipal Wanfang Hosp, Dept Emergency Med, Taipei 116, Taiwan; Taipei Med Univ, Municipal Wanfang Hosp, Dept Nucl Med, Taipei 116, Taiwan; Taipei Med Univ, Municipal Wanfang Hosp, Adm Off, Taipei 116, Taiwan; Taipei Med Univ, Inst Injury Prevent & Control, Taipei 110, Taiwan		Chiu, WT (corresponding author), Taipei Med Univ, Municipal Wanfang Hosp, Dept Neurosci, Taipei 116, Taiwan.	wtchiu@tmu.edu.tw	Carlotti, Carlos G/C-1608-2012	Carlotti, Carlos G/0000-0002-7055-0564			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FRANKOWSKI RF, 1985, EPIDEMIOLOGICAL DE 1, P33; Hung C C, 1991, J Formos Med Assoc, V90, P1227; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KLAUBER MR, 1981, AM J EPIDEMIOL, V5, P500; KRAUS JF, 1980, J NEUROSURG, V53, P803; KUO JI, 1995, J TAIPEI MED COLL, V24, P36; MCDERMOTT FT, 1995, ANN ROY COLL SURG, V77, P38; PARKISON D, 1985, CAN J SURG, V28, P78; *ROC, 2002, STAT DAT DEP HLTH; Runge J W, 1993, Emerg Med Clin North Am, V11, P241; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; Servadei F, 1985, J Neurosurg Sci, V29, P297; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x; WU DM, 1991, J MED SCI, V12, P104; WU DT, 1991, MED SCI, V12, P104	22	16	16	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.		2006	66			2			S20	S25		10.1016/j.surneu.2006.04.005			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	107OW	WOS:000242181900005	17071250				2022-02-06	
J	Van Hulle, A; Hux, K				Van Hulle, A; Hux, K			Improvement patterns among survivors of brain injury: Three case examples documenting the effectiveness of memory compensation strategies	BRAIN INJURY			English	Article						assistive technology; memory	AIDS	Three case examples illustrate possible patterns of improved functioning that may emerge as survivors of traumatic brain injury (TBI) attempt compensation for persistent memory deficits impeding independent living. The task selected for report was independence in remembering to take regularly-prescribed medications. Strategies applied to promote learning included use of written reminders and use of two assistivetechnology (AT) devices-a wristwatch alarm (WatchMinder (R)) and a digital voice recorder and alarm system (Voice Craft(TM)). With participation in the intervention programme, two of the three individuals demonstrated increased independence in remembering to take medications; the third did not. The case examples illustrate varying responses of people with TBI to intervention using compensatory strategies and AT devices. Professionals and caretakers working with survivors must recognize the uniqueness of each survivor, must adjust intervention programmes accordingly and must be willing to persist in trying to increase functional independence repeatedly for many years post-injury.	Univ Nebraska, Barkley Mem Ctr Speech & Hearing, Lincoln, NE 68506 USA		Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 318N, Lincoln, NE 68506 USA.	khux1@unl.edu	Hux, Karen/AAQ-2078-2020				Delis D.C., 2000, CALIFORNIA VERBAL LE; GILES GM, 1989, AM J OCCUP THER, V43, P409, DOI 10.5014/ajot.43.6.409; Hux K, 2003, ASSISTING SURVIVORS OF TRAUMATIC BRAIN INJURY, P169; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kertesz A., 1982, W APHASIA BATTERY; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; MOSEY AC, 1993, AOTA SELF STUDY SERI, P23; SANDLER AB, 1992, AM J OCCUP THER, V46, P163, DOI 10.5014/ajot.46.2.163; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; Sohlberg M., 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; WOODS RT, 1983, BEHAV RES THER, V21, P173, DOI 10.1016/0005-7967(83)90164-X	16	16	16	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					101	109		10.1080/02699050500309684			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000011	16403705				2022-02-06	
J	Yen, K; Weis, J; Kreis, R; Aghayev, E; Jackowski, C; Thali, M; Boesch, C; Maier, SE; Dirnhofer, R; Lovblad, KO				Yen, K; Weis, J; Kreis, R; Aghayev, E; Jackowski, C; Thali, M; Boesch, C; Maier, SE; Dirnhofer, R; Lovblad, KO			Line-scan diffusion tensor imaging of the posttraumatic brain stem: Changes with neuropathologic correlation	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; FIBER TRACT ANATOMY; WHITE-MATTER; POSTMORTEM; INJURY; MRI	Following trauma, imaging of brain stem lesions is often inconclusive. In a man who suffered a lethal accident, postmortem MR diffusion tensor (DT) imaging of the brain and neuropathologic examination were performed. DT imaging showed a disorganization of fibers in the brain stem that was not found in 2 controls and corresponded to changes on neuropathologic correlation. Diffusion tensor imaging provides an insight into the organization of myelinated structures of the CNS, potentially allowing diagnosis of traumatic fiber tract rupture.	Univ Bern, Inst Forens Med, CH-3012 Bern, Switzerland; Univ Bern, Dept Clin Res, CH-3012 Bern, Switzerland; Univ Bern, Dept Neuroradiol, CH-3012 Bern, Switzerland; Univ Geneva, Dept Neuroradiol, Geneva, Switzerland; Univ Aachen, Inst Pathol, Div Neuropathol, D-5100 Aachen, Germany; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA		Yen, K (corresponding author), Univ Bern, Inst Forens Med, Buehlstr 20, CH-3012 Bern, Switzerland.		Boesch, Chris/F-2577-2010; Lovblad, Karl/AAF-7678-2020; Kreis, Roland/F-2550-2010; Weis, Joachim/G-1984-2014	Boesch, Chris/0000-0001-8498-8543; Kreis, Roland/0000-0002-8618-6875; Weis, Joachim/0000-0003-3280-6773; lovblad, karl-olof/0000-0003-2768-9779			Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Larsson EM, 2004, DEMENT GERIATR COGN, V17, P316, DOI 10.1159/000077162; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Mamata H, 2002, AM J NEURORADIOL, V23, P67; Roberts TPL, 2003, EUR J RADIOL, V45, P185, DOI 10.1016/S0720-048X(02)00305-4; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Watanabe T, 2004, J NEUROSURG, V100, P56, DOI 10.3171/jns.2004.100.1.0056; Yen K, 2005, INT J LEGAL MED, V119, P129, DOI 10.1007/s00414-004-0507-7	12	16	18	0	1	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	JAN	2006	27	1					70	73					4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	004VC	WOS:000234779600025	16418359				2022-02-06	
J	Turkstra, LS				Turkstra, LS			Looking while listening and speaking: Eye-to-face gaze in adolescents with and without traumatic brain injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						eye contact; pragmatics; communication; traumatic brain injury	CLOSED-HEAD-INJURY; SOCIAL-SKILLS; CONVERSATIONAL DISCOURSE; NARRATIVES; BEHAVIORS; ABILITIES; RECOVERY; MEMORY; ADULTS	Purpose: The purpose of this study was to address the lack of quantitative data on eye-to-face gaze (also known as eye contact) in the literature on pragmatic communication. The study focused on adolescents and young adults with traumatic brain injury (TBI), as gaze often is included in social skills intervention in this population. Method: Gaze times were calculated for participants with TBI (n = 16) and their typically developing (TD) peers (n = 16) engaged in 3-min extemporaneous conversations. Results: The TD group members looked at the face of their conversation partner an average of 62% of the time while listening and 43% of the time while speaking, versus 67% and 51 %, respectively, for the TBI group. There were no significant between-groups differences in average gaze times, but the within-group variability was significantly greater in the TBI group. Implications: As there was no evidence of a uniform trend in gaze times among participants with TBI, general intervention to increase eye contact does not appear warranted. Instead, goals must consider that gaze is a highly complex behavior, not necessarily indicative of attention to one's partner, and that there are potential reasons for gaze aversion in individuals with cognitive limitations.	Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-00163] Funding Source: Medline		Arnold A, 2000, J INTELLECT DEV DIS, V25, P207, DOI 10.1080/13269780050144271; ASHER SR, 1986, SOCIAL WORK ED, V8, P205; Baker SR, 2002, BRIT J CLIN PSYCHOL, V41, P243, DOI 10.1348/014466502760379118; Baron-Cohen S., 1995, MIND BLINDNESS ESSAY; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bavelas JB, 2000, J LANG SOC PSYCHOL, V19, P163, DOI 10.1177/0261927X00019002001; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; CHERULNIK PD, 1978, J SOC PSYCHOL, V104, P263, DOI 10.1080/00224545.1978.9924068; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cohen M.J., 1997, CHILDRENS MEMORY SCA; DUNCAN S, 1972, J PERS SOC PSYCHOL, V23, P283, DOI 10.1037/h0033031; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Gueguen N, 2002, J SOC PSYCHOL, V142, P393, DOI 10.1080/00224540209603907; Hansen DJ, 1996, BEHAV MODIF, V20, P281, DOI 10.1177/01454455960203003; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; JENNETT B, 1975, LANCET, V1, P480; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; LAFRANCE M, 1976, J PERS SOC PSYCHOL, V33, P547, DOI 10.1037/0022-3514.33.5.547; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Larson R., 1984, BEING ADOLESCENT CON; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; MARCELLE YM, 1976, THESIS KANSAS STATE; McNeil M.R, 1991, CLIN APHASIOLOGY C; MIRENDA PL, 1983, J AUTISM DEV DISORD, V13, P397, DOI 10.1007/BF01531588; Murphy NA, 2003, J PERS, V71, P465, DOI 10.1111/1467-6494.7103008; Newtson D., 1993, DYNAMIC SYSTEMS APPR, P241; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; PLACE KS, 1991, DISCOURSE PROCESS, V14, P227, DOI 10.1080/01638539109544783; RAFFAELLI M, 1989, J YOUTH ADOLESCENCE, V18, P567, DOI 10.1007/BF02139074; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; SNOW P, 1995, TRAUMATIC BRAIN INJU, P137; SPENCE SH, 1981, J APPL BEHAV ANAL, V14, P159, DOI 10.1901/jaba.1981.14-159; STEPHENS J, 1986, J LANG SOC PSYCHOL, V5, P119, DOI DOI 10.1177/0261927X8652003; Turkstra L, 2003, LANG SPEECH HEAR SER, V34, P117, DOI 10.1044/0161-1461(2003/010); Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2001, J COMMUN DISORD, V34, P151, DOI 10.1016/S0021-9924(00)00046-0; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Wechsler D, 1987, MEMORY SCALE REVISED; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WIEMANN JM, 1981, HUM COMMUN RES, V7, P302, DOI 10.1111/j.1468-2958.1981.tb00577.x; WINT G, 1965, 3 KILLER MEDITATIONS	52	16	16	0	7	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	DEC	2005	48	6					1429	1441		10.1044/1092-4388(2005/099)			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	022KY	WOS:000236055900014	16478381				2022-02-06	
J	Ellis, C; Rosenbek, JC; Rittman, MR; Boylstein, CA				Ellis, Charles; Rosenbek, John C.; Rittman, Maude R.; Boylstein, Craig A.			Recovery of cohesion in narrative discourse after left-hemisphere stroke	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						aphasia; cohesion; cohesive markers; cohesive ties; communication; discourse; language; narratives; speech; stroke	CLOSED-HEAD-INJURY; SUBCORTICAL APHASIA; ELICITATION TASK; LANGUAGE; ADULTS; COHERENCE; PATTERNS; DEFICITS; NEGLECT	Little is known about the recovery of narrative discourse after stroke. While several studies have analyzed the recovery of language in individuals with aphasia, few known studies exist on the recovery of narrative discourse in stroke survivors, particularly those who have not been diagnosed with aphasia. In this study, we evaluated the cohesiveness of narrative discourse in a cohort of individuals who had suffered a left-hemisphere stroke and had not been diagnosed with expressive language impairment. We analyzed their narrative discourse at 1, 6, and 12 months poststroke. Our findings indicate that, while the mean number of cohesive ties in narrative discourse remained generally constant during the first year poststroke, the percentage correct use of cohesive ties increased significantly during the same time period. These findings suggest that subtle disruptions in expressive language can be present initially in narrative discourse, and recovery from these disruptions can occur naturally over time.	Rehabil Outcomes Res Ctr, Dept Vet Affairs, Gainesville, FL USA; Univ Florida, Dept Communicat Disorders, Gainesville, FL 32611 USA		Ellis, C (corresponding author), Med Univ S Carolina, Dept Rehabil Sci, Coll Hlth Profess, 151-B Rutledge Ave,POB 250965, Charleston, SC 29425 USA.	ellisc@musc.edu					Bays C L, 2001, J Neurosci Nurs, V33, P310; Bloom RL, 1996, INT J NEUROSCI, V88, P125, DOI 10.3109/00207459608999818; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Copland DA, 2000, J MED SPEECH-LANG PA, V8, P1; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; ELLIS C, 2004, AM SPEECH LANG HEAR; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; HALLIDAY M, 1976, COHESIONE NGLISH; Han MK, 2003, STROKE, V34, P259; HARTLEY LL, 1990, BRAIN INJURY, V6, P271; HARTMAN J, 1981, ANN NEUROL, V9, P89, DOI 10.1002/ana.410090119; Hillis AE, 2004, BRAIN LANG, V89, P524, DOI 10.1016/j.bandl.2004.01.007; Hillis AE, 2002, BRAIN, V125, P1094, DOI 10.1093/brain/awf113; Hunt K. W., 1965, GRAMMATICAL STRUCTUR; Kauhanen ML, 2000, CEREBROVASC DIS, V10, P455, DOI 10.1159/000016107; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Lapointe Leonard L., 1999, Seminars in Speech and Language, V20, P5, DOI 10.1055/s-2008-1064005; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Lemme M.L., 1984, P CLIN APH C SEABR I, P215; LENDREM W, 1985, J NEUROL NEUROSUR PS, V48, P743, DOI 10.1136/jnnp.48.8.743; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Lock S, 1997, CLIN LINGUIST PHONET, V11, P299, DOI 10.3109/02699209708985197; LOMAS J, 1978, BRAIN LANG, V5, P388, DOI 10.1016/0093-934X(78)90034-2; Mackenzie C, 2000, INT J LANG COMM DIS, V35, P269, DOI 10.1080/136828200247188; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW; Pedersen PM, 2004, CEREBROVASC DIS, V17, P35, DOI 10.1159/000073896; Radanovic M, 2003, BRAIN LANG, V84, P337, DOI 10.1016/S0093-934X(02)00554-0; ROSENBEK JC, 1989, CLIN APPROACH; STOVER SE, 1989, CLIN LINGUIST PHONET, V3, P137, DOI 10.3109/02699208908985277; Ulatowska Hanna K., 1990, DISCOURSE ABILITY BR, P180, DOI 10.1007/978-1-4612-3262-9_8; Ulatowska HK, 1997, J NARRAT LIFE HIST, V7, P259, DOI 10.1075/jnlh.7.1-4.32som; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; ULATOWSKA HK, 1986, BRAIN LANG, V28, P24, DOI 10.1016/0093-934X(86)90088-X; ULATOWSKA HK, 1983, BRAIN LANG, V19, P317, DOI 10.1016/0093-934X(83)90074-3; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; WEILLER C, 1993, BRAIN, V116, P1509, DOI 10.1093/brain/116.6.1509	44	16	17	0	4	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.	NOV-DEC	2005	42	6					737	746		10.1682/JRRD.2005.02.0026			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	047MQ	WOS:000237883800004	16680611	Bronze			2022-02-06	
J	Ganesh, JS; Rogers, CA; Banner, NR; Bonser, RS				Ganesh, JS; Rogers, CA; Banner, NR; Bonser, RS		Royal Coll Surg England London	Donor cause of death and mid-term survival in lung transplantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article							BRAIN-DEATH; INJURY; RISK	Background: The influence of donor cause of death (DCD) on survival after lung transplantation (LTx) is uncertain. This was investigated using data from a national prospective cohort study of adult single and bilateral LTx undertaken between July 1995 and June 2002. Methods: DCD was categorized a priori into vascular and tumor (V), traumatic (T), hylJoxic brain damage (H) and infective (1) causes. All T donor deaths were the result of blunt trauma. Risk factors for early (30 days), late (30 days to 5 years) and overall (5 years) mortality were identified using Cox regression analysis. Results: Of 580 eligible transplants,. DCDs were classified as V (n = 372), T (n = 153), H (n = 38) and I (n = 17). V donors were older (median 42 years) than the others (medians < 27 years) (p < 0.001). T donors were more likely to be of male gender (p < 0.001). Two hundred fifty-nine patients died within 5 years of surgery. The median follow-up time of survivors was 37 months. Unadjusted 5-year Kaplan-Meier survival rates did not vary with DCD (p = 0.6). Cox analysis identified donor age group, recipient diagnosis, pre-operative recipient ventilation, donor-recipient size mismatch, donor-recipient blood group variance, cytomegalovirus (CMV) mismatch and recipient creatinine clearance as predictors of mortality. After adjustment for these risk factors, DCD was not identified as a predictor of early (p = 0.2), late (p = 0.5) or overall mortality (p = 0.4) in LTx recipients. Conclusion: We found that DCD did not affect mid-term survival after LTx.	Royal Coll Surgeons England, Clin Effectiveness Unit, UK Cardiothorac Transplant Audit, Steering Grp, London WC2A 3PN, England		Bonser, RS (corresponding author), Queen Elizabeth Hosp, Cardiac Surg Unit, Birmingham B15 2TH, W Midlands, England.	robert.bonser@uhb.nhs.uk					CAMERON AC, 1996, ANAL COUNT DATA; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; COX DR, 1972, J R STAT SOC B, V34, P187; Endo H, 1974, Nihon Kyobu Geka Gakkai Zasshi, V22, P806; Feduska N J Jr, 1994, Clin Transpl, P381; Fiser SM, 2001, J HEART LUNG TRANSPL, V20, P1291, DOI 10.1016/S1053-2498(01)00355-2; Fisher AJ, 2002, J HEART LUNG TRANSPL, V21, P1206, DOI 10.1016/S1053-2498(02)00450-3; NOVITZKY D, 1987, ANN THORAC SURG, V43, P288, DOI 10.1016/S0003-4975(10)60615-7; Oto T, 2004, J HEART LUNG TRANSPL, V23, P309, DOI 10.1016/S1053-2498(03)00192-X; Pessione F, 2003, TRANSPLANTATION, V75, P361, DOI 10.1097/01.TP.0000044171.97375.61; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Pratschke J, 2001, J AM SOC NEPHROL, V12, P2474, DOI 10.1681/ASN.V12112474; ROSENDALE BE, 1992, J HEART LUNG TRANSPL, V11, P72; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Trulock EP, 2003, J HEART LUNG TRANSPL, V22, P625, DOI 10.1016/S1053-2498(03)00182-7; WALLER DA, 1995, J HEART LUNG TRANSPL, V14, P318; WANEBO H, 1972, J THORAC CARDIOV SUR, V64, P537	18	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	OCT	2005	24	10					1544	1549		10.1016/j.healun.2004.11.316			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	973EU	WOS:000232506500014	16210128				2022-02-06	
J	Layman, DE; Dijkers, MPJM; Ashman, TA				Layman, DE; Dijkers, MPJM; Ashman, TA			Exploring the impact of traumatic brain injury on the older couple: 'Yes, but how much of it is age, I can't tell you ...'	BRAIN INJURY			English	Article						head injuries; closed; aging; adaptation; psychological; family health; quality of life; qualitative research; couples; sexuality; support; interpersonal; role changes	QUALITY-OF-LIFE; HEAD-INJURY; FOLLOW-UP; MARITAL RELATIONSHIPS; SOCIAL-ADJUSTMENT; INDIVIDUALS; PSYCHOPATHOLOGY; REHABILITATION; DYSFUNCTION; SYMPTOMS	Primary objective: To qualitatively explore the partner relationships of older couples faced with traumatic brain injury (TBI). Research design: Qualitative analysis comparing individuals with TBI and a comparison group. Methods and procedures: Twenty-one individuals were interviewed using a semi-structured format focusing on various aspects of their partner relationship. A qualitative analysis of transcripts identified general themes. Main outcomes and results: Variability of relationship experiences (relationship relatedness and persistence of the partnership) was shown across groups. Aspects of relationship commitment to the partnership were revealed. Many individuals with TBI and their partners attributed various relationship changes to ageing and age-related issues and not to the TBI. Conclusions: These findings suggest that the effects of TBI are not clearly distinguished from age-related causes for change in the partners and their relationship. Older couples' experiences may be different from those of younger couples impacted by TBI, in the areas of sexuality, inter-personal support and role functions.	Jamaica Hosp Med Ctr, Dept Phys Med & Rehabil, Queens, NY USA; Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA		Layman, DE (corresponding author), Jamaica Hosp Med Ctr, 8900 Van Wyck Expressway, Jamaica, NY 11418 USA.	dave@layman.com	Ashman, Teresa/B-1621-2013	Dijkers, Marcel/0000-0002-8362-5596			Barrett AE, 1999, GERONTOLOGIST, V39, P695, DOI 10.1093/geront/39.6.695; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; Brooks N, 1988, Acta Neurochir Suppl (Wien), V44, P59; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; CDC, 1999, TRAUM BRAIN INJ US R; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Folkman S., 1984, STRESS; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Gosling J, 1999, BRAIN INJURY, V13, P785; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Katz S, 1999, INT J REHABIL RES, V22, P45, DOI 10.1097/00004356-199903000-00006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kumashiro M, 2002, J PERS, V70, P1009, DOI 10.1111/1467-6494.05030; Lazarus RS, 1998, CLINICAL GEROPSYCHOLOGY, P109, DOI 10.1037/10295-007; LEVENSON RW, 1993, PSYCHOL AGING, V8, P301, DOI 10.1037/0882-7974.8.2.301; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PARLESZ A, 1998, INT J REHABILITATION, V21, P339; Patton M.Q., 1990, QUALITATIVE EVALUATI; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; RICHARDS L, 1997, QSR NUD IST 4 USER G; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Sandelowski M, 1991, Image J Nurs Sch, V23, P161, DOI 10.1111/j.1547-5069.1991.tb00662.x; Schulz R, 1996, AM PSYCHOL, V51, P702, DOI 10.1037/0003-066X.51.7.702; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; White GW, 2004, ARCH PHYS MED REHAB, V85, pS3, DOI 10.1016/j.apmr.2003.08.109; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; [No title captured]	44	16	16	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2005	19	11					909	923		10.1080/02699050500109928			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	983YY	WOS:000233269500006	16243747				2022-02-06	
J	Fargo, JD; Schefft, BK; Dulay, MF; Privitera, MD; Yeh, HS				Fargo, JD; Schefft, BK; Dulay, MF; Privitera, MD; Yeh, HS			Confrontation naming in individuals with temporal lobe epilepsy: A quantitative analysis of paraphasic error subtypes	NEUROPSYCHOLOGY			English	Article						epilepsy; seizures; paraphasias; confrontation naming; lateralization	CLOSED-HEAD-INJURY; POSTICTAL LANGUAGE DYSFUNCTION; SPREADING-ACTIVATION THEORY; ALZHEIMERS-DISEASE; VERBAL MEMORY; SENTENCE PRODUCTION; SEMANTIC KNOWLEDGE; CASE-SERIES; IMPAIRMENT; RETRIEVAL	Although confrontation naming deficits have been observed in dominant temporal lobe epilepsy (DTLE), the relative contribution of impoverished phonologic word retrieval and/or semantic knowledge remains unclear. Analysis of verbal-semantic, phonemic-literal, and combination paraphasias produced during confrontation naming by participants with seizure disorders (52 DTLE; 47 nondominant temporal lobe epilepsy [NDTLE]; 54 psychogenic nonepileptic seizures [PNES]) indicated that the frequency of: (a) verbal-semantic paraphasias was similar across groups, (b) phonemic-literal paraphasias was highest in DTLE, and (c) combination paraphasias was lowest in PNES. Confrontation naming ability was most strongly related to phonemic-literal paraphasia frequency in DTLE and to verbal IQ in both NDTLE and PNES. Greater confrontation naming deficits in DTLE may be attributed to impairments in phonological processing.	Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; Utah State Univ, Dept Psychol, Res & Evaluat Methodol Program, Logan, UT 84322 USA; Univ Cincinnati, Med Ctr, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Med Ctr, Dept Neurosurg, Cincinnati, OH 45267 USA		Schefft, BK (corresponding author), Univ Cincinnati, Dept Psychol, POB 210376, Cincinnati, OH 45221 USA.	scheffbk@email.uc.edu	Fargo, Jamison/E-8361-2010				ARDILA A, 1993, BRAIN LANG, V44, P165, DOI 10.1006/brln.1993.1011; Barbarotto R, 1998, NEUROPSYCHOLOGIA, V36, P397, DOI 10.1016/S0028-3932(97)00124-3; Basso A, 1996, J CLIN EXP NEUROPSYC, V18, P77, DOI 10.1080/01688639608408264; BAYLES KA, 1983, BRAIN LANG, V19, P98, DOI 10.1016/0093-934X(83)90057-3; Beausoleil N, 2003, APHASIOLOGY, V17, P143, DOI 10.1080/729255219; Bell BD, 2001, NEUROPSYCHOLOGY, V15, P434, DOI 10.1037//0894-4105.15.4.434; BLAXTON TA, 1993, BRAIN LANG, V44, P221, DOI 10.1006/brln.1993.1015; Bookheimer SY, 1998, NEUROREPORT, V9, P2409, DOI 10.1097/00001756-199807130-00047; Bowman ES, 1998, PSYCHIAT CLIN N AM, V21, P649, DOI 10.1016/S0193-953X(05)70029-0; CAPPA SF, 1990, NEUROPSYCHOLOGIA, V28, P503, DOI 10.1016/0028-3932(90)90076-Z; CARAMAZZA A, 1978, PSYCHOL BULL, V85, P898, DOI 10.1037/0033-2909.85.4.898; CHARBOLLA DR, 1996, MAYO CLIN P, V71, P493; Cragar DE, 2002, NEUROPSYCHOL REV, V12, DOI 10.1023/A:1015491123070; CUMMINGS JL, 1985, NEUROLOGY, V35, P394, DOI 10.1212/WNL.35.3.394; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Daum I, 1996, J CLIN EXP NEUROPSYC, V18, P648, DOI 10.1080/01688639608408289; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Fedio P, 1997, BRAIN COGNITION, V33, P98, DOI 10.1006/brcg.1997.0886; Ficker DM, 2001, NEUROLOGY, V56, P1590, DOI 10.1212/WNL.56.11.1590; FLICKER C, 1987, BRAIN LANG, V31, P187, DOI 10.1016/0093-934X(87)90069-1; GAINOTTI G, 1986, BRAIN LANG, V29, P18, DOI 10.1016/0093-934X(86)90031-3; Gates J.R., 1991, EPILEPSY BEHAV, P251; Gates JR, 2000, EPILEPSY BEHAV, V1, P2, DOI 10.1006/ebeh.2000.0029; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Goodglass H, 1997, J Int Neuropsychol Soc, V3, P128; Goodglass H, 1998, BRAIN LANG, V64, P1, DOI 10.1006/brln.1998.1950; GOODGLASS H, 1980, AM SCI, V68, P647; Goodglass H, 1983, ASSESSMENT APHASIA R; Goodglass Harold, 1993, UNDERSTANDING APHASI; Gurd JM, 1997, BEHAV NEUROL, V10, P31, DOI 10.3233/BEN-1997-10106; HENRY TR, 1993, ARCH NEUROL-CHICAGO, V50, P582, DOI 10.1001/archneur.1993.00540060022011; Hermann B.P., 1992, HDB HEAD TRAUMA ACUT; HERMANN BP, 1992, CORTEX, V28, P423, DOI 10.1016/S0010-9452(13)80152-9; Hillis AE, 2002, COGN NEUROPSYCHOL, V19, P523, DOI 10.1080/02643290244000077; HOWELL RA, 1994, CORTEX, V30, P469, DOI 10.1016/S0010-9452(13)80342-5; HUFF FJ, 1988, BRAIN LANG, V34, P262, DOI 10.1016/0093-934X(88)90138-1; Humphreys GW, 2003, COGN NEUROPSYCHOL, V20, P263, DOI 10.1080/02643290342000023; Johnson CJ, 1996, PSYCHOL BULL, V120, P113, DOI 10.1037/0033-2909.120.1.113; Jones-Gotman M, 2000, CAN J NEUROL SCI, V27, pS39, DOI 10.1017/S0317167100000639; JONESGOTMAN M, 2000, CAN J NEUROL SCI S1, V27, pS50; Jordan FM, 1996, APHASIOLOGY, V10, P755, DOI 10.1080/02687039608248448; Kaplan E, 1983, BOSTON NAMING TEST; KEMPEN G, 1983, COGNITION, V14, P185, DOI 10.1016/0010-0277(83)90029-X; Krumholz A, 1999, NEUROLOGY, V53, pS76; LaBarge E., 1992, NEUROPSYCHOLOGY, V6, P77, DOI [10.1037/0894-4105.6.1.77, DOI 10.1037/0894-4105.6.1.77]; Lambon Ralph Matthew A., 2000, Neuropsychologia, V38, P186; LETHLEAN JB, 1994, J NEUROLINGUIST, V8, P207, DOI 10.1016/0911-6044(94)90027-2; Levelt W.J.M., 1989, SPEAKING INTENTION A; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; Lewis FM, 1998, APHASIOLOGY, V12, P193, DOI 10.1080/02687039808249446; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; Martin N, 1996, LANG COGNITIVE PROC, V11, P257, DOI 10.1080/016909696387187; MAYEUX R, 1980, NEUROLOGY, V30, P120, DOI 10.1212/WNL.30.2.120; Nagarajan L, 1996, ACTA NEUROL SCAND, V93, P81; NEBES RD, 1989, PSYCHOL BULL, V106, P377, DOI 10.1037/0033-2909.106.3.377; Norman Geschwind, 1967, CORTEX, V3, P97; Ogden-Epker M, 2001, CLIN NEUROPSYCHOL, V15, P183, DOI 10.1076/clin.15.2.183.1900; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; Privitera M, 1996, EPILEPSIA, V37, P936, DOI 10.1111/j.1528-1157.1996.tb00530.x; Ralph MAL, 2002, APHASIOLOGY, V16, P56, DOI 10.1080/02687040143000448; Ralph MAL, 1998, NEUROPSYCHOLOGIA, V36, P775, DOI 10.1016/S0028-3932(97)00169-3; Ralph MAL, 2001, J COGNITIVE NEUROSCI, V13, P341, DOI 10.1162/08989290151137395; Ramani V, 2000, NONEPILEPTIC SEIZURE, P311; ROELOFS A, 1992, COGNITION, V42, P107, DOI 10.1016/0010-0277(92)90041-F; Salmon DP, 1996, BRAIN COGNITION, V31, P148, DOI 10.1006/brcg.1996.0039; SASS KJ, 1992, J CLIN EXP NEUROPSYC, V14, P662, DOI 10.1080/01688639208402854; Sawrie SM, 2000, BRAIN, V123, P770, DOI 10.1093/brain/123.4.770; Schefft BK, 2003, EPILEPSY BEHAV, V4, P161, DOI 10.1016/S1525-5050(03)00026-X; SCHWARTZ MF, 1979, BRAIN LANG, V7, P277, DOI 10.1016/0093-934X(79)90024-5; Shiel A, 1992, CLIN REHABIL, V6, P283; Wechsler, 1997, WECHSLER ADULT INTEL; Wheeler DW, 1997, BRAIN LANG, V59, P147, DOI 10.1006/brln.1997.1816; White R F, 1990, J Neuropsychiatry Clin Neurosci, V2, P422; [No title captured]	77	16	16	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2005	19	5					603	611		10.1037/0894-4105.19.5.603			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	970HU	WOS:000232296700005	16187878				2022-02-06	
J	Lung, HL; Shan, SW; Tsang, D; Leung, KN				Lung, HL; Shan, SW; Tsang, D; Leung, KN			Tumor necrosis factor-alpha mediates the proliferation of rat C6 glioma cells via beta-adrenergic receptors	JOURNAL OF NEUROIMMUNOLOGY			English	Article						tumor necrosis factor-alpha; b-adrenergic receptor; cell proliferation; rat C6 glioma cells	CLOSED-HEAD INJURY; TNF-ALPHA; GLIAL-CELL; GENE-EXPRESSION; NERVOUS-SYSTEM; BRAIN-INJURY; BETA-1-ADRENERGIC RECEPTOR; INFLAMMATORY CYTOKINES; MESSENGER-RNA; ASTROCYTES	In the present study, we observed that isoproterenol, a beta-adrenergic receptor (beta-AR) agonist, stimulated rat C6 glioma cell proliferation, while propranolol, a beta-AR blocker, greatly reduced the proliferative effect of TNF-alpha on C6 cells. The gene and protein expressions of both beta 1- and beta 2-ARs were enhanced in C6 cells after TNF-alpha treatment, and the increase in beta-AR was due to an increased number of binding sites and not due to increase in receptor affinity. We further showed that protein kinase C (PKC) was involved in the TNF-alpha-induced beta-AR expression. Collectively, our results indicate that TNF-alpha-induced proliferation in C6 glioma cells might be via the induction and activation of beta-ARs, (C) 2005 Elsevier B.V. All rights reserved.	Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China		Leung, KN (corresponding author), Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China.	knleung@cuhk.edu.hk	Lung, Hong Lok/C-4494-2009	SHAN, SW/0000-0001-6876-9914			BARNA BP, 1990, J NEUROIMMUNOL, V30, P239, DOI 10.1016/0165-5728(90)90108-Y; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; BENVENISTE EN, 1989, J NEUROIMMUNOL, V25, P209, DOI 10.1016/0165-5728(89)90139-2; BUCKLAND PR, 1990, NUCLEIC ACIDS RES, V18, P682, DOI 10.1093/nar/18.3.682; CHUNG IY, 1990, J IMMUNOL, V144, P2999; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; DEBLASI A, 1990, DRUG EXP CLIN RES, V16, P107; Desai D, 2004, BIOCHEM BIOPH RES CO, V318, P642, DOI 10.1016/j.bbrc.2004.04.073; DIBNER MD, 1981, J BIOL CHEM, V256, P7343; ELALOUF JM, 1993, J CLIN INVEST, V91, P264, DOI 10.1172/JCI116180; Feuerstein G, 1998, CELL MOL NEUROBIOL, V18, P695, DOI 10.1023/A:1020226020062; Friedlander DR, 1998, J NEUROBIOL, V37, P291, DOI 10.1002/(SICI)1097-4695(19981105)37:2<291::AID-NEU8>3.0.CO;2-F; Gabryel B, 2001, NEUROTOX RES, V3, P205, DOI 10.1007/BF03033192; GOCAYNE J, 1987, P NATL ACAD SCI USA, V84, P8296, DOI 10.1073/pnas.84.23.8296; GUBITS RM, 1992, J NEUROSCI RES, V33, P297, DOI 10.1002/jnr.490330213; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; HodgesSavola C, 1996, GLIA, V17, P52, DOI 10.1002/(SICI)1098-1136(199605)17:1<52::AID-GLIA5>3.0.CO;2-9; HOUGH C, 1990, BIOCHEM BIOPH RES CO, V170, P46, DOI 10.1016/0006-291X(90)91238-N; Huang H, 1998, LIFE SCI, V62, P889, DOI 10.1016/S0024-3205(98)00006-X; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; KEMPSKI O, 1992, PROG BRAIN RES, V94, P69; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lau CBS, 2004, LIFE SCI, V75, P797, DOI 10.1016/j.lfs.2004.04.001; Lavine SD, 1998, J CEREBR BLOOD F MET, V18, P52, DOI 10.1097/00004647-199801000-00005; Leker RR, 1999, J NEUROL SCI, V162, P114, DOI 10.1016/S0022-510X(98)00301-3; LIBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lung HL, 2004, INT J MOL MED, V13, P465; Lung HL, 2001, LIFE SCI, V68, P2081, DOI 10.1016/S0024-3205(01)00997-3; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORGANTIKOSSMAN.MC, 1992, TRENDS PHARMACOL SCI, V13, P291; Morin D, 1996, LIFE SCI, V60, P315, DOI 10.1016/S0024-3205(96)00632-7; MUNOZFERNANDEZ MA, 1993, BIOCHEM BIOPH RES CO, V194, P319, DOI 10.1006/bbrc.1993.1822; MUNOZFERNANDEZ MA, 1991, EXP CELL RES, V194, P161, DOI 10.1016/0014-4827(91)90147-M; MURPHY S, 1987, NEUROSCIENCE, V22, P381, DOI 10.1016/0306-4522(87)90342-3; Nakamura A, 1998, J NEUROIMMUNOL, V88, P144, DOI 10.1016/S0165-5728(98)00109-X; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; PARKER KK, 1980, SCIENCE, V208, P179, DOI 10.1126/science.6102413; Roymans D, 2001, J NEUROCHEM, V76, P610, DOI 10.1046/j.1471-4159.2001.00077.x; SELMAJ KW, 1990, J IMMUNOL, V144, P129; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; SUTIN J, 1993, EXP NEUROL, V120, P214, DOI 10.1006/exnr.1993.1056; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Van Kolen K, 2004, J NEUROCHEM, V89, P442, DOI 10.1111/j.1471-4159.2004.02339.x; VERNADAKIS A, 1992, PROG BRAIN RES, V94, P391; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Wang L, 2001, ENDOCRINOLOGY, V142, P3041, DOI 10.1210/en.142.7.3041; Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041; YU NC, 1995, MOL PHARMACOL, V48, P550; ZHONG HY, 1993, MOL PHARMACOL, V44, P1085	57	16	16	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	SEP	2005	166	1-2					102	112		10.1016/j.jneuroim.2005.05.011			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	958ZQ	WOS:000231487100011	16005083				2022-02-06	
J	Casselbrant, ML; Mandel, EM				Casselbrant, ML; Mandel, EM			Balance disorders in children	NEUROLOGIC CLINICS			English	Article							BENIGN PAROXYSMAL VERTIGO; BASILAR ARTERY MIGRAINE; CONGENITAL PERILYMPHATIC FISTULA; FLUCTUATING HEARING-LOSS; TRAUMATIC BRAIN-INJURY; MIDDLE-EAR EFFUSION; OTITIS-MEDIA; VESTIBULAR SYSTEM; MENIERES-DISEASE; CHILDHOOD	Balance disorders in children may be difficult to recognize. Children often are unable to describe their symptoms and may seem just clumsy. The episodes may be of short duration, autonomic symptoms may be prominent, or symptoms may be thought of as a behavioral disorder. Dizziness may indicate a problem in the vestibular system, a problem in other sensory systems, or an abnormality of other organ systems. Management of these disorders depends on an accurate diagnosis. Disorders associated with dizziness in children are divided into three categories: (1) acute nonrecurring spontaneous vertigo; (2) recurrent vertigo; and (3) nonvertiginous dizziness, disequilibrium, and ataxia.	Childrens Hosp Pittsburgh, Dept Pediat Otolaryngol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA		Casselbrant, ML (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat Otolaryngol, 3705 5th Ave, Pittsburgh, PA 15213 USA.	margaretha.casselbrant@chp.edu					Anoh-Tanon MJ, 2000, PEDIATR NEUROL, V23, P49, DOI 10.1016/S0887-8994(00)00140-5; BALKANY TJ, 1986, EAR HEARING, V7, P138, DOI 10.1097/00003446-198606000-00004; BARABAS G, 1983, PEDIATRICS, V72, P188; BASSER LS, 1964, BRAIN, V87, P141, DOI 10.1093/brain/87.1.141; BICKERSTAFF ER, 1961, LANCET, V1, P15; Bille BS, 1962, ACTA PAED STOCK S136, V136, P1; BLAYNEY AW, 1984, CLIN OTOLARYNGOL, V9, P77, DOI 10.1111/j.1365-2273.1984.tb01477.x; BRANDT T, 1980, ANN NEUROL, V7, P195, DOI 10.1002/ana.410070302; Busis S N, 1976, Pediatr Ann, V5, P478; CASSELBRANT ML, 1995, ANN OTO RHINOL LARYN, V104, P620, DOI 10.1177/000348949510400806; Casselbrant ML, 1998, ANN OTO RHINOL LARYN, V107, P401, DOI 10.1177/000348949810700507; CASSELBRANT ML, 1983, ANN OTO RHINOL LARYN, V107, P46; Casselbrant ML, 2003, PEDIAT OTOLARYNGOLOG, P351; Cohen H, 1997, INT J PEDIATR OTORHI, V42, P107, DOI 10.1016/S0165-5876(97)00113-4; CROWE T K, 1990, Physical and Occupational Therapy in Pediatrics, V10, P1; CYR DG, 1992, INSIGHTS, V7, P1; Dandy WE, 1941, SURG GYNECOL OBSTET, V72, P421; DUNN DW, 1976, AM J DIS CHILD, V130, P1099, DOI 10.1001/archpedi.1976.02120110061008; EVIATAR L, 1977, PEDIATRICS, V59, P833; EVIATAR L, 1981, ANN NEUROL, V9, P126, DOI 10.1002/ana.410090205; FARMER TW, 1963, ARCH NEUROL-CHICAGO, V8, P471, DOI 10.1001/archneur.1963.00460050021002; FILIPO R, 1985, J LARYNGOL OTOL, V99, P193, DOI 10.1017/S0022215100096523; Folio MR, 1983, PEABODY DEV MOTOR SC; FRIED MP, 1980, LARYNGOSCOPE, V90, P1548; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; FURMAN JM, 2003, PEDIAT OTOLARYNGOLOG, P273; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; GATES GA, 1980, EAR NOSE THROAT J, V59, P358; Gawron W, 2002, DIABETOLOGIA, V45, P728, DOI 10.1007/s00125-002-0813-x; GOLDEN GS, 1975, PEDIATRICS, V56, P722; Golz A, 1998, OTOLARYNG HEAD NECK, V119, P695, DOI 10.1016/S0194-5998(98)70039-7; GOLZ A, 1991, J LARYNGOL OTOL, V105, P987, DOI 10.1017/S002221510011802X; GOODHILL V, 1973, ANN OTO RHINOL LARYN, V82, P2, DOI 10.1177/000348947308200103; GRUNDFAST KM, 1978, ANN OTO RHINOL LARYN, V87, P761, DOI 10.1177/000348947808700603; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HARKER LA, 1987, OTOLARYNG HEAD NECK, V96, P239, DOI 10.1177/019459988709600303; Hart MC, 1998, LARYNGOSCOPE, V108, P665, DOI 10.1097/00005537-199805000-00008; HASLAM RHA, 2000, NELSON TXB PEDIAT, P1810; HAUSLER R, 1987, AM J OTOLARYNG, V8, P187, DOI 10.1016/S0196-0709(87)80001-7; HORAK FB, 1988, DEV MED CHILD NEUROL, V30, P64, DOI 10.1111/j.1469-8749.1988.tb04727.x; JONES NS, 1990, ANN OTO RHINOL LARYN, V99, P477, DOI 10.1177/000348949009900612; Kaga K, 1999, INT J PEDIATR OTORHI, V49, P215, DOI 10.1016/S0165-5876(99)00206-2; KOEHLER B, 1980, EUR J PEDIATR, V134, P149, DOI 10.1007/BF01846035; LANZI G, 1994, CEPHALALGIA, V14, P458, DOI 10.1046/j.1468-2982.1994.1406458.x; LOVE JT, 1978, OTOLARYNG HEAD NECK, V86, P450, DOI 10.1177/019459987808600314; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MERCIA FW, 1942, JAMA-J AM MED ASSOC, V118, P1282; MEYERHOFF WL, 1978, LARYNGOSCOPE, V88, P1504; Orlin MN, 1997, PEDIATRICS, V99, P334, DOI 10.1542/peds.99.3.334; PARKER HL, 1946, MAYO CLIN P, V38, P642; PARKER W, 1989, AM J OTOL, V10, P364; SEKITANI T, 1993, ACTA OTO-LARYNGOL, P9; Weber PC, 2003, AM J OTOLARYNG, V24, P138, DOI 10.1016/S0196-0709(02)32418-9; WEBER PC, 1994, OTOLARYNG HEAD NECK, V110, P381, DOI 10.1177/019459989411000405; WEISSMAN JL, 1994, OTOLARYNG HEAD NECK, V111, P243, DOI 10.1016/S0194-5998(94)70598-4; [No title captured]	56	16	16	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2005	23	3					807	+		10.1016/j.ncl.2005.03.003			24	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	955TB	WOS:000231249400009	16026677				2022-02-06	
J	Kumar, S; Rao, SL; Nair, RG; Pillai, S; Chandramouli, BA; Subbakrishna, DK				Kumar, S; Rao, SL; Nair, RG; Pillai, S; Chandramouli, BA; Subbakrishna, DK			Sensory gating impairment in development of post-concussive symptoms in mild head injury	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article; Proceedings Paper	56th National Conference of the Indian-Psychiatric-Society	JAN, 2004	Mysore, INDIA	Indian Psychiat Soc		information processing; mild head injury; sensory gating	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COMBAT VETERANS; STARTLE REFLEX; P50; SCHIZOPHRENIA; HABITUATION; ATTENTION; SEQUELAE; LESIONS	Post-concussive symptoms reported by mild head injury (MHI) patients have been inadequately understood. Post-concussive symptoms reported by patients with MHI have so far been explained in terms of impairment in neurocognitive functions or deficits in modulation of flow of information. There are no studies that have looked into sensory gating impairment in MHI and its relation to post-concussive symptoms. The purpose of the present paper was to investigate the role of sensory gating impairment in post-concussive symptoms in mild head injury patients. Thirty MHI patients were evaluated for their neuropsychological functions, sensory gating deficits, and post-concussive symptoms. Neuropsychological functions were in the domain of attention, executive functions, and learning and memory. Sensory gating was assessed by Structured Interview for Assessing Perceptual Anomalies and post-concussive symptoms were assessed using the Neurobehavioral Rating Scale. Multiple regression method was used to identify predictors for post-concussive symptoms. Post-concussive symptoms were predicted by sensory gating deficits when sensory gating deficit was one of the predictors along with neuropsychological functions. Post-concussive symptoms were predicted by scores of Digit Vigilance and Digit Symbol Substitution Test, when predictors were restricted to neuropsychological functions. Sensory gating deficits were correlated with performance on Digit Symbol Substitution test. Post-concussive symptoms reported by MHI patients are the result of poor modulation of incoming sensory information.	Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Div Neuropsychol, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore, Karnataka, India		Rao, SL (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Div Neuropsychol, Bangalore 560029, Karnataka, India.	raos@vsnl.com		Kumar, Sanjay/0000-0001-5018-4184			ADLER LE, 1992, BIOL PSYCHIAT, V32, P607, DOI 10.1016/0006-3223(92)90073-9; ADLER LE, 1990, PSYCHIAT RES, V31, P297, DOI 10.1016/0165-1781(90)90099-Q; Ambrosini A, 2001, NEUROSCI LETT, V306, P132, DOI 10.1016/S0304-3940(01)01871-7; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BOUTROS NN, 1991, CLIN ELECTROENCEPHAL, V22, P40, DOI 10.1177/155005949102200109; Boutros NN, 1999, BIOL PSYCHIAT, V45, P917, DOI 10.1016/S0006-3223(98)00253-4; BOUTROS NN, 1995, PSYCHIAT RES, V57, P83, DOI 10.1016/0165-1781(95)02637-C; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Bunney WE, 1999, SCHIZOPHRENIA BULL, V25, P577, DOI 10.1093/oxfordjournals.schbul.a033402; DAWSON ME, 1993, J ABNORM PSYCHOL, V102, P633, DOI 10.1037/0021-843X.102.4.633; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FRANKS RD, 1983, BIOL PSYCHIAT, V18, P989; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Ghisolfi ES, 2004, INT J PSYCHOPHYSIOL, V51, P209, DOI 10.1016/j.ijpsycho.2003.09.002; Gillette GM, 1997, LIFE SCI, V61, P1421, DOI 10.1016/S0024-3205(97)00688-7; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Gronwall D, 1989, MILD HEAD INJURY, P153; Grunwald T, 2003, BIOL PSYCHIAT, V53, P511, DOI 10.1016/S0006-3223(02)01673-6; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Kisley MA, 2004, PSYCHOPHYSIOLOGY, V41, P604, DOI 10.1111/j.1469-8986.2004.00191.x; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P51; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Meyers J., 1995, REY COMPLEX FIGURE R; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Nelson EB, 1998, AM J PSYCHIAT, V155, P137, DOI 10.1176/ajp.155.1.137; Neylan TC, 1999, BIOL PSYCHIAT, V46, P1656, DOI 10.1016/S0006-3223(99)00047-5; RAO SL, 2004, IN PRESS NIMHANS NEU; RAO SL, 2004, NIMHANS NEUROPSYCHO; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schall U, 1996, NEUROREPORT, V7, P652, DOI 10.1097/00001756-199601310-00065; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWERDLOW NR, 1993, BIOL PSYCHIAT, V33, P298, DOI 10.1016/0006-3223(93)90300-3; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; TEASDALE G, 1974, LANCET, V2, P81; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wechsler D., 1981, WAIS R MANUAL	44	16	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	AUG	2005	59	4					466	472		10.1111/j.1440-1819.2005.01400.x			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychiatry	946LS	WOS:000230574300014	16048453	Bronze			2022-02-06	
J	Mori, K; Iwata, J; Miyazaki, M; Nakao, Y; Maeda, M				Mori, K; Iwata, J; Miyazaki, M; Nakao, Y; Maeda, M			Functional recovery of neuronal activity in rat whisker-barrel cortex sensory pathway from freezing injury after transplantation of adult bone marrow stromal cells	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						bone marrow stromal cell; cortical freezing lesion; local cerebral glucose utilization; transplantation	CEREBRAL GLUCOSE-UTILIZATION; TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR; 2-DEOXYGLUCOSE UPTAKE; C-14 2-DEOXYGLUCOSE; AXONAL INJURY; ALBINO-RAT; THALAMUS; ACTIVATION; FOREBRAIN	The effect of transplantation of adult bone marrow stromal cells (MSCs) into the freeze-lesioned left barrel field cortex in the rat was investigated by measurement of local cerebral glucose utilization (ICMRglc) in the anatomic structures of the whisker-to-barrel cortex sensory pathway. Bone marrow stromal cells or phosphate-buffered saline (PBS) were injected intracerebrally into the boundary zone 1 h after induction of the freezing cortical lesion. Three weeks after surgery, the 21 [C-14]deoxyglucose method was used to measure ICMRgfc during right whisker stimulation. The volume of the primary necrotic freezing lesion was significantly reduced (P < 0.05), and secondary retrograde degeneration in the left ventral posteromedial (VPM) thalamic nucleus was diminished in the MSC-treated group. Local cerebral glucose utilization measurements showed that the freezing cortical lesion did not alter the metabolic responses to stimulation in the brain stem trigeminal nuclei, but eliminated the responses in the left VPM nucleus and periphery of the barrel cortex in the PBS-treated group. The left/right (stimulated/unstimulated) ICMRglc ratios were significantly improved in both the VPM nucleus and periphery of the barrel cortex in the MSC-treated group compared with the PBS-treated group (P < 0.05). These results indicate that MSC transplantation in adults may stimulate metabolic and functional recovery in injured neuronal pathways.	Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, Izunagaoka, Shizuoka 4102295, Japan; Juntendo Casualty Ctr, Shizuoka, Japan		Mori, K (corresponding author), Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, 1129 Nagaoka, Izunagaoka, Shizuoka 4102295, Japan.	KMORI1919@hkg.odn.ne.jp					Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BARRON KD, 1973, J NEUROPATH EXP NEUR, V32, P218, DOI 10.1097/00005072-197304000-00004; Buki A, 2000, J NEUROSCI, V20, P2825; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; CIRICILLO SP, 1994, NEUROSCIENCE, V59, P975, DOI 10.1016/0306-4522(94)90300-X; COOPER RM, 1984, EXP NEUROL, V86, P261, DOI 10.1016/0014-4886(84)90185-7; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; EAGLESON KL, 1992, EXP NEUROL, V116, P156, DOI 10.1016/0014-4886(92)90163-K; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; GINSBERG MD, 1989, J CEREBR BLOOD F MET, V9, P329, DOI 10.1038/jcbfm.1989.51; GONZALEZ MF, 1985, J COMP NEUROL, V231, P457, DOI 10.1002/cne.902310405; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HEFTI F, 1986, J NEUROSCI, V6, P2155; HOSOKAWA S, 1985, BRAIN RES, V343, P8, DOI 10.1016/0006-8993(85)91152-7; IIZUKA H, 1990, STROKE, V21, P790, DOI 10.1161/01.STR.21.5.790; KATAOKA K, 1989, STROKE, V20, P1226, DOI 10.1161/01.STR.20.9.1226; Klatzo I, 1965, Prog Brain Res, V15, P73; Kolb Bryan, 2003, Phys Med Rehabil Clin N Am, V14, pS7, DOI 10.1016/S1047-9651(02)00056-6; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; MATA M, 1980, J NEUROCHEM, V34, P213, DOI 10.1111/j.1471-4159.1980.tb04643.x; MEYER JS, 1993, NEUROL RES, V15, P362; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nakao Y, 2001, P NATL ACAD SCI USA, V98, P7593, DOI 10.1073/pnas.121179898; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; Paxinos G., 1997, RAT BRAIN STEROTAXIC, VThird; PEREIRA RF, 1999, SCIENCE, V284, P143; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reilly JF, 1996, EXP NEUROL, V140, P139, DOI 10.1006/exnr.1996.0124; SHARP FR, 1986, NEUROSCI LETT, V71, P247, DOI 10.1016/0304-3940(86)90567-7; SHARP FR, 1985, J COMP NEUROL, V234, P489, DOI 10.1002/cne.902340407; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1982, ADV NEUROCHEM, V4, P1; SORENSEN JC, 1989, NEUROSCI LETT, V98, P33, DOI 10.1016/0304-3940(89)90369-8; Takai K, 1997, BLOOD, V89, P1560, DOI 10.1182/blood.V89.5.1560.1560_1560_1565; TAKAMI K, 1992, EXP BRAIN RES, V90, P1; TITMUS MJ, 1990, PROG NEUROBIOL, V35, P1, DOI 10.1016/0301-0082(90)90039-J; TOKUNO T, 1992, J CEREBR BLOOD F MET, V12, P954, DOI 10.1038/jcbfm.1992.132; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; YAMADA K, 1991, J CEREBR BLOOD F MET, V11, P472, DOI 10.1038/jcbfm.1991.90; YUAN B, 1986, J NEUROSCI, V6, P3611	55	16	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2005	25	7					887	898		10.1038/sj.jcbfm.9600083			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	940CW	WOS:000230122300011	15843791	Bronze			2022-02-06	
J	Enochsson, L; Carlsson-Sanz, S; van der Linden, J				Enochsson, L; Carlsson-Sanz, S; van der Linden, J			The influence of alcohol and time on the S-100B levels of patients with minor head injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						alcohol intoxication; minor head injury; S-100B; screening test	TRAUMATIC BRAIN-INJURY; PROTEIN MEASUREMENTS; SERUM; MARKER; DAMAGE	The present study aimed at evaluating the S-100B serum level's reaction to (i) alcohol consumption and (ii) time elapsing between head injury and blood sampling. Nineteen patients with minor head trauma and with at least one of the following symptoms: amnesia, transient loss of consciousness or severe headache, were included in the study. Immediately after arrival venous blood samples were drawn for determination of alcohol concentration and S-100B level. Four hours later a new blood sample was taken for repeat analysis. Twenty-one healthy volunteers drank a moderate amount of alcohol. Blood samples were taken just before alcohol intake and 4 h later. Patients - After 4 h the mean S-100B level had fallen from 0.26 to 0.21 ng/ml (P &LT; 0.01), i.e. a mean decrease of 0.05 ng/ml, 95% confidence limits: 0.02-0.09 ng/ml. The alcohol concentrations also decreased significantly from 2.00 &PLUSMN; 0.27% to 1.31 &PLUSMN; 0.20%, P &LT; 0.001, mean difference = 0.69%, 95% confidence limits: 0.27-1.11%. No difference was found between the S-100B levels of patients whose serum did contain alcohol and the levels of those whose serum did not. Volunteers - The serum alcohol level reached a mean value of 0.81% &PLUSMN; 0.09%. The mean S-100B level rose from 0.077 &PLUSMN; 0.02 ng/ml before alcohol intake to 0.103 &PLUSMN; 0.06 ng/ml, 4 h later (P &LT; 0.01). These data indicate that the time that elapses between trauma and blood test has an effect on the S-100B level. The same goes for the drinking of even a very moderate amount of alcohol. The relative importance of these two sources of error remains to be determined.	Karolinska Univ Hosp, Karolinska Inst, Dept Surg, S-14186 Stockholm, Sweden; Stockholm S Hosp, Dept Emergency Surg, Stockholm, Sweden		Enochsson, L (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Surg, K53,Campus Huddinge, S-14186 Stockholm, Sweden.	lars.enochsson@cfss.ki.se		Enochsson, Lars/0000-0002-1930-654X; Enochsson, Lars/0000-0001-8947-4736			Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391	12	16	16	0	0	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	1351-5101			EUR J NEUROL	Eur. J. Neurol.	JUN	2005	12	6					445	448		10.1111/j.1468-1331.2005.00996.x			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	924XK	WOS:000229014100006	15885048				2022-02-06	
J	Wechsler, B; Kim, H; Gallagher, PR; DiScala, C; Stineman, MG				Wechsler, B; Kim, H; Gallagher, PR; DiScala, C; Stineman, MG			Functional status after childhood traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury; children; National Pediatric Trauma Registry; PRM; Functional Independence Measure; Injury Severity Score; outcome prediction	PEDIATRIC INTENSIVE-CARE; CLOSED-HEAD-INJURY; INDEPENDENCE MEASURE; DEVELOPMENTAL PLASTICITY; ENDOTRACHEAL INTUBATION; COMMUNITY INTEGRATION; SEVERITY SCORE; PRISM-III; CHILDREN; RISK	Background: Identification of children after traumatic brain injury (TBI) likely to have functional deficits at trauma center discharge will facilitate care. Methods: Two logistic regression models were derived from data on 4,439 children after TBI 7 to 14 years old enrolled in the National Pediatric Trauma Registry between 1994 and 2001 to predict physical and cognitive disabilities. Results: Children with open or multiple fractures or closed fractures or injured by motor vehicles were 8.2, 3.5, or 2.5 times more likely, respectively, than those without those circumstances to have discharge physical disabilities. Likelihood of cognitive impairment was increased by factors of 3.2 and 5.8 in children obtunded or comatose on arrival. Preexisting cognitive deficits, injury severity, and intubation predicted physical and cognitive disabilities. The C statistic was 0.862 for the motor model and 0.860 for the cognitive model. Conclusion: Predicting the likelihood of morbidity after acute management of childhood TBI can provide information pertinent to providing effective care.	Cleveland Clin Childrens Hosp Rehabil, Rehabil Program, Cleveland, OH USA; Univ Penn, Dept Rehabil Med, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Clin Epidemiol Unit, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Biostat & Epidemiol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Div Pediat Metab & Rehabil, Philadelphia, PA 19104 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA		Wechsler, B (corresponding author), Cleveland Clin Childrens Hosp, Pediat Rehabil Program, 2801 Martin Luther King,Jr,Dr, Cleveland, OH 44104 USA.	wechsleb@ccf.org					Alaranta H, 2000, Wien Med Wochenschr, V150, P444; *AM AC PED, 2000, MED HOM IN CHILDR SP; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Beattie T F, 1998, Inj Prev, V4, P228; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Broman S. H., 1995, TRAUMATIC HEAD INJUR; BUCKLEY SL, 1994, J PEDIATR ORTHOPED, V14, P449, DOI 10.1097/01241398-199407000-00005; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Deutsch A, 1996, CRITICAL REV PHYS ME, V8, P267; Fern KT, 1998, J TRAUMA, V45, P489, DOI 10.1097/00005373-199809000-00010; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GOTSCHALL CS, 1995, J NEUROTRAUM, V12, P611, DOI 10.1089/neu.1995.12.611; Grisoni E, 2001, J TRAUMA, V50, P1106, DOI 10.1097/00005373-200106000-00021; HALEY SM, 1992, PEDIAT EVALUATION DI; Hamilton BB, 1987, REHABILITATION OUTCO, P137; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MASSAGLI TL, 1994, PEDIATR ANN, V23, P29, DOI 10.3928/0090-4481-19940101-08; Max JE, 1998, BRAIN INJURY, V12, P31; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; *NAT HEAD INJ FDN, 1981, SIL EP; *NIH, 1998, REH PERS TRAUM BRAIN, V16, P1; NORUSIS MJ, 2002, SPSS REGR MOD 10 0; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Randolph AG, 1998, CRIT CARE MED, V26, P1603, DOI 10.1097/00003246-199809000-00036; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Ruttimann UE, 1996, CRIT CARE MED, V24, P78, DOI 10.1097/00003246-199601000-00014; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; *STAT U NEW YORK B, 1998, WEEF SYST CLIN GUID; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Tepas JJ, 1997, J TRAUMA, V43, P258, DOI 10.1097/00005373-199708000-00009; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; *US DEP HHS, 1996, INT CLASS DIS; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	64	16	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2005	58	5					940	949		10.1097/01.TA.0000162630.78386.98			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	932PU	WOS:000229566600015	15920407				2022-02-06	
J	Syring, RS				Syring, RS			Assessment and treatment of central nervous system abnormalities in the emergency patient	VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; INTRACRANIAL-PRESSURE; PULMONARY-EDEMA; DOGS; CATS; RESUSCITATION; HYPERTENSION; INCREASES; SEIZURES	Disease of or injury to the central nervous system is a common reason for hospital admission on an emergency basis in veterinary medicine. Head injuries, seizures, and diseases that lead to intracranial hypertension frequently result in significant alteration of neurologic function. A thorough understanding of the pathophysiologic disturbances that occur during these conditions is paramount for providing stabilizing emergent care. A detailed approach that focuses on meticulous physical evaluation, provision of timely and optimal stabilizing treatment, and continued monitoring can aid in improving outcomes in animals with signs and symptoms of neurologic disease or injury.	Univ Penn, Ryan Vet Hosp, Sch Vet Med, Dept Clin Studies,Sect Crit Care, Philadelphia, PA 19104 USA		Syring, RS (corresponding author), Univ Penn, Ryan Vet Hosp, Sch Vet Med, Dept Clin Studies,Sect Crit Care, 3900 Delancey St, Philadelphia, PA 19104 USA.	resyring@vet.upenn.edu					Angle N, 1998, J TRAUMA, V45, P7, DOI 10.1097/00005373-199807000-00002; Bagley RS, 1996, COMP CONT EDUC PRACT, V18, P605; Bazarian JJ, 2002, ANN EMERG MED, V40, P515, DOI 10.1067/mem.2002.128780; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P513; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; BUSIJA DW, 1980, CIRC RES, V46, P696, DOI 10.1161/01.RES.46.5.696; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Drobatz K. J., 2000, Kirk's current veterinary therapy XIII: small animal practice., P810; DROBATZ KJ, 1995, J AM VET MED ASSOC, V206, P1732; Fenner W. R., 2000, Textbook of veterinary internal medicine: diseases of the dog and cat, Volumes 1 and 2., P552; GANONG WF, 1997, REV MED PHYSL, P553; Gutin P H, 1977, Natl Cancer Inst Monogr, V46, P151; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Johnston SC, 1996, EPILEPSIA, V37, P428, DOI 10.1111/j.1528-1157.1996.tb00587.x; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KRAMER GC, 1986, SURGERY, V100, P239; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Meixensberger J, 1997, NEUROL RES, V19, P249, DOI 10.1080/01616412.1997.11740808; MIZOI K, 1986, Neurological Research, V8, P75; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; OLIVERJr J. E., 1997, HDB VET NEUROLOGY, P274; Platt SR, 2000, AM J VET RES, V61, P651, DOI 10.2460/ajvr.2000.61.651; Platt SR, 2002, J SMALL ANIM PRACT, V43, P151, DOI 10.1111/j.1748-5827.2002.tb00047.x; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Podell M, 1996, VET CLIN N AM-SMALL, V26, P779, DOI 10.1016/S0195-5616(96)50105-1; PODELL M, 1995, J VET INTERN MED, V9, P68, DOI 10.1111/j.1939-1676.1995.tb03275.x; PROVENCIO JJ, 1998, NEUROLOGIC NEUROSURG, P39; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; SHORES A, 1983, CURRENT VET THERAPY, P847; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Speciale J, 1999, J AM VET MED ASSOC, V214, P663; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023	39	16	16	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0195-5616	1878-1306		VET CLIN N AM-SMALL	Vet. Clin. N. Am.-Small Anim. Pract.	MAR	2005	35	2					343	+		10.1016/j.cvsm.2004.10.007			17	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	901GQ	WOS:000227271400005	15698914				2022-02-06	
J	Backhaus, SL; Fichtenberg, NL; Hanks, RA				Backhaus, SL; Fichtenberg, NL; Hanks, RA			Detection of sub-optimal performance using a floor effect strategy in patients with traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							MINOR HEAD-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; RECOGNITION MEMORY TEST; TESTS; EXAGGERATION; IMPAIRMENT; SEQUELAE; BATTERY	This archival study examined the effectiveness of using a normative floor effect method to detect suboptimal performance in a clinical sample of 120 cases consecutively referred for a neuropsychological evaluation. These cases were divided into moderate-severe TBI, mild TBI, and poor effort litigants (demonstrating suboptimal effort). Percentiles, sensitivity, specificity, positive and negative predictive power, and overall correct classification rates were calculated using the moderate-severe TBI sample as the clinical reference group. Several levels of stringency for the floor effect using different base rates were also examined. Setting the floor at the 50th percentile consistently appeared to provide for the best overall hit rate when comparing cases with mild brain injury versus poor effort. At this level, a strong trend (greater than one third of total scores) toward the generation of positive scores offers compelling evidence that, in general, the neuropsychological data have been invalidated by poor motivation. Clinical implications are discussed.	Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA		Hanks, RA (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, 261 Mack Blvd, Detroit, MI 48201 USA.	Rhanks@dmc.org					BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BENTON A, 1975, NEUROLOGY, V25, P907, DOI 10.1212/WNL.25.10.907; BENTON AL, 1959, RIGHT LEFT DISCRIINA; BINDER L, 1992, J CONSULT CLIN PSYCH, V3, P175; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Frederick RI, 2000, J CLIN EXP NEUROPSYC, V22, P720, DOI 10.1076/jcen.22.6.720.951; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Hamsher K., 1989, MULTILINGUAL APHASIA; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Millis Scott R., 1996, P481; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; REITAN RM, 1955, J COMP PHYSIOL PSYCH, V48, P474, DOI 10.1037/h0048581; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith, 1973, SYMBOL DIGIT MODALIT; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Warrington E, 1984, RECOGNITION MEMORY T, V1	34	16	16	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2004	18	4					591	603		10.1080/13854040490888558			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	895BH	WOS:000226835400008	15841959				2022-02-06	
J	Braham, R; Finch, CF; McCrory, P				Braham, R; Finch, CF; McCrory, P			The incidence of head/neck/orofacial injuries in non-elite Australian Football	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article							LEVEL	injuries to the head/neck/orofacial region are common in contact and collision sports such as Australian Football. A total of 294 players who did not wear headgear from 23 teams from a large metropolitan community football league in Victoria. Austratia. were monitored for head/neck/orofacial injuries over one playing season. This short report describes the incidence of head/neck/orofacial injuries in this cohort. Overall. there were 37 head/neck/orofacial injuries reported at a rate of 2.6 injuries/1000 participation hours. Over 70% of these were the result of being struck by another player through inadvertent contact during competitive play. Facial lacerations were most common (0.97/1000 player hours). followed by concussion (0.49/1000 player hours). Nine of the cases were referred to hospital for further treatment.	Monash Univ, Sport Injury Prevent Res Unit, Clayton, Vic 3168, Australia; Univ New S Wales, NSW Injury Risk Management Res Ctr, Kensington, NSW 2033, Australia; Univ Melbourne, Inst & Ctr Hlth Excerise & Sports Med, Parkville, Vic 3052, Australia		Braham, R (corresponding author), Monash Univ, Sport Injury Prevent Res Unit, Clayton, Vic 3168, Australia.		McCrory, Paul/Q-8688-2019				Braham RA, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2002.004002; Finch C, 2002, AUST NZ J PUBL HEAL, V26, P462, DOI 10.1111/j.1467-842X.2002.tb00348.x; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; McCrory PR, 2000, MED J AUSTRALIA, V172, P217, DOI 10.5694/j.1326-5377.2000.tb123912.x; Orchard J, 1998, J SCI MED SPORT, V1, P82; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x	6	16	16	0	1	SPORTS MEDICINE AUSTRALIA	DICKSON	PO BOX 237, DICKSON, ACT 2602, AUSTRALIA	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	DEC	2004	7	4					451	453		10.1016/S1440-2440(04)80263-9			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	890TE	WOS:000226532900008	15712501				2022-02-06	
J	Phipps, E; Harris, D; Brown, N; Harralson, T; Brecher, A; Polansky, M; Whyte, J				Phipps, E; Harris, D; Brown, N; Harralson, T; Brecher, A; Polansky, M; Whyte, J			Investigation of ethnic differences in willingness to enroll in a rehabilitation research registry - A Study of the Northeast Cognitive Rehabilitation Research Network	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						research subjects; research Enrollment; ethnicity; brain injury	MINORITY RECRUITMENT; AFRICAN-AMERICANS; PARTICIPATION; TRIAL; PROSTATE; PATIENT; LUNG	Objective: To investigate differences between African American and white respondents in willingness to enroll in a rehabilitation research registry for future research and to determine if reasons for consenting and refusing to enroll differ by ethnicity. Design: Inpatient recruitment results from 739 African American and white respondents in which patients were admitted to a rehabilitation hospital with a diagnosis of stroke or traumatic brain injury. Results: A similar proportion of African American and white respondents (both patients and surrogates) consented to enroll in the registry (72% of all African American respondents vs. 68% of all white respondents). African Americans and whites provided similar reasons for consenting and refusing to enroll. Demographic variables associated with consent were: higher education, younger age, and facility. The odds of consenting to enroll in the registry were 5 times as high for those who thought they had a great deal to gain from enrollment compared with those who thought they had less to gain and were nearly 2 times as high for those who reported little concern about privacy compared with those who were more concerned about privacy. Conclusions: Ethnicity was not found to be a predictor of willingness to enroll in a study registry. A greater belief of gain and less concern over privacy were associated with willingness to enroll, even after controlling for age, education, facility, and ethnic group.	Thomas Jefferson Univ, Ctr Urban Hlth Policy & Res, Albert Einstein Healthcare Network, Philadelphia, PA 19144 USA; Moss Rehabil Res Inst, Philadelphia, PA USA; Drexel Univ, Sch Publ Hlth, Philadelphia, PA USA		Phipps, E (corresponding author), Thomas Jefferson Univ, Ctr Urban Hlth Policy & Res, Albert Einstein Healthcare Network, 1 Penn Blvd,Wister 4442, Philadelphia, PA 19144 USA.			Whyte, John/0000-0002-4381-1474	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039621] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD39621] Funding Source: Medline		APPELBAUM PS, 1987, INFORMED CONSENT LEG, P237; Blackmer J, 2003, BMC MED ETHICS, V4, P2, DOI DOI 10.1186/1472-6939-4-2; BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468; Brown DR, 2003, GERONTOLOGIST, V43, P62, DOI 10.1093/geront/43.1.62; Cheng JD, 2000, J CLIN ONCOL, V18, P421, DOI 10.1200/JCO.2000.18.2.421; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Freeman H P, 1993, Ann Epidemiol, V3, P145; Giuliano AR, 2000, ANN EPIDEMIOL, V10, pS22, DOI 10.1016/S1047-2797(00)00195-2; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; KAPLAN SH, 1995, MED CARE, V33, P1176, DOI 10.1097/00005650-199512000-00002; Karlawish JHT, 2002, J AM GERIATR SOC, V50, P2019, DOI 10.1046/j.1532-5415.2002.50615.x; Kressin Nancy R., 2000, Journal of the National Medical Association, V92, P62; Levkoff S, 2003, GERONTOLOGIST, V43, P18, DOI 10.1093/geront/43.1.18; MILLONUNDERWOOD S, 1993, CANCER NURS, V16, P25; Moye LA, 2002, J NATL MED ASSOC, V94, P272; Phipps Etienne, 1999, Account Res, V6, P215, DOI 10.1080/08989629908573929; ROBERSON NL, 1994, CANCER, V74, P2687, DOI 10.1002/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B; Sengupta S, 2000, J ACQ IMMUN DEF SYND, V24, P275; Seto B, 2001, AM J MED SCI, V322, P246, DOI 10.1097/00000441-200111000-00002; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Simpson NK, 2000, CONTROL CLIN TRIALS, V21, p356S, DOI 10.1016/S0197-2456(00)00102-1; Stallings FL, 2000, CONTROL CLIN TRIALS, V21, p379S, DOI 10.1016/S0197-2456(00)00093-3; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Vastag B, 2003, JAMA-J AM MED ASSOC, V289, P536, DOI 10.1001/jama.289.5.536	25	16	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2004	83	12					875	883		10.1097/01.PHM.0000143436.57173.E1			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	874HB	WOS:000225340400001	15624565				2022-02-06	
J	Rush, BK; Malec, JF; Moessner, AM; Brown, AW				Rush, BK; Malec, JF; Moessner, AM; Brown, AW			Preinjury personality traits and the prediction of early neurobehavioral symptoms following mild traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article							HEAD-INJURY; INDIVIDUALS; CONCORDANCE; POPULATION; SEVERITY; RATINGS; ADULTS	Objective: To determine if preinjury personality predicts early outcome in mild traumatic brain injury (MTBI) compared with orthopedic injury (01). Study Design:, Participants and significant others (SO) completed preinjury personality and early postinjury symptom questionnaires. Setting: Inpatient hospital and outpatient follow-up. Subjects: Eighty-seven people with MTBI and 82 with OI. Outcome Measures- NEO Personality Inventory-Revised (NEO-PI-R); Neurobehavioral Functioning Inventory (NFI). Results: Personality ratings and symptom endorsement were within normal limits. Concordance between self- and SO ratings was moderate (r greater than or equal to 50). In both groups, there were very modest associations between preinjury personality and early symptoms. Significant effects were primarily due to overlapping item-content between the personality and symptom questionnaires. Conclusions- Preinjury personality holds limited predictive value for MTBI outcome.	Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Nursing, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Phys Med & Rehabil, Rochester, MN 55905 USA		Rush, BK (corresponding author), Mayo Clin, Coll Med, Dept Psychiat & Psychol, 200 1st St SW,Generose ME-248, Rochester, MN 55905 USA.	rush.beth@mayo.edu		Brown, Allen W./0000-0001-7228-3351			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cherpitel CJ, 1999, ALCOHOL CLIN EXP RES, V23, P121, DOI 10.1111/j.1530-0277.1999.tb04032.x; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.ps.41.020190.002221; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; HOVLAND D, 2000, NEUROPSYCHOLOGICAL M, P187; John O.P., 1990, HDB PERSONALITY THEO, P66; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; KAY T, 1991, REHABILITATION POSTC, P109; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Lehr E, 1990, PSYCHOL MANAGEMENT T; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McCrae, 1991, REVISED NEO PERSONAL; Nemeth AJ, 1996, ARCH CLIN NEUROPSYCH, V11, P677, DOI 10.1016/S0887-6177(96)80004-7; NORMAN WT, 1963, J ABNORM PSYCHOL, V66, P574, DOI 10.1037/h0040291; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Peterson T, 1999, ANN EMERG MED, V33, P192, DOI 10.1016/S0196-0644(99)70393-8; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Stella Julian, 2002, Emerg Med (Fremantle), V14, P58, DOI 10.1046/j.1442-2026.2002.00287.x; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	33	16	16	0	4	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2004	49	4					275	281		10.1037/0090-5550.49.4.275			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	874OR	WOS:000225360200001					2022-02-06	
J	Munirathinam, S; Bahr, BA				Munirathinam, S; Bahr, BA			Repeated contact with subtoxic Soman leads to synaptic vulnerability in hippocampus	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						excitotoxicity; hippocampal slice culture; Soman; spectrin breakdown product; synaptic decline	AGENT-INDUCED SEIZURE; INDUCED BRAIN-DAMAGE; GLUTAMATE RECEPTORS; AMINO-ACIDS; SYNAPSIN-I; CALPAIN; MODEL; INDUCTION; RAT; INTOXICATION	Soman, an anticholinesterase and dangerous nerve agent, produces convulsions, memory impairment, and cell loss in the brain, especially in the hippocampus. Soman-induced accumulation of acetylcholine initiates mechanisms responsible for the development of incapacitating seizures. The prolonged epileptiform nature of these seizures causes the release of another excitatory neurotransmitter, glutamate, which has been linked to the toxic action of the nerve agent. Here, we tested whether subtoxic soman exposures influence the brain's sensitivity to glutamate-based excitotoxicity. Over a 1-week period, hippocampal slice cultures were exposed daily to a transient level of soman that produced no evidence of synaptic deterioration. After the subtoxic soman treatments, however, the tissue became vulnerable to a brief episode of glutamate receptor overstimulation that normally resulted in little or no excitotoxic damage. In those slice cultures treated with subtoxic soman, a decline in synaptic markers as well as an increase in spectrin breakdown occurred 24 hr after the mild excitotoxic event. Exposure to high soman concentrations alone produced similar synaptic degeneration, but without evident cell death, suggesting that synaptic decline is an early neurotoxicological response to the nerve agent. Interestingly, enhanced excitotoxic sensitivity caused the brain tissue to become susceptible to disparate insults initiated before or after the soman contact. These findings indicate that seemingly innocuous soman exposures leave the hippocampus sensitive to the types of insults implicated in traumatic brain injury and stroke. They also warn that asymptomatic contact with soman may lead to progressive synaptopathogenesis and that early indicators of soman exposure are critical to prevent potential brain injury. (C) 2004 Wiley-Liss, Inc.	Univ Connecticut, Dept Pharmaceut Sci, Ctr Drug Discovery, Storrs, CT 06269 USA		Bahr, BA (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Ctr Drug Discovery, Storrs, CT 06269 USA.	bahr@uconn.edu					BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902; Bahr BA, 2002, EXP NEUROL, V174, P37, DOI 10.1006/exnr.2001.7852; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; BAHR BA, 1994, EXP NEUROL, V129, P81, DOI 10.1006/exnr.1994.1149; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; Bahr BA, 1996, NEUROSCIENCE, V74, P707, DOI 10.1016/0306-4522(96)00133-9; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; BROCK TO, 1987, J NEUROSCI, V7, P931; CARPENTIER P, 1991, BRAIN RES, V541, P293, DOI 10.1016/0006-8993(91)91030-5; Cowan FM, 2001, J APPL TOXICOL, V21, P293, DOI 10.1002/jat.757; de Groot DMG, 2001, J APPL TOXICOL, V21, pS57, DOI 10.1002/jat.812; DESHPANDE SS, 1995, ARCH TOXICOL, V69, P384, DOI 10.1007/s002040050188; FELDMAN RG, 1993, ARCH NEUROL-CHICAGO, V50, P1320, DOI 10.1001/archneur.1993.00540120035010; Filliat P, 1999, NEUROTOXICOLOGY, V20, P535; HARRY GJ, 1985, BRAIN RES, V326, P9, DOI 10.1016/0006-8993(85)91379-4; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Ishikawa K, 1997, BEHAV BRAIN RES, V83, P39, DOI 10.1016/S0166-4328(97)86043-3; Kalivas PW, 2001, NEUROSCIENCE, V104, P129, DOI 10.1016/S0306-4522(01)00054-9; KREYBERG S, 1992, CLIN NEUROPATHOL, V11, P256; LALLEMENT G, 1993, BRAIN RES, V618, P227, DOI 10.1016/0006-8993(93)91270-3; LALLEMENT G, 1991, BRAIN RES, V563, P234, DOI 10.1016/0006-8993(91)91539-D; LALLEMENT G, 1992, NEUROSCI LETT, V139, P104, DOI 10.1016/0304-3940(92)90868-8; LEMERCIER G, 1983, ACTA NEUROPATHOL, V61, P123, DOI 10.1007/BF00697391; MATTSON MP, 1990, NEURON, V4, P105, DOI 10.1016/0896-6273(90)90447-N; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; Munirathinam S, 2002, TOXICOL APPL PHARM, V185, P111, DOI 10.1006/taap.2002.9534; MUNIRATHINAM S, 2002, TOXICOL SCI S, V58, P1551; Pavlovsky L, 2003, EXP NEUROL, V179, P181, DOI 10.1016/S0014-4886(02)00016-X; PAZDERNIK TL, 1985, NEUROSCIENCE, V14, P823, DOI 10.1016/0306-4522(85)90146-0; Raval AP, 2003, J NEUROSCI, V23, P384, DOI 10.1523/JNEUROSCI.23-02-00384.2003; Raveh L, 2003, TOXICOL SCI, V75, P108, DOI 10.1093/toxsci/kfg166; Raveh L, 2002, NEUROTOXICOLOGY, V23, P7, DOI 10.1016/S0161-813X(02)00005-0; Schaller B, 2002, J NEUROL, V249, P1503, DOI 10.1007/s00415-002-0933-8; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SIMAN R, 1989, J NEUROSCI, V9, P1579; Somani S.M., 2001, CHEM WARFARE AGENTS; SPARENBORG S, 1992, NEUROPHARMACOLOGY, V31, P357, DOI 10.1016/0028-3908(92)90068-Z; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAYLOR P, 2001, GOODMAN GILMANS PHAR, P175; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1111/j.1365-2613.2000.00169.x; WADE JV, 1987, J NEUROCHEM, V49, P645, DOI 10.1111/j.1471-4159.1987.tb02912.x; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wenk GL, 1996, NEUROBIOL AGING, V17, P1, DOI 10.1016/0197-4580(95)02025-X; Wood SJ, 2001, J APPL TOXICOL, V21, pS83, DOI 10.1002/jat.817	45	16	16	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	SEP 1	2004	77	5					739	746		10.1002/jnr.20209			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	852DL	WOS:000223735300014	15352221				2022-02-06	
J	Daley, ML; Pourcyrous, M; Timmons, SD; Leffler, CW				Daley, ML; Pourcyrous, M; Timmons, SD; Leffler, CW			Assessment of cerebrovascular autoregulation - Changes of highest modal frequency of cerebrovascular pressure transmission with cerebral perfusion pressure	STROKE			English	Article						cerebrovascular disorder; intracranial pressure; brain injuries	TRAUMATIC BRAIN-INJURY	Background and Purpose-Development of a method to continuously assess cerebrovascular autoregulation of patients with traumatic brain injury would facilitate therapeutic intervention and thus reduce secondary complications. Methods-Changes in arterial blood pressure (ABP), intracranial pressure (ICP), cerebral blood flow velocity (CBFV), and pial arteriolar diameter (PAD) induced by acute pressor challenge (norepinephrine; 1 mug/[kg.min]) were evaluated in both uninjured and fluid percussion injured piglets equipped with cranial windows. The linear correlation coefficient and corresponding slope of the regression line of the relationship between highest modal frequency (HMF) of cerebrovascular pressure transmission of ABP to ICP and cerebral perfusion pressure (CPP) were determined for each challenge. Results-For all uninjured piglets, pressor challenge resulted in an inverse relationship between HMF and CPP characterized by significant negative correlation values and negative corresponding regression line slopes with respective group mean values (+/-SD) of -0.50 (+/-0.14) and -0.6 (+/-0.44) Hz/mm Hg, respectively. Consistent with functional autoregulation of the uninjured preparations, pressor challenge resulted in a decrease of PAD, and CBFV remained relatively constant. For all injured piglets, pressor challenge resulted in direct relationship between HMF and CPP, characterized by positive correlation values and corresponding regression line slopes with group mean values of 0.48 (+/-0.21) and 1.13 (+/-2.08) Hz/mm Hg, respectively. Consistent with impaired autoregulation, PAD and CBFV increased during pressor challenge after brain injury. Conclusions-Evaluation of changes of the HMF of cerebrovascular pressure transmission with respect to CPP changes permits continuous monitoring of cerebral autoregulation.	Univ Memphis, Dept Elect & Comp Engn, Memphis, TN 38152 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Obstet Gynecol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA		Daley, ML (corresponding author), Univ Memphis, Dept Elect & Comp Engn, Engn Sci Bldg,Room 208B, Memphis, TN 38152 USA.	mdaley@memphis.edu					ANTSAKLIS JP, 1997, LINEAR SYSTEM, P94; Asano T, 1999, CRIT REV NEUROSURG, V9, P303, DOI 10.1007/s003290050147; Chestnut R. M., 1996, NEUROTRAUMA, P445; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Daley ML, 2003, MED ENG PHYS, V25, P679, DOI 10.1016/S1350-4533(03)00077-8; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; LJUNG L, 1991, SYSTEM IDENTIFICATIO, P8; Oertel M, 2002, ACT NEUR S, V81, P67; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696	11	16	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	AUG	2004	35	8					1952	1956		10.1161/01.STR.0000133690.94288.c9			5	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	840CZ	WOS:000222835900038	15205491	Bronze			2022-02-06	
J	Holmes, JF; Palchak, MJ; Conklin, MJ; Kuppermann, N				Holmes, JF; Palchak, MJ; Conklin, MJ; Kuppermann, N			Do children require hospitalization after immediate posttraumatic seizures?	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY, 2003	BOSTON, MA	Soc Acad Emergency Med			MINOR HEAD-INJURY; PREDICTORS; TRAUMA; RISK	Study objective: We determine whether children with immediate posttraumatic seizures require hospitalization for observation of possible neurologic complications. Methods: This was a prospective observational cohort study of children younger than 18 years with blunt head trauma resulting in immediate posttraumatic seizures. Patients were examined by faculty emergency physicians and underwent cranial computed tomography (CT) scanning. Children were divided into 2 cohorts according to the presence or absence of traumatic brain injury on cranial CT scan, with the a priori assumption that children with posttraumatic seizures who have abnormal cranial CT scan results require hospitalization. The outcomes of interest were neurologic complications (including further seizure activity or neurologic deficits) or the necessity for neurosurgical intervention. Medical records of hospitalized patients were reviewed, and patients discharged from the emergency department (ED) were contacted by telephone approximately 1 week after hospital discharge to identify those who developed short-term neurologic complications. Results: Sixty-three children with a median age of 7 years (interquartile range 3 to 14 years) had posttraumatic seizures, and all but 1 child underwent cranial CT imaging. Ten (16%; 95% confidence interval [CI] 8% to 27%) patients had traumatic brain injuries on CT scan, and all were hospitalized. Three of these 10 patients underwent craniotomy, and 2 patients had further seizure activity. Fifty-two patients had normal cranial CT scan results, and 20 patients were hospitalized for observation. Telephone follow-up was obtained in 31 of the 32 patients with normal CT scan results who were discharged from the ED. None of the 52 patients (0%; 95% CI 0% to 5.6%) with normal cranial CT scan results had further seizure activity or required neurosurgical interventions. Conclusion: Children with normal neurologic examination results and normal cranial CT scan results after immediate posttraumatic seizures are at low risk for further short-term complications that require immediate hospitalization. These children may be considered for discharge home from the ED.	Univ Calif Davis, Ctr Med, Div Emergency Med, Sacramento, CA 95817 USA; Univ Calif Dave, Sch Med, Dept Internal Med, Sacramento, CA USA; Univ Calif Dave, Sch Med, Dept Pediat, Sacramento, CA USA		Holmes, JF (corresponding author), Univ Calif Davis, Ctr Med, Div Emergency Med, PSSB 2100,2315 Stockton Blvd, Sacramento, CA 95817 USA.	jfholmes@ucdavis.edu					Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; Spencer MT, 2003, AM J EMERG MED, V21, P111, DOI 10.1053/ajem.2003.50031	10	16	16	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	2004	43	6					706	710		10.1016/j.annemergmed.2003.11.008			5	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	825JT	WOS:000221753700002	15159700				2022-02-06	
J	Vakil, E; Blachstein, H; Rochberg, J; Vardi, M				Vakil, E; Blachstein, H; Rochberg, J; Vardi, M			Characterization of memory impairment following closed-head injury in children using the Rey Auditory Verbal Learning Test (AVLT)	CHILD NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DEVELOPMENTAL NORMS; RETRIEVAL; SEVERITY; RECOVERY; DISSOCIATION; SENSITIVITY; COMPONENTS	Memory impairment following closed-head injury (CHI) in children is well documented. Characterization of the memory deficits of children with CHI could contribute to the prediction of academic performance and rehabilitation of these children. Twenty-five children who sustained closed-head injury and 25 matched controls were administered the Rey Auditory Verbal Learning Test (AVLT). The advantage of this memory test is that a number of memory components are measured simultaneously, thus enabling us to study the relations between different aspects of memory within the same patient sample. The findings indicate that the Rey AVLT is a good test for characterization of impaired verbal memory in children following CHI. Transformation of scores derived from the Rey AVLT to Z-scores enables us to determine the relative effect of CHI in children on different memory scores. Raw scores were more vulnerable than relational ones, derived as the difference between two raw scores (e.g., learning, Trial 5 - 1), to closed-head injury in children, and scores reflecting word span were the least vulnerable. The results are discussed in terms of the possible contribution of the frontal lobes, which are frequently affected in closed-head injuries, to memory performance.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	vakile@mail.biu.ac.il					Benson D.F., 1986, FRONTAL LOBES; BISHOP J, 1990, CLIN NEUROPSYCHOL, V4, P133, DOI DOI 10.1080/13854049008401506; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Dalla Barba G, 2002, J CLIN EXP NEUROPSYC, V24, P633, DOI 10.1076/jcen.24.5.633.1008; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1989, CALIFORNIA VERBAL LE; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI [10.1080/13854049108404102, DOI 10.1080/13854049108404102]; GEFFEN GM, 1994, BRAIN INJURY, V8, P405, DOI 10.3109/02699059409150992; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLATZKY RL, 1980, HUMAN MEMORY; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Vakil E, 2002, BRAIN COGNITION, V50, P304, DOI 10.1016/S0278-2626(02)00515-8; Vakil E, 1998, CHILD NEUROPSYCHOL, V4, P161, DOI 10.1076/chin.4.3.161.3173; Vakil E, 1997, CLIN NEUROPSYCHOL, V11, P356, DOI 10.1080/13854049708400464; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; VAKIL E, 1994, J CLIN PSYCHOL, V50, P240, DOI 10.1002/1097-4679(199403)50:2<240::AID-JCLP2270500215>3.0.CO;2-5; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	38	16	16	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	2004	10	2					57	66		10.1080/09297040490911078			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	863TN	WOS:000224586100001	15590485				2022-02-06	
J	Small, SL				Small, SL			A biological model of aphasia rehabilitation: Pharmacological perspectives	APHASIOLOGY			English	Article; Proceedings Paper	33rd Annual Clinical Aphasiology Conference	MAY, 2003	Orcas Isl, WA				MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; ACUTE ISCHEMIC-STROKE; MOTOR RECOVERY; DOUBLE-BLIND; POSTSTROKE DEPRESSION; BEHAVIORAL RECOVERY; FUNCTIONAL RECOVERY; OPEN-LABEL; BROMOCRIPTINE TREATMENT	Background: Aphasia is a multi-modality disturbance of speech, language, and memory caused by neurological injury, particularly stroke. Aims : This review article views aphasia as fundamentally a disease of the brain, and aims to survey biological treatments for aphasia that address amelioration of brain injury. Main Contribution: The review examines the effects of different drugs on both direct and indirect mechanisms of neural circuit reorganisation, gauged through effects on multi-modal measures of speech, language, and memory. Based on this review, therapists might choose to analyse and change the pharmacological state of their patients with aphasia. Conclusions: We conclude that (a) both biological and behavioural therapies affect brain repair and reorganisation; (b) pharmacotherapy is not yet proven, but has promise, but only when accompanied by concomitant behavioural therapy; (c) the most important biological interventions that can be accomplished at present are to withdraw certain drugs that impede aphasia recovery and to administer anti-depressants to all patients with major or minor post-stroke depression.	Univ Chicago, Dept Neurol, Chicago, IL 60637 USA		Small, SL (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave,MC-2030, Chicago, IL 60637 USA.	small@uchicago.edu		Small, Steven/0000-0002-5293-6172			AARSLAND D, 1994, BRAIN, V117, P1377, DOI 10.1093/brain/117.6.1377; ALBERT ML, 1988, NEUROLOGY, V38, P877, DOI 10.1212/WNL.38.6.877; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; BERGMAN PS, 1951, NEUROLOGY, V1, P471, DOI 10.1212/WNL.1.11-12.471; Berthier ML, 2003, NEUROLOGY, V60, P1218, DOI 10.1212/01.WNL.0000055871.82308.41; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1994, AM J PHYS MED REHAB, V73, P76, DOI 10.1097/00002060-199404000-00002; Boyeson MG, 1996, STROKE, V27, P2145; BOYESON MG, 1984, ANN M SOC NEUROSCIEN, V10, P68; BRACCO L, 1984, NEUROSCI LETT, V50, P301, DOI 10.1016/0304-3940(84)90503-2; Bragoni M, 2000, NEUROL SCI, V21, P19, DOI 10.1007/s100720070114; BROWN RM, 1974, ACTA PHYSIOL SCAND, V90, P789, DOI 10.1111/j.1748-1716.1974.tb05647.x; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; *CEBM, 2003, VOL 2003; CLARK ANG, 1979, J AM GERIATR SOC, V27, P174, DOI 10.1111/j.1532-5415.1979.tb06442.x; COHEN HP, 1975, J NEUROSURG, V43, P32, DOI 10.3171/jns.1975.43.1.0032; Connors John J 3rd, 2002, Rev Cardiovasc Med, V3 Suppl 2, pS92; CRISOSTOMO EA, 1988, ANN NEUROL, V23, P94, DOI 10.1002/ana.410230117; DARLEY FL, 1977, CLIN APHASIOL, V7, P91; De Keyser J, 1999, TRENDS NEUROSCI, V22, P535, DOI 10.1016/S0166-2236(99)01463-0; DeDeyn PP, 1997, STROKE, V28, P2347, DOI 10.1161/01.STR.28.12.2347; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DOWNHILL JE, 1994, J NERV MENT DIS, V182, P425, DOI 10.1097/00005053-199408000-00001; ENDERBY P, 1994, CLIN NEUROPHARMACOL, V17, P320, DOI 10.1097/00002826-199408000-00003; FEENEY DM, 1985, BRAIN RES, V342, P352, DOI 10.1016/0006-8993(85)91135-7; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; FERE C, 1886, REV GEN CLIN THERAPE, V785; Freund HJ, 1997, BRAIN PLASTICITY; Friel KM, 1998, SOMATOSENS MOT RES, V15, P173, DOI 10.1080/08990229870745; Fruehwald S, 2003, J NEUROL, V250, P347, DOI 10.1007/s00415-003-1014-3; GIL R, 1995, J NEUROL, V242, P251, DOI 10.1007/BF00919600; Giurgea C E, 1983, Acta Psychiatr Belg, V83, P349; GOLDBERG E, 1982, Journal of Clinical Neuropsychology, V4, P219, DOI 10.1080/01688638208401131; Goldstein Larry B, 2003, Phys Med Rehabil Clin N Am, V14, pS125, DOI 10.1016/S1047-9651(02)00060-8; Goldstein LB, 2000, NEUROPHARMACOLOGY, V39, P852, DOI 10.1016/S0028-3908(99)00249-X; Goldstein LB, 1999, REV NEUROL-FRANCE, V155, P731; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Goldstein LB, 1998, RESTORATIVE NEUROLOGY, P241; GOLDSTEIN LB, 1987, ANN NEUROL, V22, P159; Goldstein LB, 1997, PHARMACOL BIOCHEM BE, V58, P1151, DOI 10.1016/S0091-3057(97)00324-9; Goldstein LB, 1998, ARCH NEUROL-CHICAGO, V55, P454, DOI 10.1001/archneur.55.4.454; Goldstein LB, 2000, DRUG SAFETY, V22, P13, DOI 10.2165/00002018-200022010-00002; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; Greener J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD000424]; GROTTA JC, 1987, NEW ENGL J MED, V317, P1505, DOI 10.1056/NEJM198712103172405; Gupta SR, 1995, NEUROLOGY, V45, P2170, DOI 10.1212/WNL.45.12.2170; GUPTA SR, 1992, ARCH PHYS MED REHAB, V73, P373, DOI 10.1016/0003-9993(92)90012-L; GUSTAFSON Y, 1995, DRUG AGING, V7, P298, DOI 10.2165/00002512-199507040-00005; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Helmuth L, 2003, SCIENCE, V299, P1300, DOI 10.1126/science.299.5611.1300; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Huber W, 1997, ARCH PHYS MED REHAB, V78, P245, DOI 10.1016/S0003-9993(97)90028-9; Huber W, 1999, PHARMACOPSYCHIATRY, V32, P38, DOI 10.1055/s-2007-979235; Hughes JD, 2000, BRAIN LANG, V71, P96, DOI 10.1006/brln.1999.2223; Jacobs DH, 1996, NEUROCASE, V2, P83; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jambaque I, 1998, J CHILD NEUROL, V13, P296, DOI 10.1177/088307389801300614; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Kent TA, 1999, J NEUROSCI RES, V55, P357, DOI 10.1002/(SICI)1097-4547(19990201)55:3<357::AID-JNR11>3.0.CO;2-W; Kessler J, 2000, STROKE, V31, P2112, DOI 10.1161/01.STR.31.9.2112; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Koller G, 2003, NEUROPSYCHOBIOLOGY, V48, P87, DOI 10.1159/000072883; Kondziolka D, 2002, J CLIN NEUROSCI, V9, P225, DOI 10.1054/jocn.2001.1043; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka Douglas, 2003, Phys Med Rehabil Clin N Am, V14, pS153, DOI 10.1016/S1047-9651(02)00057-8; LAZARUS LW, 1992, J CLIN PSYCHIAT, V53, P447; Lecours A. R., 1983, APHASIOLOGY; LINN L, 1947, ARCH NEURO PSYCHIATR, V58, P357, DOI 10.1001/archneurpsyc.1947.02300320108007; LIPSEY JR, 1984, LANCET, V1, P297; Lutsep H, 2001, Curr Opin Investig Drugs, V2, P1732; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; MACLENNAN DL, 1991, CLIN APHASIOL, V21, P145; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McCloskey M., 1989, PSYCHOL LEARN MOTIV, V24, P109, DOI DOI 10.1016/S0079-7421(08)60536-8; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; MORRIS PLP, 1992, MED J AUSTRALIA, V157, P239, DOI 10.5694/j.1326-5377.1992.tb137126.x; Mula M, 2003, NEUROLOGY, V60, P1104, DOI 10.1212/01.WNL.0000056637.37509.C6; Mulrow CD., 1998, SYSTEMATIC REV SYNTH; Neville HJ, 1998, CURR OPIN NEUROBIOL, V8, P254, DOI 10.1016/S0959-4388(98)80148-7; Nudo RJ, 1999, REV NEUROL, V155, P713; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; OLSON L, 1994, J NEUROL, V242, pS12, DOI 10.1007/BF00939233; Orgogozo JM, 1999, PHARMACOPSYCHIATRY, V32, P25, DOI 10.1055/s-2007-979233; Pashek GV, 2003, BRAIN LANG, V87, P179, DOI 10.1016/S0093-934X(03)00259-1; PETERSEN RC, 1977, PSYCHOPHARMACOLOGY, V52, P283, DOI 10.1007/BF00426713; Porch, 1967, PORCH INDEX COMMUNIC, V1; PORCH B, 1985, Society for Neuroscience Abstracts, V11, P52; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Robinson R. G., 1998, CLIN NEUROPSYCHIATRY; ROBINSON RG, 1975, NATURE, V255, P332, DOI 10.1038/255332a0; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Robinson RG, 2000, AM J PSYCHIAT, V157, P351, DOI 10.1176/appi.ajp.157.3.351; ROBINSON RG, 1980, BRAIN RES, V181, P202, DOI 10.1016/0006-8993(80)91271-8; Rocamora N, 1996, J NEUROSCI, V16, P4411; SABE L, 1992, NEUROLOGY, V42, P1637, DOI 10.1212/WNL.42.8.1637; SAIJA A, 1988, Journal of Neurotrauma, V5, P161, DOI 10.1089/neu.1988.5.161; SARNO MT, 1972, J SPEECH HEAR RES, V15, P42, DOI 10.1044/jshr.1501.42; SCHALLERT T, 1992, PHYS MED REHABIL, V6, P375; Sherman SJ, 2003, BEHAV NEUROSCI, V117, P526, DOI 10.1037/0735-7044.117.3.526; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Small S. L., 2001, HDB ADULT LANGUAGE D, P397; SMALL SL, 1994, STROKE, V25, P1282, DOI 10.1161/01.STR.25.6.1282; Small SL, 2000, BRAIN LANG, V71, P227, DOI 10.1006/brln.1999.2256; SMALL SL, 2001, HDB NEUROPSYCHOLOGY, V3, P335; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; St John MF, 1998, FOREIGN LANGUAGE LEARNING, P231; STARKSTEIN SE, 1991, J NEUROPSYCH CLIN N, V3, P276; STARKSTEIN SE, 1989, BRIT J PSYCHIAT, V154, P170, DOI 10.1192/bjp.154.2.170; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Taffe MA, 1999, COGNITIVE BRAIN RES, V8, P203, DOI 10.1016/S0926-6410(99)00021-X; Tanaka Y, 1997, LANCET, V350, P116, DOI 10.1016/S0140-6736(05)61820-X; *TASK FORC DSM IV, 1994, DIAGN STAT MAN MENT, V4; Tsz-Ming C., 2001, J NEUROPSYCHIATRY CL, V13, P140; van de Weg FB, 1999, CLIN REHABIL, V13, P268, DOI 10.1191/026921599672495022; VERNON M W, 1991, Drugs and Aging, V1, P17; Walker-Batson D, 2000, BRAIN LANG, V71, P252, DOI 10.1006/brln.1999.2262; Walker-Batson D, 1991, CLIN APHASIOLOGY, V21, P137; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; WEST R, 1965, J SPEECH HEAR RES, V8, P57, DOI 10.1044/jshr.0801.57; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; Wong ICK, 2000, DRUG SAFETY, V23, P35, DOI 10.2165/00002018-200023010-00003; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Yu AJ, 2002, NEURAL NETWORKS, V15, P719, DOI 10.1016/S0893-6080(02)00058-8; Zhang WR, 1999, BRAIN RES, V842, P211, DOI 10.1016/S0006-8993(99)01818-1; Zlokovic BV, 1997, NEUROSURGERY, V40, P805, DOI 10.1097/00006123-199704000-00028	136	16	17	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	MAY-JUL	2004	18	5-7					473	492		10.1080/02687030444000156			20	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	817NC	WOS:000221183200006					2022-02-06	
J	Tate, RL; Pfaff, A; Veerabangsa, A; Hodgkinson, AE				Tate, RL; Pfaff, A; Veerabangsa, A; Hodgkinson, AE			Measuring psychosocial recovery after brain injury: Change versus competency	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; outcome assessment (health care); rehabilitation; social adjustment	COMMUNITY INTEGRATION QUESTIONNAIRE; NEUROBEHAVIORAL RATING-SCALE; HEAD-INJURY; REHABILITATION SERVICES; DISABILITY; OUTCOMES; RELIABILITY; HANDICAP; HEALTH; IMPACT	Objectives: To determine the psychometric properties of an alternative form of the Sydney Psychosocial Reintegration Scale (SPRS) that focuses on competency of functioning (Form B) as opposed to the original form that examines change from the premorbid level (Form A). Design: Descriptive correlational study. Ratings were made by 2 treating clinicians on patients at discharge and I week later by using Forms A and B of the SPRS. A subset of 25 close relatives of the patients also completed the 2 SPRS forms and the London Handicap Scale at patient discharge. Setting: Inpatient brain injury rehabilitation unit. Participants: Sixty-six people with brain injury. Interventions: Not applicable. Main Outcome Measure: The SPRS is a 12-item questionnaire, rated on a 7-point scale, that measures function in occupational, interpersonal, and living skills domains. Results: The internal consistency of Form B was high (alpha=.90), as was stability (intraclass correlation coefficient [ICC]=.90) and interrater agreement (ICC=.84). Similarly, good psychometric properties were found for Form A for internal consistency (a=.90), stability (ICC=.90) and interrater agreement (ICC=.82), which replicated previous findings with this form. Comparability between forms was excellent (ICC=.97), and correspondence between ratings of the clinician and close relatives on Forms A and B was fair to good (ICC=.57, ICC=.67, respectively). Conclusions: Form B of the SPRS has psychometric properties equally sound to those of Form A. It is anticipated that there will be many advantages in having alternative forms of the same instrument, thus enabling measurement of psychosocial integration from different perspectives.	Royal Rehabil Ctr Sydney, Rehabil Studies Unit, Ryde, NSW 1680, Australia; Univ Sydney, Dept Med, Rehabil Studies Unit, Ryde, NSW, Australia; Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Tate, RL (corresponding author), Royal Rehabil Ctr Sydney, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	rtate@med.usyd.edu.au					Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Cardol M, 1999, DISABIL REHABIL, V21, P97, DOI 10.1080/096382899297819; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dahl TH, 2002, J REHABIL MED, V34, P201, DOI 10.1080/165019702760279170; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Gray DB, 2000, ARCH PHYS MED REHAB, V81, pS10, DOI 10.1053/apmr.2000.20616; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Harwood R H, 1994, Qual Health Care, V3, P11, DOI 10.1136/qshc.3.1.11; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; NEWITT H, 2002, THESIS U MELBOURNE M; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Stilwell P, 1999, NEUROPSYCHOL REHABIL, V9, P277, DOI 10.1080/096020199389374; Stilwell P, 1998, CLIN REHABIL, V12, P521, DOI 10.1191/026921598673761855; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; *WHO, 1980, MAN CLASS REL CONS D; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS	38	16	16	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2004	85	4					538	545		10.1016/j.apmr.2003.08.078			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	810MM	WOS:000220708400003	15083428				2022-02-06	
J	Collignon, FP; Friedman, JA; Piepgras, DG; Pichelmann, MA; McIver, JI; Toussaint, LG; McClelland, RL				Collignon, FP; Friedman, JA; Piepgras, DG; Pichelmann, MA; McIver, JI; Toussaint, LG; McClelland, RL			Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage	NEUROCRITICAL CARE			English	Article						magnesium; subarachnoid hemorrhage; aneurysm; vasospasm; stroke; cerebrovascular	INTRACELLULAR FREE MG-2+; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; IONIZED MAGNESIUM; CONTROLLED TRIAL; NMDA RECEPTOR; SULFATE; RATS; ECLAMPSIA; PREECLAMPSIA	Introduction: Recent evidence suggests that magnesium may be neuroprotective in the setting of cerebral ischemia, and therapeutic magnesium infusion has been proposed for prophylaxis and treatment of delayed ischemic neurological deficit (DIND) resulting from vasospasm in patients with aneurysmal subarachnoid hemorrhage (SAH). We studied the association between serum magnesium levels, the development of DIND, and the outcomes of patients with SAH. Methods: We studied 128 consecutive patients with aneurysmal SAH treated at our institution between 1990 and 1997 who had a serum magnesium level measured at least once during the acute phase of their hospitalization. Delayed ischemic neurological deficit was defined as severe (major focal deficit or coma), moderate (incomplete focal deficit or decreased sensorium without coma), or none. Results: There was no significant difference in mean, minimum, or maximum serum magnesium levels between patients with and without DIND (1.93,1.83, 2.02 versus 1.91, 1.84, 1.97 mg/dL, respectively). Similarly, no difference was found in mean serum magnesium levels among patients with severe (1.94 mg/dL), moderate (1.92 mg/dL), or no DIND (1.91 mg/dL). Analyses of serum magnesium levels before (0-4 days following SAH), during (4-14 days following SAH), and after (greater than 14 days following SAH) the period of highest risk for vasospasm revealed no association with the development or severity of DIND. Permanent deficit or death resulting from vasospasm and Glasgow Outcome Scale score at longest follow-up were similarly unaffected by serum magnesium levels overall or during any time interval. Forty (31.5%) patients were hypomagnesemic (less than 1.7 mg/dL) during hospitalization, but no difference in outcome (p = 0.185) or development of DIND (p = 0.785) was found when compared to patients with normal (1.7-2.1 mg/dL) or high (greater than 2.1 mg/dL) magnesium serum levels. Conclusion: We identified no relationship between serum magnesium levels and the development of DIND or outcome following aneurysmal SAIL Based on these data, magnesium supplementation to normal or high-normal physiological ranges seems unlikely to be beneficial for DIND resulting from vasospasm. However, no inference can be made regarding the value of therapeutic infusion of magnesium to supraphysiological levels.	Dartmouth Hitchcock Med Ctr, Neurosurg Sect, Lebanon, NH 03766 USA; Mayo Clin, Dept Neurol Surg, Rochester, MN USA; Mayo Clin, Dept Biostat, Rochester, MN USA		Friedman, JA (corresponding author), Dartmouth Hitchcock Med Ctr, Neurosurg Sect, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	Jonathan.A.Friedman@hitchcock.org		Toussaint, L. Gerard/0000-0003-0000-7782			ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; ALTURA BM, 1992, BIOCHIM BIOPHYS ACTA, V1111, P271, DOI 10.1016/0005-2736(92)90320-L; ALTURA BM, 1981, FED PROC, V40, P2672; ALTURA BM, 1974, MICROVASC RES, V7, P145, DOI 10.1016/0026-2862(74)90001-6; ALTURA BM, 1994, ALCOHOL CLIN EXP RES, V18, P1057, DOI 10.1111/j.1530-0277.1994.tb00082.x; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; ALTURA BT, 1980, NEUROSCI LETT, V20, P323, DOI 10.1016/0304-3940(80)90168-8; ALTURA BT, 1982, MAGNESIUM EXP CLIN R, V1, P277; Anthony J, 1996, DRUG SAFETY, V15, P188, DOI 10.2165/00002018-199615030-00004; ANTHONY J, 1994, FETAL MATERNAL MED R, V6, P219; BECK DW, 1981, JAMA-J AM MED ASSOC, V246, P1442, DOI 10.1001/jama.246.13.1442; BELFORT MA, 1992, AM J OBSTET GYNECOL, V167, P661, DOI 10.1016/S0002-9378(11)91567-1; BITO LZ, 1969, SCIENCE, V165, P81, DOI 10.1126/science.165.3888.81; Boet R, 2000, NEUROSURGERY, V47, P602, DOI 10.1097/00006123-200009000-00014; BOISVERT DP, 1983, NEW ENGL J MED, V308, P619; Brewer RP, 2001, CLIN NEUROPHARMACOL, V24, P341, DOI 10.1097/00002826-200111000-00005; CHEUNG JY, 1986, NEW ENGL J MED, V314, P1670; Elliott JP, 1998, J NEUROSURG, V88, P277, DOI 10.3171/jns.1998.88.2.0277; Ema M, 1991, Magnes Trace Elem, V10, P269; EVANS S, 1983, NEW ENGL J MED, V309, P1644, DOI 10.1056/NEJM198312293092612; EWLIN RJ, 1988, DIS MONTH, V34, P165; FARBER JL, 1981, AM J PATHOL, V102, P271; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Gee JB, 2001, PEDIATR NEUROL, V25, P304, DOI 10.1016/S0887-8994(01)00317-4; GOLDMAN RS, 1988, NEW ENGL J MED, V319, P1224; HALEY EC, 1992, STROKE, V23, P205, DOI 10.1161/01.STR.23.2.205; HALEY EC, 1993, J NEUROSURG, V78, P537, DOI 10.3171/jns.1993.78.4.0537; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; KASS IS, 1988, ANESTHESIOLOGY, V69, P710, DOI 10.1097/00000542-198811000-00012; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kim YJ, 1996, ANESTH ANALG, V83, P1223, DOI 10.1097/00000539-199612000-00016; LEWIS LK, 1988, NEURORADIOLOGY, V30, P59, DOI 10.1007/BF00341945; MacDonald R. Loch, 1997, P1111; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1996, LAB INVEST, V74, P315; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MCLEAN RM, 1994, AM J MED, V96, P63, DOI 10.1016/0002-9343(94)90117-1; MELDRUM BS, 1987, MED BIOL, V65, P153; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; MULLINS PGM, 1995, NEUROREPORT, V6, P1633, DOI 10.1097/00001756-199508000-00011; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OPPELT WW, 1963, AM J PHYSIOL, V205, P959, DOI 10.1152/ajplegacy.1963.205.5.959; PRIESTLEY T, 1990, BRAIN RES, V531, P183, DOI 10.1016/0006-8993(90)90772-4; PRITCHARD JA, 1975, AM J OBSTET GYNECOL, V123, P543, DOI 10.1016/0002-9378(75)90042-3; RAM Z, 1991, STROKE, V22, P922, DOI 10.1161/01.STR.22.7.922; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; RYZEN E, 1985, CRIT CARE MED, V13, P19, DOI 10.1097/00003246-198501000-00006; SABAI GM, 1986, NEUROLOGICAL DISORDE, P1; SADEH M, 1989, STROKE, V20, P1273, DOI 10.1161/01.STR.20.9.1273; TAKAKU A, 1979, SURG NEUROL, V12, P137; TROMMER BL, 1988, STROKE, V19, P326, DOI 10.1161/01.STR.19.3.326; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; Veyna RS, 2002, J NEUROSURG, V96, P510, DOI 10.3171/jns.2002.96.3.0510; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1990, J NEUROSCI, V10, P3524; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; WATSON KV, 1986, P NATL ACAD SCI USA, V83, P1075, DOI 10.1073/pnas.83.4.1075; WILL AD, 1987, NEUROLOGY, V37, P1555, DOI 10.1212/WNL.37.9.1555; WILLIAMS GD, 1995, MAGNET RESON MED, V33, P853, DOI 10.1002/mrm.1910330618; WOODRUFF GN, 1987, NEUROPHARMACOLOGY, V26, P903, DOI 10.1016/0028-3908(87)90068-2	69	16	17	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2004	1	4					441	448		10.1385/NCC:1:4:441			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945FS	WOS:000230489000006	16174947				2022-02-06	
J	Lenzlinger, PM; Saatman, KE; Hoover, RC; Cheney, JA; Bareyre, FM; Raghupathi, R; Arnold, LD; McIntosh, TK				Lenzlinger, PM; Saatman, KE; Hoover, RC; Cheney, JA; Bareyre, FM; Raghupathi, R; Arnold, LD; McIntosh, TK			Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling by BSF476921 attenuates regional cerebral edema following traumatic brain injury in rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						blood brain-barrier; cerebral edema; head injury; neuromotor function	LATERAL FLUID-PERCUSSION; SPINAL-CORD; BARRIER BREAKDOWN; UP-REGULATION; IN-VITRO; ANGIOGENESIS; EXPRESSION; PERMEABILITY; ISCHEMIA; DAMAGE	Purpose: In the present study we assessed the ability of BSF476921, an inhibitor of vascular endothelial growth factor receptor (VEGFR) kinase signal transduction, to reduce edema formation and neurologic motor dysfunction following lateral fluid percussion (FP) brain injury in rats. Methods: Anesthetized adult male rats were subjected to either lateral FP brain injury of moderate severity (n = 37) or sham injury (n = 22, surgery without brain injury). Animals were randomized to receive i.p. injections of either BSF476921 (30 mg/kg bw; injured n = 15, sham n = 11) or sterile water (injured n = 14, sham n = 11) at 1, 11 and 22 hours post-injury. After assessment of motor function using a standard 28-point neuroscore, animals were sacrificed 24 hours following trauma and their brains evaluated for regional water content using the wet-weight/dry-weight technique. Results: Although brain-injured animals showed a significant motor deficit compared to uninjured animals, no differences were detected between BSF476921- and vehicle-treated animals at the acute 24 hour post-injury time point. However, BSF476921 significantly attenuated regional edema formation in brain-injured animals in the ipsilateral hippocampus (p < 0.05) and in the cortex adjacent to the injury (p < 0.05) when compared to vehicle treatment. Conclusions: To our knowledge, this is the first report of a small molecule VEGFR kinase inhibitor reducing cerebral edema in a widely accepted model of brain injury.	Univ Penn, Dept Neurosurg, Head Injury Ctr, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA; BASF AG, Biores Corp, Worcester, MA USA		McIntosh, TK (corresponding author), Univ Penn, Dept Neurosurg, Head Injury Ctr, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	mcintosh@seas.upenn.edu	Lenzlinger, Philipp/A-3822-2008; Raghupathi, Ramesh/AAX-5538-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978, T32NS007413, P50NS008803] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM R01-34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS07413-04, NS R01-40978, NS P50-08803] Funding Source: Medline		Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bao WL, 1999, ACTA PHARMACOL SIN, V20, P313; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Carmeliet P, 1997, AM J PHYSIOL-HEART C, V273, pH2091, DOI 10.1152/ajpheart.1997.273.5.H2091; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eriksson U, 2002, NAT MED, V8, P775, DOI 10.1038/nm0802-775; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; ISCHER S, 1999, AM J PHYSIOL, V276, pC812; Issa R, 1999, LAB INVEST, V79, P417; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Lee MY, 1999, NEUROSCI LETT, V265, P107, DOI 10.1016/S0304-3940(99)00219-0; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; MARMAROU A, 1991, J NEUROSURG S, V75, P59; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO;2-7; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salhia B, 2000, BRAIN RES, V883, P87, DOI 10.1016/S0006-8993(00)02825-0; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Smallwood I.M, 1996, HDB ORGANIC SOLVENT, P1; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; Tsao MN, 1999, J NEUROPATH EXP NEUR, V58, P1051, DOI 10.1097/00005072-199910000-00003; Unterberg AW, 1997, ACT NEUR S, V70, P106; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Wick A, 2002, J NEUROSCI, V22, P6401; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; [No title captured]	51	16	16	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2004	22	2					73	79					7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837VV	WOS:000222670200003	15272142				2022-02-06	
J	Page, RB; Spott, MA; Krishnamurthy, S; Taleghani, C; Chinchilli, VM				Page, RB; Spott, MA; Krishnamurthy, S; Taleghani, C; Chinchilli, VM			Head injury and pulmonary embolism: A retrospective report based on the Pennsylvania trauma outcomes study	NEUROSURGERY			English	Article						head injury; pulmonary embolus; traumatic brain injury	MAJOR TRAUMA; VENOUS THROMBOEMBOLISM; RISK; STATEWIDE	OBJECTIVE: We retrospectively examined the database of the Pennsylvania Trauma a Systems Foundation to determine the risk of pulmonary embolism in adult patients sustaining isolated head trauma or multiple injuries, including head trauma, to answer two questions: What is the incidence of symptomatic pulmonary embolism during 3 hospitalization in a trauma center in patients who have sustained a head injury? Are patients with head injuries more at risk for pulmonary embolism than trauma patients without head injuries? METHODS: We determined the total number of adult submissions per year to the Pennsylvania Trauma Outcomes Study from 1992 to 1996. Age, sex, Glasgow Coma Scale score, Abbreviated Injury Score for head injury, injury Severity Score, intensive care unit days, hospital days, and the presence or absence of head injury, spinal injury, pelvic fractures, and/or femur fractures were recorded. Statistical techniques to evaluate their correlation with the incidence of pulmonary embolism included X-2 testing, linear regression analysis, Kendall analysis, and logistic regression analysis. RESULTS: The average incidence of symptomatic pulmonary embolism in head;. injured patients occurring during their acute hospital stay was 0.38%. This rate was not significantly greater than the 0.27% incidence of pulmonary embolism inpatients without head injury. Factors that significantly increased this incidence were age greater than 45 years, Injury Severity Score greater than 15, male sex, and the presence of pelvic or femur fractures or of spinal cord injury. CONCLUSION: We found no evidence that head injury is a significant independent risk factor for development of symptomatic pulmonary embolism during the acute hospitalization of the trauma patient.	Penn State Univ, Milton S Hershey Med Ctr, Div Neurosurg, Coll Med,Dept Surg, Hershey, PA 17033 USA; Penn Trauma Syst Fdn, Dept Neurosurg, Mechanicsburg, PA USA; SUNY Syracuse, Hlth Sci Ctr, Dept Neurosurg, Syracuse, NY 13210 USA; Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA		Page, RB (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Div Neurosurg, Coll Med,Dept Surg, POB 850, Hershey, PA 17033 USA.			Krishnamurthy, Satish/0000-0001-7808-7407			[Anonymous], 1972, JAMA, V220, P717; BUERGER PM, 1993, AM SURGEON, V59, P505; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; GILLOTT AR, 1989, J TRAUMA, V29, P1667, DOI 10.1097/00005373-198912000-00015; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Hollander M, 1999, NONPARAMETRIC STAT M; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; JENNETT B, 1976, LANCET, V1, P1031; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; MIKE V, 1982, STAT MED RES; OMALLEY KF, 1990, J TRAUMA, V30, P748, DOI 10.1097/00005373-199006000-00018; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Spain DA, 1997, J TRAUMA, V42, P463, DOI 10.1097/00005373-199703000-00014; TuttleNewhall JE, 1997, J TRAUMA, V42, P90, DOI 10.1097/00005373-199701000-00016; WISNER DH, 1992, ARCH SURG-CHICAGO, V127, P111	16	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2004	54	1					143	148		10.1227/01.NEU.0000097514.60813.1B			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	761ZA	WOS:000187944300033	14683551				2022-02-06	
J	Beaudry, M; Spence, JD				Beaudry, M; Spence, JD			Motor vehicle accidents: the most common cause of traumatic vertebrobasilar ischemia	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRANSIENT GLOBAL AMNESIA; WHIPLASH; MIGRAINE; BRAIN; INSUFFICIENCY; POSITION; INJURY	Background: Recent media exposure of strokes from chiropractic manipulation have focused attention on traumatic vertebrobasilar ischemia. However, chiropractic manipulation, while the easiest cause to recognize, is probably not the most common cause of this condition. Methods: We reviewed all consecutive cases of traumatic vertebrobasilar ischemia referred to a single neurovascular practice over 20 years, from the office files and hospital records. Results: There were 80 patients whose vertebrobasilar ischemia was attributed to neck trauma. Five were diagnosed as due to chiropractic manipulation, but the commonest attributed cause was motor vehicle accidents (MVAs), which accounted for 70 cases; one was a sports injury, and five were industrial accidents. In some cases neck pain from an MVA led to chiropractic manipulation, so the cause may have been compounded. In most vehicular cases the diagnosis had been missed, even denied, by the neurologists and neurosurgeons initially involved. The longest delay between the injury and the onset of delayed symptoms was five years. Conclusions: Traumatic vertebrobasilar ischemia is most often due to MVAs; the diagnosis is often missed, in part because of the delay between injury and onset of symptoms and, in part, we hypothesize, because of reluctance of doctors to be involved in medicolegal cases.	Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada; Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada		Spence, JD (corresponding author), Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, Siebens Drake Bldg,1400 Western Rd, London, ON N6G 2V2, Canada.		Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098			AUER RN, 1994, J NEUROL NEUROSUR PS, V57, P500, DOI 10.1136/jnnp.57.4.500; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P223, DOI 10.1212/WNL.38.2.223; BOGOUSSLAVSKY J, 1988, CURR OPIN NEUROL NEU, V1, P63; CAPLAN LR, 1985, STROKE, V16, P1030, DOI 10.1161/01.STR.16.6.1030; CAPLAN LR, 1986, STROKE PATHOPHYSIOLO, P570; FISHER CM, 1982, NEUROLOGY, V32, P667, DOI 10.1212/WNL.32.6.667; FISHER CM, 1986, CAN J NEUROL SCI, V13, P1; HAAS DC, 1988, J NEUROSURG, V68, P181, DOI 10.3171/jns.1988.68.2.0181; HAAS DC, 1986, BRAIN, V109, P251, DOI 10.1093/brain/109.2.251; HART RG, 1983, S CER DIS, P155; HOFSTAD H, 1985, J NEUROL NEUROSUR PS, V48, P956, DOI 10.1136/jnnp.48.9.956; HUGHES JT, 1979, CEREBRAL ARTERIAL SP; JACOME DE, 1986, HEADACHE, V26, P515, DOI 10.1111/j.1526-4610.1986.hed2610515.x; Jeret JS, 2002, CEREBROVASC DIS, V13, P210, DOI 10.1159/000047778; MAS JL, 1987, STROKE, V18, P1037, DOI 10.1161/01.STR.18.6.1037; Mayer SA, 1996, NEUROLOGY, V47, P552, DOI 10.1212/WNL.47.2.552; MOKRI B, 1988, J NEUROSURG, V68, P189, DOI 10.3171/jns.1988.68.2.0189; NICHELLI P, 1983, STROKE, V14, P617, DOI 10.1161/01.STR.14.4.617; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; SCHNEIDE.RC, 1970, J NEUROSURG, V33, P363, DOI 10.3171/jns.1970.33.4.0363; SCHNEIDER RC, 1959, NEUROLOGY, V9, P643, DOI 10.1212/WNL.9.10.643; SHERMAN DG, 1981, STROKE, V12, P2, DOI 10.1161/01.STR.12.1.2; SJAASTAD O, 1983, CEPHALALGIA, V3, P249, DOI 10.1046/j.1468-2982.1983.0304249.x; Stopford JSB, 1916, J ANAT PHYSIOL, V50, P131; TETTENBORN B, 1993, NEUROLOGY, V43, P471, DOI 10.1212/WNL.43.3_Part_1.471; THIE A, 1988, HEADACHE, V28, P183, DOI 10.1111/j.1526-4610.1988.hed2803183.x; VANDEKELFT E, 1992, STROKE, V23, P114, DOI 10.1161/01.STR.23.1.114; VIKTRUP L, 1995, STROKE, V26, P2194, DOI 10.1161/01.STR.26.11.2194; VINCHON M, 1995, NEUROSURGERY, V36, P839, DOI 10.1227/00006123-199504000-00027; Weintraub M I, 1995, J Neuroimaging, V5, P16; WEINTRAUB MI, 1993, JAMA-J AM MED ASSOC, V269, P2085, DOI 10.1001/jama.1993.03500160051022; WINSTON KR, 1987, HEADACHE, V27, P452, DOI 10.1111/j.1526-4610.1987.hed2708452.x	34	16	16	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2003	30	4					320	325		10.1017/S0317167100003024			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744WN	WOS:000186656000006	14672263	Bronze			2022-02-06	
J	Elovic, EP				Elovic, EP			Anterior pituitary dysfunction after traumatic brain injury, part I	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TESTOSTERONE; PREVALENCE; MEN		Kessler Med Rehabil Res & Educ Corp, TBI Res Lab, W Orange, NJ 07052 USA		Elovic, EP (corresponding author), Kessler Med Rehabil Res & Educ Corp, TBI Res Lab, 1199 Pleasant Valley W, W Orange, NJ 07052 USA.						Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Larsen P, 2003, WILLIAMS TXB ENDOCRI; LARSEN PR, 2003, WILLIAMS TXB ENDOCRI, P423; Larsen PR, 2003, WILLIAMS TXB ENDOCRI, P491, DOI 10.1097/00060793-200106000-00001; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Melmed S, 2003, WILLIAMS TXB ENDOCRI, P177; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Seidman SN, 2002, AM J PSYCHIAT, V159, P456, DOI 10.1176/appi.ajp.159.3.456; Wagner GJ, 1998, GEN HOSP PSYCHIAT, V20, P209, DOI 10.1016/S0163-8343(98)00024-3	14	16	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					541	543		10.1097/00001199-200311000-00008			3	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200008	14707884				2022-02-06	
J	Suchy, Y; Leahy, B; Sweet, JJ; Lam, CS				Suchy, Y; Leahy, B; Sweet, JJ; Lam, CS			Behavioral dyscontrol scale deficits among traumatic brain injury patients, part II: Comparison to other measures of executive functioning	CLINICAL NEUROPSYCHOLOGIST			English	Article							CARD SORTING TEST; OBSESSIVE-COMPULSIVE DISORDER; FRONTAL-LOBE FUNCTION; NEUROPSYCHOLOGICAL DEFICITS; TEST-PERFORMANCE; WORD FLUENCY; HEAD-INJURY; LESIONS; MEMORY; TESTS	The clinical utility of the Behavioral Dyscontrol Scale (BDS) was compared to that of verbal fluency, the Trail Making Test, and the Stroop Color-Word Test, as well as measures of processing speed/cognitive efficiency and manual dexterity. The ability of these measures to classify 49 TBI patients into frontal versus nonfrontal and mild to moderate versus severe groups was examined. The results showed that the Fluid Intelligence Factor of the BDS improved classifications above and beyond traditional executive measures, but was particularly successful at classifying patients who sustained mild injuries. In contrast, traditional executive instruments were successful at lesion location classifications only among the patients with severe injuries. Severity classifications were successful both for traditional measures of processing speed/cognitive efficiency and for the Motor Programming Factor of the BDS, but only among patients with nonfrontal injuries. These results demonstrate that severity of injury may be an important moderator of tests' sensitivity to frontal lobe involvement.	Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; IIT, Chicago, IL 60616 USA; Evanston NW Healthcare, Evanston, IL USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Suchy, Y (corresponding author), Univ Utah, Dept Psychol, 380 S 1530 E,Rm 502, Salt Lake City, UT 84112 USA.	yana.suchy@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			Ahola K, 1996, BRAIN COGNITION, V31, P1, DOI 10.1006/brcg.1996.0021; Allen DN, 2000, PSYCHIAT RES, V93, P33, DOI 10.1016/S0165-1781(00)00112-8; Amieva H, 1998, J CLIN EXP NEUROPSYC, V20, P280, DOI 10.1076/jcen.20.2.280.1161; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Benson D.F., 1986, FRONTAL LOBES; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bond M. R., 1986, NEUROPSYCHOLOGICAL A; Borkowska A, 2002, PROG NEURO-PSYCHOPH, V26, P1349, DOI 10.1016/S0278-5846(02)00300-7; Borkowska A, 2001, BIPOLAR DISORD, V3, P88, DOI 10.1034/j.1399-5618.2001.030207.x; BORNSTEIN RA, 1986, INT J CLIN NEUROPSYC, V8, P18; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; Cohen MJ, 2000, ARCH CLIN NEUROPSYCH, V15, P267, DOI 10.1016/S0887-6177(99)00017-7; Cools R, 2000, BRAIN COGNITION, V43, P108; deZubicaray G, 1996, CLIN NEUROPSYCHOL, V10, P245, DOI 10.1080/13854049608406687; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Fassino S, 2002, INT J EAT DISORDER, V31, P274, DOI 10.1002/eat.10028; Fos L A, 2000, Appl Neuropsychol, V7, P140, DOI 10.1207/S15324826AN0703_4; Golden CJ, 1978, STROOP COLOR WORD TE; GRIGSBY J, 1995, ARCH GERONTOL GERIAT, V21, P167, DOI 10.1016/0167-4943(95)00636-Y; GRIGSBY J, 1993, ARCH PHYS MED REHAB, V74, P1350, DOI 10.1016/0003-9993(93)90091-N; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Grigsby J, 1996, BEHAV DYSCONTROL SCA; HECK ET, 1986, J CLIN EXP NEUROPSYC, V8, P313, DOI 10.1080/01688638608401321; Heffernan TM, 2001, HUM PSYCHOPHARM CLIN, V16, P607, DOI 10.1002/hup.349; Jurado MA, 2001, PSYCHIAT RES, V104, P213, DOI 10.1016/S0165-1781(01)00322-5; KAYE K, 1990, J AM GERIATR SOC, V38, P1304, DOI 10.1111/j.1532-5415.1990.tb03452.x; Kim MS, 2002, J PSYCHIAT RES, V36, P257, DOI 10.1016/S0022-3956(02)00017-1; Landro NI, 2001, NEUROPSY NEUROPSY BE, V14, P233; Leahy B, 2003, CLIN NEUROPSYCHOL, V17, P474, DOI 10.1076/clin.17.4.474.27941; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; MARENCO S, 1993, PSYCHIAT RES-NEUROIM, V50, P177, DOI 10.1016/0165-1781(93)80012-T; Matthews CG., 1964, INSTRUCTION MANUAL A; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Moritz S, 2002, ARCH CLIN NEUROPSYCH, V17, P477, DOI 10.1016/S0887-6177(01)00130-5; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; PONTIUS AA, 1980, J NERV MENT DIS, V168, P111, DOI 10.1097/00005053-198002000-00008; Ravnkilde B, 2002, J CLIN EXP NEUROPSYC, V24, P534, DOI 10.1076/jcen.24.4.534.1033; REISCHIES FM, 2001, Z FUER NEUROPSYCHOLO, V12, P42; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; ROZENTHAL M, 2000, J BRASILEIRO PSIQUIA, V49, P5; Salthouse TA, 1996, NEUROPSYCHOLOGY, V10, P272, DOI 10.1037/0894-4105.10.2.272; Schatzberg AF, 2000, AM J PSYCHIAT, V157, P1095, DOI 10.1176/appi.ajp.157.7.1095; Schwartz S, 2001, NEUROPSYCHOLOGIA, V39, P1209, DOI 10.1016/S0028-3932(01)00053-7; SEGALOWITZ SJ, 1992, J CLIN EXPT NEUROPSY, V52, P658; Smith ML, 2000, J DEV PHYS DISABIL, V12, P317, DOI 10.1023/A:1009480013237; Spreen O, 1991, COMPENDIUM NEUROPSYC; Steffens DC, 2001, BIOL PSYCHIAT, V50, P358, DOI 10.1016/S0006-3223(01)01165-9; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Suchy Y, 2003, J CLIN EXP NEUROPSYC, V25, P190, DOI 10.1076/jcen.25.2.190.13640; Suchy Y, 1997, CLIN NEUROPSYCHOL, V11, P258, DOI 10.1080/13854049708400454; Suchy Y, 1999, CLIN NEUROPSYCHOL, V13, P487, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT487; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; Sylvester CYC, 2002, NEUROPSYCHOLOGY, V16, P197, DOI 10.1037//0894-4105.16.2.197; Szatkowska I, 2000, ACTA NEUROBIOL EXP, V60, P503; Tierney MC, 2001, ARCH NEUROL-CHICAGO, V58, P1654, DOI 10.1001/archneur.58.10.1654; Tripp G, 2002, AUST NZ J PSYCHIAT, V36, P771, DOI 10.1046/j.1440-1614.2002.01093.x; VANDENBROEK MD, 1993, BRIT J CLIN PSYCHOL, V32, P333; Vilkki JA, 2002, NEUROPSYCHOLOGIA, V40, P340, DOI 10.1016/S0028-3932(01)00090-2; *WAR DEP ADJ GEN O, 1944, ARM IND TEST BATT; Wildgruber D, 2000, CLIN REHABIL, V14, P272, DOI 10.1191/026921500676524726	70	16	16	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					492	506		10.1076/clin.17.4.492.27949			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400006	15168914				2022-02-06	
J	Yoshiya, K; Tanaka, H; Kasai, K; Irisawa, T; Shiozaki, T; Sugimoto, H				Yoshiya, K; Tanaka, H; Kasai, K; Irisawa, T; Shiozaki, T; Sugimoto, H			Profile of gene expression in the subventricular zone after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cDNA microarrays; in situ hybridization; neural stem cell; RT-PCR; subventricular zone; traumatic brain injury	GROWTH-INHIBITORY FACTOR; CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELL; RAT-BRAIN; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; MAMMALIAN FOREBRAIN; MICROARRAY ANALYSIS; ALZHEIMERS-DISEASE	Neural stem cells, which reside in the subventricular zone (SVZ) and dentate gyrus (DG) of adult mammals, give rise to new neurons throughout life. However, these neural stem cells do not appear to contribute to regeneration in the damaged central nervous system. Following traumatic brain injury (TBI) in adult rats, the number of proliferating cells labeled with bromodeoxyuridine (BrdU) is significantly increased in the bilateral SVZ and DG; however, these proliferating cells do not contribute to effective regeneration in the damaged area. To gain insight into the molecular mechanisms of these biological actions, changes in gene expression in the SVZ after brain trauma were examined by cDNA microarray. Of 9,596 genes screened, 97 were upregulated and 204 were down-regulated. Classifying these genes according to their function suggests that TBI affects a broad range of cellular functions. The validity of the data was confirmed by RT-PCR. The expression of some genes localized in the SVZ was confirmed by in situ hybridization. This combined strategy is effective for comprehensive analysis of the pathophysiological changes in the SVZ after brain injury and should contribute to the understanding of the molecular events that occur after injury. In the future, this may enable regeneration of the damaged central nervous system.	Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan		Yoshiya, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.						ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ANEZAKI T, 1995, NEUROCHEM INT, V27, P89, DOI 10.1016/0197-0186(94)00170-Y; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; CATTANEO E, 1991, TRENDS NEUROSCI, V14, P338, DOI 10.1016/0166-2236(91)90158-Q; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; HOZUMI I, 1995, BRAIN RES, V688, P143, DOI 10.1016/0006-8993(95)00522-R; Hozumi I, 1996, BRAIN RES, V741, P197, DOI 10.1016/S0006-8993(96)00912-2; Hwang SY, 1999, DEV GENES EVOL, V209, P120, DOI 10.1007/s004270050234; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KUBO T, 2002, J NEUROCHEM, V83, P67; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Liu JL, 1998, J NEUROSCI, V18, P7768; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; MEANS AR, 1994, FEBS LETT, V349, P1; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Parent JM, 1997, J NEUROSCI, V17, P3727; Pende M, 1997, J NEUROSCI, V17, P1291; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; YUGICHI T, 1995, J NEUROTRAUM, V12, P299; Yuguchi T, 1997, J CEREBR BLOOD F MET, V17, P745	45	16	17	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2003	20	11					1147	1162		10.1089/089771503770802844			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	747BE	WOS:000186784600001	14651803				2022-02-06	
J	Goozee, JV; Murdoch, BE; Theodoros, DG				Goozee, JV; Murdoch, BE; Theodoros, DG			Electropalatographic assessment of tongue-to-palate contacts exhibited in dysarthria following traumatic brain injury: Spatial characteristics	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							EPG DATA REDUCTION; LINGUAL ACTIVITY; SPEAKERS	Consonant imprecision has been reported to be a common feature of the dysarthric speech disturbances exhibited by individuals who have sustained a traumatic brain injury (TBI). Inaccurate tongue placements against the hard palate during consonant articulation may be one factor underlying the imprecision. To investigate this hypothesis, electropalatography (EPG) was used to assess the spatial characteristics of the tongue-to-palate contacts exhibited by three males (aged 23-29 years) with dysarthria following severe TBI. Five nonneurologically impaired adults served as control subjects. Twelve single-syllable words of CV or CVC construction (where initial C = /t, d, S, z, k, g/, V=/i, a/) were read aloud three times by each subject while wearing an EPG palate. Spatial characteristics were analyzed in terms of the location, pattern, and amount of tongue-to-palate contact at the frame of maximum contact during production of each consonant. The results revealed that for the majority of consonants, the patterns and locations of contacts exhibited by the TBI subjects were consistent with the contacts generated by the group of control subjects. One notable exception was one subject's production of the alveolar fricatives in which complete closure across the palate was demonstrated, rather than the characteristic groove configuration. Major discrepancies were also noted in relation to the amount of tongue-to-palate contact exhibited, with two TBI subjects consistently demonstrating increased contacts compared to the control subjects. The implications of these findings for the development of treatment programs for dysarthric speech disorders subsequent to TBI are highlighted.	Univ Queensland, Dept Speech Pathol & Audiol, Motor Speech Res Unit, Brisbane, Qld, Australia		Goozee, JV (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, St Lucia, Qld 4072, Australia.		Murdoch, Bruce E/C-1397-2012; Theodoros, Deborah/F-1362-2010				ADAMS SG, 1993, J SPEECH HEAR RES, V36, P41, DOI 10.1044/jshr.3601.41; Brown J.R., 1975, MOTOR SPEECH DISORDE; BYRD D, 1995, J SPEECH HEAR RES, V38, P821, DOI 10.1044/jshr.3804.821; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; GIBBON F, 1990, BRIT J DISORD COMMUN, V25, P329; Gibbon Fiona., 1999, COARTICULATION DATA, P229; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; HARDCASTLE W, 1989, CLIN LINGUIST PHONET, V3, P1, DOI 10.3109/02699208908985268; Hardcastle W.J., 1976, PHYSL SPEECH PRODUCT; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1987, J SPEECH HEAR RES, V30, P171, DOI 10.1044/jshr.3002.171; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HARDCASTLE WJ, 1984, PHONETICS LABORATORY, V4, P1; HARDCASTLE WJ, 1997, INSTRUMENTAL CLIN PH, P149; JONES W, 1995, EUR J DISORDER COMM, V30, P183; MORGAN BR, 1995, CASE STUDIES CLIN LI, P181; NGUYEN N, 1996, QMC WORKING PAPERS S, V1, P5; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; [No title captured]	21	16	16	0	6	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2003	11	3					115	129					15	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	722PH	WOS:000185384900004					2022-02-06	
J	Kiening, KL; Schoening, WN; Stover, JF; Unterberg, AW				Kiening, KL; Schoening, WN; Stover, JF; Unterberg, AW			Continuous monitoring of intracranial compliance after severe head injury: relation to data quality, intracranial pressure and brain tissue PO2	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cerebral oxygenation; multimodal cerebral monitoring; traumatic brain injury	SPIEGELBERG COMPLIANCE MONITOR; MULTICENTER ASSESSMENT; OXYGEN-SATURATION; COMPLIANCE DEVICE; HYDROCEPHALUS; PO-2	The objective of the present study was to test the new continuous intracranial compliance (cICC) device in terms of data quality, relationship to intracranial pressure (ICP) and brain tissue oxygenation (PtiO(2)). A total of 10 adult patients with severe traumatic brain injury underwent computerized monitoring of arterial blood pressure, ICP, cerebral perfusion pressure, end-tidal CO2, cICC and PtiO(2) providing a total of 1726 h of data. ( 1) The data quality assessed by calculating the 'time of good data quality' (TGDQ, %), i.e. the median duration of artefact-free time as a percentage of total monitoring time reached 98 and 99% for ICP and PtiO(2), while cICC measurements were free of artefacts in only 81%. ( 2) Individual regression analysis showed broad scattered correlation between cICC and ICP ranging from low (r= 0.05) to high (r = 0.52) correlation coefficients. ( 3) From 225 episodes of increased ICP ( ICP 420 mmHg 410 min), only 37 were correctly predicted by a preceding decline in cICC to pathological values (<0.5 ml/mmHg). ( 4) In all episodes of cerebral hypoxia ( PtiO2 <10 mmHg >10min), cICC was not pathologically altered. Based on the present results, we conclude that the current hardware and software version of the cICC monitoring system is unsatisfactory concerning data quality, prediction of increased ICP and revelance of cerebral hypoxic episodes.	Humboldt Univ, Virchow Med Ctr, Dept Neurosurg, Berlin, Germany		Kiening, KL (corresponding author), Univ Med Ctr, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	karl.kiening@gmx.de					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bardt TF, 1998, ACTA NEUROCHIR, V140, P357, DOI 10.1007/s007010050109; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; DEARDEN NM, 1993, ACTA NEUROCHIR, P91; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Piper I, 2000, ACTA NEUROCHIR SUPPL, V76, P491; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Yau Y, 2002, ACTA NEUROCHIR SUPPL, V81, P167; Yau YH, 2000, J NEUROSURG, V93, P1072, DOI 10.3171/jns.2000.93.6.1072; Yau YH, 2002, ACT NEUR S, V81, P181; Yau YH, 2002, ACT NEUR S, V81, P171	20	16	19	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	AUG	2003	17	4					311	318		10.1080/02688690310001601199			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	722FC	WOS:000185363900003	14579896				2022-02-06	
J	Shackelford, DA; Yeh, RY				Shackelford, DA; Yeh, RY			Activation of extracellular signal-regulated kinases (ERK) during reperfusion of ischemic spinal cord	MOLECULAR BRAIN RESEARCH			English	Article						MAP kinase; ERK; JNK/SAPK; ischemia; reperfusion; spinal cord	FOCAL CEREBRAL-ISCHEMIA; TRANSIENT FOREBRAIN ISCHEMIA; DEPENDENT PROTEIN-KINASE; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; NEURONAL CELL-LINE; MAP-KINASE; TYROSINE PHOSPHORYLATION; REACTIVE ASTROCYTES; OXIDATIVE STRESS	The extracellular signal-regulated kinases (ERK) participate in numerous signaling pathways and are abundantly expressed in the CNS. It has been proposed that ERK activation promotes survival in models of neuronal injury. Inhibition of MEK, the upstream kinase that activates ERK, however, leads to neuroprotection in models of cerebral ischemia and trauma, suggesting that in this context ERK activation contributes to cellular damage. The effect of ischemia and reperfusion on activity and expression of ERK was investigated using a reversible model of rabbit spinal cord ischemia. Active ERK was observed in naive animals, which decreased during 15 to 60 min of ischemia. Upon reperfusion, a robust activation of ERK was observed in animals occluded for 60 min that remained permanently paraplegic. Immunohistochemical analyses revealed increased staining of phosphorylated ERK (PERK) in glial cells and faint nuclear staining in motor neurons of animals occluded for 60 min and reperfused for 18 h. In contrast ERK activity did not increase in animals occluded for 15 min that regained motor function. No evidence of increased pERK immunoreactivity in motor neurons or nuclear translocation was noted in these animals. ERK1 was demonstrated to be identical to a p46 c-Jun/ATF-2 kinase previously shown to be activated by reperfusion after a 60-min occlusion. The results suggest that activation of ERK during reperfusion of ischemic spinal cord participates in the cellular pathways leading to neuronal damage. (C) 2003 Elsevier B.V. All rights reserved.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA		Shackelford, DA (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS028121] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS28121] Funding Source: Medline		Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAMPOSGONZALEZ R, 1992, J NEUROCHEM, V59, P1955, DOI 10.1111/j.1471-4159.1992.tb11032.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Flood DG, 1998, J COMP NEUROL, V398, P373, DOI 10.1002/(SICI)1096-9861(19980831)398:3<373::AID-CNE6>3.0.CO;2-X; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Gu ZL, 2000, BRAIN RES, V860, P157, DOI 10.1016/S0006-8993(00)02006-0; Gu ZL, 2001, BRAIN RES, V901, P79, DOI 10.1016/S0006-8993(01)02275-2; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; HU BR, 1994, J NEUROCHEM, V62, P1357; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Irving EA, 2000, MOL BRAIN RES, V77, P65, DOI 10.1016/S0169-328X(00)00043-7; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Kanterewicz BI, 1998, J NEUROCHEM, V70, P1009; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Mandell JW, 2001, GLIA, V34, P283, DOI 10.1002/glia.1062; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murray B, 1998, P NATL ACAD SCI USA, V95, P11975, DOI 10.1073/pnas.95.20.11975; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Noshita N, 2002, J NEUROSCI, V22, P7923; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Park JA, 1999, J NEUROCHEM, V73, P450, DOI 10.1046/j.1471-4159.1999.0730450.x; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roy M, 1999, TRENDS NEUROSCI, V22, P419, DOI 10.1016/S0166-2236(99)01435-6; Runden E, 1998, J NEUROSCI, V18, P7296; Saluja I, 1999, NEUROCHEM RES, V24, P669, DOI 10.1023/A:1021004525979; Satoh T, 2000, NEUROSCI LETT, V288, P163, DOI 10.1016/S0304-3940(00)01229-5; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHACKELFORD DA, 1993, J NEUROCHEM, V61, P738; Shackelford DA, 1999, J NEUROSCI, V19, P4727; Shackelford DA, 2001, MOL BRAIN RES, V94, P178, DOI 10.1016/S0169-328X(01)00245-5; SHACKELFORD DA, 1997, CELL BIOL LAB HDB, V4, P466; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Sugino T, 2000, J NEUROSCI, V20, P4506, DOI 10.1523/JNEUROSCI.20-12-04506.2000; Tan SL, 1998, J NEUROCHEM, V71, P95; Wang XK, 2003, J PHARMACOL EXP THER, V304, P172, DOI 10.1124/jpet.102.040246; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wu DC, 2000, J CEREBR BLOOD F MET, V20, P1320, DOI 10.1097/00004647-200009000-00007; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; ZIVIN JA, 1982, ARCH NEUROL-CHICAGO, V39, P408, DOI 10.1001/archneur.1982.00510190026008; ZIVIN JA, 1986, STROKE, V17, P509, DOI 10.1161/01.STR.17.3.509	59	16	16	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	JUL 23	2003	115	2					173	186		10.1016/S0169-328X(03)00206-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	713FW	WOS:000184847300009	12877988				2022-02-06	
J	Kennedy, RE; Nakase-Thompson, R; Nick, TG; Sherer, M				Kennedy, RE; Nakase-Thompson, R; Nick, TG; Sherer, M			Use of the cognitive test for delirium in patients with traumatic brain injury	PSYCHOSOMATICS			English	Article							CONFUSION ASSESSMENT METHOD; OLDER HOSPITAL PATIENTS; DIFFERENTIAL-DIAGNOSIS; PRACTICAL SCALE; VALIDATION; ICU; INSTRUMENTS; PROGNOSIS; AMNESIA; STATE	The sensitivity and specificity of the Cognitive Test for Delirium, which was originally developed for use in intensive care units, were tested in a group of patients with traumatic brain injury who were admitted to a neurorehabilitation center Sixty-five consecutive patients were evaluated weekly by using the DSM-IV criteria for delirium and the Cognitive Test for Delirium. Complete ratings were available for 249 of 304 weekly observations. Analysis of the receiver operating characteristic curve suggested an optimum cutoff score of less than 22 for identification of delirium by using the Cognitive Test for Delirium, with a sensitivity of 72% and a specificity of 71% compared with the DSM-IV diagnosis. The results suggest that the Cognitive Test for Delirium provides an acceptable level of differentiation between delirious and nondelirious patients with traumatic brain injury.	Univ Mississippi, Med Ctr, Dept Psychiat, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Prevent Med, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; Methodist Rehabil Ctr, Dept Neuropsychol, Jackson, MS USA		Kennedy, RE (corresponding author), Virginia Commonwealth Univ, Dept Psychiat, Med Coll Virginia Campus,Box 980268, Richmond, VA 23298 USA.		Kennedy, Richard/K-1525-2018	Kennedy, Richard/0000-0003-4638-126X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980035] Funding Source: Medline		American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bettin KM, 1998, AM J GERIAT PSYCHIAT, V6, P296; COLE MG, 1993, CAN MED ASSOC J, V149, P41; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; Grant I, 1987, NEUROBEHAVIORAL RECO, P234; Hagen C., 1972, LEVELS COGNITIVE FUN; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; KANE FJ, 1993, SOUTHERN MED J, V86, P985, DOI 10.1097/00007611-199309000-00001; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MURRAY AM, 1993, J GERONTOL, V48, pM181, DOI 10.1093/geronj/48.5.M181; MYSIW WJ, 1995, NEUROREHABILITATION, V5, P197, DOI 10.3233/NRE-1995-5302; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; OKeeffe ST, 1997, J AM GERIATR SOC, V45, P470, DOI 10.1111/j.1532-5415.1997.tb05173.x; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SMITH MJ, 1995, J PAIN SYMPTOM MANAG, V10, P35, DOI 10.1016/0885-3924(94)00066-T; *STAT CORP, 2001, STAT REF MAN REL 7 0; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; TAYLOR D, 1993, J NEUROL NEUROSUR PS, V56, P742, DOI 10.1136/jnnp.56.7.742; TEASDALE G, 1974, LANCET, V2, P81; THOMAS RI, 1988, ARCH GEN PSYCHIAT, V45, P937; Thompson R, 2001, J INT NEUROPSYCH SOC, V7, P177; THOMPSON RN, 2002, J INT NEUROPSYCH SOC, V8, P219; Trzepacz Paula T., 1994, P189; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Trzepacz PT, 1996, PSYCHIAT CLIN N AM, V19, P429, DOI 10.1016/S0193-953X(05)70299-9; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P433; TRZEPACZ PT, 1994, GEN HOSP PSYCHIAT, V16, P397, DOI 10.1016/0163-8343(94)90115-5; TRZEPACZ PT, 1997, AM PSYCHIAT PRESS TX, P447; TRZEPASC PT, 1994, PSYCHOSOMATICS, V35, P375; Wise MG, 1996, TXB CONSULTATION LIA, P258	38	16	18	0	9	AMER PSYCHIATRIC PRESS, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUL-AUG	2003	44	4					283	289		10.1176/appi.psy.44.4.283			7	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	694CQ	WOS:000183756600002	12832593				2022-02-06	
J	Putukian, M; Echemendia, RJ				Putukian, M; Echemendia, RJ			Psychological aspects of serious head injury in the competitive athlete	CLINICS IN SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN INJURY; SPORTS INJURIES; CHILDREN; RESPONSES; DISORDER; STRESS; RISK	In addition to the physical aspects of athletic injury, there are psychological aspects to consider. These are important during all phases of injury management: the acute injury, the rehabilitative process, and the return-to-play progression. Emotional disturbances are often associated with mild traumatic brain injury (mTBI) both directly and indirectly. Evaluating the athlete with mTBI can be made more difficult by the need to distinguish the physical and the emotional effects of injury and to differentiate the emotional factors directly related to the brain injury from those that arise indirectly (eg, reaction to being held out of play). This article discusses some of the psychological issues related to evaluating the head injured athlete.	Penn State Univ, University Pk, PA 16803 USA; Milton S Hershey Med Ctr, Dept Orthopaed & Rehabil, Hershey, PA 17033 USA		Putukian, M (corresponding author), Penn State Univ, 1850 E Pk Ave,Suite 112, University Pk, PA 16803 USA.		Echemendia, Ruben/R-6939-2019	Echemendia, Ruben/0000-0001-6116-8462			ANDERSEN MB, 1988, J SPORT EXERCISE PSY, V10, P294, DOI 10.1123/jsep.10.3.294; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; BRUCE DA, 1984, PRIMARY CARE, V11, P175; CHAN CS, 1988, PERCEPT MOTOR SKILL, V66, P875, DOI 10.2466/pms.1988.66.3.875; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Garrick J G, 1981, Phys Sportsmed, V9, P115, DOI 10.1080/00913847.1981.11711015; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Harris JKJ, 2001, BRAIN INJURY, V15, P223; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; KEUBLERROSS E, 1969, DEATH DYING; Kraus JF, 1987, HEAD INJURY, V2, P1; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P349; LINDER DE, 1989, J SPORT EXERCISE PSY, V11, P270, DOI 10.1123/jsep.11.3.270; LITTLE JC, 1979, PSYCHIAT ANN, V9, P148; McDonald SA, 1990, SPORT PSYCHOL, V4, P261; MCGOWAN RW, 1994, J SPORT MED PHYS FIT, V34, P299; McNair DM, 1971, PROFILE MOOD STATES; Morrey MA, 1999, CLIN J SPORT MED, V9, P63, DOI 10.1097/00042752-199904000-00004; *NCAA, 1996, INJ SURV SYST 1984 1; PEDERSEN P, 1986, Athletic Training, V21, P312; PUTUKIAN M, 2001, PRINCIPLES PRACTICE, P331; PUTUKIAN M, 2002, PEDIAT SPORTS MED PR, V28, P266; ROSENBERG M, 1968, SOC ADOLESCNET SELF; Smith AM, 1996, SPORTS MED, V22, P391, DOI 10.2165/00007256-199622060-00006; SMITH AM, 1990, SPORTS MED, V9, P352, DOI 10.2165/00007256-199009060-00004; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; SMITH AM, 1994, J ATHL TRAINING, V29, P337; SMITH AM, 1990, MAYO CLIN PROC, V65, P38, DOI 10.1016/S0025-6196(12)62108-9; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Wiese-Bjornstal D. M., 1995, ATHLETIC TRAINING SP, V1, P16; ZARICZNYJ B, 1980, AM J SPORT MED, V8, P318, DOI 10.1177/036354658000800504; [No title captured]	37	16	16	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JUL	2003	22	3					617	+		10.1016/S0278-5919(02)00100-X			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	692LT	WOS:000183663100015	12852690				2022-02-06	
J	Villaverde-Gonzalez, R; Fernandez-Villalba, E; Moreno-Escribano, A; Alias-Linares, E; Garcia-Santos, JM				Villaverde-Gonzalez, R; Fernandez-Villalba, E; Moreno-Escribano, A; Alias-Linares, E; Garcia-Santos, JM			Foreign language syndrome as a first sign of multiple sclerosis	REVISTA DE NEUROLOGIA			Spanish	Article						aphasia; demyelinating lesions; foreign accent syndrome; multiple sclerosis; pseudotumoral lesions	APHASIC STATUS EPILEPTICUS; ACCENT SYNDROME; DEMYELINATING DISEASE; DIAGNOSTIC-CRITERIA; MRI; LESION; GUIDELINES; PATIENT; TUMOR	Introduction. Foreign accent syndrome (FAS) is a little known disorder affecting language which has been described in a few cases after acute strokes or traumatic brain injuries, but until now has not been reported in multiple sclerosis (MS). It is characterised by the appearance of what is perceived to be a foreign accent in the language of the patient. Although it could be included within the dysprosodias that accompany motor aphasias it should be considered as an entity in its own right, since it may appear without the accompanying aphasia. Aphasia is an infrequent manifestation of MS and even less so when it appears as an initial symptom of the disease. When it does occur it usually accompanies large demyelinating lesions in the dominant hemisphere, and it is usually of a motor type. Case report. Patient, aged 38 years, who presented FAS that accompanied mild non-fluent aphasia as the first manifestation of MS with pseudotumoral lesions. Initially the clinical features were interpreted as a somatoform disorder, which delayed diagnosis. Conclusions. Like aphasia, FAS can occur in MS as a manifestation of a cortical language disorder. It is important to recognise this in order to prevent mistaken diagnoses.	Univ Murcia, Hosp Jose Maria Morales Mesegur, Neurol Sect, E-30008 Murcia, Spain; Univ Murcia, Hosp Jose Maria Morales Mesegur, Serv Radiol, E-30008 Murcia, Spain				Villalba, Emiliano Fernandez/AAP-1187-2021	VILLAVERDE GONZALEZ, RAMON/0000-0002-0064-8910			ACHIRON A, 1992, NEUROLOGY, V42, P2195, DOI 10.1212/WNL.42.11.2195; Arnett PA, 1996, NEUROLOGY, V47, P576, DOI 10.1212/WNL.47.2.576; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; BLUMSTEIN SE, 1987, BRAIN LANG, V31, P215, DOI 10.1016/0093-934X(87)90071-X; Carbary TJ, 2000, BRAIN COGNITION, V43, P78; Devere TR, 2000, ARCH NEUROL-CHICAGO, V57, P1207, DOI 10.1001/archneur.57.8.1207; Di Majo L, 2002, NEUROL SCI, V23, P79, DOI 10.1007/s100720200030; Ernst T, 1998, NEUROLOGY, V51, P1486, DOI 10.1212/WNL.51.5.1486; GRAFFRADFORD NR, 1986, BRAIN LANG, V28, P86, DOI 10.1016/0093-934X(86)90093-3; GURD JM, 1988, NEUROPSYCHOLOGIA, V26, P237, DOI 10.1016/0028-3932(88)90077-2; Kearns Kevin P., 1997, P1; Khan OA, 1997, NEUROLOGY, V48, P1330, DOI 10.1212/WNL.48.5.1330; Kurowski KM, 1996, BRAIN LANG, V54, P1, DOI 10.1006/brln.1996.0059; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MOEN I, 1991, BRAIN LANG, V41, P538, DOI 10.1016/0093-934X(91)90173-X; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Primavera A, 1996, EUR NEUROL, V36, P374, DOI 10.1159/000117296; Saindane AM, 2002, AM J NEURORADIOL, V23, P1378; SCHIFF HB, 1983, ARCH NEUROL-CHICAGO, V40, P720, DOI 10.1001/archneur.1983.04050110038005; SELIGER GM, 1992, STROKE, V23, P1655, DOI 10.1161/01.STR.23.11.1655; Silva HCA, 1999, ARQ NEURO-PSIQUIAT, V57, P921, DOI 10.1590/S0004-282X1999000600004; TAKAYAMA Y, 1993, NEUROLOGY, V43, P1361, DOI 10.1212/WNL.43.7.1361; Trinka E, 2002, J NEUROL, V249, P782, DOI 10.1007/s00415-002-0705-5; Trinka E, 2001, ARCH NEUROL-CHICAGO, V58, P133, DOI 10.1001/archneur.58.1.133; ZAGZAG D, 1993, AM J SURG PATHOL, V17, P537, DOI 10.1097/00000478-199306000-00001	25	16	18	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	JUN 1	2003	36	11					1035	1039		10.33588/rn.3611.2002609			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	696HU	WOS:000183882200009	12808499				2022-02-06	
J	Yousaf, I; Flynn, P; Mcconnell, R				Yousaf, I; Flynn, P; Mcconnell, R			Symptomatic intraspinal pneumocoele resulting from closed head injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury; intraspinal pneumocele; pneumocephalus; radicular symptoms		Intraspinal pneumocoele is rarely associated with closed head injury. We describe a case of intra-spinal pneumocoele following a closed head injury. We believe this to be the first case presenting with radicular symptoms.	Royal Victoria Hosp, Dept Neurosurg, Belfast BT6 12BA, Antrim, North Ireland; Royal Victoria Hosp, Dept Neuroradiol, Belfast BT6 12BA, Antrim, North Ireland		Yousaf, I (corresponding author), Royal Victoria Hosp, Dept Neurosurg, Grosvenor Rd, Belfast BT6 12BA, Antrim, North Ireland.			Yousaf, Irfan/0000-0003-4992-5154			Aribas OK, 2001, EUR J CARDIO-THORAC, V20, P645, DOI 10.1016/S1010-7940(01)00851-X; CHENG TM, 1994, J NEUROSURG, V81, P453, DOI 10.3171/jns.1994.81.3.0453; Dexter F, 1996, ANESTHESIOLOGY, V84, P442, DOI 10.1097/00000542-199602000-00024; GRAF CJ, 1981, J NEUROSURG, V54, P392, DOI 10.3171/jns.1981.54.3.0392; KAKITSUBATA Y, 1994, ACTA RADIOL, V35, P305; MANGIARDI JR, 1987, SURG NEUROL, V27, P587, DOI 10.1016/0090-3019(87)90161-3; Romano L, 1996, Radiol Med, V92, P642; Uemura K, 2000, BRIT J NEUROSURG, V14, P154	8	16	16	0	0	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2003	17	3					248	249		10.1080/0268869031000153143			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	715PK	WOS:000184981000008	14565522				2022-02-06	
J	Meythaler, JM; Fisher, WS; Rue, LW; Johnson, A; Davis, L; Brunner, RC				Meythaler, JM; Fisher, WS; Rue, LW; Johnson, A; Davis, L; Brunner, RC			Screening for venous thromboembolism in traumatic brain injury: Limitations of D-dieter assay	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; fibrin fibrinogen degradation products; rehabilitation; thromboembolism; ultrasonography; Doppler	DEEP-VEIN THROMBOSIS; COST-EFFECTIVENESS ANALYSIS; D-DIMER; COMPRESSION ULTRASONOGRAPHY; IMPEDANCE PLETHYSMOGRAPHY; DIAGNOSIS; PROPHYLAXIS; ADMISSION; STROKE; FIBRIN	Objectives: To assess whether 2 different D-dieter fibrin degradation assays-a second-generation latex immunosorbent agglutination (LIA) and an enzyme-linked immunosorbent assay (ELISA)-are predictive for the development of deep venous thrombosis (DVT) at the currently accepted level of 500 mug/L of D-dieter assay during the first weeks after traumatic brain injury (TBI) and to correlate over 8 weeks the second-generation LIA assay with the ELISA assay after acute TBI. Design: A case series of persons with TBI were screened for DVT at 2 weeks (+/-3d) using real-time, spectral Doppler ultrasound, as well as D-dieter fibrin split products. All persons were rescreened at 4, 6, and 8 weeks ( 3d) after injury using D-dieter LIA and ELISA assays. Setting: A university hospital with a directly connected comprehensive in- and outpatient rehabilitation center that are part of the Traumatic Brain Injury Model Systems. Participants: Over 3 years, 35 TBI subjects with a mean Glasgow Coma Scale score of 6.5 were consecutively enrolled into the trial while on acute care. Persons were at least 16 years of age with no history of treatment for DVT. Interventions: Not applicable. Main Outcome Measures: Data were analyzed for the levels of D-dieter and risk as established by a predictive value of 500 mug/L. Changes in D-dieter values over time and within subjects were assessed by analysis of variance (ANOVA) with repeated measures, and the methods were correlated. Results: The mean LIA level at 2 weeks was 4.3mg/L and averaged 1.6 mg/L at 8 weeks from injury (P=.012, ANOVA), and the ELISA dropped from 4748 mug/L to 1695 mug/L (P=.0022, ANOVA). Except for 1 ELISA value in 1 patient, D-dieter levels were elevated beyond 500 mug/L at 2 weeks. There was a very good correlation between the LIA and the ELISA at 2, 4, 6, and 8 weeks after TBI (P<.0001). In individual cases, there were only occasional discrepancies between the LIA and ELISA methods. There were no positive DVTs at 2 weeks using ultrasound, so prediction of the sensitivity and the specificity of D-dieter with DVT was not possible. Conclusion: Using the currently recommended levels of D-dieter to predict DVT is not clinically useful in the acute TBI population.	Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35249 USA; Univ Alabama Birmingham, Sch Med, Div Neurol Surg, Birmingham, AL 35249 USA; Univ Alabama Birmingham, Sch Med, Dept Trauma Surg, Birmingham, AL 35249 USA		Meythaler, JM (corresponding author), Univ Alabama Birmingham, Spain Rehabil Ctr R157, 619 19th St S, Birmingham, AL 35249 USA.	JMeythal@uab.edu					Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744; BRANDSTATER ME, 1992, ARCH PHYS MED REHAB, V73, pS379; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; COON WW, 1984, CLIN CHEST MED, V5, P391; Crippa L, 1997, HAEMATOLOGICA, V82, P446; FOGELHOLM R, 1992, J NEUROL NEUROSUR PS, V55, P1121, DOI 10.1136/jnnp.55.12.1121; Freyburger G, 1998, THROMB HAEMOSTASIS, V79, P32; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; GITEL SN, 1979, J BONE JOINT SURG AM, V61, P653, DOI 10.2106/00004623-197961050-00002; GREEN D, 1988, JAMA-J AM MED ASSOC, V260, P1255, DOI 10.1001/jama.260.9.1255; HAGER K, 1995, GERONTOLOGY, V41, P159; Harvey RL, 1996, STROKE, V27, P1516, DOI 10.1161/01.STR.27.9.1516; HEIJBOER H, 1993, NEW ENGL J MED, V329, P1365, DOI 10.1056/NEJM199311043291901; HULL RD, 1985, ANN INTERN MED, V102, P21, DOI 10.7326/0003-4819-102-1-21; KARIO K, 1991, THROMB RES, V62, P501, DOI 10.1016/0049-3848(91)90023-P; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Lamb G C, 1993, J Am Paraplegia Soc, V16, P153; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Meythaler JM, 1998, ARCH PHYS MED REHAB, V79, P115, DOI 10.1016/S0003-9993(98)90220-9; OSTER G, 1987, JAMA-J AM MED ASSOC, V257, P203, DOI 10.1001/jama.257.2.203; OUDKERK M, 1993, ARCH INTERN MED, V153, P947, DOI 10.1001/archinte.153.8.947; PEDERSEN OM, 1991, ARCH INTERN MED, V151, P2217, DOI 10.1001/archinte.151.11.2217; Perrier A, 1997, ARCH INTERN MED, V157, P2309, DOI 10.1001/archinte.157.20.2309; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; ROSBERG B, 1981, ANN CLIN RES, V13, P84; SASAHARA AA, 1979, AM J CARDIOL, V43, P1214, DOI 10.1016/0002-9149(79)90156-5; SEVITT S, 1961, BRIT J SURG, V48, P475, DOI 10.1002/bjs.18004821103; SEVITT S, 1969, THROMBOSIS, P29; STAMATAKIS JD, 1977, BRIT MED J, V2, P223, DOI 10.1136/bmj.2.6081.223; STEINBERG DP, 1993, ARCH PHYS MED REHAB, V64, P1243; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; VERSTRAETE M, 1993, NEW ENGL J MED, V329, P1418, DOI 10.1056/NEJM199311043291911; WEINMANN EE, 1994, NEW ENGL J MED, V331, P1630, DOI 10.1056/NEJM199412153312407; YABLON SA, 1997, ARCH PHYS MED REHAB, V78, P1027	39	16	17	3	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					285	290		10.1053/apmr.2003.50116			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700020	12601662				2022-02-06	
J	Stringer, AY				Stringer, AY			Cognitive rehabilitation practice patterns: A survey of American hospital association rehabilitation programs	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN-INJURY; STROKE; EPIDEMIOLOGY; DISABILITY; AMNESIA	Results of a survey of cognitive rehabilitation (CRT) practice patterns are reported. Of 270 programs contacted, 45% responded. Most patients were under age 65, had a stroke or brain injury, and underwent individual CRT for attention or memory problems while hospitalized. CRT typically lasted 1-6 months and cost $130 per session. Rehearsal and compensation approaches were employed equally, while computer-based procedures were infrequent. Speech and occupational therapists provided services more than neuropsychologists and few programs incorporated neuropsychological testing. Results suggest opportunities for research and expansion of neuropsychological practice and highlight the need for better communication between researchers and clinicians.	Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA		Stringer, AY (corresponding author), Emory Univ, Dept Rehabil Med, 1441 Clifton Rd NE, Atlanta, GA 30322 USA.	anthony_stringer@emoryhealthcare.org					BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BUTLER RW, 1988, J NEUROLOGICAL REHAB, V2, P97; CHESTNUT RM, 1999, J HEAD TRAUMA REHAB, V14, P277; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132; Clare L, 1999, NEUROCASE, V5, P37, DOI 10.1080/13554799908404063; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GLISKY EL, 1992, NEUROPSYCHOLOGIA, V30, P899, DOI 10.1016/0028-3932(92)90034-J; GLISKY EL, 1992, J HEAD TRAUMA REHAB, V7, P1; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HARTER GW, 1987, REHABILITATION COGNI, P95; Kuller LH, 2000, EPIDEMIOL REV, V22, P14, DOI 10.1093/oxfordjournals.epirev.a018011; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Lincoln NB, 2002, J NEUROL NEUROSUR PS, V72, P93, DOI 10.1136/jnnp.72.1.93; MACKAY LE, 1994, J HEAD TRAUMA REHAB, V9, P11; Matthews E, 1991, GLOBAL BIOGEOCHEM CY, V5, P3, DOI 10.1029/90GB02311; Mazmanian Paul E., 1993, Brain Injury, V7, P319, DOI 10.3109/02699059309034958; Nadolne MJ, 2001, J INT NEUROPSYCH SOC, V7, P675, DOI 10.1017/S1355617701766039; Ruff R, 1991, COGNITIVE REHABILITA, P23; Sohlberg MM, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199604000-00007; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; WILLER B, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P18; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	27	16	16	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2003	17	1					34	44		10.1076/clin.17.1.34.15625			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	707XM	WOS:000184535300003	12854009				2022-02-06	
J	van der Heijden, P; Donders, J				van der Heijden, P; Donders, J			A confirmatory factor analysis of the WAIS-III in patients with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MEMORY MALINGERING TOMM; WISC-III; REPLICATION; SAMPLE; INTELLIGENCE; CHILDREN; SCORES	Maximum likelihood confirmatory factor analysis was performed on the WAIS-III data of a sample of 166 patients with traumatic brain injury (TBI). Four competing hypothetical models were tested for model fit and parsimony. A four-factor model composed of Verbal Comprehension, Perceptual Organization, Working Memory, and Processing Speed, identical to that proposed for the standardization sample, provided the best fit to the clinical data. The results support the construct validity of these four factors in patients with TBI.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.						Arnau RC, 2000, ASSESSMENT, V7, P237, DOI 10.1177/107319110000700304; Benton A., 1994, CONTRIBUTIONS NEUROP; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P185, DOI 10.1080/09297049608402251; Gorsuch R.L., 1983, FACTOR ANAL; Hatcher L., 1994, STEP STEP APPROACH U; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Kaufman AS, 2001, ASSESSMENT, V8, P267, DOI 10.1177/107319110100800303; KAUFMAN AS, 1999, ESSENTIALS WAIS 3 AS; Konold TR, 1997, J PSYCHOEDUC ASSESS, V15, P123, DOI 10.1177/073428299701500203; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MILLIS SR, 1997, M INT NEUR SOC BERG; NETEMEYER RG, 1990, J APPL PSYCHOL, V75, P148, DOI 10.1037/0021-9010.75.2.148; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; ROID GH, 1993, J PSYCHOEDUC ASSESS, P6; Ryan JJ, 2001, ARCH CLIN NEUROPSYCH, V16, P151, DOI 10.1016/S0887-6177(99)00061-X; Saklofske DH, 2000, PSYCHOL ASSESSMENT, V12, P436, DOI 10.1037/1040-3590.12.4.436; *SAS I, 1990, SAS STAT US GUID VER, V0001; Smith A., 1991, SYMBOL DIGIT MODALIT; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; THOMPSON B, 1992, EDUC PSYCHOL MEAS, V52, P69, DOI 10.1177/001316449205200107; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Ward LC, 2000, PSYCHOL ASSESSMENT, V12, P341, DOI [10.1037/1040-3590.12.3.341, 10.1037//1040-3590.12.3.341]; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	34	16	16	0	5	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2003	25	1					59	65		10.1076/jcen.25.1.59.13627			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	666YD	WOS:000182203300006	12607172				2022-02-06	
J	Prins, ML; Povlishock, JT; Phillips, LL				Prins, ML; Povlishock, JT; Phillips, LL			The effects of combined fluid percussion traumatic brain injury and unilateral entorhinal deafferentation on the juvenile rat brain	DEVELOPMENTAL BRAIN RESEARCH			English	Article						traumatic brain injury; entorhinal lesion; synaptic plasticity; development; deafferentation; synaptic reorganization	CEREBRAL BLOOD-FLOW; DENTATE GYRUS; HISTOCHEMICAL EVIDENCE; GLUCOSE-METABOLISM; CORTICAL LESION; AXONAL INJURY; HEAD-INJURY; TIME-COURSE; ADULT-RAT; IMMATURE	The current study was designed to address the effects of traumatic brain injury (TBI) on plasticity and reorganization in the juvenile brain. Given that two of the major pathological sequelae of TBI involve a generalized neuroexcitation insult and diffuse axonal injury, we have employed models of these pathologies, delivered either independently or in combination, to examine their effects on injury-induced synaptic reorganization of the dentate gyrus in the developing rat. Postnatal day 28 rats received either sham, central fluid percussion traumatic brain injury (TBI), unilateral entorhinal cortical lesion (UEC), or TBI+UEC (TUEC) injury. Cognitive performance was assessed in the Morris water maze (MWM) between 11 and 15 days post-injury and the brains were processed for synaptophysin immunohistochemistry and routine electron microscopy. The MWM results revealed that TBI or UEC lesions delivered independently do not produce significant morbidity in P28 rats. However, when these injuries are combined, they reveal significant deficits in the MWM, accompanied by measurable changes in the distribution of presynaptic synaptophysin immunoreactivity over the deafferented dentate molecular layer. These observations are further supported by qualitative ultrastructural alterations in synaptic architecture in the same subregions of the dentate neuropil. The present findings show that the resilience of the immature brain following TBI is reduced when neuroexcitatory insult is combined with deafferentation. Moreover, when deafferented tissue is assessed morphologically, evidence exists for aberrant plasticity and abnormal synaptic reorganization in the juvenile brain. (C) 2002 Elsevier Science B.V. All rights reserved.	Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA		Prins, ML (corresponding author), Univ Calif Los Angeles, Div Neurosurg, NPI 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587, NS07288-13] Funding Source: Medline		Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; COTMAN CW, 1973, P NATL ACAD SCI USA, V70, P3473, DOI 10.1073/pnas.70.12.3473; DUPREE JL, 1994, J NEUROSCI RES, V39, P567, DOI 10.1002/jnr.490390508; ELBADAWI A, 1967, J HISTOCHEM CYTOCHEM, V15, P580, DOI 10.1177/15.10.580; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; KOLB B, 1991, BEHAV BRAIN RES, V43, P51, DOI 10.1016/S0166-4328(05)80051-8; KOLB B, 1988, BEHAV BRAIN RES, V28, P259, DOI 10.1016/0166-4328(88)90129-5; KOLB B, 1987, BEHAV BRAIN RES, V26, P119, DOI 10.1016/0166-4328(87)90161-6; KRAUS JF, 1987, PEDIATRICS, V79, P501; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; LYNCH G, 1972, BRAIN RES, V42, P311, DOI 10.1016/0006-8993(72)90533-1; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NADLER JV, 1977, J COMP NEUROL, V171, P561, DOI 10.1002/cne.901710409; Phillips LL, 1998, HIPPOCAMPUS, V8, P390, DOI 10.1002/(SICI)1098-1063(1998)8:4<390::AID-HIPO7>3.3.CO;2-9; Phillips LL, 1997, J NEUROSCI RES, V49, P197; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PHILLIPS LL, 1987, MOL BRAIN RES, V2, P251, DOI 10.1016/0169-328X(87)90032-5; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; PRINS ML, IN PRESS J NEUROTRAU; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; STEWARD O, 1976, SCIENCE, V194, P426, DOI 10.1126/science.982024; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	37	16	17	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-3806			DEV BRAIN RES	Dev. Brain Res.	JAN 13	2003	140	1					93	104	PII S0165-3806(02)00588-6	10.1016/S0165-3806(02)00588-6			12	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	640KV	WOS:000180688800009	12524180				2022-02-06	
J	Malmvik, J; Herbertsson, P; Josefsson, PO; Hasserius, R; Besjakov, J; Karlsson, MK				Malmvik, J; Herbertsson, P; Josefsson, PO; Hasserius, R; Besjakov, J; Karlsson, MK			Fracture of the radial head and neck of Mason types II and III during growth: a 14-25 year follow-up	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						children; fracture; long-term; radial head; radial neck	CHILDREN; REDUCTION	Twenty-four individuals, who were 16 years of age or younger when they sustained a fracture of the radial head or neck, were examined at a mean of 19 years (range 14-25 years) after injury. The 12 girls and 12 boys were a mean age of 11 years (range 5-16 years) when the fracture was sustained. Two were excluded due to late resection of the radial head following persisting pain. The fractures, which were of Mason type II in 19 and type III in three cases, were treated by mobilization in eight cases, plaster in eight, open reduction and internal fixation in three and closed reduction and plaster in three. At the follow-up examination, 19 (86%) had no complaints, while three (14%) had occasional pain. Flexion was decreased in the formerly injured compared with the uninjured elbow (139 + 8degrees versus 142+/-5degrees; P<0.05). None had developed elbow osteoarthritis. Isolated, closed fracture of the radial head and neck during growth has a favourable, long-term outcome.	UMAS, Univ Hosp, Dept Orthopaed & Radiol, Malmo, Sweden		Karlsson, MK (corresponding author), Malmo Univ Hosp, Dept Orthopaed, SE-20502 Malmo, Sweden.						AKESSON K, 1992, OSTEOPOROSIS INT, V2, P201, DOI 10.1007/BF01623927; BLOUNT WP, 1955, FRACTURES CHILDREN, P56; COLTON CL, 1973, INJURY, V5, P121, DOI 10.1016/S0020-1383(73)80088-9; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; HENRIKSON B, 1969, ACTA ORTHOP SCAND, V40, P246, DOI 10.3109/17453676908989505; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314, DOI 10.1302/0301-620X.32B3.314; JONES ERL, 1971, J BONE JOINT SURG BR, V53, P423; JONSSON B, 1994, J EPIDEMIOL COMMUN H, V48, P489, DOI 10.1136/jech.48.5.489; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; MERCHAN ECR, 1994, J TRAUMA, V37, P812; MERCHAN ECR, 1991, ORTHOPEDICS, V14, P697; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; Patterson RF, 1934, J BONE JOINT SURG, V16, P695; PESUDO JV, 1982, CLIN ORTHOP RELAT R, V169, P215; RADOMISLI TE, 1998, CLIN ORTHOP RELAT R, V353, P30; REIDY JA, 1963, J BONE JOINT SURG AM, V45, P1355, DOI 10.2106/00004623-196345070-00002; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; SPONSELLER PD, 1994, HAND CLIN, V10, P495; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760, DOI 10.1302/0301-620X.74B5.1527130; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; TACHDJIAN MO, 1972, PEDIATRIC ORTHOPEDIC, P1613; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013; VAHVANEN V, 1978, ACTA ORTHOP SCAND, V49, P32, DOI 10.3109/17453677809005720	26	16	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JAN	2003	12	1					63	68		10.1097/00009957-200301000-00012			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	640FK	WOS:000180677500012	12488775				2022-02-06	
J	Prigatano, GP; Borgaro, SR				Prigatano, GP; Borgaro, SR			Qualitative features of finger movement during the Halstead finger oscillation test following traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						finger tapping; speed; abnormal patterns; TBI	HEAD-INJURY; 1-YEAR	Qualitative and quantitative performance on the Halstead Finger Tapping test may help differentiate brain dysfunctional patients from normal controls. "Normal" and "abnormal" finger tapping patterns during this task have been characterized and illustrated pictorially. Data from 65 patients with traumatic brain injury (TBI) and 15 normal controls support the dual proposition that (1) abnormal finger tapping patterns are more commonly observed in TBI patients than in controls and (2) the frequency of abnormal finger movements may relate to the severity of TBI during the acute stages after trauma. Future prospective studies are needed to replicate these findings.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Sect Neuropsychol, Phoenix, AZ USA		Prigatano, GP (corresponding author), Barrow Neurol Inst, Dept Clin Neuropsychol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.						DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead W.C., 1947, BRAIN INTELLIGENCE; Heilman K.M., 1993, CLIN NEUROPSYCHOLOGY, P141; JENNETT B, 1974, MANAGEMENT HEAD INJU; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; JOHNSON SC, 2000, BNI Q, V16, P155; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; PRIGATANO GP, 1976, J CONSULT CLIN PSYCH, V44, P527, DOI 10.1037/0022-006X.44.4.527; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P847, DOI 10.1016/S0003-9993(97)90198-2; PRIGATANO GP, 1995, MANUAL BNI SCREEN HI; Prigatano GP, 1997, BNI Q, V13, P14; REITAN RM, 1994, CLIN NEUROPSYCHOL, V8, P193, DOI 10.1080/13854049408401557; Reitan RM., 1955, MANUAL ADM NEUROPSYC; VEGA A, 1967, J CONSULT PSYCHOL, V31, P619, DOI 10.1037/h0025112; [No title captured]	18	16	16	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2003	9	1					128	133		10.1017/S1355617703000134			6	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	661HL	WOS:000181885100013	12570365				2022-02-06	
J	Yamamoto, T; Mori, K; Maeda, M				Yamamoto, T; Mori, K; Maeda, M			Assessment of prognostic factors in severe traumatic brain injury patients treated by mild therapeutic cerebral hypothermia therapy	NEUROLOGICAL RESEARCH			English	Article						cerebral perfusion pressure; hypothermia; intracranial pressure; jugular venous blood oxygen saturation; prognosis; traumatic brain injury	SEVERE HEAD-INJURY; NITRIC-OXIDE SYNTHESIS; MODERATE HYPOTHERMIA; NEURONAL INJURY; METABOLIC-RATE; BLOOD-FLOW; TEMPERATURE; MANAGEMENT; ISCHEMIA; RELEASE	This study analyzed the predictable factors of outcome such as neuro-para meters and systemic complications to elucidate the indications for therapeutic hypothermia. In our institute, 35 patients with severe head injury (Glasgow Coma Scale 3-7) were treated with mild hypothermia therapy (33degrees-35degreesC). Twenty-two of these 35 patients underwent complete neuromonitoring and outcome assessments by Glasgow Outcome Scale (GOS) at three months after injury. GOS of hypothermia group was significantly better than another patient group which was treated without mild hypothermia therapy. The hypothermia group was divided into two groups: good outcome (GOOD) (good recovery or moderate disability; n = 9, 40.9%) and poor outcome (POOR) (severe disability, vegetative state, or death, n = 13, 59.1%). The mean age (mean 30.2 years, range 9-46) was significantly lower in GOOD than in POOR (mean 45.2 years, range 17-62). Patients aged over 50 years had poor outcome. CPP was significantly higher in GOOD during hypothermia. All patients with thrombocytopenia had poor outcome. Hypothermia therapy can improve outcome in patients with traumatic brain injury who are younger than 50 years old, without severe brain damage, and if improvement of cerebral perfusion is expected. Systemic complications must be prevented as far as possible by combination with other therapies.	Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, Izunagaoka Cho, Shizuoka 4102295, Japan		Yamamoto, T (corresponding author), Juntendo Univ, Izunagaoka Hosp, Dept Neurosurg, 1129 Nagaoka, Izunagaoka Cho, Shizuoka 4102295, Japan.						Alkan T, 2001, NEUROSURG QUART, V11, P96, DOI 10.1097/00013414-200106000-00003; Aoki A, 2002, NEUROL RES, V24, P271, DOI 10.1179/016164102101199909; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHOPP M, 1991, STROKE, V22, P37, DOI 10.1161/01.STR.22.1.37; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; FREWEN TC, 1989, CRIT CARE MED, V17, P912, DOI 10.1097/00003246-198909000-00015; Fujisawa H, 1999, J NEUROTRAUM, V16, P1083, DOI 10.1089/neu.1999.16.1083; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; Mori K, 1998, NEUROL RES, V20, P719; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	30	16	17	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	DEC	2002	24	8					789	795		10.1179/016164102101200906			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622PR	WOS:000179655900008	12500702				2022-02-06	
J	Zhou, F; Braddock, JF; Hu, Y; Zhu, XW; Castellani, RJ; Smith, MA; Drew, KL				Zhou, F; Braddock, JF; Hu, Y; Zhu, XW; Castellani, RJ; Smith, MA; Drew, KL			Microbial origin of glutamate, hibernation and tissue trauma: an in vivo microdialysis study	JOURNAL OF NEUROSCIENCE METHODS			English	Article; Proceedings Paper	9th International Conference on In Vivo Methods Monitoring Molecules in Neuroscience	JUN 16-19, 2001	UNIV COLL DUBLIN, DUBLIN, IRELAND	Natl Univ Ireland	UNIV COLL DUBLIN	excitotoxicity; microdialysis; Ralstonia; hibernation; penetrating brain injury; Pseudomonas; Burkholderia	GAMMA-AMINOBUTYRIC-ACID; EXCITATORY AMINO-ACIDS; GROUND-SQUIRRELS; BRAIN INJURY; EXTRACELLULAR GLUTAMATE; RELEASE; CALCIUM; SUPPRESSION; MENINGITIS; METABOLISM	Using quantitative microdialysis in hibernating Arctic ground squirrels (AGS), striatal glutamate concentrations ([glu](dia)) progressively increased to approximately 200 muM after 3 days of microdialysis in euthermic but not hibernating ground squirrels. Initially, the progressive increase in [glu](dia) was thought to be related to greater tissue response in euthermic animals. Alternatively, given the vastly different body temperatures between the two groups (37 vs. 3 degreesC), glutamate might have originated from microbes," replicating at a faster rate in the warmer animals. To test these hypotheses, microdialysis was repeated using sterile technique and tissue response surrounding the probe tract was assessed in hematoxylin and eosin stained sections. Using sterile microdialysis technique, traumatic tissue response was greater in euthermic compared to hibernating tissue. However, sterile microdialysis abolished the progressive increase in glutamate. To confirm the microbial origin of glutamate we monitored [glu](dia), collected in vitro from probes immersed in glutamine-rich liquid medium incubated at 37 degreesC. In vitro, [glu](dia) increased as much as in vivo. Two bacteria isolated from in vitro dialysate and liquid medium were both identified as Ralstonia pickettii. Growth of these isolates as well as glutamate release was enhanced when glutamine rather than NH4NO3 was added to the medium suggesting the bacteria utilize glutamine preferentially over ammonium as a nitrogen source. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Alaska, Inst Arctic Biol, Dept Chem & Biochem, Fairbanks, AK 99775 USA; Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA		Drew, KL (corresponding author), Univ Alaska, Inst Arctic Biol, Dept Chem & Biochem, POB 757000, Fairbanks, AK 99775 USA.		Drew, Kelly L/B-7995-2013; Zhu, Xiongwei/A-9629-2009; Smith, Mark A/A-9053-2009; Castellani, Rudy J/A-9555-2009	Zhu, Xiongwei/0000-0003-2092-6508; 	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS41069-01, NS38648] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038648, U54NS041069] Funding Source: NIH RePORTER		Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; BURKOVSKI A, 1995, ARCH MICROBIOL, V164, P24; Drew KL, 1999, BRAIN RES, V851, P1, DOI 10.1016/S0006-8993(99)01969-1; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; DREW KL, 1991, J NEUROCHEM, V57, P1927, DOI 10.1111/j.1471-4159.1991.tb06405.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; FRERICHS KU, 1995, AM J PHYSIOL-REG I, V268, pR445, DOI 10.1152/ajpregu.1995.268.2.R445; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Gentile NT, 1996, NEUROCHEM RES, V21, P947, DOI 10.1007/BF02532345; Glazer A.N., 2007, MICROBIAL BIOTECHNOL; GUERRAROMERO L, 1993, PEDIATR RES, V33, P510, DOI 10.1203/00006450-199305000-00018; HU Y, 1998, SOC NEUR ABSTR, P676; Kaufman B A, 1990, Infect Dis Clin North Am, V4, P677; LACY S, 1991, J HOSP INFECT, V17, P45; LYMAN CP, 1948, J EXP ZOOL, V109, P55, DOI 10.1002/jez.1401090105; MCKENNA, 1968, P SOC EXP BIOL MED, V129, P720; Neidhardt FC., 1990, PHYSL BACTERIAL CELL; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Osborne PG, 1999, BRAIN RES, V839, P1, DOI 10.1016/S0006-8993(99)01627-3; PHILLIPS I, 1972, LANCET, V1, P1258; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; SIDKY YA, 1969, P SOC EXP BIOL MED, V132, P760; SNAPP BD, 1981, PHYSIOL ZOOL, V54, P297, DOI 10.1086/physzool.54.3.30159944; Spranger M, 1996, ARCH NEUROL-CHICAGO, V53, P992, DOI 10.1001/archneur.1996.00550100066016; TOEIN O, 2001, AM J PHYSIOL, V281, pR572; WESTERINK BHC, 1988, N-S ARCH PHARMACOL, V337, P373, DOI 10.1007/BF00169526; White D., 1995, PHYSL BIOCH PROKARYO; Xue CJ, 1996, J NEUROCHEM, V67, P352; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X	31	16	17	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2002	119	2					121	128	PII S0165-0270(02)00177-2	10.1016/S0165-0270(02)00177-2			8	Biochemical Research Methods; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	610RZ	WOS:000178975700003	12323415				2022-02-06	
J	Duchnick, JJ; Vanderploeg, RD; Curtiss, G				Duchnick, JJ; Vanderploeg, RD; Curtiss, G			Identifying retrieval problems using the California Verbal Learning Test	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; RECOGNITION-RECALL DISCREPANCIES; CLOSED-HEAD INJURY; MEMORY DEFICITS; PATTERNS; CVLT; ACQUISITION; COMA	Wilde, Boake, and Sherer (1995) examined the discrepancy between Long Delayed Free Recall (LDFR) and Recognition Discriminability (RD)-the California Verbal Learning Test (CVLT) index thought to indicate the presence of memory retrieval problems-and found little evidence to recommend its use in traumatic brain injury (TBI). The present investigation re-examined this index from the perspective of a continuum of retrieval deficit severity. CVLT performance was examined in 122 TBI patients, and 2 retrieval deficit indicators of varying severity were evaluated. Memory-impaired control groups were matched with retrieval deficit groups on initial acquisition and demographic characteristics. Individuals with a LDFR/RD discrepancy did not show predicted differences on other CVLT indices of retrieval problems, similar to the findings of Wilde et al. (1995). In contrast, individuals with a consistent discrepancy between free recall and semantic cued recall (Short and Long Delay) had greater improvement with recognition cueing and made fewer intrusive errors than controls. Individuals who benefited from semantic cues (where retrieval of the target word is still required) also benefited from recognition cues (where retrieval demands are minimal). Evidence supported the existence of a continuum of retrieval deficit severity. An LDFR/RD discrepancy without performance improvement from semantic cueing appears to indicate a more severe retrieval deficit, whereas performance improvement from both recognition and semantic cueing indicates less severe retrieval deficits.	James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA; Univ S Florida, Dept Psychiat, Tampa, FL 33620 USA; Univ S Florida, Dept Psychol, Tampa, FL 33620 USA		Duchnick, JJ (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA.		Curtiss, Glenn/ABB-5566-2020				Baum KM, 1996, CLIN NEUROPSYCHOL, V10, P340; Cicchetti DV, 1997, J CLIN EXP NEUROPSYC, V19, P144, DOI 10.1080/01688639708403844; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 2000, CALIFORNIA VERBAL LE; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Fuerst DR, 1997, J CLIN EXP NEUROPSYC, V19, P149, DOI 10.1080/01688639708403845; Hart R. P., 1994, NEUROPSYCHOLOGY, V8, P325, DOI [10.1037/0894-4105.8.3.325, DOI 10.1037/0894-4105.8.3.325]; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MASSMAN PJ, 1990, J CLIN EXP NEUROPSYC, V12, P729, DOI 10.1080/01688639008401015; NOVACK TA, 1995, CLIN NEUROPSYCHOL, V9, P38; Spencer J, 1998, CLIN NEUROPSYCHOL, V12, P296; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P141, DOI 10.1080/01688639708403843; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; Wilde MC, 1997, J CLIN EXP NEUROPSYC, V19, P153, DOI 10.1080/01688639708403846	22	16	17	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP	2002	24	6					840	851		10.1076/jcen.24.6.840.8405			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	611UM	WOS:000179036200012	12424657				2022-02-06	
J	Al-Haddad, SA; Kirollos, R				Al-Haddad, SA; Kirollos, R			A 5-year study of the outcome of surgically treated depressed skull fractures	ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND			English	Article						head injury; depressed skull fractures; post-traumatic epilepsy; neurosurgical infection; outcome	ANTIBIOTIC-PROPHYLAXIS; NONMISSILE INJURIES; INFECTION; MANAGEMENT	Background: Many changes and improvement have taken place in the management of head injured patients in the last 20 years. There have been few recent studies analysing the overall outcomes including early complications of depressed skull fractures. The aim of our study was, therefore, to examine the factors influencing the surgical outcome of patients with depressed skull fractures. Methods: We reviewed case notes of 73 consecutive surgically treated depressed skull fractures during the period from 1 January 1994 to 31 December 1998 admitted to the Walton Centre for Neurology and Neurosurgery Liverpool. Results: There was a male preponderance of 9:1. Alleged assault was the most common cause of depressed skull fractures followed by road traffic accidents. Postoperative infection rate was 8.2%. More than 80% of patients received prophylactic antibiotics. We failed to show any statistically significant association between the use of antibiotics and reduction of the rate of infection. However, prevalence of infection was significantly associated with brain contusion, low GCS score and dural tear (P < 0.05). Prevalence of early post-traumatic epilepsy was 12.3%. No patients received prophylactic anticonvulsants. There was no significant association between dural tear and prevalence of post-traumatic epilepsy. Mortality rate was 1.4%. Conclusions: Paediatric populations have better outcome; 7 out of 10 patients in this series progressed to full recovery. Use of prophylactic antibiotics did not reduce the infection rate. Presence of dural tear was not associated with an increase risk of post-traumatic epilepsy.	Walton Ctr Neurol & Neurosurg, Liverpool L9 7LJ, Merseyside, England				Al-Haddad, S. A. R./AAM-6449-2020				American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; BRAAKMAN R, 1971, J NEUROL NEUROSUR PS, V34, P106, DOI 10.1136/jnnp.34.1.106; BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V32, P395; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; BROWN EM, 1994, LANCET, V344, P1547; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; DUNN LT, 1994, ANN ROY COLL SURG, V76, P147; GERAGHTY J, 1984, J NEUROSURG, V60, P724, DOI 10.3171/jns.1984.60.4.0724; HAINES SJ, 1982, J NEUROSURG, V56, P103, DOI 10.3171/jns.1982.56.1.0103; JAMIESON KG, 1972, J NEUROSURG, V36, P333; JENNETT B, 1972, J NEUROSURG, V36, P333, DOI 10.3171/jns.1972.36.3.0333; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1974, J NEUROSURG, V41, P208, DOI 10.3171/jns.1974.41.2.0208; JENNETT B, 1975, EPILEPSY NONMISSILE; MALIS LI, 1979, NEUROSURGERY, V5, P339, DOI 10.1227/00006123-197909000-00006; Mendelow A D, 1983, J R Coll Surg Edinb, V28, P80; MENDELOW AD, 1989, J R COLL SURG EDINB, V71, P186; MILLER JD, 1968, LANCET, V2, P991; PAGNI CA, 1990, ACT NEUR S, V50, P38; Plese J P, 1981, Arq Neuropsiquiatr, V39, P286; SANDE GM, 1980, SCOT MED J, V25, P227, DOI 10.1177/003693308002500308; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; *WORK PART NEUR SO, 1996, REC TRANSF PAT AC HE; Wylen EL, 1999, SURG NEUROL, V51, P452, DOI 10.1016/S0090-3019(98)00040-8	25	16	17	0	1	ROYAL COLL SURGEONS ENGLAND	LONDON	35-43 LINCOLN'S INN FIELDS, LONDON WC2A 3PN, ENGLAND	0035-8843			ANN ROY COLL SURG	Ann. R. Coll. Surg. Engl.	MAY	2002	84	3					196	200					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	560TW	WOS:000176098300014	12092875				2022-02-06	
J	Csokay, A; Pataki, G; Nagy, L; Belan, K				Csokay, A; Pataki, G; Nagy, L; Belan, K			Vascular tunnel construction in the treatment of severe brain swelling caused by trauma and SAH. (Evidence based on intra-operative blood flow measure)	NEUROLOGICAL RESEARCH			English	Article						traumatic brain swelling; decompressive craniectomy; vascular tunnel	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; CEREBRAL EDEMA; INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; MANAGEMENT; BIOMECHANICS; CRANIOTOMY; PRESSURE; SUPPORT	Decompressive craniectomy with durotomy, is possible as a last resort therapy for severe traumatic brain swelling. Although the method successfully diminishes the ICP, partial or total vascular insufficiency occurs in the herniated part of the brain. The actual cause of the insufficiency is most likely due to the compression of the cortical veins and arteries supplying the herniated brain, caused by shearing and pressure forces between the dural edge and brain tissue. Furthermore venous congestion may induce edema in the protruding parts of the brain, thus further compromising neurone viability. The new surgical technique consists of a stellate type durotomy and the creation of a vascular tunnel around the main cortical veins and arteries, with the aim that the vessels do not become compressed by the dural or bone edge. The effect of the novel vascular tunnel technique was proven by measuring the blood flow of the protected and nonprotected veins with Doppler UH, intra-operatively. In the last two years 28 patients were operated on with this method. One case of edema was caused by SAH. All were in severe GCS 3 or GCS 4 status, with more than 30 mmHg ICP. In comparison with the traditional surgical and nonsurgical treatment, where the reported mortality rates are 80%-90% in these severe cases the mortality rate was reduced to 40%, and recovery (GOS 4, 5) rate also increased significantly. With this technique the ICP was significantly reduced and further edema and vascular insufficiency was prevented. This was due to protection of the arterial circulation and venous drainage of the herniated part of the brain, by the formation of a vascular tunnel at the durotomy edges.	Natl Inst Traumatol, H-1081 Budapest, Hungary		Csokay, A (corresponding author), Natl Inst Traumatol, Fiumei Ut 17, H-1081 Budapest, Hungary.	parkdros@elender.hu	Guo, Ruyan/E-1714-2011; Bhalla, Amar S/E-2203-2011	Guo, Ruyan/0000-0002-7661-6042; 			Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Bagley RS, 1996, AM J VET RES, V57, P116; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; COSKAY A, 2001, HUNGARIAN MED J, V142, P75; Csokay A, 2001, ACTA NEUROCHIR, V143, P173, DOI 10.1007/s007010170125; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB MR, 1990, ACT NEUR S, V51, P326; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Harrington ML, 1996, AM J VET RES, V57, P1659; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hieu PD, 1996, CHILD NERV SYST, V12, P270; KERR FWL, 1968, P M MAYO CLIN STAFF, V43, P852; KIRKHAM FJ, 1986, DEV MED CHILD NEUROL, V28, P506; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; RINALDI A, 1990, ACT NEUR S, V51, P394; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; WHITFIELD P, 1995, STROKE, V26, P1125; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	34	16	18	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2002	24	2			SI		157	160	UNSP 0161-6412/02/020157-04	10.1179/016164102101199701			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	521YR	WOS:000173869400007	11877899				2022-02-06	
J	Reed, AR; Welsh, DG				Reed, AR; Welsh, DG			Secondary injury in traumatic brain injury patients - A prospective study	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							COMATOSE PATIENTS; HEAD-INJURY; HEMATOMA	Objective. Secondary insults of hypotension and hypoxia significantly impact on outcome in patients with traumatic brain injury (TBI). More than 4 hours' delay in evacuation of intracranial haematomas has been demonstrated to have an additional impact on outcome. The objective of this study was to document the incidence of these preventable secondary insults in patients admitted with moderate or severe brain injury. Methodology. All moderate and severe head injury patients admitted to Groote Schuur Hospital over a 3-month period were studied prospectively. Data were obtained from ambulance dockets, referral letters, patient charts and attending medical staff. Preventable secondary insults (hypotension, hypoxia) and time delay to assessment and surgery were documented. Outcome was assessed using the Glasgow outcome scale (GOS) at discharge or outpatient follow-up. Results. Ninety-six patients were studied. Forty-nine patients experienced at least one recorded preventable event of hypoxia or hypotension. Seventeen had an intracranial haematoma requiring evacuation. The mean time interval between injury and surgery was 455 minutes. No haematoma was evacuated within 4 hours of injury. Patients referred via a primary or secondary care facility experienced a mean additional delay of 70 minutes. These results demonstrated a significant incidence of secondary injury and delay to assessment and surgery. We believe that education and a raised awareness of the impact of secondary insults may have a positive impact on TBI outcome in our referral area.	Groote Schuur Hosp, Dept Anaesthesia, ZA-7925 Cape Town, South Africa; Groote Schuur Hosp, Dept Neurosurg, ZA-7925 Cape Town, South Africa		Reed, AR (corresponding author), Groote Schuur Hosp, Dept Anaesthesia, ZA-7925 Cape Town, South Africa.						CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SEELIG JM, 1984, NEUROSURGERY, V15, P617, DOI 10.1227/00006123-198411000-00001; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363	8	16	22	0	2	MED ASSOC S AFRICA	JOHANNESBURG	MED HOUSE CENTRAL SQ 7430 PINELANDS  PRIV BAG X1, JOHANNESBURG, SOUTH AFRICA	0256-9574			SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	MAR	2002	92	3					221	224					4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553YE	WOS:000175704200028	12040951				2022-02-06	
J	Beaumont, A; Hayasaki, K; Marmarou, A; Barzo, P; Fatouros, P; Corwin, F				Beaumont, A; Hayasaki, K; Marmarou, A; Barzo, P; Fatouros, P; Corwin, F			Contrasting effects of dopamine therapy in experimental brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral perfusion pressure; dopamine; edema; magnetic resonance spectroscopy; secondary insult; traumatic brain injury	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; PERFUSION-PRESSURE; INTRACRANIAL HYPERTENSION; ARTERIAL-PRESSURE; IMPACT INJURY; TRAUMA; EDEMA; AUTOREGULATION; MORTALITY	Management of cerebral perfusion pressure (CPP) is thought to be important for the treatment of traumatic brain injury (TBI). Vasopressors have been advocated as a method of increasing mean arterial blood pressure (mABP) and cerebral perfusion pressure (CPP) in the face of rising intracranial pressure (ICP). There are unresolved issues and theoretical risks about this therapy. This study therefore examined the effects of dopamine on physiological and MRI/MRS parameters in (1) a rodent model of rapidly rising intracranial pressure, caused by diffuse injury with secondary insult and (2) a model of cortical contusion. Dopamine was capable of restoring CPP in the model of rapidly rising ICP. This CPP restoration was associated with a partial restoration of CBF. Two profiles of change in the Apparent Diffusion Coefficient of water (ADC(W)) were seen; one in which ADC(W) recovered to baseline, and one in which ADC(W) remained persistently low. Dopamine did not alter these profiles. MRI assessed tissue water content was increased four hours after injury and dopamine increased cerebral water content in both subgroups of injury; significantly in the group with a persistently low ADC(W) (p < 0.01). In contusional injury, dopamine significantly worsened edema in both the ipsi- and contralateral hippocampus and temporal cortex. This occurred in the absence of ADC(W) changes, except in the contralateral hippocampus, where both water content and ADC(W) values rose with treatment, suggesting extracellular accumulation of water. In conclusion, although dopamine is capable of partially restoring CBF after injury, situations exist in which dopamine therapy worsens the swelling process. It is possible therefore that subgroups of patients exist who experience adverse effects of vasopressor treatment, and consequently the effects of vasopressor therapy in the clinical setting need to be more carefully evaluated.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Phys, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Physiol, Richmond, VA 23298 USA		Marmarou, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA.		Beaumont, Andrew/AAJ-7457-2020				ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; AUKLAND K, 1964, CIRC RES, V14, P164, DOI 10.1161/01.RES.14.2.164; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P115; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; DeWitt DS, 1997, J NEUROTRAUM, V14, P931, DOI 10.1089/neu.1997.14.931; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; EDVINSSON L, 1985, BRIT J PHARMACOL, V85, P403, DOI 10.1111/j.1476-5381.1985.tb08875.x; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MARION DW, 1993, J NEUROSURG, V78, pA347; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1975, J NEUROL NEUROSUR PS, V38, P657, DOI 10.1136/jnnp.38.7.657; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, INTRACRANIAL PRESSUR, P508; NAG S, 1977, LAB INVEST, V36, P150; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; Paolin A, 1998, J TRAUMA, V44, P495, DOI 10.1097/00005373-199803000-00012; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1990, J TRAUMA, V30, P949; SCHUTTA HS, 1968, BRAIN, V91, P281, DOI 10.1093/brain/91.2.281; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; WESTERGAARD E, 1977, ACTA NEUROPATHOL, V37, P141, DOI 10.1007/BF00692060; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	46	16	16	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2001	18	12					1359	1372		10.1089/08977150152725650			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	504RE	WOS:000172869000006	11780866				2022-02-06	
J	Csokay, A; Nagy, L; Novoth, B				Csokay, A; Nagy, L; Novoth, B			Avoidance of vascular compression in decompressive surgery for brain edema caused by trauma and tumor ablation	NEUROSURGICAL REVIEW			English	Article; Proceedings Paper	Traumatic Brain Injury Symposium EBIS	SEP 20-23, 2000	PARIS, FRANCE			decompressive surgery; traumatic brain swelling; operative technique; vascular tunnel	HEAD-INJURY; CEREBRAL EDEMA; CRANIECTOMY; BIOMECHANICS; SUPPORT; RAT	Background. In case of severe brain swelling especially caused by trauma or other operative manipulation (tumor ablation), decompressive craniectomy with durotomy has not resulted in significant chances of recovery. Decompressive craniectomy has been defined only as an option within guidelines. Method. A new operative technique was developed to improve the efficacy of decompressive surgery. With an increase in intracranial pressure (ICP) threatening with brainstem herniation, wide bilateral craniectomy was carried out, followed by dura opening and subsequent formation of a vascular tunnel in a simple way -using hemostatic sponge cushions around the main cortical veins at the entering points of the herniated area. The maintenance of vessel patency prevents the herniated brain segment from venous congestion, i.e., from further swelling and necrosis. Results. Twenty operations with traumatic brain edema were performed using this vascular tunnel method. All patients were exposed to surgery in the state of coma. One operation was performed after tumor removal. The results were promising in comparison with the well-known surgical or conservative treatment. Discussion. Applying very strict selection criteria (Glasgow coma scale <6, signs of severe edema on CT, or intracranial pressure permanently greater than or equal to 30 mmHg) in this small series of patients with severe brain injury, good results were achieved using the new operative technique. In case of postoperative edema after tumor ablation, it also showed promising results.	Natl Inst Traumatol, Dept Neurosurg, H-1039 Budapest, Hungary		Csokay, A (corresponding author), Natl Inst Traumatol, Dept Neurosurg, Fiumei Ut 17, H-1039 Budapest, Hungary.	parkdros@elender.hu					Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; CSOKAY A, 2000, CHILDS NERV SYST S, V16, P371; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB MR, 1990, ACT NEUR S, V51, P326; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; ISHII S, 1983, INTRACRANIAL PRESSUR, P549; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; RINALDI A, 1990, ACT NEUR S, V51, P394; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Shigemori M, 1979, Acta Neurochir Suppl (Wien), V28, P195; Shimada K, 1999, SPINAL CORD, V37, P410, DOI 10.1038/sj.sc.3100858; WHITFIELD P, 1995, STROKE, V26, P1125; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	29	16	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	DEC	2001	24	4					209	213		10.1007/s101430100158			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	505VY	WOS:000172937300010	11778828				2022-02-06	
J	Jacobs, U; Iacopino, V				Jacobs, U; Iacopino, V			Torture and its consequences: A challenge to clinical neuropsychology	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN INJURY	The high incidence of head trauma and other causes of brain damage during political torture challenges psychologists and other health professionals to consider the need for thorough neurological and neuropsychological evaluations of the survivors they may treat. In this article, the authors argue for contributions to the assessment, documentation, and rehabilitation of the consequences of torture from the perspective of clinical neuropsychology on the basis of ethical, humanitarian, and epidemiological considerations. Traumatic brain injury and posttraumatic stress disorder are among the most common sequelae of torture. Neuropsychologists are uniquely qualified to make significant contributions in this area. Indications and limitations of the utility of neuropsychological assessment in the documentation of torture are discussed, and a brief clinical case study is provided.	Survivors Int, San Francisco, CA 94108 USA		Jacobs, U (corresponding author), Survivors Int, 447 Sutter St,Suite 811, San Francisco, CA 94108 USA.						Basoglu M, 1992, TORTURE ITS CONSEQUE; DALTON JE, 1989, INT J CLIN NEUROPSYC, V11, P121; Fastenau PS, 1996, J CLIN EXP NEUROPSYC, V18, P444; Fletcher-Janzen E., 2000, HDB CROSS CULTURAL N; Fuld P. A., 1977, FULD OBJECT MEMORY E; GIANUTSOS R, 1991, Brain Injury, V5, P353, DOI 10.3109/02699059109008108; Gil T., 1990, J TRAUMA STRESS, V3, P29, DOI DOI 10.1002/JTS.2490030104; Gorman W, 2001, PROF PSYCHOL-RES PR, V32, P443; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; Iacopino V, 1996, JAMA-J AM MED ASSOC, V276, P396, DOI 10.1001/jama.276.5.396; IACOPINO V, IN PRESS MANUAL EFFE; IFORTUNY LA, 1998, CLIN NEUROPSYCHOL, V12, P113; IVNIK RJ, 1978, AM PSYCHOL, V33, P766; Jacobs DM, 1997, J CLIN EXP NEUROPSYC, V19, P331, DOI 10.1080/01688639708403862; Jacobs Uwe, 2000, TORTURE, V10, P68; Jaranson JM, 1998, CARING FOR VICTIMS OF TORTURE, P15; Jaranson JM, 1995, TRANSCULT PSYCHIATRY, V32, P253; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; KAPLAN E, 1988, CLIN NEUROPSYCHOLOGY, P127; Knight J, 1997, ASSESSING PSYCHOL TR; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LURIA AR, 1977, AM PSYCHOL, V32, P959, DOI 10.1037/0003-066X.32.11.959; McAllister Thomas W., 1994, P357; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P1567; Nell V., 2000, CROSS CULTURAL NEURO; PEEL M, 2000, TORTURE, V1, P12; Price K. P., 1994, DEF LAW J, V43, P113; RASMUSSEN OV, 1990, DAN MED B, V1, P1; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Suedfeld Peter, 1990, PSYCHOL TORTURE; TRAUE HC, 1997, VERHALTENSTHERAPIE V, V1, P41; VANDERKOLK BA, 1994, HARVARD REV PSYCHIAT, V1, P253, DOI 10.3109/10673229409017088	34	16	16	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028			PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	OCT	2001	32	5					458	464		10.1037/0735-7028.32.5.458			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	478DB	WOS:000171326700003					2022-02-06	
J	Ozveren, MF; Uchida, K; Erol, FS; Tiftikci, MT; Cobanoglu, B; Kawase, T				Ozveren, MF; Uchida, K; Erol, FS; Tiftikci, MT; Cobanoglu, B; Kawase, T			Isolated abducens nerve paresis associated with incomplete Horner's syndrome caused by petrous apex fracture - Case report and anatomical study	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						abducens nerve; incomplete Horner's syndrome; petrous apex fracture; sympathetic plexus	PALSY; MECHANISM; INJURY	A 17-year-old male presented with a wound on the right temporal region, oozing hemorrhagic necrotic brain tissue and cerebrospinal fluid, following a fall. Computed tomography showed temporoparietal and petrous apex fractures on the right. Neurological examination revealed abducens nerve paresis, ptosis, and myosis on the right side. The patient was treated surgically for the removal of the free bony fragments at the fracture site and to close the dural tear. The abducens nerve paresis, ptosis, and myosis persisted at the 3rd monthly postoperative follow-up examination. The anatomy of the abducens nerve at the petroclival region was studied in four cadaveric heads. Two silicone-injected heads were used for microsurgical dissections and two for histological sections. The abducens nerve has three different angulations in the petroclival region, located at the dural entrance porus, the petrous apex, and the lateral wall of the cavernous segment of the internal carotid artery. The abducens nerve had fine anastomoses with the trigeminal nerve and the periarterial sympathetic plexus. There were fibrous connections extending inside the venous space of the petroclival area. The abducens nerve seems to be vulnerable to damage in the petroclival region, either directly by trauma to its dural porus and petrous apex or indirectly by stretching of the nerve through the nervous and/or fibrous connections. Concurrent functional loss of the abducens nerve and the periarterial sympathetic plexus clinically manifested as incomplete Horner's syndrome in our patient.	Firat Univ, Sch Med, Dept Neurosurg, Arastirma Hastanesi, TR-23200 Elazig, Turkey; Firat Univ, Sch Med, Dept Pathol, TR-23200 Elazig, Turkey; Keio Univ, Sch Med, Dept Neurosurg, Tokyo 160, Japan		Ozveren, MF (corresponding author), Firat Univ, Sch Med, Dept Neurosurg, Arastirma Hastanesi, TR-23200 Elazig, Turkey.						ANSON J, 1991, NEUROSURGERY, V29, P89, DOI 10.1227/00006123-199107000-00015; ARIAS MJ, 1985, NEUROSURGERY, V16, P232, DOI 10.1227/00006123-198502000-00020; CSERR HF, 1971, PHYSIOL REV, V51, P273, DOI 10.1152/physrev.1971.51.2.273; Destrieux C, 1997, J NEUROSURG, V87, P67, DOI 10.3171/jns.1997.87.1.0067; GUTMAN I, 1986, OPHTHALMOLOGY, V93, P913; HARDMAN JM, 1991, TXB NEUROPATHOLOGY, P962; Kanpolat Y, 1999, NEUROSURGERY, V44, P1364; KRIVOSIC I, 1987, CAVERNOUS SINUS, P117; LAZOW SK, 1995, J ORAL MAXIL SURG, V53, P1197, DOI 10.1016/0278-2391(95)90634-7; OVERBEEKE J J V, 1991, Neurosurgery (Baltimore), V29, P838; PARKINSON D, 1978, ANAT REC, V191, P221, DOI 10.1002/ar.1091910207; SCHNEIDER RC, 1971, J NEUROSURG, V34, P33, DOI 10.3171/jns.1971.34.1.0033; STRIPH GG, 1988, J CLIN NEURO-OPHTHAL, V8, P13; Takagi H, 1976, No Shinkei Geka, V4, P963; Turner JWA, 1943, BRAIN, V66, P140; UMANSKY F, 1992, LARYNGOSCOPE, V102, P1285, DOI 10.1288/00005537-199211000-00016; Uzan M, 1996, Eur Spine J, V5, P275, DOI 10.1007/BF00301333; Ziyal IM, 1998, ACTA NEUROCHIR, V140, P201, DOI 10.1007/s007010050086	18	16	18	0	3	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0387-2572			NEUROL MED-CHIR	Neurol. Med.-Chir.	OCT	2001	41	10					494	498		10.2176/nmc.41.494			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	481ZM	WOS:000171550400012	11760384	Bronze			2022-02-06	
J	Pusch, F; Wildling, E; Freitag, H; Weinstabl, C				Pusch, F; Wildling, E; Freitag, H; Weinstabl, C			Procalcitonin as a diagnostic marker in patients with aspiration after closed head injury	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						closed head injury; procalcitonin; aspiration; prognostic; C-reactive protein	GENE-RELATED PEPTIDE; C-REACTIVE PROTEIN; GLASGOW COMA SCALE; SERUM PROCALCITONIN; CALCITONIN; PNEUMONIA; MORTALITY; SEPSIS; LUNG	Background: Aspiration of gastric content frequently induces early onset of pneumonia in patients with impaired consciousness after closed head injury and thus worsens the prognosis. Early detection of aspiration and appropriate therapy are essential. The purpose of the study was to assess the diagnostic value of procalcitonin (ProCT) in aspiration of gastric content and to evaluate its prognostic impact in patients with closed head injury. Methods: Twenty-three patients with isolated closed head injury (Glasgow Coma Scale [GCS] score less than or equal to 8) were studied. Bronchoscopy was done on admission; chest radiographs and routine laboratory examination including C-reactive protein were performed daily. ProCT was analyzed 12, 24, 36 and 72 hours after trauma using an immunoluminometric assay. Results: ProCT was higher throughout the study period in 9 patients with persistent radiological signs suspect for aspiration of gastric content and there was evidence of aspiration of gastric content during bronchoscopy on admission. Median ProCT values of 1.397 ng/ml (range, 0.372 to 8.358 ng/ml) on admission increased to 2.144 ng/ml (range, 0.716 to 6.910 ng/ml) 24 hours after trauma, and then decreased to baseline values of 1.711 ng/ml (range, 0.611 to 6.639 ng/ml) as early as 36 hours after trauma. In patients without signs of aspiration of gastric content, ProCT values did not exceed 0.418 ng/ml. Non-survivors had higher serum levels of ProCT throughout the study period. Conclusion: Our findings suggest that ProCT is a useful diagnostic marker for detecting aspiration of gastric content while the prognostic value of ProCT for predicting survival after isolated closed head injury was moderate.	Univ Vienna, Dept Anesthesiol & Gen Intens Care, A-1090 Vienna, Austria; Gen Hosp, Dept Anesthesiol & Gen Intens Care, Korneuburg, Austria		Pusch, F (corresponding author), Univ Vienna, Dept Anesthesiol & Gen Intens Care, Waehringer Guertel 18-20, A-1090 Vienna, Austria.						Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; Adnet F, 1997, CHEST, V112, P466, DOI 10.1378/chest.112.2.466; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; BECKER KL, 1980, ARCH PATHOL LAB MED, V104, P196; Carsin H, 1997, BURNS, V23, P218, DOI 10.1016/S0305-4179(96)00124-6; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; DANDONA P, 1994, J CLIN ENDOCR METAB, V79, P1605, DOI 10.1210/jc.79.6.1605; DOYLE RL, 1995, AM J RESP CRIT CARE, V152, P1818, DOI 10.1164/ajrccm.152.6.8520742; GOLDMAN G, 1993, SURGERY, V114, P13; HOLLAND JP, 1994, STROKE, V25, P2055, DOI 10.1161/01.STR.25.10.2055; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; LIND L, 1995, INTENS CARE MED, V21, P63, DOI 10.1007/BF02425156; Mimoz O, 1998, INTENS CARE MED, V24, P185, DOI 10.1007/s001340050543; NYLEN ES, 1992, HORM METAB RES, V24, P439, DOI 10.1055/s-2007-1003354; Nylen ES, 1996, AM J MED SCI, V312, P12, DOI 10.1016/S0002-9629(15)41740-9; Nylen ES, 1998, CRIT CARE MED, V26, P1001, DOI 10.1097/00003246-199806000-00015; REDDINGTON M, 1995, CAN J PHYSIOL PHARM, V73, P1047, DOI 10.1139/y95-148; SKOLNICK A, 1990, JAMA-J AM MED ASSOC, V264, P565; Woratyla S P, 1995, Conn Med, V59, P643	19	16	17	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0043-5325			WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	SEP 17	2001	113	17-18					676	680					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UZ	WOS:000171188800007	11603102				2022-02-06	
J	Isaksson, J; Hillered, L; Olsson, Y				Isaksson, J; Hillered, L; Olsson, Y			Cognitive and histopathological outcome after weight-drop brain injury in the rat: influence of systemic administration of monoclonal antibodies to ICAM-1	ACTA NEUROPATHOLOGICA			English	Article						adhesion molecules; brain injury; ICAM-1; Morris-Water maze; rat	INTERCELLULAR-ADHESION MOLECULE-1; CEREBRAL-ARTERY OCCLUSION; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD-INJURY; SPINAL-CORD INJURY; CENTRAL-NERVOUS-SYSTEM; ISCHEMIC CELL-DAMAGE; NEUTROPHIL ACCUMULATION; CONTUSION TRAUMA; EXPRESSION	The aim of this study was to evaluate whether treatment with the anti-ICAM-1 antibody 1A29 influences functional or histopathological outcome following severe controlled cortical contusion in rats. The spatial learning deficits were studied using Morris water maze (MWM) paradigm in which the animals were given four daily acquisition trials for four consecutive days, starting on day 10 post-injury. Both 1A29-treated (n=8) and vehicle-treated (n=8) traumatized animals needed longer time than sham-operated rats (n=8) to find the hidden escape platform on days 11, 12 and 13. Compared to shams, significantly increased escape latency was noted on day 12 in vehicle-treated group and on days 12 and 13 in 1A29-treated animals. MWM performance did not differ significantly between the two trauma groups. Histopathological evaluation of the injured brains 15 days after trauma revealed ipsilateral cortical cavitation as well as ipsilateral hippocampal and thalamic lesions. MAP2 immunostaining showed a nonsignificant tendency towards more pronounced hippocampal injury in the 1A29-treated animals. Image analysis of glial fibrillary acidic protein- and ionized calcium binding adapter molecule 1-immunostained sections revealed astrocytic activation in the ipsilateral thalamus and microglial activation in both ipsilateral thalamus and hippocampus of traumatized animals, but no significant differences between the trauma groups. In summary, this study shows that spatial memory deficits occur following a weight-drop injury to the rat brain. Treatment with the anti-ICAM-1 antibody 1A29 did not significantly change the recorded functional or histopathological measures of outcome.	Univ Uppsala Hosp, Res Grp Neuropathol, Dept Genet & Pathol, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden		Isaksson, J (corresponding author), Univ Uppsala Hosp, Res Grp Neuropathol, Dept Genet & Pathol, S-75185 Uppsala, Sweden.						Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; BERGERSWEENEY J, 1994, J NEUROSCI, V14, P4507; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; Cotran RS, 1998, PATHOL BIOL, V46, P164; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Farooque M, 1999, NEUROREPORT, V10, P131, DOI 10.1097/00001756-199901180-00024; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fujie K, 1999, EUR J PHARMACOL, V374, P117, DOI 10.1016/S0014-2999(99)00268-X; FUJITA H, 1994, ARCH BIOCHEM BIOPHYS, V309, P62, DOI 10.1006/abbi.1994.1085; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Grady MS, 1999, J NEUROTRAUM, V16, P13, DOI 10.1089/neu.1999.16.13; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Isaksson J, 1997, ACTA NEUROPATHOL, V94, P16, DOI 10.1007/s004010050666; Isaksson J, 1999, J NEUROTRAUM, V16, P165, DOI 10.1089/neu.1999.16.165; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nishimura Y, 1996, TRANSPLANTATION, V61, P99, DOI 10.1097/00007890-199601150-00020; Olschowka JA, 1997, BRAIN BEHAV IMMUN, V11, P273, DOI 10.1006/brbi.1997.0506; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Ranefall P, 1997, ANAL CELL PATHOL, V15, P145, DOI 10.1155/1997/304073; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Shibayama M, 1996, J NEUROTRAUM, V13, P801, DOI 10.1089/neu.1996.13.801; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SOBEL RA, 1990, AM J PATHOL, V136, P1309; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Taoka Y, 1998, BRAIN RES, V799, P264, DOI 10.1016/S0006-8993(98)00459-4; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; WASHINGTON R, 1994, ANN NEUROL, V35, P89, DOI 10.1002/ana.410350114; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; ZHANG RL, 1995, STROKE, V26, P1438, DOI 10.1161/01.STR.26.8.1438; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747; Zou LB, 1999, NEUROSCIENCE, V92, P819, DOI 10.1016/S0306-4522(99)00029-9	62	16	20	0	3	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	SEP	2001	102	3					246	256					11	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	470UD	WOS:000170888800006	11585249				2022-02-06	
J	Holtzer, S; Vigue, B; Ract, C; Samii, K; Escourrou, P				Holtzer, S; Vigue, B; Ract, C; Samii, K; Escourrou, P			Hypoxia-hypotension decreases pressor responsiveness to exogenous catecholamines after severe traumatic brain injury in rats	CRITICAL CARE MEDICINE			English	Article						experimental traumatic brain injury; hypoxia-hypotension; phenylephrine; alpha-1 adrenergic stimulation; pressor responsiveness; arterial pressure; intracranial pressure; cerebral perfusion pressure	CLOSED-HEAD INJURY; HEMORRHAGIC-SHOCK; AXONAL INJURY; INTRACRANIAL-PRESSURE; RESPONSES; MODEL; DYSFUNCTION; MUSCLE; CELLS	Objective. To quantify the phenylephrine pressor responsiveness after severe brain injury combined with hypoxia-hypotension, and to study the respective roles of brain injury and hypoxia-hypotension in the observed alteration. Design: Randomized study. Setting. Accredited animal laboratory. Subjects: Adult Sprague Dawley rats. Interventions: Anesthetized animals were assigned to control, brain injury, hypoxia-hypotension, and brain injury combined with hypoxia-hypotension groups. Brain injury was induced with an impact-acceleration device. During the 15-min hypoxia-hypotension, arterial oxygen pressure was decreased to 40 torr (5.3 kPa) and mean arterial pressure to 30 mm Hg. Thirty-six of the 53 included rats were alive at the end of hypoxia-hypotension (nine animals per group). In an additional group (Hypo, n = 8), mean arterial pressure was lowered to the level observed in brain injury combined with hypoxia-hypotension with pentobarbital infusion. Sixty minutes after injuries (T60), animals received 0.1, 1, and 10 mug/kg phenylephrine in a random order. Pressor responsiveness to phenylephrine was defined as maximal postinjection minus preinjection mean arterial pressure. Measurements and Main Results, During hypoxia-hypotension, mortality was higher and residual restored blood volume was lower (p < .01) in the animals with brain injury and hypoxia-hypotension compared with hypoxia-hypotension alone. At T60, mean arterial pressure (mm Hg) was lower (p < .01) in the brain injury group (83 +/- 22) compared with controls (110 +/- 10) and in brain injury combined with hypoxia-hypotension (76 +/- 18) compared with controls and hypoxia-hypotension (107 +/- 14). Pressor responsiveness (mm Hg) to 1 and 10 mug/kg phenylephrine was less (p < .05) in brain injury combined with hypoxia-hypotension (15 +/- 6 and 44 +/- 8) and hypoxia-hypotension (15 +/- 3 and 44 +/- 8) compared with controls (26 +/- 2 and 57 +/- 11). No significant difference was observed for phenylephrine pressor responsiveness between controls and the Hypo group (25 +/- 5 and 66 +/- 7). Conclusions, Combination of brain injury and hypoxia-hypotension induces a severe hemodynamic alteration associated with a decreased pressor responsiveness to phenylephrine. Transient hypoxia-hypotension is responsible for the depressed alpha -1 adrenergic reactivity.	Univ Paris Sud, Fac Med Bicetre, Physiol Lab, UPRESS EA 2704, F-94275 Le Kremlin Bicetre, France; Univ Paris Sud, Fac Med Bicetre, Lab Anesthesiol, F-94275 Le Kremlin Bicetre, France		Holtzer, S (corresponding author), Ctr Hosp Univ Beaujon APHP, Dept Anesthesie Reanimat, 110 Blvd Gen Leclerc, F-92118 Clichy, France.	sabine.holtzer@bjn.ap-hop-paris.fr					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DeWitt D S, 1995, New Horiz, V3, P376; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Gao H, 1996, FREE RADICAL BIO MED, V21, P591, DOI 10.1016/0891-5849(96)00157-8; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; KIRKEBY OJ, 1995, J NEUROSURG, V83, P1067, DOI 10.3171/jns.1995.83.6.1067; KITA H, 1994, ACTA NEUROCHIR, P452; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; LENOBLE JLML, 1987, ARCH INT PHARMACOD T, V289, P82; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856, DOI 10.1152/jappl.1980.49.5.856; MONTASSER A, 1994, J NEUROSURG, V80, P301; Nagashima M, 1997, GEN PHARMACOL, V28, P721, DOI 10.1016/S0306-3623(96)00356-4; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; PERBECK L, 1982, ACTA CHIR SCAND, V148, P3; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; STEINFATH M, 1992, BRIT J PHARMACOL, V107, P185, DOI 10.1111/j.1476-5381.1992.tb14484.x; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; WANG P, 1993, AM J PHYSIOL, V265, pH973, DOI 10.1152/ajpheart.1993.265.3.H973; WATKINS MT, 1995, AM J PHYSIOL-HEART C, V268, pH749, DOI 10.1152/ajpheart.1995.268.2.H749; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; WILSON SP, 1982, J NEUROSCI, V2, P1150; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; ZHAO KS, 1985, MICROVASC RES, V30, P143, DOI 10.1016/0026-2862(85)90046-9	36	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2001	29	8					1609	1614		10.1097/00003246-200108000-00018			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465FZ	WOS:000170580100018	11505138				2022-02-06	
J	Qureshi, AI; Suri, FK; Ling, GSF; Khan, J; Guterman, LR				Qureshi, AI; Suri, FK; Ling, GSF; Khan, J; Guterman, LR			Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage	NEUROSURGERY			English	Article; Proceedings Paper	53rd Annual Meeting of the American-Academy-of-Neurology	APR 05-12, 2001	PHILADELPHIA, PA	Amer Acad Neurol		cerebrospinal fluid; cytokines; interleukins; intracerebral hemorrhage; tissue necrosis factor	TUMOR-NECROSIS-FACTOR; BRAIN-BARRIER PERMEABILITY; CEREBRAL-BLOOD-FLOW; FACTOR-ALPHA; TNF-ALPHA; INTRACRANIAL-PRESSURE; INJURY; EDEMA; RAT; IL-6	OBJECTIVE: We sought to analyze the regional concentrations of proinflammatory cytokines in the acute period of intracerebral hemorrhage (ICH) and to test the hypothesis that ICH is associated with the expression of proinflammatory cytokines in the acute period. Although the expression of cytokines and their role in neuronal injury and inflammation is well characterized in cerebral ischemia and head injury, no information exists regarding expression of cytokines in ICH. METHODS: We introduced ICH in eight anesthetized mongrel dogs by autologous blood injection (6 ml) under arterial pressure in the deep white matter adjacent to the left basal ganglia. Samples of arterial blood and cerebrospinal fluid were collected, and tissue extracts were prepared from different regions of the brain for immunoassay of tumor necrosis factor alpha, interleukin (IL)-1 beta, and IL-6 concentrations in animals with and without ICH. RESULTS: The tumor necrosis factor alpha levels (+/- standard error) in the cerebrospinal fluid 1 hour after ICH did not differ significantly between the ICH group and the control group (7.1 +/- 1.3 pg/ml versus 10.8 +/- 2.3 pg/ml, P = 0.22). Levels in the perihematoma region in the ICH group (96.6 +/- 3.1 pg/ml) were not significantly different from those in the control group (93.4 +/- 6.7 pg/ml, P = 0.7). IL-6 levels (+/- standard error) in the perihematoma region in the ICH group (116.3 +/- 13.3 pg/ml) did not differ significantly from those in corresponding regions in the control group (122.3 +/- 12.8 pg/ml, P = 0.7). IL-1 beta levels were below 5 pg/ml in serum, cerebrospinal fluid, and extracts of different brain regions. CONCLUSION: The early pathophysiology of ICH does not involve significant expression of tumor necrosis factor a either in the perihematoma region or other regions of the brain. The observation suggests that the pathophysiology of ICH in the acute period is different from both cerebral ischemia and traumatic brain injury.	SUNY Buffalo, Dept Neurosurg, Buffalo, NY USA; SUNY Buffalo, Toshiba Stroke Res Ctr, Buffalo, NY USA; Uniformed Serv Univ Hlth Sci, Div Crit Care Med, Bethesda, MD 20814 USA		Qureshi, AI (corresponding author), Millard Fillmore Hosp, Dept Neurosurg, 3 Gates Circle, Buffalo, NY 14209 USA.	aiqureshi@hotmail.com		Qureshi, Adnan/0000-0003-4962-540X			Arvin B, 1995, ANN NY ACAD SCI, V765, P62, DOI 10.1111/j.1749-6632.1995.tb16561.x; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; KANNO T, 1993, STROKE S, V24, P96; KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; LISK DR, 1994, NEUROLOGY, V44, P133, DOI 10.1212/WNL.44.1.133; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; MOHLER KM, 1993, J IMMUNOL, V151, P1548; NATH FP, 1986, J NEUROSURG, V65, P697, DOI 10.3171/jns.1986.65.5.0697; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Qureshi AI, 1999, CRIT CARE MED, V27, P965, DOI 10.1097/00003246-199905000-00036; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; QURESHI AI, 1995, STROKE, V26, P1764, DOI 10.1161/01.STR.26.10.1764; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TROST LC, 1994, ANAL BIOCHEM, V220, P149, DOI 10.1006/abio.1994.1311; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; ZUCKER K, 1994, LYMPHOKINE CYTOK RES, V13, P191	29	16	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	AUG	2001	49	2					416	420		10.1097/00006123-200108000-00027			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	457MQ	WOS:000170141700086	11504118				2022-02-06	
J	[Anonymous]				[Anonymous]			Antiseizure prophylaxis for penetrating brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							POST-TRAUMATIC EPILEPSY; HEAD-INJURY; POSTTRAUMATIC SEIZURES; MISSILE WOUNDS; PREVENTION; PHENYTOIN										AARABI B, 2000, NEUROSURG FOCUS, V8; ADELOYE A, 1971, Ghana Medical Journal, V10, P56; ADELOYE A, 1971, J NEUROL NEUROSUR PS, V34, P98, DOI 10.1136/jnnp.34.1.98; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ascroft PB, 1941, BMJ-BRIT MED J, V1941, P739, DOI 10.1136/bmj.1.4193.739; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; MEIROWSKY AM, 1982, MIL MED, V147, P632, DOI 10.1093/milmed/147.8.632; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1999, MISSILE WOUNDS HEAD, V2, P281; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Wagstaffe WW, 1928, LANCET, V2, P861; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WHITTY CWM, 1947, BRAIN, V70, P416, DOI 10.1093/brain/70.4.416; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236	18	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2001	51	2		S			S41	S43					3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	464LR	WOS:000170534500009	11505199				2022-02-06	
J	Quan, L; Zhu, BL; Oritani, S; Ishida, K; Fujita, MQ; Maeda, H				Quan, L; Zhu, BL; Oritani, S; Ishida, K; Fujita, MQ; Maeda, H			Intranuclear ubiquitin immunoreactivity in the pigmented neurons of the substantia nigra in fire fatalities	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						ubiquitin; pigmented substantia nigra neurons immunohistochemistry; fire fatality; physical activity	HEAT-SHOCK-PROTEIN; TRAUMATIC BRAIN INJURY; ISCHEMIC BRAIN; MESSENGER-RNA; NEURODEGENERATIVE DISEASES; AXONAL INJURY; C-FOS; HYPERTHERMIA; EXPRESSION; STRESS	To evaluate the significance of immunohistochemical staining of ubiquitin (heat shock protein) in the midbrain for medico-legal investigation of death in fires. we examined forensic autopsy cases of fire fatalities (n = 35) in comparison with controls (n = 27; brain stem injury, acute myocardial infarction and carbon monoxide poisoning other than fire fatality). There were two intranuclear staining patterns in the nuclei of pigmented substantia nigra neurons: a type of inclusion (possible Marinesco bodies) and a diffuse staining. Percentage of nuclear ubiquitin positivity (Ub-positive %) in fire fatalities (2.7-44.7%; mean, 18.5%) was significantly higher than in brain stem injury (n = 9; 0-10.4%; mean, 4.5%) and myocardial infarction (n = 14; 1.5-14.6%; mean, 6.9%), independently of blood carboxyhemoglobin (COHb) levels. Age-dependent increase in Ub-positive % was observed in lower COHb (< 60%) cases. The intranuclear diffuse ubiquitin staining was not observed in cases of high blood cyanide level (> 1.0 mug/ml). These observations showed that intranuclear ubiquitin immunoreactivity of the pigmented substantia nigra neurons in the midbrain was induced by severe stress in fires.	Osaka City Univ, Sch Med, Dept Legal Med, Osaka 5458585, Japan		Quan, L (corresponding author), Osaka City Univ, Sch Med, Dept Legal Med, Asahimachi 1-4-3, Osaka 5458585, Japan.						Abe H, 1996, ADV NEUROL, V71, P451; Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; BROWN IR, 1990, J NEUROSCI RES, V25, P14, DOI 10.1002/jnr.490250103; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; DICKSON DW, 1990, LAB INVEST, V63, P87; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Funayama Masato, 1994, Research and Practice in Forensic Medicine, V37, P169; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hirai S, 1977, Nihon Ronen Igakkai Zasshi, V14, P6; Hirai S., 1968, ADV NEUROL SCI, V12, P845; Ichinose H, 1999, Adv Neurol, V80, P195; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Ikeda K, 1974, Seishin Shinkeigaku Zasshi, V76, P778; Ikeda Takuya, 1992, Research and Practice in Forensic Medicine, V35, P81; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; KITAMURA O, 1994, INT J LEGAL MED, V107, P69, DOI 10.1007/BF01225492; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kubo Shin-Ichi, 1994, Research and Practice in Forensic Medicine, V37, P159; Kurimura M, 1997, Rinsho Shinkeigaku, V37, P963; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEESTMA JE, 1969, ARCH PATHOL, V88, P431; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; Marinesco G, 1902, CR HEBD ACAD SCI, V135, P1000; MORRISONBOGORAD M, 1995, J NEUROCHEM, V64, P235; Nogami M, 1999, INT J LEGAL MED, V112, P351, DOI 10.1007/PL00007703; NOLTE J, 1999, HUMAN BRAIN INTRO IT, P450; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; OHTANI S, 1993, J MED TECHNOL, V37, P1391; Okamoto K, 1981, Rinsho Shinkeigaku, V21, P781; ORITANI S, 1997, P 35 M INT ASS FOR T, P366; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SEITE R, 1971, BRAIN RES, V34, P277, DOI 10.1016/0006-8993(71)90281-2; SEITE R, 1972, J PHYSIOL-PARIS, V65, P502; Sharma HS, 1998, PROG BRAIN RES, V115, P351; Sharma HS, 1998, PROG BRAIN RES, V115, P297; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Sharp FR, 1998, ANN NEUROL, V44, P581, DOI 10.1002/ana.410440402; SHOJI T, 1997, NIPPON HOIGAKU ZASSH, V51, P77; TIPTON KF, 1993, ADV NEUROL, V60, P186; TYTELL M, 1993, ADV NEUROL, V59, P293; TYTELL M, 1994, J NEUROSCI RES, V38, P19, DOI 10.1002/jnr.490380105; Tytell M, 1998, MOL CHEM NEUROPATHOL, V35, P97, DOI 10.1007/BF02815118; WEISS JH, 1994, NEUROSCIENCE, V60, P659, DOI 10.1016/0306-4522(94)90494-4; Westman J, 1998, PROG BRAIN RES, V115, P207; Yu SP, 1999, SCIENCE, V284, P336, DOI 10.1126/science.284.5412.336; YUEN P, 1963, J NEUROL NEUROSUR PS, V26, P178, DOI 10.1136/jnnp.26.2.178; Zipfel GJ, 1999, NEW ENGL J MED, V341, P1543, DOI 10.1056/NEJM199911113412011	57	16	20	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0937-9827			INT J LEGAL MED	Int. J. Legal Med.	JUL	2001	114	6					310	315		10.1007/s004140000192			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	457DY	WOS:000170122900002	11508795				2022-02-06	
J	Bezner, JR; Hunter, DL				Bezner, JR; Hunter, DL			Wellness perception in persons with traumatic brain injury and its relation to functional independence	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						activities of daily living; brain injuries; quality of life; rehabilitation; reproducibility of results	QUALITY-OF-LIFE; SELF-RATED HEALTH; FOLLOW-UP; MORTALITY; REHABILITATION; PREDICTORS; INDICATORS; OUTCOMES	Objectives: To test the reliability and validity of a perceptual wellness measure in persons after traumatic brain injury (TBI) and to determine whether a relation exists between functional independence and wellness perceptions in the same population. Design: Survey research. Setting: A private, residential brain injury program. Participants: A convenience sample of 49 patients (43 men, 6 women) with TBI whose mean age was 32.1 years (range, 18-61 yr) and mean time since injury was 10.47 years (range, 1-21 yr). Main Outcome Measures: The Perceived Wellness Survey (PWS) assessed wellness. The PWS has 6 subscales measuring physical, psychologic, emotional, intellectual, spiritual, and social wellness. The FIM (TM) instrument was used to measure functional status. Results: The mean PWS score (15.99) for the sample was comparable to published samples of adults (mean, 15.31-16.51); however, the reliability of the composite score (alpha = .58) and the subscales (alpha = .32-.64) was less than that obtained in previous samples (composite alpha = 0.91; subscale alpha = .64-.81). The correlations between the PWS and the FTM scores were not significant, Conclusions: The PWS in its composite form is a reliable measure for use with persons with TBI. The finding that perceived wellness and functional independence were not related suggests that these constructs are unique and thus should both be measured. The measurement of perceptions will enable the provider to consider a client holistically and to develop programs that address quality of lire issues. Further, because perceptions influence behaviors, understanding a person's perceptions in multiple dimensions may provide a useful and necessary framework for developing intervention programs that address behavioral and cognitive issues that are important to that person. (C) 2001 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	SW Texas State Univ, Dept Phys Therapy, San Marcos, TX 78666 USA		Bezner, JR (corresponding author), SW Texas State Univ, Dept Phys Therapy, 601 Univ Dr, San Marcos, TX 78666 USA.						Adams T, 1997, AM J HEALTH PROMOT, V11, P208, DOI 10.4278/0890-1171-11.3.208; Adams T, 1998, AM J HLTH STUD, V14, P212; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Antonovsky A., 1988, UNRAVELING MYSTERY H; Bergquist TF, 1994, J HEAD TRAUMA REHAB, V9, P50, DOI 10.1097/00001199-199412000-00007; COHEN S, 1986, J PERS SOC PSYCHOL, V50, P963, DOI 10.1037/0022-3514.50.5.963; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052; Evans RW., 1998, NEUROL REPORT, V22, P144; FYLKESNES K, 1991, SOC SCI MED, V32, P141, DOI 10.1016/0277-9536(91)90053-F; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hamilton BB, 1987, REHABILITATION OUTCO, P137; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446; KAPLAN GA, 1983, AM J EPIDEMIOL, V117, P292, DOI 10.1093/oxfordjournals.aje.a113541; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Pain K, 1998, J REHABIL, V64, P5; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416; PROCIDANO ME, 1992, ADV PERS AS, V9, P1; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Warren L, 1996, J REHABIL RES DEV, V33, P404; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7; [No title captured], DOI DOI 10.1177/026921559000400405	30	16	16	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2001	82	6					787	792		10.1053/apmr.2001.23269			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	439KK	WOS:000169115900012	11387584				2022-02-06	
J	Keren, O; Cohen, M; Lazar-Zweker, I; Groswasser, Z				Keren, O; Cohen, M; Lazar-Zweker, I; Groswasser, Z			Tracheotomy in severe TBI patients: sequelae and relation to vocational outcome	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; TRACHEAL INTUBATION; COMPLICATIONS	The aim of the present study was to find the influence of performing tracheotomy on outcome of severe TBI patients. TBI patients, many of them intubated during the very acute phase post-injury, who remain unconscious for more than a few days, undergo tracheotomy to provide a reliable long term artificial airway. Tracheotomy, although being a simple elective surgical procedure, may have a negative influence on the rehabilitation process. Tracheotomy was performed in 25% (n = 69) of 277 consecutive severe TBI patients admitted to the rehabilitation department during 3 years. In seven patients (10%), tracheotomy was performed immediately after injury due to cranio-facial trauma, in 18 patients (29%) due to respiratory disturbances, in 42 patients (55%) after prolonged intubation, and in two patients (6%) due to combined problems. Forty-five per cent of patients with tracheotomy suffered from respiratory disturbances and 8.6% from complications of tracheotomy. Longer periods of unconsciousness and mechanical ventilation were significantly associated with respiratory complications ( p < 0.0001 and p < 0.001, respectively). However, presence of tracheotomies per se, did not affect vocational rehabilitation.	Loewentein Rehabil Hosp, IL-43100 Raanana, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Groswasser, Z (corresponding author), Loewentein Rehabil Hosp, 278 Achuza St,POB 3, IL-43100 Raanana, Israel.	zeevgros@ccsg.tau.ac.il					BLANC VF, 1974, ANESTH ANALG, V53, P202; CITTAPIETROLUNGO TJ, 1993, ARCH PHYS MED REHAB, V74, P905; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; MACKENZIE CF, 1984, CRITICAL CARE MONITO, V4, P1; Najenson T, 1980, Int Rehabil Med, V2, P17; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; SPLAINGARD ML, 1989, ARCH PHYS MED REHAB, V70, P318; WEICKER W, 1982, ZBL CHIR, V107, P945; WHITED RE, 1984, LARYNGOSCOPE, V94, P367; Wilson B, 1994, BRAIN INJURY NEUROPS, P85	12	16	17	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2001	15	6					531	536		10.1080/02699050010007371			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	439VE	WOS:000169137600006	11394972				2022-02-06	
J	McCauley, SR; Hannay, HJ; Swank, PR				McCauley, SR; Hannay, HJ; Swank, PR			Use of the Disability Rating Scale recovery curve as a predictor of psychosocial outcome following closed-head injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Proceedings Paper	27th Annual Meeting of the International-Neuropsychological-Society	FEB 10-13, 1999	BOSTON, MASSACHUSETTS	Int Neuropsychol Soc		closed-head injury; growth curves; outcome measures; outcome prediction; Disability Rating Scare	TRAUMATIC BRAIN INJURY; INDIVIDUAL GROWTH; EVOKED-POTENTIALS; RELATIVES VIEW; VALIDITY; PATIENT; MODELS	Rapid rate of recovery has been associated with better outcome following closed-head injuries, but few studies have compellingly demonstrated this. This study used growth curve analyses of Disability Rating Scale (DRS) scores at acute hospitalization discharge, 1, 3, and 6 months post injury in a sample of 55 patients with a closed-head injury. Six month post-injury outcome measures were taken from significant other (SO) responses on the NYU Head Injury Family Interview (NYU-HIFI) including severity and burden ratings of affective/neurobehavioral disturbance, cognitive deficits, and physical/dependency status. Rate of recovery (linear and curvilinear recovery curve components) was significantly related to the level of affective/neurobehavioral severity, and the severity and burden of SO-perceived cognitive deficits. Only the intercept of the DRS recovery curve was associated with the SO-perceived severity and burden of physical/dependency status. Growth curve modeling is a meaningful and powerful tool in predicting head injury outcome.	Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Univ Houston, Dept Psychol, Houston, TX 77004 USA; Univ Texas, Hlth Sci Ctr, Dept Nursing, Houston, TX USA		McCauley, SR (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 6560 Fannin,Suite 1144,Box 67, Houston, TX 77030 USA.			Hannay, H. Julia/0000-0001-7023-912X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; BROOKS DN, 1984, CLOSED HEAD INJURY P; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bryk A.S., 1987, HIERARCHICAL LINEAR; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Francis DJ, 1996, J EDUC PSYCHOL, V88, P3, DOI 10.1037/0022-0663.88.1.3; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; GIANCINO JT, 1991, ARCH PHYSICAL MED RE, V72, P897; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HEDRICK WP, 1995, BRAIN INJURY, V9, P563, DOI 10.3109/02699059509008215; JENNETT B, 1975, LANCET, V7905, P480; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1991, CLIN ELECTROENCEPHAL, V22, P199, DOI 10.1177/155005949102200407; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RAPPAPORT M, 1990, CLIN ELECTROENCEPHAL, V21, P188, DOI 10.1177/155005949002100406; Rappaport M, 1989, J HEAD TRAUMA REHAB, V4, P45; RAPPAPORT M, 1986, J HEAD TRAUMA REHABI, P00015, DOI DOI 10.1097/00001199-198603000-00005; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; SCHENTZEL SJ, 1993, THESIS WALDEN U CHIC; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x	47	16	16	0	2	CAMBRIDGE UNIV PRESS	PORT CHESTER	110 MIDLAND AVE, PORT CHESTER, NY 10573-9863 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2001	7	4					457	467		10.1017/S1355617701744025			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	436RE	WOS:000168948600003	11396548				2022-02-06	
J	Teng, CJ; Bhalerao, S; Lee, ZL; Farber, J; Morris, H; Foran, T; Tucker, W				Teng, CJ; Bhalerao, S; Lee, ZL; Farber, J; Morris, H; Foran, T; Tucker, W			The use of bupropion in the treatment of restlessness after a traumatic brain injury	BRAIN INJURY			English	Article							AKATHISIA; MECHANISM; AGITATION	The occurrence of restlessness after a traumatic brain injury (TBI) is common. Severe restlessness can be a barrier in the multidisciplinary treatment of patients with TBI. The following case describes a patient with restlessness after a head-on motor vehicle accident. The patient was tachycardic, diaphoretic, demonstrating decerebrate posturing and a Rancho Los Amigos Stage II-III. Significant left lower leg restlessness was severe enough to cause bruising and ulceration. A multidisciplinary look was taken at the effects of using different neurotransmitter modulators in the treatment of restlessness after a TBI. Current biology treatment options include the use of medications that either modulate dopamine or noradrenaline alone. Bupropion effects both the dopaminergic and noradrenergic pathways. In the following case, the patient's restlessness was resistant to almost every medication employed. The only medication that proved to be effective in significantly reducing the patient's restlessness was bupropion. The evidence for the use of bupropion in the treatment of restlessness after a TBI has never been discussed previously, aside from anecdotal accounts. It is hoped that this case will prove insight into another treatment option for patients who have severe restlessness.	Univ Toronto, St Michaels Hosp, Dept Psychiat, Sch Med, Toronto, ON M5B 1W8, Canada		Bhalerao, S (corresponding author), Univ Toronto, St Michaels Hosp, Dept Psychiat, Sch Med, 30 Bond St,4M-028B, Toronto, ON M5B 1W8, Canada.	bhaleraos@8mh.toronto.on.ca					ASCHER JA, 1995, J CLIN PSYCHIAT, V56, P395; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Chandler M C, 1988, Brain Inj, V2, P309; COHEN BM, 1991, BIOL PSYCHIAT, V29, P1215, DOI 10.1016/0006-3223(91)90329-K; COOPER BR, 1994, NEUROPSYCHOPHARMACOL, V11, P133, DOI 10.1038/npp.1994.43; FRIEDMAN EH, 1990, J NEUROL NEUROSUR PS, V53, P1017, DOI 10.1136/jnnp.53.11.1017-a; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; Jauss M, 1998, PHARMACOPSYCHIATRY, V31, P146, DOI 10.1055/s-2007-979317; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; Silver BV, 1996, BRAIN INJURY, V10, P609; STEWART J, 1989, J NEUROL NEUROSUR PS, V52, P1200, DOI 10.1136/jnnp.52.10.1200; VASSOUT A, 1993, J RECEPTOR RES, V13, P341, DOI 10.3109/10799899309073665	13	16	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2001	15	5					463	467		10.1080/02699050010005931			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	431TW	WOS:000168648700009	11350660				2022-02-06	
J	Zurita, M; Vaquero, J; Oya, S; Montilla, J				Zurita, M; Vaquero, J; Oya, S; Montilla, J			Functional recovery in chronic paraplegic rats after co-grafts of fetal brain and adult peripheral nerve tissue	SURGICAL NEUROLOGY			English	Article						paraplegia; neural grafts; spinal cord injury	SPINAL-CORD; ADRENAL-MEDULLA; INJURY; REGENERATION; TRANSPLANTS	BACKGROUND In recent years, experimental studies have sought some type of functional improvement in traumatic paraplegia by transplanting neural tissue into the injured spinal cord. The aim of this work is to study the possibility of functional recovery in chronic paraplegic rats after cotransplantation of fetal cerebral tissue and adult peripheral nerve tissue. METHODS Seventy adult female Wistar rats were subjected to spinal cord injury at the T6-T8 lever, causing complete paraplegia. Three months later, in 50 rats (grafted group) the injured spinal cord tissue received a graft of fetal brain cortex associated with crushed adult peripheral nerve. All the animals (grafted and control groups) were subjected to daily rehabilitation procedures from the first week after the injury, and evaluated weekly for motor and sensory recovery. Statistical analysis of different behavioral data between control and grafted animals was performed using the Kruskal-Wallis ANOVA and the nonparametric Wilcoxon test. RESULTS Between 8 and 12 months after transplantation, progressive signs of functional recovery were observed in the grafted animals, associated with an increase in muscle mass in the lower extremities, findings that were significantly different from those in nongrafted animals (p < 0.05). At this time, donor cerebral tissue is integrated into previously injured spinal cord and results in formation of bundles of nerve fibers that emerge from the area of the transplant and surround the spinal cord beneath the lesion. CONCLUSIONS Delayed co-transplantation of fetal cerebral tissue and peripheral nerve tissue can be used to achieve anatomical remodeling and long-term functional recovery in rats rendered paraplegic as result of severe spinal cord injury. These findings support the possibility of functional recovery after chronic traumatic paraplegia. (C) 2001 by Elsevier Science Inc.	Autonomous Univ Madrid, Serv Neurochirurg, Clin Puerta de Hierro, Mapfre Med Fdn,Neurosci Res Unit, Madrid, Spain		Vaquero, J (corresponding author), Autonomous Univ Madrid, Serv Neurochirurg, Clin Puerta de Hierro, Mapfre Med Fdn,Neurosci Res Unit, San Martin de Porres 4, Madrid, Spain.						BERNSTEIN JJ, 1995, PARAPLEGIA, V33, P250, DOI 10.1038/sc.1995.57; DATE I, 1990, BRAIN RES, V537, P33, DOI 10.1016/0006-8993(90)90336-A; DOERING LC, 1992, EXP NEUROL, V118, P253, DOI 10.1016/0014-4886(92)90182-P; EGAR M, 1972, EXP NEUROL, V37, P422, DOI 10.1016/0014-4886(72)90085-4; FAWCETT J, 1995, PARAPLEGIA, V33, P491, DOI 10.1038/sc.1995.108; MATTHEWS MA, 1979, ACTA NEUROPATHOL, V45, P27, DOI 10.1007/BF00691801; NORLANDER RH, 1978, J COMP NEUROL, V180, P349; Ramon y Cajal S., 1914, STUDIES DEGENERATION, VII; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Reier P.J., 1986, ASTROCYTES, V3, P263; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; Sugar O, 1940, J NEUROPHYSIOL, V3, P1; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; TATOR CH, 1973, J NEUROSURG, V39, P52, DOI 10.3171/jns.1973.39.1.0052; Tello J.F., 1911, TRAB LAB INVEST BIOL, V9, P123; VAQUERO J, 1981, ACTA NEUROCHIR, V59, P209, DOI 10.1007/BF01406350; WALLACE MC, 1987, SURG NEUROL, V27, P209, DOI 10.1016/0090-3019(87)90031-0; WEI Y, 1998, PAIN, V74, P115; Zompa EA, 1997, J NEUROTRAUM, V14, P479, DOI 10.1089/neu.1997.14.479; Zurita M, 2000, SURG NEUROL, V54, P117, DOI 10.1016/S0090-3019(00)00287-1; ZURITA M, 1994, POLYTRAUMATIZED, P343	21	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	MAY	2001	55	5					249	254		10.1016/S0090-3019(01)00442-6			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	445GM	WOS:000169449800001	11516457				2022-02-06	
J	Eilig, I; Rachinsky, M; Artru, AA; Alonchin, A; Kapuler, V; Tarnapolski, A; Shapira, Y				Eilig, I; Rachinsky, M; Artru, AA; Alonchin, A; Kapuler, V; Tarnapolski, A; Shapira, Y			The effect of treatment with albumin, hetastarch, or hypertonic saline on neurological status and brain edema in a rat model of closed head trauma combined with uncontrolled hemorrhage and concurrent resuscitation in rats	ANESTHESIA AND ANALGESIA			English	Article							ISOVOLEMIC HEMODILUTION; 5-PERCENT DEXTROSE; ONCOTIC PRESSURE; CEREBRAL EDEMA; RAPID INFUSION; FLUID THERAPY; OSMOLALITY; INJURY; SHOCK	In rats subjected to closed head trauma (CHT) plus uncontrolled hemorrhage, giving 0.3 mL of 0.9% saline per 0.1 mL of blood lost did not restore mean arterial blood pressure (MAP) or improve neurological severity score (NSS). In CHT without hemorrhage, giving 20% albumin or 10% hetastarch improved NSS. We hypothesized that these latter treatments would also improve NSS after CHT plus uncontrolled hemorrhage. Rats were randomly assigned to one of seven groups. Experimental conditions were CHT (yes or no), uncontrolled hemorrhage (yes or no), and fluid given to replace blood loss (none; 10% hetastarch, 20% albumin, or 3% saline [0.1 mL per 0.1 mt of blood lost]; or 0.9% saline [0.3 mt per 0.1 mL of blood lost]). NSS (0-25 scale, where 0 = no impairment) was determined at 1, 4, and 24 h, and brain water content was determined at 24 h after CHT. NSS (median +/- range) at 24 h was 11 +/- 6 when no fluid was given; 16 +/- 5 with 10% hetastarch; 14 +/- 5 with 20% albumin; 12 +/- 4 with 3% saline; and 13 +/- 4 with 0.9% saline given (not significant). In addition, brain water content and MAP did not differ among the groups receiving CHT with or without uncontrolled hemorrhage. In our model of CHT plus uncontrolled hemorrhage in rats, giving 10% hetastarch, 20% albumin, 3% saline, or 0.9% saline failed to improve NSS, brain water content, or MAP.	Ben Gurion Univ Negev, Soroka Med Ctr, Dept Pediat Surg, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, IL-84105 Beer Sheva, Israel		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540,1959 NE Pacific St, Seattle, WA 98195 USA.						Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; GOSLINGA H, 1992, STROKE, V23, P181, DOI 10.1161/01.STR.23.2.181; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; KEE DB, 1987, CEREBRAL BLOOD FLOW, P173; LEE SH, 1994, J NEUROSURG, V80, P469, DOI 10.3171/jns.1994.80.3.0469; POOLE GV, 1986, CRIT CARE MED, V14, P629, DOI 10.1097/00003246-198607000-00009; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Talmor D, 1999, ANESTH ANALG, V89, P950, DOI 10.1097/00000539-199910000-00024; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; WARNER DS, 1988, ANESTHESIOLOGY, V68, P86, DOI 10.1097/00000542-198801000-00014; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010; Zornow MH, 1997, TXB NEUROANESTHESIA, P117	20	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	2001	92	3					669	675		10.1213/00000539-200103000-00023			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	405JW	WOS:000167157100022	11226099				2022-02-06	
J	Xiong, Y; Peterson, PL; Lee, CP				Xiong, Y; Peterson, PL; Lee, CP			Alterations in cerebral energy metabolism induced by traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						antioxidants; brain mitochondria; calcium channel blockers; energy metabolism; oxidative stress; traumatic brain injury	SEVERE HEAD-INJURY; TRANSIENT FOREBRAIN ISCHEMIA; CALCIUM-CHANNEL BLOCKER; BLOOD-FLOW; MITOCHONDRIAL DYSFUNCTION; N-ACETYLCYSTEINE; OXIDATIVE-METABOLISM; CEREBROSPINAL-FLUID; LIPID-PEROXIDATION; RATS	Energy metabolism of the brain is unique, possessing high aerobic metabolism with no significant capacity for anaerobic glycolysis and limited tissue stores of glucose. A steady supply of oxygen and glucose is essential in order to maintain cerebral function and integrity. Extensive research in experimental and human head injury has been conducted regarding the delivery of oxygen and outcome. This research has provided evidence which indicates that in addition to the availability of oxygen and glucose, other factors, such as perturbation of mitochondrial energy transducing processes which also follow head trauma, play significant roles. In this paper, the salient findings from biochemical studies of experimental and clinical brain injury are summarized and indicate that the mitochondrial respiratory chain-linked oxidative phosphorylation and calcium transport are compromised by trauma-induced brain injury and support the idea that oxidative stress and perturbation of cellular calcium homeostasis play significant roles in traumatic brain injury.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA		Lee, CP (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA.	cplee@med.wayne.edu		Xiong, Ye/0000-0001-9770-6031			Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bowersox S, 1997, DRUG METAB DISPOS, V25, P379; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRAUGHLER JM, 1985, J NEUROCHEM, V45, P1288, DOI 10.1111/j.1471-4159.1985.tb05555.x; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CADOUXHUDSON TAD, 1990, ACTA NEUROCHIR, V104, P1, DOI 10.1007/BF01842884; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK JB, 1970, J BIOL CHEM, V245, P4724; CORCORAN GB, 1986, J PHARMACOL EXP THER, V238, P54; Davey GP, 1997, J NEUROCHEM, V69, P2564; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; Hall ED, 1996, ACT NEUR S, V66, P107; Hall ED, 1996, J NEUROSCI RES, V44, P293, DOI 10.1002/(SICI)1097-4547(19960501)44:3<293::AID-JNR10>3.0.CO;2-6; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1990, BEHAV BRAIN RES, V37, P119, DOI 10.1016/0166-4328(90)90087-U; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; Jiang XB, 1999, NEUROL MED-CHIR, V39, P649, DOI 10.2176/nmc.39.649; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly G S, 1998, Altern Med Rev, V3, P114; KNUCKEY NW, 1995, STROKE, V26, P305, DOI 10.1161/01.STR.26.2.305; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lai J C, 1979, Methods Enzymol, V55, P51; Landolt H, 1996, EUR J ANAESTH, V13, P269, DOI 10.1046/j.1365-2346.1996.00975.x; Lee C. P., 1993, V2, P41; LEE CP, 1994, CURR TOP BIOENERG, V17, pR11; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LUST WD, 1985, CEREBRAL ENERGY META, P79; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MCHENRY LC, 1978, CEREBRAL CIRCULATION; MCINTOSH TK, 1988, AM J PHYSIOL, V254, pR785, DOI 10.1152/ajpregu.1988.254.5.R785; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Petit PX, 1997, MOL CELL BIOCHEM, V174, P185, DOI 10.1023/A:1006848205880; PRASAD MR, 1994, J NEUROCHEM, V63, P773; PROCTOR HJ, 1988, J TRAUMA, V28, P347, DOI 10.1097/00005373-198803000-00010; Ritter A M, 1994, Neurosurg Clin N Am, V5, P633; Robertson C S, 1995, New Horiz, V3, P410; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROSENTHAL RE, 1990, CEREBRAL ISCHEMIA RE, P289; Rossen R, 1943, ARCH NEURO PSYCHIATR, V50, P510; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SCIAMANNA MA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P223, DOI 10.1016/0167-4889(92)90180-J; SCIAMANNA MA, 1993, ARCH BIOCHEM BIOPHYS, V305, P215, DOI 10.1006/abbi.1993.1414; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; Siesj? BK., 1978, BRAIN ENERGY METABOL; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SIMS NR, 1991, J NEUROCHEM, V56, P1836, DOI 10.1111/j.1471-4159.1991.tb03438.x; SIMS NR, 1987, J NEUROCHEM, V49, P1367, DOI 10.1111/j.1471-4159.1987.tb01001.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vinas FC, 1998, CRIT REV NEUROSURG, V8, P31, DOI 10.1007/s003290050058; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WAGNER KR, 1985, J NEUROSURG, V63, P88, DOI 10.3171/jns.1985.63.1.0088; Whittingham TS, 1990, CEREBRAL ISCHEMIA RE, P101; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; [No title captured]	87	16	27	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					129	138		10.1179/016164101101198460			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200004	11320591				2022-02-06	
J	Rauch, RJ; Ferry, SM				Rauch, RJ; Ferry, SM			Social networks as support interventions following traumatic brain injury	NEUROREHABILITATION			English	Article						TBI; social networks; social support; rehabilitation	SEVERE HEAD-INJURY; MODERATE; STRESS; REHABILITATION; INTEGRATION; INDIVIDUALS; DIMENSIONS; ADJUSTMENT	The social network and social support needs of people following traumatic brain injury (TBI) are considerable and related to both health outcomes and community integration. We review what is known of the structure of social networks following TBI and explore the relationship of these networks to social support and health. Social network interventions in TBI are described and discussed. Empirically based suggestions are given for the development of interventions based on culturally sensitive programmes which develop social networks and support in a naturalistic manner.	Thompson House Hosp, Down Lisburn Hlth & Social Serv Trust, Brain Injury Rehabil Serv, Lisburn BT28 3BP, North Ireland; Queens Univ, Sch Psychol, Belfast BT1 7NN, Antrim, North Ireland		Rauch, RJ (corresponding author), Thompson House Hosp, Down Lisburn Hlth & Social Serv Trust, Brain Injury Rehabil Serv, 19-21 Magheralave Rd, Lisburn BT28 3BP, North Ireland.						ANTONUCCI TC, 1986, J CONSULT CLIN PSYCH, V54, P432, DOI 10.1037/0022-006X.54.4.432; BENNET D, 1983, THEORY PRACTISE PSYC; BIEGEL DE, 1994, HEALTH SOC WORK, V19, P206; BROWN DSO, 1992, ARCH PHYS MED REHAB, V73, P758; Brugha TS, 1995, SOCIAL SUPPORT PSYCH; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; DEAN A, 1977, J NERV MENT DIS, V165, P403, DOI 10.1097/00005053-197712000-00006; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; HARING TG, 1992, J APPL BEHAV ANAL, V25, P319, DOI 10.1901/jaba.1992.25-319; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HENDERSON S, 1978, BRIT J PSYCHIAT, V132, P74, DOI 10.1192/S0007125000283001; HORWITZ AV, 1999, HDB STUDY MENTAL HLT; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johnson K, 1998, BEHAV MODIF, V22, P502, DOI 10.1177/01454455980224004; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; Kessler R. C., 1985, SOCIAL SUPPORT HLTH; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KUIPERS P, 1999, J COGNITIVE REHABILI, V17, P6; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; MCCORMICK IA, 1987, AM J COMMUN PSYCHOL, V15, P73, DOI 10.1007/BF00919758; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; NORBECK JS, 1983, J HEALTH SOC BEHAV, V24, P30, DOI 10.2307/2136301; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; SANDLER IN, 1984, AM J COMMUN PSYCHOL, V12, P37, DOI 10.1007/BF00896927; Smith J, 1998, CANADIAN J REHABILIT, V11, P131; THOITS PA, 1992, MEANING MEASUREMENT; THORNICROFT G, 1991, BRIT J PSYCHIAT, V159, P245, DOI 10.1192/bjp.159.2.245; VEIEL HOF, 1985, SOC PSYCHIATR, V20, P156, DOI 10.1007/BF00583293; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wellman B., 1985, SOCIAL SUPPORT THEOR; WETHINGTON E, 1986, J HEALTH SOC BEHAV, V27, P78, DOI 10.2307/2136504; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; WILLER BS, 1993, CIRCLES SUPPORT INDI; Wood-Dauphinee S, 1992, CANADIAN J REHABILIT, V6, P3; Zencius AH, 1999, BRAIN INJURY, V13, P723	39	16	17	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2001	16	1					11	16					6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	439YA	WOS:000169144100003	11455099				2022-02-06	
J	Guerit, JM				Guerit, JM			The usefulness of EEG, exogenous evoked potentials, and cognitive evoked potentials in the acute stage of post-anoxic and post-traumatic coma	ACTA NEUROLOGICA BELGICA			English	Article						EEG; evoked potentials; coma; brain death; prognosis; anoxia; head trauma	INTENSIVE-CARE UNIT; MISMATCH NEGATIVITY; PROGNOSTIC VALUE; HEAD-INJURY; PREDICTION; DIAGNOSIS; STATES; DEATH	Three-modality evoked potentials (TMEPs) have been used for several years in association with the EEG as a diagnostic and prognostic tool in acute anoxic or traumatic coma. Cognitive EPs have been recently introduced. EEG and cognitive EPs provide functional assessment of the cerebral cortex. TMEP parameters can be described by two indices: the index of global cortical function (IGCF) and the index of brainstem conduction (IBSC). Although it remains a unique tool for epilepsy assessment, the value of EEG is largely limited by its high sensitivity to the electrical environmental noise, its dependence on sedative drugs. and its inability to test the brainstem. Major TMEP alterations (absence of cortical activities more than 24 hours after the onset of post-anoxic coma, major pontine involvement in head trauma) are associated in all cases with an ominous prognosis (death or vegetative state). However even if mild TMEP changes are associated with a good prognosis in 65% (post-anoxic coma) to 90% (head trauma) of cases, some patients never recover despite exogenous TMEPs that are only mildly altered in the acute stage. Thus, cognitive EPs can usefully complement exogenous EPs as a prognostic tool in coma. Indeed, even if the absence of cognitive EPs in comatose patients does not have any prognostic value, their presence implies a very high (more than 90%) probability of consciousness recovery. The major technical challenge for the future will be the development of reliable tools for continuous EEG and TMEP monitoring.	Clin Univ St Luc, Unite Explorat Electrophysiol Syst Nerveux, B-1200 Brussels, Belgium		Guerit, JM (corresponding author), Clin Univ St Luc, Unite Explorat Electrophysiol Syst Nerveux, Ave Hippocrate 10, B-1200 Brussels, Belgium.						Berkhoff M, 2000, CLIN NEUROPHYSIOL, V111, P297, DOI 10.1016/S1388-2457(99)00246-1; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; de Tourtchaninoff M, 1999, QJM-MON J ASSOC PHYS, V92, P407, DOI 10.1093/qjmed/92.7.407; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; FISCHER C, 1994, NEUROSURGERY, V35, P45, DOI 10.1227/00006123-199407000-00007; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit J M, 1992, Eur J Med, V1, P233; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Guerit JM, 1999, NEUROPHYSIOL CLIN, V29, P301, DOI 10.1016/S0987-7053(99)90044-8; Guerit JM, 1998, ELECTROEN CLIN NEURO, V106, P1, DOI 10.1016/S0013-4694(97)00077-1; GUERIT JM, 1999, ELECTROENCEPHALOGR S, V52, P117; GUERIT JM, 1999, CURR OPIN ORGAN TRAN, V4, P143; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; HANTSON P, 2000, REANIM URGENCES, V9, P197; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; Kane NM, 2000, AUDIOL NEURO-OTOL, V5, P186, DOI 10.1159/000013879; NIEDERMEYER E, 1982, ELECTROENCEPHALOGRAP; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; SOHMER H, 1986, ELECTROEN CLIN NEURO, V64, P334, DOI 10.1016/0013-4694(86)90157-4; Task Force on Death and Dying of the Institute of Society Ethics and the Life Sciences, 1972, JAMA-J AM MED ASSOC, V221, P48; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	24	16	19	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	DEC	2000	100	4					229	236					8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404BD	WOS:000167076800005	11233678				2022-02-06	
J	McPherson, KM; McNaughton, H; Pentland, B				McPherson, KM; McNaughton, H; Pentland, B			Information needs of families when one member has a severe brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injury; carers; information; rehabilitation	CASE-MANAGEMENT; STROKE; CARERS; IMPACT; WANT	Despite calls for health and social services to respond to the needs of informal carers, there is little evidence to guide practioners in the best way to provide support and/or information in situations of complex need such as brain injury. This study addressed such an intervention in a prospective descriptive study, using both qualitative and quantitative methodology. Eighty-nine patients who had been admitted to a regional neurorehabilitation unit for management of traumatic or haemorrhagic brain injuries were consecutively discharged to the community over a period of 12 months. Eighty-two of these people identified a carer who agreed to be interviewed at approximately six weeks after discharge regarding their concerns. The study identified that even soon after discharge from inpatient rehabilitation, carers wanted more information. In many cases the need for information was unrelated to either the severity of injury or level of functional deficit. In addition, requests for information were in many cases not sought spontaneously, but required prompting. Such findings have implications if interventions in this field are to have the optimum chance of succeeding in providing support and assistance.	Wellington Sch Med, Dept Med, Wellington, New Zealand; Scottish Brian Injury Rehabil Serv, Edinburgh, Midlothian, Scotland		McPherson, KM (corresponding author), Wellington Sch Med, Dept Med, POB 7343, Wellington, New Zealand.			McPherson, Kathryn/0000-0003-1240-8882; McPherson, Kath/0000-0003-0487-8497			BECKER S, 1999, WERE THIS TOGETHER; Bostrom J, 1996, APPL NURS RES, V9, P47, DOI 10.1016/S0897-1897(96)80402-2; Brereton L, 1997, J CLIN NURS, V6, P425, DOI 10.1111/j.1365-2702.1997.tb00339.x; Exall K, 1999, Nurs Times, V95, P50; Grahn G, 1996, Eur J Cancer Care (Engl), V5, P182, DOI 10.1111/j.1365-2354.1996.tb00231.x; GRONWALL DMA, 1998, HEAD INJURY FACTS GU; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; Hanger HC, 1998, CLIN REHABIL, V12, P45, DOI 10.1191/026921598668677675; HUBERT J, 1995, LIFE HEAD INJURY; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; Kreutzer JS, 1997, J HEAD TRAUMA REHAB, V12, P63, DOI 10.1097/00001199-199712000-00006; LINDBERG M, 1996, CLIN REHABIL, V10, P69; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; Mant J, 1998, CLIN REHABIL, V12, P465, DOI 10.1191/026921598668972226; Marshall M, 1996, BRIT MED J, V312, P523, DOI 10.1136/bmj.312.7030.523; Martin J., 1988, PREVALENCE DISABILIT; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; MCLEAN J, 1991, J ADV NURS, V16, P559, DOI 10.1111/j.1365-2648.1991.tb01691.x; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; PATTON MQ, 1989, QUALITATIVE METHODS; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Slevin ML, 1996, BRIT J CANCER, V74, P1275, DOI 10.1038/bjc.1996.529; Smith N, 1999, Community Nurse, V5, P15; SORYAL I, 1992, CLIN REHABIL, V6, P103; STRAUSS AL, 1990, BASICS QUALITATIVE R, P249; THOMPSON C, 1999, COCHRANE LIB; Waterman H, 1996, J ADV NURS, V24, P960, DOI 10.1111/j.1365-2648.1996.tb02932.x; Wiles R, 1998, J ADV NURS, V28, P794, DOI 10.1046/j.1365-2648.1998.00709.x; [No title captured]	30	16	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2000	23	4					295	301		10.1097/00004356-200023040-00005			7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	385DF	WOS:000165986200005	11192565				2022-02-06	
J	Xu, H; Aibiki, M; Seki, K; Ogura, S; Yokono, S; Ogli, K				Xu, H; Aibiki, M; Seki, K; Ogura, S; Yokono, S; Ogli, K			Effects of induced hypothermia on renal sympathetic nerve activity and baroreceptor reflex in urethane-anesthetized rabbits	CRITICAL CARE MEDICINE			English	Article						arterial baroreceptors; autonomic nervous system; baroreflex sensitivity; catecholamines; induced hypothermia	TRAUMATIC BRAIN INJURY; HEART-RATE; MODERATE HYPOTHERMIA; CARDIOPULMONARY BYPASS; CIRCULATORY ARREST; CATECHOLAMINE; SYSTEM; VARIABILITY; RESPONSES; HUMANS	Objective: To evaluate the role of the autonomic nervous system in hemodynamic changes during induced hypothermia. Design: Prospective, randomized animal study. Setting: An animal research laboratory in a medical university. Subjects: A total of 29 anesthetized rabbits. Interventions: Animals were anesthetized by intraperitoneal urethane. After tracheostomy and administration of gallamine, respiration was maintained by mechanical ventilatory support. The animals were divided into five groups (one control and the four experimental groups); animals were treated with an intact neuraxis and normothermia (control group), animals with an intact neuraxis (intact group), cervical vagotomized animals (vagotomy group), the carotid sinus and aortic nerves denervated animals (SAD group), and animals with SAD plus vagotomy (SADV group). The left renal sympathetic nerves were exposed by a retroperitoneal approach. Measurements and Main Results:We examined the effects of surface cooling on HR, mean arterial pressure, central venous pressure, and renal sympathetic nerve activity (RSNA) in the animals. Changes of baroreflex sensitivity and plasma catecholamines were also measured simultaneously. Surface cooling caused progressive and profound decreases in DC in all experimental groups. In all groups, RSNAs increased at the early phase, which were followed by return to the precooling level. Conclusions: Hemodynamics and RSNA during induced hypothermia are regulated by mechanisms other than the baroreceptor reflex system, possibly the dermal cold receptors. Suppression of the baroreflex occurred on HR but not on RSNA during hypothermia, which may indicate direct effects of hypothermia on the heart. RSNA responses may be activated earlier than systemic catecholamine responses during induced hypothermia.	Kagawa Med Univ Hosp, Intens Care Unit, Kita Ku, Kagawa 7610793, Japan		Aibiki, M (corresponding author), Kagawa Med Univ Hosp, Intens Care Unit, Kita Ku, 1750-1 Ikenobe, Kagawa 7610793, Japan.			Ogura, Shinji/0000-0001-7686-6001			Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; AIBIKI M, 1994, AM J PHYSIOL, V266, pR790, DOI 10.1152/ajpregu.1994.266.3.R790; AIBIKI M, 1988, HIGH ALTITUDE MED SC, P126; BARAKA A, 1994, BRIT J ANAESTH, V73, P418, DOI 10.1093/bja/73.3.418; BIGELOW WG, 1950, AM J PHYSIOL, V160, P125, DOI 10.1152/ajplegacy.1949.160.1.125; BLACK PR, 1976, J SURG RES, V20, P49, DOI 10.1016/0022-4804(76)90083-4; Broman M, 1998, ACTA PHYSIOL SCAND, V163, P241, DOI 10.1046/j.1365-201x.1998.00356.x; CARRUBA MO, 1987, EUR J PHARMACOL, V134, P15, DOI 10.1016/0014-2999(87)90126-9; CHEN RYZ, 1978, AM J PHYSIOL, V235, pH136, DOI 10.1152/ajpheart.1978.235.2.H136; CHEN RYZ, 1977, AM J PHYSIOL, V233, P605; CHERNOW B, 1983, CRIT CARE MED, V11, P677, DOI 10.1097/00003246-198309000-00001; CHURCHILLDAVIDS.HC, 1953, LANCET, V14, P1011; COOKSON BA, 1955, AM J PHYSIOL, V182, P447, DOI 10.1152/ajplegacy.1955.182.3.447; CORK RC, 1983, ANESTH ANALG, V62, P211; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; ESLER M, 1984, AM J PHYSIOL, V247, pE21, DOI 10.1152/ajpendo.1984.247.1.E21; FRANK SM, 1995, ANESTHESIOLOGY, V82, P83, DOI 10.1097/00000542-199501000-00012; GALLEGO R, 1979, J NEUROPHYSIOL, V42, P665, DOI 10.1152/jn.1979.42.3.665; GREEN JF, 1979, CIRC RES, V44, P411, DOI 10.1161/01.RES.44.3.411; Hayano J, 1997, AM HEART J, V134, P411, DOI 10.1016/S0002-8703(97)70075-9; HOELDTKE RD, 1983, J LAB CLIN MED, V101, P772; KAUL SU, 1973, BRIT J ANAESTH, V45, P433, DOI 10.1093/bja/45.5.433; KIMURA T, 1994, ANESTHESIOLOGY, V80, P694, DOI 10.1097/00000542-199403000-00032; KOYAMA S, 1992, AM J PHYSIOL, V262, pR579, DOI 10.1152/ajpregu.1992.262.4.R579; Liu JL, 1996, AM J PHYSIOL-REG I, V270, pR1361, DOI 10.1152/ajpregu.1996.270.6.R1361; Ma D, 1998, BRIT J ANAESTH, V80, P68, DOI 10.1093/bja/80.1.68; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATSUKAWA K, 1993, AM J PHYSIOL, V265, P792; MAYFIELD SR, 1989, J DEV PHYSIOL, V11, P331; NOSE H, 1982, JPN J PHYSIOL, V32, P831; REVES JG, 1982, CIRCULATION, V66, P49, DOI 10.1161/01.CIR.66.1.49; RITTENHOUSE EA, 1974, ANN THORAC SURG, V17, P63, DOI 10.1016/S0003-4975(10)65062-X; SCHNEIDER FH, 1966, AM J PHYSIOL, V211, P890, DOI 10.1152/ajplegacy.1966.211.4.890; Seki K, 1997, J AUTONOM NERV SYST, V64, P49, DOI 10.1016/S0165-1838(97)00016-7; Spyer KM, 1988, AUTONOMIC FAILURE TX, P56; Tokunaga S, 1996, CARDIOVASC RES, V31, P769, DOI 10.1016/S0008-6363(96)00021-1; WONG KC, 1983, WESTERN J MED, V138, P227; WOOD M, 1980, CAN ANAESTH SOC J, V27, P125, DOI 10.1007/BF03007773; Xu H, 1998, J AUTONOM NERV SYST, V71, P48, DOI 10.1016/S0165-1838(98)00061-7; Zheng F, 1996, EXP PHYSIOL, V81, P409, DOI 10.1113/expphysiol.1996.sp003945	40	16	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	DEC	2000	28	12					3854	3860		10.1097/00003246-200012000-00019			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	388NB	WOS:000166186200013	11153626				2022-02-06	
J	Shum, D; Short, L; Tunstall, J; O'Gorman, JG; Wallace, G; Shephard, K; Murray, R				Shum, D; Short, L; Tunstall, J; O'Gorman, JG; Wallace, G; Shephard, K; Murray, R			Performance of children with traumatic brain injury on a 4-disk version of the Tower of London and the Porteus Maze	BRAIN AND COGNITION			English	Article								The aim of this study was to assess planning ability in children with traumatic brain injury (TBI) using a 4-disk Tower of London (TOL) and the Porteas Maze. Participants were 10, 6-10 years old, and 12, 11-16 years old, children with moderate to severe TBI and 15, 6-10 years old and 15, 11-16 years old controls. On both tests, children in the older age group performed significantly better than children in the younger age group. On the TOL, children with TBI performed significantly more poorly than the controls on the 5 complex problems but not on the 5 simple problems. There was no effect for TBI on Porteus Maze performance. Results confirm the adverse impact of TBI on planning ability in children but point to subtleties in assessing it, (C) 2000 Academic Press.	Griffith Univ, Neuropsychol Unit, Brisbane, Qld 4111, Australia; Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; Univ Queensland, Mater Childrens Hosp, Brisbane, Qld 4101, Australia; Royal Childrens Hosp, Brisbane, Qld, Australia		Shum, D (corresponding author), Griffith Univ, Neuropsychol Unit, Brisbane, Qld 4111, Australia.		Wallace, Geoff/H-1252-2013; Shum, David/A-3914-2008	Wallace, Geoff/0000-0001-9306-3542; Shum, David/0000-0002-4810-9262			Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Porteus S.D., 1965, PORTEUS MAZE TEST 50; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082	5	16	16	0	5	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					59	62					4	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300015					2022-02-06	
J	Squier, M; Chamberlain, P; Zaiwalla, Z; Anslow, P; Oxbury, J; Gould, S; McShane, MA				Squier, M; Chamberlain, P; Zaiwalla, Z; Anslow, P; Oxbury, J; Gould, S; McShane, MA			Five cases of brain injury following amniocentesis in mid-term pregnancy	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							MIDTRIMESTER AMNIOCENTESIS; TRIMESTER AMNIOCENTESIS; NEURONAL MIGRATION; CYST	This paper describes the neuroimaging and neuropathological findings in five cases of severe brain damage after traumatic mid-trimester amniocentesis, all performed between 1986 and 1994. Although fetal injury after amniocentesis has been reported, reports of brain injury are infrequent. Continuous ultrasound monitoring may reduce the risk of fetal injury but follow-up ultrasound scans can be falsely reassuring. Withdrawal of blood-stained fluid, particularly if it contains tissue fragments, should alert the operator to the possibility of fetal damage. Histological examination of such tissue fragments may confirm the nature of the fetal damage. The consequences of fetal brain injury are severe, all five of our cases showed evidence of disruption of brain development compatible with mid-term injury. Obstetricians and their patients should be aware of the small but significant risk of brain damage after mid-term amniocentesis.	Radcliffe Infirm, Dept Neuropathol, Oxford OX2 6HE, England; John Radcliffe Hosp, Womens Ctr, Dept Obstet, Oxford, England; John Radcliffe Hosp, Dept Neuroradiol, Oxford OX3 9DU, England; John Radcliffe Hosp, Dept Neurol, Oxford OX3 9DU, England; John Radcliffe Hosp, Dept Pathol, Oxford OX3 9DU, England; John Radcliffe Hosp, Dept Pediat, Oxford OX3 9DU, England		Squier, M (corresponding author), Radcliffe Infirm, Dept Neuropathol, Oxford OX2 6HE, England.	waney.squier@clneuro.ox.ac.uk					ACHIRON R, 1986, ACTA OBSTET GYN SCAN, V65, P869, DOI 10.3109/00016348609157041; ANANDAKUMAR C, 1992, AUST NZ J OBSTET GYN, V32, P97, DOI 10.1111/j.1479-828X.1992.tb01916.x; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P822; BARTH PG, 1987, CAN J NEUROL SCI, V14, P1; BENZIE RJ, 1994, PRENATAL DIAG, V14, P235, DOI 10.1002/pd.1970140402; Bruce S, 1984, Pediatr Dermatol, V2, P140, DOI 10.1111/j.1525-1470.1984.tb00459.x; CHONG SKF, 1989, PRENATAL DIAG, V9, P677, DOI 10.1002/pd.1970090912; COOK LN, 1974, PEDIATRICS, V53, P421; CREASMAN WT, 1968, J AMER MED ASSOC, V204, P949; ELLER KM, 1995, OBSTET GYNECOL, V85, P865, DOI 10.1016/0029-7844(94)00315-5; EVRARD P, 1992, HDB NEUROPSYCHOLOGY, V6; EZRA DB, 1989, OPHTHALMOLOGICA, V198, P140; FINEGAN JAK, 1985, BRIT J OBSTET GYNAEC, V92, P1015, DOI 10.1111/j.1471-0528.1985.tb02996.x; FRIEDE RL, 1989, DEV NEUROPATHOLOGY, P372; GOTTDIENER JS, 1975, NEW ENGL J MED, V293, P1302, DOI 10.1056/NEJM197512182932508; HERSHEY DW, 1993, OPHTHALMOLOGY, V100, P1601; HYMAN CJ, 1973, OBSTET GYNECOL, V41, P43; KARP LE, 1977, OBSTET GYNECOL, V49, P115; KUBAN KCK, 1985, ANN NEUROL, V17, P539, DOI 10.1002/ana.410170603; LEAKE RD, 1974, OBSTET GYNECOL, V43, P884; MUROFUSHI K, 1974, ACTA NEUROPATHOL, V27, P317, DOI 10.1007/BF00690696; NAYLOR G, 1990, Eye (London), V4, P845; PATEL CK, 1993, BRIT J OPHTHALMOL, V77, P530, DOI 10.1136/bjo.77.8.530; PORTMAN MA, 1982, AM J OBSTET GYNECOL, V144, P731, DOI 10.1016/0002-9378(82)90447-1; RAIMER SS, 1984, ARCH DERMATOL, V120, P1360, DOI 10.1001/archderm.120.10.1360; ROESSMANN U, 1986, ACTA NEUROPATHOL, V70, P302, DOI 10.1007/BF00686088; RON M, 1982, ACTA OBSTET GYN SCAN, V61, P43, DOI 10.3109/00016348209156950; RUMMELT V, 1993, OPHTHALMOLOGY, V100, P776; SCHINZEL A, 1981, ARCH DIS CHILD, V56, P405, DOI 10.1136/adc.56.5.405-a; Shafrir Y, 1996, ANN NEUROL, V40, P42; SHERWOOD A, 1978, NEUROPATH APPL NEURO, V4, P245, DOI 10.1111/j.1365-2990.1978.tb00543.x; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; VERJAAL M, 1981, PRENATAL DIAG, V1, P173, DOI 10.1002/pd.1970010303; Whittle MJ, 1998, LANCET, V351, P226, DOI 10.1016/S0140-6736(98)22004-6; WILLIAMSON RA, 1985, OBSTET GYNECOL, V65, P751; Wilson RD, 1998, LANCET, V351, P242; YOUROUKOS S, 1980, ARCH DIS CHILD, V55, P814, DOI 10.1136/adc.55.10.814	37	16	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	AUG	2000	42	8					554	560		10.1017/S0012162200001043			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	346CF	WOS:000088852400009	10981934				2022-02-06	
J	Zhang, L; Dhillon, HS; Barron, S; Hicks, RR; Prasad, RM; Seroogy, KB				Zhang, L; Dhillon, HS; Barron, S; Hicks, RR; Prasad, RM; Seroogy, KB			Effects of chronic ethanol administration on expression of BDNF and trkB mRNAs in rat hippocampus after experimental brain injury	MOLECULAR BRAIN RESEARCH			English	Article						traumatic brain injury; fluid percussion; chronic ethanol; neurotrophin; neurotrophin receptor; in situ hybridization; neuronal plasticity	NEUROTROPHIC FACTOR; MESSENGER-RNA; UP-REGULATION; AMINO-ACIDS; NEURONS; CONSUMPTION; RECEPTOR; TRAUMA; GENE; PROTEIN	Previous evidence indicates that both chronic alcohol treatment and traumatic brain injury modulate expression of certain neurotrophins and neurotrophin receptors in cortical tissue. However, the combined effects of chronic alcohol and brain trauma on expression of neurotrophins and their receptors have not been investigated. In the present study, we examined the effects of 6 weeks of chronic ethanol administration on lateral fluid percussion (FP) brain injury-induced alterations in expression of mRNAs for the neurotrophin brain-derived neurotrophic factor (BDNF) and its high affinity receptor, trkB, in rat hippocampus. In both the control- (pair-fed isocaloric sucrose) diet and the chronic ethanol-diet groups, unilateral FP brain injury induced a bilateral increase in levels of both BDNF and trkB mRNAs in the dentate gyrus granule cell layer, and of BDNF mRNA in hippocampal region CA3. However, no significant differences in expression were found between the control-diet and ethanol-diet groups, in either the sham-injured or FP-injured animals. These findings suggest that 6 weeks of chronic ethanol administration does not alter the plasticity of hippocampal BDNF/trkB expression in response to experimental brain injury. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA; Univ Kentucky, Dept Clin Sci, Lexington, KY 40536 USA		Seroogy, KB (corresponding author), Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA.	kseroog@pop.uky.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035164, R01NS034264] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34264, NS35164] Funding Source: Medline		Baek JK, 1996, MOL BRAIN RES, V40, P161; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; BOMBARDIER CH, 1995, WESTERN J MED, V162, P150; BRENNAN CH, 1989, NEUROPHARMACOLOGY, V28, P1303, DOI 10.1016/0028-3908(89)90003-8; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CREWS FT, 1993, NIAAA RES MONOGRAPH, V22, P355; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HAYES RL, 1995, NEUROSCI LETT, V191, P121, DOI 10.1016/0304-3940(95)11561-X; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; IORIO KR, 1992, MOL PHARMACOL, V41, P1142; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kokaia Z, 1996, MOL BRAIN RES, V38, P139, DOI 10.1016/0169-328X(96)00002-2; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Luo J, 1998, BRAIN RES REV, V27, P157, DOI 10.1016/S0165-0173(98)00009-5; MACLENNAN AJ, 1995, NEUROSCI LETT, V197, P105; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCMULLEN PA, 1984, J COMP NEUROL, V225, P111, DOI 10.1002/cne.902250112; MICHAELIS EK, 1978, BIOCHEM PHARMACOL, V27, P1685, DOI 10.1016/0006-2952(78)90179-X; Mitchell JJ, 1998, DEV BRAIN RES, V105, P241, DOI 10.1016/S0165-3806(97)00182-X; MOCHETTI I, 1995, J NEUROTRAUM, V12, P853; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Numan S, 1999, J COMP NEUROL, V403, P295, DOI 10.1002/(SICI)1096-9861(19990118)403:3<295::AID-CNE2>3.0.CO;2-L; PADMAPERUMA B, 1995, NEUROSCI RES COMMUN, V16, P121; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PRASAD MR, 1994, J NEUROCHEM, V63, P773; Prasad RM, 1997, J NEUROTRAUM, V14, P919, DOI 10.1089/neu.1997.14.919; Seabold GK, 1998, DEV BRAIN RES, V108, P139, DOI 10.1016/S0165-3806(98)00043-1; Seroogy K., 1997, NEUROCHEMISTRY PRACT, P121; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Tate PS, 1999, BRAIN INJURY, V13, P767; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Walker D. W., 1993, NIAAA MONOGRAPH, P231; WALKER DW, 1978, NEUROPSYCHOLOGIA, V16, P545, DOI 10.1016/0028-3932(78)90082-9; WALKER DW, 1992, NEUROSCI LETT, V147, P77, DOI 10.1016/0304-3940(92)90778-6; WALKER DW, 1980, SCIENCE, V209, P711, DOI 10.1126/science.7394532; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243	48	16	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	JUN 23	2000	79	1-2					174	179		10.1016/S0169-328X(00)00124-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	344ZM	WOS:000088791000019	10925157				2022-02-06	
J	Avellino, AM; Loeser, JD				Avellino, AM; Loeser, JD			Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology	NEUROMODULATION			English	Article						baclofen; cerebral palsy; multiple sclerosis; programmable intrathecal pump; spasticity; spinal cord injury; traumatic brain injury	CEREBRAL-PALSY; PROGRAMMABLE PUMP; INFUSION; ORIGIN; INJURY; DELIVERY; THERAPY	Objective, To determine the long-term relief of spasticity and complication rates in patients who underwent placement of a programmable intrathecal baclofen pump for treatment of medically intractable spasticity of spine or brain etiology. Methods, Sixty-two consecutive adult patients who underwent placement of a programmable pump were retrospectively reviewed. Results, Spasticity was clinically and statistically significantly decreased in all patients. Catheter-related kinks, breaks, dislodgments, and disconnections were the most common complications followed by drug-related effects, infections, and wound complications. Conclusions. Intrathecal baclofen is a very effective strategy for the relief of medically intractable spasticity of spine or brain etiology, Even though 36% of patients have required revisions, no patient has experienced any long-term morbidity. Patients and their primary care givers have been pleased with the long-term effects of this therapy upon qualify of life.	Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA		Loeser, JD (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Box 356470,1959 NE Pacific St, Seattle, WA 98195 USA.						ABEL NA, 1994, ARCH PHYS MED REHAB, V75, P54; AKMAN MN, 1993, PARAPLEGIA, V31, P516, DOI 10.1038/sc.1993.84; Albright AL, 1998, J NEUROSURG, V88, P73, DOI 10.3171/jns.1998.88.1.0073; ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; Albright AL, 1996, J CHILD NEUROL, V11, pS29, DOI 10.1177/0883073896011001S05; Albright AL, 1996, J CHILD NEUROL, V11, P77, DOI 10.1177/088307389601100202; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Kroin JS, 1992, PARENTERAL DRUG THER, P67; LOUBSER PG, 1991, PARAPLEGIA, V29, P48, DOI 10.1038/sc.1991.7; Mertens P, 1995, ADV STER F, V11, P17; MEYTHALER JM, 1992, AM J PHYS MED REHAB, V71, P321, DOI 10.1097/00002060-199212000-00003; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Middel B, 1997, J NEUROL NEUROSUR PS, V63, P204, DOI 10.1136/jnnp.63.2.204; MULLERSCHWEFE G, 1989, J NEUROSURG, V71, P273, DOI 10.3171/jns.1989.71.2.0273; NANCE P, 1995, CAN J NEUROL SCI, V22, P22, DOI 10.1017/S0317167100040452; OCHS G, 1989, J NEUROL NEUROSUR PS, V52, P933, DOI 10.1136/jnnp.52.8.933; Ordia JI, 1996, J NEUROSURG, V85, P452, DOI 10.3171/jns.1996.85.3.0452; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; PENN RD, 1995, J NEUROSURG, V83, P215, DOI 10.3171/jns.1995.83.2.0215; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Saltuari L, 1992, Acta Neurol (Napoli), V14, P195; SEITZ RJ, 1995, J NEUROL, V242, P618, DOI 10.1007/BF00866910; Stayer C, 1997, NEUROLOGY, V49, P1591, DOI 10.1212/WNL.49.6.1591	26	16	16	0	1	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	1094-7159			NEUROMODULATION	Neuromodulation	APR	2000	3	2					75	81		10.1046/j.1525-1403.2000.00075.x			7	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	319HD	WOS:000087334700003	22151402				2022-02-06	
J	Ludwig, HC; Klingler, M; Timmermann, A; Weyland, W; Mursch, K; Reparon, C; Markakis, E				Ludwig, HC; Klingler, M; Timmermann, A; Weyland, W; Mursch, K; Reparon, C; Markakis, E			The influence of airway pressure changes on intracranial pressure (ICP) and the blood flow velocity in the middle cerebral artery (V-MCA)	ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE			English	Article						traumatic brain injury; intracranial pressure monitoring; ventilation; compliance	SEVERE HEAD-INJURY; PERFUSION-PRESSURE; RESISTANCE; MANAGEMENT; BIPAP	Objective: Due to the exponential shape of the intracranial volume-pressure relation, simple measurement of epidural, parenchymal or intraventricular intracranial pressure (ICP) in traumatic brain injury (TBI) often fails to early recognize patients with a fulminant development of intracranial hypertension even during recently available methods of tissue PO2 and microdialysis measurements. One approach to this problem could be repetitive intracranial volume provocations to evaluate a trend of the intracranial elastance. Several previously published methods use invasive volume challenge through access to the cerebrospinal fluid (CSF). This pilot study describes changes in intracranial pressure due to variations of airway pressure with BIPAP ventilation maneuvers. Patients and methods: Ten patients with severe TBI were enrolled and completed the study. The inclusion was based on radiologic signs due to TBI in the first CT-scan and the clinical indication for insertion of an ICP monitoring device. Patients with elevated ICP above 20 mm Hg were excluded. The epidural ICP response together with haemodynamic parameters in relation to defined airway pressure changes (Delta P-AW) was detected. The influence of the duration of Delta P-AW was evaluated additionally. Data of central venous pressure (CVP), ICP, mean arterial pressure (MAP), cerebral perfusion pressure (CPP), airway pressure (P-AW) and blood flow velocity of the middle cerebral artery (V-MCA) were analyzed on the basis of differences between the maximum (inspiration) and minimum P-AW values (expiration). Results: Elevations of P-AW in the range of 20 to 35 cm H2O resulted in changes of the ICPmean from 4.1 to 6.0 mm Hg (r = 0.9, p < 0.05). A correlation was estimated for the changes of systolic arterial pressure (P-art) and CPPmean due to P-AW variations which ranged between 4.5 and 11.6 mm Hg (r = 0.99, p < 0.05). Concerning the transcranial doppler measurements the data of changes of the blood flow velocity of the middle cerebral artery (V-MCA) revealed a positive correlation to P-AW with a r = 0.99, p < 0.05. Conclusions: Elevation of the venous outflow resistance and a transient increase in cardiac output have to be considered as mechanisms for transduction of transthoracic pressure changes to intracranial pressure variations. We conclude, that trends of changes in elastance can be derived from intermittent airway pressure variations. This can be useful in easy and on line dynamic monitoring of ICP in traumatic brain injury.	Univ Gottingen, Dept Neurosurg, D-37075 Gottingen, Germany; Univ Gottingen, Dept Anaesthesiol Ernergency & Intens Care Med, D-37075 Gottingen, Germany		Ludwig, HC (corresponding author), Univ Gottingen, Dept Neurosurg, Robert Koch Str 40, D-37075 Gottingen, Germany.						BAUM M, 1989, ANAESTHESIST, V38, P452; BRINKER T, 1984, ANASTH INTENSIVMED, V1, P19; Chesnut R M, 1995, New Horiz, V3, P581; CUYPERS J, 1976, J NEUROSURG, V45, P89, DOI 10.3171/jns.1976.45.1.0089; HORMANN C, 1994, EUR J ANAESTH, V11, P37; LAKIN W D, 1992, Neurological Research, V14, P219; Lang E W, 1995, New Horiz, V3, P400; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Marmarou A, 1992, J NEURORAUMA, V9, P327; MURR R, 1995, NEUROL RES, V17, P329, DOI 10.1080/01616412.1995.11740338; MURSCH K, 1995, ACTA NEUROCHIR, V137, P19, DOI 10.1007/BF02188774; NARAYAN RK, 1995, J NEUROTRAUM, V12, P907, DOI 10.1089/neu.1995.12.907; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; Pollard C, 1995, Aust Fam Physician, V24, P2230; Raabe A, 1999, ACTA NEUROCHIR, V141, P31, DOI 10.1007/s007010050263; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHEDL R, 1985, ANAESTHESIST, V34, P578; STOCHAJ U, 1993, EUR J CELL BIOL, V59, P1	19	16	17	0	3	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0939-2661			ANASTH INTENSIV NOTF	Anasthesiol. Intensivmed. NotfMed. Schmerzther.	MAR	2000	35	3					141	145		10.1055/s-2000-13008			5	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	296JT	WOS:000086021800004	10768051				2022-02-06	
J	York, J; Arrillaga, A; Graham, R; Miller, R				York, J; Arrillaga, A; Graham, R; Miller, R			Fluid resuscitation of patients with multiple injuries and severe closed head injury: Experience with an aggressive fluid resuscitation strategy	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	59th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 16-18, 1999	BOSTON, MASSACHUSETTS	Amer Assoc Surgery Trauma			PERFUSION	Background: Despite increasing experimental and clinical evidence to the contrary, a dichotomy of management strategies of the patient with multiple injuries still exists, based on the presence or absence of traumatic brain injury. Many still advocate fluid restriction or small volume resuscitation if traumatic brain injury is present. Purpose: To demonstrate results of aggressive fluid resuscitation in a prospective case series of patients with multiple injuries and with severe head injury. Methods: Thirty-four patients with Glasgow Coma Scale score less than or equal to 8 and Injury Severity Score greater than or equal to 16 were enrolled into the study over a period of 18 months. Fluid resuscitation was guided in part by cerebral perfusion pressures (mean cerebral perfusion pressures > 80) as well as by hemodynamic monitoring and evidence of end organ perfusion. Overall fluid intake, intensive care unit fluid balance, presence or absence of hypoxia, hypotension, or both, were analyzed. Ninety- and 180-day Glasgow Outcome Scale and Disability Rating Scale scores were also obtained. Results: By using an aggressive fluid resuscitation strategy, secondary insults were avoided in 74% of the patients. A good functional outcome,vas achieved in 74% and mortality was impressively low at 6%. Conclusion: Fluid restriction is not necessary to achieve good results in the severely injured patient who also has a severe head injury.	Greenville Hosp Syst, Dept Trauma Surg, Div Med Educ & Res, Greenville, SC 29605 USA		York, J (corresponding author), Greenville Hosp Syst, Dept Trauma Surg, Div Med Educ & Res, Greenville, SC 29605 USA.						BORDER JR, 1995, J TRAUMA, V39, P12, DOI 10.1097/00005373-199507000-00002; Bullock MR, 1996, J NEUROTRAUM, V13, P643; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Kirton OC, 1999, NEW HORIZ-SCI PRACT, V7, P87; MeierHellmann A, 1997, CRIT CARE MED, V25, P399, DOI 10.1097/00003246-199703000-00005; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SHIRES GT, 1994, PRINCIPLES SURG, P119	8	16	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2000	48	3					376	379		10.1097/00005373-200003000-00002			4	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	295QT	WOS:000085979900003	10744272				2022-02-06	
J	Allgulander, C; Nilsson, B				Allgulander, C; Nilsson, B			Victims of criminal homicide in Sweden: A matched case-control study of health and social risk factors among all 1,739 cases during 1978-1994	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							UNITED-STATES; VIOLENT DEATH; BRAIN INJURY; ALCOHOL; WOMEN; HOME	Objective: The psychiatric and medical characteristics of victims of homicide have not been systematically studied and are often confounded by race. This study was undertaken to determine health and social factors contributing to the risk of being murdered in the Swedish, predominantly Caucasian population. Method: All 1,739 homicides between 1978 and 1994 in Sweden were studied in terms of variables in national case registers regarding health, crimes, immigration, and marital status. The same data were extracted for matched comparison persons in the general population, with controls for time of exposure. The data were analyzed by conditional logistic regression on matched pairs. Results: Traumatic brain injury, physical abuse, alcohol dependence, and criminal recidivism conferred risk of being murdered. Conclusions: To the authors' knowledge, this is the first report of traumatic brain injury, in both men and women, as a risk factor for being murdered. Brain injury may mark risk-taking behavior in general or may cause provocative behavior.	Karolinska Inst, Radiumhemmet, Div Psychiat, Stockholm, Sweden; Karolinska Inst, Radiumhemmet, Div Canc Epidemiol, Stockholm, Sweden		Allgulander, C (corresponding author), Huddinge Hosp, M57, S-14186 Huddinge, Sweden.		McCarthy, Jodie/B-5760-2012				Bailey JE, 1997, ARCH INTERN MED, V157, P777, DOI 10.1001/archinte.157.7.777; BRESLOW NE, 1980, INT AGENCY RES CANC, V32; CENTERWALL BS, 1984, AM J PUBLIC HEALTH, V74, P813, DOI 10.2105/AJPH.74.8.813; Daly M., 1988, HOMICIDE; Decker S. H., 1993, JUSTICE Q, V10, P585, DOI DOI 10.1080/07418829300092031; GOODMAN RA, 1986, AM J PUBLIC HEALTH, V76, P144, DOI 10.2105/AJPH.76.2.144; GUDJONSSON GH, 1990, ACTA PSYCHIAT SCAND, V82, P49; Hwang SW, 1997, ANN INTERN MED, V126, P625, DOI 10.7326/0003-4819-126-8-199704150-00007; Ikeda RM, 1997, AM J PREV MED, V13, P396, DOI 10.1016/S0749-3797(18)30161-2; KELLERMANN AL, 1992, J TRAUMA, V33, P1, DOI 10.1097/00005373-199207000-00001; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; LINDQVIST P, 1991, BRIT J ADDICT, V86, P321; LINDQVIST P, 1995, NORD J PSYCHIAT, V49, P17, DOI 10.3109/08039489509011879; Norstrom T, 1998, ADDICTION, V93, P689, DOI 10.1046/j.1360-0443.1998.9356895.x; PONZER S, 1996, PUBLIC HLTH, V110, P42; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rivara FP, 1997, JAMA-J AM MED ASSOC, V278, P569, DOI 10.1001/jama.278.7.569; SAVITZ LD, 1991, DEVIANT BEHAV, V12, P19, DOI 10.1080/01639625.1991.9967865; Sosin DM, 1996, BRAIN INJURY, V10, P47; TARDIFF K, 1995, J FORENSIC SCI, V40, P387; Tiihonen J, 1997, AM J PSYCHIAT, V154, P1711, DOI 10.1176/ajp.154.12.1711; Volavka J., 1995, NEUROBIOLOGY VIOLENC; Wikstrom P.O.H., 1991, J CRIME JUSTICE, V14, P71, DOI [https://doi.org/10.1080/0735648X.1991.9721439, DOI 10.1080/0735648X.1991.9721439]; WOLFGANG ME, 1957, J CRIM LAW CRIM, V48, P1, DOI 10.2307/1140160; 1997, YB NORD STAT 1996	25	16	16	0	3	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	FEB	2000	157	2					244	247		10.1176/appi.ajp.157.2.244			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	281PC	WOS:000085169000015	10671394				2022-02-06	
J	McAdoo, DJ; Robak, G; Xu, GY; Hughes, MG				McAdoo, DJ; Robak, G; Xu, GY; Hughes, MG			Adenosine release upon spinal cord injury	BRAIN RESEARCH			English	Article						adenosine; excitatory amino acid; microdialysis; spinal cord injury; theophylline	AMINO-ACID RELEASE; RAT CEREBRAL-CORTEX; TRAUMATIC BRAIN INJURY; GLUTAMATE RELEASE; SUPERIOR COLLICULUS; SECONDARY DAMAGE; POTENTIAL ROLE; MICRODIALYSIS; HIPPOCAMPUS; ISCHEMIA	The hypothesis that release of adenosine following spinal cord injury (SCI) may provide neuroprotective feedback is explored. Consistent with this hypothesis, substantial release of adenosine, estimated to reach 100 mu M in the extracellular space, was detected by microdialysis sampling immediately following contusion SCI. There is also considerable release of excitatory amino acids following SCI. The latter was not affected by administration of the general adenosine receptor antagonist theophylline and the A, antagonist 8-cyclopentyl-1,3-dipropylxanthine, implying that the adenosine released following SCI does not significantly influence the release of neurotoxic amino acids. Administration of the concentration of glutamate released upon SCI into the spinal cord caused only about 1% as much release of adenosine as did injury, evidence that elevated excitatory amino acids do not elicit an appreciable fraction of the release of adenosine that follows SCI. Results obtained suggest that release of endogenous adenosine is not neuroprotective by blocking release of excitatory amino acids following SCI. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77555 USA		McAdoo, DJ (corresponding author), Univ Texas, Med Branch, Inst Marine Biomed, 301 Univ Blvd, Galveston, TX 77555 USA.	djmcadoo@utmb.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [11255] Funding Source: Medline		Akpek EA, 1999, SPINE, V24, P128, DOI 10.1097/00007632-199901150-00006; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CLARK GD, 1989, CLIN PERINATOL, V16, P459, DOI 10.1016/S0095-5108(18)30641-9; DEMONTIGNY P, 1987, ANAL CHEM, V59, P1096, DOI 10.1021/ac00135a007; Dora CD, 1998, J NEUROTRAUM, V15, P473, DOI 10.1089/neu.1998.15.473; DUX E, 1990, BRAIN RES, V516, P248, DOI 10.1016/0006-8993(90)90925-2; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FERN R, 1994, J NEUROPHYSIOL, V72, P2609, DOI 10.1152/jn.1994.72.6.2609; FREDHOLM BB, 1988, TRENDS PHARMACOL SCI, V9, P130, DOI 10.1016/0165-6147(88)90194-0; GERBER U, 1989, J PHYSIOL-LONDON, V417, P567, DOI 10.1113/jphysiol.1989.sp017819; GLOBUS MYT, 1991, NEUROSCI LETT, V127, P39, DOI 10.1016/0304-3940(91)90889-2; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; HEROLD JA, 1994, J THORAC CARDIOV SUR, V107, P536, DOI 10.1016/S0022-5223(12)70100-9; HERON A, 1993, BRAIN RES, V608, P27, DOI 10.1016/0006-8993(93)90769-J; HIRAI H, 1995, J NEUROPHYSIOL, V74, P950, DOI 10.1152/jn.1995.74.3.950; HIRAI H, 1994, EUR J PHARMACOL, V256, P65, DOI 10.1016/0014-2999(94)90617-3; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; KAUPPINEN RA, 1988, NEUROSCIENCE, V27, P175, DOI 10.1016/0306-4522(88)90228-X; Kochanek PM, 1997, ACT NEUR S, V70, P109; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu D X, 1800, Adv Exp Med Biol, V380, P405; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1993, J NEUROTRAUM, V10, P349, DOI 10.1089/neu.1993.10.349; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MATUSZEWSKI BK, 1987, ANAL CHEM, V59, P1102, DOI 10.1021/ac00135a008; MILLER LP, 1992, J NEUROTRAUM, V9, pS563; MORRISON PF, 1991, J NEUROCHEM, V57, P103, DOI 10.1111/j.1471-4159.1991.tb02105.x; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OKADA Y, 1980, EUR J PHARMACOL, V68, P483; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1016/0893-133X(95)00079-S; OREGAN MH, 1992, NEUROSCI LETT, V138, P169, DOI 10.1016/0304-3940(92)90498-V; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PHILLIS JW, 1991, J NEUROCHEM, V56, P644, DOI 10.1111/j.1471-4159.1991.tb08198.x; RUDOLPHI KA, 1992, CEREBROVAS BRAIN MET, V4, P346; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; SORKIN LS, 1988, J NEUROSCI METH, V23, P131, DOI 10.1016/0165-0270(88)90185-9; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; WOJCIK WJ, 1982, J NEUROCHEM, V39, P280, DOI 10.1111/j.1471-4159.1982.tb04736.x; Xu GY, 1998, NEUROSCIENCE, V86, P1011, DOI 10.1016/S0306-4522(98)00063-3	47	16	16	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 31	2000	854	1-2					152	157		10.1016/S0006-8993(99)02333-1			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	280UN	WOS:000085122300018	10784116				2022-02-06	
J	Eder, HG; Legat, JA; Gruber, W				Eder, HG; Legat, JA; Gruber, W			Traumatic brain stem lesions in children	CHILDS NERVOUS SYSTEM			English	Article						children; Glasgow Coma Scale; Glasgow Outcome Scale; prognosis; traumatic brain stem lesions	SEVERE HEAD-INJURY; DIFFUSE AXONAL INJURY; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; MR; FEATURES; PRESSURE; AGE; CT	Glasgow Coma Scale (GCS) scores on admission may be predictors of outcome in patients with brain injuries. This study correlated the outcomes of children with traumatic brain stem lesions with their initial GCS scores and morphological patterns of injury as shown on computed tomography (CT) or magnetic resonance (MR) imaging. During the last 16 years, we have treated 1,108 children with brain injuries. The entire series included only 21 (1.9%) children who had clinical signs of brain stem lesions with morphological correlates on CT or MR imaging. Clinical findings were assessed according to the GCS and compared with scores on the Glasgow Outcome Scale (GOS). Of these 21 children, 16 (76%) had morphological lesions seen on CT scans. In 5 (24%) of the children only the MR images revealed brain stem lesions and their CT scans were negative. Generalized severe brain swelling was present in 6 cases (28%). There was a significant difference in GOS scores between patients with initial GCS scores of 3 and 4 and those with GCS scores between 5 and 7 (P<0.02). Children with intracranial pressure higher than 40 mmHg had poorer outcomes than patients whose intracranial pressure was lower, but the differences were not significant. Outcome did not correlate significantly with morphological patterns of injury or the presence of extracranial injuries. The GCS is a reliable indicator of severity of injury and of outcome in children with brain stem injuries. MR imaging was more sensitive than CT in detecting brain stem lesions.	Karl Franzens Univ Graz, Dept Pediat, A-8036 Graz, Austria; Sch Med, A-8036 Graz, Austria		Eder, HG (corresponding author), Karl Franzens Univ Graz, Dept Neurosurg, Auenbruggerpl 29, A-8036 Graz, Austria.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; FACCO E, 1986, CHILD NERV SYST, V2, P67; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GOSCINSKI I, 1995, ACTA NEUROCHIR, V134, P16, DOI 10.1007/BF01428496; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Holbourn AHS, 1943, LANCET, V2, P438; HUMPHREYS RP, 1998, CONCEPTS PEDIAT NEUR, P230; JENNETT B, 1975, LANCET, V1, P480; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; ROUSSEAUX M, 1989, REV NEUROL, V145, P384; Shigemori M, 1992, Acta Neurochir Suppl (Wien), V55, P37	31	16	16	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JAN	2000	16	1					21	24		10.1007/s003810050005			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	275VH	WOS:000084840500005	10672425				2022-02-06	
J	Kelly, JP				Kelly, JP			Concussion in sports and recreation	SEMINARS IN NEUROLOGY			English	Article						brain concussion; sports injury; traumatic brain injury; sports concussion guidelines	TRAUMATIC BRAIN INJURY; CEREBRAL CONCUSSION; HEAD-INJURIES; NEUROPSYCHOLOGICAL ASSESSMENT; CONTACT-SPORTS; GUIDELINES; MANAGEMENT	More than 800 sports-related concussions occur in the United Stares each day, sometimes involving high-profile athletes whose injuries reach public awareness through sports broadcasts and news media. Although nonphysicians are often present and relied upon for the detection of concussion in the sports setting, the proper diagnosis and management of this neurological problem require a physician's thoughtful attention to the athlete's signs and symptoms, This article offers a diagnostic protocol and treatment recommendations as well as a useful grading scale and management strategy for return to competition.	Chicago Neurol Inst, Dept Neurol, Chicago, IL 60611 USA		Kelly, JP (corresponding author), Chicago Neurol Inst, Dept Neurol, 233 E Erie St,Suite 704, Chicago, IL 60611 USA.						American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BAILES JE, 1999, SPORTS RELATED CONCU; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cooper PR, 1993, HEAD INJURY; Farber M, 1994, SPORTS ILLUSTRATED, p[38, 39, 46]; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; HOVDA DA, 1994, SOC NEUROSCI, V20, P85; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly J, 1997, JAMA-J AM MED ASSOC, V277, P1190; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, pV, DOI 10.1097/00001199-199804000-00001; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Narayan RK, 1996, NEUROTRAUMA; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PLUM F, 1986, DIAGNOSIS STUPOR COM, P349; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; STONE JL, 1993, HEAD INJURY ITS COMP; TORG JS, 1995, CURRENT THERAPY SPOR; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	35	16	16	1	10	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.		2000	20	2					165	171		10.1055/s-2000-9835			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339NU	WOS:000088484300003	10946735				2022-02-06	
J	Reynolds, HN; Cottingham, C; McCunn, M; Habashi, NM; Scalea, TM				Reynolds, HN; Cottingham, C; McCunn, M; Habashi, NM; Scalea, TM			Extracorporeal lung support in a patient with traumatic brain injury: the benefit of heparin-bonded circuitry	PERFUSION-UK			English	Article							ACUTE RESPIRATORY-FAILURE; CLINICAL-TRIAL; CO2 REMOVAL; VENTILATION		Univ Maryland Med, R Adams Cowley Shock Trauma Ctr, Div Crit Care Med, Baltimore, MD 21201 USA; Univ Maryland Med, R Adams Cowley Shock Trauma Ctr, Div Trauma Surg, Baltimore, MD 21201 USA		Reynolds, HN (corresponding author), Univ Maryland Med, R Adams Cowley Shock Trauma Ctr, Div Crit Care Med, 22 S Greene St, Baltimore, MD 21201 USA.						BINDSLEV L, 1987, ANESTHESIOLOGY, V67, P117, DOI 10.1097/00000542-198707000-00024; BINDSLEV L, 1991, ACTA ANAESTH SCAND, V35, P125, DOI 10.1111/j.1399-6576.1991.tb03409.x; GATTINONI L, 1986, JAMA-J AM MED ASSOC, V256, P881, DOI 10.1001/jama.256.7.881; KNOCH M, 1992, INT J ARTIF ORGANS, V15, P103, DOI 10.1177/039139889201500208; LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Mottaghy K, 1989, ASAIO Trans, V35, P146, DOI 10.1097/00002480-198904000-00006; OREILLY RA, 1985, PHARMACOL BASIS THER, V58, P1338; SELL LL, 1986, J PEDIATR SURG, V21, P1087, DOI 10.1016/0022-3468(86)90015-1; Toomasian J M, 1988, ASAIO Trans, V34, P410; WILLMS D, 1992, CHEST, V102, P968, DOI 10.1378/chest.102.3.968	11	16	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0267-6591	1477-111X		PERFUSION-UK	Perfusion-UK	NOV	1999	14	6					489	493		10.1177/026765919901400612			5	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	299ED	WOS:000086182000011	10585157				2022-02-06	
J	Miller, LJ; Mittenberg, W; Carey, VM; McMorrow, MA; Kushner, TE; Weinstein, JM				Miller, LJ; Mittenberg, W; Carey, VM; McMorrow, MA; Kushner, TE; Weinstein, JM			Astereopsis caused by traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							BINOCULAR DEPTH PERCEPTION; STEREOSCOPIC VISION; CHIASMAL SYNDROME; HEAD-INJURY; STEREOPSIS; PERFORMANCE; DRIVERS	Impaired depth perception (astereopsis) has been observed in a variety of cerebral pathologies affecting the posterior parietal lobe. In the current study of 93 consecutive head trauma admissions, 24% had complete astereopsis and 41% performed more than 2 SDs below the orthopedic control group mean. Degree of impairment was related to Glascow Coma Scale score, length of posttraumatic amnesia, reduced visuospatial and memory abilities, and th-e presence of intracranial pathology of the parietal lobes. Impairment was also related to trauma severity in patients without any visualized intracranial pathology, presumably due to diffuse axonal sheaving. Clinically meaningful impairment was observed in 24% of this group; 10% had complete astereopsis. Stereoacuity screening requires I to 2 minutes. Undetected astereopsis may increase risk for subsequent motor vehicle accidents or falls. (C) 1999 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Arizona, Coll Med, Hlth Sci Ctr, Dept Psychiat, Tucson, AZ 85724 USA; Nova SE Univ, Ft Lauderdale, FL 33314 USA; Miami Inst Psychol, Miami, FL USA		Miller, LJ (corresponding author), Univ Arizona, Coll Med, Hlth Sci Ctr, Dept Psychiat, POB 245002, Tucson, AZ 85724 USA.						AMIGO G, 1973, BRIT J OPHTHALMOL, V57, P125, DOI 10.1136/bjo.57.2.125; ATKINSON J, 1976, PERCEPTION, V5, P29, DOI 10.1068/p050029; BENTON AL, 1970, NEUROLOGY, V20, P1084, DOI 10.1212/WNL.20.11.1084; BLAKEMORE C, 1970, VISION RES, V10, P43, DOI 10.1016/0042-6989(70)90060-X; BOWER TGR, 1971, SCI AM, V225, P30, DOI 10.1038/scientificamerican1071-30; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; COOPER J, 1979, J AM OPTOM ASSOC, V50, P41; COOPER J, 1979, J AM OPTOM ASSOC, V50, P821; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Falk N S, 1992, J Am Optom Assoc, V63, P547; FOX R, 1980, SCIENCE, V207, P323, DOI 10.1126/science.7350666; HAMSHER KDS, 1978, INVEST OPHTH VIS SCI, V17, P336; Harrison RJ., 1987, BINO VIS, V2, P93; HEINZ GW, 1994, AM J OPHTHALMOL, V117, P90, DOI 10.1016/S0002-9394(14)73020-X; Howard I.P., 1995, BINOCULAR VISION STE; HUMPHRISS D, 1987, OPHTHAL PHYSL OPT, V7, P73; JULESZ B, 1986, VISION RES, V26, P1601, DOI 10.1016/0042-6989(86)90178-1; JULESZ B, 1987, FDN CYCLOPEAN PERCEP; KEANE JR, 1993, NEUROLOGY, V43, P2439, DOI 10.1212/WNL.43.12.2439; LEHMANN D, 1975, J NEUROL, V209, P157, DOI 10.1007/BF00312538; LEPORT FE, 1995, ARCH NEUROL-CHICAGO, V52, P925; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MCKNIGHT AJ, 1991, ACCIDENT ANAL PREV, V23, P225, DOI 10.1016/0001-4575(91)90002-M; MITCHELL DE, 1970, VISION RES, V10, P49, DOI 10.1016/0042-6989(70)90061-1; MITTENBERG W, 1994, ARCH CLIN NEUROPSYCH, V9, P71, DOI 10.1016/0887-6177(94)90015-9; MUNCKFAIRWOOD RC, 1992, PERCEPTION, V21, P747, DOI 10.1068/p210747; PADULA WV, 1988, N ENGL J OPTOM   DEC, P16; POGGIO GF, 1984, ANNU REV NEUROSCI, V7, P379, DOI 10.1146/annurev.ne.07.030184.002115; PTITO A, 1991, BRAIN, V114, P1323, DOI 10.1093/brain/114.3.1323; PTITO M, 1991, NEUROPSYCHOLOGIA, V29, P443, DOI 10.1016/0028-3932(91)90004-R; RICHARDSON ED, 1994, CLIN NEUROPSYCHOL, V8, P416, DOI 10.1080/13854049408402044; Riddoch M., 1989, NEUROPSYCHOLOGY VISU, V1, P79; ROMANO P, 1976, ORTHOPTICS, P11; ROSS JE, 1983, BEHAV BRAIN RES, V7, P99, DOI 10.1016/0166-4328(83)90007-4; RUSSELL WR, 1960, INJURIES BRAIN SPINA, P118; Sattler J. M., 1988, ASSESSMENT CHILDREN; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; SPIERER A, 1995, AM J OPHTHALMOL, V120, P258, DOI 10.1016/S0002-9394(14)72622-4; *STER OPT CO INC, STER REIND SO 004; Wechsler, 1997, WECHSLER ADULT INTEL; Wheatstone C, 1838, PHILOS T ROY SOC LON, V128, P371, DOI DOI 10.1098/RSTL.1838.0019; YEKTA AA, 1989, OPHTHAL PHYSL OPT, V9, P115, DOI 10.1111/j.1475-1313.1989.tb00829.x	45	16	16	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	1999	14	6					537	543					7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	218YJ	WOS:000081580400007	14590581				2022-02-06	
J	Warschausky, S; Kewman, D; Kay, J				Warschausky, S; Kewman, D; Kay, J			Empirically supported psychological and behavioral therapies in pediatric rehabilitation of TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavioral disorder; brain injury; children; psychology; treatment outcome	TRAUMATIC BRAIN INJURY; OBSESSIVE-COMPULSIVE DISORDER; SOCIAL-ADJUSTMENT; HEAD-INJURY; CHILDREN; ADOLESCENTS; COMPETENCE; INTERVENTIONS; STUDENTS; SETTINGS	This article examines the empirical support for psychological therapies for children with traumatic brain injury (TBI). Empirical support for psychological treatments of noninjured children provides a foundation upon and a framework in which to discuss applications to children with neurobehavioral dysfunction. Behavioral interventions to address externalizing behaviors have received the greatest focus, whereas there is a paucity of work that pertains to internalizing features and prosocial behavior such as assertiveness. Although the systematic study of psychological intervention lags far behind the rapidly increasing knowledge of neurobehavioral sequelae to TBI, there are promising directions that stem from initial findings.	Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Warschausky, S (corresponding author), Univ Michigan Hosp, Dept Phys Med & Rehabil, Box 0050, Ann Arbor, MI 49109 USA.	sethaw@umich.edu					AENCIUS A, 1989, BRAIN INJURY, V3, P67; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Borkovec TD, 1998, J CONSULT CLIN PSYCH, V66, P136, DOI 10.1037/0022-006X.66.1.136; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; BRACK UB, 1973, ACTA PAEDOPSYCHIATR, V40, P68; Chambless DL, 1998, J CONSULT CLIN PSYCH, V66, P7, DOI 10.1037/0022-006X.66.1.7; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; COOLEY EA, 1997, STUDENTS ACQUIRED BR; CRASILNE.HB, 1970, INT J CLIN EXP HYP, V18, P145, DOI 10.1080/00207147008415914; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; DEATON AV, 1987, J LEARN DISABIL, V20, P581, DOI 10.1177/002221948702001003; Deaton AV, 1996, REHABIL PSYCHOL, V41, P33, DOI 10.1037/0090-5550.41.1.33; DODGE KA, 1986, MONOGR SOC RES CHILD, V2, P51; DONDERS J, 1993, DEATH STUD, V17, P517, DOI 10.1080/07481189308252636; Ducharme JM, 1996, BEHAV THER, V27, P353, DOI 10.1016/S0005-7894(96)80022-0; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; HORTON AM, 1994, BEHAV INTERVENTIONS; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kazdin AE, 1998, J CONSULT CLIN PSYCH, V66, P19, DOI 10.1037/0022-006X.66.1.19; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kendall PC, 1998, J CONSULT CLIN PSYCH, V66, P3, DOI 10.1037/0022-006X.66.1.3; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; PACE GM, 1994, J APPL BEHAV ANAL, V27, P301, DOI 10.1901/jaba.1994.27-301; PAPWORTH MA, 1989, J BEHAV THER EXP PSY, V20, P265, DOI 10.1016/0005-7916(89)90033-5; PETTIT GS, 1988, CHILD DEV, V59, P107, DOI 10.2307/1130393; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SILVER BV, 1992, DEV MED CHILD NEUROL, V34, P539; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Slifer KJ, 1996, J HEAD TRAUMA REHAB, V11, P39, DOI 10.1097/00001199-199602000-00006; SLIFER KJ, 1995, BRAIN INJURY, V9, P585, DOI 10.3109/02699059509008217; SooMeng K, 1997, INT J CLIN PRACT, V51, P336; SOWERS JA, 1996, ROAD AUTONOMY PROMOT; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; WALLANDER JL, 1987, CLIN PSYCHOL REV, V7, P205, DOI 10.1016/0272-7358(87)90034-1; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Zimmerman MA, 1998, REHABIL PSYCHOL, V43, P3, DOI 10.1037/0090-5550.43.1.3	50	16	16	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1999	14	4					373	383		10.1097/00001199-199908000-00006			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	224LW	WOS:000081901400007	10407210				2022-02-06	
J	Kosmidis, MH; Breier, A; Fantie, BD				Kosmidis, MH; Breier, A; Fantie, BD			Avoidance learning in schizophrenia: a dissociation between the effects of aversive and non-aversive stimuli	SCHIZOPHRENIA RESEARCH			English	Article						learning; operant conditioning; schizophrenia	CLOSED-HEAD-INJURY; ANTICIPATORY BEHAVIOR DEFICITS; ONSET SCHIZOPHRENIA; PREFRONTAL CORTEX; PERFORMANCE; DYSFUNCTION; DEMENTIA; TESTS; AGE	Patients with schizophrenia did not take significantly more trials than normal controls to learn to use a visual warning signal to avoid a non-aversive stimulus on a simple computer-administered avoidance learning task. When the stimulus to be avoided was aversive (i.e. a loud buzzer), however, the schizophrenic group could be divided into two subgroups based upon their performance; almost one half of the schizophrenic group failed to learn how to avoid this task successfully. The other half, like the normal controls and the closed head injury group in our previous studies, benefited from the aversiveness of the stimulus to be avoided, and learned to avoid more quickly than in the non-aversive condition. A post-hoc analysis of the differences between these two subgroups of the patients suggested that the discrepancy in learning was related to the age of onset of illness. (C) 1999 Elsevier Science B.V. All rights reserved.	American Univ, Dept Psychol, Human Neuropsychol Lab, Washington, DC 20016 USA; NIMH, Expt Therapeut Branch, Bethesda, MD 20892 USA		Fantie, BD (corresponding author), American Univ, Dept Psychol, Human Neuropsychol Lab, 4400 Massachusetts Ave NW, Washington, DC 20016 USA.		Kosmidis, Mary H/AAN-2104-2021	Fantie, Bryan D./0000-0002-1901-378X; Kosmidis, Mary/0000-0001-8790-1220			BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benson D.F., 1986, FRONTAL LOBES; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; Bleuler E., 1950, DEMENTIA PRAECOX GRO; Charbonneau D, 1996, CAN J NEUROL SCI, V23, P271, DOI 10.1017/S031716710003821X; CROW TJ, 1991, PROGR PSYCHIAT, V28, P163; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; DUNCAN CC, 1987, CURRENT TRENDS EVE S, V40, P670; FANTIE BD, 1994, CLIN NEUROPSYCHOL, V8, P379, DOI 10.1080/13854049408402040; FERSTL R, 1994, SCHIZOPHRENIA B, V20, P117; First MB, 1995, STRUCTURED CLIN INTE; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; Frith C.D., 1992, COGN NEUROPSYCHOL; FRITH CD, 1988, BRIT J PSYCHIAT, V153, P437, DOI 10.1192/bjp.153.4.437; GOLDBERG G, 1987, FRONTAL LOBE REVISIT; GOLDBERG TE, 1988, INT J NEUROSCI, V42, P51, DOI 10.3109/00207458808985758; GOLDBERG TE, 1987, ARCH GEN PSYCHIAT, V44, P1008; Goldberg Terry E., 1995, P1245; Hanewinkel R, 1996, J ABNORM PSYCHOL, V105, P459; Hoff AL, 1996, SCHIZOPHR RES, V20, P21, DOI 10.1016/0920-9964(95)00065-8; Jeste DV, 1997, AM J GERIAT PSYCHIAT, V5, P302, DOI 10.1097/00019442-199700540-00005; JOHNSTONE EC, 1989, PSYCHOL MED, V19, P91, DOI 10.1017/S0033291700011053; Kohler C, 1998, BIOL PSYCHIAT, V43, P165, DOI 10.1016/S0006-3223(97)00033-4; KOLB B, 1983, J NERV MENT DIS, V171, P435, DOI 10.1097/00005053-198307000-00008; KOSMIDIS MH, 1995, J CLIN EXP NEUROPSYC, V17, P622, DOI 10.1080/01688639508405150; LINDSTROM E, 1994, ACTA PSYCHIAT SCAND, V89, P274, DOI 10.1111/j.1600-0447.1994.tb01513.x; MAZZIOTTA JC, 1985, NEUROLOGY, V34, P825; McKay A. P., 1995, BROKEN MEMORIES CASE, P124; Paivio A., 1971, IMAGERY VERBAL PROCE; PERLICK D, 1992, SCHIZOPHR RES, V6, P257, DOI 10.1016/0920-9964(92)90009-T; RAPAPORT D, 1945, DIAGNOSTIC PSYCHOL T; ROTHKE S, 1987, INT J CLIN NEUROPSYC, V9, P81; SEIDMAN LJ, 1983, PSYCHOL BULL, V94, P195, DOI 10.1037/0033-2909.94.2.195; SHAKOW D, 1979, ADAPTATION SCHIZOPHR; SHALLICE T, 1991, ARCH GEN PSYCHIAT, V48, P618; SUTTON S, 1961, AM J PSYCHOL, V74, P224, DOI 10.2307/1419407; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Wilder KE, 1998, SCHIZOPHR RES, V30, P169, DOI 10.1016/S0920-9964(97)00135-7; [No title captured]; [No title captured]	41	16	17	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964			SCHIZOPHR RES	Schizophr. Res.	JUL 27	1999	38	1					51	59		10.1016/S0920-9964(98)00181-9			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	216BC	WOS:000081419800006	10427610				2022-02-06	
J	McDonald, RPA; Horsburgh, KJ; Graham, DI; Nicoll, JAR				McDonald, RPA; Horsburgh, KJ; Graham, DI; Nicoll, JAR			Mitochondrial DNA deletions in acute brain injury	NEUROREPORT			English	Article						brain; DNA; free radicals; ischaemia; mitochondria; trauma	OXIDATIVE DAMAGE; HEAD-INJURY; DISEASE	WE hypothesized that generation of free radicals following acute brain injury leads to increased accumulation of mitochondrial DNA deletions. We determined the prevalence of two deletions (mtDNA(Delta 4977bp) and mtDNA(Delta 7436bp)) in brain from 53 patients with a shout survival interval (mean 5 days) following transient global cerebral ischaemia due to cardiorespiratory arrest, 14 patients with long survival (mean 8.75 years) following traumatic brain injury and 43 ace-matched controls. A higher prevalence of mtDNA(Delta 4977bp) was found in aged controls. There was a strong correlation between the presence of the two mtDNA deletions in individual cases (p < 0.05). The deletion prevalence did not differ significantly between short-term survivors of global ischaemia (57% mtDNA(Delta 4977bp), 62% mtDNA(Delta 7436bp)) and controls (54% mtDNA(Delta 4977bp), 56% mtDNA(Delta 7436bp)). Unexpectedly, there was a lower prevalence of deleted mtDNA in long-term survivors of traumatic brain injury (14.3% mtDNA(Delta 7436bp), P < 0.05) raising the possibility that free radical-induced accumulation of mtDNA damage may selectively influence the survival of mitochondria or their host. NeuroReport 10:1875-1878 (C) 1999 Lippincott Williams & Wilkins.	Univ Glasgow, Inst Neurol Sci, So Gen Hosp NHS Trust, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland		Nicoll, JAR (corresponding author), Univ Glasgow, Inst Neurol Sci, So Gen Hosp NHS Trust, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland.		; Nicoll, James/I-9253-2017	Horsburgh, Karen/0000-0002-9620-3691; Nicoll, James/0000-0002-9444-7246			ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BLANKENSHIP KM, 1993, GENDER SOC, V7, P8, DOI 10.1177/089124393007001002; Bozner P, 1997, J NEUROPATH EXP NEUR, V56, P1356, DOI 10.1097/00005072-199712000-00010; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P328; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; KIRSCH JR, 1992, J NEUROTRAUM, V9, pS157; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; MORTIMER JA, 1995, RES ADV ALZHEIMERS D, P1; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; REILLY PM, 1991, AM J SURG, V161, P488, DOI 10.1016/0002-9610(91)91120-8; SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0; WHITE BC, 1992, J NEUROCHEM, V58, P1716, DOI 10.1111/j.1471-4159.1992.tb10045.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514	16	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	JUN 23	1999	10	9					1875	1878		10.1097/00001756-199906230-00014			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212PM	WOS:000081225500017	10501524				2022-02-06	
J	Venkatesh, B; Townsend, S; Boots, RJ				Venkatesh, B; Townsend, S; Boots, RJ			Does splanchnic ischemia occur in isolated neurotrauma? A prospective observational study	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Australian-and-New-Zealand-Intensive-Care-Society	OCT 16-19, 1997	HOBART, AUSTRALIA	Australian & New Zealand Intens Care Soc		head injury; intracranial pressure; cerebral perfusion pressure; gastric tonometry; splanchnic; ischemia; outcome; intensive care unit	GASTRIC INTRAMUCOSAL PH; CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; INTRAMURAL PH; BLOOD LACTATE; SEVERE SEPSIS; SEPTIC SHOCK; NOREPINEPHRINE; HEMODYNAMICS; OXYGENATION	Objective: To characterize the incidence and severity of splanchnic ischemia, as defined by gastric tonometry, in patients with isolated severe head injury and to examine the relationship between cerebral hemodynamics and splanchnic ischemia, Design: Prospective observational study. Setting: Neurosurgical intensive care unit in a tertiary referral center. Patients: Ten patients with severe neurotrauma. Interventions: None. Measurements and Main Results: The mean arterial pressure, intracranial pressure, and gastric mucosal Pco(2) measurements were recorded at 15-min intervals. Intramucosal pH was calculated every 3 hrs. All patients received stress ulcer prophylaxis. Nine patients received noradrenaline infusions to maintain a target cerebral perfusion pressure of 70 mm Hg. The mean baseline gastric mucosal Pco(2) and intramucosal pH were 38 +/- 10 torr and 7.38 +/- 0.1 pH units, respectively. Nine patients manifested low intramucosal pH during the study period. Gastric mucosal Pco(2) values ranged from 36 to 132 torr. Intramucosal pH measurements ranged from 6.9 to 7.47. The mucosal gap ranged from -12 to +93 torr (mean +/- SD, 17 +/- 17 torr). The pH gap ranged from -0.1 to +0.54 pH units (mean +/- SD, 0.14 +/- 0.11 pH units). There was no statistically significant relationship between cerebral hemodynamics, the use of inotropes, and gastric mucosal Pco(2), or intramucosal pH. Conclusions: Splanchnic ischemia (intramucosal pH, <7.3) occurs commonly in isolated neurotrauma, with a statistically nonsignificant trend toward development of mucosal ischemia with decreased cerebral perfusion.	Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia		Venkatesh, B (corresponding author), Univ Queensland, Royal Brisbane Hosp, Herston, Qld, Australia.		Venkatesh, Bala/F-4700-2010; Boots, Robert/K-1159-2013	Boots, Robert/0000-0002-2436-7654; Venkatesh, Bala/0000-0002-3234-5244			BOUZARTH WF, 1968, SURG GYNECOL OBSTETR, V126, P995; CLIFTON CL, 1991, NEUROSURGERY, V8, P10; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Deitch E A, 1996, New Horiz, V4, P289; DOGLIO GR, 1991, CRIT CARE MED, V19, P1037, DOI 10.1097/00003246-199108000-00011; FIDDIAN-GREEN R G, 1984, European Surgical Research, V16, P32; FIDDIANGREEN RG, 1982, J SURG RES, V33, P39, DOI 10.1016/0022-4804(82)90007-5; FRIEDMAN G, 1995, CRIT CARE MED, V23, P1184, DOI 10.1097/00003246-199507000-00006; GYS T, 1988, CRIT CARE MED, V16, P1222, DOI 10.1097/00003246-198812000-00009; HIGGINS D, 1994, INTENS CARE MED, V20, P105, DOI 10.1007/BF01707663; Hill D. B., 1992, Journal of the American College of Nutrition, V11, P630; Joynt GM, 1997, ANAESTHESIA, V52, P726, DOI 10.1111/j.1365-2044.1997.173-az0307.x; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Levy B, 1997, INTENS CARE MED, V23, P282, DOI 10.1007/s001340050329; LUNDGREN O, 1989, SPLANCHNIC ISCHEMIA, P29; MARIK PE, 1994, JAMA-J AM MED ASSOC, V272, P1354, DOI 10.1001/jama.272.17.1354; MARIK PE, 1993, CHEST, V104, P225, DOI 10.1378/chest.104.1.225; Marik PE, 1996, CRIT CARE MED, V24, P1498, DOI 10.1097/00003246-199609000-00011; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MCARTHUR CJ, 1995, INTENS CARE MED, V21, P573, DOI 10.1007/BF01700162; MCCAIN CJ, 1991, J LAB CLIN MED, V118, P225; MYBURGH JA, 1996, YB INTENSIVE CARE EM, P723; MYTHEN MG, 1994, INTENS CARE MED, V20, P99, DOI 10.1007/BF01707662; NIMMO W S, 1976, Clinical Pharmacokinetics, V1, P189, DOI 10.2165/00003088-197601030-00002; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; Ott L, 1994, NUTR CRITICAL CARE, P691; PRIEBE HJ, 1995, ACTA ANAESTH SCAND, V39, P1088, DOI 10.1111/j.1399-6576.1995.tb04236.x; RIDDINGTON D, 1994, CRIT CARE MED, V22, P96, DOI 10.1097/00003246-199401000-00019; Riddington DW, 1996, JAMA-J AM MED ASSOC, V275, P1007, DOI 10.1001/jama.275.13.1007; Roberts P R, 1995, New Horiz, V3, P506; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Schlichtig R, 1996, J CRIT CARE, V11, P51, DOI 10.1016/S0883-9441(96)90020-9; TAKALA J, 1994, CRIT CARE MED, V22, P1877; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; VANDERMEER TJ, 1995, CRIT CARE MED, V23, P1217, DOI 10.1097/00003246-199507000-00011; Venkatesh B, 1998, ANAESTH INTENS CARE, V26, P46, DOI 10.1177/0310057X9802600106	37	16	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JUN	1999	27	6					1175	1180		10.1097/00003246-199906000-00047			6	Critical Care Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	212BW	WOS:000081197300037	10397225				2022-02-06	
J	Shum, D; Jamieson, E; Bahr, M; Wallace, G				Shum, D; Jamieson, E; Bahr, M; Wallace, G			Implicit and explicit memory in children with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; DOUBLE DISSOCIATION; COMPLETION; PICTURES	This study aimed to investigate whether implicit memory is preserved in children with traumatic brain injury (TBI). A fragmented picture-completion procedure (Snodgrass, Smith, Feenan, & Corwin, 1987) was used to compare implicit and explicit memory of 12 children with severe long-term TBI and 12 controls, matched for age and gender. On the implicit memory task, both the TBI and control groups were found to show significant priming. In addition, the extent of priming for the two groups was not found to be different. On the explicit memory task, however, the TBI group was found to perform significantly more poorly than the control group. These results are consistent with those reported in the adult TBI literature and have implications for understanding and rehabilitating memory impairments in children with TBI.	Griffith Univ, Neuropsychol Unit, Brisbane, Qld 4111, Australia; Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; Mater Misericordiae Childrens Hosp, Brisbane, Qld, Australia		Shum, D (corresponding author), Griffith Univ, Sch Appl Psychol, Nathan, Qld 4111, Australia.		Baehr, Mathias/K-2188-2014; Shum, David/A-3914-2008; Wallace, Geoff/H-1252-2013	Shum, David/0000-0002-4810-9262; Wallace, Geoff/0000-0001-9306-3542			BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; GLISKY EL, 1989, HDB NEUROPSYCHOLOGY, V3, P233; GLISKY EL, 1992, J HEAD TRAUMA REHAB, V7, P1; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; KEANE MM, 1995, BRAIN, V118, P1129, DOI 10.1093/brain/118.5.1129; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; PARKIN AJ, 1988, BRIT J PSYCHOL, V79, P361, DOI 10.1111/j.2044-8295.1988.tb02295.x; ROEDIGER HL, 1990, B PSYCHONOMIC SOC, V28, P373; RUSSO R, 1995, J EXP CHILD PSYCHOL, V59, P566, DOI 10.1006/jecp.1995.1026; RYAN TV, 1996, PAEDIAT NEUROPSYCHOL, P117; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SNODGRASS JG, 1987, BEHAV RES METH INSTR, V19, P270, DOI 10.3758/BF03203798; SNODGRASS JG, 1990, J EXP PSYCHOL GEN, V119, P276, DOI 10.1037/0096-3445.119.3.276; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SNODGRASS JG, 1988, PERCEPT MOTOR SKILL, V67, P3, DOI 10.2466/pms.1988.67.1.3; SNODGRASS JG, 1990, IMPLICIT MEMORY THEO, P259; SNOW JH, 1994, PAEDIAT TRAUMATIC BR; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; Wilson B. A., 1992, NEUROPSYCHOLOGY MEMO, P315; [No title captured]	23	16	17	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1999	21	2					149	158		10.1076/jcen.21.2.149.929			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226CL	WOS:000082002700001	10425513				2022-02-06	
J	Asikainen, I; Nybo, T; Muller, K; Sarna, S; Kaste, M				Asikainen, I; Nybo, T; Muller, K; Sarna, S; Kaste, M			Speed performance and long-term functional and vocational outcome in a group of young patients with moderate or severe traumatic brain injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						speed performance; traumatic brain injury; outcome	CLOSED HEAD-INJURY; CHILDREN; RECOVERY; SCALE; REHABILITATION	We studied specific aspects of speed performance in neuropsychological tests and functional and vocational long-term outcome among moderate or severe traumatic brain injury (TBI) patients admitted to a rehabilitation programme. A group of 140 patients with mild, moderate or severe TBI,vas followed up for a minimum of 5 years in a rehabilitation programme. Severity of TBI was estimated using the Glasgow Coma Scale (GCS) scores on emergency hospital admission. The patients, grouped by age at injury into the categories: 7 or younger, 8-16 and 17 years of age or older, were tested five or more gears post-injury with comprehensive neuropsychological tests, including a speed performance test with the Stroop material, the Purdue Pegboard (PB) test and simple visual and auditive reaction times. The outcome variables were functional outcome, as measured by the Glasgow Outcome Scale (GOS) score, and capacity for employment at the end of follow-up, i.e, on average 12 years post-injury The patients,vith mild TBI mere excluded from further analysis of outcome. The study was carried out at the Kauniala outpatient neurological clinic. In the Stroop test, patients with a GOS score of 3 and patients who were incapable of employment were slower (P = 0.0046 and P = 0.0015, respectively) than those with a GOS score of 1 or 2 and those capable of independent or subsidized employment, respectively. The PB test also differentiated significantly between the patients with a GOS score of 3 and those with a GOS score of 1 or 2 at the end of follow-up (P = 0.0413), and predicted incapacity for employment (P = 0.032), those with worse outcome being slower. Simple reaction times did not differ significantly between the GOS scores at the end of follow-up, and neither did they predict capacity or incapacity for employment. Our data suggest that the Stroop and PB tests can help estimate functional outcome, as measured by the GOS, among patients with initially moderate or severe TBI and who were referred to a rehabilitation programme. The same tests could also be useful in predicting long-term vocational outcome. Eur J Neurol 6:179-185 (C) 1999 Lippincott Williams & Wilkins.	Kauniala Hosp, Dept Neurol, Kauniainen 02700, Finland; Finnish Inst Occupat Hlth, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Clin Neurosci, FIN-00014 Helsinki, Finland		Asikainen, I (corresponding author), Kauniala Hosp, Dept Neurol, Kylpylantie 19, Kauniainen 02700, Finland.			Kaste, Markku/0000-0001-6557-6412; Sarna, Seppo/0000-0003-3458-1627			Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; BOWER A J, 1990, British Journal of Neurosurgery, V4, P253, DOI 10.3109/02688699008992734; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Chugani HT, 1996, BRAIN DEV-JPN, V18, P347, DOI 10.1016/0387-7604(96)00032-0; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; COHEN RA, 1993, NEUROPSYCHOLOGY ATTE, P260; COSTEFF H, 1988, BRAIN DEV-JPN, V10, P371, DOI 10.1016/S0387-7604(88)80095-0; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRIEL RL, 1988, PEDIATR NEUROL, V4, P337, DOI 10.1016/0887-8994(88)90079-3; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; LEVIN HS, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P89; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P171; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SILVER SM, 1992, AM PSYCHIAT TXB NEUR, P363; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Tiffin, 1968, PURDUE PEGBOARD EXAM; Van Zomeren A. H., 1981, REACTION TIME ATTENT; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; [No title captured]	29	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1351-5101			EUR J NEUROL	Eur. J. Neurol.	MAR	1999	6	2					179	185		10.1111/j.1468-1331.1999.tb00011.x			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	178LM	WOS:000079267200011	10053230				2022-02-06	
J	Gill, DRJ; Torchia, ME				Gill, DRJ; Torchia, ME			The spiral compression plate for proximal humeral shaft nonunion: A case report and description of a new technique	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						proximal humeral shaft nonunion; narrowed dynamic compression plate	EXPERIENCE; NAILS	We present a case of humeral nonunion managed with a dynamic compression plate (DCP) contoured in a spiral fashion to preserve the deltoid muscle insertion. A forty-one-year-old woman sustained a closed proximal third humeral shaft fracture with an associated supraclavicular brachial plexus injury. She presented five months later with an atrophic nonunion of the proximal humeral shaft, inferior subluxation of the humeral head, and a resolving brachial plexopathy. Autogenous cancellous bone grafting and open reduction and internal fixation with a narrow DCP was performed. The deltoid muscle insertion was preserved by contouring the plate to fix the proximal humerus laterally over the greater tuberosity and anteriorly over the mid-humeral shaft. During the postoperative period, the humeral head reduced spontaneously. Five months after surgery, the fracture healed, and an excellent clinical result was achieved. We recommend the use of the spiral DCP for proximal shaft fractures and nonunions when preservation of the deltoid insertion is desirable.	Mayo Clin & Mayo Fdn, Dept Orthopaed Surg, Rochester, MN 55905 USA		Torchia, ME (corresponding author), Mayo Clin & Mayo Fdn, Dept Orthopaed Surg, 200 1st St SW, Rochester, MN 55905 USA.						BARQUET A, 1989, J TRAUMA, V29, P95, DOI 10.1097/00005373-198901000-00020; BELL MJ, 1985, J BONE JOINT SURG BR, V67, P293, DOI 10.1302/0301-620X.67B2.3980544; BRIEN WW, 1990, J BONE JOINT SURG AM, V72A, P1208, DOI 10.2106/00004623-199072080-00012; COFIELD RH, 1984, J BONE JOINT SURG AM, V66A, P899, DOI 10.2106/00004623-198466060-00010; FOSTER RJ, 1985, J BONE JOINT SURG AM, V67A, P857, DOI 10.2106/00004623-198567060-00005; Gregory, 1997, J Am Acad Orthop Surg, V5, P215; HEALY WL, 1987, CLIN ORTHOP RELAT R, P206; HEIM D, 1993, J TRAUMA, V35, P226, DOI 10.1097/00005373-199308000-00009; Henley M. Bradford, 1993, P91; JUPITER JB, 1990, J BONE JOINT SURG AM, V72A, P701, DOI 10.2106/00004623-199072050-00009; McKee MD, 1996, J ORTHOP TRAUMA, V10, P492, DOI 10.1097/00005131-199610000-00008; NEER CS, 1982, J BONE JOINT SURG AM, V64, P319, DOI 10.2106/00004623-198264030-00001; ROSEN H, 1990, ORTHOP CLIN N AM, V21, P725; Schatzker J, 1996, RATIONALE OPERATIVE; VANDERGRIEND R, 1986, J BONE JOINT SURG AM, V68A, P430, DOI 10.2106/00004623-198668030-00018; WU CC, 1992, CAN J SURG, V35, P661	16	16	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	FEB	1999	13	2					141	144		10.1097/00005131-199902000-00013			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	165LB	WOS:000078521300013	10052791				2022-02-06	
J	Patt, S; Brodhun, M				Patt, S; Brodhun, M			Neuropathological sequelae of traumatic injury in the brain. An overview	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain, injury; head injury; trauma, brain; axonal injury; diffuse; beta amino precursor protein (beta APP); intracranial pressure	DIFFUSE AXONAL INJURY; HEAD-INJURY; CHILDREN	The identification and interpretation of brain damage resulting from head injury is often not easy. The most obvious structural damage, which is identified post-mortem by neuropathologists, may not be the most reliable alteration with regard to clinico-pathological correlations. For example patients with a fracture of the skull, a severe cerebral contusion or a large intracerebral hematoma that is successfully treated can lead to a complete recovery if no other types of brain damage are present. Thus more subtle forms of pathology, which are often present and some of which can only be identified microscopically, may be more important. It is therefore necessary to get deeper insights into the consequences of brain injury. Though of course not exclusively, this aim can be reached by autopsy. Primary traumatic brain lesions result immediately from mechanical injury. Secondary alterations injuries develop through intracranial and extracranial trauma sequelae, which determine the course and outcome of brain damage. Traumatic brain damage can be classified as focal or diffuse. It may sometimes be difficult to distinguish traumatic from ischemic brain injury. One difference, however, is that the initial events of trauma involve mechanical distorsion of the brain. Mechanoporation as traumatic defect in the cell membrane has recently been found to be one of the first steps which leads via ionic influxes to the activation of immediate early genes. Oxygen radicals and cell membrane lipid peroxidation occur also very early. Increased intracellular calcium, activation of phospholipases and calpains furthermore damage the membrane and cytoskeleton and block the axoplasmatic transport, by which delayed cell death can appear. For the description of the extent of traumatically induced brain damage and the possible clinico-pathological correlations it is necessary to take these alterations into consideration as specifically as possible. Neuropathology can contribute to this aim.	Univ Jena, Inst Pathol Neuropathol, D-07740 Jena, Germany		Patt, S (corresponding author), Univ Jena, Inst Pathol Neuropathol, Bachstr 18, D-07740 Jena, Germany.	patt@bach.med.uni-jena.de					ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson RM, 1998, AM J FOREN MED PATH, V19, P1, DOI 10.1097/00000433-199803000-00001; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; ELLISON D, 1998, NEUROPATHOLOGY REFER; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P198; LEESTMA JE, 1997, NEUROPATHOLOGY DIAGN, P500; McIntosh TK, 1996, LAB INVEST, V74, P315; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Pearl GS, 1998, CLIN LAB MED, V18, P39; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	21	16	16	0	6	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					119	123		10.1016/S0940-2993(99)80084-0			5	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	177NZ	WOS:000079218000002	10192579				2022-02-06	
J	Melchers, P; Maluck, A; Suhr, L; Scholten, S; Lehmkuhl, G				Melchers, P; Maluck, A; Suhr, L; Scholten, S; Lehmkuhl, G			An early onset rehabilitation program for children and adolescents after traumatic brain injury (TBI): Methods and first results	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						traumatic brain injury; neurotrauma-children; rehabilitation; neuropsychology; neurotrauma-psychotherapy		Survived traumatic brain injuries (TBI) are one of the most serious challenges to the patient's future life. Recent literature increasingly questions the long believed protective effects of functional cerebral plasticity in children. Although TBI in children and adolescents is frequent, they are less frequently admitted to rehabilitation centers as in-patients than adults. This emphasizes the role of out-patient treatment. The progressing study described here aims to achieve a contribution to a comprehensive approach in TBI-rehabilitation for youngsters. A two-stage multimethodal program, starting with stimulation in coma while the patient is on the intensive care unit, and neuropsychological therapy after regaining consciousness is to be evaluated in a controlled, prospective and randomized study. After including nearly 50 % of the planned sample (100 persons), some preliminary results can be mentioned with all applicable caution The effectiveness of the applied therapy can be stated here with respect to the posttraumatic development of intellectual abilities in the 6- and 12 months follow ups. Moreover, in the control group development of psychopathological alterations was found to a considerable degree and also lower ratings in a quality of life questionnaire, compared to the experimental group. It is expected to prove these differences statistically, after the total sample has been included, and thus equal distributions have been achieved in all predictive variables.	Univ Cologne, Klin & Poliklin Psychiat & Psychotherapie Kindes, D-50931 Cologne, Germany		Melchers, P (corresponding author), Univ Cologne, Klin & Poliklin Psychiat & Psychotherapie Kindes, Robert Koch Str 10, D-50931 Cologne, Germany.						BENZ B, IN PRESS RESTORATIVE; BROWN G, 1981, PSYCHIAT SEQUELAE PS, V2, P63; FLECHTNER H, 1998, QUALITATSSICHERUNG L, P175; FLECHTNER H, 1995, LEBENSQUALITAT ONK 2, V82, P217; LEHMKUHL G, 1986, THESIS U HEIDELBERG; Levin HS., 1982, NEUROBEHAVIORAL CONS; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Temple CM, 1997, J CHILD PSYCHOL PSYC, V38, P27, DOI 10.1111/j.1469-7610.1997.tb01504.x; Ylvisaker M., 1985, HEAD INJURY REHABILI	11	16	18	0	5	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		1999	14	2-3					153	160					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	183XN	WOS:000079579700010					2022-02-06	
J	Schutze, M; Dauch, WA; Guttinger, M; Hampel-Christiansen, M; Firsching, R				Schutze, M; Dauch, WA; Guttinger, M; Hampel-Christiansen, M; Firsching, R			Risk factors for posttraumatic fits and epilepsies	ZENTRALBLATT FUR NEUROCHIRURGIE			German	Article						antiepileptic prophylaxis; intracranial hemorrhage; brain injury	PROPHYLACTICALLY ADMINISTERED PHENYTOIN; POST-TRAUMATIC SEIZURES; PROPHYLAXIS; FAILURE	There is still a considerable controversy about the usefulness of antiepileptic prophylaxis after traumatic brain injury. Overall incidence of posttraumatic fits and epilepsy's is well known, but an individual decision on prophylaxis requires knowledge about the individual risk. We performed a prospective observational study on 612 patients with traumatic brain injury of every degree of severity. Follow-up by phone call included 96.2% of the study population after 6 month and 91.2% after 36 month, respectively. The overall incidence for early fits (within 7 days after trauma), late fits (up to 36 month) and epilepsy (as defined by the International League Against Epilepsy) was 4.2%, 3.7% and 2.5%, respectively. These incidences increased according to the severity of the trauma, but the most powerful single predictor was intracranial hemorrhage. There was no significant difference related to the hemorrhage localisation. Development of epilepsy was much more common after late fits (48%) than after early fits (17%). These features established a hierarchy of risks for the development of epilepsy: no intracranial hemorrhage/no fit : 1% (4/437), intracranial hemorrhage/no fit : 8% (10/122), intracranial hemorrhage/early fit : 16% (3/19), intracranial hemorrhage/late fit : 53% (7/13). f prophylactic antiepileptic treatment is desired, but should be restricted to patients at high risk. These are patients with intracranial hemorrhage - are a well defined high risk group - when their first fit is a late fit.	Univ Magdeburg, Neurochirurg Klin, D-39120 Magdeburg, Germany; Allgemeines Krankenhaus Eilbeck, Zentrum Schwerst Schadel Hirnverletzte Freien & H, Hamburg, Germany								BAUER J, 1992, NERVENHEILKUNDE, V11, P74; Dauch WA, 1996, ZBL NEUROCHIR, V57, P190; Dugan Ellen M., 1994, Emergency Medicine Clinics of North America, V12, P1081; HAINES SJ, 1983, J NEUROSURG, V59, P730; JENNETT B, 1973, SCOT MED J, P8; KELLY DF, 1989, NEUROSURGERY, V25, P976, DOI 10.1227/00006123-198912000-00022; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MURRI L, 1992, ITAL J NEUROL SCI, V13, P755, DOI 10.1007/BF02229161; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	13	16	16	0	2	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		1999	60	4					163	167					5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	273JC	WOS:000084703300001	10674332				2022-02-06	
